0001099800-22-000005.txt : 20220214 0001099800-22-000005.hdr.sgml : 20220214 20220214161549 ACCESSION NUMBER: 0001099800-22-000005 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 161 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220214 DATE AS OF CHANGE: 20220214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Edwards Lifesciences Corp CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 22632170 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP. DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP DATE OF NAME CHANGE: 20000203 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 10-K 1 ew-20211231.htm 10-K ew-20211231
0001099800false2021FYP3Y00010998002021-01-012021-12-3100010998002021-06-30iso4217:USD00010998002022-01-31xbrli:shares00010998002021-12-3100010998002020-12-31iso4217:USDxbrli:shares00010998002020-01-012020-12-3100010998002019-01-012019-12-3100010998002019-12-3100010998002018-12-310001099800us-gaap:CommonStockMember2018-12-310001099800us-gaap:TreasuryStockMember2018-12-310001099800us-gaap:AdditionalPaidInCapitalMember2018-12-310001099800us-gaap:RetainedEarningsMember2018-12-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-310001099800us-gaap:RetainedEarningsMember2019-01-012019-12-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-01-012019-12-310001099800us-gaap:CommonStockMember2019-01-012019-12-310001099800us-gaap:AdditionalPaidInCapitalMember2019-01-012019-12-310001099800us-gaap:TreasuryStockMember2019-01-012019-12-310001099800us-gaap:CommonStockMember2019-12-310001099800us-gaap:TreasuryStockMember2019-12-310001099800us-gaap:AdditionalPaidInCapitalMember2019-12-310001099800us-gaap:RetainedEarningsMember2019-12-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001099800us-gaap:RetainedEarningsMember2020-01-012020-12-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-12-310001099800us-gaap:CommonStockMember2020-01-012020-12-310001099800us-gaap:AdditionalPaidInCapitalMember2020-01-012020-12-310001099800us-gaap:TreasuryStockMember2020-01-012020-12-310001099800us-gaap:CommonStockMember2020-12-310001099800us-gaap:TreasuryStockMember2020-12-310001099800us-gaap:AdditionalPaidInCapitalMember2020-12-310001099800us-gaap:RetainedEarningsMember2020-12-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001099800us-gaap:RetainedEarningsMember2021-01-012021-12-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-12-310001099800us-gaap:CommonStockMember2021-01-012021-12-310001099800us-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-310001099800us-gaap:TreasuryStockMember2021-01-012021-12-310001099800us-gaap:CommonStockMember2021-12-310001099800us-gaap:TreasuryStockMember2021-12-310001099800us-gaap:AdditionalPaidInCapitalMember2021-12-310001099800us-gaap:RetainedEarningsMember2021-12-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-3100010998002020-05-072020-05-07xbrli:pure0001099800srt:MinimumMemberew:HemodynamicMonitorsMember2021-12-310001099800srt:MaximumMemberew:HemodynamicMonitorsMember2021-12-310001099800us-gaap:ShippingAndHandlingMember2021-01-012021-12-310001099800us-gaap:ShippingAndHandlingMember2020-01-012020-12-310001099800us-gaap:ShippingAndHandlingMember2019-01-012019-12-310001099800srt:MinimumMember2021-12-310001099800srt:MinimumMember2021-01-012021-12-310001099800srt:MaximumMember2021-01-012021-12-310001099800srt:MinimumMemberus-gaap:BuildingAndBuildingImprovementsMember2021-01-012021-12-310001099800srt:MaximumMemberus-gaap:BuildingAndBuildingImprovementsMember2021-01-012021-12-310001099800srt:MinimumMemberus-gaap:MachineryAndEquipmentMember2021-01-012021-12-310001099800srt:MaximumMemberus-gaap:MachineryAndEquipmentMember2021-01-012021-12-310001099800srt:MinimumMemberus-gaap:SoftwareAndSoftwareDevelopmentCostsMember2021-01-012021-12-310001099800srt:MaximumMemberus-gaap:SoftwareAndSoftwareDevelopmentCostsMember2021-01-012021-12-310001099800us-gaap:InProcessResearchAndDevelopmentMember2021-01-012021-12-310001099800us-gaap:InProcessResearchAndDevelopmentMember2020-01-012020-12-310001099800us-gaap:InProcessResearchAndDevelopmentMember2019-01-012019-12-310001099800us-gaap:StockCompensationPlanMember2021-01-012021-12-310001099800us-gaap:StockCompensationPlanMember2020-01-012020-12-310001099800us-gaap:StockCompensationPlanMember2019-01-012019-12-310001099800us-gaap:CostOfSalesMember2021-01-012021-12-310001099800us-gaap:CostOfSalesMember2020-01-012020-12-310001099800us-gaap:CostOfSalesMember2019-01-012019-12-310001099800us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-12-310001099800us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-12-310001099800us-gaap:SellingGeneralAndAdministrativeExpensesMember2019-01-012019-12-310001099800us-gaap:ResearchAndDevelopmentExpenseMember2021-01-012021-12-310001099800us-gaap:ResearchAndDevelopmentExpenseMember2020-01-012020-12-310001099800us-gaap:ResearchAndDevelopmentExpenseMember2019-01-012019-12-310001099800us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-12-310001099800ew:AbbottLaboratoriesMember2020-06-012020-06-300001099800ew:AbbottLaboratoriesMembersrt:ScenarioForecastMember2024-05-012024-05-310001099800ew:AbbottLaboratoriesMember2020-07-012020-07-310001099800ew:RestOfWorldSegmentMemberew:ValtechCardioLtdMemberus-gaap:DevelopedTechnologyRightsMember2019-12-012019-12-310001099800ew:EarlystageTranscatheterIntellectualPropertyMember2019-03-310001099800srt:MaximumMember2021-12-310001099800us-gaap:BankTimeDepositsMember2021-12-310001099800us-gaap:BankTimeDepositsMember2020-12-310001099800us-gaap:CommercialPaperMember2021-12-310001099800us-gaap:CommercialPaperMember2020-12-310001099800us-gaap:USTreasuryAndGovernmentMember2021-12-310001099800us-gaap:USTreasuryAndGovernmentMember2020-12-310001099800us-gaap:AssetBackedSecuritiesMember2021-12-310001099800us-gaap:AssetBackedSecuritiesMember2020-12-310001099800us-gaap:CorporateDebtSecuritiesMember2021-12-310001099800us-gaap:CorporateDebtSecuritiesMember2020-12-310001099800us-gaap:MunicipalBondsMember2021-12-310001099800us-gaap:MunicipalBondsMember2020-12-31ew:investment0001099800us-gaap:OtherNonoperatingIncomeExpenseMember2021-12-310001099800ew:KardionIncMember2021-04-300001099800us-gaap:EquitySecuritiesMemberew:KardionIncMember2021-04-300001099800ew:KardionIncMember2021-10-012021-12-310001099800ew:KardionIncMember2021-12-310001099800ew:CASMedicalSystemsInc.Member2019-02-110001099800ew:CASMedicalSystemsInc.Member2019-02-112019-02-110001099800ew:CASMedicalSystemsInc.Member2019-04-182019-04-180001099800ew:HarpoonMedicalInc.Member2017-12-010001099800ew:CardiAQValveTechnologiesInc.Member2015-07-030001099800ew:UnitedStatesSegmentMember2019-12-310001099800ew:EuropeSegmentMember2019-12-310001099800ew:RestOfWorldSegmentMember2019-12-310001099800ew:UnitedStatesSegmentMember2020-01-012020-12-310001099800ew:EuropeSegmentMember2020-01-012020-12-310001099800ew:RestOfWorldSegmentMember2020-01-012020-12-310001099800ew:UnitedStatesSegmentMember2020-12-310001099800ew:EuropeSegmentMember2020-12-310001099800ew:RestOfWorldSegmentMember2020-12-310001099800ew:UnitedStatesSegmentMember2021-01-012021-12-310001099800ew:EuropeSegmentMember2021-01-012021-12-310001099800ew:RestOfWorldSegmentMember2021-01-012021-12-310001099800ew:UnitedStatesSegmentMember2021-12-310001099800ew:EuropeSegmentMember2021-12-310001099800ew:RestOfWorldSegmentMember2021-12-310001099800us-gaap:PatentsMember2021-01-012021-12-310001099800us-gaap:PatentsMember2021-12-310001099800us-gaap:PatentsMember2020-12-310001099800us-gaap:DevelopedTechnologyRightsMember2021-01-012021-12-310001099800us-gaap:DevelopedTechnologyRightsMember2021-12-310001099800us-gaap:DevelopedTechnologyRightsMember2020-12-310001099800us-gaap:OtherIntangibleAssetsMember2021-01-012021-12-310001099800us-gaap:OtherIntangibleAssetsMember2021-12-310001099800us-gaap:OtherIntangibleAssetsMember2020-12-310001099800us-gaap:InProcessResearchAndDevelopmentMember2021-12-310001099800us-gaap:InProcessResearchAndDevelopmentMember2020-12-310001099800ew:FixedRate4.3002018NotesMemberus-gaap:SeniorNotesMember2018-06-300001099800ew:SeniorNotesDue2018Member2018-06-012018-06-300001099800ew:FixedRate4.3002018NotesMemberus-gaap:SeniorNotesMember2021-12-310001099800ew:FixedRate4.3002018NotesMemberus-gaap:SeniorNotesMember2020-12-310001099800us-gaap:SeniorNotesMember2021-12-310001099800us-gaap:SeniorNotesMember2020-12-310001099800us-gaap:FairValueInputsLevel2Memberew:SeniorNotesDue2018Member2021-12-310001099800us-gaap:FairValueInputsLevel2Memberew:SeniorNotesDue2018Member2020-12-310001099800us-gaap:LineOfCreditMemberew:CreditAgreementMaturityJuly2019Member2018-04-012018-04-300001099800us-gaap:LineOfCreditMemberew:CreditAgreementMaturityApril2023Member2018-04-300001099800srt:MaximumMemberus-gaap:LineOfCreditMemberew:CreditAgreementMaturityApril2023Member2018-04-300001099800us-gaap:LineOfCreditMembersrt:MinimumMemberus-gaap:LondonInterbankOfferedRateLIBORMemberew:CreditAgreementMaturityApril2023Member2018-04-012018-04-300001099800srt:MaximumMemberus-gaap:LineOfCreditMemberus-gaap:LondonInterbankOfferedRateLIBORMemberew:CreditAgreementMaturityApril2023Member2018-04-012018-04-300001099800us-gaap:LineOfCreditMembersrt:MinimumMemberew:CreditAgreementMaturityApril2023Member2018-04-012018-04-300001099800srt:MaximumMemberus-gaap:LineOfCreditMemberew:CreditAgreementMaturityApril2023Member2018-04-012018-04-300001099800us-gaap:LineOfCreditMemberus-gaap:LondonInterbankOfferedRateLIBORMemberew:CreditAgreementMaturityApril2023Member2021-01-012021-12-310001099800us-gaap:LineOfCreditMemberew:CreditAgreementMaturityApril2023Member2021-01-012021-12-310001099800us-gaap:LineOfCreditMemberew:CreditAgreementMaturityApril2023Member2021-12-310001099800us-gaap:LineOfCreditMemberew:CreditAgreementMaturityApril2023Member2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Member2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001099800us-gaap:BankTimeDepositsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Member2021-12-310001099800us-gaap:BankTimeDepositsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001099800us-gaap:BankTimeDepositsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001099800us-gaap:BankTimeDepositsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMember2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CorporateDebtSecuritiesMember2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CorporateDebtSecuritiesMember2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CorporateDebtSecuritiesMember2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Member2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AssetBackedSecuritiesMember2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AssetBackedSecuritiesMember2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AssetBackedSecuritiesMember2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:USTreasuryAndGovernmentMember2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:USTreasuryAndGovernmentMember2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:USTreasuryAndGovernmentMember2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:USTreasuryAndGovernmentMember2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Member2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MunicipalBondsMemberus-gaap:FairValueInputsLevel1Member2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MunicipalBondsMember2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MunicipalBondsMember2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MunicipalBondsMember2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Member2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-12-310001099800us-gaap:BankTimeDepositsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Member2020-12-310001099800us-gaap:BankTimeDepositsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-12-310001099800us-gaap:BankTimeDepositsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-12-310001099800us-gaap:BankTimeDepositsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMember2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CorporateDebtSecuritiesMember2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CorporateDebtSecuritiesMember2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CorporateDebtSecuritiesMember2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Member2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AssetBackedSecuritiesMember2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AssetBackedSecuritiesMember2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AssetBackedSecuritiesMember2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:USTreasuryAndGovernmentMember2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:USTreasuryAndGovernmentMember2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:USTreasuryAndGovernmentMember2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:USTreasuryAndGovernmentMember2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MunicipalBondsMemberus-gaap:FairValueInputsLevel1Member2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MunicipalBondsMember2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MunicipalBondsMember2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MunicipalBondsMember2020-12-310001099800ew:ContingentConsiderationLiabilityMember2019-12-310001099800us-gaap:OtherLiabilitiesMember2019-12-310001099800ew:ContingentConsiderationLiabilityMember2020-01-012020-12-310001099800us-gaap:OtherLiabilitiesMember2020-01-012020-12-310001099800ew:ContingentConsiderationLiabilityMember2020-12-310001099800us-gaap:OtherLiabilitiesMember2020-12-310001099800ew:ContingentConsiderationLiabilityMember2021-01-012021-12-310001099800us-gaap:OtherLiabilitiesMember2021-01-012021-12-310001099800ew:ContingentConsiderationLiabilityMember2021-12-310001099800us-gaap:OtherLiabilitiesMember2021-12-310001099800ew:PreviousAcquisitionsMember2021-01-012021-12-310001099800ew:TwoPreviousAcquisitionsMember2020-01-012020-12-310001099800srt:MinimumMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ObligationsMemberus-gaap:MeasurementInputDiscountRateMember2021-12-310001099800srt:MaximumMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ObligationsMemberus-gaap:MeasurementInputDiscountRateMember2021-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:ObligationsMemberus-gaap:MeasurementInputDiscountRateMembersrt:WeightedAverageMember2021-12-310001099800ew:MeasurementInputProbabilityOfMilestoneAchievementMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ObligationsMember2021-12-310001099800srt:MaximumMemberew:MeasurementInputProbabilityOfMilestoneAchievementMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ObligationsMember2021-12-310001099800ew:MeasurementInputProbabilityOfMilestoneAchievementMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ObligationsMembersrt:WeightedAverageMember2021-12-310001099800srt:MaximumMemberus-gaap:FairValueInputsLevel3Memberew:MeasurementInputVolatilityOfFutureRevenueMemberus-gaap:ObligationsMember2021-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMember2021-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMember2020-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMember2021-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMember2020-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2021-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2020-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:OtherNoncurrentAssetsMember2021-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:OtherNoncurrentAssetsMember2020-12-310001099800us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2021-12-310001099800us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2020-12-310001099800us-gaap:ForeignExchangeContractMember2021-12-310001099800us-gaap:CurrencySwapMember2021-12-310001099800us-gaap:ForeignExchangeContractMember2020-12-310001099800us-gaap:CurrencySwapMember2020-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2021-01-012021-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2020-01-012020-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMember2021-01-012021-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMember2020-01-012020-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-12-310001099800us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMember2021-01-012021-12-310001099800us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMember2020-01-012020-12-310001099800us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:InterestIncomeMember2021-01-012021-12-310001099800us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:InterestIncomeMember2020-01-012020-12-310001099800us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMember2021-12-31iso4217:EUR0001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2021-01-012021-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2020-01-012020-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2019-01-012019-12-310001099800us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2021-01-012021-12-310001099800us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2020-01-012020-12-310001099800us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2019-01-012019-12-310001099800us-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMember2021-01-012021-12-310001099800us-gaap:ForeignExchangeContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-12-310001099800us-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2021-01-012021-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMember2021-01-012021-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2021-01-012021-12-310001099800us-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMember2020-01-012020-12-310001099800us-gaap:ForeignExchangeContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-12-310001099800us-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2020-01-012020-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMember2020-01-012020-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2020-01-012020-12-310001099800us-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMember2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMember2021-01-012021-12-310001099800us-gaap:PensionPlansDefinedBenefitMember2020-01-012020-12-310001099800us-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMember2019-01-012019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanEquitySecuritiesMember2021-12-310001099800us-gaap:DefinedBenefitPlanDebtSecurityMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanRealEstateMember2021-12-310001099800us-gaap:OtherInvestmentsMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:FairValueInputsLevel2Memberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:FairValueInputsLevel12And3Memberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:USGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:USGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:USGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:USGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:FairValueInputsLevel12And3Memberus-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanRealEstateMember2021-12-310001099800us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanRealEstateMember2021-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanRealEstateMember2021-12-310001099800us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanRealEstateMember2021-12-310001099800us-gaap:MortgagesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:FairValueInputsLevel2Memberus-gaap:MortgagesMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:MortgagesMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:MortgagesMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800ew:InsuranceContractsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800ew:InsuranceContractsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800ew:InsuranceContractsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800ew:InsuranceContractsMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2021-12-310001099800us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2021-12-310001099800us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:FairValueInputsLevel2Memberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:FairValueInputsLevel12And3Memberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:USGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:USGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:USGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:USGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:FairValueInputsLevel12And3Memberus-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanRealEstateMember2020-12-310001099800us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanRealEstateMember2020-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanRealEstateMember2020-12-310001099800us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanRealEstateMember2020-12-310001099800us-gaap:MortgagesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:FairValueInputsLevel2Memberus-gaap:MortgagesMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:MortgagesMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:MortgagesMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800ew:InsuranceContractsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800ew:InsuranceContractsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800ew:InsuranceContractsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800ew:InsuranceContractsMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2020-12-310001099800us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2020-12-310001099800ew:InsuranceContractsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2019-12-310001099800ew:InsuranceContractsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2020-01-012020-06-300001099800ew:InsuranceContractsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2021-01-012021-12-310001099800country:US2021-01-012021-12-310001099800country:PR2021-01-012021-12-310001099800ew:NonqualifiedDeferredCompensationPlanSelectEmployeeGroupMember2021-12-310001099800ew:NonqualifiedDeferredCompensationPlanSelectEmployeeGroupMember2020-12-310001099800ew:May2019StockRepurchaseProgramMember2019-05-310001099800ew:May2021StockRepurchaseProgramMember2021-05-310001099800ew:InitialDeliveryofSharesSettledMay2019Member2019-05-310001099800ew:InitialDeliveryofSharesSettledMay2019Member2019-05-012019-05-310001099800ew:May2019StockRepurchaseProgramSharesPurchasedAndSoldInMay2019Member2019-05-012019-05-310001099800ew:InitialDeliveryOfSharesSettledJune2019Member2019-05-310001099800ew:InitialDeliveryOfSharesSettledJune2019Member2019-05-012019-05-310001099800ew:May2019StockRepurchaseProgramSharesSoldInJune2019Member2019-06-012019-06-300001099800ew:InitialDeliveryOfSharesSettledFebruary2021Member2021-02-280001099800ew:InitialDeliveryOfSharesSettledFebruary2021Member2021-02-012021-02-280001099800ew:February2021StockRepurchaseProgramSharesSoldInMarch2021Member2021-03-012021-03-3100010998002020-05-292020-05-290001099800ew:EmployeeAndNonemployeeStockOptionsMembersrt:MinimumMemberew:LongTermStockIncentiveCompensationProgramMember2021-01-012021-12-310001099800srt:MaximumMemberew:EmployeeAndNonemployeeStockOptionsMemberew:LongTermStockIncentiveCompensationProgramMember2021-01-012021-12-310001099800ew:EmployeeAndNonemployeeStockOptionsMemberew:LongTermStockIncentiveCompensationProgramMember2021-01-012021-12-310001099800srt:MaximumMemberew:LongTermStockIncentiveCompensationProgramMemberus-gaap:RestrictedStockUnitsRSUMember2021-01-012021-12-310001099800ew:LongTermStockIncentiveCompensationProgramMemberew:MarketBasedRestrictedStockUnitsMember2021-01-012021-12-310001099800ew:LongTermStockIncentiveCompensationProgramMember2021-12-310001099800srt:MaximumMemberew:RestrictedStockAndRestrictedStockUnitAwardsMemberew:LongTermStockIncentiveCompensationProgramMember2021-12-310001099800srt:MaximumMemberew:EmployeeAndNonemployeeStockOptionsMemberew:ShareBasedCompensationArrangementsAwardGrantedAnnuallyToNonemployeeDirectorMemberew:NonemployeeDirectorsStockIncentiveCompensationProgramMember2021-12-310001099800srt:MaximumMemberew:ShareBasedCompensationArrangementsAwardGrantedAnnuallyToNonemployeeDirectorMemberew:NonemployeeDirectorsStockIncentiveCompensationProgramMemberus-gaap:RestrictedStockUnitsRSUMember2021-12-310001099800ew:ShareBasedCompensationArrangementsAwardGrantedAnnuallyToNonemployeeDirectorMemberew:NonemployeeDirectorsStockIncentiveCompensationProgramMember2021-01-012021-12-310001099800ew:EmployeeAndNonemployeeStockOptionsMemberew:ShareBasedCompensationArrangementsAwardsGranted2012AndAfterMemberew:NonemployeeDirectorsStockIncentiveCompensationProgramMember2021-01-012021-12-310001099800ew:NonemployeeDirectorsStockIncentiveCompensationProgramMember2021-12-310001099800us-gaap:EmployeeStockMemberew:EmployeeStockPurchasePlanMember2021-01-012021-12-310001099800us-gaap:EmployeeStockMemberew:EmployeeStockPurchasePlanMember2021-12-310001099800ew:EmployeeAndNonemployeeStockOptionsMember2021-01-012021-12-310001099800ew:EmployeeAndNonemployeeStockOptionsMember2020-01-012020-12-310001099800ew:EmployeeAndNonemployeeStockOptionsMember2019-01-012019-12-310001099800us-gaap:EmployeeStockMember2021-01-012021-12-310001099800us-gaap:EmployeeStockMember2020-01-012020-12-310001099800us-gaap:EmployeeStockMember2019-01-012019-12-310001099800ew:MarketBasedRestrictedStockUnitsMember2021-01-012021-12-310001099800ew:MarketBasedRestrictedStockUnitsMember2020-01-012020-12-310001099800ew:MarketBasedRestrictedStockUnitsMember2019-01-012019-12-310001099800ew:EmployeeAndNonemployeeStockOptionsMember2020-12-310001099800ew:EmployeeAndNonemployeeStockOptionsMember2021-12-310001099800us-gaap:RestrictedStockUnitsRSUMember2020-12-310001099800us-gaap:RestrictedStockUnitsRSUMember2021-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2018-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2018-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2018-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2018-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2019-01-012019-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2019-01-012019-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-01-012019-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-01-012019-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2019-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2019-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-01-012020-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-01-012020-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-01-012020-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-012021-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-01-012021-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2021-01-012021-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2021-01-012021-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2020-01-012020-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2020-01-012020-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2019-01-012019-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2019-01-012019-12-310001099800us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-12-310001099800us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-01-012021-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-01-012020-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-01-012021-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-01-012020-12-310001099800us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-12-310001099800us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-01-012020-12-310001099800country:USew:CarryforwardPeriodEnds20302037Memberus-gaap:DomesticCountryMember2021-12-310001099800country:USew:TaxCarryforwardsNoExpirationMemberus-gaap:DomesticCountryMember2021-12-310001099800us-gaap:StateAndLocalJurisdictionMembercountry:USew:TaxCarryforwardsExpirationPeriodYears20262039Member2021-12-310001099800us-gaap:StateAndLocalJurisdictionMembercountry:USew:TaxCarryforwardsNoExpirationMember2021-12-310001099800us-gaap:NonUsMemberew:TaxCarryforwardsExpirationPeriodYears20202027Memberus-gaap:ForeignCountryMember2021-12-310001099800us-gaap:NonUsMemberus-gaap:ForeignCountryMemberew:TaxCarryforwardsNoExpirationMember2021-12-310001099800country:USew:CapitalLossCarryforwardPeriodEnds2024Memberus-gaap:DomesticCountryMember2021-12-310001099800us-gaap:StateAndLocalJurisdictionMemberus-gaap:ResearchMemberew:TaxCarryforwardsNoExpirationMemberstpr:CA2021-12-310001099800country:USus-gaap:ResearchMemberew:TaxCarryforwardsNoExpirationMemberus-gaap:DomesticCountryMember2021-12-310001099800us-gaap:NonUsMemberew:ForeignTaxCreditMemberus-gaap:ForeignCountryMemberew:TaxCarryforwardsNoExpirationMember2021-12-310001099800ew:PurchaseCreditMemberus-gaap:ForeignCountryMembercountry:PRew:TaxCarryforwardsNoExpirationMember2021-12-310001099800ew:PuertoRicoPurchasesCreditMemberus-gaap:ForeignCountryMembercountry:PRew:TaxCarryforwardsNoExpirationMember2021-12-310001099800us-gaap:ForeignCountryMember2021-01-012021-12-310001099800us-gaap:ForeignCountryMember2020-01-012020-12-310001099800us-gaap:ForeignCountryMember2019-01-012019-12-31ew:lawsuit0001099800us-gaap:OperatingSegmentsMemberew:UnitedStatesSegmentMember2021-01-012021-12-310001099800us-gaap:OperatingSegmentsMemberew:UnitedStatesSegmentMember2020-01-012020-12-310001099800us-gaap:OperatingSegmentsMemberew:UnitedStatesSegmentMember2019-01-012019-12-310001099800ew:EuropeSegmentMemberus-gaap:OperatingSegmentsMember2021-01-012021-12-310001099800ew:EuropeSegmentMemberus-gaap:OperatingSegmentsMember2020-01-012020-12-310001099800ew:EuropeSegmentMemberus-gaap:OperatingSegmentsMember2019-01-012019-12-310001099800us-gaap:OperatingSegmentsMemberew:JapanSegmentMember2021-01-012021-12-310001099800us-gaap:OperatingSegmentsMemberew:JapanSegmentMember2020-01-012020-12-310001099800us-gaap:OperatingSegmentsMemberew:JapanSegmentMember2019-01-012019-12-310001099800us-gaap:OperatingSegmentsMemberew:RestOfWorldSegmentMember2021-01-012021-12-310001099800us-gaap:OperatingSegmentsMemberew:RestOfWorldSegmentMember2020-01-012020-12-310001099800us-gaap:OperatingSegmentsMemberew:RestOfWorldSegmentMember2019-01-012019-12-310001099800us-gaap:OperatingSegmentsMember2021-01-012021-12-310001099800us-gaap:OperatingSegmentsMember2020-01-012020-12-310001099800us-gaap:OperatingSegmentsMember2019-01-012019-12-310001099800us-gaap:MaterialReconcilingItemsMember2021-01-012021-12-310001099800us-gaap:MaterialReconcilingItemsMember2020-01-012020-12-310001099800us-gaap:MaterialReconcilingItemsMember2019-01-012019-12-310001099800us-gaap:CorporateNonSegmentMember2021-01-012021-12-310001099800us-gaap:CorporateNonSegmentMember2020-01-012020-12-310001099800us-gaap:CorporateNonSegmentMember2019-01-012019-12-310001099800country:US2021-01-012021-12-310001099800country:US2020-01-012020-12-310001099800country:US2019-01-012019-12-310001099800srt:EuropeMember2021-01-012021-12-310001099800srt:EuropeMember2020-01-012020-12-310001099800srt:EuropeMember2019-01-012019-12-310001099800country:JP2021-01-012021-12-310001099800country:JP2020-01-012020-12-310001099800country:JP2019-01-012019-12-310001099800ew:RestOfWorldMember2021-01-012021-12-310001099800ew:RestOfWorldMember2020-01-012020-12-310001099800ew:RestOfWorldMember2019-01-012019-12-310001099800ew:TranscatheterAorticValveReplacementMember2021-01-012021-12-310001099800ew:TranscatheterAorticValveReplacementMember2020-01-012020-12-310001099800ew:TranscatheterAorticValveReplacementMember2019-01-012019-12-310001099800ew:TranscatheterMitralAndTricuspidTherapiesMember2021-01-012021-12-310001099800ew:TranscatheterMitralAndTricuspidTherapiesMember2020-01-012020-12-310001099800ew:TranscatheterMitralAndTricuspidTherapiesMember2019-01-012019-12-310001099800ew:SurgicalHeartValveTherapyMember2021-01-012021-12-310001099800ew:SurgicalHeartValveTherapyMember2020-01-012020-12-310001099800ew:SurgicalHeartValveTherapyMember2019-01-012019-12-310001099800ew:CriticalCareMember2021-01-012021-12-310001099800ew:CriticalCareMember2020-01-012020-12-310001099800ew:CriticalCareMember2019-01-012019-12-310001099800country:US2021-12-310001099800country:US2020-12-310001099800country:US2019-12-310001099800srt:EuropeMember2021-12-310001099800srt:EuropeMember2020-12-310001099800srt:EuropeMember2019-12-310001099800country:JP2021-12-310001099800country:JP2020-12-310001099800country:JP2019-12-310001099800ew:RestOfWorldMember2021-12-310001099800ew:RestOfWorldMember2020-12-310001099800ew:RestOfWorldMember2019-12-310001099800us-gaap:AllowanceForCreditLossMember2020-12-310001099800us-gaap:AllowanceForCreditLossMember2021-01-012021-12-310001099800us-gaap:AllowanceForCreditLossMember2021-12-310001099800us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2020-12-310001099800us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2021-01-012021-12-310001099800us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2021-12-310001099800us-gaap:AllowanceForCreditLossMember2019-12-310001099800us-gaap:AllowanceForCreditLossMember2020-01-012020-12-310001099800us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2019-12-310001099800us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2020-01-012020-12-310001099800us-gaap:AllowanceForCreditLossMember2018-12-310001099800us-gaap:AllowanceForCreditLossMember2019-01-012019-12-310001099800us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2018-12-310001099800us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2019-01-012019-12-310001099800ew:January2022StockRepurchaseProgramMemberus-gaap:SubsequentEventMember2022-01-310001099800ew:January2022StockRepurchaseProgramMemberus-gaap:SubsequentEventMember2022-01-012022-01-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
(Mark One)
☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Fiscal Year Ended December 31, 2021
OR
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Transition Period From            to
Commission File Number 1-15525
EDWARDS LIFESCIENCES CORPORATION
(Exact name of registrant as specified in its charter)
Delaware36-4316614
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
One Edwards WayIrvineCalifornia92614
(Address of Principal Executive Offices)(Zip Code)
(949) 250-2500
Registrant's telephone number, including area code
Securities registered pursuant to Section 12(b) of the Act: 
Title of each classTrading Symbols(s)Name of each exchange on which registered:
Common Stock, par value $1.00 per shareEWNew York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined by Rule 405 of the Securities Act.    Yes ☒ No ☐
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act.    Yes ☐ No ☒
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ý No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☒
Accelerated filer
☐
Non-accelerated filer
☐
Smaller reporting company
☐
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report ☒. 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes ☐ No ý
The aggregate market value of the registrant's common stock held by non-affiliates as of June 30, 2021 (the last trading day of the registrant's most recently completed second quarter): $64,028,235,982 based on the closing price of the registrant's common stock on the New York Stock Exchange. This calculation does not reflect a determination that persons are affiliates for any other purpose.
The number of shares outstanding of the registrant's common stock, $1.00 par value, as of January 31, 2022, was 623,207,437.
Documents Incorporated by Reference
Portions of the registrant's proxy statement for the 2022 Annual Meeting of Stockholders (to be filed within 120 days of December 31, 2021) are incorporated by reference into Part III, as indicated herein.

EDWARDS LIFESCIENCES CORPORATION
Form 10-K Annual Report—2021
Table of Contents

  
  
  
  


PART I

NOTE REGARDING FORWARD-LOOKING STATEMENTS
This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. We intend the forward-looking statements contained in this report to be covered by the safe harbor provisions of such Acts. Some statements other than statements of historical fact in this report or referred to or incorporated by reference into this report are "forward-looking statements" for purposes of these sections. These statements include, among other things, the continued impact of COVID-19 on our business, any predictions, opinions, expectations, plans, strategies, objectives and any statements of assumptions underlying any of the foregoing relating to our current and future business and operations, including, but not limited to, financial matters, development activities, clinical trials and regulatory matters, manufacturing and supply operations, and product sales and demand. These statements can sometimes be identified by the use of the forward-looking words such as "may," "believe," "will," "expect," "project," "estimate," "should," "anticipate," "plan," "goal," "continue," "seek," "pro forma," "forecast," "intend," "guidance," "optimistic," "aspire," "confident," other forms of these words or similar words or expressions or the negative thereof. Statements of past performance, efforts, or results about which inferences or assumptions may be made can also be forward-looking statements and are not indicative of future performance or results; these statements can be identified by the use of words such as "preliminary," "initial," diligence," "industry-leading," "compliant," "indications," or "early feedback" or other forms of these words or similar words or expressions or the negative thereof. These forward-looking statements are subject to substantial risks and uncertainties that could cause our results or future business, financial condition, results of operations or performance to differ materially from our historical results or experiences or those expressed or implied in any forward-looking statements contained in this report. These risks and uncertainties include, but are not limited to: uncertainties regarding the severity and duration of the COVID-19 pandemic and its impact on our business and the economy generally, clinical trial or commercial results or new product approvals and therapy adoption; inability or failure to comply with applicable regulations; unpredictability of product launches; competitive dynamics; changes to reimbursement for the company's products; the company’s success in developing new products and avoiding manufacturing and quality issues; the impact of currency exchange rates; the timing or results of research and development and clinical trials; unanticipated actions by the United States Food and Drug Administration and other regulatory agencies; unexpected impacts or expenses resulting from litigation or internal or government investigations; and other risks detailed under "Risk Factors" in Part I, Item 1A below, as such risks and uncertainties may be amended, supplemented or superseded from time to time by our subsequent reports on Forms 10-Q and 8-K we file with the U.S. Securities and Exchange Commission. These forward-looking statements speak only as of the date on which they are made and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of the statement. If we do update or correct one or more of these statements, investors and others should not conclude that we will make additional updates or corrections.

Unless otherwise indicated or otherwise required by the context, the terms "we," "our," "it," "its," "Company," "Edwards," and "Edwards Lifesciences" refer to Edwards Lifesciences Corporation and its subsidiaries.

1
Item 1.    Business
       
Overview

Edwards Lifesciences Corporation is the global leader in patient-focused medical innovations for structural heart disease and critical care monitoring. Driven by a passion to help patients, we partner with the world’s leading clinicians and researchers and invest in research and development to transform care for those impacted by structural heart disease or who require hemodynamic monitoring in the hospital setting. Edwards Lifesciences has been a leader in these areas for over six decades. Since our founder, Lowell Edwards, first dreamed of using engineering to address diseases of the human heart, we have steadily built a company on the premise of imagining, building, and realizing a better future for patients.

A pioneer in the development of heart valve therapies, we are the world's leading manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. Our innovative work in heart valves encompasses both surgical and transcatheter therapies for heart valve replacement and repair. In addition, our robust pipeline of future technologies is focused on the less invasive repair or replacement of the mitral and tricuspid valves of the heart, which are more complex and more challenging to treat than the aortic valve that is currently the focus of many of our commercially approved valve technologies. We are also a global leader in hemodynamic and noninvasive brain and tissue oxygenation monitoring systems used to measure a patient's cardiovascular function in the hospital setting.

Cardiovascular disease is the number-one cause of death in the world and is the top disease in terms of health care spending in nearly every country. Cardiovascular disease is progressive in that it tends to worsen over time and often affects the structure of an individual's heart.

Patients undergoing treatment for cardiovascular disease can be treated with a number of our medical technologies, which are designed to address individual patient needs with respect to disease process, comorbidities, and health status. For example, an individual with a heart valve disorder may have a faulty valve that is affecting the function of his or her heart or blood flow throughout his or her body. A clinician may elect to remove the valve and replace it with one of our bioprosthetic surgical tissue heart valves or surgically re-shape and repair the faulty valve with an Edwards Lifesciences annuloplasty ring. Alternatively, a clinician may implant an Edwards Lifesciences transcatheter valve or repair system via a catheter-based approach that does not require traditional open-heart surgery and can be done while the heart continues to beat. Patients in the hospital setting, including high-risk patients in the operating room or intensive care unit, are candidates for having their cardiac function or fluid levels monitored by our Critical Care products through multiple monitoring options, including noninvasive and minimally- invasive technologies. These technologies enable proactive clinical decisions while also providing the opportunity for improving diagnoses and developing individualized therapeutic management plans for patients.

Corporate Background

Edwards Lifesciences Corporation was incorporated in Delaware on September 10, 1999.

Our principal executive offices are located at One Edwards Way, Irvine, California 92614. The telephone number at that address is (949) 250-2500. We make available, free of charge on our website located at www.edwards.com, our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and any amendments to those reports, as soon as reasonably practicable after filing such reports with the Securities and Exchange Commission ("SEC"). The contents of our website are not incorporated by reference into this report.

Edwards Lifesciences' Product and Technology Offerings

The following discussion summarizes the main areas of products and technologies we offer to treat advanced cardiovascular disease. Our products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. For more information on net sales from these four main areas, see "Net Sales by Product Group" in Part II, Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations."

Transcatheter Aortic Valve Replacement

We are the global leader in transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves. The Edwards SAPIEN family of valves, including Edwards SAPIEN XT, the Edwards SAPIEN 3, and the Edwards SAPIEN 3 Ultra transcatheter heart valves, and their respective delivery systems, are used to treat heart valve disease using catheter-based approaches for patients who have severe symptomatic aortic stenosis and certain
2
patients with congenital heart disease. Delivered while the heart is beating, these valves can enable patients to experience a better quality of life sooner than patients receiving traditional surgical therapies. We began offering our transcatheter aortic heart valves to patients commercially in Europe in 2007, in the United States in 2011, and in Japan in 2013. Supported by extensive customer training and service, and a growing body of compelling clinical evidence, our SAPIEN family of transcatheter aortic heart valves are the most widely prescribed transcatheter heart valves in the world.

Sales of our transcatheter aortic valve replacement products represented 65%, 65%, and 63% of our net sales in 2021, 2020, and 2019, respectively.

Transcatheter Mitral and Tricuspid Therapies

We continue to make significant investments in the development of transcatheter heart valve repair and replacement technologies designed to treat mitral and tricuspid valve diseases. While many of these technologies are in development and clinical phases, the PASCAL and Cardioband transcatheter valve repair systems are commercially available in Europe for mitral and tricuspid valve repair. The PASCAL system provides a differentiated, minimally-invasive therapy to address the needs of patients with mitral or tricuspid regurgitation through leaflet approximation, while the Cardioband system enables clinicians to reduce the valve's annulus to restore a patient’s mitral or tricuspid valve to a more functional state and lower regurgitation. In addition to transcatheter repair, we believe transcatheter replacement is key to unlocking the full mitral and tricuspid opportunity, given the complex and diverse patient population. Our two-platform mitral replacement strategy positions us for leadership in the mid-to-long term. SAPIEN M3 is based on the proven SAPIEN valve, paired with a novel docking system. EVOQUE Eos is our next generation transcatheter replacement system, designed specifically for mitral patients. Both SAPIEN M3 and EVOQUE Eos are implanted with transfemoral delivery systems that are sub 30-French, which has benefits for femoral puncture and septal crossing, contributing to ease of use, and patient safety. For tricuspid valve replacement, our EVOQUE system is also sub 30-French, and available in three valve sizes to enable treatment in a wide range of patient anatomies.

Surgical Structural Heart

We are pioneering more resilient surgical therapies that help patients and can improve the quality of their lives. Our RESILIA tissue, now with five years of published clinical data showing 0% structural valve deterioration through five years1, is helping us redefine tissue durability standards. Our latest innovation, the INSPIRIS RESILIA aortic valve, is built on our PERIMOUNT platform and offers RESILIA tissue and VFit technology. INSPIRIS is the leading aortic surgical valve in the world. Sales of our surgical therapies in the United States also continue to gain traction with KONECT RESILIA, the first pre-assembled, aortic tissue valved conduit, for patients who require replacement of the valve, root, and ascending aorta. In 2021, we also received regulatory approval with reimbursement in Japan for our MITRIS RESILIA valve, a new mitral valve incorporating our newest tissue technology. In addition to our replacement valves, we are the worldwide leader in surgical heart valve repair therapies. Our recently launched HARPOON Beating Heart Mitral Valve Repair System can help transform care for many patients with degenerative mitral regurgitation. We believe the demand for surgical structural heart therapies is growing worldwide and that our innovation strategy will continue to extend our leadership and patient impact.

Sales of our surgical tissue heart valve products represented 15%, 16%, and 17% of our net sales in 2021, 2020, and 2019, respectively.

Critical Care

We are a world leader in advanced hemodynamic monitoring systems used to measure a patient's heart function and fluid status in surgical and intensive care settings. Hemodynamic monitoring plays an important role in enhancing surgical recovery. Edwards’ complete hemodynamic portfolio helps clinicians make proactive clinical decisions that can improve patient outcomes. The portfolio includes the minimally invasive FloTrac and Acumen IQ sensors, the noninvasive ClearSight and Acumen IQ cuffs, and the ForeSight noninvasive tissue oximetry sensor. We also support clinical needs with our well-established Swan-Ganz line of pulmonary artery catheters and arterial pressure monitoring products. Compatible with our portfolio of sensors and catheters, the HemoSphere monitoring platform displays valuable physiological information in an easy to understand and actionable manner. Our first predictive algorithm, Acumen Hypotension Prediction Index software, alerts clinicians in advance of a patient developing dangerously low blood pressure and amplifies the clinical need for our Acumen IQ and HemoSphere monitoring solutions.

1 Bavaria, et al. Five-year Outcomes of the COMMENCE trial investigating Aortic Valve Replacement with a Bioprosthetic Valve with a Novel Tissue. The Society of Thoracic Surgeons 2021 Annual Meeting; Bartus, et al. Final 5-year outcomes following aortic valve replacement with RESILIA tissue bio prosthesis. European Journal of Cardio-Thoracic Surgery, 2020.
3
Sales of our hemodynamic products represented 8%, 9%, and 10% of our net sales in 2021, 2020, and 2019, respectively.

Competition

The medical technology industry is highly competitive. We compete with many companies, including divisions of companies much larger than us and smaller companies that compete in specific product lines or certain geographies. Furthermore, new product development and technological change characterize the areas in which we compete. Our present or future products could be rendered obsolete or uneconomical as a result of technological advances by one or more of our present or future competitors or by other therapies, including drug therapies. We must continue to develop and commercialize new products and technologies to remain competitive in the cardiovascular medical technology industry. We believe that we are competitive primarily because we deliver superior clinical outcomes that are supported by extensive data, and innovative features that enhance patient benefit, product performance, and reliability; these superior clinical outcomes are in part due to the level of customer and clinical support we provide.

The cardiovascular segment of the medical technology industry is dynamic and subject to significant change due to cost-of-care considerations, regulatory reform, industry and customer consolidation, and evolving patient needs. The ability to provide products and technologies that demonstrate value and improve clinical outcomes is becoming increasingly important for medical technology manufacturers.
    
We believe that we are a leading global competitor in each of our product lines. In Transcatheter Aortic Valve Replacement, our primary competitors include Medtronic PLC and Abbott Laboratories ("Abbott"). In Transcatheter Mitral and Tricuspid Therapies, our primary competitor is Abbott, and there are a considerable number of large and small companies with development efforts in these fields. In Surgical Structural Heart, our primary competitors include Medtronic PLC, Abbott, and Artivion, Inc (formerly CryoLife). In Critical Care, we compete primarily with a variety of companies in specific product lines including ICU Medical, Inc., PULSION Medical Systems SE, a subsidiary of Getinge AB, Cheetah Medical, Inc., a subsidiary of Baxter International, and LiDCO Group PLC, a subsidiary of Masimo Corporation.

Sales and Marketing

Our portfolio includes some of the most recognizable cardiovascular device product brands in treating structural heart disease today. We have a number of product lines that require sales and marketing strategies tailored to deliver high-quality, cost-effective products and technologies to customers worldwide. Because of the diverse global needs of the population that we serve, our distribution system consists of several direct sales forces as well as independent distributors. We are not dependent on any single customer and no single customer accounted for 10% or more of our net sales in 2021.

To ensure optimal outcomes for patients, we conduct educational symposia and best practices training for our physician, hospital executive, service line leadership, nursing, and clinical-based customers. We rely extensively on our sales and field clinical specialist personnel who work closely with our customers in hospitals. Field clinical specialists routinely attend procedures where Edwards' products are being used in order to provide guidance on the use of our devices, thereby enabling physicians and staff to reach expert proficiency and deliver positive patient outcomes. Our customers include physicians, nurses, and other clinical personnel, but can also include decision makers such as service line leaders, material managers, biomedical staff, hospital administrators and executives, purchasing managers, and ministries of health. Also, for certain of our product lines and where appropriate, our corporate sales team actively pursues approval of Edwards Lifesciences as a qualified supplier for hospital group purchasing organizations ("GPOs") that negotiate contracts with suppliers of medical products. Additionally, we have contracts with a number of United States and European national and regional buying groups, including healthcare systems and Integrated Delivery Networks. Where we choose to market our products is also influenced by the existence of, or potential for, adequate reimbursement to hospitals and other providers by national healthcare systems.

United States.    In the United States, we sell substantially all of our products through our direct sales forces. In 2021, 57% of our net sales were derived from sales to customers in the United States.

Outside of the United States.    In 2021, 43% of our net sales were derived outside of the United States through our direct sales forces and independent distributors. Of the total sales outside of the United States, 53% were in Europe, 23% were in Japan, and 24% were in Rest of World. We sell our products in approximately 100 countries, and our major international markets include Canada, China, France, Germany, Italy, Japan, Spain, and the United Kingdom. A majority of the sales and marketing approach outside of the United States is direct sales, although it varies depending on each country's size and state of development.

4
Raw Materials and Manufacturing

We operate manufacturing facilities in various geographies around the world. We manufacture our Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid technologies, and Structural Surgical Heart products primarily in the United States (California and Utah), Singapore, Costa Rica, and Ireland. We manufacture our Critical Care products primarily in Puerto Rico and the Dominican Republic.

We use a diverse and broad range of raw and organic materials in the design, development, and manufacture of our products. We manufacture our non-implantable products from fabricated raw materials including resins, chemicals, electronics, and metals. Most of our replacement heart valves are manufactured from natural tissues harvested from animal tissue, as well as fabricated materials. We purchase certain materials and components used in manufacturing our products from external suppliers. In addition, we purchase certain supplies from single sources for reasons of sole source availability or constraints resulting from regulatory requirements.

We work with our suppliers to mitigate risk and seek continuity of supply while maintaining quality and reliability. Alternative supplier options are generally considered, identified, and approved for materials deemed critical to our products, although we do not typically pursue immediate regulatory qualification of alternative sources due to the strength of our existing supplier relationships and the time and expense associated with the regulatory validation process.

We comply with all current global guidelines regarding risks for products incorporating animal tissue intended to be implanted in humans. We follow rigorous sourcing and manufacturing procedures intended to safeguard humans from potential risks associated with diseases such as bovine spongiform encephalopathy ("BSE"). We obtain bovine tissue used in our pericardial tissue valve products only from sources within the United States and Australia, where strong control measures and surveillance programs exist. In addition, bovine tissue used in our pericardial tissue valve products is from tissue types considered by global health and regulatory organizations to have shown no risk of infectibility. Our manufacturing and sterilization processes are designed to render tissue biologically safe from all known infectious agents and viruses.

Quality Assurance

We are committed to providing to our patients quality products and have implemented modern quality systems and concepts throughout the organization. The quality system starts with the initial design concept, risk management, and product specification, and continues through the design of the product, packaging and labeling, and the manufacturing, sales, support, and servicing of the product. The quality system is intended to design quality into the products and utilizes continuous improvement concepts, including Lean/Six Sigma principles, throughout the product lifecycle.

Our operations are frequently inspected by the many regulators that oversee medical device manufacturing, including the United States Food and Drug Administration ("FDA"), European Notified Bodies, and other regulatory entities. The medical technology industry is highly regulated and our facilities and operations are designed to comply with all applicable quality systems standards, including the International Organization for Standardization ("ISO") 13485. These standards require, among other items, quality system controls that are applied to product design, component material, suppliers, and manufacturing operations. These regulatory approvals and ISO certifications can be obtained only after a successful audit of a company's quality system has been conducted by regulatory or independent outside auditors. Periodic reexamination by an independent outside auditor is required to maintain these certifications.

Environmental, Health, and Safety

We are committed to providing a safe and healthy workplace and complying with all relevant regulations and medical technology industry standards. Through our corporate and site level Environmental, Health, and Safety functions, we establish and monitor programs to reduce pollution, prevent injuries, and maintain compliance with applicable regulations. In order to measure performance, we monitor and report on a number of metrics, including regulated and non-regulated waste disposal, energy usage, water consumption, air toxic emissions, and injuries from our production activities. Each of our manufacturing sites is evaluated regularly with respect to a broad range of Environmental, Health, and Safety criteria.

5
Research and Development

In 2021, we made significant investments in research and development as we worked to develop therapies that we believe have the potential to change the practice of medicine. Research and development spending increased 19% year over year, representing 17% of 2021 sales. This increase was primarily the result of significant investments in our transcatheter structural heart programs, including an increase in clinical research for our mitral and tricuspid therapies. We are engaged in ongoing research and development to deliver clinically advanced new products, to enhance the effectiveness, ease of use, safety, and reliability of our current leading products, and to expand the applications of our products as appropriate. We focus on opportunities within specific areas of structural heart disease and critical care monitoring.

A considerable portion of our research and development investment includes clinical trials and the collection of evidence that provide data for use in regulatory submissions, and required post-market approval studies involving applications of our products. Our investment in clinical studies also includes outcomes and cost-effectiveness data for payers, clinicians, and healthcare systems.

In Transcatheter Aortic Valve Replacement, we are developing new products to further improve and streamline transcatheter aortic heart valve replacement procedures.

In Transcatheter Mitral and Tricuspid Therapies, we are making significant investments in innovation and clinical evidence to develop technologies designed to treat mitral and tricuspid valve diseases. In addition to our internally developed programs, we have made investments in several companies that are independently developing minimally-invasive technologies to treat structural heart diseases.

Our Surgical Structural Heart development programs include innovative platforms for patients who are best treated surgically, specifically active patients and patients with more complex combined procedures.

In our Critical Care product line, we are pursuing the development of a variety of decision support solutions for our clinicians.  This includes next-generation noninvasive and minimally-invasive hemodynamic monitoring systems, and a next-generation monitor platform.  We are also developing a decision support software suite with advanced algorithms for proactive hemodynamic management, including a semi-closed loop system for standardized management of patient fluid levels. Lastly, we are developing a connectivity platform that will offer clinicians additional clinical support, remote monitoring capability, analytics, and insights for their patients’ hemodynamic status.

Our research and development activities are conducted primarily in facilities located in the United States and Israel. Our experienced research and development staff are focused on product design and development, quality, clinical research, and regulatory compliance. To pursue primary research efforts, we have developed alliances with several leading research institutions and universities, and also work with leading clinicians around the world in conducting scientific studies on our existing and developing products.

Proprietary Technology

Patents, trademarks, and other proprietary rights are important to the success of our business. We also rely upon trade secrets, know-how, continuing innovations, licensing opportunities, and non-disclosure agreements to develop and maintain our competitive position.

We own or have rights to a substantial number of patents and have patent applications pending both in the United States and in foreign countries. We continue to innovate and file new patent applications to protect our new products and technologies.

Additionally, we are a party to license agreements with various third parties pursuant to which we have obtained, for varying terms, the exclusive or non-exclusive rights to certain patents held by such third parties in consideration for cross-licensing rights and/or royalty payments. We have also licensed certain patent rights to others.

We undertake reasonable measures to protect our patent rights, including monitoring the products of our competitors for possible infringement of our patents. Litigation has been necessary to enforce certain patent rights held by us, and we plan to continue to defend and prosecute our rights with respect to such patents.

6
Moreover, we own certain United States registered trademarks used in our business. Many of our trademarks have also been registered for use in certain foreign countries where registration is available and where we have determined it is commercially advantageous to do so.

Government Regulation and Other Matters

Our products and facilities are subject to regulation by numerous government agencies, including the FDA, European Union Member States competent authorities, and the Japanese Pharmaceuticals and Medical Devices Agency, to confirm compliance with the various laws and regulations governing the development, testing, manufacturing, labeling, marketing, and distribution of our products.

We are also governed by federal, state, local, and international laws of general applicability, including, but not limited to, those regulating employee health and safety, labor, competition, trade secret, and the protection of the environment. Overall, the amount and scope of domestic and foreign laws and regulations applicable to our business has increased over time. Compliance with these regulations has not had a material effect on our capital expenditures, earnings, or competitive position to date, but new regulations or amendments to existing regulations to make them more stringent could have such an effect in the future. We cannot estimate the expenses we may incur to comply with potential new laws or changes to existing laws, or the other potential effects these laws may have on our business.

United States Regulation.    In the United States, the FDA has responsibility for regulating medical devices. The FDA regulates design, development, testing, clinical studies, manufacturing, labeling, promotion, and record keeping for medical devices, and reporting of adverse events, recalls, or other field actions by manufacturers and users to identify potential problems with marketed medical devices. Many of the devices that we develop and market are in a category for which the FDA has implemented stringent clinical investigation and pre-market clearance or approval requirements. The process of obtaining FDA clearance or approval to market a product is resource intensive, lengthy, and costly. FDA review may involve substantial delays that adversely affect the marketing and sale of our products. A number of our products are pending regulatory clearance or approval to begin commercial sales in various markets. Ultimately, the FDA may not authorize the commercial release of a medical device if it determines the device is not safe and effective or does not meet other regulatory standards. Additionally, even if a product is cleared or approved, the FDA may impose restrictions or require testing and surveillance programs to monitor the effects of these products once commercialized.

The FDA has the authority to halt the distribution of certain medical devices, detain or seize adulterated or misbranded medical devices, order the repair, replacement, or refund of the costs of such devices, or preclude the importation of devices that are or appear violative. The FDA also conducts inspections to determine compliance with the quality system regulations concerning the manufacturing and design of devices and current medical device reporting regulations, recall regulations, clinical testing regulations, and other requirements. The FDA may withdraw product clearances or approvals due to failure to comply with regulatory standards, or the occurrence of unforeseen problems following initial approval, and require notification of health professionals and others with regard to medical devices that present unreasonable risks of substantial harm to the public health. Additionally, the failure to comply with FDA or comparable regulatory standards or the discovery of previously unknown product problems could result in fines, delays, suspensions or withdrawals of regulatory clearances or approvals, seizures, injunctions, recalls, refunds, civil money penalties, or criminal prosecution. Our compliance with applicable regulatory requirements is subject to continual review. Moreover, the FDA and several other United States agencies administer controls over the export of medical devices from the United States and the import of medical devices into the United States, which could also subject us to sanctions for noncompliance.

We are also subject to additional laws and regulations that govern our business operations, products, and technologies, including:

•federal, state, and foreign anti-kickback laws and regulations, which generally prohibit payments to anyone, including physicians as an inducement to purchase or recommend a product;

•the Stark law, which prohibits physicians from referring Medicare or Medicaid patients to a provider that bills these programs for the provision of certain designated health services if the physician (or a member of the physician's immediate family) has a financial relationship with that provider;

•federal and state laws and regulations that protect the confidentiality of certain patient health information, including patient records, and restrict the use and disclosure of such information, in particular, the Health Insurance Portability and Accountability Act of 1996;

7
•the Physician Payments Sunshine Act, which requires public disclosure of the financial relationships of United States physicians and teaching hospitals with applicable manufacturers, including medical device, pharmaceutical, and biologics companies;

•the False Claims Act, which prohibits the submission of false or otherwise improper claims for payment to a federally funded health care program, and health care fraud statutes that prohibit false statements and improper claims to any third-party payor; and

•the United States Foreign Corrupt Practices Act, which can be used to prosecute United States companies for arrangements with foreign government officials or other parties, or for not keeping accurate financial records or maintaining adequate internal controls to prevent and detect arrangements with foreign government officials or other parties.

Failure to comply with these laws and regulations could result in criminal liability, significant fines or penalties, negative publicity, and substantial costs and expenses associated with investigation and enforcement activities. To assist in our compliance efforts, we work to adhere to many codes of ethics and conduct regarding our business activities in the United States and other countries in which we operate. In addition, we have in place a dedicated team to improve our internal business compliance programs and policies.

Regulation Outside of the United States.    Outside of the United States, the regulation of medical devices is complex. In Europe, our products are subject to extensive regulatory requirements. The regulatory regime in the European Union for medical devices became mandatory in June 1998. It requires that medical devices may only be placed on the market if they do not compromise safety and health when properly installed, maintained, and used in accordance with their intended purpose. National laws conforming to the European Union's legislation regulate our products under the medical devices regulatory system. Although the more variable national requirements under which medical devices were formerly regulated have been substantially replaced by the European Union Medical Devices Directive, individual nations can still impose unique requirements that may require supplemental submissions. The European Union medical device laws require manufacturers to declare that their products conform to the essential regulatory requirements after which the products may be placed on the market bearing the CE Mark. Manufacturers' quality systems for products in all but the lowest risk classification are also subject to certification and audit by an independent notified body. In Europe, particular emphasis is being placed on more sophisticated and faster procedures for the reporting of adverse events to the competent authorities.

In May 2017, the European Union (the "EU") implemented a new regulatory scheme for medical devices under the Medical Device Regulation ("MDR"). The MDR became fully effective on May 26, 2021 and brought significant new requirements for many medical devices, including enhanced requirements for clinical evidence and documentation, increased focus on device identification and traceability, new definitions and registration of economic operators throughout the distribution chain, and additional post-market surveillance and vigilance. Compliance with the MDR requires re-certification of many of our products to the enhanced standards, and has resulted in and will continue to result in substantial additional expense. In addition, in the EU, we import some of our devices through our offices in Switzerland. Switzerland is not a member state of the EU, but is linked to the EU through bilateral treaties; therefore, the free movement of goods, including medical devices, between the EU and Switzerland after implementation of the MDR requires a revised Mutual Recognition Agreement ("MRA"). If an MRA covering the MDR is not put in place, then non-EU manufacturers may be required to make significant changes, including replacement of Swiss economic operators with operators based in EU Member States, and changes will need to be made to our device labeling and/or packaging to satisfy MDR requirements. If these measures are unable to be taken, it may no longer be possible to place such devices on the EU market.

In Japan, pre-market approval and clinical studies are required as is governmental pricing approval for medical devices. Clinical studies are subject to a stringent Japanese "Good Clinical Practices" standard. Approval time frames from the Japanese Ministry of Health, Labour and Welfare vary from simple notifications to review periods of one or more years, depending on the complexity and risk level of the device. In addition, importation of medical devices into Japan is subject to the "Good Import Practices" regulations. As with any highly regulated market, significant changes in the regulatory environment could adversely affect future sales.

In many of the other foreign countries in which we market our products, we may be subject to regulations affecting, among other things:

•product standards and specifications;

•packaging requirements;
8

•labeling requirements;

•product collection and disposal requirements;

•quality system requirements;

•import restrictions;

•tariffs;

•duties; and

•tax requirements.

Many of the regulations applicable to our devices and products in these countries are similar to those of the FDA. In some regions, the level of government regulation of medical devices is increasing, which can lengthen time to market and increase registration and approval costs. In many countries, the national health or social security organizations require our products to be qualified before they can be marketed and considered eligible for reimbursement.

Health Care Initiatives.    Government and private sector initiatives to limit the growth of health care costs, including price regulation and competitive pricing, coverage and payment policies, comparative effectiveness reviews, technology assessments, increasing evidentiary demands, and managed-care arrangements, are continuing in many countries where we do business, including the United States, Europe, and Japan. As a result of these changes, the marketplace has placed increased emphasis on the delivery of more cost-effective medical therapies. For example, government programs, private health care insurance, and managed-care plans have attempted to control costs by restricting coverage and limiting the level of reimbursement for procedures or treatments, and some third-party payors require their pre-approval before new or innovative devices or therapies are utilized by patients. These various initiatives have created increased price sensitivity over medical products generally and may impact demand for our products and technologies.

The delivery of our products is subject to regulation by the United States Department of Health and Human Services ("HHS") and comparable state and foreign agencies responsible for reimbursement and regulation of health care items and services. Foreign governments also impose regulations in connection with their health care reimbursement programs and the delivery of health care items and services. Reimbursement schedules regulate the amount the United States government will reimburse hospitals and doctors for the inpatient care of persons covered by Medicare. HHS' Centers for Medicare & Medicaid Services ("CMS") may also review whether and/or under what circumstances a procedure or technology is reimbursable for Medicare beneficiaries. Changes in current coverage and reimbursement levels could have an adverse effect on market demand and our pricing flexibility. The CMS National Coverage Determination for Transcatheter Aortic Valve Replacement was issued in June 2019.  The modernized requirements and more streamlined patient evaluation process are meaningful enhancements that may help ensure equitable access for more patients suffering from severe aortic stenosis.

Health care cost containment efforts have also prompted domestic hospitals and other customers of medical device manufacturers to consolidate into larger purchasing groups to enhance purchasing power. The medical technology industry has also experienced some consolidation, partly in order to offer a broader range of products to large purchasers. As a result, transactions with customers are larger, more complex, and tend to involve more long-term contracts than in the past. These larger customers, due to their enhanced purchasing power, may have a material impact on product pricing.

These laws or any future legislation, including deficit reduction legislation, could impact medical procedure volumes, reimbursement for our products, and demand for our products or the prices at which we sell our products.

Seasonality

Our quarterly net sales are influenced by many factors, including new product introductions, acquisitions, regulatory approvals, patient and physician holiday schedules, and other factors. Net sales in the third quarter are typically lower than other quarters of the year due to the seasonality of the United States and European markets, where summer vacation schedules normally result in fewer medical procedures.

9
Human Capital Management Strategy

Human Capital Management ("HCM") Governance

Attracting, developing, and retaining talent is fundamental to our success. The primary goals of our talent management strategy are to attract and maintain a motivated, professional workforce and to ensure alignment on our patient-focused innovation strategy.

Our Board of Directors routinely engages with leadership in human capital management with time dedicated at each regularly scheduled meeting to discuss talent management, including, among other things, talent strategy, diversity, succession planning, employee development, employee health, safety, and welfare, results of employee surveys, and compensation. The Board of Directors also approves Key Operating Drivers, which are strategic milestones that include financial objectives and are tracked using a point system across our entire organization, that focus the Company and management toward short, medium, and long-term goals that align with our talent management strategy. In addition, the Chief Executive Officer ("CEO") has talent management related performance goals tied to his compensation; these Performance Management Objectives are reviewed on an annual basis, tracked, and then reported to and evaluated by our Board of Directors.

As we scale to reach more patients around the world, we have integrated our Talent & Organization (“T&O”) Strategy with our Edwards Strategic Planning process. The purpose of our T&O Strategy is to anticipate dynamic global trends related to our workforce, develop our talent to meet future organizational needs, and enable us to be well-poised for ongoing market success. The T&O Strategy enables us to explore external workforce signals, share insights, and identify and build emerging capabilities across our organization. The T&O Strategy framework takes a comprehensive approach which includes envisioning the future of our work (the "what" and "how" we deliver our patient focused strategy), planning our workforce (the "who" joining our community of trusted partners), and designing our workplace (the "where" and "when" work gets done). This consistent and scalable approach looks across all our product groups, regions, and significant functions to align and elevate priorities, critical capabilities, and organizational evolutions in line with our strategic plan. This integrated approach informs our yearly objectives and fuels our talent roadmap across the strategic horizon.

Our HCM governance includes a global talent development review ("TDR") process as well as an HCM dashboard. The purpose of our TDR process is to align our business strategy with talent strategies, assess talent against future organizational needs, evaluate critical talent populations, and enhance the strength of our succession planning. Our HCM dashboard is generated quarterly and provides insights on key metrics related to areas such as attraction and growth rates, retention trends, diversity, and employee sentiment.

Culture

Investing in our workforce means our employees can stay focused on our patient-focused innovation strategy and the development of life-saving therapies for the patients we serve. We are committed to maintaining an ethical culture where we celebrate diversity, promote good health and safety, empower employees to speak up, and ensure that employees' voices are heard. We strive to offer competitive employee benefits packages and are committed to fair and equitable pay practices. We track compensation patterns in all geographies where we operate, and we regularly look for ways to ensure fair and equitable pay.

We are committed to fostering an environment where all employees can grow and thrive. A diverse workforce results in a broader range of perspectives, helping drive our commitment to innovation. We have established a Diversity, Inclusion, and Belonging strategy that incorporates the four pillars of Business, People, Communication, and Community.

We believe in empowering our employees and providing avenues that enable their voices to be heard. We conduct a multilingual global employee survey, called myVoice, to pulse our employees and gain their feedback in a confidential manner. We gain insights on various topics including patient focus, diversity, inclusion and belonging, quality, innovation, and engagement. Speak-Up is a resource available to all employees to bring forth compliance related concerns; a key element of our compliance program is that each employee is accountable for maintaining ethical business practices. In addition, during each quarterly townhall meeting, our CEO has an "Ask Mike" section in which he answers questions that have been submitted to him by employees. Answers to questions that are not covered in the townhall meeting are posted online internally.

We understand that good health leads to better performance. We offer competitive employee benefits packages that include, among other things, health and welfare insurance, health savings accounts, family support services, and a variety of site-specific programs. We regularly evaluate our benefits package to make modifications that are aligned with the competitive landscape, legislative changes, and the unique needs of our population. We also provide robust wellness programs that address prevention, nutrition, mental health, physical activity, education, financial fitness, and community service. In recent years, mental wellness has become a central topic for organizations worldwide. As part of our regular evaluation and commitment to putting employees first, we launched a new program, Mind+, which offers a wide variety of mental health benefits and wellness
10
programs for our employees. This commitment extends to creating a work environment where employees can feel confident speaking about mental health with their managers and know how best to access the tools and resources available to support them. We believe there are strong benefits when employees are feeling their best. Employees who are mentally healthy are more innovative, resilient, better decision-makers, and able to build stronger relationships. We also believe that prioritizing and promoting Mind+ allows us to help patients around the world to live longer, healthier, and more productive lives and supports employees to be their best self at home and at work.

Talent Development

In addition to our robust TDR process and tuition reimbursement programs, we provide a variety of leadership, technical, and professional development programs around the globe.

Headcount and Labor Representation

As of December 31, 2021, we had approximately 15,700 employees worldwide, the majority of whom were located in the United States, Singapore, the Dominican Republic, and Costa Rica. None of our North American employees are represented by a labor union. In various countries outside of North America, we interact with trade unions and work councils that represent employees.

Additional details regarding diversity, talent development, compensation, and employee health and safety can be found in our Sustainability Report posted on our website at www.edwards.com under "About Us — Corporate Responsibility."

References to our website in this Annual Report on Form 10-K are provided for convenience only and the content on our website does not constitute a part of this Report.

Item 1A.    Risk Factors

Our business and assets are subject to varying degrees of risk and uncertainty. An investor should carefully consider the risks described below, as well as other information contained in this Annual Report on Form 10-K and in our other filings with the SEC. Additional risks not presently known to us or that we currently deem immaterial may also adversely affect our business. If any of these events or circumstances occurs, our business, financial condition, results of operations, or prospects could be materially harmed. In that case, the value of our securities could decline and an investor could lose part or all of his or her investment. In addition, forward-looking statements within the meaning of the federal securities laws that are contained in this Annual Report on Form 10-K or in our other filings or statements may be subject to the risks described below as well as other risks and uncertainties. Please note that the headers provided below are intended to assist the reader in navigating the risk factors; however, some risks, present or future, may implicate multiple types of risks. Please read the cautionary notice regarding forward-looking statements in Part I above.

Business and Operating Risks

We are subject to risks associated with public health threats and epidemics, including the novel coronavirus ("COVID-19") and any variants of COVID-19.

We are subject to risks associated with public health threats and epidemics, including the global health concerns related to the COVID-19 pandemic. The global pandemic has adversely impacted and is likely to further adversely impact nearly all aspects of our business and markets, including our workforce and operations and the operations of our customers, suppliers, and business partners. In particular, we may experience material financial or operational impacts, including:

•Significant volatility or reductions in demand for our products;

•Impacts and delays to clinical trials, our pipeline milestones, or regulatory clearances and approvals; or

•The inability to meet our customers’ needs or other obligations due to disruptions to our operations or the operations of our third-party partners, suppliers, contractors, logistics partners, or customers including disruptions to production, development, manufacturing, administrative, and supply operations and arrangements.

The extent to which the COVID-19 global pandemic and measures taken in response thereto impact our business, results
of operations, and financial condition will depend on future developments, which are highly uncertain and are difficult to
11
predict. These developments include, but are not limited to, the duration and spread of the outbreak (including new variants of COVID-19), its severity, the actions to contain the virus or address its impact, the timing, distribution, and efficacy of vaccines and other treatments, United States and foreign government actions to respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume.

Failure to successfully innovate and develop new and differentiated products in a timely manner and effectively market these products could have a material effect on our prospects.

Our continued growth and success depend on our ability to innovate and develop new and differentiated products in a timely manner and effectively market these products. Without the timely innovation and development of products, our products could be rendered obsolete or less competitive by changing customer preferences or because of the introduction of a competitor’s newer technologies. Innovating products requires the devotion of significant financial and other resources to research and development activities; however, there is no certainty that the products we are currently developing will complete the development process, or that we will obtain the regulatory or other approvals required to market such products in a timely manner or at all. Even if we timely innovate and develop products, our ability to market them could be constrained by a number of different factors, including barriers in patients' treatment pathway (including disease awareness, detection, and diagnosis), the need for regulatory clearance, restrictions imposed on approved indications, and uncertainty over third-party reimbursement. Failure in any of these areas could have a material effect on our prospects.

Unsuccessful clinical trials or procedures relating to products could have a material adverse effect on our prospects.

The regulatory approval process for new products and new indications for existing products requires extensive clinical trials and procedures, including early clinical feasibility and regulatory studies. Unfavorable or inconsistent clinical data from current or future clinical trials or procedures conducted by us, our competitors, or third parties, or perceptions regarding this clinical data, could adversely affect our ability to obtain necessary approvals and the market's view of our future prospects. Such clinical trials and procedures are inherently uncertain and there can be no assurance that these trials or procedures will be enrolled or completed in a timely or cost-effective manner or result in a commercially viable product or indication; failure to do so could have a material adverse effect on our prospects. Clinical trials or procedures may experience significant setbacks even after earlier trials have shown promising results. Further, preliminary results from clinical trials or procedures may be contradicted by subsequent analyses. In addition, results from our clinical trials or procedures may not be supported by actual long-term studies or clinical experience. If preliminary clinical results are later contradicted, or if initial results cannot be supported by actual long-term studies or clinical experience, our business could be adversely affected. Clinical trials or procedures may be delayed, suspended, or terminated by us, the FDA, or other regulatory authorities at any time if it is believed that the trial participants face unacceptable health risks or any other reasons, and any such delay, suspension, or termination could have a material adverse effect on our prospects or the market's view of our future prospects.

We operate in highly competitive markets, and if we do not compete effectively, our business will be harmed.

We face substantial competition and compete with companies of all sizes on the basis of cost-effectiveness, technological innovations, product performance, brand name recognition, breadth of product offerings, real or perceived product advantages, pricing and availability and rate of reimbursement. In addition, given the trend toward value-based healthcare, if we are not able to continue to demonstrate the full value of our differentiated products to healthcare providers and payors, our competitive position could be adversely affected. See "Competition" under "Business" in Part I, Item 1 included herein.

If we identify underperforming operations or products or if there are unforeseen operating difficulties and expenditures in connection with business acquisitions or strategic alliances, we may be required, from time to time, to recognize charges, which could be substantial and which could adversely affect our results of operations.

We actively manage a portfolio of research and development products, and we regularly explore potential acquisitions of complementary businesses, technologies, services, or products, as well as potential strategic alliances. From time to time, we identify operations and products that are underperforming, do not fit with our longer-term business strategy or there may be unforeseen operating difficulties and significant expenditures during the integration of an acquired business, technology, service, or product into our existing operations. We may seek to dispose of these underperforming operations or products, and we may also seek to dispose of other operations or products for strategic or other business reasons. If we cannot dispose of an operation or product on acceptable terms, we may voluntarily cease operations related to that product. In addition, we may be required to take charges or write-downs in connection with acquisitions and divestitures. In particular, acquisitions of businesses engaged in the development of new products may give rise to developed technology and/or in-process research and development assets. To the extent that the value of these assets decline, we may be required to write down the value of the assets. Also, in connection with certain asset acquisitions, we may be required to take an immediate charge related to acquired in-process research and development assets. Any of these events could result in charges, which could be substantial and which could adversely affect our results of operations.

12
The success of many of our products depends upon certain key physicians.

We work with leading global physicians who provide considerable knowledge and experience. These physicians may assist us as researchers, marketing consultants, product trainers and consultants, inventors, and as public speakers. If new laws, regulations, or other developments limit our ability to appropriately engage these professionals or to continue to receive their advice and input or we are otherwise unsuccessful in maintaining strong working relationships with these physicians, the development, marketing, and successful use of our products could suffer, which could have a material adverse effect on our business, financial condition, and results of operations.


If we or one of our suppliers or logistics partners encounters manufacturing, logistics, or quality problems, our business could be materially adversely affected.

The manufacture and sterilization of many of our products is highly complex due in part to rigorous regulatory requirements. Quality is extremely important due to the serious and costly consequences of a product failure. Problems can arise for a number of reasons, including disruption of facility utilities, equipment malfunction, failure to follow protocols and procedures, raw material problems, software problems, cyber incidents, or human error. Disruptions can occur at any time, including during production line transfers and expansions. Disruptions can also occur if our manufacturing and warehousing facilities are damaged by earthquakes, hurricanes, volcanoes, fires, and other natural disasters or catastrophic circumstances. As we expand into new markets and scale new products for commercial production, we may face unanticipated delays or surges in demand which could strain our production capacity and lead to other types of disruption. If any of these manufacturing, logistics, or quality problems arise or if we or one of our suppliers or logistics partners otherwise fail to meet internal quality standards or those of the FDA or other applicable regulatory body, our reputation could be damaged, we could become subject to a safety alert or a recall, we could incur product liability and other costs, product approvals and production could be delayed, and our business could otherwise be materially adversely affected.

We rely on third parties in the design, manufacture, and sterilization of our products. Any failure by or loss of a vendor could result in delays and increased costs, which may adversely affect our business.

We rely on third parties for a broad range of raw and organic materials and other items in the design, manufacture, and sterilization of our products, and we purchase certain supplies and services from single sources for reasons of quality assurance, cost-effectiveness, availability, constraints resulting from regulatory requirements, and other reasons. We may experience supply interruptions due to a variety of factors, including:

•General economic conditions that could adversely affect the financial viability of our vendors;

•Vendors' election to no longer service medical technology companies due to the burdens of applicable quality requirements and regulations;

•The limitation or ban of certain chemicals or other materials used in the manufacture of our products; and

•Delays or shortages due to trade or regulatory embargoes.

A change or addition to our vendors could require significant effort due to the rigorous regulations and requirements of the FDA and other regulatory authorities; it could be difficult to establish additional or replacement sources on a timely basis or at all, which could have a material adverse effect on our business.

13
Failure to protect our information technology infrastructure and our products against cyber-based attacks, network security breaches, service interruptions, or data corruption could materially disrupt our operations and adversely affect our business and operating results.

The operation of our business depends on our information technology systems. We rely on our information technology systems to, among other things, effectively manage sales and marketing data, accounting and financial functions, inventory management, product development tasks, clinical data, customer service and technical support functions. Our information technology systems are vulnerable to damage or interruption from earthquakes, fires, floods and other natural disasters, terrorist attacks, power losses, computer system or data network failures, security breaches, and data corruption.

In addition, our information technology infrastructure and products are vulnerable to cyber-based attacks. Cyber-based attacks can include, but are not limited to, computer viruses, denial-of-service attacks, phishing attacks, ransomware attacks, and other introduction of malware to computers and networks; unauthorized access through the use of compromised credentials; exploitation of design flaws, bugs, or security vulnerabilities; intentional or unintentional acts by employees or other insiders with access privileges; and intentional acts of vandalism by third parties and sabotage. In addition, United States federal and state laws and regulations, and the laws and regulations of jurisdictions outside of the United States, such as the General Data Protection Regulation adopted by the European Union and the California Consumer Privacy Act, can expose us to investigations and enforcement actions by regulatory authorities and claims from individuals potentially resulting in penalties and significant legal liability, if our information technology security efforts are inadequate. In addition, we rely upon technology suppliers, including cloud‑based data management applications hosted by third‑party service providers, whose security and information technology systems are subject to similar risks.

Significant disruption in either our or our service providers’ or suppliers’ information technology or the security of our products could impede our operations or result in decreased sales, result in liability claims or regulatory penalties, or lead to increased overhead costs, product shortages, loss or misuse of proprietary or confidential information, intellectual property, or sensitive or personal information, all of which could have a material adverse effect on our reputation, business, financial condition, and operating results.

Our business and results of operations may be adversely affected if we are unable to recruit and retain qualified management and other personnel.

Our continued success depends, in large part, on our ability to hire and retain qualified people or otherwise have access to such qualified people globally and if we are unable to do so, our business and operations may be impaired or disrupted. See "Human Capital Management Strategy" under "Business" in Part I, Item 1 included herein. Competition for highly qualified people is intense, and there is no assurance that we will be successful in attracting or retaining replacements to fill vacant positions, successors to fill retirements or employees moving to new positions, or other highly qualified personnel.

Market and Other External Risks

Because we operate globally, our business is subject to a variety of risks associated with international sales and operations.

Our extensive global operations and business activity as well as the fact that many of our manufacturing facilities and suppliers are outside of the United States are accompanied by certain financial, economic, political, and other risks, including those listed below.

Domestic and Global Economic Conditions.  We cannot predict to what extent general domestic and global economic conditions may negatively impact our business. These include, but are not limited to, credit and capital markets, interest rates, tax law, including tax rate and policy changes, factors affecting global economic stability, and the political environment relating to health care. These and other conditions could also adversely affect our customers, payers, vendors and other stakeholders and may impact their ability or decision to purchase our products or make payments on a timely basis.

Health Care Legislation and Other Regulations. We are subject to various federal and foreign laws that govern our domestic and international business practices. For example, in the United States, the Affordable Care Act, the Medicare Access and CHIP Reauthorization Act of 2015, and the 21st Century Cures Act, or any future legislation, including deficit reduction legislation, could impact medical procedure volumes, reimbursement for our products, and demand for our products or the prices at which we sell our products. In addition, a Mutual Recognition Agreement still under negotiation for the Medical Device Regulation can result in a lack of free movement of medical devices between the European Union and Switzerland, can impact our access in the European Union and can, ultimately, have a material effect on our business, financial condition, and results of operations. For more information about these laws as they relate to our business, see the section entitled “Government Regulation and Other Matters” in Part I, Item 1, “Business.”

14
In addition, the United States Foreign Corrupt Practices Act, the United Kingdom Bribery Act, and similar laws in other jurisdictions contain prohibitions against bribery and other illegal payments, and make it an offense to fail to have procedures in place that prevent such payments. Penalties resulting from any violation of these laws could adversely affect us and our business.

Taxes. We are subject to income taxes in the United States as well as other jurisdictions.

•Provision for Income Taxes. Our provision for income taxes and our underlying effective tax rate could fluctuate due to changes in the mix of earnings and losses in countries with differing statutory tax rates. Our income tax provision could also be impacted by changes in excess tax benefits of stock-based compensation, federal and state tax credits, non-deductible expenses, changes in the valuation of deferred tax assets and liabilities and our ability to utilize them, the applicability and creditability of withholding taxes, and effects from acquisitions.

•Tax Reform. Our provision for income taxes could be materially impacted by changes in accounting principles or evolving tax laws, including, but not limited to, global corporate tax reform and base-erosion and tax transparency efforts. For example, many countries are aligning their international tax rules with the Organisation for Economic Co-operation and Development’s Base Erosion and Profit Shifting recommendations and action plans that aim to standardize and modernize international corporate tax policy, including changes to cross-border taxes, transfer pricing documentation rules, nexus-based tax practices, and taxation of digital activities.

•Tax Audits. We are subject to ongoing tax audits in the various jurisdictions in which we operate. Tax authorities may disagree with certain positions we have taken and assess additional taxes. Although we regularly assess the likely outcomes of the audits and record reserves for potential tax payments, the calculation of tax liabilities involves the application of complex tax laws, and our estimates could be different than the amounts for which we are ultimately liable.

•Tax Incentives. We benefit from various global tax incentives extended to encourage investment or employment. Several foreign jurisdictions have granted us tax incentives which require renewal at various times in the future. If our incentives are not renewed or we cannot or do not wish to satisfy all or part of the tax incentive conditions, we may lose the tax incentives and could be required to refund tax incentives previously realized. As a result, our provision for income taxes could be higher than it would have been had we maintained the benefits of the tax incentives.

Other economic, political, and social risks. In addition to the factors enumerated above, we are from time to time impacted by a variety of other factors associated with doing business internationally that can harm our future results, including the following:

•trade protection measures, quotas, embargoes, import or export requirements, and duties, tariffs, or surcharges;

•cultural or other local factors affecting financial terms with customers;

•differing labor regulations; and

•currency exchange rate fluctuations; that is, decreases in the value of the United States dollar to the Euro or the Japanese yen, as well as other currencies, have the effect of increasing our reported revenues even when the volume of sales outside of the United States has remained constant. Increases in the value of the United States dollar relative to the Euro or the Japanese yen, as well as other currencies, have the opposite effect. Significant increases or decreases in the value of the United States dollar could have a material adverse effect on our revenues, cost of sales, or results of operations.

If government and other third-party payors decline to reimburse our customers for our products or impose other cost containment measures to reduce reimbursement levels, our ability to profitably sell our products will be harmed.

We sell our products and technologies to hospitals and other health care providers, nearly all of which receive reimbursement for the health care services provided to patients from third-party payors, such as government programs (both domestic and outside of the United States), private insurance plans, and managed care programs. The ability of customers to obtain appropriate reimbursement for their products from private and governmental third-party payors is critical to our success. The availability of reimbursement affects which products customers purchase and the prices they are willing to pay. Reimbursement varies from country to country and can significantly impact acceptance of new products.

15
Government and other third-party payors are increasingly attempting to contain health care costs by limiting both coverage and the level of reimbursement for medical products and services. Reimbursement levels may be decreased in the future. Additionally, future legislation, regulation, or reimbursement policies of third-party payors may otherwise adversely affect the demand for and price levels of our products. The introduction of cost containment incentives, combined with closer scrutiny of health care expenditures by both private health insurers and employers, has resulted in increased discounts and contractual adjustments to hospital charges for services performed. Hospitals or physicians may respond to such cost-containment pressures by substituting lower cost products or other therapies.

Third-party payors may deny reimbursement if they determine that a device used in a procedure was not used in accordance with cost-effective treatment methods as determined by such third-party payors or was used for an unapproved indication. Third-party payors may also deny reimbursement for experimental procedures and devices. We believe that many of our existing products are cost-effective, even though the one-time cost may be significant, because they are intended to improve quality of life and reduce overall health care costs over a long period of time. We cannot be certain that these third-party payors will recognize these cost savings and quality of life benefits instead of merely focusing on the lower initial costs associated with competing therapies. If our products are not considered cost-effective by third-party payors, our customers may not be reimbursed for them, resulting in lower sales of our products.

Continued consolidation in the health care industry could have an adverse effect on our sales and results of operations.

The health care industry has been consolidating, and organizations such as GPOs, independent delivery networks, and large single accounts, such as the United States Veterans Administration, continue to consolidate purchasing decisions for many of our health care provider customers. As a result, transactions with customers are larger and more complex, and tend to involve more long-term contracts. The purchasing power of these larger customers has increased, and may continue to increase, causing downward pressure on product pricing. If we are not one of the providers selected by one of these organizations, we may be precluded from making sales to its members or participants. Even if we are one of the selected providers, we may be at a disadvantage relative to other selected providers that are able to offer volume discounts based on purchases of a broader range of medical equipment and supplies. Further, we may be required to commit to pricing that has a material adverse effect on our revenues, profit margins, business, financial condition, and results of operations. We expect that market demand, governmental regulation, third-party reimbursement policies, and societal pressures will continue to drive consolidation and increase pricing pressure.

Legal, Compliance, and Regulatory Risks

Our inability to protect our intellectual property or failure to maintain the confidentiality and integrity of data or other sensitive company information, by cyber-attack or other event, could have a material adverse effect on our business.

Our success and competitive position are dependent in part upon our ability to protect our proprietary intellectual property through a combination of patents and trade secrets. We cannot guarantee that the protective steps we take are adequate to protect these rights:

•Patents issued to or licensed by us in the past or in the future may be challenged and held invalid.

•As our patents expire, we may be unsuccessful in extending their protection through patent term extensions.

•Confidentiality agreements with certain employees, consultants, and other third parties intended to protect, in part, trade secrets and other proprietary information could be breached, and we may not have adequate remedies.

•Others could independently develop substantially equivalent proprietary information or gain access to our trade secrets or proprietary information, design around our technology, or develop competing technologies.
•Our intellectual property, other proprietary technology, and other sensitive company information is dependent on sophisticated information technology systems and is potentially vulnerable to cyber-attacks, loss, theft, damage, destruction from system malfunction, computer viruses, loss of data privacy, or misappropriation or misuse of it by those with permitted access, and other events.

•We may not detect infringement.

•Intellectual property protection may also be unavailable or limited in some foreign countries.

16
We spend significant resources to protect and enforce our intellectual property rights, sometimes resulting in expensive and time-consuming litigation that is complex and may ultimately be unsuccessful. Our inability to protect our intellectual property could have a material adverse effect on our business or prospects.

Third parties may claim we are infringing their intellectual property, and we could suffer significant litigation or licensing expenses or be prevented from selling products.

During recent years, we and our competitors have been involved in substantial litigation regarding patent and other intellectual property rights which is typically costly and time-consuming. We may be forced to defend against claims and legal actions alleging infringement of the intellectual property rights of others, and, if our defense is unsuccessful, we could have significant liabilities to third parties or face injunctions that bar the sale of our products, or could require us to seek licenses from third parties. Such licenses may not be available on commercially reasonable terms, may prevent us from manufacturing, selling, or using certain products, or may be non-exclusive, which could provide our competitors access to the same technologies.

In addition, third parties could also obtain patents that may require us to either redesign products, negotiate licenses from such third parties, which may be costly, unavailable or require us to exit a particular product offering.

We and our customers are subject to rigorous governmental regulations and we may incur significant expenses to comply with these regulations and develop products that are compatible with these regulations. In addition, failure to comply with these regulations could subject us to substantial sanctions which could adversely affect our business, results of operations, and financial condition.

The medical technologies we create, study, manufacture and market globally are subject to rigorous regulation and scrutiny by the FDA and various other federal, state, and foreign governmental authorities. Government regulation applies to nearly all aspects of our products’ lifecycles, including testing, clinical study, manufacturing, transporting, sourcing, safety, labeling, storing, packaging, recordkeeping, reporting, advertising, promoting, distributing, marketing, and importing or exporting of medical devices and products. In general, unless an exemption applies, a medical device or product must receive regulatory approval or clearance before it can be marketed or sold. Modifications to existing products or the marketing of new uses for existing products also may require regulatory approvals, approval supplements, or clearances. If we are unable to obtain these required approvals, we may be required to cease manufacturing and sale, or recall or restrict the use of such modified device, pay fines, or take other action until such time as appropriate clearance or approval is obtained.

Regulatory agencies may refuse to grant approval or clearance, or review and disagree with our interpretation of approvals or clearances, or with our decision that regulatory approval is not required or has been maintained. Regulatory submissions may require the provision of additional data and may be time consuming and costly, and their outcome is uncertain. Regulatory agencies may also change policies, adopt additional regulations, or revise existing regulations, each of which could prevent or delay approval or clearance of devices, or could impact our ability to market a previously cleared, approved, or unregulated device. Our failure to comply with these regulatory requirements of the FDA or other applicable regulatory requirements in the United States or elsewhere might subject us to administratively or judicially imposed sanctions. These sanctions include, among others, warning letters, fines, civil penalties, criminal penalties, injunctions, debarment, product seizure or detention, product recalls and total or partial suspension of production, sale and/or promotion. Any of the foregoing actions could result in decreased sales including as a result of negative publicity and product liability claims, and could have a material adverse effect on our financial condition, results of operations, and prospects. In addition to the sanctions for noncompliance described above, commencement of an enforcement proceeding, inspection, or investigation could divert substantial management attention from the operation of our business and have an adverse effect on our business, results of operations, and financial condition.

We are also subject to various United States and foreign laws pertaining to health care pricing, anti-corruption, and fraud and abuse, including prohibitions on kickbacks and the submission of false claims laws and restrictions on relationships with physicians and other referral sources. These laws are broad in scope and are subject to evolving interpretation, which could require us to incur substantial costs to monitor compliance. If we are found not to be in compliance, we may be required to alter our practices or have sanctions imposed against us and our officers and employees, including substantial fines, imprisonment, and exclusion from participation in governmental health care programs.

In addition, as a global company, we are subject to global data privacy and security laws, regulations and codes of conduct that apply to our businesses. We are required to comply with increasingly complex and changing legal and regulatory requirements that govern the collection, use, storage, security, transfer, disclosure and other processing of personal data in the United States and in other countries, which may include, but are not limited to, The Health Insurance Portability and Accountability Act, as amended ("HIPAA"), The Health Information Technology for Economic and Clinical Health Act, the California Consumer Privacy Act ("CCPA"), and the European Union’s General Data Protection Regulation ("GDPR"). The GDPR imposes stringent European Union data protection requirements and provides for significant penalties for noncompliance. HIPAA also imposes stringent data privacy and security requirements and the regulatory authority has imposed
17
significant fines and penalties on organizations found to be out of compliance. CCPA provides consumers with a private right of action against companies who have a security breach due to lack of appropriate security measures. We or our third-party providers and business partners may also be subjected to audits or investigations by one or more domestic or foreign government agencies relating to compliance with information security and privacy laws and regulations, and noncompliance with the laws and regulations could result in substantial and material fines or class action litigation.

Additional risks related to government regulation are also described under "Health Care Legislation and Other Regulations" in the risk factor above titled "Because we operate globally, our business is subject to a variety of risks associated with international sales and operations."

We may incur losses from product liability or other claims that could adversely affect our operating results.

Our business exposes us to potential product liability risks that are inherent in the design, manufacture, and marketing of medical technologies. Our products are often used in surgical and intensive care settings with seriously ill patients. In addition, many of the devices we manufacture and sell are designed to be implanted in the human body for long periods of time. Component failures, manufacturing and assembly flaws, design defects, software defects, medical procedure errors, or inadequate disclosure of product-related risks or information could result in an unsafe condition, injury to, or death of, patients. Such problems could result in product liability, medical malpractice or other lawsuits and claims, safety alerts, or product recalls in the future. We establish reserves and may incur charges in excess of those reserves. Although we maintain product liability and other insurance with coverages we believe are adequate, product liability or other claims may exceed insurance coverage limits, fines, and penalties. In addition, regulatory sanctions may not be covered by insurance, or insurance may not continue to be available or available on commercially reasonable terms. These litigation matters and regulatory actions, recalls or other actions, regardless of outcome, could have a material adverse effect on our business, reputation, and ability to attract and retain customers.

Use of our products in unapproved circumstances could expose us to liabilities.

The marketing approval from the FDA and other regulators of certain of our products are, or are expected to be, limited to specific indications. We are prohibited from marketing or promoting any unapproved use of our products. Physicians, however, can use these products in ways or circumstances other than those strictly within the scope of the regulatory approval. Although the product training we provide to physicians and other health care professionals is conducted in compliance with applicable laws, and therefore, is mainly limited to approved uses or for clinical trials, no assurance can be given that claims might not be asserted against us if our products are used in ways or for procedures that are not approved.

Our operations are subject to environmental, health, and safety regulations that could result in substantial costs.

Our operations are subject to environmental, health, and safety laws, and regulations concerning, among other things, the generation, handling, transportation, and disposal of hazardous substances or wastes, the cleanup of hazardous substance releases, and emissions or discharges into the air or water. We have incurred and may incur in the future expenditures in connection with environmental, health and safety laws, and regulations. New laws and regulations, violations of these laws or regulations, stricter enforcement of existing requirements, or the discovery of previously unknown contamination could require us to incur costs or could become the basis for new or increased liabilities that could be material.

Climate change, or legal, regulatory or market measures to address climate change, may materially adversely affect our financial condition and business operations.

Climate change resulting from increased concentrations of carbon dioxide and other greenhouse gases in the atmosphere could present risks to our future operations from natural disasters and extreme weather conditions, such as hurricanes, tornadoes, seismic events, wildfires, or flooding. Such extreme weather conditions could pose physical risks to our facilities and disrupt operation of our supply chain and may impact operational costs. Concern over climate change could result in new legal or regulatory requirements designed to mitigate the effects of climate change on the environment. If such laws or regulations are more stringent than current legal or regulatory requirements, we may experience increased compliance burdens and costs to meet the regulatory obligations, and it may adversely affect our raw material sourcing, manufacturing operations, and the distribution of our products.

We are subject to risks arising from concerns and/or regulatory actions relating to animal borne illnesses, including “mad cow disease.”

Certain of our products, including pericardial tissue valves, are manufactured using bovine tissue. Concerns relating to the potential transmission of animal borne illnesses, including BSE, commonly known as "mad cow disease," from cows to humans may result in reduced acceptance of products containing bovine materials. Certain medical device regulatory agencies have considered whether to continue to permit the sale of medical devices that incorporate bovine material. We obtain bovine tissue
18
only from closely controlled sources within the United States and Australia. The bovine tissue used in our pericardial tissue valves is from tissue types considered by global health and regulatory organizations to have shown no risk of infectibility for the suspected BSE infectious agent. We have not experienced any significant adverse impact on our sales as a result of concerns regarding BSE, but no assurance can be given that such an impact may not occur in the future.

Item 1B.    Unresolved Staff Comments

None.

Item 2.    Properties

The locations and uses of our major properties are as follows:
North America  
Irvine, California(1)Corporate Headquarters, Research and Development, Regulatory and Clinical Affairs, Manufacturing, Marketing, Administration
Draper, Utah(1),(2)Manufacturing, Administration
Haina, Dominican Republic(1),(2)Manufacturing
Añasco, Puerto Rico(2)Manufacturing
Central America  
Cartago, Costa Rica(1),(2)Manufacturing
Europe  
Nyon, Switzerland(1)Administration, Marketing
Prague, Czech Republic(2)Administration
Shannon, Limerick, Ireland(1),(2)Manufacturing
Asia  
Singapore(1),(2)Manufacturing, Distribution, Administration
Tokyo, Japan(2)Administration, Marketing, Distribution
Shanghai, China(2)Administration, Marketing
Caesarea, Israel(2)Research and Development
_______________________________________________________________________________
(1)     Owned property.

(2)    Leased property.

The Draper, Utah lease expires in 2031; the Dominican Republic lease expires in 2022; the Puerto Rico property has two leases that expire in 2023; the Costa Rica lease expires in 2026; the Prague, Czech Republic lease expires in 2026; the Shannon, Ireland lease expires in 2024; the Tokyo, Japan lease expires in 2024; the Shanghai, China lease expires in 2024; Singapore has one land lease that expires in 2036 and one that expires in 2041; and the Caesarea, Israel lease expires in 2030. We believe our properties have been well maintained, are in good operating condition, and are adequate for current needs. We do not anticipate difficulty in renewing existing leases as they expire or in finding alternative facilities.

Item 3.    Legal Proceedings

For a description of our material pending legal proceedings, please see Note 18 to the "Consolidated Financial Statements" of this Annual Report on Form 10-K, which is incorporated by reference.

Item 4.    Mine Safety Disclosures

Not applicable.
19
PART II

Item 5.    Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Market Information

Our common stock is traded on the New York Stock Exchange (the "NYSE") under the symbol "EW."

Number of Stockholders

On January 31, 2022, there were 8,413 stockholders of record of our common stock.

Dividends

We have never paid any cash dividends on our capital stock and have no current plans to pay any cash dividends. Our current policy is to retain any future earnings for use in our business.

Issuer Purchases of Equity Securities

PeriodTotal Number
 of Shares 
(or Units) 
Purchased (a)		Average
Price Paid
per Share
(or Unit)		Total Number of 
Shares (or Units) 
Purchased as Part of Publicly Announced Plans or Programs		Maximum Number
(or Approximate 
Dollar Value) of 
Shares that
May Yet Be 
Purchased
Under the Plans
or Programs
(in millions) (b)
October 1, 2021 through October 31, 2021
— $— — $1,222.7 
November 1, 2021 through November 30, 2021
458,862 114.46 456,745 1,170.4 
December 1, 2021 through December 31, 2021
401,444 109.58 401,444 1,126.4 
Total860,306 112.18 858,189 
(a)    The difference between the total number of shares (or units) purchased and the total number of shares (or units) purchased as part of publicly announced plans or programs is due to shares withheld by us to satisfy tax withholding obligations in connection with the vesting of restricted stock units issued to employees.

(b)    On May 8, 2019, the Board of Directors approved a stock repurchase program authorizing us to purchase up to $1.0 billion of our common stock. On May 4, 2021, the Board of Directors approved a new stock repurchase program providing for an additional $1.0 billion of repurchases of our common stock. Repurchases under the programs may be made on the open market, including pursuant to a Rule 10b5-1 plan, and in privately negotiated transactions. These repurchase programs do not have an expiration date.


20
Performance Graph

The following graph compares the performance of our common stock with that of the S&P 500 Index and the S&P 500 Health Care Equipment Index. The cumulative total return listed below assumes an initial investment of $100 at the market close on December 31, 2016 and reinvestment of dividends. Stockholder returns over the indicated period should not be considered indicative of future stockholder returns.

ew-20211231_g1.jpg
Total Cumulative Return
20172018201920202021
Edwards Lifesciences$120.29 $163.47 $248.98 $292.09 $414.78 
S&P 500121.83 116.49 153.17 181.35 233.41 
S&P 500 Health Care Equipment130.90 152.15 196.77 231.46 276.26 

Item 6.    [Reserved]


21
Item 7.    Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis presents the factors that had a material effect on our results of operations during the two years ended December 31, 2021. Also discussed is our financial position as of December 31, 2021. You should read this discussion in conjunction with the historical consolidated financial statements and related notes included elsewhere in this Form 10-K. For a discussion related to the results of operations for 2020 compared to 2019 and a discussion related to our consolidated cash flows for 2020 compared to 2019, refer to Part II, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our 2020 Annual Report on Form 10–K filed with the Securities and Exchange Commission on February 12, 2021.

Overview

We are the global leader in patient-focused medical innovations for structural heart disease and critical care monitoring. Driven by a passion to help patients, we partner with the world's leading clinicians and researchers and invest in research and development to transform care for those impacted by structural heart disease or who require hemodynamic monitoring during surgery or in intensive care. We conduct operations worldwide and are managed in the following geographical regions: United States, Europe, Japan, and Rest of World. Our products are categorized into the following areas: Transcatheter Aortic Valve Replacement ("TAVR"), Transcatheter Mitral and Tricuspid Therapies ("TMTT"), Surgical Structural Heart ("Surgical"), and Critical Care.

Financial Highlights and COVID-19
ew-20211231_g2.jpgew-20211231_g3.jpg
The COVID-19 pandemic has adversely impacted, and may further adversely impact, nearly all aspects of our business and markets, including our workforce and the operations of our customers, suppliers, and business partners. Our priority has been to maintain access for patients to our life-saving technologies while providing continuous front-line support to our clinician partners, and protecting the well-being of our employees. Our manufacturing operations have continued to respond to impacts related to COVID-19, and we have been able to supply our technologies around the world. Across the organization, we are proactively managing inventory, assessing alternative logistics options, and closely monitoring the supply of components.

TAVR and Surgical procedure volumes varied greatly since the middle of March 2020 by geography, and even by hospital, as patients and their physicians analyzed the trade-off between aortic stenosis and their concern for COVID-19. In the last few weeks of the first quarter of 2020, procedure volumes related to our TAVR and Surgical products dropped significantly. Beginning in the second quarter of 2020, procedure volumes improved. In the second quarter of 2020, we also started to progressively resume patient enrollment in all clinical trials that were voluntarily paused or slowed at the end of the first quarter of 2020. While we saw improvements to pre-COVID levels when we resumed enrollment, procedure volumes and enrollment in our clinical trials were negatively impacted in late 2020 due to a resurgence of COVID-19. In Critical Care, during 2020 there was greater demand in Europe and the United States for our pressure monitoring products, but demand for
22
other Critical Care products began to decrease at the end of the first quarter of 2020 due to decreased hospital spending related to COVID-19, and that trend continued through the fourth quarter of 2020.

During the first quarter of 2021, COVID-19 stressed the global healthcare system during the winter months. However, we saw strong recovery beginning in the second quarter of 2021 as widespread vaccine adoption contributed to an increased number of patients. However, the Delta variant had a significant impact on hospital resources during the last two months of the third quarter of 2021, and the Omicron variant had a significant impact during December 2021, especially in the United States.

Despite the challenges associated with COVID-19, our net sales for 2021 were $5.2 billion, representing an increase of $846.2 million over 2020, driven by sales growth of our TAVR products. During the first half of 2021, United States TAVR procedures began to grow as COVID-19 hospitalizations decreased and vaccinations increased. However, TAVR sales were negatively impacted in the second half of 2021 as United States procedures declined due to the significant impact the Delta and Omicron variants had on hospital resources. Surgical sales grew during 2021 due to increased adoption of our premium high-value technologies around the world and rebounding surgical aortic treatment rates in the United States. We also saw an increased demand for our Critical Care products in 2021 as hospital capital spending continued to show signs of recovery and elevated COVID hospitalizations in the United States and Europe increased demand for our pressure monitoring devices.

Our gross profit increase in 2021 was driven by our sales growth and lower incremental costs associated with COVID-19. The increase in our diluted earnings per share in 2021 was driven by our gross profit increase and an after-tax charge of $305.1 million in 2020 to settle certain patent litigation related to transcatheter mitral and tricuspid repair products.

We are closely monitoring the impact of COVID-19 on all aspects of our business and geographies, including its impact on our customers, employees, suppliers, vendors, business partners and distribution channels. The extent to which COVID-19 and measures taken in response thereto impact our business, results of operations, and financial condition will depend on future developments, which are highly uncertain and are difficult to predict. These developments include, but are not limited to, the duration and spread of the outbreak (including new and more contagious variants of COVID-19), its severity, the actions to contain the virus or address its impact, the timing, distribution, public acceptance and efficacy of vaccines and other treatments, United States and foreign government actions to respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume. Even after the COVID-19 outbreak has subsided, we may continue to experience materially adverse impacts on our financial condition and results of operations.

Healthcare Environment, Opportunities, and Challenges

The medical technology industry is highly competitive and continues to evolve. Our success is measured both by the development of innovative products and the value we bring to our stakeholders. We are committed to developing new technologies and providing innovative patient care, and we are committed to defending our intellectual property in support of those developments. Despite the challenges of the COVID-19 pandemic, our dedicated field teams found creative ways to support physicians, our engineers continued to advance innovation, and our colleagues worked diligently to keep our clinical trials on track. In 2021, we invested 17.3% of our net sales in research and development. The following is a summary of important developments during 2021:

•we received United States Food and Drug Administration ("FDA") clearance for the Acumen Hypotension Prediction Index software with the Acumen IQ finger cuff. This is the first noninvasive solution that uses machine learning to alert clinicians of the likelihood a patient is trending toward hypotension, or low blood pressure;
•we received FDA approval for the use of the Edwards SAPIEN 3 transcatheter valve with the Alterra adaptive prestent for patients with severe pulmonary regurgitation;
•we completed enrollment in EARLY TAVR, a pivotal trial studying the treatment of severe aortic stenosis patients before their symptoms develop, and CLASP IID, a pivotal trial studying Edwards PASCAL in patients with degenerative mitral regurgitation;
•we received CE Mark approval to begin treating patients with a previously repaired or replaced valve in the pulmonic position;
•we received regulatory approval in Japan for our MITRIS valve, a new mitral valve incorporating RESILIA technology; and
•we received FDA approval for our ALLIANCE pivotal trial to study our next generation TAVR technology, SAPIEN X4.
23
We are dedicated to generating robust clinical, economic, and quality-of-life evidence increasingly expected by patients, clinicians, and payors in the current healthcare environment, with the goal of encouraging the adoption of innovative new medical therapies that demonstrate superior outcomes.

Results of Operations

Net Sales by Major Regions
(dollars in millions)
 Years Ended December 31,Change
 20212020$%
United States$2,963.1 $2,516.8 $446.3 17.7 %
Europe1,190.3 973.6 216.7 22.3 %
Japan528.9 460.1 68.8 15.0 %
Rest of World550.2 435.8 114.4 26.3 %
Outside of the United States2,269.4 1,869.5 399.9 21.4 %
Total net sales$5,232.5 $4,386.3 $846.2 19.3 %

Net sales outside of the United States include the impact of foreign currency exchange rate fluctuations. The impact of foreign currency exchange rate fluctuations on net sales is not necessarily indicative of the impact on net income due to the corresponding effect of foreign currency exchange rate fluctuations on international manufacturing and operating costs, and our hedging activities. For more information, see "Quantitative and Qualitative Disclosures About Market Risk."

Net Sales by Product Group
(dollars in millions)
 Years Ended December 31,Change
 2021 2020$%
Transcatheter Aortic Valve Replacement$3,422.5  $2,857.3  $565.2 19.8 %
Transcatheter Mitral and Tricuspid Therapies86.0 41.8 44.2 105.5 %
Surgical Heart Valve Therapy889.1  761.8  127.3 16.7 %
Critical Care834.9  725.4  109.5 15.1 %
Total net sales$5,232.5  $4,386.3  $846.2 19.3 %
24

Transcatheter Aortic Valve Replacement
ew-20211231_g4.jpg
The increase in net sales of TAVR products was driven by:

•higher sales of the Edwards SAPIEN platform in 2021 in the United States, Europe, and Japan driven by improved COVID-19 conditions compared to 2020. Sales, however, were negatively impacted in the second half of 2021 as United States procedures declined due to the significant impact COVID had on hospital resources; and

•foreign currency exchange rate fluctuations, which increased net sales outside of the United States by $33.9 million primarily due to the strengthening of the Euro against the United States dollar.

In the second quarter of 2021, we (1) received approval for a United States pivotal trial for TAVR in moderate aortic stenosis patients, (2) received approval in Japan to begin treating low-risk patients with SAPIEN 3, and (3) received SAPIEN 3 CE Mark approval to begin treating patients with a previously repaired or replaced valve in the pulmonic position. In the fourth quarter of 2021, we (1) completed enrollment of our EARLY TAVR pivotal trial, which is focused on the treatment of asymptomatic aortic stenosis patients, (2) initiated enrollment in our PROGRESS pivotal trial for moderate aortic stenosis patients, (3) received FDA approval for our ALLIANCE pivotal trial to study our next generation TAVR device, SAPIEN X4, and (4) received FDA approval for the use of the Edwards SAPIEN 3 transcatheter valve with the Alterra adaptive prestent for congenital heart patients. The Alterra prestent compensates for variations in size and morphology of the right ventricular outflow tract to provide a stable landing zone for the SAPIEN 3 valve.
25

Transcatheter Mitral and Tricuspid Therapies
ew-20211231_g5.jpg
The increase in net sales of TMTT products was due primarily to improved COVID-19 conditions compared to 2020 and continued adoption of our PASCAL system in Europe.

In the fourth quarter of 2021, we completed enrollment of our CLASP IID pivotal trial studying Edwards PASCAL in patients with degenerative mitral regurgitation. We continued to treat patients with both of our transcatheter mitral replacement therapies through the ENCIRCLE trial for SAPIEN M3 and the MISCEND study for EVOQUE Eos. The MISCEND study will evaluate the safety and performance of EVOQUE Eos, which is designed to advance the treatment of patients with mitral regurgitation with a low-profile valve delivered through a sub 30 French transfemoral delivery system. We also began treating patients with EVOQUE in the TRISCEND II pivotal trial. This study will evaluate the safety and effectiveness of the EVOQUE tricuspid valve replacement system for patients with severe tricuspid regurgitation.

Surgical Structural Heart
ew-20211231_g6.jpg
The increase in net sales of Surgical products was due primarily to improved COVID-19 conditions compared to 2020 and increased sales of the INSPIRIS RESILIA aortic valve and the KONECT aortic valved conduit, primarily in the United States. In
26
addition, foreign currency exchange rate fluctuations increased net sales outside of the United States by $13.1 million primarily due to the strengthening of the Euro against the United States dollar.
In January 2021, we received regulatory approval in Japan for our MITRIS valve, a new mitral valve incorporating RESILIA technology, which was launched in Japan during the second quarter of 2021.
Critical Care
ew-20211231_g7.jpg
The increase in net sales of Critical Care products was driven by:

•increased demand for our capital products, primarily Hemosphere platforms in the United States, as hospital capital spending continued to show signs of recovery;

•increased demand for our pressure monitoring products due to elevated COVID hospitalizations, primarily in the United States;

•increased demand for our enhanced surgical recovery products, primarily in the United States; and

•foreign currency exchange rate fluctuations, which increased net sales outside of the United States by $9.0 million primarily due to the strengthening of the Euro against the United States dollar.

In June 2021, we received FDA clearance for the Acumen Hypotension Prediction Index software with the Acumen IQ finger cuff. This is the first noninvasive solution that uses machine learning to alert clinicians of the likelihood a patient is trending toward hypotension, or low blood pressure.

27
Gross Profit

ew-20211231_g8.jpg
The increase in gross profit as a percentage of net sales in 2021 compared to 2020 was driven primarily by:

•a 0.5 percentage point increase in the United States due to an improved product mix, driven by TAVR products; and

•lower incremental costs associated with COVID-19;

partially offset by:

•a 0.5 percentage point decrease due to the impact of foreign currency exchange rate fluctuations, including the settlement of foreign currency hedging contracts.

Selling, General, and Administrative ("SG&A") Expenses
ew-20211231_g9.jpg
SG&A expenses increased in 2021 compared to 2020 due primarily to (1) increased commercial activities, primarily in the United States and Europe, compared to the COVID-19 impacted prior year, (2) higher personnel-related costs, and (3) the impact of foreign currency exchange rate fluctuations, which increased expenses by $22.2 million due primarily to the strengthening of the Euro against the United States dollar.
28

Research and Development ("R&D") Expenses
ew-20211231_g10.jpg
R&D expenses increased in 2021 compared to 2020 due primarily to continued investments in our transcatheter innovations. Clinical trial activity also increased compared to 2020 since spending in 2020 was reduced as we temporarily paused certain mitral and tricuspid active pivotal clinical trials at the end of the first quarter of 2020 due to COVID-19.

Intellectual Property Litigation Expenses, net

We incurred intellectual property litigation expenses, including settlements and external legal costs, of $20.6 million and $405.4 million during 2021 and 2020, respectively. On July 12, 2020, we reached an agreement with Abbott Laboratories and its direct and indirect subsidiaries ("Abbott") to, among other things, settle all outstanding patent disputes between the companies (the “Settlement Agreement”) in cases related to transcatheter mitral and tricuspid repair products. The Settlement Agreement resulted in us recording an estimated $367.9 million pre-tax charge and related liability in June 2020 related to past damages. In addition, we will incur royalty expenses through May 2024 totaling an estimated $100 million. We made a one-time $100.0 million payment to Abbott in July 2020, and are making quarterly payments in subsequent years. For further information, see Note 3 to the "Consolidated Financial Statements."

Change in Fair Value of Contingent Consideration Liabilities, net

The change in fair value of contingent consideration liabilities resulted in income of $124.1 million in 2021 and expense of $13.6 million in 2020. The income in 2021 was driven by changes in the projected probability and timing of milestone achievements and the projected timing of cash inflows. The expense in 2020 was primarily driven by the accretion of interest due to the passage of time and adjustments to discount rates, partially offset by changes in the projected probability and timing of milestone achievements and the projected timing of cash inflows.

Special Charges

For information on special charges, see Note 4 to the "Consolidated Financial Statements."

Interest Expense

Interest expense was $18.4 million and $15.8 million in 2021 and 2020, respectively. The increase in interest expense resulted primarily from lower capitalized interest due to decreased facilities construction.

Interest Income

Interest income was $17.4 million and $23.4 million in 2021 and 2020, respectively. The decrease in interest income resulted primarily from lower average yield, partially offset by a higher average investment balance.

29
Other Income, net
(in millions)
 Years Ended December 31,
 20212020
Foreign exchange gains, net$(5.0)$(12.3)
Gain on investments(5.8)(0.6)
Non-service cost components of net periodic pension benefit cost0.3 0.4 
Other(2.2)1.0 
Total other income, net$(12.7)$(11.5)

The net foreign exchange gains relate to the foreign currency fluctuations on our global trade and intercompany receivable and payable balances, partially offset by the gains and losses on non-designated derivative instruments.

The gain on investments primarily represents our net share of gains and losses in investments accounted for under the equity method, and realized gains and losses on investments in equity securities.

The non-service cost components of net periodic pension benefit cost includes the costs of our defined benefit plans that are not attributed to services rendered by eligible employees during the year, such as interest costs, expected return on plan assets, and amortization of actuarial gains or losses.

Provision for Income Taxes
($ in millions)
 Years Ended December 31,Change
 2021 2020$%
Provision for income taxes$198.9 $93.3 $105.6 113.2 %
Effective tax rate11.7 %10.2 %
Our effective income tax rate in 2021 and 2020 was 11.7% and 10.2%, respectively. Our effective tax rate for 2021 increased in comparison to 2020 primarily due to the impact of the litigation settlement agreement reached in 2020 with Abbott to settle all outstanding patent disputes and the decrease in the excess tax benefit from employee share-based compensation, partially offset by the tax benefit from the change in fair value of contingent consideration liabilities.

In 2021, the difference between our 11.7% effective tax rate and the Federal statutory rate of 21% was primarily due to (1) foreign earnings taxed at lower rates net of the United States tax on global intangible low-taxed income, (2) Federal and California research and development credits, (3) the excess tax benefit from employee share-based compensation and (4) the tax benefit from the change in fair value of contingent consideration liabilities.

As of December 31, 2021, we had $167.0 million of California research expenditure tax credits that we expect to use in future periods. The credits may be carried forward indefinitely. Based upon anticipated future taxable income, we expect that it is more likely than not that all California research expenditure tax credits will be utilized, although the utilization of the full benefit is expected to occur over a number of years into the distant future.

As of December 31, 2021, our gross uncertain tax positions were $358.4 million. We estimate that these liabilities would be reduced by $135.1 million from offsetting tax benefits associated with the correlative effects of potential transfer pricing adjustments, state income taxes, and timing adjustments. The net amount of $223.3 million, if not required, would favorably affect our effective tax rate.

In the normal course of business, the Internal Revenue Service ("IRS") and other taxing authorities are in different stages of examining various years of our tax filings. During these audits, we may receive proposed audit adjustments that could be material. Therefore, there is a possibility that an adverse outcome in these audits could have a material effect on our results of operations and financial condition. We strive to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time. While we have accrued for matters we believe are more likely than not to require settlement, the eventual outcome with a tax authority may result in a tax liability that is more or less than that reflected in the consolidated financial statements. Furthermore, we may later decide to challenge any assessments, if made, and may exercise our right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential
30
liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law. We believe that adequate amounts of tax and related penalty and interest have been provided in income tax expense for any adjustments that may result from our uncertain tax positions.

At December 31, 2021, all material state, local, and foreign income tax matters have been concluded for years through 2015. While not material, we continue to address matters in India for years from 2010.

We executed an Advance Pricing Agreement (“APA”) in 2018 between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters. The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement (collectively "Surgical/TAVR") intercompany royalty transactions, then reverted to IRS Examination for further consideration as part of the respective years' regular tax audits. In addition, we executed other bilateral APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Japan and Singapore and between Switzerland and Japan covering tax years 2015 through 2019. We have filed to renew all of the APAs which cover transactions with Japan for the years 2020 and forward. The execution of some or all these APA renewals depends on many variables outside of our control.

Our United States federal income tax returns through 2014 have been audited. The IRS began its examination of the 2015 and 2016 tax years during the fourth quarter of 2018 and later added the 2017 tax year to this audit cycle during the first quarter of 2019. The IRS audit field work for the 2015-2017 tax years was substantially completed during the fourth quarter of 2020, except for transfer pricing and related matters.

During the second quarter of 2021, we received a Notice of Proposed Adjustment (“NOPA”) from the IRS for the 2015-2017 tax years relating to transfer pricing involving certain Surgical/TAVR intercompany royalty transactions between our United States and Switzerland subsidiaries. During the third quarter of 2021, we completed our review of the NOPA and provided comments to the IRS and the IRS subsequently revised the NOPA. The revised NOPA proposes an increase to our United States taxable income which could result in additional tax expense for this period of approximately $180 million and represents a significant change to previously agreed upon transfer pricing methodologies for these types of transactions.

We have formally disagreed with the NOPA and have submitted a formal protest on the matter to the IRS Independent Office of Appeals during the fourth quarter of 2021. We also have received the final Revenue Agent's Report for these tax years. We continue to evaluate all possible remedies available to us, which could take several years to resolve. No payment of any amount related to the NOPA is required to be made, if at all, until all applicable proceedings have been completed. We believe the amounts previously accrued related to this uncertain tax position are sufficient and, accordingly, have not accrued any additional amount based on the NOPA received.

Certain Surgical/TAVR intercompany royalty transactions covering tax years 2015 - 2021 that were not resolved under the APA program remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of December 31, 2021. We have considered this information, as well as information regarding the NOPA described above, in our evaluation of our uncertain tax positions. The impact of these unresolved transfer pricing matters, net of any correlative repatriation tax adjustment, may be significant to our consolidated financial statements. Based on the information currently available and numerous possible outcomes, we cannot reasonably estimate what, if any, changes in our existing uncertain tax positions may occur in the next 12 months and, therefore, have continued to record the uncertain tax positions as a long-term liability.

We have received tax incentives in certain non-United States tax jurisdictions, the primary benefit for which will expire in 2029. The tax reductions as compared to the local statutory rates were $208.0 million ($0.33 per diluted share) and $189.2 million ($0.30 per diluted share) for the years ended December 31, 2021 and 2020, respectively.

Beginning in 2022, the Tax Cuts and Jobs Act of 2017 (the "2017 Act"), which was signed into law on December 22, 2017, eliminates the option to deduct research and development expenditures currently and requires taxpayers to amortize domestic expenditures over five years and foreign expenditures over fifteen years. Although Congress is considering legislation that would defer the amortization requirement to later years, we have no assurance that the provision will be repealed or otherwise modified. If the requirement is not modified, it will materially reduce our cash flows beginning in 2022.

31
Liquidity and Capital Resources

Our sources of cash liquidity include cash and cash equivalents, short-term investments, cash from operations, and amounts available under credit facilities. We believe that these sources are sufficient to fund the current and long-term requirements of working capital, capital expenditures, and other financial commitments. However, we periodically consider various financing alternatives and may, from time to time, seek to take advantage of favorable interest rate environments or other market conditions.

The 2017 Act included extensive changes to the international tax regime. The 2017 Act required a deemed repatriation of post-1986 undistributed foreign earnings and profits. The one-time transition tax liability, as adjusted, is payable in four remaining annual installments, as outlined in the contractual obligations table below. As of December 31, 2021, we had a remaining tax obligation of $213.1 million related to the deemed repatriation. See Note 17 to the "Consolidated Financial Statements" for additional information about the one-time transition tax.

As of December 31, 2021, cash and cash equivalents and short-term investments held in the United States and outside of the United States were $903.4 million and $563.4 million, respectively. During 2021, we repatriated cash of $1.1 billion. We assert that $1.0 billion of our foreign earnings continue to be permanently reinvested and our intent is to repatriate $392.9 million of our foreign earnings as of December 31, 2021.

We have a Five-Year Credit Agreement ("the Credit Agreement") which matures on April 28, 2023. The Credit Agreement provides up to an aggregate of $750.0 million in borrowings in multiple currencies. Subject to certain terms and conditions, we may increase the amount available under the Credit Agreement by up to an additional $250.0 million in the aggregate. As of December 31, 2021, there were no borrowings outstanding under the Credit Agreement. The Credit Agreement is unsecured and contains various financial and other covenants, including a maximum leverage ratio, as defined in the Credit Agreement. The Company was in compliance with all covenants at December 31, 2021.

In June 2018, we issued $600.0 million of 4.3% fixed-rate unsecured senior notes (the "2018 Notes") due June 15, 2028. We may redeem the 2018 Notes, in whole or in part, at any time and from time to time at specified redemption prices. As of December 31, 2021, we have not elected to redeem any of the 2018 Notes. As of December 31, 2021, the total carrying value of our 2018 Notes was $595.7 million. For further information on our debt, see Note 10 to the "Consolidated Financial Statements."

From time to time, we repurchase shares of our common stock under share repurchase programs authorized by the Board of Directors. We consider several factors in determining when to execute share repurchases, including, among other things, expected dilution from stock plans, cash capacity, and the market price of our common stock. During 2021, under the Board authorized repurchase programs, we repurchased a total of 5.6 million shares at an aggregate cost of $498.5 million, and as of December 31, 2021, we had remaining authority to purchase $1.1 billion of our common stock. In January 2022, we entered into an accelerated share repurchase agreement to repurchase $250.0 million of our common stock. For further information, see Notes 14 and 21 to the "Consolidated Financial Statements."

Certain of our business acquisitions involve contingent consideration arrangements. Payment of additional consideration in the future may be required, contingent upon the acquired business reaching certain performance milestones, such as attaining specified revenue levels or obtaining regulatory approvals. For further information, see Note 11 to the "Consolidated Financial Statements."

In April 2021, we purchased an exclusive option to acquire a medical device company (the "Investee") for up to approximately $390 million, depending on the paid-in capital at closing. Per the agreement, depending on the Investee's achievement of certain milestones, we may be required to invest up to an additional $9.9 million in the Investee's equity securities and up to an additional $21.8 million for the option to acquire the Investee, of which we invested $10.8 million in 2021 upon achievement of the first milestone. We also agreed to loan the Investee up to $45 million under a secured promissory note. For further information, see Note 7 to the "Consolidated Financial Statements."

On July 12, 2020, we reached the Settlement Agreement with Abbott to settle all outstanding patent disputes between the companies in cases related to transcatheter mitral and tricuspid repair products. The Settlement Agreement resulted in us recording an estimated $367.9 million pretax charge in June 2020 related to past damages. In addition, we will incur royalty expenses through May 2024 totaling an estimated $100 million. We made a one-time $100.0 million payment to Abbott in July 2020, and are making quarterly payments in subsequent years. For further information, see Note 3 to the "Consolidated Financial Statements."
32
Consolidated Cash Flows - For the twelve months ended December 31, 2021 and 2020
ew-20211231_g11.jpg ew-20211231_g12.jpg ew-20211231_g13.jpg
Net cash flows provided by operating activities of $1.7 billion for 2021 increased $677.8 million from 2020 due to (1) improved operating performance in 2021, (2) a higher bonus payout in 2020 associated with 2019 performance, and (3) a payment of $100.0 million in 2020 for a litigation settlement.

Net cash used in investing activities of $1.7 billion in 2021 consisted primarily of capital expenditures of $325.8 million and net purchases of investments of $1.4 billion.

Net cash used in investing activities of $531.1 million in 2020 consisted primarily of capital expenditures of $407.0 million and net purchases of investments of $87.6 million.

We currently anticipate making capital expenditures of approximately $300 million in 2022 as we continue to invest in our operations.
Net cash used in financing activities of $356.3 million in 2021 consisted primarily of purchases of treasury stock of $512.8 million, partially offset by proceeds from stock plans of $158.6 million.

Net cash used in financing activities of $486.9 million in 2020 consisted primarily of purchases of treasury stock of $625.4 million, partially offset by proceeds from stock plans of $140.5 million.

Material Cash Requirements

A summary of our material cash requirements as of December 31, 2021 is as follows (in millions):
 Payments Due by Period
Contractual ObligationsTotalYear 1
Years 2-3
Years 4-5		After 5
Years
Debt$600.0 $— $— $— $600.0 
Operating leases104.5 27.5 36.6 15.8 24.6 
Interest on debt125.0 20.0 38.6 38.4 28.0 
Transition tax on unremitted foreign earnings and profits (a)213.1 25.1 109.5 78.5 — 
Litigation settlement obligation (minimum payments)212.5 50.0 100.0 62.5 — 
Pension obligations (b)2.2 2.2 — — — 
Purchase and other commitments (c)30.1 14.3 10.5 2.9 2.4 
Total contractual cash obligations (d), (e)$1,287.4 $139.1 $295.2 $198.1 $655.0 
_______________________________________________________________________________
(a)     As of December 31, 2021, we had recorded $213.1 million of income tax liabilities related to the one-time transition tax that resulted from the enactment of the 2017 Act. The transition tax is due in eight annual installments, with the first four installments paid in 2018 through 2021. The remaining installment amounts will be equal to 8% of the total liability payable in 2022, 15% in 2023, 20% in 2024, and 25% in 2025. See Note 17 to the "Consolidated Financial Statements" for additional information about the one-time transition tax.

33
(b)    The amount included in "Less Than 1 Year" reflects anticipated contributions to our various pension plans. Anticipated contributions beyond one year are not determinable. The total accrued benefit liability for our pension plans recognized as of December 31, 2021 was $41.0 million. This amount is impacted by, among other items, pension expense funding levels, changes in plan demographics and assumptions, and investment returns on plan assets. Therefore, we are unable to make a reasonably reliable estimate of the amount and period in which the liability might be paid, and did not include this amount in the contractual obligations table. See Note 13 to the "Consolidated Financial Statements" for further information.

(c)    Purchase and other commitments consists primarily of open purchase orders for the acquisition of goods and services in the normal course of business. We have excluded open purchase orders with a remaining term of less than one year. For certain purchase and other commitments, such as commitments to fund equity method or other investments, the timing of the payment is not certain. In these cases, the maturity dates in the table reflect our best estimates.

(d)    As of December 31, 2021, the gross liability for uncertain tax positions, including interest, was $386.0 million and relates primarily to transfer pricing matters which are discussed in detail in Note 17 to the "Consolidated Financial Statements." Based upon the information currently available and numerous possible outcomes, we cannot reasonably estimate the amount and period in which the liability might be paid, and did not include this amount in the contractual obligations table.

(e)    We acquire assets still in development, enter into research and development arrangements, acquire businesses, and sponsor certain clinical trials that often require milestone, royalty, or other future payments to third-parties, contingent upon the occurrence of certain future events. In situations where we have no ability to influence the achievement of the milestone or otherwise avoid the payment, we have included those payments in the table above. However, we have excluded from the table contingent milestone payments and other contingent liabilities for which we cannot reasonably predict future payments or for which we can avoid making payment by unilaterally deciding to stop development of a product or cease progress of a clinical trial. We estimate that these contingent payments could be up to $835.0 million if all milestones or other contingent obligations are met. This amount includes certain milestone-based contingent obligations that may be paid through a combination of cash and issuance of common stock, and certain sales-based royalties in excess of minimum payment thresholds related to litigation settlements.

Critical Accounting Policies and Estimates

Our results of operations and financial position are determined based upon the application of our accounting policies, as discussed in the notes to the "Consolidated Financial Statements." Certain of our accounting policies represent a selection among acceptable alternatives under GAAP. In evaluating our transactions, management assesses all relevant GAAP and chooses the accounting policy that most accurately reflects the nature of the transactions.

The application of accounting policies requires the use of judgments and estimates. These matters that are subject to judgments and estimates are inherently uncertain, and different amounts could be reported using different assumptions and estimates. Management uses its best estimates and judgments in determining the appropriate amount to reflect in the consolidated financial statements, using historical experience and all available information. We also use outside experts where appropriate. We apply estimation methodologies consistently from year to year.

We believe the following are the critical accounting policies which could have the most significant effect on our reported results and require subjective or complex judgments by management.

Revenue Recognition

When we recognize revenue from the sale of our products, the amount of consideration we ultimately receive varies depending upon the return terms, sales rebates, discounts, and other incentives that we may offer, which are accounted for as variable consideration when estimating the amount of revenue to recognize. The estimate of variable consideration requires significant judgment. We include estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely upon an assessment of historical payment experience, historical relationship to revenues, estimated customer inventory levels, and current contract sales terms with direct and indirect customers. Product returns are typically not significant because returns are generally not allowed unless the product is damaged at time of receipt. If the historical data and inventory estimates used to calculate the variable consideration do not approximate future activity, our financial position, results of operations, and cash flows could be impacted.

34
In addition, in limited circumstances, we may allow customers to return previously purchased products, such as for next-generation product offerings. For these transactions, we defer recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls, and variation in product utilization all affect the estimates related to sales returns and could cause actual returns to differ from these estimates.

Our sales adjustment related to distributor rebates given to our United States distributors represents the difference between our sales price to the distributor and the negotiated price to be paid by the end-customer. We validate the distributor rebate accrual quarterly through either a review of the inventory reports obtained from our distributors or an estimate of the distributor's inventory. This distributor inventory information is used to verify the estimated liability for future distributor rebate claims based on historical rebates and contract rates. We periodically monitor current pricing trends and distributor inventory levels to ensure the credit for future distributor rebates is fairly stated.

Excess and Obsolete Inventory

The valuation of our inventory requires us to estimate excess, obsolete, and expired inventory. We base our provisions for excess, obsolete, and expired inventory on our estimates of forecasted sales. A significant change in the timing or level of demand for our products as compared to forecasted amounts may result in recording additional allowances for excess, obsolete, and expired inventory in the future. In addition, our industry is characterized by rapid product development and frequent new product introductions. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls, increasing levels of consigned inventory, and variation in product utilization all affect our estimates related to excess, obsolete, and expired inventory.

Intangible Assets and Long-lived Assets

We acquire intangible assets in connection with business combinations and asset purchases. The acquired intangible assets are recorded at fair value, which is determined based on a discounted cash flow analysis. The determination of fair value requires significant estimates, including, but not limited to, the amount and timing of projected future cash flows, the discount rate used to discount those cash flows, the assessment of the asset's life cycle, including the timing and expected costs to complete in-process projects, and the consideration of legal, technical, regulatory, economic, and competitive risks.

In-process research and development assets acquired in business combinations is reviewed for impairment annually, or whenever an event occurs or circumstances change that would indicate the carrying amount may be impaired. Additionally, management reviews the carrying amounts of other intangible and long-lived assets whenever events or circumstances indicate that the carrying amounts of an asset may not be recoverable. The impairment reviews require significant estimates about fair value, including estimation of future cash flows, selection of an appropriate discount rate, and estimates of long-term growth rates.

Contingent Consideration

We record contingent consideration resulting from a business combination at its fair value on the acquisition date. We determine the fair value of the contingent consideration based primarily on the following factors:

•discount rates used to present value the projected cash flows;

•the probability of success of clinical events and regulatory approvals, and/or meeting commercial milestones;

•projected payment dates; and

•volatility of future sales.

On a quarterly basis, we revalue these obligations and record changes in their fair value as an adjustment to earnings. Changes to contingent consideration obligations can result from adjustments to discount rates, accretion of the discount rates due to the passage of time, changes in our estimates of the likelihood or timing of achieving development or commercial milestones, changes in the probability of certain clinical events, or changes in the assumed probability associated with regulatory approval.

35
The assumptions related to determining the value of contingent consideration include a significant amount of judgment, and any changes in the underlying estimates could have a material impact on the amount of contingent consideration expense recorded in any given period.

Income Taxes

The determination of our provision for income taxes requires significant judgment, the use of estimates, and the interpretation and application of complex tax laws. Realization of certain deferred tax assets, primarily tax credits, net operating loss and other carryforwards, is dependent upon generating sufficient taxable income in the appropriate jurisdiction prior to the expiration of the carryforward periods. Failure to achieve forecasted taxable income in the applicable taxing jurisdictions could affect the ultimate realization of deferred tax assets and could result in an increase in our effective tax rate on future earnings.

We have made an accounting policy election to recognize the United States tax effects of global intangible low-taxed income as a component of income tax expense in the period the tax arises.

We are subject to income taxes in the United States and numerous foreign jurisdictions. Our income tax returns are periodically audited by domestic and foreign tax authorities. These audits include questions regarding our tax filing positions, including the timing and amount of deductions and the allocation of income amongst various tax jurisdictions. We evaluate our tax positions and establish liabilities in accordance with the applicable accounting guidance on uncertainty in income taxes. Significant judgment is required in evaluating our uncertain tax positions, including estimating the ultimate resolution to intercompany pricing controversies between countries when there are numerous possible outcomes. We review these tax uncertainties quarterly and adjust the liability as events occur that affect potential liabilities for additional taxes, such as the progress of tax audits, lapsing of applicable statutes of limitations, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law.

For additional details on our income taxes, see Note 2 and Note 17 to the "Consolidated Financial Statements."

Stock-based Compensation

We measure and recognize compensation expense for all stock-based awards based on estimated fair values. Stock-based awards consist of stock options, service-based restricted stock units, market-based restricted stock units, and employee stock purchase subscriptions. The fair value of each option award and employee stock purchase subscription is estimated on the date of grant using the Black-Scholes option valuation model. The fair value of market-based restricted stock units is determined using a Monte Carlo simulation model, which uses multiple input variables to determine the probability of satisfying the market condition requirements. The Black-Scholes and Monte Carlo models require various highly judgmental assumptions, including stock price volatility, risk-free interest rate, and expected option term. Stock-based compensation expense is recorded net of estimated forfeitures. Judgment is required in estimating the stock awards that will ultimately be forfeited. If actual results differ significantly from these estimates, stock-based compensation expense and our results of operations would be impacted.

Legal Contingencies

We are or may be a party to, or may otherwise be responsible for, pending or threatened lawsuits, including those related to products and services currently or formerly manufactured or performed by us, workplace and employment matters, matters involving real estate, our operations or health care regulations, or governmental investigations. We accrue for loss contingencies to the extent that we conclude that it is probable that a loss will be incurred and the amount of the loss can be reasonably estimated. If a reasonable estimate of a known or probable loss cannot be made, but a range of probable losses can be estimated, the low-end of the range of losses is recognized if no amount within the range is a better estimate than any other. If we determine that a loss is possible, but not probable, and the range of the loss can be reasonably determined, then we disclose the range of the possible loss. These matters raise difficult and complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. As such, significant judgment is required in determining our legal accruals. We describe our legal proceedings in Note 18 to the "Consolidated Financial Statements."

New Accounting Standards

Information regarding new accounting standards is included in Note 2 to the "Consolidated Financial Statements."

36
Item 7A.    Quantitative and Qualitative Disclosures About Market Risk

Our business and financial results are affected by fluctuations in world financial markets, including changes in currency exchange rates and interest rates. We manage these risks through a combination of normal operating and financing activities and derivative financial instruments. We do not use derivative financial instruments for trading or speculative purposes.

Interest Rate Risk

Our exposure to market risk for changes in interest rates relates primarily to our investment portfolio and our long-term debt. Our investment strategy is focused on preserving capital and supporting our liquidity requirements, while earning a reasonable market return. We invest in a variety of debt securities, primarily time deposits, commercial paper, United States and foreign government and agency securities, asset-backed securities, corporate debt securities, and municipal debt securities. The market value of our investments may decline if current market interest rates rise. As of December 31, 2021, we had $2.3 billion of investments in debt securities which had an average remaining term to maturity of 1.29 years. Taking into consideration the average maturity of our debt securities, a hypothetical 0.5% to 1.0% absolute increase in interest rates at December 31, 2021 would have resulted in a $15.3 million to $30.6 million decrease in the fair value of these investments. Such a decrease would only result in a realized loss if we choose or are forced to sell the investments before the scheduled maturity, which we currently do not anticipate.

For more information related to investments, see Note 7 to the "Consolidated Financial Statements."

We are also exposed to interest rate risk on our debt obligations. As of December 31, 2021, we had $600.0 million of 2018 Notes outstanding that carry a fixed rate, and also had available a $750.0 million Credit Agreement that carries a variable interest rate based on the London interbank offered rate ("LIBOR"). As of December 31, 2021, there were no borrowings outstanding under the Credit Agreement. Based on our December 31, 2021 variable debt levels, a hypothetical 1.0% absolute increase in floating market interest rates would not have impacted our interest expense since we had no variable debt outstanding during the year. As of December 31, 2021, a hypothetical 1.0% absolute increase in market interest rates would decrease the fair value of the fixed-rate debt by approximately $36.0 million. This hypothetical change in interest rates would not impact the interest expense on the fixed-rate debt.

For more information related to outstanding debt obligations, see Note 10 to the "Consolidated Financial Statements."

Currency Risk

We are exposed to foreign currency risks that arise from normal business operations. These risks include the translation of local currency balances and results of our non-United States subsidiaries into United States dollars, currency gains and losses related to intercompany and third-party transactions denominated in currencies other than a subsidiary's functional currency, and currency gains and losses associated with intercompany loans. Our principal currency exposures relate to the Euro and the Japanese yen. Our objective is to minimize the volatility of our exposure to these risks through a combination of normal operating and financing activities and the use of derivative financial instruments in the form of foreign currency forward exchange contracts and cross currency swap contracts. The total notional amount of our derivative financial instruments entered into for foreign currency management purposes at December 31, 2021 was $1.8 billion. A hypothetical 10% increase/decrease in the value of the United States dollar against all hedged currencies would increase/decrease the fair value of these derivative contracts by $134.9 million. Any gains or losses on the fair value of derivative contracts would generally be offset by gains and losses on the underlying transactions, so the net impact would not be significant to our financial condition or results of operations.

For more information related to outstanding foreign exchange contracts, see Note 2 and Note 12 to the "Consolidated Financial Statements."

Credit Risk

Derivative financial instruments involve credit risk in the event the financial institution counterparty should default. It is our policy to execute such instruments with major financial institutions that we believe to be creditworthy. At December 31, 2021, all derivative financial instruments were with bank counterparties assigned investment grade ratings by national rating agencies. We further diversify our derivative financial instruments among counterparties to minimize exposure to any one of these entities. We have not experienced a counterparty default and do not anticipate any non-performance by our current derivative counterparties.

37
Concentrations of Risk

We invest excess cash in a variety of debt securities, and diversify the investments between financial institutions. Our investment policy limits the amount of credit exposure to any one issuer.

In the normal course of business, we provide credit to customers in the health care industry, perform credit evaluations of these customers, and maintain allowances for potential credit losses, which have historically been adequate compared to actual losses. In 2021, we had no customers that represented 10% or more of our total net sales or accounts receivable, net.

Investment Risk

We are exposed to investment risks related to changes in the underlying financial condition and credit capacity of certain of our investments. As of December 31, 2021, we had $2.3 billion of investments in debt securities of various companies, of which $1.7 billion were long-term. In addition, we had $92.5 million of investments in equity instruments. Should these companies experience a decline in financial performance, financial condition or credit capacity, or fail to meet certain development milestones, including as a result of the impact from COVID-19 on their business or operations or otherwise, a decline in the investments' value may occur, resulting in unrealized or realized losses.

38
Item 8.    Financial Statements and Supplementary Data


INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2021

Financial Statements: 
For the Years Ended December 31, 2021, 2020, and 2019:
 
All other schedules are omitted as they are not applicable or the required information is furnished in the Consolidated Financial Statements or notes thereto. 

39
Report of Independent Registered Public Accounting Firm

To the Board of Directors and Stockholders of Edwards Lifesciences Corporation

Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated balance sheets of Edwards Lifesciences Corporation and its subsidiaries (the “Company”) as of December 31, 2021 and 2020, and the related consolidated statements of operations, of comprehensive income, of stockholders’ equity and of cash flows for each of the three years in the period ended December 31, 2021, including the related notes (collectively referred to as the “consolidated financial statements”). We also have audited the Company's internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2021 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.

Basis for Opinions

The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management's Report on Internal Control Over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

40
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matters
The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that (i) relate to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

Uncertain Tax Positions Related to Intercompany Transfer Pricing

As described in Note 17 to the consolidated financial statements, the Company had an uncertain gross tax position liability balance of $358.4 million as of December 31, 2021, of which a majority is related to intercompany transfer pricing. As disclosed by management, the Company is subject to income taxes in the United States and numerous foreign jurisdictions. The Company’s income tax returns in these jurisdictions are periodically audited by domestic and foreign tax authorities. These audits include questions regarding the Company’s tax filing positions, including the timing and amount of deductions and the allocation of income amongst various tax jurisdictions. Significant judgment is required by management in evaluating uncertain tax positions, including estimating the ultimate resolution to intercompany pricing controversies between countries when there are numerous possible outcomes.

The principal considerations for our determination that performing procedures relating to uncertain tax positions related to intercompany transfer pricing is a critical audit matter are the significant judgment by management when determining uncertain tax positions related to intercompany transfer pricing, including a high degree of estimation uncertainty in estimating the ultimate resolution to intercompany pricing controversies between countries when there are numerous possible outcomes. This in turn led to a high degree of auditor judgment, effort, and subjectivity in performing procedures to evaluate the accurate measurement of uncertain tax positions related to intercompany transfer pricing. In addition, the audit effort involved the use of professionals with specialized skill and knowledge.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to intercompany transfer pricing, and controls over measurement of the liability. These procedures also included, among others (i) testing the information used in the calculation of the liability for uncertain tax positions related to intercompany transfer pricing, including US federal filing positions, and the related final income tax returns; (ii) testing the calculation of the liability for uncertain tax positions related to intercompany transfer pricing, by jurisdiction, including management’s assessment of the technical merits of tax positions and estimates of the amount of tax benefit expected to be sustained; (iii) testing management’s assessment of possible outcomes of uncertain tax positions related to intercompany transfer pricing controversies between countries; and (iv) evaluating the status and results of income tax audits with the relevant tax authorities. Professionals with specialized skill and knowledge were used to assist in the evaluation of the accurate measurement of the Company’s uncertain tax positions related to intercompany transfer pricing, including evaluating the reasonableness of management’s assessment of whether tax positions are more-likely-than not to be sustained and the amount of potential tax benefit to be realized, and the application of relevant tax laws.

Fair Value of Contingent Consideration Liabilities
As described in Note 11 to the consolidated financial statements, certain of the Company’s acquisitions involve contingent consideration arrangements. As of December 31, 2021, the Company had a contingent consideration liability of $62.0 million. Payment of additional consideration is contingent upon the acquired company reaching certain performance milestones, such as attaining specified sales levels or obtaining regulatory approvals. These contingent consideration liabilities are measured by management at estimated fair value using either a probability weighted discounted cash flow analysis or a Monte Carlo simulation model, both of which consider significant unobservable inputs. These inputs include (1) the discount rate used to present value the projected cash flows, (2) the probability of milestone achievement, (3) the projected payment dates, and (4) the volatility of future sales.
The principal considerations for our determination that performing procedures relating to the fair value of contingent consideration liabilities is a critical audit matter are the significant judgment by management when estimating the fair value of
41
these contingent consideration liabilities, including a high degree of estimation uncertainty in evaluating the discount rate, the probability of milestone achievement, the projected payment dates, and the volatility of future sales. This in turn led to a high degree of auditor judgment, effort, and subjectivity in performing procedures to evaluate the fair value of contingent consideration liabilities. In addition, the audit effort involved the use of professionals with specialized skill and knowledge.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to management’s process for estimating the fair value of contingent consideration liabilities, including controls over the determination of the significant unobservable inputs selected by management. These procedures also included, among others (i) testing management’s process for estimating the fair value of these contingent consideration liabilities and (ii) testing management’s probability weighted discounted cash flow analysis or Monte Carlo simulation model used to estimate the fair value of the contingent consideration liabilities. Testing management’s process included evaluating the appropriateness of the valuation methods used and the reasonableness of the significant assumptions related to the discount rate, the probability of milestone achievement, the projected payment dates, and the volatility of future sales. Evaluating the reasonableness of the probability of milestone achievement and projected payment dates involved consideration of information obtained from the Company’s product engineers, clinical trial data, and third-party industry data. The reasonableness of the discount rate was evaluated by considering the cost of capital of comparable businesses and other industry factors. Professionals with specialized skill and knowledge were used to assist in the evaluation of the reasonableness of significant assumptions related to the discount rate and volatility of future sales. 



/s/ PricewaterhouseCoopers LLP
Irvine, California
February 14, 2022

We have served as the Company’s auditor since 1999.
42
EDWARDS LIFESCIENCES CORPORATION
CONSOLIDATED BALANCE SHEETS
(in millions, except par value)
December 31,
20212020
ASSETS
Current assets  
Cash and cash equivalents$862.8 $1,183.2 
Short-term investments (Note 7)604.0 219.4 
Accounts receivable, net of allowances of $9.3 and $9.6, respectively
582.2 514.6 
Other receivables82.7 88.2 
Inventories (Note 5)726.7 802.3 
Prepaid expenses85.2 75.1 
Other current assets237.1 208.2 
Total current assets3,180.7 3,091.0 
Long-term investments (Note 7)1,834.2 801.6 
Property, plant, and equipment, net (Note 5)1,546.6 1,395.2 
Operating lease right-of-use assets (Note 6)92.1 94.2 
Goodwill (Note 9)1,167.9 1,173.2 
Other intangible assets, net (Note 9)323.6 331.4 
Deferred income taxes246.7 230.9 
Other assets110.8 119.6 
Total assets$8,502.6 $7,237.1 
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities  
Accounts payable$204.5 $196.5 
Accrued and other liabilities (Note 5)802.3 670.2 
Operating lease liabilities (Note 6)25.5 27.2 
Total current liabilities1,032.3 893.9 
Long-term debt (Note 10)595.7 595.0 
Contingent consideration liabilities (Notes 8 and 11)62.0 186.1 
Taxes payable (Note 17)190.0 215.3 
Operating lease liabilities (Note 6)69.1 72.7 
Uncertain tax positions (Note 17)259.0 214.4 
Litigation settlement accrual (Note 3)191.3 233.0 
Other liabilities267.3 252.4 
Total liabilities2,666.7 2,662.8 
Commitments and contingencies (Notes 6, 10, and 18)
Stockholders' equity (Notes 14 and 21)
  
Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding
— — 
Common stock, $1.00 par value, 1,050.0 shares authorized, 642.0 and 636.4 shares issued, and 624.1 and 624.3 shares outstanding, respectively
642.0 636.4 
Additional paid-in capital1,700.4 1,438.1 
Retained earnings6,068.1 4,565.0 
Accumulated other comprehensive loss(157.7)(161.1)
Treasury stock, at cost, 17.9 and 12.1 shares, respectively
(2,416.9)(1,904.1)
Total stockholders' equity5,835.9 4,574.3 
Total liabilities and stockholders' equity$8,502.6 $7,237.1 
   
The accompanying notes are an integral part of these consolidated financial statements.
43
EDWARDS LIFESCIENCES CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(in millions, except per share information)
Years Ended December 31,
 202120202019
Net sales$5,232.5 $4,386.3 $4,348.0 
Cost of sales1,248.9 1,080.6 1,114.4 
Gross profit3,983.6 3,305.7 3,233.6 
Selling, general, and administrative expenses1,493.7 1,228.4 1,242.2 
Research and development expenses903.1 760.7 752.7 
Intellectual property litigation expenses, net (Note 3)20.6 405.4 33.4 
Change in fair value of contingent consideration liabilities, net(124.1)13.6 (6.1)
Special charges (Note 4)— — 64.6 
Operating income1,690.3 897.6 1,146.8 
Interest expense18.4 15.8 20.7 
Interest income(17.4)(23.4)(32.2)
Other income, net (Note 16)(12.7)(11.5)(8.2)
Income before provision for income taxes1,702.0 916.7 1,166.5 
Provision for income taxes (Note 17)198.9 93.3 119.6 
Net income$1,503.1 $823.4 $1,046.9 
Share information (Note 2):
   
Earnings per share:   
Basic$2.41 $1.32 $1.68 
Diluted$2.38 $1.30 $1.64 
Weighted-average number of common shares outstanding:  
Basic623.3 622.6 624.8 
Diluted631.2 631.9 636.7 

   The accompanying notes are an integral part of these consolidated financial statements.

44
EDWARDS LIFESCIENCES CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in millions)
 Years Ended December 31,
 202120202019
Net income$1,503.1 $823.4 $1,046.9 
Other comprehensive income (loss), net of tax (Note 15):   
Foreign currency translation adjustments(50.1)32.4 (11.2)
Unrealized gain (loss) on hedges57.4 (40.2)(11.1)
Unrealized pension credits (costs)11.6 (4.2)(1.9)
Unrealized (loss) gain on available-for-sale investments(24.1)6.6 6.3 
Reclassification of net realized investment loss to earnings8.6 0.3 0.4 
Other comprehensive income (loss), net of tax3.4 (5.1)(17.5)
Comprehensive income$1,506.5 $818.3 $1,029.4 
   
The accompanying notes are an integral part of these consolidated financial statements.

45
EDWARDS LIFESCIENCES CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)
 Years Ended December 31,
 202120202019
Cash flows from operating activities   
Net income$1,503.1 $823.4 $1,046.9 
Adjustments to reconcile net income to cash provided by operating activities:  
Depreciation and amortization134.8 107.2 89.3 
Non-cash operating lease cost28.5 28.2 25.3 
Stock-based compensation (Notes 2 and 14)109.3 92.6 81.3 
Inventory write off (Note 2)— — 73.1 
Impairment charges (Note 4)— — 40.6 
Change in fair value of contingent consideration liabilities, net (Note 11)(124.1)13.6 (6.1)
Deferred income taxes(41.4)(49.4)12.1 
Purchased in-process research and development (Note 4)— — 24.0 
Other(23.4)(3.5)(2.8)
Changes in operating assets and liabilities:  
Accounts and other receivables, net(91.1)41.9 (88.0)
Inventories19.0 (120.6)(105.4)
Prepaid expenses and other current assets7.9 (28.5)(6.8)
Accounts payable and accrued liabilities195.2 (84.5)116.5 
Litigation settlement accrual(29.2)270.5 (180.0)
Income taxes62.0 (52.9)43.2 
Other(18.5)16.3 19.7 
Net cash provided by operating activities1,732.1 1,054.3 1,182.9 
Cash flows from investing activities  
Capital expenditures(325.8)(407.0)(254.4)
Purchases of held-to-maturity investments (Note 7)(250.0)(162.0)(130.2)
Proceeds from sales and maturities of held-to-maturity investments (Note 7)138.0 212.2 50.0 
Purchases of available-for-sale investments (Note 7)(1,629.3)(689.7)(437.9)
Proceeds from sales and maturities of available-for-sale investments (Note 7)391.2 564.8 359.9 
Acquisition (Note 8)— — (100.2)
Payment for acquisition option(13.1)(10.0)(35.0)
Issuances of notes receivable(5.1)(27.0)(12.9)
Collections of notes receivable20.0 — — 
Investments in intangible assets and in-process research and development(4.0)(0.3)(24.0)
Other(44.4)(12.1)(11.1)
Net cash used in investing activities(1,722.5)(531.1)(595.8)
Cash flows from financing activities   
Proceeds from issuance of debt5.2 16.2 18.9 
Payments on debt and finance lease obligations(7.0)(17.0)(28.9)
Purchases of treasury stock(512.8)(625.4)(263.3)
Proceeds from stock plans158.6 140.5 160.5 
Other(0.3)(1.2)(2.8)
Net cash used in financing activities(356.3)(486.9)(115.6)
Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash13.9 (20.5)(3.0)
Net (decrease) increase in cash, cash equivalents, and restricted cash(332.8)15.8 468.5 
Cash, cash equivalents, and restricted cash at beginning of year1,200.2 1,184.4 715.9 
Cash, cash equivalents, and restricted cash at end of year$867.4 $1,200.2 $1,184.4 

The accompanying notes are an integral part of these consolidated financial statements.
46
EDWARDS LIFESCIENCES CORPORATION
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(in millions)
 Common StockTreasury Stock
 SharesPar ValueSharesAmountAdditional Paid-in CapitalRetained EarningsAccumulated Other Comprehensive LossTotal Stockholders' Equity
BALANCE AT DECEMBER 31, 2018215.2 $215.2 7.5 $(1,015.4)$1,384.4 $2,694.7 $(138.5)$3,140.4 
Net income     1,046.9  1,046.9 
Other comprehensive loss, net of tax      (17.5)(17.5)
Common stock issued under equity plans
2.9 2.9   157.6   160.5 
Stock-based compensation expense    81.3   81.3 
Purchases of treasury stock  1.5 (263.3)  (263.3)
BALANCE AT DECEMBER 31, 2019218.1 218.1 9.0 (1,278.7)1,623.3 3,741.6 (156.0)4,148.3 
Net income     823.4  823.4 
Other comprehensive loss, net of tax      (5.1)(5.1)
Common stock issued under equity plans
4.5 4.5   136.0   140.5 
Stock-based compensation expense    92.6   92.6 
Purchases of treasury stock  3.1 (625.4)  (625.4)
Stock issued to effect stock split413.8 413.8 (413.8)— 
BALANCE AT DECEMBER 31, 2020636.4 636.4 12.1 (1,904.1)1,438.1 4,565.0 (161.1)4,574.3 
Net income     1,503.1  1,503.1 
Other comprehensive income, net of tax      3.4 3.4 
Common stock issued under equity plans
5.6 5.6   153.0   158.6 
Stock-based compensation expense    109.3   109.3 
Purchases of treasury stock  5.8 (512.8)   (512.8)
BALANCE AT DECEMBER 31, 2021642.0 $642.0 17.9 $(2,416.9)$1,700.4 $6,068.1 $(157.7)$5,835.9 
   
The accompanying notes are an integral part of these consolidated financial statements.
47
EDWARDS LIFESCIENCES CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1.    DESCRIPTION OF BUSINESS

Edwards Lifesciences Corporation ("Edwards Lifesciences" or the "Company") conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. Edwards Lifesciences is focused on technologies that treat structural heart disease and critically ill patients. The products and technologies provided by Edwards Lifesciences are categorized into the following main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care.

2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of Edwards Lifesciences and its majority-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The Company reviews its investments in other entities to determine whether the Company is the primary beneficiary of a variable interest entity ("VIE"). The Company would be the primary beneficiary of the VIE, and would be required to consolidate the VIE, if it has the power to direct the significant activities of the entity and the obligation to absorb losses or receive benefits from the entity that may be significant to the VIE. Based on the Company's analysis, it determined it is not the primary beneficiary of any material VIEs; however, future events may require VIEs to be consolidated if the Company becomes the primary beneficiary.

Stock Split

On May 7, 2020, the Company’s Board of Directors declared a three-for-one stock split of the Company's outstanding shares of common stock effected in the form of a stock dividend, distributed on May 29, 2020 to stockholders of record on May 18, 2020. The Company distributed two newly issued shares of common stock to holders of record of each share of common stock to effect the stock split. All applicable share and per-share amounts in the consolidated financial statements and the notes to consolidated financial statements have been retroactively adjusted to reflect this stock split. The consolidated statement of stockholders' equity for the year ended December 31, 2019 has not been retroactively adjusted to reflect the stock split.

Use of Estimates

The consolidated financial statements of Edwards Lifesciences have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") which have been applied consistently in all material respects. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. In particular, the COVID-19 pandemic has adversely impacted, and may further adversely impact, nearly all aspects of the Company's business and markets, including its workforce and the operations of its customers, suppliers, and business partners. The full extent to which the pandemic will directly or indirectly impact the Company's business, results of operations, and financial condition, including sales, expenses, manufacturing, clinical trials, research and development costs, reserves and allowances, fair value measurements, asset impairment charges, contingent consideration obligations, and the effectiveness of the Company's hedging instruments, will depend on future developments that are highly uncertain and difficult to predict. These developments include, but are not limited to, the duration and spread of the outbreak (including new and more contagious variants of COVID-19), its severity, the actions to contain the virus or address its impact, the timing, distribution, public acceptance and efficacy of vaccines and other treatments, United States and foreign government actions to respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume.

48
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)


Foreign Currency Translation

When the local currency of the Company's foreign entities is the functional currency, all assets and liabilities are translated into United States dollars at the rate of exchange in effect at the balance sheet date. Income and expense items are translated at the weighted-average exchange rate prevailing during the period. The effects of foreign currency translation adjustments for these entities are deferred and reported in stockholders' equity as a component of "Accumulated Other Comprehensive Loss." The effects of foreign currency transactions denominated in a currency other than an entity's functional currency are included in "Other Income, net."

Revenue Recognition

Revenue is recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those products or services.

The Company generates nearly all of its revenue from direct product sales and sales of products under consignment arrangements. Revenue from direct product sales is recognized at a point in time when the performance obligation is satisfied upon delivery of the product. Revenue from sales of consigned inventory is recognized at a point in time when the performance obligation is satisfied once the product has been implanted or used by the customer. The Company periodically reviews consignment inventories to confirm the accuracy of customer reporting. The Company also generates a small portion of its revenue from service contracts, and recognizes revenue from service contracts ratably over the term of the contracts. Sales taxes and other similar taxes that the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company does not typically have any significant unusual payment terms beyond 90 days in its contracts with customers. In addition, the Company receives royalty payments for the licensing of certain intellectual property and recognizes the royalty when the subsequent sale of product using the intellectual property occurs.

The amount of consideration the Company ultimately receives varies depending upon the return terms, sales rebates, discounts, and other incentives that the Company may offer, which are accounted for as variable consideration when estimating the amount of revenue to recognize. The Company includes estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely upon an assessment of historical payment experience, historical relationship to revenues, estimated customer inventory levels, and current contract sales terms with direct and indirect customers.

The Company's sales adjustment related to distributor rebates given to the Company's United States distributors represents the difference between the Company's sales price to the distributor and the negotiated price to be paid by the end-customer. This distributor rebate is recorded as a reduction to sales and a reduction to the distributor's accounts receivable at the time of sale to a distributor. The Company periodically monitors current pricing trends and distributor inventory levels to ensure the credit for future distributor rebates is fairly stated.

The Company offers volume rebates to certain group purchasing organizations ("GPOs") and customers based upon targeted sales levels. Volume rebates offered to GPOs are recorded as a reduction to sales and an obligation to the GPOs, as the Company expects to pay in cash. Volume rebates offered to customers are recorded as a reduction to sales and either a reduction to accounts receivable if the Company expects a net payment from the customer, or as an obligation to the customer if the Company expects to pay in cash. The provision for volume rebates is estimated based upon customers' contracted rebate programs, projected sales levels, and historical experience of rebates paid. The Company periodically monitors its customer rebate programs to ensure that the allowance and liability for accrued rebates is fairly stated.

Product returns are typically not significant because returns are generally not allowed unless the product is damaged at time of receipt. In limited circumstances, the Company may allow customers to return previously purchased products, such as for next-generation product offerings. For these transactions, the Company defers recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer.

49
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)


The Company sells separately priced service contracts, which range from 12 to 36 months, to owners of its hemodynamic monitors. The Company invoices the customer the total amount of consideration at the inception of the contract and recognizes revenue ratably over the term of the contract. As of December 31, 2021 and 2020, $10.2 million and $6.3 million, respectively, of deferred revenue associated with outstanding service contracts was recorded in “Accrued and Other Liabilities” and "Other Long-term Liabilities." During 2021, the Company recognized as revenue $7.3 million that was included in the balance of deferred revenue as of December 31, 2020, and during 2020, the Company recognized as revenue $6.3 million that was included in the balance of deferred revenue as of December 31, 2019.

A limited number of the Company’s contracts with customers contain multiple performance obligations. For these contracts, the transaction price is allocated to each performance obligation based on its relative standalone selling price charged to other customers.

The Company applies the optional exemption of not disclosing the amount of the transaction price allocated to unsatisfied performance obligations for contracts with an original expected duration of one year or less.

Shipping and Handling Costs

Shipping costs, which are costs incurred to physically move product from the Company's premises or third party distribution centers, including storage, to the customer's premises, are included in "Selling, General, and Administrative Expenses." Handling costs, which are costs incurred to store at the Company's premises, move, and prepare products for shipment, are included in "Cost of Sales." For the years ended December 31, 2021, 2020, and 2019, shipping costs of $85.3 million, $74.0 million, and $71.5 million, respectively, were included in "Selling, General, and Administrative Expenses."

Cash Equivalents

The Company considers highly liquid investments with original maturities of three months or less to be cash equivalents. These investments are valued at cost, which approximates fair value.

Investments

The Company invests its excess cash in debt securities, including time deposits, commercial paper, United States government and agency securities, asset-backed securities, corporate debt securities, and municipal debt securities. Investments with maturities of one year or less are classified as short-term, and investments with maturities greater than one year are classified as long-term. Investments that the Company has the ability and intent to hold until maturity are classified as held-to-maturity and carried at amortized cost. Investments in debt securities that are classified as available-for-sale are carried at fair value with unrealized gains and losses included in "Accumulated Other Comprehensive Loss." The Company determines the appropriate classification of its investments in debt securities at the time of purchase and reevaluates such designation at each balance sheet date.

The Company also has long-term equity investments in companies that are in various stages of development. These investments are reported at fair value or under the equity method of accounting, as appropriate. Equity investments that do not have readily determinable fair values are recorded at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The Company accounts for investments in limited partnerships and limited liability corporations, whereby the Company owns a minimum of 5% of the investee's outstanding voting stock, under the equity method of accounting. These investments are recorded at the amount of the Company's investment and adjusted each period for the Company's share of the investee's income or loss, and dividends paid.

Realized gains and losses on investments that are sold are determined using the specific identification method, or the first-in, first-out method, depending on the investment type, and recorded to "Other Income, net." Income relating to investments in debt securities is recorded to "Interest Income."

Equity investments without readily determinable fair value are considered impaired when there is an indication that the fair value of the Company's interest is less than the carrying amount. Equity method investments are considered impaired when
50
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)


there is an indication of an other-than-temporary decline in value below the carrying amount. Impairments of equity investments are recorded in "Other Income, net."

Debt securities in an unrealized loss position are written down to fair value through “Other Income, net” if the Company intends to sell the security or it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. For debt securities in an unrealized loss position that do not meet the aforementioned criteria, the Company assesses whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. When a credit loss exists, the Company compares the present value of cash flows expected to be collected from the debt security to the amortized cost basis of the security to determine the allowance amount that should be recorded, if any.

Accounts Receivable

The majority of the Company’s accounts receivable arise from direct product sales and sales of products under consignment arrangements, and have payment terms that generally require payment within 30 to 90 days. The Company does not adjust its receivables for the effects of a significant financing component at contract exception if collection of the receivable is expected within one year or less from the time of sale. In countries where the Company has experienced a pattern of payments extending beyond the stated terms and collection of the receivable is expected beyond one year from the time of sale, the Company assesses whether the customer has a significant financing component and discounts the receivable and reduces the related revenues over the period of time that the Company estimates those amounts will be paid using the country’s market-based borrowing rate for such period.

The Company provides reserves against accounts receivable for estimated losses that may result from a customer’s inability to pay based on customer-specific analysis and general matters such as current assessments of past due balances, economic conditions and forecasts, and historical credit loss activity. Amounts determined to be uncollectible are charged or written-off against the reserve.

Inventories

Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. Market value for raw materials is based on replacement costs, and for other inventory classifications is based on net realizable value.

A write-down for excess or slow moving inventory is recorded for inventory which is obsolete, damaged, nearing its expiration date (generally triggered at six months prior to expiration), or slow moving (generally defined as quantities in excess of a two-year supply).

The Company allocates to inventory general and administrative costs that are related to the production process. These costs include insurance, manufacturing accounting and human resources personnel, and information technology. During the years ended December 31, 2021, 2020, and 2019, the Company allocated $77.9 million, $63.1 million, and $56.6 million, respectively, of general and administrative costs to inventory. General and administrative costs included in inventory at December 31, 2021 and 2020 were $33.7 million and $30.7 million, respectively.

At December 31, 2021 and 2020, $125.8 million and $130.0 million, respectively, of the Company's finished goods inventories were held on consignment.

In 2019, the Company recorded a $73.1 million charge to "Cost of Sales," primarily comprised of the write off of inventory related to strategic decisions regarding its transcatheter aortic valve portfolio, including the decision to discontinue its CENTERA program.
51
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)



Property, Plant, and Equipment

Property, plant, and equipment are recorded at cost. Depreciation is principally calculated for financial reporting purposes on the straight-line method over the estimated useful lives of the related assets, which range from 10 to 40 years for buildings and improvements, from 3 to 15 years for machinery and equipment, and from 3 to 5 years for software. Leasehold improvements are amortized over the life of the related facility leases or the asset, whichever is shorter. Straight-line and accelerated methods of depreciation are used for income tax purposes. Construction in progress is not depreciated until the asset is ready for its intended use.

Depreciation expense for property, plant, and equipment was $127.0 million, $101.8 million, and $84.7 million for the years ended December 31, 2021, 2020, and 2019, respectively.

Leases

The Company determines whether a contract is, or contains, a lease at inception. Right-of-use assets represent the Company’s right to use an underlying asset during the lease term, and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at lease commencement based upon the estimated present value of unpaid lease payments over the lease term. The Company uses its incremental borrowing rate based on the information available at lease commencement in determining the present value of unpaid lease payments. The Company's incremental borrowing rate is determined based on the estimated rate of interest for collateralized borrowing over a similar term as the associated lease. Right-of-use assets also include any lease payments made at or before lease commencement and any initial direct costs incurred, and exclude any lease incentives received.

The Company determines the lease term as the noncancellable period of the lease, and may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Leases with a term of 12 months or less are not recognized on the balance sheet. Certain of the Company’s leases include variable lease payments that are based on costs incurred or actual usage, or adjusted periodically based on an index or a rate. The Company’s leases do not contain any residual value guarantees.

The Company accounts for the lease and non-lease components as a single lease component for all of its leases except vehicle leases, for which the lease and non-lease components are accounted for separately.

Operating leases are included in “Operating Lease Right-of-Use Assets” and “Operating Lease Liabilities” on the Company’s consolidated balance sheets. See Note 6 for further information.

Impairment of Goodwill and Long-lived Assets

Goodwill is reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate that the carrying amount may be impaired. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the Company performs a quantitative impairment test. The Company determined, after performing a qualitative review of each reporting unit, that it is more likely than not that the fair value of each of its reporting units substantially exceeds the respective carrying amounts. Accordingly, in 2021, 2020, and 2019, the Company did not record any goodwill impairment loss.

Indefinite-lived intangible assets relate to in-process research and development acquired in business combinations. The estimated fair values of in-process research and development projects acquired in a business combination which have not reached technological feasibility are capitalized and accounted for as indefinite-lived intangible assets subject to impairment testing until completion or abandonment of the projects. Upon successful completion of the project, the capitalized amount is amortized over its estimated useful life. If the project is abandoned, all remaining capitalized amounts are written off immediately. Indefinite-lived intangible assets are reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate the carrying amount may be impaired. An impairment
52
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)


loss is recognized when the asset's carrying value exceeds its fair value. In-process research and development projects acquired in an asset acquisition are expensed unless the project has an alternative future use.

Management reviews the carrying amounts of other finite-lived intangible assets and long-lived tangible assets whenever events or circumstances indicate that the carrying amounts of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit, and adverse legal or regulatory developments. If it is determined that such indicators are present and the review indicates that the assets will not be fully recoverable, based on undiscounted estimated cash flows over the remaining amortization periods, their carrying values are reduced to estimated fair market value. Estimated fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. For the purposes of identifying and measuring impairment, long-lived assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities.

In 2021 and 2020, the Company did not record any impairment loss related to its in-process research and development assets. In 2019, the Company recorded a $40.6 million charge related to the impairment of certain in-process research and development assets. See Note 4 for further information.

Income Taxes

The Company is subject to income taxes in the United States and numerous foreign jurisdictions. Significant judgment is required in evaluating the Company's uncertain tax positions and determining its provision for income taxes. The Company recognizes the financial statement benefit of a tax position only after determining that a position would more likely than not be sustained based upon its technical merit if challenged by the relevant taxing authority and taken by management to the court of last resort. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon settlement with the relevant tax authority. The Company recognizes interest and penalties related to income tax matters in income tax expense. The Company has made an accounting policy election to recognize the United States tax effects of global intangible low-taxed income as a component of income tax expense in the period the tax arises.

Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been recognized in the Company's financial statements or tax returns. The Company evaluates quarterly the realizability of its deferred tax assets by assessing its valuation allowance and adjusting the amount, if necessary. The factors used to assess the likelihood of realization are both historical experience and the Company's forecast of future taxable income and available tax planning strategies that could be implemented to realize the net deferred tax assets. Failure to achieve forecasted taxable income in the applicable taxing jurisdictions could affect the ultimate realization of deferred tax assets and could result in an increase in the Company's effective tax rate on future earnings.

Research and Development Costs

Research and development costs are charged to expense when incurred.

Earnings per Share

Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during the period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive.

53
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)


The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):
 Years Ended December 31,
 202120202019
Basic:   
Net income$1,503.1 $823.4 $1,046.9 
Weighted-average shares outstanding623.3 622.6 624.8 
Basic earnings per share$2.41 $1.32 $1.68 
Diluted:   
Net income$1,503.1 $823.4 $1,046.9 
Weighted-average shares outstanding623.3 622.6 624.8 
Dilutive effect of stock plans7.9 9.3 11.9 
Dilutive weighted-average shares outstanding631.2 631.9 636.7 
Diluted earnings per share$2.38 $1.30 $1.64 

Stock options, restricted stock units, and market-based restricted stock units to purchase approximately 1.8 million, 2.0 million, and 1.5 million shares were outstanding for the years ended December 31, 2021, 2020, and 2019, respectively, but were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive.

Stock-based Compensation

The Company measures and recognizes compensation expense for all stock-based awards based on estimated fair values. Stock-based awards consist of stock options, restricted stock units (service-based and market-based), and employee stock purchase subscriptions. Stock-based compensation expense is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period (vesting period) on a straight-line basis. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Upon exercise of stock options or vesting of restricted stock units, the Company issues common stock.

Total stock-based compensation expense was as follows (in millions):
 Years Ended December 31,
 202120202019
Cost of sales$20.4 $17.2 $14.7 
Selling, general, and administrative expenses65.6 56.6 51.2 
Research and development expenses23.3 18.8 15.4 
Total stock-based compensation expense109.3 92.6 81.3 
Income tax benefit(18.9)(15.4)(14.8)
Total stock-based compensation expense, net of tax$90.4 $77.2 $66.5 

Upon a participant's retirement, all unvested stock options are immediately forfeited. In addition, upon retirement, a participant will immediately vest in 25% of service-based restricted stock units for each full year of employment with the Company measured from the grant date. All remaining unvested service-based restricted stock units are immediately forfeited. For market-based restricted stock units, upon retirement and in certain other specified cases, a participant will receive a pro-rated portion of the shares that would ultimately be issued based on attainment of the performance goals as determined on the vesting date. The pro-rated portion is based on the participant's whole months of service with the Company during the performance period prior to the date of termination.

54
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)


Derivatives

The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk. It is the Company's policy not to enter into derivative financial instruments for speculative purposes.

Derivative financial instruments involve credit risk in the event the counterparty should default. It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy. The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities. The Company also uses International Swap Dealers Association master-netting agreements. The master-netting agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.

The Company uses foreign currency forward exchange contracts and cross currency swap contracts to manage its exposure to changes in currency exchange rates from (1) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within the next 13 months (designated as cash flow hedges), (2) its net investment in certain foreign subsidiaries (designated as net investment hedges) and (3) foreign currency denominated assets or liabilities (designated as fair value hedges). The Company also uses foreign currency forward exchange contracts that are not designated as hedging instruments to offset the transaction gains and losses associated with the revaluation of certain assets and liabilities denominated in currencies other than their functional currencies resulting principally from intercompany and local currency transactions.

All derivative financial instruments are recognized at fair value in the consolidated balance sheets. For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings, and offsets the loss or gain on the underlying hedged item. The Company reports in "Accumulated Other Comprehensive Loss" the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges. The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings. Changes in the fair value of net investment hedges are reported in "Accumulated Other Comprehensive Loss" as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated. The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative. The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument. Cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.

New Accounting Standards Not Yet Adopted

In November 2021, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on government assistance. The guidance requires certain disclosures about transactions with a government that are accounted for by applying a grant or contribution model. The guidance is effective for annual periods beginning after December 15, 2021, and should be applied either prospectively or retrospectively. The Company does not expect the adoption of this guidance will have a material impact on its consolidated financial statements.

3.    INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET

The Company incurred intellectual property litigation expenses, including settlements and external legal costs, of $20.6 million, $405.4 million and $33.4 million during 2021, 2020 and 2019, respectively.

On July 12, 2020, the Company reached an agreement with Abbott Laboratories and its direct and indirect subsidiaries ("Abbott") to, among other things, settle all outstanding patent disputes between the companies (the “Settlement Agreement”) in cases related to transcatheter mitral and tricuspid repair products. The Settlement Agreement resulted in the Company recording an estimated $367.9 million pre-tax charge and related liability in June 2020 related to past damages. In addition, the
55
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Company will incur royalty expenses through May 2024 totaling an estimated $100 million. The Company made a one-time $100.0 million payment to Abbott in July 2020, and is making quarterly payments in subsequent years.

4. SPECIAL CHARGES

Impairment of Long-lived Assets

In December 2019, the Company recorded a charge of $40.6 million to fully impair certain in-process research and development assets. These assets were acquired as part of the acquisition of Valtech Cardio Ltd. ("Valtech") in 2017. The Company measured the amount of the impairment by calculating the amount by which the carrying values exceeded the estimated fair values, which was based on projected discounted future net cash flows. Based on market and clinical trial developments at the time of the impairment, the Company re-evaluated the clinical development plans for the technologies acquired from Valtech, which resulted in a reduction to the projected near-term discounted future net cash flows related to the acquired mitral and tricuspid technology. The impairment was recorded to the Company’s Rest of World segment.

Acquisition of Intellectual Property

In March 2019, the Company recorded a $24.0 million charge related to the acquisition of early-stage transcatheter intellectual property and associated clinical and regulatory experience.

5. OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS

Composition of Certain Financial Statement Captions

Components of selected captions in the consolidated balance sheets are as follows:
 As of December 31,
 20212020
 (in millions)
Inventories  
Raw materials$132.8 $136.7 
Work in process164.3 140.0 
Finished products429.6 525.6 
$726.7 $802.3 
Property, plant, and equipment, net  
Land$116.5 $97.6 
Buildings and leasehold improvements1,010.1 881.5 
Machinery and equipment613.4 564.9 
Equipment with customers39.2 42.2 
Software88.2 94.2 
Construction in progress333.8 313.3 
2,201.2 1,993.7 
Accumulated depreciation(654.6)(598.5)
$1,546.6 $1,395.2 
Accrued and other liabilities  
Employee compensation and withholdings$319.7 $236.7 
Accrued rebates77.0 67.2 
Property, payroll, and other taxes68.9 49.7 
Research and development accruals58.2 52.3 
56
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
5. OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Continued)
As of December 31,
20212020
(in millions)
Legal and insurance (Notes 3 and 18)79.1 60.8 
Taxes payable30.6 18.6 
Fair value of derivatives3.9 39.3 
Accrued marketing expenses20.1 14.3 
Accrued professional services11.9 7.6 
Accrued realignment reserves19.1 14.5 
Accrued relocation costs26.2 21.0 
Other accrued liabilities87.6 88.2 
$802.3 $670.2 

Supplemental Cash Flow Information
(in millions)
Years Ended December 31,
202120202019
Cash paid during the year for:   
Interest$20.2 $19.9 $19.9 
Income taxes$182.5 $197.9 $61.5 
Amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases
$31.9 $29.7 $28.6 
Non-cash investing and financing transactions:   
Right-of-use assets obtained in exchange for new lease liabilities$28.7 $39.7 $49.6 
Capital expenditures accruals$54.3 $80.4 $50.8 
Conversion of notes receivable to equity investment$21.5 $4.5 $— 

Cash, Cash Equivalents, and Restricted Cash
(in millions)
Years Ended December 31,
202120202019
Cash and cash equivalents$862.8 $1,183.2 $1,179.1 
Restricted cash included in other current assets1.5 16.6 1.6 
Restricted cash included in other assets3.1 0.4 3.7 
Total cash, cash equivalents, and restricted cash$867.4 $1,200.2 $1,184.4 

Amounts included in restricted cash primarily represent funds placed in escrow related to litigation and real estate purchases. Restricted cash as of December 31, 2020 also included funds restricted for construction.

6. LEASES

The Company leases certain office space, manufacturing facilities, land, apartments, warehouses, vehicles, and equipment with remaining lease terms ranging from less than 1 year to 19 years, some of which include options to extend or terminate the leases.

57
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
6. LEASES (Continued)

Operating lease costs for the years ended December 31, 2021, 2020, and 2019 were $29.7 million, $30.5 million, and $27.9 million, respectively. Short-term and variable lease costs were not material for the years ended December 31, 2021, 2020, and 2019.

Supplemental balance sheet information related to operating leases was as follows (in millions, except lease term and discount rate):
As of December 31,
20212020
Operating lease right-of-use assets$92.1 $94.2 
Operating lease liabilities, current portion$25.5 $27.2 
Operating lease liabilities, long-term portion69.1 72.7 
Total operating lease liabilities
$94.6 $99.9 

Maturities of operating lease liabilities at December 31, 2021 were as follows (in millions):
2022$27.5 
202323.0 
202413.6 
20258.3 
20267.5 
Thereafter24.6 
Total lease payments
104.5 
Less: imputed interest
(9.9)
Total lease liabilities
$94.6 

The following table provides information on the lease terms and discount rates:
Years Ended December 31,
20212020
Weighted-average remaining lease term (in years)6.26.6
Weighted-average discount rate2.5 %2.7 %

As of December 31, 2021, the Company had additional operating lease commitments of $2.5 million for office space that have not yet commenced.

58
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

7. INVESTMENTS

Debt Securities

Investments in debt securities at the end of each period were as follows (in millions):

 December 31, 2021December 31, 2020
Held-to-maturityAmortized CostGross Unrealized GainsGross Unrealized LossesFair ValueAmortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Bank time deposits$162.0 $— $— $162.0 $50.0 $— $— $50.0 
Available-for-sale
Bank time deposits$2.5 $— $— $2.5 $24.1 $— $— $24.1 
Commercial paper127.7 — — 127.7 — — — — 
United States government and agency securities147.4 0.6 (0.7)147.3 147.0 2.2 — 149.2 
Asset-backed securities515.2 0.3 (2.9)512.6 149.6 1.9 — 151.5 
Corporate debt securities1,397.1 2.0 (8.3)1,390.8 600.8 7.5 — 608.3 
Municipal securities2.8 — — 2.8 2.8 — — 2.8 
$2,192.7 $2.9 $(11.9)$2,183.7 $924.3 $11.6 $— $935.9 

The cost and fair value of investments in debt securities, by contractual maturity, as of December 31, 2021 were as follows:

 Held-to-MaturityAvailable-for-Sale
 Amortized CostFair ValueAmortized CostFair Value
 (in millions)
Due in 1 year or less$162.0 $162.0 $441.3 $442.0 
Due after 1 year through 5 years— — 1,196.7 1,189.6 
Due after 5 years through 10 years— — 8.7 8.6 
Instruments not due at a single maturity date (a)
— — 546.0 543.5 
$162.0 $162.0 $2,192.7 $2,183.7 
_______________________________________
(a)     Consists of mortgage- and asset-backed securities.

Actual maturities may differ from the contractual maturities due to call or prepayment rights.

59
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
7. INVESTMENTS (Continued)

The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of December 31, 2021, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):
December 31, 2021
Less than 12 Months12 Months or GreaterTotal
Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
United States government and agency securities$85.1 $(0.7)$— $— $85.1 $(0.7)
Asset-backed securities433.3 (2.9)— — 433.3 (2.9)
Corporate debt securities1,114.1 (8.3)— — 1,114.1 (8.3)
$1,632.5 $(11.9)$— $— $1,632.5 $(11.9)
The unrealized losses were largely due to changes in interest rates and were considered temporary. There were no investments that were in an unrealized loss position as of December 31, 2020.

Investments in Unconsolidated Entities

The Company has a number of equity investments in unconsolidated entities. These investments are recorded in "Long-term Investments" on the consolidated balance sheets, and are as follows:

 December 31,
 20212020
 (in millions)
Equity method investments  
Carrying value of equity method investments$8.4 $5.7 
Equity securities  
Carrying value of non-marketable equity securities84.1 29.4 
Total investments in unconsolidated entities$92.5 $35.1 

Non-marketable equity securities consist of investments in privately held companies without readily determinable fair values, and are reported at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The Company recorded an upward adjustment of $4.2 million based on observable price changes during 2021, and an upward adjustment of $1.8 million based on observable price changes and a downward adjustment of $0.7 million due to an impairment during 2020. As of December 31, 2021, the Company had recorded cumulative upward adjustments of $8.0 million based on observable price changes, and cumulative downward adjustments of $2.6 million due to impairment and observable price changes.

In April 2021, the Company recorded $35.9 million related to its investment in a privately-held medical device company (the "Investee"), including an initial cash investment in the Investee's preferred equity securities and other consideration. Also, in April 2021, the Company paid $5.7 million, included in "Other Assets," for an exclusive contingent option to acquire the Investee. Per the agreement, the Company may be required to invest up to an additional $9.9 million in the Investee's preferred equity securities and up to an additional $21.8 million for the option to acquire the Investee, depending on the achievement of certain milestones, of which the Company invested $10.8 million in the fourth quarter of 2021 upon achievement of the first milestone. The Company also agreed to loan the Investee up to $45 million under a secured promissory note. As of December 31, 2021, there had been no borrowings under this secured promissory note.

60
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
7. INVESTMENTS (Continued)

The Investee is a VIE; however, Edwards has determined that it is not the primary beneficiary of the VIE since Edwards does not have the power to direct the activities of the Investee that most significantly impact the Investee's economic performance. Edwards accounts for this investment as a non-marketable equity security under the measurement alternative.

During 2021, 2020, and 2019, the gross realized gains or losses from sales of available-for-sale investments were not material.

8.    ACQUISITIONS

CAS Medical Systems, Inc.

On February 11, 2019, the Company entered into an agreement and plan of merger to acquire all the outstanding shares of CAS Medical Systems, Inc. ("CASMED") for an aggregate cash purchase price of $2.45 per share of common stock, or an equity value of approximately $100 million. The transaction closed on April 18, 2019, and the cash purchase price, net of cash acquired, was $100.2 million.

The results of operations for CASMED have been included in the accompanying consolidated financial statements from the date of acquisition. Pro forma results have not been presented as the results of CASMED are not material in relation to the consolidated financial statements of Edwards Lifesciences.

In-process Research and Development Assets

The Company acquired Harpoon Medical, Inc ("Harpoon") on December 1, 2017 and CardiAQ Valve Technologies, Inc. ("CardiAQ") on July 3, 2015. In-process research and development assets acquired as part of these transactions were capitalized at fair value, which was determined using the income approach. This approach determines fair value based on cash flow projections which are discounted to present value using a risk-adjusted rate of return. Completion of successful design developments, bench testing, pre-clinical studies and human clinical studies are required prior to selling any product. The risks and uncertainties associated with completing development within a reasonable period of time include those related to the design, development, and manufacturability of the product, the success of pre-clinical and clinical studies, and the timing of regulatory approvals.

The valuation for Harpoon assumed $41.4 million of additional research and development expenditures would be incurred prior to the date of product introduction. In the valuation, net cash inflows were modeled to commence in Europe in 2018, and in the United States and Japan in 2022. The Company does not currently anticipate significant changes to forecasted research and development expenditures, and net cash inflows commenced in Europe in 2020 and are now expected to commence in the United States and Japan in 2023.

The valuation for CardiAQ assumed $97.7 million of additional research and development expenditures would be incurred prior to the date of product introduction and that net cash inflows would commence in late 2018. As a result of certain design enhancements to increase the product's commercial life and applicability to a broader group of patients, the Company has incurred incremental research and development expenditures; however, the Company expects an increase in the net cash inflows, commencing in 2023.

Upon completion of development, the underlying research and development intangible assets will be amortized over their estimated useful lives.

Certain of the Company's business acquisitions involve contingent consideration arrangements. Payment of additional consideration in the future may be required, contingent upon the acquired business reaching certain performance milestones, such as attaining specified revenue levels or obtaining regulatory approvals. See Note 11 for further information.

9.    GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill and in-process research and development assets resulting from purchase business combinations are not subject to amortization. Other acquired intangible assets with finite lives are amortized over their expected useful lives on a straight-line basis, or if reliably determinable, based on the pattern in which the economic benefit of the asset is expected to be used. The Company expenses costs incurred to renew or extend the term of acquired intangible assets.

61
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
9.    GOODWILL AND OTHER INTANGIBLE ASSETS (Continued)

The changes in the carrying amount of goodwill, by segment, during the years ended December 31, 2021 and 2020 were as follows:
 United
States		EuropeRest of WorldTotal
 (in millions)
Goodwill at December 31, 2019
$773.7 $62.8 $331.2 $1,167.7 
Currency translation adjustment— 5.5 — 5.5 
Goodwill at December 31, 2020
773.7 68.3 331.2 1,173.2 
Currency translation adjustment— (5.3)— (5.3)
Goodwill at December 31, 2021
$773.7 $63.0 $331.2 $1,167.9 

Other intangible assets consist of the following (in millions):

 December 31,
 Weighted-Average Useful Life (in years)20212020
 CostAccumulated
Amortization		Net
Carrying
Value		CostAccumulated
Amortization		Net
Carrying
Value
Finite-lived intangible assets      
Patents7.4$185.7 $(184.2)$1.5 $186.1 $(183.6)$2.5 
Developed technology13.1153.9 (55.5)98.4 155.2 (51.0)104.2 
Other10.012.4 (6.8)5.6 12.6 (6.0)6.6 
12.6352.0 (246.5)105.5 353.9 (240.6)113.3 
Indefinite-lived intangible assets      
In-process research and development218.1 — 218.1 218.1 — 218.1 
$570.1 $(246.5)$323.6 $572.0 $(240.6)$331.4 

Amortization expense related to other intangible assets for the years ended December 31, 2021, 2020, and 2019 was $7.7 million, $5.4 million, and $4.6 million, respectively. Estimated amortization expense for each of the years ending December 31 is as follows (in millions):
2022$6.8 
20238.4 
20248.4 
202510.2 
202615.9 

10.    DEBT AND CREDIT FACILITIES

In June 2018, the Company issued $600.0 million of fixed-rate unsecured senior notes (the "Notes") due June 15, 2028. Interest is payable semi-annually in arrears, with payments due in June and December of each year. The Company may redeem the Notes, in whole or in part, at any time and from time to time at specified redemption prices. In addition, upon the occurrence of certain change of control triggering events, the Company may be required to repurchase all or a portion of the Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest. The Notes also include covenants that limit the Company's ability to incur secured indebtedness, enter into sale and leaseback transactions, and consolidate, merge, or transfer all or substantially all of its assets.

62
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
10.    DEBT AND CREDIT FACILITIES (Continued)

The following is a summary of the Notes as of December 31, 2021 and 2020:
 December 31,
 2021 2020
 AmountEffective
Interest Rate		 AmountEffective
Interest Rate
(in millions)(in millions)
Fixed-rate 4.300% 2018 Notes
$600.0 4.329 %$600.0 4.329 %
Unamortized discount(1.0)  (1.1) 
Unamortized debt issuance costs(3.3)(3.9)
Total carrying amount$595.7   $595.0  

As of December 31, 2021 and 2020, the fair value of the Notes was $675.4 million and $711.2 million, respectively, based on observable market prices in less active markets and categorized as Level 2 (Note 11). The debt issuance costs, as well as the discount, are being amortized to interest expense over the term of the Notes.

The Company has a Five-Year Credit Agreement ("the Credit Agreement") which matures on April 28, 2023. The Credit Agreement provides up to an aggregate of $750.0 million in borrowings in multiple currencies. The Company may increase the amount available under the Credit Agreement, subject to agreement of the lenders, by up to an additional $250.0 million in the aggregate. Borrowings generally bear interest at the London interbank offered rate ("LIBOR"), or a comparable or successor rate, plus a spread ranging from 0.9% to 1.3%, depending on the leverage ratio, as defined in the Credit Agreement. The Company also pays a facility fee ranging from 0.1% to 0.2%, depending on the leverage ratio, on the entire credit commitment available, whether drawn or not. The facility fee is expensed as incurred. During 2021, the spread over LIBOR was 0.9% and the facility fee was 0.1%. Issuance costs of $2.4 million are being amortized to interest expense over the term of the Credit Agreement. As of December 31, 2021 and 2020, there were no borrowings outstanding under the Credit Agreement. Amounts outstanding under the Credit Agreement, if any from time to time, are classified as long-term obligations in accordance with the terms of the Credit Agreement. The Credit Agreement is unsecured and contains various financial and other covenants, including a maximum leverage ratio, as defined in the Credit Agreement. The Company was in compliance with all covenants at December 31, 2021.

The weighted-average interest rate under all debt obligations was 3.4% and 3.5% at December 31, 2021 and 2020, respectively.
63
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)


11.    FAIR VALUE MEASUREMENTS

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The Company prioritizes the inputs used to determine fair values in one of the following three categories:

Level 1—Quoted market prices in active markets for identical assets or liabilities.

Level 2—Inputs, other than quoted prices in active markets, that are observable, either directly or indirectly.

Level 3—Unobservable inputs that are not corroborated by market data.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety.

The consolidated financial statements include financial instruments for which the fair market value of such instruments may differ from amounts reflected on a historical cost basis. Financial instruments of the Company consist of cash deposits, accounts and other receivables, investments, accounts payable, certain accrued liabilities, and borrowings under a revolving credit agreement. The carrying value of these financial instruments generally approximates fair value due to their short-term nature. Financial instruments also include notes payable. See Note 10 for further information on the fair value of the notes payable.

64
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
11.    FAIR VALUE MEASUREMENTS (Continued)
Assets and Liabilities Measured at Fair Value on a Recurring Basis

The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis as of December 31, 2021 and 2020 (in millions):

December 31, 2021Level 1Level 2Level 3Total
Assets    
Cash equivalents$15.2 $30.7 $— $45.9 
Available-for-sale investments: 
Bank time deposits— 2.5 — 2.5 
Corporate debt securities— 1,390.8 — 1,390.8 
Asset-backed securities— 512.6 — 512.6 
United States government and agency securities28.4 118.9 — 147.3 
Commercial paper— 127.7 — 127.7 
Municipal securities— 2.8 — 2.8 
Investments held for deferred compensation plans130.7 — — 130.7 
Derivatives— 55.3 — 55.3 
$174.3 $2,241.3 $— $2,415.6 
Liabilities    
Derivatives$— $3.9 $— $3.9 
Deferred compensation plans130.9 — — 130.9 
Contingent consideration liabilities— — 62.0 62.0 
Other liability— — 14.0 14.0 
$130.9 $3.9 $76.0 $210.8 
December 31, 2020
Assets
Cash equivalents$16.2 $— $— $16.2 
Available-for-sale investments: 
Bank time deposits— 24.1 — 24.1 
Corporate debt securities— 608.3 — 608.3 
Asset-backed securities— 151.5 — 151.5 
United States government and agency securities56.9 92.2 — 149.1 
Municipal securities— 2.8 — 2.8 
Investments held for deferred compensation plans111.2 — — 111.2 
Derivatives— 8.1 — 8.1 
$184.3 $887.0 $— $1,071.3 
Liabilities    
Derivatives$— $39.3 $— $39.3 
Deferred compensation plans111.6 — — 111.6 
Contingent consideration liabilities— — 186.1 186.1 
$111.6 $39.3 $186.1 $337.0 

65
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
11.    FAIR VALUE MEASUREMENTS (Continued)
The following table summarizes the changes in fair value of the contingent consideration obligation for the years ended December 31, 2021 and 2020 (in millions):

Contingent ConsiderationOther LiabilityTotal
Fair value, December 31, 2019
$172.5 $— $172.5 
Changes in fair value13.6 — 13.6 
Fair value, December 31, 2020
$186.1 $— $186.1 
Additions— 14.0 14.0 
Changes in fair value(124.1)— (124.1)
Fair value, December 31, 2021
$62.0 $14.0 $76.0 

The change in fair value of the contingent consideration liabilities in 2021 was primarily driven by a $123.2 million reduction to the liability due to changes in the projected probabilities and timing of milestone achievements and the projected timing of cash inflows. The change in fair value of the contingent consideration liabilities in 2020 was primarily driven by the accretion of interest due to the passage of time and adjustments to discount rates, partially offset by a $12.7 million reduction to the liability due to changes in the projected probabilities and timing of milestone achievements and the projected timing of cash inflows.

Cash Equivalents and Available-for-sale Investments

The Company estimates the fair values of its money market funds based on quoted prices in active markets for identical assets. The Company estimates the fair values of its time deposits, commercial paper, United States and foreign government and agency securities, municipal securities, asset-backed securities, and corporate debt securities by taking into consideration valuations obtained from third-party pricing services. The pricing services use industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades and broker-dealer quotes on the same or similar securities, benchmark yields, credit spreads, prepayment and default projections based on historical data, and other observable inputs. The Company independently reviews and validates the pricing received from the third-party pricing service by comparing the prices to prices reported by a secondary pricing source. The Company’s validation procedures have not resulted in an adjustment to the pricing received from the pricing service.

Deferred Compensation Plans

The Company holds investments in trading securities related to its deferred compensation plans. The investments are in a variety of stock, bond, and money market mutual funds. The fair values of these investments and the corresponding liabilities are based on quoted market prices.

Derivative Instruments

The Company uses derivative financial instruments in the form of foreign currency forward exchange contracts and cross currency swap contracts to manage foreign currency exposures. All derivatives contracts are recognized on the balance sheet at their fair value. The fair value of the derivative financial instruments was estimated based on quoted market foreign exchange rates, cross currency swap basis rates, and market discount rates. Judgment was employed in interpreting market data to develop estimates of fair value; accordingly, the estimates presented herein are not necessarily indicative of the amounts that the Company could realize in a current market exchange. The use of different market assumptions or valuation methodologies could have a material effect on the estimated fair value amounts.

Contingent Consideration Liabilities

Certain of the Company's acquisitions involve contingent consideration arrangements. Payment of additional consideration is contingent upon the acquired company reaching certain performance milestones, such as attaining specified
66
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
11.    FAIR VALUE MEASUREMENTS (Continued)
sales levels or obtaining regulatory approvals. These contingent consideration liabilities are measured at estimated fair value using either a probability weighted discounted cash flow analysis or a Monte Carlo simulation model, both of which consider significant unobservable inputs. These inputs include (1) the discount rate used to present value the projected cash flows (ranging from 0.06% to 9.26%; weighted average of 4.1%), (2) the probability of milestone achievement (ranging from 0% to 93.7%; weighted average of 59.2%), (3) the projected payment dates (ranging from 2026 to 2027; weighted average of 2026), and (4) the volatility of future sales (40.0%). The weighted average of each of the above inputs was determined based on the relative fair value of each obligation. The use of different assumptions could have a material effect on the estimated fair value amounts.

12.    DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.
 Notional Amount
 December 31, 2021December 31, 2020
 (in millions)
Foreign currency forward exchange contracts$1,498.8 $1,525.5 
Cross currency swap contracts300.0 300.0 

The following table presents the location and fair value amounts of derivative instruments reported in the consolidated balance sheets (in millions):

  Fair Value
 Balance Sheet LocationDecember 31, 2021December 31, 2020
Derivatives designated as hedging instruments   
Assets   
Foreign currency contractsOther current assets$36.2 $7.3 
Cross currency swap contractsOther assets$19.1 $0.8 
Liabilities   
Foreign currency contractsAccrued and other liabilities$3.9 $39.3 

67
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
12.    DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Continued)
The following table presents the effect of master-netting agreements and rights of offset on the consolidated balance sheets (in millions):

    Gross Amounts Not Offset in the Consolidated Balance Sheet 
  Gross Amounts
Offset in the
Consolidated
Balance Sheet		Net Amounts
Presented in the
Consolidated
Balance Sheet
December 31, 2021Gross
Amounts		Financial
Instruments		Cash
Collateral
Received		Net
Amount
Derivative Assets      
Foreign currency contracts$36.2 $— $36.2 $(2.8)$— $33.4 
Cross currency swap contracts$19.1 $— $19.1 $— $— $19.1 
Derivative Liabilities      
Foreign currency contracts$3.9 $— $3.9 $(2.8)$— $1.1 
December 31, 2020      
Derivative Assets      
Foreign currency contracts$7.3 $— $7.3 $(6.1)$— $1.2 
Cross currency swap contracts$0.8 $— $0.8 $— $— $0.8 
Derivative Liabilities      
Foreign currency contracts$39.3 $— $39.3 (6.1)$— $33.2 
 
The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated statements of operations and consolidated statements of comprehensive income:

 Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)Location of Gain or (Loss) Reclassified from Accumulated OCI into IncomeAmount of Gain or (Loss) Reclassified from Accumulated OCI into Income
 
 2021202020212020
(in millions)(in millions)
Cash flow hedges
Foreign currency contracts$56.7 $(33.7)Cost of sales$(23.0)$18.4 
Selling, general, and administrative expenses$(0.6)$2.2 
 Amount of Gain or (Loss)
Recognized in OCI
on Derivative
(Effective Portion)		Location of Gain or (Loss) Reclassified from Accumulated OCI into IncomeAmount of Gain or (Loss)
Recognized in Income on Derivative (Amount Excluded from
 Effectiveness Testing)
2021202020212020
(in millions) (in millions)
Net investment hedges
Cross currency swap contracts$18.4 $(12.6)Interest expense$6.4 $6.4 

The cross currency swap contracts have an expiration date of June 15, 2028. At maturity of the cross currency swap contracts, the Company will deliver the notional amount of €257.2 million and will receive $300.0 million from the counterparties. The Company will receive semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.
68
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
12.    DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Continued)
  Amount of Gain or
(Loss) Recognized in
Income on Derivative
 Location of Gain or
(Loss) Recognized in
Income on Derivative
 202120202019
 (in millions)
Fair value hedges
Foreign currency contractsOther income, net$11.6 $(1.4)$1.4 

  Amount of Gain or
(Loss) Recognized in
Income on Derivative
 Location of Gain or
(Loss) Recognized in
Income on Derivative
 202120202019
 (in millions)
Derivatives not designated as hedging instruments
Foreign currency contractsOther income, net$27.4 $(15.1)$0.3 

The following table presents the effect of fair value and cash flow hedge accounting on the consolidated statements of operations:

Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
 Twelve Months Ended December 31, 2021
 Cost of salesSelling, general, and administrative expensesOther Income, net
Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded$(1,248.9)$(1,493.7)$12.7 
The effects of fair value and cash flow hedging:
Gain (loss) on fair value hedging relationships:
Foreign currency contracts:
Hedged items
— — (9.0)
Derivatives designated as hedging instruments
— — 9.0 
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach
— — 2.6 
Gain (loss) on cash flow hedging relationships:
Foreign currency contracts:
Amount of gain (loss) reclassified from accumulated OCI into income
(23.0)(0.6)— 
69
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
12.    DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Continued)
Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
 Twelve Months Ended December 31, 2020
 Cost of salesSelling, general, and administrative expensesOther Income, net
Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded$(1,080.6)$(1,228.4)$11.5 
The effects of fair value and cash flow hedging:
Gain (loss) on fair value hedging relationships:
Foreign currency contracts:
Hedged items
— — 4.8 
Derivatives designated as hedging instruments
— — (4.8)
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach
— — 3.4 
Gain (loss) on cash flow hedging relationships:
Foreign currency contracts:
Amount of gain (loss) reclassified from accumulated OCI into income
18.4 2.2 — 
The Company expects that during 2022 it will reclassify to earnings a $7.8 million gain currently recorded in "Accumulated Other Comprehensive Loss." For the years ended December 31, 2021, 2020, and 2019, the Company did not record any gains or losses due to hedge ineffectiveness.

70
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

13.    EMPLOYEE BENEFIT PLANS

Defined Benefit Plans

The Company maintains defined benefit pension plans in Japan and certain European countries.
 Years Ended December 31,
 20212020
(in millions)
Change in projected benefit obligation:  
Beginning of year$126.2 $105.2 
Service cost6.5 6.3 
Interest cost0.4 0.5 
Participant contributions1.5 1.5 
Actuarial loss(6.1)2.9 
Benefits paid(2.5)(0.6)
Plan amendment(0.5)— 
Currency exchange rate changes and other(7.6)10.4 
End of year$117.9 $126.2 
Change in fair value of plan assets:  
Beginning of year$73.3 $63.2 
Actual return on plan assets5.8 0.4 
Employer contributions3.1 2.8 
Participant contributions1.5 1.5 
Benefits paid(2.5)(0.6)
Currency exchange rate changes and other(4.3)6.0 
End of year$76.9 $73.3 
Funded Status  
Projected benefit obligation$(117.9)$(126.2)
Plan assets at fair value76.9 73.3 
Underfunded status$(41.0)$(52.9)
Net amounts recognized on the consolidated balance sheet:  
Other long-term liabilities$41.0 $52.9 
Accumulated other comprehensive loss, net of tax:  
Net actuarial loss$(16.4)$(30.8)
Net prior service cost6.0 6.6 
Deferred income tax benefit2.4 4.6 
Total$(8.0)$(19.6)

The accumulated benefit obligation ("ABO") for all defined benefit pension plans was $113.3 million and $120.9 million as of December 31, 2021 and 2020, respectively. The projected benefit obligation and ABO were in excess of plan assets for all pension plans as of December 31, 2021 and 2020.

71
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
13.    EMPLOYEE BENEFIT PLANS (Continued)
The components of net periodic pension benefit cost are as follows (in millions):

 Years Ended December 31,
 202120202019
Service cost, net$6.5 $6.3 $5.2 
Interest cost0.4 0.5 0.9 
Expected return on plan assets(1.1)(1.0)(1.4)
Amortization of actuarial loss1.7 1.6 0.9 
Amortization of prior service credit (0.7)(0.7)(0.2)
Net periodic pension benefit cost$6.8 $6.7 $5.4 

Expected long-term returns for each of the plans' strategic asset classes were developed through consultation with investment advisors. Several factors were considered, including a survey of investment managers' expectations, current market data, minimum guaranteed returns in certain insurance contracts, and historical market returns over long periods. Using policy target allocation percentages and the asset class expected returns, a weighted-average expected return was calculated.

To select the discount rates for the defined benefit pension plans, the Company uses a modeling process that involves matching the expected duration of its benefit plans to a yield curve constructed from a portfolio of AA-rated fixed-income debt instruments, or their equivalent. For each country, the Company uses the implied yield of this hypothetical portfolio at the appropriate duration as a discount rate benchmark.

The weighted-average assumptions used to determine the benefit obligations are as follows:
 December 31,
 20212020
Discount rate0.5 %0.3 %
Rate of compensation increase2.6 %2.6 %
Cash balance interest crediting rate2.5 %2.5 %
Social securities increase1.6 %1.6 %
Pension increase1.8 %1.8 %

The weighted-average assumptions used to determine the net periodic pension benefit cost are as follows:
 Years ended December 31,
 202120202019
Discount rate0.3 %0.5 %0.9 %
Expected return on plan assets1.5 %1.5 %2.3 %
Rate of compensation increase2.6 %2.7 %2.8 %
Cash balance interest crediting rate2.5 %1.5 %1.5 %
Social securities increase1.6 %1.6 %1.8 %
Pension increase1.8 %1.8 %1.8 %

Plan Assets

The Company's investment strategy for plan assets is to seek a competitive rate of return relative to an appropriate level of risk and to earn performance rates of return in accordance with the benchmarks adopted for each asset class. Risk management practices include diversification across asset classes and investment styles, and periodic rebalancing toward asset allocation targets.

72
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
13.    EMPLOYEE BENEFIT PLANS (Continued)
The Administrative and Investment Committee decides on the defined benefit plan provider in each location and that provider decides the target allocation for the Company's defined benefit plan at that location. The target asset allocation selected reflects a risk/return profile the Company feels is appropriate relative to the plans' liability structure and return goals. In certain plans, asset allocations may be governed by local requirements. Target weighted-average asset allocations at December 31, 2021, by asset category, are as follows:
Equity securities28.3 %
Debt securities41.7 %
Real estate9.8 %
Other20.2 %
Total100.0 %

The fair values of the Company's defined benefit plan assets at December 31, 2021 and 2020, by asset category, are as follows (in millions):
December 31, 2021Level 1Level 2Level 3Total
Asset Category    
Cash$5.4 $— $— $5.4 
Equity securities:    
United States equities1.6 — — 1.6 
International equities16.3 — — 16.3 
Debt securities:    
United States government bonds6.2 — — 6.2 
International government bonds26.3 — — 26.3 
Real estate— 7.6 — 7.6 
Mortgages— 3.5 — 3.5 
Insurance contracts— — 0.9 0.9 
Total plan assets measured at fair value
$55.8 $11.1 $0.9 $67.8 
Alternative investments measured at net asset value (a)9.1 
Total plan assets
$76.9 
73
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
13.    EMPLOYEE BENEFIT PLANS (Continued)
 
December 31, 2020Level 1Level 2Level 3Total
Asset Category
Cash$3.0 $— $— $3.0 
Equity securities:
United States equities3.3 — — 3.3 
International equities16.1 — — 16.1 
Debt securities:
United States government bonds7.4 — — 7.4 
International government bonds26.0 — — 26.0 
Real estate— 5.6 — 5.6 
Mortgages— 3.1 — 3.1 
Insurance contracts— — 1.0 1.0 
Total plan assets $55.8 $8.7 $1.0 $65.5 
Alternative investments measured at net asset value (a)7.8 
Total plan assets $73.3 
_______________________________________
(a)     Certain investments that were measured at net asset value per share have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the total plan assets.

The following table summarizes the changes in fair value of the Company's defined benefit plan assets that have been classified as Level 3 for the years ended December 31, 2021 and 2020 (in millions):

 Insurance
Contracts
Balance at December 31, 2019$0.9 
Currency exchange rate impact0.1 
Balance at December 31, 20201.0 
Currency exchange rate impact(0.1)
Balance at December 31, 2021$0.9 

Equity and debt securities are valued at fair value based on quoted market prices reported on the active markets on which the individual securities are traded. Real estate investments are valued by discounting to present value the cash flows expected to be generated by the specific properties. Investments in mortgages are valued at cost, which is deemed to approximate its fair value. The insurance contracts are valued at the cash surrender value of the contracts, which is deemed to approximate its fair value. Alternative investments include hedge funds, private equity funds and other miscellaneous investments, and are valued using the net asset value provided by the fund administrator as a practical expedient. The net asset value is based on the fair value of the underlying assets owned by the fund divided by the number of shares outstanding.

74
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
13.    EMPLOYEE BENEFIT PLANS (Continued)
The following benefit payments, which reflect expected future service, as appropriate, at December 31, 2021, are expected to be paid (in millions):

2022$5.4 
20236.7 
20245.6 
20255.2 
20266.1 
2024-202636.1 

As of December 31, 2021, expected employer contributions for 2022 are $2.2 million.

Defined Contribution Plans

The Company's employees in the United States and Puerto Rico are eligible to participate in a qualified defined contribution plan. In the United States, participants may contribute up to 25% of their eligible compensation (subject to tax code limitation) to the plan. Edwards Lifesciences matches the first 4% of the participant's annual eligible compensation contributed to the plan on a dollar-for-dollar basis. Edwards Lifesciences matches the next 2% of the participant's annual eligible compensation to the plan on a 50% basis. In Puerto Rico, participants may contribute up to 25% of their annual compensation (subject to tax code limitation) to the plan. Edwards Lifesciences matches the first 4% of participant's annual eligible compensation contributed to the plan on a 50% basis. The Company also provides a 2% profit sharing contribution calculated on eligible earnings for each employee. Matching contributions relating to Edwards Lifesciences employees were $38.6 million, $36.6 million, and $31.4 million in 2021, 2020, and 2019, respectively.

The Company also has nonqualified deferred compensation plans for a select group of employees. The plans provide eligible participants the opportunity to defer eligible compensation to future dates specified by the participant with a return based on investment alternatives selected by the participant. The amount accrued under these nonqualified plans was $130.9 million and $111.6 million at December 31, 2021 and 2020, respectively.

14.    COMMON STOCK

Treasury Stock

In May 2019, the Board of Directors approved a stock repurchase program authorizing the Company to purchase up to $1.0 billion of the Company's common stock. In May 2021, the Board of Directors approved a new stock repurchase program for an additional $1.0 billion of the Company's common stock. The repurchase programs do not have an expiration date. Stock repurchased under these programs may be used to offset obligations under the Company's employee stock-based benefit programs and stock-based business acquisitions, and will reduce the total shares outstanding.

During 2021, 2020, and 2019, the Company repurchased 5.8 million, 3.1 million, and 1.5 million shares, respectively, at an aggregate cost of $512.8 million, $625.4 million, and $263.3 million, respectively, including shares purchased under the accelerated share repurchase ("ASR") agreements described below and shares acquired to satisfy tax withholding obligations in connection with the vesting of restricted stock units issued to employees. The timing and size of any future stock repurchases are subject to a variety of factors, including expected dilution from stock plans, cash capacity, and the market price of the Company's common stock.

75
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
14.    COMMON STOCK (Continued)
Accelerated Share Repurchase

During 2021 and 2019, the Company entered into ASR agreements providing for the repurchase of the Company's common stock based on the volume-weighted average price ("VWAP") of the Company's common stock during the term of the agreements, less a discount. The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):
  Initial DeliveryFinal Settlement
Agreement DateAmount
Paid		Shares
Received		Price per
Share (a)		Value of
Shares as %
of Contract
Value		Settlement
Date		Total Shares
Received		Average Price
per Share (a)
May 2019$150.0 0.7 $178.66 80 %May 20190.8 $178.42 
May 2019$100.0 0.5 $170.02 80 %June 20190.6 $178.46 
February 2021$250.0 2.4 $83.86 80 %March 20213.0 $84.51 
_______________________________________________________________________________
(a)    The three-for-one stock split distributed on May 29, 2020 excluded treasury shares. The shares and per share prices in the table are reflected at the pre-split amounts and prices at the time of the transaction.

The ASR agreements were accounted for as two separate transactions: (1) the value of the initial delivery of shares was recorded as shares of common stock acquired in a treasury stock transaction on the acquisition date and (2) the remaining amount of the purchase price paid was recorded as a forward contract indexed to the Company's own common stock and was recorded in "Additional Paid-in Capital" on the consolidated balance sheets. The initial delivery of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted-average common shares outstanding for basic and diluted earnings per share. The Company determined that the forward contract indexed to the Company's common stock met all the applicable criteria for equity classification and, therefore, was not accounted for as a derivative instrument.

Employee and Director Stock Plans

The Edwards Lifesciences Corporation Long-term Stock Incentive Compensation Program (the "Program") provides for the grant of incentive and non-qualified stock options, restricted stock, and restricted stock units for eligible employees of the Company. Under the Program, these grants are awarded at a price equal to the fair market value at the date of grant based upon the closing price on that date. Options to purchase shares of the Company's common stock granted under the Program generally vest over predetermined periods of between three to four years and expire seven years after the date of grant. Service-based restricted stock units of the Company's common stock granted under the Program generally vest over predetermined periods, typically four years after the date of grant. Market-based restricted stock units of the Company's common stock granted under the Program vest over three years based on a combination of certain service and market conditions. The actual number of shares issued will be determined based on the Company's total stockholder return relative to a selected industry peer group. Under the Program, the number of shares of common stock authorized for issuance under the Program was 327.6 million shares. No more than 33.6 million shares reserved for issuance may be granted in the form of restricted stock or restricted stock units.

The Company also maintains the Nonemployee Directors Stock Incentive Compensation Program (the "Nonemployee Directors Program"). Under the Nonemployee Directors Program, annually each nonemployee director may receive up to 120,000 stock options or 48,000 restricted stock units of the Company's common stock, or a combination thereof, provided that in no event may the total value of the combined annual award exceed $0.2 million. These grants generally vest over one year from the date of grant. Under the Nonemployee Directors Program, an aggregate of 8.4 million shares of the Company's common stock has been authorized for issuance.

The Company has an employee stock purchase plan for United States employees and a plan for employees outside of the United States (collectively "ESPP"). Under the ESPP, eligible employees may purchase shares of the Company's common stock at 85% of the lower of the fair market value of Edwards Lifesciences common stock on the effective date of subscription or the date of purchase. Under the ESPP, employees can authorize the Company to withhold up to 15% of their compensation for common stock purchases, subject to certain limitations. The ESPP is available to all active employees of the Company paid from the United States payroll and to eligible employees of the Company outside of the United States, to the extent permitted
76
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
14.    COMMON STOCK (Continued)
by local law. The ESPP for United States employees is qualified under Section 423 of the Internal Revenue Code. The number of shares of common stock authorized for issuance under the ESPP was 50.4 million shares.

The fair value of each option award and employee stock purchase subscription is estimated on the date of grant using the Black-Scholes option valuation model that uses the assumptions noted in the following tables. The risk-free interest rate is estimated using the United States Treasury yield curve and is based on the expected term of the award. Expected volatility is estimated based on a blend of the weighted-average of the historical volatility of Edwards Lifesciences' stock and the implied volatility from traded options on Edwards Lifesciences' stock. The expected term of awards granted is estimated from the vesting period of the award, as well as historical exercise behavior, and represents the period of time that awards granted are expected to be outstanding. The Company uses historical data to estimate forfeitures and has estimated an annual forfeiture rate of 6.4%.

The Black-Scholes option pricing model was used with the following weighted-average assumptions for options granted during the following periods:

Option Awards
202120202019
Average risk-free interest rate0.8 %0.3 %2.3 %
Expected dividend yieldNoneNoneNone
Expected volatility34 %33 %30 %
Expected life (years)5.05.05.1
Fair value, per share$28.90 $21.70 $18.17 

The Black-Scholes option pricing model was used with the following weighted-average assumptions for ESPP subscriptions granted during the following periods:

ESPP
202120202019
Average risk-free interest rate0.1 %1.3 %2.4 %
Expected dividend yieldNoneNoneNone
Expected volatility37 %33 %27 %
Expected life (years)0.60.60.6
Fair value, per share$23.07 $16.61 $16.43 

The fair value of market-based restricted stock units was determined using a Monte Carlo simulation model, which uses multiple input variables to determine the probability of satisfying the market condition requirements. The weighted-average assumptions used to determine the fair value of the market-based restricted stock units during the years ended December 31, 2021, 2020, and 2019 included a risk-free interest rate of 0.4%, 0.2%, and 2.2%, respectively, and an expected volatility rate of 34.4%, 32.7%, and 29.4%, respectively.

77
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
14.    COMMON STOCK (Continued)
Stock option activity during the year ended December 31, 2021 under the Program and the Nonemployee Directors Program was as follows (in millions, except years and per-share amounts):

 SharesWeighted-
Average
Exercise
Price		Weighted-
Average
Remaining
Contractual
Term		Aggregate
Intrinsic Value
Outstanding as of December 31, 2020
14.3 $41.27   
Options granted1.6 94.04   
Options exercised(3.4)23.84   
Options forfeited(0.2)67.89   
Outstanding as of December 31, 2021
12.3 52.84 3.5 years$943.1 
Exercisable as of December 31, 2021
8.2 41.84 2.6 years$719.7 
Vested and expected to vest as of December 31, 2021
11.7 51.74 3.4 years$911.4 

The following table summarizes nonvested restricted stock unit activity during the year ended December 31, 2021 under the Program and the Nonemployee Directors Program (in millions, except per-share amounts):

 SharesWeighted-
Average
Grant-Date
Fair Value
Nonvested as of December 31, 2020
2.6 $57.59 
Granted (a)0.8 92.95 
Vested(1.0)48.82 
Forfeited(0.1)66.54 
Nonvested as of December 31, 2021
2.3 73.94 
_______________________________________________________________________________
(a)    The shares granted include 0.1 million shares of market-based restricted stock units granted during 2021, which represents the target number of shares to be issued, and 0.1 million shares related to a previous year's grant of market-based restricted stock units since the payout percentage achieved at the end of the performance period was in excess of target. As described above, the actual number of shares ultimately issued is determined based on the Company's total stockholder return relative to a selected industry peer group.

The intrinsic value of stock options exercised and restricted stock units vested during the years ended December 31, 2021, 2020, and 2019 were $359.8 million, $323.5 million, and $382.1 million, respectively. The intrinsic value of stock options is calculated as the amount by which the market price of the Company's common stock exceeds the exercise price of the option. During the years ended December 31, 2021, 2020, and 2019, the Company received cash from exercises of stock options of $82.2 million, $79.2 million, and $110.4 million, respectively, and tax benefits from exercises of stock options and vesting of restricted stock units of $76.5 million, $72.1 million, and $85.1 million, respectively. The total grant-date fair value of stock options vested during the years ended December 31, 2021, 2020, and 2019 were $36.2 million, $34.0 million, and $31.2 million, respectively.

As of December 31, 2021, the total remaining unrecognized compensation expense related to nonvested stock options, restricted stock units, and employee stock purchase subscriptions amounted to $162.3 million, which will be amortized over the weighted-average remaining requisite service period of 30 months.

78
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

15.    ACCUMULATED OTHER COMPREHENSIVE LOSS

Presented below is a summary of activity for each component of "Accumulated Other Comprehensive Loss" for the years ended December 31, 2021, 2020, and 2019.

 Foreign
Currency
Translation
Adjustments		Unrealized Gain (Loss) on HedgesUnrealized (Loss) Gain on
Available-for-sale
Investments		Unrealized
Pension
Costs (a)		Total
Accumulated
Other
Comprehensive
Loss
 (in millions)
December 31, 2018$(143.6)$23.6 $(5.0)$(13.5)$(138.5)
Other comprehensive (loss) income before reclassifications(1.5)27.9 7.9 (3.2)31.1 
Amounts reclassified from accumulated other comprehensive loss(6.6)(44.2)0.4 0.7 (49.7)
Deferred income tax (expense) benefit(3.1)5.2 (1.6)0.6 1.1 
December 31, 2019(154.8)12.5 1.7 (15.4)(156.0)
Other comprehensive income (loss) before reclassifications35.7 (34.8)8.0 (5.5)3.4 
Amounts reclassified from accumulated other comprehensive loss(6.4)(19.2)0.3 0.9 (24.4)
Deferred income tax benefit (expense)3.1 13.8 (1.4)0.4 15.9 
December 31, 2020(122.4)(27.7)8.6 (19.6)(161.1)
Other comprehensive (loss) income before reclassifications(39.2)66.3 (29.2)12.8 10.7 
Amounts reclassified from accumulated other comprehensive loss(6.4)12.0 8.6 1.0 15.2 
Deferred income tax (expense) benefit(4.5)(20.9)5.1 (2.2)(22.5)
December 31, 2021$(172.5)$29.7 $(6.9)$(8.0)$(157.7)
_______________________________________________________________________________

79
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
15.    ACCUMULATED OTHER COMPREHENSIVE LOSS (Continued)

(a)For the years ended December 31, 2021, 2020, and 2019, the change in unrealized pension costs consisted of the following (in millions):
 Pre-Tax
Amount		Tax (Expense) BenefitNet of Tax
Amount
2021   
Prior service credit arising during period$0.1 $— $0.1 
Amortization of prior service credit(0.7)0.1 (0.6)
Net prior service cost arising during period(0.6)0.1 (0.5)
Net actuarial loss arising during period14.4 (2.3)12.1 
Unrealized pension costs, net$13.8 $(2.2)$11.6 
2020   
Prior service credit arising during period$0.6 $(0.2)$0.4 
Amortization of prior service credit(0.7)0.1 (0.6)
Net prior service cost arising during period(0.1)(0.1)(0.2)
Net actuarial loss arising during period(4.5)0.5 (4.0)
Unrealized pension costs, net$(4.6)$0.4 $(4.2)
2019   
Prior service credit arising during period$4.6 $(0.6)$4.0 
Amortization of prior service credit(0.2)0.1 (0.1)
Net prior service credit arising during period4.4 (0.5)3.9 
Net actuarial loss arising during period(6.9)1.1 (5.8)
Unrealized pension costs, net$(2.5)$0.6 $(1.9)

The following table provides information about amounts reclassified from "Accumulated Other Comprehensive Loss" (in millions):
 Years Ended December 31, 
Details about Accumulated Other Comprehensive Loss
Components		20212020Affected Line on Consolidated
Statements of Operations
Foreign currency translation adjustments$6.4 $6.4 Other income, net
(1.6)(1.6)Provision for income taxes
$4.8 $4.8 Net of tax
Gain (loss) on hedges$(23.0)$18.4 Cost of sales
(0.6)2.2 Selling, general, and administrative expenses
11.6 (1.4)Other income, net
(12.0)19.2 Total before tax
4.6 (5.0)Provision for income taxes
$(7.4)$14.2 Net of tax
(Loss) gain on available-for-sale investments$(8.6)$(0.3)Other income, net
2.1 (0.6)Provision for income taxes
$(6.5)$(0.9)Net of tax
Amortization of pension adjustments$(1.0)$(0.9)Other income, net
0.1 0.2 Provision for income taxes
$(0.9)$(0.7)Net of tax

80
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

16.    OTHER INCOME, NET
 Years Ended December 31,
 202120202019
(in millions)
Foreign exchange gains, net$(5.0)$(12.3)$(5.9)
Gain on investments(5.8)(0.6)(0.5)
Non-service cost components of net periodic pension benefit cost0.3 0.4 0.2 
Other(2.2)1.0 (2.0)
Total other income, net$(12.7)$(11.5)$(8.2)

17.    INCOME TAXES

The Company's income before provision for income taxes was generated from operations in the United States and outside of the United States as follows (in millions):
 Years Ended December 31,
 202120202019
United States$610.9 $151.3 $383.4 
Outside of the United States, including Puerto Rico1,091.1 765.4 783.1 
$1,702.0 $916.7 $1,166.5 

The provision for income taxes consists of the following (in millions):
 Years Ended December 31,
 202120202019
Current   
United States:   
Federal$125.2 $23.4 $31.3 
State and local25.1 48.2 48.7 
Outside of the United States, including Puerto Rico92.6 73.9 29.1 
Current income tax expense$242.9 $145.5 $109.1 
Deferred   
United States:   
Federal$(9.4)$11.0 $28.3 
State and local(25.4)(32.9)(18.3)
Outside of the United States, including Puerto Rico(9.2)(30.3)0.5 
Deferred income tax (benefit) expense(44.0)(52.2)10.5 
Total income tax provision$198.9 $93.3 $119.6 

81
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
17.    INCOME TAXES (Continued)
The components of deferred tax assets and liabilities are as follows (in millions):
 December 31,
 20212020
Deferred tax assets  
Compensation and benefits$109.8 $88.6 
Benefits from uncertain tax positions33.9 27.0 
Net tax credit carryforwards142.0 125.5 
Net operating loss carryforwards69.4 64.1 
Accrued liabilities108.0 105.0 
Inventories13.5 16.3 
Cash flow and net investment hedges— 3.3 
State income taxes0.4 0.5 
Investments0.7 1.8 
Lease liability obligations6.6 7.7 
Other1.3 3.6 
Total deferred tax assets485.6 443.4 
Deferred tax liabilities  
Property, plant, and equipment(64.1)(53.4)
Cash flow and net investment hedges(6.4)— 
Deferred tax on foreign earnings(26.3)(29.2)
Right-of-use assets (6.1)(7.0)
Other intangible assets(75.5)(76.3)
Other(2.6)(3.1)
Total deferred tax liabilities(181.0)(169.0)
Valuation allowance(82.5)(71.6)
Net deferred tax assets$222.1 $202.8 

During 2021, net deferred tax assets increased $19.3 million, including items that were recorded to stockholders' equity and which did not impact the Company's income tax provision.

The valuation allowance of $82.5 million as of December 31, 2021 reduces certain deferred tax assets to amounts that are more likely than not to be realized. This allowance primarily relates to the net operating loss carryforwards of certain non-United States subsidiaries and certain non-United States credit carryforwards.

82
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
17.    INCOME TAXES (Continued)
Net operating loss and capital loss carryforwards and the related carryforward periods at December 31, 2021 are summarized as follows (in millions):
 Carryforward
Amount		Tax Benefit
Amount		Valuation
Allowance		Net Tax
Benefit		Carryforward
Period Ends
United States federal net operating losses$17.6 $3.7 $— $3.7 2030-2037
United States federal net operating losses11.3 2.4 — 2.4 Indefinite
United States state net operating losses33.5 1.6 (1.6)— 2026-2039
United States state net operating losses1.0 0.1 (0.1)— Indefinite
Non-United States net operating losses5.8 1.5 (1.2)0.3 2022-2028
Non-United States net operating losses353.3 60.1 (50.8)9.3 Indefinite
United States capital losses34.1 0.2 (0.2)— 2024
Total$456.6 $69.6 $(53.9)$15.7  

Certain tax attributes are subject to an annual limitation as a result of the acquisitions of Harpoon and CASMED, which constitute a change of ownership as defined under Internal Revenue Code Section 382.

The gross tax credit carryforwards and the related carryforward periods at December 31, 2021 are summarized as follows (in millions):
 Carryforward
Amount		Valuation
Allowance		Net Tax
Benefit		Carryforward
Period Ends
California research expenditure tax credits$167.0 $— $167.0 Indefinite
Federal research expenditure tax credits1.5 — 1.5 2026-2039
Foreign tax credits2.9 (2.9)— 2030-2031
Puerto Rico purchases credit23.4 (23.4)— Indefinite
Total$194.8 $(26.3)$168.5  

The Company has $167.0 million of California research expenditure tax credits it expects to use in future periods. The credits may be carried forward indefinitely. Based upon anticipated future taxable income, the Company expects that it is more likely than not that all California research expenditure tax credits will be utilized, although the utilization of the full benefit is expected to occur over a number of years into the distant future. Accordingly, no valuation allowance has been provided. The Company has $23.4 million of Puerto Rico purchases credit. Throughout its history and into the future, the Puerto Rico operations generate, or are expected to generate, credits each year in excess of its ability to utilize credits in those years. As a result, even though the credits have an indefinite life, the Company continues to record a valuation allowance on the credit carryforwards.

On December 22, 2017, Public Law 115-97, commonly referred to as the Tax Cuts and Jobs Act (the "2017 Act"), was signed into law. The 2017 Act a) reduced the United States federal corporate tax rate from 35 percent to 21 percent for tax years beginning after December 31, 2017, b) required companies to pay a one-time mandatory deemed repatriation tax on the cumulative earnings of certain foreign subsidiaries that were previously tax deferred, and c) created new taxes on certain foreign earnings in future years. The Company elected to pay the repatriation tax in installments over eight years.

The Company asserts that $1.0 billion of its foreign earnings continue to be indefinitely reinvested and it intends to repatriate $392.9 million of its foreign earnings as of December 31, 2021. The estimated net tax liability on the indefinitely reinvested earnings if repatriated is $23.1 million.

The Company has received tax incentives in certain non-United States tax jurisdictions, the primary benefit for which will expire in 2029. The tax reductions as compared to the local statutory rates were $208.0 million ($0.33 per diluted share), $189.2 million ($0.30 per diluted share), and $159.2 million ($0.25 per diluted share) for the years ended December 31, 2021, 2020, and 2019, respectively.

83
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
17.    INCOME TAXES (Continued)
A reconciliation of the United States federal statutory income tax rate to the Company's effective income tax rate is as follows (in millions):
 Years Ended December 31,
 202120202019
Income tax expense at United States federal statutory rate$357.4 $192.5 $245.0 
Foreign income taxed at different rates(122.2)(80.5)(75.0)
State and local taxes, net of federal tax benefit11.9 5.0 11.9 
Tax credits, federal and state(48.4)(43.1)(42.9)
Build of reserve for prior years' uncertain tax positions3.6 4.2 5.0 
Tax on global intangible low-taxed income56.5 49.2 32.0 
Foreign-derived intangible income deduction(1.3)(2.6)(7.2)
Contingent consideration liabilities(26.1)2.9 (1.3)
United States federal deductible employee share-based compensation(47.8)(48.3)(57.6)
Nondeductible employee share-based compensation5.3 4.2 3.2 
Other10.0 9.8 6.5 
Income tax provision$198.9 $93.3 $119.6 

The Company's effective tax rate for 2021 increased in comparison to 2020 primarily due to the tax benefit from the Settlement Agreement with Abbott in 2020 (see Note 3) and the decrease in the excess tax benefit from employee share-based compensation, partially offset by the tax benefit from the change in fair value of contingent consideration liabilities. The Company's effective tax rate for 2020 decreased slightly in comparison to 2019 primarily due to the tax benefit from the Settlement Agreement with Abbott in 2020, partially offset by the increase in the United States tax on global intangible low-taxed income and the decrease in the excess tax benefit from employee share-based compensation.
Uncertain Tax Positions

As of December 31, 2021 and 2020, the gross uncertain tax positions were $358.4 million and $281.8 million, respectively. The Company estimates that these liabilities would be reduced by $135.1 million and $95.1 million, respectively, from offsetting tax benefits associated with the correlative effects of potential transfer pricing adjustments, state income taxes, and timing adjustments. The net amounts of $223.3 million and $186.7 million, respectively, if not required, would favorably affect the Company's effective tax rate.

A reconciliation of the beginning and ending amount of uncertain tax positions, excluding interest, penalties, and foreign exchange, is as follows (in millions):
 December 31,
 202120202019
Uncertain gross tax positions, January 1$281.8 $203.1 $150.7 
Current year tax positions
82.1 86.4 55.4 
Increase in prior year tax positions
2.3 6.0 0.8 
Decrease in prior year tax positions
(4.8)(10.0)(3.8)
Settlements
(0.3)(3.7)— 
Lapse of statutes of limitations
(2.7)— — 
Uncertain gross tax positions, December 31$358.4 $281.8 $203.1 

The table above summarizes the gross amounts of uncertain tax positions without regard to reduction in tax liabilities or additions to deferred tax assets and liabilities if such uncertain tax positions were settled.

84
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
17.    INCOME TAXES (Continued)
The Company recognizes interest and penalties, if any, related to uncertain tax positions in the provision for income taxes. As of December 31, 2021, the Company had accrued $19.5 million (net of $8.1 million tax benefit) of interest related to uncertain tax positions, and as of December 31, 2020, the Company had accrued $14.3 million (net of $5.1 million tax benefit) of interest related to uncertain tax positions. During 2021, 2020, and 2019, the Company recognized interest expense, net of tax benefit, of $5.2 million, $5.0 million, and $4.7 million, respectively, in "Provision for Income Taxes" on the consolidated statements of operations.

In the normal course of business, the Internal Revenue Service ("IRS") and other taxing authorities are in different stages of examining various years of the Company's tax filings. During these audits, the Company may receive proposed audit adjustments that could be material. Therefore, there is a possibility that an adverse outcome in these audits could have a material effect on the Company's results of operations and financial condition. The Company strives to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time. While the Company has accrued for matters it believes are more likely than not to require settlement, the final outcome with a tax authority may result in a tax liability that is more or less than that reflected in the consolidated financial statements. Furthermore, the Company may later decide to challenge any assessments, if made, and may exercise its right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law. Management believes that adequate amounts of tax and related penalty and interest have been provided in income tax expense for any adjustments that may result from these uncertain tax positions.

At December 31, 2021, all material state, local, and foreign income tax matters have been concluded for years through 2015. While not material, the Company continues to address matters in India for years from 2010.

The Company executed an Advance Pricing Agreement (“APA”) in 2018 between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters. The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement (collectively "Surgical/TAVR") intercompany royalty transactions, then reverted to IRS Examination for further consideration as part of the respective years' regular tax audits. In addition, the Company executed other bilateral APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Japan and Singapore and between Switzerland and Japan covering tax years 2015 through 2019. The Company has filed to renew all of the APAs which cover transactions with Japan for the years 2020 and forward. The execution of some or all of these APA renewals depends on many variables outside of the Company's control.

The Company’s United States federal income tax returns through 2014 have been audited. The IRS began its examination of the 2015 and 2016 tax years during the fourth quarter of 2018 and later added the 2017 tax year to this audit cycle during the first quarter of 2019. The IRS audit field work for the 2015-2017 tax years was substantially completed during the fourth quarter of 2020, except for transfer pricing and related matters.

During the second quarter of 2021, the Company received a Notice of Proposed Adjustment (“NOPA”) from the IRS for the 2015-2017 tax years relating to transfer pricing involving certain Surgical/TAVR intercompany royalty transactions between the Company's United States and Switzerland subsidiaries. During the third quarter of 2021, the Company completed its review of the NOPA and provided comments to the IRS and the IRS subsequently revised the NOPA. The revised NOPA proposes an increase to the Company's United States taxable income which could result in additional tax expense for this period of approximately $180 million and represents a significant change to previously agreed upon transfer pricing methodologies for these types of transactions.

The Company has formally disagreed with the NOPA and has submitted a formal protest on the matter to the IRS Independent Office of Appeals during the fourth quarter of 2021. The Company also has received the final Revenue Agent's Report for these tax years. The Company continues to evaluate all possible remedies available to it, which could take several years to resolve. No payment of any amount related to the NOPA is required to be made, if at all, until all applicable proceedings have been completed. The Company believes the amounts previously accrued related to this uncertain tax position are sufficient and, accordingly, has not accrued any additional amount based on the NOPA received.

Certain Surgical/TAVR intercompany royalty transactions covering tax years 2015 - 2021 that were not resolved under the APA program remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of
85
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
17.    INCOME TAXES (Continued)
December 31, 2021. The Company has considered this information, as well as information regarding the NOPA described above, in its evaluation of its uncertain tax positions. The impact of these unresolved transfer pricing matters, net of any correlative repatriation tax adjustment, may be significant to the Company’s consolidated financial statements. Based on the information currently available and numerous possible outcomes, the Company cannot reasonably estimate what, if any, changes in its existing uncertain tax positions may occur in the next 12 months and, therefore, has continued to record the uncertain tax positions as a long-term liability.

18.    LEGAL PROCEEDINGS

The Company is reviewing and investigating whether business activities in Japan and other markets violate certain provisions of the Foreign Corrupt Practices Act ("FCPA"). The Company has voluntarily notified the SEC and the United States Department of Justice that it has engaged outside counsel to conduct this review and investigation. Any determination that the Company’s operations or activities are not in compliance with existing laws, including the FCPA, could result in the imposition of fines, penalties, and equitable remedies. The Company cannot currently predict the outcome of the review and investigation or the potential impact on its financial statements.

On September 28, 2021, Aortic Innovations LLC, a non-practicing entity, filed a lawsuit against Edwards Lifesciences Corporation and certain of its subsidiaries ("Edwards") in the United States District Court for the District of Delaware alleging that Edwards’ SAPIEN 3 Ultra product infringes certain of its patents. The Company is unable to predict the ultimate outcome of this matter or estimate a range of possible exposure; therefore, no amounts have been accrued. The Company intends to vigorously defend itself in this litigation.

The Company is or may be a party to, or may otherwise be responsible for, pending or threatened lawsuits including those related to products and services currently or formerly manufactured or performed, as applicable, by the Company, workplace and employment matters, matters involving real estate, Company operations or health care regulations, or governmental investigations (the "Lawsuits"). The Lawsuits raise difficult and complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. Management does not believe that any loss relating to the Lawsuits would have a material adverse effect on the Company's overall financial condition, results of operations or cash flows. However, the resolution of one or more of the Lawsuits in any reporting period, could have a material adverse impact on the Company's financial results for that period. The Company is not able to estimate the amount or range of any loss for legal contingencies related to the Lawsuits for which there is no reserve or additional loss for matters already reserved.

The Company is subject to various environmental laws and regulations both within and outside of the United States. The Company's operations, like those of other medical device companies, involve the use of substances regulated under environmental laws, primarily in manufacturing and sterilization processes. While it is difficult to quantify the potential impact of continuing compliance with environmental protection laws, management believes that such compliance will not have a material impact on the Company's financial results. The Company's threshold of disclosing material environmental legal proceedings involving a governmental authority where potential monetary exposure is involved is $1 million.

19.    SEGMENT INFORMATION

Edwards Lifesciences conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. All regions sell products that are used to treat advanced cardiovascular disease.

The Company's geographic segments are reported based on the financial information provided to the Chief Operating Decision Maker (the Chief Executive Officer). The Company evaluates the performance of its geographic segments based on net sales and operating income. The accounting policies of the segments are the same as those described in Note 2. Segment net sales and segment operating income are based on internally derived standard foreign exchange rates, which may differ from year to year, and do not include inter-segment profits. Because of the interdependence of the reportable segments, the operating profit as presented may not be representative of the geographical distribution that would occur if the segments were not interdependent. Net sales by geographic area are based on the location of the customer. There were no customers that represented 10% or more of the Company's total net sales.

86
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
19.    SEGMENT INFORMATION (Continued)
Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include net interest income, global marketing expenses, corporate research and development expenses, manufacturing variances, corporate headquarters costs, special gains and charges, stock-based compensation, foreign currency hedging activities, certain litigation costs, changes in the fair value of contingent consideration liabilities, and most of the Company's amortization expense. Although most of the Company's depreciation expense is included in segment operating income, due to the Company's methodology for cost build-up, it is impractical to determine the amount of depreciation expense included in each segment, and, therefore, a portion is maintained at the corporate level. The Company neither discretely allocates assets to its operating segments, nor evaluates the operating segments using discrete asset information.

The table below presents information about Edwards Lifesciences' reportable segments (in millions):
 Years Ended December 31,
 202120202019
Segment Net Sales   
United States$2,963.1 $2,516.8 $2,532.7 
Europe1,099.6 945.2 926.1 
Japan528.0 448.6 441.4 
Rest of World533.2 451.5 433.3 
Total segment net sales$5,123.9 $4,362.1 $4,333.5 
Segment Operating Income  
United States$2,051.0 $1,727.3 $1,742.3 
Europe569.1 479.3 472.0 
Japan348.0 286.4 272.3 
Rest of World185.2 150.1 127.9 
Total segment operating income$3,153.3 $2,643.1 $2,614.5 

The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):
 Years Ended December 31,
 202120202019
Net Sales Reconciliation   
Segment net sales$5,123.9 $4,362.1 $4,333.5 
Foreign currency108.6 24.2 14.5 
Consolidated net sales$5,232.5 $4,386.3 $4,348.0 
Pre-tax Income Reconciliation  
Segment operating income$3,153.3 $2,643.1 $2,614.5 
Unallocated amounts:
Corporate items(1,613.8)(1,358.0)(1,439.7)
Special charges— — (64.6)
Intellectual property litigation expenses, net(20.6)(405.4)(33.4)
Change in fair value of contingent consideration liabilities, net124.1 (13.6)6.1 
Foreign currency47.3 31.5 63.9 
Consolidated operating income1,690.3 897.6 1,146.8 
Non-operating income11.7 19.1 19.7 
Consolidated pre-tax income$1,702.0 $916.7 $1,166.5 

87
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
19.    SEGMENT INFORMATION (Continued)
Enterprise-Wide Information
(in millions)

Enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated financial statements.

 As of or for the Years Ended December 31,
 202120202019
Net Sales by Geographic Area   
United States$2,963.1 $2,516.8 $2,532.7 
Europe1,190.3 973.6 941.2 
Japan528.9 460.1 444.7 
Rest of World550.2 435.8 429.4 
$5,232.5 $4,386.3 $4,348.0 
Net Sales by Major Product Area  
Transcatheter Aortic Valve Replacement$3,422.5 $2,857.3 $2,737.9 
Transcatheter Mitral and Tricuspid Therapies86.0 41.8 28.2 
Surgical Structural Heart889.1 761.8 841.7 
Critical Care834.9 725.4 740.2 
$5,232.5 $4,386.3 $4,348.0 
Long-lived Tangible Assets by Geographic Area   
United States$1,195.8 $1,084.3 $849.1 
Europe197.9192.7101.5
Japan19.720.421.7
Rest of World335.5311.0269.4
$1,748.9 $1,608.4 $1,241.7 

88
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)


20.    VALUATION AND QUALIFYING ACCOUNTS

  Additions  
 Balance at
Beginning
of Period		Charged to
Costs and
Expenses		Charged to
Other
Accounts		DeductionsBalance at
End of
Period
 (in millions)
Year ended December 31, 2021
     
Allowance for doubtful accounts (a)$16.4 $1.2 $0.6 $(2.5)$15.7 
Tax valuation allowance (b)71.6 12.4 — (1.5)82.5 
Year ended December 31, 2020
     
Allowance for doubtful accounts (a)$14.7 $3.1 $— $(1.4)$16.4 
Tax valuation allowance (b)65.8 6.3 0.6 (1.1)71.6 
Year ended December 31, 2019
     
Allowance for doubtful accounts (a)$13.6 $4.7 $0.2 $(3.8)$14.7 
Tax valuation allowance (b)46.7 18.9 0.2 — 65.8 
_______________________________________________________________________________
(a)    The deductions related to allowances for doubtful accounts represent accounts receivable which are written off.

(b)     The tax valuation allowances are provided for other-than-temporary impairments and unrealized losses related to certain investments that may not be recognized due to the uncertainty of the ready marketability of certain impaired investments, and net operating loss and credit carryforwards that may not be recognized due to insufficient taxable income.

21.    SUBSEQUENT EVENT

In January 2022, the Company entered into an ASR agreement to repurchase $250.0 million of Edwards Lifesciences' common stock based on the volume-weighted average price ("VWAP") of Edwards Lifesciences' common stock during the term of the agreements, less a discount. Upon entering into the agreement, the Company received an initial delivery of approximately 1.9 million shares, representing approximately 80% of the shares to be repurchased. At the termination of the ASR, the Company may receive additional shares or may be required to pay additional cash or shares (at the Company's election). The final settlement is based on the VWAP over the term of the agreement, less a discount. The ASR agreement has a scheduled termination date of February 16, 2022.


89
Item 9.    Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

None.

Item 9A.    Controls and Procedures

Evaluation of Disclosure Controls and Procedures.    The Company's management, including the Chief Executive Officer and Chief Financial Officer, performed an evaluation of the effectiveness of the design and operation of the Company's disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of December 31, 2021.

Based on their evaluation, the Chief Executive Officer and Chief Financial Officer have concluded as of December 31, 2021 that the Company's disclosure controls and procedures are designed at a reasonable assurance level and are effective in providing reasonable assurance that the information required to be disclosed by the Company in the reports it files or submits under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized, and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to the Company's management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Management's Report on Internal Control Over Financial Reporting.    The Company's management, including the Chief Executive Officer and Chief Financial Officer, is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended. Under the supervision and with the participation of the Company's management, including the Chief Executive Officer and Chief Financial Officer, the Company conducted an evaluation of the effectiveness of its internal control over financial reporting based on the framework in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on that evaluation, the Company's management concluded that its internal control over financial reporting was effective as of December 31, 2021. The effectiveness of the Company's internal control over financial reporting as of December 31, 2021 has been audited by PricewaterhouseCoopers LLP, the independent registered public accounting firm that audited the financial statements included in this Annual Report on Form 10-K, as stated in their report which appears herein.

Changes in Internal Control Over Financial Reporting.    There have been no changes in the Company's internal control over financial reporting that occurred during the Company's fourth fiscal quarter of 2021 that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

Item 9B.    Other Information

None.

Item 9C.    Information Regarding Foreign Jurisdictions That Prevent Inspections

None.
90
PART III

Item 10.    Directors, Executive Officers and Corporate Governance

Certain information required by this Item will be set forth under the headings "Board of Directors Matters—Proposal 1 - Election of Directors—Board of Director Nominees," "Board of Directors Matters—Corporate Governance Policies and Practices," and "Executive Compensation and Other Information—Executive Officers" in the definitive proxy statement to be filed in connection with the Company's 2022 Annual Meeting of Stockholders (the "Proxy Statement") (which Proxy Statement will be filed with the SEC within 120 days of December 31, 2021). The information required by this Item to be contained in the Proxy Statement is incorporated herein by reference. The Company has adopted a code of ethics that applies to all directors and employees, including the Company's principal executive officer, principal financial officer, and principal accounting officer, or persons performing similar functions. The code of ethics (business practice standards) is posted on the Company's website, which is found at https://ir.edwards.com under "Governance & Sustainability—Corporate Responsibility & Sustainability—Corporate Responsibility—Global Integrity Program." To the extent required by applicable rules of the SEC and the New York Stock Exchange, the Company intends to disclose on its website any amendments to, or waivers from, any provision of its code of ethics that apply to the Company's directors and executive officers, including the principal executive officer, principal financial officer or controller or persons performing similar functions.

Item 11.    Executive Compensation

The information contained under the heading "Executive Compensation and Other Information" in the Proxy Statement is incorporated herein by reference.

Item 12.    Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The information contained under the headings "Security Ownership of Certain Beneficial Owners and Management" and "Equity Compensation Plan Information" in the Proxy Statement is incorporated herein by reference.

Item 13.    Certain Relationships and Related Transactions, and Director Independence

The information contained under the heading "Other Matters and Business—Related Persons Transactions" and under the heading "Board of Directors Matters—Corporate Governance Policies and Practices—Director Independence" in the Proxy Statement is incorporated herein by reference.

Item 14.    Principal Accounting Fees and Services

The information contained under the headings "Audit Matters—Fees Paid to Principal Accountants" and "Audit Matters—Pre-Approval of Services" in the Proxy Statement is incorporated herein by reference.

91
PART IV

Item 15.    Exhibits and Financial Statement Schedules

(a)  The following documents are filed as part of this report:

1.  Consolidated Financial Statements.  See “Index to Consolidated Financial Statements” in Part II, Item 8 herein.

2.  Financial Statement Schedules.  Other schedules are not applicable and have not been included herein.

3.  Exhibits. 
Exhibit No.Description
3.1 
3.2 
3.3 
4.1 
4.2 
4.3 
4.4 
4.5 
10.1 
#10.2
*10.3
*10.4
*10.5
*10.6
*10.7
*10.8
*10.9
*10.10
92
Exhibit No.Description
*10.11
*10.12
*10.13
*10.14
*10.15
*10.16
*10.17
*10.18
*10.19
*10.20
*10.21
21.1
23 
31.1 
31.2 
+32
101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCHXBRL Taxonomy Extension Schema Document
101.CALXBRL Taxonomy Extension Calculation Linkbase Document
101.DEFXBRL Taxonomy Extension Definition Linkbase Document
101.LABXBRL Taxonomy Extension Label Linkbase Document
101.PREXBRL Taxonomy Extension Presentation Linkbase Document
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
______________________________________________________________________________
# Pursuant to a request for confidential treatment, confidential portions of this exhibit have been redacted and have been filed separately with the Securities and Exchange Commission
* Represents management contract or compensatory plan
+ Furnished herewith

Item 16.    Form 10-K Summary

None.
93
SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 EDWARDS LIFESCIENCES CORPORATION
February 14, 2022By: /s/ MICHAEL A. MUSSALLEM
Michael A. Mussallem
 Chairman of the Board and
Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SignatureTitleDate
   
/s/ MICHAEL A. MUSSALLEMChairman of the Board and Chief Executive OfficerFebruary 14, 2022
Michael A. Mussallem(Principal Executive Officer)
/s/ SCOTT B. ULLEMCorporate Vice President, Chief Financial OfficerFebruary 14, 2022
Scott B. Ullem(Principal Financial Officer)
/s/ ROBERT W.A. SELLERSVice President, Corporate ControllerFebruary 14, 2022
Robert W.A. Sellers(Principal Accounting Officer)
/s/ KIERAN T. GALLAHUEDirectorFebruary 14, 2022
Kieran T. Gallahue
/s/ LESLIE S. HEISZDirectorFebruary 14, 2022
Leslie S. Heisz
/s/ PAUL A. LAVIOLETTEDirectorFebruary 14, 2022
Paul A. LaViolette
/s/ STEVEN R. LORANGERDirectorFebruary 14, 2022
Steven R. Loranger
/s/ MARTHA H. MARSHDirectorFebruary 14, 2022
Martha H. Marsh
/s/ RAMONA SEQUEIRADirectorFebruary 14, 2022
Ramona Sequeira
/s/ NICHOLAS J. VALERIANIDirectorFebruary 14, 2022
Nicholas J. Valeriani

94
 EX-4.2 2 ex-4210xkq42021.htm EX-4.2 Document

Exhibit 4.2

DESCRIPTION OF CAPITAL STOCK

References to “we,” “us” and “our” refer to Edwards Lifesciences Corporation.

General

This section summarizes the rights of our capital stock, certain provisions of our amended and restated certificate of incorporation, as amended (our “certificate of incorporation”), and our bylaws, as amended and restated (our “bylaws”), and certain provisions of applicable law. The following description is only a summary and is qualified by reference to our certificate of incorporation and our bylaws, each of which is incorporated by reference as an exhibit to our Annual Report on Form 10-K for the year ended December 31, 2021 filed with the Securities and Exchange Commission.

Authorized Capitalization

Our authorized capital stock consists of:

▪1,050,000,000 shares of common stock, with a par value of $1.00 per share; and

▪50,000,000 shares of preferred stock, with a par value of $0.01 per share, of which 3,500,000 shares have been designated as “Series A Junior Participating Preferred Stock.”

As of December 31, 2021, 642 million shares of our common stock were issued and 624.1 million shares of our common stock were outstanding, and no shares of our preferred stock were issued and outstanding. As of December 31, 2021, we also had approximately 336 million shares of our common stock reserved to be issued upon exercise of outstanding stock options and restricted stock units granted to employees and directors.

Common Stock

The holders of our common stock are entitled to one vote for each share on all matters submitted to a vote of stockholders and do not have cumulative voting rights with respect to the election of directors. Holders of our common stock are entitled to receive ratably such dividends as may be declared from time to time by our board of directors out of legally available assets. In the event of our liquidation, dissolution or winding up, holders of common stock are entitled to share ratably in all assets remaining after payment of all debts and other liabilities and any amounts due to any holders of preferred stock. Holders of our common stock have no preemptive or conversion rights. No redemption or sinking fund provisions apply to our common stock. The rights, preferences and privileges of holders of our common stock are subject to the rights of the holders of shares of any series of preferred stock which we may issue. All of our outstanding shares of common stock are fully paid and non-assessable.

Preferred Stock

Our board of directors has the authority, without stockholder approval, to issue up to 50,000,000 shares of our preferred stock in one or more series and to determine, with respect to any such series, the powers, preferences and rights of the shares of such series, and the qualifications, limitations and restrictions thereof, including, without limitation, voting rights, dividend rights, conversion rights, terms of redemption, liquidation preference, sinking fund terms and the number of shares constituting any series and the designation thereof.

Our board of directors can issue, without stockholder approval, preferred stock with voting and conversion rights that could adversely affect the voting power of the holders of common stock and reduce the likelihood that such holders will receive dividend payments or payments upon liquidation. Such issuance could have the effect of decreasing the market price of the common stock. The issuance of preferred stock or even the ability to issue preferred stock could also have the effect of delaying, deterring or preventing a change of control or other corporate action.

Anti-Takeover Effects of Delaware Law and Our Certificate of Incorporation and Bylaw Provisions

Our certificate of incorporation and bylaws contain certain provisions that may make it more difficult to acquire control of us by means of a tender offer, open market purchase, proxy fight or otherwise. These provisions and certain provisions of Delaware law are expected to discourage coercive takeover practices and inadequate takeover bids.

These provisions are intended to enhance the likelihood of continued stability in the composition of our board of directors and its policies and to discourage certain types of transactions that may involve an actual or threatened acquisition of us. The


provisions also are intended to discourage certain tactics that may be used in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers for our shares and, as a consequence, could deprive stockholders of opportunities to realize takeover premiums for their shares.

Set forth below is a summary of the relevant provisions of our certificate of incorporation and bylaws and certain applicable sections of the General Corporation Law of the State of Delaware. For additional information we refer you to the provisions of our certificate of incorporation, our bylaws and those sections of the General Corporation Law of the State of Delaware.

Delaware Anti-Takeover Statute

We are subject to the provisions of Section 203 of the General Corporation Law of the State of Delaware regulating corporate takeovers. In general, Section 203, subject to certain exceptions, prohibits a publicly-held Delaware corporation from engaging in any business combination with any interested stockholder for a period of three years following the date that such person or entity became an interested stockholder, unless:

▪prior to that date, the board of directors of the corporation approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder;

▪upon consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding specified shares; or

▪at or subsequent to that date of the transaction that resulted in a person or entity becoming an interested stockholder, the business combination is approved by the board of directors and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 662⁄3% of the outstanding voting stock that is not owned by the interested stockholder.

The application of Section 203 may limit the ability of stockholders to approve a transaction that they may deem to be in their best interests. In addition, Section 203 makes it more difficult for an interested stockholder to effect various business combinations with a corporation for a three-year period, although the stockholders may, by adopting an amendment to our certificate of incorporation or bylaws, elect not to be governed by this section, effective 12 months after adoption.

In general, Section 203 defines “business combination” as:

▪any merger or consolidation involving the corporation and the interested stockholder;

▪any sale, lease, exchange, mortgage, pledge, transfer or other disposition of 10% or more of the assets of the corporation to or with the interested stockholder;

▪subject to certain exceptions, any transaction which results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;

▪any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; or

▪the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation.

In general, Section 203 defines an “interested stockholder” as any person that is:

▪the owner of 15% or more of the outstanding voting stock of the corporation;

▪an affiliate or associate of the corporation and was the owner of 15% or more of the outstanding voting stock of the corporation at any time within three years immediately prior to the relevant date; or

▪an affiliate or associate of the above.

Our certificate of incorporation and bylaws do not exclude us from the restrictions imposed under Section 203. We anticipate that the provisions of Section 203 may encourage companies interested in acquiring us to negotiate in advance with our board of directors because the stockholder approval requirement would be avoided if a majority of the directors then in


office approve either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder.

Our Board of Directors

Our certificate of incorporation provides that the number of directors may be fixed from time to time by the board of directors, subject to the rights of holders of shares of any series of preferred stock to elect additional directors under specific circumstances. The size of our board of directors is currently fixed at eight directors. Each elected director holds office until his or her successor is duly elected and qualified, or until his or her earlier death, resignation, disqualification or removal.

Our certificate of incorporation and bylaws do not authorize cumulative voting with regard to the election of directors.

Board Vacancies

Our certificate of incorporation and bylaws provide that any vacancy in our board of directors may be filled only by a majority of the directors then in office, though less than a quorum, or by our sole remaining director. Each director so elected shall hold office until his or her successor is duly elected and qualified, or until his or her earlier death, resignation, disqualification or removal.

Advance Notice Requirements for Stockholder Proposals and Director Nominees

Our bylaws provide that stockholders seeking to make nominations of candidates for election as directors, or to bring other business before an annual or special meeting of the stockholders, must provide timely notice of their intent in writing. To be timely, a stockholder’s notice must be delivered to and received at our principal executive offices not less than 90 days nor more than 120 days prior to the meeting. However, in the event that the date of the annual meeting is more than 25 days before or more than 25 days after the first anniversary date of the preceding year’s annual meeting, or in the event of a special meeting of stockholders called for the purpose of electing directors, a stockholder’s notice must be delivered to our principal executive offices not later than the close of business on the 10th day following the earlier of the date on which such notice of the date of the meeting was mailed or such public disclosure of the date of the meeting was made. Our bylaws also specify certain requirements as to the form and content of a stockholder’s notice. These provisions may restrict the ability of our stockholders to bring business before our annual meeting of stockholders or to make nominations for directors at our annual meeting or any special meeting of stockholders.

Proxy Access

Our bylaws permit an eligible stockholder or group of stockholders to include up to a specified number of director nominees in our proxy materials for an annual meeting of stockholders. To qualify, the stockholders (or group of up to thirty stockholders) must have continuously owned for at least three years 3% or more of our outstanding shares of capital stock. The maximum number of stockholder nominees permitted under the proxy access provisions of our bylaws is generally the greater of (i) two or (ii) 20% of the total number of our directors in office as of the last day on which notice of a nomination may be delivered.

Notice of a nomination under our proxy access bylaw provisions must generally be submitted to our principal executive offices not less than 120 days nor more than 150 days prior to the first anniversary of the date that we first mailed our proxy statement to stockholders for the immediately preceding annual meeting of stockholders. The notice must contain certain information specified in our bylaws.

Blank Check Preferred Stock

Our certificate of incorporation provides that our board of directors can issue, without stockholder approval, up to 50,000,000 shares of our preferred stock in one or more series and to determine, with respect to any such series, the powers, preferences and rights of the shares of such series, and the qualifications, limitations and restrictions thereof, including, without limitation, voting rights, dividend rights, conversion rights, terms of redemption, liquidation preference, sinking fund terms and the number of shares constituting any series and the designation thereof.

Stockholder Action by Written Consent

Our certificate of incorporation provides that all actions requiring the vote or consent of stockholders must be taken at a regular or special meeting of stockholders and cannot be taken by written consent without a meeting.



Choice of Forum

Our bylaws provide that, unless we consent in writing to the selection of an alternative forum, (A) the Court of Chancery of the State of Delaware will be, to the fullest extent permitted by law, the sole and exclusive forum for any derivative action or proceeding brought on our behalf; any action asserting a claim of breach of fiduciary duty; any action asserting a claim against us arising pursuant to the Delaware General Corporation Law; or any action asserting a claim against us that is governed by the internal affairs doctrine, and (B) the federal district courts of the United States will be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended.

Transfer Agent and Registrar

Computershare is the transfer agent and registrar for our common stock.

Listing

Our common stock is listed on the NYSE under the symbol “EW.”


 EX-10.11 3 ex-101110xkq42021.htm EX-10.11 Document

Exhibit 10.11

Edwards Lifesciences Corporation
Long-Term Stock Incentive Compensation Program
Global Nonqualified Stock Option Award Agreement

THIS AGREEMENT, including any appendix for the Participant’s country (the “Non-U.S. Countries Additional Terms Appendix”), the appendix containing additional defined terms (the “Additional Defined Terms Appendix” and, together with the Non-U.S. Countries Additional Terms Appendix, the “Appendices”) and the Participant Stock Option Statement attached to the front of this agreement (the “Statement”), sets forth the terms and conditions of the nonqualified stock option (the “Option”) granted by Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), to the Participant named on the Statement, pursuant to the provisions of the Company’s Long-Term Stock Incentive Compensation Program (the “Program”). This agreement, the Appendices and the Statement shall be considered one agreement and are referred to herein as the “Agreement.”

The Program provides additional terms and conditions governing the Option and is incorporated herein by reference. If there is any inconsistency between the terms of this Agreement and the terms of the Program, the Program’s terms shall completely supersede and replace the conflicting terms of this Agreement. All capitalized terms shall have the meanings ascribed to them in the Program, unless specifically set forth otherwise herein. The parties hereto agree as follows:

1.Grant of Stock Option. Effective as of the Date of Grant set forth on the Statement, the Company grants to the Participant an Option to purchase the number of Shares set forth on the Statement, at the stated Option Price set forth on the Statement, which is one hundred percent (100%) of the Fair Market Value of a Share on the Date of Grant, in the manner and subject to the terms and conditions of the Program and this Agreement.

The grant of this Option to the Participant shall not confer any right to such Participant (or any other Participant) to be granted any Option or other Awards in the future under the Program.

2. Exercise of Stock Option. Except as may otherwise be provided in Sections 3 and 4 below, the Participant may only exercise this Option according to the vesting schedule set forth on the Statement, provided the Participant continues to be employed by the Company or one of its Subsidiaries through the applicable vesting date. No exercise may occur subsequent to the close of business on (i) the Date of Expiration (as set forth on the Statement) or (ii) such earlier date of the expiration of the Option as set forth in Section 3.

The number of Shares for which this Option becomes vested and exercisable pursuant to this Section 2 shall be rounded down to the next whole number in the event that the use of the percentages set forth on the Statement results in the Option being exercisable with respect to a fractional Share. In addition, the Option may be exercised in whole or in part, but not for less than fifty (50) Shares at any one time, unless fewer than fifty (50) Shares then remain subject to the Option, and the Option is then being exercised as to all such remaining Shares.

3. Termination of Employment:

(a) By Death or Disability: All unvested Shares under this Option shall immediately vest and become exercisable as of the Participant’s date of termination by death or Disability. Shares under this Option that vest and become exercisable in accordance with this Section 3(a) or that are already vested and exercisable as of the Participant’s date of termination by reason of death or Disability, may be purchased only until the earlier of: (i) the Date of Expiration of this Option; or (ii) the first (1st) anniversary of the Participant’s date of termination by reason of death or Disability.

(b) By Retirement: Subject to Section 4, all unvested Shares under this Option shall immediately terminate and be forfeited to the Company as of the date of the Participant’s termination of employment by Retirement. All Shares under this Option that are vested as of the Participant’s date of termination by Retirement may be purchased only until the earlier of: (i) the Date of Expiration of this Option; or (ii) the fifth (5th) anniversary of the Participant’s date of Retirement.

(c) For Cause: If the Participant’s employment is terminated for Cause (as defined in the Additional Defined Terms Appendix), all vested and unvested Shares under this Option shall terminate as of the Participant’s date of termination of employment and shall be forfeited to the Company.



(d) For Other Reasons: Subject to Section 4, all unvested Shares under this Option shall immediately terminate and be forfeited to the Company as of the date of the Participant’s termination of employment for any reason other than the reasons set forth in Section 3(a) above. Shares under this Option that are vested and exercisable as of the date of an employment termination for any reason other than those reasons set forth in Sections 3(a), 3(b) or 3(c) above may be purchased until the earlier of: (i) the Date of Expiration of this Option; or (ii) the ninetieth (90th) day following the date of the Participant’s employment termination.

(e) Transfer: For the purposes of this Agreement, a transfer of the Participant’s employment between the Company and any Subsidiary (or between Subsidiaries) shall not be deemed a termination of employment. For purposes of this Agreement, if the Participant is employed by an entity that constitutes a Subsidiary and that entity ceases (as a result of a sale of equity interests in the entity, a spin-off, or otherwise) to constitute a Subsidiary, the Participant will be considered to have ceased to be employed by the Company or one of its Subsidiaries as of the date that such entity so ceases to constitute a Subsidiary unless either (x) the Participant is employed immediately after such transaction or event by the Company or another entity that continues to qualify as a Subsidiary or (y) the entity that is sold, spun-off or otherwise divested and ceases to constitute a Subsidiary (or a successor or a direct or indirect parent of such entity or such a successor) assumes the Option in connection with such transaction.

(f) Death or Disability Following Termination of Employment. If the Participant dies or incurs a Disability after termination of employment but before this Option otherwise expires in accordance with Sections 3(a), (b) or (d) above, then to the extent that this Option is still exercisable on the date of death or Disability, Shares may be purchased hereunder until the earlier of: (i) the first (1st) anniversary of the Participant’s date of death or Disability (or, if later, in the case of death or Disability following termination by reason of Retirement, the fifth (5th) anniversary of such termination) or (ii) the Date of Expiration of this Option. Except in the case of death or Disability following termination by reason of Retirement, this Option shall not be exercisable for more Shares than it was immediately before the date of death or Disability.

4. Change in Control.

(a)    Possible Acceleration on Certain Terminations: The following provisions of this Section 4(a) apply notwithstanding anything to the contrary in this Agreement or in the Program, but only to the event that Section 4(b) does not apply in the circumstances. In the event that, at any time during the Protected Period, the Participant ceases to be employed by the Company or one of its Subsidiaries and such termination is the result of a termination of employment either by the Company or such Subsidiary without Cause or by the Participant for Good Reason, this Option, to the extent then outstanding and unvested, shall immediately vest and become exercisable in full for the applicable timeframe set forth in Section 3; provided, however, that to the extent such a termination of the Participant’s employment occurs prior to a Change in Control, this Option shall:

(i) remain outstanding and unvested for a period of six (6) months following such termination of employment (or, if less, until the Date of Expiration of this Option) and, should a Change in Control occur during such period of time, vest and become exercisable in full upon the Change in Control for the applicable timeframe specified in Section 3 above as if the date of the Change in Control was the date of the Participant’s termination of employment; and

(ii) terminate and be forfeited at the end of such six-month period should no Change in Control occur during such period (or, if earlier, on the Date of Expiration of this Option).

(b) Possible Acceleration on Certain Terminations - CIC Agreement: In the event that the Participant ceases to be employed by the Company or one of its Subsidiaries and, at the time of such cessation of employment, the Participant is a party to a CIC Agreement, the extent (if any) to which this Option, to the extent then outstanding and unvested, would become vested in connection with such cessation of employment shall be determined in accordance with and subject to the terms and conditions of such CIC Agreement.

(c) Possible Acceleration and Early Termination on Change in Control: Article 13 of the Program provides, in general, that in connection with certain Change in Control events the Company may provide for either the assumption and continuation of the Option or for the termination of the Option. The Option remains subject to termination pursuant to Article 13 of the Program even if such termination occurs earlier than the Date of Expiration or any other termination date otherwise provided for in this Agreement. If the Option is to be terminated pursuant to Article 13 of the Program, however, the outstanding and otherwise unvested portion of the Option will vest to the extent provided by Article 13 of the Program.

(d) Definitions: For the purposes of this Agreement and notwithstanding anything to the contrary in the Program, the following definitions will apply:



(i) “CIC Agreement” means a Change in Control Severance Agreement (or any similar or successor written agreement) between the Participant and the Company that provides for the accelerated vesting (or all or a portion) of the equity awards granted by the Company to the Participant (to the extent then outstanding and otherwise unvested) in connection with certain terminations of the Participant’s employment and which, by its terms, would apply to the Option (subject to any applicable release or other conditions on such accelerated vesting as set forth in such agreement).

(ii) The terms “Cause”, “Change in Control”, “Good Reason”, and “Protected Period” have the respective meanings ascribed to such terms in the Additional Defined Terms Appendix.

5. Notice of Termination. Any termination of the Participant’s employment by the Company for Cause or by the Participant for Good Reason shall be communicated by a written notice to the other party indicating the specific termination provision in this Agreement relied upon, and setting forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Participant’s employment under the provision so indicated.

6. Restrictions on Transfer. This Option may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution applicable to the Participant. Further, this Option shall be exercisable during the Participant’s lifetime only by the Participant or the Participant’s legal representative.

7. Recapitalization. In the event of any change in corporate capitalization of the Company, such as a stock split, or a corporate transaction, such as any merger, consolidation, separation, including a spin-off, or other distribution of stock or property of the Company, any reorganization (whether or not such reorganization comes within the definition of such term in Code Section 368) of the Company, or any partial or complete liquidation of the Company, the number and class of Shares subject to this Option, as well as the Option Price, are subject to adjustment by the Committee pursuant to Section 5.4 of the Plan to prevent dilution or enlargement of rights.

8. Procedure for Exercise of Option. This Option may be exercised any time prior to its expiration or forfeiture in accordance with the exercise procedures established by the Committee. Payment of the Option Price may be made by any of the methods set forth in Section 6.6 of the Program, except that if the Participant resides outside the U.S., he or she may not pay the Option Price by tendering previously acquired Shares (by either actual delivery or attestation) having an aggregate Fair Market Value at the time of exercise equal to the total Option Price and may be subject to other restrictions set forth in the Non-U.S. Countries Additional Terms Appendix.

9. Responsibility for Taxes. Regardless of any action the Company or the Participant’s employer (if different) (the “Employer”) takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related items related to the Participant’s participation in the Program that are legally applicable to the Participant (“Tax-Related Items”), the Participant acknowledges that the ultimate liability for all Tax-Related Items is and remains his or her responsibility and that such liability may exceed the amount actually withheld by the Company or the Employer. The Participant further acknowledges that the Company and/or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Option or the underlying Share, including the grant, vesting or exercise of the Option, the subsequent sale of Shares acquired pursuant to such exercise and the receipt of any dividends; and (2) do not commit and are under no obligation to structure the terms of the grant or any aspect of the Option to reduce or eliminate the Participant’s liability for Tax-Related Items or achieve any particular tax result. Further, if the Participant becomes subject to Tax-Related Items in more than one jurisdiction, the Participant acknowledges that the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

Prior to any relevant taxable, tax and/or social security contribution withholding event, the Participant shall pay or make adequate arrangements satisfactory to the Company and/or the Employer to satisfy all Tax-Related Items. In this regard, the Participant authorizes the Company and/or the Employer, or their respective agents, at their sole discretion, to satisfy any applicable withholding obligations with respect to Tax-Related Items by one or a combination of the following: (i) withholding from the Participant’s wages or other cash compensation paid to him or her by the Company and/or the Employer; or (ii) withholding from the proceeds of the sale of Shares acquired upon exercise of the Option, either through a voluntary sale or through a mandatory sale arranged by the Company (on the Participant’s behalf pursuant to this authorization) subject to any insider trading policies implemented by the Company and applicable to the Participant and to the insider trading rules set forth under Section 10(b) and Rule 10b-5 of the U.S. Securities Exchange Act of 1934; or (iii) withholding in Shares to be issued upon exercise of the Option. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant will be deemed to have been issued the full number of Shares subject to the exercised Option, notwithstanding that a number of Shares are held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Participant’s participation in the Program. Depending on the withholding method, the Company or the Employer may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding rates or other applicable withholding rates, including maximum applicable rates in the Participant’s jurisdiction(s). In the event of over-withholding, the Participant may receive a refund of any over-withheld amount in cash (with no entitlement to the equivalent in Shares), or, if


not refunded, the Participant may seek a refund from the applicable tax authorities. In the event of under-withholding, the Participant may be required to pay additional Tax-Related Items directly to the tax authorities, the Company or the Employer.
Finally, the Participant shall pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of Participant’s participation in the Program or Participant’s purchase of Shares that cannot be satisfied by the means previously described. The Company may refuse to honor the exercise and refuse to issue or deliver the Shares or the proceeds of the sale of the Shares to the Participant if the Participant fails to comply with Participant’s obligations in connection with the Tax-Related Items.

10. Beneficiary Designation. This Section 10 applies only if the Participant resides in the U.S. The Participant may, from time to time, name any beneficiary or beneficiaries (who may be named contingently or successively) to whom any benefit under this Agreement is to be paid in case of his or her death before he or she receives any or all such benefit. Each such designation shall revoke all prior designations by the Participant, shall be in a form prescribed by the Company, and will be effective only when completed by the Participant in accordance with any instructions provided by the Company during the Participant’s lifetime. In the absence of any such designation, benefits remaining unpaid at the Participant’s death shall be paid to the Participant’s estate.

11. Rights as a Stockholder. The Participant shall have no rights as a stockholder of the Company until the Option is exercised and the Participant has obtained an ownership interest in the Shares.

12. Continuation of Employment. This Agreement shall not confer upon the Participant any right to continuation of employment by the Employer, nor shall this Agreement interfere in any way with the Employer’s right to terminate the Participant’s employment at any time with or without cause.

13. Miscellaneous.

(a) This Agreement and the rights of the Participant hereunder are subject to all the terms and conditions of the Program, as the same may be amended from time to time, as well as to such rules and regulations as the Committee may adopt for administration of the Program. The Committee shall have the right to impose such restrictions on any Shares acquired pursuant to the exercise of this Option, as it may deem advisable for regulatory compliance, including, without limitation, restrictions under applicable U.S. federal securities laws, under the requirements of any stock exchange or market upon which such Shares are then listed and/or traded, and under any state or foreign securities laws applicable to such Shares. It is expressly understood that the Committee is authorized to administer, construe, and make all determinations necessary or appropriate to the administration of the Program and this Agreement, all of which shall be binding upon the Participant.

(b) The Board may terminate, suspend, amend, or modify the Program and the Committee may amend this Option at anytime; provided, however, that except for the Company’s right to cash out this Option under certain circumstances pursuant to Section 6.10 of the Program, no such termination, amendment, suspension or modification of the Program or amendment of this Option may in any material way adversely affect the Participant’s rights under this Agreement, without the express consent of the Participant.

(c) The Participant agrees to take all steps necessary to comply with all applicable provisions of U.S. federal, state and foreign securities law in exercising his or her rights under this Agreement.

(d) This Agreement shall be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required.

(e) All obligations of the Company under the Program and this Agreement, with respect to this Option, shall, to the extent legally permissible, be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company.

14. Nature of Grant. In accepting the Option, the Participant acknowledges, understands and agrees that:

(a) the Program is established voluntarily by the Company and is discretionary in nature;

(b) the grant of the Option by the Company is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of options, or benefits in lieu of options, even if options have been granted in the past;

(c) all decisions with respect to future option grants, if any, will be at the sole discretion of the Company;

(d) the Participant is voluntarily participating in the Program;



(e) the Option and any Shares acquired under the Program, and the income from and value of the same, are not part of normal or expected compensation or salary;

(f) unless otherwise agreed with the Company, the Option and any Shares acquired under the Program, and the income from and value of the same, are not granted as consideration for, or in connection with, the service the Participant may provide as a director of a Subsidiary or affiliate of the Company;

(g) the Option grant and the Participant’s participation in the Program shall not be interpreted to form an employment contract or relationship with the Company or the Employer or any Subsidiary or affiliate of the Company;

(h) the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty;

(i) if the underlying Shares do not increase in value, the Option will have no value;

(j) for purposes of the Option, the Participant’s employment or other service relationship will be considered terminated as of the date the Participant is no longer actively providing services to the Company or the Employer (regardless of the reason for such termination and whether or not later found invalid or in breach of employment laws in the jurisdiction where the Participant is employed or providing services or the terms of the Participant’s employment or service agreement, if any), and unless otherwise provided in this Agreement or decided by the Committee, the Participant’s right to vest in the Option under the Program, if any, will terminate effective as of such date and the Participant’s right to exercise the Option after such date, if any, will be as set forth in Section 3 above and measured from such date, and such rights to vest in and exercise the Option will not be extended by any notice period (e.g., active employment would not include a period of “garden leave” or similar period mandated under employment laws in the jurisdiction where the Participant is employed or providing services or the terms of the Participant’s employment or service agreement, if any); furthermore, the Committee shall have the exclusive discretion to determine when the Participant is no longer actively providing services for purposes of the Option (including whether the Participant may still be considered to be providing services while on a leave of absence);

(k) for Participants who reside outside the U.S., the following additional provisions shall apply:

(i) the Option and any Shares acquired under the Program, and the income from and value of the same, are not intended to replace any pension rights or compensation;

(ii) the Option and the Shares acquired under the Program, and the income from and value of the same, are extraordinary items that do not constitute compensation of any kind for services of any kind rendered to the Company or to the Employer and are outside the scope of Participant’s employment agreement, if any; such items shall not be included in or part of any calculation of any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company or the Employer;

(iii) no claim or entitlement to compensation or damages shall arise from forfeiture of the Option resulting from termination of the Participant’s employment or other service relationship by the Company or the Employer (regardless of the reason for such termination and whether or not later found invalid or in breach of employment laws in the jurisdiction where the Participant is employed or providing services or the terms of the Participant’s employment or service agreement, if any); and

(iv) neither the Company, the Employer or any Subsidiary or affiliate shall be liable for any foreign exchange rate fluctuation between the Participant’s local currency and the United States Dollar that may affect the value of the Option or of any amounts due to the Participant pursuant to the Option or the subsequent sale of any Shares acquired upon exercise of the Option.

15. No Advice Regarding Grant. The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Participant’s participation in the Program, or his or her acquisition or sale of the underlying Shares. The Participant should consult with his or her own personal tax, legal and financial advisors regarding the Participant’s participation in the Program before taking any action related to the Program.

16. Data Privacy Notice and Consent. This Section 16 applies if the Participant resides outside the U.S.

(a) Data Collection and Usage. The Company and the Employer collect, process and use certain personal information about the Participant, including, but not limited to, the Participant’s name, home address and telephone number, email address, date of birth, social insurance, passport or other identification number,


salary, nationality, job title, any Shares or directorships held in the Company, details of all Options or any other entitlement to Shares or equivalent benefits awarded, canceled, exercised, vested, unvested or outstanding in the Participant’s favor (“Data”), for the purposes of implementing, administering and managing the Program. The legal basis, where required, for the processing of Data is the Participant’s consent.

(b) Stock Plan Administration Service Providers. The Company will transfer Data to Charles Schwab & Co., Inc. (including its affiliated companies) (collectively, “Charles Schwab”), which is assisting the Company with the implementation, administration and management of the Program. The Company may select different or additional service providers in the future and share Data with such other provider(s) serving in a similar manner. The Participant may be asked to agree on separate terms and data processing practices with Charles Schwab, with such agreement being a condition to the ability to participate in the Program.

(c) International Data Transfers. The Company and Charles Schwab are based in the United States, which means that it will be necessary for Data to be transferred to, and processed in, the United States. If the Participant is outside the United States, the Participant should note that his or her country has enacted data privacy laws that are different from the United States. The Company’s legal basis, where required, for the transfer of Data is the Participant’s consent.

(d) Data Retention. The Company will hold and use Data only as long as is necessary to implement, administer and manage the Participant’s participation in the Program, or as required to comply with legal or regulatory obligations, including under tax, exchange control, labor and securities laws. This may mean Data is retained until after the Participant’s service relationship has terminated, plus any additional time periods necessary for compliance with law, exercise or defense of legal rights, archiving, back-up and deletion purposes.

(e) Voluntariness and Consequences of Consent Denial or Withdrawal. Participation in the Program is voluntary, and the Participant is providing the consents herein on a purely voluntary basis. If the Participant does not consent, or if the Participant later seeks to revoke his or her consent, the Participant’s salary from or employment and career with the Employer will not be affected; the only consequence of refusing or withdrawing consent is that the Company would not be able to grant Options or other Awards to the Participant or administer or maintain such Awards.

(f) Data Subject Rights. The Participant may have a number of rights under data privacy laws in the Participant’s jurisdiction. Depending on where the Participant is based, such rights may include the right to (i) inquire whether and what kind of Data the Company holds about the Participant and how it is processed, and to request access or copies of Data the Company processes, (ii) request correction or supplementation of the Data about the Participant that is inaccurate, incomplete or out of date in light of the purposes underlying the processing, (iii) request deletion of Data no longer necessary for the purposes underlying the processing processed based on withdrawn consent, processed for legitimate interests that, in the context of the Participant’s objection, do not prove to be compelling, or processed in non-compliance with applicable legal requirements, (iv) request restrictions on processing of Data, (v) request portability of Data that the Participant has actively or passively provided to the Company (which does not include data derived or inferred from the collected data), where the processing of such Data is based on consent or the Participant’s employment and is carried out by automated means, (vi) object, in certain circumstances, to the processing of Data for legitimate interests, (vii) lodge complaints with competent authorities in the Participant’s jurisdiction and/or (viii) receive a list with the names and addresses of any potential recipients of Data. To receive clarification regarding these rights or to exercise these rights, the Participant should contact his or her local human resources representative.

Finally, the Participant understands that the Company may rely on a different basis for the processing or transfer of Data in the future and/or request that the Participant provide another data privacy consent. If applicable, the Participant agrees that upon request of the Company or the Employer, the Participant will provide an executed acknowledgement or data privacy consent form (or any other agreements or consents) that the Company and/or the Employer may deem necessary to obtain from the Participant for the purpose of administering the Participant’s participation in the Program in compliance with the data privacy laws in the Participant’s country, either now or in the future. The Participant understands and agrees that he or she will not be able to participate in the Program if he or she fails to provide any such consent or agreement requested by the Company and/or the Employer.

17. Severability. The provisions of this Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.

18. Dispute Resolution. The Participant shall have the right and option to elect to have any good faith dispute or controversy arising under or in connection with this Agreement settled by litigation or arbitration. If arbitration is selected,


such proceeding shall be conducted by final and binding arbitration before a panel of three (3) arbitrators in accordance with the rules and under the administration of the American Arbitration Association.

19. Governing Law and Venue. To the extent not preempted by U.S. federal law, this Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, U.S.A.

For purposes of litigating any dispute that arises directly or indirectly from the relationship of the parties evidenced by this Option, the Program or this Agreement, the parties hereby submit to and consent to the exclusive jurisdiction of the State of California and agree that such litigation shall be conducted only in the courts of Orange County, California or the federal courts for the United States for the Central District of California, and no other courts, where this grant is made and/or to be performed.

20. Language. The Participant acknowledges and represents that he or she is proficient in the English language or has consulted with an advisor who is sufficiently proficient in English, as to allow the Participant to understand the terms of this Agreement and any other documents related to the Program. If the Participant has received this Agreement or any other document related to the Program translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

21. Electronic Delivery. The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Program by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Program through an online or electronic system established and maintained by the Company or a third party designated by the Company.

22. Insider Trading Restrictions/Market Abuse Laws. The Participant acknowledges that the Participant may be subject to insider trading restrictions and/or market abuse laws in applicable jurisdictions, including the United States and the Participant’s country, the broker’s country or the country in which the Shares are listed (if different), which may affect his or her ability to accept or otherwise acquire, sell, attempt to sell or otherwise dispose of, Shares or rights to Shares (e.g., Options) under the Program or rights linked to the value of Shares during such times as the Participant is considered to have “inside information” regarding the Company (as defined by the laws in the applicable jurisdictions, including the United States and the Participant’s country). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders the Participant placed before possessing inside information. Furthermore, the Participant could be prohibited from (i) disclosing the inside information to any third party and (ii) “tipping” third parties or otherwise causing them to buy or sell Company securities; “third parties” include fellow employees. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. The Participant is responsible for ensuring compliance with any applicable restrictions and should consult his or her personal legal advisor on this matter.

23. Foreign Asset/Account, Exchange Control and Tax Reporting. The Participant acknowledges that, depending on his or her country, the Participant may be subject to foreign asset/account, exchange control and/or tax reporting requirements as a result of the acquisition, holding and/or transfer of Shares or cash (including dividends and the proceeds arising from the sale of Shares) derived from his or her participation in the Program, in, to and/or from a brokerage/bank account or legal entity located outside the Participant’s country. The Participant may be required to report such accounts, assets, the balances therein, the value thereof and/or the transactions related thereto to the applicable authorities in the Participant’s country. The Participant also may be required to repatriate sale proceeds or other funds received as a result of the Participant’s participation in the Program to the Participant’s country through a designated bank or broker and/or within a certain time after receipt. The Participant acknowledges that he or she is responsible for ensuring compliance with any applicable foreign asset/account, exchange control and tax reporting requirements and should consult his or her personal tax, legal and/or financial advisors on this matter.

24. Non-U.S. Countries Additional Terms Appendix. Notwithstanding any provisions in this Agreement, the Option shall be subject to any additional terms and conditions for the Participant’s country set forth in the Non-U.S. Countries Additional Terms Appendix. Moreover, if the Participant relocates to one of the countries included in the Non-U.S. Countries Additional Terms Appendix, the additional terms and conditions for such country shall apply to the Participant, to the extent that the Company determines that the application of such terms and conditions is necessary or advisable in order to comply with local law or facilitate administration of the Program.

25. Imposition of Other Requirements. The Company reserves the right to impose other requirements on the Participant’s participation in the Program, on the Option and on any Shares acquired under the Option, to the extent the Company determines it is necessary or advisable to comply with local law or facilitate the administration of the Program, and to require the Participant to accept any additional agreements or undertakings that may be necessary to accomplish the foregoing.

26. Waiver. The Participant acknowledges that a waiver by the Company of breach of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by the Participant or any other Participant.



27. Benefit Limit. Notwithstanding anything else contained herein or in the Program to the contrary, in the event that any payments or benefits to which the Participant becomes entitled in accordance with the provisions of this Agreement (or any other agreement with the Company) would otherwise constitute a parachute payment under Code Section 280G(b)(2), then such payments and/or benefits will be subject to reduction to the extent necessary to assure that the Participant receives only the greater of (i) the amount of those payments which would not constitute such a parachute payment or (ii) the amount which yields the Participant the greatest after-tax amount of benefits after taking into account any excise tax imposed under Code Section 4999 on the payments and benefits provided the Participant under this Agreement (or on any other payments or benefits to which the Participant may become entitled in connection with any change in control or ownership of the Company or the subsequent termination of his or her employment with the Company).

Should a reduction in benefits be required to satisfy the benefit limit of this Section 27, then the portion of any parachute payment otherwise payable in cash to the Participant shall be reduced to the extent necessary to comply with such benefit limit. Should such benefit limit still be exceeded following such reduction, then the number of Shares which would otherwise vest on an accelerated basis under each of the Participant’s Awards (based on the amount of the parachute payment attributable to each such Award under Code Section 280G) shall be reduced to the extent necessary to eliminate such excess, with such reduction to be made in the same chronological order in which those Awards were made.

In the event there is any disagreement between the Participant and the Company as to whether one or more payments or benefits to which the Participant becomes entitled constitute a parachute payment under Code Section 280G or as to the determination of the present value thereof, such dispute will be resolved as follows:

(a) In the event the Treasury Regulations under Code Section 280G (or applicable judicial decisions) specifically address the status of any such payment or benefit or the method of valuation therefor, the characterization afforded to such payment or benefit by the Regulations (or such decisions) will, together with the applicable valuation methodology, be controlling.

(b) In the event Treasury Regulations (or applicable judicial decisions) do not address the status of any payment in dispute, the matter will be submitted for resolution to independent auditors selected and paid for by the Company. The resolution reached by the independent auditors will be final and controlling; provided, however, that if in the judgment of the independent auditors, the status of the payment in dispute can be resolved through the obtainment of a private letter ruling from the Internal Revenue Service, a formal and proper request for such ruling will be prepared and submitted by the independent auditors, and the determination made by the Internal Revenue Service in the issued ruling will be controlling. All expenses incurred in connection with the preparation and submission of the ruling request shall be paid by the Company.

(c) In the event Treasury Regulations (or applicable judicial decisions) do not address the appropriate valuation methodology for any payment in dispute, the present value thereof will, at the independent auditor’s election, be determined through an independent third-party appraisal, and the expenses incurred in obtaining such appraisal shall be paid by the Company.

28. Compliance with Code Section 409A. This Section 28 applies only to the extent that the Participant is a U.S. taxpayer. It is intended that any amounts payable under this Agreement shall either be exempt from or comply with Code Section 409A (including the Treasury regulations and other published guidance relating thereto) (“Code Section 409A”) so as not to subject the Participant to payment of any additional tax, penalty or interest imposed under Code Section 409A. The provisions of this Agreement shall be construed and interpreted to avoid the imputation of any such additional tax, penalty or interest under Code Section 409A yet preserve (to the nearest extent reasonably possible) the intended benefit payable to the Participant. This Agreement may be amended at any time, without the consent of any party, to avoid the application of Code Section 409A, but the Company shall not be under any obligation to make any such amendment. Nothing in this Agreement shall provide a basis for any person to take action against the Company or any affiliate based on matters covered by Code Section 409A, including the tax treatment of any amount paid or Option granted under the Agreement, and neither the Company nor any of its Subsidiaries or affiliates shall under any circumstances have any liability to any Participant or his estate or any other party for any taxes, penalties or interest due on amounts paid or payable under this Agreement, including taxes, penalties or interest imposed under Code Section 409A.

* * * *








By the Participant’s electronic acceptance of the Agreement and participation in the Program, the Participant agrees that this Option is granted under and governed by the terms and conditions of the Program and this Agreement, including the Appendices and the Statement.


Further, by the Participant’s electronic acceptance of the Agreement and participation in the Program, the Participant declares, without limitation, his or her consent to the data processing operations described in this Agreement. The Participant understands and acknowledges that the Participant may withdraw consent at any time with future effect for any or no reason as described in Section 16(e) above





NON-U.S. COUNTRIES ADDITIONAL TERMS APPENDIX
EDWARDS LIFESCIENCES CORPORATION
GLOBAL NON-QUALIFIED STOCK OPTION AGREEMENT
Terms and Conditions
This Non-U.S. Countries Additional Terms Appendix includes additional terms and conditions that govern the Option granted to the Participant under the Program if the Participant resides in any of the non-U.S. countries listed below. Certain capitalized terms used but not defined in this Non-U.S. Countries Additional Terms Appendix have the meanings set forth in the Program and/or the Agreement.

Notifications

This Non-U.S. Countries Additional Terms Appendix also includes information regarding exchange controls and certain other issues of which the Participant should be aware with respect to his or her participation in the Program. The information is based on the securities, exchange control and other laws in effect in the respective countries as of May 2021. Such laws are often complex and change frequently. As a result, the Participant should not rely on the information in this Non-U.S. Countries Additional Terms Appendix as the only source of information relating to the consequences of his or her participation in the Program because the information may be out of date at the time that the Participant exercises the Option or sell Shares acquired under the Program.

In addition, the information contained herein is general in nature and may not apply to the Participant’s particular situation and the Company is not in a position to assure the Participant of any particular result. Accordingly, the Participant should seek appropriate professional advice as to how the relevant laws in the Participant’s country may apply to his or her situation.

Finally, the Participant understands that if the Participant is a citizen or resident of a country other than the one in which the Participant is currently working, transfers employment after the Date of Grant, or is considered a resident of another country for local law purposes, the information contained herein may not apply to the Participant, and the Company shall, in its discretion, determine to what extent the terms and conditions contained herein shall apply.

AUSTRALIA

Terms and Conditions

Tax Information. The Program and the Agreement is a program to which Subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) (the “Act”) applies (subject to the conditions in the Act).

Notifications

Exchange Control Information. Exchange control reporting is required for cash transactions exceeding A$10,000 and international fund transfers of any amount (e.g., Option Price, proceeds from the sale of Shares). If an Australian bank is assisting with the transaction, the bank will file the report on the Participant’s behalf.

BRAZIL

Terms and Conditions

Compliance with Law. By accepting the Option, the Participant agrees to comply with applicable Brazilian laws and to report and pay any and all Tax-Related Items associated with the vesting of the Option, the exercise of the Option and the sale of Shares obtained pursuant to the Option.

Labor Law Acknowledgment. By accepting the Option, the Participant agrees that he or she is (i) making an investment decision and (ii) the value of the underlying Shares is not fixed and may increase or decrease in value over the vesting period without compensation to the Participant.
Further, the Participant acknowledges and agrees that for all legal purposes, (i) any benefits provided to the Participant under the Plan are unrelated to his or her employment or service; (ii) the Plan is not part of the terms and conditions of the Participant’s employment or service; and (iii) the income from the Participant’s participation in the Plan, if any, is not part of his or her remuneration from employment or service.

Notifications

Foreign Asset and Account Reporting. If the Participant holds assets and rights outside Brazil with an aggregate value of US$1,000,000 or more, then the Participant will be required to prepare and submit to the Central Bank of Brazil an annual declaration of such assets and rights. Assets and rights that must be reported include Shares acquired under the Program.


Please note that foreign individuals holding Brazilian visas are considered Brazilian residents for purposes of this reporting requirement and must declare at least the assets held abroad that were acquired subsequent to the date of admittance as a resident of Brazil.

Tax on Financial Transaction (IOF). Payments to foreign countries and repatriation of funds into Brazil (including proceeds from the sale of Shares or from cash dividends paid on such Shares) and the conversion of USD into BRL associated with such fund transfers may be subject to Tax on Financial Transactions. Brazilian residents must comply with any applicable Tax on Financial Transactions arising from participation in the Program. Brazilian residents should consult with their personal tax advisor for additional details.

CANADA

Terms and Conditions

Termination of Employment. This provision replaces Section 14(j) of the Agreement.

For purposes of the Option, the Participant’s employment or other service relationship will be considered terminated (regardless of the reason for such termination and whether or not later found to be invalid, unlawful or in breach of employment laws in the jurisdiction where the Participant is employed or providing services, or the terms of the Participant’s employment or service agreement, if any), as of the earliest of: (1) the date the Participant’s employment or service relationship is terminated; (2) the date the Participant receives notice of termination of his or her employment or service relationship; and (3) the date the Participant is no longer actively providing services to the Company or the Employer, regardless of any notice period or period of pay in lieu of such notice required under applicable employment law (including, without limitation, statutory law, regulatory law and common law) in the jurisdiction where the Participant is employed or providing services or the terms of the Participant’s employment or service agreement, if any. Unless otherwise expressly provided in this Agreement or determined by the Company, the Participant’s right to vest in the Option, if any, will terminate as of such date, and the period, if any, during which the Participant may exercise the Option after such termination will commence on such date. If notwithstanding the foregoing, applicable employment legislation explicitly requires continued vesting during a statutory notice period, the Participant’s right to vest in the Option, if any, will terminate effective as of the last date of the minimum statutory notice period, but the Participant will not earn or be entitled to any pro-rated vesting if the vesting date falls after the end of the Participant’s statutory notice period, nor will the Participant be entitled to any compensation for lost vesting.

Data Privacy. The following provision will apply if the Participant is a resident of Quebec and supplements Section 16 of the Agreement:

The Participant hereby authorizes the Company and the Company’s representatives, including the broker(s) designated by the Company, to discuss with and obtain all relevant information from all personnel, professional or not, involved in the administration and operation of the Program. The Participant further authorizes the Company and any Subsidiary or affiliate and the Program administrator to disclose and discuss the Program with their advisors. The Participant further authorizes the Employer to record such information and to keep such information in the Participant’s employee file.

French Language Provision. The following provision will apply if the Participant is a resident of Quebec:

The parties acknowledge that it is their express wish that this Agreement, as well as all documents, notices and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be drawn up in English.

Les parties reconnaissent avoir exigé la rédaction en anglais de cette convention, ainsi que de tous documents exécutés, avis donnés et procedures judiciaries intentées, directement ou indirectement, relativement à la présente convention.

Notification

Securities Law Notice. The Participant is permitted to sell Shares acquired through the Program through the designated broker appointed under the Program, if any, provided the resale of Shares acquired under the Program takes place outside of Canada through the facilities of a stock exchange on which the shares are listed. The Company’s Shares are currently listed on the New York Stock Exchange.

Foreign Asset and Account Reporting. Specified foreign property, including Shares acquired under the Program, must be reported on Form T1135 (Foreign Income Verification Statement) if the total cost of such foreign property exceeds CAD 100,000 at any time during the year. Options also must be reported--generally at a nil cost--if the $100,000 cost threshold is exceeded because of other specified foreign property the Participant holds. The Form T1135 must be filed by April 30 of the following year. The Participant should consult with his or her personal tax advisor for further details regarding this requirement.



CHINA

Terms and Conditions

Exercise. The following supplements Section 8 of the Agreement:

Due to regulatory requirements in the People’s Republic of China (“PRC”), the Participant will be required to exercise the Option using the cashless sell-all exercise method pursuant to which all Shares subject to the exercised Option will be sold immediately upon exercise and the proceeds of sale, less any broker’s fees or commissions, will be remitted to the Participant in accordance with any applicable exchange control laws and regulations and provided any liability for Tax-Related Items resulting from the exercise has been satisfied. The Participant acknowledges that the Company’s designated broker is under no obligation to arrange for the sale of the Shares pursuant to the cashless sell-all exercise method at any particular price. The Company reserves the right to provide additional methods of exercise depending on the development of local law.

Termination of Employment. The following supplements Section 3 of the Agreement:

Due to exchange control laws in the PRC, in no event can any exercise period following termination of employment exceed six months from the date of termination. Therefore, notwithstanding Sections 3(a), (b) and (f) of the Agreement, in the event of the Participant’s termination of employment due to death or Disability, Retirement or if the Participant dies or incurs a Disability after termination of employment but before the Option expires in accordance with Section 3(a), (b) or (d), any Option that is vested under the terms of Section 3(a), (b) and (f) may be exercised to purchase Shares until the earlier of: (i) the Date of Expiration of the Option; or (ii) the six month anniversary of the Participant’s date of termination by reason of death, Disability or Retirement or date of death or Disability following termination of employment.

Exchange Control Requirements. Due to exchange control laws in the PRC, if the Participant is a PRC national, he or she will be required to repatriate the proceeds from the cashless sell-all exercise to the PRC. The Participant understands and agrees that such cash proceeds may need to be repatriated to the PRC through a special exchange control account established by the Company, a Subsidiary, or the Employer, and the Participant hereby consents and agrees that any proceeds from the sale of Shares may be transferred to such special account prior to being delivered to him or her. The cash proceeds may be paid in U.S. dollars or local currency at the Company’s discretion. If the cash proceeds are paid in U.S. dollars, the Participant acknowledges that he or she will be required to set up a U.S. dollar bank account in China so that the cash proceeds may be delivered to this account. If the cash proceeds are converted to local currency, the Participant acknowledges that the Company is under no obligation to secure any currency conversion rate.

The Participant further understands and agrees that there will be a delay between the date the Shares are sold and the date the cash proceeds are distributed to him or her. The Participant also understands and agrees that the Company is not responsible for any currency fluctuation that may occur between the date the Shares are sold and the date the cash proceeds are received by the Participant.

The Participant further agrees to comply with any other requirements that may be imposed by the Company in the future to facilitate compliance with exchange control requirements in the PRC.

COSTA RICA

There are no country-specific provisions.

CZECH REPUBLIC

Notifications

Exchange Control Information. The Czech National Bank may require the Participant to fulfill certain notification duties in relation to the purchase of Shares and the opening and maintenance of a foreign account (e.g., the Participant may be required to report foreign direct investments, financial credits from abroad, investment in foreign securities and associated collections and payments). However, because exchange control regulations change frequently and without notice, the Participant should consult his or her personal legal advisor prior to the exercise of the Option and the sale of Shares to ensure compliance with current regulations. It is the Participant’s responsibility to comply with any applicable exchange control laws.

DOMINICAN REPUBLIC

There are no country-specific provisions.



FRANCE

Terms and Conditions

French-Qualified Option. This Option is intended to qualify for the favorable tax and social security regime in France under Section L. 225-177 to L. 225-186-1 of the French Commercial Code, as amended. Certain events may affect the status of the Option as French-qualified, and the French-qualified Option may be disqualified in the future. The Company does not make any undertaking or representation to maintain the qualified status of the Option. If the Option no longer qualifies as French-qualified, the favorable tax and social security treatment will not apply, and the Participant will be required to pay his or her portion of social security contributions and income tax due with respect to the Option which will be withheld by the Company or the Employer by any of the means referred to in Section 13 of the Agreement.

Program and Sub-Plan Terms. The Option is subject to the terms and conditions of the Rules of the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program French Sub-plan (the “French Sub-Plan”). To the extent that any term is defined in both the Program and the French Sub-Plan, for purposes of this grant of a French-qualified Option, the definitions in the French Sub-Plan shall prevail.

Option Price. This provision replaces Section 1 of the Agreement with respect to how the Option Price is determined:

The Option Price shall be determined in the manner set forth in Section 4(b) of the Sub-Plan.

Expiration. Notwithstanding anything to the contrary in the Statement, no Option shall have a term in excess of nine years and six months measured from the Date of Grant.

Termination of Employment by Death. This provision replaces Section 3(a) of the Agreement with respect to termination of employment by death:

If the Participant’s employment is terminated because of death, all unvested Shares under the Option shall immediately vest and become exercisable as of the Participant’s date of termination by death. The vested Option will remain exercisable by the Participant’s heirs for a period of six (6) months following the Participant’s death. If the Participant’s heirs do not exercise the Option within six (6) months of the Participant’s death, the Option will be forfeited and the Participant’s heirs will not be able to exercise the Option.

Changes in Capitalization. This provision supplements Section 7 in the Agreement:

Certain adjustments may disqualify the Option, in which case it may no longer benefit from favorable tax and social security treatment in France.

Language Consent. By accepting the Option, the Participant confirms having read and understood the Agreement and the Program, including all terms and conditions included therein, that were provided in the English language. The Participant accepts the terms of these documents accordingly.

En acceptant l’Option, vous confirmez avoir lu et compris ce Contrat et le Program, inclutant tous leur termes et conditions, qui lui ont été transmis en langue anglaise. Vous acceptez les dispositions de ces documents en connaissance de cause.

Notifications

Foreign Asset and Account Reporting. If the Participant holds cash or Shares outside of France, he or she must declare all foreign bank and brokerage accounts (including any accounts that were opened or closed during the tax year) on an annual basis on form No. 3916, together with their income tax return. Failure to complete this reporting triggers penalties for a French resident Participant.

GERMANY

Notifications

Exchange Control Information. Cross-border payments in excess of €12,500 must be reported monthly to the German Federal Bank. If the Participant makes or receives a cross-border payment in excess of €12,500 (e.g., payment of the Option Price and/or the repatriation of proceeds from the sale of Shares acquired under the Program), he or she must report the payment to the German Federal Bank electronically using the “General Statistics Reporting Portal” available via the Bank’s website (www.bundesbank.de). If required, the report must be filed by the 5th day of the month following the month in which the payment occurred.



Foreign Account and Asset Reporting. If the Participant’s acquisition of Shares under the Program leads to a so-called “qualified participation” at any point during the calendar year, the Participant will need to report the acquisition of Shares when the Participant files his or her tax return for the relevant year. A qualified participation occurs only if (i) the Participant owns 1% or more of the Company and the value of the Shares acquired exceeds €150,000 or (ii) the Shares held exceed 10% of the Company’s total common stock. The Participant should consult with the Participant’s personal tax advisor to ensure he or she complies with applicable reporting obligations.

INDIA

Terms and Conditions

Method of Exercise. The following provision supplements Section 8 of the Agreement:

The Participant will not be permitted to pay the Option Price through a cashless sell-to-cover method of exercise, whereby the Participant issues instructions to his or her broker to exercise the Option and to effect the immediate sale of the number of Shares necessary to cover the aggregate Option Price payable for the purchased Shares, plus applicable Tax-Related Items and brokerage fees, if any, and remit the remaining Shares to the Participant.

Depending on the development of local laws or the Participant’s country of residence, the Company reserves the right to modify the methods of exercising the Option and, in its sole discretion, to permit cashless sell-to-cover exercise, or any other method of exercise and payment of Tax-Related Items permitted under the Program.

Notifications

Exchange Control Information. The Participant understands that he or she must repatriate any proceeds from the sale of Shares acquired under the Program to India within the required time period specified under applicable exchange control regulations in India. The Participant will receive a foreign inward remittance certificate (“FIRC”) from the bank where the Participant deposits the foreign currency. The Participant should maintain the FIRC as evidence of the repatriation of funds in the event the Reserve Bank of India or the Employer requests proof of repatriation.

Foreign Account and Asset Reporting. The Participant is required to declare any foreign bank accounts and assets (including Shares acquired under the Program) on his or her annual tax return. The Participant should consult with his or her personal tax advisor to ensure compliance with applicable reporting obligations.

IRELAND

There are no country-specific provisions.

ISRAEL

Terms and Conditions

Securities Law Exemption. An exemption from the requirement to file a prospectus with respect to the Program has been granted to the Company by the Israeli Securities Authority under Section 15D of the Securities Law, 1968. Copies of the Program and Form S-8 registration statement for the Program filed with the United States Securities and Exchange Commission are available free of charge upon request at the Participant’s local HR department.

The following provisions apply to Participants who are in Israel on the Date of Grant.

Trustee Arrangement. The Participant acknowledges and agrees that the Option is granted under the Israeli Subplan to the Program and shall be allocated under the provisions of the track referred to as the “Capital Gains Track” pursuant to Sections 102(b) and 102(b)(3) of the Israel Income Tax Ordinance [New Version], 1961 and shall be held by the trustee engaged by the Company (the “Trustee”) for the 24 month period from the Date or Grant or such other period as required under Section 102 (the “Holding Period”).

The Participant hereby declares that:

1.Participant understands the provisions of Section 102 and the applicable tax track of this grant of Options.

2.Subject to the provisions of Section 102, the Participant hereby confirms that the Participant shall not sell and/or transfer the Option, or any Shares or additional rights associated with the Option, before the end of the Holding Period. In the event that Participant elects to sell or release the Shares or additional rights, as the


case may be, prior to the expiration of the Holding Period, the sanctions under Section 102 shall apply to and shall be borne solely by the Participant.

3.The Participant understands that this grant of the Option is conditioned upon the receipt of all required approvals from Israeli tax authorities.

4.The Participant agrees to be bound by the provisions of the trust agreement with the Trustee.

The Participant hereby confirms that he or she has: (i) read and understands this Agreement; (ii) received all the clarifications and explanations that he or she has requested; and (iii) had the opportunity to consult with his or her advisers before accepting this Agreement.

Written Acceptance. IMPORTANT: If the Participant has not already executed a Section 102 Capital Gains Track Grant Consent (“Consent”) in connection with grants made under the Israeli Subplan to the Program, the Participant must print, sign and deliver the Consent within 45 days to Altshuler Shaham Investment House at the following address and the attention of: Olga Pitzik, Account Manager, Altshuler Shaham Investment House, 19A Habarzel St., Ramat Hachayal, Tel Aviv 6971026 or Adi Waisbard, Edwards Lifesciences (Israel) Ltd. If the signed Consent is not received at the above address within 45 days, the RSU shall not qualify for favorable tax treatment.

The following provision applies only to Participants who transfer into Israel after the Date of Grant.

Exercise. This provision supplements Section 8 of the Agreement.

To ensure proper withholding of Tax-Related Items, the Participant will be required to exercise the Option using the cashless sell-all exercise method pursuant to which all Shares subject to the exercised Option will be sold immediately upon exercise and the proceeds of sale, less Tax-Related Items and any broker’s fees or commissions, will be remitted to the Participant. The Participant acknowledges that the Company’s designated broker is under no obligation to arrange for the sale of the Shares pursuant to the cashless sell-all exercise method at any particular price.

ITALY

Terms and Conditions

Exercise. The following supplements Section 8 of the Agreement:
Due to regulatory requirements Italy, the Participant will be required to exercise the Option using the cashless sell-all exercise method pursuant to which all Shares subject to the exercised Option will be sold immediately upon exercise and the proceeds of sale, less any broker’s fees or commissions, will be remitted to the Participant, provided any liability for Tax-Related Items resulting from the exercise has been satisfied. The Participant acknowledges that the Company’s designated broker is under no obligation to arrange for the sale of the Shares pursuant to the cashless sell-all exercise method at any particular price. The Company reserves the right to provide additional methods of exercise depending on the development of local law.

Grant Terms Acknowledgment. By accepting the Option, the Participant acknowledges that the Participant has received a copy of the Program and the Agreement and has reviewed the Program and the Agreement, including the Appendices, in their entirety and fully understands and accepts all provisions of the Program and the Agreement, including the Appendices. The Participant further acknowledges having read and specifically approves the following sections of the Agreement: Section 9 (Responsibility for Taxes), Section 13 (Miscellaneous), Section 14 (Nature of Grant), Section 16 (Data Privacy Notice and Consent), Section 19 (Governing Law and Venue) and Section 25 (Imposition of Other Requirements).

Notifications

Foreign Asset and Account Reporting. To the extent the Participant holds investments abroad or foreign financial assets that may general taxable income in Italy (such as Shares acquired under the Program) during the calendar year, the Participant is required to report them on his or her annual tax return (UNICO Form, RW Schedule), or on a special form if no tax return is due and pay the foreign financial assets tax. The tax is assessed at the end of the calendar year or on the last day the shares are held (in such case, or when shares are acquired during the course of the year, the tax is levied in proportion to the number of days the shares are held over the calendar year). No tax payment duties arise if the amount of the foreign financial assets tax calculated on all financial assets held abroad does not exceed a certain threshold.

JAPAN

Notifications



Foreign Asset and Account Reporting. If the Participant holds assets outside of Japan with a value exceeding ¥50,000,000 (as of December 31 each year), he or she is required to comply annual tax reporting obligations with respect to such assets. The Participant should consult with his or her personal tax advisor to ensure that he or she is properly complying with applicable reporting obligations.

KOREA

Notifications

Exchange Control Information. To remit funds out of Korea to exercise the Option by means of a cash exercise method, the Participant must obtain a confirmation of the remittance by a foreign exchange bank in Korea. This is an automatic procedure (i.e., the bank does not need to approve the remittance and the process should not take more than a single day). The Participant likely will need to present to the bank processing the transaction supporting documentation evidencing the nature of the remittance.

Foreign Asset and Account Reporting. Korean residents must declare all foreign financial accounts (i.e., non-Korean bank accounts, brokerage accounts, etc.) they hold in any foreign country that does not enter into an “inter-governmental agreement for automatic exchange of tax information” with Korea, to the Korean tax authority and file a report with respect to such accounts if the value of such accounts exceeds KRW 500 million (or an equivalent amount in foreign currency) on any month-end date during a calendar year. Korean residents should consult their personal tax advisor to determine their personal reporting obligations.

NETHERLANDS

There are no country-specific provisions.

PUERTO RICO

There are no country-specific provisions.

SINGAPORE

Notifications

Securities Law Notification. The Option was granted to the Participant pursuant to the “Qualifying Person” exemption under section 273(1)(f) of the Singapore Securities and Futures Act (Chapter 289, 2006 Ed.) (“SFA”). Neither the Agreement nor the Program have been lodged or registered as a prospectus with the Monetary Authority of Singapore. The Participant should note that his or her Option is subject to section 257 of the SFA and the Participant will not be able to make any subsequent sale of the Shares in Singapore, or any offer of such subsequent sale of the Shares underlying the Option unless such sale or offer in Singapore is made (i) after six months from the Date of Grant, or (ii) pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the SFA (Chapter 289, 2006 Ed.), or pursuant to, and in accordance with the conditions of, any other applicable provisions of the SFA.

Director Notification. If the Participant is a director, associate director or shadow director of a Singapore Subsidiary or other related company in Singapore, then the Participant is subject to certain notification requirements under the Singapore Companies Act. Among these requirements is an obligation to notify the Singapore Subsidiary in writing when the Participant receives an interest (e.g., Options, Shares) in the Company or any related company. In addition, the Participant must notify the Singapore Subsidiary when he or she sells Shares of the Company or any related company (including when the Participant sells Shares acquired under the Program). These notifications must be made within two (2) business days of acquiring or disposing of any interest in the Company or any related company. In addition, a notification must be made of the Participant’s interests in the Company or any related company within two (2) business days of becoming a director.

SPAIN

Terms and Conditions

Responsibility for Taxes. By accepting the Option, the Participant agrees that the amount of any payment on account payable by the Employer with respect to the exercise of the Option will be transferred to the Participant and withheld by the Company or the Employer.

Nature of Grant. The following provision supplements Section 14 of the Agreement:



In accepting the Option, the Participant consents to participate in the Program and acknowledges that the Participant has received a copy of the Program.

The Participant understands that the Company has unilaterally, gratuitously and discretionally decided to grant Options under the Program to individuals who may be employees of the Company or a Subsidiary throughout the world. The decision is a limited decision that is entered into upon the express assumption and condition that any grant will not economically or otherwise bind the Company or any Subsidiary. Consequently, the Participant understands that the Option is granted on the assumption and condition that the Option and any Shares acquired upon exercise of the Option are not part of any employment contract (either with the Company or any Subsidiary) and shall not be considered a mandatory benefit, salary for any purposes (including severance compensation) or any other right whatsoever. In addition, the Participant understands that the Option would not be granted to him or her but for the assumptions and conditions referred to herein; thus, the Participant acknowledges and freely accepts that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, then the grant of this Option shall be null and void.

Further, this Option is a conditional right to Shares and can be forfeited in the case of, or affected by, the Participant’s termination of employment. This will be the case, for example, even if (1) the Participant is considered to be unfairly dismissed without good cause (i.e., subject to a “despido improcedente”); (2) the Participant is dismissed for disciplinary or objective reasons or due to a collective dismissal; (3) the Participant terminates employment due to a change of work location, duties or any other employment or contractual condition; (4) the Participant terminates employment due to unilateral breach of contract of the Company or any of its Subsidiaries; or (5) the Participant’s employment terminates for any other reason whatsoever, except for Cause. Consequently, upon termination of the Participant’s employment for any of the reasons set forth above, the Participant may automatically lose any rights to the unvested Options granted to the Participant as of the date of his or her termination of employment, as described in the Program and the Agreement.

Notifications

Foreign Asset and Account Reporting. To the extent that Spanish residents hold assets (e.g., Shares, cash, etc.) in a bank or brokerage account outside of Spain with a value in excess of €50,000 per type of asset as of December 31 each year, such residents are required to report information on such assets on their tax return for such year. Shares constitute securities for purposes of this requirement, but unvested rights (e.g., Options) are not considered assets for purposes of this requirement.

If applicable, Spanish residents must report the assets on Form 720 by no later than March 31 following the end of the relevant year. After such assets are initially reported, the reporting obligation will only apply for subsequent years if the value of any previously-reported assets increases by more than €20,000. Failure to comply with this reporting requirement may result in penalties.

Exchange Control Information. The Participant must declare the acquisition of Shares to the Dirección General de Política Comercial e Inversiones (“DGCI”) of the Ministry of Economy and Competitiveness for statistical purposes. Generally, the declaration must be made by filing a D-6 form each January for Shares purchased or sold during (or owned by the Participant as of December 31) of the prior year; however, if the value of Shares purchased or sold exceeds €1,502,530, the declaration must also be filed within one month of the purchase or sale, as applicable.

Spanish residents are also required to electronically declare to the Bank of Spain any securities accounts (including brokerage accounts) held abroad, any foreign instruments (including Shares), and any transactions with non-Spanish residents (including any payments of Shares made by the Company) if the value of the transactions during the relevant year or the balances in such accounts and the value of such instruments as of December 31 of the relevant year exceed €1,000,000. Spanish residents should consult with their personal tax and legal advisors to ensure compliance with their personal reporting obligations.

Securities Law Notification. The grant of Options and the Shares issued pursuant to the exercise of the Option are considered a private placement outside of the scope of Spanish laws on public offerings and issuances of securities.

SWITZERLAND

Notifications

Securities Law Notification. Neither this document nor any other materials relating to the Option (1) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services (“FinSA”), (2) may be publicly distributed nor otherwise made available in Switzerland to any person other than an employee of the Company, or (3) have been or will be filed with, approved or supervised by any Swiss reviewing body according to article 51 of FinSA or any Swiss Regulatory Authority, including the Swiss Financial Market Supervisory Authority (FINMA).

Foreign Asset and Account Reporting. The Participant is required to declare all of his or her foreign bank and brokerage accounts in which the Participant holds cash or securities, including the accounts that were opened and/or closed during the tax


year, as well as any other assets, on an annual basis in his or her tax return. This includes the Option granted to you under the Plan which should not be subject to the net wealth tax, but must be reflected “pro memoria” in the statement on bank accounts and securities (Wertschriftenverzeichnis) that you are required to file with your tax return.

TAIWAN

Notifications

Securities Law Notification. The offer of participation in the Program is made only to employees of the Company and its Subsidiaries. The offer of participation in the Program is not a public offer of securities by a Taiwanese company.

Exchange Control Information. The Participant may remit foreign currency in relation to Shares into and out of Taiwan through an authorized foreign exchange bank in an amount of up to US$5,000,000 per year. If the transaction amount is TWD$500,000 or more in a single transaction, the Participant must submit a foreign exchange transaction form and also provide supporting documentation to the satisfaction of the remitting bank. The Participant should consult his or her personal advisor to ensure compliance with applicable exchange control laws in Taiwan.

UNITED ARAB EMIRATES

Notifications

Securities Law Information. Participation in the Program is being offered only to eligible Employees and Contractors and is in the nature of providing equity incentives to Employees and Contractors in the United Arab Emirates. The Program and the Agreement are intended for distribution only to such persons must not be delivered to, or relied on by, any other person. Prospective acquirers of the securities offered should conduct their own due diligence on the securities. The Emirates Securities and Commodities Authority has no responsibility for reviewing or verifying any documents in connection with the Program. Neither the Ministry of Economy nor the Dubai Department of Economic Development: (i) have approved the Program or the Agreement; (ii) have taken steps to verify the information set out therein; and (iii) have any responsibility for such documents.

UNITED KINGDOM

Terms and Conditions

Responsibility for Taxes. The following supplements Section 9 of the Agreement:

Without limitation to Section 9 of the Agreement, the Participant agrees to be liable for any Tax-Related Items related to his or her participation in the Program and legally applicable to the Participant and hereby covenants to pay any such Tax-Related Items, as and when requested by the Company or, if different, the Employer or by Her Majesty’s Revenue & Customs (“HMRC”) (or any other tax authority or any other relevant authority). The Participant also agrees to indemnify and keep indemnified the Company and, if different, the Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC (or any other tax authority or any other relevant authority) on the Participant’s behalf.

Notwithstanding the foregoing, if the Participant is a director or executive officer of the Company (as within the meaning of Section 13(k) of the Exchange Act), the amount of any uncollected income tax not collected within ninety (90) days of the end of the U.K. tax year may constitute a benefit to the Participant on which additional income tax and National Insurance contributions (“NICs”) may be payable. The Participant understands that he or she will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for reimbursing the Company and/or Employer for the value of any NICs due on this additional benefit, which may be recovered from the Participant by the Company or the Employer by any of the means referred to in Section 9 of the Agreement.

ADDITIONAL DEFINED TERMS APPENDIX

When used in this Agreement, the following terms shall have the meanings set forth below and, when the meaning is intended, the initial letter of the word is capitalized:

“Cause” shall mean the occurrence of any one or more of the following (provided that the determination of whether “Cause” exists at any time prior to the occurrence of a Change in Control shall be determined solely by the Company, in the exercise of the Company’s good faith and reasonable judgment, and any such determination shall be final and binding upon the parties):

(a) A continuing material breach by the Participant of the duties and responsibilities of the Participant, which duties shall not differ in any material respect from the duties and responsibilities during the 90-day period immediately prior to a


Change in Control (other than as a result of incapacity due to a physical or mental condition or illness), which breach is demonstrably willful and deliberate on the Participant’s part, is committed in bad faith and without a reasonable belief that such a breach is in the best interests of the Company; or

(b) The Participant has engaged in conduct that is willfully, demonstrably and materially injurious to the Company, monetarily or otherwise; or

(c) The Participant is convicted of, or pled guilty or nolo contendere to a felony (under the laws of the United States or any relevant state, or a similar crime or offense under the applicable laws of any relevant foreign jurisdiction) that adversely affects the reputation of the Participant or the Company;

provided, that no act or failure to act on the Participant’s part shall be deemed “willful” unless done, or omitted to be done, by the Participant not in good faith and without reasonable belief that the action or omission was in the best interest of the Company.

“Change in Control” of the Company shall mean the first to occur of any one of the following events after the Date of Grant set forth on the Statement:

(a) Any “Person,” as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934 (as amended) (other than the Company, any corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company, and any trustee or other fiduciary holding securities under an employee benefit plan of the Company or such proportionately owned corporation), is or becomes the “beneficial owner” (as defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended), directly or indirectly, of securities of the Company representing thirty percent (30%) or more of the combined voting power of the Company’s then outstanding securities; or

(b) During any period of not more than twenty-four (24) months, individuals who at the beginning of such period constitute the Board, and any new director (other than a director designated by a Person who has entered into an agreement with the Company to effect a transaction described in (a), (c), or (d) of this definition) whose election by the Board or nomination for election by the Company’s stockholders was approved by a vote of at least two-thirds (2/3) of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority thereof; or

(c) The consummation of a merger or consolidation of the Company with any other entity, other than: (i) a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than sixty percent (60%) of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation; or (ii) a merger or consolidation effected to implement a recapitalization of the Company (or similar transaction) in which no Person acquires more than thirty percent (30%) of the combined voting power of the Company’s then outstanding securities; or

(d) The Company’s stockholders approve a plan of complete liquidation or dissolution of the Company, or an agreement for the sale or disposition by the Company of all or substantially all of the Company’s assets (or any transaction having a similar effect).

“Good Reason” means, without the Participant’s express written consent, the occurrence of any one or more of the following conditions during the Protected Period:

(a) The assignment of the Participant to duties materially inconsistent with the Participant’s authorities, duties, responsibilities, and status (including offices, titles, and reporting requirements) as an employee, executive and/or officer of the Company, or a material reduction or alteration in the nature or status of the Participant’s authorities, duties, or responsibilities, other than an insubstantial or inadvertent act that is remedied by the Company promptly after receipt of notice thereof given by the Participant;

(b) The Company’s requiring the Participant to be based at a location in excess of fifty (50) miles from the location of the Participant’s principal job location or office immediately prior to such change, except for required travel on the Company’s business to an extent substantially consistent with the Participant’s then present business travel obligations;
(c) A reduction by the Company of the Participant’s base salary or base rate of compensation, as applicable; or

(d) The failure of the Company to continue in effect any of the Company’s short- and long-term incentive compensation plans, or employee benefit or retirement plans, policies, practices, or other compensation arrangements in which the Participant participates, unless the Participant is permitted to participate in other plans that provide the Participant


with substantially comparable benefits; or the failure by the Company to continue the Participant’s participation therein on substantially the same basis, both in terms of the amount of benefits provided and the level of the Participant’s participation relative to other participants;

provided, however, that any such condition shall not constitute “Good Reason” unless the following requirements are satisfied: (x) the Participant provides the Company the written notice which sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination by the Participation for Good Reason within sixty (60) days following the initial existence of the event giving rise to the condition claimed to constitute “Good Reason,” (y) the Company fails to remedy such condition within thirty (30) days after receiving such notice (the “Cure Period”), and (z) the Participant resigns in writing from his or her employment, citing failure to remedy the condition giving rise to Good Reason, within thirty (30) days following the expiration of such thirty (30) day cure period.

The Participant’s right to terminate employment for Good Reason shall not be affected by the Participant’s incapacity due to physical or mental illness. The Participant’s continued employment shall not constitute consent to, or a waiver of rights with respect to, any circumstance constituting Good Reason herein.

“Protected Period” means, with respect to a Change in Control, the period commencing the date that is six (6) months prior to the date of such Change in Control and ending on the date that is twenty four (24) months following such Change in Control.

 EX-10.12 4 ex-101210xkq42021.htm EX-10.12 Document

Exhibit 10.12

Edwards Lifesciences Corporation
Long-Term Stock Incentive Compensation Program
Global Restricted Stock Unit Award Agreement

THIS AGREEMENT, including any appendix for the Participant’s country (the “Non-U.S. Countries Additional Terms Appendix”), the appendix containing additional defined terms related to a change in control (the “Additional Defined Terms Appendix” and, together with the Non-U.S. Countries Additional Terms Appendix, the “Appendices”) and the Participant Restricted Stock Unit Statement attached to the front of this agreement (the “Statement”) sets forth the terms and conditions of the restricted stock unit (the “RSU”) granted by Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), to the Participant named on the Statement, pursuant to the provisions of the Company’s Long-Term Stock Incentive Compensation Program (the “Program”). This agreement, the Appendices and the Statement shall be considered one agreement and are referred to herein as the “Agreement.”

The Program provides additional terms and conditions governing the RSU and is incorporated herein by reference. If there is any inconsistency between the terms of this Agreement and the terms of the Program, the Program’s terms shall completely supersede and replace the conflicting terms of this Agreement. All capitalized terms shall have the meanings ascribed to them in the Program, unless specifically set forth otherwise herein. The parties hereto agree as follows:

1.Grant of RSU. Effective as of the Date of Grant set forth in the Statement, the Company hereby grants to the Participant an RSU in the manner and subject to the terms and conditions of the Program and this Agreement.

The grant of this RSU to the Participant shall not confer any right to such Participant (or any other Participant) to be granted any RSU or other Awards in the future under the Program.

2. Vesting of RSU and Issuance of Shares. Except as may otherwise be provided in Sections 3, 4 and 6 below, the RSU will vest according to the vesting schedule set forth on the Statement (“Normal Vesting Schedule”), provided the Participant continues to be employed by the Company or one of its Subsidiaries through the applicable vesting date. Except as expressly provided herein, Shares shall be issued to the Participant as soon as practicable after (and in all events within 74 days after) the applicable vesting date, subject to satisfaction of all Tax-Related Items (as defined in Section 13 below) and to the provisions for U.S. taxpayers set forth in Sections 4 and 10 below.

3. Termination of Employment:

(a) By Death or Disability: All unvested Shares under this RSU shall immediately vest as of the Participant’s date of termination by death or Disability.

(b) By Retirement: Regardless of the vesting schedule set forth in the Statement, in the event of the Participant’s termination by Retirement after age fifty-five (55) and with at least ten (10) years of service with the Company or any Subsidiary, the Participant shall immediately vest in 25% of the RSU for each full year of employment with the Company or a Subsidiary measured from the Date of Grant. All remaining unvested Shares under this RSU shall immediately terminate and be forfeited to the Company as of the date of the Participant’s termination of employment by Retirement. (For example, if the Participant retires after the first anniversary of the Date of Grant, the Participant will vest in 25% of the RSU with the remainder forfeited; if the Participant retires after the second anniversary of the Date of Grant, the Participant will vest in 50% of the RSU with the remainder forfeited; if the Participant retires after the third anniversary, the Participant will be entitled to an additional 25% vesting as he or she would have already vested in 50% with the remainder forfeited; and if the Participant retires after the fourth anniversary, the Participant shall not receive any additional vesting as he or she would have already vested in 100% of the RSU.)

(c) For Other Reasons: Subject to Section 6, all unvested Shares under this RSU shall immediately terminate and be forfeited to the Company as of the date of the Participant’s termination of employment for any reason other than the reasons set forth in Sections 3(a) and (b).

(d) Transfer: For the purposes of this Agreement, a transfer of the Participant’s employment between the Company and any Subsidiary (or between Subsidiaries) shall not be deemed a termination of employment. For purposes of this Agreement, if the Participant is employed by an entity that constitutes a Subsidiary and that entity ceases (as a result of a sale of equity interests in the entity, a spin-off, or otherwise) to constitute a Subsidiary, the Participant will be considered to have ceased to be employed by the Company or one of its Subsidiaries as of the date that such entity so ceases to constitute a Subsidiary unless either (x) the Participant is employed immediately after such transaction or event by the Company or another entity that continues to qualify as a Subsidiary or (y) the entity that is sold, spun-off


or otherwise divested and ceases to constitute a Subsidiary (or a successor or a direct or indirect parent of such entity or such a successor) assumes the RSU award in connection with such transaction.

4. Issuance of Shares for RSUs Subject to Code Section 409A. This Section 4 applies only to the extent that the Participant is a U.S. taxpayer and the RSUs are treated as deferred compensation under Code Section 409A (for instance, if the Participant becomes eligible for retirement vesting acceleration benefits under Section 3(b) hereof prior to the date the RSUs are scheduled to fully vest according to the Normal Vesting Schedule). Except as provided in this Section and Section 6(a), the Shares will be issued on the date they vest in accordance with the Normal Vesting Schedule, provided the Participant continues to be employed by the Company or one of its Subsidiaries through the applicable vesting date. If this Section 4 applies, the following rules set forth in Sections 4(a), (b) and (c) also apply notwithstanding any provision to the contrary in this Agreement.

(a) Separation from Service. Any Shares that vest prior to the date that they were otherwise scheduled to vest as set forth in the Normal Vesting Schedule by reason of the Participant’s Separation from Service pursuant to Section 3(a), 3(b), 6(b), or 6(c) shall be issued or distributed to the Participant on or within thirty (30) days following the earlier of (i) the first day of the seventh (7th) month following the date of the Participant’s Separation from Service or (ii) the date of the Participant’s death. Upon the expiration of such period, all such Shares or other amounts shall be issued or distributed in a lump sum to the Participant. For purposes of this Agreement, “Separation from Service” means the Participant’s separation from service as determined in accordance with Code Section 409A and the applicable standards of the Treasury Regulations issued thereunder.

(b) Change in Control. Any Shares that vest upon a termination of the RSU pursuant to Section 6(a) hereof in connection with a 409A Change in Control shall be issued or distributed in accordance with the plan-termination rules set forth in Treasury Regulation Section 1.409A-3(j)(4)(ix) or, in the event the Company is not able to make issuance or distribution in accordance with such regulation, shall be issued or distributed on or within thirty (30) days following the applicable date set forth in the Normal Vesting Schedule on which such Shares were otherwise scheduled to become vested or, if the Participant dies or has a Separation from Service before the applicable date set forth in the Normal Vesting Schedule, any remaining Shares subject to the RSU that have not previously been paid will be issued or distributed on or within thirty (30) days following the first to occur of (i) the first day of the seventh (7th) month following the date of the Participant’s Separation from Service or (ii) the date of the Participant’s death. In the event that any issuance of vested Shares is delayed until after a 409A Change in Control, instead of the issuance of Shares, such portion of the RSU shall be settled in cash in an amount equal to the Fair Market Value of such vested Shares, determined as of the date of the 409A Change in Control.

(c) Employment Taxes. In the event the employee portion of the U.S. federal, state and local employment taxes required to be withheld by the Company (the “Employment Taxes”) becomes due in a calendar year that precedes the year in which the Shares are scheduled to be issued based on the Normal Vesting Schedule (such as in the case where the Participant becomes eligible for retirement vesting acceleration benefits under Section 3(b) hereof before the RSUs are scheduled to fully vest according to the Normal Vesting Schedule), the Participant shall, on or before the last business day of the calendar year in which the Employment Taxes become due, deliver to the Company a check payable to its order in the dollar amount equal to the Employment Taxes required to be withheld with respect to those Shares. Alternatively, the Company is vested with the authority, in its sole discretion, to collect the Employment Taxes from the Participant by any of the other methods authorized in Section 13 hereof.

5. No Fractional Shares. In no event shall any fractional Shares be issued. Accordingly, the total number of Shares to be issued at the time this RSU vests shall, to the extent necessary, be rounded down to the next whole Share in order to avoid the issuance of a fractional share.

6. Change in Control.

(a) Possible Acceleration on 409A Change in Control: Notwithstanding anything to the contrary in this Agreement or in the Program, if a 409A Change in Control occurs, the Board or the Committee may provide for either (i) the assumption, substitution or exchange of this RSU by the acquiring or successor entity (or a parent thereof) based upon, to the extent relevant under the circumstances, the distribution or consideration payable to holders of the Shares upon or in respect of such event, or (ii) the termination of this RSU upon such event; provided, however, that if this RSU will terminate upon such event as provided in clause (ii), this RSU, to the extent then outstanding and unvested, will fully vest upon (or, to the extent necessary to give effect to this acceleration, immediately prior to) such event.

(b) Possible Acceleration on Certain Terminations: The following provisions of this Section 6(b) apply notwithstanding anything to the contrary in this Agreement or in the Program, but only to the extent that Section 6(c) does not apply in the circumstances. In the event that, at any time during the Protected Period, the Participant ceases to be employed by the Company or one of its Subsidiaries and such termination is the result of a termination of employment either by the Company or such Subsidiary without Cause or by the Participant for Good Reason, this RSU, to the extent then


outstanding and unvested, shall immediately vest in full and be paid as provided in Section 2 or 4(a), as applicable; provided, however, that in the case of such a termination of the Participant’s employment that occurs prior to a 409A Change in Control, this RSU shall:

(i) remain outstanding and unvested for a period of six (6) months following such termination of employment and, should a 409A Change in Control occur during such six-month period, shall vest in full upon the 409A Change in Control and shall be paid as provided in Section 2 or 4(a), as applicable; and

(ii) terminate and be forfeited at the end of such six-month period should no 409A Change in Control occur during such six-month period.

For purposes of clarity, the accelerated vesting and any alternative timing of payment provisions provided in Article 13 of the Program shall not apply to this RSU.

(c) Possible Acceleration on Certain Terminations - CIC Agreement: In the event that the Participant ceases to be employed by the Company or one of its Subsidiaries and, at the time of such cessation of employment, the Participant is a party to a CIC Agreement, the extent (if any) to which this RSU, to the extent then outstanding and unvested, would become vested in connection with such cessation of employment shall be determined in accordance with and subject to the terms and conditions of such CIC Agreement.

(d) Definitions: For the purposes of this Agreement and notwithstanding any to the contrary in the Program, the following definitions will apply:
(i) “409A Change in Control” means a Change in Control; provided, however, that a transaction shall not constitute a 409A Change in Control unless it is a “change in the ownership or effective control” of the Company, or a change “in the ownership of a substantial portion of the assets” of the Company within the meaning of Section 409A of the Code.

(ii) “CIC Agreement” means a Change in Control Severance Agreement (or any similar or successor written agreement) between the Participant and the Company that provides for the accelerated vesting (or all or a portion) of the equity awards granted by the Company to the Participant (to the extent then outstanding and otherwise unvested) in connection with certain terminations of the Participant’s employment and which, by its terms, would apply to the RSU (subject to any applicable release or other conditions on such accelerated vesting as set forth in such agreement).

(iii) The terms “Cause”, “Change in Control”, “Good Reason”, “Protected Period”, and “Separation Benefits” have the respective meanings ascribed to such terms in the Additional Defined Terms Appendix.

7. Notice of Termination. Any termination of the Participant’s employment by the Company for Cause or by the Participant for Good Reason shall be communicated by a written notice to the other party indicating the specific termination provision in this Agreement relied upon, and setting forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Participant’s employment under the provision so indicated.

8. Restrictions on Transfer. This RSU may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution applicable to the Participant.

9. Recapitalization. In the event of any change in corporate capitalization of the Company, such as a stock split, or a corporate transaction, such as any merger, consolidation, separation, including a spin-off, or other distribution of stock or property of the Company, any reorganization (whether or not such reorganization comes within the definition of such term in Code Section 368) of the Company, or any partial or complete liquidation of the Company, the number and class of Shares subject to this RSU are subject to adjustment by the Committee pursuant to Section 5.4 of the Plan to prevent dilution or enlargement of rights.

10. Section 409A. This Section 10 applies only to the extent that the Participant is a U.S. taxpayer. This Agreement is intended to either be exempt from or comply with the requirements of Section 409A of the Code so as not to subject the Participant to payment of any additional tax, penalty or interest imposed under Code Section 409A. The provisions of this Agreement shall be construed and interpreted to avoid the imputation of any such additional tax, penalty or interest under Code Section 409A yet preserve (to the nearest extent reasonably possible) the intended benefit payable to the Participant. This Agreement may be amended at any time, without the consent of any party, to avoid the application of Code Section 409A in a particular circumstance or that is necessary or desirable to satisfy any of the requirements under Code Section 409A, but the Company shall not be under any obligation to make any such amendment. Nothing in the Agreement shall provide a basis for any person to take action against the Company or any affiliate based on matters covered by Code Section 409A, including the tax treatment of any amount paid or RSU granted under the Agreement, and neither the Company nor any of its Subsidiaries or affiliates shall under any circumstances have any liability to any Participant or his estate or any other party for any taxes,


penalties or interest due on amounts paid or payable under the this Agreement, including taxes, penalties or interest imposed under Code Section 409A.

11. Beneficiary Designation. This Section 11 applies only if the Participant resides in the U.S. The Participant may, from time to time, name any beneficiary or beneficiaries (who may be named contingently or successively) to whom any benefit under this Agreement is to be paid in case of his or her death before he or she receives any or all such benefit. Each such designation shall revoke all prior designations by the Participant, shall be in a form prescribed by the Company, and will be effective only when filed by the Participant in writing with the Secretary of the Company during the Participant’s lifetime. In the absence of any such designation, benefits remaining unpaid at the Participant’s death shall be paid to the Participant’s estate.

12. Rights as a Stockholder. The Participant shall have no rights as a stockholder of the Company until the Participant has obtained an ownership interest in the Shares.

13. Responsibility for Taxes.

(a) Regardless of any action the Company or the Participant’s employer (if different) (the “Employer”) takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related items related to the Participant’s participation in the Program that are legally applicable to the Participant (“Tax-Related Items”), the Participant acknowledges that the ultimate liability for all Tax-Related Items is and remains his or her responsibility and that such liability may exceed the amount actually withheld by the Company or the Employer. The Participant further acknowledges that the Company and/or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of this RSU or the underlying Shares, including the grant or vesting of this RSU, the issuance of Shares on the applicable vesting date, the subsequent sale of any Shares acquired at vesting of the RSU and the receipt of any dividends; and (2) do not commit and are under no obligation to structure the terms of the grant or any aspect of the RSU to reduce or eliminate the Participant’s liability for Tax-Related Items or achieve any particular tax result. Further, if the Participant becomes subject to Tax-Related Items in more than one jurisdiction, the Participant acknowledges that the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

(b) Prior to any relevant taxable, tax and/or social security contribution withholding event, the Participant shall pay or make adequate arrangements satisfactory to the Company and/or the Employer to satisfy all Tax-Related Items. In this regard, the Participant authorizes the Company and/or the Employer, or their respective agents, at their sole discretion, to satisfy any applicable withholding obligations with respect to Tax-Related Items by one or a combination of the following: (i) withholding from the Participant’s wages or other cash compensation paid to him or her by the Company and/or the Employer or from any equivalent cash payment received upon vesting of the RSU; or (ii) withholding from the proceeds of the sale of Shares acquired at vesting of the RSU, either through a voluntary sale or through a mandatory sale arranged by the Company (on the Participant’s behalf pursuant to this authorization); or (iii) withholding in Shares to be issued upon vesting of the RSU. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant will be deemed to have been issued the full number of Shares subject to the vested RSU, notwithstanding that a number of the Shares is held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Participant’s participation in the Program. Depending on the withholding method, the Company or the Employer may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding rates or other applicable withholding rates, including maximum applicable rates in the Participant’s jurisdiction(s). In the event of over-withholding, the Participant may receive a refund of any over-withheld amount in cash (with no entitlement to the equivalent in Shares), or, if not refunded, the Participant may seek a refund from the applicable tax authorities. In the event of under-withholding, the Participant may be required to pay additional Tax-Related Items directly to the tax authorities, the Company or the Employer.

(c) Finally, the Participant shall pay to the Company or the Employer any amount of Tax-Related Items and/or Employment Taxes that the Company or the Employer may be required to withhold or account for as a result of Participant’s participation in the Program that cannot be satisfied by the means described in this Section 13 or in Section 4(c). The Company may refuse to issue or deliver Shares or the proceeds of the sale of Shares to the Participant if the Participant fails to comply with Participant’s obligation in connection with the Tax-Related Items and/or Employment Taxes.

14. Continuation of Employment. This Agreement shall not confer upon the Participant any right to continuation of employment with the Employer, nor shall this Agreement interfere in any way with the Employer’s right to terminate the Participant’s employment at any time with or without cause.





15. Miscellaneous.

(a) This Agreement and the rights of the Participant hereunder are subject to all the terms and conditions of the Program, as the same may be amended from time to time, as well as to such rules and regulations as the Committee may adopt for administration of the Program. The Committee shall have the right to impose such restrictions on any Shares acquired pursuant to this Award, as it may deem advisable for regulatory compliance, including, without limitation, restrictions under applicable U.S. federal securities laws, under the requirements of any stock exchange or market upon which such Shares are then listed and/or traded, and under any state or foreign securities laws applicable to such Shares. It is expressly understood that the Committee is authorized to administer, construe, and make all determinations necessary or appropriate to the administration of the Program and this Agreement, all of which shall be binding upon the Participant.

(b) The Board may terminate, amend, suspend or modify the Program and the Committee may amend this RSU at anytime; provided, however, that no such termination, amendment, suspension or modification of the Program or amendment of this Award may in any material way adversely affect the Participant’s rights under this Agreement, without the express consent of the Participant.

(c) The Participant agrees to take all steps necessary to comply with all applicable provisions of U.S. federal, state and foreign securities law in exercising his or her rights under this Agreement.

(d) This Agreement shall be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required.

(e) All obligations of the Company under the Program and this Agreement, with respect to this Award, shall, to the extent legally permissible, be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company.

16. Nature of Grant. In accepting the RSU, the Participant acknowledges, understands and agrees that:

(a) the Program is established voluntarily by the Company and is discretionary in nature;

(b) the grant of the RSU by the Company is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of RSUs, or benefits in lieu of RSUs, even if RSUs have been granted in the past;

(c) all decisions with respect to future RSU grants, if any, will be at the sole discretion of the Company;

(d) the Participant is voluntarily participating in the Program;

(e) the RSU and any Shares, and the income from and value of the same, acquired under the Program are not part of normal or expected compensation or salary;

(f) unless otherwise agreed with the Company, the RSU and any Shares acquired under the Program, and the income from and value of the same, are not granted as consideration for, or in connection with, the service the Participant may provide as a director of a Subsidiary or affiliate of the Company;

(g) the RSU grant and the Participant’s participation in the Program shall not be interpreted to form an employment contract or relationship with the Company or the Employer or any Subsidiary or affiliate of the Company;

(h) the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty;

(i) for purposes of the RSU, the Participant’s employment or other service relationship will be considered terminated as of the date the Participant is no longer actively providing services to the Company or the Employer (regardless of the reason for such termination and whether or not later found invalid or in breach of employment laws in the jurisdiction where the Participant is employed or providing services or the terms of the Participant’s employment or service agreement, if any), and unless otherwise provided in this Agreement or decided by the Committee, the Participant’s right to vest in the RSU under the Program, if any, will terminate effective as of such date and will not be extended by any notice period (e.g., active employment or service would not include a period of “garden leave” or similar period mandated under employment laws in the jurisdiction where the Participant is employed or providing services or the terms of the Participant’s employment or service agreement, if any); furthermore, the Committee shall have the exclusive discretion to determine when the Participant is no longer actively providing services for purposes of the RSU (including whether the Participant may still be considered to be providing services while on a leave of absence);



(j) for Participants who reside outside the U.S., the following additional provisions shall apply:

(i) the RSU and any Shares, and the income from and value of the same, acquired under the Program are not intended to replace any pension rights or compensation;

(ii) the RSU and the underlying Shares, and the income from and value of the same, are extraordinary items that do not constitute compensation of any kind for services of any kind rendered to the Company or to the Employer and are outside the scope of Participant’s employment agreement, if any; such items shall not be included in or part of any for any calculation of any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company or the Employer;

(iii) no claim or entitlement to compensation or damages shall arise from forfeiture of the RSU resulting from termination of the Participant’s employment or other service relationship by the Company or the Employer (regardless of the reason for such termination and whether or not later found invalid or in breach of employment laws in the jurisdiction where the Participant is employed or providing services or the terms of the Participant’s employment or service agreement, if any); and

(iv) neither the Company, the Employer or any Subsidiary or affiliate shall be liable for any foreign exchange rate fluctuation between the Participant’s local currency and the United States Dollar that may affect the value of the RSU or of any amounts due to the Participant pursuant to the vesting of the RSU or the subsequent sale of any Shares acquired upon settlement.

17. No Advice Regarding Grant. The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Participant’s participation in the Program, or his or her acquisition or sale of the underlying Shares. The Participant should consult with his or her own personal tax, legal and financial advisors regarding the Participant’s participation in the Program before taking any action related to the Program.

18. Data Privacy Notice and Consent. This Section 18 applies if the Participant resides outside the U.S.

(a) Data Collection and Usage. The Company and the Employer collect, process and use certain personal information about the Participant, including, but not limited to, the Participant’s name, home address and telephone number, email address, date of birth, social insurance, passport or other identification number, salary, nationality, job title, any Shares or directorships held in the Company, details of all RSUs or any other entitlement to Shares or equivalent benefits awarded, canceled, exercised, vested, unvested or outstanding in the Participant’s favor (“Data”), for the purposes of implementing, administering and managing the Program. The legal basis, where required, for the processing of Data is the Participant’s consent.

(b) Stock Plan Administration Service Providers. The Company will transfer Data to Charles Schwab & Co., Inc. (including its affiliated companies) (collectively, “Charles Schwab”), which is assisting the Company with the implementation, administration and management of the Program. The Company may select different or additional service providers in the future and share Data with such other provider(s) serving in a similar manner. The Participant may be asked to agree on separate terms and data processing practices with Charles Schwab, with such agreement being a condition to the ability to participate in the Program.

(c) International Data Transfers. The Company and Charles Schwab are based in the United States, which means that it will be necessary for Data to be transferred to, and processed in, the United States. If the Participant is outside the United States, the Participant should note that his or her country has enacted data privacy laws that are different from the United States. The Company’s legal basis, where required, for the transfer of Data is the Participant’s consent.

(d) Data Retention. The Company will hold and use Data only as long as is necessary to implement, administer and manage the Participant’s participation in the Program, or as required to comply with legal or regulatory obligations, including under tax, exchange control, labor and securities laws. This may mean Data is retained until after the Participant’s service relationship has terminated, plus any additional time periods necessary for compliance with law, exercise or defense of legal rights, archiving, back-up and deletion purposes.

(e) Voluntariness and Consequences of Consent Denial or Withdrawal. Participation in the Program is voluntary, and the Participant is providing the consents herein on a purely voluntary basis. If the Participant does not consent, or if the Participant later seeks to revoke his or her consent, the Participant’s salary from or employment and career with the Employer will not be affected; the only consequence of refusing or withdrawing consent is that the Company would not be able to grant RSUs or other Awards to the Participant or administer or maintain such Awards.



(f) Data Subject Rights. The Participant may have a number of rights under data privacy laws in the Participant’s jurisdiction. Depending on where the Participant is based, such rights may include the right to (i) inquire whether and what kind of Data the Company holds about the Participant and how it is processed, and to request access or copies of Data the Company processes, (ii) request correction or supplementation of the Data about the Participant that is inaccurate, incomplete or out of date in light of the purposes underlying the processing, (iii) request deletion of Data no longer necessary for the purposes underlying the processing processed based on withdrawn consent, processed for legitimate interests that, in the context of the Participant’s objection, do not prove to be compelling, or processed in non-compliance with applicable legal requirements, (iv) request restrictions on processing of Data, (v) request portability of Data that the Participant has actively or passively provided to the Company (which does not include data derived or inferred from the collected data), where the processing of such Data is based on consent or the Participant’s employment and is carried out by automated means, (vi) object, in certain circumstances, to the processing of Data for legitimate interests, (vii) lodge complaints with competent authorities in the Participant’s jurisdiction and/or (viii) receive a list with the names and addresses of any potential recipients of Data. To receive clarification regarding these rights or to exercise these rights, the Participant should contact his or her local human resources representative.
Finally, the Participant understands that the Company may rely on a different basis for the processing or transfer of Data in the future and/or request that the Participant provide another data privacy consent. If applicable, the Participant agrees that upon request of the Company or the Employer, the Participant will provide an executed acknowledgement or data privacy consent form (or any other agreements or consents) that the Company and/or the Employer may deem necessary to obtain from the Participant for the purpose of administering the Participant’s participation in the Program in compliance with the data privacy laws in the Participant’s country, either now or in the future. The Participant understands and agrees that he or she will not be able to participate in the Program if he or she fails to provide any such consent or agreement requested by the Company and/or the Employer.

19. Severability. The provisions of this Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.

20. Dispute Resolution. The Participant shall have the right and option to elect to have any good faith dispute or controversy arising under or in connection with this Agreement settled by litigation or arbitration. If arbitration is selected, such proceeding shall be conducted by final and binding arbitration before a panel of three (3) arbitrators in accordance with the rules and under the administration of the American Arbitration Association.

21. Governing Law and Venue. To the extent not preempted by U.S. federal law, this Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, U.S.A.

For purposes of litigating any dispute that arises directly or indirectly from the relationship of the parties evidenced by this Award, the Program or this Agreement, the parties hereby submit to and consent to the exclusive jurisdiction of the State of California and agree that such litigation shall be conducted only in the courts of Orange County, California, or the federal courts for the United States for the Central District of California, and no other courts, where this grant is made and/or to be performed.

22. Language. The Participant acknowledges and represents that he or she is proficient in the English language or has consulted with an advisor who is sufficiently proficient in English, as to allow the Participant to understand the terms of this Agreement and any other documents related to the Program. If the Participant has received this Agreement or any other document related to the Program translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

23. Electronic Delivery. The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Program by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Program through an online or electronic system established and maintained by the Company or a third party designated by the Company.

24. Insider Trading Restrictions/Market Abuse Laws. The Participant acknowledges that the Participant may be subject to insider trading restrictions and/or market abuse laws in applicable jurisdictions, including the United States and the Participant’s country, the broker’s country or the country in which the Shares are listed (if different), which may affect his or her ability to accept or otherwise acquire, sell, attempt to sell or otherwise dispose of, Shares or rights to Shares (e.g., RSUs) under the Program or rights linked to the value of Shares during such times as the Participant is considered to have “inside information” regarding the Company (as defined by the laws in the applicable jurisdictions, including the United States and the Participant’s country). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders the Participant placed before possessing inside information. Furthermore, the Participant could be prohibited from (i) disclosing the inside information to any third party and (ii) “tipping” third parties or otherwise causing them to buy or sell Company securities; “third parties” include fellow employees. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. The Participant is


responsible for ensuring compliance with any applicable restrictions and should consult his or her personal legal advisor on this matter.

25. Foreign Asset/Account, Exchange Control and Tax Reporting. The Participant acknowledges that, depending on his or her country, the Participant may be subject to foreign asset/account, exchange control and/or tax reporting requirements as a result of the acquisition, holding and/or transfer of Shares or cash (including dividends and the proceeds arising from the sale of Shares) derived from his or her participation in the Program, in, to and/or from a brokerage/bank account or legal entity located outside the Participant’s country. The Participant may be required to report such accounts, assets, the balances therein, the value thereof and/or the transactions related thereto to the applicable authorities in the Participant’s country. The Participant also may be required to repatriate sale proceeds or other funds received as a result of the Participant’s participation in the Program to the Participant’s country through a designated bank or broker and/or within a certain time after receipt. The Participant acknowledges that he or she is responsible for ensuring compliance with any applicable foreign asset/account, exchange control and tax reporting requirements and should consult his or her personal tax, legal and/or financial advisors on this matter.

26. Non-U.S. Countries Additional Terms Appendix. Notwithstanding any provisions in this Agreement, the RSU shall be subject to any additional terms and conditions for the Participant’s country set forth in the Non-U.S. Countries Additional Terms Appendix. Moreover, if the Participant relocates to one of the countries included in the Non-U.S. Countries Additional Terms Appendix, the additional terms and conditions for such country shall apply to the Participant, to the extent that the Company determines that the application of such terms and conditions is necessary or advisable in order to comply with local law or facilitate administration of the Program.

27. Imposition of Other Requirements. The Company reserves the right to impose other requirements on the Participant’s participation in the Program, on the RSU and on any Shares acquired at vesting of the RSU, to the extent the Company determines it is necessary or advisable to comply with local law or facilitate the administration of the Program, and to require the Participant to accept any additional agreements or undertakings that may be necessary to accomplish the foregoing.

28. Waiver. The Participant acknowledges that a waiver by the Company of breach of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by the Participant or any other Participant.

29. Benefit Limit. Notwithstanding anything else contained herein or in the Program to the contrary, in the event that any payments or benefits to which the Participant becomes entitled in accordance with the provisions of this Agreement (or any other agreement with the Company) would otherwise constitute a parachute payment under Code Section 280G(b)(2), then such payments and/or benefits will be subject to reduction to the extent necessary to assure that the Participant receives only the greater of (i) the amount of those payments which would not constitute such a parachute payment or (ii) the amount which yields the Participant the greatest after-tax amount of benefits after taking into account any excise tax imposed under Code Section 4999 on the payments and benefits provided the Participant under this Agreement (or on any other payments or benefits to which the Participant may become entitled in connection with any change in control or ownership of the Company or the subsequent termination of his or her employment with the Company).

Should a reduction in benefits be required to satisfy the benefit limit of this Section 29, then the portion of any parachute payment otherwise payable in cash to the Participant shall be reduced to the extent necessary to comply with such benefit limit. Should such benefit limit still be exceeded following such reduction, then the number of Shares which would otherwise vest on an accelerated basis under each of the Participant’s Awards (based on the amount of the parachute payment attributable to each such Award under Code Section 280G) shall be reduced to the extent necessary to eliminate such excess, with such reduction to be made in the same chronological order in which those Awards were made.

In the event there is any disagreement between the Participant and the Company as to whether one or more payments or benefits to which the Participant becomes entitled constitute a parachute payment under Code Section 280G or as to the determination of the present value thereof, such dispute will be resolved as follows:

(a) In the event the Treasury Regulations under Code Section 280G (or applicable judicial decisions) specifically address the status of any such payment or benefit or the method of valuation therefor, the characterization afforded to such payment or benefit by the Regulations (or such decisions) will, together with the applicable valuation methodology, be controlling.

(b) In the event Treasury Regulations (or applicable judicial decisions) do not address the status of any payment in dispute, the matter will be submitted for resolution to independent auditors selected and paid for by the Company. The resolution reached by the independent auditors will be final and controlling; provided, however, that if in the judgment of the independent auditors, the status of the payment in dispute can be resolved through the obtainment of a private letter ruling from the Internal Revenue Service, a formal and proper request for such ruling will be prepared and submitted by the independent auditors, and the determination made by the Internal Revenue Service in the issued


ruling will be controlling. All expenses incurred in connection with the preparation and submission of the ruling request shall be paid by the Company.

(c) In the event Treasury Regulations (or applicable judicial decisions) do not address the appropriate valuation methodology for any payment in dispute, the present value thereof will, at the independent auditor’s election, be determined through an independent third-party appraisal, and the expenses incurred in obtaining such appraisal shall be paid by the Company.

* * * *

By the Participant’s electronic acceptance of the Agreement and participation in the Program, the Participant agrees that this RSU is granted under and governed by the terms and conditions of the Program and this Agreement, including the Appendices and the Statement.


Further, by the Participant’s electronic acceptance of the Agreement and participation in the Program, the Participant declares, without limitation, his or her consent to the data processing operations described in this Agreement. The Participant understands and acknowledges that the Participant may withdraw consent at any time with future effect for any or no reason as described in Section 18(e) above




NON-U.S. COUNTRIES ADDITIONAL TERMS APPENDIX
EDWARDS LIFESCIENCES CORPORATION
GLOBAL RESTRICTED STOCK UNIT AGREEMENT

Terms and Conditions

This Non-U.S. Countries Additional Terms Appendix includes additional terms and conditions that govern the RSU granted to the Participant under the Program if the Participant resides in any of the non-U.S. countries listed below. Certain capitalized terms used but not defined in this Non-U.S. Countries Additional Terms Appendix have the meanings set forth in the Program and/or the Agreement.

Notifications

This Non-U.S. Countries Additional Terms Appendix also includes information regarding exchange controls and certain other issues of which the Participant should be aware with respect to his or her participation in the Program. The information is based on the securities, exchange control and other laws in effect in the respective countries as of May 2021. Such laws are often complex and change frequently. As a result, the Participant should not rely on the information in this Non-U.S. Countries Additional Terms Appendix as the only source of information relating to the consequences of his or her participation in the Program because the information may be out of date at the time that the RSU vests or the Participant sells Shares acquired under the Program.

In addition, the information contained herein is general in nature and may not apply to the Participant’s particular situation and the Company is not in a position to assure the Participant of any particular result. Accordingly, the Participant should seek appropriate professional advice as to how the relevant laws in the Participant’s country may apply to his or her situation.

Finally, the Participant understands that if the Participant is a citizen or resident of a country other than the one in which the Participant is currently working, transfers employment after the Date of Grant, or is considered a resident of another country for local law purposes, the information contained herein may not apply to the Participant and the Company shall, in its discretion, determine to what extent the terms and conditions contained herein shall apply.

AUSTRALIA

Terms and Conditions

Australian Addendum. The grant of this RSU is intended to comply with the provisions of the Australian Corporations Act 2001 (Cth), Australian Securities and Investments Commission (“ASIC”) Regulatory Guide 49 and ASIC Class Order 14/1000. As a condition of ASIC Class Order 14/1000, the Participant will receive an Offer Document which sets forth certain key terms of the RSU, as well as the risks inherent in investment in Shares and a summary of the Australian tax consequences of the RSU.

Tax Information. The Program and the Agreement is a program to which Subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) (the “Act”) applies (subject to the conditions in the Act).

Notifications

Exchange Control Information. Exchange control reporting is required for cash transactions exceeding A$10,000 and international fund transfers of any amount (e.g., proceeds from the sale of Shares). If an Australian bank is assisting with the transaction, the bank will file the report on the Participant’s behalf.

AUSTRIA

Notifications

Exchange Control Information. If the Participant holds Shares acquired under the Program outside of Austria (e.g., in a U.S. brokerage account), a reporting obligation to the Austrian National Bank will apply. An exemption applies if the value of the securities held outside Austria as of December 31 does not exceed €5,000,000 or the value of the securities as of any quarter does not exceed €30,000,000. If the former threshold is exceeded, the annual reporting obligations are imposed, whereas if the latter threshold is exceeded, then quarterly reports must be submitted. The annual reporting date is December 31; the deadline for filing the annual report is January 31 of the following year. If the quarterly reporting is required, the reports must be filed on or before the 15th day of the month following the last day of the quarter.

If the Participant holds cash (e.g., dividends or proceeds from the sale of Shares) outside of Austria (e.g., in a U.S. brokerage or bank account), he or she will be subject to monthly reporting if the transaction volume of all cash accounts abroad is €10,000,000 or greater. In this case, transfers of cash into or out of the cash accounts and the balances of such accounts must be


reported monthly, as of the last day of the month, on or before the 15th day of the following month, using the form “Meldungen SI-Forderungen und/oder SI-Verpflichtungen.”

BELGIUM

Notifications

Foreign Asset and Account Reporting. The Participant is required to report any security or bank account (including brokerage accounts) that the Participant maintains outside Belgium on his or her annual tax return. The first time the Participant reports the foreign security and/or bank account on his or her annual income tax return, the Participant will have to provide the National Bank of Belgium with the account number, the name of the bank and the country in which the account was opened in a separate form. The form, as well as additional information on how to complete it, can be found on the website of the National Bank of Belgium, www.nbb.be, under the caption Kredietcentrales / Centrales des crédits. The Participant should consult with his or her personal tax advisor regarding the specific requirements applicable to the Participant.

Annual Securities Accounts Tax. If the value of securities held in a Belgian or foreign securities account exceeds €1 million, a new “annual securities account tax” applies. Belgian residents should consult with their personal tax advisor regarding the new tax.

BRAZIL

Terms and Conditions

Compliance with Law. By accepting the RSU, the Participant agrees to comply with applicable Brazilian laws and to report and pay any and all Tax-Related Items associated with the vesting of the RSU and the sale of Shares obtained pursuant to the RSU.

Labor Law Acknowledgment. By accepting the RSU, the Participant agrees that he or she is (i) making an investment decision and (ii) the value of the underlying Shares is not fixed and may increase or decrease in value over the vesting period without compensation to the Participant.

Further, the Participant acknowledges and agrees that for all legal purposes, (i) any benefits provided to the Participant under the Plan are unrelated to his or her employment or service; (ii) the Plan is not part of the terms and conditions of the Participant’s employment or service; and (iii) the income from the Participant’s participation in the Plan, if any, is not part of his or her remuneration from employment or service.

Notifications

Foreign Asset and Account Reporting. If the Participant holds assets and rights outside Brazil with an aggregate value of US$1,000,000 or more, then the Participant will be required to prepare and submit to the Central Bank of Brazil an annual declaration of such assets and rights. Assets and rights that must be reported include Shares acquired under the Program. Please note that foreign individuals holding Brazilian visas are considered Brazilian residents for purposes of this reporting requirement and must declare at least the assets held abroad that were acquired subsequent to the date of admittance as a resident of Brazil.

If the value of the Shares the Participant receives under the Plan exceeds BRL 5,000, the Participant must report the Shares acquired in the assets and rights section of the annual Natural Person Income Tax Return typically due by the last business day of April.

Tax on Financial Transaction (IOF). Payments to foreign countries and repatriation of funds into Brazil (including proceeds from the sale of Shares or from cash dividends paid on such Shares) and the conversion of USD into BRL associated with such fund transfers may be subject to the Tax on Financial Transactions. Brazilian residents must comply with any applicable Tax on Financial Transactions arising from participation in the Program. Brazilian residents should consult with their personal tax advisor for additional details.

CANADA

Terms and Conditions

Award Payable Only in Shares. The grant of the RSU does not provide the Participant with a right to receive a cash payment; the RSU is payable only in Shares.

Termination of Employment. This provision replaces Section 16(i) of the Agreement.



For purposes of the RSU, the Participant’s employment or other service relationship will be considered terminated (regardless of the reason for such termination and whether or not later found to be invalid, unlawful or in breach of employment laws in the jurisdiction where the Participant is employed or providing services, or the terms of the Participant’s employment or service agreement, if any), as of the earliest of: (1) the date the Participant’s employment or service relationship is terminated; (2) the date the Participant receives notice of termination of his or her employment or service relationship; and (3) the date that the Participant is no longer actively providing services to the Company or the Employer, regardless of any notice period or period of pay in lieu of such notice required under applicable employment law (including, without limitation, statutory law, regulatory law and common law) in the jurisdiction where the Participant is employed or providing services or the terms of the Participant’s employment or service agreement, if any. If, notwithstanding the foregoing, applicable employment legislation explicitly requires continued vesting during a statutory notice period, the Participant’s right to vest in the RSU, if any, will terminate effective as of the last date of the minimum statutory notice period, but the Participant will not earn or be entitled to any pro-rated vesting if the vesting date falls after the end of the Participant’s statutory notice period, nor will the Participant be entitled to any compensation for lost vesting.

Data Privacy. The following provision will apply if the Participant is a resident of Quebec and supplements Section 18 of the Agreement:

The Participant hereby authorizes the Company and the Company’s representatives, including the broker(s) designated by the Company, to discuss with and obtain all relevant information from all personnel, professional or not, involved in the administration and operation of the Program. The Participant further authorizes the Company and any Subsidiary or affiliate and the Program administrator to disclose and discuss the Program with their advisors. The Participant further authorizes the Employer to record such information and to keep such information in the Participant’s employee file.

French Language Provision. The following provision will apply if the Participant is a resident of Quebec:

The parties acknowledge that it is their express wish that this Agreement, as well as all documents, notices and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be drawn up in English.

Les parties reconnaissent avoir exigé la rédaction en anglais de cette convention, ainsi que de tous documents exécutés, avis donnés et procedures judiciaries intentées, directement ou indirectement, relativement à la présente convention.

Notification

Securities Law Notice. The Participant is permitted to sell Shares acquired through the Program through the designated broker appointed under the Program, if any, provided the resale of Shares acquired under the Program takes place outside of Canada through the facilities of a stock exchange on which the shares are listed. The Company’s Shares are currently listed on the New York Stock Exchange.

Foreign Asset and Account Reporting. Specified foreign property, including Shares acquired under the Program, must be reported on Form T1135 (Foreign Income Verification Statement) if the total cost of such foreign property exceeds CAD 100,000 at any time during the year. RSUs also must be reported--generally at a nil cost--if the $100,000 cost threshold is exceeded because of other specified foreign property the Participant holds. The Form T1135 must be filed by April 30 of the following year. The Participant should consult with his or her personal tax advisor for further details regarding this requirement.

CHINA

Terms and Conditions

Immediate Sale of Shares. This provision supplements Section 2 of the Agreement:

Due to regulatory requirements in the People’s Republic of China (“PRC”), upon the vesting and settlement of the RSU, the Participant agrees to the immediate sale of any Shares to be issued. The Participant further agrees that the Company is authorized to instruct its designated broker to assist with the mandatory sale of such Shares (on the Participant’s behalf pursuant to this authorization), and the Participant expressly authorizes the Company’s designated broker to complete the sale of such Shares. The Participant acknowledges that the Company’s designated broker is under no obligation to arrange for the sale of the Shares at any particular price. Upon the sale of the Shares, the Company agrees to pay the cash proceeds from the sale, less any brokerage fees or commissions, to the Participant in accordance with any applicable exchange control laws and regulations and provided any liability for Tax-Related Items resulting from the vesting of the RSU has been satisfied.

Exchange Control Requirements. Due to exchange control laws in the PRC, if the Participant is a PRC national, he or she will be required to immediately repatriate the cash proceeds from the sale of the Shares to the PRC. The Participant


understands and agrees that such cash proceeds will need to be repatriated to the PRC through a special exchange control account established by the Company, a Subsidiary, or the Employer, and the Participant hereby consents and agrees that any proceeds from the sale of Shares may be transferred to such special account prior to being received by him or her. The cash proceeds may be paid in U.S. dollars or local currency at the Company’s discretion. If the cash proceeds are paid in U.S. dollars, the Participant acknowledges that he or she will be required to set up a U.S. dollar bank account in China so that the cash proceeds may be delivered to this account. If the cash proceeds are converted to local currency, the Participant acknowledges that the Company is under no obligation to secure any currency conversion rate.

The Participant further understands and agrees that there will be a delay between the date the Shares are sold and the date the cash proceeds are distributed to the Participant. The Participant also understands and agrees that the Company is not responsible for any currency fluctuation that may occur between the date the Shares are sold and the date the cash proceeds are distributed to the Participant.

The Participant further agrees to comply with any other requirements that may be imposed by the Company in the future to facilitate compliance with exchange control requirements in the PRC.

COLOMBIA

Terms and Conditions

Labor Law Acknowledgment. This provision supplements the acknowledgment contained in Section 16 of the Agreement:
The Participant acknowledges that, pursuant to Article 128 of the Colombian Labor Code, the Program and related benefits do not constitute a component of his or her “salary” for any legal purpose.

Notifications

Securities Law Information. The Shares are not and will not be registered in the Colombian registry of publicly traded securities (Registro Nacional de Valores y Emisores) and, therefore, the Shares may not be offered to the public in Colombia. Nothing in the Program, the Agreement or any other document evidencing the grant of the RSU shall be construed as the making of a public offer of securities in Colombia.

Exchange Control Information. Investments in assets located outside Colombia (including Shares) are subject to registration with the Central Bank (Banco de la República). Further, the Participant must repatriate any proceeds from the sale of Shares or any cash dividends paid on such Shares through the Colombian foreign exchange market (i.e., local Colombian banks). The Participant is responsible for complying with any and all Colombian foreign exchange restrictions, approvals and reporting requirements in connection with the RSU and any Shares acquired or funds received under the Program. The Participant should consult with his or her personal legal advisor to ensure compliance with the applicable requirements.

Foreign Asset / Account Tax Reporting Information. The Participant must file an annual informative return with the Colombian Tax Office detailing any assets (e.g. Shares) held abroad. If the individual value of any of these assets exceeds a certain threshold, the Participant must describe each asset and indicate the jurisdiction in which it is located, its nature and its value.

COSTA RICA

There are no country-specific provisions.

CZECH REPUBLIC

Notifications

Exchange Control Information. The Czech National Bank may require the Participant to fulfill certain notification duties in relation to the RSU and the opening and maintenance of a foreign account (e.g., the Participant may be required to report foreign direct investments, financial credits from abroad, investment in foreign securities and associated collections and payments). However, because exchange control regulations change frequently and without notice, the Participant should consult the Participant’s personal legal advisor prior to the vesting of the RSU to ensure compliance with current regulations. It is the Participant’s responsibility to comply with applicable exchange control laws.



DENMARK

Terms and Conditions

Stock Option Act. The Participant acknowledges that he or she has received an Employer Statement in Danish, which sets forth the additional terms of the RSU to the extent that the Danish Stock Option Act applies.

Notifications

Exchange Control Information. If the Participant establishes an account holding Shares or cash outside Denmark, he or she may be required to report the account to the Danish Tax Administration as part of his or her annual tax return under the section on foreign affairs and income.

DOMINICAN REPUBLIC

There are no country-specific provisions.

FINLAND

There are no country-specific provisions.

FRANCE

Terms and Conditions

French-Qualified RSU. This RSU is intended to qualify for the favorable tax and social security regime in France under Section L. 225-197-1 to L. 225-197-5 and Sections L. 22-10-59 and L. 22-10-60 of the French Commercial Code, as amended. Certain events may affect the status of the RSU as French-qualified, and the French-qualified RSU may be disqualified in the future. The Company does not make any undertaking or representation to maintain the qualified status of the RSU. If the RSU no longer qualifies as French-qualified, the favorable tax and social security treatment will not apply, and the Participant will be required to pay his or her portion of social security contributions and income tax due with respect to the RSU which will be withheld by the Company or the Employer by any of the means referred to in Section 13 of the Agreement.

Program and Sub-Plan Terms. The RSU is subject to the terms and conditions of the Program and the Rules for the Grant of Restricted Stock Units under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program to Employees in France (the “French Sub-Plan”). To the extent that any term is defined in both the Program and the French Sub-Plan, for purposes of this grant of a French-qualified RSU, the definitions in the French Sub-Plan shall prevail.

Vesting. This provision supplements Section 2 in the Agreement:

Except in the event of the Participant’s death or Disability (as defined in the French Sub-Plan), to benefit from the favorable tax and social security regime, no vesting shall occur prior to the first anniversary of the Date of Grant, or such other minimum period as required for the vesting period applicable to French-qualified RSUs under Section L.225-197-1 of the French Commercial Code, as amended, or relevant Sections of the French Tax Code or the French Social Security Code, as amended.

Termination of Employment by Death. This provision replaces Section 3(a) of the Agreement with respect to termination of employment by death:

All unvested Shares under this RSU shall immediately vest as of the Participant’s date of termination by death. The Participant’s heirs may request issuance of the underlying Shares within six (6) months of the Participant’s death. If the Participant’s heirs do not request the issuance of the underlying Shares within six (6) months of the Participant’s death, this RSU will be forfeited.

Restriction on Transfer and Sale of Shares. This provision supplements Section 2 in the Agreement:

The Participant may not sell or transfer the Shares issued at vesting of the RSU or transfer such Shares to another broker prior to the second anniversary of the Date of Grant specified in the Statement, or such other period as is required to comply with the minimum mandatory holding period applicable to French-qualified RSUs under Section L. 225–197-1 of the French Commercial Code, as amended or the relevant sections of the French Tax Code or the French Social Security Code to benefit from the French specific tax and social security regime. These restrictions will apply even after the Participant is no longer employed by the Employer, the Company or one of its Subsidiaries. Notwithstanding the above, the Participant’s heirs, in the case of the Participant’s death, or the Participant, in the case of Disability (as defined under the French Sub-Plan), are not subject to this restriction on the sale or transfer of Shares.



Further, as long as the RSU and the Shares acquired at vesting of the RSU maintain their French-qualified status, the Shares cannot be sold during certain “Closed Periods” as provided for by Section L. 225-197-1 of the French Commercial Code, as amended, and as interpreted by the French administrative guidelines, so long as these Closed Periods are applicable to Shares issued pursuant to French-qualified RSUs, and to the extent applicable. Notwithstanding the above, the Participant’s heirs, in the case of the Participant’s death, or the Participant, in the case of Disability (as defined under the French Sub-Plan), are not subject to the restriction on the sale of Shares during Closed Periods.

Changes in Capitalization. This provision supplements Section 9 in the Agreement:

Certain adjustments may disqualify the RSU, in which case it may no longer benefit from favorable tax and social security treatment in France.

Language Consent. By accepting the RSU, the Participant confirms having read and understood the Agreement and the Program, including all terms and conditions included therein, that were provided in the English language. The Participant accepts the terms of these documents accordingly.

En acceptant le RSU, vous confirmez avoir lu et compris ce Contrat et le Program, inclutant tous leur termes et conditions, qui lui ont été transmis en langue anglaise. Vous acceptez les dispositions de ces documents en connaissance de cause.

Notifications

Foreign Asset and Account Reporting. If the Participant holds cash or Shares outside of France, he or she must declare all foreign bank and brokerage accounts (including any accounts that were opened or closed during the tax year) on an annual basis on form No. 3916, together with their income tax return. Failure to complete this reporting triggers penalties for a French resident Participant.

GERMANY

Notifications

Exchange Control Information. Cross-border payments in excess of €12,500 must be reported monthly to the German Federal Bank. If the Participant makes or receives a cross-border payment in excess of €12,500 (e.g., repatriation of proceeds from the sale of Shares acquired under the Program), he or she must report the payment to the German Federal Bank electronically using the “General Statistics Reporting Portal” available via the Bank’s website (www.bundesbank.de). If required, the report must be filed by the 5th day of the month following the month in which the payment occurred.

Foreign Account and Asset Reporting. If the Participant’s acquisition of Shares under the Program leads to a so-called “qualified participation” at any point during the calendar year, the Participant will need to report the acquisition of Shares when the Participant files his or her tax return for the relevant year. A qualified participation occurs only if (i) the Participant owns 1% or more of the Company and the value of the Shares acquired exceeds €150,000 or (ii) the Shares held exceed 10% of the Company’s total common stock. The Participant should consult with the Participant’s personal tax advisor to ensure he or she complies with applicable reporting obligations.

GREECE

There are no country-specific provisions.

INDIA

Notifications

Exchange Control Information. The Participant understands that he or she must repatriate any proceeds from the sale of Shares acquired under the Program to India within the required time period specified under applicable exchange control regulations in India. The Participant will receive a foreign inward remittance certificate (“FIRC”) from the bank where the Participant deposits the foreign currency. The Participant should maintain the FIRC as evidence of the repatriation of funds in the event the Reserve Bank of India or the Employer requests proof of repatriation.

Foreign Account and Asset Reporting. The Participant is required to declare any foreign bank accounts and assets (including Shares acquired under the Program) on his or her annual tax return. The Participant should consult with his or her personal tax advisor to ensure compliance with applicable reporting obligations.



IRELAND

There are no country-specific provisions.

ISRAEL

Terms and Conditions

Securities Law Exemption. An exemption from the requirement to file a prospectus with respect to the Program has been granted to the Company by the Israeli Securities Authority under Section 15D of the Securities Law, 1968. Copies of the Program and Form S-8 registration statement for the Program filed with the United States Securities and Exchange Commission are available free of charge upon request at the Participant’s local HR department.

The following provisions apply to Participants who are in Israel on the Date of Grant.

Trustee Arrangement. The Participant acknowledges and agrees that the RSU is granted under the Israeli Subplan to the Program and shall be allocated under the provisions of the track referred to as the “Capital Gains Track” pursuant to Sections 102(b) and 102(b)(3) of the Israel Income Tax Ordinance [New Version], 1961 and shall be held by the trustee engaged by the Company (the “Trustee”) for the 24 month period from the Date or Grant or such other period as required under Section 102 (the “Holding Period”).

The Participant hereby declares that:

1.Participant understands the provisions of Section 102 and the applicable tax track of this grant of RSUs.

2.Subject to the provisions of Section 102, the Participant hereby confirms that the Participant shall not sell and/or transfer the RSU, or any Shares or additional rights associated with the RSU, before the end of the Holding Period. In the event that Participant elects to sell or release the Shares or additional rights, as the case may be, prior to the expiration of the Holding Period, the sanctions under Section 102 shall apply to and shall be borne solely by the Participant.

3.The Participant understands that this grant of the RSU is conditioned upon the receipt of all required approvals from Israeli tax authorities.

4.The Participant agrees to be bound by the provisions of the trust agreement with the Trustee.

The Participant hereby confirms that he or she has: (i) read and understands this Agreement; (ii) received all the clarifications and explanations that he or she has requested; and (iii) had the opportunity to consult with his or her advisers before accepting this Agreement.

Written Acceptance. IMPORTANT: If the Participant has not already executed a Section 102 Capital Gains Track Grant Consent (“Consent”) in connection with grants made under the Israeli Subplan to the Program, the Participant must print, sign and deliver the Consent within 45 days to Altshuler Shaham Investment House at the following address and the attention of: Olga Pitzik, Account Manager, Altshuler Shaham Investment House, 19A Habarzel St., Ramat Hachayal, Tel Aviv 6971026 or Adi Waisbard, Edwards Lifesciences (Israel) Ltd. If the signed Consent is not received at the above address within 45 days, the RSU shall not qualify for favorable tax treatment.

The following provision applies only to Participants who transfer into Israel after the Date of Grant.

Immediate Sale of Shares. This provision supplements Section 2 of the Agreement:
To ensure proper withholding of Tax-Related Items, upon the vesting and settlement of the RSU, the Participant agrees to the immediate sale of any Shares to be issued. The Participant further agrees that the Company is authorized to instruct its designated broker to assist with the mandatory sale of such Shares (on the Participant’s behalf pursuant to this authorization), and the Participant expressly authorizes the Company’s designated broker to complete the sale of such Shares. Upon the sale of the Shares, the Company agrees to pay the cash proceeds from the sale, less Tax-Related Items and any brokerage fees or commissions, to the Participant. The Participant acknowledges that the Company’s designated broker is under no obligation to arrange for the sale of the Shares at any particular price.



ITALY

Terms and Conditions

Grant Terms Acknowledgment. By accepting the RSU, the Participant acknowledges that the Participant has received a copy of the Program and the Agreement and has reviewed the Program and the Agreement, including the Appendices, in their entirety and fully understands and accepts all provisions of the Program and the Agreement, including the Appendices. The Participant further acknowledges having read and specifically approves the following sections of the Agreement: Section 13 (Responsibility for Taxes), Section 15 (Miscellaneous), Section 16 (Nature of Grant), Section 18 (Data Privacy Notice and Consent), Section 21 (Governing Law and Venue) and Section 27 (Imposition of Other Requirements).

Notifications

Foreign Asset and Account Reporting. To the extent the Participant holds investments abroad or foreign financial assets that may general taxable income in Italy (such as Shares acquired under the Program) during the calendar year, the Participant is required to report them on his or her annual tax return (UNICO Form, RW Schedule), or on a special form if no tax return is due and pay the foreign financial assets tax. The tax is assessed at the end of the calendar year or on the last day the shares are held (in such case, or when shares are acquired during the course of the year, the tax is levied in proportion to the number of days the shares are held over the calendar year). No tax payment duties arise if the amount of the foreign financial assets tax calculated on all financial assets held abroad does not exceed a certain threshold.

JAPAN

Notifications

Foreign Asset and Account Reporting. If the Participant holds assets outside of Japan with a value exceeding ¥50,000,000 (as of December 31 each year), he or she is required to comply annual tax reporting obligations with respect to such assets. The Participant should consult with his or her personal tax advisor to ensure that he or she is properly complying with applicable reporting obligations.

KOREA

Notifications

Foreign Asset and Account Reporting. Korean residents must declare all foreign financial accounts (i.e., non-Korean bank accounts, brokerage accounts, etc.) they hold in any foreign country that does not enter into an “inter-governmental agreement for automatic exchange of tax information” with Korea, to the Korean tax authority and file a report with respect to such accounts if the value of such accounts exceeds KRW 500 million (or an equivalent amount in foreign currency) on any month-end date during a calendar year. Korean residents should consult their personal tax advisor to determine their personal reporting obligations.

MALAYSIA

Notifications

Director Notification Obligations. If the Participant is a director of a Malaysian Subsidiary or affiliate of the Company, he or she is subject to certain notification requirements under the Malaysian Companies Act. Among these requirements is an obligation to notify the Malaysian Subsidiary or affiliate in writing when the Participant receives or disposes an interest in the Company (e.g., Shares) within 14 days of such transaction.

MEXICO

Terms and Conditions

Labor Law Acknowledgement. In accepting the RSU, the Participant expressly recognizes that the Company with registered offices at One Edwards Way, Irvine, California 92614, U.S.A., is solely responsible for the administration of the Program and that his or her participation in the Program and acquisition of Shares does not constitute an employment relationship between the Participant and the Company since the Participant is participating in the Program on a wholly commercial basis and his or her sole Employer is Edwards Lifesciences México S.A. de C.V. (“Edwards Mexico”) with registered offices at Av. Insurgentes Sur 1431 Piso 15 – Oficina 1502, Col. Insurgentes Mixcoac, Benito Juárez, Ciudad de México - C.P. 03920. Based on the foregoing, the Participant expressly recognizes that the Program and the benefits that the Participant may derive from participating in the Program do not establish any rights between the Participant and the Employer, Edwards Mexico, and do not


form part of the employment conditions and/or benefits provided by Edwards Mexico and any modification of the Program or its termination shall not constitute a change or impairment of the terms and conditions of his or her employment.

The Participant further understands that his or her participation in the Program is as a result of a unilateral and discretionary decision of the Company; therefore, the Company reserves the absolute right to amend and/or discontinue the Participant’s participation at any time without any liability to the Participant.

Finally, the Participant hereby declares that the Participant does not reserve any action or right to bring any claim against the Company for any compensation or damages regarding any provision of the Program or the benefits derived under the Program, and the Participant therefore grants a full and broad release to the Company, its Subsidiaries, branches, representation offices, shareholders, officers, agents or legal representatives with respect to any claim that may arise.

Document Acknowledgment. By accepting the RSU, the Participant acknowledges that he or she has received a copy of the Program, has reviewed the Program and the Agreement in their entirety and fully understands and accepts all provisions of the Program and the Agreement. In addition, by accepting the RSU, the Participant acknowledges that he or she has read and specifically and expressly approves the terms and conditions in Section 16 of the Agreement (“Nature of Grant”), in which the following is clearly described and established: (i) participation in the Program does not constitute an acquired right; (ii) the Program and participation in the Program is offered by the Company on a wholly discretionary basis; (iii) participation in the Program is voluntary; and (iv) neither the Company, the Employer nor any Subsidiary is responsible for any decrease in the value of the Shares underlying the RSU.

Reconocimiento de Ausencia de Relación Laboral y Declaración de la Política
Al aceptar el RSU, usted expresamente recononce que la Compañía y sus oficinas registradas en One Edwards Way, Irvine, California 92614, U.S.A., es el único responsable de la administración del Program y que su participación en el mismo y la compra de Acciones no constituye de ninguna manera una relación laboral entre usted y la Compañía, toda vez que su participación en el Program deriva únicamente de una relación comercial con Edwards Lifesciences México S.A. de C.V. («Edwards México») y sus oficinas registradas en Av. Insurgentes Sur 1431 Piso 15 – Oficina 1502, Col. Insurgentes Mixcoac, Benito Juárez, Ciudad de México - C.P. 03920. Derivado de lo anterior, usted expresamente reconoce que el Program y los beneficios que pudieran derivar del mismo no establecen ningún derecho entre usted y su Empleador, Edwards México, y no forman parte de las condiciones laborales y/o prestaciones otorgadas por Edwards México, y expresamente usted reconoce que cualquier modificación al Program o la terminación del mismo de manera alguna podrá ser interpretada como una modificación de sus condiciones de trabajo.

Asimismo, usted entiende que su participación en el Program es el resultado de una decisión unilateral y discrecional de la Compañía, por lo tanto, la Compañía se reserva el derecho absoluto de modificar y/o terminar su participación en cualquier momento, sin ninguna responsabilidad hacia usted.

Finalmente, usted manifiesta que no se reserva ninguna acción o derecho que origine una demanda en contra de la Compañía, por cualquier compensación o daño en relación con cualquier disposición del Program o de los beneficios derivados del mismo, y en consecuencia usted otorga un amplio y total finiquito a la Compañía, sus afiliadas, sucursales, oficinas de representación, accionistas, directores, agentes y representantes legales con respecto a cualquier demanda que pudiera surgir.

Reconocimiento de Documentos. Al aceptar el RSU, usted reconoce que ha recibido una copia del Program, que ha revisado el Program y el Acuerdo de Concesión en su totalidad y entiende y acepta los términos del Program y del Acuerdo de Concesión. Adicionalmente, al aceptar los RSU, el Participante reconoce que ha leído y específica y expresamente aprueba los términos y condiciones del Sección 16 del Acuerdo de Concesión (denominado “Naturaleza de la Concesión”), donde claramente se establece que (i) la participación en el Program no constituye un derecho adquirido, (ii) el Program y la participación en el Program es ofrecido por la Compañía en forma totalmente discresional; (iii) la participación en el Program es voluntaria; y (iv) ni la Compañía ni el Patrón ni su Afiliada es responsable por el decremento en el valor de las acciones de los RSU.

NETHERLANDS

There are no country-specific provisions.

NEW ZEALAND

Notifications

Securities Law Information. Warning: This is an offer of rights to receive Shares upon vesting of the RSU subject to the terms of the Program and this Agreement. RSUs give the Participant a stake in the ownership of the Company. The Participant may receive a return if dividends are paid on the Shares.



If the Company runs into financial difficulties and is wound up, the Participant will be paid only after all creditors and holders of preferred shares have been paid. The Participant may lose some or all of his or her investment.

New Zealand law normally requires people who offer financial products to give information to investors before they invest. This information is designed to help investors to make an informed decision.

The usual rules do not apply to this offer because it is made under an employee share purchase scheme. As a result, the Participant may not be given all the information usually required. The Participant will also have fewer other legal protections for this investment.

The Participant should ask questions, read all documents carefully, and seek independent financial advice before committing to participate in the Program.

The Company’s Shares are currently traded on the New York Stock Exchange under the ticker symbol “EW” and Shares acquired under the Program may be sold through this exchange. The Participant may end up selling the Shares at a price that is lower than the value of the Shares when the Participant acquired them. The price will depend on the demand for the Shares.

For information on risk factors impacting the Company’s business that may affect the value of the Shares, the Participant should refer to the risk factors discussion on the Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are filed with the U.S. Securities and Exchange Commission and are available online at www.sec.gov, as well as on the Company’s website at http://ir.edwards.com/investor-relations.

Foreign Asset and Account Reporting. Interests in foreign companies (including Shares acquired under the Plan) must be declared in the annual tax return. The Participant should consult with a personal tax advisor to ensure that he or she is properly complying with applicable reporting requirements in New Zealand.

NORWAY

There are no country-specific provisions.

POLAND

Notifications

Foreign Asset and Account Reporting. Polish residents holding foreign securities (including Shares) and/or maintaining accounts abroad must report information to the National Bank of Poland on transactions and balances of the securities and cash deposited in such accounts if the value of such transactions or balances (when combined with all other assets held abroad) exceeds PLN 7 million. If required, the reports are due on a quarterly basis by the 20th day following the end of each quarter. The reports are filed on special forms available on the website of the National Bank of Poland.

Exchange Control Information. If a Polish resident transfers funds in excess of a specified threshold (currently €15,000, or PLN 15,000 if such transfer of funds is connected with business activity of an entrepreneur) into or out of Poland, the funds must be transferred via a Polish bank account or financial institution. Polish residents are required to retain the documents connected with a foreign exchange transaction for a period of five years measured from the end of the year in which the relevant transaction occurred.

PORTUGAL

Terms and Conditions

English Language Consent. The Participant hereby expressly declares that he or she has full knowledge of the English language and has read, understood and fully accepts and agrees with the terms and conditions established in the Program and the Agreement.

Consentimento de Lingua Inglesa. O beneficiário pelo presente declara expressamente que tem pleno conhecimento da língua Inglesa e que leu, compreendeu e totalmente aceitou e concordou com os termos e condições estabelecidas no Plano e no Acordo.

PUERTO RICO

There are no country-specific provisions.



SINGAPORE

Notifications

Securities Law Notification. The RSU was granted to the Participant pursuant to the “Qualifying Person” exemption under section 273(1)(f) of the Singapore Securities and Futures Act (Chapter 289, 2006 Ed.) (“SFA”). Neither the Agreement nor the Program have been lodged or registered as a prospectus with the Monetary Authority of Singapore. The Participant should note that his or her RSU is subject to section 257 of the SFA and the Participant will not be able to make any subsequent sale of the Shares in Singapore, or any offer of such subsequent sale of the Shares underlying the RSU unless such sale or offer in Singapore is made (i) after six months from the Date of Grant of the RSU, or (ii) pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the SFA (Chapter 289, 2006 Ed.), or pursuant to, and in accordance with the conditions of, any other applicable provisions of the SFA.

Director Notification. If the Participant is a director, associate director or shadow director of a Singapore Subsidiary or other related company in Singapore, then the Participant is subject to certain notification requirements under the Singapore Companies Act. Among these requirements is an obligation to notify the Singapore Subsidiary in writing when the Participant receives an interest (e.g., RSUs, Shares) in the Company or any related company. In addition, the Participant must notify the Singapore Subsidiary when the Participant sells Shares of the Company or any related company (including when the Participant sells Shares acquired under the Program). These notifications must be made within two (2) business days of acquiring or disposing of any interest in the Company or any related company. In addition, a notification must be made of the Participant’s interests in the Company or any related company within two (2) business days of becoming a director.

SOUTH AFRICA

Terms and Conditions

Responsibility for Taxes. The following provision supplements Section 13 of the Agreement:
By accepting the RSU, the Participant agrees that, immediately upon vesting and settlement of the RSU, the Participant will notify the Employer of the amount of any gain realized. The Participant will be solely responsible for paying any difference between the actual tax liability and the amount withheld by the Employer.

Notifications

Securities Law Notification. The grant of the RSU and the Shares issued pursuant to the vesting of the RSU are considered a small offering under Section 96 of the South Africa Companies Act, 2008 (Act No. 71 of 2008).

Exchange Control Information. To participate in the Program, the Participant must comply with exchange control regulations and rulings in South Africa and neither the Company nor the Employer will be liable for any fines or penalties resulting from the Participant’s failure to comply with applicable laws. Because no transfer of funds from South Africa is required under the RSU, no filing or reporting requirements should apply when the RSU is granted or when Shares are issued upon vesting and settlement of the RSU, nor should the RSU or the underlying Shares count towards the annual offshore investment limit. However, because the exchange control regulations are subject to change, the Participant should consult the Participant’s personal advisor prior to vesting and settlement of the RSU to ensure compliance with current regulations.

SPAIN

Terms and Conditions

Responsibility for Taxes. By accepting the RSU, the Participant agrees that the amount of any payment on account payable by the Employer with respect to the vesting of the RSU will be transferred to the Participant and withheld by the Company or the Employer.

Nature of Grant. The following provision supplements Section 16 of the Agreement:

By accepting the RSU, the Participant consents to participation in the Program and acknowledge that the Participant has received a copy of the Program.

The Participant understands that the Company has unilaterally, gratuitously and in its sole discretion decided to grant RSUs under the Program to individuals who may be employees of the Company or its Subsidiaries throughout the world. The decision is limited and entered into based upon the express assumption and condition that any RSUs will not economically or otherwise bind the Company or any parent, Subsidiary or affiliate, including the Employer, on an ongoing basis, other than as expressly set forth in the Agreement. Consequently, the Participant understands that the RSU is granted on the assumption and condition that the RSU shall not become part of any employment contract (whether with the Company or any parent, Subsidiary


or affiliate, including the Employer) and shall not be considered a mandatory benefit, salary for any purpose (including severance compensation) or any other right whatsoever. Furthermore, the Participant understands and freely accepts that there is no guarantee that any benefit whatsoever shall arise from the RSU, which is gratuitous and discretionary, since the future value of the RSU and the underlying Shares is unknown and unpredictable. The Participant also understands that this grant of RSUs would not be made but for the assumptions and conditions set forth hereinabove; thus, the Participant understands, acknowledges and freely accepts that, should any or all of the assumptions be mistaken or any of the conditions not be met for any reason, then the grant of this RSU shall be null and void.

Further, this RSU is a conditional right to Shares and can be forfeited in the case of, or affected by, the Participant’s termination of employment. This will be the case, for example, even if (1) the Participant is considered to be unfairly dismissed without good cause (i.e., subject to a “despido improcedente”); (2) the Participant is dismissed for disciplinary or objective reasons or due to a collective dismissal; (3) the Participant terminates employment due to a change of work location, duties or any other employment or contractual condition; (4) the Participant terminates employment due to unilateral breach of contract of the Company or any of its Subsidiaries; or (5) the Participant’s employment terminates for any other reason whatsoever, except for Cause. Consequently, upon termination of the Participant’s employment for any of the reasons set forth above, the Participant may automatically lose any rights to the unvested RSU granted to the Participant as of the date of his or her termination of employment, as described in the Program and the Agreement.

Notifications

Foreign Asset and Account Reporting. To the extent that Spanish residents hold assets (e.g., Shares, cash, etc.) in a bank or brokerage account outside of Spain with a value in excess of €50,000 per type of asset as of December 31 each year, such residents are required to report information on such assets on their tax return for such year. Shares constitute securities for purposes of this requirement, but unvested rights (e.g., RSUs) are not considered assets for purposes of this requirement.

If applicable, Spanish residents must report the assets on Form 720 by no later than March 31 following the end of the relevant year. After such assets are initially reported, the reporting obligation will only apply for subsequent years if the value of any previously-reported assets increases by more than €20,000. Failure to comply with this reporting requirement may result in penalties.

Exchange Control Information. The Participant must declare the acquisition of Shares to the Dirección General de Política Comercial e Inversiones (“DGCI”) of the Ministry of Economy and Competitiveness for statistical purposes. Generally, the declaration must be made by filing a D-6 form each January for Shares acquired or sold during (or owned by the Participant as of December 31) of the prior year; however, if the value of Shares acquired or sold exceeds €1,502,530, the declaration must also be filed within one month of the acquisition or sale, as applicable.

Spanish residents are also required to electronically declare to the Bank of Spain any securities accounts (including brokerage accounts) held abroad, any foreign instruments (including Shares), and any transactions with non-Spanish residents (including any payments of Shares made by the Company) if the value of the transactions during the relevant year or the balances in such accounts and the value of such instruments as of December 31 of the relevant year exceed €1,000,000. Spanish residents should consult with their personal tax and legal advisors to ensure compliance with their personal reporting obligations.

Securities Law Notification. The grant of the RSU and the Shares issued pursuant to the vesting of the RSU are considered a private placement outside of the scope of Spanish laws on public offerings and issuances of securities.

SWEDEN

Terms and Conditions

Responsibility for Taxes. The following provision supplements Section 13 of the Agreement:

Without limiting the Company’s and the Employer’s authority to satisfy their withholding obligations for Tax-Related Items as set forth in Section 13 of the Agreement, in accepting the grant of the RSU, the Participant authorizes the Company and/or the Employer to sell or withhold Shares otherwise deliverable to the Participant upon vesting to satisfy Tax-Related Items, regardless of whether the Company and/or the Employer have an obligation to withhold such Tax-Related Items.

SWITZERLAND

Notifications

Securities Law Notification. Neither this document nor any other materials relating to the RSU (1) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services (“FinSA”), (2) may be publicly distributed nor otherwise made available in Switzerland to any person other than an employee of the Company, or (3) have been or will be


filed with, approved or supervised by any Swiss reviewing body according to article 51 of FinSA or any Swiss Regulatory Authority, including the Swiss Financial Market Supervisory Authority (FINMA).

Foreign Asset and Account Reporting. The Participant is required to declare all of his or her foreign bank and brokerage accounts in which the Participant holds cash or securities, including the accounts that were opened and/or closed during the tax year, as well as any other assets, on an annual basis in his or her tax return. This includes RSUs granted to you under the Plan which should not be subject to the net wealth tax, but must be reflected “pro memoria” in the statement on bank accounts and securities (Wertschriftenverzeichnis) that you are required to file with your tax return.

TAIWAN

Notifications

Securities Law Notification. The offer of participation in the Program is made only to employees of the Company and its Subsidiaries. The offer of participation in the Program is not a public offer of securities by a Taiwanese company.

Exchange Control Information. The Participant may remit foreign currency in relation to Shares into Taiwan through an authorized foreign exchange bank in an amount of up to US$5,000,000 per year. However, if the transaction amount is TWD$500,000 or more in a single transaction, the Participant must submit a foreign exchange transaction form and also provide supporting documentation to the satisfaction of the remitting bank. The Participant should consult his or her personal advisor to ensure compliance with applicable exchange control laws in Taiwan.

THAILAND

Notifications

Exchange Control Information. If the Participant receives funds in connection with the Program (e.g., dividends or sale proceeds) with a value equal to or greater than US$1,000,000 per transaction, the Participant is required to immediately repatriate such funds to Thailand. Any foreign currency repatriated to Thailand must be converted to Thai Baht or deposited into a foreign currency deposit account opened with any commercial bank in Thailand acting as the authorized agent within 360 days from the date the funds are repatriated to Thailand. The Participant is also required to inform the authorized agent of the details of the foreign currency transaction, including his or her identification information and the purpose of the transaction.

If the Participant does not comply with the above obligations, he or she may be subject to penalties by the Bank of Thailand. Because exchange control regulations change frequently and without notice, the Participant should consult his or her legal advisor before selling any Shares (or receiving any other funds in connection with the Program) to ensure compliance with current regulations. It is the Participant’s responsibility to comply with exchange control laws in Thailand, and neither the Company nor the Employer will be liable for any fines or penalties resulting from failure to comply with applicable laws.

TURKEY

Notifications

Securities Law Information. Turkish residents are not permitted to sell Shares acquired under the Program in Turkey. The Shares are currently traded on the New York Stock Exchange, which is located outside of Turkey, under the ticker symbol “EW” and the Shares may be sold through this exchange.

Exchange Control Information. In certain circumstances, Turkish residents are permitted to sell shares traded on a non-Turkish stock exchange only through a financial intermediary licensed in Turkey. Therefore, Turkish residents may be required to appoint a Turkish broker to assist with the sale of the Shares acquired under the Program. Turkish residents should consult their personal legal advisor before selling any Shares acquired under the Program to confirm the applicability of this requirement.

UNITED ARAB EMIRATES

Notifications

Securities Law Information. Participation in the Program is being offered only to eligible Employees and Contractors and is in the nature of providing equity incentives to Employees and Contractors in the United Arab Emirates. The Program and the Agreement are intended for distribution only to such persons and must not be delivered to, or relied on by, any other person. Prospective acquirers of the securities offered should conduct their own due diligence on the securities. The Emirates Securities and Commodities Authority has no responsibility for reviewing or verifying any documents in connection with the Program.


Neither the Ministry of Economy nor the Dubai Department of Economic Development: (i) have approved the Program or the Agreement; (ii) have taken steps to verify the information set out therein; and (iii) have any responsibility for such documents.

UNITED KINGDOM

Terms and Conditions

Responsibility for Taxes. The following supplements Section 13 of the Agreement:

Without limitation to Section 13 of the Agreement, the Participant agrees to be liable for any Tax-Related Items related to his or her participation in the Program and legally applicable to the Participant and hereby covenants to pay any such Tax-Related Items, as and when requested by the Company or, if different, the Employer or by Her Majesty’s Revenue & Customs (“HMRC”) (or any other tax authority or any other relevant authority). The Participant also agrees to indemnify and keep indemnified the Company and, if different, the Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC (or any other tax authority or any other relevant authority) on the Participant’s behalf.

Notwithstanding the foregoing, if the Participant is a director or executive officer of the Company (as within the meaning of Section 13(k) of the Exchange Act), the amount of any uncollected income tax not collected within ninety (90) days of the end of the U.K. tax year may constitute a benefit to the Participant on which additional income tax and National Insurance contributions (“NICs”) may be payable. The Participant understands that he or she will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for reimbursing the Company and/or Employer for the value of any NICs due on this additional benefit, which may be recovered from the Participant by the Company or the Employer by any of the means referred to in Section 13 of the Agreement.

ADDITIONAL DEFINED TERMS APPENDIX

When used in this Agreement, the following terms shall have the meanings set forth below and, when the meaning is intended, the initial letter of the word is capitalized:

“Cause” shall mean the occurrence of any one or more of the following (provided that the determination of whether “Cause” exists at any time prior to the occurrence of a Change in Control shall be determined solely by the Company, in the exercise of the Company’s good faith and reasonable judgment, and any such determination shall be final and binding upon the parties):

(a) A continuing material breach by the Participant of the duties and responsibilities of the Participant, which duties shall not differ in any material respect from the duties and responsibilities during the 90-day period immediately prior to a Change in Control (other than as a result of incapacity due to a physical or mental condition or illness), which breach is demonstrably willful and deliberate on the Participant’s part, is committed in bad faith and without a reasonable belief that such a breach is in the best interests of the Company; or

(b) The Participant has engaged in conduct that is willfully, demonstrably and materially injurious to the Company, monetarily or otherwise; or

(c) The Participant is convicted of, or pled guilty or nolo contendere to a felony (under the laws of the United States or any relevant state, or a similar crime or offense under the applicable laws of any relevant foreign jurisdiction) that adversely affects the reputation of the Participant or the Company;

provided, that no act or failure to act on the Participant’s part shall be deemed “willful” unless done, or omitted to be done, by the Participant not in good faith and without reasonable belief that the action or omission was in the best interest of the Company.

“Change in Control” of the Company shall mean the first to occur of any one of the following events after the Date of Grant set forth on the Statement:

(a) Any “Person,” as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934 (as amended) (other than the Company, any corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company, and any trustee or other fiduciary holding securities under an employee benefit plan of the Company or such proportionately owned corporation), is or becomes the “beneficial owner” (as defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended), directly or indirectly, of securities of the Company representing thirty percent (30%) or more of the combined voting power of the Company’s then outstanding securities; or



(b) During any period of not more than twenty-four (24) months, individuals who at the beginning of such period constitute the Board, and any new director (other than a director designated by a Person who has entered into an agreement with the Company to effect a transaction described in (a), (c), or (d) of this definition) whose election by the Board or nomination for election by the Company’s stockholders was approved by a vote of at least two-thirds (2/3) of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority thereof; or

(c) The consummation of a merger or consolidation of the Company with any other entity, other than: (i) a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than sixty percent (60%) of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation; or (ii) a merger or consolidation effected to implement a recapitalization of the Company (or similar transaction) in which no Person acquires more than thirty percent (30%) of the combined voting power of the Company’s then outstanding securities; or

(d) The Company’s stockholders approve a plan of complete liquidation or dissolution of the Company, or an agreement for the sale or disposition by the Company of all or substantially all of the Company’s assets (or any transaction having a similar effect).

“Good Reason” means, without the Participant’s express written consent, the occurrence of any one or more of the following conditions during the Protected Period:

(a) The assignment of the Participant to duties materially inconsistent with the Participant’s authorities, duties, responsibilities, and status (including offices, titles, and reporting requirements) as an employee, executive and/or officer of the Company, or a material reduction or alteration in the nature or status of the Participant’s authorities, duties, or responsibilities, other than an insubstantial or inadvertent act that is remedied by the Company promptly after receipt of notice thereof given by the Participant;

(b) The Company’s requiring the Participant to be based at a location in excess of fifty (50) miles from the location of the Participant’s principal job location or office immediately prior to such change, except for required travel on the Company’s business to an extent substantially consistent with the Participant’s then present business travel obligations;

(c) A reduction by the Company of the Participant’s base salary or base rate of compensation, as applicable; or

(d) The failure of the Company to continue in effect any of the Company’s short- and long-term incentive compensation plans, or employee benefit or retirement plans, policies, practices, or other compensation arrangements in which the Participant participates, unless the Participant is permitted to participate in other plans that provide the Participant with substantially comparable benefits; or the failure by the Company to continue the Participant’s participation therein on substantially the same basis, both in terms of the amount of benefits provided and the level of the Participant’s participation relative to other participants;

provided, however, that any such condition shall not constitute “Good Reason” unless the following requirements are satisfied: (x) the Participant provides the Company the written notice which sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination by the Participation for Good Reason within sixty (60) days following the initial existence of the event giving rise to the condition claimed to constitute “Good Reason,” (y) the Company fails to remedy such condition within thirty (30) days after receiving such notice (the “Cure Period”), and (z) the Participant resigns in writing from his or her employment, citing failure to remedy the condition giving rise to Good Reason, within thirty (30) days following the expiration of such thirty (30) day cure period.

The Participant’s right to terminate employment for Good Reason shall not be affected by the Participant’s incapacity due to physical or mental illness. The Participant’s continued employment shall not constitute consent to, or a waiver of rights with respect to, any circumstance constituting Good Reason herein.

“Protected Period” means, with respect to a Change in Control, the period commencing the date that is six (6) months prior to the date of such Change in Control and ending on the date that is twenty four (24) months following such Change in Control.

 EX-10.13 5 ex-101310xkq42021.htm EX-10.13 Document

Exhibit 10.13


Edwards Lifesciences Corporation
Long-Term Stock Incentive Compensation Program
Global Performance-Based Restricted Stock Unit Award Agreement

THIS AGREEMENT, including any appendix for the Participant’s country (the “Appendix”) and the Performance-Based Restricted Stock Unit Statement attached to the front of this agreement (the “Statement”), sets forth the terms and conditions of the performance-based restricted stock unit award (the “PRSU”) granted by Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), to the Participant named on the Statement, pursuant to the provisions of the Company’s Long-Term Stock Incentive Compensation Program (the “Program”). This agreement, the Appendix and the Statement shall be considered one agreement and are referred to herein as the “Agreement.”
The Program provides additional terms and conditions governing the PRSU and is incorporated herein by reference. If there is any inconsistency between the terms of this Agreement and the terms of the Program, the Program’s terms shall completely supersede and replace the conflicting terms of this Agreement. All capitalized terms shall have the meanings ascribed to them in the Program, unless specifically set forth otherwise herein. The parties hereto agree as follows:
1.Grant of PRSU. Effective as of the Date of Grant set forth in the Statement, the Company hereby grants to the Participant a PRSU award with respect to the target number of Shares set forth in the Statement (the “Target Award”) in the manner and subject to the terms and conditions of the Program and this Agreement.
The grant of this PRSU to the Participant shall not confer any right to the Participant (or any other Participant) to be granted any Awards in the future under the Program.
2.Vesting of PRSU and Issuance of Shares. Except as may otherwise be provided in Sections 3 and 6 below, the PRSU will vest on the Vesting Date set forth in the Statement, provided the Participant continues to be employed by the Company or one of its Subsidiaries through the Vesting Date and subject to the attainment of certain performance goals set forth in the Statement. Except as expressly provided in Section 4 below, the earned Shares shall be issued to the Participant as soon as practicable (and in all events within sixty (60) days) after the Vesting Date, subject to satisfaction of all Tax-Related Items (as defined in Section 13 below) and to the provisions for U.S. taxpayers set forth in Sections 4 and 10 below.
3.Termination of Employment:
(a)By Death or Disability. In the event that, prior to the Vesting Date set forth in the Statement, the Participant ceases to be employed by the Company or one of its Subsidiaries due to the Participant’s death or Disability, the PRSU shall remain eligible to vest on the Vesting Date (subject to the attainment of the performance goals set forth in the Statement) and, except as expressly provided in Section 6 if a Change in Control occurs during the Performance Period, the Participant shall vest in the number of Shares subject to the PRSU that would otherwise vest based on performance on the Vesting Date.
(b)By Retirement. In the event that, prior to the Vesting Date set forth in the Statement, the Participant ceases to be employed by the Company or one of its Subsidiaries due to the Participant’s Retirement after attaining age fifty-five (55) and with at least ten (10) years of service with the Company or any Subsidiary (“Retirement”), the PRSU shall remain eligible to vest on the Vesting Date (subject to the attainment of the performance goals set forth in the Statement) and, except as expressly provided in Section 6 if a Change in Control occurs during the Performance Period, the Participant shall vest in a pro-rated portion of the Shares subject to the PRSU that would otherwise vest based on performance on the Vesting Date, with the pro-rated portion based on the Participant’s whole months of service with the Company or any Subsidiary during the Performance Period prior to the date of such Retirement; provided that a partial month of employment will be considered a whole “month of service” for purposes of this Agreement only if the Participant was employed by the Company or any Subsidiary for at least fifteen (15) days during such month. Any portion of the PRSU that remains unvested on the Vesting Date (after giving effect to such pro-ration) shall be considered to have terminated on the Vesting Date.
(c)For Other Reasons. Subject to Section 6, the entire PRSU award shall immediately terminate and be forfeited to the Company as of the date of the Participant’s termination of employment with the Company or any Subsidiary prior to the Vesting Date for any reason other than one of the reasons expressly covered by Sections 3(a) and 3(b).
(d)Transfer. For the purposes of this Agreement, a transfer of the Participant’s employment between the Company and any Subsidiary (or between Subsidiaries) shall not be deemed a termination of employment. For purposes of this Agreement, if the Participant is employed by an entity that


constitutes a Subsidiary and that entity ceases (as a result of a sale of equity interests in the entity, a spin-off, or otherwise) to constitute a Subsidiary, the Participant will be considered to have ceased to be employed by the Company or one of its Subsidiaries as of the date that such entity so ceases to constitute a Subsidiary unless either (x) the Participant is employed immediately after such transaction or event by the Company or another entity that continues to qualify as a Subsidiary or (y) the entity that is sold, spun-off or otherwise divested and ceases to constitute a Subsidiary (or a successor or a direct or indirect parent of such entity or such a successor) assumes the PRSU award in connection with such transaction.
4.Issuance of Shares for RSUs Subject to Code Section 409A. This Section 4 applies only to the extent that the Participant is a U.S. taxpayer and the RSUs are treated as deferred compensation under Code Section 409A. Except as provided in this Section 4, the Shares that vest pursuant to the terms of this Agreement will be issued on or within sixty (60) days after the Vesting Date. If this Section 4 applies, the following rules set forth in Sections 4(a) and (b) also apply notwithstanding any provision to the contrary in this Agreement.
(a)Change in Control. If this PRSU is terminated pursuant to Section 6(c) hereof in connection with a 409A Change in Control, any vested Shares hereunder shall be issued or distributed in accordance with the plan-termination rules set forth in Treasury Regulation Section 1.409A-3(j)(4)(ix) or, in the event the Company is not able to make issuance or distribution in accordance with such regulation, shall be issued or distributed on or within thirty (30) days following the Vesting Date. In the event that any issuance of vested Shares is delayed until after a 409A Change in Control, instead of the issuance of Shares, such portion of the RSU shall be settled in cash in an amount equal to the Fair Market Value of such vested Shares, determined as of the date of the 409A Change in Control.
(b)Employment Taxes. In the event the employee portion of the U.S. federal, state and local employment taxes required to be withheld by the Company (the “Employment Taxes”) becomes due in a calendar year that precedes the year in which the Vesting Date occurs, the Participant shall, on or before the last business day of the calendar year in which the Employment Taxes become due, deliver to the Company a check payable to its order in the dollar amount equal to the Employment Taxes required to be withheld with respect to those Shares. Alternatively, the Company is vested with the authority, in its sole discretion, to collect the Employment Taxes from the Participant by any of the other methods authorized in Section 13 hereof.
5.No Fractional Shares. In no event shall any fractional Shares subject to the PRSU be issued. Accordingly, the total number of Shares to be issued at the time this PRSU vests (if any) shall, to the extent necessary, be rounded down to the next whole Share in order to avoid the issuance of a fractional share.
6.Change in Control.
(a)Change in Control During the Performance Period. Notwithstanding anything to the contrary in this Agreement, in the event of a Change in Control of the Company during the Performance Period, the following provisions shall apply:
(i)    If the Participant’s employment with the Company or any of its Subsidiaries continues through the Vesting Date, the Participant shall vest in 100% of the Target Award set forth in the Statement. Except as expressly provided below in this Section 6, the entire PRSU award shall immediately terminate and be forfeited to the Company if the Participant’s employment with the Company or any Subsidiary terminates prior to the Vesting Date.
(ii)    If the Participant’s employment with the Company or any Subsidiary terminates at any time prior to the Vesting Date (whether before or after the Change in Control) due to the Participant’s death or Disability, the vesting provided for in Section 3(a) shall be based on the Target Award set forth in the Statement. If the Participant’s employment with the Company or any Subsidiary terminates at any time prior to the Vesting Date (whether before or after the Change in Control) due to the Participant’s Retirement, the pro-rata vesting provided for in Section 3(b) shall be based on the Target Award set forth in the Statement.
(iii)    If, at any time during the Protected Period and prior to the Vesting Date, the Participant ceases to be employed by the Company or one of its Subsidiaries and such termination is the result of (x) a termination of employment either by the Company or such Subsidiary without Cause or by the Participant for Good Reason, and (y) the Participant is entitled to receive (and the Participant satisfies any applicable conditions for) Separation Benefits under the CIC Agreement in connection with such termination of employment, the Participant shall vest in the Target Award set forth in the Statement.
(b)Change in Control After the Performance Period. In the event of a Change in Control of the Company after the Performance Period and prior to the Vesting Date, the vesting of the PRSU shall


be determined based on the attainment of the performance goals set forth in the Statement and the applicable termination of employment rules set forth in Section 3; provided, however, that if, at any time during the Protected Period and prior to the Vesting Date, the Participant ceases to be employed by the Company or one of its Subsidiaries and such termination is the result of (x) a termination of employment either by the Company or such Subsidiary without Cause or by the Participant for Good Reason, and (y) the Participant is entitled to receive (and the Participant satisfies any applicable conditions for) Separation Benefits under the CIC Agreement in connection with such termination of employment, the Participant shall vest in the number of Shares subject to the PRSU that would otherwise vest based on performance on the Vesting Date.
(c)Possible Acceleration on 409A Change in Control. Notwithstanding anything to the contrary in this Agreement or in the Program, if a 409A Change in Control occurs, the Board or the Committee may provide for either (i) the assumption, substitution or exchange of this PRSU by the acquiring or successor entity (or a parent thereof) based upon, to the extent relevant under the circumstances, the distribution or consideration payable to holders of the Shares upon or in respect of such event, or (ii) the termination of this PRSU upon such event (in each case, after giving effect to any applicable vesting provisions herein); provided, however, that if this PRSU will terminate upon such event as provided in clause (ii) and the Participant’s employment with the Company or any of its Subsidiaries continues through such event, the vesting of the PRSU will be determined hereunder as though the Participant’s employment had continued through the Vesting Date.
(d)Application of Other Agreements. For purposes of clarity, the accelerated vesting and any alternative timing of payment provisions provided in Article 13 of the Program and Section 2.3(e) of the CIC Agreement shall not apply to this PRSU.
(e)Certain Terminations Prior to Change in Control. If the Participant’s employment terminates prior to a Change in Control in the circumstances contemplated by Section 6(a)(iii) or Section 6(b), this PRSU shall (i) remain outstanding and unvested for a period of six (6) months following such termination of employment and, should a Change in Control occur during such six-month period, shall vest as provided in Section 6(a)(iii) or 6(b), as applicable; and (B) terminate and be forfeited at the end of such six-month period should no Change in Control occur during such six-month period.
(f)Definitions. For purposes of this Agreement and notwithstanding any to the contrary in the Program, the following definitions shall apply:
(i)    “409A Change in Control” means a Change in Control; provided, however, that a transaction shall not constitute a 409A Change in Control unless it is a “change in the ownership or effective control” of the Company, or a change “in the ownership of a substantial portion of the assets” of the Company within the meaning of Section 409A of the Code.
(ii)    “CIC Agreement” means the Change-in-Control Severance Agreement between the Participant and the Company as in effect on the Date of Grant and as it may thereafter be amended from time to time.
(iii)    The terms “Cause”, “Change in Control”, “Good Reason”, “Protected Period”, and “Separation Benefits” have the respective meanings ascribed to such terms in the CIC Agreement.
7.Notice of Termination. Any termination of the Participant’s employment by the Company for Cause or by the Participant for Good Reason shall be communicated by a written notice to the other party indicating the specific termination provision in this Agreement relied upon, and setting forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Participant’s employment under the provision so indicated.
8.Restrictions on Transfer. This PRSU may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution applicable to the Participant.
9.Recapitalization. In the event of any change in corporate capitalization of the Company, such as a stock split, or a corporate transaction, such as any merger, consolidation, separation, including a spin-off, or other distribution of stock or property of the Company, any reorganization (whether or not such reorganization comes within the definition of such term in Code Section 368) of the Company, or any partial or complete liquidation of the Company, the number and class of Shares subject to this PRSU are subject to adjustment by the Committee pursuant to Section 5.4 of the Plan to prevent dilution or enlargement of rights.
10.Section 409A. This Section 10 applies only to the extent that the Participant is a U.S. taxpayer. This Agreement is intended to either be exempt from or comply with the requirements of Section 409A of the Code so as not to subject the Participant to payment of any additional tax, penalty or interest imposed under Code Section 409A. The provisions of this Agreement shall be construed and interpreted to avoid the imputation of any such additional tax, penalty or interest


under Code Section 409A yet preserve (to the nearest extent reasonably possible) the intended benefit payable to the Participant. This Agreement may be amended at any time, without the consent of any party, to avoid the application of Code Section 409A in a particular circumstance or that is necessary or desirable to satisfy any of the requirements under Code Section 409A, but the Company shall not be under any obligation to make any such amendment. Nothing in the Agreement shall provide a basis for any person to take action against the Company or any affiliate based on matters covered by Code Section 409A, including the tax treatment of any amount paid or RSU granted under the Agreement, and neither the Company nor any of its Subsidiaries or affiliates shall under any circumstances have any liability to any Participant or his estate or any other party for any taxes, penalties or interest due on amounts paid or payable under the this Agreement, including taxes, penalties or interest imposed under Code Section 409A.
11.Beneficiary Designation. This Section 11 applies only if the Participant resides in the U.S. The Participant may, from time to time, name any beneficiary or beneficiaries (who may be named contingently or successively) to whom any benefit under this Agreement is to be paid in case of his or her death before he or she receives any or all such benefit. Each such designation shall revoke all prior designations by the Participant, shall be in a form prescribed by the Company, and will be effective only when filed by the Participant in writing with the Secretary of the Company during the Participant’s lifetime. In the absence of any such designation, benefits remaining unpaid at the Participant’s death shall be paid to the Participant’s estate.
12.Rights as a Stockholder. The Participant shall have no rights as a stockholder of the Company until the Participant has obtained an ownership interest in the Shares.
13.Responsibility for Taxes.
(a)Regardless of any action the Company or the Participant’s employer (if different) (the “Employer”) takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related items related to the Participant’s participation in the Program that are legally applicable to the Participant (“Tax-Related Items”), the Participant acknowledges that the ultimate liability for all Tax-Related Items is and remains his or her responsibility and that such liability may exceed the amount actually withheld by the Company or the Employer. The Participant further acknowledges that the Company and/or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of this PRSU or the underlying Shares, including the grant or vesting of this PRSU, the issuance of Shares, the subsequent sale of any Shares acquired at vesting of the PRSU and the receipt of any dividends; and (2) do not commit and are under no obligation to structure the terms of the grant or any aspect of the PRSU to reduce or eliminate the Participant’s liability for Tax-Related Items or achieve any particular tax result. Further, if the Participant becomes subject to Tax-Related Items in more than one jurisdiction, the Participant acknowledges that the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.
(b)Prior to any relevant taxable, tax and/or social security contribution withholding event, the Participant shall pay or make adequate arrangements satisfactory to the Company and/or the Employer to satisfy all Tax-Related Items. In this regard, the Participant authorizes the Company and/or the Employer, or their respective agents, at their sole discretion, to satisfy any applicable withholding obligations with respect to Tax-Related Items by one or a combination of the following: (i) withholding from the Participant’s wages or other cash compensation paid to him or her by the Company and/or the Employer or from any equivalent cash payment received upon vesting of the PRSU; or (ii) withholding from the proceeds of the sale of Shares acquired at vesting of the PRSU, either through a voluntary sale or through a mandatory sale arranged by the Company (on the Participant’s behalf pursuant to this authorization); or (iii) withholding in Shares to be issued upon vesting of the PRSU. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant will be deemed to have been issued the full number of Shares subject to the vested PRSU, notwithstanding that a number of the Shares is held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Participant’s participation in the Program. Depending on the withholding method, the Company or the Employer may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding rates or other applicable withholding rates, including maximum applicable rates in the Participant’s jurisdiction(s). In the event of over-withholding, the Participant may receive a refund of any over-withheld amount in cash (with no entitlement to the equivalent in Shares), or, if not refunded, the Participant may seek a refund from the applicable tax authorities. In the event of under-withholding, the Participant may be required to pay additional Tax-Related Items directly to the tax authorities, the Company or the Employer.
(c)Finally, the Participant shall pay to the Company or the Employer any amount of Tax-Related Items and/or Employment Taxes that the Company or the Employer may be required to withhold or account for as a result of Participant’s participation in the Program that cannot be satisfied by the means described in this Section 13. The Company may refuse to issue or deliver Shares or the proceeds of the sale of Shares to the Participant if the Participant fails to comply with Participant’s obligation in connection with the Tax-Related Items and/or Employment Taxes.


14.Continuation of Employment. This Agreement shall not confer upon the Participant any right to continuation of employment with the Employer, nor shall this Agreement interfere in any way with the Employer’s right to terminate the Participant’s employment at any time with or without cause.
15.Miscellaneous.
(a)This Agreement and the rights of the Participant hereunder are subject to all the terms and conditions of the Program, as the same may be amended from time to time, as well as to such rules and regulations as the Committee may adopt for administration of the Program. The Committee shall have the right to impose such restrictions on any Shares acquired pursuant to this Award, as it may deem advisable for regulatory compliance, including, without limitation, restrictions under applicable U.S. federal securities laws, under the requirements of any stock exchange or market upon which such Shares are then listed and/or traded, and under any state or foreign securities laws applicable to such Shares. It is expressly understood that the Committee is authorized to administer, construe, and make all determinations necessary or appropriate to the administration of the Program and this Agreement, all of which shall be binding upon the Participant.
(b)The Board may terminate, amend, suspend or modify the Program and the Committee may amend this PRSU at anytime; provided, however, that no such termination, amendment, suspension or modification of the Program or amendment of this Award may in any material way adversely affect the Participant’s rights under this Agreement, without the express consent of the Participant.
(c)The Participant agrees to take all steps necessary to comply with all applicable provisions of U.S. federal, state and foreign securities law in exercising his or her rights under this Agreement.
(d)This Agreement shall be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required.
(e)All obligations of the Company under the Program and this Agreement, with respect to this Award, shall, to the extent legally permissible, be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company.
16.Nature of Grant. In accepting the PRSU, the Participant acknowledges, understands and agrees that:
(a)the Program is established voluntarily by the Company and is discretionary in nature;
(b)the grant of the PRSU by the Company is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of Restricted Stock Units, or benefits in lieu of Restricted Stock Units, even if Restricted Stock Units have been granted in the past;
(c)all decisions with respect to future Restricted Stock Units grants, if any, will be at the sole discretion of the Company;
(d)the Participant is voluntarily participating in the Program;
(e)the PRSU and any Shares acquired under the Program, and the income from and value of the same, are not part of normal or expected compensation or salary;
(f)unless otherwise agreed with the Company, the PRSU and any Shares acquired under the Program, and the income from and value of the same, are not granted as consideration for, or in connection with, the service the Participant may provide as a director of a Subsidiary or affiliate of the Company;
(g)the PRSU grant and the Participant’s participation in the Program shall not be interpreted to form an employment contract or relationship with the Company or the Employer or any Subsidiary or affiliate of the Company;
(h)the future value of the Shares subject to the PRSU is unknown, indeterminable and cannot be predicted with certainty;
(i)for purposes of the PRSU, the Participant’s employment or other service relationship will be considered terminated as of the date the Participant is no longer actively providing services to the Company or the Employer (regardless of the reason for such termination and whether or not later found invalid or in breach of employment laws in the jurisdiction where the Participant is employed or providing services or the terms of the Participant’s employment or service agreement, if any), and unless otherwise provided in this Agreement or decided by the Committee, the Participant’s right to


vest in the PRSU under the Program, if any, will terminate effective as of such date and will not be extended by any notice period (e.g., active employment or service would not include a period of “garden leave” or similar period mandated under employment laws in the jurisdiction where the Participant is employed or providing services or the terms of the Participant’s employment or service agreement, if any); furthermore, the Committee shall have the exclusive discretion to determine when the Participant is no longer actively providing services for purposes of the PRSU (including whether the Participant may still be considered to be providing services while on a leave of absence);
(j)for Participants who reside outside the U.S., the following additional provisions shall apply:
(i)the PRSU and any Shares, and the income from and value of the same, acquired under the Program are not intended to replace any pension rights or compensation;
(ii)the PRSU and the underlying Shares, and the income from and value of the same, are extraordinary items that do not constitute compensation of any kind for services of any kind rendered to the Company or to the Employer and are outside the scope of Participant’s employment agreement, if any; such items shall not be included in or part of any for any calculation of any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company or the Employer;
(iii)no claim or entitlement to compensation or damages shall arise from forfeiture of the PRSU resulting from termination of the Participant’s employment or other service relationship by the Company or the Employer (regardless of the reason for such termination and whether or not later found invalid or in breach of employment laws in the jurisdiction where the Participant is employed or providing services or the terms of the Participant’s employment or service agreement, if any); and
(iv)neither the Company, the Employer or any Subsidiary or affiliate shall be liable for any foreign exchange rate fluctuation between the Participant’s local currency and the United States Dollar that may affect the value of the PRSU or of any amounts due to the Participant pursuant to the vesting of the PRSU or the subsequent sale of any Shares acquired upon settlement.
17.No Advice Regarding Grant. The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Participant’s participation in the Program, or his or her acquisition or sale of the underlying Shares. The Participant should consult with his or her own personal tax, legal and financial advisors regarding the Participant’s participation in the Program before taking any action related to the Program.
18.Data Privacy Notice and Consent. This Section 18 applies if the Participant resides outside the U.S.
(a)Data Collection and Usage. The Company and the Employer collect, process and use certain personal information about the Participant, including, but not limited to, the Participant’s name, home address and telephone number, email address, date of birth, social insurance, passport or other identification number, salary, nationality, job title, any Shares or directorships held in the Company, details of all PRSUs or any other entitlement to Shares or equivalent benefits awarded, canceled, exercised, vested, unvested or outstanding in the Participant’s favor (“Data”), for the purposes of implementing, administering and managing the Program. The legal basis, where required, for the processing of Data is the Participant’s consent.
(b)Stock Plan Administration Service Providers. The Company will transfer Data to Charles Schwab & Co., Inc. (including its affiliated companies) (collectively, “Charles Schwab”), which is assisting the Company with the implementation, administration and management of the Program. The Company may select different or additional service providers in the future and share Data with such other provider(s) serving in a similar manner. The Participant may be asked to agree on separate terms and data processing practices with Charles Schwab, with such agreement being a condition to the ability to participate in the Program.
(c)International Data Transfers. The Company and Charles Schwab are based in the United States, which means that it will be necessary for Data to be transferred to, and processed in, the United States. If the Participant is outside the United States, the Participant should note that his or her country has enacted data privacy laws that are different from the United States. The Company’s legal basis, where required, for the transfer of Data is the Participant’s consent.
(d)Data Retention. The Company will hold and use Data only as long as is necessary to implement, administer and manage the Participant’s participation in the Program, or as required to comply with legal or regulatory obligations, including under tax, exchange control, labor and securities laws. This may mean Data is retained until after the Participant’s service relationship has terminated, plus any additional time periods necessary for compliance with law, exercise or defense of legal rights, archiving, back-up and deletion purposes.


(e)Voluntariness and Consequences of Consent Denial or Withdrawal. Participation in the Program is voluntary, and the Participant is providing the consents herein on a purely voluntary basis. If the Participant does not consent, or if the Participant later seeks to revoke his or her consent, the Participant’s salary from or employment and career with the Employer will not be affected; the only consequence of refusing or withdrawing consent is that the Company would not be able to grant PRSUs or other Awards to the Participant or administer or maintain such Awards.
(f)Data Subject Rights. The Participant may have a number of rights under data privacy laws in the Participant’s jurisdiction. Depending on where the Participant is based, such rights may include the right to (i) inquire whether and what kind of Data the Company holds about the Participant and how it is processed, and to request access or copies of Data the Company processes, (ii) request correction or supplementation of the Data about the Participant that is inaccurate, incomplete or out of date in light of the purposes underlying the processing, (iii) request deletion of Data no longer necessary for the purposes underlying the processing processed based on withdrawn consent, processed for legitimate interests that, in the context of the Participant’s objection, do not prove to be compelling, or processed in non-compliance with applicable legal requirements, (iv) request restrictions on processing of Data, (v) request portability of Data that the Participant has actively or passively provided to the Company (which does not include data derived or inferred from the collected data), where the processing of such Data is based on consent or the Participant’s employment and is carried out by automated means, (vi) object, in certain circumstances, to the processing of Data for legitimate interests, (vii) lodge complaints with competent authorities in the Participant’s jurisdiction and/or (viii) receive a list with the names and addresses of any potential recipients of Data. To receive clarification regarding these rights or to exercise these rights, the Participant should contact his or her local human resources representative.
Finally, the Participant understands that the Company may rely on a different basis for the processing or transfer of Data in the future and/or request that the Participant provide another data privacy consent. If applicable, the Participant agrees that upon request of the Company or the Employer, the Participant will provide an executed acknowledgement or data privacy consent form (or any other agreements or consents) that the Company and/or the Employer may deem necessary to obtain from the Participant for the purpose of administering the Participant’s participation in the Program in compliance with the data privacy laws in the Participant’s country, either now or in the future. The Participant understands and agrees that he or she will not be able to participate in the Program if he or she fails to provide any such consent or agreement requested by the Company and/or the Employer.
19.Severability. The provisions of this Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.
20.Dispute Resolution. The Participant shall have the right and option to elect to have any good faith dispute or controversy arising under or in connection with this Agreement settled by litigation or arbitration. If arbitration is selected, such proceeding shall be conducted by final and binding arbitration before a panel of three (3) arbitrators in accordance with the rules and under the administration of the American Arbitration Association.
21.Governing Law and Venue. To the extent not preempted by U.S. federal law, this Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, U.S.A.
For purposes of litigating any dispute that arises directly or indirectly from the relationship of the parties evidenced by this Award, the Program or this Agreement, the parties hereby submit to and consent to the exclusive jurisdiction of the State of California and agree that such litigation shall be conducted only in the courts of Orange County, California, or the federal courts for the United States for the Central District of California, and no other courts, where this grant is made and/or to be performed.
22.Language. The Participant acknowledges and represents that he or she is proficient in the English language or has consulted with an advisor who is sufficiently proficient in English, as to allow the Participant to understand the terms of this Agreement and any other documents related to the Program. If the Participant has received this Agreement or any other document related to the Program translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.
23.Electronic Delivery. The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Program by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Program through an online or electronic system established and maintained by the Company or a third party designated by the Company.
24.Insider Trading Restrictions/Market Abuse Laws. The Participant acknowledges that the Participant may be subject to insider trading restrictions and/or market abuse laws in applicable jurisdictions, including the United States and the Participant’s country, the broker’s country or the country in which the Shares are listed (if different), which may affect his or her ability to accept or otherwise acquire, sell, attempt to sell or otherwise dispose of, Shares or rights to Shares (e.g., PRSUs) under the Program or rights linked to the value of Shares during such times as the Participant is considered to have “inside information” regarding the Company (as defined by the laws in the applicable jurisdictions, including the United States and the Participant’s country). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders the Participant placed before possessing inside information. Furthermore, the Participant could be prohibited from (i) disclosing the inside information to any third party and (ii) “tipping” third parties or otherwise causing them to buy or sell Company securities: “third parties” include fellow employees. Any restrictions under these laws or regulations are separate from and in


addition to any restrictions that may be imposed under any applicable Company insider trading policy. The Participant is responsible for ensuring compliance with any applicable restrictions and should consult his or her personal legal advisor on this matter.
25.Foreign Asset/Account, Exchange Control and Tax Reporting. The Participant acknowledges that, depending on his or her country, the Participant may be subject to foreign asset/account, exchange control and/or tax reporting requirements as a result of the acquisition, holding and/or transfer of Shares or cash (including dividends and the proceeds arising from the sale of Shares) derived from his or her participation in the Program, in, to and/or from a brokerage/bank account or legal entity located outside the Participant’s country. The Participant may be required to report such accounts, assets, the balances therein, the value thereof and/or the transactions related thereto to the applicable authorities in Participant’s country. The Participant also may be required to repatriate sale proceeds or other funds received as a result of the Participant’s participation in the Program to the Participant’s country through a designated bank or broker and/or within a certain time after receipt. The Participant acknowledges that he or she is responsible for ensuring compliance with any applicable foreign asset/account, exchange control and tax reporting requirements and should consult his or her personal tax, legal and/or financial advisors on this matter.
26.Non-U.S. Countries Additional Terms Appendix. Notwithstanding any provisions in this Agreement, the PRSU shall be subject to any additional terms and conditions for the Participant’s country set forth in the Appendix. Moreover, if the Participant relocates to one of the countries included in the Appendix, the additional terms and conditions for such country shall apply to the Participant, to the extent that the Company determines that the application of such terms and conditions is necessary or advisable in order to comply with local law or facilitate administration of the Program.
27.Imposition of Other Requirements. The Company reserves the right to impose other requirements on the Participant’s participation in the Program, on the PRSU and on any Shares acquired at vesting of the PRSU, to the extent the Company determines it is necessary or advisable to comply with local law or facilitate the administration of the Program, and to require the Participant to accept any additional agreements or undertakings that may be necessary to accomplish the foregoing.
28.Waiver. The Participant acknowledges that a waiver by the Company of breach of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by the Participant or any other Participant.
29.Benefit Limit. Notwithstanding anything else contained herein or in the Program to the contrary, in the event that any payments or benefits to which the Participant becomes entitled in accordance with the provisions of this Agreement (or any other agreement with the Company) would otherwise constitute a parachute payment under Code Section 280G(b)(2), then such payments and/or benefits will be subject to reduction to the extent necessary to assure that the Participant receives only the greater of (i) the amount of those payments which would not constitute such a parachute payment or (ii) the amount which yields the Participant the greatest after-tax amount of benefits after taking into account any excise tax imposed under Code Section 4999 on the payments and benefits provided the Participant under this Agreement (or on any other payments or benefits to which the Participant may become entitled in connection with any change in control or ownership of the Company or the subsequent termination of his or her employment with the Company).
    Should a reduction in benefits be required to satisfy the benefit limit of this Section 29, then the portion of any parachute payment otherwise payable in cash to the Participant shall be reduced to the extent necessary to comply with such benefit limit. Should such benefit limit still be exceeded following such reduction, then the number of Shares which would otherwise vest on an accelerated basis under each of the Participant’s Awards (based on the amount of the parachute payment attributable to each such Award under Code Section 280G) shall be reduced to the extent necessary to eliminate such excess, with such reduction to be made in the same chronological order in which those Awards were made.
    In the event there is any disagreement between the Participant and the Company as to whether one or more payments or benefits to which the Participant becomes entitled constitute a parachute payment under Code Section 280G or as to the determination of the present value thereof, such dispute will be resolved as follows:
(a)In the event the Treasury Regulations under Code Section 280G (or applicable judicial decisions) specifically address the status of any such payment or benefit or the method of valuation therefor, the characterization afforded to such payment or benefit by the Regulations (or such decisions) will, together with the applicable valuation methodology, be controlling.
(b)In the event Treasury Regulations (or applicable judicial decisions) do not address the status of any payment in dispute, the matter will be submitted for resolution to independent auditors selected and paid for by the Company.  The resolution reached by the independent auditors will be final and controlling; provided, however, that if in the judgment of the independent auditors, the status of the payment in dispute can be resolved through the obtainment of a private letter ruling from the Internal Revenue Service, a formal and proper request for such ruling will be prepared and submitted by the independent auditors, and the determination made by the Internal Revenue Service in the issued ruling will be controlling.  All expenses incurred in connection with the preparation and submission of the ruling request shall be paid by the Company.


(c)In the event Treasury Regulations (or applicable judicial decisions) do not address the appropriate valuation methodology for any payment in dispute, the present value thereof will, at the independent auditor’s election, be determined through an independent third-party appraisal, and the expenses incurred in obtaining such appraisal shall be paid by the Company.
*    *     *    *
By the Participant’s electronic acceptance of the Agreement and participation in the Program, the Participant agrees that this PRSU is granted under and governed by the terms and conditions of the Program and this Agreement, including the Appendix and the Statement.
Further, by the Participant’s electronic acceptance of the Agreement and participation in the Program, the Participant declares, without limitation, his or her consent to the data processing operations described in this Agreement. The Participant understands and acknowledges that the Participant may withdraw consent at any time with future effect for any or no reason as described in Section 18(e) above.


NON-U.S. COUNTRIES ADDITIONAL TERMS APPENDIX
EDWARDS LIFESCIENCES CORPORATION
GLOBAL PERFORMANCE-BASED RESTRICTED STOCK UNIT AGREEMENT


Terms and Conditions
This Appendix includes additional terms and conditions that govern the PRSU granted to the Participant under the Program if the Participant resides in any of the non-U.S. countries listed below. Certain capitalized terms used but not defined in this Appendix have the meanings set forth in the Program and/or the Agreement.
Notifications
This Appendix also includes information regarding exchange controls and certain other issues of which the Participant should be aware with respect to his or her participation in the Program. The information is based on the securities, exchange control and other laws in effect in the respective countries as of May 2021. Such laws are often complex and change frequently. As a result, the Participant should not rely on the information in this Appendix as the only source of information relating to the consequences of his or her participation in the Program because the information may be out of date at the time that the PRSU vests or the Participant sells Shares acquired under the Program.
In addition, the information contained herein is general in nature and may not apply to the Participant’s particular situation and the Company is not in a position to assure the Participant of any particular result. Accordingly, the Participant should seek appropriate professional advice as to how the relevant laws in the Participant’s country may apply to his or her situation.
Finally, the Participant understands that if the Participant is a citizen or resident of a country other than the one in which the Participant is currently working, transfers employment after the Date of Grant, or is considered a resident of another country for local law purposes, the information contained herein may not apply to the Participant and the Company shall, in its discretion, determine to what extent the terms and conditions contained herein shall apply.
AUSTRIA
Notifications
Exchange Control Information. If the Participant holds Shares acquired under the Program outside of Austria (e.g., in a U.S. brokerage account), a reporting obligation to the Austrian National Bank will apply. An exemption applies if the value of the securities held outside Austria as of December 31 does not exceed €5,000,000 or the value of the securities as of any quarter does not exceed €30,000,000. If the former threshold is exceeded, the annual reporting obligations are imposed, whereas if the latter threshold is exceeded, then quarterly reports must be submitted. The annual reporting date is December 31; the deadline for filing the annual report is January 31 of the following year. If the quarterly reporting is required, the reports must be filed on or before the 15th day of the month following the last day of the quarter.
If the Participant holds cash (e.g., dividends or proceeds from the sale of Shares) outside of Austria (e.g., in a U.S. brokerage or bank account), he or she will be subject to monthly reporting if the transaction volume of all cash accounts abroad is €10,000,000 or greater. In this case, transfers of cash into or out of the cash accounts and the balances of such accounts must be reported monthly, as of the last day of the month, on or before the 15th day of the following month, using the form “Meldungen SI-Forderungen und/oder SI-Verpflichtungen.”
BELGIUM
Notifications
Foreign Asset and Account Reporting. The Participant is required to report any security or bank account (including brokerage accounts) that the Participant maintains outside Belgium on his or her annual tax return. The first time the Participant reports the foreign security and/or bank account on his or her annual income tax return, the Participant will have to provide the National Bank of Belgium with the account number, the name of the bank and the country in which the account was opened in a separate form. The form, as well as additional information on how to complete it, can be found on the website of the National Bank of Belgium, www.nbb.be, under the caption Kredietcentrales / Centrales des crédits. The Participant should consult with his or her personal tax advisor regarding the specific requirements applicable to the Participant.
Annual Securities Accounts Tax. If the value of securities held in a Belgian or foreign securities account exceeds €1 million, a new “annual securities account tax” applies. Belgian residents should consult with their personal tax advisor regarding the new tax.
BRAZIL
Terms and Conditions
-10-

Compliance with Law. By accepting the PRSU, the Participant agrees to comply with applicable Brazilian laws and to report and pay any and all Tax-Related Items associated with the vesting of the PRSU and the sale of Shares obtained pursuant to the PRSU.
Labor Law Acknowledgment. By accepting the PRSU, the Participant agrees that he or she is (i) making an investment decision and (ii) the value of the underlying Shares is not fixed and may increase or decrease in value over the vesting period without compensation to the Participant.
Further, the Participant acknowledges and agrees that for all legal purposes, (i) any benefits provided to the Participant under the Plan are unrelated to his or her employment or service; (ii) the Plan is not part of the terms and conditions of the Participant’s employment or service; and (iii) the income from the Participant’s participation in the Plan, if any, is not part of his or her remuneration from employment or service.
Notifications
Foreign Asset and Account Reporting. If the Participant holds assets and rights outside Brazil with an aggregate value of US$1,000,000 or more, then the Participant will be required to prepare and submit to the Central Bank of Brazil an annual declaration of such assets and rights. Assets and rights that must be reported include Shares acquired under the Program. Please note that foreign individuals holding Brazilian visas are considered Brazilian residents for purposes of this reporting requirement and must declare at least the assets held abroad that were acquired subsequent to the date of admittance as a resident of Brazil.
Tax on Financial Transaction (IOF). Payments to foreign countries and repatriation of funds into Brazil (including proceeds from the sale of Shares or from cash dividends paid on such Shares) and the conversion of USD into BRL associated with such fund transfers may be subject to the Tax on Financial Transactions. Brazilian residents must comply with any applicable Tax on Financial Transactions arising from participation in the Program. Brazilian residents should consult with their personal tax advisor for additional details.
CANADA
Terms and Conditions
Award Payable Only in Shares. The grant of the PRSU does not provide the Participant with a right to receive a cash payment; the PRSU is payable only in Shares.
Termination of Employment. This provision replaces Section 16(i) of the Agreement.
For purposes of the PRSU, the Participant’s employment or other service relationship will be considered terminated (regardless of the reason for such termination and whether or not later found to be invalid, unlawful or in breach of employments laws in the jurisdiction where the Participant is employed or providing services, or the terms of the Participant’s employment or service agreement, if any) as of the earliest of: (1) the date the Participant’s employment or service relationship is terminated; (2) the date the Participant receives notice of termination of his or her employment or service relationship; and (3) the date that the Participant is no longer actively providing services to the Company or the Employer, regardless of any notice period or period of pay in lieu of such notice required under applicable employment law (including, without limitation, statutory law, regulatory law and common law) in the jurisdiction where the Participant is employed or providing services or the terms of the Participant’s employment or service agreement, if any. If, notwithstanding the foregoing, applicable employment legislation explicitly requires continued vesting during a statutory notice period, the Participant’s right to vest in the RSU, if any, will terminate effective as of the last date of the minimum statutory notice period, but the Participant will not earn or be entitled to any pro-rated vesting if the vesting date falls after the end of the Participant’s statutory notice period, nor will the Participant be entitled to any compensation for lost vesting.
Data Privacy. The following provision will apply if the Participant is a resident of Quebec and supplements Section 18 of the Agreement:
The Participant hereby authorizes the Company and the Company’s representatives, including the broker(s) designated by the Company, to discuss with and obtain all relevant information from all personnel, professional or not, involved in the administration and operation of the Program. The Participant further authorizes the Company and any Subsidiary or affiliate and the Program administrator to disclose and discuss the Program with their advisors. The Participant further authorizes the Employer to record such information and to keep such information in the Participant’s employee file.
French Language Provision. The following provision will apply if the Participant is a resident of Quebec:
The parties acknowledge that it is their express wish that this Agreement, as well as all documents, notices and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be drawn up in English.
Les parties reconnaissent avoir exigé la rédaction en anglais de cette convention, ainsi que de tous documents exécutés, avis donnés et procedures judiciaries intentées, directement ou indirectement, relativement à la présente convention.


Notification
Securities Law Notice. The Participant is permitted to sell Shares acquired through the Program through the designated broker appointed under the Program, if any, provided the resale of Shares acquired under the Program takes place outside of Canada through the facilities of a stock exchange on which the shares are listed. The Company’s Shares are currently listed on the New York Stock Exchange.
Foreign Asset and Account Reporting. Specified foreign property, including Shares acquired under the Program, must be reported on Form T1135 (Foreign Income Verification Statement) if the total cost of such foreign property exceeds CAD 100,000 at any time during the year. PRSUs also must be reported--generally at a nil cost--if the $100,000 cost threshold is exceeded because of other specified foreign property the Participant holds. The Form T1135 must be filed by April 30 of the following year. The Participant should consult with his or her personal tax advisor for further details regarding this requirement.
CHINA
Terms and Conditions
Immediate Sale of Shares. This provision supplements Section 2 of the Agreement:
Due to regulatory requirements in the People’s Republic of China (“PRC”), upon the vesting and settlement of the PRSU, the Participant agrees to the immediate sale of any Shares to be issued. The Participant further agrees that the Company is authorized to instruct its designated broker to assist with the mandatory sale of such Shares (on the Participant’s behalf pursuant to this authorization), and the Participant expressly authorizes the Company’s designated broker to complete the sale of such Shares. The Participant acknowledges that the Company’s designated broker is under no obligation to arrange for the sale of the Shares at any particular price. Upon the sale of the Shares, the Company agrees to pay the cash proceeds from the sale, less any brokerage fees or commissions, to the Participant in accordance with any applicable exchange control laws and regulations and provided any liability for Tax-Related Items resulting from the vesting of the PRSU has been satisfied.
Exchange Control Requirements. Due to exchange control laws in the PRC, if the Participant is a PRC national, he or she will be required to immediately repatriate the cash proceeds from the sale of the Shares to the PRC. The Participant understands and agrees that such cash proceeds will need to be repatriated to the PRC through a special exchange control account established by the Company, a Subsidiary, or the Employer, and the Participant hereby consents and agrees that any proceeds from the sale of Shares may be transferred to such special account prior to being received by him or her. The cash proceeds may be paid in U.S. dollars or local currency at the Company’s discretion. If the cash proceeds are paid in U.S. dollars, the Participant acknowledges that he or she will be required to set up a U.S. dollar bank account in China so that the cash proceeds may be delivered to this account. If the cash proceeds are converted to local currency, the Participant acknowledges that the Company is under no obligation to secure any currency conversion rate.
The Participant further understands and agrees that there will be a delay between the date the Shares are sold and the date the cash proceeds are distributed to the Participant. The Participant also understands and agrees that the Company is not responsible for any currency fluctuation that may occur between the date the Shares are sold and the date the cash proceeds are distributed to the Participant.
The Participant further agrees to comply with any other requirements that may be imposed by the Company in the future to facilitate compliance with exchange control requirements in the PRC.
COLOMBIA
Terms and Conditions
Labor Law Acknowledgment. This provision supplements the acknowledgment contained in Section 16 of the Agreement:
The Participant acknowledges that, pursuant to Article 128 of the Colombian Labor Code, the Program and related benefits do not constitute a component of his or her “salary” for any legal purpose.
Notifications
Securities Law Information. The Shares are not and will not be registered in the Colombian registry of publicly traded securities (Registro Nacional de Valores y Emisores) and, therefore, the Shares may not be offered to the public in Colombia. Nothing in the Program, the Agreement or any other document evidencing the grant of the PRSU shall be construed as the making of a public offer of securities in Colombia.
Exchange Control Information. Investments in assets located outside Colombia (including Shares) are subject to registration with the Central Bank (Banco de la República). Further, the Participant must repatriate any proceeds from the sale of Shares or any cash dividends paid on such Shares through the Colombian foreign exchange market (i.e., local Colombian banks). The Participant is responsible for complying with any and all Colombian foreign exchange restrictions, approvals and reporting


requirements in connection with the PRSU and any Shares acquired or funds received under the Program. The Participant should consult with his or her personal legal advisor to ensure compliance with the applicable requirements.
Foreign Asset / Account Tax Reporting Information. The Participant must file an annual informative return with the Colombian Tax Office detailing any assets (e.g. Shares) held abroad. If the individual value of any of these assets exceeds a certain threshold, the Participant must describe each asset and indicate the jurisdiction in which it is located, its nature and its value.
COSTA RICA
There are no country-specific provisions.
CZECH REPUBLIC
Notifications
Exchange Control Information. The Czech National Bank may require the Participant to fulfill certain notification duties in relation to the PRSU and the opening and maintenance of a foreign account (e.g., the Participant may be required to report foreign direct investments, financial credits from abroad, investment in foreign securities and associated collections and payments). However, because exchange control regulations change frequently and without notice, the Participant should consult the Participant’s personal legal advisor prior to the vesting of the PRSU to ensure compliance with current regulations. It is the Participant’s responsibility to comply with applicable exchange control laws.
DENMARK
Terms and Conditions
Stock Option Act. The Participant acknowledges that he or she has received an Employer Statement in Danish, which sets forth the additional terms of the PRSU to the extent that the Danish Stock Option Act applies.
Notifications
Exchange Control Information. If the Participant establishes an account holding Shares or cash outside Denmark, he or she may be required to report the account to the Danish Tax Administration as part of his or her annual tax return under the section on foreign affairs and income.
DOMINICAN REPUBLIC
There are no country-specific provisions.
FINLAND
There are no country-specific provisions.
GERMANY
Notifications
Exchange Control Information. Cross-border payments in excess of €12,500 must be reported monthly to the German Federal Bank. If the Participant makes or receives a cross-border payment in excess of €12,500 (e.g., repatriation of proceeds from the sale of Shares acquired under the Program), he or she must report the payment to the German Federal Bank electronically using the “General Statistics Reporting Portal” available via the Bank’s website (www.bundesbank.de). If required, the report must be filed by the 5th day of the month following the month in which the payment occurred.
Foreign Account and Asset Reporting. If the Participant’s acquisition of Shares under the Program leads to a so-called “qualified participation” at any point during the calendar year, the Participant will need to report the acquisition of Shares when the Participant files his or her tax return for the relevant year. A qualified participation occurs only if (i) the Participant owns 1% or more of the Company and the value of the Shares acquired exceeds €150,000 or (ii) the Shares held exceed 10% of the Company’s total common stock. The Participant should consult with the Participant’s personal tax advisor to ensure he or she complies with applicable reporting obligations.
GREECE
There are no country-specific provisions.
INDIA


Notifications
Exchange Control Information. The Participant understands that he or she must repatriate any proceeds from the sale of Shares acquired under the Program to India within the required time period specified under applicable exchange control regulations in India. The Participant will receive a foreign inward remittance certificate (“FIRC”) from the bank where the Participant deposits the foreign currency. The Participant should maintain the FIRC as evidence of the repatriation of funds in the event the Reserve Bank of India or the Employer requests proof of repatriation.
Foreign Account and Asset Reporting. The Participant is required to declare any foreign bank accounts and assets (including Shares acquired under the Program) on his or her annual tax return. The Participant should consult with his or her personal tax advisor to ensure compliance with applicable reporting obligations.
IRELAND
There are no country-specific provisions.
ISRAEL
Terms and Conditions
Securities Law Exemption. An exemption from the requirement to file a prospectus with respect to the Program has been granted to the Company by the Israeli Securities Authority under Section 15D of the Securities Law, 1968. Copies of the Program and Form S-8 registration statement for the Program filed with the United States Securities and Exchange Commission are available free of charge upon request at the Participant’s local HR department.
The following provisions apply to Participants who are in Israel on the Date of Grant.
Trustee Arrangement. The Participant acknowledges and agrees that the PRSU is granted under the Israeli Subplan to the Program and shall be allocated under the provisions of the track referred to as the “Capital Gains Track” pursuant to Sections 102(b) and 102(b)(3) of the Israel Income Tax Ordinance [New Version], 1961 and shall be held by the trustee engaged by the Company (the “Trustee”) for the 24 month period from the Date or Grant or such other period as required under Section 102 (the “Holding Period”).
The Participant hereby declares that:
1.Participant understands the provisions of Section 102 and the applicable tax track of this grant of PRSUs.
2.Subject to the provisions of Section 102, the Participant hereby confirms that the Participant shall not sell and/or transfer the PRSU, or any Shares or additional rights associated with the PRSU, before the end of the Holding Period. In the event that Participant elects to sell or release the Shares or additional rights, as the case may be, prior to the expiration of the Holding Period, the sanctions under Section 102 shall apply to and shall be borne solely by the Participant.
3.The Participant understands that this grant of the PRSU is conditioned upon the receipt of all required approvals from Israeli tax authorities.
4.The Participant agrees to be bound by the provisions of the trust agreement with the Trustee.
The Participant hereby confirms that he or she has: (i) read and understands this Agreement; (ii) received all the clarifications and explanations that he or she has requested; and (iii) had the opportunity to consult with his or her advisers before accepting this Agreement.
Written Acceptance. IMPORTANT: If the Participant has not already executed a Section 102 Capital Gains Track Grant Consent (“Consent”) in connection with grants made under the Israeli Subplan to the Program, the Participant must print, sign and deliver the Consent within 45 days to Altshuler Shaham Investment House at the following address and the attention of: Olga Pitzik, Account Manager, Altshuler Shaham Investment House, 19A Habarzel St., Ramat Hachayal, Tel Aviv 6971026 or Adi Waisbard, Edwards Lifesciences (Israel) Ltd. If the signed Consent is not received at the above address within 45 days, the PRSU shall not qualify for favorable tax treatment.
The following provision applies only to Participants who transfer into Israel after the Date of Grant.
Immediate Sale of Shares. This provision supplements Section 2 of the Agreement:
To ensure proper withholding of Tax-Related Items, upon the vesting and settlement of the PRSU, the Participant agrees to the immediate sale of any Shares to be issued. The Participant further agrees that the Company is authorized to instruct its designated broker to assist with the mandatory sale of such Shares (on the Participant’s behalf pursuant to this authorization),


and the Participant expressly authorizes the Company’s designated broker to complete the sale of such Shares. Upon the sale of the Shares, the Company agrees to pay the cash proceeds from the sale, less Tax-Related Items and any brokerage fees or commissions, to the Participant. The Participant acknowledges that the Company’s designated broker is under no obligation to arrange for the sale of the Shares at any particular price.
ITALY
Terms and Conditions
Grant Terms Acknowledgment. By accepting the PRSU, the Participant acknowledges that the Participant has received a copy of the Program and the Agreement and has reviewed the Program and the Agreement, including this Appendix, in their entirety and fully understands and accepts all provisions of the Program and this Agreement, including the Appendix. The Participant further acknowledges having read and specifically approves the following sections of the Agreement: Section 13 (Responsibility for Taxes), Section 15 (Miscellaneous), Section 16 (Nature of Grant), Section 18 (Data Privacy Notice and Consent), Section 21 (Governing Law and Venue) and Section 27 (Imposition of Other Requirements).
Notifications
Foreign Asset and Account Reporting. To the extent the Participant holds investments abroad or foreign financial assets that may generate taxable income in Italy (such as Shares acquired under the Program) during the calendar year, the Participant is required to report them on his or her annual tax return (UNICO Form, RW Schedule), or on a special form if no tax return is due and pay the foreign financial assets tax. The tax is assessed at the end of the calendar year or on the last day the shares are held (in such case, or when shares are acquired during the course of the year, the tax is levied in proportion to the number of days the shares are held over the calendar year). No tax payment duties arise if the amount of the foreign financial assets tax calculated on all financial assets held abroad does not exceed a certain threshold.
JAPAN
Notifications
Foreign Asset and Account Reporting. If the Participant holds assets outside of Japan with a value exceeding ¥50,000,000 (as of December 31 each year), he or she is required to comply annual tax reporting obligations with respect to such assets. The Participant should consult with his or her personal tax advisor to ensure that he or she is properly complying with applicable reporting obligations.
KOREA
Notifications
Foreign Asset and Account Reporting. Korean residents must declare all foreign financial accounts (i.e., non-Korean bank accounts, brokerage accounts, etc.) they hold in any foreign country that does not enter into an “inter-governmental agreement for automatic exchange of tax information” with Korea, to the Korean tax authority and file a report with respect to such accounts if the value of such accounts exceeds KRW 500 million (or an equivalent amount in foreign currency) on any month-end date during a calendar year. Korean residents should consult their personal tax advisor to determine their personal reporting obligations.
MEXICO
Terms and Conditions
Labor Law Acknowledgement. In accepting the PRSU, the Participant expressly recognizes that the Company with registered offices at One Edwards Way, Irvine, California 92614, U.S.A., is solely responsible for the administration of the Program and that his or her participation in the Program and acquisition of Shares does not constitute an employment relationship between the Participant and the Company since the Participant is participating in the Program on a wholly commercial basis and his or her sole Employer is Edwards Lifesciences México S.A. de C.V. (“Edwards Mexico”) with registered offices at Av. Insurgentes Sur 1431 Piso 15 – Oficina 1502, Col. Insurgentes Mixcoac, Benito Juárez, Ciudad de México - C.P. 03920. Based on the foregoing, the Participant expressly recognizes that the Program and the benefits that the Participant may derive from participating in the Program do not establish any rights between the Participant and the Employer, Edwards Mexico, and do not form part of the employment conditions and/or benefits provided by Edwards Mexico and any modification of the Program or its termination shall not constitute a change or impairment of the terms and conditions of his or her employment.
The Participant further understands that his or her participation in the Program is as a result of a unilateral and discretionary decision of the Company; therefore, the Company reserves the absolute right to amend and/or discontinue the Participant’s participation at any time without any liability to the Participant.
Finally, the Participant hereby declares that the Participant does not reserve any action or right to bring any claim against the Company for any compensation or damages regarding any provision of the Program or the benefits derived under the Program,


and the Participant therefore grants a full and broad release to the Company, its Subsidiaries, branches, representation offices, shareholders, officers, agents or legal representatives with respect to any claim that may arise.
Document Acknowledgment. By accepting the PRSU, the Participant acknowledges that he or she has received a copy of the Program, has reviewed the Program and the Agreement in their entirety and fully understands and accepts all provisions of the Program and the Agreement. In addition, by accepting the PRSU, the Participant acknowledges that he or she has read and specifically and expressly approves the terms and conditions in Section 16 of the Agreement (“Nature of Grant”), in which the following is clearly described and established: (i) participation in the Program does not constitute an acquired right; (ii) the Program and participation in the Program is offered by the Company on a wholly discretionary basis; (iii) participation in the Program is voluntary; and (iv) neither the Company, the Employer nor any Subsidiary is responsible for any decrease in the value of the Shares underlying the PRSU.
Reconocimiento de Ausencia de Relación Laboral y Declaración de la Política
Al aceptar el PRSU, usted expresamente recononce que la Compañía y sus oficinas registradas en One Edwards Way, Irvine, California 92614, U.S.A., es el único responsable de la administración del Program y que su participación en el mismo y la compra de Acciones no constituye de ninguna manera una relación laboral entre usted y la Compañía, toda vez que su participación en el Program deriva únicamente de una relación comercial con Edwards Lifesciences México S.A. de C.V. («Edwards México») y sus oficinas registradas en Av. Insurgentes Sur 1431 Piso 15 – Oficina 1502, Col. Insurgentes Mixcoac, Benito Juárez, Ciudad de México - C.P. 03920. Derivado de lo anterior, usted expresamente reconoce que el Program y los beneficios que pudieran derivar del mismo no establecen ningún derecho entre usted y su Empleador, Edwards México, y no forman parte de las condiciones laborales y/o prestaciones otorgadas por Edwards México, y expresamente usted reconoce que cualquier modificación al Program o la terminación del mismo de manera alguna podrá ser interpretada como una modificación de sus condiciones de trabajo.
Asimismo, usted entiende que su participación en el Program es el resultado de una decisión unilateral y discrecional de la Compañía, por lo tanto, la Compañía se reserva el derecho absoluto de modificar y/o terminar su participación en cualquier momento, sin ninguna responsabilidad hacia usted.
Finalmente, usted manifiesta que no se reserva ninguna acción o derecho que origine una demanda en contra de la Compañía, por cualquier compensación o daño en relación con cualquier disposición del Program o de los beneficios derivados del mismo, y en consecuencia usted otorga un amplio y total finiquito a la Compañía, sus afiliadas, sucursales, oficinas de representación, accionistas, directores, agentes y representantes legales con respecto a cualquier demanda que pudiera surgir.
Reconocimiento de Documentos. Al aceptar el PRSU, usted reconoce que ha recibido una copia del Program, que ha revisado el Program y el Acuerdo de Concesión en su totalidad y entiende y acepta los términos del Program y del Acuerdo de Concesión. Adicionalmente, al aceptar los PRSU, el Participante reconoce que ha leído y específica y expresamente aprueba los términos y condiciones del Sección 16 del Acuerdo de Concesión (denominado “Naturaleza de la Concesión”), donde claramente se establece que (i) la participación en el Program no constituye un derecho adquirido, (ii) el Program y la participación en el Program es ofrecido por la Compañía en forma totalmente discresional; (iii) la participación en el Program es voluntaria; y (iv) ni la Compañía ni el Patrón ni su Afiliada es responsable por el decremento en el valor de las acciones de los PRSU.
NETHERLANDS
There are no country-specific provisions.
NEW ZEALAND
Notifications
Securities Law Information. Warning: This is an offer of rights to receive Shares upon vesting and settlement of the PRSU subject to the terms of the Program and this Agreement. PRSUs give the Participant a stake in the ownership of the Company. The Participant may receive a return if dividends are paid on the Shares.
If the Company runs into financial difficulties and is wound up, the Participant will be paid only after all creditors and holders of preferred shares have been paid. The Participant may lose some or all of his or her investment.
New Zealand law normally requires people who offer financial products to give information to investors before they invest. This information is designed to help investors to make an informed decision.
The usual rules do not apply to this offer because it is made under an employee share purchase scheme. As a result, the Participant may not be given all the information usually required. The Participant will also have fewer other legal protections for this investment.
The Participant should ask questions, read all documents carefully, and seek independent financial advice before committing to participate in the Program.


The Company’s Shares are currently traded on the New York Stock Exchange under the ticker symbol “EW” and Shares acquired under the Program may be sold through this exchange. The Participant may end up selling the Shares at a price that is lower than the value of the Shares when the Participant acquired them. The price will depend on the demand for the Shares.
For information on risk factors impacting the Company’s business that may affect the value of the Shares, the Participant should refer to the risk factors discussion on the Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are filed with the U.S. Securities and Exchange Commission and are available online at www.sec.gov, as well as on the Company’s website at http://ir.edwards.com/investor-relations.
Foreign Asset and Account Reporting. Interests in foreign companies (including Shares acquired under the Plan) must be declared in the annual tax return. The Participant should consult with a personal tax advisor to ensure that he or she is properly complying with applicable reporting requirements in New Zealand.
NORWAY
There are no country-specific provisions.
POLAND
Notifications
Foreign Asset and Account Reporting. Polish residents holding foreign securities (including Shares) and/or maintaining accounts abroad must report information to the National Bank of Poland on transactions and balances of the securities and cash deposited in such accounts if the value of such transactions or balances (when combined with all other assets held abroad) exceeds PLN 7 million. If required, the reports are due on a quarterly basis by the 20th day following the end of each quarter. The reports are filed on special forms available on the website of the National Bank of Poland.
Exchange Control Information. If a Polish resident transfers funds in excess of a specified threshold (currently € 15,000, or PLN 15,000 if such transfer of funds is connected with business activity of an entrepreneur) into or out of Poland, the funds must be transferred via a Polish bank account or financial institution. Polish residents are required to retain the documents connected with a foreign exchange transaction for a period of five years measured from the end of the year in which the relevant transaction occurred.
PORTUGAL
Terms and Conditions
English Language Consent. The Participant hereby expressly declares that he or she has full knowledge of the English language and has read, understood and fully accepts and agrees with the terms and conditions established in the Program and the Agreement.
Consentimento de Lingua Inglesa.  O beneficiário pelo presente declara expressamente que tem pleno conhecimento da língua Inglesa e que leu, compreendeu e totalmente aceitou e concordou com os termos e condições estabelecidas no Plano e no Acordo.
PUERTO RICO
There are no country-specific provisions.
SINGAPORE
Notifications
Securities Law Notification. The PRSU was granted to the Participant pursuant to the “Qualifying Person” exemption under section 273(1)(f) of the Singapore Securities and Futures Act (Chapter 289, 2006 Ed.) (“SFA”). Neither the Agreement nor the Program have been lodged or registered as a prospectus with the Monetary Authority of Singapore. The Participant should note that his or her PRSU is subject to section 257 of the SFA and the Participant will not be able to make any subsequent sale of the Shares in Singapore, or any offer of such subsequent sale of the Shares underlying the PRSU unless such sale or offer in Singapore is made (i) after six months from the Date of Grant of the PRSU, or (ii) pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the SFA (Chapter 289, 2006 Ed.), or pursuant to, and in accordance with the conditions of, any other applicable provisions of the SFA.
Director Notification. If the Participant is a director, associate director or shadow director of a Singapore Subsidiary or other related company in Singapore, then the Participant is subject to certain notification requirements under the Singapore Companies Act. Among these requirements is an obligation to notify the Singapore Subsidiary in writing when the Participant receives an interest (e.g., PRSUs, Shares) in the Company or any related company. In addition, the Participant must notify the Singapore Subsidiary when the Participant sells Shares of the Company or any related company (including when the Participant


sells Shares acquired under the Program). These notifications must be made within two (2) business days of acquiring or disposing of any interest in the Company or any related company. In addition, a notification must be made of the Participant’s interests in the Company or any related company within two (2) business days of becoming a director.
SOUTH AFRICA
Terms and Conditions
Responsibility for Taxes. The following provision supplements Section 13 of the Agreement:
By accepting the PRSU, the Participant agrees that, immediately upon vesting and settlement of the PRSU, the Participant will notify the Employer of the amount of any gain realized. The Participant will be solely responsible for paying any difference between the actual tax liability and the amount withheld by the Employer.
Notifications
Securities Law Notification. The grant of the PRSU and the Shares issued pursuant to the vesting of the PRSU are considered a small offering under Section 96 of the South Africa Companies Act, 2008 (Act No. 71 of 2008).
Exchange Control Information. To participate in the Program, the Participant must comply with exchange control regulations and rulings in South Africa and neither the Company nor the Employer will be liable for any fines or penalties resulting from the Participant’s failure to comply with applicable laws. Because no transfer of funds from South Africa is required under the PRSU, no filing or reporting requirements should apply when the PRSU is granted or when Shares are issued upon vesting and settlement of the PRSU, nor should the PRSU or the underlying Shares count towards the annual offshore investment limit. However, because the exchange control regulations are subject to change, the Participant should consult the Participant’s personal advisor prior to vesting and settlement of the PRSU to ensure compliance with current regulations.
SPAIN
Terms and Conditions
Nature of Grant. The following provision supplements Section 16 of the Agreement:
By accepting the PRSU, the Participant consents to participation in the Program and acknowledge that the Participant has received a copy of the Program.
The Participant understands that the Company has unilaterally, gratuitously and in its sole discretion decided to grant PRSUs under the Program to individuals who may be employees of the Company or its Subsidiaries throughout the world. The decision is limited and entered into based upon the express assumption and condition that any PRSUs will not economically or otherwise bind the Company or any parent, Subsidiary or affiliate, including the Employer, on an ongoing basis, other than as expressly set forth in the Agreement. Consequently, the Participant understands that the PRSU is granted on the assumption and condition that the PRSU shall not become part of any employment contract (whether with the Company or any parent, Subsidiary or affiliate, including the Employer) and shall not be considered a mandatory benefit, salary for any purpose (including severance compensation) or any other right whatsoever. Furthermore, the Participant understands and freely accepts that there is no guarantee that any benefit whatsoever shall arise from the PRSU, which is gratuitous and discretionary, since the future value of the PRSU and the underlying Shares is unknown and unpredictable. The Participant also understands that this grant of PRSUs would not be made but for the assumptions and conditions set forth hereinabove; thus, the Participant understands, acknowledges and freely accepts that, should any or all of the assumptions be mistaken or any of the conditions not be met for any reason, then the grant of this PRSU shall be null and void.
Further, this PRSU is a conditional right to Shares and can be forfeited in the case of, or affected by, the Participant’s termination of employment. This will be the case, for example, even if (1) the Participant is considered to be unfairly dismissed without good cause (i.e., subject to a “despido improcedente”); (2) the Participant is dismissed for disciplinary or objective reasons or due to a collective dismissal; (3) the Participant terminates employment due to a change of work location, duties or any other employment or contractual condition; (4) the Participant terminates employment due to unilateral breach of contract of the Company or any of its Subsidiaries; or (5) the Participant’s employment terminates for any other reason whatsoever, except for Cause. Consequently, upon termination of the Participant’s employment for any of the reasons set forth above, the Participant may automatically lose any rights to the unvested PRSU granted to the Participant as of the date of his or her termination of employment, as described in the Program and the Agreement.
Notifications
Foreign Asset and Account Reporting. To the extent that Spanish residents hold assets (e.g., Shares, cash, etc.) in a bank or brokerage account outside of Spain with a value in excess of €50,000 per type of asset as of December 31 each year, such residents are required to report information on such assets on their tax return for such year. Shares constitute securities for purposes of this requirement, but unvested rights (e.g., PRSUs) are not considered assets for purposes of this requirement.


If applicable, Spanish residents must report the assets on Form 720 by no later than March 31 following the end of the relevant year. After such assets are initially reported, the reporting obligation will only apply for subsequent years if the value of any previously-reported assets increases by more than €20,000. Failure to comply with this reporting requirement may result in penalties.
Exchange Control Information. The Participant must declare the acquisition of Shares to the Dirección General de Política Comercial e Inversiones (“DGCI”) of the Ministry of Economy and Competitiveness for statistical purposes. Generally, the declaration must be made by filing a D-6 form each January for Shares acquired or sold during (or owned by the Participant as of December 31) of the prior year; however, if the value of Shares acquired or sold exceeds €1,502,530, the declaration must also be filed within one month of the acquisition or sale, as applicable.
Spanish residents are also required to electronically declare to the Bank of Spain any securities accounts (including brokerage accounts) held abroad, any foreign instruments (including Shares), and any transactions with non-Spanish residents (including any payments of Shares made by the Company) if the value of the transactions during the relevant year or the balances in such accounts and the value of such instruments as of December 31 of the relevant year exceed €1,000,000. Spanish residents should consult with their personal tax and legal advisors to ensure compliance with their personal reporting obligations.
Securities Law Notification. The grant of the PRSU and the Shares issued pursuant to the vesting of the PRSU are considered a private placement outside of the scope of Spanish laws on public offerings and issuances of securities.
SWEDEN
Terms and Conditions
Responsibility for Taxes. The following provision supplements Section 13 of the Agreement:
Without limiting the Company’s and the Employer’s authority to satisfy their withholding obligations for Tax-Related Items as set forth in Section 13 of the Agreement, in accepting the grant of the PRSU, the Participant authorizes the Company and/or the Employer to sell or withhold Shares otherwise deliverable to the Participant upon vesting to satisfy Tax-Related Items, regardless of whether the Company and/or the Employer have an obligation to withhold such Tax-Related Items.
SWITZERLAND
Notifications
Securities Law Notification. Neither this document nor any other materials relating to the PRSU (1) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services (“FinSA”), (2) may be publicly distributed nor otherwise made available in Switzerland to any person other than an employee of the Company, or (3) have been or will be filed with, approved or supervised by any Swiss reviewing body according to article 51 of FinSA or any Swiss Regulatory Authority, including the Swiss Financial Market Supervisory Authority (FINMA).
TAIWAN
Notifications
Securities Law Notification. The offer of participation in the Program is made only to employees of the Company and its Subsidiaries. The offer of participation in the Program is not a public offer of securities by a Taiwanese company.
Exchange Control Information. The Participant may remit foreign currency in relation to Shares into Taiwan through an authorized foreign exchange bank in an amount up to US$5,000,000 per year. However, if the transaction amount is TWD$500,000 or more in a single transaction, the Participant must submit a foreign exchange transaction form and also provide supporting documentation to the satisfaction of the remitting bank. The Participant should consult his or her personal advisor to ensure compliance with applicable exchange control laws in Taiwan.
THAILAND
Notifications
Exchange Control Information. If the Participant receives funds in connection with the Program (e.g., dividends or sale proceeds) with a value equal to or greater than US$1,000,000 per transaction, the Participant is required to immediately repatriate such funds to Thailand. Any foreign currency repatriated to Thailand must be converted to Thai Baht or deposited into a foreign currency deposit account opened with any commercial bank in Thailand acting as the authorized agent within 360 days from the date the funds are repatriated to Thailand. The Participant is also required to inform the authorized agent of the details of the foreign currency transaction, including his or her identification information and the purpose of the transaction.
If the Participant does not comply with the above obligations, he or she may be subject to penalties by the Bank of Thailand. Because exchange control regulations change frequently and without notice, the Participant should consult with his or her legal


advisor before selling any Shares (or receiving any other funds in connection with the Program) to ensure compliance with current regulations. It is the Participant’s responsibility to comply with exchange control laws in Thailand, and neither the Company nor the Employer will be liable for any fines or penalties resulting from failure to comply with applicable laws.
TURKEY
Notifications
Securities Law Information. Turkish residents are not permitted to sell Shares acquired under the Program in Turkey. The Shares are currently traded on the New York Stock Exchange, which is located outside of Turkey, under the ticker symbol “EW” and the Shares may be sold through this exchange.
Exchange Control Information. In certain circumstances, Turkish residents are permitted to sell shares traded on a non-Turkish stock exchange only through a financial intermediary licensed in Turkey. Therefore, Turkish residents may be required to appoint a Turkish broker to assist with the sale of the Shares acquired under the Program. Turkish residents should consult their personal legal advisor before selling any Shares acquired under the Program to confirm the applicability of this requirement.
UNITED ARAB EMIRATES
Notifications
Securities Law Information. Participation in the Program is being offered only to eligible Employees and Contractors and is in the nature of providing equity incentives to Employees and Contractors in the United Arab Emirates. The Program and the Agreement are intended for distribution only to such persons and must not be delivered to, or relied on by, any other person. Prospective acquirers of the securities offered should conduct their own due diligence on the securities. The Emirates Securities and Commodities Authority has no responsibility for reviewing or verifying any documents in connection with the Program. Neither the Ministry of Economy nor the Dubai Department of Economic Development: (i) have approved the Program or the Agreement; (ii) have taken steps to verify the information set out therein; and (iii) have any responsibility for such documents.
UNITED KINGDOM
Terms and Conditions
Responsibility for Taxes. The following supplements Section 13 of the Agreement:
Without limitation to Section 13 of the Agreement, the Participant agrees to be liable for any Tax-Related Items related to his or her participation in the Program and legally applicable to the Participant and hereby covenants to pay any such Tax-Related Items, as and when requested by the Company or, if different, the Employer or by Her Majesty’s Revenue & Customs (“HMRC”) (or any other tax authority or any other relevant authority). The Participant also agrees to indemnify and keep indemnified the Company and, if different, the Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC (or any other tax authority or any other relevant authority) on the Participant’s behalf.
Notwithstanding the foregoing, if the Participant is a director or executive officer of the Company (as within the meaning of Section 13(k) of the Exchange Act), the amount of any uncollected income tax not collected within ninety (90) days of the end of the U.K. tax year may constitute a benefit to the Participant on which additional income tax and National Insurance contributions (“NICs”) may be payable. The Participant understands that he or she will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for reimbursing the Company and/or Employer for the value of any NICs due on this additional benefit, which may be recovered from the Participant by the Company or the Employer by any of the means referred to in Section 13 of the Agreement.



 EX-10.15 6 ex-101510xkq42021.htm EX-10.15 Document

Exhibit 10.15

2020 Nonemployee Directors Stock Incentive Program
Edwards Lifesciences Corporation

(as amended and restated November 18, 2021)
























Table of Contents
Article 1.Establishment, Objectives, and Duration
Article 2.Definitions
Article 3.Administration
Article 4.Eligibility and Participation
Article 5.Shares Subject to the Program
Article 6.Stock Options
Article 7.Stock Issuances
Article 8.Restricted Stock
Article 9.Restricted Stock Units
Article 10.Stock Appreciation Rights
Article 11.Automatic Awards to Nonemployee Directors
Article 12.Beneficiary Designation
Article 13.Deferrals
Article 14.Rights of Participants
Article 15.Change in Control
Article 16.Amendment, Modification, and Termination
Article 17.Compliance with Applicable Law and Withholding
Article 18.Indemnification
Article 19.Successors
Article 20.Legal Construction






Edwards Lifesciences Corporation

2020 Nonemployee Directors Stock Incentive Program
(Amended and Restated as of November 18, 2021)1

Article 1.Establishment, Objectives, and Duration
1.1.Establishment of the Program. Edwards Lifesciences Corporation, a Delaware corporation (hereinafter referred to as the “Company”), hereby adopts the 2020 Nonemployee Directors Stock Incentive Program (hereinafter referred to as the “Program”), as set forth in this document, effective as of February 20, 2020 (the “Effective Date”). The Program permits the grant of Nonqualified Stock Options, Stock Issuances, Restricted Stock, Restricted Stock Units and Stock Appreciation Rights.
1.2.Objectives of the Program. The objectives of the Program are to optimize the profitability and growth of the Company through long-term incentives which are consistent with the Company’s goals and which link the personal interests of Participants to those of the Company’s stockholders. The Program is further intended to provide flexibility to the Company in its ability to motivate, attract, and retain the services of Participants who make significant contributions to the Company’s success and to allow Participants to share in the success of the Company.
1.3.Duration of the Program. The Program shall commence on the Effective Date, as described in Section 1.1 hereof, and shall remain in effect, subject to the right of the Board to amend or terminate the Program at any time pursuant to Article 16 hereof, until all Shares subject to it shall have been purchased or acquired according to the Program’s provisions.
Article 2.Definitions
Whenever used in the Program, the following terms shall have the meanings set forth below, and when the meaning is intended, the initial letter of the word shall be capitalized:
2.1     “Annual Retainer” means the fixed annual fee of a Nonemployee Director in effect on the first day of the year in which such Annual Retainer is payable for services to be rendered as a Nonemployee Director of the Company. The Annual Retainer does not include meeting or chairmanship fees.
2.2     “Award” means, individually or collectively, a grant under this Program of Nonqualified Stock Options, Stock Issuances, Restricted Stock, Restricted Stock Units, or Stock Appreciation Rights.
2.3     “Award Agreement” means an agreement entered into by the Company and each Participant setting forth the terms and provisions applicable to Awards granted under this Program.
2.4     “Board” or “Board of Directors” means the Board of Directors of the Company.
2.5     “Change in Control” of the Company shall mean the occurrence of any one of the following events:
(a)Any “Person”, as such term is used in Sections 13(d) and 14(d) of the Exchange Act (other than the Company, any corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company, and any trustee or other fiduciary holding securities under an employee benefit plan of the Company or such proportionately owned corporation), is or becomes the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of
1 Share limits reflect stock splits and stock dividends through June 2020.
1

securities of the Company representing thirty percent (30%) or more of the combined voting power of the Company’s then outstanding securities; or
(b)During any period of not more than twenty-four (24) months, individuals who at the beginning of such period constitute the Board of Directors of the Company, and any new director (other than a director designated by a Person who has entered into an agreement with the Company to effect a transaction described in Sections 2.5(a), 2.5(c), or 2.5(d) of this Section 2.5) whose election by the Board or nomination for election by the Company’s stockholders was approved by a vote of at least two-thirds (2/3) of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority thereof; or
(c)The consummation of a merger or consolidation of the Company with any other entity, other than: (i) a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than sixty percent (60%) of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation; or (ii) a merger or consolidation effected to implement a recapitalization of the Company (or similar transaction) in which no Person acquires more than thirty percent (30%) of the combined voting power of the Company’s then outstanding securities; or
(d)The Company’s stockholders approve a plan of complete liquidation or dissolution of the Company, or an agreement for the sale or disposition by the Company of all or substantially all of the Company’s assets (or any transaction having a similar effect.
2.6     “Code” means the Internal Revenue Code of 1986, as amended from time to time.
2.7     “Committee” means the Compensation and Governance Committee and any successor thereto or any other committee appointed by the Board to administer Awards to Participants, as specified in Article 3 herein. To the extent the Board determines it will administer this Program, references to the Committee shall mean the Board.
2.8     “Company” means Edwards Lifesciences Corporation, a Delaware corporation, and any successor thereto as provided in Article 19 herein.
2.9     “Disability” means the inability of the Participant to attend any meetings of the Board or a Committee thereof for a period of twenty-six (26) weeks by reason of a medically determinable physical or mental impairment or the resignation or replacement of the Participant as a member of the Board by reason of such impairment.
2.10     “Effective Date” shall have the meaning ascribed to such term in Section 1.1 hereof.
2.11     “Employee” means an employee of the Company or of a Subsidiary of the Company.
2.12     “Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time, or any successor act thereto.
2.13     “Fair Market Value” means the closing price of a Share on the New York Stock Exchange (or the principal exchange on which the Shares are then traded, if not the New York Stock Exchange) on the date as of which such value is being determined or, if there shall be no reported transactions in the Shares on such exchange for such date, on the next preceding date for which such transactions were reported on such exchange.
2.14     “Nonemployee Director” means a member of the Company’s Board who is not an Employee of the Company.
2

2.15     “Nonqualified Stock Option” or “Option” means an option to purchase Shares granted under Article 6 or Article 11 herein and which is not intended to meet the requirements of Code Section 422.
2.16     “Option Price” means the price at which a Share may be purchased by a Participant pursuant to an Option.
2.17     “Participant” means a Nonemployee Director who has been selected to receive an Award or who has outstanding an Award granted under the Program.
2.18     “Period of Restriction” means the period during which the transfer of Shares of Restricted Stock is limited in some way (based on the passage of time, the achievement of performance goals, or upon the occurrence of other events as determined by the Committee, in its discretion), and the Shares are subject to a substantial risk of forfeiture, as provided in Article 8 herein.
2.19     “Restricted Stock” means an Award granted to a Participant pursuant to Article 8 herein.
2.20     “Restricted Stock Unit” means an Award granted to a Participant pursuant to Article 9 herein.
2.21     “Shares” means the shares of common stock of the Company.
2.22     “Stock Appreciation Right” means an Award granted to a Participant pursuant to Article 10 herein.
2.23     “Stock Issuance” means an Award granted to a Participant pursuant to Article 7 herein.
2.24     “Subsidiary” means any business, whether or not incorporated, in which the Company beneficially owns, directly or indirectly through another entity or entities, securities or interests representing more than fifty percent (50%) of the combined voting power of the voting securities or voting interests of such business.
Article 3.Administration
3.1     General. The Program shall be administered by the Compensation and Governance Committee of the Board, or by any other Committee appointed by the Board for such purpose (or the Board itself if the Board elects to administer this Program). Any Committee administering the Program shall be comprised entirely of directors. The members of the Committee shall be appointed in accordance with the bylaws of the Company and the charter of such Committee. Members of the Committee may participate in the Program. The Committee shall have the authority to delegate administrative duties to officers, Employees, or directors of the Company; provided that the Committee shall not be able to delegate its authority with respect to granting Awards.
3.2     Authority of the Committee. Except as limited by law or by the Certificate of Incorporation or Bylaws of the Company, and subject to the provisions of the Program, the Committee shall have the authority to: (a) interpret the provisions of the Program, and prescribe, amend, and rescind rules and procedures relating to the Program; (b) grant Awards under the Program, in such forms and amounts and subject to such terms and conditions as it deems appropriate, including, without limitation, Awards which are made in combination with or in tandem with other Awards (whether or not contemporaneously granted) or compensation or in lieu of current or deferred compensation; (c) subject to Article 16, modify the terms of, cancel and reissue, or repurchase outstanding Awards; (d) prescribe the form of agreement, certificate or other instrument evidencing any Award under the Program; (e) correct any defect or omission and reconcile any inconsistency in the Program or in any Award hereunder; (f) design Awards to satisfy requirements to make such Awards tax-advantaged to Participants in any jurisdiction or for any other reason that the Company desires; and (g) make all other determinations and take all other actions as it deems necessary or desirable for the administration of the Program; provided, however, that no outstanding Option will be (i) amended to lower the exercise
3

price, (ii) canceled, exchanged or surrendered in exchange for cash or other awards for the purpose of repricing the Option, or (iii) canceled, exchanged or surrendered for the purpose of reissuing such Option to a Participant at a lower exercise price (other than, in each case, pursuant to Section 5.4) without the approval of the Company’s stockholders. The determination of the Committee on matters within its authority shall be conclusive and binding on the Company and all other persons. The Committee shall comply with all applicable laws in administering the Program. If and to the extent permitted by law (and subject to Section 3.1 herein), the Committee may delegate its authority as identified herein.
3.3     Decisions Binding. All determinations and decisions made by the Committee pursuant to the provisions of the Program and all related orders and resolutions of the Board shall be final, conclusive and binding on all persons, including the Company, its stockholders, directors, Participants, and their estates and beneficiaries.
Article 4.Eligibility and Participation
4.1     Eligibility. Persons eligible to participate in this Program shall be all Nonemployee Directors.
4.2     Actual Participation. Subject to the provisions of the Program, the Committee may, from time to time, select from all eligible Nonemployee Directors those to whom Awards shall be granted and shall determine the nature and amount of each Award.
Article 5.Shares Subject to the Program
5.1     Number of Shares Available for Grants. Subject to adjustment as provided in Section 5.4 herein, the number of Shares hereby reserved for delivery to Participants under the Program shall be Eight Million Four Hundred Thousand (8,400,000) Shares. Subject to the restrictions for Nonemployee Directors set forth in Article 11, the Committee shall determine the appropriate methodology for calculating the number of Shares issued pursuant to the Program.
5.2     Type of Shares. Shares issued under the Program in connection with Awards may be authorized and unissued Shares or issued Shares held as treasury Shares.
5.3     Reuse of Shares.
(a)General. In the event of the expiration or termination (by reason of forfeiture, expiration, cancellation, surrender, failure to vest or otherwise) of any Award under the Program, that number of Shares that was subject to the Award but not delivered shall again be available for subsequent Awards under the Program.
(b)Restricted Stock. In the event that Shares are delivered under the Program as Restricted Stock and are thereafter forfeited or reacquired by the Company pursuant to rights reserved upon the grant thereof, such forfeited or reacquired Shares shall again be available as Awards under the Program.
(c)Stock Appreciation Rights. Upon exercise of any Stock Appreciation Right, the Share reserve under Section 5.1 shall be reduced by the gross number of Shares as to which such Stock Appreciation Right is exercised.
5.4     Adjustments in Authorized Shares. In the event of any change in corporate capitalization, such as a stock split, or a corporate transaction, such as any merger, consolidation, separation, including a spin-off, or other distribution of stock or property of the Company, any reorganization (whether or not such reorganization comes within the definition of such term in Code Section 368) or any partial or complete liquidation of the Company, such adjustment shall be made in the number and class of Shares which may be delivered under Section 5.1, in the number and class of and/or price of Shares subject to outstanding Awards granted under the Program and in the number and/or class of Shares subject to Awards to be granted to Nonemployee Directors under Article 11
4

(including the applicable limits set forth in Article 11), as shall be determined to be appropriate and equitable by the Committee, in its sole discretion, to prevent dilution or enlargement of rights; provided, however, that the number of Shares subject to any Award shall always be a whole number. In a stock-for-stock acquisition of the Company, the Committee may, in its sole discretion, substitute securities of another issuer for any Shares subject to outstanding Awards.
Article 6.Stock Options
6.1     Grant of Options.
(a)Subject to the terms and provisions of the Program, Options may be granted to Participants in such number, and upon such terms, and at any time and from time to time as shall be determined by the Committee.
(b)All Options under the Program shall be granted in the form of nonqualified stock options as no Option under the Program may be granted in the form of an incentive stock option as defined under the provisions of Code Section 422.
6.2     Award Agreement. Each Option grant shall be evidenced by an Award Agreement that shall specify the Option Price, the duration of the Option, the number of Shares to which the Option pertains, and such other provisions as the Committee shall determine.
6.3     Option Price. The Option Price for each grant of an Option under this Program shall be at least equal to one hundred percent (100%) of the Fair Market Value of a Share on the date the Option is granted.
6.4     Duration of Options. Unless the Committee determines otherwise, the term of each Option shall expire on the seventh (7th) anniversary date of its grant, subject to such provisions for earlier expiration as the Committee may specify in accordance with Section 6.8 (relating to termination of directorship) or otherwise.
6.5     Exercise of Options. Options granted under this Article 6 shall be exercisable at such times and be subject to such restrictions and conditions as the Committee shall in each instance approve, which need not be the same for each grant or for each Participant.
6.6     Payment. Options granted under this Article 6 shall be exercised by the delivery of a written notice of exercise (or such other form of notice as the Company may specify) to the Company, setting forth the number of Shares with respect to which the Option is to be exercised, or compliance with such procedures as the Company may establish for notifying the Company, either directly or through an on-line internet transaction with a brokerage firm authorized by the Company to effect such option exercise, of the exercise of the Option for one or more Shares. Exercise of an Option must be accompanied by full payment for the Shares for which the Option is exercised (or a satisfactory “cashless exercise” notice).
The Option Price upon exercise of any Option shall be payable to the Company in full either: (a) in cash or its equivalent; (b) by tendering previously acquired Shares (by either actual delivery or attestation) having an aggregate Fair Market Value at the time of exercise equal to the total Option Price; (c) by a cashless exercise as permitted under Federal Reserve Board’s Regulation T, subject to applicable securities law restrictions and such procedures and limitations as the Company may specify from time to time; (d) by any other means which the Committee determines to be consistent with the Program’s purpose and applicable law; or (e) by a combination of two or more of (a) through (d).
Subject to any governing rules or regulations, including cashless exercise procedures, as soon as practicable after receipt of a notification of exercise and full payment (or a satisfactory “cashless exercise” notice), the Company shall cause to be issued and delivered to the Participant, in certificate form or otherwise, evidence of the Shares purchased under the Option(s).
5

6.7     Restrictions on Share Transferability. The Committee may impose such restrictions on any Shares acquired pursuant to the exercise of an Option granted under this Article 6 as it may deem advisable, including, without limitation, restrictions under applicable federal securities laws, under the requirements of any stock exchange or market upon which such Shares are then listed and/or traded, and under any blue sky or state securities laws applicable to such Shares.
6.8     Termination of Directorship. Each Participant’s Option Award Agreement shall set forth the extent to which the Participant shall have the right to exercise the Option following termination of the Participant’s service to the Company as a Nonemployee Director. Such provisions shall be determined in the sole discretion of the Committee, shall be included in the Award Agreement entered into with each Participant, need not be uniform among all Options issued pursuant to this Article 6, and may reflect distinctions based on the reasons for termination.
6.9     Nontransferability of Options. Except as otherwise provided in a Participant’s Award Agreement, no Option granted under this Article 6 may be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution. Further, except as otherwise provided in a Participant’s Award Agreement, all Options granted to a Participant under this Article 6 shall be exercisable during his or her lifetime only by such Participant.
6.10     Substitution of Cash. Unless otherwise provided in a Participant’s Award Agreement, and notwithstanding any provision in the Program to the contrary (including but not limited to Section 16.2), in the event of a Change in Control in which the Company’s stockholders holding Shares receive consideration other than shares of common stock that are registered under Section 12 of the Exchange Act, the Committee shall have the authority to require that any outstanding Option be surrendered to the Company by a Participant for cancellation by the Company, with the Participant receiving in exchange a cash payment from the Company within ten (10) days of the Change in Control. Such cash payment shall be equal to the number of Shares under Option, multiplied by the excess, if any, of the fair market value of a Share on the date the Change in Control occurs, over the Option Price.
Article 7.Stock Issuances
7.1     Stock Issuance Awards. Subject to the terms and provisions of the Program, the Committee may issue Shares as fully vested shares (“Stock Issuances”) in such number and upon such terms as shall be determined by the Committee.
7.2     Consideration. A Stock Issuance may be awarded in consideration for cash, past services rendered to the Company or an affiliate or for such other consideration as determined by the Committee.
Article 8.Restricted Stock
8.1     Grant of Restricted Stock. Subject to the terms and provisions of the Program, the Committee, at any time and from time to time, may grant Shares of Restricted Stock to Participants in such amounts as the Committee shall determine.
8.2     Restricted Stock Agreement. Each Restricted Stock grant shall be evidenced by a Restricted Stock Award Agreement that shall specify the Period(s) of Restriction, the number of Shares of Restricted Stock granted, and such other provisions as the Committee shall determine.
8.3     Restriction on Transferability. Except as provided in this Article 8, the Shares of Restricted Stock granted herein may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated until the end of the applicable Period of Restriction established by the Committee and specified in the Restricted Stock Award Agreement, or upon earlier satisfaction of any other conditions, as specified by the Committee in its sole discretion and set forth in the Restricted Stock Award Agreement. All rights with respect
6

to the Restricted Stock granted to a Participant under the Program shall be available during his or her lifetime only to such Participant.
8.4     Other Restrictions. The Committee shall impose such other conditions and/or restrictions on any Shares of Restricted Stock granted pursuant to the Program as it may deem advisable including, without limitation, any or all of the following:
(a)A required period of service with the Company, as determined by the Committee, prior to the vesting of Shares of Restricted Stock.
(b)A requirement that Participants forfeit (or in the case of Shares sold to a Participant, resell to the Company at his or her cost) all or a part of Shares of Restricted Stock in the event of termination of his or her service as a Nonemployee Director during the Period of Restriction.
(c)A prohibition against such Participants’ dissemination of any secret or confidential information belonging to the Company, or the solicitation by Participants of the Company’s Employees for employment by another entity.
Shares of Restricted Stock awarded pursuant to the Program shall be registered in the name of the Participant and if such Shares are certificated, in the sole discretion of the Committee, such certificate may be deposited in a bank designated by the Committee or with the Company. The Committee may require a stock power endorsed in blank with respect to Shares of Restricted Stock whether or not certificated.
Except as otherwise provided in this Article 8, Shares of Restricted Stock covered by each Restricted Stock grant made under the Program shall become freely transferable (subject to any restrictions under any applicable securities law) by the Participant after the last day of the applicable Period of Restriction.
8.5     Voting Rights. Unless the Committee determines otherwise, Participants holding Shares of Restricted Stock issued hereunder shall be entitled to exercise full voting rights with respect to those Shares during the Period of Restriction.
8.6     Dividends and Other Distributions. Unless the Committee determines otherwise, during the Period of Restriction, Participants holding Shares of Restricted Stock issued hereunder shall be entitled to regular cash dividends paid with respect to such Shares. The Committee may apply any restrictions to the dividends that the Committee deems appropriate.
8.7     Termination of Directorship. Each Restricted Stock Award Agreement shall set forth the extent to which the Participant shall have the right to vest in previously unvested Shares of Restricted Stock following termination of the Participant’s service to the Company as a Nonemployee Director. Such provisions shall be determined in the sole discretion of the Committee, shall be included in the Award Agreement entered into with each Participant, need not be uniform among all Shares of Restricted Stock issued pursuant to the Program, and may reflect distinctions based on the reasons for termination.
Article 9.Restricted Stock Units
9.1     Restricted Stock Units Awards. Subject to the terms and conditions of the Program, the Committee may, at any time and from time to time, issue Restricted Stock Units which entitle the Participant to receive the Shares underlying those units following the lapse of specified restrictions (whether based on the achievement of designated performance goals or the satisfaction of specified services or upon the expiration of a designated time period following the vesting of the units).
9.2     Restricted Stock Units Award Agreement. Each Restricted Stock Units award shall be evidenced by a Restricted Stock Units Award Agreement that shall specify the vesting restrictions, the number of Shares subject to the Restricted Stock Units award, and such other provisions as the Committee shall determine.
7

9.3     Restrictions. The Committee shall impose such other conditions and/or restrictions on the issuance of any Shares under the Restricted Stock Units granted pursuant to the Program as it may deem advisable including, without limitation, any or all of the following:
(a)A required period of service with the Company, as determined by the Committee, prior to the issuance of Shares under the Restricted Stock Units award.
(b)A requirement that the Restricted Stock Units award be forfeited in whole or in part in the event of termination of the Participant’s services as a Nonemployee Director during the vesting period.
(c)A prohibition against such Participants’ dissemination of any secret or confidential information belonging to the Company, or the solicitation by Participants of the Company’s Employees for employment by another entity.
Except as otherwise provided in this Article 9, Shares subject to Restricted Stock Units under the Program shall be freely transferable (subject to any restrictions under applicable securities law) by the Participant after receipt of such shares.
9.4     Stockholder Rights. Participants holding Restricted Stock Units issued hereunder shall not have any rights with respect to Shares subject to the award until the award vests and the Shares are issued hereunder. However, dividend-equivalent units may be paid or credited, either in cash or in actual or phantom Shares, on outstanding Restricted Stock Units awards, subject to such terms and conditions as the Committee may deem appropriate.
9.5     Termination of Directorship. Each Restricted Stock Units Award Agreement shall set forth the extent to which the Participant shall have the right to vest in previously unvested Shares subject to the Restricted Stock Units award following termination of the Participant’s service to the Company as a Nonemployee Director. Such provisions shall be determined in the sole discretion of the Committee, shall be included in the Award Agreement entered into with each Participant, need not be uniform among all Restricted Stock Unit awards issued pursuant to the Program, and may reflect distinctions based on the reasons for termination.
Article 10.Stock Appreciation Rights
10.1     Stock Appreciation Rights Awards. Subject to the terms and conditions of the Program, the Committee may issue a Stock Appreciation Rights award which shall entitle the Participant to receive upon exercise a payment in cash or Shares underlying the exercised award equal to the excess (if any) of (a) the Fair Market Value of the Shares on the date of exercise over (b) the aggregate base price in effect for such Shares. A Stock Appreciation Right shall become exercisable during such times and subject to such conditions as shall be determined by the Committee, in its sole discretion.
10.2     Stock Appreciation Rights Agreement. Each Stock Appreciation Rights award shall be evidenced by a Stock Appreciation Rights Award Agreement that shall specify the vesting restriction, the number of Shares subject to the award and such additional terms and conditions as the Committee shall determine.
10.3     Base Price. The base price for each grant of a Stock Appreciation Right under this Program shall be at least equal to one hundred percent (100%) of the Fair Market Value of a Share on the date the award is granted.
10.4     Nontransferability of Stock Appreciation Rights. Except as otherwise provided in a Participant’s Award Agreement, no Stock Appreciation Right granted under this Article 10 may be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution. Further, except as otherwise provided in a Participant’s Award Agreement, all Stock Appreciation Rights granted to a
8

Participant under this Article 10 shall be exercisable during his or her lifetime only by such Participant.
Article 11.Automatic Awards to Nonemployee Directors
11.1     [Intentionally Omitted.]
11.2     Annual Awards.
(a)Unless otherwise determined by the Committee, each Nonemployee Director shall receive annually, effective as of the day following each annual meeting of the Company’s stockholders an award as follows (the “Annual Award”):
(i)An Option for up to one hundred twenty thousand (120,000) Shares, or
(ii)A Restricted Stock Units award for up to forty eight thousand (48,000) Shares, or
(iii)A combination of an Option and Restricted Stock Units award, provided that in no event may the total value of the Option and Restricted Stock Units award subject to such combined award exceed eighty thousand dollars ($80,000). The Committee shall have the sole discretion to determine the amount and type of award for each year and to change the maximum grant date value set forth in the preceding sentence from year to year if it determines that a change is advisable; provided, however, that in the event of a combined Annual Award to a Nonemployee Director for a particular year in no event shall the total number of shares subject to the Option component of such award for the Nonemployee Director for that year exceed the limit in clause (i) above and in no event shall the total number of shares subject to the Restricted Stock Units component of such award for the Nonemployee Director for that year exceed the limit in clause (ii) above. For such purposes, the value of the Annual Award shall be calculated as follows: (A) the value of an Option shall be equal to the fair value of an option share as estimated on the date of grant under a valuation model approved by Financial Accounting Standards Board (“FASB”) for purposes of the Company’s financial statements under Financial Accounting Standards Board Accounting Standards Codification Topic 718 (or any successor provision); and (B) the value of a Restricted Stock Unit shall be equal to the Fair Market Value of the Share on the award date.
(b)Each Annual Award shall vest upon the first to occur of (i) the Participant’s completion of one (1) year of Board service measured from the award date or (ii) the next annual meeting of the Company’s stockholders that occurs after the calendar year in which the Annual Award is granted (or such longer period as determined by the Committee). Each Annual Award shall become fully vested in the event of the Participant’s death or Disability.
(c)Notwithstanding any other provision of the Program to the contrary and unless both of the Company’s nonemployee director stock ownership guidelines and holding requirements are met, each as set forth in the Corporate Governance Guidelines of the Company, the Shares acquired under an Annual Award (net of any Shares sold to cover the exercise price and applicable taxes due in connection with the exercise or settlement of the award) may not be sold, transferred or otherwise disposed of prior to the Participant’s cessation of Board service.
(d)All additional terms of an Annual Award will be as set forth in Articles 6 and 9, as applicable, or as set forth in the specific Award Agreement governing such award.
9

11.3     Annual Retainer Election.
(a)Subject to the terms and provisions of the Program and any other restrictions set out by the Committee in its sole discretion, the Committee may permit each Nonemployee Director to elect to receive all or a portion of his or her Annual Retainer in the form of Options or Restricted Stock to be issued as of the first day on which such Annual Retainer is otherwise due and payable (the “Conversion Date”) and using the Fair Market Value of a Share as of the Conversion Date as the Option Price of the Options.
(b)If conversion elections are permitted by the Committee, each irrevocable election shall be made in accordance with such rules as the Committee may determine in its sole discretion which shall be consistent with the requirements of Code Section 409A and the Treasury Regulations and rulings promulgated thereunder. Except as may otherwise be determined by the Committee, in the event of a Participant’s election to receive an Option in lieu of his Annual Retainer, the number of shares subject to the Option shall be determined by dividing that portion of the Annual Retainer to be paid in the form of the Option by the Fair Market Value of a Share on the Conversion Date and multiplying the quotient by four (4). In the event of a Participant’s election to receive Restricted Stock in lieu of an Annual Retainer, the number of Shares of such Restricted Stock shall be determined by dividing that portion of the Annual Retainer to be paid in the form of Shares of Restricted Stock by the Fair Market Value of a Share on the Conversion Date. In the event the preceding formula would result in a fractional Share being issued or subject to an Option, the number of Shares subject to the issuance or Option shall be rounded up to the nearest whole Share.
(c)Restricted Stock granted pursuant to this Section 11.3 shall vest upon the first to occur of (i) the Participant’s completion of one (1) year of Board service measured from the grant date or (ii) the next annual meeting of the Company’s stockholders at which Board members are to be elected. Each Annual Award shall become fully vested in the event of the Participant’s death or Disability.
(d)Any portion of a Nonemployee Director’s Annual Retainer for which an election has not been made pursuant to this Section 11.3, shall be paid in cash to such Nonemployee Director at such time or times as payments thereof are customarily made by the Company.
(e)All additional terms of an Award received as a result of the election described herein will be as set-forth in Sections 6 and 7, as applicable, or as set forth in the specific Award Agreement governing such Award.
Article 12.Beneficiary Designation
Each Participant under the Program may, from time to time, name any beneficiary or beneficiaries (who may be named contingently or successively) to whom any benefit under the Program is to be paid in case of his or her death before he or she receives any or all of such benefit. Each such designation shall revoke all prior designations by the same Participant, shall be in a form prescribed by the Company, and will be effective only when filed by the Participant in writing with the Company during the Participant’s lifetime. In the absence of any such designation, benefits remaining unpaid at the Participant’s death shall be paid to the Participant’s estate.
Article 13 Deferrals
The Committee may permit or require a Participant to defer such Participant’s receipt of the payment of cash or the delivery of Shares that would otherwise be due to such Participant by virtue of the exercise of an Option, or Stock Appreciation Right or the lapse or waiver of restrictions with respect to Restricted Stock or Restricted Stock Units. If any such deferral election is required or permitted, the Committee shall, in its sole discretion, establish rules and procedures for such payment deferrals which shall be consistent with the requirements of Code Section 409A and the Treasury Regulations and rulings promulgated thereunder.
10

Article 14     Rights of Participants
14.1     Directorship. Nothing in the Program or any Award Agreement shall interfere with or limit in any way the right of the Company to terminate at any time any Participant’s service to the Company as a Nonemployee Director, nor confer upon any Participant any right to continue in the service of the Company.

14.2     Participation. No Nonemployee Director shall have the right to be selected to receive an Award under this Program, or, having been so selected, to be selected to receive a future Award.

Article 15     Change in Control

Upon the occurrence of a Change in Control and notwithstanding the terms of any Award Agreement, unless otherwise specifically prohibited under applicable laws, or by the rules and regulations of any governing governmental agencies or national securities exchanges:

(a)Any and all Options granted hereunder shall become immediately exercisable, and shall terminate upon the earlier of (i) the third anniversary of the Participant’s date of termination of service or (ii) expiration of the Option term.
(b)Any restriction periods and restrictions imposed on Awards shall lapse.

Article 16.Amendment, Modification, and Termination
16.1     Amendment, Modification, and Termination. Subject to the terms of the Program including Section 16.2, the Board may at any time and from time to time, alter, amend, suspend or terminate the Program in whole or in part. However, stockholder approval shall be required for any amendment of the Program only to the extent required by applicable law.
16.2     Awards Previously Granted. Notwithstanding any provision of the Program or of any Award Agreement to the contrary (but subject to Section 6.10 hereof), no termination, amendment, or modification of the Program or amendment of an Award previously granted under the Program shall adversely affect in any material way any Award previously granted under the Program, without the express consent of the Participant holding such Award.

Article 17.Compliance with Applicable Law and Withholding
17.1     General. The granting of Awards and the issuance of Shares under the Program shall be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required. Notwithstanding anything to the contrary in the Program or any Award Agreement, the following shall apply:
(a)The Company shall have no obligation to issue any Shares under the Program if such issuance would violate any applicable law or any applicable regulation or requirement of any securities exchange or similar entity.
(b)Prior to the issuance of any Shares under the Program, the Company may require a written statement that the recipient is acquiring the Shares for investment and not for the purpose or with the intention of distributing the Shares and that the recipient will not dispose of them in violation of the registration requirements of the Securities Act of 1933.
(c)With respect to any Participant who is subject to Section 16(a) of the Exchange Act, the Committee may, at any time, add such conditions and limitations to
11

Award or payment under the Program or implement procedures for the administration of the Program which it deems necessary or desirable to comply with the requirements of Rule 16b-3 of the Exchange Act.
(d)If, at any time, the Company, determines that the listing, registration, or qualification (or any updating of any such document) of any Award, or the Shares issuable pursuant thereto, is necessary on any securities exchange or under any federal or state securities or blue sky law, or that the consent or approval of any governmental regulatory body is necessary or desirable as a condition of, or in connection with, any Award, the issuance of Shares pursuant to any Award, or the removal of any restrictions imposed on Shares subject to an Award, such Award shall not be granted and the Shares shall not be issued or such restrictions shall not be removed, as the case may be, in whole or in part, unless such listing, registration, qualification, consent, or approval shall have been effected or obtained free of any conditions not acceptable to the Company or the Committee otherwise provides.
17.2     Securities Law Compliance. Transactions under this Program are intended to comply with all applicable conditions of Rule 16b-3 or its successors under the 1934 Act.
17.3     Tax Withholding. The Company shall have the power and the right to deduct or withhold, or require a Participant to remit to the Company, an amount sufficient to satisfy federal, state, and local taxes, domestic or foreign, required or permitted by law or regulation to be withheld with respect to any taxable event arising as a result of this Program.
17.4     Share Withholding. Awards payable in Shares may provide that with respect to withholding required upon any taxable event arising thereunder, Participants may elect to satisfy the withholding requirement (or the Committee may require that the tax withholding requirement be satisfied), in whole or in part, by having the Company withhold Shares to satisfy their withholding tax obligations. Unless otherwise provided by the Committee, all elections shall be irrevocable, made in writing, signed by the Participant, and shall be subject to any restrictions or limitations, including prior Committee approval, that the Committee, in its sole discretion, deems appropriate.

Article 18.Indemnification
Each person who is or shall have been a member of the Committee, or of the Board, shall be indemnified and held harmless by the Company against and from any loss, cost, liability, or expense that may be imposed upon or reasonably incurred by him or her in connection with or resulting from any claim, action, suit, or proceeding to which he or she may be a party or in which he or she may be involved by reason of any action taken or failure to act under the Program and against and from any and all amounts paid by him or her in settlement thereof, with the Company’s approval, or paid by him or her in satisfaction of any judgment in any such action, suit, or proceeding against him or her, provided he or she shall give the Company an opportunity, at its own expense, to handle and defend the same before he or she undertakes to handle and defend it on his or her own behalf. The foregoing right of indemnification shall not be exclusive of any other rights of indemnification to which such persons may be entitled under the Company’s Certificate of Incorporation or Bylaws, as a matter of law, or otherwise, or any power that the Company may have to indemnify them or hold them harmless.
Article 19.    Successors
All obligations of the Company under the Program with respect to Awards granted hereunder shall, to the extent legally permissible, be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company.
12

Article 20     Legal Construction

20.1     Gender and Number. Except where otherwise indicated by the context, any masculine term used herein also shall include the feminine; the plural shall include the singular and the singular shall include the plural.
20.2    Severability. In the event any provision of the Program shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of the Program, and the Program shall be construed and enforced as if the illegal or invalid provision had not been included.

20.3     Governing Law. To the extent not preempted by federal law, the Program, and all Award or other agreements hereunder, shall be construed in accordance with and governed by the laws of the state of Delaware without giving effect to principles of conflicts of laws.

20.4     Non-Exclusivity of the Program; No Corporate Action Restriction. Nothing in this Program shall limit or be deemed to limit the authority of the Board or the Committee to grant awards or authorize any other compensation, with or without reference to the Shares, under any other plan or authority. The existence of this Program, the award agreements and the awards granted hereunder shall not limit, affect, or restrict in any way the right or power of the Company or any of its subsidiaries (or any of their respective shareholders, boards of directors or committees thereof (or any subcommittees), as the case may be) to make or authorize: (a) any adjustment, recapitalization, reorganization or other change in the capital structure or business of the Company or any subsidiary, (b) any merger, amalgamation, consolidation or change in the ownership of the Company or any subsidiary, (c) any issue of bonds, debentures, capital, preferred or prior preference stock ahead of or affecting the capital stock (or the rights thereof) of the Company or any subsidiary, (d) any dissolution or liquidation of the Company or any subsidiary, (e) any sale or transfer of all or any part of the assets or business of the Company or any subsidiary, (f) any other award, grant, or payment of incentives or other compensation under any other plan or authority (or any other action with respect to any benefit, incentive or compensation), or (g) any other corporate act or proceeding by the Company or any subsidiary. No participant, beneficiary or any other person shall have any claim under any award or award agreement against any member of the Board or the Committee, or the Company or any employees, officers or agents of the Company or any subsidiary, as a result of any such action. Awards need not be structured so as to be deductible for tax purposes.
13
 EX-10.16 7 ex-101610xkq42021.htm EX-10.16 Document

Exhibit 10.16

image_0.jpg




Name:
Date of Grant:Option Price
Date of Expiration:Number of Shares Covered:

Vesting Schedule

This certifies that on _________, Edwards Lifesciences Corporation granted to the Participant shown above a Nonqualified Stock Option to purchase shares of its common stock as indicated above upon the terms and conditions of the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program and the attached Nonqualified Stock Option Award Agreement (the “Award Agreement”). The Award Agreement imposes additional limitations on the Participant’s rights under the Option and provides for early termination of the Option (before the Expiration Date set forth above) in the event of termination of the Participant’s Directorship.
Edwards Lifesciences Corporation

By
image_1.jpg
Michael A. Mussallem
Chairman and Chief Executive Officer



Edwards Lifesciences Corporation
2020 Nonemployee Directors Stock Incentive Program—Nonqualified Stock Option Award Agreement

THIS AGREEMENT, in conjunction with the Participant Stock Option Statement attached to the front of this agreement (the “Statement”) effective as of the Date of Grant set forth on the Statement, represents the grant of a nonqualified stock option (the “Option”) by Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), to the Participant named on the Statement, pursuant to the provisions of the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program (the “Program”). This agreement and the Statement shall be considered one agreement and are referred to herein as the “Agreement.”
The Program provides additional terms and conditions governing the Option. If there is any inconsistency between the terms of this Agreement and the terms of the Program, the Program’s terms shall completely supersede and replace the conflicting terms of this Agreement. All capitalized terms shall have the meanings ascribed to them in the Program, unless specifically set forth otherwise herein. The parties hereto agree as follows:
1.    Grant of Stock Option. The Company hereby grants to the Participant an Option to purchase the number of Shares set forth on the Statement, at the stated Option Price set forth on the Statement, which is one hundred percent (100%) of the Fair Market Value of a Share on the Date of Grant, in the manner and subject to the terms and conditions of the Program and this Agreement.
The grant of this Option to the Participant shall not confer any right to such Participant (or any other Participant) to be granted any Option or other Awards in the future under the Program.
2.    Exercise of Stock Option. Except as may otherwise be provided in Sections 3 and 4 below, the Participant may only exercise this Option according to the vesting schedule set forth on the Statement, provided that no exercise may occur subsequent to the close of business on the Date of Expiration (as set forth on the Statement).
The number of Shares for which this Option becomes vested and exercisable pursuant to this Section 2 shall be rounded up to the next whole number in the event that the use of the percentages set forth on the Statement results in the Option being exercisable with respect to a fractional Share. In addition, the Option may be exercised in whole or in part, but not for less than fifty (50) Shares at any one time, unless fewer than fifty (50) Shares then remain subject to the Option, and the Option is then being exercised as to all such remaining Shares.
3.    Termination of Directorship:
(a)By Death or Disability: All unvested Shares under this Option shall immediately vest and become exercisable as of the Participant’s date of termination of service by reason of his or her death or Disability. Shares under this Option that vest and become exercisable in accordance with this Section 3(a) or that are already vested and exercisable as of the Participant’s date of termination by reason of the Participant’s death or Disability, may be purchased only until the earlier of: (i) the Date of Expiration of this Option; or (ii) the third (3rd) anniversary of the Participant’s date of termination of service with the Company by reason of his or her death or Disability.


(b)For Other Reasons: Unless determined otherwise by the Committee or its designee in their sole discretion, all unvested Shares under this Option shall immediately terminate and be forfeited to the Company as of the date of the Participant’s termination of service with the Company for any reason other than the reasons set forth in Section 3(a) above. Shares under this Option that are vested and exercisable as of the date of a termination of the Participant’s service with the Company for any reason other than those reasons set forth in Section 3(a) above may be purchased until the earlier of: (i) the Date of Expiration of this Option; or (ii) the third (3rd) anniversary of the Participant’s date termination of service with the Company.
4.    Change in Control. Notwithstanding anything to the contrary in this Agreement, in the event of a Change in Control of the Company prior to the Participant’s termination of service for any reason, all Shares under this Option shall immediately vest and become exercisable in full.
5.    Restrictions on Transfer. This Option may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution. Further, this Option shall be exercisable during the Participant’s lifetime only by the Participant or the Participant’s legal representative.
6.    Recapitalization. The Options subject to this Agreement are subject to adjustment pursuant to Section 5.4 of the Program.
7.    Procedure for Exercise of Option. This Option may be exercised by delivery of written notice (or such other form of notice as the Company may specify) to the Company at its executive offices, addressed to the attention of its Secretary or the Company’s designee. Such notice: (a) shall be signed by the Participant or his or her legal representative (or assented to in a form other than written signature if and to the extent that the Company specifies); (b) shall specify the number of full Shares then elected to be purchased with respect to the Option; (c) if a Registration Statement under the Securities Act of 1933 is not in effect with respect to the Shares to be purchased, shall contain a representation of the Participant that the Shares are being acquired by him or her for investment and with no present intention of selling or transferring them, and that he or she will not sell or otherwise transfer the Shares except in compliance with all applicable securities laws and requirements of any stock exchange upon which the Shares may then be listed; and (d) shall be accompanied by payment in full of the Option Price of the Shares to be purchased (or a satisfactory “cashless exercise” notice).
The Option Price upon exercise of this Option shall be payable to the Company in full either: (a) in cash or its equivalent (acceptable cash equivalents shall be determined at the sole discretion of the Committee); (b) by tendering previously acquired Shares (by either actual delivery or attestation) having an aggregate Fair Market Value at the time of exercise equal to the total Option Price; (c) by a “cashless exercise” to the extent permitted under Federal Reserve Board’s Regulation T and other applicable law, and subject to such procedures and limitations as the Company may specify from time to time; (d) by any other means which the Committee determines to be consistent with the Program’s purpose and applicable law; or (e) by a combination of two or more of (a) through (d).
As promptly as practicable after receipt of notice and payment upon exercise (or satisfactory “cashless exercise” notice) and subject to any Company “cashless exercise” procedures, the Company shall cause to be issued and delivered to the Participant in certificate form or otherwise, evidence of the Shares so purchased, which may, if appropriate, be endorsed with or otherwise include appropriate restrictive legends. The Company shall maintain a record of all information pertaining to the Participant’s rights under this Agreement, including the number of Shares for which the Option is exercisable. If


the Option shall have been exercised in full, this Agreement shall be returned to the Company and canceled.
8.    Beneficiary Designation. The Participant may, from time to time, name any beneficiary or beneficiaries (who may be named contingently or successively) to whom any benefit under this Agreement is to be paid in case of his or her death before he or she receives any or all of such benefit. Each such designation shall revoke all prior designations by the Participant, shall be in a form prescribed by the Company, and will be effective only when filed by the Participant in writing with the Secretary of the Company during the Participant’s lifetime. In the absence of any such designation, benefits remaining unpaid at the Participant’s death shall be paid to the Participant’s estate.
9.    Rights as a Stockholder. The Participant shall have no rights as a stockholder of the Company with respect to the Shares subject to this Agreement until such time as the purchase price has been paid, and the Shares have been issued and delivered to him or her.
10.    Continuation of Service. This Agreement shall not confer upon the Participant any right to continue providing services to the Company or to be nominated to the Board, nor shall this Agreement interfere in any way with the Company’s right to terminate the Participant’s service at any time.
11.    Miscellaneous.
(a)    This Agreement and the rights of the Participant hereunder are subject to all the terms and conditions of the Program, as the same may be amended from time to time, as well as to such rules and regulations as the Committee may adopt for administration of the Program. The Committee shall have the right to impose such restrictions on any Shares acquired pursuant to the exercise of this Option, as it may deem advisable for regulatory compliance, including, without limitation, restrictions under applicable federal securities laws, under the requirements of any stock exchange or market upon which such Shares are then listed and/or traded, and under any blue sky or state securities laws applicable to such Shares. It is expressly understood that the Committee is authorized to administer, construe, and make all determinations necessary or appropriate to the administration of the Program and this Agreement, all of which shall be binding upon the Participant.
(b)    The Committee may terminate, amend, or modify the Program and the Committee may amend or modify this Option at any time; provided, however, that except for the Company’s right to cash out this Option under certain circumstances pursuant to Section 6.10 of the Program, no such termination, amendment, or modification of the Program or amendment of this Option may in any material way adversely affect the Participant’s rights under this Agreement, without the express consent of the Participant.
(c)    The Company shall have the power and the right to deduct or withhold, or require the Participant to remit to the Company, an amount sufficient to satisfy all federal, state, local and foreign taxes required by law or regulations to be withheld with respect to any exercise of the Participant’s rights under this Agreement.
    The Participant may elect, subject to any procedural rules adopted by the Committee, to satisfy the minimum withholding requirement, in whole or in part, by having the Company withhold Shares having an aggregate Fair


Market Value on the date the tax is to be determined, equal to or less than the minimum amount required to be withheld.
(d)    The Participant agrees to take all steps necessary to comply with all applicable provisions of federal, state and foreign securities law in exercising his or her rights under this Agreement.
(e)    This Agreement shall be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required.
(f)    All obligations of the Company under the Program and this Agreement, with respect to this Option, shall, to the extent legally permissible, be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company.
(g)    To the extent not preempted by federal law, this Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware.

Accepted and agreed:

Company:        Director:
Edwards Lifesciences Corporation

        
By: ________________________        By: __________________________

 EX-10.17 8 ex-101710xkq42021.htm EX-10.17 Document

Exhibit 10.17

Edwards Lifesciences Corporation
2020 Nonemployee Directors Stock Incentive Program
Restricted Stock Units Agreement
You have been selected to be a Participant in the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program (the “Program”), as specified below:
Participant:
Date of Grant:
Number of Restricted Stock Units Granted:
Vesting Date: The Restricted Stock Units shall vest on the date and in the amount listed below:
Vesting DateNumber of Units Which Vest


THIS AGREEMENT, effective as of the Date of Grant set forth above, represents the grant of Restricted Stock Units by Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), to the Participant named above, pursuant to the provisions of the Program.
The Program provides additional terms and conditions governing the Restricted Stock Units. If there is any inconsistency between the terms of this Agreement and the terms of the Program, the Program’s terms shall completely supersede and replace the conflicting terms of this Agreement. All capitalized terms shall have the meanings ascribed to them in the Program, unless specifically set forth otherwise herein. The parties hereto agree as follows:
1.    Restricted Stock Units. The Participant is entitled to receive one Share for each Restricted Stock Unit, provided the Restricted Stock Units have not terminated.
2.    Service to the Company. Except as may otherwise be provided in Sections 5 or 6, the Restricted Stock Units granted hereunder shall vest in full on the Vesting Date (as set forth above) provided the Participant remains a Nonemployee Director of the Company from the Date of Grant through (and including) such date.
This grant of Restricted Stock Units shall not confer any right to the Participant (or any other Participant) to be granted Restricted Stock Units or other Awards in the future under the Program.
3.    Issuance of Shares. Except as may otherwise be provided herein and in the Program, the Shares issuable with respect to any Restricted Stock Units that have vested shall be issued as soon as administratively feasible following the vesting date applicable to such units. Any such issuance of Shares shall be subject to applicable Federal and state securities laws.
4.    Shareholder Rights. The Participant shall not have any shareholder rights hereunder with respect to any Shares issuable until the Shares have been issued.

        
5.    Termination of Directorship.
a)By Death or Disability: In the event the service of the Participant is terminated due to the Participant’s death or Disability, then the Restricted Stock Units held by the Participant at the time of his or her death or Disability shall immediately become fully vested.
b)Termination for Other Reasons: In the event of the Participant’s termination of service with the Company for any reason other than the Participant’s death or Disability, all Restricted Stock Units held by the Participant at the time of service termination and still subject to vesting shall be forfeited by the Participant to the Company.
6.    Change in Control. Notwithstanding anything to the contrary in this Agreement, in the event of a Change in Control of the Company prior to the Participant’s termination of service, the Restricted Stock Units shall immediately become fully vested.
7.    Nontransferability. Restricted Stock Units granted pursuant to this Agreement may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution, except as provided in the Program.
8.    Restriction on Sale of Shares. Notwithstanding any other provision of the Program or this Agreement to the contrary, the Shares acquired upon vesting of the Restricted Stock Units (net of any Shares sold to cover applicable taxes due in connection with the settlement of the Restricted Stock Units) may not be sold, transferred or otherwise disposed of prior to the Participant's cessation of service as a Nonemployee Director of the Company.
9.    Recapitalization. The Restricted Stock Units subject to this Agreement are subject to adjustment pursuant to Section 5.4 of the Program.
10.    Tax Withholding. The Company shall have the power and the right to deduct or withhold, or require the Participant or beneficiary to remit to the Company, an amount sufficient to satisfy federal, state, and local taxes (including the Participant’s FICA obligation), domestic or foreign, required by law or regulation to be withheld with respect to any taxable event arising as a result of this Agreement. The Participant may elect, subject to any procedural rules adopted by the Committee, to satisfy the minimum withholding tax requirement, in whole or in part, by having the Company withhold Shares having an aggregate Fair Market Value on the date the tax is to be determined, equal to or less than such minimum withholding tax.
11.    Beneficiary Designation. The Participant may, from time to time, name any beneficiary or beneficiaries (who may be named contingently or successively) to whom any benefit under this Agreement is to be paid in case of his or her death before he or she receives any or all of such benefit. Each such designation shall revoke all prior designations by the Participant, shall be in a form prescribed by the Company, and will be effective only when filed by the Participant in writing with the Secretary of the Company during the Participant’s lifetime. In the absence of any such designation, benefits remaining unpaid at the Participant’s death shall be paid to the Participant’s estate.    
12.    Continuation of Service. This Agreement shall not confer upon the Participant any right to continue providing services to the Company or to be nominated to the Board, nor shall this Agreement interfere in any way with the Company’s right to terminate the Participant’s service at any time.
13.    Miscellaneous.
a)This Agreement and the rights of the Participant hereunder are subject to all the terms and conditions of the Program, as the same may be amended from time to time, as well as to such rules and regulations as the Committee may adopt for administration of the Program. The Committee shall have the right to impose such restrictions on any Shares acquired pursuant to this Agreement, as it may deem advisable for regulatory compliance, including, without limitation, restrictions under applicable Federal securities laws, under the requirements of any stock exchange or market upon which such Shares are then listed and/or traded, and under any blue sky or state securities laws applicable to such Shares. It is expressly understood that the Committee is authorized to administer, construe, and make

        
all determinations necessary or appropriate to the administration of the Program and this Agreement, all of which shall be binding upon the Participant.
b)The Committee may terminate, amend or modify the Program or this Agreement; provided, however, that no such termination, amendment, or modification of the Program or this Agreement may in any material way adversely affect the Participant’s rights under this Agreement, without the express consent of the Participant.
c)The Participant agrees to take all steps necessary to comply with all applicable provisions of federal, state and foreign securities law in exercising his or her rights under this Agreement.
d)This Agreement shall be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required.
e)All obligations of the Company under the Program and this Agreement, with respect to the Restricted Stock Units, shall to the extent legally permissible, be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company.
f)To the extent not preempted by federal law, this Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware.

Accepted and agreed:

Company:        Director:
Edwards Lifesciences Corporation
    
    
By: ________________________    By: __________________________

 EX-10.18 9 ex-101810xkq42021.htm EX-10.18 Document

Exhibit 10.18


Edwards Lifesciences Corporation
2020 Nonemployee Directors Stock Incentive Program
Restricted Stock Agreement

You have been selected to be a Participant in the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program (the “Program”), as specified below:

Participant:

Date of Grant:

Number of Shares of Restricted Stock Granted:

Lapse of Restrictions Dates: Restrictions placed on the Shares of Restricted Stock shall lapse on the date and in the amount listed below:

Date on Which Restrictions LapseNumber of Shares for Which Restrictions LapseCumulative Number of Shares for Which Restrictions Lapse

THIS AGREEMENT, effective as of the Date of Grant set forth above, represents the grant of Shares of Restricted Stock by Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), to the Participant named above, pursuant to the provisions of the Program.

This program provides additional terms and conditions governing the Restricted Stock. If there is any inconsistency between the terms of this Agreement and the terms of the Program, the Program’s terms shall completely supersede and replace the conflicting terms of this Agreement. All capitalized terms shall have the meanings ascribed to them in the Program, unless specifically set forth otherwise herein. The parties hereto agree as follows:

1. Service to the Company. Except as may otherwise be provided in Sections 5 or 6, the Restricted Stock granted hereunder is granted on the condition that the Participant remains a Nonemployee Director of the Company from the Date of Grant through (and including) each of the separate Lapse of Restrictions Dates, as set forth above (each such time period is referred to herein as a “Period of Restriction”).

This grant of Restricted Stock shall not confer any right to the Participant (or any other Participant) to be granted Restricted Stock or other Awards in the future under the Program.

2. Certificate Legend. Shares of Restricted Stock granted hereunder shall be registered in the name of the Participant and the Company shall cause to be issued and delivered to the Participant, in certificate form or otherwise, evidence of the purchased Shares of Restricted Stock. If such Shares are certificated, in the sole discretion of the Committee, such certificate may be deposited in a bank or with the Company. Each certificate representing Shares of Restricted Stock granted pursuant to the Program shall bear the following legend:

“The sale or other transfer of the shares of stock represented by this certificate, whether voluntary, involuntary, or by operation of law is subject to certain restrictions on transfer set forth in the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program, rules of administration adopted pursuant to such Program, and a Restricted Stock Agreement dated May 5, 2021. A copy of the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program, such rules, and such Restricted Stock Agreement may be obtained from the Secretary of Edwards Lifesciences Corporation.”

3. Removal of Restrictions. Except as may otherwise be provided herein and in the Program, the Shares of Restricted Stock granted pursuant to this Agreement shall become freely transferable by the Participant on the day following the date and in the amount set forth under the Lapse of Restrictions Dates above (or such earlier date as the Shares of Restricted Stock granted pursuant to this Agreement become vested pursuant to Section 5(a) or 6 below), subject to applicable Federal and state


securities laws. Once Shares of Restricted Stock are no longer subject to any Period of Restriction, the Participant shall be entitled to have the legend required by Section 2 of this Agreement removed from the applicable stock certificates; provided, however, one or more other legends may continue to apply, such as a legend pertaining to transfer restrictions imposed pursuant to Rule 144 of the Securities Act of 1933, as amended.

4. Voting Rights and Dividends. During the Period of Restriction, the Participant may exercise full voting rights and shall accrue all dividends and other distributions paid with respect to the Shares of Restricted Stock while they are held. If any such dividends or distributions are paid in Shares, such Shares shall be subject to the same restrictions on transferability, and vesting and forfeiture conditions, as are the Shares of Restricted Stock with respect to which they were paid.

5. Termination of Directorship.

a) By Death or Disability: In the event the service of the Participant is terminated due to the Participant’s death or Disability during the Periods of Restriction, the Periods of Restriction and the restrictions imposed on the Shares of Restricted Stock held by the Participant at the time of his or her death or Disability shall immediately lapse with all such Shares becoming immediately transferable by the Participant or his or her estate, subject to applicable Federal and state securities laws.

b) Termination for Other Reasons: In the event of the Participant’s termination of service with the Company for any reason other than the Participant’s death or Disability during the Periods of Restriction, all Shares of Restricted Stock held by the Participant at the time of service termination and still subject to a Period of Restriction and other restrictions shall be forfeited by the Participant to the Company.

6. Change in Control. Notwithstanding anything to the contrary in this Agreement, in the event of a Change in Control of the Company during the Periods of Restriction and prior to the Participant’s termination of service, the Periods of Restriction and restrictions imposed on the Shares shall immediately lapse with all such Shares of Restricted Stock vesting and becoming freely transferable by the Participant, subject to applicable Federal and state securities laws.

7. Nontransferability. During the Periods of Restriction, Shares of Restricted Stock granted pursuant to this Agreement may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated (a “Transfer”), other than by will or by the laws of descent and distribution, except as provided in the Program. If any Transfer, whether voluntary or involuntary, of unvested Shares of Restricted Stock is made, or if any attachment, execution, garnishment, or lien shall be issued against or placed upon the Shares of Restricted Stock, the Participant’s right to such Shares of Restricted Stock shall be immediately forfeited by the Participant to the Company, and this Agreement shall lapse.

8. Recapitalization. The Shares of Restricted Stock subject to this Agreement are subject to adjustment pursuant to Section 5.4 of the Program.

9. Tax Withholding. The Company shall have the power and the right to deduct or withhold, or require the Participant or beneficiary to remit to the Company, an amount sufficient to satisfy federal, state, and local taxes (including the Participant’s FICA obligation), domestic or foreign, required by law or regulation to be withheld with respect to any taxable event arising as a result of this Agreement. The Participant may elect, subject to any procedural rules adopted by the Committee, to satisfy the minimum withholding tax requirement, in whole or in part, by having the Company withhold Shares having an aggregate Fair Market Value on the date the tax is to be determined, equal to such minimum withholding tax.

10. Beneficiary Designation. The Participant may, from time to time, name any beneficiary or beneficiaries (who may be named contingently or successively) to whom any benefit under this Agreement is to be paid in case of his or her death before he or she receives any or all of such benefit. Each such designation shall revoke all prior designations by the Participant, shall be in a form prescribed by the Company, and will be effective only when filed by the Participant in writing with the Secretary of the Company during the Participant’s lifetime. In the absence of any such designation, benefits remaining unpaid at the Participant’s death shall be paid to the Participant’s estate.

11. Continuation of Service. This Agreement shall not confer upon the Participant any right to continue providing services to the Company or to be nominated to the Board, nor shall this Agreement interfere in any way with the Company’s right to terminate the Participant’s service at any time.

12. Special Tax Election.

a) Section 83(b) Election. Under Code Section 83, the excess of the Fair Market Value of the Shares of Restricted Stock on the date any forfeiture restrictions applicable to such Shares lapse over the price paid for those shares, if any, will be reportable as ordinary income on the lapse date. Participant may elect under Code Section 83(b) to be taxed at the time the Shares of Restricted Stock are acquired, rather than on the Lapse of Restrictions Dates. If


Participant chooses to make an election under Code Section 83(b), such election must be filed with the Internal Revenue Service within thirty (30) days after the date of this Agreement.

b) Filing Responsibility. Participant acknowledges that, if Participant, chooses to file an election under Section 83(b), it is the Participant’s sole responsibility, and not the Company’s to file a timely election under Code Section 83(b), even if Participant requests the Company or its representatives to make this filing on his or her behalf.

13. Miscellaneous.

a) This Agreement and the rights of the Participant hereunder are subject to all the terms and conditions of the Program, as the same may be amended from time to time, as well as to such rules and regulations as the Committee may adopt for administration of the Program. The Committee shall have the right to impose such restrictions on any Shares acquired pursuant to this Agreement, as it may deem advisable for regulatory compliance, including, without limitation, restrictions under applicable Federal securities laws, under the requirements of any stock exchange or market upon which such Shares are then listed and/or traded, and under any blue sky or state securities laws applicable to such Shares. It is expressly understood that the Committee is authorized to administer, construe, and make all determinations necessary or appropriate to the administration of the Program and this Agreement, all of which shall be binding upon the Participant.

b) The Committee may terminate, amend or modify the Program or this Agreement; provided, however, that no such termination, amendment, or modification of the Program or this Agreement may in any material way adversely affect the Participant’s rights under this Agreement, without the express consent of the Participant.

c) The Participant agrees to take all steps necessary to comply with all applicable provisions of federal, state and foreign securities law in exercising his or her rights under this Agreement.

d) This Agreement shall be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required.

e) All obligations of the Company under the Program and this Agreement, with respect to the Restricted Stock, shall to the extent legally permissible, be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company.

f) To the extent not preempted by federal law, this Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware.


Accepted and agreed:

Company: Director:
Edwards Lifesciences Corporation


By: ________________________ By: __________________________


 EX-21.1 10 ex-21110xkq42021.htm EX-21.1 Document

Exhibit 21.1

The following is a list of subsidiaries of Edwards Lifesciences Corporation, omitting subsidiaries which, considered in the aggregate as a single subsidiary, would not constitute a significant subsidiary as of December 31, 2021:


Legal Entity  State of
Incorporation/
Formation		 Country of
Incorporation/
Formation
Edwards Lifesciences LLC Delaware U.S.
Edwards Lifesciences (U.S.) Inc.DelawareU.S.
Edwards Lifesciences (Japan) Limited   Japan
Edwards Lifesciences Holding B.V.   The Netherlands


 EX-23 11 ex-2310xkq42021.htm EX-23 Document

Exhibit 23

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-33054, 333-33056, 333-40434, 333-52334, 333-52346, 333-60670, 333-98219, 333-105961, 333-127260, 333-150810, 333-154242, 333-168462, 333-183106, 333-192229, 333-195853, 333-204180, 333-211333, 333-217909, 333-255853, and 333-255854, ) and Form S-3 (No. 333-232866) of Edwards Lifesciences Corporation of our report dated February 14, 2022 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.


/s/ PricewaterhouseCoopers LLP
Irvine, California
February 14, 2022


EX-31.1 12 ex-31110xkq42021.htm EX-31.1 Document

Exhibit 31.1

EDWARDS LIFESCIENCES CORPORATION
CERTIFICATIONS PURSUANT TO
SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
CERTIFICATION
I, Michael A. Mussallem, certify that:
1.I have reviewed this annual report on Form 10-K of Edwards Lifesciences Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
By:/s/ MICHAEL A. MUSSALLEM
Michael A. Mussallem
Chairman of the Board and Chief Executive Officer
February 14, 2022


 EX-31.2 13 ex-31210xkq42021.htm EX-31.2 Document

Exhibit 31.2

EDWARDS LIFESCIENCES CORPORATION
CERTIFICATIONS PURSUANT TO
SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
CERTIFICATION
I, Scott B. Ullem, certify that:
1.I have reviewed this annual report on Form 10-K of Edwards Lifesciences Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
By:/s/ SCOTT B. ULLEM
Scott B. Ullem
 Corporate Vice President,
Chief Financial Officer
February 14, 2022

EX-32 14 ex-3210xkq42021.htm EX-32 Document

Exhibit 32

EDWARDS LIFESCIENCES CORPORATION
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Edwards Lifesciences Corporation (the "Company") on Form 10-K for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), we, Michael A. Mussallem, Chairman of the Board and Chief Executive Officer of the Company, and Scott B. Ullem, Corporate Vice President, Chief Financial Officer, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ MICHAEL A. MUSSALLEM
February 14, 2022
Michael A. Mussallem
 Chairman of the Board and Chief Executive Officer
/s/ SCOTT B. ULLEM
February 14, 2022
Scott B. Ullem
 Corporate Vice President,
 Chief Financial Officer


 EX-101.SCH 15 ew-20211231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 000010001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 000020002 - Document - Audit Information link:presentationLink link:calculationLink link:definitionLink 100010003 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 100020004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 100030005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 100040006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 100050007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 100060008 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 210011001 - Disclosure - DESCRIPTION OF BUSINESS link:presentationLink link:calculationLink link:definitionLink 210021002 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 220032001 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 230043001 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 240054001 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock Split (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240064002 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240074003 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Shipping and Handling Costs (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240084004 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investments (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240094005 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 240104006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventories (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240114007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property, Plant, and Equipment (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240124008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Intangible Assets (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240134009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 240144010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per Share (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240154011 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Stock-Based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 240164012 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock-based Compensation (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240174013 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivatives (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 210181003 - Disclosure - INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET link:presentationLink link:calculationLink link:definitionLink 240194014 - Disclosure - INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET (Details) link:presentationLink link:calculationLink link:definitionLink 210201004 - Disclosure - SPECIAL CHARGES link:presentationLink link:calculationLink link:definitionLink 240214015 - Disclosure - SPECIAL CHARGES - Impairment of Long-lived Assets (Details) link:presentationLink link:calculationLink link:definitionLink 240224016 - Disclosure - SPECIAL CHARGES - Acquisition of Intellectual Property (Details) link:presentationLink link:calculationLink link:definitionLink 210231005 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS link:presentationLink link:calculationLink link:definitionLink 230243002 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables) link:presentationLink link:calculationLink link:definitionLink 240254017 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions (Details) link:presentationLink link:calculationLink link:definitionLink 240264018 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Supplemental Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 240274019 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Cash, Cash Equivalents, and Restricted Cash (Details) link:presentationLink link:calculationLink link:definitionLink 210281006 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 230293003 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 240304020 - Disclosure - LEASES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240314021 - Disclosure - LEASES - Assets and Liabilities of Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 240324022 - Disclosure - LEASES - Maturities Of Operating Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 240324022 - Disclosure - LEASES - Maturities Of Operating Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 210331007 - Disclosure - INVESTMENTS link:presentationLink link:calculationLink link:definitionLink 230343004 - Disclosure - INVESTMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 240354023 - Disclosure - INVESTMENTS - Schedule of Investments in Debt Securities (Details) link:presentationLink link:calculationLink link:definitionLink 240364024 - Disclosure - INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details) link:presentationLink link:calculationLink link:definitionLink 240374025 - Disclosure - INVESTMENTS - Schedule of Unrealized Losses on Debt Securities (Details) link:presentationLink link:calculationLink link:definitionLink 240384026 - Disclosure - INVESTMENTS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240394027 - Disclosure - INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details) link:presentationLink link:calculationLink link:definitionLink 210401008 - Disclosure - ACQUISITIONS link:presentationLink link:calculationLink link:definitionLink 240414028 - Disclosure - ACQUISITIONS - Narratives (Details) link:presentationLink link:calculationLink link:definitionLink 210421009 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 230433005 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 240444029 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in the Carrying Amount of Goodwill, by Segment (Details) link:presentationLink link:calculationLink link:definitionLink 240454030 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 240464031 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240474032 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Estimated Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 210481010 - Disclosure - DEBT AND CREDIT FACILITIES link:presentationLink link:calculationLink link:definitionLink 230493006 - Disclosure - DEBT AND CREDIT FACILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 240504033 - Disclosure - DEBT AND CREDIT FACILITIES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240514034 - Disclosure - DEBT AND CREDIT FACILITIES - Summary of the Notes (Details) link:presentationLink link:calculationLink link:definitionLink 210521011 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 230533007 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 240544035 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on a Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 240554036 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Changes in Fair Value of Contingent Consideration Obligation (Details) link:presentationLink link:calculationLink link:definitionLink 240564037 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 210571012 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES link:presentationLink link:calculationLink link:definitionLink 230583008 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 240594038 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Derivative Financial Instruments Used to Manage Currency Exchange and Interest Rate Risk (Details) link:presentationLink link:calculationLink link:definitionLink 240604039 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 240614040 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset (Details) link:presentationLink link:calculationLink link:definitionLink 240624041 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 240634042 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240644043 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location of Gain or Loss on Derivative Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 210651013 - Disclosure - EMPLOYEE BENEFIT PLANS link:presentationLink link:calculationLink link:definitionLink 230663009 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables) link:presentationLink link:calculationLink link:definitionLink 240674044 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Information Regarding Defined Benefit Pension Plans (Details) link:presentationLink link:calculationLink link:definitionLink 240684045 - Disclosure - EMPLOYEE BENEFIT PLANS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240694046 - Disclosure - EMPLOYEE BENEFIT PLANS - Components of Net Periodic Benefit Cost (Details) link:presentationLink link:calculationLink link:definitionLink 240704047 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 240714048 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Target Weighted-Average Asset Allocations and Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 240724049 - Disclosure - EMPLOYEE BENEFIT PLANS - Summary of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3 (Details) link:presentationLink link:calculationLink link:definitionLink 240734050 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Benefit Payments Which Reflect Expected Future Service (Details) link:presentationLink link:calculationLink link:definitionLink 210741014 - Disclosure - COMMON STOCK link:presentationLink link:calculationLink link:definitionLink 230753010 - Disclosure - COMMON STOCK (Tables) link:presentationLink link:calculationLink link:definitionLink 240764051 - Disclosure - COMMON STOCK - Treasury Stock (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240774052 - Disclosure - COMMON STOCK - Accelerated Share Repurchases (Details) link:presentationLink link:calculationLink link:definitionLink 240784053 - Disclosure - COMMON STOCK - Employee and Director Stock Plans (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240794054 - Disclosure - COMMON STOCK - Schedule of Weighted-Average Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 240804055 - Disclosure - COMMON STOCK - Schedule of Stock Option (Details) link:presentationLink link:calculationLink link:definitionLink 240814056 - Disclosure - COMMON STOCK - Schedule of Restricted Stock Unit Activity (Details) link:presentationLink link:calculationLink link:definitionLink 240824057 - Disclosure - COMMON STOCK - Schedule of Restricted Stock Unit Activity (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240834058 - Disclosure - COMMON STOCK - Additional Information (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 210841015 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS link:presentationLink link:calculationLink link:definitionLink 230853011 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables) link:presentationLink link:calculationLink link:definitionLink 240864059 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Summary of Activity for Each Component of Accumulated Other Comprehensive Loss (Details) link:presentationLink link:calculationLink link:definitionLink 240874060 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Change in Unrealized Pension Costs (Details) link:presentationLink link:calculationLink link:definitionLink 240874060 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Change in Unrealized Pension Costs (Details) link:presentationLink link:calculationLink link:definitionLink 240884061 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Information About Amounts Reclassified from Accumulated Other Comprehensive Loss (Details) link:presentationLink link:calculationLink link:definitionLink 210891016 - Disclosure - OTHER INCOME, NET link:presentationLink link:calculationLink link:definitionLink 230903012 - Disclosure - OTHER INCOME, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 240914062 - Disclosure - OTHER INCOME, NET (Details) link:presentationLink link:calculationLink link:definitionLink 210921017 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 230933013 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 240944063 - Disclosure - INCOME TAXES - Schedule of Income Before Provisions for Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 240954064 - Disclosure - INCOME TAXES - Provision for Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 240964065 - Disclosure - INCOME TAXES - Components of Deferred Tax Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 240974066 - Disclosure - INCOME TAXES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240984067 - Disclosure - INCOME TAXES - Summary of Net Operating Loss Carryforwards (Details) link:presentationLink link:calculationLink link:definitionLink 240994068 - Disclosure - INCOME TAXES - Summary of Tax Credit Carryforwards (Details) link:presentationLink link:calculationLink link:definitionLink 241004069 - Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 241014070 - Disclosure - INCOME TAXES - Reconciliation of Uncertain Tax Positions (Details) link:presentationLink link:calculationLink link:definitionLink 211021018 - Disclosure - LEGAL PROCEEDINGS link:presentationLink link:calculationLink link:definitionLink 241034071 - Disclosure - LEGAL PROCEEDINGS (Details) link:presentationLink link:calculationLink link:definitionLink 211041019 - Disclosure - SEGMENT INFORMATION link:presentationLink link:calculationLink link:definitionLink 231053014 - Disclosure - SEGMENT INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 241064072 - Disclosure - SEGMENT INFORMATION - Schedule of Information About Reportable Segments (Details) link:presentationLink link:calculationLink link:definitionLink 241074073 - Disclosure - SEGMENT INFORMATION - Reconciliation of Segment Net Sales and Pre-Tax Income to Consolidated Net Sales and Pre-Tax Income (Details) link:presentationLink link:calculationLink link:definitionLink 241084074 - Disclosure - SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details) link:presentationLink link:calculationLink link:definitionLink 211091020 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS link:presentationLink link:calculationLink link:definitionLink 241104075 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS (Details) link:presentationLink link:calculationLink link:definitionLink 211111021 - Disclosure - SUBSEQUENT EVENT link:presentationLink link:calculationLink link:definitionLink 241124076 - Disclosure - SUBSEQUENT EVENT (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 16 ew-20211231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 17 ew-20211231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 18 ew-20211231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cash paid during the year for: Supplemental Cash Flow Information [Abstract] Unrealized (Loss) Gain on Available-for-sale Investments (Loss) gain on available-for-sale investments AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member] INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET Legal Matters and Contingencies [Text Block] Amortization of prior service credit Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Actuarial loss Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) State and local Current State and Local Tax Expense (Benefit) Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Accrued relocation costs Accrued Relocation Costs, Current Accrued Relocation Costs, Current Other Other Intangible Assets [Member] Derivatives Fair Value Net Amounts Presented in the Consolidated Balance Sheet Derivative Liability Security Exchange Name Security Exchange Name Investment Carrying value of non-marketable equity securities Equity Securities, FV-NI, Current Forfeited (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Net Tax Benefit Deferred Tax Assets, Capital Loss Carryforwards, Net Of Valuation Allowance Deferred Tax Assets, Capital Loss Carryforwards, Net Of Valuation Allowance Intrinsic value of stock options exercised and restricted stock units vested Share Based Compensation Arrangement by Share Based Payment Award, Intrinsic Value of Stock Options Exercised and Vested Restricted Stock Units This element represents the intrinsic value of stock options exercised and restricted stock units that vested during the period. Options forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Weighted-average remaining lease term (in years) Operating Lease, Weighted Average Remaining Lease Term Foreign Currency Translation Foreign Currency Transactions and Translations Policy [Policy Text Block] Option Awards Stock option activity Employee and Nonemployee Stock Options [Member] An arrangement whereby an employee or nonemployee (including a member of the entity's Board of Directors) is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement. Impairment of equity securities Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount Investment, Name [Axis] Investment, Name [Axis] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Derivatives Derivatives, Policy [Policy Text Block] Aggregate Intrinsic Value Aggregate Intrinsic Value [Abstract] Amount accrued under nonqualified plans Deferred Compensation Liability, Current and Noncurrent Net (decrease) increase in cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Conversion of notes receivable to equity investment Notes Receivable Converted To Equity Investment Notes Receivable Converted To Equity Investment Expected volatility (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Income taxes Increase (Decrease) in Income Taxes Payable Changes in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Additional amount available, subject to lender approval Line of Credit Facility, Additional Capacity Increase Option Represents the amount by which the borrowing capacity of the line of credit may be increased at the entity's option, subject to certain conditions, under the terms of the credit agreement. Schedule of Information About Amounts Reclassified from Accumulated Other Comprehensive Loss Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Foreign-derived intangible income deduction Effective Income Tax Rate Reconciliation, Deduction, Amount Tax credit carryforwards and the related carryforward periods Tax Credit Carryforward [Line Items] Fair value hedges Fair Value Hedging [Member] Charged to Costs and Expenses SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense Subsequent Event Type [Domain] Subsequent Event Type [Domain] Other comprehensive income (loss) Other Comprehensive Income, Other, Net of Tax Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Amortization expense related to other intangible assets Amortization of Intangible Assets Secured promissory note Equity Securities, FV-NI, Promissory Note Equity Securities, FV-NI, Promissory Note Increase in prior year tax positions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Debt securities Defined Benefit Plan, Debt Security [Member] Net deferred tax assets Deferred Tax Assets, Net Cash Collateral Received Derivative, Collateral, Obligation to Return Cash Anti-dilutive securities excluded from the computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Revenue recognized that was previously deferred Contract with Customer, Liability, Revenue Recognized Research and development expenses Research and Development Expense [Member] Subsequent Events [Abstract] Subsequent Events [Abstract] Summary of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3 Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block] Business Combination and Asset Acquisition [Abstract] Stock split, conversion ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Business Acquisition [Axis] Business Acquisition [Axis] Cash flow hedges Cash Flow Hedging [Member] Schedule of Indefinite-Lived Other Intangible Assets Schedule of Indefinite-Lived Intangible Assets [Table Text Block] Award Type [Domain] Award Type [Domain] Purchases credit Purchase Credit [Member] Represents information pertaining to purchase credit carryforward. Local Phone Number Local Phone Number Accelerated Share Repurchases, Date [Domain] Accelerated Share Repurchases, Date [Domain] Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Exercisable as of period end (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Amortization of actuarial loss Defined Benefit Plan, Amortization of Gain (Loss) Purchased and sold in May 2019 May 2019 Stock Repurchase Program, Shares Purchased And Sold In May 2019 [Member] May 2019 Stock Repurchase Program, Shares Purchased And Sold In May 2019 [Member] Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity Investments Classified by Contractual Maturity Date [Table Text Block] Estimated decrease in unrecognized tax benefits Decrease in Unrecognized Tax Benefits is Reasonably Possible Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding Preferred Stock, Value, Issued Retained Earnings Retained Earnings [Member] Weighted-average assumptions used to determine the net periodic benefit cost Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract] Fair value of the notes, based on Level 2 inputs Debt Instrument, Fair Value Disclosure Measurement Input, Probability of Milestone Achievement Measurement Input, Probability Of Milestone Achievement [Member] Measurement Input, Probability Of Milestone Achievement [Member] SPECIAL CHARGES Unusual or Infrequent Items, or Both, Disclosure [Text Block] Schedule of Accelerated Share Repurchases Accelerated Share Repurchases [Table Text Block] CardiAQ CardiAQ Valve Technologies, Inc. [Member] CardiAQ Valve Technologies, Inc. [Member] Segment Operating Income Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Valuation Allowance Capital Loss Carryforwards, Valuation Allowance Capital Loss Carryforwards, Valuation Allowance Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table Text Block] Equity securities Investments, All Other Investments [Abstract] Capital expenditures accruals Capital Expenditures Incurred but Not yet Paid Fair Value Fair Value Debt Securities, Held-to-maturity, Fair Value Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Tax Period [Domain] Tax Period [Domain] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Litigation settlement accrual (Note 3) Estimated Litigation Liability, Noncurrent Stock-based Compensation Compensation Related Costs, Policy [Policy Text Block] Other income, net Other Nonoperating Income (Expense) [Member] Allocation of stock-based compensation expense Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Basic (in dollars per share) Basic earnings per share (in dollars per share) Earnings Per Share, Basic Due after 5 years through 10 years Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Through Ten Years, Amortized Cost Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Beginning balance (in shares) Ending balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Fair value beginning balance Fair value ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Gross Amounts Not Offset in the Consolidated Balance Sheet Derivative Fair Value of Derivative Liability Gross Amounts Not Offset [Abstract] Rest of World Rest of World Rest of World Segment [Member] Represents the reportable segment of the entity comprised of regions other than the United States, Europe and Japan (Rest of World). Fair Value Measurement [Domain] Fair Value Measurement [Domain] Diluted: Earnings Per Share, Diluted [Abstract] VALUATION AND QUALIFYING ACCOUNTS SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Other long-term liabilities Liability, Defined Benefit Pension Plan, Noncurrent Harpoon Medical Harpoon Medical, Inc. [Member] Harpoon Medical, Inc. [Member] Machinery and equipment Machinery and Equipment [Member] Commercial paper Commercial Paper [Member] Other Other Noncash Income (Expense) Gross Amounts Derivative Asset, Fair Value, Gross Asset Net prior service cost Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax Transcatheter Mitral and Tricuspid Therapies Transcatheter Mitral And Tricuspid Therapies [Member] Transcatheter Mitral And Tricuspid Therapies [Member] Property, plant, and equipment Deferred Tax Liabilities, Property, Plant and Equipment Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion) Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Investments held for deferred compensation plans Deferred Compensation Plan Assets Schedule of Enterprise-Wide Information Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Funded Status Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract] Offsetting Assets [Line Items] Offsetting Assets [Line Items] Entity Voluntary Filers Entity Voluntary Filers Defined Benefit Plan, Plan Assets, Category [Domain] Defined Benefit Plan, Plan Assets, Category [Domain] Plan Name [Axis] Plan Name [Axis] Assets Assets, Fair Value Disclosure [Abstract] Total carrying amount Long-term Debt Amount excluded from effectiveness testing recognized in earnings based on an amortization approach Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax Level 1 Fair Value, Inputs, Level 1 [Member] Impairment charges (Note 4) Other than Temporary Impairment Losses, Investments Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Insurance contracts Insurance Contracts Insurance Contracts [Member] This element represents the information about insurance contracts. State and local taxes, net of federal tax benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount Entity Small Business Entity Small Business Current year tax positions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Amounts included in the measurement of lease liabilities: Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract] International equities Defined Benefit Plan, Equity Securities, Non-US [Member] Scenario [Axis] Scenario [Axis] Plan amendment Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment Accounts and other receivables, net Increase (Decrease) in Accounts and Other Receivables Issuance costs Debt Issuance Cost, Gross, Noncurrent Impairment of intangible assets Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] Net amounts favorably affecting tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate Hedging Relationship [Domain] Hedging Relationship [Domain] Additions Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] Offsetting Assets [Table] Offsetting Assets [Table] Fair value of derivatives Derivative Liability, Current Payments on debt and finance lease obligations Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security Entity Interactive Data Current Entity Interactive Data Current State income taxes Deferred Tax Assets, State Taxes 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Four Settlements Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities Retirement Plan Name [Axis] Retirement Plan Name [Axis] Change in fair value of contingent consideration liabilities, net Change in fair value of contingent consideration liabilities, net (Note 11) Change in fair value of contingent consideration liabilities, net Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Uncertain tax positions (Note 17) Liability for Uncertainty in Income Taxes, Noncurrent Balance Sheet Location [Domain] Balance Sheet Location [Domain] Unrecognized tax benefits Uncertain gross tax positions, beginning balance Uncertain gross tax positions, ending balance Unrecognized Tax Benefits Income Tax Authority [Domain] Income Tax Authority [Domain] Total deferred tax assets Deferred Tax Assets, Gross Schedule of Net Operating Loss Carryforwards Summary of Operating Loss Carryforwards [Table Text Block] Non-service cost components of net periodic pension benefit cost Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Gross Unrealized Gains Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax Entity Address, State or Province Entity Address, State or Province Previous Acquisitions Previous Acquisitions [Member] Previous Acquisitions Value of Shares as % of Contract Value Percentage of shares repurchased Accelerated Share Repurchases, Value Of Shares Repurchased As Percentage Of Contract Amount Represents the value of the initial shares repurchased as a percentage of the contract amount under accelerated share repurchase agreement. Accrued marketing expenses Accrued Marketing Costs, Current Deferred income taxes Deferred Income Tax Assets, Net 2013 Notes Senior Notes Due 2018 [Member] Represents information pertaining to senior notes which are due in 2018. Current liabilities Liabilities, Current [Abstract] Valuation Allowance Operating Loss Carryforwards, Valuation Allowance Audit Information [Abstract] Audit Information [Abstract] Number of lawsuits that if settled could have a material adverse impact on net income or cash flows Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number Due after 5 years through 10 years Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling after Five through Ten Years Exercisable as of period end (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Equity Securities Equity Securities [Member] Accounting Policies [Abstract] Accounting Policies [Abstract] 2025 Defined Benefit Plan, Expected Future Benefit Payment, Year Four Foreign government bonds Debt Security, Government, Non-US [Member] Outstanding as of period end Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Derivative Instrument [Axis] Derivative Instrument [Axis] Retirement Plan Sponsor Location [Axis] Retirement Plan Sponsor Location [Axis] Federal Current Federal Tax Expense (Benefit) Accelerated Share Repurchases, Date [Axis] Accelerated Share Repurchases, Date [Axis] Total operating lease liabilities Total lease liabilities Operating Lease, Liability Document Transition Report Document Transition Report Common stock, $1.00 par value, 1,050.0 shares authorized, 642.0 and 636.4 shares issued, and 624.1 and 624.3 shares outstanding, respectively Common Stock, Value, Issued Benefits from uncertain tax positions Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves Weighted-average remaining requisite service period (in months) Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Annual award to nonemployee director Share-based Compensation Arrangements Award Granted Annually to Nonemployee Director [Member] This element represents details pertaining to an award granted annually to a nonemployee director. Beginning balance (in dollars per share) Ending balance (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value LEASES Lessee, Operating Leases [Text Block] Instruments not due at a single maturity date (a) Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value Underfunded status Defined Benefit Plan, Funded (Unfunded) Status of Plan ACQUISITIONS Business Combination Disclosure [Text Block] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Schedule of Weighted-Average Assumptions for Options Granted Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Outside of the United States, including Puerto Rico Deferred Foreign Income Tax Expense (Benefit) INVESTMENTS Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Dilutive effect of stock plans (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Carrying amount of goodwill Goodwill [Line Items] Accrued liabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities Reconciliation of Beginning and Ending Amount of Uncertain Tax Positions Summary of Income Tax Contingencies [Table Text Block] Income Tax Authority [Axis] Income Tax Authority [Axis] Europe Europe Europe Segment [Member] Represents the Europe reportable segment of the entity. Work in process Inventory, Work in Process, Net of Reserves MRSUs Market Based Restricted Stock Units [Member] Market Based Restricted Stock Units [Member] Prior service credit arising during period Other Comprehensive Income (Loss) before Reclassifications, Tax Selling, general, and administrative expenses Selling, general, and administrative expenses Selling, General and Administrative Expenses [Member] Net sales Total segment net sales Revenue from Contract with Customer, Excluding Assessed Tax Due after 1 year through 5 years Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost Finished products Inventory, Finished Goods, Net of Reserves Surgical Structural Heart Surgical Heart Valve Therapy [Member] This element represents the surgical heart valve therapy product line. Consolidation Items [Domain] Consolidation Items [Domain] Equity [Abstract] Equity [Abstract] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Measurement Input Type [Domain] Measurement Input Type [Domain] Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion) Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax Fair value, less than 12 months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months Variable Rate [Axis] Variable Rate [Axis] SEGMENT INFORMATION Segment Reporting Disclosure [Text Block] Abbott Laboratories Abbott Laboratories [Member] Abbott Laboratories [Member] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-sale [Line Items] Increase (Decrease) in Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Document Fiscal Year Focus Document Fiscal Year Focus Variable Rate [Domain] Variable Rate [Domain] Additional Paid-in Capital Additional Paid-in Capital [Member] Cash flow and net investment hedges Deferred Tax Assets, Hedging Transactions 2024-2026 Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Company match, second level (as a percent) Defined Contribution Plan, Employer Matching Contribution Percent of Match, Second Level Percentage employer matches for the second level of the employee's percentage contribution matched. Maximum additional option to acquire investment Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment Tax benefit of accrued interest Unrecognized Tax Benefits, Accrued Interest, Tax Benefit The tax benefits pertaining to the amount of interest expense accrued on unrecognized tax benefits. Nondeductible employee share-based compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount Other income, net (Note 16) Other income, net Other income, net Total other income, net Other Nonoperating Income (Expense) Other Payments for (Proceeds from) Other Investing Activities Maximum High Maximum [Member] Raw materials Inventory, Raw Materials, Net of Reserves Japan JAPAN Purchased in May 2019 and sold in June 2019 May 2019 Stock Repurchase Program, Shares Sold In June 2019 [Member] May 2019 Stock Repurchase Program, Shares Sold In June 2019 [Member] Award Type [Axis] Award Type [Axis] Schedule of Lessee, Operating Lease, Liability, Maturity Lessee, Operating Lease, Liability, Maturity [Table Text Block] Total stockholders' equity Beginning balance Ending balance Stockholders' Equity Attributable to Parent Contingent consideration liabilities Obligations, Fair Value Disclosure City Area Code City Area Code Accounts payable and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Exercisable as of period end Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Schedule of Cash Flow Information Schedule of Cash Flow, Supplemental Disclosures [Table Text Block] Derivatives designated as hedging instruments Designated as Hedging Instrument [Member] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Intellectual property litigation expenses, net Intellectual Property Litigation Expense Represents the net amount of judgment or settlement awarded to (against) the entity and legal, forensic, accounting, investigative fees and other expenses related to intellectual property litigation. Finished goods inventories held on consignment Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross Gross Unrealized Gains Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain Purchases of treasury stock Payments for Repurchase of Common Stock Estimated useful life (in years) Property, Plant and Equipment, Useful Life Consideration per share to be transferred (in dollars per share) Business Acquisition, Share Price Stockholders' equity (Notes 14 and 21) Stockholders' Equity Attributable to Parent [Abstract] Carryforward Period Ends 2026-2039 Tax Carryforwards Expiration Period Years 2026-2039 [Member] Tax Carryforwards Expiration Period Years 2026-2039 [Member] Stock Repurchase Program May 2021 May 2021 Stock Repurchase Program [Member] May 2021 Stock Repurchase Program Treasury Stock Equity, Class of Treasury Stock [Line Items] Due after 1 year through 5 years Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value Land Land Operating lease liabilities (Note 6) Operating lease liabilities, long-term portion Operating Lease, Liability, Noncurrent Net deferred tax assets increase Increase (Decrease) in Deferred Tax Assets (Liabilities), Net The increase or decrease during the year in net deferred tax assets. Includes items recorded to stockholders' equity and which did not impact the income tax provision. Current income tax expense Current Income Tax Expense (Benefit) Fixed-rate unsecured senior notes Debt Instrument, Face Amount Net periodic pension benefit cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Total Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax Assets Derivative Asset [Abstract] Income tax benefit Share-based Payment Arrangement, Expense, Tax Benefit Operating segments Operating Segments [Member] Carryforward Amount Capital Loss Carryforwards Capital Loss Carryforwards Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Stock compensation plan Share-based Payment Arrangement [Member] Lease term (in years) Lessee, Operating Lease, Term of Contract Puerto Rico PUERTO RICO Derivatives designated as hedging instruments Derivatives, Fair Value [Line Items] Restricted stock units Nonvested restricted stock unit activity Restricted Stock Units (RSUs) [Member] Charged to Other Accounts SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account Total deferred tax liabilities Deferred Tax Liabilities, Gross Business Acquisition [Line Items] Business Acquisition [Line Items] Equity securities Defined Benefit Plan, Equity Securities [Member] Share Repurchase Program [Axis] Share Repurchase Program [Axis] Carrying value of equity method investments Equity Method Investments Schedule of Restricted Cash Restrictions on Cash and Cash Equivalents [Table Text Block] Income Statement [Abstract] Income Statement [Abstract] Entity Registrant Name Entity Registrant Name Deductions SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction Offsetting Liabilities [Line Items] Offsetting Liabilities [Line Items] Participant contributions Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant Other Effective Income Tax Rate Reconciliation, Other Adjustments, Amount Options forfeited (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Provision for income taxes (Note 17) Provision for income taxes Total income tax provision Income Tax Expense (Benefit) 2024 Defined Benefit Plan, Expected Future Benefit Payment, Year Three Accounts receivable, net of allowances of $9.3 and $9.6, respectively Accounts Receivable, after Allowance for Credit Loss, Current Inventories Deferred Tax Assets, Inventory Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Entity Tax Identification Number Entity Tax Identification Number Change in fair value of plan assets: Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] Pre-Tax Amount Other Comprehensive Income (Loss), before Tax [Abstract] Investment Type [Axis] Investment Type [Axis] Document Fiscal Period Focus Document Fiscal Period Focus Total current assets Assets, Current Company match of eligible compensation after dollar-for-dollar basis (as a percent) Defined Contribution Plan, Employer Matching Contribution Percent, Second Level Represents the percentage of the second level of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan. Total lease payments Lessee, Operating Lease, Liability, to be Paid Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Amount of gain (loss) reclassified from accumulated OCI into income Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] Stock issued to effect stock split (in shares) Stock Issued During Period, Shares, Stock Splits Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Derivative Instruments, Gain (Loss) Derivative Instruments, Gain (Loss) [Line Items] Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Schedule of the Effect of Fair Value and Cash Flow Hedge Disclosure Of Fair Value Hedging Instruments And Cash Flow Hedging Instruments, Statements Of Financial Performance And Financial Position, Location [Table Text Block] Disclosure Of Fair Value Hedging Instruments And Cash Flow Hedging Instruments, Statements Of Financial Performance And Financial Position, Location [Table Text Block] Period used to evaluate slow-moving inventory levels (in years) Inventory Write Down Slow Moving Period Trigger The time period used to identify slow-moving inventory which triggers an inventory write-down. Fair value, per share (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Equity Component [Domain] Equity Component [Domain] Other receivables Other Receivables 2022 Lessee, Operating Lease, Liability, to be Paid, Year One Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Additional research and development expenditures to be incurred prior to product introduction Business Combination, In-process Research and Development, Expected Costs Business Combination, In-process Research and Development, Expected Costs Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Defined Benefit Plan, Plan Assets, Category [Axis] Defined Benefit Plan, Plan Assets, Category [Axis] Deferred tax assets Components of Deferred Tax Assets [Abstract] Litigation Case [Axis] Litigation Case [Axis] Domestic Plan Domestic Plan [Member] Restricted cash included in other assets Restricted Cash, Noncurrent Available-for-Sale Available-for-sale Securities, Debt Maturities [Abstract] Schedule of Target Weighted-Average Asset Allocations and Fair Value Schedule of Allocation of Plan Assets [Table Text Block] Cost Intangible Assets, Gross (Excluding Goodwill) 2025 Lessee, Operating Lease, Liability, to be Paid, Year Four Weighted Average Weighted Average [Member] Income before provision for income taxes Consolidated pre-tax income Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Level 2 Fair Value, Inputs, Level 2 [Member] Auditor Location Auditor Location Amount of Gain or (Loss) Recognized in Income on Derivative Derivative, Gain (Loss) on Derivative, Net Total fair value Debt Securities, Available-for-sale, Unrealized Loss Position Segment Reporting [Abstract] Segment Reporting [Abstract] Amortized Cost Debt Securities, Available-for-sale, Amortized Cost Weighted-Average Useful Life (in years) Finite-Lived Intangible Asset, Useful Life Compensation and benefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits Use of Estimates Use of Estimates, Policy [Policy Text Block] Schedule of Computation of Basic and Diluted Earnings Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Other comprehensive income (loss), net of tax Other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Carryforward Period Ends 2022 Capital Loss Carryforward Period Ends 2024 [Member] Capital Loss Carryforward Period Ends 2022 [Member] Title of 12(b) Security Title of 12(b) Security Investment, Name [Domain] Investment, Name [Domain] Instruments not due at a single maturity date (a) Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost Common stock, shares authorized (in shares) Common Stock, Shares Authorized Decrease in non-marketable equity securities due to observable price changes Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount Net income Net income Net Income (Loss) Available to Common Stockholders, Basic Document Type Document Type Schedule of Restricted Stock Unit Activity Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Product and Service [Domain] Product and Service [Domain] OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS Supplemental Balance Sheet Disclosures [Text Block] Purchased in February 2021 and sold in March 2021 February 2021 Stock Repurchase Program, Shares Sold In March 2021 [Member] February 2021 Stock Repurchase Program, Shares Sold In March 2021 Fixed interest rate Debt Instrument, Interest Rate, Stated Percentage Credit agreement, maturity July 2019 Credit Agreement, Maturity July 2019 [Member] Represents the credit agreement with a maturity of July 2019. Net Amount Derivative Asset, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election Property, payroll, and other taxes Accrual for Property Payroll and Other Taxes Other than Income Taxes Current Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes, payroll taxes and other taxes, excluding income taxes payable. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Tax reductions compared to local statutory rates Income Tax Holiday, Aggregate Dollar Amount Deferred tax on foreign earnings Deferred Tax Liabilities, Undistributed Foreign Earnings Measurement Frequency [Axis] Measurement Frequency [Axis] Reclassification of net realized investment loss to earnings Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax Tax valuation allowance SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member] Geographical [Axis] Geographical [Axis] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Weighted- Average Remaining Contractual Term Weighted Average Remaining Contractual Term Years [Abstract] Other Other Investments [Member] Cash balance interest crediting rate (as a percent) Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Weighted-Average Interest Crediting Rate State and local jurisdiction United States state net operating losses California research expenditure tax credits State and Local Jurisdiction [Member] Net investment hedges Net Investment Hedging [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Weighted-average interest rate under all debt obligations (as a percent) Long-term Debt, Weighted Average Interest Rate, at Point in Time Cash Collateral Received Derivative, Collateral, Right to Reclaim Cash SUBSEQUENT EVENT Subsequent Events [Text Block] Foreign income taxed at different rates Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount Gain on investments Gain (Loss) on Investments, Other Income Expense, Net This item represents the portion of gain (loss) on investments categorized by the entity as other income (expense). Includes, but is not limited to, (1) the net realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including those trading securities held for investment under deferred compensation agreements net of the gain (loss) of the related deferred compensation liability; (2) the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied; (3) gains (losses) realized during the period from the sale of investments accounted for under the cost method of accounting; (4) losses recognized for other than temporary impairments (OTTI) of the subject investments; and (5) the amount of recovery of investments which had previously been fully or partially written-off. Investments Investment, Policy [Policy Text Block] Share information (Note 2): Share Information [Abstract] Net prior service cost arising during period Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member] Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Treasury stock, at cost, 17.9 and 12.1 shares, respectively Treasury Stock, Value Weighted-average number of common shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Vesting period (in years) Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Accounts receivable, required payment terms (in days) Accounts Receivable, Payment Terms Accounts Receivable, Payment Terms FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Three Legal and insurance (Notes 3 and 18) Accrued Litigation And Insurance Reserves Accrued Litigation And Insurance Reserves Net Tax Benefit Tax Credit Carryforward, Deferred Tax Asset, Net of Valuation Allowance Represents the amount after allocation of valuation allowances of deferred tax asset attributable to tax credit carryforwards. Non-U.S. Non-United States net operating losses Foreign tax authority Foreign Tax Authority [Member] Equipment with customers Equipment with Customers The gross amount, as of the balance sheet date, of long-lived, depreciable equipment at customer locations. Gain (loss) on cash flow hedging relationships: Effect of Cash Flow Hedges on Results of Operations [Abstract] Foreign earnings to be repatriated Foreign Earnings To Be Repatriated Foreign Earnings To Be Repatriated Tax (Expense) Benefit Other Comprehensive Income (Loss), Tax [Abstract] Derivative [Table] Derivative [Table] Segment Net Sales Net Sales by Geographic Area and by Major Product Area Revenues [Abstract] Maximum secured promissory note Equity Securities, FV-NI, Maximum Secured Promissory Note Equity Securities, FV-NI, Maximum Secured Promissory Note Document Period End Date Document Period End Date Investments in intangible assets and in-process research and development Payments to Acquire Intangible Assets Due after 1 year through 5 years Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling after One through Five Years Total plan assets measured at fair value Fair Value, Inputs, Level 1, 2 and 3 [Member] Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] State and local Deferred State and Local Income Tax Expense (Benefit) Cash flows from investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Award Date [Domain] Award Date [Domain] Term of the credit agreement (in years) Debt Instrument, Term Income Statement Location [Domain] Income Statement Location [Domain] Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-sale [Table] Non-cash investing and financing transactions: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Dollar-for-dollar match of employee's annual eligible compensation (as a percent) Defined Contribution Plan Employer Matching Contribution Percent, First Level Represents the percentage of the first level of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan. Acquisition transaction costs Business Acquisition, Transaction Costs Property, plant, and equipment, net (Note 5) Total property, plant and equipment, net Property, Plant and Equipment, Net Schedule of Estimated Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Earnings per share: Earnings Per Share [Abstract] Upward price adjustments Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount Total property, plant and equipment, gross Property, Plant and Equipment, Gross Amortization of prior service credit Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Carryforward Period Ends 2030-2037 Carryforward Period Ends 2030-2037 [Member] Carryforward Period Ends 2030-2037 [Member] Bank time deposits Bank Time Deposits [Member] Foreign currency contracts Foreign Exchange Contract [Member] Other liability Other Liabilities, Fair Value Disclosure Beginning balance (in dollars per share) Ending balance (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Number of investments in an unrealized loss position Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions Initial Delivery of Shares Settled February 2021 Initial Delivery Of Shares Settled February 2021 [Member] Initial Delivery Of Shares Settled February 2021 Patents Patents [Member] Additional federal tax Income Tax Examination, Estimate of Possible Loss Debt Securities, Trading, and Equity Securities, FV-NI [Table] Debt Securities, Trading, and Equity Securities, FV-NI [Table] Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Europe Europe [Member] Entity Current Reporting Status Entity Current Reporting Status Weighted- Average Grant-Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Beginning of year End of year Plan assets at fair value Defined Benefit Plan, Plan Assets, Amount Expected employer contributions Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year Schedule of Investments in Unconsolidated Affiliates Schedule of Investments in and Advances to Affiliates, Schedule of Investments [Table Text Block] Beginning balance (in shares) Ending balance (in shares) Shares, Issued Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward, Name [Domain] United States UNITED STATES Product Information [Line Items] Product Information [Line Items] Measurement Input, Discount Rate Measurement Input, Discount Rate [Member] Schedule of Information Regarding Defined Benefit Pension Plans Defined Benefit Plan, Change in Benefit Obligation Plan Assets, Net Amount Recognized on Balance Sheet [Table Text Block] This element represents the changes in benefit obligations, plan assets and the net amount recognized in the balance sheet for defined benefit plans. Award Date [Axis] Award Date [Axis] Leases [Abstract] Leases [Abstract] Income Taxes Income Tax, Policy [Policy Text Block] LIBOR London Interbank Offered Rate (LIBOR) [Member] Accumulated Other Comprehensive Loss Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Proceeds from sales and maturities of held-to-maturity investments (Note 7) Proceeds from Sale and Maturity of Held-to-maturity Securities Amounts reclassified from accumulated other comprehensive loss Reclassification from AOCI, Current Period, before Tax, Attributable to Parent Entity Address, Postal Zip Code Entity Address, Postal Zip Code Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Due after 5 years through 10 years Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Rolling after Five Through Ten Years, Fair Value Diluted (in shares) Dilutive weighted-average shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted United States Income (Loss) from Continuing Operations before Income Taxes, Domestic Collections of notes receivable Proceeds from Collection of Notes Receivable INCOME TAXES Income Tax Disclosure [Text Block] Lease liability obligations Deferred Tax Assets, Lease Liability Obligations Deferred Tax Assets, Lease Liability Obligations Contingent Consideration Contingent Consideration Liability [Member] Contingent Consideration Liability Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Schedule of Stock Option Activity Share-based Payment Arrangement, Option, Activity [Table Text Block] Basis spread on variable rate (as a percent) Debt Instrument, Basis Spread on Variable Rate Due in 1 year or less Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost Schedule of Net Periodic Benefit Cost Schedule of Net Benefit Costs [Table Text Block] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Weighted-average discount rate (in years) Lessee, Operating Lease, Discount Rate Derivatives not designated as hedging instruments Not Designated as Hedging Instrument [Member] Credit Facility [Axis] Credit Facility [Axis] Valtech Valtech Cardio, Ltd [Member] Valtech Cardio, Ltd [Member] Indefinite-lived Intangible Assets [Line Items] Indefinite-lived Intangible Assets [Line Items] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Entity Address, Address Line One Entity Address, Address Line One Retirement Plan Sponsor Location [Domain] Retirement Plan Sponsor Location [Domain] Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Principles of Consolidation Consolidation, Policy [Policy Text Block] Entity Shell Company Entity Shell Company Accrued and other liabilities (Note 5) Total accrued and other liabilities Accrued And Other Liabilities, Current Expected life (in years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Total current liabilities Liabilities, Current ESPP Employee Stock [Member] Hedged items Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge Measurement Input, Volatility of Future Revenue Measurement Input, Volatility Of Future Revenue [Member] Measurement Input, Volatility Of Future Revenue [Member] CAS Medical Systems, Inc. CAS Medical Systems, Inc. [Member] CAS Medical Systems, Inc. [Member] Foreign currency forward exchange contracts Foreign Exchange Forward [Member] Amounts reclassified from accumulated other comprehensive loss to affected line on Consolidated Statements of Operations Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Amount Reclassified from Accumulated Other Comprehensive Loss Reclassification out of Accumulated Other Comprehensive Income [Member] Loss Contingencies [Table] Loss Contingencies [Table] Vested and expected to vest as of period end Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Current Fiscal Year End Date Current Fiscal Year End Date Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Rest of World Rest of World [Member] Represents the geographic areas of the world other than the United States, Europe and Japan. Statement [Table] Statement [Table] New Accounting Standards Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Other Deferred Tax Assets, Other 2026 Defined Benefit Plan, Expected Future Benefit Payment, Year Five Employee stock purchase subscriptions Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Schedule of Change in Unrealized Pension Costs Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block] Estimated annual forfeiture rate (as a percent) Estimated Annual Forfeiture Rate Percent This element represents the estimated annual forfeiture rate of the entity's stock-based compensation plans, percentage. Statistical Measurement [Axis] Statistical Measurement [Axis] Accounts Receivable Accounts Receivable [Policy Text Block] Subsequent Event Subsequent Event [Member] Net Carrying Value Finite-Lived Intangible Assets, Net Goodwill (Note 9) Beginning balance Ending balance Goodwill Cash Defined Benefit Plan, Cash and Cash Equivalents [Member] Company match, first level (as a percent) Defined Contribution Plan, Employer Matching Contribution Percent of Match First Level Percentage employer matches for the first level of the employee's percentage contribution matched. Derivative Assets Offsetting Derivative Assets [Abstract] Accrued and other liabilities Accrued Liabilities and Other Liabilities [Abstract] Gross unrealized losses, less than 12 months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss Period prior to expiration date which triggers write-down of inventory (in months) Inventory Write Down Expiration Period Trigger The period prior to the expiration date which triggers the write down of inventory, expressed in months. Alternative investments measured at net asset value Fair Value Measured at Net Asset Value Per Share [Member] Tax credits, federal and state Effective Income Tax Rate Reconciliation, Tax Credit, Amount Schedule of Changes in the Carrying Amount of Goodwill, by Segment Schedule of Goodwill [Table Text Block] Scenario [Domain] Scenario [Domain] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Operating lease cost Operating Lease, Cost Increase in non-marketable equity securities due to observable price changes Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount Unrealized Pension Costs Unrealized pension costs, net Amortization of pension adjustments Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Investment option to acquire Equity Securities, FV-NI, Option To Acquire Investment Equity Securities, FV-NI, Option To Acquire Investment Gross unrealized losses, 12 months or greater Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss Maximum contributions of a participant's eligible compensation (as a percent) Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent Deferred income tax (benefit) expense Deferred Income Tax Expense (Benefit) Vested and expected to vest as of period end Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Amortized Cost Debt Securities, Available-for-sale, Maturity, Amortized Cost, Rolling Maturity [Abstract] Authorized amount for share repurchase Amount Paid Stock Repurchase Program, Authorized Amount Hedging Designation [Domain] Hedging Designation [Domain] Revenue recognized that was previously deferred excluding opening balance Contract With Customer, Liability, Revenue Recognized Excluding Opening Balance Contract With Customer, Liability, Revenue Recognized Excluding Opening Balance Earnings per Share Earnings Per Share, Policy [Policy Text Block] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Operating lease right-of-use assets (Note 6) Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Schedule of Derivative Financial Instruments Used to Manage Currency Exchange and Interest Rate Risk Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Tax Benefit Amount Deferred Tax Assets, Operating Loss Carryforwards Interest cost Interest cost Defined Benefit Plan, Interest Cost Employee compensation and withholdings Employee-related Liabilities, Current Income Statement Location [Axis] Income Statement Location [Axis] Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Statistical Measurement [Domain] Statistical Measurement [Domain] Credit Agreement Maturity April 2023 Credit Agreement Maturity April 2023 [Member] Credit Agreement Maturity April 2023 [Member] Schedule of Effect of Master-Netting Agreements and Rights of Offset, Assets Offsetting Assets [Table Text Block] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Additional paid-in capital Additional Paid in Capital, Common Stock Other assets Other Assets, Noncurrent Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Segments [Axis] Segments [Axis] Special charges (Note 4) Special charges Other Nonrecurring (Income) Expense Instruments not due at a single maturity date (a) Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, without Single Maturity Date Expected dividend yield (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Retirement Benefits [Abstract] Retirement Benefits [Abstract] In-process research and development In Process Research and Development [Member] Entity File Number Entity File Number Price equal to principal amount, plus accrued and unpaid interest (as a percent) Debt Instrument, Redemption Price, Percentage Schedule of Other Expense, Net Schedule of Other Nonoperating Income (Expense) [Table Text Block] Stock-based compensation expense APIC, Share-based Payment Arrangement, Increase for Cost Recognition Valuation and Qualifying Accounts Disclosure SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] Retirement Plan Name [Domain] Retirement Plan Name [Domain] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Intellectual property litigation expenses, net (Note 3) Intellectual property litigation expenses Litigation Settlement, Expense Other current assets Other Current Assets [Member] Liability Class [Axis] Liability Class [Axis] Granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Facility fee (as a percent) Line of Credit Facility, Commitment Fee Percentage Actual return on plan assets Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss) Municipal securities Municipal securities Municipal Bonds [Member] Unrealized (loss) gain on available-for-sale investments OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Share Repurchase Program [Domain] Share Repurchase Program [Domain] Credit Facility [Domain] Credit Facility [Domain] ASSETS Assets [Abstract] Revenue, Initial Application Period Cumulative Effect Transition [Table] Revenue, Initial Application Period Cumulative Effect Transition [Table] Vested and expected to vest as of period end (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Other Liability Other Liabilities [Member] DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES Derivative Instruments and Hedging Activities Disclosure [Text Block] Segment reconciling items Segment Reconciling Items [Member] Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill and Intangible Assets Disclosure [Text Block] Property, Plant and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Beginning balance (in shares) Ending balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Discount rate (as a percent) Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate Debt Instrument [Axis] Debt Instrument [Axis] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Available-for-sale Debt Securities, Available-for-sale [Abstract] LEGAL PROCEEDINGS Commitments and Contingencies Disclosure [Text Block] Cash balance interest crediting rate (as a percent) Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate Build of reserve for prior years' uncertain tax positions Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount Financial Instruments Derivative Liability, Not Offset, Policy Election Deduction Interest expense (benefit), net of tax benefit Unrecognized Tax Benefits, Interest on Income Taxes Expense Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Amortization of prior service credit Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Contingent consideration liability measurement input Business Combination, Contingent Consideration, Liability, Measurement Input Litigation settlement accrual Increase (Decrease) In Legal Settlement Accrual Increase (Decrease) In Legal Settlement Accrual Net Tax Benefit Deferred Tax Assets Operating Loss Carryforwards Net of Valuation Allowance Represents the amount after allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. Right-of-use assets obtained in exchange for new lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Schedule of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Maximum percentage of compensation employees can authorize to be withheld for common stock purchases (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate Maximum additional required investment Equity Securities, FV-NI, Maximum Additional Required Equity Securities, FV-NI, Maximum Additional Required Percentage vesting upon retirement for each full year of employment subsequent to the grant date (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Target asset allocations (as a percent) Defined Benefit Plan, Plan Assets, Target Allocation, Percentage Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Tax Credit Carryforward [Table] Tax Credit Carryforward [Table] Other comprehensive income (loss) Other Comprehensive Income (Loss), before Tax Initial Delivery of Shares Settled June 2019 Initial Delivery Of Shares Settled June 2019 [Member] Initial Delivery Of Shares Settled June 2019 [Member] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Unrealized pension credits (costs) Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax United States government and agency securities US Treasury and Government [Member] 2024 Lessee, Operating Lease, Liability, to be Paid, Year Three Lease commitments for leases not yet commenced Lessee, Operating Lease, Lease Not Yet Commenced, Amount Lessee, Operating Lease, Lease Not Yet Commenced, Amount Allowance for doubtful accounts SEC Schedule, 12-09, Allowance, Credit Loss [Member] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] Schedule of Product Information [Table] Schedule of Product Information [Table] Prepaid expenses Prepaid Expense, Current Matching contributions relating to entity's employees Defined Contribution Plan, Cost Shipping and Handling Shipping and Handling [Member] Shares Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Machinery and equipment Machinery and Equipment, Gross Net tax credit carryforwards Deferred Tax Assets, Tax Credit Carryforwards Amount of Gain or (Loss) Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing) Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred Common stock available for issuance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Operating cash flows from operating leases Operating Lease, Payments Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Debt Securities, Held-to-maturity [Table] Debt Securities, Held-to-maturity [Table] Cash purchase price Business Combination, Consideration Transferred Due in 1 year or less Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling within One Year Long-lived Tangible Assets by Geographic Area Geographic Areas, Long-Lived Assets [Abstract] Amount Long-term Debt, Gross Goodwill Goodwill [Roll Forward] Profit sharing contribution calculated on eligible earnings (as a percent) Defined Contribution Plan Profit Sharing Contribution Rate For a defined contribution plan, the percent of the participant's eligible compensation that the employer will contribute to the profit sharing plan. Total assets Assets, Fair Value Disclosure Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Investment after first milestone Equity Securities, FV-NI, Investment After First Milestone Equity Securities, FV-NI, Investment After First Milestone General and administrative costs included in inventory General and Administrative Costs in Inventory, Amount Remaining Total liabilities and stockholders' equity Liabilities and Equity Other accrued liabilities Other Accrued Liabilities, Current Investments, Debt and Equity Securities [Abstract] Investments, Debt and Equity Securities [Abstract] ESPP Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan [Member] Unrealized gain (loss) on hedges Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Other Income and Expenses [Abstract] Other Income and Expenses [Abstract] 2026 Lessee, Operating Lease, Liability, to be Paid, Year Five Proceeds from sales and maturities of available-for-sale investments (Note 7) Proceeds from Sale and Maturity of Debt Securities, Available-for-sale Options exercised (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Due after 5 years through 10 years Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Through Ten Years, Fair Value Benefits paid Defined Benefit Plan, Plan Assets, Benefits Paid Net Amount Derivative Liability, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Offsetting Liabilities [Table] Offsetting Liabilities [Table] Stock issued to effect stock split Adjustments to Additional Paid in Capital, Stock Split Derivative [Line Items] Derivative [Line Items] Property, plant, and equipment, net Property, Plant and Equipment, Net [Abstract] Held-to-maturity Debt Securities, Held-to-Maturity, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract] Amortization of prior service credit Reclassification from AOCI, Current Period, Tax Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Purchases of treasury stock Treasury Stock, Value, Acquired, Cost Method Equity method investment, ownership percentage (as a percent) Equity Method Investment, Ownership Percentage Foreign Plan Foreign Plan [Member] 2023 Defined Benefit Plan, Expected Future Benefit Payment, Year Two Minimum Low Minimum [Member] Other Increase (Decrease) in Other Operating Assets and Liabilities, Net Gross profit Gross Profit Realized tax benefits from exercises of stock options and vesting of restricted stock units Employee Service Share Based Compensation, Tax Benefit Realized from Exercise of Stock Options and Vesting of Restricted Stock Units Disclosure of aggregate tax benefit realized from the exercise of stock options and vesting of restricted stock units during the period. Borrowings outstanding Long-term Line of Credit 2023 Lessee, Operating Lease, Liability, to be Paid, Year Two Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Total liabilities Financial and Nonfinancial Liabilities, Fair Value Disclosure Income before provision for income taxes Total segment operating income Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Selling, general, and administrative expenses Selling, general, and administrative expenses Selling, General and Administrative Expense Pension increase (as a percent) Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Pension Increase This element represents the percentage of increase in pension. Unamortized debt issuance costs Debt Issuance Costs, Net Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Other comprehensive income (loss), net of tax (Note 15): Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Preferred stock, authorized shares (in shares) Preferred Stock, Shares Authorized Amortized Cost Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity [Abstract] Schedule of Components of Selected Captions in the Consolidated Balance Sheets Schedule of Selected Captions Balance Sheet Disclosures [Table Text Block] Schedule of the aggregate supplemental balance sheet disclosures, including descriptions and amounts, related to assets and liabilities. Fair value, 12 months or greater Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer Puerto Rico purchases credit Puerto Rico Purchases Credit [Member] Puerto Rico Purchases Credit [Member] Foreign Currency Translation Adjustments Foreign currency translation adjustments Accumulated Foreign Currency Adjustment Attributable to Parent [Member] DEBT AND CREDIT FACILITIES Debt Disclosure [Text Block] Net amounts recognized on the consolidated balance sheet: Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract] Schedule of Provision for Income Taxes Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Due in 1 year or less Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value Credit Facility Line of Credit [Member] Issuances of notes receivable Increase (Decrease) in Notes Receivables Senior Notes Senior Notes [Member] Level 3 Fair Value, Inputs, Level 3 [Member] Leases Lessee, Leases [Policy Text Block] Accrued professional services Accrued Professional Fees, Current Deferred income tax benefit Defined Benefit Plan, Accumulated Other Comprehensive Income, Deferred Income Tax Expense (Benefit), Net of Tax Defined Benefit Plan, Accumulated Other Comprehensive Income, Deferred Income Tax Expense (Benefit), Net of Tax Foreign exchange gains, net Foreign currency Foreign Currency Transaction Gain (Loss), before Tax Non-operating income Nonoperating Income (Expense) Inventories Inventory, Net [Abstract] Commitments and contingencies (Notes 6, 10, and 18) Commitments and Contingencies Subsequent Event [Table] Subsequent Event [Table] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Emerging Growth Company Entity Emerging Growth Company Class of Treasury Stock [Table] Class of Treasury Stock [Table] Allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss, Current Inventory write off (Note 2) Inventory Write-down Contingent consideration liabilities Effective Income Tax Rate Reconciliation, Contingent Consideration Liability Effective Income Tax Rate Reconciliation, Contingent Consideration Liability Currency exchange rate changes and other Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss) Fair Value Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract] Auditor Name Auditor Name Cover [Abstract] Cover [Abstract] Enterprise-Wide Information Revenues from External Customers and Long-Lived Assets [Line Items] Corporate items Costs and Expenses Prior service credit arising during period Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Royalty expense Royalty Expense Gain (loss) on fair value hedging relationships: Effect of Fair Value Hedges on Results of Operations [Abstract] Kardion, Inc. Kardion, Inc. [Member] Kardion, Inc. Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Treasury stock, shares (in shares) Treasury Stock, Shares Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Rate of compensation increase (as a percent) Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase California CALIFORNIA United States federal deductible employee share-based compensation Effective Income Tax Rate Reconciliation, Deduction, Share-based Compensation Cost, Amount Effective Income Tax Rate Reconciliation, Deduction, Share-based Compensation Cost, Amount Financial Instrument [Axis] Financial Instrument [Axis] Financial Instrument [Axis] United States United States United States Segment [Member] Represents the United States reportable segment of the entity. Schedule of Available-for-sale Securities [Table] Schedule of Available-for-sale Securities [Table] Foreign tax credits Foreign Tax Credit [Member] Foreign Tax Credit Current Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Unallocated amounts: Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract] Gross Unrealized Losses Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss Common Stock Common Stock [Member] Interest income Investment Income, Interest Capital Loss Carryforward [Abstract] Capital Loss Carryforward [Abstract] Capital Loss Carryforward [Abstract] Outside of the United States, including Puerto Rico Income (Loss) from Continuing Operations before Income Taxes, Foreign Operating income Operating income Operating Income (Loss) Derivative Liabilities Offsetting Derivative Liabilities [Abstract] Japan Japan Segment [Member] Represents the Japan reportable segment of the entity. Accumulated other comprehensive loss, net of tax: Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax [Abstract] Operating lease liabilities (Note 6) Operating lease liabilities, current portion Operating Lease, Liability, Current Gross Unrealized Losses Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax 2023 Finite-Lived Intangible Asset, Expected Amortization, Year Two Hedging Designation [Axis] Hedging Designation [Axis] Stock-based compensation (Notes 2 and 14) Share-based Payment Arrangement, Noncash Expense Accumulated Other Comprehensive Income (Loss), Net of Tax AOCI Attributable to Parent, Net of Tax [Roll Forward] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Depreciation expense for property, plant and equipment Depreciation Deferred income tax (expense) benefit Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent Deferred income taxes Increase (Decrease) in Deferred Income Taxes Treasury Stock Treasury Stock [Member] Real estate Defined Benefit Plan, Real Estate [Member] Transcatheter Aortic Valve Replacement Transcatheter Aortic Valve Replacement [Member] Transcatheter Aortic Valve Replacement [Member] Purchases of available-for-sale investments (Note 7) Payments to Acquire Debt Securities, Available-for-sale Net actuarial loss arising during period Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member] Income taxes Income Taxes Paid Notional Amount Derivative, Notional Amount Benefits paid Defined Benefit Plan, Benefit Obligation, Benefits Paid Purchased in-process research and development (Note 4) Research and Development Asset Acquired Other than Through Business Combination, Written-off Currency exchange rate changes and other Currency exchange rate impact Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss) Capital expenditures Payments to Acquire Property, Plant, and Equipment Valuation Allowance Tax Credit Carryforward, Valuation Allowance General and administrative costs allocated to inventory General and Administrative Costs in Inventory, Amount Incurred Accumulated benefit obligation Defined Benefit Plan, Accumulated Benefit Obligation Employer contributions Defined Benefit Plan, Plan Assets, Contributions by Employer United States government bonds US Government Debt Securities [Member] Total liabilities Liabilities 2022 Finite-Lived Intangible Asset, Expected Amortization, Year One Options granted (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Outstanding as of period end Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Consolidation Items [Axis] Consolidation Items [Axis] Measurement Input Type [Axis] Measurement Input Type [Axis] Carryforward Amount Operating Loss Carryforwards Common stock, shares issued (in shares) Common Stock, Shares, Issued Hemodynamic Monitors Hemodynamic Monitors [Member] Hemodynamic Monitors [Member] Due in 1 year or less Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations Defined Benefit Plan, Assumptions [Table Text Block] Entity Address, City or Town Entity Address, City or Town Taxes payable (Note 17) Taxes Payable Threshold of disclosing material environmental legal proceedings Accrual for Environmental Loss Contingencies, Threshold Amount For Disclosure Accrual for Environmental Loss Contingencies, Threshold Amount For Disclosure Schedule of Benefit Payments Which Reflect Expected Future Service Schedule of Expected Benefit Payments [Table Text Block] Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Retirement Plan Type [Axis] Retirement Plan Type [Axis] Interest expense Interest Income [Member] Schedule of Indefinite-Lived Intangible Assets [Table] Schedule of Indefinite-Lived Intangible Assets [Table] Software Software and Software Development Costs [Member] Balance Sheet Location [Axis] Balance Sheet Location [Axis] ACCUMULATED OTHER COMPREHENSIVE LOSS Comprehensive Income (Loss) Note [Text Block] Measurement Frequency [Domain] Measurement Frequency [Domain] Interest expense Interest Expense Deferred Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Expected return on plan assets (as a percent) Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets Effective Interest Rate Debt Instrument, Interest Rate, Effective Percentage 2022 Defined Benefit Plan, Expected Future Benefit Payment, Year One Retained earnings Retained Earnings (Accumulated Deficit) Expiration date (in years) Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Litigation Case [Domain] Litigation Case [Domain] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Entity Filer Category Entity Filer Category Average risk-free interest rate (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Schedule of Effect of Derivative Instruments Derivative Instruments, Gain (Loss) [Table Text Block] Deferred compensation plans Deferred Compensation Cash-based Arrangements, Liability, Classified, Noncurrent Carryforward period indefinite Carryforward Period Indefinite Tax Carryforwards, No Expiration [Member] Represents tax carryforwards with no expiration. Accelerated Share Repurchase Accelerated Share Repurchases [Line Items] Estimate of Fair Value Measurement Estimate of Fair Value Measurement [Member] Schedule of Location and Fair Value Amounts of Derivative Instruments Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block] Held-to-Maturity Debt Securities, Held-to-maturity, Maturity [Abstract] Schedule of Changes in Fair Value of Contingent Consideration Obligation Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Other assets Other Noncurrent Assets [Member] Cash from exercises of stock options Proceeds from Stock Options Exercised In-process research and development Indefinite-lived Intangible Assets (Excluding Goodwill) Short-term investments (Note 7) Short-term Investments Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Schedule of Tax Credit Carryforwards Summary of Tax Credit Carryforwards [Table Text Block] Amendment Flag Amendment Flag Proceeds from issuance of debt Proceeds from Issuance of Long-term Debt Equity Components [Axis] Equity Components [Axis] Movement in Valuation Allowances and Reserves SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Derivatives designated as hedging instruments Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments Inventories (Note 5) Total inventories Inventory, Net Schedule of Information About Reportable Segments and Reconciliation of Segment Net Sales and Pre-Tax Income Schedule of Segment Reporting Information, by Segment [Table Text Block] Options granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Initial Delivery of Shares Settled May 2019 Initial Delivery of Shares Settled May 2019 [Member] Initial Delivery of Shares Settled May 2019 [Member] Federal Deferred Federal Income Tax Expense (Benefit) Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five Estimated net tax liability on permanently reinvested earnings Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Foreign Subsidiaries Contingent consideration liabilities (Notes 8 and 11) Business Combination, Contingent Consideration, Liability, Noncurrent January 2022 Stock Repurchase Program January 2022 Stock Repurchase Program [Member] January 2022 Stock Repurchase Program Product and Service [Axis] Product and Service [Axis] Instruments not due at a single maturity date (a) Debt Securities, Held-to-maturity, Maturity, without Single Maturity Date, Fair Value OTHER INCOME, NET Other Income and Other Expense Disclosure [Text Block] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Entity Public Float Entity Public Float Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Non-cash operating lease cost Operating Lease, Right Of Use Asset Amortization Operating Lease, Right Of Use Asset Amortization Common stock issued under equity plans (in shares) Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture Limit on total value of the award Share Based Goods and Nonemployee Services Transaction Nonemployee Award Value Maximum This element represents the maximum total grant date fair value of stock-based awards that can be granted to nonemployee directors. Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Statement [Line Items] Statement [Line Items] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] Weighted- Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Common stock issued under equity plans Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture United States federal net operating losses Federal research expenditure tax credits Domestic Tax Authority [Member] Retirement Plan Type [Domain] Retirement Plan Type [Domain] Fair Value Fair Value Available-for-sale investments: Debt Securities, Available-for-sale Debt Disclosure [Abstract] Debt Disclosure [Abstract] Tax Period [Axis] Tax Period [Axis] Percentage of lower of fair market value of common stock on effective date of subscription or date of purchase (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Valuation allowance Valuation allowance that reduces certain deferred tax assets Deferred Tax Assets, Valuation Allowance Corporate items Corporate, Non-Segment [Member] Two Previous Acquisitions Two Previous Acquisitions [Member] Two Previous Acquisitions [Member] EMPLOYEE BENEFIT PLANS Retirement Benefits [Text Block] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Accrued interest related to unrecognized tax benefits, net of tax benefit Unrecognized Tax Benefits, Interest on Income Taxes Accrued Document Annual Report Document Annual Report Forecast Forecast [Member] Schedule of Stock-Based Compensation Expense Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Obligations Obligations [Member] United States: Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract] Cash flow hedge loss to be reclassified Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months Nonqualified deferred compensation plans Nonqualified Deferred Compensation Plan Select Employee Group [Member] Represents a nonqualified deferred compensation plan for a select group of employees. Other comprehensive income (loss) Other Comprehensive Income (Loss), Tax Total assets Assets Deferred tax liabilities Components of Deferred Tax Liabilities [Abstract] Plan Name [Domain] Plan Name [Domain] United States equities Defined Benefit Plan, Equity Securities, US [Member] Interest Interest Paid, Excluding Capitalized Interest, Operating Activities Geographical [Domain] Geographical [Domain] Research and development expenses Research and Development Expense Derivative Contract [Domain] Derivative Contract [Domain] Foreign earnings to be indefinitely reinvested Undistributed Earnings of Foreign Subsidiaries Accelerated Share Repurchases [Table] Accelerated Share Repurchases [Table] Other Other Income Expense Items Reflects all other income and expense recognized by the entity in the period not otherwise specified in the income statement. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Accrued and other liabilities Accounts Payable and Accrued Liabilities [Member] Revenue, remaining performance obligation, expected timing of satisfaction, period (in years) Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Carryforward amount Carryforward Amount Tax Credit Carryforward, Amount Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Subsequent Event [Line Items] Subsequent Event [Line Items] Basic: Earnings Per Share, Basic [Abstract] Tax Credit Carryforward [Axis] Tax Credit Carryforward [Axis] Carryforward Period Ends 2020-2027 Tax Carryforwards Expiration Period Years 2020-2027 [Member] Tax Carryforwards Expiration Period Years 2020-2027 [Member] Basic (in shares) Weighted-average shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Diluted (in dollars per share) Diluted earnings per share (in dollars per share) Earnings Per Share, Diluted Segments [Domain] Segments [Domain] Net operating loss carryforwards Deferred Tax Assets Operating Loss Carryforwards Net of Reduction Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards, net of the reduction for the benefit related to windfall to be recorded to additional paid in capital when realized as a reduction to income taxes payable. Service cost Service cost, net Defined Benefit Plan, Service Cost Number of newly issued shares of common stock per holder Stockholders' Equity Note, Stock Split, Number Of Newly Issued Shares Per Holder Stockholders' Equity Note, Stock Split, Number Of Newly Issued Shares Per Holder Total investments in unconsolidated entities Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures International Foreign Non-US [Member] Comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Other intangible assets, net (Note 9) Net Carrying Value Intangible Assets, Net (Excluding Goodwill) Deferred revenue Contract with Customer, Liability Accrued realignment reserves Restructuring Reserve, Current Net of Tax Amount Other Comprehensive Income (Loss), Net of Tax [Abstract] Indefinite-lived intangible assets Indefinite-lived Intangible Assets (Excluding Goodwill) [Abstract] Other long-term liabilities Other Noncurrent Liabilities [Member] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Accrued rebates Accrued Rebates Aggregate carrying amount, as of the balance sheet date, of current obligations associated with sales rebates. Corporate debt securities Corporate Debt Securities [Member] Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Accounts payable Accounts Payable, Current Financial Instruments Derivative Asset, Not Offset, Policy Election Deduction Depreciation and amortization Depreciation, Depletion and Amortization Final settlement per share price (in dollars per share) Accelerated Share Repurchases, Final Price Paid Per Share Initial delivery, price per share (in dollars per share) Accelerated Share Repurchases, Initial Price Paid Per Share Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Total stock-based compensation expense, net of tax Share-based Payment Arrangement, Expense, after Tax Cash flow and net investment hedges Deferred Tax Liabilities, Derivatives Accumulated Other Comprehensive Loss Total Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Inventories Increase (Decrease) in Inventories Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Other income, net Other Operating Income (Expense), Net Schedule of Investments in Debt Securities Unrealized Gain (Loss) on Investments [Table Text Block] Long-term investments (Note 7) Long-term Investments Financial Instruments [Domain] Financial Instruments [Domain] Pension increase (as a percent) Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Pension Increase This element represents the percentage of increase in pension. Cost of sales Cost of sales Cost of Goods and Services Sold Entity Central Index Key Entity Central Index Key Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Other comprehensive (loss) income before reclassifications Prior service credit arising during period OCI, before Reclassifications, before Tax, Attributable to Parent The Program Long Term Stock Incentive Compensation Program [Member] This element represents details pertaining to the Long-Term Stock Incentive Compensation Program of the entity. Schedule of Held-to-maturity Securities [Line Items] Schedule of Held-to-maturity Securities [Line Items] United States: Current Federal, State and Local, Tax Expense (Benefit) [Abstract] Decrease in prior year tax positions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Gross Amounts Not Offset in the Consolidated Balance Sheet Derivative Fair Value of Derivative Asset Gross Amounts Not Offset [Abstract] Tax on global intangible low-taxed income Effective Income Tax Rate Reconciliation, Tax On Global Intangible Low-Taxed Income, Amount Effective Income Tax Rate Reconciliation, Tax On Global Intangible Low-Taxed Income, Amount Loss Contingencies [Line Items] Loss Contingencies [Line Items] Other liabilities Other Liabilities, Noncurrent Fair Value Debt Securities, Held-to-maturity, Maturity, Fair Value, Rolling Maturity [Abstract] Beginning of year End of year Projected benefit obligation Defined Benefit Plan, Benefit Obligation Gross Amounts Offset in the Consolidated Balance Sheet Derivative Asset, Fair Value, Gross Liability Research and development accruals Research And Development Accruals Aggregate carrying amount, as of the balance sheet date, of current obligations associated with research and development and clinical trials. Period when cash flows associated with future transactions and certain local currency expenses are expected to occur (in months) Maximum Length of Time, Foreign Currency Cash Flow Hedge Software Capitalized Computer Software, Gross Schedule of the Notes Schedule of Long-term Debt Instruments [Table Text Block] Purchases of treasury stock (in shares) Purchases of treasury stock (in shares) Shares repurchased (in shares) Treasury Stock, Shares, Acquired Debt Instrument [Line Items] Debt Instrument [Line Items] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Trading Symbol Trading Symbol Derivatives Fair Value Net Amounts Presented in the Consolidated Balance Sheet Derivative Asset Social securities increase (as a percent) Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Social Securities Increase This element represents the percentage of increase in social security. Other Deferred Tax Liabilities, Other Total gross unrealized losses Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss Gross Amounts Offset in the Consolidated Balance Sheet Derivative Liability, Fair Value, Gross Asset Vested and expected to vest as of period end (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Total grant date fair value of stock options vested Share-based Compensation Arrangement by Share-based Payment Award, Options Vested in Period, Grant Date Fair Value Represents the total grant-date fair value of options that vested during the period. Social securities increase (as a percent) Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Social Securities Increase This element represents the percentage of increase in social security. Weighted-average assumptions used to determine the benefit obligations Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract] Participant contributions Defined Benefit Plan, Plan Assets, Contributions by Plan Participant Acquisition price, subject uncertain adjustments Business Combination, Consideration To Be Transferred Business Combination, Consideration To Be Transferred Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Impairment of Goodwill and Long-lived Assets Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block] Long-term debt (Note 10) Long-term Debt, Excluding Current Maturities Liabilities Liabilities, Fair Value Disclosure [Abstract] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Total stock-based compensation expense Share-based Payment Arrangement, Expense Exercisable as of period end Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Research expenditure tax credits Research Tax Credit Carryforward [Member] Right-of-use assets Deferred Tax Liability, Operating Lease Right Of Use Amortization Deferred Tax Liability, Operating Lease Right Of Use Amortization Defined Contribution Plans Defined Contribution Plan Disclosure [Line Items] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] Investments [Domain] Investments [Domain] Restricted cash included in other current assets Restricted Cash, Current Schedule of Income Before Provisions for Income Taxes Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Cash, cash equivalents, and restricted cash at beginning of year Cash, cash equivalents, and restricted cash at end of year Total cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Critical Care Critical Care [Member] This element represents the critical care product line. Schedule of Assets And Liabilities Of Lessee Assets And Liabilities Of Lessee [Table Text Block] Assets And Liabilities Of Lessee [Table Text Block] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Purchases of held-to-maturity investments (Note 7) Payments to Acquire Held-to-maturity Securities Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Current assets Assets, Current [Abstract] Other Proceeds from (Payments for) Other Financing Activities Cost Finite-Lived Intangible Assets, Gross Finite-lived intangible assets Finite-Lived Intangible Assets, Net [Abstract] Schedule of Finite-Lived Other Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Tax reductions compared to local statutory rates per diluted share (in dollars per share) Income Tax Holiday, Income Tax Benefits Per Share Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Due after 1 year through 5 years Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value Options exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Fair Value on a Recurring Basis Fair Value, Recurring [Member] COMMON STOCK Stockholders' Equity Note Disclosure [Text Block] Lapse of statutes of limitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Unrealized Gain (Loss) on Hedges Gain (loss) on hedges Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Measurement Basis [Axis] Measurement Basis [Axis] 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Five Auditor Firm ID Auditor Firm ID Cross currency swap contracts Cross currency swap contracts Currency Swap [Member] Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Change in projected benefit obligation: Defined Benefit Plan, Change in Benefit Obligation [Roll Forward] Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Buildings and improvements Building and Building Improvements [Member] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Amortized Cost Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss Vested (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Shares related to previous year's grant (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Grants In Previous Period Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Grants In Previous Period Acquisition (Note 8) Payments to Acquire Businesses, Gross Restricted stock or restricted stock units Restricted Stock and Restricted Stock Unit Awards [Member] Restricted stock and restricted stock units awarded by a company to their employees as a form of incentive compensation. Other intangible assets Deferred Tax Liabilities, Goodwill and Intangible Assets Awards granted in 2012 and later Share Based Compensation Arrangements Awards Granted 2012 and after [Member] This element represents details pertaining to awards granted in 2012 and years after. Defined Contribution Plan [Table] Defined Contribution Plan [Table] Aggregate borrowings in multiple currencies Line of Credit Facility, Maximum Borrowing Capacity Debt and Equity Securities, FV-NI [Line Items] Debt and Equity Securities, FV-NI [Line Items] Currency translation adjustment Goodwill, Foreign Currency Translation Gain (Loss) Equity method investments Equity Method Investment, Financial Statement, Reported Amounts [Abstract] Payment for acquisition option Other Payments to Acquire Businesses Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Stock Repurchase Program May 2019 May 2019 Stock Repurchase Program [Member] May 2019 Stock Repurchase Program Payments for legal settlements Payments for Legal Settlements Discount rate (as a percent) Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Long-lived tangible assets Long-Lived Assets Proceeds from stock plans Proceeds from Stock Plans Other current assets Other Assets, Current Rate of compensation increase (as a percent) Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase Asset-backed securities Asset-backed Securities [Member] Early-stage Transcatheter Intellectual Property Early-stage Transcatheter Intellectual Property [Member] Early-stage Transcatheter Intellectual Property [Member] Schedule of Effect of Master-Netting Agreements and Rights of Offset, Liabilities Offsetting Liabilities [Table Text Block] Gross Amounts Derivative Liability, Fair Value, Gross Liability Net actuarial loss Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax Income tax expense at United States federal statutory rate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount Mortgages Mortgages [Member] Liabilities Derivative Liability [Abstract] Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Balance at Beginning of Period Balance at End of Period SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount Construction in progress Construction in Progress, Gross Cost of sales Cost of sales Cost of Sales [Member] Taxes payable Accrued Income Taxes, Current Tax Benefit Amount Deferred Tax Assets, Capital Loss Carryforwards Inventories Inventory, Policy [Policy Text Block] Outside of the United States, including Puerto Rico Current Foreign Tax Expense (Benefit) Fixed-rate 4.300% 2018 Notes Fixed Rate 4.300% 2018 Notes [Member] Fixed Rate 4.300% 2018 Notes [Member] DESCRIPTION OF BUSINESS Nature of Operations [Text Block] Defined benefit pension plans Pension Plan [Member] Developed technology Developed Technology Rights [Member] Unamortized discount Debt Instrument, Unamortized Discount Buildings and leasehold improvements Buildings and Leasehold Improvements Gross Gross amount, as of the balance sheet date, of long-lived, depreciable assets, that includes building structures and leasehold improvements. Nonemployee Directors Program Nonemployee Directors Stock Incentive Compensation Program [Member] This element represents details pertaining to the Nonemployee Directors Stock Incentive Compensation Program of the entity. Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Investments Deferred Tax Assets, Investments in Unconsolidated Affiliates Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments. Includes equity method investments; excludes investments in subsidiaries. Schedule of Weighted-Average Assumptions for ESPP Subscriptions Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Adjustments to reconcile net income to cash provided by operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] EX-101.PRE 19 ew-20211231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 20 ew-20211231_g1.jpg begin 644 ew-20211231_g1.jpg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�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end GRAPHIC 21 ew-20211231_g10.jpg begin 644 ew-20211231_g10.jpg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end GRAPHIC 22 ew-20211231_g11.jpg begin 644 ew-20211231_g11.jpg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end GRAPHIC 23 ew-20211231_g12.jpg begin 644 ew-20211231_g12.jpg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end GRAPHIC 24 ew-20211231_g13.jpg begin 644 ew-20211231_g13.jpg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ew-20211231_g2.jpg begin 644 ew-20211231_g2.jpg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ew-20211231_g3.jpg begin 644 ew-20211231_g3.jpg M_]C_X 02D9)1@ ! @$ 8 !@ #_[@ .061O8F4 90 !_]L 0P " 0$! M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D* M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H* M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\ $0@" MF@)B P$B (1 0,1 ?_$ !\ $% 0$! 0$! ! @,$!08'" D* M"__$ +40 (! P,"! ,%!00$ !?0$" P $$042(3%!!A-180'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H MJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V M]_CY^O_$ !\! ,! 0$! 0$! 0$ ! @,$!08'" D*"__$ +41 (! M @0$ P0'!00$ $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P M%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_: P# M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OR5_X M.0?^"O7[>/\ P2%\7_"[4_V=O$7@?5]%^)<>M^9I?BGPA)-+IKZ>;#[DT5U' MYBN+WHRY4Q]3NP/UJK\ ?^#YSI^R[]?&W_N!H ^U_P#@HE_P4&_X*=_\$E_A M+X;_ &M_B=I7PP^./PDN-1M+3QK!H'A2]\,:[H9N>(95D:_O;>:(L1'N,:$. M\2XPY=?M&TWQ?XU\3Z#;W?@73?$(BC*2"[ M2*]ADCED6+[5;HMROEM)L,L0&7& WG'_ <3ZCX": /T3_P""J/\ P4E_X*A_\$Z/ M^"1OPE_:]\7:1X"T7XOWVLZ?HOQ+\*7^B&_L1<7-M=2[XG@NE$4B?9DW*K21 M[I'"G"J3^A7[)OQ-\1_&O]ECX:?&3QBELNK^+?A_HVM:JME$4A%S=6,,\HC4 MDE4WR-@$D@8Y-?@Y_P %-;BXN_\ @T&_9EN;J=Y9'\4Z&7DD8LS'R=7ZD]:/ M^#EO1]+TW_@CM^Q!X\TZPBM];_X1+1[ ZM @2Y-J?#UM)Y!D'S&/> VTG&>< M9- ']$=?/O[57_!1CX'_ ++W[0OPA_90U34H-4^(7QA\60:9HWARWNP)K*PP MYFU*< $I"OEF- <&21L+D)(5_*?_ (+&Z3IGAO\ X.4OV(=4\/6,5A<:\/"D MNN2V:"(ZA(FN31))-MQYKB-4C#-D[$57"111*6DEE<*J*.I)/ %%O<07<"75K.DD4B!HY(V#*RD9!!'4$=Z_%'_ M (**?%YK/_@O'^S%_P $K?#GP:&M_!#P1X2&L6OP;L+NVM=/U_5/L6I2VGG+ M=R);S16[6MLT<([.]D\%W>IZ@;6=((;9WCMHT^V13K$O[I'M_E'S-D ^VO^"XO[9'Q\ M_8._X)\^-?VN?V9/%GAE-?\ -QI1O\ 1/$6BF_AO(K[4K2Q"L$GB> J+@R! MN=VW&.X]$_X)7?M-?$?]LK_@GI\*?VH/B[!IL7B7QIX874-8CT>U:&U64RR) M^[1G/K7PS?^'?%7A9[M )K&^N MA;Y+8X)4 \>#_ /!ZC_RBN\"_ M]E]TK_TRZW6__P $AO@Y^VGI>O\ [&'Q>^(WQPT[Q+\(IOV6+BR\->&M+\,_ MV2P!^B7[&7Q)^(WQE_8_^%/Q? M^,.DP6'B[Q7\-M#UCQ38VULT,=MJ-SI\$US&D;,QC597&YTAC;J\DCM<>6#;HCF9H# 1AV%?G!X M>^*.E?#G_@YU_9SUS]ECX*7WP:\)?$WX;Z>FK^'K7P];Z#%XIL98M407\^EV MSL+>.7R(9(X9P)D\B)W1'P ?T(5';W=I=[_ +)=1R^5(8Y/+<-L<=5..A'I M7X&?\%)/A5?^)_\ @[4^$/PP^&/BJ]\%'QEX3LY?$&J>&)!:W3K+9ZK'>S1N MH^2Z>UC:-;C!=&V.#N0&O9_^"I?_ 20_9A_X)D_\$(_VG=%^!VJ^)]:37_% M>D>++2X\9:E'>W&BWK:MI]M_HDJQ(R'R7EC,K%I725E=V!Q0!^Q5QJ.GVEQ! M:7=]#%+6( )X[5\E?\%;/'__ 5M\!>%/AY-_P $G_A% MX5\6:I=^,!'XZC\2S0*+>PVKY?\ KYX@(68N)70F5 $V 98C\&/VZO@)X&^% M'_!OC^QY^W)X.OM>B^*]SXYDMHO&LWB.[DNK*V4ZI-%;VH,FRUCCDM89$$2J M0^]R2\CLWUC_ ,'??*8RV=A M!ISXKTI=8N;D:JS^'K^Z9[B2XD>29VN;2"YZ*,GDGTJ>OQ ^$^E:)XO_ .#B3]IFR_X+(VFB3>%K3X<: ML?@[;_%$1?V&GAO[7:@2Z:+K]QYGV+)E:']X':Z+?,),>:_\$6?V-?VU?B-_ MP0G_ &D/&?P:\%ZOHGQ.\?0W.F?";Q;J%]<6FI:]HBK;2SV\+2R!%23;<0PS MX7]Y*X\P*@*@'] -KJ^E7PW66IV\P\]H'XFT3P__9UKX]MX].DAFAU* MWPCPZK$L8N#+*'+^5<;63S?+'[8?M4>$O"_CK]FGQ]X3\9^'K/5=,O?!^HK= MV&H6RS0R@6[L-RL"#A@"/0@$^(-;\+WFO3^"KK4=7G:'P M_?6WA^"ZCO;:+>$29I!&)'()>.)8S\NX'?\ A/\ \%;_ -L'P=_P:DZYXNTK MXDZTGC'2OC$?A7HOC9KQVU"STF2T@O\ >DY.X.D,LEHDF=T:[-I#(I !_1E; M:CI][--;V=]#-);2;+A(I0QB;&=K ?=."#@^M35^./[.W[&W[7<'Q4_8B_:S M_P""?/[*%K\//"GA_P &Z?8_&S79O%VDQGQWX>OXK"5KN>.VG=[Z8*]_=AIQ MYGG31L#NZ> :U^SO9_&#_@[X^+/[,OA[Q5JO@[P9KOA8/XJMO!MZ=.GGL[CP MIIUS=Q0R18-NUS<2?O94Q(5FFPRN^\ ']!-K>6E]#]HLKJ.:,LRB2)PRY!(( MR.X((/H17PY_P46_X*=>*?@G^WM\#/\ @F3\'_&?AKP7XG^,27%_K'Q%\7V/ MVJVT/3T6=;>"UMS+&DU[=SVTD$?F/L1BGR2&0!?9O^":W_!.3X,?\$N?V6-?,W_!&[>_P!+O[BU>6UN-)OY[M(+>\51N\IK MBPNMDL99X660E'#@$ ]HUGQE_P %$?V>?VK/@Q\+O&/CGPI\2?A7X_\ %.H: M7XB\7-X7.F:]HT\6A:E>V\,J02M;30RS6J8G2.$H5\ME?S5>OG>^_P""K'[8 MWA7_ (.0=#_X)1:K?>#]0^&&NZ5/^P+O48X?/%P4;;- J[O M+&Y., \U\6_\$_OV^_\ @L%_P1N_;X^&O_!-'_@J19ZCXO\ A_\ $+Q!::%X M0US5K_\ M)K4W$Z6D%WIVI6[D\NUCG MG5&F?^Z@)^8^PK\0O^#;93\#/^"S/[;G[''PQN+C3?AMX?\ $VK2Z%X46[DD MM; VFNR6D!C5V."()/++9W,J)N+;1CP7]O+X=Z7X-_8-_;*\$?&CXC>'/VF? MC!HGQ%TW7[[XT^&O#:,WPWBDU6R@BT^XU>Z*NDS[9(4TNQ,RVP><-L0M@ _I M J.6\M()HK:>ZC22=BL$;N TA )(4=R ">.PK\0?VS?&GB7X\?\ !FSX?^-_ MQ?U67Q#XOT_PUX="1+*]JMNTCDEC(7))))H ][HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH *_.;_@MC_P0@^(?_!9KQ;X&O\ MQ+^V=I'@'0_A['J8T'3+'X5RZA]G\$_"?X<-X537KB M",I$]_ M/M#^$/@F:#2[)6@\&/JHM+&PNX+J&"WC%[;!&,MM'ND=I"P+Y&YMX^LZ* /S M+_:"_P"#?CXI_M!?\$I/AE_P2MUK]N;0]/T?X<:['?KXOMOA!*USJ,4*7"V\ M)A;6MD17[5*7<,V_;'A8]K;^I_X*"_\ !"FZ_;[_ ."9OPO_ &&_&O[1]I8^ M+?A'!IR>'/'EAX0>&UO1:61LMD]BUW*RB2':6*SDB1 P&W,9_0NB@#\OOBS_ M ,&_W[3GQ\_;$^"?[>7QA_X*:VVK_$#X0)I3"TN?@ZATJ[:QO#K?MD?MY_"+_@HU\&OVHS\-_B)\*[2WL5 M-]X-36K'4+2"YGN(AY)N8#&X:ZN58EF#*Z\*4R?NZB@#\\?^"HW_ 0?N/V[ M_'7PM_:>^#7[6>M?#OXZ?">RM+73/B/<:1'>-JZ6\IGB>YBB:%8YDG>617C' MEXFD0Q%"@3W#PM_P3[\=?%?]F7QO\$/^"BG[2=[\8]6^(WAAM!\0:G8:!!H5 MCIUD5;:MA9P%DBF$C^:URY>1WCBSM2*.-?IZB@#\E;'_ (-S/VLHO^"4QN)%D,H MC4PM]]?\$Y/V/M:_8'_8\\'_ +(^J_%W_A-X/!=H]GI>O-H"Z=(]L7,BQO$L MTH)5GX44 ?$W_!:G_@DM\0_^"P7P7T#]GL_M2Z1\._"^A^*X M/$1V_#F35KZXO(K6ZMD4S?VG;HL6R[E)7RBV0OS8!!D^#/[!O_!3K]G[]D?P MQ^R#\)?^"E/PPTK3O!_A:WT#0?%G_#--U/K$%M!&(HG)E\3-:O(J!1DVY!V@ ME2Z]_:V_X)@?#?_@GYXE_;4UB/Q!X \7W?B6^^(U[X M8-P/$6H7<]]/=SW5D;L-YCR7\SA_/8JQ;.[><9WBS_@WI^+/BO\ ;>^"G[>F ML_\ !3GQ;J_COX7Z+::;KNL>(/ .G32ZNENT^S[*D1B@LAY=Q)'B2*Y.?WCM M(Y\3?\%'OV*/%?[&N@ M?&6R\!V_C&2R75O$%UX5?5WCM[>[AN]D4*W=L%=I((P79F 4N-N2&7Z&HH _ M*S]H/_@VZ^)'[0?_ 3)^#W_ 3-UO\ ;VT>PT7X1^(+K5+?Q/;?!V5KG4]_ MVD0QM$=:VQ>6+N<,P+;_ -W@)M;?V_\ P5._X(1_%3_@J+\%/@U\&?&'[;.B M>$XOA-IQ6;4--^$LMR^L7IABA,X5]846\?EPIB+,AW%CYA!"K^CE% 'YZ_\ M!4#_ ((E_&3_ (*9_&[X*_'/Q%^VEX=\(ZA\&&%W86EC\(Y[N'4M0:YMKB65 M]^LH8X6:TB"P@LR@MF1R01+XX_X(G_%?QK_P62\,_P#!8"7]LG0;?5/#-M%9 M6W@9/A3,UO+9_P!G36,J-^,__!5G]I3QQ_P34LOAI\;/"6@:]IGAB]/Q$LK,P^#[JSMR9-(M(M1DA:)T ME>5II+?=#,Q1V8N"$]Y_8T_:*_X*P_\ !0!OCI_P3%_;Z\"Z!\'?BEX&T?PW MKFA_$KP#;I=Q:6TE]'=6KO''=S023_Z,)8@LB B-U=!M)/WOXZ_8$_9 ^(7Q M&U'XP:U\$-.L_%FLK&NM^)?#EW"/^"E'[6_Q3\$Z_XN^&OA2;1_#L?@+P%+HO]L7$ MD"M3^'GC?3Y+O1]9LWM-3M([N6#[1 XP\9>)E<*PRK $;E)4Y!((! M_/9_P;9_LK_M>_M6_P#!)KX[_!W]F[]JOP_X"T?QSXXO?#/BVT\2>!6U5HK2 MXTBS2:ZL)H;JW>WN6AE>)O-$\;*$*"%U,C?J)X>_X('?LF:-_P $D)_^"2U[ MKNJW6AW@;4+SQJ(8TU!]>,RSC5%3E4*NJ((LD>0HB+-DN?HK]EK]@W]D;]B: M'4K+]E'X)Z?X%M-88/JFGZ'=7"6MS( )7@:0QF0!0HDV[PN5S@D5Z[0!\$? M\$S_ /@E/^VU^Q;X2\/? KX[_P#!2R\^(7PH\"7D+2YW$4GFV\ M5W?F:6X:UBDPZVJ-@[$1I#"# U3P7_P12^*?A'_@L]KW_!8:3]L;0[K4/$2" MSO\ P'_PJN5(5T\:?;Z>L27?]KEA,(;:(^<8BI?!M9TOX8VGA#_A$]2\)_VKI&MP1ZA>WDOV^,7$$C*3 M<1"-H9(Y(F1VW,KE#]4T4 ?(GB[_ ()P_$']JO\ :P^%W[4_[=GQ&\*ZS#\$ M[RXU+X<>!? _AV>TLX]7E,).HWMS=3RRW#1F")HH46)4>,,S2(?^"T^D_\%BXOVP]%@O-%!M+3X?M\+97B;3CILVG-$]Y_:P)F,,\C"81! M1)M/E%04/Z T4 ?GY_P3Z_X(F?$C]A__ (*'?%[]OC6_VQ=)\72?&B;59O$_ MA:S^&,NEBTDO;_[<#:W)U:ZCO;;0+7P1911PWT$R2VMW?R22R37A0QH'CADM%E*!F MSA0OZ]T4 ?G5KW_!"_XJ>)/^"+EK_P $?-1_;CMGLQ=6PNO&MU\,4D,5C!J, M>H16EM:Q7\)3$\2DRRS3,P9P H*A/J7_ ()R?LD^+/V$OV./!?[)/BKXLV'C M4>!]/.GZ9X@L?"[Z29K4,602P-=W69!N8%U=01CY!@Y]PHH _,&P_P"" 7Q^ M_9D_X* >,/VT/^"9G_!0,?"+2OB5=S3>-O!6L?#^+6[8>=*9Y?(62=(V43,S MQ*RJT.YE$C(Q0_HU\(?AS_PJ?X=:;X#E\8:OXAN+-)'O]?UZ=9+S4KJ61I9[ MF4HJHK/*[MY<:I'&"$C1$55'244 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%<9\#/C-IGQ MS\(77B_2=%GL8[76KO3FAN)%9F:"0H7RO8D9%=G0 4444 %%%% !1110 444 M4 %%%5-0U6/3[JUM7B9C=2^6I!^Z<9R: +=%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 454U#58]/NK6U>)F-U+Y:D'[IQG M)JW0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X7_ M ,$]_P#DB>K?]CWK/_I2:]TKPO\ X)[_ /)$]6_['O6?_2DU[I0 4444 %%% M% !1110 4444 %8_B7_D+Z/_ -?I_P#036Q6/XE_Y"^C_P#7Z?\ T$T ;%%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C^)? M^0OH_P#U^G_T$UL5C^)?^0OH_P#U^G_T$UL4 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110!Y+^U]XZ_:<\-^!M.\'_L>>"-"U3Q]XHU3[#IVJ>+S.-$\/6ZQ/+/ MJ5]Y'[R5$"+&D*$-+-/$,J@D=?COX4?ML?\ !3K]CK_@I!\-?V&/^"DUY\/O MB!X4^.=GJ0^'/Q)^'VAS:9+8ZE8P>?/9W=L[L"FTH 0,_OD;>P$B)^CK,J*7 M=@ !DDGI7R5X(^&5G^W)^W;X8_;MU*W#_#KX,Z-JND?!>=A_R,.K:B$AU/7H M_6S6"%+2U;D3%KB=,Q- \@!];5\9?LP?M1?M"?\ !0SQ!\;/$/P<^.^A_#S3 M/A9\5M8\!:'X=/A2+4[F6ZTW8DE]JIFE5_*GE9C';P?9V6)1F9G)V?9M?B9^ MU'^R+\;OVM/CG\?_ /@H5_P1MDGT2VT?Q'/X,^+'P\.NW-K9?&^ZT]E.KB-+ M9XS:8W?95F219+IS<,CVY)>Y /T[_P""9?[8.L_MZ_L/>!/VJO$?@R#0-2\2 MVUY'J6G64K26IN+2]N+*6:V9_F:WE>W:6(MD^7(F23R?>*^>?^"5W[6/P6_; M0_84\!_&GX#?#-? ^AKI[:1)X$2V6$>&KJR5/'45Y#_ ,.] M_@G_ -#;X[_\+*Y_QH /^">__)$]6_['O6?_ $I->Z5\X?\ !/'P%HT'P-U* MW2ZOBL7C358E)O&)(2;8,GN<*,GNE '5T5C_\ "#Z1_P _-[_X%M1_P@^D M?\_-[_X%M0!L45C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;4 ;%%8__ @^ MD?\ /S>_^!;4?\(/I'_/S>_^!;4 ;%%8_P#P@^D?\_-[_P"!;4?\(/I'_/S> M_P#@6U &Q16/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U &Q16/\ \(/I'_/S M>_\ @6U'_"#Z1_S\WO\ X%M0!L45C_\ "#Z1_P _-[_X%M1_P@^D?\_-[_X% MM0!L45C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;4 ;%%8__ @^D?\ /S>_ M^!;4?\(/I'_/S>_^!;4 ;%%8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@6U & MQ16/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U !XE_P"0OH__ %^G_P!!-;%< MIKGA73K74=-ACGN2)[DJY:X8D#;V]*T_^$'TC_GYO?\ P+:@#8HK'_X0?2/^ M?F]_\"VH_P"$'TC_ )^;W_P+:@#8HK'_ .$'TC_GYO?_ +:C_A!](_Y^;W_ M ,"VH V**Q_^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VH V**Q_P#A!](_Y^;W M_P "VH_X0?2/^?F]_P# MJ -BBL?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJ M -BBJ^FZ=!I5J+2W>1E#$YE?#X*?L^?MAV? MP>L[V\W>+;^3X>+K\VLV@VE;'$E[;I%;N0PF0K)YR$1G:AD63R3X9_\ !.__ M (*H:?X^\)R?'?\ X+52^+/A_H.KVEUK/@'PY^SUH_AO^V;:W=9$LC>VETTM MO 6C171!AX]\9&UN/N&B@#Q[0_@K^TU8?MPZU\>]6_:KEO/A/?>!(=*TKX/G MPW"B6&K+.COJ7VT-YCDHKKL(Y\[DXC2O/_@A^PS\9OV//$GQ#TS]DCXR^%[/ MP1\0O&5[XLB\,^-/"-Q?/X:U>]*M>-:S6][!Y]I)(OFK:NJ&-BP$VU@%^H:* M /+?V.?V4? O[&/P+L_@IX&U*ZU'_B9W^KZ[K=^B)/JVJWUS)=7EVZQ@(F^: M5RJ*-J($0<**]2HHH **** /"_\ @GO_ ,D3U;_L>]9_]*37NE>%_P#!/?\ MY(GJW_8]ZS_Z4FO=* "BBB@ HHHH **** "BBB@ K'\2_P#(7T?_ *_3_P"@ MFMBL?Q+_ ,A?1_\ K]/_ *": -BBBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH Q_$O_(7T?\ Z_3_ .@FMBL?Q+_R%]'_ .OT M_P#H)K8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M \+_ .">_P#R1/5O^Q[UG_TI->Z5X7_P3W_Y(GJW_8]ZS_Z4FO=* "BBB@ H MHHH **** "BBB@ K'\2_\A?1_P#K]/\ Z":V*Q_$O_(7T?\ Z_3_ .@F@#8H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **^+/VF? M^"0[?MU>*_%'Q&_:;_:U^+>CZG<7MQ;_ \T?X<>.IM*TOPC8QL4M9XH(U N M;R4*)YY9]_S2^4F$B1C2_P"#??XW_M-_&G]@BZLOVJ_'$_B[7_ GQ*U_P=I_ MC>[+--XDL-.N!#'>R.0"Y9RS$ ^R/$O_(7T?_K]/_H)K8KR MO]J[X.:W\>_"NC_"ZR^*NO>$-,U'6 /$>H>%+QK35+BQ$3EK:VNT.^S:1_+# M31_O!&)%0QNZRI\:_L;_ +)'Q(_8N_X+*^(OA'^RW\7_ !WK?P%NO@W'JWQ! M\,^,_%UWK5KX>\237I2RBMI[IWDCN)K>)YC&S%O*)9R5>W /T>HK\Y?C/\ MM&?#6?\ X+>ZA^R1_P %!=>FTKP)K'PPTNX_9]TS6=2EM/#NMZFTLHU1IP&6 M&YU#?Y44*S9\M(B(PKSCS/6?^"27B?XD^*5^-=Q8Z_K&L?!.W^*L\'P!UC7[ MZ:[FNM'6VA%W]EN)V:2XTU;WSUM9"S Q@A&,2QX /L&BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HKS+]K']J;PA^R3\,(_B#XB\&^)O%.HZEJD6E>%O!G@O23?:OX@U M*1))$M+6'*@MY<4TKN[*D<4,DCL%0FOGC]D__@M!X0^-W[6T/["G[2'[*7Q& M^ WQ2U;29-4\(Z%\0;>!K?Q%:QH[R?9+F!V1Y%2.5BN-N(G )?VI?C.\\^GZ%:L-/T:Q(-WK%Z49HK. 'J[;69FZ1QQ MR2-A(V( /9J*Y'X ?%FS^/?P'\$_'33M&ETZW\:>$=-UZ#3YY1(]JEY:QW"Q M,P #%1(%) )&:ZZ@ HHHH \+_X)[_\ )$]6_P"Q[UG_ -*37NE>%_\ !/?_ M )(GJW_8]ZS_ .E)KW2@ HHHH **** "BBB@ HHHH *Q_$O_ "%]'_Z_3_Z" M:V*Q_$O_ "%]'_Z_3_Z": -BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@#Q+]I;XJ>.O%^KS?LE?LSZ\+7Q_K6FA]<\411B6+P)I4 MVY#J

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end GRAPHIC 27 ew-20211231_g4.jpg begin 644 ew-20211231_g4.jpg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ew-20211231_g5.jpg begin 644 ew-20211231_g5.jpg M_]C_X 02D9)1@ ! @$ 8 !@ #_[@ .061O8F4 90 !_]L 0P " 0$! M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D* M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H* M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\ $0@" MF@.D P$B (1 0,1 ?_$ !\ $% 0$! 0$! ! @,$!08'" D* M"__$ +40 (! P,"! ,%!00$ !?0$" P $$042(3%!!A-180'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H MJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V M]_CY^O_$ !\! ,! 0$! 0$! 0$ ! @,$!08'" D*"__$ +41 (! M @0$ P0'!00$ $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P M%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_: P# M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH *^7_P#@L)^T+^T-^R%^P1X]_:P_9O\ %VAV.M^ -(_M M%M-\1>'S?VNI(9X8S&VV:)XB%9R&5CR1D&OJ"OCC_@X*_P"4,G[07_8CG_TJ M@H B^!*_\%4OVA_V/?!'[0OA#]LSX5Z=K_CCX=:7XCL=&U'X(W#V=O9-9W^6&DV&0(2!\VP_=/T[^SYK?Q0\3? 3P/XD^-^@PZ5XTU#PAIESXOT MRWCV1V>J26L;7<*KN;:J3&10,G '4]:^'OV1_P!F']N3QK^PA^RMXA\-?MG& M]\+:9H_PWUS6/ (\"V-J;S2(%TZ=[7[>)!(HAC42YP6F^S["/WA%:/[67Q1]+FVMU@ MFN/(;,3N5,BOY:@ 'W_17YDZWH,O_!/[_@NW\*/V8_V6&+,YRX0KY1_P $R_\ @FS\ M!_VS_'W[6OA']H/Q?\0]8TKX>_MGZN?!5NOQ$U..739K$VYBG>X\XRW5( ?#J0#[KX[\"^#_ (G> M#M2^'OQ \/6VKZ)K-F]KJNEWL>^&Z@<8>-U_B5AP0>""0:_*+_@@Q\#/A!X: M_P""*WQ!^+F@?#S3+3Q+-#\0M*EUJ"W"SM9):YJ<=A!:K/*+N= 1% B1H B* M,*HZ9.223],U^!C_ +''PJO/^#6/PG^VW<:QXI/Q3^'W@*'6OA[XMB\5WD#^ M&)8=:P([&"&1((5*EPS>69',A9G)5"OVO^T+^T;\5_VA/VPOV9?V.[KP?X9\ M3Z/XT^!U]\0?%/A+Q9XIGT;3/%.H+':1PVUPUO97?VF&%7N[@V;1&*1MCO\ MZE5(!^CE%?#?[ O[ '[2O[('[='Q!^*6F7'P\\!_ _Q_X;C:T^!?@KQ3?:C: M:/K\+0!M0L4FL+2*UBDC\_S8H8U7=)'P0J[?;O\ @I!^Q1X<_;Y_9%\7_L_7 MVH/I6NWVDS2>#?$MMM 'NU%?E%^S;\ M>/#?[<__ 27^$O[!MQX*M] ^)6K^/8OA7\2?#UO&(KGPU=Z&_VKQ!J7R,_AY\'O@QH=YHW MPO\ 'OBB;2]%GGOYIA-?M9Q:9?17YAB2U@C$R!;$_@I\+O%UG)J_PNN-"\27VK_\ "H[>7SA?)#/> M16;_ &9@8Q$D7EF-@QC"N ]?_9FL-0UKP\OCW4\7,MQJ4<9C69IS+#;J MRI*+:)DAWQQY0HI1E_;/TB'_ ()A_M!:5XB_:9_8<\0?'O\ 9'TGX0Z%X5\- M^(!;IXBOOAE+8&X2YNI[6YR1]I62!I;T%&VP0HK_ +L14 ?K317A7_!-&Z_9 M[O?V'_ 5U^RG\66\;_#R6RN9/"OB.5Y6FGMGO)W$4YF)E,\18PR&3$ADBEZS?W> MK-9M=7$46G7JZ@MM%%&L<,T?EH]U))@ND90 _0"BOS.^'_\ P3F_:,_98^$_ M[5^C^,OB!HWA;X.>-O!5_K_PU^%/PY^(VLM+X'U&"QD-S]CNA!8M':2R,)#! M&JQ+^[CV%-]XD\73?%WP)X!T_7? ?C4^+KV. M;PY.FL(-EG#%(D$2LK2!V\LR.7+N[,JLH!^]5?$GC;]J;]K#PC_P79^'_P"Q MQ>_%#1YOA7XK^#.K^)E\/6/A:.&Y6[@N#"GG74CRR2;0NX&/R5.XAD. :\[_ M &A_VB/$/[47_!0?]D[_ ()Y?$34Y8_!?C;X5W7Q)^)FEP2F&/Q9+%9L+/3) MMA&^T6>.:XFMSE)@D:NI0$'EY?V9O@I^S;_PTTZ'3H(M%N M/[--M$EO-B"X4W#NTLIS,P&G\2/$O[6?PTU?]AG_ (([?M;_ +0$7B?5OB/K M/B'_ (7%XY\,ZK22:3H4ES'YM[*\C M,IGDBD'DK 0(@K&0%L_:6M6NHWVDW-GH^J?8;J6!EM[SR!+Y#D"7\*?%F_.F_#7XY?#:"[L=,DU+8IY42M#PO_!"_P#Y2-?\%$_^R_6W\]1KC/\ @\&BM_%?["/P MH^$'A6 W?C[Q1\?-(A\"Z=:'_2Y;@6=]$S18^; >>!#C^*:/VH _6FBOSF\6 M>+/'W[9O_!4[XV_LD^./@=\.?BCX8^#'@#PG#I_@;XF>+KC3]*N+G5K:XNKW M5#9)I=_%?RX^S6ZO*J_9E0B/FXD->,?&W1OVYO\ @B;_ ,$SOV@IK[XY>']/ MT/Q+\0]+B^"^G:%XBO=8D^%VF:OJ)M[N%;F^MH6:*"$@VQV!5E5W*@DA@#]@ M**^/_B%_P2/^!NF_%GX._M#?LV^/YOA%KWPM\0Q7GBCQ#H=HDMWX_P!)(3[3 MIVLW;R+)>^=MR;BX:9U,DC ;GW#PKX9Q^)O^"F_[1?[4>E?%G]E_X6_%C1?A MY\7+CX?^'_#WQ+^(%Y8+X=L+.RMC]HL[.+2+U(9[BX>YF-^DB7!*I&"J6\>0 M#]-:*_$?_@IK^Q]^U7^R)_P;6_$CX9?M8?M*W/C#Q1\._%U@G@S5O#'C;566 M'0KW5=+@33M1W^1]O:-+BX11/&ZI$T6S;C ]6_X+'?LD^!/V8/BW^RI^UQ\" M?&WC+P_\5_%W[4OACP+XJ^(L7BB>?4=5TG5HKL7<5I9DGF,GFD[B47)XKGO@ M7^Q'\"_VZ/\ @LO_ ,%#?AE^TE#X@U;PA#??#-KWPEIGBB\TNSU.5_#UR(Y+ MHV4D4T_E!7V1F3RMTK,R.Z1-& ?K317X;>#_ -J+]HG_ ()0_LL_\%#/V4O M/Q:US7-"_9RU_P )P?!WQ%XAO#=W?A^S\42K"(1*ZMN^QI+'*H*E1(';9AMA M^F?CI_P2W_:6\3ZY\+_CO^QUX ^#'P0\=^ /$UGJVJ?%+2?BMJVJWGB_1EC? M[58ZO(=%MVU-;C*2-/^ _$'[,5CJ.M^'E\>ZGBZEN-3CC:)9FG,L%NK(DHMHF2'?%'E" M@*-^GWP,^#GA']GGX,^%O@3X FU&30_"&@VND:2^K:@]W6_D0HK,4*-++$SM'#[?_ ,$^_P!J+7/VT_V(?AG^ MU;KG@0^'-1\=>$+;5;O1'=O+@F=2&\MF&XPLP+QL028W0\YKE_\ @I]^S!^U MI^UU^RYXB^"?[*'[4&F?#/4M9TN:WO)[_P *+J U6-E(:RDF:3_1895S&[I% M(X5S@$94\S_P1,_:U^)G[8W_ 3W\+^/OC3\/--\+^,/#>I:AX1\2Z5HMFMO M8K=:7<-:%H(D^2)"L:9C3Y$<.J *%% &%^QU^VY^UC\7?^"J7[0?[%_Q]\/^ M"]+T'X6^%?#NH>&K?PDUQ<-+_:,;3L\]S<*C2N%*QX6*)1L)VG.:^T*_/3]C MK_E8H_;'_P"R9^ ?_2(U^A= #9YH[:%[B8D)&I9B%)X R>!R:_-W]JSXV?\ M!?KP7\'/$/[>WPAL?@QI7@[P[IDOB&#X$:]H5[/KDV@PHTS_ &R^$B*NH^0# M(UO$%1&!C5Y&7]Y^DE?.G_!0K7O&'Q4^&VH?L)_ B^0>/OBOH-QIEYJ.S?'X M3\/7 :WOM;N .FV)I8[:,D&>Z**/DCGDB /./B[_ ,%C/ _@;_@D]X._X*1^ M&/AO/>:M\2M-TFT\ ^ KJ\"/>^(=1;RH=/:8 91)1*SR M% [*,D+3_ (L? MM8_M,_\ !/OXL?!.#]L3XF>&_&G@KXS>+H?!.M:QHWA@Z5_PBGB>ZA>6P-O^ M^D\[3IFBFA(G)EBVI(97!9!\X?\ !=CX#>$/V1MXAM88Y(H'F;'S-Y<'HXO]8UZR7QC"8YW<'IZT >^?M67G_!6CXR_$S7?!?[!?B7 MX9_#/PSX2$5N_BKXDZ%=ZE=>)]2>WCG:.UABQ';V,8E2)KAA)(\RRJJ!8LO1 M_P"".W_!0;XW?MO_ U^(7@+]J[X7:;X3^+WP7\?W/@[XA6>@.[:;=W,0!2Z MMM[,51QO&WIVR*J_1WQ^^.7AC]GSXM_$RYLKOXD_ M%3QQJ/CGXGWNFL6MEU>_<,;.V9@&-M:PK%;1DXW"$R$*9" >777[;G[6FE? M\%MO#O[ 7C'P[X*L/ASK7P;U+QAIT^CR7%UJ5U+%>_98Q<32K&D6-C/Y<<9Q MYF#(^VOM*OST^*__ "L\?"G_ +-+UG_T\O7Z%T %%?"7[5'PO^"'Q _X*5S1 M_&#SOC_J-S\(XK/PS^S,_A>TO;#PRK7I:X\1W=A(%DF5;AE1U@\[ M;Y8^0?V9KCQIX]_X-KOVGO#WC;QSXKMY_A3XA^(5EX/;3_&U_'/I<&G(TMK9 MFYBDCDNK:)G91%+F-E"@IA5"@'[5T5^''[:W[,G@3X#?\$,_VM>$KDYL_%FM3:C!96\5]$ M?EN[6VAF,RP/F-IFW.C>6A4 Z7X4?M3?M87/_!=[QY^Q-\1/BAH^I?#;3O@! M%XR\-Z'I7A:.S>VN9M7@M5,T[O+--(L8E!(=(V\S/E*0,?67QM\?>(OAA\*= M<\<>#? %YXJUJRLB-#\-6$@CDU.^=A';V_F$%84>5T5IF&V)"SM\JFOSH_91 M_9[^%'[-W_!S5\3O!WP6\*P:!H.H_LFV>IP^']/7R['3I)-=MXWCM(!\EM"S M1&3RHPJ"261@ 7-?J!0!^67[9'[:/_!;7_@EAHFB_MK?M=ZG\%/B+\&W\1V= MC\2O!_P^T&^L[[PK;74RQ)/9W5P^Z[".RINE&7=T7RU#EX_JW]O7]N'Q=\%/ MB]\&?V-/V>[?2I_BK\>/$5U::#>:Y:O<6>@:18VYNM2U::"-XVG:*$8B@+QB M20\N%C8')_;=^&EC_P %&?B'HO[#5A"MW\//"GBS3/$7QVU3&Z"86Y_,/VF/&W_!>G MQ?X;\2_M-?LAM\'?#'A;0UN;SP;\)_&/A^]N]<\3Z=;EBLMY_P"#AO\ 8)TGPHK&^TW2?'-]J;Q]8K$Z:58N M1T4A)4&>"6QWK[%_;9^+?CC0/A^WP&_9^2&[^+/Q$L;G3O!-M*28M*0J([C6 M[S'*6=DLJR,>/,D,-NG[R= 0#PGPO_P6V^%<_P#P10L_^"POC3P#/86L_AN5 MSX/BN\O<:VE])I@L8I2N3&][&0)-I*Q'>5^4BH_C9^V)^V%_P3X\#?"G]I;] MM3QEX6UWP?XX\5:9X?\ BKH>B>&C8+X"N=25OL]W9W!F=[BTMYPL$XGW22!Q M+&8\&(_-'_!?;]DGP3^Q=_P0L^$_[-/PFAF_X0CX9?%'PG#KMU.H#7%H'N%G MNI\?*&FNYUE?^'?+P.E>O_\ !UO+%-_P1<\=:)% 9KW5?%/ANUTN"-=SRSG5 M;=PJ HKPOQ)^PK\,_BK\??@U^UQ\3]9\2_P#">?!_0KRTT:+3 M_$$D5A/)>VJP7+7, R)C]X@@KGC?O 4#W2@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^?_P#@IC^Q MO\1OV_?V2/%7[)/@OXWZ1X"T_P ::>+'7M9O_!?H"B@#RO]BOX#_$?]E_]F7P7^SM\1OBGH_C%_ WA?3] TS7-)\*2 MZ.;BTL[:.WB::%[VZS*4C4LRNJDYPJC@>8_MR_\ !.*?]I;XZ_#']LSX$_%M M/AW\:?A'<3KX:\3W.BG4K#5--N%9;G2M1M5FA>:WD5Y &25'B,LC+DGCZBHH M ^<_AW^Q7X^U3]I]/VW_ -I7XC^'O$'Q'TCP3-X8\"67A[PY-:Z+X8MIY/-N MIEBFN9)KJYF=8U>8R1 0QB-$3+N_._\ !.G_ ()Y?&+]AGXF?&CQMXQ_::T# MQOI_QG^)>H>.=1TJP^'$VD2:9J=VP\Q(IFU2Z#P!510C)O\ ESOY(KZNHH * M^&OV4O\ @DQ\??V1?@!\3_V7OA[^W!977@GQ79K MJ2.^CDU!X@SB+:]N@,CLZOE%B^Y:* /@E/\ @CE\9D_X(['_ ()%?\-B^&SI MQT8Z,/'/_"II_M'V WOVK;]F_MG;YV?D\S?MQ_RSSS5S]KO_ ((V^+OVGO@I M\%;G0/VM)_ GQW^ 5I'#X!^,GA'PJUO&R"".&6&XT^2[E+Q2I"FY3.0"7X*2 M21/]U44 ?.?[%'[)?[3_ ,*-8G^+O[<7[8\_QF^(+Z4VE:3>6?A.UT+2M"T] MY(Y9XK:TMO\ 62SR0PO+<2DL1!$B+&JD/[3\4OC%\(_@=X8'C;XU_%/PYX/T M5KN*T75_%.N6^GVIGD.(XO-G=$WN>%7.6/0&NCK@OVD/V7?V>_VOOAJ_P>_: M:^$>C>-/#+WT-Z='URV\R);B(DQRK@@JXRPR"#M9E/#$$ ^5/^"?O[+W[/'B MK_@I'^T7_P %*_@BD=WH_BB\M/"N@ZG97:RZ=?W\$$#:[J-GL^0I+.7[.K*PCNOA[XU\%7-S%IUY;VRVS7T-W; MWL98RQJBR0-%AQ#$!)&0Q/T'10!XK_P3Y_8E\"_\$]OV6="_9C\ ZW)JD&F7 M=[?ZAJCV:VRW=[>7,ES.\<"$K;Q!Y2L<(+;(U12SD%V\<_X*5_\ !*+Q5^V# M\9O ?[9/[*_[4.I_!3XZ_#BSET_0_'%CI":C;:AIDC.[6%Y:R,JRQ!Y)2N=R M_OI0\<@9=OV;10!\H^!/V#OVI#^S[\0-"^/7[;L7CSXN?$3PK-X>G\?ZI\/X MH=*T'3I(I4^S6.DVES J@-,\CRM-OF=8S(=D4<:>&UTY=%CT4^.A\)I_/.GI>+=*OV7^V=HFRNPR>9MQ_RS!YK[THH ^&/ MVH_^"07Q'^.?ASX%_%GX>_M76W@K]H+]GZS2S\)?%'1_!9%AJ5IY*PS6=YIL MMW*6AE12"//;;YLPP5D*U/HW_!,7]KCQ5_P4'^'/_!0SXY_MR:-=:_X+\"W7 MAS4?#_@_X9)8V-Y#<3,[Q0?:;JXDA7!!:21YF9QE1"HV5]P44 ?G3<_\$7OV MN/V>OVG_ !S\7O\ @F3_ ,%*[OX,^"?BKX@EUSQQ\/-5^'EIX@M+34ICF>\T M\7,@2%W/1-@V@*I9T1(T]"_;-_X(V^%OVC_@C\*]"^$_[0/B+P/\5?@CXBE\ M0_#OXNW5NFIWQU6XF%Q?S7\3&-+E;R<>=,HV+OQA?+W1-]J44 ?!_BC_ ()> M?MM_&[]KGX!?MG_M ?M\>'E\4?!2'78ULO!'PJ2TL[E-2M8;258ENKNX99'A M$WF32%TSY0B@BVNS_<^LQ:S/I-S#X>O[:UOV@86=S>VC3PQ28^5GC62-I%!Z MJ'4GIN'6K-% 'P9^R?\ \$K_ -MS]CCX]?&WX^?"_P#;S^&>H7WQU\8MXD\2 MZ?XC_9]OYH;&Y#SM'':F#Q/"PC47#*0Y\(*_WY-.TR)I-L[=YYYIY.$((9$8?6 M=% 'P[^WK_P22^*OQL_:TT/_ (*$?L'_ +85[\#?C/IV@#0=>U/_ (1Z/5M+ M\2Z6K[D@O+61U5F4X^=A("(XOE#1HZ]AJ'_!++2_CK^QM\0?V:?V[_CQK/Q: M\2_%:P@A\:^/CI5OI3P&V;S+!-.M(08;.&TES-''\^Z625Y"_FL*^LJ* /AC M]C?_ ()C_MU?")/#'PP_:X_X*P& MJ7XDDGN(K=XXW$(;]Z\2&61U!C;(_:*_X(]?M':;^VWXC_;O_P"":'[>MQ\# MO$OQ$MK>'XI>'-2\&0:[H^NR0ILCO1;RR*LH>(+^&YM;A98K M>WO+2"R0&SMX4B4.D=O#'&HRN\[_ .WK_P $Z/VB/VY_"OP5T75/VL/"/AR] M^$/Q0T;X@27L'PFN;J/6-8TPSB!?+.M(;>V9)R'CWR.6&1(H.T?7U% 'R1^U M)_P3N^/7[2'[:_P"_;*M/VI?"FA3_ 3^UY-,\/M\++FZ35IM5LH;2_:6;^V( MS&A6',2JI,>[YFEQDPVW_!/;]H7X(?MV_%C]MO\ 9(_:(\+6?_"\;;14^('A M#XA^"9]1@@N-+M&M;2YL;BSO+:2/$;OOAD#AR[?.OR[?KVB@#Y>\-_\ !*7X M!WG[,7Q:_9[^-VJ7WC74/CU?W>I?%SQE/"EK=ZMJ$RJL?\ @JWK/Q#^ ?A=XH])^'__ @- MI9ZEJ=C"08-,OM4+R3M9KM5'A0_OHP8B4B)CK]!J* /DSPC_ ,$[_CCX7_X* MI>(O^"E$G[47AJXL_$G@.#P==^ 1\,9T,>EPW*7,;+??VL?])#J09# 8R'/[ MH8!'UG110!\R:-\"?^"IVE?$;QC%=?M_^ -1\%:_K5S<^&QJ7P3SK?AFRD=C M'9V\T&HPVTS1(P59[F"8L45G1P60^P_LU?LZ_#3]E#X*:)\!OA+97,>C:)'* M1/?W'G75[9/-/++-(V "\C8 & .ZHH ^2O@'_P $[_CO\'O^ M"CGQ/_;_ /$'[4?A;6D^*NB:1I6M^#[3X77%F+2#3H5B@,%TVL3$.0&+EXF! M+\*H&*I?MI:3^V=;?M__ -\6?LY?M?I8>&OM]M8^,_@6GAJ&Y_MG3GNG;4- M8GN=V^UABM 521EVBXB@B0[[DBOL*FB&%9FN%B42,H5G"\D D@$^@R?S/K0! M7UN'6;C1;R#PYJ%M::B]K(MA=7MHUQ##,5(1Y(EDC:1 V"4#H6 (#+G(_/;P ME_P2N_X+"> O$7BGQ;X,_P""[VGV.I^,=8?4M>U!_P!E;1KF>:4C;%&);C4) M'$,*8CBASLC0851EL_HG10!\OZ__ ,$T[7XX?\$^]0_8G_;*^/VO?$W7MFZB=8^U&YMM0M((V>*R-LRP)%%&3&$@"$%68%#^P=\5OC9\9_A? M\6OVW_C=X?\ &T/P9NWU3P9H?A?P=)I-M?:\8?)36K\2W=SOFB0N88(O+2*2 M1W+2?(L?U#10!\0?M,?\$Z/^"E7QD_:VN/VG?A!_P5ITCX?6EEI[Z=X,\*G] MGBQUJ/P_:28\XQRWNHG=ZDN6:2\&L*38(0F$_U?-?6M%% 'QKXU_X)E?'W2?\ @I+XJ_;X_9C_ M &TAX$M?B9X6TW1?B5X7U#P)#J\DXL$$5O_P!BCP]^WDMSX?\ C1X@\075G=:U\-8[E]&M-7 6 MZ\SR[V%[N[VJH6;S(XE)D/D-O79^AE% 'PC^TI_P2$^-_P"T?_P2S\%?\$QM M1_;&\-:39^$M-T'3I_&=M\)9Y)KVUT=;86>+9M9"Q2DVRF5][J^["I'WV?VQ MO^"67QA^.'[1/PU_;[_9Z_:CTSX=_M!?#W1'T34/$<7@Q[G0?%.DNTCO8W>G MO=F1(PTLA5A.[+O/)98GB^U:* /BWX+_ /!,O]I;PI_P4LF_X*2?%[]M6PUK M5]2^%UMX.UWPQX>^'46GV5S"EY]K9(#+>+M4LC;Z1XTOO"XUE=)9B TRVAN(%ED";MFY]J MN59ED *-VM% 'YR_#[_@E%_P6)^$_P -8/A/\-/^"]UOHVDP++AK;]E;1)+J M665VDFN);B6^>6:XED=Y))W9I7D=G9RQ+5]'_M&?\$]]!^,W@_X1ZAX/^)-[ MH?Q&^!.IVNH?#;X@ZK;-J4PE2W6VNH+]&DC>[M[R %+A1+'(YVN)%9>?HNB@ M#YZ^#W[$FNZ=^U?K'[=O[1/C_2O%/Q-N?!Z>$_"ZZ+H4EEI/AC15G:X>&WAE MGFDEGFF;?-?\%>-'^+7C'XS>$/\ @N+I&D:QXUO4 MEU%H_P!EG2KO[-;1!A;V-N]WJ4LD5I"&?9#O*AY)9&W22R._Z$T4 ?,OA'_@ MG7J7C[]ASQG^QW^W_P#M$ZI\=+[XC27C^-?&EWH<&C-,9/+6V^QV4#20V'V9 M8+=HUCROG1--MS(PK!G_ ."&X;A?%4D\.RV:MX=U%+NU2\A"&6$2QDH[+O4':2 3C.00.@\4 M>%/"_C?0KCPOXT\-V&KZ9=A1=:=JEFEQ!,%8,N^.0%6PR@C(X(![5^?/_!LS MHVE>'/V)/B7X>T+3X;2QL/VDO&=O9VMO&$CAB2YA5$51PJA0 .@% 'VM\:O MVI?V?/V=KG3M.^,WQ6TO0[W5TFDTO3)G:6\NXH0#--';Q*TK11@J9) NR/<- MS#(SU?@KQMX.^)'A+3O'WP]\5Z=KNAZQ9I=Z3K&D7J7-K>0.,I+%+&2LB,#D M,I(-?GM_P2!^(&J_M0?\%.?VY?VF/'$AN[WPM\2K3X7^$C,=PTO2-':[26"# M/W$GG N' X:3YJ^4-?\ VWOB3^PI^RY_P5'^!OPJUV?3[7X1?$:UNOAJ;:0J M= 7Q?>/!)%:8_P!2EO,[SQJN CR,1UH _7KP[^VU^R5XM^**_!CPU^T!X9O? M$3^ M\:^ZOV,/C5J/[27['OPI_:'UF".*\\=_#?0_$-Y#$NU8YKRPAN'4#L TA&/: M@#TNBBN,^,VB?'+6],LHO@=XWT70[M)V-]+K6F-_MW_ <^&FL_$_7/CAX-NK31;,W$]O:>%&\QU! PNYP,\]S7MW@^Y\>: M_P"$M+UV?6[+?>Z=!._^B8Y>-6/&>.M '545C_8O&_\ T&[+_P !C_C1]B\; M_P#0;LO_ &/^- &Q16/]B\;_P#0;LO_ &/^-'V+QO_ -!NR_\ 8_XT ;% M%8_V+QO_ -!NR_\ 8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\ T&[+_P ! MC_C1]B\;_P#0;LO_ &/^- &Q16/]B\;_P#0;LO_ &/^-'V+QO_ -!NR_\ M 8_XT ;%%8_V+QO_ -!NR_\ 8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\ MT&[+_P !C_C1]B\;_P#0;LO_ &/^- &Q16/]B\;_P#0;LO_ &/^-'V+QO_ M -!NR_\ 8_XT ;%%8_V+QO_ -!NR_\ 8_XT?8O&_\ T&[+_P !C_C0!L45 MC_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_ &/^- &Q17.Q7'C&;5I=(75[4/# M$LC,;;@@_C5K[%XW_P"@W9?^ Q_QH V**Q_L7C?_ *#=E_X#'_&C[%XW_P"@ MW9?^ Q_QH V**Q_L7C?_ *#=E_X#'_&C[%XW_P"@W9?^ Q_QH V**Q_L7C?_ M *#=E_X#'_&C[%XW_P"@W9?^ Q_QH V**Q_L7C?_ *#=E_X#'_&C[%XW_P"@ MW9?^ Q_QH V**Q_L7C?_ *#=E_X#'_&C[%XW_P"@W9?^ Q_QH V**Q_L7C?_ M *#=E_X#'_&C[%XW_P"@W9?^ Q_QH V**Q_L7C?_ *#=E_X#'_&C[%XW_P"@ MW9?^ Q_QH V**Q_L7C?_ *#=E_X#'_&C[%XW_P"@W9?^ Q_QH V**Q_L7C?_ M *#=E_X#'_&C[%XW_P"@W9?^ Q_QH V**Q_L7C?_ *#=E_X#'_&C[%XW_P"@ MW9?^ Q_QH V**Q_L7C?_ *#=E_X#'_&C[%XW_P"@W9?^ Q_QH V**Q_L7C?_ M *#=E_X#'_&C[%XW_P"@W9?^ Q_QH V**Q_L7C?_ *#=E_X#'_&C[%XW_P"@ MW9?^ Q_QH V**Q_L7C?_ *#=E_X#'_&C[%XW_P"@W9?^ Q_QH V**Q_L7C?_ M *#=E_X#'_&C[%XW_P"@W9?^ Q_QH V**Q_L7C?_ *#=E_X#'_&C[%XW_P"@ MW9?^ Q_QH V**Q_L7C?_ *#=E_X#'_&C[%XW_P"@W9?^ Q_QH V**Q_L7C?_ M *#=E_X#'_&C[%XW_P"@W9?^ Q_QH V**Q_L7C?_ *#=E_X#'_&C[%XW_P"@ MW9?^ Q_QH V**Q_L7C?_ *#=E_X#'_&C[%XW_P"@W9?^ Q_QH V**Q_L7C?_ M *#=E_X#'_&JND7'C'6+9KJ#5[50LK1D/;-_^@W9?^ Q_ MQH^Q>-_^@W9?^ Q_QH V**Q_L7C?_H-V7_@,?\:/L7C?_H-V7_@,?\: -BBL M?[%XW_Z#=E_X#'_&C[%XW_Z#=E_X#'_&@#8HK'^Q>-_^@W9?^ Q_QH^Q>-_^ M@W9?^ Q_QH V**Q_L7C?_H-V7_@,?\:/L7C?_H-V7_@,?\: -BBL?[%XW_Z# M=E_X#'_&C[%XW_Z#=E_X#'_&@#8HK'^Q>-_^@W9?^ Q_QH^Q>-_^@W9?^ Q_ MQH V**Q_L7C?_H-V7_@,?\:/L7C?_H-V7_@,?\: -BBL?[%XW_Z#=E_X#'_& MC[%XW_Z#=E_X#'_&@#8HK'^Q>-_^@W9?^ Q_QH^Q>-_^@W9?^ Q_QH V**HZ M5!K\,CG6+^"92OR"*+:0:O4 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110!1\2^)_#7@O0KGQ3XQ\0V.DZ991^9>:CJ=VD$$ M"9 W/(Y"J,D#)(ZU^<'_ ;&?%OX6^-OV5_BOX:\(_$71-2U(?M$>,-2.G66 MJ127'V*:Y@:&Y\M6+>2X9=LF-K9X-?I;10!^;_[%=CX._P""8G_!2O\ :O\ MA]^T=XSTCP=X/^-7B:#XI?#;Q9XEU&*QT_4S,)SK5H+B9EC%Q;3NC&'=O,+B M7 7FO%_A[_P3(^)?[>?[%O[?/Q@&@W&E:A^UAXW?4OA-9:Q"UK+?:3H=RT^A M74JRA6@6[F!8;P,1,DG(85^P&IZ1I.M0+:ZQI=O=QI(LB1W,"R*KKR& 8'!' M8]JL4 ?E-^U5^T]9?M5%14$;$@2IG])/V;/@SI?[.7[.O@']GO1+S[19^! M/!>E^'K2X*[?-CLK2*V5\=LB('\:ZV+2-)@U*768=+MTO)XU2:[6!1+(HZ*S M8R0.P)JQ0 4444 >4?MS_P#)H_CW_L O_P"AK7=?"[_DF?AW_L!6G_HE*X7] MN?\ Y-'\>_\ 8!?_ -#6NZ^%W_),_#O_ & K3_T2E &[1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110!CV7_([WO_7E%_,UL5CV7_([ MWO\ UY1?S-;% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%8_@?_D$2_\ 7[-_Z%6Q6/X'_P"01+_U^S?^A4 ;%%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y M1^W/_P FC^/?^P"__H:UW7PN_P"29^'?^P%:?^B4KA?VY_\ DT?Q[_V 7_\ M0UKNOA=_R3/P[_V K3_T2E &[1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110!CV7_([WO\ UY1?S-;%8]E_R.][_P!>47\S6Q0 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 445XI_P48_;%TW]@#]B3XB_M@ZGX M1EUX>"-#%U:Z-%-Y?VRYEFCM[>-GP=D9FFCWN 2J;B <8H ]KHK\^_#'Q:_X M*;6B>/\ XX^!OV@? 7Q%DT#0/#&OW?@2'P3.FDZA87=D;FZ32)XKUIX9!%N> M)Y#<"=D0%%+Y7U_]KK]L;QUX3_;<^#7_ 3Z^%7BC2?"FL_%32=;UJ^\9:UI MPNVM[/38T;['80,Z1RWDS.S;I"R110NWER%E"@'U+6/X'_Y!$O\ U^S?^A5\ M[_ ?]IWXQZ+_ ,%#O&7_ 3R^+NN6?C&/2?A;IWCWP[XYL=*6SN(+:XOY[&3 M3=1CB)A-P)(?.BDB6(/$Q!CRF]ND>$!<,QM].AMH98FO]2E57;R_-CB@5"SL[ PT ?8=%8W@/P[XC M\+^&H=(\5^/K[Q-?J6:?5M0M+:!Y"3G:([:*-%4= ,%L=68\U\\_M]_MO>,/ M@;\7/@W^QI^S_;:3/\5_COXENK'0+K6[9[BST#2;&W-UJ>K301O&UPT4 Q%! MOC$DC. M[72%T^;4#:R.FH:3=P1L8VN(E47,4?MS_\ MFC^/?^P"_P#Z&M=U\+O^29^'?^P%:?\ HE*X7]N?_DT?Q[_V 7_]#6NZ^%W_ M "3/P[_V K3_ -$I0!NT444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 8]E_R.][_P!>47\S6Q6/9?\ ([WO_7E%_,UL4 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %^#/QH\+66M^%?%.FR M:9KFD:A_JKN"8;#&2""K$D;64AE;:5(8 UTU>:_M=_ 7Q)^TM\ ]5^$G@OXM M7G@36Y]1TK4]#\76.G1WDFEWVGZE;:A;R^1(RK,OFVJ!HV(#*S#/- 'Y&:"G M[4?_ ;??'GXB^(/A8^K?&+]D31-0T&'QQI6M78D\2>!K:\5A;36DAP)[:%I M"FSA6W@%8B3.?JO_ (+)?"SX%_\ !0[Q?\#OV,OA_J5Y8?&?Q')<>-?A?\5= M$O)+:?X?Z5:"&2YUC=&5DF$Q^SP1VH*>;*4^,+6P3>]G"9]1N&TJ)Y%19B1-(Z MY6)T!+5[9^T+^PD_CC]H+X:_M=_L^^.['P5\0_AEH]YH-C_:&B&^TG6= NE7 MS=,NK>.:&1 KQI)#-%(#$X)*2J=E 'RG_P $9?C5\:?@G^U/\6O^"=W[?'PK MMA^TAI*+6WNQ-+S&+?>D,=N@2*-3(JPPM'*&\2_X- M_?V+?%?[7O\ P2W\9?'>_P#VNOBMX'^(?Q3^)WB/6]0UCP3XG.FG3]:$PB%Q M,L*+)=Y:-6:"Y>2/#,$6,N[-^E_PT_9&UB/]J^[_ &VOCKXOTK6_'">"/^$0 M\-6F@:.]G8:)I+W0NYU'FS2R7%Q-,L9>9BBA(D1(TS(TGF/[//[!?QH_94US MXF0_L7_'7PUX:\$?$OQ7>>(G\+>*?!*[ M306D'R-?Q6^HOW%R]Z+J_N;B-]BR373--N9=H7S,* JA1U?[77[#UO\ MM/VGPV\?:?\ $3^P/BG\(/$46N^ O'K:.MPD5T8A#>6]S:K)'YMG=Q;HYH4D MB;&PJZE!0!\D_P#!2BWU37O^#A+]@71_":L;_3M/\&(M"T22PTKP MSHHG:XDAMHI9YI);B>9M\MR[@E52-$C16#_0E !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'E'[<__)H_CW_L M O\ ^AK7=?"[_DF?AW_L!6G_ *)2N%_;G_Y-'\>_]@%__0UKNOA=_P DS\._ M]@*T_P#1*4 ;M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% &/9?\CO>_\ 7E%_,UL5CV7_ ".][_UY1?S-;% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445\1_\ M%6_VO/VA_P!FOQSX1T?X*?$+^Q;;5-)N)KZ/^R;2Y\UUE55.9XG*X!/ P*]_ MAGAS'<5YQ#+<)*,9S3:X3AS*YX_$QDX1LFHI-ZM) M;M+=]S[G_1=_\ RU]+_P#D6OU# M_B ?&'_/^A_X%4_^5'YY_P 1HX6_Y\UO_ 8?_+#]C**_'/\ X>I?MZ?]%W_\ MM?2__D6C_AZE^WI_T7?_ ,M?2_\ Y%H_X@'QA_S_ *'_ (%4_P#E0?\ $:.% MO^?-;_P&'_RP_8RBOQS_ .'J7[>G_1=__+7TO_Y%H_X>I?MZ?]%W_P#+7TO_ M .1:/^(!\8?\_P"A_P"!5/\ Y4'_ !&CA;_GS6_\!A_\L/V,HK\<_P#AZE^W MI_T7?_RU]+_^1:/^'J7[>G_1=_\ RU]+_P#D6C_B ?&'_/\ H?\ @53_ .5! M_P 1HX6_Y\UO_ 8?_+#]C**_'/\ X>I?MZ?]%W_\M?2__D6C_AZE^WI_T7?_ M ,M?2_\ Y%H_X@'QA_S_ *'_ (%4_P#E0?\ $:.%O^?-;_P&'_RP_8RBOQS_ M .'J7[>G_1=__+7TO_Y%H_X>I?MZ?]%W_P#+7TO_ .1:/^(!\8?\_P"A_P"! M5/\ Y4'_ !&CA;_GS6_\!A_\L/V,K'\#_P#((E_Z_9O_ $*OR+_X>I?MZ?\ M1=__ "U]+_\ D6H;'_@J'^W3IL)@LOCCL1G+D?\ ",Z8>2%:W^VE>>(_VAO%O[,7[.'P M>N?'7B/X>V-C<>/[Z?7(-,TW19;V)IK2Q,T@>2:[DA7SMD<1C1'0R2(753J_ MLX?ML_!W]HSX1>*OBQ;O=>%1\/O$&J:#\2-(\4M##/X7U/31NO(+EXY'A*I& M4E$T_]@%__0UKNOA=_P DS\._]@*T_P#1*5PO[<__ ":/X]_[ +_^AK7= M?"[_ ))GX=_[ 5I_Z)2@#=HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH Q[+_D=[W_ *\HOYFMBL>R_P"1WO?^O*+^9K8H **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "OS:_X+G_\E,\!?]@*[_\ 1RU^DM?FU_P7/_Y*9X"_[ 5W_P"CEK]3\&?^ M3@8;_#4_](D?G7BK_P D3B/6'_I<3X4HHHK^U3^3 HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#=^%W_)3/#O_ &'; M3_T7_X:GYP/Z#\$?\ =L=Z MT_RF%%%%?SF?NH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110!^1G_!0SQ%^U7_P3?\ ^"E7Q"_; M+_X)GZ6GQ;NO&?@.RUK]H_X%BTEG?28+. VFG:[')$1Y;NJ,!; ^=*L-PZH\ M>^2WY']J'XG? *W_ .#77X]?M*?L8?&:_P#&M[\5M8&L?$SQ9?6:V5]=:]K& MM:;:ZO%<6D;,MELMY1 MLK.J0+%AY582O]I_"#X-?'C]C#_@H-^T#\:K[X/Z M]\0O!'QWO-$UO2?$7A>XM);[0KRPL#9R:7>6]Q/%(T)"J\$L(=%#,DFPX+ ]&_:@\:ZEK5CX*L98+@^$8Y+:&*VG<0.UN M;LW$/VQTA=XE)CC5W";B 9G_ 4Q\">%=)_X-IO%G@3[+$=,T?\ 9XT6.QCV MC:IM;>R:WQ]'BC(^@KZD_P"";7C7Q1\2?^"=OP%^(GC:YEGUG7?@SX7U#5KB M>:^1OBG^S;^WA^U/_P $Q_#/_!)/XA?!/4/#&O2Z M=HOA/XD_%\ZOI\VA?V%ID]N9M2L-EPUU:8U16?]#? M7@CPU\,_ VB_#?P7IJV>C^'])MM-TFS0Y$%M!$L448]E1%'X4 :U<9\9M$^. M6MZ991? [QOHNAW:3L;Z76M,:Y66/;PJ@$;3GG-=G10!\D_M6^#?VT[#]G7Q M=>?$#XS^#]0T6/26.HV5CX<>*::/_P#8!?\ ]#6NZ^%W_),_#O\ V K3_P!$I0!+ M]B\;_P#0;LO_ &/^-'V+QO_ -!NR_\ 8_XUL44 8_V+QO_ -!NR_\ 8_X MT?8O&_\ T&[+_P !C_C6Q10!C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_ &/ M^-;%% &/]B\;_P#0;LO_ &/^-'V+QO_ -!NR_\ 8_XUL44 8_V+QO_ -!N MR_\ 8_XT?8O&_\ T&[+_P !C_C6Q10!C_8O&_\ T&[+_P !C_C1]B\;_P#0 M;LO_ &/^-;%% &/]B\;_P#0;LO_ &/^-'V+QO_ -!NR_\ 8_XUL44 8_V M+QO_ -!NR_\ 8_XT?8O&_\ T&[+_P !C_C6Q10!C_8O&_\ T&[+_P !C_C1 M]B\;_P#0;LO_ &/^-;%% &/]B\;_P#0;LO_ &/^-'V+QO_ -!NR_\ 8_X MUL44 !1K%Y#,QT.ZV&&/;@>*O\ R1.(]8?^EQ/A2BBBO[5/Y,"BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** -SX9!S\2/#PC8! MO[-_^@W9?^ Q M_P :V**_G,_=3'^Q>-_^@W9?^ Q_QH^Q>-_^@W9?^ Q_QK8HH Q_L7C?_H-V M7_@,?\:/L7C?_H-V7_@,?\:V** *.E0:_#(YUB_@F4K\@BBVD&KU%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% 'E'[<_P#R:/X]_P"P"_\ Z&M=U\+O^29^'?\ L!6G_HE* MX7]N?_DT?Q[_ -@%_P#T-:[KX7?\DS\._P#8"M/_ $2E &[1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110!CV7_ ".][_UY1?S-;%8] ME_R.][_UY1?S-;% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 5^;7_!<_\ Y*9X"_[ 5W_Z.6OTEK\VO^"Y M_P#R4SP%_P!@*[_]'+7ZGX,_\G PW^&I_P"D2/SKQ5_Y(G$>L/\ TN)\*444 M5_:I_)@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110!N_"[_ )*9X=_[#MI_Z.2OWSK\#/A=_P E,\._]AVT_P#1R5^^ M=?S'](3_ 'O+_P##4_.!_0?@C_NV.]:?Y3"BBBOYS/W4**** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH \H_;G_Y-'\>_]@%__0UKNOA=_P DS\._]@*T_P#1 M*5PO[<__ ":/X]_[ +_^AK7=?"[_ ))GX=_[ 5I_Z)2@#=HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Q[+_D=[W_ *\HOYFMBL>R M_P"1WO?^O*+^9K8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "OS:_X+G_\E,\!?]@*[_\ 1RU^DM?FU_P7 M/_Y*9X"_[ 5W_P"CEK]3\&?^3@8;_#4_](D?G7BK_P D3B/6'_I<3X4HHHK^ MU3^3 HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@#=^%W_)3/#O_ &';3_T7_X:GYP/Z#\$?\ =L=ZT_RF%%%%?SF?NH4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110!Y1^W/_ ,FC^/?^P"__ *&M=U\+O^29^'?^P%:?^B4KA?VY M_P#DT?Q[_P!@%_\ T-:[KX7?\DS\._\ 8"M/_1*4 ;M%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% &/9?\CO>_]>47\S6Q6/9?\CO> M_P#7E%_,UL4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !7YM?\ !<__ )*9X"_[ 5W_ .CEK]):_-K_ (+G M_P#)3/ 7_8"N_P#T'?^P[:?\ HY*_?.OP,^%W_)3/#O\ V';3_P!')7[Y MU_,?TA/][R__ U/S@?T'X(_[MCO6G^4PHHHK^17C1T8 QOVA? MVSOV2/V2[.&]_:;_ &EO _@(749>SA\5>)K:RFNE!P3%%(X>7H?N*>AKGO@% M_P %)O\ @G_^U+X@7PA^SU^V7\-_%NM29\K0]'\76LE](!U*VQ<2L/<*17FW MA'_@AI_P3!TC6+GQK\2?V8M,^*'BW4W\W7O&OQL\88_W M8T1%P JJ !6'XV_X)=?\$(/B/\26_9\O?V7O@-IWCN"W%XOAGPB++1-?MXPH M=;A(].DANXP!AQ(N,?>![T ?:5%>8_LY?"7XD? 2SNOA-K7Q)UCQIX3LH8Y/ M".N^*;_[3K-G'DA]/NYR UXJ?(T-R^961F28LT8EF].H **** "BBB@ HHHH M **** /*/VY_^31_'O\ V 7_ /0UKNOA=_R3/P[_ -@*T_\ 1*5PO[<__)H_ MCW_L O\ ^AK7=?"[_DF?AW_L!6G_ *)2@#=HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH Q[+_ )'>]_Z\HOYFMBL>R_Y'>]_Z\HOY MFMB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH *_-K_@N?\ \E,\!?\ 8"N__1RU^DM?FU_P7/\ ^2F> O\ ML!7?_HY:_4_!G_DX&&_PU/\ TB1^=>*O_)$XCUA_Z7$^%****_M4_DP**** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH W M?A=_R4SP[_V';3_TM/\IA1117\YG[J%%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 ?"/_ 46EM?V=/VHKK]MR3_@G9XJ M^.WBVS^%5EHGP:N?!_@8:Y+HFO0W^HSSK<;,RZ?'+]ITYA>!3L2WN K(S;9? MF7]GK_@GKIW['_P(\ >-OVB?V9O&'Q#_ &ROC)\6M"\5^)_B;HWP\U#5G\$W M-UK<$D[S:Q;0/;Z=;6MJ)1<0B4",=9^(GBOPK_;-QJ4T6HI9R:=9V\A\HF%9;:60G! NH_F M' ;BM7_9 _X+H:3XL\#>(?BI_P %8/!GBWPEIGQ/\*WGBSPKI_PBL-"EU;38 MMD^$="C?9+K6JO%^\\K?^[BMX]KSR80/' MD/7;>/OBI=_L1_LP^-?VDOVL/C9/XHM/"/AZXUK7+BRT"VT^WC6"-F,%E;H6 MD!D;:B)-/,Q8H-_)S^=__!.']G2__;(_X*C_ +?GQ=^*GQJ^('AO5]/^)MKX M,LD\$^)#I%U'I5K'/':,+J%/M,:^7# RI'(D;E/=513J6K>'+S6+>[1+QXU EF MBM;5WDD(R1,020H- 'W!XP_;W_;A^!/[ 7A?_@K7\9V\.7?@[4XM(U_QI\'- M(\/L)]"\+:G-"D,EK?F7S)]1MHKF">;S4$,N)D6.'"N/OWPUXCT+QCXDII[#&PB6VLT@Q]2Z8_"OI;_ ()D:+XE\.?\$W/V??#WC*.5-6L? M@EX5M]3CFSO2=-(M5=6SSN# @^X- 'N%%%<9\9O@9X0^.>F66D^+]4UJUCL9 MVFA;1=6DM&9BNTABGWACL: .;_;G_P"31_'O_8!?_P!#6NZ^%W_),_#O_8"M M/_1*5\S?M6_L4_"?X??LZ^+O&FB>)/&$UWIVDM-!'?>*9YH68,HPZ,<,.>AK MW_X5^!='3X8>'$%U>X&@V8&;MO\ G@E ';T5C_\ "#Z1_P _-[_X%M1_P@^D M?\_-[_X%M0!L45C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;4 ;%%8__ @^ MD?\ /S>_^!;4?\(/I'_/S>_^!;4 ;%%8_P#P@^D?\_-[_P"!;4?\(/I'_/S> M_P#@6U &Q16/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U &Q16/\ \(/I'_/S M>_\ @6U'_"#Z1_S\WO\ X%M0!L45C_\ "#Z1_P _-[_X%M1_P@^D?\_-[_X% MM0!L45C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;4 ;%%8__ @^D?\ /S>_ M^!;4?\(/I'_/S>_^!;4 ;%%8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@6U ! M9?\ ([WO_7E%_,UL5REKX5TZ3Q3=6#3W.R.VC92+AMV23U-:?_"#Z1_S\WO_ M (%M0!L45C_\(/I'_/S>_P#@6U'_ @^D?\ /S>_^!;4 ;%%8_\ P@^D?\_- M[_X%M1_P@^D?\_-[_P"!;4 ;%%8__"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6 MU &Q16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U &Q16/_P@^D?\_-[_ .!; M4?\ "#Z1_P _-[_X%M0!L45C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M0!L4 M5C_\(/I'_/S>_P#@6U'_ @^D?\ /S>_^!;4 ;%%8_\ P@^D?\_-[_X%M1_P M@^D?\_-[_P"!;4 ;%%8__"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6U &Q16/_ M ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U &Q16/_P@^D?\_-[_ .!;4?\ "#Z1 M_P _-[_X%M0!L45C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M0!L45C_\(/I' M_/S>_P#@6U'_ @^D?\ /S>_^!;4 ;%?FU_P7/\ ^2F> O\ L!7?_HY:_0W_ M (0?2/\ GYO?_ MJ_.?_ (+'KRPN)?"GCEM*:?6))!]EEMHV#*\SVTVHQ2^6IF= M%A4;D5L?/O[''[-'[-?[8WQ*\+>(OV4/^#BKXX?&>^\#>/O#WB?4_ASXV^)< MDMMJ5GIVKVEY,MQI\L,4\L96$A7VF,2F/<:^E/V]?"W_ 3^'_!0GPC\0O\ M@J9?^%4\%V7PZAM_@X/BA+&OA6'7S?7CZRTQN?\ 1!>&V&C^4+C&4CF,8)1B MOFO[2/[37_!'WQ+\5OA;\(_^"?=G\*?&'Q^OOB5H,G@*]^".EV-Q/HULFH0/ MJ5U=:AIR^7#9#3Q=K/$TA\V-RI0C+( ?IU1110 4444 ?,VJ_L'^,OAC^VCX MJ_;;_9$^)FB>&=5^)>B6>G_%7PEXE\/RWNF:]/9*R6.IQM!<0R6MW$CO$Q^> M.6-CE4?]X=OX&?\ !/;X3?#GX8?%'P9\5I(?'FK_ !RU6_U#XP:U?:?]ECUU M[J#[,;:.!71O?J* /B9_P#@DWX^\9_LT^$O^"?/ MQL_:4M/$WP \'W]@$T/_ (15X-?\0:1ITZ3Z=HVH7WVIH&MXFB@222&WCDG2 MWC7]R=[/]KPPPV\*6]O$L<:*%1$7 4#@ =!3J* "BBB@#RC]N?_ )-'\>_] M@%__ $-:[KX7?\DS\._]@*T_]$I7"_MS_P#)H_CW_L O_P"AK7=?"[_DF?AW M_L!6G_HE* -VBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@#'LO^1WO?^O*+^9K8K'LO^1WO?\ KRB_F:V* "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\VO^"Y__ M "4SP%_V KO_ -'+7Z2U^;7_ 7/_P"2F> O^P%=_P#HY:_4_!G_ ).!AO\ M#4_](D?G7BK_ ,D3B/6'_I<3X4HHHK^U3^3 HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#=^%W_)3/#O\ V';3_P!' M)7[YU^!GPN_Y*9X=_P"P[:?^CDK]\Z_F/Z0G^]Y?_AJ?G _H/P1_W;'>M/\ M*84445_.9^ZA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %>7?M5_M%^)_V;/#7A;Q!X6_9Q\<_$N7Q'XZTWP]=:=X"TU;J? M2(+HN'U.Y!("6L(3YWZ*73)526'J->"_\%%OVFOVDOV3O@3I_P 3?V7/V4!\ M8_$-YXQTS19?"8\4KI#)%>R&WCN%G>&5.+E[:,A]BA9BY*"Y?\ :A\->9'&Y1G0,5RJL8XR1W*+G[HJ.Y_;Z_X+>:QXP\#^ M&/B]_P $4K+X>^%=9^)WA;3O$GC5/C;HGB/^R+"?6[**XF^PVR&1_P!VS@2# M'E$B3(V9H _1JBBB@ HHHH **** "BBB@ HHHH \H_;G_P"31_'O_8!?_P!# M6NZ^%W_),_#O_8"M/_1*5PO[<_\ R:/X]_[ +_\ H:UW7PN_Y)GX=_[ 5I_Z M)2@#=HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Q[ M+_D=[W_KRB_F:V*Q[+_D=[W_ *\HOYFMB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_-K_@N?_P E,\!? M]@*[_P#1RU^DM?FU_P %S_\ DIG@+_L!7?\ Z.6OU/P9_P"3@8;_ U/_2)' MYUXJ_P#)$XCUA_Z7$^%****_M4_DP**** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH W?A=_R4SP[_ -AVT_\ 1R5^^=?@ M9\+O^2F>'?\ L.VG_HY*_?.OYC^D)_O>7_X:GYP/Z#\$?]VQWK3_ "F%%%%? MSF?NH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !7@W_ 42^('[=_PT^!>G^(_^">/PT\%^+/',WC#3+"\TGQU'=&S73KF0 MP27 -K-$Z&*62"1W)95A29BO (]YKRS]J_PG^U7XN\,^%;3]DKXS^&_!.J6O MCS3+KQ3>>)M!_M"/4="1G^V6,*9'ES2 IM?@@(P#(6#J ?(?_"=_\'2?_1#? MV,/_ >>(_\ XY4*>./^#E.;QIX)M?B_\'OV;+/P9-\2?#,?C6\^&FI:U-K4 M.C'6;,7S0+N?MZ?#G_@K[X[_: \+67_ 3Z_:7\ M"> O \WA"[?Q/+XP\'1ZF8M4ANHA$$.TO^_AN&P,A5^Q.>KC/D8_9E_X.$+/ MQGX)U7XJ_P#!0KX5^)?"-A\2O#%WXPT#PW\/ETN]O])BUJSDO(H[DH=F8%DR MHP74,@/S8(!^BM%%% !1110 4444 %%%% !1110!Y1^W/_R:/X]_[ +_ /H: MUW7PN_Y)GX=_[ 5I_P"B4KA?VY_^31_'O_8!?_T-:[KX7?\ ),_#O_8"M/\ MT2E &[1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%?FK^SC^W) M^U[_ ,%)M<\$_';]GW]H3PW\._#.O^-O&6B>&_"+^#VU5H8M*C*12:UNNXFF MFF($X@A,'DQS1X>1LN0#]*J*\Z_90\=_&CXC_ 31/$_[1/@_3-!\<"6]LO$^ MF:()OL27=K>SVKR6_G$R&&3R1(A8DE)%.2.3\DZ1_P %2?BS\5?^"T/@7]C? MX7Z-9P?!O4?!?B6X?Q)-;J\OBC4].D$,TUJYY2TM[A)+=7&/.EBG(W1K&S ' MW'9?\CO>_P#7E%_,UL5\=?\ !9']K?\ :>_88_8Y^(W[4G[,'AGP;?ZGX3T. MVN+V7Q?-%0)G'G%_GEC4>6!M?=@?4'P:\2ZKXT^#_A3QCKT MJO?:MX:L;R]=$"JTLMNCN0!P!N8\=J .EHKPO_@I?^V6G_!/G]A?XB?M@#PB M->F\&Z3#)8Z4\K)'/=7%U#:0>:R@LL2RW$;2%02$5L+OCEX=^*VB?$3XD^'O"?B'0M*\*Q6, O^P%=_^CEK]):_-K_@N?\ \E,\ M!?\ 8"N__1RU^I^#/_)P,-_AJ?\ I$C\Z\5?^2)Q'K#_ -+B?"E%%%?VJ?R8 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 ;OPN_P"2F>'?^P[:?^CDK]\Z_ SX7?\ )3/#O_8=M/\ T)MT,R'S(DDC >-D)?#84DCZ!HH M _$#X<_$_P#X.+=8\;67P;^/_P#P5A^'WP7\?W\WD6'A+XH?![3;)-5EZ;=- MU&.PDL-3SR0MM.\H RT:=*]VF_8^_P"#C[3_ !U\/M9^/G_!1[X?>/\ P)IO MQ;\'WWC3PEX9\ 6]A>WVF0:_8RW&R:+3T95C1#*X#H#'&X+8R#ZG_P %'O\ M@M-_P2_^$MO??LH>,M%A_:)\;:VQL1\$O 7AZ+Q+/?3\X@N4P]O$0<;HV+3 M+-"\/?L\?LZW@^/O$?PZD_M70;"2Q%O:I=6Z:FD6I2QH%CCD18@?+4RH M_P Q8 \W^,G_ 7"^&OQW_X)_?"?XM^%?"GQ(\(6/QLU;4-$\<7OA?PQ>:KJ MG@JWT\^7JT$7V.(NMW(Q6WMIRJ;!<&Y(#0>2WS3XD_X*I_L-:+_P6=_9X^)O MPF^&WQ&T7P!X!^!VL^%;70X_A1JEM5LZ;/*?=_>6@#Q7_ (.)/^41/[1?_8EZ?_Z<[2OKS]F_ M_DW?P%_V)>E_^DD5>+_\%+_V+?'?_!0K]G7QO^R%X4^->E>!+#QGI-M:ZYK5 M]X.DUB988[J&<"!%OK58V)A*DMO&'X (R?8O@K\./B5\./@-H_PK\9?$K2]6 MUS1] BTR'Q)HWAI[")C% L4(?#:0>9)K NG2VALHAE<2S3311HVY=CNK;EV[ MA^5OPP^#O[3?_!"[X[?!+Q7^VQHTGQ2_9MO=7CTOP3+>ZW/J,_P%UK4V*+$- M^V*[B1'^SB],2L$$ODK;&5H+G]%Q_P $X?'OQY_X)I:I^P/_ ,%"OVG]2^*N MMZ['/_:?Q(L-&ATF\CE6^^V6,T,2%U62V=(""V0WE88%216A\2_V*/CU^U/\ M,?#OP#_;,^.'A/Q)X-TK7-*U3Q.OAGP3-I]YXNDTZZBN[9)S+>31V437$$,D MZ1*QDVLB/"I((!]/4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 5^;7_!<__DIG@+_L!7?_ *.6OTEK\VO^"Y__ "4S MP%_V KO_ -'+7ZGX,_\ )P,-_AJ?^D2/SKQ5_P"2)Q'K#_TN)\*4445_:I_) M@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110!N_"[_DIGAW_ +#MI_Z.2OWSK\#/A=_R4SP[_P!AVT_]')7[YU_,?TA/ M][R__#4_.!_0?@C_ +MCO6G^4PHHHK^TM[@&+)W*&)4J&%?2- M>49&0A?8I)VJHXKTSXE?L??\% =?/A6>7_@HM?^(=/TCXC^%]7USPX_PST: MQ35-.LM;LKNZ@:XC DB_-()/#?BM%_A2Y:":+3I\# ,L:Q%SDF-,XK%^'_Q-_P"#G#X]:JOA MSQ-^SE^SI\!M*E?;?>)=Y\27]O$3]^UMK*\:&24#D+,R(<')% 'Z'#7-& M.MGPVNJVYU!;47+6(F7S5A+%!(4SD*6! /0E2!T-6J\W_9J_9UB^ 'A:['B+ MXCZUXY\8Z[,ESXP\>>)/+%[K%PJD*!'"JQ6MM&"RPVL*K%$K,0"[R2/Z10 4 M444 %%?.G[?_ ,<_B7HGA.7]F_\ 9HUL6/Q*\6>';^_.O+$)!X0T.WC/VK69 M%/'F@E;>UC;_ %ES*A(:*&O?L;?\&M?AW]MWQ5>S^(-<\,> M=7NK*36KJ2%]#^('B_Q/K'B"ZEA\1M9Y)T_[/ M<3116Z1HL'DPO$$==U?I%\#/BUX=^/OP2\'?';P>CKI/C7PKI^O:6LA!86UY M;1W$0)'&=DBT =51110!Y1^W/_R:/X]_[ +_ /H:UW7PN_Y)GX=_[ 5I_P"B M4KA?VY_^31_'O_8!?_T-:[KX7?\ ),_#O_8"M/\ T2E &[1110 4444 %%%% M !17@W_!2#XS_$KX"?LP7WQ$^$WB3^R=9AU:SACO/L<,^$>3##9,CIR.^,^E M?G9_P]2_;T_Z+O\ ^6OI?_R+7Z1PGX7<0<8Y6\?@JM*,%)QM.4T[I)_9A)6U M74^"XE\1,EX6S%8/%TZDI.*E>*BU9MKK.+OIV/V,HK\<_P#AZE^WI_T7?_RU M]+_^1:/^'J7[>G_1=_\ RU]+_P#D6OI_^(!\8?\ /^A_X%4_^5'S_P#Q&CA; M_GS6_P# 8?\ RP_8RBOQS_X>I?MZ?]%W_P#+7TO_ .1:/^'J7[>G_1=__+7T MO_Y%H_X@'QA_S_H?^!5/_E0?\1HX6_Y\UO\ P&'_ ,L/V,HK\<_^'J7[>G_1 M=_\ RU]+_P#D6C_AZE^WI_T7?_RU]+_^1:/^(!\8?\_Z'_@53_Y4'_$:.%O^ M?-;_ ,!A_P#+#]C**_'/_AZE^WI_T7?_ ,M?2_\ Y%H_X>I?MZ?]%W_\M?2_ M_D6C_B ?&'_/^A_X%4_^5!_Q&CA;_GS6_P# 8?\ RP_8RBOQS_X>I?MZ?]%W M_P#+7TO_ .1:/^'J7[>G_1=__+7TO_Y%H_X@'QA_S_H?^!5/_E0?\1HX6_Y\ MUO\ P&'_ ,L/V,HK\<_^'J7[>G_1=_\ RU]+_P#D6C_AZE^WI_T7?_RU]+_^ M1:/^(!\8?\_Z'_@53_Y4'_$:.%O^?-;_ ,!A_P#+#]=++_D=[W_KRB_F:V*_ M&U/^"H?[=,=\^I)\<<32($=_^$9TSD#H,?9L5-_P]2_;T_Z+O_Y:^E__ "+1 M_P 0#XP_Y_T/_ JG_P J#_B-'"W_ #YK?^ P_P#EA^QE%?CG_P /4OV]/^B[ M_P#EKZ7_ /(M'_#U+]O3_HN__EKZ7_\ (M'_ ! /C#_G_0_\"J?_ "H/^(T< M+?\ /FM_X##_ .6'[&45^.?_ ]2_;T_Z+O_ .6OI?\ \BT?\/4OV]/^B[_^ M6OI?_P BT?\ $ ^,/^?]#_P*I_\ *@_XC1PM_P ^:W_@,/\ Y8?L917XY_\ M#U+]O3_HN_\ Y:^E_P#R+1_P]2_;T_Z+O_Y:^E__ "+1_P 0#XP_Y_T/_ JG M_P J#_B-'"W_ #YK?^ P_P#EA^QE%?CG_P /4OV]/^B[_P#EKZ7_ /(M'_#U M+]O3_HN__EKZ7_\ (M'_ ! /C#_G_0_\"J?_ "H/^(T<+?\ /FM_X##_ .6' M[&45^.?_ ]2_;T_Z+O_ .6OI?\ \BT?\/4OV]/^B[_^6OI?_P BT?\ $ ^, M/^?]#_P*I_\ *@_XC1PM_P ^:W_@,/\ Y8?L917XY_\ #U+]O3_HN_\ Y:^E M_P#R+1_P]2_;T_Z+O_Y:^E__ "+1_P 0#XP_Y_T/_ JG_P J#_B-'"W_ #YK M?^ P_P#EA^QE%>9?L:?$+QA\5_V8/!GQ$\?:O]OUG5M)\[4+S[/'%YK^8XSL MC547@#@ "O3:_&\?@ZN78ZKA*C3E3E*+MM>+:=KV=KK31'ZI@L53QV#IXFFF MHSBI*^]I)-7WUU[A1117(=(4444 %%%% !1110 4444 %%%% !7YM?\ !<__ M )*9X"_[ 5W_ .CEK]):_-K_ (+G_P#)3/ 7_8"N_P#T'?^P[:?\ HY*_ M?.OP,^%W_)3/#O\ V';3_P!')7[YU_,?TA/][R__ U/S@?T'X(_[MCO6G^4 MPHHHK^']-FUK7M4MK*SMDWW%W=SK'%$O]YF8@*/*?#/B[2UUSPGXBL-4LF9E6\TZ\2>(D<$!T)&1WYKS_X1 M_ML?L=?'[Q_JGPJ^!O[5'P\\8>)M%#G5= \,^,;*^O+8(0KLT4,C.%5B%9L8 M5N"0>*_*;]LS]OW]J3]O7Q-I?_!%S_@F9XA^"TM[XZTIF\=_$/X*>*[K4='\ M'>'%P+B-[F.TCAB,JGRSY)=@&$6 \R[?1OBC_P $^;?_ ()]_ ?X77_PC_9- M_9T\&>+?!_Q%\*Z;\/O&FB>)=07Q/JVK7.J6UH;>6Z_LR.6^%W%+/'H **** /R^OY?^"YOPG7XR^.[W]@[X0>(KWQSGV4, MR(H;:U8[8@QW32W$K'?/(3\E?L\?#;]LG]J#_ (-(/'?P M4U;X+Z)9^%](\"0ZS\,=9T77FN]1\0Q:?XEGU/45N+38/L[(+0I&H+&3=Q@X M%?O9K>C:;XCT6\\/:S;>=9W]K);W<.]EWQ.I5ERI!&02,@@UQ_[-O[-7P3_9 M$^!V@_LW?L\^"AX?\%^&8)8=$T4ZC"OA9X?T+5%W9Q:%F#*,.C'##GH:]_^%?@71T^&'AQ!=7N!H-F!F[;_ )X)7/\ [<__ M ":/X]_[ +_^AK7=?"[_ ))GX=_[ 5I_Z)2@"7_A!](_Y^;W_P "VH_X0?2/ M^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\ X0?2 M/^?F]_\ MJ/^$'TC_GYO?\ P+:MBB@#Y-_X*W>&-/TO]C34KNWGN68:Y8#$ MMP6',OH:_*&OUO\ ^"P'_)E6I_\ 8=T__P!&U^2%?V#X$_\ )%3_ .OT_P#T MF!_+OC%_R5D?^O4?_2I!1117[.?E(4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110!^RO_!/[PEIM]^QI\/[N:XN@TFAY M(2Y8#_6OT%>Q_P#"#Z1_S\WO_@6U>8?\$\?^3*OAY_V O_:LE>SU_GIQ1_R4 MV._Z_5?_ $N1_;_#O_)/X/\ Z]4__2$8_P#P@^D?\_-[_P"!;4?\(/I'_/S> M_P#@6U;%%>$>R8__ @^D?\ /S>_^!;4?\(/I'_/S>_^!;5L44 8_P#P@^D? M\_-[_P"!;4?\(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO M_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M6Q10!C_\ "#Z1_P _ M-[_X%M1_P@^D?\_-[_X%M6Q10!C_ /"#Z1_S\WO_ (%M7YS_ /!;G1K71_B1 MX%CM9)F#Z'=$^=*6_P"6R^M?IA7YM?\ !<__ )*9X"_[ 5W_ .CEK]3\&?\ MDX&&_P -3_TB1^=>*O\ R1.(]8?^EQ/A2BBBO[5/Y,"BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** -SX9()/B1X>C8G M#:Y: X/_ $V2OW<_X0?2/^?F]_\ MJ_"3X7?\E,\._]AVT_]')7[YU_,?TA M/][R_P#PU/S@?T'X(_[MCO6G^4S'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P " MVK8HK^"_"=GI8O9!G:TOV:-/,(W-@MG&3BG>,OV8_V=/B+\4]#^.'C[X& M^%-;\8^&'5_#GBC5=!@N+_2V&<-;S.I>$C<>5(/-=S10 4444 %%%% !1110 M 4444 %%%% 'E'[<_P#R:/X]_P"P"_\ Z&M=U\+O^29^'?\ L!6G_HE*X7]N M?_DT?Q[_ -@%_P#T-:[KX7?\DS\._P#8"M/_ $2E &[1110 4444 %%%% 'R M]_P6 _Y,JU/_ +#NG_\ HVOR0K];_P#@L!_R95J?_8=T_P#]&U^2%?V#X$_\ MD5/_ *_3_P#28'\N^,7_ "5D?^O4?_2I!1117[.?E(4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^U/_!/'_DRKX>? M]@+_ -JR5[/7C'_!/'_DRKX>?]@+_P!JR5[/7^>G%'_)38[_ *_5?_2Y']O\ M._\ )/X/_KU3_P#2$%%%%>$>R%%%% !1110 4444 %%%% !1110 5^;7_!<_ M_DIG@+_L!7?_ *.6OTEK\VO^"Y__ "4SP%_V KO_ -'+7ZGX,_\ )P,-_AJ? M^D2/SKQ5_P"2)Q'K#_TN)\*4445_:I_)@4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110!N_"[_DIGAW_ +#MI_Z.2OWS MK\#/A=_R4SP[_P!AVT_]')7[YU_,?TA/][R__#4_.!_0?@C_ +MCO6G^4PHH MHK^H M_P#I4@HHHK]G/RD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH _:G_@GC_R95\//^P%_P"U9*]GKQC_ ()X_P#)E7P\ M_P"P%_[5DKV>O\].*/\ DIL=_P!?JO\ Z7(_M_AW_DG\'_UZI_\ I""BBBO" M/9"BBB@ HHHH **** "BBB@ HHHH *_-K_@N?_R4SP%_V KO_P!'+7Z2U^;7 M_!<__DIG@+_L!7?_ *.6OU/P9_Y.!AO\-3_TB1^=>*O_ "1.(]8?^EQ/A2BB MBO[5/Y,"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** -WX7?\E,\._\ 8=M/_1R5^^=?@9\+O^2F>'?^P[:?^CDK]\Z_ MF/Z0G^]Y?_AJ?G _H/P1_P!VQWK3_*84445_.9^ZA1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% 'E'[<_\ R:/X]_[ +_\ H:UW7PN_Y)GX=_[ 5I_Z)2N% M_;G_ .31_'O_ & 7_P#0UKNOA=_R3/P[_P!@*T_]$I0!NT444 %%%% !1110 M!\O?\%@/^3*M3_[#NG_^C:_)"OUO_P""P'_)E6I_]AW3_P#T;7Y(5_8/@3_R M14_^OT__ $F!_+OC%_R5D?\ KU'_ -*D%%%%?LY^4A1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '[4_P#!/'_DRKX> M?]@+_P!JR5[/7C'_ 3Q_P"3*OAY_P!@+_VK)7L]?YZ<4?\ )38[_K]5_P#2 MY']O\._\D_@_^O5/_P!(04445X1[(4444 %%%% !1110 4444 %%%% !7YM? M\%S_ /DIG@+_ + 5W_Z.6OTEK\VO^"Y__)3/ 7_8"N__ $\O\ \-3\X']!^"/^[8[UI_E,**** M_G,_=0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HKQ/\ :9_X*0?L'_L:^*=.\#_M1?M7>"O! M.M:K")K+2-;UE$N6A+%1,T2Y:.(D,!(X"DJP!X./6O!_C'PC\0O"NG^.? /B MG3M;T35K1+K2M8TB]CN;6\@<;DEBEC)21&!!#*2"#Q0!I45Y;X=_;:_9*\6_ M%%?@QX:_: \,WOB.34Y]-M[ R7-_ I:>RAF_U4UU$%8R6Z.TJ!&W*-K8] M2H **** /*/VY_\ DT?Q[_V 7_\ 0UKNOA=_R3/P[_V K3_T2E<+^W/_ ,FC M^/?^P"__ *&M=U\+O^29^'?^P%:?^B4H W:*** "BBB@ HHHH ^7O^"P'_)E M6I_]AW3_ /T;7Y(5^M__ 6 _P"3*M3_ .P[I_\ Z-K\D*_L'P)_Y(J?_7Z? M_I,#^7?&+_DK(_\ 7J/_ *5(****_9S\I"BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** /VI_P"">/\ R95\//\ L!?^ MU9*]GKQC_@GC_P F5?#S_L!?^U9*]GK_ #TXH_Y*;'?]?JO_ *7(_M_AW_DG M\'_UZI_^D(****\(]D**** "BBB@ HHHH **** "BBB@ K\VO^"Y_P#R4SP% M_P!@*[_]'+7Z2U^;7_!<_P#Y*9X"_P"P%=_^CEK]3\&?^3@8;_#4_P#2)'YU MXJ_\D3B/6'_I<3X4HHHK^U3^3 HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@#=^%W_)3/#O_8=M/_1R5^^=?@9\+O\ MDIGAW_L.VG_HY*_?.OYC^D)_O>7_ .&I^<#^@_!'_=L=ZT_RF%%%%?SF?NH4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110!XI>_L%?L(/&>C M6UW<7MNP(CMY9I4RMM;6ZQP1("%C2$-]\L[?EW\"_'7Q=_X)N?\ !K=\9_C3 M\/M?U>PT_4?$6N3?!"6[GD%WI7AS6-8M]-TZXC+?,A(GDOHV[^>LG\5>[_MP M?\%QO^"6GC#XY:_^PS\9OVQ=,\-^!O#TOV7XJW=CI>I7C^)90Q$GA^VEL;>5 M4M\J5O9BP+*3;1@F2:2'L?C[\0?V=/\ @OI_P2L^.W[/W[ >IS:SX>AT>WTC MPOXAET.?2M.O==LC#J,%A!'=1Q2(D;PV2/(8UC N1M+;&P ?+N=/UNP:SOC?Q2#E)WF$S,XP29Y/[Q MK[J_8P^-6H_M)?L>_"G]H?68(XKSQW\-]#\0WD,2[5CFO+"&X=0.P#2$8]J_ M/']JK]IZR_:X_P""%6B?L=?!V:'4/C_\2O"6A_#^;X4F4)K.D:U%+:V^L"^M M?]=9P6B0W,DD\J*BH(V) E3/Z2?LV?!G2_VB7GVBS\">"]+\/6 MEP5V^;'96D5LKX[9$0/XT =K7,_$SXR_"[X-V-KJ?Q0\:V6B6][,8K66]<@2 M.!DJ, \XYKIJI:SX<\/>(XD@\0Z#97Z1MNC2]M4E"'U 8'!H ^;?VN_VN_V: M?'/[-/C'PEX2^,>CW^I7^CM%9V<$K%Y7W*=HRO7BO;_A9XS\+/\ #'PXZZW M0=!LR#D_\\4K@/VV/A]X!TO]E+QSJ&F>"-'M[B+0W:*>#3(D=#N7D,%R#7IG MPNTW3A\,O#@%A" -"L\#RA_SQ3VH T?^$Q\,?]!J#_OJC_A,?#'_ $&H/^^J MN?V=I_\ SXP_]^A1_9VG_P#/C#_WZ% %/_A,?#'_ $&H/^^J/^$Q\,?]!J#_ M +ZJY_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A0!3_ .$Q\,?]!J#_ +ZH_P"$ MQ\,?]!J#_OJKG]G:?_SXP_\ ?H4?V=I__/C#_P!^A0!\K_\ !7/Q%HFI?L9: MG:V.I12R'7+ A%/./-K\G:_6O_@KY9VD/[%NIO#:QHW]NZ?RJ '_ %M?DI7] M@^!/_)%3_P"OT_\ TF!_+OC%_P E9'_KU'_TJ04445^SGY2%%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?LU_P3Z\3 M^'[+]C+X?6MUJL22)H>'1CR#YLE>R?\ "8^&/^@U!_WU7DO_ 3TLK*3]BWX M>/):1,QT+DM&"3^]DKV;^SM/_P"?&'_OT*_STXH_Y*;'?]?JO_IJ?\ Z0BG_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]5<_L[3_P#GQA_[ M]"C^SM/_ .?&'_OT*\(]DI_\)CX8_P"@U!_WU1_PF/AC_H-0?]]5<_L[3_\ MGQA_[]"C^SM/_P"?&'_OT* *?_"8^&/^@U!_WU1_PF/AC_H-0?\ ?57/[.T_ M_GQA_P"_0H_L[3_^?&'_ +]"@"G_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?57 M/[.T_P#Y\8?^_0H_L[3_ /GQA_[]"@"G_P )CX8_Z#4'_?5'_"8^&/\ H-0? M]]5<_L[3_P#GQA_[]"C^SM/_ .?&'_OT* *?_"8^&/\ H-0?]]4?\)CX8_Z# M4'_?57/[.T__ )\8?^_0H_L[3_\ GQA_[]"@"G_PF/AC_H-0?]]5^7_X:GYP/Z#\$?\ =L=ZT_RF M4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ M%?SF?NI3_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZJY_9VG_ //C#_WZ%']G:?\ M\^,/_?H4 4_^$Q\,?]!J#_OJC_A,?#'_ $&H/^^JN?V=I_\ SXP_]^A1_9VG M_P#/C#_WZ% $>GZWI.JNT>G7\I1 ,T^@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH KQ:1I,&I2ZS#I=NEY/&J37:P*)9%'16;&2!V!-6*** "BBB@#RC]N?_ M )-'\>_]@%__ $-:[KX7?\DS\._]@*T_]$I7"_MS_P#)H_CW_L O_P"AK7=? M"[_DF?AW_L!6G_HE* -VBBB@ HHHH **** /E[_@L!_R95J?_8=T_P#]&U^2 M%?K?_P %@/\ DRK4_P#L.Z?_ .C:_)"O[!\"?^2*G_U^G_Z3 _EWQB_Y*R/_ M %ZC_P"E2"BBBOV<_*0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@#]J?\ @GC_ ,F5?#S_ + 7_M62O9Z\8_X)X_\ M)E7P\_[ 7_M62O9Z_P ].*/^2FQW_7ZK_P"ER/[?X=_Y)_!_]>J?_I""BBBO M"/9"BBB@ HHHH **** "BBB@ HHHH *_-K_@N?\ \E,\!?\ 8"N__1RU^DM? MFU_P7/\ ^2F> O\ L!7?_HY:_4_!G_DX&&_PU/\ TB1^=>*O_)$XCUA_Z7$^ M%****_M4_DP**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH W?A=_R4SP[_V';3_TM/\IA1117\YG[J%%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 >4?MS_\ )H_CW_L O_Z&M=U\+O\ DF?AW_L!6G_H ME*X7]N?_ )-'\>_]@%__ $-:[KX7?\DS\._]@*T_]$I0!NT444 %%%% !111 M0!\O?\%@/^3*M3_[#NG_ /HVOR0K];_^"P'_ "95J?\ V'=/_P#1M?DA7]@^ M!/\ R14_^OT__28'\N^,7_)61_Z]1_\ 2I!1117[.?E(4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^U/_ 3Q_P"3 M*OAY_P!@+_VK)7L]>,?\$\?^3*OAY_V O_:LE>SU_GIQ1_R4V._Z_5?_ $N1 M_;_#O_)/X/\ Z]4__2$%%%%>$>R%%%% !1110 4444 %%%% !1110 5^;7_! M<_\ Y*9X"_[ 5W_Z.6OTEK\VO^"Y_P#R4SP%_P!@*[_]'+7ZGX,_\G PW^&I M_P"D2/SKQ5_Y(G$>L/\ TN)\*4445_:I_)@4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110!N_"[_ )*9X=_[#MI_Z.2O MWSK\#/A=_P E,\._]AVT_P#1R5^^=?S'](3_ 'O+_P##4_.!_0?@C_NV.]:? MY3"BBBOYS/W4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \H_;G_Y-'\>_ M]@%__0UKNOA=_P DS\._]@*T_P#1*5PO[<__ ":/X]_[ +_^AK7=?"[_ ))G MX=_[ 5I_Z)2@#=HHHH **** "BBB@#Y>_P""P'_)E6I_]AW3_P#T;7Y(5^M_ M_!8#_DRK4_\ L.Z?_P"C:_)"O[!\"?\ DBI_]?I_^DP/Y=\8O^2LC_UZC_Z5 M(****_9S\I"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** /VI_X)X_\ )E7P\_[ 7_M62O9Z\8_X)X_\F5?#S_L!?^U9 M*]GK_/3BC_DIL=_U^J_^ER/[?X=_Y)_!_P#7JG_Z0@HHHKPCV0HHHH **** M"BBB@ HHHH **** "OS:_P""Y_\ R4SP%_V KO\ ]'+7Z2U^;7_!<_\ Y*9X M"_[ 5W_Z.6OU/P9_Y.!AO\-3_P!(D?G7BK_R1.(]8?\ I<3X4HHHK^U3^3 H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@#=^%W_ "4SP[_V';3_ -')7[YU^!GPN_Y*9X=_[#MI_P"CDK]\Z_F/Z0G^ M]Y?_ (:GYP/Z#\$?]VQWK3_*84445_.9^ZA1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% 'E'[<__)H_CW_L O\ ^AK7=?"[_DF?AW_L!6G_ *)2N%_;G_Y- M'\>_]@%__0UKNOA=_P DS\._]@*T_P#1*4 ;M%%% !1110 4444 ?+W_ 6 M_P"3*M3_ .P[I_\ Z-K\D*_6_P#X+ ?\F5:G_P!AW3__ $;7Y(5_8/@3_P D M5/\ Z_3_ /28'\N^,7_)61_Z]1_]*D%%%%?LY^4A1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '[4_\$\?^3*OAY_V MO_:LE>SUXQ_P3Q_Y,J^'G_8"_P#:LE>SU_GIQ1_R4V._Z_5?_2Y']O\ #O\ MR3^#_P"O5/\ ](04445X1[(4444 %%%% !1110 4444 %%%% !7YM?\ !<__ M )*9X"_[ 5W_ .CEK]):_-K_ (+G_P#)3/ 7_8"N_P#T'?^P[:?\ HY*_ M?.OP,^%W_)3/#O\ V';3_P!')7[YU_,?TA/][R__ U/S@?T'X(_[MCO6G^4 MPHHHK^V^G+<1L.5DC^UF16[,@/:@#V/P[^VU^R5X MM^**_!CPU^T!X9O?$3^\:^ZOV,/C5J/[27['OPI_:'UF".*\\=_#?0_$-Y#$NU8 MYKRPAN'4#L TA&/:@#TNBBN,^,WQ-\7_ RTRRO_ A\'=:\8R74[1S6VBR1 MJUNH7(=MY'!/'% '-_MS_P#)H_CW_L O_P"AK7=?"[_DF?AW_L!6G_HE*^>? MCU\8OCG\9_@[X@^%MM^QOXXT^36]/:V2\DDMI!$20=Q4.,].F17)Z/\ \%!O MVKO!VD6OA"+_ ()9?%"]32K9+-;R.X"K.(E""0#R#@-MSC)Z]30!]GT5\<_\ M/*?VLO\ I$_\4_\ P+'_ ,CT?\/*?VLO^D3_ ,4__ L?_(] 'V-17QS_ ,/* M?VLO^D3_ ,4__ L?_(]'_#RG]K+_ *1/_%/_ ,"Q_P#(] 'V-17QS_P\I_:R M_P"D3_Q3_P# L?\ R/1_P\I_:R_Z1/\ Q3_\"Q_\CT =+_P6 _Y,JU/_ +#N MG_\ HVOR0K[Z_; _:8_:R_:N^"MU\'_^':7Q3T#[3?V]S_:/DBZV^4^[;Y?E MQYSTSNX]Z^1_^&2OVLO^C1_BG_X20_\ CU?TCX3\?<)<,\,2PF98GV=1U)2M MR5):-12=XQDNCZW/P7Q*X+XEX@XACBH_X9*_:R_Z-'^*?_A)#_X]7Z;_ ,1?\._^@W_R MG6_^5GY__P 0PXY_Z!/_ "I2_P#DSSVBO0O^&2OVLO\ HT?XI_\ A)#_ ./4 M?\,E?M9?]&C_ !3_ /"2'_QZC_B+_AW_ -!O_E.M_P#*P_XAAQS_ - G_E2E M_P#)GGM%>A?\,E?M9?\ 1H_Q3_\ "2'_ ,>H_P"&2OVLO^C1_BG_ .$D/_CU M'_$7_#O_ *#?_*=;_P"5A_Q##CG_ *!/_*E+_P"3//:*]"_X9*_:R_Z-'^*? M_A)#_P"/4?\ #)7[67_1H_Q3_P#"2'_QZC_B+_AW_P!!O_E.M_\ *P_XAAQS M_P! G_E2E_\ )GGM%>A?\,E?M9?]&C_%/_PDA_\ 'J/^&2OVLO\ HT?XI_\ MA)#_ ./4?\1?\._^@W_RG6_^5A_Q##CG_H$_\J4O_DSSVBO0O^&2OVLO^C1_ MBG_X20_^/4?\,E?M9?\ 1H_Q3_\ "2'_ ,>H_P"(O^'?_0;_ .4ZW_RL/^(8 M<<_] G_E2E_\F>>T5UUK^SW^T;>^++OP1:_LR?$:35;*UCN+K3D\-J9XHG.% M=D\[*J<<'O6I_P ,E?M9?]&C_%/_ ,)(?_'J/^(O^'?_ $&_^4ZW_P K#_B& M''/_ $"?^5*7_P F>>T5Z%_PR5^UE_T:/\4__"2'_P >H_X9*_:R_P"C1_BG M_P"$D/\ X]1_Q%_P[_Z#?_*=;_Y6'_$,..?^@3_RI2_^3//:*]"_X9*_:R_Z M-'^*?_A)#_X]1_PR5^UE_P!&C_%/_P )(?\ QZC_ (B_X=_]!O\ Y3K?_*P_ MXAAQS_T"?^5*7_R9Y[17H7_#)7[67_1H_P 4_P#PDA_\>H_X9*_:R_Z-'^*? M_A)#_P"/4?\ $7_#O_H-_P#*=;_Y6'_$,..?^@3_ ,J4O_DSSVBO0O\ ADK] MK+_HT?XI_P#A)#_X]1_PR5^UE_T:/\4__"2'_P >H_XB_P"'?_0;_P"4ZW_R ML/\ B&''/_0)_P"5*7_R9Y[17H7_ R5^UE_T:/\4_\ PDA_\>H_X9*_:R_Z M-'^*?_A)#_X]1_Q%_P ._P#H-_\ *=;_ .5A_P 0PXY_Z!/_ "I2_P#DSSVB MO0O^&2OVLO\ HT?XI_\ A)#_ ./4?\,E?M9?]&C_ !3_ /"2'_QZC_B+_AW_ M -!O_E.M_P#*P_XAAQS_ - G_E2E_P#)GZS_ /!/'_DRKX>?]@+_ -JR5[/7 MP-^SQ^V9^UE\!?@KX=^#_P#PZ_\ BGJW]@6'V;^T>(//^=FW>7Y3[?O8QN/2 MNS_X>4_M9?\ 2)_XI_\ @6/_ )'K^-\^Q-#&YYBL11=X3J3E%ZJZMA,GPU"JK2A3A%K>S44FM--^Q]C45\<_P##RG]K+_I$_P#%/_P+ M'_R/1_P\I_:R_P"D3_Q3_P# L?\ R/7DGI'V-17QS_P\I_:R_P"D3_Q3_P# ML?\ R/1_P\I_:R_Z1/\ Q3_\"Q_\CT ?8U%?'/\ P\I_:R_Z1/\ Q3_\"Q_\ MCT?\/*?VLO\ I$_\4_\ P+'_ ,CT ?8U%?'/_#RG]K+_ *1/_%/_ ,"Q_P#( M]'_#RG]K+_I$_P#%/_P+'_R/0!]C45\<_P##RG]K+_I$_P#%/_P+'_R/1_P\ MI_:R_P"D3_Q3_P# L?\ R/0!]C45\<_\/*?VLO\ I$_\4_\ P+'_ ,CT?\/* M?VLO^D3_ ,4__ L?_(] 'V-7YM?\%S_^2F> O^P%=_\ HY:]?_X>4_M9?](G M_BG_ .!8_P#D>OFW]N?Q!^UE^VEXFT#Q%_P[\^*?AK^P[":V\G^RQ>>?O<-N MS^ZVXQCWWAGG66I)PLKI;23>LFELNY\CT5Z%_PR5^UE_T:/\4__"2'_P >H_X9*_:R_P"C M1_BG_P"$D/\ X]7]0?\ $7_#O_H-_P#*=;_Y6?SQ_P 0PXY_Z!/_ "I2_P#D MSSVBO0O^&2OVLO\ HT?XI_\ A)#_ ./4?\,E?M9?]&C_ !3_ /"2'_QZC_B+ M_AW_ -!O_E.M_P#*P_XAAQS_ - G_E2E_P#)GGM%>A?\,E?M9?\ 1H_Q3_\ M"2'_ ,>H_P"&2OVLO^C1_BG_ .$D/_CU'_$7_#O_ *#?_*=;_P"5A_Q##CG_ M *!/_*E+_P"3//:*]"_X9*_:R_Z-'^*?_A)#_P"/4?\ #)7[67_1H_Q3_P#" M2'_QZC_B+_AW_P!!O_E.M_\ *P_XAAQS_P! G_E2E_\ )GGM%>A?\,E?M9?] M&C_%/_PDA_\ 'J/^&2OVLO\ HT?XI_\ A)#_ ./4?\1?\._^@W_RG6_^5A_Q M##CG_H$_\J4O_DSSVBO0O^&2OVLO^C1_BG_X20_^/4?\,E?M9?\ 1H_Q3_\ M"2'_ ,>H_P"(O^'?_0;_ .4ZW_RL/^(8<<_] G_E2E_\F>>T5Z%_PR5^UE_T M:/\ %/\ \)(?_'JR_"?[/?[1OCC39-7\*_LR?$;4;:*ZDMY)[#PVLJ++&VUT M)$W# \$=C1_Q%_P[_P"@W_RG6_\ E8?\0PXY_P"@3_RI2_\ DSD:*]"_X9*_ M:R_Z-'^*?_A)#_X]1_PR5^UE_P!&C_%/_P )(?\ QZC_ (B_X=_]!O\ Y3K? M_*P_XAAQS_T"?^5*7_R9Y[17H7_#)7[67_1H_P 4_P#PDA_\>H_X9*_:R_Z- M'^*?_A)#_P"/4?\ $7_#O_H-_P#*=;_Y6'_$,..?^@3_ ,J4O_DSSVBO0O\ MADK]K+_HT?XI_P#A)#_X]1_PR5^UE_T:/\4__"2'_P >H_XB_P"'?_0;_P"4 MZW_RL/\ B&''/_0)_P"5*7_R9Y[17H7_ R5^UE_T:/\4_\ PDA_\>H_X9*_ M:R_Z-'^*?_A)#_X]1_Q%_P ._P#H-_\ *=;_ .5A_P 0PXY_Z!/_ "I2_P#D MSSVBO0O^&2OVLO\ HT?XI_\ A)#_ ./4?\,E?M9?]&C_ !3_ /"2'_QZC_B+ M_AW_ -!O_E.M_P#*P_XAAQS_ - G_E2E_P#)GGM%>A?\,E?M9?\ 1H_Q3_\ M"2'_ ,>H_P"&2OVLO^C1_BG_ .$D/_CU'_$7_#O_ *#?_*=;_P"5A_Q##CG_ M *!/_*E+_P"3.:^%W_)3/#O_ &';3_T%_V9/VLO#7B;3O$7_#'O MQ3F^P7\-SY/_ BH7S-CAMN?-.,XQG!K[Y_X>4_M9?\ 2)_XI_\ @6/_ )'K M\*\8^+>'^*L1@Y976]HJ:FI>[.-KN-OCC&][/:Y^Q>%G#.=\.4,5',:7LW-P MY?>C*]E*_P +=MUN?8U%?'/_ \I_:R_Z1/_ !3_ / L?_(]'_#RG]K+_I$_ M\4__ +'_P CU^+'ZP?8U%?'/_#RG]K+_I$_\4__ +'_P CT?\ #RG]K+_I M$_\ %/\ \"Q_\CT ?8U%?'/_ \I_:R_Z1/_ !3_ / L?_(]'_#RG]K+_I$_ M\4__ +'_P CT ?8U%>&?LJ?M6?&?]H#Q3J>@?$W]C+QC\,[:QT\7%MJ?B2< M-%=R%PODI^[0[L$MWX!KW.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ KYR_X*X_L@:[^WI_P3>^+?[*?A)H_P"V M_$_AD/X>2:0(DNI6D\5]:1LQX17N+:)"QX4,3VKZ-HH _*;]JK]IZR_:X_X( M5:)^QU\'9H=0^/\ \2O"6A_#^;X4F4)K.D:U%+:V^L"^M?\ 76<%HD-S))/* MBHJ"-B0)4S^DG[-GP9TO]G+]G7P#^SWHEY]HL_ G@O2_#UI<%=OFQV5I%;*^ M.V1$#^-=;%I&DP:E+K,.EVZ7D\:I-=K HED4=%9L9('8$U8H **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \+\ _\ M*03Q_P#]B)I7_HQJ]TJ"/2],BU"35HM.@6[EC"2W2PJ)'4=%+8R0/2IZ "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\+_ .">_P#R1/5O M^Q[UG_TI->Z5!I^EZ9I$!MM*TZ"UC:1G:.WA5%+$Y+8 ')/4T 3T444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7S M'^V/_P %'=:_9S\?-\&_@-^QK\3OCGXRLM*CU3Q%I7P]L(A:Z%:2;_)^UW<[ M+&MQ*(W:.V3?*RH6*JI0M].5D747@?X>V6O>.;X:;HUM,6U3Q)JTQ2"-O*MH MXFN;B0X'R06\:EV/"1*,X6@#Q'_@G'_P4H^ W_!3#X1ZI\2/@_I6O:!JWAC6 MY-%\;^"/%U@+75O#NI1_>M[B(,PP<':P.#M92%='1>-U3_@K7X#E^'GC']I7 MP!\"_%/B?X(_#[6[K3?%?Q5TFYM3$PM)/*O[^QLR_GWUC:.&$UPFTD0S&%)P MF3\^_"7X:^-O@Q^Q+^WI_P %0O#6BWGAS5_CCHWB;QCX"TM[=K>YM]'TW1;M M-)OI8R T5Q=$RWI0_,JSQ!L/N ZO_@E3X$\*VW_!MCX-\&W-K$VEZG\!]*-3)\ M_3XWZ2QV-FY,I!PD]X(_O)*% /9/B9^W):Z;^T=??LB_L_?"34?B3\0=!\.0 MZ]XPL+#5K:PL?#ME.Q6U6ZNIVPMS<%6,-NJLS(C2.8DVNW6_LF?M8?"O]LKX M2#XM?"I[ZW2UU>\T;Q%H.LP+#J.@:O:2F&[TV\B5F$=Q#(,, S*05=&9'5C\ M-_\ !!S5M5\=?MN_\%!OB?XKE>76)_VF;C07DE.7%CI;7=M91Y_NI"0H[8'% M/_X(P:]J-A_P56_X**?"S3G<>']/^+.@:U:6ZG]W'J%_;W_VQP.FYS;Q9/7Y M!GM0!^EM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?!?[2W_!=*Q^ 4VO_ M !#\+?\ !/?XX^//A#X0U":T\4?&+PUH=NNEKY$ACN;BSCFE62\M8G5U:Z 2 M$F-MKE0'/TO)^W7^RQ#^QD/^"@$WQ7LT^%!\*#Q$/$[1N%^QE00/+QO\XN1% MY.WS/-/E[=W%9/[1CI]]/"K/%"QD5C&\ M9D64"-H?VQ_^"CNM?LY^/F^#?P&_8U^)WQS\966E1ZIXBTKX>V$0M="M)-_D M_:[N=EC6XE$;M';)OE94+%54H6^$A49PM 'B?_ 3C_P""E'P&_P""F'PCU3XD?!_2 MM>T#5O#&MR:+XW\$>+K 6NK>'=2C^];W$09A@X.U@<':RD*Z.BU?$/\ P4M^ M%FB?\%#O"'_!.%?AAXU_X2GQ9H6I:O#XCU#0VLM)6VLXY"_E23;7NF+QE24Z="W+6[I&;B55\S]RC1S_?%% 'RQ^S#\0_V\_VPI?'7@G]O?\ X)]Z M;\$? %QX6;2;;0;CXEZ?XGO/$SWF^.X"?"' M]FW]N[]EK_@FAXJ_X))^!?@EJ'B;6H;'7/"?PS^+S:QI\.A?V!J4MP8-2U#= M<"ZM[BSBNG1[:.VD+O!'Y9D1V=/TBHH ^$/C'\+OVU?^"=_[!/PL_8<_X)>? MLFZU\3Y-%T2#2/$/BZS\;:'H$NFVJ8-Y=0G4I^+^ZD>9XV$,L4+.SL'VK&\G M[)'QL_X*E1>+O ?[.+?\$:-/^!'PRLKL#7O&VJ?';1O$9L;*,//*BV=F1<7% MS=2#RS<.[,)+AII-YW&ONNB@#XE\ ?LW_%W_ ()]_M^?&W]H;X2_!#7OB'\- M?V@8M/UW4=(\(75@NH^'?%-HDL4X,-[W$MK9S7 M4%E+@W$#)Y('-2T4 ?F>?VA/^"T5Q^T;JWQY\9? M\$)-4\5-ITYUVO-Y(DG!O[@9$UQO.R+$$05?.:?TK M]IO]D7]J_P#X*P?\$P-=^'?[4WPVT7X-?%N^\0#Q%X \.0:]%J\?A&_T^<'3 MTN;ZVW1W1F$B::+.YG>YBGN)-[W$@A5((U(S M*QB5O_!0GXE?\%.O%_[0=K\+OA/_ ,$G=6^*WP3T-8[K4BWQG\-Z"GC#4%*R M11SQ7,\DITZ%N6MW2,W$JKYG[E&CG^^** /FW]B;X\?\%&/CQX\\0ZA^V)^P M;8? 3PQI&EPQ:!ILGQ*T[Q/>Z_>2R$O-YMAA+6*".,*8W4M(UR"&Q&17C/[2 MWP;_ &M/$_\ P6U^!W[6?@O]D/Q3K'PX^'7@/Q#H6O\ B2V\2>'HB\]^CK%) M#;SZG'.\8*IN+(K /PIP17WQ10 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 A10 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9 end GRAPHIC 29 ew-20211231_g6.jpg begin 644 ew-20211231_g6.jpg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ew-20211231_g7.jpg begin 644 ew-20211231_g7.jpg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end GRAPHIC 31 ew-20211231_g8.jpg begin 644 ew-20211231_g8.jpg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end GRAPHIC 32 ew-20211231_g9.jpg begin 644 ew-20211231_g9.jpg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˳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end GRAPHIC 33 image_0.jpg begin 644 image_0.jpg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end GRAPHIC 34 image_1.jpg begin 644 image_1.jpg MB5!.1PT*&@H -24A$4@ ! $ #8" 8 ":_?KL "7!(67, $SE M !,Y0%USO"5 !>Z4E$051XG.V=>?Q-U?[_+U&&7&-1(1$)N21#288R-$F$ M%(40(0HA0H1<8R)#)6F0H2*S5#)FC%3*/!,R#S>E]?N^UOWMSSV?\SF?SQGV M6GNM?<[K^7B\_[C7IWWV6GOMM==ZK??P#T$((8000@@AA)"$X!^F;X 00@@A MA!!"""'>0!& $$(((8000@A)$"@"$$(((8000@@A"0)% $(((8000@@A)$&@ M"$ ((8000@@AA"0(% $((8000@@AA) $@2( (8000@@AA!"2(% $((000@@A MA!!"$@2* (000@@AA!!"2() $8 00@@AA!!""$D0* (00@@AA!!"""$) D4 M0@@AA!!"""$D0: (0 @AA!!"""&$) @4 0@AA!!"""&$D 2!(@ AA!!"""&$ M$)(@4 0@A!!B/8G3 MI\6^??N2V8P9,T3Z].G%/_[QCV0V??KT%'\+.WKTJ.EF$$(((818"44 0@@A M5C%^_'A1HD2)9%:H4*$4 @#LQAMO3/&WL!8M6IAN!B&$$$*(E5 $((008I0E M2Y:(%U]\,-&V>ZF8000@@A5D 1@!!"B*?LVK5+ M+%RX,,F:-V_N>M,?SLJ6+9OT>SMW[C3=!8000@@AQJ (0 @AQ%,&#QXLTJ5+ ME\QTBP PY[<&#AQHN@L((8000HQ!$8 00HAVMF[=*AY^^&%1ITX=4:Q8,4\V M_:E9T:)%Y7T\]-!#XJ>??C+=-8000@@AGD(1@!!"B%;6K5LG.G7J)#)DR&!T M\Q]L5UQQA7C^^>?%FC5K3'<1(8000HAG4 0@A!"B#93KZ]*EB_$-?UK6N7-G ML7?O7M-=10@AA!#B"10!""&$:..IIYX2.7+D,+[13\MP?TV;-C7=58000@@A MGD 1@!!"B%*0@;]-FS;24*K/]"8_$JM=N[;I;B.$$$((\02* (000I2Q___Z[Z2XDA/Q_SI\_+Q8L6"!FSIR9IC&>?LJI(H4*% MPKZ[$R=.%.?.G9-ST-]__VWZU@DAQ'HH A!""'$-%NOWW7>?R)4KE_'-/$4 M0OP/PHK*ER\O,F7*%/;=1=G1N^^^6S1JU$C\]MMOIF^=$$*LAR( (8005ZQ> MO5H\^^RSXLHKKS2^D7=C*&'8NG5K&=) "/&>TZ=/BS%CQHC^_?N+!@T:1/T. MY\R94W3MVE7\\,,/IIM"""%60Q& $$*(*X8.'6I\ Z_2!@\>;+I+"4DH=N_> M+=:N72OFSITK\N?/[_H=?O755^7U( ;\\<>>DH\_?33 MT@8-&I24!1RE_?#_X=_Q=RI^KTZ=.H9[F-@&$LY-F3)%3)X\66S M7;MVB9$C1RI[9RD"$$)(Y% $((00$A4HP[5X\6)Q]=57:]_\(]$7-@F///*( M+$.8%A %ZM6K)UV!W?YN]>K5Y:;OTJ5+'O4JL16<5A\YQN M.)LP88+X_OOOQ?;MVR.Z-_Q=FS9M7/]NMFS91,6*%9EEG(BV;=M*CY>B18N* M=.G2R?$!80K_7VHV;MPXT[=M-Z%"A<3 @0/%GCU[HK['9<$';LV%'\]==?,=\O8K:K5:LFLF?/3A& Q 1!("T+-G M3]>Q^,@?<.'"!5&YFY2\DOP7B@"$$&(' M% $((82DR>S9LT75JE5%A@P9M"_6$2N\=>M6)?>-#=B*%2OD_<-01:!$B1)1 M;>2J5*DB/OWT4R7W0_Q!OW[]1-VZ=<7==]_M2O3".T,1X+\@"2#Z%*$57B04 MI0A ""%I0Q& $$)(JLR;-T\T:-! ^R+]NNNN$^W:M5,F (0"W@'#AP\7Y7G_]=6WW1.Q@PX8-8LR8,=*B$8HH D0&DBMZO?&G"$ ((:E#$8 00D@* M_O.?_\@ZWO?==Y_V!3J2=S5JU$C\^>>?GK0-0@!$!XH !,!%_:677E(^KBM4 MJ""K52 L)5%!7H]]^_:))DV:4 0@A!"+H A ""$D!3___+.X_?;;1=:L6;4O MT'%*B#)>7IV:'C]^7$R>/)DB )&T;-E2Y,Z=6_FX1DX)E*A+Y+P21X\>E2$ M;A)T4@0@A!#U4 0@A!"2 B0"S)$CA[9%^4TWW21&CAPIWGSS3;%Z]6K/VX?3 MR5&C1LG[H B0V-Q___U:-Z#??/.-Z28:X_#APZ)X\>)&!0"* (00DA** (00 M0E*@4P3 Z6C7KEU=5P!P"\(/NG7K)HH6+4H1( $Y>?*DS'D1;8X(B@"10Q& M$$+LA"* "[" Q"(V-6-"($*(WT ,+^:O=>O6:1,!4 +0)EY^^>4T[W?0H$&> MY2L@WK%FS1J1)4L6[1O01!4!D(@383ZWW'(+10!""+$,B@ NP E2C1HU4C5D M&R:$$#_1IT\?.7^5+U]>6TE OXD 18H4$3UZ]#!]FT0Q% 'T@G:CS*(7?4P1 M@!!"HH,B0)0@=A6NH;!P+J2M6[=.^EO8GCU[3-]^S"!3^*1)DY*U)]#>>.,- M<>S8,=.W20B)$23P0HQ\R9(EM2S"K[_^>M&E2Q?1O7MWL6#! M/-348X$0#V MP ,/F+Y-HA DZ^O0H8/(F#$C10 -+%JT2#SQQ!/&-_\4 0@A)#04 :($;J&Q M?H3>?OMM&1_G)PX>/"@V;=HDEB]?+HH5*Y9JVY#Y=^;,F?)O_2QV$)*H;-Z\ M69;JT[$ O_;::T73IDVEF&@CHT>/%H4+%Z8(D$ ,&3+$LPUH(HH [=JU,[[Q MIPA ""&I0Q$@2MR( +ERY1)#APXUW82H@&MPOGSYY"(^+=?@].G3BSQY\LB_ M;=6JE>G;)H1$B4X1H'W[]K(LGZUY4LZ<.2.F3IU*$2"!H B@%XH A!!B-Q0! MHL2-" #KV[>OZ29$Q(4+%Z0 4*)$B:C;>..--XKFS9LGV=BQ8TTWAQ"2!E]^ M^:6H6[>NN/+**[4LP!$"8#L'#AP0[[WWGK0''WR0(D"<0Q% #Z=/GY8Y/VQ( M!D@1@!!"4HW M4:-&IIM$"$D#Y/10O>C.G3NW:-BPH6C2I(GX^../33*&&VXPONFG"$ ((6E#$2 *ZM2IH^1C5+5J56O= M8N$!@ 6[RH\O10!"[.7LV;,RN:?J17>%"A7$^?/G33!W* )$QY$C1\2*%2ND MU:Q9,UG?O?KJJ_+_W[!A@U%A:.W:M2)KUJR>;T 3001 !1#3&_VTC"( (80D MAR) &$:,&"$R9\ZL]&-DFP@P?_Y\N3!"F3_5'UZ* (38R8\__B@*%BR89NG/ M6(TB0.*!J@I77WVUM. QE2E3)OG_WW[[[>*WWWXS=H\4 ?1!$8 00OP%18 P MJ$Z8A6S9R$QL$U]\\86V#R]% $+L!"[:R."O^IU'>3!;W+_=0!$@@UUUPCFC=O'A<" $ ?M6[=.LFPT26A>?+))Z,:*VW:M)'A M 5XR=.A08QO0>!8!CAX]*DJ6+*FEWY"[P7G_W(8K4@0@A)#D4 1(@_OOOU_Y M1\T6$0#A"(CAQ&),Q\<;&P(LH@DA]C%Z]&BE[[MSPNOG:@ D>O[\\T]Q\.!! M4:]>O:C'S%-//24.'SXL+E^^K/T^CQT[)GKW[JWE6Q>)402(WG+ERB4Z=>J4 M]#LM6K1P=3V* (00DAR* &D0SR( %NL(3=#A#@RC"$"(O:@6 ;! W[5KER<; M.F(/>_?N%=6K5Q?9LV>/>LSDS)E3//SPPS(QK6[:M6LG\N;-J^5;%XE1!(C> M4,4!B9D=* (00HA:* *D@6H1 N15:M6F6Z6Y.S9L^*..^[0MNBA"$"(G4R> M/%ENW%2^[UV[=C7=+&* [=NWB_SY\\<\;DJ4*.%)HD!XJ>CZUD5B\2H";-Z\ M6;1MVU;+80)*C((3)TZ(UUY[+6:A(4^>/+),Y=:M6PWW%B&$V 5%@!"<.G5* M?/GEEZ)\^?)*/VI???65Z:9)H-S/FC5+:ZUDB@"$V ER=:A\UY'Q?>+$B::; M%37'CQ\7"Q;OB5?@5/:29,FR4U6K&,'U2D^^>03&9JF$XH >I@Q M8X:V/G-$ 'B;%"Y<..;KW'SSS6+__OV&>XH00NR#(D (4#M;1QDA6T2 >?/F MB73ITFE=]% $(,1.5(L <^;,L:KD::1 Z,4\Z%CMVK5-WY*O>/?==Y5\1W - M;"9U0A% #Q0!""'$OU $" %$@"Q9LBC_J-DB LR=.U?[HH\Z1 _L''C1E&G3ITD"PZ'PHEVX+_WZM7+]"U;#39IJL;0].G3 MM=XK10 ]Z! !\!["P\39N%,$((00/5 $"(%J$>"&&VZ0=72W;=MFNFEBV;)E MLMR.[D4/10!"[ +OHQO7[6"[]MIK1?OV[<5//_UDNFEA05UZY&2)IGT0 DAH M4#ZW<>/&RL:2+A$ ^0;&C!DC<>:[)F=^O6S9-%#T4 M0NP!R;6^^.(+F9%=U3M>KEPY<>;,&=--"PL\(*(5 &!WWWVW^/GGGZ4%;DJ( M$,V:-5/ZO= A J#J $ZJ=83V16OQ* )TZ-!!>3\U;=HTQ>^X$0&>>>89 SU# M""'^@") ""@"N#>* (38P_OOOR^NN^XZD3Y]>F7ON!]$@+_^^DOF0(BEA%VF M3)EDXCK86V^]9;HI5N$'$0#)*A'ZHG+,QVH4 2(SB@"$$.(=% &"0);H>O7J MB0P9,BCYJ#WXX(/R!,YTXJP__OA##!HT2)0N7=J310]% $+L 2[1*M_OFC5K MBL\^^TQ6;=NG9@Y?OOM%+\! 6#\^/$B;]Z\,5W3#R( \A7,GCT[Q?MV^/!AT[=&"(ES* ($ M$8\B %QBCQT[)MUWO5KT4 0@Q [^\Y__B!$C1BA]OVT7 ?KTZ:-E7D.8&,+% MXI$___Q3G#MW3AKOOG?AC") > LE M DR9,B7FZUUUU54R%XAM(#04AS+.N[1\^7)Q]=57I[C_3S_]5/[[A0L73-\R M(21.H0@01#R* *M7KQ9WWGFGR)8MFV>+'HH A-@!YJ B18HH?;\I L0?R/B/ M9(@P5'X(;CM.8]/Z=S>F6@3HWKV[N.FFFSS[WH4SB@#A3;4(T+MW;RLJ,@6# M>ZI5JU;2NU2F3!EQQ157I+A_5+3 OZ.:$T0M0@A1#46 *9.G2HG9Y4?-AM$ M@'GSYGFZX+GUUEO%X,a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end XML 35 R1.htm IDEA: XBRL DOCUMENT v3.22.0.1
Cover - USD ($)
 12 Months Ended
Dec. 31, 2021
Jan. 31, 2022
Jun. 30, 2021
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2021    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 1-15525    
Entity Registrant Name EDWARDS LIFESCIENCES CORPORATION    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 36-4316614    
Entity Address, Address Line One One Edwards Way    
Entity Address, City or Town Irvine    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 92614    
City Area Code 949    
Local Phone Number 250-2500    
Title of 12(b) Security Common Stock, par value $1.00 per share    
Trading Symbol EW    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Entity Shell Company false    
Entity Public Float     $ 64,028,235,982
Entity Common Stock, Shares Outstanding   623,207,437  
Documents Incorporated by Reference Portions of the registrant's proxy statement for the 2022 Annual Meeting of Stockholders (to be filed within 120 days of December 31, 2021) are incorporated by reference into Part III, as indicated herein.    
Entity Central Index Key 0001099800    
Amendment Flag false    
Document Fiscal Year Focus 2021    
Document Fiscal Period Focus FY    

XML 36 R2.htm IDEA: XBRL DOCUMENT v3.22.0.1
Audit Information
 12 Months Ended
Dec. 31, 2021
Audit Information [Abstract]  
Auditor Name PricewaterhouseCoopers LLP
Auditor Location Irvine, California
Auditor Firm ID 238
XML 37 R3.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 862.8 $ 1,183.2
Short-term investments (Note 7) 604.0 219.4
Accounts receivable, net of allowances of $9.3 and $9.6, respectively 582.2 514.6
Other receivables 82.7 88.2
Inventories (Note 5) 726.7 802.3
Prepaid expenses 85.2 75.1
Other current assets 237.1 208.2
Total current assets 3,180.7 3,091.0
Long-term investments (Note 7) 1,834.2 801.6
Property, plant, and equipment, net (Note 5) 1,546.6 1,395.2
Operating lease right-of-use assets (Note 6) 92.1 94.2
Goodwill (Note 9) 1,167.9 1,173.2
Other intangible assets, net (Note 9) 323.6 331.4
Deferred income taxes 246.7 230.9
Other assets 110.8 119.6
Total assets 8,502.6 7,237.1
Current liabilities    
Accounts payable 204.5 196.5
Accrued and other liabilities (Note 5) 802.3 670.2
Operating lease liabilities (Note 6) 25.5 27.2
Total current liabilities 1,032.3 893.9
Long-term debt (Note 10) 595.7 595.0
Contingent consideration liabilities (Notes 8 and 11) 62.0 186.1
Taxes payable (Note 17) 190.0 215.3
Operating lease liabilities (Note 6) 69.1 72.7
Uncertain tax positions (Note 17) 259.0 214.4
Litigation settlement accrual (Note 3) 191.3 233.0
Other liabilities 267.3 252.4
Total liabilities 2,666.7 2,662.8
Commitments and contingencies (Notes 6, 10, and 18)
Stockholders' equity (Notes 14 and 21)    
Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding 0.0 0.0
Common stock, $1.00 par value, 1,050.0 shares authorized, 642.0 and 636.4 shares issued, and 624.1 and 624.3 shares outstanding, respectively 642.0 636.4
Additional paid-in capital 1,700.4 1,438.1
Retained earnings 6,068.1 4,565.0
Accumulated other comprehensive loss (157.7) (161.1)
Treasury stock, at cost, 17.9 and 12.1 shares, respectively (2,416.9) (1,904.1)
Total stockholders' equity 5,835.9 4,574.3
Total liabilities and stockholders' equity $ 8,502.6 $ 7,237.1
XML 38 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts $ 9.3 $ 9.6
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, authorized shares (in shares) 50,000,000.0 50,000,000.0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 1.00 $ 1.00
Common stock, shares authorized (in shares) 1,050,000,000 1,050,000,000
Common stock, shares issued (in shares) 642,000,000.0 636,400,000
Common stock, shares outstanding (in shares) 624,100,000 624,300,000
Treasury stock, shares (in shares) 17,900,000 12,100,000
XML 39 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]      
Net sales $ 5,232.5 $ 4,386.3 $ 4,348.0
Cost of sales 1,248.9 1,080.6 1,114.4
Gross profit 3,983.6 3,305.7 3,233.6
Selling, general, and administrative expenses 1,493.7 1,228.4 1,242.2
Research and development expenses 903.1 760.7 752.7
Intellectual property litigation expenses, net (Note 3) 20.6 405.4 33.4
Change in fair value of contingent consideration liabilities, net (124.1) 13.6 (6.1)
Special charges (Note 4) 0.0 0.0 64.6
Operating income 1,690.3 897.6 1,146.8
Interest expense 18.4 15.8 20.7
Interest income (17.4) (23.4) (32.2)
Other income, net (Note 16) (12.7) (11.5) (8.2)
Income before provision for income taxes 1,702.0 916.7 1,166.5
Provision for income taxes (Note 17) 198.9 93.3 119.6
Net income $ 1,503.1 $ 823.4 $ 1,046.9
Earnings per share:      
Basic (in dollars per share) $ 2.41 $ 1.32 $ 1.68
Diluted (in dollars per share) $ 2.38 $ 1.30 $ 1.64
Weighted-average number of common shares outstanding:      
Basic (in shares) 623.3 622.6 624.8
Diluted (in shares) 631.2 631.9 636.7
XML 40 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Statement of Comprehensive Income [Abstract]      
Net income $ 1,503.1 $ 823.4 $ 1,046.9
Other comprehensive income (loss), net of tax (Note 15):      
Foreign currency translation adjustments (50.1) 32.4 (11.2)
Unrealized gain (loss) on hedges 57.4 (40.2) (11.1)
Unrealized pension credits (costs) 11.6 (4.2) (1.9)
Unrealized (loss) gain on available-for-sale investments (24.1) 6.6 6.3
Reclassification of net realized investment loss to earnings 8.6 0.3 0.4
Other comprehensive income (loss), net of tax 3.4 (5.1) (17.5)
Comprehensive income $ 1,506.5 $ 818.3 $ 1,029.4
XML 41 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities      
Net income $ 1,503.1 $ 823.4 $ 1,046.9
Adjustments to reconcile net income to cash provided by operating activities:      
Depreciation and amortization 134.8 107.2 89.3
Non-cash operating lease cost 28.5 28.2 25.3
Stock-based compensation (Notes 2 and 14) 109.3 92.6 81.3
Inventory write off (Note 2) 0.0 0.0 73.1
Impairment charges (Note 4) 0.0 0.0 40.6
Change in fair value of contingent consideration liabilities, net (Note 11) (124.1) 13.6 (6.1)
Deferred income taxes (41.4) (49.4) 12.1
Purchased in-process research and development (Note 4) 0.0 0.0 24.0
Other (23.4) (3.5) (2.8)
Changes in operating assets and liabilities:      
Accounts and other receivables, net (91.1) 41.9 (88.0)
Inventories 19.0 (120.6) (105.4)
Prepaid expenses and other current assets 7.9 (28.5) (6.8)
Accounts payable and accrued liabilities 195.2 (84.5) 116.5
Litigation settlement accrual (29.2) 270.5 (180.0)
Income taxes 62.0 (52.9) 43.2
Other (18.5) 16.3 19.7
Net cash provided by operating activities 1,732.1 1,054.3 1,182.9
Cash flows from investing activities      
Capital expenditures (325.8) (407.0) (254.4)
Purchases of held-to-maturity investments (Note 7) (250.0) (162.0) (130.2)
Proceeds from sales and maturities of held-to-maturity investments (Note 7) 138.0 212.2 50.0
Purchases of available-for-sale investments (Note 7) (1,629.3) (689.7) (437.9)
Proceeds from sales and maturities of available-for-sale investments (Note 7) 391.2 564.8 359.9
Acquisition (Note 8) 0.0 0.0 (100.2)
Payment for acquisition option (13.1) (10.0) (35.0)
Issuances of notes receivable (5.1) (27.0) (12.9)
Collections of notes receivable 20.0 0.0 0.0
Investments in intangible assets and in-process research and development (4.0) (0.3) (24.0)
Other (44.4) (12.1) (11.1)
Net cash used in investing activities (1,722.5) (531.1) (595.8)
Cash flows from financing activities      
Proceeds from issuance of debt 5.2 16.2 18.9
Payments on debt and finance lease obligations (7.0) (17.0) (28.9)
Purchases of treasury stock (512.8) (625.4) (263.3)
Proceeds from stock plans 158.6 140.5 160.5
Other (0.3) (1.2) (2.8)
Net cash used in financing activities (356.3) (486.9) (115.6)
Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash 13.9 (20.5) (3.0)
Net (decrease) increase in cash, cash equivalents, and restricted cash (332.8) 15.8 468.5
Cash, cash equivalents, and restricted cash at beginning of year 1,200.2 1,184.4 715.9
Cash, cash equivalents, and restricted cash at end of year $ 867.4 $ 1,200.2 $ 1,184.4
XML 42 R8.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2018   215.2 7.5      
Beginning balance at Dec. 31, 2018 $ 3,140.4 $ 215.2 $ (1,015.4) $ 1,384.4 $ 2,694.7 $ (138.5)
Increase (Decrease) in Stockholders' Equity            
Net income 1,046.9       1,046.9  
Other comprehensive income (loss), net of tax (17.5)         (17.5)
Common stock issued under equity plans (in shares)   2.9        
Common stock issued under equity plans 160.5 $ 2.9   157.6    
Stock-based compensation expense 81.3     81.3    
Purchases of treasury stock (in shares)     1.5      
Purchases of treasury stock (263.3)   $ (263.3)      
Ending balance (in shares) at Dec. 31, 2019   218.1 9.0      
Ending balance at Dec. 31, 2019 4,148.3 $ 218.1 $ (1,278.7) 1,623.3 3,741.6 (156.0)
Increase (Decrease) in Stockholders' Equity            
Net income 823.4       823.4  
Other comprehensive income (loss), net of tax (5.1)         (5.1)
Common stock issued under equity plans (in shares)   4.5        
Common stock issued under equity plans 140.5 $ 4.5   136.0    
Stock-based compensation expense 92.6     92.6    
Purchases of treasury stock (in shares)     3.1      
Purchases of treasury stock (625.4)   $ (625.4)      
Stock issued to effect stock split (in shares)   413.8        
Stock issued to effect stock split 0.0 $ 413.8   (413.8)    
Ending balance (in shares) at Dec. 31, 2020   636.4 12.1      
Ending balance at Dec. 31, 2020 4,574.3 $ 636.4 $ (1,904.1) 1,438.1 4,565.0 (161.1)
Increase (Decrease) in Stockholders' Equity            
Net income 1,503.1       1,503.1  
Other comprehensive income (loss), net of tax 3.4         3.4
Common stock issued under equity plans (in shares)   5.6        
Common stock issued under equity plans 158.6 $ 5.6   153.0    
Stock-based compensation expense 109.3     109.3    
Purchases of treasury stock (in shares)     5.8      
Purchases of treasury stock (512.8)   $ (512.8)      
Ending balance (in shares) at Dec. 31, 2021   642.0 17.9      
Ending balance at Dec. 31, 2021 $ 5,835.9 $ 642.0 $ (2,416.9) $ 1,700.4 $ 6,068.1 $ (157.7)
XML 43 R9.htm IDEA: XBRL DOCUMENT v3.22.0.1
DESCRIPTION OF BUSINESS
 12 Months Ended
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
DESCRIPTION OF BUSINESS DESCRIPTION OF BUSINESSEdwards Lifesciences Corporation ("Edwards Lifesciences" or the "Company") conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. Edwards Lifesciences is focused on technologies that treat structural heart disease and critically ill patients. The products and technologies provided by Edwards Lifesciences are categorized into the following main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care.
XML 44 R10.htm IDEA: XBRL DOCUMENT v3.22.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Principles of Consolidation

The accompanying consolidated financial statements include the accounts of Edwards Lifesciences and its majority-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The Company reviews its investments in other entities to determine whether the Company is the primary beneficiary of a variable interest entity ("VIE"). The Company would be the primary beneficiary of the VIE, and would be required to consolidate the VIE, if it has the power to direct the significant activities of the entity and the obligation to absorb losses or receive benefits from the entity that may be significant to the VIE. Based on the Company's analysis, it determined it is not the primary beneficiary of any material VIEs; however, future events may require VIEs to be consolidated if the Company becomes the primary beneficiary.

Stock Split

On May 7, 2020, the Company’s Board of Directors declared a three-for-one stock split of the Company's outstanding shares of common stock effected in the form of a stock dividend, distributed on May 29, 2020 to stockholders of record on May 18, 2020. The Company distributed two newly issued shares of common stock to holders of record of each share of common stock to effect the stock split. All applicable share and per-share amounts in the consolidated financial statements and the notes to consolidated financial statements have been retroactively adjusted to reflect this stock split. The consolidated statement of stockholders' equity for the year ended December 31, 2019 has not been retroactively adjusted to reflect the stock split.

Use of Estimates

The consolidated financial statements of Edwards Lifesciences have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") which have been applied consistently in all material respects. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. In particular, the COVID-19 pandemic has adversely impacted, and may further adversely impact, nearly all aspects of the Company's business and markets, including its workforce and the operations of its customers, suppliers, and business partners. The full extent to which the pandemic will directly or indirectly impact the Company's business, results of operations, and financial condition, including sales, expenses, manufacturing, clinical trials, research and development costs, reserves and allowances, fair value measurements, asset impairment charges, contingent consideration obligations, and the effectiveness of the Company's hedging instruments, will depend on future developments that are highly uncertain and difficult to predict. These developments include, but are not limited to, the duration and spread of the outbreak (including new and more contagious variants of COVID-19), its severity, the actions to contain the virus or address its impact, the timing, distribution, public acceptance and efficacy of vaccines and other treatments, United States and foreign government actions to respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume.
Foreign Currency Translation

When the local currency of the Company's foreign entities is the functional currency, all assets and liabilities are translated into United States dollars at the rate of exchange in effect at the balance sheet date. Income and expense items are translated at the weighted-average exchange rate prevailing during the period. The effects of foreign currency translation adjustments for these entities are deferred and reported in stockholders' equity as a component of "Accumulated Other Comprehensive Loss." The effects of foreign currency transactions denominated in a currency other than an entity's functional currency are included in "Other Income, net."

Revenue Recognition

Revenue is recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those products or services.

The Company generates nearly all of its revenue from direct product sales and sales of products under consignment arrangements. Revenue from direct product sales is recognized at a point in time when the performance obligation is satisfied upon delivery of the product. Revenue from sales of consigned inventory is recognized at a point in time when the performance obligation is satisfied once the product has been implanted or used by the customer. The Company periodically reviews consignment inventories to confirm the accuracy of customer reporting. The Company also generates a small portion of its revenue from service contracts, and recognizes revenue from service contracts ratably over the term of the contracts. Sales taxes and other similar taxes that the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company does not typically have any significant unusual payment terms beyond 90 days in its contracts with customers. In addition, the Company receives royalty payments for the licensing of certain intellectual property and recognizes the royalty when the subsequent sale of product using the intellectual property occurs.

The amount of consideration the Company ultimately receives varies depending upon the return terms, sales rebates, discounts, and other incentives that the Company may offer, which are accounted for as variable consideration when estimating the amount of revenue to recognize. The Company includes estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely upon an assessment of historical payment experience, historical relationship to revenues, estimated customer inventory levels, and current contract sales terms with direct and indirect customers.

The Company's sales adjustment related to distributor rebates given to the Company's United States distributors represents the difference between the Company's sales price to the distributor and the negotiated price to be paid by the end-customer. This distributor rebate is recorded as a reduction to sales and a reduction to the distributor's accounts receivable at the time of sale to a distributor. The Company periodically monitors current pricing trends and distributor inventory levels to ensure the credit for future distributor rebates is fairly stated.

The Company offers volume rebates to certain group purchasing organizations ("GPOs") and customers based upon targeted sales levels. Volume rebates offered to GPOs are recorded as a reduction to sales and an obligation to the GPOs, as the Company expects to pay in cash. Volume rebates offered to customers are recorded as a reduction to sales and either a reduction to accounts receivable if the Company expects a net payment from the customer, or as an obligation to the customer if the Company expects to pay in cash. The provision for volume rebates is estimated based upon customers' contracted rebate programs, projected sales levels, and historical experience of rebates paid. The Company periodically monitors its customer rebate programs to ensure that the allowance and liability for accrued rebates is fairly stated.

Product returns are typically not significant because returns are generally not allowed unless the product is damaged at time of receipt. In limited circumstances, the Company may allow customers to return previously purchased products, such as for next-generation product offerings. For these transactions, the Company defers recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer.
The Company sells separately priced service contracts, which range from 12 to 36 months, to owners of its hemodynamic monitors. The Company invoices the customer the total amount of consideration at the inception of the contract and recognizes revenue ratably over the term of the contract. As of December 31, 2021 and 2020, $10.2 million and $6.3 million, respectively, of deferred revenue associated with outstanding service contracts was recorded in “Accrued and Other Liabilities” and "Other Long-term Liabilities." During 2021, the Company recognized as revenue $7.3 million that was included in the balance of deferred revenue as of December 31, 2020, and during 2020, the Company recognized as revenue $6.3 million that was included in the balance of deferred revenue as of December 31, 2019.

A limited number of the Company’s contracts with customers contain multiple performance obligations. For these contracts, the transaction price is allocated to each performance obligation based on its relative standalone selling price charged to other customers.

The Company applies the optional exemption of not disclosing the amount of the transaction price allocated to unsatisfied performance obligations for contracts with an original expected duration of one year or less.

Shipping and Handling Costs

Shipping costs, which are costs incurred to physically move product from the Company's premises or third party distribution centers, including storage, to the customer's premises, are included in "Selling, General, and Administrative Expenses." Handling costs, which are costs incurred to store at the Company's premises, move, and prepare products for shipment, are included in "Cost of Sales." For the years ended December 31, 2021, 2020, and 2019, shipping costs of $85.3 million, $74.0 million, and $71.5 million, respectively, were included in "Selling, General, and Administrative Expenses."

Cash Equivalents

The Company considers highly liquid investments with original maturities of three months or less to be cash equivalents. These investments are valued at cost, which approximates fair value.

Investments

The Company invests its excess cash in debt securities, including time deposits, commercial paper, United States government and agency securities, asset-backed securities, corporate debt securities, and municipal debt securities. Investments with maturities of one year or less are classified as short-term, and investments with maturities greater than one year are classified as long-term. Investments that the Company has the ability and intent to hold until maturity are classified as held-to-maturity and carried at amortized cost. Investments in debt securities that are classified as available-for-sale are carried at fair value with unrealized gains and losses included in "Accumulated Other Comprehensive Loss." The Company determines the appropriate classification of its investments in debt securities at the time of purchase and reevaluates such designation at each balance sheet date.

The Company also has long-term equity investments in companies that are in various stages of development. These investments are reported at fair value or under the equity method of accounting, as appropriate. Equity investments that do not have readily determinable fair values are recorded at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The Company accounts for investments in limited partnerships and limited liability corporations, whereby the Company owns a minimum of 5% of the investee's outstanding voting stock, under the equity method of accounting. These investments are recorded at the amount of the Company's investment and adjusted each period for the Company's share of the investee's income or loss, and dividends paid.

Realized gains and losses on investments that are sold are determined using the specific identification method, or the first-in, first-out method, depending on the investment type, and recorded to "Other Income, net." Income relating to investments in debt securities is recorded to "Interest Income."

Equity investments without readily determinable fair value are considered impaired when there is an indication that the fair value of the Company's interest is less than the carrying amount. Equity method investments are considered impaired when
there is an indication of an other-than-temporary decline in value below the carrying amount. Impairments of equity investments are recorded in "Other Income, net."

Debt securities in an unrealized loss position are written down to fair value through “Other Income, net” if the Company intends to sell the security or it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. For debt securities in an unrealized loss position that do not meet the aforementioned criteria, the Company assesses whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. When a credit loss exists, the Company compares the present value of cash flows expected to be collected from the debt security to the amortized cost basis of the security to determine the allowance amount that should be recorded, if any.

Accounts Receivable

The majority of the Company’s accounts receivable arise from direct product sales and sales of products under consignment arrangements, and have payment terms that generally require payment within 30 to 90 days. The Company does not adjust its receivables for the effects of a significant financing component at contract exception if collection of the receivable is expected within one year or less from the time of sale. In countries where the Company has experienced a pattern of payments extending beyond the stated terms and collection of the receivable is expected beyond one year from the time of sale, the Company assesses whether the customer has a significant financing component and discounts the receivable and reduces the related revenues over the period of time that the Company estimates those amounts will be paid using the country’s market-based borrowing rate for such period.

The Company provides reserves against accounts receivable for estimated losses that may result from a customer’s inability to pay based on customer-specific analysis and general matters such as current assessments of past due balances, economic conditions and forecasts, and historical credit loss activity. Amounts determined to be uncollectible are charged or written-off against the reserve.

Inventories

Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. Market value for raw materials is based on replacement costs, and for other inventory classifications is based on net realizable value.

A write-down for excess or slow moving inventory is recorded for inventory which is obsolete, damaged, nearing its expiration date (generally triggered at six months prior to expiration), or slow moving (generally defined as quantities in excess of a two-year supply).

The Company allocates to inventory general and administrative costs that are related to the production process. These costs include insurance, manufacturing accounting and human resources personnel, and information technology. During the years ended December 31, 2021, 2020, and 2019, the Company allocated $77.9 million, $63.1 million, and $56.6 million, respectively, of general and administrative costs to inventory. General and administrative costs included in inventory at December 31, 2021 and 2020 were $33.7 million and $30.7 million, respectively.

At December 31, 2021 and 2020, $125.8 million and $130.0 million, respectively, of the Company's finished goods inventories were held on consignment.

In 2019, the Company recorded a $73.1 million charge to "Cost of Sales," primarily comprised of the write off of inventory related to strategic decisions regarding its transcatheter aortic valve portfolio, including the decision to discontinue its CENTERA program.
Property, Plant, and Equipment

Property, plant, and equipment are recorded at cost. Depreciation is principally calculated for financial reporting purposes on the straight-line method over the estimated useful lives of the related assets, which range from 10 to 40 years for buildings and improvements, from 3 to 15 years for machinery and equipment, and from 3 to 5 years for software. Leasehold improvements are amortized over the life of the related facility leases or the asset, whichever is shorter. Straight-line and accelerated methods of depreciation are used for income tax purposes. Construction in progress is not depreciated until the asset is ready for its intended use.

Depreciation expense for property, plant, and equipment was $127.0 million, $101.8 million, and $84.7 million for the years ended December 31, 2021, 2020, and 2019, respectively.

Leases

The Company determines whether a contract is, or contains, a lease at inception. Right-of-use assets represent the Company’s right to use an underlying asset during the lease term, and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at lease commencement based upon the estimated present value of unpaid lease payments over the lease term. The Company uses its incremental borrowing rate based on the information available at lease commencement in determining the present value of unpaid lease payments. The Company's incremental borrowing rate is determined based on the estimated rate of interest for collateralized borrowing over a similar term as the associated lease. Right-of-use assets also include any lease payments made at or before lease commencement and any initial direct costs incurred, and exclude any lease incentives received.

The Company determines the lease term as the noncancellable period of the lease, and may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Leases with a term of 12 months or less are not recognized on the balance sheet. Certain of the Company’s leases include variable lease payments that are based on costs incurred or actual usage, or adjusted periodically based on an index or a rate. The Company’s leases do not contain any residual value guarantees.

The Company accounts for the lease and non-lease components as a single lease component for all of its leases except vehicle leases, for which the lease and non-lease components are accounted for separately.

Operating leases are included in “Operating Lease Right-of-Use Assets” and “Operating Lease Liabilities” on the Company’s consolidated balance sheets. See Note 6 for further information.

Impairment of Goodwill and Long-lived Assets

Goodwill is reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate that the carrying amount may be impaired. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the Company performs a quantitative impairment test. The Company determined, after performing a qualitative review of each reporting unit, that it is more likely than not that the fair value of each of its reporting units substantially exceeds the respective carrying amounts. Accordingly, in 2021, 2020, and 2019, the Company did not record any goodwill impairment loss.

Indefinite-lived intangible assets relate to in-process research and development acquired in business combinations. The estimated fair values of in-process research and development projects acquired in a business combination which have not reached technological feasibility are capitalized and accounted for as indefinite-lived intangible assets subject to impairment testing until completion or abandonment of the projects. Upon successful completion of the project, the capitalized amount is amortized over its estimated useful life. If the project is abandoned, all remaining capitalized amounts are written off immediately. Indefinite-lived intangible assets are reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate the carrying amount may be impaired. An impairment
loss is recognized when the asset's carrying value exceeds its fair value. In-process research and development projects acquired in an asset acquisition are expensed unless the project has an alternative future use.

Management reviews the carrying amounts of other finite-lived intangible assets and long-lived tangible assets whenever events or circumstances indicate that the carrying amounts of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit, and adverse legal or regulatory developments. If it is determined that such indicators are present and the review indicates that the assets will not be fully recoverable, based on undiscounted estimated cash flows over the remaining amortization periods, their carrying values are reduced to estimated fair market value. Estimated fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. For the purposes of identifying and measuring impairment, long-lived assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities.

In 2021 and 2020, the Company did not record any impairment loss related to its in-process research and development assets. In 2019, the Company recorded a $40.6 million charge related to the impairment of certain in-process research and development assets. See Note 4 for further information.

Income Taxes

The Company is subject to income taxes in the United States and numerous foreign jurisdictions. Significant judgment is required in evaluating the Company's uncertain tax positions and determining its provision for income taxes. The Company recognizes the financial statement benefit of a tax position only after determining that a position would more likely than not be sustained based upon its technical merit if challenged by the relevant taxing authority and taken by management to the court of last resort. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon settlement with the relevant tax authority. The Company recognizes interest and penalties related to income tax matters in income tax expense. The Company has made an accounting policy election to recognize the United States tax effects of global intangible low-taxed income as a component of income tax expense in the period the tax arises.

Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been recognized in the Company's financial statements or tax returns. The Company evaluates quarterly the realizability of its deferred tax assets by assessing its valuation allowance and adjusting the amount, if necessary. The factors used to assess the likelihood of realization are both historical experience and the Company's forecast of future taxable income and available tax planning strategies that could be implemented to realize the net deferred tax assets. Failure to achieve forecasted taxable income in the applicable taxing jurisdictions could affect the ultimate realization of deferred tax assets and could result in an increase in the Company's effective tax rate on future earnings.

Research and Development Costs

Research and development costs are charged to expense when incurred.

Earnings per Share

Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during the period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive.
The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):
 Years Ended December 31,
 202120202019
Basic:   
Net income$1,503.1 $823.4 $1,046.9 
Weighted-average shares outstanding623.3 622.6 624.8 
Basic earnings per share$2.41 $1.32 $1.68 
Diluted:   
Net income$1,503.1 $823.4 $1,046.9 
Weighted-average shares outstanding623.3 622.6 624.8 
Dilutive effect of stock plans7.9 9.3 11.9 
Dilutive weighted-average shares outstanding631.2 631.9 636.7 
Diluted earnings per share$2.38 $1.30 $1.64 

Stock options, restricted stock units, and market-based restricted stock units to purchase approximately 1.8 million, 2.0 million, and 1.5 million shares were outstanding for the years ended December 31, 2021, 2020, and 2019, respectively, but were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive.

Stock-based Compensation

The Company measures and recognizes compensation expense for all stock-based awards based on estimated fair values. Stock-based awards consist of stock options, restricted stock units (service-based and market-based), and employee stock purchase subscriptions. Stock-based compensation expense is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period (vesting period) on a straight-line basis. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Upon exercise of stock options or vesting of restricted stock units, the Company issues common stock.

Total stock-based compensation expense was as follows (in millions):
 Years Ended December 31,
 202120202019
Cost of sales$20.4 $17.2 $14.7 
Selling, general, and administrative expenses65.6 56.6 51.2 
Research and development expenses23.3 18.8 15.4 
Total stock-based compensation expense109.3 92.6 81.3 
Income tax benefit(18.9)(15.4)(14.8)
Total stock-based compensation expense, net of tax$90.4 $77.2 $66.5 

Upon a participant's retirement, all unvested stock options are immediately forfeited. In addition, upon retirement, a participant will immediately vest in 25% of service-based restricted stock units for each full year of employment with the Company measured from the grant date. All remaining unvested service-based restricted stock units are immediately forfeited. For market-based restricted stock units, upon retirement and in certain other specified cases, a participant will receive a pro-rated portion of the shares that would ultimately be issued based on attainment of the performance goals as determined on the vesting date. The pro-rated portion is based on the participant's whole months of service with the Company during the performance period prior to the date of termination.
Derivatives

The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk. It is the Company's policy not to enter into derivative financial instruments for speculative purposes.

Derivative financial instruments involve credit risk in the event the counterparty should default. It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy. The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities. The Company also uses International Swap Dealers Association master-netting agreements. The master-netting agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.

The Company uses foreign currency forward exchange contracts and cross currency swap contracts to manage its exposure to changes in currency exchange rates from (1) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within the next 13 months (designated as cash flow hedges), (2) its net investment in certain foreign subsidiaries (designated as net investment hedges) and (3) foreign currency denominated assets or liabilities (designated as fair value hedges). The Company also uses foreign currency forward exchange contracts that are not designated as hedging instruments to offset the transaction gains and losses associated with the revaluation of certain assets and liabilities denominated in currencies other than their functional currencies resulting principally from intercompany and local currency transactions.

All derivative financial instruments are recognized at fair value in the consolidated balance sheets. For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings, and offsets the loss or gain on the underlying hedged item. The Company reports in "Accumulated Other Comprehensive Loss" the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges. The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings. Changes in the fair value of net investment hedges are reported in "Accumulated Other Comprehensive Loss" as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated. The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative. The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument. Cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.

New Accounting Standards Not Yet Adopted

In November 2021, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on government assistance. The guidance requires certain disclosures about transactions with a government that are accounted for by applying a grant or contribution model. The guidance is effective for annual periods beginning after December 15, 2021, and should be applied either prospectively or retrospectively. The Company does not expect the adoption of this guidance will have a material impact on its consolidated financial statements.
XML 45 R11.htm IDEA: XBRL DOCUMENT v3.22.0.1
INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET
 12 Months Ended
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET
The Company incurred intellectual property litigation expenses, including settlements and external legal costs, of $20.6 million, $405.4 million and $33.4 million during 2021, 2020 and 2019, respectively.

On July 12, 2020, the Company reached an agreement with Abbott Laboratories and its direct and indirect subsidiaries ("Abbott") to, among other things, settle all outstanding patent disputes between the companies (the “Settlement Agreement”) in cases related to transcatheter mitral and tricuspid repair products. The Settlement Agreement resulted in the Company recording an estimated $367.9 million pre-tax charge and related liability in June 2020 related to past damages. In addition, the
Company will incur royalty expenses through May 2024 totaling an estimated $100 million. The Company made a one-time $100.0 million payment to Abbott in July 2020, and is making quarterly payments in subsequent years.
XML 46 R12.htm IDEA: XBRL DOCUMENT v3.22.0.1
SPECIAL CHARGES
 12 Months Ended
Dec. 31, 2021
Other Income and Expenses [Abstract]  
SPECIAL CHARGES SPECIAL CHARGES
Impairment of Long-lived Assets

In December 2019, the Company recorded a charge of $40.6 million to fully impair certain in-process research and development assets. These assets were acquired as part of the acquisition of Valtech Cardio Ltd. ("Valtech") in 2017. The Company measured the amount of the impairment by calculating the amount by which the carrying values exceeded the estimated fair values, which was based on projected discounted future net cash flows. Based on market and clinical trial developments at the time of the impairment, the Company re-evaluated the clinical development plans for the technologies acquired from Valtech, which resulted in a reduction to the projected near-term discounted future net cash flows related to the acquired mitral and tricuspid technology. The impairment was recorded to the Company’s Rest of World segment.

Acquisition of Intellectual Property

In March 2019, the Company recorded a $24.0 million charge related to the acquisition of early-stage transcatheter intellectual property and associated clinical and regulatory experience.
XML 47 R13.htm IDEA: XBRL DOCUMENT v3.22.0.1
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS
 12 Months Ended
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS
Composition of Certain Financial Statement Captions

Components of selected captions in the consolidated balance sheets are as follows:
 As of December 31,
 20212020
 (in millions)
Inventories  
Raw materials$132.8 $136.7 
Work in process164.3 140.0 
Finished products429.6 525.6 
$726.7 $802.3 
Property, plant, and equipment, net  
Land$116.5 $97.6 
Buildings and leasehold improvements1,010.1 881.5 
Machinery and equipment613.4 564.9 
Equipment with customers39.2 42.2 
Software88.2 94.2 
Construction in progress333.8 313.3 
2,201.2 1,993.7 
Accumulated depreciation(654.6)(598.5)
$1,546.6 $1,395.2 
Accrued and other liabilities  
Employee compensation and withholdings$319.7 $236.7 
Accrued rebates77.0 67.2 
Property, payroll, and other taxes68.9 49.7 
Research and development accruals58.2 52.3 
As of December 31,
20212020
(in millions)
Legal and insurance (Notes 3 and 18)79.1 60.8 
Taxes payable30.6 18.6 
Fair value of derivatives3.9 39.3 
Accrued marketing expenses20.1 14.3 
Accrued professional services11.9 7.6 
Accrued realignment reserves19.1 14.5 
Accrued relocation costs26.2 21.0 
Other accrued liabilities87.6 88.2 
$802.3 $670.2 

Supplemental Cash Flow Information
(in millions)
Years Ended December 31,
202120202019
Cash paid during the year for:   
Interest$20.2 $19.9 $19.9 
Income taxes$182.5 $197.9 $61.5 
Amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases
$31.9 $29.7 $28.6 
Non-cash investing and financing transactions:   
Right-of-use assets obtained in exchange for new lease liabilities$28.7 $39.7 $49.6 
Capital expenditures accruals$54.3 $80.4 $50.8 
Conversion of notes receivable to equity investment$21.5 $4.5 $— 

Cash, Cash Equivalents, and Restricted Cash
(in millions)
Years Ended December 31,
202120202019
Cash and cash equivalents$862.8 $1,183.2 $1,179.1 
Restricted cash included in other current assets1.5 16.6 1.6 
Restricted cash included in other assets3.1 0.4 3.7 
Total cash, cash equivalents, and restricted cash$867.4 $1,200.2 $1,184.4 

Amounts included in restricted cash primarily represent funds placed in escrow related to litigation and real estate purchases. Restricted cash as of December 31, 2020 also included funds restricted for construction.
XML 48 R14.htm IDEA: XBRL DOCUMENT v3.22.0.1
LEASES
 12 Months Ended
Dec. 31, 2021
Leases [Abstract]  
LEASES LEASESThe Company leases certain office space, manufacturing facilities, land, apartments, warehouses, vehicles, and equipment with remaining lease terms ranging from less than 1 year to 19 years, some of which include options to extend or terminate the leases.
Operating lease costs for the years ended December 31, 2021, 2020, and 2019 were $29.7 million, $30.5 million, and $27.9 million, respectively. Short-term and variable lease costs were not material for the years ended December 31, 2021, 2020, and 2019.

Supplemental balance sheet information related to operating leases was as follows (in millions, except lease term and discount rate):
As of December 31,
20212020
Operating lease right-of-use assets$92.1 $94.2 
Operating lease liabilities, current portion$25.5 $27.2 
Operating lease liabilities, long-term portion69.1 72.7 
Total operating lease liabilities
$94.6 $99.9 

Maturities of operating lease liabilities at December 31, 2021 were as follows (in millions):
2022$27.5 
202323.0 
202413.6 
20258.3 
20267.5 
Thereafter24.6 
Total lease payments
104.5 
Less: imputed interest
(9.9)
Total lease liabilities
$94.6 

The following table provides information on the lease terms and discount rates:
Years Ended December 31,
20212020
Weighted-average remaining lease term (in years)6.26.6
Weighted-average discount rate2.5 %2.7 %
As of December 31, 2021, the Company had additional operating lease commitments of $2.5 million for office space that have not yet commenced.
XML 49 R15.htm IDEA: XBRL DOCUMENT v3.22.0.1
INVESTMENTS
 12 Months Ended
Dec. 31, 2021
Investments, Debt and Equity Securities [Abstract]  
INVESTMENTS INVESTMENTS
Debt Securities

Investments in debt securities at the end of each period were as follows (in millions):

 December 31, 2021December 31, 2020
Held-to-maturityAmortized CostGross Unrealized GainsGross Unrealized LossesFair ValueAmortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Bank time deposits$162.0 $— $— $162.0 $50.0 $— $— $50.0 
Available-for-sale
Bank time deposits$2.5 $— $— $2.5 $24.1 $— $— $24.1 
Commercial paper127.7 — — 127.7 — — — — 
United States government and agency securities147.4 0.6 (0.7)147.3 147.0 2.2 — 149.2 
Asset-backed securities515.2 0.3 (2.9)512.6 149.6 1.9 — 151.5 
Corporate debt securities1,397.1 2.0 (8.3)1,390.8 600.8 7.5 — 608.3 
Municipal securities2.8 — — 2.8 2.8 — — 2.8 
$2,192.7 $2.9 $(11.9)$2,183.7 $924.3 $11.6 $— $935.9 

The cost and fair value of investments in debt securities, by contractual maturity, as of December 31, 2021 were as follows:

 Held-to-MaturityAvailable-for-Sale
 Amortized CostFair ValueAmortized CostFair Value
 (in millions)
Due in 1 year or less$162.0 $162.0 $441.3 $442.0 
Due after 1 year through 5 years— — 1,196.7 1,189.6 
Due after 5 years through 10 years— — 8.7 8.6 
Instruments not due at a single maturity date (a)
— — 546.0 543.5 
$162.0 $162.0 $2,192.7 $2,183.7 
_______________________________________
(a)     Consists of mortgage- and asset-backed securities.

Actual maturities may differ from the contractual maturities due to call or prepayment rights.
The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of December 31, 2021, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):
December 31, 2021
Less than 12 Months12 Months or GreaterTotal
Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
United States government and agency securities$85.1 $(0.7)$— $— $85.1 $(0.7)
Asset-backed securities433.3 (2.9)— — 433.3 (2.9)
Corporate debt securities1,114.1 (8.3)— — 1,114.1 (8.3)
$1,632.5 $(11.9)$— $— $1,632.5 $(11.9)
The unrealized losses were largely due to changes in interest rates and were considered temporary. There were no investments that were in an unrealized loss position as of December 31, 2020.

Investments in Unconsolidated Entities

The Company has a number of equity investments in unconsolidated entities. These investments are recorded in "Long-term Investments" on the consolidated balance sheets, and are as follows:

 December 31,
 20212020
 (in millions)
Equity method investments  
Carrying value of equity method investments$8.4 $5.7 
Equity securities  
Carrying value of non-marketable equity securities84.1 29.4 
Total investments in unconsolidated entities$92.5 $35.1 

Non-marketable equity securities consist of investments in privately held companies without readily determinable fair values, and are reported at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The Company recorded an upward adjustment of $4.2 million based on observable price changes during 2021, and an upward adjustment of $1.8 million based on observable price changes and a downward adjustment of $0.7 million due to an impairment during 2020. As of December 31, 2021, the Company had recorded cumulative upward adjustments of $8.0 million based on observable price changes, and cumulative downward adjustments of $2.6 million due to impairment and observable price changes.

In April 2021, the Company recorded $35.9 million related to its investment in a privately-held medical device company (the "Investee"), including an initial cash investment in the Investee's preferred equity securities and other consideration. Also, in April 2021, the Company paid $5.7 million, included in "Other Assets," for an exclusive contingent option to acquire the Investee. Per the agreement, the Company may be required to invest up to an additional $9.9 million in the Investee's preferred equity securities and up to an additional $21.8 million for the option to acquire the Investee, depending on the achievement of certain milestones, of which the Company invested $10.8 million in the fourth quarter of 2021 upon achievement of the first milestone. The Company also agreed to loan the Investee up to $45 million under a secured promissory note. As of December 31, 2021, there had been no borrowings under this secured promissory note.
The Investee is a VIE; however, Edwards has determined that it is not the primary beneficiary of the VIE since Edwards does not have the power to direct the activities of the Investee that most significantly impact the Investee's economic performance. Edwards accounts for this investment as a non-marketable equity security under the measurement alternative.

During 2021, 2020, and 2019, the gross realized gains or losses from sales of available-for-sale investments were not material.
XML 50 R16.htm IDEA: XBRL DOCUMENT v3.22.0.1
ACQUISITIONS
 12 Months Ended
Dec. 31, 2021
Business Combination and Asset Acquisition [Abstract]  
ACQUISITIONS ACQUISITIONS
CAS Medical Systems, Inc.

On February 11, 2019, the Company entered into an agreement and plan of merger to acquire all the outstanding shares of CAS Medical Systems, Inc. ("CASMED") for an aggregate cash purchase price of $2.45 per share of common stock, or an equity value of approximately $100 million. The transaction closed on April 18, 2019, and the cash purchase price, net of cash acquired, was $100.2 million.

The results of operations for CASMED have been included in the accompanying consolidated financial statements from the date of acquisition. Pro forma results have not been presented as the results of CASMED are not material in relation to the consolidated financial statements of Edwards Lifesciences.

In-process Research and Development Assets

The Company acquired Harpoon Medical, Inc ("Harpoon") on December 1, 2017 and CardiAQ Valve Technologies, Inc. ("CardiAQ") on July 3, 2015. In-process research and development assets acquired as part of these transactions were capitalized at fair value, which was determined using the income approach. This approach determines fair value based on cash flow projections which are discounted to present value using a risk-adjusted rate of return. Completion of successful design developments, bench testing, pre-clinical studies and human clinical studies are required prior to selling any product. The risks and uncertainties associated with completing development within a reasonable period of time include those related to the design, development, and manufacturability of the product, the success of pre-clinical and clinical studies, and the timing of regulatory approvals.

The valuation for Harpoon assumed $41.4 million of additional research and development expenditures would be incurred prior to the date of product introduction. In the valuation, net cash inflows were modeled to commence in Europe in 2018, and in the United States and Japan in 2022. The Company does not currently anticipate significant changes to forecasted research and development expenditures, and net cash inflows commenced in Europe in 2020 and are now expected to commence in the United States and Japan in 2023.

The valuation for CardiAQ assumed $97.7 million of additional research and development expenditures would be incurred prior to the date of product introduction and that net cash inflows would commence in late 2018. As a result of certain design enhancements to increase the product's commercial life and applicability to a broader group of patients, the Company has incurred incremental research and development expenditures; however, the Company expects an increase in the net cash inflows, commencing in 2023.

Upon completion of development, the underlying research and development intangible assets will be amortized over their estimated useful lives.

Certain of the Company's business acquisitions involve contingent consideration arrangements. Payment of additional consideration in the future may be required, contingent upon the acquired business reaching certain performance milestones, such as attaining specified revenue levels or obtaining regulatory approvals. See Note 11 for further information.
XML 51 R17.htm IDEA: XBRL DOCUMENT v3.22.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS
 12 Months Ended
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL AND OTHER INTANGIBLE ASSETSGoodwill and in-process research and development assets resulting from purchase business combinations are not subject to amortization. Other acquired intangible assets with finite lives are amortized over their expected useful lives on a straight-line basis, or if reliably determinable, based on the pattern in which the economic benefit of the asset is expected to be used. The Company expenses costs incurred to renew or extend the term of acquired intangible assets.
The changes in the carrying amount of goodwill, by segment, during the years ended December 31, 2021 and 2020 were as follows:
 United
States		EuropeRest of WorldTotal
 (in millions)
Goodwill at December 31, 2019
$773.7 $62.8 $331.2 $1,167.7 
Currency translation adjustment— 5.5 — 5.5 
Goodwill at December 31, 2020
773.7 68.3 331.2 1,173.2 
Currency translation adjustment— (5.3)— (5.3)
Goodwill at December 31, 2021
$773.7 $63.0 $331.2 $1,167.9 

Other intangible assets consist of the following (in millions):

 December 31,
 Weighted-Average Useful Life (in years)20212020
 CostAccumulated
Amortization		Net
Carrying
Value		CostAccumulated
Amortization		Net
Carrying
Value
Finite-lived intangible assets      
Patents7.4$185.7 $(184.2)$1.5 $186.1 $(183.6)$2.5 
Developed technology13.1153.9 (55.5)98.4 155.2 (51.0)104.2 
Other10.012.4 (6.8)5.6 12.6 (6.0)6.6 
12.6352.0 (246.5)105.5 353.9 (240.6)113.3 
Indefinite-lived intangible assets      
In-process research and development218.1 — 218.1 218.1 — 218.1 
$570.1 $(246.5)$323.6 $572.0 $(240.6)$331.4 

Amortization expense related to other intangible assets for the years ended December 31, 2021, 2020, and 2019 was $7.7 million, $5.4 million, and $4.6 million, respectively. Estimated amortization expense for each of the years ending December 31 is as follows (in millions):
2022$6.8 
20238.4 
20248.4 
202510.2 
202615.9 
XML 52 R18.htm IDEA: XBRL DOCUMENT v3.22.0.1
DEBT AND CREDIT FACILITIES
 12 Months Ended
Dec. 31, 2021
Debt Disclosure [Abstract]  
DEBT AND CREDIT FACILITIES DEBT AND CREDIT FACILITIESIn June 2018, the Company issued $600.0 million of fixed-rate unsecured senior notes (the "Notes") due June 15, 2028. Interest is payable semi-annually in arrears, with payments due in June and December of each year. The Company may redeem the Notes, in whole or in part, at any time and from time to time at specified redemption prices. In addition, upon the occurrence of certain change of control triggering events, the Company may be required to repurchase all or a portion of the Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest. The Notes also include covenants that limit the Company's ability to incur secured indebtedness, enter into sale and leaseback transactions, and consolidate, merge, or transfer all or substantially all of its assets.
The following is a summary of the Notes as of December 31, 2021 and 2020:
 December 31,
 2021 2020
 AmountEffective
Interest Rate		 AmountEffective
Interest Rate
(in millions)(in millions)
Fixed-rate 4.300% 2018 Notes
$600.0 4.329 %$600.0 4.329 %
Unamortized discount(1.0)  (1.1) 
Unamortized debt issuance costs(3.3)(3.9)
Total carrying amount$595.7   $595.0  

As of December 31, 2021 and 2020, the fair value of the Notes was $675.4 million and $711.2 million, respectively, based on observable market prices in less active markets and categorized as Level 2 (Note 11). The debt issuance costs, as well as the discount, are being amortized to interest expense over the term of the Notes.

The Company has a Five-Year Credit Agreement ("the Credit Agreement") which matures on April 28, 2023. The Credit Agreement provides up to an aggregate of $750.0 million in borrowings in multiple currencies. The Company may increase the amount available under the Credit Agreement, subject to agreement of the lenders, by up to an additional $250.0 million in the aggregate. Borrowings generally bear interest at the London interbank offered rate ("LIBOR"), or a comparable or successor rate, plus a spread ranging from 0.9% to 1.3%, depending on the leverage ratio, as defined in the Credit Agreement. The Company also pays a facility fee ranging from 0.1% to 0.2%, depending on the leverage ratio, on the entire credit commitment available, whether drawn or not. The facility fee is expensed as incurred. During 2021, the spread over LIBOR was 0.9% and the facility fee was 0.1%. Issuance costs of $2.4 million are being amortized to interest expense over the term of the Credit Agreement. As of December 31, 2021 and 2020, there were no borrowings outstanding under the Credit Agreement. Amounts outstanding under the Credit Agreement, if any from time to time, are classified as long-term obligations in accordance with the terms of the Credit Agreement. The Credit Agreement is unsecured and contains various financial and other covenants, including a maximum leverage ratio, as defined in the Credit Agreement. The Company was in compliance with all covenants at December 31, 2021.
The weighted-average interest rate under all debt obligations was 3.4% and 3.5% at December 31, 2021 and 2020, respectively.
XML 53 R19.htm IDEA: XBRL DOCUMENT v3.22.0.1
FAIR VALUE MEASUREMENTS
 12 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS FAIR VALUE MEASUREMENTS
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The Company prioritizes the inputs used to determine fair values in one of the following three categories:

Level 1—Quoted market prices in active markets for identical assets or liabilities.

Level 2—Inputs, other than quoted prices in active markets, that are observable, either directly or indirectly.

Level 3—Unobservable inputs that are not corroborated by market data.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety.

The consolidated financial statements include financial instruments for which the fair market value of such instruments may differ from amounts reflected on a historical cost basis. Financial instruments of the Company consist of cash deposits, accounts and other receivables, investments, accounts payable, certain accrued liabilities, and borrowings under a revolving credit agreement. The carrying value of these financial instruments generally approximates fair value due to their short-term nature. Financial instruments also include notes payable. See Note 10 for further information on the fair value of the notes payable.
Assets and Liabilities Measured at Fair Value on a Recurring Basis

The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis as of December 31, 2021 and 2020 (in millions):

December 31, 2021Level 1Level 2Level 3Total
Assets    
Cash equivalents$15.2 $30.7 $— $45.9 
Available-for-sale investments: 
Bank time deposits— 2.5 — 2.5 
Corporate debt securities— 1,390.8 — 1,390.8 
Asset-backed securities— 512.6 — 512.6 
United States government and agency securities28.4 118.9 — 147.3 
Commercial paper— 127.7 — 127.7 
Municipal securities— 2.8 — 2.8 
Investments held for deferred compensation plans130.7 — — 130.7 
Derivatives— 55.3 — 55.3 
$174.3 $2,241.3 $— $2,415.6 
Liabilities    
Derivatives$— $3.9 $— $3.9 
Deferred compensation plans130.9 — — 130.9 
Contingent consideration liabilities— — 62.0 62.0 
Other liability— — 14.0 14.0 
$130.9 $3.9 $76.0 $210.8 
December 31, 2020
Assets
Cash equivalents$16.2 $— $— $16.2 
Available-for-sale investments: 
Bank time deposits— 24.1 — 24.1 
Corporate debt securities— 608.3 — 608.3 
Asset-backed securities— 151.5 — 151.5 
United States government and agency securities56.9 92.2 — 149.1 
Municipal securities— 2.8 — 2.8 
Investments held for deferred compensation plans111.2 — — 111.2 
Derivatives— 8.1 — 8.1 
$184.3 $887.0 $— $1,071.3 
Liabilities    
Derivatives$— $39.3 $— $39.3 
Deferred compensation plans111.6 — — 111.6 
Contingent consideration liabilities— — 186.1 186.1 
$111.6 $39.3 $186.1 $337.0 
The following table summarizes the changes in fair value of the contingent consideration obligation for the years ended December 31, 2021 and 2020 (in millions):

Contingent ConsiderationOther LiabilityTotal
Fair value, December 31, 2019
$172.5 $— $172.5 
Changes in fair value13.6 — 13.6 
Fair value, December 31, 2020
$186.1 $— $186.1 
Additions— 14.0 14.0 
Changes in fair value(124.1)— (124.1)
Fair value, December 31, 2021
$62.0 $14.0 $76.0 

The change in fair value of the contingent consideration liabilities in 2021 was primarily driven by a $123.2 million reduction to the liability due to changes in the projected probabilities and timing of milestone achievements and the projected timing of cash inflows. The change in fair value of the contingent consideration liabilities in 2020 was primarily driven by the accretion of interest due to the passage of time and adjustments to discount rates, partially offset by a $12.7 million reduction to the liability due to changes in the projected probabilities and timing of milestone achievements and the projected timing of cash inflows.

Cash Equivalents and Available-for-sale Investments

The Company estimates the fair values of its money market funds based on quoted prices in active markets for identical assets. The Company estimates the fair values of its time deposits, commercial paper, United States and foreign government and agency securities, municipal securities, asset-backed securities, and corporate debt securities by taking into consideration valuations obtained from third-party pricing services. The pricing services use industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades and broker-dealer quotes on the same or similar securities, benchmark yields, credit spreads, prepayment and default projections based on historical data, and other observable inputs. The Company independently reviews and validates the pricing received from the third-party pricing service by comparing the prices to prices reported by a secondary pricing source. The Company’s validation procedures have not resulted in an adjustment to the pricing received from the pricing service.

Deferred Compensation Plans

The Company holds investments in trading securities related to its deferred compensation plans. The investments are in a variety of stock, bond, and money market mutual funds. The fair values of these investments and the corresponding liabilities are based on quoted market prices.

Derivative Instruments

The Company uses derivative financial instruments in the form of foreign currency forward exchange contracts and cross currency swap contracts to manage foreign currency exposures. All derivatives contracts are recognized on the balance sheet at their fair value. The fair value of the derivative financial instruments was estimated based on quoted market foreign exchange rates, cross currency swap basis rates, and market discount rates. Judgment was employed in interpreting market data to develop estimates of fair value; accordingly, the estimates presented herein are not necessarily indicative of the amounts that the Company could realize in a current market exchange. The use of different market assumptions or valuation methodologies could have a material effect on the estimated fair value amounts.

Contingent Consideration Liabilities

Certain of the Company's acquisitions involve contingent consideration arrangements. Payment of additional consideration is contingent upon the acquired company reaching certain performance milestones, such as attaining specified
sales levels or obtaining regulatory approvals. These contingent consideration liabilities are measured at estimated fair value using either a probability weighted discounted cash flow analysis or a Monte Carlo simulation model, both of which consider significant unobservable inputs. These inputs include (1) the discount rate used to present value the projected cash flows (ranging from 0.06% to 9.26%; weighted average of 4.1%), (2) the probability of milestone achievement (ranging from 0% to 93.7%; weighted average of 59.2%), (3) the projected payment dates (ranging from 2026 to 2027; weighted average of 2026), and (4) the volatility of future sales (40.0%). The weighted average of each of the above inputs was determined based on the relative fair value of each obligation. The use of different assumptions could have a material effect on the estimated fair value amounts.
XML 54 R20.htm IDEA: XBRL DOCUMENT v3.22.0.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
 12 Months Ended
Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.
 Notional Amount
 December 31, 2021December 31, 2020
 (in millions)
Foreign currency forward exchange contracts$1,498.8 $1,525.5 
Cross currency swap contracts300.0 300.0 

The following table presents the location and fair value amounts of derivative instruments reported in the consolidated balance sheets (in millions):

  Fair Value
 Balance Sheet LocationDecember 31, 2021December 31, 2020
Derivatives designated as hedging instruments   
Assets   
Foreign currency contractsOther current assets$36.2 $7.3 
Cross currency swap contractsOther assets$19.1 $0.8 
Liabilities   
Foreign currency contractsAccrued and other liabilities$3.9 $39.3 
The following table presents the effect of master-netting agreements and rights of offset on the consolidated balance sheets (in millions):

    Gross Amounts Not Offset in the Consolidated Balance Sheet 
  Gross Amounts
Offset in the
Consolidated
Balance Sheet		Net Amounts
Presented in the
Consolidated
Balance Sheet
December 31, 2021Gross
Amounts		Financial
Instruments		Cash
Collateral
Received		Net
Amount
Derivative Assets      
Foreign currency contracts$36.2 $— $36.2 $(2.8)$— $33.4 
Cross currency swap contracts$19.1 $— $19.1 $— $— $19.1 
Derivative Liabilities      
Foreign currency contracts$3.9 $— $3.9 $(2.8)$— $1.1 
December 31, 2020      
Derivative Assets      
Foreign currency contracts$7.3 $— $7.3 $(6.1)$— $1.2 
Cross currency swap contracts$0.8 $— $0.8 $— $— $0.8 
Derivative Liabilities      
Foreign currency contracts$39.3 $— $39.3 (6.1)$— $33.2 
 
The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated statements of operations and consolidated statements of comprehensive income:

 Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)Location of Gain or (Loss) Reclassified from Accumulated OCI into IncomeAmount of Gain or (Loss) Reclassified from Accumulated OCI into Income
 
 2021202020212020
(in millions)(in millions)
Cash flow hedges
Foreign currency contracts$56.7 $(33.7)Cost of sales$(23.0)$18.4 
Selling, general, and administrative expenses$(0.6)$2.2 
 Amount of Gain or (Loss)
Recognized in OCI
on Derivative
(Effective Portion)		Location of Gain or (Loss) Reclassified from Accumulated OCI into IncomeAmount of Gain or (Loss)
Recognized in Income on Derivative (Amount Excluded from
 Effectiveness Testing)
2021202020212020
(in millions) (in millions)
Net investment hedges
Cross currency swap contracts$18.4 $(12.6)Interest expense$6.4 $6.4 

The cross currency swap contracts have an expiration date of June 15, 2028. At maturity of the cross currency swap contracts, the Company will deliver the notional amount of €257.2 million and will receive $300.0 million from the counterparties. The Company will receive semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.
  Amount of Gain or
(Loss) Recognized in
Income on Derivative
 Location of Gain or
(Loss) Recognized in
Income on Derivative
 202120202019
 (in millions)
Fair value hedges
Foreign currency contractsOther income, net$11.6 $(1.4)$1.4 

  Amount of Gain or
(Loss) Recognized in
Income on Derivative
 Location of Gain or
(Loss) Recognized in
Income on Derivative
 202120202019
 (in millions)
Derivatives not designated as hedging instruments
Foreign currency contractsOther income, net$27.4 $(15.1)$0.3 

The following table presents the effect of fair value and cash flow hedge accounting on the consolidated statements of operations:

Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
 Twelve Months Ended December 31, 2021
 Cost of salesSelling, general, and administrative expensesOther Income, net
Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded$(1,248.9)$(1,493.7)$12.7 
The effects of fair value and cash flow hedging:
Gain (loss) on fair value hedging relationships:
Foreign currency contracts:
Hedged items
— — (9.0)
Derivatives designated as hedging instruments
— — 9.0 
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach
— — 2.6 
Gain (loss) on cash flow hedging relationships:
Foreign currency contracts:
Amount of gain (loss) reclassified from accumulated OCI into income
(23.0)(0.6)— 
Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
 Twelve Months Ended December 31, 2020
 Cost of salesSelling, general, and administrative expensesOther Income, net
Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded$(1,080.6)$(1,228.4)$11.5 
The effects of fair value and cash flow hedging:
Gain (loss) on fair value hedging relationships:
Foreign currency contracts:
Hedged items
— — 4.8 
Derivatives designated as hedging instruments
— — (4.8)
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach
— — 3.4 
Gain (loss) on cash flow hedging relationships:
Foreign currency contracts:
Amount of gain (loss) reclassified from accumulated OCI into income
18.4 2.2 — 
The Company expects that during 2022 it will reclassify to earnings a $7.8 million gain currently recorded in "Accumulated Other Comprehensive Loss." For the years ended December 31, 2021, 2020, and 2019, the Company did not record any gains or losses due to hedge ineffectiveness.
XML 55 R21.htm IDEA: XBRL DOCUMENT v3.22.0.1
EMPLOYEE BENEFIT PLANS
 12 Months Ended
Dec. 31, 2021
Retirement Benefits [Abstract]  
EMPLOYEE BENEFIT PLANS EMPLOYEE BENEFIT PLANS
Defined Benefit Plans

The Company maintains defined benefit pension plans in Japan and certain European countries.
 Years Ended December 31,
 20212020
(in millions)
Change in projected benefit obligation:  
Beginning of year$126.2 $105.2 
Service cost6.5 6.3 
Interest cost0.4 0.5 
Participant contributions1.5 1.5 
Actuarial loss(6.1)2.9 
Benefits paid(2.5)(0.6)
Plan amendment(0.5)— 
Currency exchange rate changes and other(7.6)10.4 
End of year$117.9 $126.2 
Change in fair value of plan assets:  
Beginning of year$73.3 $63.2 
Actual return on plan assets5.8 0.4 
Employer contributions3.1 2.8 
Participant contributions1.5 1.5 
Benefits paid(2.5)(0.6)
Currency exchange rate changes and other(4.3)6.0 
End of year$76.9 $73.3 
Funded Status  
Projected benefit obligation$(117.9)$(126.2)
Plan assets at fair value76.9 73.3 
Underfunded status$(41.0)$(52.9)
Net amounts recognized on the consolidated balance sheet:  
Other long-term liabilities$41.0 $52.9 
Accumulated other comprehensive loss, net of tax:  
Net actuarial loss$(16.4)$(30.8)
Net prior service cost6.0 6.6 
Deferred income tax benefit2.4 4.6 
Total$(8.0)$(19.6)

The accumulated benefit obligation ("ABO") for all defined benefit pension plans was $113.3 million and $120.9 million as of December 31, 2021 and 2020, respectively. The projected benefit obligation and ABO were in excess of plan assets for all pension plans as of December 31, 2021 and 2020.
The components of net periodic pension benefit cost are as follows (in millions):

 Years Ended December 31,
 202120202019
Service cost, net$6.5 $6.3 $5.2 
Interest cost0.4 0.5 0.9 
Expected return on plan assets(1.1)(1.0)(1.4)
Amortization of actuarial loss1.7 1.6 0.9 
Amortization of prior service credit (0.7)(0.7)(0.2)
Net periodic pension benefit cost$6.8 $6.7 $5.4 

Expected long-term returns for each of the plans' strategic asset classes were developed through consultation with investment advisors. Several factors were considered, including a survey of investment managers' expectations, current market data, minimum guaranteed returns in certain insurance contracts, and historical market returns over long periods. Using policy target allocation percentages and the asset class expected returns, a weighted-average expected return was calculated.

To select the discount rates for the defined benefit pension plans, the Company uses a modeling process that involves matching the expected duration of its benefit plans to a yield curve constructed from a portfolio of AA-rated fixed-income debt instruments, or their equivalent. For each country, the Company uses the implied yield of this hypothetical portfolio at the appropriate duration as a discount rate benchmark.

The weighted-average assumptions used to determine the benefit obligations are as follows:
 December 31,
 20212020
Discount rate0.5 %0.3 %
Rate of compensation increase2.6 %2.6 %
Cash balance interest crediting rate2.5 %2.5 %
Social securities increase1.6 %1.6 %
Pension increase1.8 %1.8 %

The weighted-average assumptions used to determine the net periodic pension benefit cost are as follows:
 Years ended December 31,
 202120202019
Discount rate0.3 %0.5 %0.9 %
Expected return on plan assets1.5 %1.5 %2.3 %
Rate of compensation increase2.6 %2.7 %2.8 %
Cash balance interest crediting rate2.5 %1.5 %1.5 %
Social securities increase1.6 %1.6 %1.8 %
Pension increase1.8 %1.8 %1.8 %

Plan Assets

The Company's investment strategy for plan assets is to seek a competitive rate of return relative to an appropriate level of risk and to earn performance rates of return in accordance with the benchmarks adopted for each asset class. Risk management practices include diversification across asset classes and investment styles, and periodic rebalancing toward asset allocation targets.
The Administrative and Investment Committee decides on the defined benefit plan provider in each location and that provider decides the target allocation for the Company's defined benefit plan at that location. The target asset allocation selected reflects a risk/return profile the Company feels is appropriate relative to the plans' liability structure and return goals. In certain plans, asset allocations may be governed by local requirements. Target weighted-average asset allocations at December 31, 2021, by asset category, are as follows:
Equity securities28.3 %
Debt securities41.7 %
Real estate9.8 %
Other20.2 %
Total100.0 %

The fair values of the Company's defined benefit plan assets at December 31, 2021 and 2020, by asset category, are as follows (in millions):
December 31, 2021Level 1Level 2Level 3Total
Asset Category    
Cash$5.4 $— $— $5.4 
Equity securities:    
United States equities1.6 — — 1.6 
International equities16.3 — — 16.3 
Debt securities:    
United States government bonds6.2 — — 6.2 
International government bonds26.3 — — 26.3 
Real estate— 7.6 — 7.6 
Mortgages— 3.5 — 3.5 
Insurance contracts— — 0.9 0.9 
Total plan assets measured at fair value
$55.8 $11.1 $0.9 $67.8 
Alternative investments measured at net asset value (a)9.1 
Total plan assets
$76.9 
 
December 31, 2020Level 1Level 2Level 3Total
Asset Category
Cash$3.0 $— $— $3.0 
Equity securities:
United States equities3.3 — — 3.3 
International equities16.1 — — 16.1 
Debt securities:
United States government bonds7.4 — — 7.4 
International government bonds26.0 — — 26.0 
Real estate— 5.6 — 5.6 
Mortgages— 3.1 — 3.1 
Insurance contracts— — 1.0 1.0 
Total plan assets $55.8 $8.7 $1.0 $65.5 
Alternative investments measured at net asset value (a)7.8 
Total plan assets $73.3 
_______________________________________
(a)     Certain investments that were measured at net asset value per share have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the total plan assets.

The following table summarizes the changes in fair value of the Company's defined benefit plan assets that have been classified as Level 3 for the years ended December 31, 2021 and 2020 (in millions):

 Insurance
Contracts
Balance at December 31, 2019$0.9 
Currency exchange rate impact0.1 
Balance at December 31, 20201.0 
Currency exchange rate impact(0.1)
Balance at December 31, 2021$0.9 

Equity and debt securities are valued at fair value based on quoted market prices reported on the active markets on which the individual securities are traded. Real estate investments are valued by discounting to present value the cash flows expected to be generated by the specific properties. Investments in mortgages are valued at cost, which is deemed to approximate its fair value. The insurance contracts are valued at the cash surrender value of the contracts, which is deemed to approximate its fair value. Alternative investments include hedge funds, private equity funds and other miscellaneous investments, and are valued using the net asset value provided by the fund administrator as a practical expedient. The net asset value is based on the fair value of the underlying assets owned by the fund divided by the number of shares outstanding.
The following benefit payments, which reflect expected future service, as appropriate, at December 31, 2021, are expected to be paid (in millions):

2022$5.4 
20236.7 
20245.6 
20255.2 
20266.1 
2024-202636.1 

As of December 31, 2021, expected employer contributions for 2022 are $2.2 million.

Defined Contribution Plans

The Company's employees in the United States and Puerto Rico are eligible to participate in a qualified defined contribution plan. In the United States, participants may contribute up to 25% of their eligible compensation (subject to tax code limitation) to the plan. Edwards Lifesciences matches the first 4% of the participant's annual eligible compensation contributed to the plan on a dollar-for-dollar basis. Edwards Lifesciences matches the next 2% of the participant's annual eligible compensation to the plan on a 50% basis. In Puerto Rico, participants may contribute up to 25% of their annual compensation (subject to tax code limitation) to the plan. Edwards Lifesciences matches the first 4% of participant's annual eligible compensation contributed to the plan on a 50% basis. The Company also provides a 2% profit sharing contribution calculated on eligible earnings for each employee. Matching contributions relating to Edwards Lifesciences employees were $38.6 million, $36.6 million, and $31.4 million in 2021, 2020, and 2019, respectively.

The Company also has nonqualified deferred compensation plans for a select group of employees. The plans provide eligible participants the opportunity to defer eligible compensation to future dates specified by the participant with a return based on investment alternatives selected by the participant. The amount accrued under these nonqualified plans was $130.9 million and $111.6 million at December 31, 2021 and 2020, respectively.
XML 56 R22.htm IDEA: XBRL DOCUMENT v3.22.0.1
COMMON STOCK
 12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
COMMON STOCK COMMON STOCK
Treasury Stock

In May 2019, the Board of Directors approved a stock repurchase program authorizing the Company to purchase up to $1.0 billion of the Company's common stock. In May 2021, the Board of Directors approved a new stock repurchase program for an additional $1.0 billion of the Company's common stock. The repurchase programs do not have an expiration date. Stock repurchased under these programs may be used to offset obligations under the Company's employee stock-based benefit programs and stock-based business acquisitions, and will reduce the total shares outstanding.

During 2021, 2020, and 2019, the Company repurchased 5.8 million, 3.1 million, and 1.5 million shares, respectively, at an aggregate cost of $512.8 million, $625.4 million, and $263.3 million, respectively, including shares purchased under the accelerated share repurchase ("ASR") agreements described below and shares acquired to satisfy tax withholding obligations in connection with the vesting of restricted stock units issued to employees. The timing and size of any future stock repurchases are subject to a variety of factors, including expected dilution from stock plans, cash capacity, and the market price of the Company's common stock.
Accelerated Share Repurchase

During 2021 and 2019, the Company entered into ASR agreements providing for the repurchase of the Company's common stock based on the volume-weighted average price ("VWAP") of the Company's common stock during the term of the agreements, less a discount. The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):
  Initial DeliveryFinal Settlement
Agreement DateAmount
Paid		Shares
Received		Price per
Share (a)		Value of
Shares as %
of Contract
Value		Settlement
Date		Total Shares
Received		Average Price
per Share (a)
May 2019$150.0 0.7 $178.66 80 %May 20190.8 $178.42 
May 2019$100.0 0.5 $170.02 80 %June 20190.6 $178.46 
February 2021$250.0 2.4 $83.86 80 %March 20213.0 $84.51 
_______________________________________________________________________________
(a)    The three-for-one stock split distributed on May 29, 2020 excluded treasury shares. The shares and per share prices in the table are reflected at the pre-split amounts and prices at the time of the transaction.

The ASR agreements were accounted for as two separate transactions: (1) the value of the initial delivery of shares was recorded as shares of common stock acquired in a treasury stock transaction on the acquisition date and (2) the remaining amount of the purchase price paid was recorded as a forward contract indexed to the Company's own common stock and was recorded in "Additional Paid-in Capital" on the consolidated balance sheets. The initial delivery of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted-average common shares outstanding for basic and diluted earnings per share. The Company determined that the forward contract indexed to the Company's common stock met all the applicable criteria for equity classification and, therefore, was not accounted for as a derivative instrument.

Employee and Director Stock Plans

The Edwards Lifesciences Corporation Long-term Stock Incentive Compensation Program (the "Program") provides for the grant of incentive and non-qualified stock options, restricted stock, and restricted stock units for eligible employees of the Company. Under the Program, these grants are awarded at a price equal to the fair market value at the date of grant based upon the closing price on that date. Options to purchase shares of the Company's common stock granted under the Program generally vest over predetermined periods of between three to four years and expire seven years after the date of grant. Service-based restricted stock units of the Company's common stock granted under the Program generally vest over predetermined periods, typically four years after the date of grant. Market-based restricted stock units of the Company's common stock granted under the Program vest over three years based on a combination of certain service and market conditions. The actual number of shares issued will be determined based on the Company's total stockholder return relative to a selected industry peer group. Under the Program, the number of shares of common stock authorized for issuance under the Program was 327.6 million shares. No more than 33.6 million shares reserved for issuance may be granted in the form of restricted stock or restricted stock units.

The Company also maintains the Nonemployee Directors Stock Incentive Compensation Program (the "Nonemployee Directors Program"). Under the Nonemployee Directors Program, annually each nonemployee director may receive up to 120,000 stock options or 48,000 restricted stock units of the Company's common stock, or a combination thereof, provided that in no event may the total value of the combined annual award exceed $0.2 million. These grants generally vest over one year from the date of grant. Under the Nonemployee Directors Program, an aggregate of 8.4 million shares of the Company's common stock has been authorized for issuance.

The Company has an employee stock purchase plan for United States employees and a plan for employees outside of the United States (collectively "ESPP"). Under the ESPP, eligible employees may purchase shares of the Company's common stock at 85% of the lower of the fair market value of Edwards Lifesciences common stock on the effective date of subscription or the date of purchase. Under the ESPP, employees can authorize the Company to withhold up to 15% of their compensation for common stock purchases, subject to certain limitations. The ESPP is available to all active employees of the Company paid from the United States payroll and to eligible employees of the Company outside of the United States, to the extent permitted
by local law. The ESPP for United States employees is qualified under Section 423 of the Internal Revenue Code. The number of shares of common stock authorized for issuance under the ESPP was 50.4 million shares.

The fair value of each option award and employee stock purchase subscription is estimated on the date of grant using the Black-Scholes option valuation model that uses the assumptions noted in the following tables. The risk-free interest rate is estimated using the United States Treasury yield curve and is based on the expected term of the award. Expected volatility is estimated based on a blend of the weighted-average of the historical volatility of Edwards Lifesciences' stock and the implied volatility from traded options on Edwards Lifesciences' stock. The expected term of awards granted is estimated from the vesting period of the award, as well as historical exercise behavior, and represents the period of time that awards granted are expected to be outstanding. The Company uses historical data to estimate forfeitures and has estimated an annual forfeiture rate of 6.4%.

The Black-Scholes option pricing model was used with the following weighted-average assumptions for options granted during the following periods:

Option Awards
202120202019
Average risk-free interest rate0.8 %0.3 %2.3 %
Expected dividend yieldNoneNoneNone
Expected volatility34 %33 %30 %
Expected life (years)5.05.05.1
Fair value, per share$28.90 $21.70 $18.17 

The Black-Scholes option pricing model was used with the following weighted-average assumptions for ESPP subscriptions granted during the following periods:

ESPP
202120202019
Average risk-free interest rate0.1 %1.3 %2.4 %
Expected dividend yieldNoneNoneNone
Expected volatility37 %33 %27 %
Expected life (years)0.60.60.6
Fair value, per share$23.07 $16.61 $16.43 

The fair value of market-based restricted stock units was determined using a Monte Carlo simulation model, which uses multiple input variables to determine the probability of satisfying the market condition requirements. The weighted-average assumptions used to determine the fair value of the market-based restricted stock units during the years ended December 31, 2021, 2020, and 2019 included a risk-free interest rate of 0.4%, 0.2%, and 2.2%, respectively, and an expected volatility rate of 34.4%, 32.7%, and 29.4%, respectively.
Stock option activity during the year ended December 31, 2021 under the Program and the Nonemployee Directors Program was as follows (in millions, except years and per-share amounts):

 SharesWeighted-
Average
Exercise
Price		Weighted-
Average
Remaining
Contractual
Term		Aggregate
Intrinsic Value
Outstanding as of December 31, 2020
14.3 $41.27   
Options granted1.6 94.04   
Options exercised(3.4)23.84   
Options forfeited(0.2)67.89   
Outstanding as of December 31, 2021
12.3 52.84 3.5 years$943.1 
Exercisable as of December 31, 2021
8.2 41.84 2.6 years$719.7 
Vested and expected to vest as of December 31, 2021
11.7 51.74 3.4 years$911.4 

The following table summarizes nonvested restricted stock unit activity during the year ended December 31, 2021 under the Program and the Nonemployee Directors Program (in millions, except per-share amounts):

 SharesWeighted-
Average
Grant-Date
Fair Value
Nonvested as of December 31, 2020
2.6 $57.59 
Granted (a)0.8 92.95 
Vested(1.0)48.82 
Forfeited(0.1)66.54 
Nonvested as of December 31, 2021
2.3 73.94 
_______________________________________________________________________________
(a)    The shares granted include 0.1 million shares of market-based restricted stock units granted during 2021, which represents the target number of shares to be issued, and 0.1 million shares related to a previous year's grant of market-based restricted stock units since the payout percentage achieved at the end of the performance period was in excess of target. As described above, the actual number of shares ultimately issued is determined based on the Company's total stockholder return relative to a selected industry peer group.

The intrinsic value of stock options exercised and restricted stock units vested during the years ended December 31, 2021, 2020, and 2019 were $359.8 million, $323.5 million, and $382.1 million, respectively. The intrinsic value of stock options is calculated as the amount by which the market price of the Company's common stock exceeds the exercise price of the option. During the years ended December 31, 2021, 2020, and 2019, the Company received cash from exercises of stock options of $82.2 million, $79.2 million, and $110.4 million, respectively, and tax benefits from exercises of stock options and vesting of restricted stock units of $76.5 million, $72.1 million, and $85.1 million, respectively. The total grant-date fair value of stock options vested during the years ended December 31, 2021, 2020, and 2019 were $36.2 million, $34.0 million, and $31.2 million, respectively.

As of December 31, 2021, the total remaining unrecognized compensation expense related to nonvested stock options, restricted stock units, and employee stock purchase subscriptions amounted to $162.3 million, which will be amortized over the weighted-average remaining requisite service period of 30 months.
XML 57 R23.htm IDEA: XBRL DOCUMENT v3.22.0.1
ACCUMULATED OTHER COMPREHENSIVE LOSS
 12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
ACCUMULATED OTHER COMPREHENSIVE LOSS ACCUMULATED OTHER COMPREHENSIVE LOSS
Presented below is a summary of activity for each component of "Accumulated Other Comprehensive Loss" for the years ended December 31, 2021, 2020, and 2019.

 Foreign
Currency
Translation
Adjustments		Unrealized Gain (Loss) on HedgesUnrealized (Loss) Gain on
Available-for-sale
Investments		Unrealized
Pension
Costs (a)		Total
Accumulated
Other
Comprehensive
Loss
 (in millions)
December 31, 2018$(143.6)$23.6 $(5.0)$(13.5)$(138.5)
Other comprehensive (loss) income before reclassifications(1.5)27.9 7.9 (3.2)31.1 
Amounts reclassified from accumulated other comprehensive loss(6.6)(44.2)0.4 0.7 (49.7)
Deferred income tax (expense) benefit(3.1)5.2 (1.6)0.6 1.1 
December 31, 2019(154.8)12.5 1.7 (15.4)(156.0)
Other comprehensive income (loss) before reclassifications35.7 (34.8)8.0 (5.5)3.4 
Amounts reclassified from accumulated other comprehensive loss(6.4)(19.2)0.3 0.9 (24.4)
Deferred income tax benefit (expense)3.1 13.8 (1.4)0.4 15.9 
December 31, 2020(122.4)(27.7)8.6 (19.6)(161.1)
Other comprehensive (loss) income before reclassifications(39.2)66.3 (29.2)12.8 10.7 
Amounts reclassified from accumulated other comprehensive loss(6.4)12.0 8.6 1.0 15.2 
Deferred income tax (expense) benefit(4.5)(20.9)5.1 (2.2)(22.5)
December 31, 2021$(172.5)$29.7 $(6.9)$(8.0)$(157.7)
_______________________________________________________________________________
(a)For the years ended December 31, 2021, 2020, and 2019, the change in unrealized pension costs consisted of the following (in millions):
 Pre-Tax
Amount		Tax (Expense) BenefitNet of Tax
Amount
2021   
Prior service credit arising during period$0.1 $— $0.1 
Amortization of prior service credit(0.7)0.1 (0.6)
Net prior service cost arising during period(0.6)0.1 (0.5)
Net actuarial loss arising during period14.4 (2.3)12.1 
Unrealized pension costs, net$13.8 $(2.2)$11.6 
2020   
Prior service credit arising during period$0.6 $(0.2)$0.4 
Amortization of prior service credit(0.7)0.1 (0.6)
Net prior service cost arising during period(0.1)(0.1)(0.2)
Net actuarial loss arising during period(4.5)0.5 (4.0)
Unrealized pension costs, net$(4.6)$0.4 $(4.2)
2019   
Prior service credit arising during period$4.6 $(0.6)$4.0 
Amortization of prior service credit(0.2)0.1 (0.1)
Net prior service credit arising during period4.4 (0.5)3.9 
Net actuarial loss arising during period(6.9)1.1 (5.8)
Unrealized pension costs, net$(2.5)$0.6 $(1.9)

The following table provides information about amounts reclassified from "Accumulated Other Comprehensive Loss" (in millions):
 Years Ended December 31, 
Details about Accumulated Other Comprehensive Loss
Components		20212020Affected Line on Consolidated
Statements of Operations
Foreign currency translation adjustments$6.4 $6.4 Other income, net
(1.6)(1.6)Provision for income taxes
$4.8 $4.8 Net of tax
Gain (loss) on hedges$(23.0)$18.4 Cost of sales
(0.6)2.2 Selling, general, and administrative expenses
11.6 (1.4)Other income, net
(12.0)19.2 Total before tax
4.6 (5.0)Provision for income taxes
$(7.4)$14.2 Net of tax
(Loss) gain on available-for-sale investments$(8.6)$(0.3)Other income, net
2.1 (0.6)Provision for income taxes
$(6.5)$(0.9)Net of tax
Amortization of pension adjustments$(1.0)$(0.9)Other income, net
0.1 0.2 Provision for income taxes
$(0.9)$(0.7)Net of tax
XML 58 R24.htm IDEA: XBRL DOCUMENT v3.22.0.1
OTHER INCOME, NET
 12 Months Ended
Dec. 31, 2021
Other Income and Expenses [Abstract]  
OTHER INCOME, NET OTHER INCOME, NET
 Years Ended December 31,
 202120202019
(in millions)
Foreign exchange gains, net$(5.0)$(12.3)$(5.9)
Gain on investments(5.8)(0.6)(0.5)
Non-service cost components of net periodic pension benefit cost0.3 0.4 0.2 
Other(2.2)1.0 (2.0)
Total other income, net$(12.7)$(11.5)$(8.2)
XML 59 R25.htm IDEA: XBRL DOCUMENT v3.22.0.1
INCOME TAXES
 12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
INCOME TAXES INCOME TAXES
The Company's income before provision for income taxes was generated from operations in the United States and outside of the United States as follows (in millions):
 Years Ended December 31,
 202120202019
United States$610.9 $151.3 $383.4 
Outside of the United States, including Puerto Rico1,091.1 765.4 783.1 
$1,702.0 $916.7 $1,166.5 

The provision for income taxes consists of the following (in millions):
 Years Ended December 31,
 202120202019
Current   
United States:   
Federal$125.2 $23.4 $31.3 
State and local25.1 48.2 48.7 
Outside of the United States, including Puerto Rico92.6 73.9 29.1 
Current income tax expense$242.9 $145.5 $109.1 
Deferred   
United States:   
Federal$(9.4)$11.0 $28.3 
State and local(25.4)(32.9)(18.3)
Outside of the United States, including Puerto Rico(9.2)(30.3)0.5 
Deferred income tax (benefit) expense(44.0)(52.2)10.5 
Total income tax provision$198.9 $93.3 $119.6 
The components of deferred tax assets and liabilities are as follows (in millions):
 December 31,
 20212020
Deferred tax assets  
Compensation and benefits$109.8 $88.6 
Benefits from uncertain tax positions33.9 27.0 
Net tax credit carryforwards142.0 125.5 
Net operating loss carryforwards69.4 64.1 
Accrued liabilities108.0 105.0 
Inventories13.5 16.3 
Cash flow and net investment hedges— 3.3 
State income taxes0.4 0.5 
Investments0.7 1.8 
Lease liability obligations6.6 7.7 
Other1.3 3.6 
Total deferred tax assets485.6 443.4 
Deferred tax liabilities  
Property, plant, and equipment(64.1)(53.4)
Cash flow and net investment hedges(6.4)— 
Deferred tax on foreign earnings(26.3)(29.2)
Right-of-use assets (6.1)(7.0)
Other intangible assets(75.5)(76.3)
Other(2.6)(3.1)
Total deferred tax liabilities(181.0)(169.0)
Valuation allowance(82.5)(71.6)
Net deferred tax assets$222.1 $202.8 

During 2021, net deferred tax assets increased $19.3 million, including items that were recorded to stockholders' equity and which did not impact the Company's income tax provision.

The valuation allowance of $82.5 million as of December 31, 2021 reduces certain deferred tax assets to amounts that are more likely than not to be realized. This allowance primarily relates to the net operating loss carryforwards of certain non-United States subsidiaries and certain non-United States credit carryforwards.
Net operating loss and capital loss carryforwards and the related carryforward periods at December 31, 2021 are summarized as follows (in millions):
 Carryforward
Amount		Tax Benefit
Amount		Valuation
Allowance		Net Tax
Benefit		Carryforward
Period Ends
United States federal net operating losses$17.6 $3.7 $— $3.7 2030-2037
United States federal net operating losses11.3 2.4 — 2.4 Indefinite
United States state net operating losses33.5 1.6 (1.6)— 2026-2039
United States state net operating losses1.0 0.1 (0.1)— Indefinite
Non-United States net operating losses5.8 1.5 (1.2)0.3 2022-2028
Non-United States net operating losses353.3 60.1 (50.8)9.3 Indefinite
United States capital losses34.1 0.2 (0.2)— 2024
Total$456.6 $69.6 $(53.9)$15.7  

Certain tax attributes are subject to an annual limitation as a result of the acquisitions of Harpoon and CASMED, which constitute a change of ownership as defined under Internal Revenue Code Section 382.

The gross tax credit carryforwards and the related carryforward periods at December 31, 2021 are summarized as follows (in millions):
 Carryforward
Amount		Valuation
Allowance		Net Tax
Benefit		Carryforward
Period Ends
California research expenditure tax credits$167.0 $— $167.0 Indefinite
Federal research expenditure tax credits1.5 — 1.5 2026-2039
Foreign tax credits2.9 (2.9)— 2030-2031
Puerto Rico purchases credit23.4 (23.4)— Indefinite
Total$194.8 $(26.3)$168.5  

The Company has $167.0 million of California research expenditure tax credits it expects to use in future periods. The credits may be carried forward indefinitely. Based upon anticipated future taxable income, the Company expects that it is more likely than not that all California research expenditure tax credits will be utilized, although the utilization of the full benefit is expected to occur over a number of years into the distant future. Accordingly, no valuation allowance has been provided. The Company has $23.4 million of Puerto Rico purchases credit. Throughout its history and into the future, the Puerto Rico operations generate, or are expected to generate, credits each year in excess of its ability to utilize credits in those years. As a result, even though the credits have an indefinite life, the Company continues to record a valuation allowance on the credit carryforwards.

On December 22, 2017, Public Law 115-97, commonly referred to as the Tax Cuts and Jobs Act (the "2017 Act"), was signed into law. The 2017 Act a) reduced the United States federal corporate tax rate from 35 percent to 21 percent for tax years beginning after December 31, 2017, b) required companies to pay a one-time mandatory deemed repatriation tax on the cumulative earnings of certain foreign subsidiaries that were previously tax deferred, and c) created new taxes on certain foreign earnings in future years. The Company elected to pay the repatriation tax in installments over eight years.

The Company asserts that $1.0 billion of its foreign earnings continue to be indefinitely reinvested and it intends to repatriate $392.9 million of its foreign earnings as of December 31, 2021. The estimated net tax liability on the indefinitely reinvested earnings if repatriated is $23.1 million.

The Company has received tax incentives in certain non-United States tax jurisdictions, the primary benefit for which will expire in 2029. The tax reductions as compared to the local statutory rates were $208.0 million ($0.33 per diluted share), $189.2 million ($0.30 per diluted share), and $159.2 million ($0.25 per diluted share) for the years ended December 31, 2021, 2020, and 2019, respectively.
A reconciliation of the United States federal statutory income tax rate to the Company's effective income tax rate is as follows (in millions):
 Years Ended December 31,
 202120202019
Income tax expense at United States federal statutory rate$357.4 $192.5 $245.0 
Foreign income taxed at different rates(122.2)(80.5)(75.0)
State and local taxes, net of federal tax benefit11.9 5.0 11.9 
Tax credits, federal and state(48.4)(43.1)(42.9)
Build of reserve for prior years' uncertain tax positions3.6 4.2 5.0 
Tax on global intangible low-taxed income56.5 49.2 32.0 
Foreign-derived intangible income deduction(1.3)(2.6)(7.2)
Contingent consideration liabilities(26.1)2.9 (1.3)
United States federal deductible employee share-based compensation(47.8)(48.3)(57.6)
Nondeductible employee share-based compensation5.3 4.2 3.2 
Other10.0 9.8 6.5 
Income tax provision$198.9 $93.3 $119.6 

The Company's effective tax rate for 2021 increased in comparison to 2020 primarily due to the tax benefit from the Settlement Agreement with Abbott in 2020 (see Note 3) and the decrease in the excess tax benefit from employee share-based compensation, partially offset by the tax benefit from the change in fair value of contingent consideration liabilities. The Company's effective tax rate for 2020 decreased slightly in comparison to 2019 primarily due to the tax benefit from the Settlement Agreement with Abbott in 2020, partially offset by the increase in the United States tax on global intangible low-taxed income and the decrease in the excess tax benefit from employee share-based compensation.
Uncertain Tax Positions

As of December 31, 2021 and 2020, the gross uncertain tax positions were $358.4 million and $281.8 million, respectively. The Company estimates that these liabilities would be reduced by $135.1 million and $95.1 million, respectively, from offsetting tax benefits associated with the correlative effects of potential transfer pricing adjustments, state income taxes, and timing adjustments. The net amounts of $223.3 million and $186.7 million, respectively, if not required, would favorably affect the Company's effective tax rate.

A reconciliation of the beginning and ending amount of uncertain tax positions, excluding interest, penalties, and foreign exchange, is as follows (in millions):
 December 31,
 202120202019
Uncertain gross tax positions, January 1$281.8 $203.1 $150.7 
Current year tax positions
82.1 86.4 55.4 
Increase in prior year tax positions
2.3 6.0 0.8 
Decrease in prior year tax positions
(4.8)(10.0)(3.8)
Settlements
(0.3)(3.7)— 
Lapse of statutes of limitations
(2.7)— — 
Uncertain gross tax positions, December 31$358.4 $281.8 $203.1 

The table above summarizes the gross amounts of uncertain tax positions without regard to reduction in tax liabilities or additions to deferred tax assets and liabilities if such uncertain tax positions were settled.
The Company recognizes interest and penalties, if any, related to uncertain tax positions in the provision for income taxes. As of December 31, 2021, the Company had accrued $19.5 million (net of $8.1 million tax benefit) of interest related to uncertain tax positions, and as of December 31, 2020, the Company had accrued $14.3 million (net of $5.1 million tax benefit) of interest related to uncertain tax positions. During 2021, 2020, and 2019, the Company recognized interest expense, net of tax benefit, of $5.2 million, $5.0 million, and $4.7 million, respectively, in "Provision for Income Taxes" on the consolidated statements of operations.

In the normal course of business, the Internal Revenue Service ("IRS") and other taxing authorities are in different stages of examining various years of the Company's tax filings. During these audits, the Company may receive proposed audit adjustments that could be material. Therefore, there is a possibility that an adverse outcome in these audits could have a material effect on the Company's results of operations and financial condition. The Company strives to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time. While the Company has accrued for matters it believes are more likely than not to require settlement, the final outcome with a tax authority may result in a tax liability that is more or less than that reflected in the consolidated financial statements. Furthermore, the Company may later decide to challenge any assessments, if made, and may exercise its right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law. Management believes that adequate amounts of tax and related penalty and interest have been provided in income tax expense for any adjustments that may result from these uncertain tax positions.

At December 31, 2021, all material state, local, and foreign income tax matters have been concluded for years through 2015. While not material, the Company continues to address matters in India for years from 2010.

The Company executed an Advance Pricing Agreement (“APA”) in 2018 between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters. The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement (collectively "Surgical/TAVR") intercompany royalty transactions, then reverted to IRS Examination for further consideration as part of the respective years' regular tax audits. In addition, the Company executed other bilateral APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Japan and Singapore and between Switzerland and Japan covering tax years 2015 through 2019. The Company has filed to renew all of the APAs which cover transactions with Japan for the years 2020 and forward. The execution of some or all of these APA renewals depends on many variables outside of the Company's control.

The Company’s United States federal income tax returns through 2014 have been audited. The IRS began its examination of the 2015 and 2016 tax years during the fourth quarter of 2018 and later added the 2017 tax year to this audit cycle during the first quarter of 2019. The IRS audit field work for the 2015-2017 tax years was substantially completed during the fourth quarter of 2020, except for transfer pricing and related matters.

During the second quarter of 2021, the Company received a Notice of Proposed Adjustment (“NOPA”) from the IRS for the 2015-2017 tax years relating to transfer pricing involving certain Surgical/TAVR intercompany royalty transactions between the Company's United States and Switzerland subsidiaries. During the third quarter of 2021, the Company completed its review of the NOPA and provided comments to the IRS and the IRS subsequently revised the NOPA. The revised NOPA proposes an increase to the Company's United States taxable income which could result in additional tax expense for this period of approximately $180 million and represents a significant change to previously agreed upon transfer pricing methodologies for these types of transactions.

The Company has formally disagreed with the NOPA and has submitted a formal protest on the matter to the IRS Independent Office of Appeals during the fourth quarter of 2021. The Company also has received the final Revenue Agent's Report for these tax years. The Company continues to evaluate all possible remedies available to it, which could take several years to resolve. No payment of any amount related to the NOPA is required to be made, if at all, until all applicable proceedings have been completed. The Company believes the amounts previously accrued related to this uncertain tax position are sufficient and, accordingly, has not accrued any additional amount based on the NOPA received.

Certain Surgical/TAVR intercompany royalty transactions covering tax years 2015 - 2021 that were not resolved under the APA program remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of
December 31, 2021. The Company has considered this information, as well as information regarding the NOPA described above, in its evaluation of its uncertain tax positions. The impact of these unresolved transfer pricing matters, net of any correlative repatriation tax adjustment, may be significant to the Company’s consolidated financial statements. Based on the information currently available and numerous possible outcomes, the Company cannot reasonably estimate what, if any, changes in its existing uncertain tax positions may occur in the next 12 months and, therefore, has continued to record the uncertain tax positions as a long-term liability.
XML 60 R26.htm IDEA: XBRL DOCUMENT v3.22.0.1
LEGAL PROCEEDINGS
 12 Months Ended
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
LEGAL PROCEEDINGS LEGAL PROCEEDINGS
The Company is reviewing and investigating whether business activities in Japan and other markets violate certain provisions of the Foreign Corrupt Practices Act ("FCPA"). The Company has voluntarily notified the SEC and the United States Department of Justice that it has engaged outside counsel to conduct this review and investigation. Any determination that the Company’s operations or activities are not in compliance with existing laws, including the FCPA, could result in the imposition of fines, penalties, and equitable remedies. The Company cannot currently predict the outcome of the review and investigation or the potential impact on its financial statements.

On September 28, 2021, Aortic Innovations LLC, a non-practicing entity, filed a lawsuit against Edwards Lifesciences Corporation and certain of its subsidiaries ("Edwards") in the United States District Court for the District of Delaware alleging that Edwards’ SAPIEN 3 Ultra product infringes certain of its patents. The Company is unable to predict the ultimate outcome of this matter or estimate a range of possible exposure; therefore, no amounts have been accrued. The Company intends to vigorously defend itself in this litigation.

The Company is or may be a party to, or may otherwise be responsible for, pending or threatened lawsuits including those related to products and services currently or formerly manufactured or performed, as applicable, by the Company, workplace and employment matters, matters involving real estate, Company operations or health care regulations, or governmental investigations (the "Lawsuits"). The Lawsuits raise difficult and complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. Management does not believe that any loss relating to the Lawsuits would have a material adverse effect on the Company's overall financial condition, results of operations or cash flows. However, the resolution of one or more of the Lawsuits in any reporting period, could have a material adverse impact on the Company's financial results for that period. The Company is not able to estimate the amount or range of any loss for legal contingencies related to the Lawsuits for which there is no reserve or additional loss for matters already reserved.

The Company is subject to various environmental laws and regulations both within and outside of the United States. The Company's operations, like those of other medical device companies, involve the use of substances regulated under environmental laws, primarily in manufacturing and sterilization processes. While it is difficult to quantify the potential impact of continuing compliance with environmental protection laws, management believes that such compliance will not have a material impact on the Company's financial results. The Company's threshold of disclosing material environmental legal proceedings involving a governmental authority where potential monetary exposure is involved is $1 million.
XML 61 R27.htm IDEA: XBRL DOCUMENT v3.22.0.1
SEGMENT INFORMATION
 12 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
SEGMENT INFORMATION SEGMENT INFORMATION
Edwards Lifesciences conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. All regions sell products that are used to treat advanced cardiovascular disease.

The Company's geographic segments are reported based on the financial information provided to the Chief Operating Decision Maker (the Chief Executive Officer). The Company evaluates the performance of its geographic segments based on net sales and operating income. The accounting policies of the segments are the same as those described in Note 2. Segment net sales and segment operating income are based on internally derived standard foreign exchange rates, which may differ from year to year, and do not include inter-segment profits. Because of the interdependence of the reportable segments, the operating profit as presented may not be representative of the geographical distribution that would occur if the segments were not interdependent. Net sales by geographic area are based on the location of the customer. There were no customers that represented 10% or more of the Company's total net sales.
Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include net interest income, global marketing expenses, corporate research and development expenses, manufacturing variances, corporate headquarters costs, special gains and charges, stock-based compensation, foreign currency hedging activities, certain litigation costs, changes in the fair value of contingent consideration liabilities, and most of the Company's amortization expense. Although most of the Company's depreciation expense is included in segment operating income, due to the Company's methodology for cost build-up, it is impractical to determine the amount of depreciation expense included in each segment, and, therefore, a portion is maintained at the corporate level. The Company neither discretely allocates assets to its operating segments, nor evaluates the operating segments using discrete asset information.

The table below presents information about Edwards Lifesciences' reportable segments (in millions):
 Years Ended December 31,
 202120202019
Segment Net Sales   
United States$2,963.1 $2,516.8 $2,532.7 
Europe1,099.6 945.2 926.1 
Japan528.0 448.6 441.4 
Rest of World533.2 451.5 433.3 
Total segment net sales$5,123.9 $4,362.1 $4,333.5 
Segment Operating Income  
United States$2,051.0 $1,727.3 $1,742.3 
Europe569.1 479.3 472.0 
Japan348.0 286.4 272.3 
Rest of World185.2 150.1 127.9 
Total segment operating income$3,153.3 $2,643.1 $2,614.5 

The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):
 Years Ended December 31,
 202120202019
Net Sales Reconciliation   
Segment net sales$5,123.9 $4,362.1 $4,333.5 
Foreign currency108.6 24.2 14.5 
Consolidated net sales$5,232.5 $4,386.3 $4,348.0 
Pre-tax Income Reconciliation  
Segment operating income$3,153.3 $2,643.1 $2,614.5 
Unallocated amounts:
Corporate items(1,613.8)(1,358.0)(1,439.7)
Special charges— — (64.6)
Intellectual property litigation expenses, net(20.6)(405.4)(33.4)
Change in fair value of contingent consideration liabilities, net124.1 (13.6)6.1 
Foreign currency47.3 31.5 63.9 
Consolidated operating income1,690.3 897.6 1,146.8 
Non-operating income11.7 19.1 19.7 
Consolidated pre-tax income$1,702.0 $916.7 $1,166.5 
Enterprise-Wide Information
(in millions)

Enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated financial statements.

 As of or for the Years Ended December 31,
 202120202019
Net Sales by Geographic Area   
United States$2,963.1 $2,516.8 $2,532.7 
Europe1,190.3 973.6 941.2 
Japan528.9 460.1 444.7 
Rest of World550.2 435.8 429.4 
$5,232.5 $4,386.3 $4,348.0 
Net Sales by Major Product Area  
Transcatheter Aortic Valve Replacement$3,422.5 $2,857.3 $2,737.9 
Transcatheter Mitral and Tricuspid Therapies86.0 41.8 28.2 
Surgical Structural Heart889.1 761.8 841.7 
Critical Care834.9 725.4 740.2 
$5,232.5 $4,386.3 $4,348.0 
Long-lived Tangible Assets by Geographic Area   
United States$1,195.8 $1,084.3 $849.1 
Europe197.9192.7101.5
Japan19.720.421.7
Rest of World335.5311.0269.4
$1,748.9 $1,608.4 $1,241.7 
XML 62 R28.htm IDEA: XBRL DOCUMENT v3.22.0.1
VALUATION AND QUALIFYING ACCOUNTS
 12 Months Ended
Dec. 31, 2021
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
VALUATION AND QUALIFYING ACCOUNTS VALUATION AND QUALIFYING ACCOUNTS
  Additions  
 Balance at
Beginning
of Period		Charged to
Costs and
Expenses		Charged to
Other
Accounts		DeductionsBalance at
End of
Period
 (in millions)
Year ended December 31, 2021
     
Allowance for doubtful accounts (a)$16.4 $1.2 $0.6 $(2.5)$15.7 
Tax valuation allowance (b)71.6 12.4 — (1.5)82.5 
Year ended December 31, 2020
     
Allowance for doubtful accounts (a)$14.7 $3.1 $— $(1.4)$16.4 
Tax valuation allowance (b)65.8 6.3 0.6 (1.1)71.6 
Year ended December 31, 2019
     
Allowance for doubtful accounts (a)$13.6 $4.7 $0.2 $(3.8)$14.7 
Tax valuation allowance (b)46.7 18.9 0.2 — 65.8 
_______________________________________________________________________________
(a)    The deductions related to allowances for doubtful accounts represent accounts receivable which are written off.

(b)     The tax valuation allowances are provided for other-than-temporary impairments and unrealized losses related to certain investments that may not be recognized due to the uncertainty of the ready marketability of certain impaired investments, and net operating loss and credit carryforwards that may not be recognized due to insufficient taxable income.
XML 63 R29.htm IDEA: XBRL DOCUMENT v3.22.0.1
SUBSEQUENT EVENT
 12 Months Ended
Dec. 31, 2021
Subsequent Events [Abstract]  
SUBSEQUENT EVENT SUBSEQUENT EVENTIn January 2022, the Company entered into an ASR agreement to repurchase $250.0 million of Edwards Lifesciences' common stock based on the volume-weighted average price ("VWAP") of Edwards Lifesciences' common stock during the term of the agreements, less a discount. Upon entering into the agreement, the Company received an initial delivery of approximately 1.9 million shares, representing approximately 80% of the shares to be repurchased. At the termination of the ASR, the Company may receive additional shares or may be required to pay additional cash or shares (at the Company's election). The final settlement is based on the VWAP over the term of the agreement, less a discount. The ASR agreement has a scheduled termination date of February 16, 2022.
XML 64 R30.htm IDEA: XBRL DOCUMENT v3.22.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Principles of Consolidation
Principles of Consolidation

The accompanying consolidated financial statements include the accounts of Edwards Lifesciences and its majority-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The Company reviews its investments in other entities to determine whether the Company is the primary beneficiary of a variable interest entity ("VIE"). The Company would be the primary beneficiary of the VIE, and would be required to consolidate the VIE, if it has the power to direct the significant activities of the entity and the obligation to absorb losses or receive benefits from the entity that may be significant to the VIE. Based on the Company's analysis, it determined it is not the primary beneficiary of any material VIEs; however, future events may require VIEs to be consolidated if the Company becomes the primary beneficiary.
Use of Estimates
Use of Estimates

The consolidated financial statements of Edwards Lifesciences have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") which have been applied consistently in all material respects. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. In particular, the COVID-19 pandemic has adversely impacted, and may further adversely impact, nearly all aspects of the Company's business and markets, including its workforce and the operations of its customers, suppliers, and business partners. The full extent to which the pandemic will directly or indirectly impact the Company's business, results of operations, and financial condition, including sales, expenses, manufacturing, clinical trials, research and development costs, reserves and allowances, fair value measurements, asset impairment charges, contingent consideration obligations, and the effectiveness of the Company's hedging instruments, will depend on future developments that are highly uncertain and difficult to predict. These developments include, but are not limited to, the duration and spread of the outbreak (including new and more contagious variants of COVID-19), its severity, the actions to contain the virus or address its impact, the timing, distribution, public acceptance and efficacy of vaccines and other treatments, United States and foreign government actions to respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume.
Foreign Currency Translation
Foreign Currency Translation

When the local currency of the Company's foreign entities is the functional currency, all assets and liabilities are translated into United States dollars at the rate of exchange in effect at the balance sheet date. Income and expense items are translated at the weighted-average exchange rate prevailing during the period. The effects of foreign currency translation adjustments for these entities are deferred and reported in stockholders' equity as a component of "Accumulated Other Comprehensive Loss." The effects of foreign currency transactions denominated in a currency other than an entity's functional currency are included in "Other Income, net."
Revenue Recognition
Revenue Recognition

Revenue is recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those products or services.

The Company generates nearly all of its revenue from direct product sales and sales of products under consignment arrangements. Revenue from direct product sales is recognized at a point in time when the performance obligation is satisfied upon delivery of the product. Revenue from sales of consigned inventory is recognized at a point in time when the performance obligation is satisfied once the product has been implanted or used by the customer. The Company periodically reviews consignment inventories to confirm the accuracy of customer reporting. The Company also generates a small portion of its revenue from service contracts, and recognizes revenue from service contracts ratably over the term of the contracts. Sales taxes and other similar taxes that the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company does not typically have any significant unusual payment terms beyond 90 days in its contracts with customers. In addition, the Company receives royalty payments for the licensing of certain intellectual property and recognizes the royalty when the subsequent sale of product using the intellectual property occurs.

The amount of consideration the Company ultimately receives varies depending upon the return terms, sales rebates, discounts, and other incentives that the Company may offer, which are accounted for as variable consideration when estimating the amount of revenue to recognize. The Company includes estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely upon an assessment of historical payment experience, historical relationship to revenues, estimated customer inventory levels, and current contract sales terms with direct and indirect customers.

The Company's sales adjustment related to distributor rebates given to the Company's United States distributors represents the difference between the Company's sales price to the distributor and the negotiated price to be paid by the end-customer. This distributor rebate is recorded as a reduction to sales and a reduction to the distributor's accounts receivable at the time of sale to a distributor. The Company periodically monitors current pricing trends and distributor inventory levels to ensure the credit for future distributor rebates is fairly stated.

The Company offers volume rebates to certain group purchasing organizations ("GPOs") and customers based upon targeted sales levels. Volume rebates offered to GPOs are recorded as a reduction to sales and an obligation to the GPOs, as the Company expects to pay in cash. Volume rebates offered to customers are recorded as a reduction to sales and either a reduction to accounts receivable if the Company expects a net payment from the customer, or as an obligation to the customer if the Company expects to pay in cash. The provision for volume rebates is estimated based upon customers' contracted rebate programs, projected sales levels, and historical experience of rebates paid. The Company periodically monitors its customer rebate programs to ensure that the allowance and liability for accrued rebates is fairly stated.

Product returns are typically not significant because returns are generally not allowed unless the product is damaged at time of receipt. In limited circumstances, the Company may allow customers to return previously purchased products, such as for next-generation product offerings. For these transactions, the Company defers recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer.
The Company sells separately priced service contracts, which range from 12 to 36 months, to owners of its hemodynamic monitors. The Company invoices the customer the total amount of consideration at the inception of the contract and recognizes revenue ratably over the term of the contract. As of December 31, 2021 and 2020, $10.2 million and $6.3 million, respectively, of deferred revenue associated with outstanding service contracts was recorded in “Accrued and Other Liabilities” and "Other Long-term Liabilities." During 2021, the Company recognized as revenue $7.3 million that was included in the balance of deferred revenue as of December 31, 2020, and during 2020, the Company recognized as revenue $6.3 million that was included in the balance of deferred revenue as of December 31, 2019.

A limited number of the Company’s contracts with customers contain multiple performance obligations. For these contracts, the transaction price is allocated to each performance obligation based on its relative standalone selling price charged to other customers.

The Company applies the optional exemption of not disclosing the amount of the transaction price allocated to unsatisfied performance obligations for contracts with an original expected duration of one year or less.

Shipping and Handling Costs
Shipping costs, which are costs incurred to physically move product from the Company's premises or third party distribution centers, including storage, to the customer's premises, are included in "Selling, General, and Administrative Expenses." Handling costs, which are costs incurred to store at the Company's premises, move, and prepare products for shipment, are included in "Cost of Sales."
Cash Equivalents
Cash Equivalents

The Company considers highly liquid investments with original maturities of three months or less to be cash equivalents. These investments are valued at cost, which approximates fair value.
Investments
Investments

The Company invests its excess cash in debt securities, including time deposits, commercial paper, United States government and agency securities, asset-backed securities, corporate debt securities, and municipal debt securities. Investments with maturities of one year or less are classified as short-term, and investments with maturities greater than one year are classified as long-term. Investments that the Company has the ability and intent to hold until maturity are classified as held-to-maturity and carried at amortized cost. Investments in debt securities that are classified as available-for-sale are carried at fair value with unrealized gains and losses included in "Accumulated Other Comprehensive Loss." The Company determines the appropriate classification of its investments in debt securities at the time of purchase and reevaluates such designation at each balance sheet date.

The Company also has long-term equity investments in companies that are in various stages of development. These investments are reported at fair value or under the equity method of accounting, as appropriate. Equity investments that do not have readily determinable fair values are recorded at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The Company accounts for investments in limited partnerships and limited liability corporations, whereby the Company owns a minimum of 5% of the investee's outstanding voting stock, under the equity method of accounting. These investments are recorded at the amount of the Company's investment and adjusted each period for the Company's share of the investee's income or loss, and dividends paid.

Realized gains and losses on investments that are sold are determined using the specific identification method, or the first-in, first-out method, depending on the investment type, and recorded to "Other Income, net." Income relating to investments in debt securities is recorded to "Interest Income."

Equity investments without readily determinable fair value are considered impaired when there is an indication that the fair value of the Company's interest is less than the carrying amount. Equity method investments are considered impaired when
there is an indication of an other-than-temporary decline in value below the carrying amount. Impairments of equity investments are recorded in "Other Income, net." Debt securities in an unrealized loss position are written down to fair value through “Other Income, net” if the Company intends to sell the security or it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. For debt securities in an unrealized loss position that do not meet the aforementioned criteria, the Company assesses whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. When a credit loss exists, the Company compares the present value of cash flows expected to be collected from the debt security to the amortized cost basis of the security to determine the allowance amount that should be recorded, if any.
Accounts Receivable
Accounts Receivable

The majority of the Company’s accounts receivable arise from direct product sales and sales of products under consignment arrangements, and have payment terms that generally require payment within 30 to 90 days. The Company does not adjust its receivables for the effects of a significant financing component at contract exception if collection of the receivable is expected within one year or less from the time of sale. In countries where the Company has experienced a pattern of payments extending beyond the stated terms and collection of the receivable is expected beyond one year from the time of sale, the Company assesses whether the customer has a significant financing component and discounts the receivable and reduces the related revenues over the period of time that the Company estimates those amounts will be paid using the country’s market-based borrowing rate for such period.

The Company provides reserves against accounts receivable for estimated losses that may result from a customer’s inability to pay based on customer-specific analysis and general matters such as current assessments of past due balances, economic conditions and forecasts, and historical credit loss activity. Amounts determined to be uncollectible are charged or written-off against the reserve.
Inventories
Inventories

Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. Market value for raw materials is based on replacement costs, and for other inventory classifications is based on net realizable value.

A write-down for excess or slow moving inventory is recorded for inventory which is obsolete, damaged, nearing its expiration date (generally triggered at six months prior to expiration), or slow moving (generally defined as quantities in excess of a two-year supply).
The Company allocates to inventory general and administrative costs that are related to the production process. These costs include insurance, manufacturing accounting and human resources personnel, and information technology.
Property, Plant and Equipment
Property, Plant, and Equipment

Property, plant, and equipment are recorded at cost. Depreciation is principally calculated for financial reporting purposes on the straight-line method over the estimated useful lives of the related assets, which range from 10 to 40 years for buildings and improvements, from 3 to 15 years for machinery and equipment, and from 3 to 5 years for software. Leasehold improvements are amortized over the life of the related facility leases or the asset, whichever is shorter. Straight-line and accelerated methods of depreciation are used for income tax purposes. Construction in progress is not depreciated until the asset is ready for its intended use.
Leases
Leases

The Company determines whether a contract is, or contains, a lease at inception. Right-of-use assets represent the Company’s right to use an underlying asset during the lease term, and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at lease commencement based upon the estimated present value of unpaid lease payments over the lease term. The Company uses its incremental borrowing rate based on the information available at lease commencement in determining the present value of unpaid lease payments. The Company's incremental borrowing rate is determined based on the estimated rate of interest for collateralized borrowing over a similar term as the associated lease. Right-of-use assets also include any lease payments made at or before lease commencement and any initial direct costs incurred, and exclude any lease incentives received.

The Company determines the lease term as the noncancellable period of the lease, and may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Leases with a term of 12 months or less are not recognized on the balance sheet. Certain of the Company’s leases include variable lease payments that are based on costs incurred or actual usage, or adjusted periodically based on an index or a rate. The Company’s leases do not contain any residual value guarantees.

The Company accounts for the lease and non-lease components as a single lease component for all of its leases except vehicle leases, for which the lease and non-lease components are accounted for separately.

Operating leases are included in “Operating Lease Right-of-Use Assets” and “Operating Lease Liabilities” on the Company’s consolidated balance sheets. See Note 6 for further information.
Impairment of Goodwill and Long-lived Assets
Impairment of Goodwill and Long-lived Assets

Goodwill is reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate that the carrying amount may be impaired. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the Company performs a quantitative impairment test. The Company determined, after performing a qualitative review of each reporting unit, that it is more likely than not that the fair value of each of its reporting units substantially exceeds the respective carrying amounts. Accordingly, in 2021, 2020, and 2019, the Company did not record any goodwill impairment loss.

Indefinite-lived intangible assets relate to in-process research and development acquired in business combinations. The estimated fair values of in-process research and development projects acquired in a business combination which have not reached technological feasibility are capitalized and accounted for as indefinite-lived intangible assets subject to impairment testing until completion or abandonment of the projects. Upon successful completion of the project, the capitalized amount is amortized over its estimated useful life. If the project is abandoned, all remaining capitalized amounts are written off immediately. Indefinite-lived intangible assets are reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate the carrying amount may be impaired. An impairment
loss is recognized when the asset's carrying value exceeds its fair value. In-process research and development projects acquired in an asset acquisition are expensed unless the project has an alternative future use.

Management reviews the carrying amounts of other finite-lived intangible assets and long-lived tangible assets whenever events or circumstances indicate that the carrying amounts of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit, and adverse legal or regulatory developments. If it is determined that such indicators are present and the review indicates that the assets will not be fully recoverable, based on undiscounted estimated cash flows over the remaining amortization periods, their carrying values are reduced to estimated fair market value. Estimated fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. For the purposes of identifying and measuring impairment, long-lived assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities.
In 2021 and 2020, the Company did not record any impairment loss related to its in-process research and development assets. In 2019, the Company recorded a $40.6 million charge related to the impairment of certain in-process research and development assets. See Note 4 for further information.
Income Taxes
Income Taxes

The Company is subject to income taxes in the United States and numerous foreign jurisdictions. Significant judgment is required in evaluating the Company's uncertain tax positions and determining its provision for income taxes. The Company recognizes the financial statement benefit of a tax position only after determining that a position would more likely than not be sustained based upon its technical merit if challenged by the relevant taxing authority and taken by management to the court of last resort. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon settlement with the relevant tax authority. The Company recognizes interest and penalties related to income tax matters in income tax expense. The Company has made an accounting policy election to recognize the United States tax effects of global intangible low-taxed income as a component of income tax expense in the period the tax arises.

Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been recognized in the Company's financial statements or tax returns. The Company evaluates quarterly the realizability of its deferred tax assets by assessing its valuation allowance and adjusting the amount, if necessary. The factors used to assess the likelihood of realization are both historical experience and the Company's forecast of future taxable income and available tax planning strategies that could be implemented to realize the net deferred tax assets. Failure to achieve forecasted taxable income in the applicable taxing jurisdictions could affect the ultimate realization of deferred tax assets and could result in an increase in the Company's effective tax rate on future earnings.
Research and Development Costs
Research and Development Costs

Research and development costs are charged to expense when incurred.
Earnings per Share
Earnings per Share

Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during the period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive.
Stock-based Compensation
Stock-based Compensation

The Company measures and recognizes compensation expense for all stock-based awards based on estimated fair values. Stock-based awards consist of stock options, restricted stock units (service-based and market-based), and employee stock purchase subscriptions. Stock-based compensation expense is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period (vesting period) on a straight-line basis. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Upon exercise of stock options or vesting of restricted stock units, the Company issues common stock.
Upon a participant's retirement, all unvested stock options are immediately forfeited. In addition, upon retirement, a participant will immediately vest in 25% of service-based restricted stock units for each full year of employment with the Company measured from the grant date. All remaining unvested service-based restricted stock units are immediately forfeited. For market-based restricted stock units, upon retirement and in certain other specified cases, a participant will receive a pro-rated portion of the shares that would ultimately be issued based on attainment of the performance goals as determined on the vesting date. The pro-rated portion is based on the participant's whole months of service with the Company during the performance period prior to the date of termination.
Derivatives
Derivatives

The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk. It is the Company's policy not to enter into derivative financial instruments for speculative purposes.

Derivative financial instruments involve credit risk in the event the counterparty should default. It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy. The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities. The Company also uses International Swap Dealers Association master-netting agreements. The master-netting agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.

The Company uses foreign currency forward exchange contracts and cross currency swap contracts to manage its exposure to changes in currency exchange rates from (1) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within the next 13 months (designated as cash flow hedges), (2) its net investment in certain foreign subsidiaries (designated as net investment hedges) and (3) foreign currency denominated assets or liabilities (designated as fair value hedges). The Company also uses foreign currency forward exchange contracts that are not designated as hedging instruments to offset the transaction gains and losses associated with the revaluation of certain assets and liabilities denominated in currencies other than their functional currencies resulting principally from intercompany and local currency transactions.

All derivative financial instruments are recognized at fair value in the consolidated balance sheets. For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings, and offsets the loss or gain on the underlying hedged item. The Company reports in "Accumulated Other Comprehensive Loss" the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges. The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings. Changes in the fair value of net investment hedges are reported in "Accumulated Other Comprehensive Loss" as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated. The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative. The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument. Cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.
New Accounting Standards Not Yet Adopted
New Accounting Standards Not Yet Adopted

In November 2021, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on government assistance. The guidance requires certain disclosures about transactions with a government that are accounted for by applying a grant or contribution model. The guidance is effective for annual periods beginning after December 15, 2021, and should be applied either prospectively or retrospectively. The Company does not expect the adoption of this guidance will have a material impact on its consolidated financial statements.
XML 65 R31.htm IDEA: XBRL DOCUMENT v3.22.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Schedule of Computation of Basic and Diluted Earnings Per Share
The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):
 Years Ended December 31,
 202120202019
Basic:   
Net income$1,503.1 $823.4 $1,046.9 
Weighted-average shares outstanding623.3 622.6 624.8 
Basic earnings per share$2.41 $1.32 $1.68 
Diluted:   
Net income$1,503.1 $823.4 $1,046.9 
Weighted-average shares outstanding623.3 622.6 624.8 
Dilutive effect of stock plans7.9 9.3 11.9 
Dilutive weighted-average shares outstanding631.2 631.9 636.7 
Diluted earnings per share$2.38 $1.30 $1.64 
Schedule of Stock-Based Compensation Expense
Total stock-based compensation expense was as follows (in millions):
 Years Ended December 31,
 202120202019
Cost of sales$20.4 $17.2 $14.7 
Selling, general, and administrative expenses65.6 56.6 51.2 
Research and development expenses23.3 18.8 15.4 
Total stock-based compensation expense109.3 92.6 81.3 
Income tax benefit(18.9)(15.4)(14.8)
Total stock-based compensation expense, net of tax$90.4 $77.2 $66.5 
XML 66 R32.htm IDEA: XBRL DOCUMENT v3.22.0.1
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)
 12 Months Ended
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Components of Selected Captions in the Consolidated Balance Sheets
Components of selected captions in the consolidated balance sheets are as follows:
 As of December 31,
 20212020
 (in millions)
Inventories  
Raw materials$132.8 $136.7 
Work in process164.3 140.0 
Finished products429.6 525.6 
$726.7 $802.3 
Property, plant, and equipment, net  
Land$116.5 $97.6 
Buildings and leasehold improvements1,010.1 881.5 
Machinery and equipment613.4 564.9 
Equipment with customers39.2 42.2 
Software88.2 94.2 
Construction in progress333.8 313.3 
2,201.2 1,993.7 
Accumulated depreciation(654.6)(598.5)
$1,546.6 $1,395.2 
Accrued and other liabilities  
Employee compensation and withholdings$319.7 $236.7 
Accrued rebates77.0 67.2 
Property, payroll, and other taxes68.9 49.7 
Research and development accruals58.2 52.3 
As of December 31,
20212020
(in millions)
Legal and insurance (Notes 3 and 18)79.1 60.8 
Taxes payable30.6 18.6 
Fair value of derivatives3.9 39.3 
Accrued marketing expenses20.1 14.3 
Accrued professional services11.9 7.6 
Accrued realignment reserves19.1 14.5 
Accrued relocation costs26.2 21.0 
Other accrued liabilities87.6 88.2 
$802.3 $670.2 
Schedule of Cash Flow Information
Supplemental Cash Flow Information
(in millions)
Years Ended December 31,
202120202019
Cash paid during the year for:   
Interest$20.2 $19.9 $19.9 
Income taxes$182.5 $197.9 $61.5 
Amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases
$31.9 $29.7 $28.6 
Non-cash investing and financing transactions:   
Right-of-use assets obtained in exchange for new lease liabilities$28.7 $39.7 $49.6 
Capital expenditures accruals$54.3 $80.4 $50.8 
Conversion of notes receivable to equity investment$21.5 $4.5 $— 
Schedule of Cash and Cash Equivalents
Cash, Cash Equivalents, and Restricted Cash
(in millions)
Years Ended December 31,
202120202019
Cash and cash equivalents$862.8 $1,183.2 $1,179.1 
Restricted cash included in other current assets1.5 16.6 1.6 
Restricted cash included in other assets3.1 0.4 3.7 
Total cash, cash equivalents, and restricted cash$867.4 $1,200.2 $1,184.4 
Schedule of Restricted Cash
Cash, Cash Equivalents, and Restricted Cash
(in millions)
Years Ended December 31,
202120202019
Cash and cash equivalents$862.8 $1,183.2 $1,179.1 
Restricted cash included in other current assets1.5 16.6 1.6 
Restricted cash included in other assets3.1 0.4 3.7 
Total cash, cash equivalents, and restricted cash$867.4 $1,200.2 $1,184.4 
XML 67 R33.htm IDEA: XBRL DOCUMENT v3.22.0.1
LEASES (Tables)
 12 Months Ended
Dec. 31, 2021
Leases [Abstract]  
Schedule of Assets And Liabilities Of Lessee
Supplemental balance sheet information related to operating leases was as follows (in millions, except lease term and discount rate):
As of December 31,
20212020
Operating lease right-of-use assets$92.1 $94.2 
Operating lease liabilities, current portion$25.5 $27.2 
Operating lease liabilities, long-term portion69.1 72.7 
Total operating lease liabilities
$94.6 $99.9 
Schedule of Lessee, Operating Lease, Liability, Maturity
Maturities of operating lease liabilities at December 31, 2021 were as follows (in millions):
2022$27.5 
202323.0 
202413.6 
20258.3 
20267.5 
Thereafter24.6 
Total lease payments
104.5 
Less: imputed interest
(9.9)
Total lease liabilities
$94.6 

The following table provides information on the lease terms and discount rates:
Years Ended December 31,
20212020
Weighted-average remaining lease term (in years)6.26.6
Weighted-average discount rate2.5 %2.7 %
XML 68 R34.htm IDEA: XBRL DOCUMENT v3.22.0.1
INVESTMENTS (Tables)
 12 Months Ended
Dec. 31, 2021
Investments, Debt and Equity Securities [Abstract]  
Schedule of Investments in Debt Securities
Investments in debt securities at the end of each period were as follows (in millions):

 December 31, 2021December 31, 2020
Held-to-maturityAmortized CostGross Unrealized GainsGross Unrealized LossesFair ValueAmortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Bank time deposits$162.0 $— $— $162.0 $50.0 $— $— $50.0 
Available-for-sale
Bank time deposits$2.5 $— $— $2.5 $24.1 $— $— $24.1 
Commercial paper127.7 — — 127.7 — — — — 
United States government and agency securities147.4 0.6 (0.7)147.3 147.0 2.2 — 149.2 
Asset-backed securities515.2 0.3 (2.9)512.6 149.6 1.9 — 151.5 
Corporate debt securities1,397.1 2.0 (8.3)1,390.8 600.8 7.5 — 608.3 
Municipal securities2.8 — — 2.8 2.8 — — 2.8 
$2,192.7 $2.9 $(11.9)$2,183.7 $924.3 $11.6 $— $935.9 
Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity
The cost and fair value of investments in debt securities, by contractual maturity, as of December 31, 2021 were as follows:

 Held-to-MaturityAvailable-for-Sale
 Amortized CostFair ValueAmortized CostFair Value
 (in millions)
Due in 1 year or less$162.0 $162.0 $441.3 $442.0 
Due after 1 year through 5 years— — 1,196.7 1,189.6 
Due after 5 years through 10 years— — 8.7 8.6 
Instruments not due at a single maturity date (a)
— — 546.0 543.5 
$162.0 $162.0 $2,192.7 $2,183.7 
_______________________________________
(a)     Consists of mortgage- and asset-backed securities.
Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of December 31, 2021, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):
December 31, 2021
Less than 12 Months12 Months or GreaterTotal
Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
United States government and agency securities$85.1 $(0.7)$— $— $85.1 $(0.7)
Asset-backed securities433.3 (2.9)— — 433.3 (2.9)
Corporate debt securities1,114.1 (8.3)— — 1,114.1 (8.3)
$1,632.5 $(11.9)$— $— $1,632.5 $(11.9)
Schedule of Investments in Unconsolidated Affiliates in unconsolidated entities. These investments are recorded in "Long-term Investments" on the consolidated balance sheets, and are as follows:
 December 31,
 20212020
 (in millions)
Equity method investments  
Carrying value of equity method investments$8.4 $5.7 
Equity securities  
Carrying value of non-marketable equity securities84.1 29.4 
Total investments in unconsolidated entities$92.5 $35.1 
XML 69 R35.htm IDEA: XBRL DOCUMENT v3.22.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)
 12 Months Ended
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Changes in the Carrying Amount of Goodwill, by Segment
The changes in the carrying amount of goodwill, by segment, during the years ended December 31, 2021 and 2020 were as follows:
 United
States		EuropeRest of WorldTotal
 (in millions)
Goodwill at December 31, 2019
$773.7 $62.8 $331.2 $1,167.7 
Currency translation adjustment— 5.5 — 5.5 
Goodwill at December 31, 2020
773.7 68.3 331.2 1,173.2 
Currency translation adjustment— (5.3)— (5.3)
Goodwill at December 31, 2021
$773.7 $63.0 $331.2 $1,167.9 
Schedule of Finite-Lived Other Intangible Assets
Other intangible assets consist of the following (in millions):

 December 31,
 Weighted-Average Useful Life (in years)20212020
 CostAccumulated
Amortization		Net
Carrying
Value		CostAccumulated
Amortization		Net
Carrying
Value
Finite-lived intangible assets      
Patents7.4$185.7 $(184.2)$1.5 $186.1 $(183.6)$2.5 
Developed technology13.1153.9 (55.5)98.4 155.2 (51.0)104.2 
Other10.012.4 (6.8)5.6 12.6 (6.0)6.6 
12.6352.0 (246.5)105.5 353.9 (240.6)113.3 
Indefinite-lived intangible assets      
In-process research and development218.1 — 218.1 218.1 — 218.1 
$570.1 $(246.5)$323.6 $572.0 $(240.6)$331.4 
Schedule of Indefinite-Lived Other Intangible Assets
Other intangible assets consist of the following (in millions):

 December 31,
 Weighted-Average Useful Life (in years)20212020
 CostAccumulated
Amortization		Net
Carrying
Value		CostAccumulated
Amortization		Net
Carrying
Value
Finite-lived intangible assets      
Patents7.4$185.7 $(184.2)$1.5 $186.1 $(183.6)$2.5 
Developed technology13.1153.9 (55.5)98.4 155.2 (51.0)104.2 
Other10.012.4 (6.8)5.6 12.6 (6.0)6.6 
12.6352.0 (246.5)105.5 353.9 (240.6)113.3 
Indefinite-lived intangible assets      
In-process research and development218.1 — 218.1 218.1 — 218.1 
$570.1 $(246.5)$323.6 $572.0 $(240.6)$331.4 
Schedule of Estimated Amortization Expense Estimated amortization expense for each of the years ending December 31 is as follows (in millions):
2022$6.8 
20238.4 
20248.4 
202510.2 
202615.9 
XML 70 R36.htm IDEA: XBRL DOCUMENT v3.22.0.1
DEBT AND CREDIT FACILITIES (Tables)
 12 Months Ended
Dec. 31, 2021
Debt Disclosure [Abstract]  
Schedule of the Notes
The following is a summary of the Notes as of December 31, 2021 and 2020:
 December 31,
 2021 2020
 AmountEffective
Interest Rate		 AmountEffective
Interest Rate
(in millions)(in millions)
Fixed-rate 4.300% 2018 Notes
$600.0 4.329 %$600.0 4.329 %
Unamortized discount(1.0)  (1.1) 
Unamortized debt issuance costs(3.3)(3.9)
Total carrying amount$595.7   $595.0  
XML 71 R37.htm IDEA: XBRL DOCUMENT v3.22.0.1
FAIR VALUE MEASUREMENTS (Tables)
 12 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis
The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis as of December 31, 2021 and 2020 (in millions):

December 31, 2021Level 1Level 2Level 3Total
Assets    
Cash equivalents$15.2 $30.7 $— $45.9 
Available-for-sale investments: 
Bank time deposits— 2.5 — 2.5 
Corporate debt securities— 1,390.8 — 1,390.8 
Asset-backed securities— 512.6 — 512.6 
United States government and agency securities28.4 118.9 — 147.3 
Commercial paper— 127.7 — 127.7 
Municipal securities— 2.8 — 2.8 
Investments held for deferred compensation plans130.7 — — 130.7 
Derivatives— 55.3 — 55.3 
$174.3 $2,241.3 $— $2,415.6 
Liabilities    
Derivatives$— $3.9 $— $3.9 
Deferred compensation plans130.9 — — 130.9 
Contingent consideration liabilities— — 62.0 62.0 
Other liability— — 14.0 14.0 
$130.9 $3.9 $76.0 $210.8 
December 31, 2020
Assets
Cash equivalents$16.2 $— $— $16.2 
Available-for-sale investments: 
Bank time deposits— 24.1 — 24.1 
Corporate debt securities— 608.3 — 608.3 
Asset-backed securities— 151.5 — 151.5 
United States government and agency securities56.9 92.2 — 149.1 
Municipal securities— 2.8 — 2.8 
Investments held for deferred compensation plans111.2 — — 111.2 
Derivatives— 8.1 — 8.1 
$184.3 $887.0 $— $1,071.3 
Liabilities    
Derivatives$— $39.3 $— $39.3 
Deferred compensation plans111.6 — — 111.6 
Contingent consideration liabilities— — 186.1 186.1 
$111.6 $39.3 $186.1 $337.0 
Schedule of Changes in Fair Value of Contingent Consideration Obligation
The following table summarizes the changes in fair value of the contingent consideration obligation for the years ended December 31, 2021 and 2020 (in millions):

Contingent ConsiderationOther LiabilityTotal
Fair value, December 31, 2019
$172.5 $— $172.5 
Changes in fair value13.6 — 13.6 
Fair value, December 31, 2020
$186.1 $— $186.1 
Additions— 14.0 14.0 
Changes in fair value(124.1)— (124.1)
Fair value, December 31, 2021
$62.0 $14.0 $76.0 
XML 72 R38.htm IDEA: XBRL DOCUMENT v3.22.0.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)
 12 Months Ended
Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Financial Instruments Used to Manage Currency Exchange and Interest Rate Risk
The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.
 Notional Amount
 December 31, 2021December 31, 2020
 (in millions)
Foreign currency forward exchange contracts$1,498.8 $1,525.5 
Cross currency swap contracts300.0 300.0 
Schedule of Location and Fair Value Amounts of Derivative Instruments
The following table presents the location and fair value amounts of derivative instruments reported in the consolidated balance sheets (in millions):

  Fair Value
 Balance Sheet LocationDecember 31, 2021December 31, 2020
Derivatives designated as hedging instruments   
Assets   
Foreign currency contractsOther current assets$36.2 $7.3 
Cross currency swap contractsOther assets$19.1 $0.8 
Liabilities   
Foreign currency contractsAccrued and other liabilities$3.9 $39.3 
Schedule of Effect of Master-Netting Agreements and Rights of Offset, Assets
The following table presents the effect of master-netting agreements and rights of offset on the consolidated balance sheets (in millions):

    Gross Amounts Not Offset in the Consolidated Balance Sheet 
  Gross Amounts
Offset in the
Consolidated
Balance Sheet		Net Amounts
Presented in the
Consolidated
Balance Sheet
December 31, 2021Gross
Amounts		Financial
Instruments		Cash
Collateral
Received		Net
Amount
Derivative Assets      
Foreign currency contracts$36.2 $— $36.2 $(2.8)$— $33.4 
Cross currency swap contracts$19.1 $— $19.1 $— $— $19.1 
Derivative Liabilities      
Foreign currency contracts$3.9 $— $3.9 $(2.8)$— $1.1 
December 31, 2020      
Derivative Assets      
Foreign currency contracts$7.3 $— $7.3 $(6.1)$— $1.2 
Cross currency swap contracts$0.8 $— $0.8 $— $— $0.8 
Derivative Liabilities      
Foreign currency contracts$39.3 $— $39.3 (6.1)$— $33.2 
Schedule of Effect of Master-Netting Agreements and Rights of Offset, Liabilities
The following table presents the effect of master-netting agreements and rights of offset on the consolidated balance sheets (in millions):

    Gross Amounts Not Offset in the Consolidated Balance Sheet 
  Gross Amounts
Offset in the
Consolidated
Balance Sheet		Net Amounts
Presented in the
Consolidated
Balance Sheet
December 31, 2021Gross
Amounts		Financial
Instruments		Cash
Collateral
Received		Net
Amount
Derivative Assets      
Foreign currency contracts$36.2 $— $36.2 $(2.8)$— $33.4 
Cross currency swap contracts$19.1 $— $19.1 $— $— $19.1 
Derivative Liabilities      
Foreign currency contracts$3.9 $— $3.9 $(2.8)$— $1.1 
December 31, 2020      
Derivative Assets      
Foreign currency contracts$7.3 $— $7.3 $(6.1)$— $1.2 
Cross currency swap contracts$0.8 $— $0.8 $— $— $0.8 
Derivative Liabilities      
Foreign currency contracts$39.3 $— $39.3 (6.1)$— $33.2 
Schedule of Effect of Derivative Instruments
The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated statements of operations and consolidated statements of comprehensive income:

 Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)Location of Gain or (Loss) Reclassified from Accumulated OCI into IncomeAmount of Gain or (Loss) Reclassified from Accumulated OCI into Income
 
 2021202020212020
(in millions)(in millions)
Cash flow hedges
Foreign currency contracts$56.7 $(33.7)Cost of sales$(23.0)$18.4 
Selling, general, and administrative expenses$(0.6)$2.2 
 Amount of Gain or (Loss)
Recognized in OCI
on Derivative
(Effective Portion)		Location of Gain or (Loss) Reclassified from Accumulated OCI into IncomeAmount of Gain or (Loss)
Recognized in Income on Derivative (Amount Excluded from
 Effectiveness Testing)
2021202020212020
(in millions) (in millions)
Net investment hedges
Cross currency swap contracts$18.4 $(12.6)Interest expense$6.4 $6.4 

The cross currency swap contracts have an expiration date of June 15, 2028. At maturity of the cross currency swap contracts, the Company will deliver the notional amount of €257.2 million and will receive $300.0 million from the counterparties. The Company will receive semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.
  Amount of Gain or
(Loss) Recognized in
Income on Derivative
 Location of Gain or
(Loss) Recognized in
Income on Derivative
 202120202019
 (in millions)
Fair value hedges
Foreign currency contractsOther income, net$11.6 $(1.4)$1.4 

  Amount of Gain or
(Loss) Recognized in
Income on Derivative
 Location of Gain or
(Loss) Recognized in
Income on Derivative
 202120202019
 (in millions)
Derivatives not designated as hedging instruments
Foreign currency contractsOther income, net$27.4 $(15.1)$0.3 
Schedule of the Effect of Fair Value and Cash Flow Hedge
The following table presents the effect of fair value and cash flow hedge accounting on the consolidated statements of operations:

Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
 Twelve Months Ended December 31, 2021
 Cost of salesSelling, general, and administrative expensesOther Income, net
Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded$(1,248.9)$(1,493.7)$12.7 
The effects of fair value and cash flow hedging:
Gain (loss) on fair value hedging relationships:
Foreign currency contracts:
Hedged items
— — (9.0)
Derivatives designated as hedging instruments
— — 9.0 
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach
— — 2.6 
Gain (loss) on cash flow hedging relationships:
Foreign currency contracts:
Amount of gain (loss) reclassified from accumulated OCI into income
(23.0)(0.6)— 
Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
 Twelve Months Ended December 31, 2020
 Cost of salesSelling, general, and administrative expensesOther Income, net
Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded$(1,080.6)$(1,228.4)$11.5 
The effects of fair value and cash flow hedging:
Gain (loss) on fair value hedging relationships:
Foreign currency contracts:
Hedged items
— — 4.8 
Derivatives designated as hedging instruments
— — (4.8)
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach
— — 3.4 
Gain (loss) on cash flow hedging relationships:
Foreign currency contracts:
Amount of gain (loss) reclassified from accumulated OCI into income
18.4 2.2 — 
XML 73 R39.htm IDEA: XBRL DOCUMENT v3.22.0.1
EMPLOYEE BENEFIT PLANS (Tables)
 12 Months Ended
Dec. 31, 2021
Retirement Benefits [Abstract]  
Schedule of Information Regarding Defined Benefit Pension Plans
 Years Ended December 31,
 20212020
(in millions)
Change in projected benefit obligation:  
Beginning of year$126.2 $105.2 
Service cost6.5 6.3 
Interest cost0.4 0.5 
Participant contributions1.5 1.5 
Actuarial loss(6.1)2.9 
Benefits paid(2.5)(0.6)
Plan amendment(0.5)— 
Currency exchange rate changes and other(7.6)10.4 
End of year$117.9 $126.2 
Change in fair value of plan assets:  
Beginning of year$73.3 $63.2 
Actual return on plan assets5.8 0.4 
Employer contributions3.1 2.8 
Participant contributions1.5 1.5 
Benefits paid(2.5)(0.6)
Currency exchange rate changes and other(4.3)6.0 
End of year$76.9 $73.3 
Funded Status  
Projected benefit obligation$(117.9)$(126.2)
Plan assets at fair value76.9 73.3 
Underfunded status$(41.0)$(52.9)
Net amounts recognized on the consolidated balance sheet:  
Other long-term liabilities$41.0 $52.9 
Accumulated other comprehensive loss, net of tax:  
Net actuarial loss$(16.4)$(30.8)
Net prior service cost6.0 6.6 
Deferred income tax benefit2.4 4.6 
Total$(8.0)$(19.6)
Schedule of Net Periodic Benefit Cost
The components of net periodic pension benefit cost are as follows (in millions):

 Years Ended December 31,
 202120202019
Service cost, net$6.5 $6.3 $5.2 
Interest cost0.4 0.5 0.9 
Expected return on plan assets(1.1)(1.0)(1.4)
Amortization of actuarial loss1.7 1.6 0.9 
Amortization of prior service credit (0.7)(0.7)(0.2)
Net periodic pension benefit cost$6.8 $6.7 $5.4 
Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations
The weighted-average assumptions used to determine the benefit obligations are as follows:
 December 31,
 20212020
Discount rate0.5 %0.3 %
Rate of compensation increase2.6 %2.6 %
Cash balance interest crediting rate2.5 %2.5 %
Social securities increase1.6 %1.6 %
Pension increase1.8 %1.8 %

The weighted-average assumptions used to determine the net periodic pension benefit cost are as follows:
 Years ended December 31,
 202120202019
Discount rate0.3 %0.5 %0.9 %
Expected return on plan assets1.5 %1.5 %2.3 %
Rate of compensation increase2.6 %2.7 %2.8 %
Cash balance interest crediting rate2.5 %1.5 %1.5 %
Social securities increase1.6 %1.6 %1.8 %
Pension increase1.8 %1.8 %1.8 %
Schedule of Target Weighted-Average Asset Allocations and Fair Value Target weighted-average asset allocations at December 31, 2021, by asset category, are as follows:
Equity securities28.3 %
Debt securities41.7 %
Real estate9.8 %
Other20.2 %
Total100.0 %

The fair values of the Company's defined benefit plan assets at December 31, 2021 and 2020, by asset category, are as follows (in millions):
December 31, 2021Level 1Level 2Level 3Total
Asset Category    
Cash$5.4 $— $— $5.4 
Equity securities:    
United States equities1.6 — — 1.6 
International equities16.3 — — 16.3 
Debt securities:    
United States government bonds6.2 — — 6.2 
International government bonds26.3 — — 26.3 
Real estate— 7.6 — 7.6 
Mortgages— 3.5 — 3.5 
Insurance contracts— — 0.9 0.9 
Total plan assets measured at fair value
$55.8 $11.1 $0.9 $67.8 
Alternative investments measured at net asset value (a)9.1 
Total plan assets
$76.9 
 
December 31, 2020Level 1Level 2Level 3Total
Asset Category
Cash$3.0 $— $— $3.0 
Equity securities:
United States equities3.3 — — 3.3 
International equities16.1 — — 16.1 
Debt securities:
United States government bonds7.4 — — 7.4 
International government bonds26.0 — — 26.0 
Real estate— 5.6 — 5.6 
Mortgages— 3.1 — 3.1 
Insurance contracts— — 1.0 1.0 
Total plan assets $55.8 $8.7 $1.0 $65.5 
Alternative investments measured at net asset value (a)7.8 
Total plan assets $73.3 
_______________________________________
(a)     Certain investments that were measured at net asset value per share have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the total plan assets.
Summary of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3
The following table summarizes the changes in fair value of the Company's defined benefit plan assets that have been classified as Level 3 for the years ended December 31, 2021 and 2020 (in millions):

 Insurance
Contracts
Balance at December 31, 2019$0.9 
Currency exchange rate impact0.1 
Balance at December 31, 20201.0 
Currency exchange rate impact(0.1)
Balance at December 31, 2021$0.9 
Schedule of Benefit Payments Which Reflect Expected Future Service
The following benefit payments, which reflect expected future service, as appropriate, at December 31, 2021, are expected to be paid (in millions):

2022$5.4 
20236.7 
20245.6 
20255.2 
20266.1 
2024-202636.1 
XML 74 R40.htm IDEA: XBRL DOCUMENT v3.22.0.1
COMMON STOCK (Tables)
 12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Schedule of Accelerated Share Repurchases The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):
  Initial DeliveryFinal Settlement
Agreement DateAmount
Paid		Shares
Received		Price per
Share (a)		Value of
Shares as %
of Contract
Value		Settlement
Date		Total Shares
Received		Average Price
per Share (a)
May 2019$150.0 0.7 $178.66 80 %May 20190.8 $178.42 
May 2019$100.0 0.5 $170.02 80 %June 20190.6 $178.46 
February 2021$250.0 2.4 $83.86 80 %March 20213.0 $84.51 
_______________________________________________________________________________
(a)    The three-for-one stock split distributed on May 29, 2020 excluded treasury shares. The shares and per share prices in the table are reflected at the pre-split amounts and prices at the time of the transaction.
Schedule of Weighted-Average Assumptions for Options Granted
The Black-Scholes option pricing model was used with the following weighted-average assumptions for options granted during the following periods:

Option Awards
202120202019
Average risk-free interest rate0.8 %0.3 %2.3 %
Expected dividend yieldNoneNoneNone
Expected volatility34 %33 %30 %
Expected life (years)5.05.05.1
Fair value, per share$28.90 $21.70 $18.17 
Schedule of Weighted-Average Assumptions for ESPP Subscriptions
The Black-Scholes option pricing model was used with the following weighted-average assumptions for ESPP subscriptions granted during the following periods:

ESPP
202120202019
Average risk-free interest rate0.1 %1.3 %2.4 %
Expected dividend yieldNoneNoneNone
Expected volatility37 %33 %27 %
Expected life (years)0.60.60.6
Fair value, per share$23.07 $16.61 $16.43 
Schedule of Stock Option Activity
Stock option activity during the year ended December 31, 2021 under the Program and the Nonemployee Directors Program was as follows (in millions, except years and per-share amounts):

 SharesWeighted-
Average
Exercise
Price		Weighted-
Average
Remaining
Contractual
Term		Aggregate
Intrinsic Value
Outstanding as of December 31, 2020
14.3 $41.27   
Options granted1.6 94.04   
Options exercised(3.4)23.84   
Options forfeited(0.2)67.89   
Outstanding as of December 31, 2021
12.3 52.84 3.5 years$943.1 
Exercisable as of December 31, 2021
8.2 41.84 2.6 years$719.7 
Vested and expected to vest as of December 31, 2021
11.7 51.74 3.4 years$911.4 
Schedule of Restricted Stock Unit Activity
The following table summarizes nonvested restricted stock unit activity during the year ended December 31, 2021 under the Program and the Nonemployee Directors Program (in millions, except per-share amounts):

 SharesWeighted-
Average
Grant-Date
Fair Value
Nonvested as of December 31, 2020
2.6 $57.59 
Granted (a)0.8 92.95 
Vested(1.0)48.82 
Forfeited(0.1)66.54 
Nonvested as of December 31, 2021
2.3 73.94 
_______________________________________________________________________________
(a)    The shares granted include 0.1 million shares of market-based restricted stock units granted during 2021, which represents the target number of shares to be issued, and 0.1 million shares related to a previous year's grant of market-based restricted stock units since the payout percentage achieved at the end of the performance period was in excess of target. As described above, the actual number of shares ultimately issued is determined based on the Company's total stockholder return relative to a selected industry peer group.
XML 75 R41.htm IDEA: XBRL DOCUMENT v3.22.0.1
ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)
 12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss
Presented below is a summary of activity for each component of "Accumulated Other Comprehensive Loss" for the years ended December 31, 2021, 2020, and 2019.

 Foreign
Currency
Translation
Adjustments		Unrealized Gain (Loss) on HedgesUnrealized (Loss) Gain on
Available-for-sale
Investments		Unrealized
Pension
Costs (a)		Total
Accumulated
Other
Comprehensive
Loss
 (in millions)
December 31, 2018$(143.6)$23.6 $(5.0)$(13.5)$(138.5)
Other comprehensive (loss) income before reclassifications(1.5)27.9 7.9 (3.2)31.1 
Amounts reclassified from accumulated other comprehensive loss(6.6)(44.2)0.4 0.7 (49.7)
Deferred income tax (expense) benefit(3.1)5.2 (1.6)0.6 1.1 
December 31, 2019(154.8)12.5 1.7 (15.4)(156.0)
Other comprehensive income (loss) before reclassifications35.7 (34.8)8.0 (5.5)3.4 
Amounts reclassified from accumulated other comprehensive loss(6.4)(19.2)0.3 0.9 (24.4)
Deferred income tax benefit (expense)3.1 13.8 (1.4)0.4 15.9 
December 31, 2020(122.4)(27.7)8.6 (19.6)(161.1)
Other comprehensive (loss) income before reclassifications(39.2)66.3 (29.2)12.8 10.7 
Amounts reclassified from accumulated other comprehensive loss(6.4)12.0 8.6 1.0 15.2 
Deferred income tax (expense) benefit(4.5)(20.9)5.1 (2.2)(22.5)
December 31, 2021$(172.5)$29.7 $(6.9)$(8.0)$(157.7)
Schedule of Change in Unrealized Pension Costs For the years ended December 31, 2021, 2020, and 2019, the change in unrealized pension costs consisted of the following (in millions):
 Pre-Tax
Amount		Tax (Expense) BenefitNet of Tax
Amount
2021   
Prior service credit arising during period$0.1 $— $0.1 
Amortization of prior service credit(0.7)0.1 (0.6)
Net prior service cost arising during period(0.6)0.1 (0.5)
Net actuarial loss arising during period14.4 (2.3)12.1 
Unrealized pension costs, net$13.8 $(2.2)$11.6 
2020   
Prior service credit arising during period$0.6 $(0.2)$0.4 
Amortization of prior service credit(0.7)0.1 (0.6)
Net prior service cost arising during period(0.1)(0.1)(0.2)
Net actuarial loss arising during period(4.5)0.5 (4.0)
Unrealized pension costs, net$(4.6)$0.4 $(4.2)
2019   
Prior service credit arising during period$4.6 $(0.6)$4.0 
Amortization of prior service credit(0.2)0.1 (0.1)
Net prior service credit arising during period4.4 (0.5)3.9 
Net actuarial loss arising during period(6.9)1.1 (5.8)
Unrealized pension costs, net$(2.5)$0.6 $(1.9)
Schedule of Information About Amounts Reclassified from Accumulated Other Comprehensive Loss
The following table provides information about amounts reclassified from "Accumulated Other Comprehensive Loss" (in millions):
 Years Ended December 31, 
Details about Accumulated Other Comprehensive Loss
Components		20212020Affected Line on Consolidated
Statements of Operations
Foreign currency translation adjustments$6.4 $6.4 Other income, net
(1.6)(1.6)Provision for income taxes
$4.8 $4.8 Net of tax
Gain (loss) on hedges$(23.0)$18.4 Cost of sales
(0.6)2.2 Selling, general, and administrative expenses
11.6 (1.4)Other income, net
(12.0)19.2 Total before tax
4.6 (5.0)Provision for income taxes
$(7.4)$14.2 Net of tax
(Loss) gain on available-for-sale investments$(8.6)$(0.3)Other income, net
2.1 (0.6)Provision for income taxes
$(6.5)$(0.9)Net of tax
Amortization of pension adjustments$(1.0)$(0.9)Other income, net
0.1 0.2 Provision for income taxes
$(0.9)$(0.7)Net of tax
XML 76 R42.htm IDEA: XBRL DOCUMENT v3.22.0.1
OTHER INCOME, NET (Tables)
 12 Months Ended
Dec. 31, 2021
Other Income and Expenses [Abstract]  
Schedule of Other Expense, Net
 Years Ended December 31,
 202120202019
(in millions)
Foreign exchange gains, net$(5.0)$(12.3)$(5.9)
Gain on investments(5.8)(0.6)(0.5)
Non-service cost components of net periodic pension benefit cost0.3 0.4 0.2 
Other(2.2)1.0 (2.0)
Total other income, net$(12.7)$(11.5)$(8.2)
XML 77 R43.htm IDEA: XBRL DOCUMENT v3.22.0.1
INCOME TAXES (Tables)
 12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Schedule of Income Before Provisions for Income Taxes
The Company's income before provision for income taxes was generated from operations in the United States and outside of the United States as follows (in millions):
 Years Ended December 31,
 202120202019
United States$610.9 $151.3 $383.4 
Outside of the United States, including Puerto Rico1,091.1 765.4 783.1 
$1,702.0 $916.7 $1,166.5 
Schedule of Provision for Income Taxes
The provision for income taxes consists of the following (in millions):
 Years Ended December 31,
 202120202019
Current   
United States:   
Federal$125.2 $23.4 $31.3 
State and local25.1 48.2 48.7 
Outside of the United States, including Puerto Rico92.6 73.9 29.1 
Current income tax expense$242.9 $145.5 $109.1 
Deferred   
United States:   
Federal$(9.4)$11.0 $28.3 
State and local(25.4)(32.9)(18.3)
Outside of the United States, including Puerto Rico(9.2)(30.3)0.5 
Deferred income tax (benefit) expense(44.0)(52.2)10.5 
Total income tax provision$198.9 $93.3 $119.6 
Schedule of Deferred Tax Assets and Liabilities
The components of deferred tax assets and liabilities are as follows (in millions):
 December 31,
 20212020
Deferred tax assets  
Compensation and benefits$109.8 $88.6 
Benefits from uncertain tax positions33.9 27.0 
Net tax credit carryforwards142.0 125.5 
Net operating loss carryforwards69.4 64.1 
Accrued liabilities108.0 105.0 
Inventories13.5 16.3 
Cash flow and net investment hedges— 3.3 
State income taxes0.4 0.5 
Investments0.7 1.8 
Lease liability obligations6.6 7.7 
Other1.3 3.6 
Total deferred tax assets485.6 443.4 
Deferred tax liabilities  
Property, plant, and equipment(64.1)(53.4)
Cash flow and net investment hedges(6.4)— 
Deferred tax on foreign earnings(26.3)(29.2)
Right-of-use assets (6.1)(7.0)
Other intangible assets(75.5)(76.3)
Other(2.6)(3.1)
Total deferred tax liabilities(181.0)(169.0)
Valuation allowance(82.5)(71.6)
Net deferred tax assets$222.1 $202.8 
Schedule of Net Operating Loss Carryforwards
Net operating loss and capital loss carryforwards and the related carryforward periods at December 31, 2021 are summarized as follows (in millions):
 Carryforward
Amount		Tax Benefit
Amount		Valuation
Allowance		Net Tax
Benefit		Carryforward
Period Ends
United States federal net operating losses$17.6 $3.7 $— $3.7 2030-2037
United States federal net operating losses11.3 2.4 — 2.4 Indefinite
United States state net operating losses33.5 1.6 (1.6)— 2026-2039
United States state net operating losses1.0 0.1 (0.1)— Indefinite
Non-United States net operating losses5.8 1.5 (1.2)0.3 2022-2028
Non-United States net operating losses353.3 60.1 (50.8)9.3 Indefinite
United States capital losses34.1 0.2 (0.2)— 2024
Total$456.6 $69.6 $(53.9)$15.7  
Schedule of Tax Credit Carryforwards
The gross tax credit carryforwards and the related carryforward periods at December 31, 2021 are summarized as follows (in millions):
 Carryforward
Amount		Valuation
Allowance		Net Tax
Benefit		Carryforward
Period Ends
California research expenditure tax credits$167.0 $— $167.0 Indefinite
Federal research expenditure tax credits1.5 — 1.5 2026-2039
Foreign tax credits2.9 (2.9)— 2030-2031
Puerto Rico purchases credit23.4 (23.4)— Indefinite
Total$194.8 $(26.3)$168.5  
Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate
A reconciliation of the United States federal statutory income tax rate to the Company's effective income tax rate is as follows (in millions):
 Years Ended December 31,
 202120202019
Income tax expense at United States federal statutory rate$357.4 $192.5 $245.0 
Foreign income taxed at different rates(122.2)(80.5)(75.0)
State and local taxes, net of federal tax benefit11.9 5.0 11.9 
Tax credits, federal and state(48.4)(43.1)(42.9)
Build of reserve for prior years' uncertain tax positions3.6 4.2 5.0 
Tax on global intangible low-taxed income56.5 49.2 32.0 
Foreign-derived intangible income deduction(1.3)(2.6)(7.2)
Contingent consideration liabilities(26.1)2.9 (1.3)
United States federal deductible employee share-based compensation(47.8)(48.3)(57.6)
Nondeductible employee share-based compensation5.3 4.2 3.2 
Other10.0 9.8 6.5 
Income tax provision$198.9 $93.3 $119.6 
Reconciliation of Beginning and Ending Amount of Uncertain Tax Positions
A reconciliation of the beginning and ending amount of uncertain tax positions, excluding interest, penalties, and foreign exchange, is as follows (in millions):
 December 31,
 202120202019
Uncertain gross tax positions, January 1$281.8 $203.1 $150.7 
Current year tax positions
82.1 86.4 55.4 
Increase in prior year tax positions
2.3 6.0 0.8 
Decrease in prior year tax positions
(4.8)(10.0)(3.8)
Settlements
(0.3)(3.7)— 
Lapse of statutes of limitations
(2.7)— — 
Uncertain gross tax positions, December 31$358.4 $281.8 $203.1 
XML 78 R44.htm IDEA: XBRL DOCUMENT v3.22.0.1
SEGMENT INFORMATION (Tables)
 12 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
Schedule of Information About Reportable Segments and Reconciliation of Segment Net Sales and Pre-Tax Income
The table below presents information about Edwards Lifesciences' reportable segments (in millions):
 Years Ended December 31,
 202120202019
Segment Net Sales   
United States$2,963.1 $2,516.8 $2,532.7 
Europe1,099.6 945.2 926.1 
Japan528.0 448.6 441.4 
Rest of World533.2 451.5 433.3 
Total segment net sales$5,123.9 $4,362.1 $4,333.5 
Segment Operating Income  
United States$2,051.0 $1,727.3 $1,742.3 
Europe569.1 479.3 472.0 
Japan348.0 286.4 272.3 
Rest of World185.2 150.1 127.9 
Total segment operating income$3,153.3 $2,643.1 $2,614.5 

The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):
 Years Ended December 31,
 202120202019
Net Sales Reconciliation   
Segment net sales$5,123.9 $4,362.1 $4,333.5 
Foreign currency108.6 24.2 14.5 
Consolidated net sales$5,232.5 $4,386.3 $4,348.0 
Pre-tax Income Reconciliation  
Segment operating income$3,153.3 $2,643.1 $2,614.5 
Unallocated amounts:
Corporate items(1,613.8)(1,358.0)(1,439.7)
Special charges— — (64.6)
Intellectual property litigation expenses, net(20.6)(405.4)(33.4)
Change in fair value of contingent consideration liabilities, net124.1 (13.6)6.1 
Foreign currency47.3 31.5 63.9 
Consolidated operating income1,690.3 897.6 1,146.8 
Non-operating income11.7 19.1 19.7 
Consolidated pre-tax income$1,702.0 $916.7 $1,166.5 
Schedule of Enterprise-Wide Information
Enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated financial statements.

 As of or for the Years Ended December 31,
 202120202019
Net Sales by Geographic Area   
United States$2,963.1 $2,516.8 $2,532.7 
Europe1,190.3 973.6 941.2 
Japan528.9 460.1 444.7 
Rest of World550.2 435.8 429.4 
$5,232.5 $4,386.3 $4,348.0 
Net Sales by Major Product Area  
Transcatheter Aortic Valve Replacement$3,422.5 $2,857.3 $2,737.9 
Transcatheter Mitral and Tricuspid Therapies86.0 41.8 28.2 
Surgical Structural Heart889.1 761.8 841.7 
Critical Care834.9 725.4 740.2 
$5,232.5 $4,386.3 $4,348.0 
Long-lived Tangible Assets by Geographic Area   
United States$1,195.8 $1,084.3 $849.1 
Europe197.9192.7101.5
Japan19.720.421.7
Rest of World335.5311.0269.4
$1,748.9 $1,608.4 $1,241.7 
XML 79 R45.htm IDEA: XBRL DOCUMENT v3.22.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock Split (Narrative) (Details)
May 29, 2020
May 07, 2020
shares
Accounting Policies [Abstract]    
Stock split, conversion ratio 3 3
Number of newly issued shares of common stock per holder   2
XML 80 R46.htm IDEA: XBRL DOCUMENT v3.22.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue (Narrative) (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Deferred revenue $ 10.2 $ 6.3
Revenue recognized that was previously deferred excluding opening balance $ 7.3  
Revenue recognized that was previously deferred   $ 6.3
Hemodynamic Monitors | Minimum    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Revenue, remaining performance obligation, expected timing of satisfaction, period (in years) 12 months  
Hemodynamic Monitors | Maximum    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Revenue, remaining performance obligation, expected timing of satisfaction, period (in years) 36 months  
XML 81 R47.htm IDEA: XBRL DOCUMENT v3.22.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Shipping and Handling Costs (Narrative) (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Product Information [Line Items]      
Cost of sales $ 1,248.9 $ 1,080.6 $ 1,114.4
Shipping and Handling      
Product Information [Line Items]      
Cost of sales $ 85.3 $ 74.0 $ 71.5
XML 82 R48.htm IDEA: XBRL DOCUMENT v3.22.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investments (Narrative) (Details)
Dec. 31, 2021
Minimum  
Schedule of Equity Method Investments [Line Items]  
Equity method investment, ownership percentage (as a percent) 5.00%
XML 83 R49.htm IDEA: XBRL DOCUMENT v3.22.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts Receivable (Details)
 12 Months Ended
Dec. 31, 2021
Minimum  
Accounts, Notes, Loans and Financing Receivable [Line Items]  
Accounts receivable, required payment terms (in days) 30 days
Maximum  
Accounts, Notes, Loans and Financing Receivable [Line Items]  
Accounts receivable, required payment terms (in days) 90 days
XML 84 R50.htm IDEA: XBRL DOCUMENT v3.22.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventories (Narrative) (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Accounting Policies [Abstract]      
Period prior to expiration date which triggers write-down of inventory (in months) 6 months    
Period used to evaluate slow-moving inventory levels (in years) 2 years    
General and administrative costs allocated to inventory $ 77.9 $ 63.1 $ 56.6
General and administrative costs included in inventory 33.7 30.7  
Finished goods inventories held on consignment 125.8 130.0  
Inventory write off (Note 2) $ 0.0 $ 0.0 $ 73.1
XML 85 R51.htm IDEA: XBRL DOCUMENT v3.22.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property, Plant, and Equipment (Narrative) (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Property, Plant and Equipment [Line Items]      
Depreciation expense for property, plant and equipment $ 127.0 $ 101.8 $ 84.7
Buildings and improvements | Minimum      
Property, Plant and Equipment [Line Items]      
Estimated useful life (in years) 10 years    
Buildings and improvements | Maximum      
Property, Plant and Equipment [Line Items]      
Estimated useful life (in years) 40 years    
Machinery and equipment | Minimum      
Property, Plant and Equipment [Line Items]      
Estimated useful life (in years) 3 years    
Machinery and equipment | Maximum      
Property, Plant and Equipment [Line Items]      
Estimated useful life (in years) 15 years    
Software | Minimum      
Property, Plant and Equipment [Line Items]      
Estimated useful life (in years) 3 years    
Software | Maximum      
Property, Plant and Equipment [Line Items]      
Estimated useful life (in years) 5 years    
XML 86 R52.htm IDEA: XBRL DOCUMENT v3.22.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Intangible Assets (Narrative) (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
In-process research and development      
Indefinite-lived Intangible Assets [Line Items]      
Impairment of intangible assets $ 0 $ 0 $ 40,600,000
XML 87 R53.htm IDEA: XBRL DOCUMENT v3.22.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Basic:      
Net income $ 1,503.1 $ 823.4 $ 1,046.9
Weighted-average shares outstanding (in shares) 623.3 622.6 624.8
Basic earnings per share (in dollars per share) $ 2.41 $ 1.32 $ 1.68
Diluted:      
Net income $ 1,503.1 $ 823.4 $ 1,046.9
Weighted-average shares outstanding (in shares) 623.3 622.6 624.8
Dilutive effect of stock plans (in shares) 7.9 9.3 11.9
Dilutive weighted-average shares outstanding (in shares) 631.2 631.9 636.7
Diluted earnings per share (in dollars per share) $ 2.38 $ 1.30 $ 1.64
XML 88 R54.htm IDEA: XBRL DOCUMENT v3.22.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per Share (Narrative) (Details) - shares
shares in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Stock compensation plan      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Anti-dilutive securities excluded from the computation of earnings per share (in shares) 1.8 2.0 1.5
XML 89 R55.htm IDEA: XBRL DOCUMENT v3.22.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Stock-Based Compensation Expense (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Allocation of stock-based compensation expense      
Total stock-based compensation expense $ 109.3 $ 92.6 $ 81.3
Income tax benefit (18.9) (15.4) (14.8)
Total stock-based compensation expense, net of tax 90.4 77.2 66.5
Cost of sales      
Allocation of stock-based compensation expense      
Total stock-based compensation expense 20.4 17.2 14.7
Selling, general, and administrative expenses      
Allocation of stock-based compensation expense      
Total stock-based compensation expense 65.6 56.6 51.2
Research and development expenses      
Allocation of stock-based compensation expense      
Total stock-based compensation expense $ 23.3 $ 18.8 $ 15.4
XML 90 R56.htm IDEA: XBRL DOCUMENT v3.22.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock-based Compensation (Narrative) (Details)
 12 Months Ended
Dec. 31, 2021
Restricted stock units  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Percentage vesting upon retirement for each full year of employment subsequent to the grant date (as a percent) 25.00%
XML 91 R57.htm IDEA: XBRL DOCUMENT v3.22.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivatives (Narrative) (Details)
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Period when cash flows associated with future transactions and certain local currency expenses are expected to occur (in months) 13 months
XML 92 R58.htm IDEA: XBRL DOCUMENT v3.22.0.1
INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET (Details) - USD ($)
$ in Millions
 1 Months Ended 12 Months Ended
May 31, 2024
Jul. 31, 2020
Jun. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Loss Contingencies [Line Items]            
Intellectual property litigation expenses       $ 20.6 $ 405.4 $ 33.4
Abbott Laboratories            
Loss Contingencies [Line Items]            
Intellectual property litigation expenses     $ 367.9      
Payments for legal settlements   $ 100.0        
Abbott Laboratories | Forecast            
Loss Contingencies [Line Items]            
Royalty expense $ 100.0          
XML 93 R59.htm IDEA: XBRL DOCUMENT v3.22.0.1
SPECIAL CHARGES - Impairment of Long-lived Assets (Details)
$ in Millions
 1 Months Ended
Dec. 31, 2019
USD ($)
Rest of World | Developed technology | Valtech  
Indefinite-lived Intangible Assets [Line Items]  
Impairment of intangible assets $ 40.6
XML 94 R60.htm IDEA: XBRL DOCUMENT v3.22.0.1
SPECIAL CHARGES - Acquisition of Intellectual Property (Details)
$ in Millions
Mar. 31, 2019
USD ($)
Early-stage Transcatheter Intellectual Property  
Business Acquisition [Line Items]  
Acquisition transaction costs $ 24.0
XML 95 R61.htm IDEA: XBRL DOCUMENT v3.22.0.1
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Inventories    
Raw materials $ 132.8 $ 136.7
Work in process 164.3 140.0
Finished products 429.6 525.6
Total inventories 726.7 802.3
Property, plant, and equipment, net    
Land 116.5 97.6
Buildings and leasehold improvements 1,010.1 881.5
Machinery and equipment 613.4 564.9
Equipment with customers 39.2 42.2
Software 88.2 94.2
Construction in progress 333.8 313.3
Total property, plant and equipment, gross 2,201.2 1,993.7
Accumulated depreciation (654.6) (598.5)
Total property, plant and equipment, net 1,546.6 1,395.2
Accrued and other liabilities    
Employee compensation and withholdings 319.7 236.7
Accrued rebates 77.0 67.2
Property, payroll, and other taxes 68.9 49.7
Research and development accruals 58.2 52.3
Legal and insurance (Notes 3 and 18) 79.1 60.8
Taxes payable 30.6 18.6
Fair value of derivatives 3.9 39.3
Accrued marketing expenses 20.1 14.3
Accrued professional services 11.9 7.6
Accrued realignment reserves 19.1 14.5
Accrued relocation costs 26.2 21.0
Other accrued liabilities 87.6 88.2
Total accrued and other liabilities $ 802.3 $ 670.2
XML 96 R62.htm IDEA: XBRL DOCUMENT v3.22.0.1
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Supplemental Cash Flow Information (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash paid during the year for:      
Interest $ 20.2 $ 19.9 $ 19.9
Income taxes 182.5 197.9 61.5
Amounts included in the measurement of lease liabilities:      
Operating cash flows from operating leases 31.9 29.7 28.6
Non-cash investing and financing transactions:      
Right-of-use assets obtained in exchange for new lease liabilities 28.7 39.7 49.6
Capital expenditures accruals 54.3 80.4 50.8
Conversion of notes receivable to equity investment $ 21.5 $ 4.5 $ 0.0
XML 97 R63.htm IDEA: XBRL DOCUMENT v3.22.0.1
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Cash, Cash Equivalents, and Restricted Cash (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
Cash and cash equivalents $ 862.8 $ 1,183.2 $ 1,179.1  
Restricted cash included in other current assets 1.5 16.6 1.6  
Restricted cash included in other assets 3.1 0.4 3.7  
Total cash, cash equivalents, and restricted cash $ 867.4 $ 1,200.2 $ 1,184.4 $ 715.9
XML 98 R64.htm IDEA: XBRL DOCUMENT v3.22.0.1
LEASES - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Lessee, Lease, Description [Line Items]      
Operating lease cost $ 29.7 $ 30.5 $ 27.9
Lease commitments for leases not yet commenced $ 2.5    
Minimum      
Lessee, Lease, Description [Line Items]      
Lease term (in years) 1 year    
Maximum      
Lessee, Lease, Description [Line Items]      
Lease term (in years) 19 years    
XML 99 R65.htm IDEA: XBRL DOCUMENT v3.22.0.1
LEASES - Assets and Liabilities of Operating Leases (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Leases [Abstract]    
Operating lease right-of-use assets $ 92.1 $ 94.2
Operating lease liabilities, current portion 25.5 27.2
Operating lease liabilities, long-term portion 69.1 72.7
Total operating lease liabilities $ 94.6 $ 99.9
XML 100 R66.htm IDEA: XBRL DOCUMENT v3.22.0.1
LEASES - Maturities Of Operating Lease Liabilities (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Leases [Abstract]    
2022 $ 27.5  
2023 23.0  
2024 13.6  
2025 8.3  
2026 7.5  
Thereafter 24.6  
Total lease payments 104.5  
Less: imputed interest (9.9)  
Total lease liabilities $ 94.6 $ 99.9
Weighted-average remaining lease term (in years) 6 years 2 months 12 days 6 years 7 months 6 days
Weighted-average discount rate (in years) 2.50% 2.70%
XML 101 R67.htm IDEA: XBRL DOCUMENT v3.22.0.1
INVESTMENTS - Schedule of Investments in Debt Securities (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Held-to-maturity    
Amortized Cost $ 162.0  
Fair Value 162.0  
Available-for-sale    
Amortized Cost 2,192.7 $ 924.3
Gross Unrealized Gains 2.9 11.6
Gross Unrealized Losses (11.9) 0.0
Fair Value 2,183.7 935.9
Bank time deposits    
Held-to-maturity    
Amortized Cost 162.0 50.0
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses 0.0 0.0
Fair Value 162.0 50.0
Available-for-sale    
Amortized Cost 2.5 24.1
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses 0.0 0.0
Fair Value 2.5 24.1
Commercial paper    
Available-for-sale    
Amortized Cost 127.7 0.0
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses 0.0 0.0
Fair Value 127.7 0.0
United States government and agency securities    
Available-for-sale    
Amortized Cost 147.4 147.0
Gross Unrealized Gains 0.6 2.2
Gross Unrealized Losses (0.7) 0.0
Fair Value 147.3 149.2
Asset-backed securities    
Available-for-sale    
Amortized Cost 515.2 149.6
Gross Unrealized Gains 0.3 1.9
Gross Unrealized Losses (2.9) 0.0
Fair Value 512.6 151.5
Corporate debt securities    
Available-for-sale    
Amortized Cost 1,397.1 600.8
Gross Unrealized Gains 2.0 7.5
Gross Unrealized Losses (8.3) 0.0
Fair Value 1,390.8 608.3
Municipal securities    
Available-for-sale    
Amortized Cost 2.8 2.8
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses 0.0 0.0
Fair Value $ 2.8 $ 2.8
XML 102 R68.htm IDEA: XBRL DOCUMENT v3.22.0.1
INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Amortized Cost    
Due in 1 year or less $ 162.0  
Due after 1 year through 5 years 0.0  
Due after 5 years through 10 years 0.0  
Instruments not due at a single maturity date (a) 0.0  
Amortized Cost 162.0  
Fair Value    
Due in 1 year or less 162.0  
Due after 1 year through 5 years 0.0  
Due after 5 years through 10 years 0.0  
Instruments not due at a single maturity date (a) 0.0  
Fair Value 162.0  
Amortized Cost    
Due in 1 year or less 441.3  
Due after 1 year through 5 years 1,196.7  
Due after 5 years through 10 years 8.7  
Instruments not due at a single maturity date (a) 546.0  
Amortized Cost 2,192.7 $ 924.3
Fair Value    
Due in 1 year or less 442.0  
Due after 1 year through 5 years 1,189.6  
Due after 5 years through 10 years 8.6  
Instruments not due at a single maturity date (a) 543.5  
Fair Value $ 2,183.7 $ 935.9
XML 103 R69.htm IDEA: XBRL DOCUMENT v3.22.0.1
INVESTMENTS - Schedule of Unrealized Losses on Debt Securities (Details)
$ in Millions
Dec. 31, 2021
USD ($)
Debt Securities, Available-for-sale [Line Items]  
Fair value, less than 12 months $ 1,632.5
Gross unrealized losses, less than 12 months (11.9)
Fair value, 12 months or greater 0.0
Gross unrealized losses, 12 months or greater 0.0
Total fair value 1,632.5
Total gross unrealized losses (11.9)
United States government and agency securities  
Debt Securities, Available-for-sale [Line Items]  
Fair value, less than 12 months 85.1
Gross unrealized losses, less than 12 months (0.7)
Fair value, 12 months or greater 0.0
Gross unrealized losses, 12 months or greater 0.0
Total fair value 85.1
Total gross unrealized losses (0.7)
Asset-backed securities  
Debt Securities, Available-for-sale [Line Items]  
Fair value, less than 12 months 433.3
Gross unrealized losses, less than 12 months (2.9)
Fair value, 12 months or greater 0.0
Gross unrealized losses, 12 months or greater 0.0
Total fair value 433.3
Total gross unrealized losses (2.9)
Corporate debt securities  
Debt Securities, Available-for-sale [Line Items]  
Fair value, less than 12 months 1,114.1
Gross unrealized losses, less than 12 months (8.3)
Fair value, 12 months or greater 0.0
Gross unrealized losses, 12 months or greater 0.0
Total fair value 1,114.1
Total gross unrealized losses $ (8.3)
XML 104 R70.htm IDEA: XBRL DOCUMENT v3.22.0.1
INVESTMENTS - Narrative (Details)
 3 Months Ended 12 Months Ended
Dec. 31, 2021
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
investment
Apr. 30, 2021
USD ($)
Investments, Debt and Equity Securities [Abstract]        
Number of investments in an unrealized loss position | investment     0  
Debt and Equity Securities, FV-NI [Line Items]        
Upward price adjustments   $ 4,200,000 $ 1,800,000  
Impairment of equity securities     (700,000)  
Investment $ 84,100,000 84,100,000 $ 29,400,000  
Kardion, Inc.        
Debt and Equity Securities, FV-NI [Line Items]        
Investment       $ 35,900,000
Investment option to acquire       5,700,000
Maximum additional option to acquire investment       21,800,000
Investment after first milestone 10,800,000      
Maximum secured promissory note       45,000,000
Secured promissory note 0 0    
Kardion, Inc. | Equity Securities        
Debt and Equity Securities, FV-NI [Line Items]        
Maximum additional required investment       $ 9,900,000
Other income, net        
Debt and Equity Securities, FV-NI [Line Items]        
Increase in non-marketable equity securities due to observable price changes 8,000,000 8,000,000    
Decrease in non-marketable equity securities due to observable price changes $ 2,600,000 $ 2,600,000    
XML 105 R71.htm IDEA: XBRL DOCUMENT v3.22.0.1
INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Equity method investments    
Carrying value of equity method investments $ 8.4 $ 5.7
Equity securities    
Carrying value of non-marketable equity securities 84.1 29.4
Total investments in unconsolidated entities $ 92.5 $ 35.1
XML 106 R72.htm IDEA: XBRL DOCUMENT v3.22.0.1
ACQUISITIONS - Narratives (Details) - USD ($)
$ / shares in Units, $ in Millions
Apr. 18, 2019
Feb. 11, 2019
Dec. 01, 2017
Jul. 03, 2015
CAS Medical Systems, Inc.        
Business Acquisition [Line Items]        
Consideration per share to be transferred (in dollars per share)   $ 2.45    
Acquisition price, subject uncertain adjustments   $ 100.0    
Cash purchase price $ 100.2      
Harpoon Medical        
Business Acquisition [Line Items]        
Additional research and development expenditures to be incurred prior to product introduction     $ 41.4  
CardiAQ        
Business Acquisition [Line Items]        
Additional research and development expenditures to be incurred prior to product introduction       $ 97.7
XML 107 R73.htm IDEA: XBRL DOCUMENT v3.22.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in the Carrying Amount of Goodwill, by Segment (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Goodwill    
Beginning balance $ 1,173.2 $ 1,167.7
Currency translation adjustment (5.3) 5.5
Ending balance 1,167.9 1,173.2
United States    
Goodwill    
Beginning balance 773.7 773.7
Currency translation adjustment 0.0 0.0
Ending balance 773.7 773.7
Europe    
Goodwill    
Beginning balance 68.3 62.8
Currency translation adjustment (5.3) 5.5
Ending balance 63.0 68.3
Rest of World    
Goodwill    
Beginning balance 331.2 331.2
Currency translation adjustment 0.0 0.0
Ending balance $ 331.2 $ 331.2
XML 108 R74.htm IDEA: XBRL DOCUMENT v3.22.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Finite-lived intangible assets    
Weighted-Average Useful Life (in years) 12 years 7 months 6 days  
Cost $ 352.0 $ 353.9
Accumulated Amortization (246.5) (240.6)
Net Carrying Value 105.5 113.3
Indefinite-lived intangible assets    
Cost 570.1 572.0
Net Carrying Value 323.6 331.4
In-process research and development    
Indefinite-lived intangible assets    
In-process research and development $ 218.1 218.1
Patents    
Finite-lived intangible assets    
Weighted-Average Useful Life (in years) 7 years 4 months 24 days  
Cost $ 185.7 186.1
Accumulated Amortization (184.2) (183.6)
Net Carrying Value $ 1.5 2.5
Developed technology    
Finite-lived intangible assets    
Weighted-Average Useful Life (in years) 13 years 1 month 6 days  
Cost $ 153.9 155.2
Accumulated Amortization (55.5) (51.0)
Net Carrying Value $ 98.4 104.2
Other    
Finite-lived intangible assets    
Weighted-Average Useful Life (in years) 10 years  
Cost $ 12.4 12.6
Accumulated Amortization (6.8) (6.0)
Net Carrying Value $ 5.6 $ 6.6
XML 109 R75.htm IDEA: XBRL DOCUMENT v3.22.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]      
Amortization expense related to other intangible assets $ 7.7 $ 5.4 $ 4.6
XML 110 R76.htm IDEA: XBRL DOCUMENT v3.22.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Estimated Amortization Expense (Details)
$ in Millions
Dec. 31, 2021
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
2022 $ 6.8
2023 8.4
2024 8.4
2025 10.2
2026 $ 15.9
XML 111 R77.htm IDEA: XBRL DOCUMENT v3.22.0.1
DEBT AND CREDIT FACILITIES - Narrative (Details) - USD ($)
 1 Months Ended 12 Months Ended
Jun. 30, 2018
Apr. 30, 2018
Dec. 31, 2021
Dec. 31, 2020
Debt Instrument [Line Items]        
Weighted-average interest rate under all debt obligations (as a percent)     3.40% 3.50%
Senior Notes | Fixed-rate 4.300% 2018 Notes        
Debt Instrument [Line Items]        
Fixed-rate unsecured senior notes $ 600,000,000      
2013 Notes        
Debt Instrument [Line Items]        
Price equal to principal amount, plus accrued and unpaid interest (as a percent) 101.00%      
2013 Notes | Level 2        
Debt Instrument [Line Items]        
Fair value of the notes, based on Level 2 inputs     $ 675,400,000 $ 711,200,000
Credit Facility | Credit agreement, maturity July 2019        
Debt Instrument [Line Items]        
Term of the credit agreement (in years)   5 years    
Credit Facility | Credit Agreement Maturity April 2023        
Debt Instrument [Line Items]        
Aggregate borrowings in multiple currencies   $ 750,000,000    
Facility fee (as a percent)     0.10%  
Issuance costs     $ 2,400,000  
Borrowings outstanding     $ 0 $ 0
Credit Facility | Credit Agreement Maturity April 2023 | LIBOR        
Debt Instrument [Line Items]        
Basis spread on variable rate (as a percent)     0.90%  
Credit Facility | Credit Agreement Maturity April 2023 | High        
Debt Instrument [Line Items]        
Additional amount available, subject to lender approval   $ 250,000,000    
Facility fee (as a percent)   0.20%    
Credit Facility | Credit Agreement Maturity April 2023 | High | LIBOR        
Debt Instrument [Line Items]        
Basis spread on variable rate (as a percent)   1.30%    
Credit Facility | Credit Agreement Maturity April 2023 | Low        
Debt Instrument [Line Items]        
Facility fee (as a percent)   0.10%    
Credit Facility | Credit Agreement Maturity April 2023 | Low | LIBOR        
Debt Instrument [Line Items]        
Basis spread on variable rate (as a percent)   0.90%    
XML 112 R78.htm IDEA: XBRL DOCUMENT v3.22.0.1
DEBT AND CREDIT FACILITIES - Summary of the Notes (Details) - Senior Notes - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Debt Instrument [Line Items]    
Unamortized discount $ (1.0) $ (1.1)
Unamortized debt issuance costs (3.3) (3.9)
Total carrying amount $ 595.7 595.0
Fixed-rate 4.300% 2018 Notes    
Debt Instrument [Line Items]    
Fixed interest rate 4.30%  
Amount $ 600.0 $ 600.0
Effective Interest Rate 4.329% 4.329%
XML 113 R79.htm IDEA: XBRL DOCUMENT v3.22.0.1
FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Assets    
Available-for-sale investments: $ 2,183.7 $ 935.9
Bank time deposits    
Assets    
Available-for-sale investments: 2.5 24.1
Corporate debt securities    
Assets    
Available-for-sale investments: 1,390.8 608.3
Asset-backed securities    
Assets    
Available-for-sale investments: 512.6 151.5
United States government and agency securities    
Assets    
Available-for-sale investments: 147.3 149.2
Commercial paper    
Assets    
Available-for-sale investments: 127.7 0.0
Municipal securities    
Assets    
Available-for-sale investments: 2.8 2.8
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis    
Assets    
Cash equivalents 45.9 16.2
Investments held for deferred compensation plans 130.7 111.2
Derivatives 55.3 8.1
Total assets 2,415.6 1,071.3
Liabilities    
Derivatives 3.9 39.3
Deferred compensation plans 130.9 111.6
Contingent consideration liabilities 62.0 186.1
Other liability 14.0  
Total liabilities 210.8 337.0
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Bank time deposits    
Assets    
Available-for-sale investments: 2.5 24.1
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Corporate debt securities    
Assets    
Available-for-sale investments: 1,390.8 608.3
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Asset-backed securities    
Assets    
Available-for-sale investments: 512.6 151.5
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | United States government and agency securities    
Assets    
Available-for-sale investments: 147.3 149.1
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Commercial paper    
Assets    
Available-for-sale investments: 127.7  
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Municipal securities    
Assets    
Available-for-sale investments: 2.8 2.8
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1    
Assets    
Cash equivalents 15.2 16.2
Investments held for deferred compensation plans 130.7 111.2
Derivatives 0.0 0.0
Total assets 174.3 184.3
Liabilities    
Derivatives 0.0 0.0
Deferred compensation plans 130.9 111.6
Contingent consideration liabilities 0.0 0.0
Other liability 0.0  
Total liabilities 130.9 111.6
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | Bank time deposits    
Assets    
Available-for-sale investments: 0.0 0.0
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | Corporate debt securities    
Assets    
Available-for-sale investments: 0.0 0.0
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | Asset-backed securities    
Assets    
Available-for-sale investments: 0.0 0.0
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | United States government and agency securities    
Assets    
Available-for-sale investments: 28.4 56.9
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | Commercial paper    
Assets    
Available-for-sale investments: 0.0  
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | Municipal securities    
Assets    
Available-for-sale investments: 0.0 0.0
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2    
Assets    
Cash equivalents 30.7 0.0
Investments held for deferred compensation plans 0.0 0.0
Derivatives 55.3 8.1
Total assets 2,241.3 887.0
Liabilities    
Derivatives 3.9 39.3
Deferred compensation plans 0.0 0.0
Contingent consideration liabilities 0.0 0.0
Other liability 0.0  
Total liabilities 3.9 39.3
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | Bank time deposits    
Assets    
Available-for-sale investments: 2.5 24.1
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | Corporate debt securities    
Assets    
Available-for-sale investments: 1,390.8 608.3
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | Asset-backed securities    
Assets    
Available-for-sale investments: 512.6 151.5
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | United States government and agency securities    
Assets    
Available-for-sale investments: 118.9 92.2
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | Commercial paper    
Assets    
Available-for-sale investments: 127.7  
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | Municipal securities    
Assets    
Available-for-sale investments: 2.8 2.8
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3    
Assets    
Cash equivalents 0.0 0.0
Investments held for deferred compensation plans 0.0 0.0
Derivatives 0.0 0.0
Total assets 0.0 0.0
Liabilities    
Derivatives 0.0 0.0
Deferred compensation plans 0.0 0.0
Contingent consideration liabilities 62.0 186.1
Other liability 14.0  
Total liabilities 76.0 186.1
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | Bank time deposits    
Assets    
Available-for-sale investments: 0.0 0.0
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | Corporate debt securities    
Assets    
Available-for-sale investments: 0.0 0.0
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | Asset-backed securities    
Assets    
Available-for-sale investments: 0.0 0.0
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | United States government and agency securities    
Assets    
Available-for-sale investments: 0.0 0.0
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | Commercial paper    
Assets    
Available-for-sale investments: 0.0  
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | Municipal securities    
Assets    
Available-for-sale investments: $ 0.0 $ 0.0
XML 114 R80.htm IDEA: XBRL DOCUMENT v3.22.0.1
FAIR VALUE MEASUREMENTS - Summary of Changes in Fair Value of Contingent Consideration Obligation (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Fair value beginning balance $ 186.1 $ 172.5
Additions 14.0  
Changes in fair value (124.1) 13.6
Fair value ending balance 76.0 186.1
Contingent Consideration    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Fair value beginning balance 186.1 172.5
Additions 0.0  
Changes in fair value (124.1) 13.6
Fair value ending balance 62.0 186.1
Other Liability    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Fair value beginning balance 0.0 0.0
Additions 14.0  
Changes in fair value 0.0 0.0
Fair value ending balance $ 14.0 $ 0.0
XML 115 R81.htm IDEA: XBRL DOCUMENT v3.22.0.1
FAIR VALUE MEASUREMENTS - Narrative (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Change in fair value of contingent consideration liabilities, net $ 124.1 $ (13.6) $ 6.1
Level 3 | Obligations | Measurement Input, Discount Rate | Minimum      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Contingent consideration liability measurement input 0.0006    
Level 3 | Obligations | Measurement Input, Discount Rate | Maximum      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Contingent consideration liability measurement input 0.0926    
Level 3 | Obligations | Measurement Input, Discount Rate | Weighted Average      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Contingent consideration liability measurement input 0.041    
Level 3 | Obligations | Measurement Input, Probability of Milestone Achievement | Minimum      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Contingent consideration liability measurement input 0    
Level 3 | Obligations | Measurement Input, Probability of Milestone Achievement | Maximum      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Contingent consideration liability measurement input 0.937    
Level 3 | Obligations | Measurement Input, Probability of Milestone Achievement | Weighted Average      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Contingent consideration liability measurement input 0.592    
Level 3 | Obligations | Measurement Input, Volatility of Future Revenue | Maximum      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Contingent consideration liability measurement input 0.400    
Previous Acquisitions      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Change in fair value of contingent consideration liabilities, net $ 123.2    
Two Previous Acquisitions      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Change in fair value of contingent consideration liabilities, net   $ 12.7  
XML 116 R82.htm IDEA: XBRL DOCUMENT v3.22.0.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Derivative Financial Instruments Used to Manage Currency Exchange and Interest Rate Risk (Details) - Derivatives designated as hedging instruments - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Foreign currency forward exchange contracts    
Derivative [Line Items]    
Notional Amount $ 1,498.8 $ 1,525.5
Cross currency swap contracts    
Derivative [Line Items]    
Notional Amount $ 300.0 $ 300.0
XML 117 R83.htm IDEA: XBRL DOCUMENT v3.22.0.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Foreign currency contracts    
Assets    
Fair Value $ 36.2 $ 7.3
Liabilities    
Fair Value 3.9 39.3
Cross currency swap contracts    
Assets    
Fair Value 19.1 0.8
Derivatives designated as hedging instruments | Foreign currency contracts | Other current assets    
Assets    
Fair Value 36.2 7.3
Derivatives designated as hedging instruments | Foreign currency contracts | Accrued and other liabilities    
Liabilities    
Fair Value 3.9 39.3
Derivatives designated as hedging instruments | Cross currency swap contracts | Other assets    
Assets    
Fair Value $ 19.1 $ 0.8
XML 118 R84.htm IDEA: XBRL DOCUMENT v3.22.0.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Foreign currency contracts    
Derivative Assets    
Gross Amounts $ 36.2 $ 7.3
Gross Amounts Offset in the Consolidated Balance Sheet 0.0 0.0
Net Amounts Presented in the Consolidated Balance Sheet 36.2 7.3
Gross Amounts Not Offset in the Consolidated Balance Sheet    
Financial Instruments (2.8) (6.1)
Cash Collateral Received 0.0 0.0
Net Amount 33.4 1.2
Derivative Liabilities    
Gross Amounts 3.9 39.3
Gross Amounts Offset in the Consolidated Balance Sheet 0.0 0.0
Net Amounts Presented in the Consolidated Balance Sheet 3.9 39.3
Gross Amounts Not Offset in the Consolidated Balance Sheet    
Financial Instruments (2.8) (6.1)
Cash Collateral Received 0.0 0.0
Net Amount 1.1 33.2
Cross currency swap contracts    
Derivative Assets    
Gross Amounts 19.1 0.8
Gross Amounts Offset in the Consolidated Balance Sheet 0.0 0.0
Net Amounts Presented in the Consolidated Balance Sheet 19.1 0.8
Gross Amounts Not Offset in the Consolidated Balance Sheet    
Financial Instruments 0.0 0.0
Cash Collateral Received 0.0 0.0
Net Amount $ 19.1 $ 0.8
XML 119 R85.htm IDEA: XBRL DOCUMENT v3.22.0.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Foreign currency contracts | Other income, net | Derivatives not designated as hedging instruments      
Derivative Instruments, Gain (Loss)      
Amount of Gain or (Loss) Recognized in Income on Derivative $ 27.4 $ (15.1) $ 0.3
Cash flow hedges | Foreign currency contracts | Derivatives designated as hedging instruments      
Derivative Instruments, Gain (Loss)      
Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion) 56.7 (33.7)  
Cash flow hedges | Foreign currency contracts | Cost of sales | Derivatives designated as hedging instruments      
Derivative Instruments, Gain (Loss)      
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (23.0) 18.4  
Cash flow hedges | Foreign currency contracts | Selling, general, and administrative expenses | Derivatives designated as hedging instruments      
Derivative Instruments, Gain (Loss)      
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (0.6) 2.2  
Net investment hedges | Cross currency swap contracts | Derivatives designated as hedging instruments      
Derivative Instruments, Gain (Loss)      
Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion) 18.4 (12.6)  
Net investment hedges | Cross currency swap contracts | Interest expense | Derivatives designated as hedging instruments      
Derivative Instruments, Gain (Loss)      
Amount of Gain or (Loss) Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing) 6.4 6.4  
Fair value hedges | Foreign currency contracts | Other income, net | Derivatives designated as hedging instruments      
Derivative Instruments, Gain (Loss)      
Amount of Gain or (Loss) Recognized in Income on Derivative $ 11.6 $ (1.4) $ 1.4
XML 120 R86.htm IDEA: XBRL DOCUMENT v3.22.0.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)
€ in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2021
USD ($)
Dec. 31, 2021
EUR (€)
Dec. 31, 2020
USD ($)
Derivative Instruments, Gain (Loss)      
Cash flow hedge loss to be reclassified $ 7.8    
Cross currency swap contracts | Derivatives designated as hedging instruments      
Derivative Instruments, Gain (Loss)      
Notional Amount 300.0   $ 300.0
Cross currency swap contracts | Net investment hedges | Derivatives designated as hedging instruments      
Derivative Instruments, Gain (Loss)      
Notional Amount $ 300.0 € 257.2  
XML 121 R87.htm IDEA: XBRL DOCUMENT v3.22.0.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location of Gain or Loss on Derivative Instruments (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Derivative Instruments, Gain (Loss)      
Cost of sales $ (1,248.9) $ (1,080.6) $ (1,114.4)
Selling, general, and administrative expenses (1,493.7) (1,228.4) (1,242.2)
Other income, net 12.7 11.5 $ 8.2
Foreign currency contracts | Cost of sales      
Gain (loss) on fair value hedging relationships:      
Hedged items 0.0 0.0  
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach 0.0 0.0  
Gain (loss) on cash flow hedging relationships:      
Amount of gain (loss) reclassified from accumulated OCI into income (23.0) 18.4  
Foreign currency contracts | Cost of sales | Derivatives designated as hedging instruments      
Gain (loss) on fair value hedging relationships:      
Derivatives designated as hedging instruments 0.0 0.0  
Foreign currency contracts | Selling, general, and administrative expenses      
Gain (loss) on fair value hedging relationships:      
Hedged items 0.0 0.0  
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach 0.0 0.0  
Gain (loss) on cash flow hedging relationships:      
Amount of gain (loss) reclassified from accumulated OCI into income (0.6) 2.2  
Foreign currency contracts | Selling, general, and administrative expenses | Derivatives designated as hedging instruments      
Gain (loss) on fair value hedging relationships:      
Derivatives designated as hedging instruments 0.0 0.0  
Foreign currency contracts | Other income, net      
Gain (loss) on fair value hedging relationships:      
Hedged items (9.0) 4.8  
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach 2.6 3.4  
Gain (loss) on cash flow hedging relationships:      
Amount of gain (loss) reclassified from accumulated OCI into income 0.0 0.0  
Foreign currency contracts | Other income, net | Derivatives designated as hedging instruments      
Gain (loss) on fair value hedging relationships:      
Derivatives designated as hedging instruments $ 9.0 $ (4.8)  
XML 122 R88.htm IDEA: XBRL DOCUMENT v3.22.0.1
EMPLOYEE BENEFIT PLANS - Schedule of Information Regarding Defined Benefit Pension Plans (Details) - Defined benefit pension plans - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Change in projected benefit obligation:      
Beginning of year $ 126.2 $ 105.2  
Service cost 6.5 6.3 $ 5.2
Interest cost 0.4 0.5 0.9
Participant contributions 1.5 1.5  
Actuarial loss (6.1) 2.9  
Benefits paid (2.5) (0.6)  
Plan amendment (0.5) 0.0  
Currency exchange rate changes and other (7.6) 10.4  
End of year 117.9 126.2 105.2
Change in fair value of plan assets:      
Beginning of year 73.3 63.2  
Actual return on plan assets 5.8 0.4  
Employer contributions 3.1 2.8  
Participant contributions 1.5 1.5  
Benefits paid (2.5) (0.6)  
Currency exchange rate changes and other (4.3) 6.0  
End of year 76.9 73.3 63.2
Funded Status      
Projected benefit obligation (117.9) (126.2) (105.2)
Plan assets at fair value 76.9 73.3 $ 63.2
Underfunded status (41.0) (52.9)  
Accumulated other comprehensive loss, net of tax:      
Net actuarial loss (16.4) (30.8)  
Net prior service cost 6.0 6.6  
Deferred income tax benefit 2.4 4.6  
Total (8.0) (19.6)  
Other long-term liabilities      
Net amounts recognized on the consolidated balance sheet:      
Other long-term liabilities $ 41.0 $ 52.9  
XML 123 R89.htm IDEA: XBRL DOCUMENT v3.22.0.1
EMPLOYEE BENEFIT PLANS - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Defined Contribution Plans      
Expected employer contributions $ 2.2    
Matching contributions relating to entity's employees 38.6 $ 36.6 $ 31.4
Nonqualified deferred compensation plans      
Defined Contribution Plans      
Amount accrued under nonqualified plans $ 130.9 111.6  
United States      
Defined Contribution Plans      
Maximum contributions of a participant's eligible compensation (as a percent) 25.00%    
Dollar-for-dollar match of employee's annual eligible compensation (as a percent) 4.00%    
Company match of eligible compensation after dollar-for-dollar basis (as a percent) 2.00%    
Company match, second level (as a percent) 50.00%    
Puerto Rico      
Defined Contribution Plans      
Maximum contributions of a participant's eligible compensation (as a percent) 25.00%    
Dollar-for-dollar match of employee's annual eligible compensation (as a percent) 4.00%    
Company match, first level (as a percent) 50.00%    
Profit sharing contribution calculated on eligible earnings (as a percent) 2.00%    
Defined benefit pension plans      
Defined Contribution Plans      
Accumulated benefit obligation $ 113.3 $ 120.9  
XML 124 R90.htm IDEA: XBRL DOCUMENT v3.22.0.1
EMPLOYEE BENEFIT PLANS - Components of Net Periodic Benefit Cost (Details) - Defined benefit pension plans - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Defined Benefit Plan Disclosure [Line Items]      
Service cost, net $ 6.5 $ 6.3 $ 5.2
Interest cost 0.4 0.5 0.9
Expected return on plan assets (1.1) (1.0) (1.4)
Amortization of actuarial loss 1.7 1.6 0.9
Amortization of prior service credit (0.7) (0.7) (0.2)
Net periodic pension benefit cost $ 6.8 $ 6.7 $ 5.4
XML 125 R91.htm IDEA: XBRL DOCUMENT v3.22.0.1
EMPLOYEE BENEFIT PLANS - Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations (Details) - Defined benefit pension plans
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Weighted-average assumptions used to determine the benefit obligations      
Discount rate (as a percent) 0.50% 0.30%  
Rate of compensation increase (as a percent) 2.60% 2.60%  
Cash balance interest crediting rate (as a percent) 2.50% 2.50%  
Social securities increase (as a percent) 1.60% 1.60%  
Pension increase (as a percent) 1.80% 1.80%  
Weighted-average assumptions used to determine the net periodic benefit cost      
Discount rate (as a percent) 0.30% 0.50% 0.90%
Expected return on plan assets (as a percent) 1.50% 1.50% 2.30%
Rate of compensation increase (as a percent) 2.60% 2.70% 2.80%
Cash balance interest crediting rate (as a percent) 2.50% 1.50% 1.50%
Social securities increase (as a percent) 1.60% 1.60% 1.80%
Pension increase (as a percent) 1.80% 1.80% 1.80%
XML 126 R92.htm IDEA: XBRL DOCUMENT v3.22.0.1
EMPLOYEE BENEFIT PLANS - Schedule of Target Weighted-Average Asset Allocations and Fair Value (Details) - Defined benefit pension plans - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Defined Benefit Plan Disclosure [Line Items]      
Target asset allocations (as a percent) 100.00%    
Plan assets at fair value $ 76.9 $ 73.3 $ 63.2
Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 67.8 65.5  
Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 55.8 55.8  
Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 11.1 8.7  
Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.9 1.0  
Alternative investments measured at net asset value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 9.1 7.8  
Cash | Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 5.4 3.0  
Cash | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 5.4 3.0  
Cash | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
Cash | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value $ 0.0 0.0  
Equity securities      
Defined Benefit Plan Disclosure [Line Items]      
Target asset allocations (as a percent) 28.30%    
United States equities | Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value $ 1.6 3.3  
United States equities | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 1.6 3.3  
United States equities | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
United States equities | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
International equities | Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 16.3 16.1  
International equities | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 16.3 16.1  
International equities | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
International equities | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value $ 0.0 0.0  
Debt securities      
Defined Benefit Plan Disclosure [Line Items]      
Target asset allocations (as a percent) 41.70%    
United States government bonds | Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value $ 6.2 7.4  
United States government bonds | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 6.2 7.4  
United States government bonds | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
United States government bonds | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
Foreign government bonds | Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 26.3 26.0  
Foreign government bonds | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 26.3 26.0  
Foreign government bonds | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
Foreign government bonds | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value $ 0.0 0.0  
Real estate      
Defined Benefit Plan Disclosure [Line Items]      
Target asset allocations (as a percent) 9.80%    
Real estate | Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value $ 7.6 5.6  
Real estate | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
Real estate | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 7.6 5.6  
Real estate | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
Mortgages | Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 3.5 3.1  
Mortgages | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
Mortgages | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 3.5 3.1  
Mortgages | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
Insurance contracts | Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.9 1.0  
Insurance contracts | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
Insurance contracts | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
Insurance contracts | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value $ 0.9 $ 1.0 $ 0.9
Other      
Defined Benefit Plan Disclosure [Line Items]      
Target asset allocations (as a percent) 20.20%    
XML 127 R93.htm IDEA: XBRL DOCUMENT v3.22.0.1
EMPLOYEE BENEFIT PLANS - Summary of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3 (Details) - Defined benefit pension plans - USD ($)
$ in Millions
 6 Months Ended 12 Months Ended
Jun. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]      
Beginning of year $ 63.2 $ 73.3 $ 63.2
Currency exchange rate impact   (4.3) 6.0
End of year   76.9 73.3
Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Beginning of year   1.0  
End of year   0.9 1.0
Level 3 | Insurance Contracts      
Defined Benefit Plan Disclosure [Line Items]      
Beginning of year 0.9 1.0 0.9
Currency exchange rate impact $ 0.1 (0.1)  
End of year   $ 0.9 $ 1.0
XML 128 R94.htm IDEA: XBRL DOCUMENT v3.22.0.1
EMPLOYEE BENEFIT PLANS - Schedule of Benefit Payments Which Reflect Expected Future Service (Details)
$ in Millions
Dec. 31, 2021
USD ($)
Retirement Benefits [Abstract]  
2022 $ 5.4
2023 6.7
2024 5.6
2025 5.2
2026 6.1
2024-2026 $ 36.1
XML 129 R95.htm IDEA: XBRL DOCUMENT v3.22.0.1
COMMON STOCK - Treasury Stock (Narrative) (Details) - USD ($)
shares in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
May 31, 2021
May 31, 2019
Treasury Stock          
Purchases of treasury stock $ (512,800,000) $ (625,400,000) $ (263,300,000)    
Treasury Stock          
Treasury Stock          
Purchases of treasury stock (in shares) 5.8 3.1 1.5    
Purchases of treasury stock $ (512,800,000) $ (625,400,000) $ (263,300,000)    
Stock Repurchase Program May 2019          
Treasury Stock          
Authorized amount for share repurchase         $ 1,000,000,000
Stock Repurchase Program May 2021          
Treasury Stock          
Authorized amount for share repurchase       $ 1,000,000,000  
XML 130 R96.htm IDEA: XBRL DOCUMENT v3.22.0.1
COMMON STOCK - Accelerated Share Repurchases (Details)
$ / shares in Units, shares in Millions
 1 Months Ended
May 29, 2020
May 07, 2020
Mar. 31, 2021
$ / shares
shares
Feb. 28, 2021
USD ($)
$ / shares
shares
Jun. 30, 2019
$ / shares
shares
May 31, 2019
USD ($)
$ / shares
shares
Accelerated Share Repurchase            
Stock split, conversion ratio 3 3        
Initial Delivery of Shares Settled May 2019            
Accelerated Share Repurchase            
Amount Paid | $           $ 150,000,000.0
Shares repurchased (in shares) | shares           0.7
Initial delivery, price per share (in dollars per share) | $ / shares           $ 178.66
Value of Shares as % of Contract Value           80.00%
Purchased and sold in May 2019            
Accelerated Share Repurchase            
Shares repurchased (in shares) | shares           0.8
Final settlement per share price (in dollars per share) | $ / shares           $ 178.42
Initial Delivery of Shares Settled June 2019            
Accelerated Share Repurchase            
Amount Paid | $           $ 100,000,000.0
Shares repurchased (in shares) | shares           0.5
Initial delivery, price per share (in dollars per share) | $ / shares           $ 170.02
Value of Shares as % of Contract Value           80.00%
Purchased in May 2019 and sold in June 2019            
Accelerated Share Repurchase            
Shares repurchased (in shares) | shares         0.6  
Final settlement per share price (in dollars per share) | $ / shares         $ 178.46  
Initial Delivery of Shares Settled February 2021            
Accelerated Share Repurchase            
Amount Paid | $       $ 250,000,000.0    
Shares repurchased (in shares) | shares       2.4    
Initial delivery, price per share (in dollars per share) | $ / shares       $ 83.86    
Value of Shares as % of Contract Value       80.00%    
Purchased in February 2021 and sold in March 2021            
Accelerated Share Repurchase            
Shares repurchased (in shares) | shares     3.0      
Final settlement per share price (in dollars per share) | $ / shares     $ 84.51      
XML 131 R97.htm IDEA: XBRL DOCUMENT v3.22.0.1
COMMON STOCK - Employee and Director Stock Plans (Narrative) (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Option Awards      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Estimated annual forfeiture rate (as a percent) 6.40%    
Average risk-free interest rate (as a percent) 0.80% 0.30% 2.30%
Expected volatility (as a percent) 34.00% 33.00% 30.00%
MRSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Average risk-free interest rate (as a percent) 0.40% 0.20% 2.20%
Expected volatility (as a percent) 34.40% 32.70% 29.40%
ESPP      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Average risk-free interest rate (as a percent) 0.10% 1.30% 2.40%
Expected volatility (as a percent) 37.00% 33.00% 27.00%
The Program      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Common stock available for issuance (in shares) 327,600,000    
The Program | Option Awards      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expiration date (in years) 7 years    
The Program | Option Awards | Low      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period (in years) 3 years    
The Program | Option Awards | High      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period (in years) 4 years    
The Program | Restricted stock units | High      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period (in years) 4 years    
The Program | MRSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period (in years) 3 years    
The Program | Restricted stock or restricted stock units | High      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Common stock available for issuance (in shares) 33,600,000    
Nonemployee Directors Program      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Common stock available for issuance (in shares) 8,400,000    
Nonemployee Directors Program | Annual award to nonemployee director      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Limit on total value of the award $ 0.2    
Nonemployee Directors Program | Option Awards | Awards granted in 2012 and later      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period (in years) 1 year    
Nonemployee Directors Program | Option Awards | High | Annual award to nonemployee director      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Common stock available for issuance (in shares) 120,000    
Nonemployee Directors Program | Restricted stock units | High | Annual award to nonemployee director      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Common stock available for issuance (in shares) 48,000    
ESPP | ESPP      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Common stock available for issuance (in shares) 50,400,000    
Percentage of lower of fair market value of common stock on effective date of subscription or date of purchase (as a percent) 85.00%    
Maximum percentage of compensation employees can authorize to be withheld for common stock purchases (as a percent) 15.00%    
XML 132 R98.htm IDEA: XBRL DOCUMENT v3.22.0.1
COMMON STOCK - Schedule of Weighted-Average Assumptions (Details) - $ / shares
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Option Awards      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Average risk-free interest rate (as a percent) 0.80% 0.30% 2.30%
Expected dividend yield (as a percent) 0.00% 0.00% 0.00%
Expected volatility (as a percent) 34.00% 33.00% 30.00%
Expected life (in years) 5 years 5 years 5 years 1 month 6 days
Fair value, per share (in dollars per share) $ 28.90 $ 21.70 $ 18.17
ESPP      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Average risk-free interest rate (as a percent) 0.10% 1.30% 2.40%
Expected dividend yield (as a percent) 0.00% 0.00% 0.00%
Expected volatility (as a percent) 37.00% 33.00% 27.00%
Expected life (in years) 7 months 6 days 7 months 6 days 7 months 6 days
Fair value, per share (in dollars per share) $ 23.07 $ 16.61 $ 16.43
XML 133 R99.htm IDEA: XBRL DOCUMENT v3.22.0.1
COMMON STOCK - Schedule of Stock Option (Details) - Stock option activity
$ / shares in Units, shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2021
USD ($)
$ / shares
shares
Shares  
Beginning balance (in shares) | shares 14.3
Options granted (in shares) | shares 1.6
Options exercised (in shares) | shares (3.4)
Options forfeited (in shares) | shares (0.2)
Ending balance (in shares) | shares 12.3
Exercisable as of period end (in shares) | shares 8.2
Vested and expected to vest as of period end (in shares) | shares 11.7
Weighted- Average Exercise Price  
Beginning balance (in dollars per share) | $ / shares $ 41.27
Options granted (in dollars per share) | $ / shares 94.04
Options exercised (in dollars per share) | $ / shares 23.84
Options forfeited (in dollars per share) | $ / shares 67.89
Ending balance (in dollars per share) | $ / shares 52.84
Exercisable as of period end (in dollars per share) | $ / shares 41.84
Vested and expected to vest as of period end (in dollars per share) | $ / shares $ 51.74
Weighted- Average Remaining Contractual Term  
Outstanding as of period end 3 years 6 months
Exercisable as of period end 2 years 7 months 6 days
Vested and expected to vest as of period end 3 years 4 months 24 days
Aggregate Intrinsic Value  
Outstanding as of period end | $ $ 943.1
Exercisable as of period end | $ 719.7
Vested and expected to vest as of period end | $ $ 911.4
XML 134 R100.htm IDEA: XBRL DOCUMENT v3.22.0.1
COMMON STOCK - Schedule of Restricted Stock Unit Activity (Details) - Nonvested restricted stock unit activity
shares in Millions
 12 Months Ended
Dec. 31, 2021
$ / shares
shares
Shares  
Beginning balance (in shares) | shares 2.6
Granted (in shares) | shares 0.8
Vested (in shares) | shares (1.0)
Forfeited (in shares) | shares (0.1)
Ending balance (in shares) | shares 2.3
Weighted- Average Grant-Date Fair Value  
Beginning balance (in dollars per share) | $ / shares $ 57.59
Granted (in dollars per share) | $ / shares 92.95
Vested (in dollars per share) | $ / shares 48.82
Forfeited (in dollars per share) | $ / shares 66.54
Ending balance (in dollars per share) | $ / shares $ 73.94
XML 135 R101.htm IDEA: XBRL DOCUMENT v3.22.0.1
COMMON STOCK - Schedule of Restricted Stock Unit Activity (Narrative) (Details) - MRSUs
shares in Millions
 12 Months Ended
Dec. 31, 2021
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Granted (in shares) 0.1
Shares related to previous year's grant (in shares) 0.1
XML 136 R102.htm IDEA: XBRL DOCUMENT v3.22.0.1
COMMON STOCK - Additional Information (Narrative) (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Equity [Abstract]      
Intrinsic value of stock options exercised and restricted stock units vested $ 359.8 $ 323.5 $ 382.1
Cash from exercises of stock options 82.2 79.2 110.4
Realized tax benefits from exercises of stock options and vesting of restricted stock units 76.5 72.1 85.1
Total grant date fair value of stock options vested 36.2 $ 34.0 $ 31.2
Employee stock purchase subscriptions $ 162.3    
Weighted-average remaining requisite service period (in months) 30 months    
XML 137 R103.htm IDEA: XBRL DOCUMENT v3.22.0.1
ACCUMULATED OTHER COMPREHENSIVE LOSS - Summary of Activity for Each Component of Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Accumulated Other Comprehensive Income (Loss), Net of Tax      
Beginning balance $ 4,574.3 $ 4,148.3 $ 3,140.4
Ending balance 5,835.9 4,574.3 4,148.3
Foreign Currency Translation Adjustments      
Accumulated Other Comprehensive Income (Loss), Net of Tax      
Beginning balance (122.4) (154.8) (143.6)
Other comprehensive (loss) income before reclassifications (39.2) 35.7 (1.5)
Amounts reclassified from accumulated other comprehensive loss (6.4) (6.4) (6.6)
Deferred income tax (expense) benefit (4.5) 3.1 (3.1)
Ending balance (172.5) (122.4) (154.8)
Unrealized Gain (Loss) on Hedges      
Accumulated Other Comprehensive Income (Loss), Net of Tax      
Beginning balance (27.7) 12.5 23.6
Other comprehensive (loss) income before reclassifications 66.3 (34.8) 27.9
Amounts reclassified from accumulated other comprehensive loss 12.0 (19.2) (44.2)
Deferred income tax (expense) benefit (20.9) 13.8 5.2
Ending balance 29.7 (27.7) 12.5
Unrealized (Loss) Gain on Available-for-sale Investments      
Accumulated Other Comprehensive Income (Loss), Net of Tax      
Beginning balance 8.6 1.7 (5.0)
Other comprehensive (loss) income before reclassifications (29.2) 8.0 7.9
Amounts reclassified from accumulated other comprehensive loss 8.6 0.3 0.4
Deferred income tax (expense) benefit 5.1 (1.4) (1.6)
Ending balance (6.9) 8.6 1.7
Unrealized Pension Costs      
Accumulated Other Comprehensive Income (Loss), Net of Tax      
Beginning balance (19.6) (15.4) (13.5)
Other comprehensive (loss) income before reclassifications 12.8 (5.5) (3.2)
Amounts reclassified from accumulated other comprehensive loss 1.0 0.9 0.7
Deferred income tax (expense) benefit (2.2) 0.4 0.6
Ending balance (8.0) (19.6) (15.4)
Total Accumulated Other Comprehensive Loss      
Accumulated Other Comprehensive Income (Loss), Net of Tax      
Beginning balance (161.1) (156.0) (138.5)
Other comprehensive (loss) income before reclassifications 10.7 3.4 31.1
Amounts reclassified from accumulated other comprehensive loss 15.2 (24.4) (49.7)
Deferred income tax (expense) benefit (22.5) 15.9 1.1
Ending balance $ (157.7) $ (161.1) $ (156.0)
XML 138 R104.htm IDEA: XBRL DOCUMENT v3.22.0.1
ACCUMULATED OTHER COMPREHENSIVE LOSS - Change in Unrealized Pension Costs (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Net prior service cost arising during period      
Pre-Tax Amount      
Prior service credit arising during period $ 0.1 $ 0.6 $ 4.6
Amortization of prior service credit (0.7) (0.7) (0.2)
Other comprehensive income (loss) (0.6) (0.1) 4.4
Tax (Expense) Benefit      
Prior service credit arising during period 0.0 (0.2) (0.6)
Amortization of prior service credit 0.1 0.1 0.1
Other comprehensive income (loss) 0.1 (0.1) (0.5)
Net of Tax Amount      
Prior service credit arising during period 0.1 0.4 4.0
Amortization of prior service credit (0.6) (0.6) (0.1)
Other comprehensive income (loss) (0.5) (0.2) 3.9
Net actuarial loss arising during period      
Pre-Tax Amount      
Other comprehensive income (loss) 14.4 (4.5) (6.9)
Tax (Expense) Benefit      
Other comprehensive income (loss) (2.3) 0.5 1.1
Net of Tax Amount      
Other comprehensive income (loss) 12.1 (4.0) (5.8)
Unrealized pension costs, net      
Pre-Tax Amount      
Prior service credit arising during period 12.8 (5.5) (3.2)
Other comprehensive income (loss) 13.8 (4.6) (2.5)
Tax (Expense) Benefit      
Other comprehensive income (loss) (2.2) 0.4 0.6
Net of Tax Amount      
Other comprehensive income (loss) $ 11.6 $ (4.2) $ (1.9)
XML 139 R105.htm IDEA: XBRL DOCUMENT v3.22.0.1
ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Information About Amounts Reclassified from Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Amounts reclassified from accumulated other comprehensive loss to affected line on Consolidated Statements of Operations      
Other income, net $ 12.7 $ 11.5 $ 8.2
Provision for income taxes (198.9) (93.3) (119.6)
Net income 1,503.1 823.4 1,046.9
Cost of sales (1,248.9) (1,080.6) (1,114.4)
Selling, general, and administrative expenses (1,493.7) (1,228.4) $ (1,242.2)
Amount Reclassified from Accumulated Other Comprehensive Loss | Foreign currency translation adjustments      
Amounts reclassified from accumulated other comprehensive loss to affected line on Consolidated Statements of Operations      
Other income, net 6.4 6.4  
Provision for income taxes (1.6) (1.6)  
Net income 4.8 4.8  
Amount Reclassified from Accumulated Other Comprehensive Loss | Gain (loss) on hedges      
Amounts reclassified from accumulated other comprehensive loss to affected line on Consolidated Statements of Operations      
Provision for income taxes 4.6 (5.0)  
Net income (7.4) 14.2  
Cost of sales (23.0) 18.4  
Selling, general, and administrative expenses (0.6) 2.2  
Other income, net 11.6 (1.4)  
Income before provision for income taxes (12.0) 19.2  
Amount Reclassified from Accumulated Other Comprehensive Loss | (Loss) gain on available-for-sale investments      
Amounts reclassified from accumulated other comprehensive loss to affected line on Consolidated Statements of Operations      
Other income, net (8.6) (0.3)  
Provision for income taxes 2.1 (0.6)  
Net income (6.5) (0.9)  
Amount Reclassified from Accumulated Other Comprehensive Loss | Amortization of pension adjustments      
Amounts reclassified from accumulated other comprehensive loss to affected line on Consolidated Statements of Operations      
Other income, net (1.0) (0.9)  
Provision for income taxes 0.1 0.2  
Net income $ (0.9) $ (0.7)  
XML 140 R106.htm IDEA: XBRL DOCUMENT v3.22.0.1
OTHER INCOME, NET (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Other Income and Expenses [Abstract]      
Foreign exchange gains, net $ (5.0) $ (12.3) $ (5.9)
Gain on investments (5.8) (0.6) (0.5)
Non-service cost components of net periodic pension benefit cost 0.3 0.4 0.2
Other (2.2) 1.0 (2.0)
Total other income, net $ (12.7) $ (11.5) $ (8.2)
XML 141 R107.htm IDEA: XBRL DOCUMENT v3.22.0.1
INCOME TAXES - Schedule of Income Before Provisions for Income Taxes (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Tax Disclosure [Abstract]      
United States $ 610.9 $ 151.3 $ 383.4
Outside of the United States, including Puerto Rico 1,091.1 765.4 783.1
Income before provision for income taxes $ 1,702.0 $ 916.7 $ 1,166.5
XML 142 R108.htm IDEA: XBRL DOCUMENT v3.22.0.1
INCOME TAXES - Provision for Income Taxes (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
United States:      
Federal $ 125.2 $ 23.4 $ 31.3
State and local 25.1 48.2 48.7
Outside of the United States, including Puerto Rico 92.6 73.9 29.1
Current income tax expense 242.9 145.5 109.1
United States:      
Federal (9.4) 11.0 28.3
State and local (25.4) (32.9) (18.3)
Outside of the United States, including Puerto Rico (9.2) (30.3) 0.5
Deferred income tax (benefit) expense (44.0) (52.2) 10.5
Total income tax provision $ 198.9 $ 93.3 $ 119.6
XML 143 R109.htm IDEA: XBRL DOCUMENT v3.22.0.1
INCOME TAXES - Components of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Deferred tax assets    
Compensation and benefits $ 109.8 $ 88.6
Benefits from uncertain tax positions 33.9 27.0
Net tax credit carryforwards 142.0 125.5
Net operating loss carryforwards 69.4 64.1
Accrued liabilities 108.0 105.0
Inventories 13.5 16.3
Cash flow and net investment hedges 0.0 3.3
State income taxes 0.4 0.5
Investments 0.7 1.8
Lease liability obligations 6.6 7.7
Other 1.3 3.6
Total deferred tax assets 485.6 443.4
Deferred tax liabilities    
Property, plant, and equipment (64.1) (53.4)
Cash flow and net investment hedges (6.4) 0.0
Deferred tax on foreign earnings (26.3) (29.2)
Right-of-use assets (6.1) (7.0)
Other intangible assets (75.5) (76.3)
Other (2.6) (3.1)
Total deferred tax liabilities (181.0) (169.0)
Valuation allowance (82.5) (71.6)
Net deferred tax assets $ 222.1 $ 202.8
XML 144 R110.htm IDEA: XBRL DOCUMENT v3.22.0.1
INCOME TAXES - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Operating Loss Carryforwards [Line Items]        
Net deferred tax assets increase $ 19.3      
Valuation allowance that reduces certain deferred tax assets 82.5 $ 71.6    
Carryforward amount 194.8      
Foreign earnings to be indefinitely reinvested 1,000.0      
Foreign earnings to be repatriated 392.9      
Estimated net tax liability on permanently reinvested earnings 23.1      
Unrecognized tax benefits 358.4 281.8 $ 203.1 $ 150.7
Estimated decrease in unrecognized tax benefits 135.1 95.1    
Net amounts favorably affecting tax rate 223.3 186.7    
Accrued interest related to unrecognized tax benefits, net of tax benefit 19.5 14.3    
Tax benefit of accrued interest 8.1 5.1    
Interest expense (benefit), net of tax benefit 5.2 5.0 4.7  
Additional federal tax 180.0      
Non-U.S.        
Operating Loss Carryforwards [Line Items]        
Tax reductions compared to local statutory rates $ 208.0 $ 189.2 $ 159.2  
Tax reductions compared to local statutory rates per diluted share (in dollars per share) $ 0.33 $ 0.30 $ 0.25  
Carryforward period indefinite | California | State and local jurisdiction | Research expenditure tax credits        
Operating Loss Carryforwards [Line Items]        
Carryforward amount $ 167.0      
Carryforward period indefinite | Puerto Rico | Non-U.S. | Puerto Rico purchases credit        
Operating Loss Carryforwards [Line Items]        
Carryforward amount $ 23.4      
XML 145 R111.htm IDEA: XBRL DOCUMENT v3.22.0.1
INCOME TAXES - Summary of Net Operating Loss Carryforwards (Details)
$ in Millions
Dec. 31, 2021
USD ($)
Operating Loss Carryforwards [Line Items]  
Carryforward Amount $ 456.6
Tax Benefit Amount 69.6
Valuation Allowance (53.9)
Net Tax Benefit 15.7
United States federal net operating losses | United States | Carryforward Period Ends 2030-2037  
Operating Loss Carryforwards [Line Items]  
Carryforward Amount 17.6
Tax Benefit Amount 3.7
Valuation Allowance 0.0
Net Tax Benefit 3.7
United States federal net operating losses | United States | Carryforward Period Indefinite  
Operating Loss Carryforwards [Line Items]  
Carryforward Amount 11.3
Tax Benefit Amount 2.4
Valuation Allowance 0.0
Net Tax Benefit 2.4
United States federal net operating losses | United States | Carryforward Period Ends 2022  
Capital Loss Carryforward [Abstract]  
Carryforward Amount 34.1
Tax Benefit Amount 0.2
Valuation Allowance (0.2)
Net Tax Benefit 0.0
United States state net operating losses | United States | Carryforward Period Indefinite  
Operating Loss Carryforwards [Line Items]  
Carryforward Amount 1.0
Tax Benefit Amount 0.1
Valuation Allowance (0.1)
Net Tax Benefit 0.0
United States state net operating losses | United States | Carryforward Period Ends 2026-2039  
Operating Loss Carryforwards [Line Items]  
Carryforward Amount 33.5
Tax Benefit Amount 1.6
Valuation Allowance (1.6)
Net Tax Benefit 0.0
Non-United States net operating losses | International | Carryforward Period Indefinite  
Operating Loss Carryforwards [Line Items]  
Carryforward Amount 353.3
Tax Benefit Amount 60.1
Valuation Allowance (50.8)
Net Tax Benefit 9.3
Non-United States net operating losses | International | Carryforward Period Ends 2020-2027  
Operating Loss Carryforwards [Line Items]  
Carryforward Amount 5.8
Tax Benefit Amount 1.5
Valuation Allowance (1.2)
Net Tax Benefit $ 0.3
XML 146 R112.htm IDEA: XBRL DOCUMENT v3.22.0.1
INCOME TAXES - Summary of Tax Credit Carryforwards (Details)
$ in Millions
Dec. 31, 2021
USD ($)
Tax credit carryforwards and the related carryforward periods  
Carryforward Amount $ 194.8
Valuation Allowance (26.3)
Net Tax Benefit 168.5
California research expenditure tax credits | California | Research expenditure tax credits | Carryforward Period Indefinite  
Tax credit carryforwards and the related carryforward periods  
Carryforward Amount 167.0
Valuation Allowance 0.0
Net Tax Benefit 167.0
Federal research expenditure tax credits | United States | Research expenditure tax credits | Carryforward Period Indefinite  
Tax credit carryforwards and the related carryforward periods  
Carryforward Amount 1.5
Valuation Allowance 0.0
Net Tax Benefit 1.5
Foreign tax authority | Foreign | Foreign tax credits | Carryforward Period Indefinite  
Tax credit carryforwards and the related carryforward periods  
Carryforward Amount 2.9
Valuation Allowance (2.9)
Net Tax Benefit 0.0
Foreign tax authority | Puerto Rico | Purchases credit | Carryforward Period Indefinite  
Tax credit carryforwards and the related carryforward periods  
Carryforward Amount 23.4
Valuation Allowance (23.4)
Net Tax Benefit $ 0.0
XML 147 R113.htm IDEA: XBRL DOCUMENT v3.22.0.1
INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Tax Disclosure [Abstract]      
Income tax expense at United States federal statutory rate $ 357.4 $ 192.5 $ 245.0
Foreign income taxed at different rates (122.2) (80.5) (75.0)
State and local taxes, net of federal tax benefit 11.9 5.0 11.9
Tax credits, federal and state (48.4) (43.1) (42.9)
Build of reserve for prior years' uncertain tax positions 3.6 4.2 5.0
Tax on global intangible low-taxed income 56.5 49.2 32.0
Foreign-derived intangible income deduction (1.3) (2.6) (7.2)
Contingent consideration liabilities (26.1) 2.9 (1.3)
United States federal deductible employee share-based compensation (47.8) (48.3) (57.6)
Nondeductible employee share-based compensation 5.3 4.2 3.2
Other 10.0 9.8 6.5
Total income tax provision $ 198.9 $ 93.3 $ 119.6
XML 148 R114.htm IDEA: XBRL DOCUMENT v3.22.0.1
INCOME TAXES - Reconciliation of Uncertain Tax Positions (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns      
Uncertain gross tax positions, beginning balance $ 281.8 $ 203.1 $ 150.7
Current year tax positions 82.1 86.4 55.4
Increase in prior year tax positions 2.3 6.0 0.8
Decrease in prior year tax positions (4.8) (10.0) (3.8)
Settlements (0.3) (3.7) 0.0
Lapse of statutes of limitations (2.7) 0.0 0.0
Uncertain gross tax positions, ending balance $ 358.4 $ 281.8 $ 203.1
XML 149 R115.htm IDEA: XBRL DOCUMENT v3.22.0.1
LEGAL PROCEEDINGS (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2021
USD ($)
lawsuit
Commitments and Contingencies Disclosure [Abstract]  
Number of lawsuits that if settled could have a material adverse impact on net income or cash flows | lawsuit 1
Threshold of disclosing material environmental legal proceedings | $ $ 1
XML 150 R116.htm IDEA: XBRL DOCUMENT v3.22.0.1
SEGMENT INFORMATION - Schedule of Information About Reportable Segments (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Segment Net Sales      
Total segment net sales $ 5,232.5 $ 4,386.3 $ 4,348.0
Operating segments      
Segment Net Sales      
Total segment net sales 5,123.9 4,362.1 4,333.5
Segment Operating Income      
Total segment operating income 3,153.3 2,643.1 2,614.5
Operating segments | United States      
Segment Net Sales      
Total segment net sales 2,963.1 2,516.8 2,532.7
Segment Operating Income      
Total segment operating income 2,051.0 1,727.3 1,742.3
Operating segments | Europe      
Segment Net Sales      
Total segment net sales 1,099.6 945.2 926.1
Segment Operating Income      
Total segment operating income 569.1 479.3 472.0
Operating segments | Japan      
Segment Net Sales      
Total segment net sales 528.0 448.6 441.4
Segment Operating Income      
Total segment operating income 348.0 286.4 272.3
Operating segments | Rest of World      
Segment Net Sales      
Total segment net sales 533.2 451.5 433.3
Segment Operating Income      
Total segment operating income $ 185.2 $ 150.1 $ 127.9
XML 151 R117.htm IDEA: XBRL DOCUMENT v3.22.0.1
SEGMENT INFORMATION - Reconciliation of Segment Net Sales and Pre-Tax Income to Consolidated Net Sales and Pre-Tax Income (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Segment Net Sales      
Net sales $ 5,232.5 $ 4,386.3 $ 4,348.0
Segment Operating Income      
Operating income 1,690.3 897.6 1,146.8
Unallocated amounts:      
Special charges 0.0 0.0 (64.6)
Change in fair value of contingent consideration liabilities, net 124.1 (13.6) 6.1
Foreign currency 5.0 12.3 5.9
Consolidated pre-tax income 1,702.0 916.7 1,166.5
Operating segments      
Segment Net Sales      
Net sales 5,123.9 4,362.1 4,333.5
Segment Operating Income      
Operating income 3,153.3 2,643.1 2,614.5
Segment reconciling items      
Segment Net Sales      
Net sales 108.6 24.2 14.5
Unallocated amounts:      
Special charges 0.0 0.0  
Intellectual property litigation expenses, net (20.6) (405.4) (33.4)
Foreign currency 47.3 31.5 63.9
Non-operating income 11.7 19.1 19.7
Corporate items      
Unallocated amounts:      
Corporate items $ (1,613.8) $ (1,358.0) $ (1,439.7)
XML 152 R118.htm IDEA: XBRL DOCUMENT v3.22.0.1
SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Net Sales by Geographic Area and by Major Product Area      
Net sales $ 5,232.5 $ 4,386.3 $ 4,348.0
Long-lived Tangible Assets by Geographic Area      
Long-lived tangible assets 1,748.9 1,608.4 1,241.7
Transcatheter Aortic Valve Replacement      
Net Sales by Geographic Area and by Major Product Area      
Net sales 3,422.5 2,857.3 2,737.9
Transcatheter Mitral and Tricuspid Therapies      
Net Sales by Geographic Area and by Major Product Area      
Net sales 86.0 41.8 28.2
Surgical Structural Heart      
Net Sales by Geographic Area and by Major Product Area      
Net sales 889.1 761.8 841.7
Critical Care      
Net Sales by Geographic Area and by Major Product Area      
Net sales 834.9 725.4 740.2
United States      
Net Sales by Geographic Area and by Major Product Area      
Net sales 2,963.1 2,516.8 2,532.7
Long-lived Tangible Assets by Geographic Area      
Long-lived tangible assets 1,195.8 1,084.3 849.1
Europe      
Net Sales by Geographic Area and by Major Product Area      
Net sales 1,190.3 973.6 941.2
Long-lived Tangible Assets by Geographic Area      
Long-lived tangible assets 197.9 192.7 101.5
Japan      
Net Sales by Geographic Area and by Major Product Area      
Net sales 528.9 460.1 444.7
Long-lived Tangible Assets by Geographic Area      
Long-lived tangible assets 19.7 20.4 21.7
Rest of World      
Net Sales by Geographic Area and by Major Product Area      
Net sales 550.2 435.8 429.4
Long-lived Tangible Assets by Geographic Area      
Long-lived tangible assets $ 335.5 $ 311.0 $ 269.4
XML 153 R119.htm IDEA: XBRL DOCUMENT v3.22.0.1
VALUATION AND QUALIFYING ACCOUNTS (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Allowance for doubtful accounts      
Movement in Valuation Allowances and Reserves      
Balance at Beginning of Period $ 16.4 $ 14.7 $ 13.6
Charged to Costs and Expenses 1.2 3.1 4.7
Charged to Other Accounts 0.6 0.0 0.2
Deductions (2.5) (1.4) (3.8)
Balance at End of Period 15.7 16.4 14.7
Tax valuation allowance      
Movement in Valuation Allowances and Reserves      
Balance at Beginning of Period 71.6 65.8 46.7
Charged to Costs and Expenses 12.4 6.3 18.9
Charged to Other Accounts 0.0 0.6 0.2
Deductions (1.5) (1.1) 0.0
Balance at End of Period $ 82.5 $ 71.6 $ 65.8
XML 154 R120.htm IDEA: XBRL DOCUMENT v3.22.0.1
SUBSEQUENT EVENT (Details) - Subsequent Event - January 2022 Stock Repurchase Program
shares in Millions, $ in Millions
 1 Months Ended
Jan. 31, 2022
USD ($)
shares
Subsequent Event [Line Items]  
Authorized amount for share repurchase | $ $ 250.0
Shares repurchased (in shares) | shares 1.9
Percentage of shares repurchased 80.00%
XML 155 ew-20211231_htm.xml IDEA: XBRL DOCUMENT 0001099800 2021-01-01 2021-12-31 0001099800 2021-06-30 0001099800 2022-01-31 0001099800 2021-12-31 0001099800 2020-12-31 0001099800 2020-01-01 2020-12-31 0001099800 2019-01-01 2019-12-31 0001099800 2019-12-31 0001099800 2018-12-31 0001099800 us-gaap:CommonStockMember 2018-12-31 0001099800 us-gaap:TreasuryStockMember 2018-12-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001099800 us-gaap:RetainedEarningsMember 2018-12-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001099800 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0001099800 us-gaap:CommonStockMember 2019-01-01 2019-12-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0001099800 us-gaap:TreasuryStockMember 2019-01-01 2019-12-31 0001099800 us-gaap:CommonStockMember 2019-12-31 0001099800 us-gaap:TreasuryStockMember 2019-12-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001099800 us-gaap:RetainedEarningsMember 2019-12-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001099800 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001099800 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001099800 us-gaap:TreasuryStockMember 2020-01-01 2020-12-31 0001099800 us-gaap:CommonStockMember 2020-12-31 0001099800 us-gaap:TreasuryStockMember 2020-12-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001099800 us-gaap:RetainedEarningsMember 2020-12-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001099800 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001099800 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001099800 us-gaap:TreasuryStockMember 2021-01-01 2021-12-31 0001099800 us-gaap:CommonStockMember 2021-12-31 0001099800 us-gaap:TreasuryStockMember 2021-12-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001099800 us-gaap:RetainedEarningsMember 2021-12-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001099800 2020-05-07 2020-05-07 0001099800 ew:HemodynamicMonitorsMember srt:MinimumMember 2021-12-31 0001099800 ew:HemodynamicMonitorsMember srt:MaximumMember 2021-12-31 0001099800 us-gaap:ShippingAndHandlingMember 2021-01-01 2021-12-31 0001099800 us-gaap:ShippingAndHandlingMember 2020-01-01 2020-12-31 0001099800 us-gaap:ShippingAndHandlingMember 2019-01-01 2019-12-31 0001099800 srt:MinimumMember 2021-12-31 0001099800 srt:MinimumMember 2021-01-01 2021-12-31 0001099800 srt:MaximumMember 2021-01-01 2021-12-31 0001099800 srt:MinimumMember us-gaap:BuildingAndBuildingImprovementsMember 2021-01-01 2021-12-31 0001099800 srt:MaximumMember us-gaap:BuildingAndBuildingImprovementsMember 2021-01-01 2021-12-31 0001099800 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2021-01-01 2021-12-31 0001099800 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2021-01-01 2021-12-31 0001099800 srt:MinimumMember us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2021-01-01 2021-12-31 0001099800 srt:MaximumMember us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2021-01-01 2021-12-31 0001099800 us-gaap:InProcessResearchAndDevelopmentMember 2021-01-01 2021-12-31 0001099800 us-gaap:InProcessResearchAndDevelopmentMember 2020-01-01 2020-12-31 0001099800 us-gaap:InProcessResearchAndDevelopmentMember 2019-01-01 2019-12-31 0001099800 us-gaap:StockCompensationPlanMember 2021-01-01 2021-12-31 0001099800 us-gaap:StockCompensationPlanMember 2020-01-01 2020-12-31 0001099800 us-gaap:StockCompensationPlanMember 2019-01-01 2019-12-31 0001099800 us-gaap:CostOfSalesMember 2021-01-01 2021-12-31 0001099800 us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0001099800 us-gaap:CostOfSalesMember 2019-01-01 2019-12-31 0001099800 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-12-31 0001099800 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0001099800 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-12-31 0001099800 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-12-31 0001099800 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-12-31 0001099800 us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-12-31 0001099800 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001099800 ew:AbbottLaboratoriesMember 2020-06-01 2020-06-30 0001099800 ew:AbbottLaboratoriesMember srt:ScenarioForecastMember 2024-05-01 2024-05-31 0001099800 ew:AbbottLaboratoriesMember 2020-07-01 2020-07-31 0001099800 ew:ValtechCardioLtdMember us-gaap:DevelopedTechnologyRightsMember ew:RestOfWorldSegmentMember 2019-12-01 2019-12-31 0001099800 ew:EarlystageTranscatheterIntellectualPropertyMember 2019-03-31 0001099800 srt:MaximumMember 2021-12-31 0001099800 us-gaap:BankTimeDepositsMember 2021-12-31 0001099800 us-gaap:BankTimeDepositsMember 2020-12-31 0001099800 us-gaap:CommercialPaperMember 2021-12-31 0001099800 us-gaap:CommercialPaperMember 2020-12-31 0001099800 us-gaap:USTreasuryAndGovernmentMember 2021-12-31 0001099800 us-gaap:USTreasuryAndGovernmentMember 2020-12-31 0001099800 us-gaap:AssetBackedSecuritiesMember 2021-12-31 0001099800 us-gaap:AssetBackedSecuritiesMember 2020-12-31 0001099800 us-gaap:CorporateDebtSecuritiesMember 2021-12-31 0001099800 us-gaap:CorporateDebtSecuritiesMember 2020-12-31 0001099800 us-gaap:MunicipalBondsMember 2021-12-31 0001099800 us-gaap:MunicipalBondsMember 2020-12-31 0001099800 us-gaap:OtherNonoperatingIncomeExpenseMember 2021-12-31 0001099800 ew:KardionIncMember 2021-04-30 0001099800 ew:KardionIncMember us-gaap:EquitySecuritiesMember 2021-04-30 0001099800 ew:KardionIncMember 2021-10-01 2021-12-31 0001099800 ew:KardionIncMember 2021-12-31 0001099800 ew:CASMedicalSystemsInc.Member 2019-02-11 0001099800 ew:CASMedicalSystemsInc.Member 2019-02-11 2019-02-11 0001099800 ew:CASMedicalSystemsInc.Member 2019-04-18 2019-04-18 0001099800 ew:HarpoonMedicalInc.Member 2017-12-01 0001099800 ew:CardiAQValveTechnologiesInc.Member 2015-07-03 0001099800 ew:UnitedStatesSegmentMember 2019-12-31 0001099800 ew:EuropeSegmentMember 2019-12-31 0001099800 ew:RestOfWorldSegmentMember 2019-12-31 0001099800 ew:UnitedStatesSegmentMember 2020-01-01 2020-12-31 0001099800 ew:EuropeSegmentMember 2020-01-01 2020-12-31 0001099800 ew:RestOfWorldSegmentMember 2020-01-01 2020-12-31 0001099800 ew:UnitedStatesSegmentMember 2020-12-31 0001099800 ew:EuropeSegmentMember 2020-12-31 0001099800 ew:RestOfWorldSegmentMember 2020-12-31 0001099800 ew:UnitedStatesSegmentMember 2021-01-01 2021-12-31 0001099800 ew:EuropeSegmentMember 2021-01-01 2021-12-31 0001099800 ew:RestOfWorldSegmentMember 2021-01-01 2021-12-31 0001099800 ew:UnitedStatesSegmentMember 2021-12-31 0001099800 ew:EuropeSegmentMember 2021-12-31 0001099800 ew:RestOfWorldSegmentMember 2021-12-31 0001099800 us-gaap:PatentsMember 2021-01-01 2021-12-31 0001099800 us-gaap:PatentsMember 2021-12-31 0001099800 us-gaap:PatentsMember 2020-12-31 0001099800 us-gaap:DevelopedTechnologyRightsMember 2021-01-01 2021-12-31 0001099800 us-gaap:DevelopedTechnologyRightsMember 2021-12-31 0001099800 us-gaap:DevelopedTechnologyRightsMember 2020-12-31 0001099800 us-gaap:OtherIntangibleAssetsMember 2021-01-01 2021-12-31 0001099800 us-gaap:OtherIntangibleAssetsMember 2021-12-31 0001099800 us-gaap:OtherIntangibleAssetsMember 2020-12-31 0001099800 us-gaap:InProcessResearchAndDevelopmentMember 2021-12-31 0001099800 us-gaap:InProcessResearchAndDevelopmentMember 2020-12-31 0001099800 ew:FixedRate4.3002018NotesMember us-gaap:SeniorNotesMember 2018-06-30 0001099800 ew:SeniorNotesDue2018Member 2018-06-01 2018-06-30 0001099800 ew:FixedRate4.3002018NotesMember us-gaap:SeniorNotesMember 2021-12-31 0001099800 ew:FixedRate4.3002018NotesMember us-gaap:SeniorNotesMember 2020-12-31 0001099800 us-gaap:SeniorNotesMember 2021-12-31 0001099800 us-gaap:SeniorNotesMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel2Member ew:SeniorNotesDue2018Member 2021-12-31 0001099800 us-gaap:FairValueInputsLevel2Member ew:SeniorNotesDue2018Member 2020-12-31 0001099800 ew:CreditAgreementMaturityJuly2019Member us-gaap:LineOfCreditMember 2018-04-01 2018-04-30 0001099800 ew:CreditAgreementMaturityApril2023Member us-gaap:LineOfCreditMember 2018-04-30 0001099800 srt:MaximumMember ew:CreditAgreementMaturityApril2023Member us-gaap:LineOfCreditMember 2018-04-30 0001099800 srt:MinimumMember ew:CreditAgreementMaturityApril2023Member us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-04-01 2018-04-30 0001099800 srt:MaximumMember ew:CreditAgreementMaturityApril2023Member us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-04-01 2018-04-30 0001099800 srt:MinimumMember ew:CreditAgreementMaturityApril2023Member us-gaap:LineOfCreditMember 2018-04-01 2018-04-30 0001099800 srt:MaximumMember ew:CreditAgreementMaturityApril2023Member us-gaap:LineOfCreditMember 2018-04-01 2018-04-30 0001099800 ew:CreditAgreementMaturityApril2023Member us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-01-01 2021-12-31 0001099800 ew:CreditAgreementMaturityApril2023Member us-gaap:LineOfCreditMember 2021-01-01 2021-12-31 0001099800 ew:CreditAgreementMaturityApril2023Member us-gaap:LineOfCreditMember 2021-12-31 0001099800 ew:CreditAgreementMaturityApril2023Member us-gaap:LineOfCreditMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:BankTimeDepositsMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:BankTimeDepositsMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:BankTimeDepositsMember 2021-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:BankTimeDepositsMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2021-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2021-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2021-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2021-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2021-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:BankTimeDepositsMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:BankTimeDepositsMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:BankTimeDepositsMember 2020-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:BankTimeDepositsMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2020-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2020-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2020-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2020-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2020-12-31 0001099800 ew:ContingentConsiderationLiabilityMember 2019-12-31 0001099800 us-gaap:OtherLiabilitiesMember 2019-12-31 0001099800 ew:ContingentConsiderationLiabilityMember 2020-01-01 2020-12-31 0001099800 us-gaap:OtherLiabilitiesMember 2020-01-01 2020-12-31 0001099800 ew:ContingentConsiderationLiabilityMember 2020-12-31 0001099800 us-gaap:OtherLiabilitiesMember 2020-12-31 0001099800 ew:ContingentConsiderationLiabilityMember 2021-01-01 2021-12-31 0001099800 us-gaap:OtherLiabilitiesMember 2021-01-01 2021-12-31 0001099800 ew:ContingentConsiderationLiabilityMember 2021-12-31 0001099800 us-gaap:OtherLiabilitiesMember 2021-12-31 0001099800 ew:PreviousAcquisitionsMember 2021-01-01 2021-12-31 0001099800 ew:TwoPreviousAcquisitionsMember 2020-01-01 2020-12-31 0001099800 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember us-gaap:MeasurementInputDiscountRateMember 2021-12-31 0001099800 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember us-gaap:MeasurementInputDiscountRateMember 2021-12-31 0001099800 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember us-gaap:MeasurementInputDiscountRateMember 2021-12-31 0001099800 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember ew:MeasurementInputProbabilityOfMilestoneAchievementMember 2021-12-31 0001099800 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember ew:MeasurementInputProbabilityOfMilestoneAchievementMember 2021-12-31 0001099800 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember ew:MeasurementInputProbabilityOfMilestoneAchievementMember 2021-12-31 0001099800 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember ew:MeasurementInputVolatilityOfFutureRevenueMember 2021-12-31 0001099800 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0001099800 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001099800 us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0001099800 us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001099800 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0001099800 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001099800 us-gaap:OtherNoncurrentAssetsMember us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0001099800 us-gaap:OtherNoncurrentAssetsMember us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001099800 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0001099800 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001099800 us-gaap:ForeignExchangeContractMember 2021-12-31 0001099800 us-gaap:CurrencySwapMember 2021-12-31 0001099800 us-gaap:ForeignExchangeContractMember 2020-12-31 0001099800 us-gaap:CurrencySwapMember 2020-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2021-01-01 2021-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-12-31 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2021-01-01 2021-12-31 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2020-01-01 2020-12-31 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2021-01-01 2021-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2020-01-01 2020-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-01-01 2019-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2021-01-01 2021-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2020-01-01 2020-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-01-01 2019-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2021-01-01 2021-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:OtherNonoperatingIncomeExpenseMember 2021-01-01 2021-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2021-01-01 2021-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2021-01-01 2021-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:OtherNonoperatingIncomeExpenseMember 2020-01-01 2020-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2020-01-01 2020-12-31 0001099800 us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001099800 us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001099800 us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:DefinedBenefitPlanDebtSecurityMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:OtherInvestmentsMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:MortgagesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:MortgagesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:MortgagesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:MortgagesMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:MortgagesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:MortgagesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:MortgagesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:MortgagesMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-06-30 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001099800 country:US 2021-01-01 2021-12-31 0001099800 country:PR 2021-01-01 2021-12-31 0001099800 ew:NonqualifiedDeferredCompensationPlanSelectEmployeeGroupMember 2021-12-31 0001099800 ew:NonqualifiedDeferredCompensationPlanSelectEmployeeGroupMember 2020-12-31 0001099800 ew:May2019StockRepurchaseProgramMember 2019-05-31 0001099800 ew:May2021StockRepurchaseProgramMember 2021-05-31 0001099800 ew:InitialDeliveryofSharesSettledMay2019Member 2019-05-31 0001099800 ew:InitialDeliveryofSharesSettledMay2019Member 2019-05-01 2019-05-31 0001099800 ew:May2019StockRepurchaseProgramSharesPurchasedAndSoldInMay2019Member 2019-05-01 2019-05-31 0001099800 ew:InitialDeliveryOfSharesSettledJune2019Member 2019-05-31 0001099800 ew:InitialDeliveryOfSharesSettledJune2019Member 2019-05-01 2019-05-31 0001099800 ew:May2019StockRepurchaseProgramSharesSoldInJune2019Member 2019-06-01 2019-06-30 0001099800 ew:InitialDeliveryOfSharesSettledFebruary2021Member 2021-02-28 0001099800 ew:InitialDeliveryOfSharesSettledFebruary2021Member 2021-02-01 2021-02-28 0001099800 ew:February2021StockRepurchaseProgramSharesSoldInMarch2021Member 2021-03-01 2021-03-31 0001099800 2020-05-29 2020-05-29 0001099800 srt:MinimumMember ew:EmployeeAndNonemployeeStockOptionsMember ew:LongTermStockIncentiveCompensationProgramMember 2021-01-01 2021-12-31 0001099800 srt:MaximumMember ew:EmployeeAndNonemployeeStockOptionsMember ew:LongTermStockIncentiveCompensationProgramMember 2021-01-01 2021-12-31 0001099800 ew:EmployeeAndNonemployeeStockOptionsMember ew:LongTermStockIncentiveCompensationProgramMember 2021-01-01 2021-12-31 0001099800 srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember ew:LongTermStockIncentiveCompensationProgramMember 2021-01-01 2021-12-31 0001099800 ew:MarketBasedRestrictedStockUnitsMember ew:LongTermStockIncentiveCompensationProgramMember 2021-01-01 2021-12-31 0001099800 ew:LongTermStockIncentiveCompensationProgramMember 2021-12-31 0001099800 srt:MaximumMember ew:RestrictedStockAndRestrictedStockUnitAwardsMember ew:LongTermStockIncentiveCompensationProgramMember 2021-12-31 0001099800 srt:MaximumMember ew:ShareBasedCompensationArrangementsAwardGrantedAnnuallyToNonemployeeDirectorMember ew:EmployeeAndNonemployeeStockOptionsMember ew:NonemployeeDirectorsStockIncentiveCompensationProgramMember 2021-12-31 0001099800 srt:MaximumMember ew:ShareBasedCompensationArrangementsAwardGrantedAnnuallyToNonemployeeDirectorMember us-gaap:RestrictedStockUnitsRSUMember ew:NonemployeeDirectorsStockIncentiveCompensationProgramMember 2021-12-31 0001099800 ew:ShareBasedCompensationArrangementsAwardGrantedAnnuallyToNonemployeeDirectorMember ew:NonemployeeDirectorsStockIncentiveCompensationProgramMember 2021-01-01 2021-12-31 0001099800 ew:ShareBasedCompensationArrangementsAwardsGranted2012AndAfterMember ew:EmployeeAndNonemployeeStockOptionsMember ew:NonemployeeDirectorsStockIncentiveCompensationProgramMember 2021-01-01 2021-12-31 0001099800 ew:NonemployeeDirectorsStockIncentiveCompensationProgramMember 2021-12-31 0001099800 us-gaap:EmployeeStockMember ew:EmployeeStockPurchasePlanMember 2021-01-01 2021-12-31 0001099800 us-gaap:EmployeeStockMember ew:EmployeeStockPurchasePlanMember 2021-12-31 0001099800 ew:EmployeeAndNonemployeeStockOptionsMember 2021-01-01 2021-12-31 0001099800 ew:EmployeeAndNonemployeeStockOptionsMember 2020-01-01 2020-12-31 0001099800 ew:EmployeeAndNonemployeeStockOptionsMember 2019-01-01 2019-12-31 0001099800 us-gaap:EmployeeStockMember 2021-01-01 2021-12-31 0001099800 us-gaap:EmployeeStockMember 2020-01-01 2020-12-31 0001099800 us-gaap:EmployeeStockMember 2019-01-01 2019-12-31 0001099800 ew:MarketBasedRestrictedStockUnitsMember 2021-01-01 2021-12-31 0001099800 ew:MarketBasedRestrictedStockUnitsMember 2020-01-01 2020-12-31 0001099800 ew:MarketBasedRestrictedStockUnitsMember 2019-01-01 2019-12-31 0001099800 ew:EmployeeAndNonemployeeStockOptionsMember 2020-12-31 0001099800 ew:EmployeeAndNonemployeeStockOptionsMember 2021-12-31 0001099800 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001099800 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-12-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-12-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-01-01 2019-12-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-12-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-12-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-12-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-12-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-12-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-12-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-01-01 2021-12-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-01-01 2021-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-01-01 2021-12-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-12-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2021-01-01 2021-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2021-01-01 2021-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2020-01-01 2020-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2020-01-01 2020-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2019-01-01 2019-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2019-01-01 2019-12-31 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-12-31 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-12-31 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-01-01 2021-12-31 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-12-31 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-01-01 2021-12-31 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-12-31 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-01-01 2021-12-31 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-12-31 0001099800 country:US us-gaap:DomesticCountryMember ew:CarryforwardPeriodEnds20302037Member 2021-12-31 0001099800 country:US us-gaap:DomesticCountryMember ew:TaxCarryforwardsNoExpirationMember 2021-12-31 0001099800 country:US us-gaap:StateAndLocalJurisdictionMember ew:TaxCarryforwardsExpirationPeriodYears20262039Member 2021-12-31 0001099800 country:US us-gaap:StateAndLocalJurisdictionMember ew:TaxCarryforwardsNoExpirationMember 2021-12-31 0001099800 us-gaap:NonUsMember us-gaap:ForeignCountryMember ew:TaxCarryforwardsExpirationPeriodYears20202027Member 2021-12-31 0001099800 us-gaap:NonUsMember us-gaap:ForeignCountryMember ew:TaxCarryforwardsNoExpirationMember 2021-12-31 0001099800 country:US us-gaap:DomesticCountryMember ew:CapitalLossCarryforwardPeriodEnds2024Member 2021-12-31 0001099800 stpr:CA us-gaap:StateAndLocalJurisdictionMember us-gaap:ResearchMember ew:TaxCarryforwardsNoExpirationMember 2021-12-31 0001099800 country:US us-gaap:DomesticCountryMember us-gaap:ResearchMember ew:TaxCarryforwardsNoExpirationMember 2021-12-31 0001099800 us-gaap:NonUsMember us-gaap:ForeignCountryMember ew:ForeignTaxCreditMember ew:TaxCarryforwardsNoExpirationMember 2021-12-31 0001099800 country:PR us-gaap:ForeignCountryMember ew:PurchaseCreditMember ew:TaxCarryforwardsNoExpirationMember 2021-12-31 0001099800 country:PR us-gaap:ForeignCountryMember ew:PuertoRicoPurchasesCreditMember ew:TaxCarryforwardsNoExpirationMember 2021-12-31 0001099800 us-gaap:ForeignCountryMember 2021-01-01 2021-12-31 0001099800 us-gaap:ForeignCountryMember 2020-01-01 2020-12-31 0001099800 us-gaap:ForeignCountryMember 2019-01-01 2019-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:UnitedStatesSegmentMember 2021-01-01 2021-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:UnitedStatesSegmentMember 2020-01-01 2020-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:UnitedStatesSegmentMember 2019-01-01 2019-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:EuropeSegmentMember 2021-01-01 2021-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:EuropeSegmentMember 2020-01-01 2020-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:EuropeSegmentMember 2019-01-01 2019-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:JapanSegmentMember 2021-01-01 2021-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:JapanSegmentMember 2020-01-01 2020-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:JapanSegmentMember 2019-01-01 2019-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:RestOfWorldSegmentMember 2021-01-01 2021-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:RestOfWorldSegmentMember 2020-01-01 2020-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:RestOfWorldSegmentMember 2019-01-01 2019-12-31 0001099800 us-gaap:OperatingSegmentsMember 2021-01-01 2021-12-31 0001099800 us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0001099800 us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0001099800 us-gaap:MaterialReconcilingItemsMember 2021-01-01 2021-12-31 0001099800 us-gaap:MaterialReconcilingItemsMember 2020-01-01 2020-12-31 0001099800 us-gaap:MaterialReconcilingItemsMember 2019-01-01 2019-12-31 0001099800 us-gaap:CorporateNonSegmentMember 2021-01-01 2021-12-31 0001099800 us-gaap:CorporateNonSegmentMember 2020-01-01 2020-12-31 0001099800 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-12-31 0001099800 country:US 2021-01-01 2021-12-31 0001099800 country:US 2020-01-01 2020-12-31 0001099800 country:US 2019-01-01 2019-12-31 0001099800 srt:EuropeMember 2021-01-01 2021-12-31 0001099800 srt:EuropeMember 2020-01-01 2020-12-31 0001099800 srt:EuropeMember 2019-01-01 2019-12-31 0001099800 country:JP 2021-01-01 2021-12-31 0001099800 country:JP 2020-01-01 2020-12-31 0001099800 country:JP 2019-01-01 2019-12-31 0001099800 ew:RestOfWorldMember 2021-01-01 2021-12-31 0001099800 ew:RestOfWorldMember 2020-01-01 2020-12-31 0001099800 ew:RestOfWorldMember 2019-01-01 2019-12-31 0001099800 ew:TranscatheterAorticValveReplacementMember 2021-01-01 2021-12-31 0001099800 ew:TranscatheterAorticValveReplacementMember 2020-01-01 2020-12-31 0001099800 ew:TranscatheterAorticValveReplacementMember 2019-01-01 2019-12-31 0001099800 ew:TranscatheterMitralAndTricuspidTherapiesMember 2021-01-01 2021-12-31 0001099800 ew:TranscatheterMitralAndTricuspidTherapiesMember 2020-01-01 2020-12-31 0001099800 ew:TranscatheterMitralAndTricuspidTherapiesMember 2019-01-01 2019-12-31 0001099800 ew:SurgicalHeartValveTherapyMember 2021-01-01 2021-12-31 0001099800 ew:SurgicalHeartValveTherapyMember 2020-01-01 2020-12-31 0001099800 ew:SurgicalHeartValveTherapyMember 2019-01-01 2019-12-31 0001099800 ew:CriticalCareMember 2021-01-01 2021-12-31 0001099800 ew:CriticalCareMember 2020-01-01 2020-12-31 0001099800 ew:CriticalCareMember 2019-01-01 2019-12-31 0001099800 country:US 2021-12-31 0001099800 country:US 2020-12-31 0001099800 country:US 2019-12-31 0001099800 srt:EuropeMember 2021-12-31 0001099800 srt:EuropeMember 2020-12-31 0001099800 srt:EuropeMember 2019-12-31 0001099800 country:JP 2021-12-31 0001099800 country:JP 2020-12-31 0001099800 country:JP 2019-12-31 0001099800 ew:RestOfWorldMember 2021-12-31 0001099800 ew:RestOfWorldMember 2020-12-31 0001099800 ew:RestOfWorldMember 2019-12-31 0001099800 us-gaap:AllowanceForCreditLossMember 2020-12-31 0001099800 us-gaap:AllowanceForCreditLossMember 2021-01-01 2021-12-31 0001099800 us-gaap:AllowanceForCreditLossMember 2021-12-31 0001099800 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2020-12-31 0001099800 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2021-01-01 2021-12-31 0001099800 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2021-12-31 0001099800 us-gaap:AllowanceForCreditLossMember 2019-12-31 0001099800 us-gaap:AllowanceForCreditLossMember 2020-01-01 2020-12-31 0001099800 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-12-31 0001099800 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2020-01-01 2020-12-31 0001099800 us-gaap:AllowanceForCreditLossMember 2018-12-31 0001099800 us-gaap:AllowanceForCreditLossMember 2019-01-01 2019-12-31 0001099800 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-12-31 0001099800 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-01-01 2019-12-31 0001099800 ew:January2022StockRepurchaseProgramMember us-gaap:SubsequentEventMember 2022-01-31 0001099800 ew:January2022StockRepurchaseProgramMember us-gaap:SubsequentEventMember 2022-01-01 2022-01-31 iso4217:USD shares iso4217:USD shares pure ew:investment iso4217:EUR ew:lawsuit 0001099800 false 2021 FY P3Y 10-K true 2021-12-31 --12-31 false 1-15525 EDWARDS LIFESCIENCES CORPORATION DE 36-4316614 One Edwards Way Irvine CA 92614 949 250-2500 Common Stock, par value $1.00 per share EW NYSE Yes No Yes Yes Large Accelerated Filer false false true false 64028235982 623207437 Portions of the registrant's proxy statement for the 2022 Annual Meeting of Stockholders (to be filed within 120 days of December 31, 2021) are incorporated by reference into Part III, as indicated herein. 238 PricewaterhouseCoopers LLP Irvine, California 862800000 1183200000 604000000.0 219400000 9300000 9600000 582200000 514600000 82700000 88200000 726700000 802300000 85200000 75100000 237100000 208200000 3180700000 3091000000 1834200000 801600000 1546600000 1395200000 92100000 94200000 1167900000 1173200000 323600000 331400000 246700000 230900000 110800000 119600000 8502600000 7237100000 204500000 196500000 802300000 670200000 25500000 27200000 1032300000 893900000 595700000 595000000.0 62000000.0 186100000 190000000.0 215300000 69100000 72700000 259000000.0 214400000 191300000 233000000.0 267300000 252400000 2666700000 2662800000 0.01 0.01 50000000.0 50000000.0 0 0 0 0 1.00 1.00 1050000000 1050000000 642000000.0 636400000 624100000 624300000 642000000.0 636400000 1700400000 1438100000 6068100000 4565000000 -157700000 -161100000 17900000 12100000 2416900000 1904100000 5835900000 4574300000 8502600000 7237100000 5232500000 4386300000 4348000000 1248900000 1080600000 1114400000 3983600000 3305700000 3233600000 1493700000 1228400000 1242200000 903100000 760700000 752700000 20600000 405400000 33400000 -124100000 13600000 -6100000 0 0 64600000 1690300000 897600000 1146800000 18400000 15800000 20700000 17400000 23400000 32200000 12700000 11500000 8200000 1702000000 916700000 1166500000 198900000 93300000 119600000 1503100000 823400000 1046900000 2.41 1.32 1.68 2.38 1.30 1.64 623300000 622600000 624800000 631200000 631900000 636700000 1503100000 823400000 1046900000 -50100000 32400000 -11200000 57400000 -40200000 -11100000 -11600000 4200000 1900000 -24100000 6600000 6300000 -8600000 -300000 -400000 3400000 -5100000 -17500000 1506500000 818300000 1029400000 1503100000 823400000 1046900000 134800000 107200000 89300000 28500000 28200000 25300000 109300000 92600000 81300000 0 0 73100000 0 0 40600000 -124100000 13600000 -6100000 41400000 49400000 -12100000 0 0 24000000.0 23400000 3500000 2800000 91100000 -41900000 88000000.0 -19000000.0 120600000 105400000 -7900000 28500000 6800000 195200000 -84500000 116500000 -29200000 270500000 -180000000.0 62000000.0 -52900000 43200000 18500000 -16300000 -19700000 1732100000 1054300000 1182900000 325800000 407000000.0 254400000 250000000.0 162000000.0 130200000 138000000.0 212200000 50000000.0 1629300000 689700000 437900000 391200000 564800000 359900000 0 0 100200000 13100000 10000000.0 35000000.0 5100000 27000000.0 12900000 20000000.0 0 0 4000000.0 300000 24000000.0 44400000 12100000 11100000 -1722500000 -531100000 -595800000 5200000 16200000 18900000 7000000.0 17000000.0 28900000 512800000 625400000 263300000 158600000 140500000 160500000 -300000 -1200000 -2800000 -356300000 -486900000 -115600000 13900000 -20500000 -3000000.0 -332800000 15800000 468500000 1200200000 1184400000 715900000 867400000 1200200000 1184400000 215200000 215200000 7500000 -1015400000 1384400000 2694700000 -138500000 3140400000 1046900000 1046900000 -17500000 -17500000 2900000 2900000 157600000 160500000 81300000 81300000 -1500000 263300000 263300000 218100000 218100000 9000000.0 -1278700000 1623300000 3741600000 -156000000.0 4148300000 823400000 823400000 -5100000 -5100000 4500000 4500000 136000000.0 140500000 92600000 92600000 -3100000 625400000 625400000 -413800000 -413800000 413800000 0 636400000 636400000 12100000 -1904100000 1438100000 4565000000 -161100000 4574300000 1503100000 1503100000 3400000 3400000 5600000 5600000 153000000.0 158600000 109300000 109300000 -5800000 512800000 512800000 642000000.0 642000000.0 17900000 -2416900000 1700400000 6068100000 -157700000 5835900000 DESCRIPTION OF BUSINESSEdwards Lifesciences Corporation ("Edwards Lifesciences" or the "Company") conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. Edwards Lifesciences is focused on technologies that treat structural heart disease and critically ill patients. The products and technologies provided by Edwards Lifesciences are categorized into the following main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements include the accounts of Edwards Lifesciences and its majority-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The Company reviews its investments in other entities to determine whether the Company is the primary beneficiary of a variable interest entity ("VIE"). The Company would be the primary beneficiary of the VIE, and would be required to consolidate the VIE, if it has the power to direct the significant activities of the entity and the obligation to absorb losses or receive benefits from the entity that may be significant to the VIE. Based on the Company's analysis, it determined it is not the primary beneficiary of any material VIEs; however, future events may require VIEs to be consolidated if the Company becomes the primary beneficiary.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Split</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 7, 2020, the Company’s Board of Directors declared a three-for-one stock split of the Company's outstanding shares of common stock effected in the form of a stock dividend, distributed on May 29, 2020 to stockholders of record on May 18, 2020. The Company distributed two newly issued shares of common stock to holders of record of each share of common stock to effect the stock split. All applicable share and per-share amounts in the consolidated financial statements and the notes to consolidated financial statements have been retroactively adjusted to reflect this stock split. The consolidated statement of stockholders' equity for the year ended December 31, 2019 has not been retroactively adjusted to reflect the stock split.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements of Edwards Lifesciences have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") which have been applied consistently in all material respects. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. In particular, the COVID-19 pandemic has adversely impacted, and may further adversely impact, nearly all aspects of the Company's business and markets, including its workforce and the operations of its customers, suppliers, and business partners. The full extent to which the pandemic will directly or indirectly impact the Company's business, results of operations, and financial condition, including sales, expenses, manufacturing, clinical trials, research and development costs, reserves and allowances, fair value measurements, asset impairment charges, contingent consideration obligations, and the effectiveness of the Company's hedging instruments, will depend on future developments that are highly uncertain and difficult to predict. These developments include, but are not limited to, the duration and spread of the outbreak (including new and more contagious variants of COVID-19), its severity, the actions to contain the virus or address its impact, the timing, distribution, public acceptance and efficacy of vaccines and other treatments, United States and foreign government actions to respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the local currency of the Company's foreign entities is the functional currency, all assets and liabilities are translated into United States dollars at the rate of exchange in effect at the balance sheet date. Income and expense items are translated at the weighted-average exchange rate prevailing during the period. The effects of foreign currency translation adjustments for these entities are deferred and reported in stockholders' equity as a component of "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." The effects of foreign currency transactions denominated in a currency other than an entity's functional currency are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, net.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those products or services.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates nearly all of its revenue from direct product sales and sales of products under consignment arrangements. Revenue from direct product sales is recognized at a point in time when the performance obligation is satisfied upon delivery of the product. Revenue from sales of consigned inventory is recognized at a point in time when the performance obligation is satisfied once the product has been implanted or used by the customer. The Company periodically reviews consignment inventories to confirm the accuracy of customer reporting. The Company also generates a small portion of its revenue from service contracts, and recognizes revenue from service contracts ratably over the term of the contracts. Sales taxes and other similar taxes that the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company does not typically have any significant unusual payment terms beyond 90 days in its contracts with customers. In addition, the Company receives royalty payments for the licensing of certain intellectual property and recognizes the royalty when the subsequent sale of product using the intellectual property occurs.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of consideration the Company ultimately receives varies depending upon the return terms, sales rebates, discounts, and other incentives that the Company may offer, which are accounted for as variable consideration when estimating the amount of revenue to recognize. The Company includes estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely upon an assessment of historical payment experience, historical relationship to revenues, estimated customer inventory levels, and current contract sales terms with direct and indirect customers.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's sales adjustment related to distributor rebates given to the Company's United States distributors represents the difference between the Company's sales price to the distributor and the negotiated price to be paid by the end-customer. This distributor rebate is recorded as a reduction to sales and a reduction to the distributor's accounts receivable at the time of sale to a distributor. The Company periodically monitors current pricing trends and distributor inventory levels to ensure the credit for future distributor rebates is fairly stated.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers volume rebates to certain group purchasing organizations ("GPOs") and customers based upon targeted sales levels. Volume rebates offered to GPOs are recorded as a reduction to sales and an obligation to the GPOs, as the Company expects to pay in cash. Volume rebates offered to customers are recorded as a reduction to sales and either a reduction to accounts receivable if the Company expects a net payment from the customer, or as an obligation to the customer if the Company expects to pay in cash. The provision for volume rebates is estimated based upon customers' contracted rebate programs, projected sales levels, and historical experience of rebates paid. The Company periodically monitors its customer rebate programs to ensure that the allowance and liability for accrued rebates is fairly stated.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product returns are typically not significant because returns are generally not allowed unless the product is damaged at time of receipt. In limited circumstances, the Company may allow customers to return previously purchased products, such as for next-generation product offerings. For these transactions, the Company defers recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells separately priced service contracts, which range from 12 to 36 months, to owners of its hemodynamic monitors. The Company invoices the customer the total amount of consideration at the inception of the contract and recognizes revenue ratably over the term of the contract. As of December 31, 2021 and 2020, $10.2 million and $6.3 million, respectively, of deferred revenue associated with outstanding service contracts was recorded in “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued and Other Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">” and "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Long-term Liabilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" During 2021, the Company recognized as revenue $7.3 million that was included in the balance of deferred revenue as of December 31, 2020, and during 2020, the Company recognized as revenue $6.3 million that was included in the balance of deferred revenue as of December 31, 2019.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited number of the Company’s contracts with customers contain multiple performance obligations. For these contracts, the transaction price is allocated to each performance obligation based on its relative standalone selling price charged to other customers.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the optional exemption of not disclosing the amount of the transaction price allocated to unsatisfied performance obligations for contracts with an original expected duration of one year or less.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling Costs</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping costs, which are costs incurred to physically move product from the Company's premises or third party distribution centers, including storage, to the customer's premises, are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General, and Administrative Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." Handling costs, which are costs incurred to store at the Company's premises, move, and prepare products for shipment, are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." For the years ended December 31, 2021, 2020, and 2019, shipping costs of $85.3 million, $74.0 million, and $71.5 million, respectively, were included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General, and Administrative Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">."</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Equivalents</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers highly liquid investments with original maturities of three months or less to be cash equivalents. These investments are valued at cost, which approximates fair value.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investments</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company invests its excess cash in debt securities, including time deposits, commercial paper, United States government and agency securities, asset-backed securities, corporate debt securities, and municipal debt securities. Investments with maturities of one year or less are classified as short-term, and investments with maturities greater than one year are classified as long-term. Investments that the Company has the ability and intent to hold until maturity are classified as held-to-maturity and carried at amortized cost. Investments in debt securities that are classified as available-for-sale are carried at fair value with unrealized gains and losses included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." The Company determines the appropriate classification of its investments in debt securities at the time of purchase and reevaluates such designation at each balance sheet date.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has long-term equity investments in companies that are in various stages of development. These investments are reported at fair value or under the equity method of accounting, as appropriate. Equity investments that do not have readily determinable fair values are recorded at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The Company accounts for investments in limited partnerships and limited liability corporations, whereby the Company owns a minimum of 5% of the investee's outstanding voting stock, under the equity method of accounting. These investments are recorded at the amount of the Company's investment and adjusted each period for the Company's share of the investee's income or loss, and dividends paid. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized gains and losses on investments that are sold are determined using the specific identification method, or the first-in, first-out method, depending on the investment type, and recorded to "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." Income relating to investments in debt securities is recorded to "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Income.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity investments without readily determinable fair value are considered impaired when there is an indication that the fair value of the Company's interest is less than the carrying amount. Equity method investments are considered impaired when </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">there is an indication of an other-than-temporary decline in value below the carrying amount. Impairments of equity investments are recorded in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, net.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities in an unrealized loss position are written down to fair value through “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">” if the Company intends to sell the security or it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. For debt securities in an unrealized loss position that do not meet the aforementioned criteria, the Company assesses whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. When a credit loss exists, the Company compares the present value of cash flows expected to be collected from the debt security to the amortized cost basis of the security to determine the allowance amount that should be recorded, if any. </span></div><div style="padding-left:36pt;text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The majority of the Company’s accounts receivable arise from direct product sales and sales of products under consignment arrangements, and have payment terms that generally require payment within 30 to 90 days. The Company does not adjust its receivables for the effects of a significant financing component at contract exception if collection of the receivable is expected within one year or less from the time of sale. In countries where the Company has experienced a pattern of payments extending beyond the stated terms and collection of the receivable is expected beyond one year from the time of sale, the Company assesses whether the customer has a significant financing component and discounts the receivable and reduces the related revenues over the period of time that the Company estimates those amounts will be paid using the country’s market-based borrowing rate for such period.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company provides reserves against accounts receivable for estimated losses that may result from a customer’s inability to pay based on customer-specific analysis and general matters such as current assessments of past due balances, economic conditions and forecasts, and historical credit loss activity. Amounts determined to be uncollectible are charged or written-off against the reserve.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. Market value for raw materials is based on replacement costs, and for other inventory classifications is based on net realizable value.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A write-down for excess or slow moving inventory is recorded for inventory which is obsolete, damaged, nearing its expiration date (generally triggered at six months prior to expiration), or slow moving (generally defined as quantities in excess of a two-year supply). </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocates to inventory general and administrative costs that are related to the production process. These costs include insurance, manufacturing accounting and human resources personnel, and information technology. During the years ended December 31, 2021, 2020, and 2019, the Company allocated $77.9 million, $63.1 million, and $56.6 million, respectively, of general and administrative costs to inventory. General and administrative costs included in inventory at December 31, 2021 and 2020 were $33.7 million and $30.7 million, respectively.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021 and 2020, $125.8 million and $130.0 million, respectively, of the Company's finished goods inventories were held on consignment.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, the Company recorded a $73.1 million charge to "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">," primarily comprised of the write off of inventory related to strategic decisions regarding its transcatheter aortic valve portfolio, including the decision to discontinue its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CENTERA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> program.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant, and Equipment</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant, and equipment are recorded at cost. Depreciation is principally calculated for financial reporting purposes on the straight-line method over the estimated useful lives of the related assets, which range from 10 to 40 years for buildings and improvements, from 3 to 15 years for machinery and equipment, and from 3 to 5 years for software. Leasehold improvements are amortized over the life of the related facility leases or the asset, whichever is shorter. Straight-line and accelerated methods of depreciation are used for income tax purposes. Construction in progress is not depreciated until the asset is ready for its intended use.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for property, plant, and equipment was $127.0 million, $101.8 million, and $84.7 million for the years ended December 31, 2021, 2020, and 2019, respectively. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company determines whether a contract is, or contains, a lease at inception. Right-of-use assets represent the Company’s right to use an underlying asset during the lease term, and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at lease commencement based upon the estimated present value of unpaid lease payments over the lease term. The Company uses its incremental borrowing rate based on the information available at lease commencement in determining the present value of unpaid lease payments. The Company's incremental borrowing rate is determined based on the estimated rate of interest for collateralized borrowing over a similar term as the associated lease. Right-of-use assets also include any lease payments made at or before lease commencement and any initial direct costs incurred, and exclude any lease incentives received.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the lease term as the noncancellable period of the lease, and may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Leases with a term of 12 months or less are not recognized on the balance sheet. Certain of the Company’s leases include variable lease payments that are based on costs incurred or actual usage, or adjusted periodically based on an index or a rate. The Company’s leases do not contain any residual value guarantees.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for the lease and non-lease components as a single lease component for all of its leases except vehicle leases, for which the lease and non-lease components are accounted for separately.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases are included in “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Lease Right-of-Use Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">” and “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Lease Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">” on the Company’s consolidated balance sheets. See Note 6 for further information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Goodwill and Long-lived Assets</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate that the carrying amount may be impaired. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the Company performs a quantitative impairment test. The Company determined, after performing a qualitative review of each reporting unit, that it is more likely than not that the fair value of each of its reporting units substantially exceeds the respective carrying amounts. Accordingly, in 2021, 2020, and 2019, the Company did not record any goodwill impairment loss.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets relate to in-process research and development acquired in business combinations. The estimated fair values of in-process research and development projects acquired in a business combination which have not reached technological feasibility are capitalized and accounted for as indefinite-lived intangible assets subject to impairment testing until completion or abandonment of the projects. Upon successful completion of the project, the capitalized amount is amortized over its estimated useful life. If the project is abandoned, all remaining capitalized amounts are written off immediately. Indefinite-lived intangible assets are reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate the carrying amount may be impaired. An impairment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">loss is recognized when the asset's carrying value exceeds its fair value. In-process research and development projects acquired in an asset acquisition are expensed unless the project has an alternative future use. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management reviews the carrying amounts of other finite-lived intangible assets and long-lived tangible assets whenever events or circumstances indicate that the carrying amounts of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit, and adverse legal or regulatory developments. If it is determined that such indicators are present and the review indicates that the assets will not be fully recoverable, based on undiscounted estimated cash flows over the remaining amortization periods, their carrying values are reduced to estimated fair market value. Estimated fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. For the purposes of identifying and measuring impairment, long-lived assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In 2021 and 2020, the Company did not record any impairment loss related to its in-process research and development assets. In 2019, the Company recorded a $40.6 million charge related to the impairment of certain in-process research and development assets. See Note 4 for further information. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to income taxes in the United States and numerous foreign jurisdictions. Significant judgment is required in evaluating the Company's uncertain tax positions and determining its provision for income taxes. The Company recognizes the financial statement benefit of a tax position only after determining that a position would more likely than not be sustained based upon its technical merit if challenged by the relevant taxing authority and taken by management to the court of last resort. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon settlement with the relevant tax authority. The Company recognizes interest and penalties related to income tax matters in income tax expense. The Company has made an accounting policy election to recognize the United States tax effects of global intangible low-taxed income as a component of income tax expense in the period the tax arises. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been recognized in the Company's financial statements or tax returns. The Company evaluates quarterly the realizability of its deferred tax assets by assessing its valuation allowance and adjusting the amount, if necessary. The factors used to assess the likelihood of realization are both historical experience and the Company's forecast of future taxable income and available tax planning strategies that could be implemented to realize the net deferred tax assets. Failure to achieve forecasted taxable income in the applicable taxing jurisdictions could affect the ultimate realization of deferred tax assets and could result in an increase in the Company's effective tax rate on future earnings.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Costs</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are charged to expense when incurred.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings per Share</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during the period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,503.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623.3 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622.6 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624.8 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.41 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.68 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,503.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623.3 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622.6 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624.8 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock plans</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.38 </span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.30 </span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.64 </span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options, restricted stock units, and market-based restricted stock units to purchase approximately 1.8 million, 2.0 million, and 1.5 million shares were outstanding for the years ended December 31, 2021, 2020, and 2019, respectively, but were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-based Compensation</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures and recognizes compensation expense for all stock-based awards based on estimated fair values. Stock-based awards consist of stock options, restricted stock units (service-based and market-based), and employee stock purchase subscriptions. Stock-based compensation expense is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period (vesting period) on a straight-line basis. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Upon exercise of stock options or vesting of restricted stock units, the Company issues common stock.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense was as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.3 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.6 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.3 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense, net of tax</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.4 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.2 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.5 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon a participant's retirement, all unvested stock options are immediately forfeited. In addition, upon retirement, a participant will immediately vest in 25% of service-based restricted stock units for each full year of employment with the Company measured from the grant date. All remaining unvested service-based restricted stock units are immediately forfeited. For market-based restricted stock units, upon retirement and in certain other specified cases, a participant will receive a pro-rated portion of the shares that would ultimately be issued based on attainment of the performance goals as determined on the vesting date. The pro-rated portion is based on the participant's whole months of service with the Company during the performance period prior to the date of termination.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk. It is the Company's policy not to enter into derivative financial instruments for speculative purposes. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative financial instruments involve credit risk in the event the counterparty should default. It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy. The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities. The Company also uses International Swap Dealers Association master-netting agreements. The master-netting agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses foreign currency forward exchange contracts and cross currency swap contracts to manage its exposure to changes in currency exchange rates from (1) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within the next 13 months (designated as cash flow hedges), (2) its net investment in certain foreign subsidiaries (designated as net investment hedges) and (3) foreign currency denominated assets or liabilities (designated as fair value hedges). The Company also uses foreign currency forward exchange contracts that are not designated as hedging instruments to offset the transaction gains and losses associated with the revaluation of certain assets and liabilities denominated in currencies other than their functional currencies resulting principally from intercompany and local currency transactions. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative financial instruments are recognized at fair value in the consolidated balance sheets. For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings, and offsets the loss or gain on the underlying hedged item. The Company reports in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges. The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings. Changes in the fair value of net investment hedges are reported in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated. The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative. The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument. Cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on government assistance. The guidance requires certain disclosures about transactions with a government that are accounted for by applying a grant or contribution model. The guidance is effective for annual periods beginning after December 15, 2021, and should be applied either prospectively or retrospectively. The Company does not expect the adoption of this guidance will have a material impact on its consolidated financial statements.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements include the accounts of Edwards Lifesciences and its majority-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The Company reviews its investments in other entities to determine whether the Company is the primary beneficiary of a variable interest entity ("VIE"). The Company would be the primary beneficiary of the VIE, and would be required to consolidate the VIE, if it has the power to direct the significant activities of the entity and the obligation to absorb losses or receive benefits from the entity that may be significant to the VIE. Based on the Company's analysis, it determined it is not the primary beneficiary of any material VIEs; however, future events may require VIEs to be consolidated if the Company becomes the primary beneficiary.</span></div> 3 2 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements of Edwards Lifesciences have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") which have been applied consistently in all material respects. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. In particular, the COVID-19 pandemic has adversely impacted, and may further adversely impact, nearly all aspects of the Company's business and markets, including its workforce and the operations of its customers, suppliers, and business partners. The full extent to which the pandemic will directly or indirectly impact the Company's business, results of operations, and financial condition, including sales, expenses, manufacturing, clinical trials, research and development costs, reserves and allowances, fair value measurements, asset impairment charges, contingent consideration obligations, and the effectiveness of the Company's hedging instruments, will depend on future developments that are highly uncertain and difficult to predict. These developments include, but are not limited to, the duration and spread of the outbreak (including new and more contagious variants of COVID-19), its severity, the actions to contain the virus or address its impact, the timing, distribution, public acceptance and efficacy of vaccines and other treatments, United States and foreign government actions to respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the local currency of the Company's foreign entities is the functional currency, all assets and liabilities are translated into United States dollars at the rate of exchange in effect at the balance sheet date. Income and expense items are translated at the weighted-average exchange rate prevailing during the period. The effects of foreign currency translation adjustments for these entities are deferred and reported in stockholders' equity as a component of "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." The effects of foreign currency transactions denominated in a currency other than an entity's functional currency are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, net.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those products or services.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates nearly all of its revenue from direct product sales and sales of products under consignment arrangements. Revenue from direct product sales is recognized at a point in time when the performance obligation is satisfied upon delivery of the product. Revenue from sales of consigned inventory is recognized at a point in time when the performance obligation is satisfied once the product has been implanted or used by the customer. The Company periodically reviews consignment inventories to confirm the accuracy of customer reporting. The Company also generates a small portion of its revenue from service contracts, and recognizes revenue from service contracts ratably over the term of the contracts. Sales taxes and other similar taxes that the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company does not typically have any significant unusual payment terms beyond 90 days in its contracts with customers. In addition, the Company receives royalty payments for the licensing of certain intellectual property and recognizes the royalty when the subsequent sale of product using the intellectual property occurs.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of consideration the Company ultimately receives varies depending upon the return terms, sales rebates, discounts, and other incentives that the Company may offer, which are accounted for as variable consideration when estimating the amount of revenue to recognize. The Company includes estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely upon an assessment of historical payment experience, historical relationship to revenues, estimated customer inventory levels, and current contract sales terms with direct and indirect customers.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's sales adjustment related to distributor rebates given to the Company's United States distributors represents the difference between the Company's sales price to the distributor and the negotiated price to be paid by the end-customer. This distributor rebate is recorded as a reduction to sales and a reduction to the distributor's accounts receivable at the time of sale to a distributor. The Company periodically monitors current pricing trends and distributor inventory levels to ensure the credit for future distributor rebates is fairly stated.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers volume rebates to certain group purchasing organizations ("GPOs") and customers based upon targeted sales levels. Volume rebates offered to GPOs are recorded as a reduction to sales and an obligation to the GPOs, as the Company expects to pay in cash. Volume rebates offered to customers are recorded as a reduction to sales and either a reduction to accounts receivable if the Company expects a net payment from the customer, or as an obligation to the customer if the Company expects to pay in cash. The provision for volume rebates is estimated based upon customers' contracted rebate programs, projected sales levels, and historical experience of rebates paid. The Company periodically monitors its customer rebate programs to ensure that the allowance and liability for accrued rebates is fairly stated.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product returns are typically not significant because returns are generally not allowed unless the product is damaged at time of receipt. In limited circumstances, the Company may allow customers to return previously purchased products, such as for next-generation product offerings. For these transactions, the Company defers recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells separately priced service contracts, which range from 12 to 36 months, to owners of its hemodynamic monitors. The Company invoices the customer the total amount of consideration at the inception of the contract and recognizes revenue ratably over the term of the contract. As of December 31, 2021 and 2020, $10.2 million and $6.3 million, respectively, of deferred revenue associated with outstanding service contracts was recorded in “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued and Other Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">” and "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Long-term Liabilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" During 2021, the Company recognized as revenue $7.3 million that was included in the balance of deferred revenue as of December 31, 2020, and during 2020, the Company recognized as revenue $6.3 million that was included in the balance of deferred revenue as of December 31, 2019.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited number of the Company’s contracts with customers contain multiple performance obligations. For these contracts, the transaction price is allocated to each performance obligation based on its relative standalone selling price charged to other customers.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the optional exemption of not disclosing the amount of the transaction price allocated to unsatisfied performance obligations for contracts with an original expected duration of one year or less.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling Costs</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping costs, which are costs incurred to physically move product from the Company's premises or third party distribution centers, including storage, to the customer's premises, are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General, and Administrative Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." Handling costs, which are costs incurred to store at the Company's premises, move, and prepare products for shipment, are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Sales</span>." P12M P36M 10200000 6300000 7300000 6300000 85300000 74000000 71500000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Equivalents</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers highly liquid investments with original maturities of three months or less to be cash equivalents. These investments are valued at cost, which approximates fair value.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investments</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company invests its excess cash in debt securities, including time deposits, commercial paper, United States government and agency securities, asset-backed securities, corporate debt securities, and municipal debt securities. Investments with maturities of one year or less are classified as short-term, and investments with maturities greater than one year are classified as long-term. Investments that the Company has the ability and intent to hold until maturity are classified as held-to-maturity and carried at amortized cost. Investments in debt securities that are classified as available-for-sale are carried at fair value with unrealized gains and losses included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." The Company determines the appropriate classification of its investments in debt securities at the time of purchase and reevaluates such designation at each balance sheet date.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has long-term equity investments in companies that are in various stages of development. These investments are reported at fair value or under the equity method of accounting, as appropriate. Equity investments that do not have readily determinable fair values are recorded at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The Company accounts for investments in limited partnerships and limited liability corporations, whereby the Company owns a minimum of 5% of the investee's outstanding voting stock, under the equity method of accounting. These investments are recorded at the amount of the Company's investment and adjusted each period for the Company's share of the investee's income or loss, and dividends paid. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized gains and losses on investments that are sold are determined using the specific identification method, or the first-in, first-out method, depending on the investment type, and recorded to "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." Income relating to investments in debt securities is recorded to "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Income.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity investments without readily determinable fair value are considered impaired when there is an indication that the fair value of the Company's interest is less than the carrying amount. Equity method investments are considered impaired when </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">there is an indication of an other-than-temporary decline in value below the carrying amount. Impairments of equity investments are recorded in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, net.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities in an unrealized loss position are written down to fair value through “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, net</span>” if the Company intends to sell the security or it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. For debt securities in an unrealized loss position that do not meet the aforementioned criteria, the Company assesses whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. When a credit loss exists, the Company compares the present value of cash flows expected to be collected from the debt security to the amortized cost basis of the security to determine the allowance amount that should be recorded, if any. 0.05 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The majority of the Company’s accounts receivable arise from direct product sales and sales of products under consignment arrangements, and have payment terms that generally require payment within 30 to 90 days. The Company does not adjust its receivables for the effects of a significant financing component at contract exception if collection of the receivable is expected within one year or less from the time of sale. In countries where the Company has experienced a pattern of payments extending beyond the stated terms and collection of the receivable is expected beyond one year from the time of sale, the Company assesses whether the customer has a significant financing component and discounts the receivable and reduces the related revenues over the period of time that the Company estimates those amounts will be paid using the country’s market-based borrowing rate for such period.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company provides reserves against accounts receivable for estimated losses that may result from a customer’s inability to pay based on customer-specific analysis and general matters such as current assessments of past due balances, economic conditions and forecasts, and historical credit loss activity. Amounts determined to be uncollectible are charged or written-off against the reserve.</span></div> P30D P90D <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. Market value for raw materials is based on replacement costs, and for other inventory classifications is based on net realizable value.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A write-down for excess or slow moving inventory is recorded for inventory which is obsolete, damaged, nearing its expiration date (generally triggered at six months prior to expiration), or slow moving (generally defined as quantities in excess of a two-year supply). </span></div>The Company allocates to inventory general and administrative costs that are related to the production process. These costs include insurance, manufacturing accounting and human resources personnel, and information technology. P6M P2Y 77900000 63100000 56600000 33700000 30700000 125800000 130000000 73100000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant, and Equipment</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant, and equipment are recorded at cost. Depreciation is principally calculated for financial reporting purposes on the straight-line method over the estimated useful lives of the related assets, which range from 10 to 40 years for buildings and improvements, from 3 to 15 years for machinery and equipment, and from 3 to 5 years for software. Leasehold improvements are amortized over the life of the related facility leases or the asset, whichever is shorter. Straight-line and accelerated methods of depreciation are used for income tax purposes. Construction in progress is not depreciated until the asset is ready for its intended use.</span></div> P10Y P40Y P3Y P15Y P3Y P5Y 127000000 101800000 84700000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company determines whether a contract is, or contains, a lease at inception. Right-of-use assets represent the Company’s right to use an underlying asset during the lease term, and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at lease commencement based upon the estimated present value of unpaid lease payments over the lease term. The Company uses its incremental borrowing rate based on the information available at lease commencement in determining the present value of unpaid lease payments. The Company's incremental borrowing rate is determined based on the estimated rate of interest for collateralized borrowing over a similar term as the associated lease. Right-of-use assets also include any lease payments made at or before lease commencement and any initial direct costs incurred, and exclude any lease incentives received.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the lease term as the noncancellable period of the lease, and may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Leases with a term of 12 months or less are not recognized on the balance sheet. Certain of the Company’s leases include variable lease payments that are based on costs incurred or actual usage, or adjusted periodically based on an index or a rate. The Company’s leases do not contain any residual value guarantees.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for the lease and non-lease components as a single lease component for all of its leases except vehicle leases, for which the lease and non-lease components are accounted for separately.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases are included in “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Lease Right-of-Use Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">” and “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Lease Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">” on the Company’s consolidated balance sheets. See Note 6 for further information.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Goodwill and Long-lived Assets</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate that the carrying amount may be impaired. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the Company performs a quantitative impairment test. The Company determined, after performing a qualitative review of each reporting unit, that it is more likely than not that the fair value of each of its reporting units substantially exceeds the respective carrying amounts. Accordingly, in 2021, 2020, and 2019, the Company did not record any goodwill impairment loss.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets relate to in-process research and development acquired in business combinations. The estimated fair values of in-process research and development projects acquired in a business combination which have not reached technological feasibility are capitalized and accounted for as indefinite-lived intangible assets subject to impairment testing until completion or abandonment of the projects. Upon successful completion of the project, the capitalized amount is amortized over its estimated useful life. If the project is abandoned, all remaining capitalized amounts are written off immediately. Indefinite-lived intangible assets are reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate the carrying amount may be impaired. An impairment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">loss is recognized when the asset's carrying value exceeds its fair value. In-process research and development projects acquired in an asset acquisition are expensed unless the project has an alternative future use. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management reviews the carrying amounts of other finite-lived intangible assets and long-lived tangible assets whenever events or circumstances indicate that the carrying amounts of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit, and adverse legal or regulatory developments. If it is determined that such indicators are present and the review indicates that the assets will not be fully recoverable, based on undiscounted estimated cash flows over the remaining amortization periods, their carrying values are reduced to estimated fair market value. Estimated fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. For the purposes of identifying and measuring impairment, long-lived assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. </span></div> In 2021 and 2020, the Company did not record any impairment loss related to its in-process research and development assets. In 2019, the Company recorded a $40.6 million charge related to the impairment of certain in-process research and development assets. See Note 4 for further information. 0 0 40600000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to income taxes in the United States and numerous foreign jurisdictions. Significant judgment is required in evaluating the Company's uncertain tax positions and determining its provision for income taxes. The Company recognizes the financial statement benefit of a tax position only after determining that a position would more likely than not be sustained based upon its technical merit if challenged by the relevant taxing authority and taken by management to the court of last resort. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon settlement with the relevant tax authority. The Company recognizes interest and penalties related to income tax matters in income tax expense. The Company has made an accounting policy election to recognize the United States tax effects of global intangible low-taxed income as a component of income tax expense in the period the tax arises. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been recognized in the Company's financial statements or tax returns. The Company evaluates quarterly the realizability of its deferred tax assets by assessing its valuation allowance and adjusting the amount, if necessary. The factors used to assess the likelihood of realization are both historical experience and the Company's forecast of future taxable income and available tax planning strategies that could be implemented to realize the net deferred tax assets. Failure to achieve forecasted taxable income in the applicable taxing jurisdictions could affect the ultimate realization of deferred tax assets and could result in an increase in the Company's effective tax rate on future earnings.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Costs</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are charged to expense when incurred.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings per Share</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during the period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive.</span></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,503.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623.3 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622.6 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624.8 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.41 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.68 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,503.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623.3 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622.6 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624.8 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock plans</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.38 </span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.30 </span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.64 </span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1503100000 823400000 1046900000 623300000 622600000 624800000 2.41 1.32 1.68 1503100000 823400000 1046900000 623300000 622600000 624800000 7900000 9300000 11900000 631200000 631900000 636700000 2.38 1.30 1.64 1800000 2000000 1500000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-based Compensation</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures and recognizes compensation expense for all stock-based awards based on estimated fair values. Stock-based awards consist of stock options, restricted stock units (service-based and market-based), and employee stock purchase subscriptions. Stock-based compensation expense is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period (vesting period) on a straight-line basis. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Upon exercise of stock options or vesting of restricted stock units, the Company issues common stock.</span></div>Upon a participant's retirement, all unvested stock options are immediately forfeited. In addition, upon retirement, a participant will immediately vest in 25% of service-based restricted stock units for each full year of employment with the Company measured from the grant date. All remaining unvested service-based restricted stock units are immediately forfeited. For market-based restricted stock units, upon retirement and in certain other specified cases, a participant will receive a pro-rated portion of the shares that would ultimately be issued based on attainment of the performance goals as determined on the vesting date. The pro-rated portion is based on the participant's whole months of service with the Company during the performance period prior to the date of termination. <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense was as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.3 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.6 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.3 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense, net of tax</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.4 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.2 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.5 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 20400000 17200000 14700000 65600000 56600000 51200000 23300000 18800000 15400000 109300000 92600000 81300000 18900000 15400000 14800000 90400000 77200000 66500000 0.25 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk. It is the Company's policy not to enter into derivative financial instruments for speculative purposes. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative financial instruments involve credit risk in the event the counterparty should default. It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy. The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities. The Company also uses International Swap Dealers Association master-netting agreements. The master-netting agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses foreign currency forward exchange contracts and cross currency swap contracts to manage its exposure to changes in currency exchange rates from (1) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within the next 13 months (designated as cash flow hedges), (2) its net investment in certain foreign subsidiaries (designated as net investment hedges) and (3) foreign currency denominated assets or liabilities (designated as fair value hedges). The Company also uses foreign currency forward exchange contracts that are not designated as hedging instruments to offset the transaction gains and losses associated with the revaluation of certain assets and liabilities denominated in currencies other than their functional currencies resulting principally from intercompany and local currency transactions. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative financial instruments are recognized at fair value in the consolidated balance sheets. For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings, and offsets the loss or gain on the underlying hedged item. The Company reports in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges. The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings. Changes in the fair value of net investment hedges are reported in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated. The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative. The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument. Cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.</span></div> P13M <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on government assistance. The guidance requires certain disclosures about transactions with a government that are accounted for by applying a grant or contribution model. The guidance is effective for annual periods beginning after December 15, 2021, and should be applied either prospectively or retrospectively. The Company does not expect the adoption of this guidance will have a material impact on its consolidated financial statements.</span></div> INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred intellectual property litigation expenses, including settlements and external legal costs, of $20.6 million, $405.4 million and $33.4 million during 2021, 2020 and 2019, respectively. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 12, 2020, the Company reached an agreement with Abbott Laboratories and its direct and indirect subsidiaries ("Abbott") to, among other things, settle all outstanding patent disputes between the companies (the “Settlement Agreement”) in cases related to transcatheter mitral and tricuspid repair products. The Settlement Agreement resulted in the Company recording an estimated $367.9 million pre-tax charge and related liability in June 2020 related to past damages. In addition, the </span></div>Company will incur royalty expenses through May 2024 totaling an estimated $100 million. The Company made a one-time $100.0 million payment to Abbott in July 2020, and is making quarterly payments in subsequent years. 20600000 405400000 33400000 367900000 100000000 100000000 SPECIAL CHARGES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Impairment of Long-lived Assets</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Company recorded a charge of $40.6 million to fully impair certain in-process research and development assets. These assets were acquired as part of the acquisition of Valtech Cardio Ltd. ("Valtech") in 2017. The Company measured the amount of the impairment by calculating the amount by which the carrying values exceeded the estimated fair values, which was based on projected discounted future net cash flows. Based on market and clinical trial developments at the time of the impairment, the Company re-evaluated the clinical development plans for the technologies acquired from Valtech, which resulted in a reduction to the projected near-term discounted future net cash flows related to the acquired mitral and tricuspid technology. The impairment was recorded to the Company’s Rest of World segment.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Acquisition of Intellectual Property</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, the Company recorded a $24.0 million charge related to the acquisition of early-stage transcatheter intellectual property and associated clinical and regulatory experience.</span></div> 40600000 24000000 OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Composition of Certain Financial Statement Captions</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in the consolidated balance sheets are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,010.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment with customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,201.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,993.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(654.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(598.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,546.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and withholdings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, payroll, and other taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal and insurance (Notes 3 and 18)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued realignment reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued relocation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Cash Flow Information</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.846%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the year for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing transactions:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures accruals</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of notes receivable to equity investment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.846%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,183.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,179.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts included in restricted cash primarily represent funds placed in escrow related to litigation and real estate purchases. Restricted cash as of December 31, 2020 also included funds restricted for construction.</span></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in the consolidated balance sheets are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,010.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment with customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,201.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,993.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(654.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(598.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,546.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and withholdings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, payroll, and other taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal and insurance (Notes 3 and 18)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued realignment reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued relocation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 132800000 136700000 164300000 140000000.0 429600000 525600000 726700000 802300000 116500000 97600000 1010100000 881500000 613400000 564900000 39200000 42200000 88200000 94200000 333800000 313300000 2201200000 1993700000 654600000 598500000 1546600000 1395200000 319700000 236700000 77000000.0 67200000 68900000 49700000 58200000 52300000 79100000 60800000 30600000 18600000 3900000 39300000 20100000 14300000 11900000 7600000 19100000 14500000 26200000 21000000.0 87600000 88200000 802300000 670200000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Cash Flow Information</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.846%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the year for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing transactions:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures accruals</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of notes receivable to equity investment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 20200000 19900000 19900000 182500000 197900000 61500000 31900000 29700000 28600000 28700000 39700000 49600000 54300000 80400000 50800000 21500000 4500000 0 <div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.846%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,183.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,179.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.846%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,183.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,179.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 862800000 1183200000 1179100000 1500000 16600000 1600000 3100000 400000 3700000 867400000 1200200000 1184400000 LEASESThe Company leases certain office space, manufacturing facilities, land, apartments, warehouses, vehicles, and equipment with remaining lease terms ranging from less than 1 year to 19 years, some of which include options to extend or terminate the leases.<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease costs for the years ended December 31, 2021, 2020, and 2019 were $29.7 million, $30.5 million, and $27.9 million, respectively. Short-term and variable lease costs were not material for the years ended December 31, 2021, 2020, and 2019.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to operating leases was as follows (in millions, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current portion</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, long-term portion</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities at December 31, 2021 were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.181%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on the lease terms and discount rates:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>As of December 31, 2021, the Company had additional operating lease commitments of $2.5 million for office space that have not yet commenced. P1Y P19Y 29700000 30500000 27900000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to operating leases was as follows (in millions, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current portion</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, long-term portion</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 92100000 94200000 25500000 27200000 69100000 72700000 94600000 99900000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities at December 31, 2021 were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.181%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on the lease terms and discount rates:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 27500000 23000000.0 13600000 8300000 7500000 24600000 104500000 9900000 94600000 P6Y2M12D P6Y7M6D 0.025 0.027 2500000 INVESTMENTS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Debt Securities</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in debt securities at the end of each period were as follows (in millions):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.092%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Held-to-maturity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,192.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,183.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">935.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost and fair value of investments in debt securities, by contractual maturity, as of December 31, 2021 were as follows:</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-to-Maturity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1 year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 1 year through 5 years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,196.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,189.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 5 years through 10 years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments not due at a single maturity date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,192.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,183.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)     Consists of mortgage- and asset-backed securities.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual maturities may differ from the contractual maturities due to call or prepayment rights.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of December 31, 2021, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.265%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,632.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,632.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.849%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unrealized losses were largely due to changes in interest rates and were considered temporary. There were no investments that were in an unrealized loss position as of December 31, 2020. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Investments in Unconsolidated Entities</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a number of equity investments in unconsolidated entities. These investments are recorded in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated balance sheets, and are as follows:</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of equity method investments</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of non-marketable equity securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investments in unconsolidated entities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-marketable equity securities consist of investments in privately held companies without readily determinable fair values, and are reported at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The Company recorded an upward adjustment of $4.2 million based on observable price changes during 2021, and an upward adjustment of $1.8 million based on observable price changes and a downward adjustment of $0.7 million due to an impairment during 2020. As of December 31, 2021, the Company had recorded cumulative upward adjustments of $8.0 million based on observable price changes, and cumulative downward adjustments of $2.6 million due to impairment and observable price changes.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company recorded $35.9 million related to its investment in a privately-held medical device company (the "Investee"), including an initial cash investment in the Investee's preferred equity securities and other consideration. Also, in April 2021, the Company paid $5.7 million, included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" for an exclusive contingent option to acquire the Investee. Per the agreement, the Company may be required to invest up to an additional $9.9 million in the Investee's preferred equity securities and up to an additional $21.8 million for the option to acquire the Investee, depending on the achievement of certain milestones, of which the Company invested $10.8 million in the fourth quarter of 2021 upon achievement of the first milestone. The Company also agreed to loan the Investee up to $45 million under a secured promissory note. As of December 31, 2021, there had been no borrowings under this secured promissory note.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Investee is a VIE; however, Edwards has determined that it is not the primary beneficiary of the VIE since Edwards does not have the power to direct the activities of the Investee that most significantly impact the Investee's economic performance. Edwards accounts for this investment as a non-marketable equity security under the measurement alternative.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, 2020, and 2019, the gross realized gains or losses from sales of available-for-sale investments were not material.</span></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in debt securities at the end of each period were as follows (in millions):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.092%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Held-to-maturity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,192.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,183.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">935.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 162000000.0 0 0 162000000.0 50000000.0 0 0 50000000.0 2500000 0 0 2500000 24100000 0 0 24100000 127700000 0 0 127700000 0 0 0 0 147400000 600000 700000 147300000 147000000.0 2200000 0 149200000 515200000 300000 2900000 512600000 149600000 1900000 0 151500000 1397100000 2000000.0 8300000 1390800000 600800000 7500000 0 608300000 2800000 0 0 2800000 2800000 0 0 2800000 2192700000 2900000 11900000 2183700000 924300000 11600000 0 935900000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost and fair value of investments in debt securities, by contractual maturity, as of December 31, 2021 were as follows:</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-to-Maturity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1 year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 1 year through 5 years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,196.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,189.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 5 years through 10 years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments not due at a single maturity date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,192.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,183.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)     Consists of mortgage- and asset-backed securities.</span></div> 162000000.0 162000000.0 441300000 442000000.0 0 0 1196700000 1189600000 0 0 8700000 8600000 0 0 546000000.0 543500000 162000000.0 162000000.0 2192700000 2183700000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of December 31, 2021, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.265%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,632.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,632.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 85100000 700000 0 0 85100000 700000 433300000 2900000 0 0 433300000 2900000 1114100000 8300000 0 0 1114100000 8300000 1632500000 11900000 0 0 1632500000 11900000 0 in unconsolidated entities. These investments are recorded in "<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated balance sheets, and are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of equity method investments</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of non-marketable equity securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investments in unconsolidated entities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 8400000 5700000 84100000 29400000 92500000 35100000 4200000 1800000 -700000 8000000 2600000 35900000 5700000 9900000 21800000 10800000 45000000 0 ACQUISITIONS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAS Medical Systems, Inc.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On February 11, 2019, the Company entered into an agreement and plan of merger to acquire all the outstanding shares of CAS Medical Systems, Inc. ("CASMED") for an aggregate cash purchase price of $2.45 per share of common stock, or an equity value of approximately $100 million. The transaction closed on April 18, 2019, and the cash purchase price, net of cash acquired, was $100.2 million. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The results of operations for CASMED have been included in the accompanying consolidated financial statements from the date of acquisition. Pro forma results have not been presented as the results of CASMED are not material in relation to the consolidated financial statements of Edwards Lifesciences.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">In-process Research and Development Assets</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company acquired Harpoon Medical, Inc ("Harpoon") on December 1, 2017 and CardiAQ Valve Technologies, Inc. ("CardiAQ") on July 3, 2015. In-process research and development assets acquired as part of these transactions were capitalized at fair value, which was determined using the income approach. This approach determines fair value based on cash flow projections which are discounted to present value using a risk-adjusted rate of return. Completion of successful design developments, bench testing, pre-clinical studies and human clinical studies are required prior to selling any product. The risks and uncertainties associated with completing development within a reasonable period of time include those related to the design, development, and manufacturability of the product, the success of pre-clinical and clinical studies, and the timing of regulatory approvals. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The valuation for Harpoon assumed $41.4 million of additional research and development expenditures would be incurred prior to the date of product introduction. In the valuation, net cash inflows were modeled to commence in Europe in 2018, and in the United States and Japan in 2022. The Company does not currently anticipate significant changes to forecasted research and development expenditures, and net cash inflows commenced in Europe in 2020 and are now expected to commence in the United States and Japan in 2023. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The valuation for CardiAQ assumed $97.7 million of additional research and development expenditures would be incurred prior to the date of product introduction and that net cash inflows would commence in late 2018. As a result of certain design enhancements to increase the product's commercial life and applicability to a broader group of patients, the Company has incurred incremental research and development expenditures; however, the Company expects an increase in the net cash inflows, commencing in 2023. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Upon completion of development, the underlying research and development intangible assets will be amortized over their estimated useful lives. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain of the Company's business acquisitions involve contingent consideration arrangements. Payment of additional consideration in the future may be required, contingent upon the acquired business reaching certain performance milestones, such as attaining specified revenue levels or obtaining regulatory approvals. See Note 11 for further information.</span></div> 2.45 100000000 100200000 41400000 97700000 GOODWILL AND OTHER INTANGIBLE ASSETSGoodwill and in-process research and development assets resulting from purchase business combinations are not subject to amortization. Other acquired intangible assets with finite lives are amortized over their expected useful lives on a straight-line basis, or if reliably determinable, based on the pattern in which the economic benefit of the asset is expected to be used. The Company expenses costs incurred to renew or extend the term of acquired intangible assets.<div style="text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill, by segment, during the years ended December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:46.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.659%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United<br/>States</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2019</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,173.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2021</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consist of the following (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.102%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Useful Life (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570.1 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246.5)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323.6 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572.0 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240.6)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.4 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense related to other intangible assets for the years ended December 31, 2021, 2020, and 2019 was $7.7 million, $5.4 million, and $4.6 million, respectively. Estimated amortization expense for each of the years ending December 31 is as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill, by segment, during the years ended December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:46.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.659%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United<br/>States</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2019</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,173.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2021</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 773700000 62800000 331200000 1167700000 0 5500000 0 5500000 773700000 68300000 331200000 1173200000 0 -5300000 0 -5300000 773700000 63000000.0 331200000 1167900000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consist of the following (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.102%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Useful Life (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570.1 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246.5)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323.6 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572.0 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240.6)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.4 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consist of the following (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.102%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Useful Life (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570.1 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246.5)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323.6 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572.0 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240.6)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.4 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> P7Y4M24D 185700000 184200000 1500000 186100000 183600000 2500000 P13Y1M6D 153900000 55500000 98400000 155200000 51000000.0 104200000 P10Y 12400000 6800000 5600000 12600000 6000000.0 6600000 P12Y7M6D 352000000.0 246500000 105500000 353900000 240600000 113300000 218100000 218100000 218100000 218100000 570100000 246500000 323600000 572000000.0 240600000 331400000 7700000 5400000 4600000 Estimated amortization expense for each of the years ending December 31 is as follows (in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 6800000 8400000 8400000 10200000 15900000 DEBT AND CREDIT FACILITIESIn June 2018, the Company issued $600.0 million of fixed-rate unsecured senior notes (the "Notes") due June 15, 2028. Interest is payable semi-annually in arrears, with payments due in June and December of each year. The Company may redeem the Notes, in whole or in part, at any time and from time to time at specified redemption prices. In addition, upon the occurrence of certain change of control triggering events, the Company may be required to repurchase all or a portion of the Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest. The Notes also include covenants that limit the Company's ability to incur secured indebtedness, enter into sale and leaseback transactions, and consolidate, merge, or transfer all or substantially all of its assets. <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Notes as of December 31, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective<br/>Interest Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective<br/>Interest Rate</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-rate 4.300% 2018 Notes</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.329 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.329 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total carrying amount</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021 and 2020, the fair value of the Notes was $675.4 million and $711.2 million, respectively, based on observable market prices in less active markets and categorized as Level 2 (Note 11). The debt issuance costs, as well as the discount, are being amortized to interest expense over the term of the Notes. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a Five-Year Credit Agreement ("the Credit Agreement") which matures on April 28, 2023. The Credit Agreement provides up to an aggregate of $750.0 million in borrowings in multiple currencies. The Company may increase the amount available under the Credit Agreement, subject to agreement of the lenders, by up to an additional $250.0 million in the aggregate. Borrowings generally bear interest at the London interbank offered rate ("LIBOR"), or a comparable or successor rate, plus a spread ranging from 0.9% to 1.3%, depending on the leverage ratio, as defined in the Credit Agreement. The Company also pays a facility fee ranging from 0.1% to 0.2%, depending on the leverage ratio, on the entire credit commitment available, whether drawn or not. The facility fee is expensed as incurred. During 2021, the spread over LIBOR was 0.9% and the facility fee was 0.1%. Issuance costs of $2.4 million are being amortized to interest expense over the term of the Credit Agreement. As of December 31, 2021 and 2020, there were no borrowings outstanding under the Credit Agreement. Amounts outstanding under the Credit Agreement, if any from time to time, are classified as long-term obligations in accordance with the terms of the Credit Agreement. The Credit Agreement is unsecured and contains various financial and other covenants, including a maximum leverage ratio, as defined in the Credit Agreement. The Company was in compliance with all covenants at December 31, 2021.</span></div>The weighted-average interest rate under all debt obligations was 3.4% and 3.5% at December 31, 2021 and 2020, respectively. 600000000 1.01 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Notes as of December 31, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective<br/>Interest Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective<br/>Interest Rate</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-rate 4.300% 2018 Notes</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.329 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.329 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total carrying amount</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div> 0.04300 600000000.0 0.04329 600000000.0 0.04329 1000000.0 1100000 3300000 3900000 595700000 595000000.0 675400000 711200000 P5Y 750000000 250000000 0.009 0.013 0.001 0.002 0.009 0.001 2400000 0 0 0.034 0.035 FAIR VALUE MEASUREMENTS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The Company prioritizes the inputs used to determine fair values in one of the following three categories:</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1—Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2—Inputs, other than quoted prices in active markets, that are observable, either directly or indirectly.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3—Unobservable inputs that are not corroborated by market data.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include financial instruments for which the fair market value of such instruments may differ from amounts reflected on a historical cost basis. Financial instruments of the Company consist of cash deposits, accounts and other receivables, investments, accounts payable, certain accrued liabilities, and borrowings under a revolving credit agreement. The carrying value of these financial instruments generally approximates fair value due to their short-term nature. Financial instruments also include notes payable. See Note 10 for further information on the fair value of the notes payable.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis as of December 31, 2021 and 2020 (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,241.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,415.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in fair value of the contingent consideration obligation for the years ended December 31, 2021 and 2020 (in millions):</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.906%"><tr><td style="width:1.0%"/><td style="width:58.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.745%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.830%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.796%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.624%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.130%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, December 31, 2019</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, December 31, 2020</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, December 31, 2021</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in fair value of the contingent consideration liabilities in 2021 was primarily driven by a $123.2 million reduction to the liability due to changes in the projected probabilities and timing of milestone achievements and the projected timing of cash inflows. The change in fair value of the contingent consideration liabilities in 2020 was primarily driven by the accretion of interest due to the passage of time and adjustments to discount rates, partially offset by a $12.7 million reduction to the liability due to changes in the projected probabilities and timing of milestone achievements and the projected timing of cash inflows. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Equivalents and Available-for-sale Investments</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the fair values of its money market funds based on quoted prices in active markets for identical assets. The Company estimates the fair values of its time deposits, commercial paper, United States and foreign government and agency securities, municipal securities, asset-backed securities, and corporate debt securities by taking into consideration valuations obtained from third-party pricing services. The pricing services use industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades and broker-dealer quotes on the same or similar securities, benchmark yields, credit spreads, prepayment and default projections based on historical data, and other observable inputs. The Company independently reviews and validates the pricing received from the third-party pricing service by comparing the prices to prices reported by a secondary pricing source. The Company’s validation procedures have not resulted in an adjustment to the pricing received from the pricing service.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Compensation Plans</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments in trading securities related to its deferred compensation plans. The investments are in a variety of stock, bond, and money market mutual funds. The fair values of these investments and the corresponding liabilities are based on quoted market prices.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments in the form of foreign currency forward exchange contracts and cross currency swap contracts to manage foreign currency exposures. All derivatives contracts are recognized on the balance sheet at their fair value. The fair value of the derivative financial instruments was estimated based on quoted market foreign exchange rates, cross currency swap basis rates, and market discount rates. Judgment was employed in interpreting market data to develop estimates of fair value; accordingly, the estimates presented herein are not necessarily indicative of the amounts that the Company could realize in a current market exchange. The use of different market assumptions or valuation methodologies could have a material effect on the estimated fair value amounts.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration Liabilities</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's acquisitions involve contingent consideration arrangements. Payment of additional consideration is contingent upon the acquired company reaching certain performance milestones, such as attaining specified </span></div>sales levels or obtaining regulatory approvals. These contingent consideration liabilities are measured at estimated fair value using either a probability weighted discounted cash flow analysis or a Monte Carlo simulation model, both of which consider significant unobservable inputs. These inputs include (1) the discount rate used to present value the projected cash flows (ranging from 0.06% to 9.26%; weighted average of 4.1%), (2) the probability of milestone achievement (ranging from 0% to 93.7%; weighted average of 59.2%), (3) the projected payment dates (ranging from 2026 to 2027; weighted average of 2026), and (4) the volatility of future sales (40.0%). The weighted average of each of the above inputs was determined based on the relative fair value of each obligation. The use of different assumptions could have a material effect on the estimated fair value amounts. <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis as of December 31, 2021 and 2020 (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,241.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,415.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 15200000 30700000 0 45900000 0 2500000 0 2500000 0 1390800000 0 1390800000 0 512600000 0 512600000 28400000 118900000 0 147300000 0 127700000 0 127700000 0 2800000 0 2800000 130700000 0 0 130700000 0 55300000 0 55300000 174300000 2241300000 0 2415600000 0 3900000 0 3900000 130900000 0 0 130900000 0 0 62000000.0 62000000.0 0 0 14000000.0 14000000.0 130900000 3900000 76000000.0 210800000 16200000 0 0 16200000 0 24100000 0 24100000 0 608300000 0 608300000 0 151500000 0 151500000 56900000 92200000 0 149100000 0 2800000 0 2800000 111200000 0 0 111200000 0 8100000 0 8100000 184300000 887000000.0 0 1071300000 0 39300000 0 39300000 111600000 0 0 111600000 0 0 186100000 186100000 111600000 39300000 186100000 337000000.0 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in fair value of the contingent consideration obligation for the years ended December 31, 2021 and 2020 (in millions):</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.906%"><tr><td style="width:1.0%"/><td style="width:58.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.745%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.830%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.796%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.624%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.130%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, December 31, 2019</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, December 31, 2020</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, December 31, 2021</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 172500000 0 172500000 -13600000 0 -13600000 186100000 0 186100000 0 14000000.0 14000000.0 124100000 0 124100000 62000000.0 14000000.0 76000000.0 -123200000 -12700000 0.0006 0.0926 0.041 0 0.937 0.592 0.400 DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,498.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,525.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the location and fair value amounts of derivative instruments reported in the consolidated balance sheets (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.139%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of master-netting agreements and rights of offset on the consolidated balance sheets (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:26.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.298%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts Not Offset in the Consolidated Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts<br/>Offset in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts<br/>Presented in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Amounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash<br/>Collateral<br/>Received</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated statements of operations and consolidated statements of comprehensive income:</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.812%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.838%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.847%"/><td style="width:0.1%"/></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss) Reclassified from Accumulated OCI into Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.812%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.838%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.847%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:45pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss) Reclassified from Accumulated OCI into Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on Derivative (Amount Excluded from<br/> Effectiveness Testing)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cross currency swap contracts have an expiration date of June 15, 2028. At maturity of the cross currency swap contracts, the Company will deliver the notional amount of €257.2 million and will receive $300.0 million from the counterparties. The Company will receive semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:36.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.936%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or<br/>(Loss) Recognized in<br/>Income on Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or<br/>(Loss) Recognized in<br/>Income on Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:36.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.936%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or<br/>(Loss) Recognized in<br/>Income on Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or<br/>(Loss) Recognized in<br/>Income on Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of fair value and cash flow hedge accounting on the consolidated statements of operations:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.090%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Income, net</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,248.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,493.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on fair value hedging relationships:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.090%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Income, net</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,080.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,228.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on fair value hedging relationships:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects that during 2022 it will reclassify to earnings a $7.8 million gain currently recorded in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." For the years ended December 31, 2021, 2020, and 2019, the Company did not record any gains or losses due to hedge ineffectiveness.</span></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,498.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,525.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 1498800000 1525500000 300000000.0 300000000.0 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the location and fair value amounts of derivative instruments reported in the consolidated balance sheets (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.139%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 36200000 7300000 19100000 800000 3900000 39300000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of master-netting agreements and rights of offset on the consolidated balance sheets (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:26.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.298%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts Not Offset in the Consolidated Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts<br/>Offset in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts<br/>Presented in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Amounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash<br/>Collateral<br/>Received</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of master-netting agreements and rights of offset on the consolidated balance sheets (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:26.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.298%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts Not Offset in the Consolidated Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts<br/>Offset in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts<br/>Presented in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Amounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash<br/>Collateral<br/>Received</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 36200000 0 36200000 2800000 0 33400000 19100000 0 19100000 0 0 19100000 3900000 0 3900000 2800000 0 1100000 7300000 0 7300000 6100000 0 1200000 800000 0 800000 0 0 800000 39300000 0 39300000 6100000 0 33200000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated statements of operations and consolidated statements of comprehensive income:</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.812%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.838%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.847%"/><td style="width:0.1%"/></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss) Reclassified from Accumulated OCI into Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.812%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.838%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.847%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:45pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss) Reclassified from Accumulated OCI into Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on Derivative (Amount Excluded from<br/> Effectiveness Testing)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cross currency swap contracts have an expiration date of June 15, 2028. At maturity of the cross currency swap contracts, the Company will deliver the notional amount of €257.2 million and will receive $300.0 million from the counterparties. The Company will receive semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:36.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.936%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or<br/>(Loss) Recognized in<br/>Income on Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or<br/>(Loss) Recognized in<br/>Income on Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:36.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.936%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or<br/>(Loss) Recognized in<br/>Income on Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or<br/>(Loss) Recognized in<br/>Income on Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 56700000 -33700000 -23000000.0 18400000 -600000 2200000 18400000 -12600000 6400000 6400000 257200000 300000000 11600000 -1400000 1400000 27400000 -15100000 300000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of fair value and cash flow hedge accounting on the consolidated statements of operations:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.090%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Income, net</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,248.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,493.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on fair value hedging relationships:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.090%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Income, net</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,080.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,228.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on fair value hedging relationships:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 1248900000 1493700000 12700000 0 0 -9000000.0 0 0 9000000.0 0 0 2600000 -23000000.0 -600000 0 1080600000 1228400000 11500000 0 0 4800000 0 0 -4800000 0 0 3400000 18400000 2200000 0 7800000 EMPLOYEE BENEFIT PLANS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined Benefit Plans</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains defined benefit pension plans in Japan and certain European countries. </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in projected benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan amendment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate changes and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in fair value of plan assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate changes and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded Status</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan assets at fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underfunded status</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net amounts recognized on the consolidated balance sheet:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accumulated benefit obligation ("ABO") for all defined benefit pension plans was $113.3 million and $120.9 million as of December 31, 2021 and 2020, respectively. The projected benefit obligation and ABO were in excess of plan assets for all pension plans as of December 31, 2021 and 2020. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic pension benefit cost are as follows (in millions):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension benefit cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected long-term returns for each of the plans' strategic asset classes were developed through consultation with investment advisors. Several factors were considered, including a survey of investment managers' expectations, current market data, minimum guaranteed returns in certain insurance contracts, and historical market returns over long periods. Using policy target allocation percentages and the asset class expected returns, a weighted-average expected return was calculated.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To select the discount rates for the defined benefit pension plans, the Company uses a modeling process that involves matching the expected duration of its benefit plans to a yield curve constructed from a portfolio of AA-rated fixed-income debt instruments, or their equivalent. For each country, the Company uses the implied yield of this hypothetical portfolio at the appropriate duration as a discount rate benchmark.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used to determine the benefit obligations are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash balance interest crediting rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Social securities increase</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used to determine the net periodic pension benefit cost are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash balance interest crediting rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Social securities increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension increase</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan Assets</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's investment strategy for plan assets is to seek a competitive rate of return relative to an appropriate level of risk and to earn performance rates of return in accordance with the benchmarks adopted for each asset class. Risk management practices include diversification across asset classes and investment styles, and periodic rebalancing toward asset allocation targets.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrative and Investment Committee decides on the defined benefit plan provider in each location and that provider decides the target allocation for the Company's defined benefit plan at that location. The target asset allocation selected reflects a risk/return profile the Company feels is appropriate relative to the plans' liability structure and return goals. In certain plans, asset allocations may be governed by local requirements. Target weighted-average asset allocations at December 31, 2021, by asset category, are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company's defined benefit plan assets at December 31, 2021 and 2020, by asset category, are as follows (in millions): </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States equities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgages</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets measured at fair value</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alternative investments measured at net asset value (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States equities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International government bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgages</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.8 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.5 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alternative investments measured at net asset value (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.3 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)     Certain investments that were measured at net asset value per share have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the total plan assets.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in fair value of the Company's defined benefit plan assets that have been classified as Level 3 for the years ended December 31, 2021 and 2020 (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.281%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance<br/>Contracts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity and debt securities are valued at fair value based on quoted market prices reported on the active markets on which the individual securities are traded. Real estate investments are valued by discounting to present value the cash flows expected to be generated by the specific properties. Investments in mortgages are valued at cost, which is deemed to approximate its fair value. The insurance contracts are valued at the cash surrender value of the contracts, which is deemed to approximate its fair value. Alternative investments include hedge funds, private equity funds and other miscellaneous investments, and are valued using the net asset value provided by the fund administrator as a practical expedient. The net asset value is based on the fair value of the underlying assets owned by the fund divided by the number of shares outstanding.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following benefit payments, which reflect expected future service, as appropriate, at December 31, 2021, are expected to be paid (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024-2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, expected employer contributions for 2022 are $2.2 million.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined Contribution Plans </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's employees in the United States and Puerto Rico are eligible to participate in a qualified defined contribution plan. In the United States, participants may contribute up to 25% of their eligible compensation (subject to tax code limitation) to the plan. Edwards Lifesciences matches the first 4% of the participant's annual eligible compensation contributed to the plan on a dollar-for-dollar basis. Edwards Lifesciences matches the next 2% of the participant's annual eligible compensation to the plan on a 50% basis. In Puerto Rico, participants may contribute up to 25% of their annual compensation (subject to tax code limitation) to the plan. Edwards Lifesciences matches the first 4% of participant's annual eligible compensation contributed to the plan on a 50% basis. The Company also provides a 2% profit sharing contribution calculated on eligible earnings for each employee. Matching contributions relating to Edwards Lifesciences employees were $38.6 million, $36.6 million, and $31.4 million in 2021, 2020, and 2019, respectively.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has nonqualified deferred compensation plans for a select group of employees. The plans provide eligible participants the opportunity to defer eligible compensation to future dates specified by the participant with a return based on investment alternatives selected by the participant. The amount accrued under these nonqualified plans was $130.9 million and $111.6 million at December 31, 2021 and 2020, respectively.</span></div> <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in projected benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan amendment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate changes and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in fair value of plan assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate changes and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded Status</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan assets at fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underfunded status</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net amounts recognized on the consolidated balance sheet:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 126200000 105200000 6500000 6300000 400000 500000 1500000 1500000 6100000 -2900000 2500000 600000 500000 0 7600000 -10400000 117900000 126200000 73300000 63200000 5800000 400000 3100000 2800000 1500000 1500000 2500000 600000 -4300000 6000000.0 76900000 73300000 117900000 126200000 76900000 73300000 -41000000.0 -52900000 41000000.0 52900000 -16400000 -30800000 -6000000.0 -6600000 -2400000 -4600000 8000000.0 19600000 113300000 120900000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic pension benefit cost are as follows (in millions):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension benefit cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 6500000 6300000 5200000 400000 500000 900000 1100000 1000000.0 1400000 -1700000 -1600000 -900000 -700000 -700000 -200000 6800000 6700000 5400000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used to determine the benefit obligations are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash balance interest crediting rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Social securities increase</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used to determine the net periodic pension benefit cost are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash balance interest crediting rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Social securities increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension increase</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 0.005 0.003 0.026 0.026 0.025 0.025 0.016 0.016 0.018 0.018 0.003 0.005 0.009 0.015 0.015 0.023 0.026 0.027 0.028 0.025 0.015 0.015 0.016 0.016 0.018 0.018 0.018 0.018 Target weighted-average asset allocations at December 31, 2021, by asset category, are as follows:<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company's defined benefit plan assets at December 31, 2021 and 2020, by asset category, are as follows (in millions): </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States equities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgages</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets measured at fair value</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alternative investments measured at net asset value (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States equities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International government bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgages</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.8 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.5 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alternative investments measured at net asset value (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.3 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)     Certain investments that were measured at net asset value per share have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the total plan assets.</span></div> 0.283 0.417 0.098 0.202 1.000 5400000 0 0 5400000 1600000 0 0 1600000 16300000 0 0 16300000 6200000 0 0 6200000 26300000 0 0 26300000 0 7600000 0 7600000 0 3500000 0 3500000 0 0 900000 900000 55800000 11100000 900000 67800000 9100000 76900000 3000000.0 0 0 3000000.0 3300000 0 0 3300000 16100000 0 0 16100000 7400000 0 0 7400000 26000000.0 0 0 26000000.0 0 5600000 0 5600000 0 3100000 0 3100000 0 0 1000000.0 1000000.0 55800000 8700000 1000000.0 65500000 7800000 73300000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in fair value of the Company's defined benefit plan assets that have been classified as Level 3 for the years ended December 31, 2021 and 2020 (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.281%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance<br/>Contracts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 900000 100000 1000000.0 -100000 900000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following benefit payments, which reflect expected future service, as appropriate, at December 31, 2021, are expected to be paid (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024-2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 5400000 6700000 5600000 5200000 6100000 36100000 2200000 0.25 0.04 0.02 0.50 0.25 0.04 0.50 0.02 38600000 36600000 31400000 130900000 111600000 COMMON STOCK<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Treasury Stock</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2019, the Board of Directors approved a stock repurchase program authorizing the Company to purchase up to $1.0 billion of the Company's common stock. In May 2021, the Board of Directors approved a new stock repurchase program for an additional $1.0 billion of the Company's common stock. The repurchase programs do not have an expiration date. Stock repurchased under these programs may be used to offset obligations under the Company's employee stock-based benefit programs and stock-based business acquisitions, and will reduce the total shares outstanding.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, 2020, and 2019, the Company repurchased 5.8 million, 3.1 million, and 1.5 million shares, respectively, at an aggregate cost of $512.8 million, $625.4 million, and $263.3 million, respectively, including shares purchased under the accelerated share repurchase ("ASR") agreements described below and shares acquired to satisfy tax withholding obligations in connection with the vesting of restricted stock units issued to employees. The timing and size of any future stock repurchases are subject to a variety of factors, including expected dilution from stock plans, cash capacity, and the market price of the Company's common stock.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accelerated Share Repurchase</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021 and 2019, the Company entered into ASR agreements providing for the repurchase of the Company's common stock based on the volume-weighted average price ("VWAP") of the Company's common stock during the term of the agreements, less a discount. The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:20.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.535%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.458%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.478%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Initial Delivery</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Settlement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agreement Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>Paid</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Price per<br/>Share (a)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value of<br/>Shares as %<br/>of Contract<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlement<br/>Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price<br/>per Share (a)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.66 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.42 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.02 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.46 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.86 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.51 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)    The three-for-one stock split distributed on May 29, 2020 excluded treasury shares. The shares and per share prices in the table are reflected at the pre-split amounts and prices at the time of the transaction.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ASR agreements were accounted for as two separate transactions: (1) the value of the initial delivery of shares was recorded as shares of common stock acquired in a treasury stock transaction on the acquisition date and (2) the remaining amount of the purchase price paid was recorded as a forward contract indexed to the Company's own common stock and was recorded in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Paid-in Capital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated balance sheets. The initial delivery of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted-average common shares outstanding for basic and diluted earnings per share. The Company determined that the forward contract indexed to the Company's common stock met all the applicable criteria for equity classification and, therefore, was not accounted for as a derivative instrument.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee and Director Stock Plans</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Edwards Lifesciences Corporation Long-term Stock Incentive Compensation Program (the "Program") provides for the grant of incentive and non-qualified stock options, restricted stock, and restricted stock units for eligible employees of the Company. Under the Program, these grants are awarded at a price equal to the fair market value at the date of grant based upon the closing price on that date. Options to purchase shares of the Company's common stock granted under the Program generally vest over predetermined periods of between <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjhlNjQwNGViZDk4ZDQxNmRhYTdmODhmNDgxNTliNjAxL3NlYzo4ZTY0MDRlYmQ5OGQ0MTZkYWE3Zjg4ZjQ4MTU5YjYwMV8xMjcvZnJhZzplMDM4ODYzNmIwMjg0NDIwYjdiM2Q2ZDRiYWFiNmNkMi90ZXh0cmVnaW9uOmUwMzg4NjM2YjAyODQ0MjBiN2IzZDZkNGJhYWI2Y2QyXzMxNjI_1d5ec811-d310-4a3b-a2b8-27b94b8011ca">three</span> to four years and expire seven years after the date of grant. Service-based restricted stock units of the Company's common stock granted under the Program generally vest over predetermined periods, typically four years after the date of grant. Market-based restricted stock units of the Company's common stock granted under the Program vest over three years based on a combination of certain service and market conditions. The actual number of shares issued will be determined based on the Company's total stockholder return relative to a selected industry peer group. Under the Program, the number of shares of common stock authorized for issuance under the Program was 327.6 million shares. No more than 33.6 million shares reserved for issuance may be granted in the form of restricted stock or restricted stock units.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains the Nonemployee Directors Stock Incentive Compensation Program (the "Nonemployee Directors Program"). Under the Nonemployee Directors Program, annually each nonemployee director may receive up to 120,000 stock options or 48,000 restricted stock units of the Company's common stock, or a combination thereof, provided that in no event may the total value of the combined annual award exceed $0.2 million. These grants generally vest over one year from the date of grant. Under the Nonemployee Directors Program, an aggregate of 8.4 million shares of the Company's common stock has been authorized for issuance.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an employee stock purchase plan for United States employees and a plan for employees outside of the United States (collectively "ESPP"). Under the ESPP, eligible employees may purchase shares of the Company's common stock at 85% of the lower of the fair market value of Edwards Lifesciences common stock on the effective date of subscription or the date of purchase. Under the ESPP, employees can authorize the Company to withhold up to 15% of their compensation for common stock purchases, subject to certain limitations. The ESPP is available to all active employees of the Company paid from the United States payroll and to eligible employees of the Company outside of the United States, to the extent permitted </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by local law. The ESPP for United States employees is qualified under Section 423 of the Internal Revenue Code. The number of shares of common stock authorized for issuance under the ESPP was 50.4 million shares.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each option award and employee stock purchase subscription is estimated on the date of grant using the Black-Scholes option valuation model that uses the assumptions noted in the following tables. The risk-free interest rate is estimated using the United States Treasury yield curve and is based on the expected term of the award. Expected volatility is estimated based on a blend of the weighted-average of the historical volatility of Edwards Lifesciences' stock and the implied volatility from traded options on Edwards Lifesciences' stock. The expected term of awards granted is estimated from the vesting period of the award, as well as historical exercise behavior, and represents the period of time that awards granted are expected to be outstanding. The Company uses historical data to estimate forfeitures and has estimated an annual forfeiture rate of 6.4%.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model was used with the following weighted-average assumptions for options granted during the following periods:</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Option Awards</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.90 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.70 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model was used with the following weighted-average assumptions for ESPP subscriptions granted during the following periods:</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ESPP</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.07 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.61 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of market-based restricted stock units was determined using a Monte Carlo simulation model, which uses multiple input variables to determine the probability of satisfying the market condition requirements. The weighted-average assumptions used to determine the fair value of the market-based restricted stock units during the years ended December 31, 2021, 2020, and 2019 included a risk-free interest rate of 0.4%, 0.2%, and 2.2%, respectively, and an expected volatility rate of 34.4%, 32.7%, and 29.4%, respectively.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity during the year ended December 31, 2021 under the Program and the Nonemployee Directors Program was as follows (in millions, except years and per-share amounts):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.27 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.04 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.84 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.89 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.84 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2021</span></div></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.84 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 years</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vested and expected to vest as of December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.74 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes nonvested restricted stock unit activity during the year ended December 31, 2021 under the Program and the Nonemployee Directors Program (in millions, except per-share amounts):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant-Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested as of December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.59 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted (a)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.95 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.82 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.54 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested as of December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.94 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)    The shares granted include 0.1 million shares of market-based restricted stock units granted during 2021, which represents the target number of shares to be issued, and 0.1 million shares related to a previous year's grant of market-based restricted stock units since the payout percentage achieved at the end of the performance period was in excess of target. As described above, the actual number of shares ultimately issued is determined based on the Company's total stockholder return relative to a selected industry peer group. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intrinsic value of stock options exercised and restricted stock units vested during the years ended December 31, 2021, 2020, and 2019 were $359.8 million, $323.5 million, and $382.1 million, respectively. The intrinsic value of stock options is calculated as the amount by which the market price of the Company's common stock exceeds the exercise price of the option. During the years ended December 31, 2021, 2020, and 2019, the Company received cash from exercises of stock options of $82.2 million, $79.2 million, and $110.4 million, respectively, and tax benefits from exercises of stock options and vesting of restricted stock units of $76.5 million, $72.1 million, and $85.1 million, respectively. The total grant-date fair value of stock options vested during the years ended December 31, 2021, 2020, and 2019 were $36.2 million, $34.0 million, and $31.2 million, respectively.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the total remaining unrecognized compensation expense related to nonvested stock options, restricted stock units, and employee stock purchase subscriptions amounted to $162.3 million, which will be amortized over the weighted-average remaining requisite service period of 30 months.</span></div> 1000000000 1000000000 -5800000 -3100000 -1500000 512800000 625400000 263300000 The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:20.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.535%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.458%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.478%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Initial Delivery</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Settlement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agreement Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>Paid</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Price per<br/>Share (a)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value of<br/>Shares as %<br/>of Contract<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlement<br/>Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price<br/>per Share (a)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.66 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.42 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.02 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.46 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.86 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.51 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)    The three-for-one stock split distributed on May 29, 2020 excluded treasury shares. The shares and per share prices in the table are reflected at the pre-split amounts and prices at the time of the transaction.</span></div> 150000000.0 700000 178.66 0.80 800000 178.42 100000000.0 500000 170.02 0.80 600000 178.46 250000000.0 2400000 83.86 0.80 3000000.0 84.51 3 P4Y P7Y P4Y P3Y 327600000 33600000 120000 48000 200000 P1Y 8400000 0.85 0.15 50400000 0.064 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model was used with the following weighted-average assumptions for options granted during the following periods:</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Option Awards</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.90 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.70 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0.008 0.003 0.023 0 0 0 0.34 0.33 0.30 P5Y P5Y P5Y1M6D 28.90 21.70 18.17 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model was used with the following weighted-average assumptions for ESPP subscriptions granted during the following periods:</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ESPP</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.07 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.61 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0.001 0.013 0.024 0 0 0 0.37 0.33 0.27 P0Y7M6D P0Y7M6D P0Y7M6D 23.07 16.61 16.43 0.004 0.002 0.022 0.344 0.327 0.294 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity during the year ended December 31, 2021 under the Program and the Nonemployee Directors Program was as follows (in millions, except years and per-share amounts):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.27 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.04 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.84 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.89 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.84 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2021</span></div></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.84 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 years</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vested and expected to vest as of December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.74 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 14300000 41.27 1600000 94.04 3400000 23.84 200000 67.89 12300000 52.84 P3Y6M 943100000 8200000 41.84 P2Y7M6D 719700000 11700000 51.74 P3Y4M24D 911400000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes nonvested restricted stock unit activity during the year ended December 31, 2021 under the Program and the Nonemployee Directors Program (in millions, except per-share amounts):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant-Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested as of December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.59 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted (a)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.95 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.82 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.54 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested as of December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.94 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div>(a)    The shares granted include 0.1 million shares of market-based restricted stock units granted during 2021, which represents the target number of shares to be issued, and 0.1 million shares related to a previous year's grant of market-based restricted stock units since the payout percentage achieved at the end of the performance period was in excess of target. As described above, the actual number of shares ultimately issued is determined based on the Company's total stockholder return relative to a selected industry peer group. 2600000 57.59 800000 92.95 1000000.0 48.82 100000 66.54 2300000 73.94 100000 100000 359800000 323500000 382100000 82200000 79200000 110400000 76500000 72100000 85100000 36200000 34000000 31200000 162300000 P30M ACCUMULATED OTHER COMPREHENSIVE LOSS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presented below is a summary of activity for each component of "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" for the years ended December 31, 2021, 2020, and 2019. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized (Loss) Gain on<br/>Available-for-sale<br/>Investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Pension<br/>Costs (a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (expense) benefit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit (expense)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (expense) benefit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">For the years ended December 31, 2021, 2020, and 2019, the change in unrealized pension costs consisted of the following (in millions):</span></div><div style="margin-top:5pt;padding-left:18pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-Tax<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax (Expense) Benefit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net of Tax<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit arising during period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net prior service cost arising during period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss arising during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized pension costs, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit arising during period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net prior service cost arising during period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss arising during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized pension costs, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit arising during period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net prior service credit arising during period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss arising during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized pension costs, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about amounts reclassified from "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.769%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about Accumulated Other Comprehensive Loss<br/>Components</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected Line on Consolidated<br/>Statements of Operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on hedges</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.0)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) gain on available-for-sale investments</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of pension adjustments</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr></table></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presented below is a summary of activity for each component of "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" for the years ended December 31, 2021, 2020, and 2019. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized (Loss) Gain on<br/>Available-for-sale<br/>Investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Pension<br/>Costs (a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (expense) benefit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit (expense)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (expense) benefit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> -143600000 23600000 -5000000.0 -13500000 -138500000 -1500000 27900000 7900000 -3200000 31100000 6600000 44200000 -400000 -700000 49700000 3100000 -5200000 1600000 -600000 -1100000 -154800000 12500000 1700000 -15400000 -156000000.0 35700000 -34800000 8000000.0 -5500000 3400000 6400000 19200000 -300000 -900000 24400000 -3100000 -13800000 1400000 -400000 -15900000 -122400000 -27700000 8600000 -19600000 -161100000 -39200000 66300000 -29200000 12800000 10700000 6400000 -12000000.0 -8600000 -1000000.0 -15200000 4500000 20900000 -5100000 2200000 22500000 -172500000 29700000 -6900000 -8000000.0 -157700000 For the years ended December 31, 2021, 2020, and 2019, the change in unrealized pension costs consisted of the following (in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-Tax<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax (Expense) Benefit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net of Tax<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit arising during period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net prior service cost arising during period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss arising during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized pension costs, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit arising during period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net prior service cost arising during period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss arising during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized pension costs, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit arising during period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net prior service credit arising during period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss arising during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized pension costs, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 100000 0 100000 700000 100000 600000 -600000 -100000 -500000 14400000 2300000 12100000 13800000 2200000 11600000 600000 200000 400000 700000 100000 600000 -100000 100000 -200000 -4500000 -500000 -4000000.0 -4600000 -400000 -4200000 4600000 600000 4000000.0 200000 100000 100000 4400000 500000 3900000 -6900000 -1100000 -5800000 -2500000 -600000 -1900000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about amounts reclassified from "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.769%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about Accumulated Other Comprehensive Loss<br/>Components</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected Line on Consolidated<br/>Statements of Operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on hedges</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.0)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) gain on available-for-sale investments</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of pension adjustments</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr></table></div> 6400000 6400000 1600000 1600000 4800000 4800000 23000000.0 -18400000 600000 -2200000 11600000 -1400000 -12000000.0 19200000 -4600000 5000000.0 -7400000 14200000 -8600000 -300000 -2100000 600000 -6500000 -900000 -1000000.0 -900000 -100000 -200000 -900000 -700000 OTHER INCOME, NET<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.454%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gains, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-service cost components of net periodic pension benefit cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.454%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gains, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-service cost components of net periodic pension benefit cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 5000000.0 12300000 5900000 5800000 600000 500000 300000 400000 200000 2200000 -1000000.0 2000000.0 12700000 11500000 8200000 INCOME TAXES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's income before provision for income taxes was generated from operations in the United States and outside of the United States as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of the United States, including Puerto Rico</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,091.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">765.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,702.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consists of the following (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of the United States, including Puerto Rico</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current income tax expense</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.9 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.5 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.1 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of the United States, including Puerto Rico</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (benefit) expense</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44.0)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.2)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total income tax provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of deferred tax assets and liabilities are as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits from uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net tax credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow and net investment hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow and net investment hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax on foreign earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, net deferred tax assets increased $19.3 million, including items that were recorded to stockholders' equity and which did not impact the Company's income tax provision.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation allowance of $82.5 million as of December 31, 2021 reduces certain deferred tax assets to amounts that are more likely than not to be realized. This allowance primarily relates to the net operating loss carryforwards of certain non-United States subsidiaries and certain non-United States credit carryforwards.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss and capital loss carryforwards and the related carryforward periods at December 31, 2021 are summarized as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:34.039%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforward<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax Benefit<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation<br/>Allowance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Tax<br/>Benefit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforward<br/>Period Ends</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States federal net operating losses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030-2037</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States federal net operating losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States state net operating losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026-2039</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States state net operating losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-United States net operating losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022-2028</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-United States net operating losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain tax attributes are subject to an annual limitation as a result of the acquisitions of Harpoon and CASMED, which constitute a change of ownership as defined under Internal Revenue Code Section 382.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross tax credit carryforwards and the related carryforward periods at December 31, 2021 are summarized as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforward<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation<br/>Allowance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Tax<br/>Benefit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforward<br/>Period Ends</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California research expenditure tax credits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal research expenditure tax credits</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026-2039</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030-2031</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Puerto Rico purchases credit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has $167.0 million of California research expenditure tax credits it expects to use in future periods. The credits may be carried forward indefinitely. Based upon anticipated future taxable income, the Company expects that it is more likely than not that all California research expenditure tax credits will be utilized, although the utilization of the full benefit is expected to occur over a number of years into the distant future. Accordingly, no valuation allowance has been provided. The Company has $23.4 million of Puerto Rico purchases credit. Throughout its history and into the future, the Puerto Rico operations generate, or are expected to generate, credits each year in excess of its ability to utilize credits in those years. As a result, even though the credits have an indefinite life, the Company continues to record a valuation allowance on the credit carryforwards.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2017, Public Law 115-97, commonly referred to as the Tax Cuts and Jobs Act (the "2017 Act"), was signed into law. The 2017 Act a) reduced the United States federal corporate tax rate from 35 percent to 21 percent for tax years beginning after December 31, 2017, b) required companies to pay a one-time mandatory deemed repatriation tax on the cumulative earnings of certain foreign subsidiaries that were previously tax deferred, and c) created new taxes on certain foreign earnings in future years. The Company elected to pay the repatriation tax in installments over eight years.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company asserts that $1.0 billion of its foreign earnings continue to be indefinitely reinvested and it intends to repatriate $392.9 million of its foreign earnings as of December 31, 2021. The estimated net tax liability on the indefinitely reinvested earnings if repatriated is $23.1 million. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has received tax incentives in certain non-United States tax jurisdictions, the primary benefit for which will expire in 2029. The tax reductions as compared to the local statutory rates were $208.0 million ($0.33 per diluted share), $189.2 million ($0.30 per diluted share), and $159.2 million ($0.25 per diluted share) for the years ended December 31, 2021, 2020, and 2019, respectively. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the United States federal statutory income tax rate to the Company's effective income tax rate is as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense at United States federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign income taxed at different rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits, federal and state</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Build of reserve for prior years' uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on global intangible low-taxed income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign-derived intangible income deduction</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States federal deductible employee share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible employee share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's effective tax rate for 2021 increased in comparison to 2020 primarily due to the tax benefit from the Settlement Agreement with Abbott in 2020 (see Note 3) and the decrease in the excess tax benefit from employee share-based compensation, partially offset by the tax benefit from the change in fair value of contingent consideration liabilities. The Company's effective tax rate for 2020 decreased slightly in comparison to 2019 primarily due to the tax benefit from the Settlement Agreement with Abbott in 2020, partially offset by the increase in the United States tax on global intangible low-taxed income and the decrease in the excess tax benefit from employee share-based compensation. </span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Uncertain Tax Positions</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021 and 2020, the gross uncertain tax positions were $358.4 million and $281.8 million, respectively. The Company estimates that these liabilities would be reduced by $135.1 million and $95.1 million, respectively, from offsetting tax benefits associated with the correlative effects of potential transfer pricing adjustments, state income taxes, and timing adjustments. The net amounts of $223.3 million and $186.7 million, respectively, if not required, would favorably affect the Company's effective tax rate.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of uncertain tax positions, excluding interest, penalties, and foreign exchange, is as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain gross tax positions, January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year tax positions</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in prior year tax positions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in prior year tax positions</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lapse of statutes of limitations</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain gross tax positions, December 31</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table above summarizes the gross amounts of uncertain tax positions without regard to reduction in tax liabilities or additions to deferred tax assets and liabilities if such uncertain tax positions were settled. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes interest and penalties, if any, related to uncertain tax positions in the provision for income taxes. As of December 31, 2021, the Company had accrued $19.5 million (net of $8.1 million tax benefit) of interest related to uncertain tax positions, and as of December 31, 2020, the Company had accrued $14.3 million (net of $5.1 million tax benefit) of interest related to uncertain tax positions. During 2021, 2020, and 2019, the Company recognized interest expense, net of tax benefit, of $5.2 million, $5.0 million, and $4.7 million, respectively, in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Provision for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated statements of operations.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Internal Revenue Service ("IRS") and other taxing authorities are in different stages of examining various years of the Company's tax filings. During these audits, the Company may receive proposed audit adjustments that could be material. Therefore, there is a possibility that an adverse outcome in these audits could have a material effect on the Company's results of operations and financial condition. The Company strives to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time. While the Company has accrued for matters it believes are more likely than not to require settlement, the final outcome with a tax authority may result in a tax liability that is more or less than that reflected in the consolidated financial statements. Furthermore, the Company may later decide to challenge any assessments, if made, and may exercise its right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law. Management believes that adequate amounts of tax and related penalty and interest have been provided in income tax expense for any adjustments that may result from these uncertain tax positions.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">At December 31, 2021, all material state, local, and foreign income tax matters have been concluded for years through 2015. While not material, the Company continues to address matters in India for years from 2010.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company executed an Advance Pricing Agreement (“APA”) in 2018 between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement (collectively "Surgical/TAVR") intercompany royalty transactions, then reverted to IRS Examination for further consideration as part of the respective years' regular tax audits.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In addition, the Company executed other bilateral APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Japan and Singapore and between Switzerland and Japan covering tax years 2015 through 2019. The Company has filed to renew all of the APAs which cover transactions with Japan for the years 2020 and forward. The execution of some or all of these APA renewals depends on many variables outside of the Company's control. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%"> </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company’s United States federal income tax returns through 2014 have been audited. The IRS began its examination of the 2015 and 2016 tax years during the fourth quarter of 2018 and later added the 2017 tax year to this audit cycle during the first quarter of 2019. The IRS audit field work for the 2015-2017 tax years was substantially completed during the fourth quarter of 2020, except for transfer pricing and related matters.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%"> </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">During the second quarter of 2021, the Company received a Notice of Proposed Adjustment (“NOPA”) from the IRS for the 2015-2017 tax years relating to transfer pricing involving certain Surgical/TAVR intercompany royalty transactions between the Company's United States and Switzerland subsidiaries. During the third quarter of 2021, the Company completed its review of the NOPA and provided comments to the IRS and the IRS subsequently revised the NOPA. The revised NOPA proposes an increase to the Company's United States taxable income which could result in additional tax expense for this period of approximately $180 million and represents a significant change to previously agreed upon transfer pricing methodologies for these types of transactions.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has formally disagreed with the NOPA and has submitted a formal protest on the matter to the IRS Independent Office of Appeals during the fourth quarter of 2021. The Company also has received the final Revenue Agent's Report for these tax years. The Company continues to evaluate all possible remedies available to it, which could take several years to resolve. No payment of any amount related to the NOPA is required to be made, if at all, until all applicable proceedings have been completed. The Company believes the amounts previously accrued related to this uncertain tax position are sufficient and, accordingly, has not accrued any additional amount based on the NOPA received.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain Surgical/TAVR intercompany royalty transactions covering tax years 2015 - 2021 that were not resolved under the APA program remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of </span></div>December 31, 2021. The Company has considered this information, as well as information regarding the NOPA described above, in its evaluation of its uncertain tax positions. The impact of these unresolved transfer pricing matters, net of any correlative repatriation tax adjustment, may be significant to the Company’s consolidated financial statements. Based on the information currently available and numerous possible outcomes, the Company cannot reasonably estimate what, if any, changes in its existing uncertain tax positions may occur in the next 12 months and, therefore, has continued to record the uncertain tax positions as a long-term liability. <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's income before provision for income taxes was generated from operations in the United States and outside of the United States as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of the United States, including Puerto Rico</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,091.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">765.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,702.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 610900000 151300000 383400000 1091100000 765400000 783100000 1702000000 916700000 1166500000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consists of the following (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of the United States, including Puerto Rico</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current income tax expense</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.9 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.5 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.1 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of the United States, including Puerto Rico</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (benefit) expense</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44.0)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.2)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total income tax provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 125200000 23400000 31300000 25100000 48200000 48700000 92600000 73900000 29100000 242900000 145500000 109100000 -9400000 11000000.0 28300000 -25400000 -32900000 -18300000 -9200000 -30300000 500000 -44000000.0 -52200000 10500000 198900000 93300000 119600000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of deferred tax assets and liabilities are as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits from uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net tax credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow and net investment hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow and net investment hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax on foreign earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 109800000 88600000 33900000 27000000.0 142000000.0 125500000 69400000 64100000 108000000.0 105000000.0 13500000 16300000 0 3300000 400000 500000 700000 1800000 6600000 7700000 1300000 3600000 485600000 443400000 64100000 53400000 6400000 0 26300000 29200000 6100000 7000000.0 75500000 76300000 2600000 3100000 181000000.0 169000000.0 82500000 71600000 222100000 202800000 19300000 82500000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss and capital loss carryforwards and the related carryforward periods at December 31, 2021 are summarized as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:34.039%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforward<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax Benefit<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation<br/>Allowance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Tax<br/>Benefit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforward<br/>Period Ends</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States federal net operating losses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030-2037</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States federal net operating losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States state net operating losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026-2039</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States state net operating losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-United States net operating losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022-2028</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-United States net operating losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div> 17600000 3700000 0 3700000 11300000 2400000 0 2400000 33500000 1600000 1600000 0 1000000.0 100000 100000 0 5800000 1500000 1200000 300000 353300000 60100000 50800000 9300000 34100000 200000 200000 0 456600000 69600000 53900000 15700000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross tax credit carryforwards and the related carryforward periods at December 31, 2021 are summarized as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforward<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation<br/>Allowance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Tax<br/>Benefit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforward<br/>Period Ends</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California research expenditure tax credits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal research expenditure tax credits</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026-2039</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030-2031</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Puerto Rico purchases credit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div> 167000000.0 0 167000000.0 1500000 0 1500000 2900000 2900000 0 23400000 23400000 0 194800000 26300000 168500000 167000000 23400000 1000000000 392900000 23100000 208000000 0.33 189200000 0.30 159200000 0.25 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the United States federal statutory income tax rate to the Company's effective income tax rate is as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense at United States federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign income taxed at different rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits, federal and state</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Build of reserve for prior years' uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on global intangible low-taxed income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign-derived intangible income deduction</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States federal deductible employee share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible employee share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 357400000 192500000 245000000.0 -122200000 -80500000 -75000000.0 11900000 5000000.0 11900000 48400000 43100000 42900000 3600000 4200000 5000000.0 56500000 49200000 32000000.0 1300000 2600000 7200000 26100000 -2900000 1300000 47800000 48300000 57600000 5300000 4200000 3200000 10000000.0 9800000 6500000 198900000 93300000 119600000 358400000 281800000 135100000 95100000 223300000 186700000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of uncertain tax positions, excluding interest, penalties, and foreign exchange, is as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain gross tax positions, January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year tax positions</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in prior year tax positions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in prior year tax positions</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lapse of statutes of limitations</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain gross tax positions, December 31</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 281800000 203100000 150700000 82100000 86400000 55400000 2300000 6000000.0 800000 4800000 10000000.0 3800000 300000 3700000 0 2700000 0 0 358400000 281800000 203100000 19500000 8100000 14300000 5100000 5200000 5000000 4700000 180000000 LEGAL PROCEEDINGS <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is reviewing and investigating whether business activities in Japan and other markets violate certain provisions of the Foreign Corrupt Practices Act ("FCPA"). The Company has voluntarily notified the SEC and the United States Department of Justice that it has engaged outside counsel to conduct this review and investigation. Any determination that the Company’s operations or activities are not in compliance with existing laws, including the FCPA, could result in the imposition of fines, penalties, and equitable remedies. The Company cannot currently predict the outcome of the review and investigation or the potential impact on its financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On September 28, 2021, Aortic Innovations LLC, a non-practicing entity, filed a lawsuit against Edwards Lifesciences Corporation and certain of its subsidiaries ("Edwards") in the United States District Court for the District of Delaware alleging that Edwards’ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">SAPIEN 3 Ultra</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> product infringes certain of its patents. The Company is unable to predict the ultimate outcome of this matter or estimate a range of possible exposure; therefore, no amounts have been accrued. The Company intends to vigorously defend itself in this litigation.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is or may be a party to, or may otherwise be responsible for, pending or threatened lawsuits including those related to products and services currently or formerly manufactured or performed, as applicable, by the Company, workplace and employment matters, matters involving real estate, Company operations or health care regulations, or governmental investigations (the "Lawsuits"). The Lawsuits raise difficult and complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. Management does not believe that any loss relating to the Lawsuits would have a material adverse effect on the Company's overall financial condition, results of operations or cash flows. However, the resolution of one or more of the Lawsuits in any reporting period, could have a material adverse impact on the Company's financial results for that period. The Company is not able to estimate the amount or range of any loss for legal contingencies related to the Lawsuits for which there is no reserve or additional loss for matters already reserved.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is subject to various environmental laws and regulations both within and outside of the United States. The Company's operations, like those of other medical device companies, involve the use of substances regulated under environmental laws, primarily in manufacturing and sterilization processes. While it is difficult to quantify the potential impact of continuing compliance with environmental protection laws, management believes that such compliance will not have a material impact on the Company's financial results. The Company's threshold of disclosing material environmental legal proceedings involving a governmental authority where potential monetary exposure is involved is $1 million.</span></div> 1 1000000 SEGMENT INFORMATION<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Edwards Lifesciences conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. All regions sell products that are used to treat advanced cardiovascular disease.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's geographic segments are reported based on the financial information provided to the Chief Operating Decision Maker (the Chief Executive Officer). The Company evaluates the performance of its geographic segments based on net sales and operating income. The accounting policies of the segments are the same as those described in Note 2. Segment net sales and segment operating income are based on internally derived standard foreign exchange rates, which may differ from year to year, and do not include inter-segment profits. Because of the interdependence of the reportable segments, the operating profit as presented may not be representative of the geographical distribution that would occur if the segments were not interdependent. Net sales by geographic area are based on the location of the customer. There were no customers that represented 10% or more of the Company's total net sales.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include net interest income, global marketing expenses, corporate research and development expenses, manufacturing variances, corporate headquarters costs, special gains and charges, stock-based compensation, foreign currency hedging activities, certain litigation costs, changes in the fair value of contingent consideration liabilities, and most of the Company's amortization expense. Although most of the Company's depreciation expense is included in segment operating income, due to the Company's methodology for cost build-up, it is impractical to determine the amount of depreciation expense included in each segment, and, therefore, a portion is maintained at the corporate level. The Company neither discretely allocates assets to its operating segments, nor evaluates the operating segments using discrete asset information.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents information about Edwards Lifesciences' reportable segments (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,963.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,516.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,532.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment net sales</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,123.9 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,362.1 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,333.5 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Operating Income</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,051.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,727.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,742.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,153.3 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,643.1 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,614.5 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales Reconciliation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,123.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,362.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,333.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,232.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,386.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,348.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-tax Income Reconciliation</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,153.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,643.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,614.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,613.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,358.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,439.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Special charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual property litigation expenses, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(405.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,690.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">897.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,146.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated pre-tax income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,702.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Enterprise-Wide Information</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated financial statements.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of or for the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Geographic Area</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,963.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,516.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,532.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,190.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,232.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,386.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,348.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Major Product Area</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Aortic Valve Replacement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,422.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,857.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,737.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Mitral and Tricuspid Therapies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Structural Heart</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">725.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,232.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,386.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,348.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-lived Tangible Assets by Geographic Area</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,608.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents information about Edwards Lifesciences' reportable segments (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,963.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,516.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,532.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment net sales</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,123.9 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,362.1 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,333.5 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Operating Income</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,051.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,727.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,742.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,153.3 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,643.1 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,614.5 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales Reconciliation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,123.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,362.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,333.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,232.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,386.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,348.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-tax Income Reconciliation</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,153.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,643.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,614.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,613.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,358.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,439.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Special charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual property litigation expenses, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(405.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,690.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">897.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,146.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated pre-tax income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,702.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2963100000 2516800000 2532700000 1099600000 945200000 926100000 528000000.0 448600000 441400000 533200000 451500000 433300000 5123900000 4362100000 4333500000 2051000000 1727300000 1742300000 569100000 479300000 472000000.0 348000000.0 286400000 272300000 185200000 150100000 127900000 3153300000 2643100000 2614500000 5123900000 4362100000 4333500000 108600000 24200000 14500000 5232500000 4386300000 4348000000 3153300000 2643100000 2614500000 1613800000 1358000000 1439700000 0 0 64600000 20600000 405400000 33400000 -124100000 13600000 -6100000 47300000 31500000 63900000 1690300000 897600000 1146800000 11700000 19100000 19700000 1702000000 916700000 1166500000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated financial statements.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of or for the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Geographic Area</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,963.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,516.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,532.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,190.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,232.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,386.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,348.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Major Product Area</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Aortic Valve Replacement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,422.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,857.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,737.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Mitral and Tricuspid Therapies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Structural Heart</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">725.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,232.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,386.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,348.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-lived Tangible Assets by Geographic Area</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,608.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2963100000 2516800000 2532700000 1190300000 973600000 941200000 528900000 460100000 444700000 550200000 435800000 429400000 5232500000 4386300000 4348000000 3422500000 2857300000 2737900000 86000000.0 41800000 28200000 889100000 761800000 841700000 834900000 725400000 740200000 5232500000 4386300000 4348000000 1195800000 1084300000 849100000 197900000 192700000 101500000 19700000 20400000 21700000 335500000 311000000.0 269400000 1748900000 1608400000 1241700000 VALUATION AND QUALIFYING ACCOUNTS<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.642%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged to<br/>Costs and<br/>Expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged to<br/>Other<br/>Accounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at<br/>End of<br/>Period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax valuation allowance (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2020</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts (a)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax valuation allowance (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2019</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax valuation allowance (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)    The deductions related to allowances for doubtful accounts represent accounts receivable which are written off.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)     The tax valuation allowances are provided for other-than-temporary impairments and unrealized losses related to certain investments that may not be recognized due to the uncertainty of the ready marketability of certain impaired investments, and net operating loss and credit carryforwards that may not be recognized due to insufficient taxable income.</span></div> 16400000 1200000 600000 2500000 15700000 71600000 12400000 0 1500000 82500000 14700000 3100000 0 1400000 16400000 65800000 6300000 600000 1100000 71600000 13600000 4700000 200000 3800000 14700000 46700000 18900000 200000 0 65800000 SUBSEQUENT EVENTIn January 2022, the Company entered into an ASR agreement to repurchase $250.0 million of Edwards Lifesciences' common stock based on the volume-weighted average price ("VWAP") of Edwards Lifesciences' common stock during the term of the agreements, less a discount. Upon entering into the agreement, the Company received an initial delivery of approximately 1.9 million shares, representing approximately 80% of the shares to be repurchased. At the termination of the ASR, the Company may receive additional shares or may be required to pay additional cash or shares (at the Company's election). The final settlement is based on the VWAP over the term of the agreement, less a discount. The ASR agreement has a scheduled termination date of February 16, 2022. 250000000 1900000 0.80 EXCEL 156 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 157 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 158 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 159 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.0.1 html 524 708 1 false 147 0 false 7 false false R1.htm 000010001 - Document - Cover Sheet http://www.edwards.com/role/Cover Cover Cover 1 false false R2.htm 000020002 - Document - Audit Information Sheet http://www.edwards.com/role/AuditInformation Audit Information Notes 2 false false R3.htm 100010003 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS CONSOLIDATED BALANCE SHEETS Uncategorized 3 false false R4.htm 100020004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Cover 4 false false R5.htm 100030005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS CONSOLIDATED STATEMENTS OF OPERATIONS Statements 5 false false R6.htm 100040006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Statements 6 false false R7.htm 100050007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 100060008 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Sheet http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Statements 8 false false R9.htm 210011001 - Disclosure - DESCRIPTION OF BUSINESS Sheet http://www.edwards.com/role/DESCRIPTIONOFBUSINESS DESCRIPTION OF BUSINESS Notes 9 false false R10.htm 210021002 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 10 false false R11.htm 210181003 - Disclosure - INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET Sheet http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNET INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET Notes 11 false false R12.htm 210201004 - Disclosure - SPECIAL CHARGES Sheet http://www.edwards.com/role/SPECIALCHARGES SPECIAL CHARGES Notes 12 false false R13.htm 210231005 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS Notes 13 false false R14.htm 210281006 - Disclosure - LEASES Sheet http://www.edwards.com/role/LEASES LEASES Notes 14 false false R15.htm 210331007 - Disclosure - INVESTMENTS Sheet http://www.edwards.com/role/INVESTMENTS INVESTMENTS Notes 15 false false R16.htm 210401008 - Disclosure - ACQUISITIONS Sheet http://www.edwards.com/role/ACQUISITIONS ACQUISITIONS Notes 16 false false R17.htm 210421009 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Sheet http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETS GOODWILL AND OTHER INTANGIBLE ASSETS Notes 17 false false R18.htm 210481010 - Disclosure - DEBT AND CREDIT FACILITIES Sheet http://www.edwards.com/role/DEBTANDCREDITFACILITIES DEBT AND CREDIT FACILITIES Notes 18 false false R19.htm 210521011 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://www.edwards.com/role/FAIRVALUEMEASUREMENTS FAIR VALUE MEASUREMENTS Notes 19 false false R20.htm 210571012 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES Notes 20 false false R21.htm 210651013 - Disclosure - EMPLOYEE BENEFIT PLANS Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANS EMPLOYEE BENEFIT PLANS Notes 21 false false R22.htm 210741014 - Disclosure - COMMON STOCK Sheet http://www.edwards.com/role/COMMONSTOCK COMMON STOCK Notes 22 false false R23.htm 210841015 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS Sheet http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS ACCUMULATED OTHER COMPREHENSIVE LOSS Notes 23 false false R24.htm 210891016 - Disclosure - OTHER INCOME, NET Sheet http://www.edwards.com/role/OTHERINCOMENET OTHER INCOME, NET Notes 24 false false R25.htm 210921017 - Disclosure - INCOME TAXES Sheet http://www.edwards.com/role/INCOMETAXES INCOME TAXES Notes 25 false false R26.htm 211021018 - Disclosure - LEGAL PROCEEDINGS Sheet http://www.edwards.com/role/LEGALPROCEEDINGS LEGAL PROCEEDINGS Notes 26 false false R27.htm 211041019 - Disclosure - SEGMENT INFORMATION Sheet http://www.edwards.com/role/SEGMENTINFORMATION SEGMENT INFORMATION Notes 27 false false R28.htm 211091020 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS Sheet http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTS VALUATION AND QUALIFYING ACCOUNTS Notes 28 false false R29.htm 211111021 - Disclosure - SUBSEQUENT EVENT Sheet http://www.edwards.com/role/SUBSEQUENTEVENT SUBSEQUENT EVENT Notes 29 false false R30.htm 220032001 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 30 false false R31.htm 230043001 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES 31 false false R32.htm 230243002 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables) Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables) Tables http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS 32 false false R33.htm 230293003 - Disclosure - LEASES (Tables) Sheet http://www.edwards.com/role/LEASESTables LEASES (Tables) Tables http://www.edwards.com/role/LEASES 33 false false R34.htm 230343004 - Disclosure - INVESTMENTS (Tables) Sheet http://www.edwards.com/role/INVESTMENTSTables INVESTMENTS (Tables) Tables http://www.edwards.com/role/INVESTMENTS 34 false false R35.htm 230433005 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) Sheet http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) Tables http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETS 35 false false R36.htm 230493006 - Disclosure - DEBT AND CREDIT FACILITIES (Tables) Sheet http://www.edwards.com/role/DEBTANDCREDITFACILITIESTables DEBT AND CREDIT FACILITIES (Tables) Tables http://www.edwards.com/role/DEBTANDCREDITFACILITIES 36 false false R37.htm 230533007 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables FAIR VALUE MEASUREMENTS (Tables) Tables http://www.edwards.com/role/FAIRVALUEMEASUREMENTS 37 false false R38.htm 230583008 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables) Tables http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES 38 false false R39.htm 230663009 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables) Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANSTables EMPLOYEE BENEFIT PLANS (Tables) Tables http://www.edwards.com/role/EMPLOYEEBENEFITPLANS 39 false false R40.htm 230753010 - Disclosure - COMMON STOCK (Tables) Sheet http://www.edwards.com/role/COMMONSTOCKTables COMMON STOCK (Tables) Tables http://www.edwards.com/role/COMMONSTOCK 40 false false R41.htm 230853011 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables) Sheet http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables) Tables http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS 41 false false R42.htm 230903012 - Disclosure - OTHER INCOME, NET (Tables) Sheet http://www.edwards.com/role/OTHERINCOMENETTables OTHER INCOME, NET (Tables) Tables http://www.edwards.com/role/OTHERINCOMENET 42 false false R43.htm 230933013 - Disclosure - INCOME TAXES (Tables) Sheet http://www.edwards.com/role/INCOMETAXESTables INCOME TAXES (Tables) Tables http://www.edwards.com/role/INCOMETAXES 43 false false R44.htm 231053014 - Disclosure - SEGMENT INFORMATION (Tables) Sheet http://www.edwards.com/role/SEGMENTINFORMATIONTables SEGMENT INFORMATION (Tables) Tables http://www.edwards.com/role/SEGMENTINFORMATION 44 false false R45.htm 240054001 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock Split (Narrative) (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockSplitNarrativeDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock Split (Narrative) (Details) Details 45 false false R46.htm 240064002 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue (Narrative) (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueNarrativeDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue (Narrative) (Details) Details http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables 46 false false R47.htm 240074003 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Shipping and Handling Costs (Narrative) (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESShippingandHandlingCostsNarrativeDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Shipping and Handling Costs (Narrative) (Details) Details 47 false false R48.htm 240084004 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investments (Narrative) (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsNarrativeDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investments (Narrative) (Details) Details 48 false false R49.htm 240094005 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts Receivable (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts Receivable (Details) Details 49 false false R50.htm 240104006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventories (Narrative) (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInventoriesNarrativeDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventories (Narrative) (Details) Details 50 false false R51.htm 240114007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property, Plant, and Equipment (Narrative) (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property, Plant, and Equipment (Narrative) (Details) Details 51 false false R52.htm 240124008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Intangible Assets (Narrative) (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsNarrativeDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Intangible Assets (Narrative) (Details) Details 52 false false R53.htm 240134009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) Details 53 false false R54.htm 240144010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per Share (Narrative) (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsperShareNarrativeDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per Share (Narrative) (Details) Details 54 false false R55.htm 240154011 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Stock-Based Compensation Expense (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Stock-Based Compensation Expense (Details) Details 55 false false R56.htm 240164012 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock-based Compensation (Narrative) (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockbasedCompensationNarrativeDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock-based Compensation (Narrative) (Details) Details 56 false false R57.htm 240174013 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivatives (Narrative) (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesNarrativeDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivatives (Narrative) (Details) Details 57 false false R58.htm 240194014 - Disclosure - INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET (Details) Sheet http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET (Details) Details http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNET 58 false false R59.htm 240214015 - Disclosure - SPECIAL CHARGES - Impairment of Long-lived Assets (Details) Sheet http://www.edwards.com/role/SPECIALCHARGESImpairmentofLonglivedAssetsDetails SPECIAL CHARGES - Impairment of Long-lived Assets (Details) Details 59 false false R60.htm 240224016 - Disclosure - SPECIAL CHARGES - Acquisition of Intellectual Property (Details) Sheet http://www.edwards.com/role/SPECIALCHARGESAcquisitionofIntellectualPropertyDetails SPECIAL CHARGES - Acquisition of Intellectual Property (Details) Details 60 false false R61.htm 240254017 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions (Details) Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions (Details) Details 61 false false R62.htm 240264018 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Supplemental Cash Flow Information (Details) Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Supplemental Cash Flow Information (Details) Details 62 false false R63.htm 240274019 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Cash, Cash Equivalents, and Restricted Cash (Details) Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Cash, Cash Equivalents, and Restricted Cash (Details) Details 63 false false R64.htm 240304020 - Disclosure - LEASES - Narrative (Details) Sheet http://www.edwards.com/role/LEASESNarrativeDetails LEASES - Narrative (Details) Details 64 false false R65.htm 240314021 - Disclosure - LEASES - Assets and Liabilities of Operating Leases (Details) Sheet http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails LEASES - Assets and Liabilities of Operating Leases (Details) Details 65 false false R66.htm 240324022 - Disclosure - LEASES - Maturities Of Operating Lease Liabilities (Details) Sheet http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails LEASES - Maturities Of Operating Lease Liabilities (Details) Details 66 false false R67.htm 240354023 - Disclosure - INVESTMENTS - Schedule of Investments in Debt Securities (Details) Sheet http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails INVESTMENTS - Schedule of Investments in Debt Securities (Details) Details 67 false false R68.htm 240364024 - Disclosure - INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details) Sheet http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details) Details 68 false false R69.htm 240374025 - Disclosure - INVESTMENTS - Schedule of Unrealized Losses on Debt Securities (Details) Sheet http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails INVESTMENTS - Schedule of Unrealized Losses on Debt Securities (Details) Details 69 false false R70.htm 240384026 - Disclosure - INVESTMENTS - Narrative (Details) Sheet http://www.edwards.com/role/INVESTMENTSNarrativeDetails INVESTMENTS - Narrative (Details) Details 70 false false R71.htm 240394027 - Disclosure - INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details) Sheet http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details) Details 71 false false R72.htm 240414028 - Disclosure - ACQUISITIONS - Narratives (Details) Sheet http://www.edwards.com/role/ACQUISITIONSNarrativesDetails ACQUISITIONS - Narratives (Details) Details 72 false false R73.htm 240444029 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in the Carrying Amount of Goodwill, by Segment (Details) Sheet http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in the Carrying Amount of Goodwill, by Segment (Details) Details 73 false false R74.htm 240454030 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details) Sheet http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details) Details 74 false false R75.htm 240464031 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) Sheet http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) Details 75 false false R76.htm 240474032 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Estimated Amortization Expense (Details) Sheet http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofEstimatedAmortizationExpenseDetails GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Estimated Amortization Expense (Details) Details 76 false false R77.htm 240504033 - Disclosure - DEBT AND CREDIT FACILITIES - Narrative (Details) Sheet http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails DEBT AND CREDIT FACILITIES - Narrative (Details) Details 77 false false R78.htm 240514034 - Disclosure - DEBT AND CREDIT FACILITIES - Summary of the Notes (Details) Notes http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails DEBT AND CREDIT FACILITIES - Summary of the Notes (Details) Details 78 false false R79.htm 240544035 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on a Recurring Basis (Details) Details 79 false false R80.htm 240554036 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Changes in Fair Value of Contingent Consideration Obligation (Details) Sheet http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinFairValueofContingentConsiderationObligationDetails FAIR VALUE MEASUREMENTS - Summary of Changes in Fair Value of Contingent Consideration Obligation (Details) Details 80 false false R81.htm 240564037 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details) Sheet http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails FAIR VALUE MEASUREMENTS - Narrative (Details) Details 81 false false R82.htm 240594038 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Derivative Financial Instruments Used to Manage Currency Exchange and Interest Rate Risk (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeandInterestRateRiskDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Derivative Financial Instruments Used to Manage Currency Exchange and Interest Rate Risk (Details) Details 82 false false R83.htm 240604039 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments (Details) Details 83 false false R84.htm 240614040 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset (Details) Details 84 false false R85.htm 240624041 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments (Details) Details 85 false false R86.htm 240634042 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details) Details 86 false false R87.htm 240644043 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location of Gain or Loss on Derivative Instruments (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location of Gain or Loss on Derivative Instruments (Details) Details 87 false false R88.htm 240674044 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Information Regarding Defined Benefit Pension Plans (Details) Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails EMPLOYEE BENEFIT PLANS - Schedule of Information Regarding Defined Benefit Pension Plans (Details) Details 88 false false R89.htm 240684045 - Disclosure - EMPLOYEE BENEFIT PLANS - Narrative (Details) Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails EMPLOYEE BENEFIT PLANS - Narrative (Details) Details 89 false false R90.htm 240694046 - Disclosure - EMPLOYEE BENEFIT PLANS - Components of Net Periodic Benefit Cost (Details) Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails EMPLOYEE BENEFIT PLANS - Components of Net Periodic Benefit Cost (Details) Details 90 false false R91.htm 240704047 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations (Details) Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails EMPLOYEE BENEFIT PLANS - Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations (Details) Details 91 false false R92.htm 240714048 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Target Weighted-Average Asset Allocations and Fair Value (Details) Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails EMPLOYEE BENEFIT PLANS - Schedule of Target Weighted-Average Asset Allocations and Fair Value (Details) Details 92 false false R93.htm 240724049 - Disclosure - EMPLOYEE BENEFIT PLANS - Summary of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3 (Details) Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details EMPLOYEE BENEFIT PLANS - Summary of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3 (Details) Details 93 false false R94.htm 240734050 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Benefit Payments Which Reflect Expected Future Service (Details) Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofBenefitPaymentsWhichReflectExpectedFutureServiceDetails EMPLOYEE BENEFIT PLANS - Schedule of Benefit Payments Which Reflect Expected Future Service (Details) Details 94 false false R95.htm 240764051 - Disclosure - COMMON STOCK - Treasury Stock (Narrative) (Details) Sheet http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails COMMON STOCK - Treasury Stock (Narrative) (Details) Details 95 false false R96.htm 240774052 - Disclosure - COMMON STOCK - Accelerated Share Repurchases (Details) Sheet http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails COMMON STOCK - Accelerated Share Repurchases (Details) Details 96 false false R97.htm 240784053 - Disclosure - COMMON STOCK - Employee and Director Stock Plans (Narrative) (Details) Sheet http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails COMMON STOCK - Employee and Director Stock Plans (Narrative) (Details) Details 97 false false R98.htm 240794054 - Disclosure - COMMON STOCK - Schedule of Weighted-Average Assumptions (Details) Sheet http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails COMMON STOCK - Schedule of Weighted-Average Assumptions (Details) Details 98 false false R99.htm 240804055 - Disclosure - COMMON STOCK - Schedule of Stock Option (Details) Sheet http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails COMMON STOCK - Schedule of Stock Option (Details) Details 99 false false R100.htm 240814056 - Disclosure - COMMON STOCK - Schedule of Restricted Stock Unit Activity (Details) Sheet http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails COMMON STOCK - Schedule of Restricted Stock Unit Activity (Details) Details 100 false false R101.htm 240824057 - Disclosure - COMMON STOCK - Schedule of Restricted Stock Unit Activity (Narrative) (Details) Sheet http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityNarrativeDetails COMMON STOCK - Schedule of Restricted Stock Unit Activity (Narrative) (Details) Details 101 false false R102.htm 240834058 - Disclosure - COMMON STOCK - Additional Information (Narrative) (Details) Sheet http://www.edwards.com/role/COMMONSTOCKAdditionalInformationNarrativeDetails COMMON STOCK - Additional Information (Narrative) (Details) Details 102 false false R103.htm 240864059 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Summary of Activity for Each Component of Accumulated Other Comprehensive Loss (Details) Sheet http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails ACCUMULATED OTHER COMPREHENSIVE LOSS - Summary of Activity for Each Component of Accumulated Other Comprehensive Loss (Details) Details 103 false false R104.htm 240874060 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Change in Unrealized Pension Costs (Details) Sheet http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails ACCUMULATED OTHER COMPREHENSIVE LOSS - Change in Unrealized Pension Costs (Details) Details 104 false false R105.htm 240884061 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Information About Amounts Reclassified from Accumulated Other Comprehensive Loss (Details) Sheet http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Information About Amounts Reclassified from Accumulated Other Comprehensive Loss (Details) Details 105 false false R106.htm 240914062 - Disclosure - OTHER INCOME, NET (Details) Sheet http://www.edwards.com/role/OTHERINCOMENETDetails OTHER INCOME, NET (Details) Details http://www.edwards.com/role/OTHERINCOMENETTables 106 false false R107.htm 240944063 - Disclosure - INCOME TAXES - Schedule of Income Before Provisions for Income Taxes (Details) Sheet http://www.edwards.com/role/INCOMETAXESScheduleofIncomeBeforeProvisionsforIncomeTaxesDetails INCOME TAXES - Schedule of Income Before Provisions for Income Taxes (Details) Details 107 false false R108.htm 240954064 - Disclosure - INCOME TAXES - Provision for Income Taxes (Details) Sheet http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails INCOME TAXES - Provision for Income Taxes (Details) Details 108 false false R109.htm 240964065 - Disclosure - INCOME TAXES - Components of Deferred Tax Assets and Liabilities (Details) Sheet http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails INCOME TAXES - Components of Deferred Tax Assets and Liabilities (Details) Details 109 false false R110.htm 240974066 - Disclosure - INCOME TAXES - Narrative (Details) Sheet http://www.edwards.com/role/INCOMETAXESNarrativeDetails INCOME TAXES - Narrative (Details) Details 110 false false R111.htm 240984067 - Disclosure - INCOME TAXES - Summary of Net Operating Loss Carryforwards (Details) Sheet http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails INCOME TAXES - Summary of Net Operating Loss Carryforwards (Details) Details 111 false false R112.htm 240994068 - Disclosure - INCOME TAXES - Summary of Tax Credit Carryforwards (Details) Sheet http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails INCOME TAXES - Summary of Tax Credit Carryforwards (Details) Details 112 false false R113.htm 241004069 - Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details) Sheet http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details) Details 113 false false R114.htm 241014070 - Disclosure - INCOME TAXES - Reconciliation of Uncertain Tax Positions (Details) Sheet http://www.edwards.com/role/INCOMETAXESReconciliationofUncertainTaxPositionsDetails INCOME TAXES - Reconciliation of Uncertain Tax Positions (Details) Details 114 false false R115.htm 241034071 - Disclosure - LEGAL PROCEEDINGS (Details) Sheet http://www.edwards.com/role/LEGALPROCEEDINGSDetails LEGAL PROCEEDINGS (Details) Details http://www.edwards.com/role/LEGALPROCEEDINGS 115 false false R116.htm 241064072 - Disclosure - SEGMENT INFORMATION - Schedule of Information About Reportable Segments (Details) Sheet http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails SEGMENT INFORMATION - Schedule of Information About Reportable Segments (Details) Details 116 false false R117.htm 241074073 - Disclosure - SEGMENT INFORMATION - Reconciliation of Segment Net Sales and Pre-Tax Income to Consolidated Net Sales and Pre-Tax Income (Details) Sheet http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails SEGMENT INFORMATION - Reconciliation of Segment Net Sales and Pre-Tax Income to Consolidated Net Sales and Pre-Tax Income (Details) Details 117 false false R118.htm 241084074 - Disclosure - SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details) Sheet http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details) Details 118 false false R119.htm 241104075 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS (Details) Sheet http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails VALUATION AND QUALIFYING ACCOUNTS (Details) Details http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTS 119 false false R120.htm 241124076 - Disclosure - SUBSEQUENT EVENT (Details) Sheet http://www.edwards.com/role/SUBSEQUENTEVENTDetails SUBSEQUENT EVENT (Details) Details http://www.edwards.com/role/SUBSEQUENTEVENT 120 false false All Reports Book All Reports ew-20211231.htm ew-20211231.xsd ew-20211231_cal.xml ew-20211231_def.xml ew-20211231_lab.xml ew-20211231_pre.xml ex-101110xkq42021.htm ex-101210xkq42021.htm ex-101310xkq42021.htm ex-101510xkq42021.htm ex-101610xkq42021.htm ex-101710xkq42021.htm ex-101810xkq42021.htm ex-21110xkq42021.htm ex-2310xkq42021.htm ex-31110xkq42021.htm ex-31210xkq42021.htm ex-3210xkq42021.htm ex-4210xkq42021.htm ew-20211231_g1.jpg ew-20211231_g10.jpg ew-20211231_g11.jpg ew-20211231_g12.jpg ew-20211231_g13.jpg ew-20211231_g2.jpg ew-20211231_g3.jpg ew-20211231_g4.jpg ew-20211231_g5.jpg ew-20211231_g6.jpg ew-20211231_g7.jpg ew-20211231_g8.jpg ew-20211231_g9.jpg http://fasb.org/srt/2021-01-31 http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true JSON 162 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ew-20211231.htm": { "axisCustom": 0, "axisStandard": 45, "contextCount": 524, "dts": { "calculationLink": { "local": [ "ew-20211231_cal.xml" ] }, "definitionLink": { "local": [ "ew-20211231_def.xml" ] }, "inline": { "local": [ "ew-20211231.htm" ] }, "labelLink": { "local": [ "ew-20211231_lab.xml" ] }, "presentationLink": { "local": [ "ew-20211231_pre.xml" ] }, "schema": { "local": [ "ew-20211231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] } }, "elementCount": 1038, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 1, "http://xbrl.sec.gov/dei/2021q4": 4, "total": 5 }, "keyCustom": 67, "keyStandard": 641, "memberCustom": 53, "memberStandard": 91, "nsprefix": "ew", "nsuri": "http://www.edwards.com/20211231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000010001 - Document - Cover", "role": "http://www.edwards.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210021002 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R100": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "id0b446af6c744d45804dff5b4f8810e2_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240814056 - Disclosure - COMMON STOCK - Schedule of Restricted Stock Unit Activity (Details)", "role": "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails", "shortName": "COMMON STOCK - Schedule of Restricted Stock Unit Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "id0b446af6c744d45804dff5b4f8810e2_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R101": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i724a596d9acb49cca1ea3ddee3079772_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240824057 - Disclosure - COMMON STOCK - Schedule of Restricted Stock Unit Activity (Narrative) (Details)", "role": "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityNarrativeDetails", "shortName": "COMMON STOCK - Schedule of Restricted Stock Unit Activity (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i724a596d9acb49cca1ea3ddee3079772_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R102": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "ew:ShareBasedCompensationArrangementByShareBasedPaymentAwardIntrinsicValueOfStockOptionsExercisedAndVestedRestrictedStockUnits", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240834058 - Disclosure - COMMON STOCK - Additional Information (Narrative) (Details)", "role": "http://www.edwards.com/role/COMMONSTOCKAdditionalInformationNarrativeDetails", "shortName": "COMMON STOCK - Additional Information (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "ew:ShareBasedCompensationArrangementByShareBasedPaymentAwardIntrinsicValueOfStockOptionsExercisedAndVestedRestrictedStockUnits", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R103": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i219c48b2d2924d56b51622391508076d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240864059 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Summary of Activity for Each Component of Accumulated Other Comprehensive Loss (Details)", "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS - Summary of Activity for Each Component of Accumulated Other Comprehensive Loss (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ia5dcca293c634509a48f49da443e685f_I20181231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R104": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i67229e67c7d74d3fb1456cb83b79ee1b_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240874060 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Change in Unrealized Pension Costs (Details)", "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS - Change in Unrealized Pension Costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i67229e67c7d74d3fb1456cb83b79ee1b_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R105": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OtherNonoperatingIncomeExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240884061 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Information About Amounts Reclassified from Accumulated Other Comprehensive Loss (Details)", "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Information About Amounts Reclassified from Accumulated Other Comprehensive Loss (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ie08bec91d8cc403182cfb09b9a0b63ec_D20210101-20211231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:OtherNonoperatingIncomeExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R106": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240914062 - Disclosure - OTHER INCOME, NET (Details)", "role": "http://www.edwards.com/role/OTHERINCOMENETDetails", "shortName": "OTHER INCOME, NET (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "lang": "en-US", "name": "ew:GainLossOnInvestmentsOtherIncomeExpenseNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R107": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240944063 - Disclosure - INCOME TAXES - Schedule of Income Before Provisions for Income Taxes (Details)", "role": "http://www.edwards.com/role/INCOMETAXESScheduleofIncomeBeforeProvisionsforIncomeTaxesDetails", "shortName": "INCOME TAXES - Schedule of Income Before Provisions for Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R108": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240954064 - Disclosure - INCOME TAXES - Provision for Income Taxes (Details)", "role": "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails", "shortName": "INCOME TAXES - Provision for Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R109": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240964065 - Disclosure - INCOME TAXES - Components of Deferred Tax Assets and Liabilities (Details)", "role": "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails", "shortName": "INCOME TAXES - Components of Deferred Tax Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210181003 - Disclosure - INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET", "role": "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNET", "shortName": "INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R110": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "ew:IncreaseDecreaseInDeferredTaxAssetsLiabilitiesNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240974066 - Disclosure - INCOME TAXES - Narrative (Details)", "role": "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "shortName": "INCOME TAXES - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "ew:IncreaseDecreaseInDeferredTaxAssetsLiabilitiesNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R111": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240984067 - Disclosure - INCOME TAXES - Summary of Net Operating Loss Carryforwards (Details)", "role": "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails", "shortName": "INCOME TAXES - Summary of Net Operating Loss Carryforwards (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R112": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SummaryOfTaxCreditCarryforwardsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:TaxCreditCarryforwardAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240994068 - Disclosure - INCOME TAXES - Summary of Tax Credit Carryforwards (Details)", "role": "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails", "shortName": "INCOME TAXES - Summary of Tax Credit Carryforwards (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SummaryOfTaxCreditCarryforwardsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:TaxCreditCarryforwardValuationAllowance", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R113": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241004069 - Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details)", "role": "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails", "shortName": "INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R114": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i219c48b2d2924d56b51622391508076d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241014070 - Disclosure - INCOME TAXES - Reconciliation of Uncertain Tax Positions (Details)", "role": "http://www.edwards.com/role/INCOMETAXESReconciliationofUncertainTaxPositionsDetails", "shortName": "INCOME TAXES - Reconciliation of Uncertain Tax Positions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R115": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "ew:LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber", "reportCount": 1, "unique": true, "unitRef": "lawsuit", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241034071 - Disclosure - LEGAL PROCEEDINGS (Details)", "role": "http://www.edwards.com/role/LEGALPROCEEDINGSDetails", "shortName": "LEGAL PROCEEDINGS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "ew:LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber", "reportCount": 1, "unique": true, "unitRef": "lawsuit", "xsiNil": "false" } }, "R116": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241064072 - Disclosure - SEGMENT INFORMATION - Schedule of Information About Reportable Segments (Details)", "role": "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails", "shortName": "SEGMENT INFORMATION - Schedule of Information About Reportable Segments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i03a92a94f4b84201b0ac09fa0a3ffbd7_D20210101-20211231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R117": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241074073 - Disclosure - SEGMENT INFORMATION - Reconciliation of Segment Net Sales and Pre-Tax Income to Consolidated Net Sales and Pre-Tax Income (Details)", "role": "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails", "shortName": "SEGMENT INFORMATION - Reconciliation of Segment Net Sales and Pre-Tax Income to Consolidated Net Sales and Pre-Tax Income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i03a92a94f4b84201b0ac09fa0a3ffbd7_D20210101-20211231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:OperatingIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R118": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241084074 - Disclosure - SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details)", "role": "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails", "shortName": "SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:NoncurrentAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R119": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "idfde984bd8ab46d59d9c482979939bed_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241104075 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS (Details)", "role": "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails", "shortName": "VALUATION AND QUALIFYING ACCOUNTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i9220582ab526496291c9f259581fe382_I20181231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210201004 - Disclosure - SPECIAL CHARGES", "role": "http://www.edwards.com/role/SPECIALCHARGES", "shortName": "SPECIAL CHARGES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R120": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i8fd7f0196d2d4665ad973e9a50b80ba7_I20220131", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241124076 - Disclosure - SUBSEQUENT EVENT (Details)", "role": "http://www.edwards.com/role/SUBSEQUENTEVENTDetails", "shortName": "SUBSEQUENT EVENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i8fd7f0196d2d4665ad973e9a50b80ba7_I20220131", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210231005 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS", "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210281006 - Disclosure - LEASES", "role": "http://www.edwards.com/role/LEASES", "shortName": "LEASES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210331007 - Disclosure - INVESTMENTS", "role": "http://www.edwards.com/role/INVESTMENTS", "shortName": "INVESTMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210401008 - Disclosure - ACQUISITIONS", "role": "http://www.edwards.com/role/ACQUISITIONS", "shortName": "ACQUISITIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210421009 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS", "role": "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETS", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210481010 - Disclosure - DEBT AND CREDIT FACILITIES", "role": "http://www.edwards.com/role/DEBTANDCREDITFACILITIES", "shortName": "DEBT AND CREDIT FACILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210521011 - Disclosure - FAIR VALUE MEASUREMENTS", "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTS", "shortName": "FAIR VALUE MEASUREMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:AuditorName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "false", "longName": "000020002 - Document - Audit Information", "role": "http://www.edwards.com/role/AuditInformation", "shortName": "Audit Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:AuditorName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210571012 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES", "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210651013 - Disclosure - EMPLOYEE BENEFIT PLANS", "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANS", "shortName": "EMPLOYEE BENEFIT PLANS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210741014 - Disclosure - COMMON STOCK", "role": "http://www.edwards.com/role/COMMONSTOCK", "shortName": "COMMON STOCK", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210841015 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS", "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210891016 - Disclosure - OTHER INCOME, NET", "role": "http://www.edwards.com/role/OTHERINCOMENET", "shortName": "OTHER INCOME, NET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210921017 - Disclosure - INCOME TAXES", "role": "http://www.edwards.com/role/INCOMETAXES", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "211021018 - Disclosure - LEGAL PROCEEDINGS", "role": "http://www.edwards.com/role/LEGALPROCEEDINGS", "shortName": "LEGAL PROCEEDINGS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "211041019 - Disclosure - SEGMENT INFORMATION", "role": "http://www.edwards.com/role/SEGMENTINFORMATION", "shortName": "SEGMENT INFORMATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "211091020 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS", "role": "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTS", "shortName": "VALUATION AND QUALIFYING ACCOUNTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "211111021 - Disclosure - SUBSEQUENT EVENT", "role": "http://www.edwards.com/role/SUBSEQUENTEVENT", "shortName": "SUBSEQUENT EVENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100010003 - Statement - CONSOLIDATED BALANCE SHEETS", "role": "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ShortTermInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "220032001 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230043001 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ew:ScheduleOfSelectedCaptionsBalanceSheetDisclosuresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230243002 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)", "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ew:ScheduleOfSelectedCaptionsBalanceSheetDisclosuresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ew:AssetsAndLiabilitiesOfLesseeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230293003 - Disclosure - LEASES (Tables)", "role": "http://www.edwards.com/role/LEASESTables", "shortName": "LEASES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ew:AssetsAndLiabilitiesOfLesseeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230343004 - Disclosure - INVESTMENTS (Tables)", "role": "http://www.edwards.com/role/INVESTMENTSTables", "shortName": "INVESTMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230433005 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)", "role": "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230493006 - Disclosure - DEBT AND CREDIT FACILITIES (Tables)", "role": "http://www.edwards.com/role/DEBTANDCREDITFACILITIESTables", "shortName": "DEBT AND CREDIT FACILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230533007 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)", "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables", "shortName": "FAIR VALUE MEASUREMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230583008 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)", "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ew:DefinedBenefitPlanChangeinBenefitObligationPlanAssetsNetAmountRecognizedonBalanceSheetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230663009 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)", "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSTables", "shortName": "EMPLOYEE BENEFIT PLANS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ew:DefinedBenefitPlanChangeinBenefitObligationPlanAssetsNetAmountRecognizedonBalanceSheetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100020004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "role": "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AcceleratedShareRepurchasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230753010 - Disclosure - COMMON STOCK (Tables)", "role": "http://www.edwards.com/role/COMMONSTOCKTables", "shortName": "COMMON STOCK (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AcceleratedShareRepurchasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230853011 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)", "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230903012 - Disclosure - OTHER INCOME, NET (Tables)", "role": "http://www.edwards.com/role/OTHERINCOMENETTables", "shortName": "OTHER INCOME, NET (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230933013 - Disclosure - INCOME TAXES (Tables)", "role": "http://www.edwards.com/role/INCOMETAXESTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "231053014 - Disclosure - SEGMENT INFORMATION (Tables)", "role": "http://www.edwards.com/role/SEGMENTINFORMATIONTables", "shortName": "SEGMENT INFORMATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ic0249bcf5ba24579b03ae57bfcbd755b_D20200529-20200529", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteStockSplitConversionRatio1", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240054001 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock Split (Narrative) (Details)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockSplitNarrativeDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock Split (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i998cd0479b2b4ad6a2cb40c5b4d254de_D20200507-20200507", "decimals": "INF", "lang": "en-US", "name": "ew:StockholdersEquityNoteStockSplitNumberOfNewlyIssuedSharesPerHolder", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240064002 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue (Narrative) (Details)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueNarrativeDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ew:DisclosureOfFairValueHedgingInstrumentsAndCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240074003 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Shipping and Handling Costs (Narrative) (Details)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESShippingandHandlingCostsNarrativeDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Shipping and Handling Costs (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ica905e4dfc97493d8d4fcbd405fbada5_D20210101-20211231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:InvestmentPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i56fa6e6345b640ccb41773379dfa9b12_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240084004 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investments (Narrative) (Details)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsNarrativeDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investments (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:InvestmentPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i56fa6e6345b640ccb41773379dfa9b12_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:TradeAndOtherAccountsReceivablePolicy", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i273d6a939324408c8b87d902c0f6e565_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ew:AccountsReceivablePaymentTerms", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240094005 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts Receivable (Details)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts Receivable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:TradeAndOtherAccountsReceivablePolicy", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i273d6a939324408c8b87d902c0f6e565_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ew:AccountsReceivablePaymentTerms", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100030005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "role": "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:InventoryPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ew:InventoryWriteDownExpirationPeriodTrigger", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240104006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventories (Narrative) (Details)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInventoriesNarrativeDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventories (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:InventoryPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ew:InventoryWriteDownExpirationPeriodTrigger", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240114007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property, Plant, and Equipment (Narrative) (Details)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property, Plant, and Equipment (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "iff53a4cc18504087bb13b94c26ea29c7_D20210101-20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240124008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Intangible Assets (Narrative) (Details)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsNarrativeDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Intangible Assets (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "iff53a4cc18504087bb13b94c26ea29c7_D20210101-20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240134009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Computation of Basic and Diluted Earnings Per Share (Details)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Computation of Basic and Diluted Earnings Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i2b410a4f5ad94cd49cba05a2bf9b77d0_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240144010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per Share (Narrative) (Details)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsperShareNarrativeDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per Share (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i2b410a4f5ad94cd49cba05a2bf9b77d0_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240154011 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Stock-Based Compensation Expense (Details)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Stock-Based Compensation Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifd4e8d5cbc1949c9a2275cd906c20775_D20210101-20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240164012 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock-based Compensation (Narrative) (Details)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockbasedCompensationNarrativeDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock-based Compensation (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifd4e8d5cbc1949c9a2275cd906c20775_D20210101-20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:DerivativesPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240174013 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivatives (Narrative) (Details)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesNarrativeDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivatives (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:DerivativesPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LitigationSettlementExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240194014 - Disclosure - INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET (Details)", "role": "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails", "shortName": "INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "if0f061f94a324d53a2990ca7d5e6acca_D20200601-20200630", "decimals": "-5", "lang": "en-US", "name": "us-gaap:LitigationSettlementExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ic2f7a132993b4e4e837cb8a747ed261e_D20191201-20191231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240214015 - Disclosure - SPECIAL CHARGES - Impairment of Long-lived Assets (Details)", "role": "http://www.edwards.com/role/SPECIALCHARGESImpairmentofLonglivedAssetsDetails", "shortName": "SPECIAL CHARGES - Impairment of Long-lived Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ic2f7a132993b4e4e837cb8a747ed261e_D20191201-20191231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100040006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "role": "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i3619e955ac9d4e78a2dc620e35e5299d_I20190331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240224016 - Disclosure - SPECIAL CHARGES - Acquisition of Intellectual Property (Details)", "role": "http://www.edwards.com/role/SPECIALCHARGESAcquisitionofIntellectualPropertyDetails", "shortName": "SPECIAL CHARGES - Acquisition of Intellectual Property (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i3619e955ac9d4e78a2dc620e35e5299d_I20190331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ew:ScheduleOfSelectedCaptionsBalanceSheetDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240254017 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions (Details)", "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ew:ScheduleOfSelectedCaptionsBalanceSheetDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InterestPaidNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240264018 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Supplemental Cash Flow Information (Details)", "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Supplemental Cash Flow Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InterestPaidNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240274019 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Cash, Cash Equivalents, and Restricted Cash (Details)", "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Cash, Cash Equivalents, and Restricted Cash (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i5aad56912bd24253ac030af5dbd18742_I20191231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240304020 - Disclosure - LEASES - Narrative (Details)", "role": "http://www.edwards.com/role/LEASESNarrativeDetails", "shortName": "LEASES - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ew:AssetsAndLiabilitiesOfLesseeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240314021 - Disclosure - LEASES - Assets and Liabilities of Operating Leases (Details)", "role": "http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails", "shortName": "LEASES - Assets and Liabilities of Operating Leases (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240324022 - Disclosure - LEASES - Maturities Of Operating Lease Liabilities (Details)", "role": "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails", "shortName": "LEASES - Maturities Of Operating Lease Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:HeldToMaturitySecurities", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240354023 - Disclosure - INVESTMENTS - Schedule of Investments in Debt Securities (Details)", "role": "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails", "shortName": "INVESTMENTS - Schedule of Investments in Debt Securities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240364024 - Disclosure - INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details)", "role": "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails", "shortName": "INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240374025 - Disclosure - INVESTMENTS - Schedule of Unrealized Losses on Debt Securities (Details)", "role": "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails", "shortName": "INVESTMENTS - Schedule of Unrealized Losses on Debt Securities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100050007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i219c48b2d2924d56b51622391508076d_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions", "reportCount": 1, "unique": true, "unitRef": "investment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240384026 - Disclosure - INVESTMENTS - Narrative (Details)", "role": "http://www.edwards.com/role/INVESTMENTSNarrativeDetails", "shortName": "INVESTMENTS - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i219c48b2d2924d56b51622391508076d_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions", "reportCount": 1, "unique": true, "unitRef": "investment", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240394027 - Disclosure - INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details)", "role": "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails", "shortName": "INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i01bfbabbd4684e1fbed1f8640f313aeb_I20190211", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionSharePrice", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240414028 - Disclosure - ACQUISITIONS - Narratives (Details)", "role": "http://www.edwards.com/role/ACQUISITIONSNarrativesDetails", "shortName": "ACQUISITIONS - Narratives (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i01bfbabbd4684e1fbed1f8640f313aeb_I20190211", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionSharePrice", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i219c48b2d2924d56b51622391508076d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240444029 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in the Carrying Amount of Goodwill, by Segment (Details)", "role": "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in the Carrying Amount of Goodwill, by Segment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i5aad56912bd24253ac030af5dbd18742_I20191231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240454030 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details)", "role": "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240464031 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)", "role": "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240474032 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Estimated Amortization Expense (Details)", "role": "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofEstimatedAmortizationExpenseDetails", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Estimated Amortization Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:LongtermDebtWeightedAverageInterestRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240504033 - Disclosure - DEBT AND CREDIT FACILITIES - Narrative (Details)", "role": "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "shortName": "DEBT AND CREDIT FACILITIES - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:LongtermDebtWeightedAverageInterestRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i83e4c14b9d7046e0817dcb02233ca3fc_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentUnamortizedDiscount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240514034 - Disclosure - DEBT AND CREDIT FACILITIES - Summary of the Notes (Details)", "role": "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails", "shortName": "DEBT AND CREDIT FACILITIES - Summary of the Notes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i83e4c14b9d7046e0817dcb02233ca3fc_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentUnamortizedDiscount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240544035 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on a Recurring Basis (Details)", "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "shortName": "FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on a Recurring Basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i9680c28227da4d63bc8e1ff4129fe753_I20211231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ic5221b97b1fe48af9e238ed8b0a85355_I20181231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100060008 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY", "role": "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ic5221b97b1fe48af9e238ed8b0a85355_I20181231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i219c48b2d2924d56b51622391508076d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240554036 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Changes in Fair Value of Contingent Consideration Obligation (Details)", "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinFairValueofContingentConsiderationObligationDetails", "shortName": "FAIR VALUE MEASUREMENTS - Summary of Changes in Fair Value of Contingent Consideration Obligation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i5aad56912bd24253ac030af5dbd18742_I20191231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240564037 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details)", "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "shortName": "FAIR VALUE MEASUREMENTS - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i72c6a159bba84904ad0239abb0815c25_I20211231", "decimals": "4", "lang": "en-US", "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ic24cdaad4b3a4f23bcf3d141d53092d3_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240594038 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Derivative Financial Instruments Used to Manage Currency Exchange and Interest Rate Risk (Details)", "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeandInterestRateRiskDetails", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Derivative Financial Instruments Used to Manage Currency Exchange and Interest Rate Risk (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ic24cdaad4b3a4f23bcf3d141d53092d3_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingAssetsTableTextBlock", "us-gaap:OffsettingLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i521aa60d328a414781ae88002e7dd6cd_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240604039 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments (Details)", "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ib1d3fae884e247c8921c042f808cc80c_I20211231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingAssetsTableTextBlock", "us-gaap:OffsettingLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i521aa60d328a414781ae88002e7dd6cd_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240614040 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset (Details)", "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingAssetsTableTextBlock", "us-gaap:OffsettingLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i521aa60d328a414781ae88002e7dd6cd_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i6ff641cefc034440b821789b6415971b_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeGainLossOnDerivativeNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240624041 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments (Details)", "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i6ff641cefc034440b821789b6415971b_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeGainLossOnDerivativeNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240634042 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)", "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ew:DisclosureOfFairValueHedgingInstrumentsAndCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240644043 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location of Gain or Loss on Derivative Instruments (Details)", "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location of Gain or Loss on Derivative Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ew:DisclosureOfFairValueHedgingInstrumentsAndCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i8ab3f57c6a9d4e24a1edb615d22be162_D20210101-20211231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ew:DefinedBenefitPlanChangeinBenefitObligationPlanAssetsNetAmountRecognizedonBalanceSheetTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ic88e17cdb33d49568df3627e60abc8c5_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanBenefitObligation", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240674044 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Information Regarding Defined Benefit Pension Plans (Details)", "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails", "shortName": "EMPLOYEE BENEFIT PLANS - Schedule of Information Regarding Defined Benefit Pension Plans (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ew:DefinedBenefitPlanChangeinBenefitObligationPlanAssetsNetAmountRecognizedonBalanceSheetTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i4925b9be41d44561bd31d323c49a8203_D20210101-20211231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240684045 - Disclosure - EMPLOYEE BENEFIT PLANS - Narrative (Details)", "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails", "shortName": "EMPLOYEE BENEFIT PLANS - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210011001 - Disclosure - DESCRIPTION OF BUSINESS", "role": "http://www.edwards.com/role/DESCRIPTIONOFBUSINESS", "shortName": "DESCRIPTION OF BUSINESS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i4925b9be41d44561bd31d323c49a8203_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240694046 - Disclosure - EMPLOYEE BENEFIT PLANS - Components of Net Periodic Benefit Cost (Details)", "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails", "shortName": "EMPLOYEE BENEFIT PLANS - Components of Net Periodic Benefit Cost (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i4925b9be41d44561bd31d323c49a8203_D20210101-20211231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "iadfd193ec4ab42198f451f9a539533fa_I20211231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240704047 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations (Details)", "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails", "shortName": "EMPLOYEE BENEFIT PLANS - Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "iadfd193ec4ab42198f451f9a539533fa_I20211231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "iadfd193ec4ab42198f451f9a539533fa_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240714048 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Target Weighted-Average Asset Allocations and Fair Value (Details)", "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "shortName": "EMPLOYEE BENEFIT PLANS - Schedule of Target Weighted-Average Asset Allocations and Fair Value (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "iadfd193ec4ab42198f451f9a539533fa_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ew:DefinedBenefitPlanChangeinBenefitObligationPlanAssetsNetAmountRecognizedonBalanceSheetTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "iadec95ff813d4d339e395942ebfb333f_I20191231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240724049 - Disclosure - EMPLOYEE BENEFIT PLANS - Summary of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3 (Details)", "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details", "shortName": "EMPLOYEE BENEFIT PLANS - Summary of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3 (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i435680040f3447fdb379784389c40563_D20200101-20200630", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240734050 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Benefit Payments Which Reflect Expected Future Service (Details)", "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofBenefitPaymentsWhichReflectExpectedFutureServiceDetails", "shortName": "EMPLOYEE BENEFIT PLANS - Schedule of Benefit Payments Which Reflect Expected Future Service (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i560f7c0677a747179c8072d986b61d5f_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ifc42bad221e14c1788369038da2d50fc_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:TreasuryStockValueAcquiredCostMethod", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240764051 - Disclosure - COMMON STOCK - Treasury Stock (Narrative) (Details)", "role": "http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails", "shortName": "COMMON STOCK - Treasury Stock (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "id651688f2e8d4e0db3885a1bf0d1e52b_I20190531", "decimals": "INF", "lang": "en-US", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "ic0249bcf5ba24579b03ae57bfcbd755b_D20200529-20200529", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteStockSplitConversionRatio1", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240774052 - Disclosure - COMMON STOCK - Accelerated Share Repurchases (Details)", "role": "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails", "shortName": "COMMON STOCK - Accelerated Share Repurchases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i2d27f01d52b0400ab2e7189b00875423_I20190531", "decimals": "INF", "lang": "en-US", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i91e2c5941cec4056bd366fc4055692cd_D20210101-20211231", "decimals": "3", "first": true, "lang": "en-US", "name": "ew:EstimatedAnnualForfeitureRatePercent", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240784053 - Disclosure - COMMON STOCK - Employee and Director Stock Plans (Narrative) (Details)", "role": "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "shortName": "COMMON STOCK - Employee and Director Stock Plans (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i91e2c5941cec4056bd366fc4055692cd_D20210101-20211231", "decimals": "3", "first": true, "lang": "en-US", "name": "ew:EstimatedAnnualForfeitureRatePercent", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R98": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i91e2c5941cec4056bd366fc4055692cd_D20210101-20211231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240794054 - Disclosure - COMMON STOCK - Schedule of Weighted-Average Assumptions (Details)", "role": "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails", "shortName": "COMMON STOCK - Schedule of Weighted-Average Assumptions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i91e2c5941cec4056bd366fc4055692cd_D20210101-20211231", "decimals": "INF", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R99": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i41225e9f36f04ff7a247632de6bbbe21_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240804055 - Disclosure - COMMON STOCK - Schedule of Stock Option (Details)", "role": "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails", "shortName": "COMMON STOCK - Schedule of Stock Option (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20211231.htm", "contextRef": "i41225e9f36f04ff7a247632de6bbbe21_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } } }, "segmentCount": 147, "tag": { "country_JP": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "JAPAN", "terseLabel": "Japan" } } }, "localname": "JP", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "country_PR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PUERTO RICO", "terseLabel": "Puerto Rico" } } }, "localname": "PR", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r930", "r931", "r932" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID", "terseLabel": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/AuditInformation" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r930", "r931", "r932" ], "lang": { "en-us": { "role": { "label": "Auditor Location", "terseLabel": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/AuditInformation" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r930", "r931", "r932" ], "lang": { "en-us": { "role": { "label": "Auditor Name", "terseLabel": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/AuditInformation" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r930", "r931", "r932" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r933" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r928" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r927" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "verboseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r927" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r927" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r942" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r927" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r927" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r927" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r927" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "verboseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r966" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "verboseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r930", "r931", "r932" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r926" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r929" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "ew_AbbottLaboratoriesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Abbott Laboratories [Member]", "label": "Abbott Laboratories [Member]", "terseLabel": "Abbott Laboratories" } } }, "localname": "AbbottLaboratoriesMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails" ], "xbrltype": "domainItemType" }, "ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the value of the initial shares repurchased as a percentage of the contract amount under accelerated share repurchase agreement.", "label": "Accelerated Share Repurchases, Value Of Shares Repurchased As Percentage Of Contract Amount", "terseLabel": "Value of Shares as % of Contract Value", "verboseLabel": "Percentage of shares repurchased" } } }, "localname": "AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails", "http://www.edwards.com/role/SUBSEQUENTEVENTDetails" ], "xbrltype": "percentItemType" }, "ew_AccountsReceivablePaymentTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounts Receivable, Payment Terms", "label": "Accounts Receivable, Payment Terms", "terseLabel": "Accounts receivable, required payment terms (in days)" } } }, "localname": "AccountsReceivablePaymentTerms", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails" ], "xbrltype": "durationItemType" }, "ew_AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrual for Environmental Loss Contingencies, Threshold Amount For Disclosure", "label": "Accrual for Environmental Loss Contingencies, Threshold Amount For Disclosure", "terseLabel": "Threshold of disclosing material environmental legal proceedings" } } }, "localname": "AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/LEGALPROCEEDINGSDetails" ], "xbrltype": "monetaryItemType" }, "ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 9.0, "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes, payroll taxes and other taxes, excluding income taxes payable. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrual for Property Payroll and Other Taxes Other than Income Taxes Current", "terseLabel": "Property, payroll, and other taxes" } } }, "localname": "AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "ew_AccruedAndOtherLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "", "label": "Accrued And Other Liabilities, Current", "terseLabel": "Accrued and other liabilities (Note\u00a05)", "totalLabel": "Total accrued and other liabilities" } } }, "localname": "AccruedAndOtherLiabilitiesCurrent", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "ew_AccruedLitigationAndInsuranceReserves": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 10.0, "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Litigation And Insurance Reserves", "label": "Accrued Litigation And Insurance Reserves", "terseLabel": "Legal and insurance (Notes 3 and\u00a018)" } } }, "localname": "AccruedLitigationAndInsuranceReserves", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "ew_AccruedRebates": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 5.0, "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying amount, as of the balance sheet date, of current obligations associated with sales rebates.", "label": "Accrued Rebates", "terseLabel": "Accrued rebates" } } }, "localname": "AccruedRebates", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "ew_AccruedRelocationCostsCurrent": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 4.0, "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Relocation Costs, Current", "label": "Accrued Relocation Costs, Current", "terseLabel": "Accrued relocation costs" } } }, "localname": "AccruedRelocationCostsCurrent", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "ew_AggregateIntrinsicValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value [Abstract]", "terseLabel": "Aggregate Intrinsic Value" } } }, "localname": "AggregateIntrinsicValueAbstract", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "stringItemType" }, "ew_AssetsAndLiabilitiesOfLesseeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets And Liabilities Of Lessee [Table Text Block]", "label": "Assets And Liabilities Of Lessee [Table Text Block]", "terseLabel": "Schedule of Assets And Liabilities Of Lessee" } } }, "localname": "AssetsAndLiabilitiesOfLesseeTableTextBlock", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/LEASESTables" ], "xbrltype": "textBlockItemType" }, "ew_AuditInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Audit Information [Abstract]", "label": "Audit Information [Abstract]" } } }, "localname": "AuditInformationAbstract", "nsuri": "http://www.edwards.com/20211231", "xbrltype": "stringItemType" }, "ew_BuildingsAndLeaseholdImprovementsGross": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount, as of the balance sheet date, of long-lived, depreciable assets, that includes building structures and leasehold improvements.", "label": "Buildings and Leasehold Improvements Gross", "terseLabel": "Buildings and leasehold improvements" } } }, "localname": "BuildingsAndLeaseholdImprovementsGross", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "ew_BusinessCombinationConsiderationToBeTransferred": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Consideration To Be Transferred", "label": "Business Combination, Consideration To Be Transferred", "terseLabel": "Acquisition price, subject uncertain adjustments" } } }, "localname": "BusinessCombinationConsiderationToBeTransferred", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSNarrativesDetails" ], "xbrltype": "monetaryItemType" }, "ew_BusinessCombinationInprocessResearchandDevelopmentExpectedCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, In-process Research and Development, Expected Costs", "label": "Business Combination, In-process Research and Development, Expected Costs", "terseLabel": "Additional research and development expenditures to be incurred prior to product introduction" } } }, "localname": "BusinessCombinationInprocessResearchandDevelopmentExpectedCosts", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSNarrativesDetails" ], "xbrltype": "monetaryItemType" }, "ew_CASMedicalSystemsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CAS Medical Systems, Inc. [Member]", "label": "CAS Medical Systems, Inc. [Member]", "terseLabel": "CAS Medical Systems, Inc." } } }, "localname": "CASMedicalSystemsInc.Member", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSNarrativesDetails" ], "xbrltype": "domainItemType" }, "ew_CapitalLossCarryforwardAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capital Loss Carryforward [Abstract]", "label": "Capital Loss Carryforward [Abstract]", "terseLabel": "Capital Loss Carryforward [Abstract]" } } }, "localname": "CapitalLossCarryforwardAbstract", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "ew_CapitalLossCarryforwardPeriodEnds2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capital Loss Carryforward Period Ends 2022 [Member]", "label": "Capital Loss Carryforward Period Ends 2024 [Member]", "terseLabel": "Carryforward Period Ends 2022" } } }, "localname": "CapitalLossCarryforwardPeriodEnds2024Member", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "ew_CapitalLossCarryforwards": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Capital Loss Carryforwards", "label": "Capital Loss Carryforwards", "terseLabel": "Carryforward Amount" } } }, "localname": "CapitalLossCarryforwards", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "ew_CapitalLossCarryforwardsValuationAllowance": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails": { "order": 2.0, "parentTag": "ew_DeferredTaxAssetsCapitalLossCarryforwardsNetOfValuationAllowance", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Capital Loss Carryforwards, Valuation Allowance", "label": "Capital Loss Carryforwards, Valuation Allowance", "negatedTerseLabel": "Valuation Allowance" } } }, "localname": "CapitalLossCarryforwardsValuationAllowance", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "ew_CardiAQValveTechnologiesInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CardiAQ Valve Technologies, Inc. [Member]", "label": "CardiAQ Valve Technologies, Inc. [Member]", "terseLabel": "CardiAQ" } } }, "localname": "CardiAQValveTechnologiesInc.Member", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSNarrativesDetails" ], "xbrltype": "domainItemType" }, "ew_CarryforwardPeriodEnds20302037Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Carryforward Period Ends 2030-2037 [Member]", "label": "Carryforward Period Ends 2030-2037 [Member]", "terseLabel": "Carryforward Period Ends 2030-2037" } } }, "localname": "CarryforwardPeriodEnds20302037Member", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "ew_ContingentConsiderationLiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contingent Consideration Liability", "label": "Contingent Consideration Liability [Member]", "terseLabel": "Contingent Consideration" } } }, "localname": "ContingentConsiderationLiabilityMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinFairValueofContingentConsiderationObligationDetails" ], "xbrltype": "domainItemType" }, "ew_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contract With Customer, Liability, Revenue Recognized Excluding Opening Balance", "label": "Contract With Customer, Liability, Revenue Recognized Excluding Opening Balance", "terseLabel": "Revenue recognized that was previously deferred excluding opening balance" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_CreditAgreementMaturityApril2023Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Credit Agreement Maturity April 2023 [Member]", "label": "Credit Agreement Maturity April 2023 [Member]", "terseLabel": "Credit Agreement Maturity April 2023" } } }, "localname": "CreditAgreementMaturityApril2023Member", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_CreditAgreementMaturityJuly2019Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the credit agreement with a maturity of July 2019.", "label": "Credit Agreement, Maturity July 2019 [Member]", "terseLabel": "Credit agreement, maturity July 2019" } } }, "localname": "CreditAgreementMaturityJuly2019Member", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_CriticalCareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents the critical care product line.", "label": "Critical Care [Member]", "terseLabel": "Critical Care" } } }, "localname": "CriticalCareMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "ew_DeferredTaxAssetsCapitalLossCarryforwardsNetOfValuationAllowance": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Capital Loss Carryforwards, Net Of Valuation Allowance", "label": "Deferred Tax Assets, Capital Loss Carryforwards, Net Of Valuation Allowance", "totalLabel": "Net Tax Benefit" } } }, "localname": "DeferredTaxAssetsCapitalLossCarryforwardsNetOfValuationAllowance", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "ew_DeferredTaxAssetsInvestmentsInUnconsolidatedAffiliates": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 9.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments. Includes equity method investments; excludes investments in subsidiaries.", "label": "Deferred Tax Assets, Investments in Unconsolidated Affiliates", "terseLabel": "Investments" } } }, "localname": "DeferredTaxAssetsInvestmentsInUnconsolidatedAffiliates", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ew_DeferredTaxAssetsLeaseLiabilityObligations": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 10.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Lease Liability Obligations", "label": "Deferred Tax Assets, Lease Liability Obligations", "terseLabel": "Lease liability obligations" } } }, "localname": "DeferredTaxAssetsLeaseLiabilityObligations", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ew_DeferredTaxAssetsOperatingLossCarryforwardsNetOfReduction": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards, net of the reduction for the benefit related to windfall to be recorded to additional paid in capital when realized as a reduction to income taxes payable.", "label": "Deferred Tax Assets Operating Loss Carryforwards Net of Reduction", "verboseLabel": "Net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNetOfReduction", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ew_DeferredTaxAssetsOperatingLossCarryforwardsNetOfValuationAllowance": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the amount after allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets Operating Loss Carryforwards Net of Valuation Allowance", "totalLabel": "Net Tax Benefit" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNetOfValuationAllowance", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "ew_DeferredTaxLiabilityOperatingLeaseRightOfUseAmortization": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Liability, Operating Lease Right Of Use Amortization", "label": "Deferred Tax Liability, Operating Lease Right Of Use Amortization", "negatedTerseLabel": "Right-of-use assets" } } }, "localname": "DeferredTaxLiabilityOperatingLeaseRightOfUseAmortization", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ew_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTaxExpenseBenefitNetofTax": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails": { "order": 3.0, "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Accumulated Other Comprehensive Income, Deferred Income Tax Expense (Benefit), Net of Tax", "label": "Defined Benefit Plan, Accumulated Other Comprehensive Income, Deferred Income Tax Expense (Benefit), Net of Tax", "negatedTerseLabel": "Deferred income tax benefit" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTaxExpenseBenefitNetofTax", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "ew_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPensionIncrease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents the percentage of increase in pension.", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Pension Increase", "verboseLabel": "Pension increase (as a percent)" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPensionIncrease", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "xbrltype": "percentItemType" }, "ew_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationSocialSecuritiesIncrease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents the percentage of increase in social security.", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Social Securities Increase", "verboseLabel": "Social securities increase (as a percent)" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationSocialSecuritiesIncrease", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "xbrltype": "percentItemType" }, "ew_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostPensionIncrease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents the percentage of increase in pension.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Pension Increase", "verboseLabel": "Pension increase (as a percent)" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostPensionIncrease", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "xbrltype": "percentItemType" }, "ew_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostSocialSecuritiesIncrease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents the percentage of increase in social security.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Social Securities Increase", "verboseLabel": "Social securities increase (as a percent)" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostSocialSecuritiesIncrease", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "xbrltype": "percentItemType" }, "ew_DefinedBenefitPlanChangeinBenefitObligationPlanAssetsNetAmountRecognizedonBalanceSheetTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents the changes in benefit obligations, plan assets and the net amount recognized in the balance sheet for defined benefit plans.", "label": "Defined Benefit Plan, Change in Benefit Obligation Plan Assets, Net Amount Recognized on Balance Sheet [Table Text Block]", "terseLabel": "Schedule of Information Regarding Defined Benefit Pension Plans" } } }, "localname": "DefinedBenefitPlanChangeinBenefitObligationPlanAssetsNetAmountRecognizedonBalanceSheetTableTextBlock", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSTables" ], "xbrltype": "textBlockItemType" }, "ew_DefinedContributionPlanEmployerMatchingContributionPercentFirstLevel": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of the first level of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.", "label": "Defined Contribution Plan Employer Matching Contribution Percent, First Level", "terseLabel": "Dollar-for-dollar match of employee's annual eligible compensation (as a percent)" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercentFirstLevel", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "percentItemType" }, "ew_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchFirstLevel": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage employer matches for the first level of the employee's percentage contribution matched.", "label": "Defined Contribution Plan, Employer Matching Contribution Percent of Match First Level", "terseLabel": "Company match, first level (as a percent)" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatchFirstLevel", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "percentItemType" }, "ew_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchSecondLevel": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage employer matches for the second level of the employee's percentage contribution matched.", "label": "Defined Contribution Plan, Employer Matching Contribution Percent of Match, Second Level", "terseLabel": "Company match, second level (as a percent)" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatchSecondLevel", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "percentItemType" }, "ew_DefinedContributionPlanEmployerMatchingContributionPercentSecondLevel": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of the second level of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.", "label": "Defined Contribution Plan, Employer Matching Contribution Percent, Second Level", "terseLabel": "Company match of eligible compensation after dollar-for-dollar basis (as a percent)" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercentSecondLevel", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "percentItemType" }, "ew_DefinedContributionPlanProfitSharingContributionRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For a defined contribution plan, the percent of the participant's eligible compensation that the employer will contribute to the profit sharing plan.", "label": "Defined Contribution Plan Profit Sharing Contribution Rate", "terseLabel": "Profit sharing contribution calculated on eligible earnings (as a percent)" } } }, "localname": "DefinedContributionPlanProfitSharingContributionRate", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "percentItemType" }, "ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Fair Value of Derivative Asset Gross Amounts Not Offset [Abstract]", "terseLabel": "Gross Amounts Not Offset in the Consolidated Balance Sheet" } } }, "localname": "DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "stringItemType" }, "ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Fair Value of Derivative Liability Gross Amounts Not Offset [Abstract]", "terseLabel": "Gross Amounts Not Offset in the Consolidated Balance Sheet" } } }, "localname": "DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "stringItemType" }, "ew_DisclosureOfFairValueHedgingInstrumentsAndCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure Of Fair Value Hedging Instruments And Cash Flow Hedging Instruments, Statements Of Financial Performance And Financial Position, Location [Table Text Block]", "label": "Disclosure Of Fair Value Hedging Instruments And Cash Flow Hedging Instruments, Statements Of Financial Performance And Financial Position, Location [Table Text Block]", "terseLabel": "Schedule of the Effect of Fair Value and Cash Flow Hedge" } } }, "localname": "DisclosureOfFairValueHedgingInstrumentsAndCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "xbrltype": "textBlockItemType" }, "ew_EarlystageTranscatheterIntellectualPropertyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Early-stage Transcatheter Intellectual Property [Member]", "label": "Early-stage Transcatheter Intellectual Property [Member]", "terseLabel": "Early-stage Transcatheter Intellectual Property" } } }, "localname": "EarlystageTranscatheterIntellectualPropertyMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/SPECIALCHARGESAcquisitionofIntellectualPropertyDetails" ], "xbrltype": "domainItemType" }, "ew_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiability": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 8.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Contingent Consideration Liability", "label": "Effective Income Tax Rate Reconciliation, Contingent Consideration Liability", "negatedTerseLabel": "Contingent consideration liabilities" } } }, "localname": "EffectiveIncomeTaxRateReconciliationContingentConsiderationLiability", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "ew_EffectiveIncomeTaxRateReconciliationDeductionSharebasedCompensationCostAmount": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 9.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Deduction, Share-based Compensation Cost, Amount", "label": "Effective Income Tax Rate Reconciliation, Deduction, Share-based Compensation Cost, Amount", "negatedTerseLabel": "United States federal deductible employee share-based compensation" } } }, "localname": "EffectiveIncomeTaxRateReconciliationDeductionSharebasedCompensationCostAmount", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "ew_EffectiveIncomeTaxRateReconciliationTaxOnGlobalIntangibleLowTaxedIncomeAmount": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 6.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Tax On Global Intangible Low-Taxed Income, Amount", "label": "Effective Income Tax Rate Reconciliation, Tax On Global Intangible Low-Taxed Income, Amount", "terseLabel": "Tax on global intangible low-taxed income" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxOnGlobalIntangibleLowTaxedIncomeAmount", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "ew_EmployeeAndNonemployeeStockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An arrangement whereby an employee or nonemployee (including a member of the entity's Board of Directors) is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement.", "label": "Employee and Nonemployee Stock Options [Member]", "terseLabel": "Option Awards", "verboseLabel": "Stock option activity" } } }, "localname": "EmployeeAndNonemployeeStockOptionsMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails" ], "xbrltype": "domainItemType" }, "ew_EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndVestingOfRestrictedStockUnits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disclosure of aggregate tax benefit realized from the exercise of stock options and vesting of restricted stock units during the period.", "label": "Employee Service Share Based Compensation, Tax Benefit Realized from Exercise of Stock Options and Vesting of Restricted Stock Units", "terseLabel": "Realized tax benefits from exercises of stock options and vesting of restricted stock units" } } }, "localname": "EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndVestingOfRestrictedStockUnits", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAdditionalInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_EmployeeStockPurchasePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee Stock Purchase Plan [Member]", "label": "Employee Stock Purchase Plan [Member]", "terseLabel": "ESPP" } } }, "localname": "EmployeeStockPurchasePlanMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_EquipmentWithCustomers": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 4.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The gross amount, as of the balance sheet date, of long-lived, depreciable equipment at customer locations.", "label": "Equipment with Customers", "terseLabel": "Equipment with customers" } } }, "localname": "EquipmentWithCustomers", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "ew_EquitySecuritiesFVNIInvestmentAfterFirstMilestone": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity Securities, FV-NI, Investment After First Milestone", "label": "Equity Securities, FV-NI, Investment After First Milestone", "terseLabel": "Investment after first milestone" } } }, "localname": "EquitySecuritiesFVNIInvestmentAfterFirstMilestone", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment", "label": "Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment", "terseLabel": "Maximum additional option to acquire investment" } } }, "localname": "EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_EquitySecuritiesFVNIMaximumAdditionalRequired": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity Securities, FV-NI, Maximum Additional Required", "label": "Equity Securities, FV-NI, Maximum Additional Required", "terseLabel": "Maximum additional required investment" } } }, "localname": "EquitySecuritiesFVNIMaximumAdditionalRequired", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity Securities, FV-NI, Maximum Secured Promissory Note", "label": "Equity Securities, FV-NI, Maximum Secured Promissory Note", "terseLabel": "Maximum secured promissory note" } } }, "localname": "EquitySecuritiesFVNIMaximumSecuredPromissoryNote", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_EquitySecuritiesFVNIOptionToAcquireInvestment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity Securities, FV-NI, Option To Acquire Investment", "label": "Equity Securities, FV-NI, Option To Acquire Investment", "terseLabel": "Investment option to acquire" } } }, "localname": "EquitySecuritiesFVNIOptionToAcquireInvestment", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_EquitySecuritiesFVNIPromissoryNote": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity Securities, FV-NI, Promissory Note", "label": "Equity Securities, FV-NI, Promissory Note", "terseLabel": "Secured promissory note" } } }, "localname": "EquitySecuritiesFVNIPromissoryNote", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_EstimatedAnnualForfeitureRatePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents the estimated annual forfeiture rate of the entity's stock-based compensation plans, percentage.", "label": "Estimated Annual Forfeiture Rate Percent", "terseLabel": "Estimated annual forfeiture rate (as a percent)" } } }, "localname": "EstimatedAnnualForfeitureRatePercent", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "ew_EuropeSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the Europe reportable segment of the entity.", "label": "Europe Segment [Member]", "terseLabel": "Europe", "verboseLabel": "Europe" } } }, "localname": "EuropeSegmentMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "ew_February2021StockRepurchaseProgramSharesSoldInMarch2021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "February 2021 Stock Repurchase Program, Shares Sold In March 2021", "label": "February 2021 Stock Repurchase Program, Shares Sold In March 2021 [Member]", "terseLabel": "Purchased in February 2021 and sold in March 2021" } } }, "localname": "February2021StockRepurchaseProgramSharesSoldInMarch2021Member", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails" ], "xbrltype": "domainItemType" }, "ew_FixedRate4.3002018NotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fixed Rate 4.300% 2018 Notes [Member]", "label": "Fixed Rate 4.300% 2018 Notes [Member]", "terseLabel": "Fixed-rate 4.300% 2018 Notes" } } }, "localname": "FixedRate4.3002018NotesMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "domainItemType" }, "ew_ForeignEarningsToBeRepatriated": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Foreign Earnings To Be Repatriated", "label": "Foreign Earnings To Be Repatriated", "terseLabel": "Foreign earnings to be repatriated" } } }, "localname": "ForeignEarningsToBeRepatriated", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_ForeignTaxCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Tax Credit", "label": "Foreign Tax Credit [Member]", "terseLabel": "Foreign tax credits" } } }, "localname": "ForeignTaxCreditMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "ew_GainLossOnInvestmentsOtherIncomeExpenseNet": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/OTHERINCOMENETDetails": { "order": 2.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This item represents the portion of gain (loss) on investments categorized by the entity as other income (expense). Includes, but is not limited to, (1) the net realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including those trading securities held for investment under deferred compensation agreements net of the gain (loss) of the related deferred compensation liability; (2) the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied; (3) gains (losses) realized during the period from the sale of investments accounted for under the cost method of accounting; (4) losses recognized for other than temporary impairments (OTTI) of the subject investments; and (5) the amount of recovery of investments which had previously been fully or partially written-off.", "label": "Gain (Loss) on Investments, Other Income Expense, Net", "negatedLabel": "Gain on investments" } } }, "localname": "GainLossOnInvestmentsOtherIncomeExpenseNet", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/OTHERINCOMENETDetails" ], "xbrltype": "monetaryItemType" }, "ew_HarpoonMedicalInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Harpoon Medical, Inc. [Member]", "label": "Harpoon Medical, Inc. [Member]", "terseLabel": "Harpoon Medical" } } }, "localname": "HarpoonMedicalInc.Member", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSNarrativesDetails" ], "xbrltype": "domainItemType" }, "ew_HemodynamicMonitorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hemodynamic Monitors [Member]", "label": "Hemodynamic Monitors [Member]", "terseLabel": "Hemodynamic Monitors" } } }, "localname": "HemodynamicMonitorsMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_IncreaseDecreaseInDeferredTaxAssetsLiabilitiesNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase or decrease during the year in net deferred tax assets. Includes items recorded to stockholders' equity and which did not impact the income tax provision.", "label": "Increase (Decrease) in Deferred Tax Assets (Liabilities), Net", "terseLabel": "Net deferred tax assets increase" } } }, "localname": "IncreaseDecreaseInDeferredTaxAssetsLiabilitiesNet", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_IncreaseDecreaseInLegalSettlementAccrual": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) In Legal Settlement Accrual", "label": "Increase (Decrease) In Legal Settlement Accrual", "terseLabel": "Litigation settlement accrual" } } }, "localname": "IncreaseDecreaseInLegalSettlementAccrual", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "ew_InitialDeliveryOfSharesSettledFebruary2021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial Delivery Of Shares Settled February 2021", "label": "Initial Delivery Of Shares Settled February 2021 [Member]", "terseLabel": "Initial Delivery of Shares Settled February 2021" } } }, "localname": "InitialDeliveryOfSharesSettledFebruary2021Member", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails" ], "xbrltype": "domainItemType" }, "ew_InitialDeliveryOfSharesSettledJune2019Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial Delivery Of Shares Settled June 2019 [Member]", "label": "Initial Delivery Of Shares Settled June 2019 [Member]", "terseLabel": "Initial Delivery of Shares Settled June 2019" } } }, "localname": "InitialDeliveryOfSharesSettledJune2019Member", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails" ], "xbrltype": "domainItemType" }, "ew_InitialDeliveryofSharesSettledMay2019Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial Delivery of Shares Settled May 2019 [Member]", "label": "Initial Delivery of Shares Settled May 2019 [Member]", "terseLabel": "Initial Delivery of Shares Settled May 2019" } } }, "localname": "InitialDeliveryofSharesSettledMay2019Member", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails" ], "xbrltype": "domainItemType" }, "ew_InsuranceContractsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents the information about insurance contracts.", "label": "Insurance Contracts [Member]", "terseLabel": "Insurance contracts", "verboseLabel": "Insurance Contracts" } } }, "localname": "InsuranceContractsMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details" ], "xbrltype": "domainItemType" }, "ew_IntellectualPropertyLitigationExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the net amount of judgment or settlement awarded to (against) the entity and legal, forensic, accounting, investigative fees and other expenses related to intellectual property litigation.", "label": "Intellectual Property Litigation Expense", "negatedLabel": "Intellectual property litigation expenses, net" } } }, "localname": "IntellectualPropertyLitigationExpense", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails" ], "xbrltype": "monetaryItemType" }, "ew_InventoryWriteDownExpirationPeriodTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period prior to the expiration date which triggers the write down of inventory, expressed in months.", "label": "Inventory Write Down Expiration Period Trigger", "terseLabel": "Period prior to expiration date which triggers write-down of inventory (in months)" } } }, "localname": "InventoryWriteDownExpirationPeriodTrigger", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInventoriesNarrativeDetails" ], "xbrltype": "durationItemType" }, "ew_InventoryWriteDownSlowMovingPeriodTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The time period used to identify slow-moving inventory which triggers an inventory write-down.", "label": "Inventory Write Down Slow Moving Period Trigger", "terseLabel": "Period used to evaluate slow-moving inventory levels (in years)" } } }, "localname": "InventoryWriteDownSlowMovingPeriodTrigger", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInventoriesNarrativeDetails" ], "xbrltype": "durationItemType" }, "ew_January2022StockRepurchaseProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "January 2022 Stock Repurchase Program", "label": "January 2022 Stock Repurchase Program [Member]", "terseLabel": "January 2022 Stock Repurchase Program" } } }, "localname": "January2022StockRepurchaseProgramMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/SUBSEQUENTEVENTDetails" ], "xbrltype": "domainItemType" }, "ew_JapanSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the Japan reportable segment of the entity.", "label": "Japan Segment [Member]", "terseLabel": "Japan" } } }, "localname": "JapanSegmentMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "ew_KardionIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kardion, Inc.", "label": "Kardion, Inc. [Member]", "terseLabel": "Kardion, Inc." } } }, "localname": "KardionIncMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_LesseeOperatingLeaseLeaseNotYetCommencedAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Amount", "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Amount", "terseLabel": "Lease commitments for leases not yet commenced" } } }, "localname": "LesseeOperatingLeaseLeaseNotYetCommencedAmount", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/LEASESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_LineOfCreditFacilityAdditionalCapacityIncreaseOption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount by which the borrowing capacity of the line of credit may be increased at the entity's option, subject to certain conditions, under the terms of the credit agreement.", "label": "Line of Credit Facility, Additional Capacity Increase Option", "terseLabel": "Additional amount available, subject to lender approval" } } }, "localname": "LineOfCreditFacilityAdditionalCapacityIncreaseOption", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_LongTermStockIncentiveCompensationProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents details pertaining to the Long-Term Stock Incentive Compensation Program of the entity.", "label": "Long Term Stock Incentive Compensation Program [Member]", "terseLabel": "The Program" } } }, "localname": "LongTermStockIncentiveCompensationProgramMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number", "label": "Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number", "terseLabel": "Number of lawsuits that if settled could have a material adverse impact on net income or cash flows" } } }, "localname": "LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/LEGALPROCEEDINGSDetails" ], "xbrltype": "integerItemType" }, "ew_MarketBasedRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Market Based Restricted Stock Units [Member]", "label": "Market Based Restricted Stock Units [Member]", "terseLabel": "MRSUs" } } }, "localname": "MarketBasedRestrictedStockUnitsMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_May2019StockRepurchaseProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "May 2019 Stock Repurchase Program", "label": "May 2019 Stock Repurchase Program [Member]", "terseLabel": "Stock Repurchase Program May 2019" } } }, "localname": "May2019StockRepurchaseProgramMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_May2019StockRepurchaseProgramSharesPurchasedAndSoldInMay2019Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "May 2019 Stock Repurchase Program, Shares Purchased And Sold In May 2019 [Member]", "label": "May 2019 Stock Repurchase Program, Shares Purchased And Sold In May 2019 [Member]", "terseLabel": "Purchased and sold in May 2019" } } }, "localname": "May2019StockRepurchaseProgramSharesPurchasedAndSoldInMay2019Member", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails" ], "xbrltype": "domainItemType" }, "ew_May2019StockRepurchaseProgramSharesSoldInJune2019Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "May 2019 Stock Repurchase Program, Shares Sold In June 2019 [Member]", "label": "May 2019 Stock Repurchase Program, Shares Sold In June 2019 [Member]", "terseLabel": "Purchased in May 2019 and sold in June 2019" } } }, "localname": "May2019StockRepurchaseProgramSharesSoldInJune2019Member", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails" ], "xbrltype": "domainItemType" }, "ew_May2021StockRepurchaseProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "May 2021 Stock Repurchase Program", "label": "May 2021 Stock Repurchase Program [Member]", "verboseLabel": "Stock Repurchase Program May 2021" } } }, "localname": "May2021StockRepurchaseProgramMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_MeasurementInputProbabilityOfMilestoneAchievementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement Input, Probability Of Milestone Achievement [Member]", "label": "Measurement Input, Probability Of Milestone Achievement [Member]", "terseLabel": "Measurement Input, Probability of Milestone Achievement" } } }, "localname": "MeasurementInputProbabilityOfMilestoneAchievementMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_MeasurementInputVolatilityOfFutureRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement Input, Volatility Of Future Revenue [Member]", "label": "Measurement Input, Volatility Of Future Revenue [Member]", "terseLabel": "Measurement Input, Volatility of Future Revenue" } } }, "localname": "MeasurementInputVolatilityOfFutureRevenueMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_NonemployeeDirectorsStockIncentiveCompensationProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents details pertaining to the Nonemployee Directors Stock Incentive Compensation Program of the entity.", "label": "Nonemployee Directors Stock Incentive Compensation Program [Member]", "terseLabel": "Nonemployee Directors Program" } } }, "localname": "NonemployeeDirectorsStockIncentiveCompensationProgramMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_NonqualifiedDeferredCompensationPlanSelectEmployeeGroupMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents a nonqualified deferred compensation plan for a select group of employees.", "label": "Nonqualified Deferred Compensation Plan Select Employee Group [Member]", "terseLabel": "Nonqualified deferred compensation plans" } } }, "localname": "NonqualifiedDeferredCompensationPlanSelectEmployeeGroupMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_NotesReceivableConvertedToEquityInvestment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Notes Receivable Converted To Equity Investment", "label": "Notes Receivable Converted To Equity Investment", "terseLabel": "Conversion of notes receivable to equity investment" } } }, "localname": "NotesReceivableConvertedToEquityInvestment", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "ew_OperatingLeaseRightOfUseAssetAmortization": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating Lease, Right Of Use Asset Amortization", "label": "Operating Lease, Right Of Use Asset Amortization", "terseLabel": "Non-cash operating lease cost" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortization", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "ew_OtherIncomeExpenseItems": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/OTHERINCOMENETDetails": { "order": 4.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reflects all other income and expense recognized by the entity in the period not otherwise specified in the income statement.", "label": "Other Income Expense Items", "negatedLabel": "Other" } } }, "localname": "OtherIncomeExpenseItems", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/OTHERINCOMENETDetails" ], "xbrltype": "monetaryItemType" }, "ew_PreviousAcquisitionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Previous Acquisitions", "label": "Previous Acquisitions [Member]", "terseLabel": "Previous Acquisitions" } } }, "localname": "PreviousAcquisitionsMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_PuertoRicoPurchasesCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Puerto Rico Purchases Credit [Member]", "label": "Puerto Rico Purchases Credit [Member]", "terseLabel": "Puerto Rico purchases credit" } } }, "localname": "PuertoRicoPurchasesCreditMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_PurchaseCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to purchase credit carryforward.", "label": "Purchase Credit [Member]", "terseLabel": "Purchases credit" } } }, "localname": "PurchaseCreditMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "ew_ResearchAndDevelopmentAccruals": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 8.0, "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying amount, as of the balance sheet date, of current obligations associated with research and development and clinical trials.", "label": "Research And Development Accruals", "terseLabel": "Research and development accruals" } } }, "localname": "ResearchAndDevelopmentAccruals", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "ew_RestOfWorldMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the geographic areas of the world other than the United States, Europe and Japan.", "label": "Rest of World [Member]", "terseLabel": "Rest of World" } } }, "localname": "RestOfWorldMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "ew_RestOfWorldSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the reportable segment of the entity comprised of regions other than the United States, Europe and Japan (Rest of World).", "label": "Rest of World Segment [Member]", "terseLabel": "Rest of World", "verboseLabel": "Rest of World" } } }, "localname": "RestOfWorldSegmentMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails", "http://www.edwards.com/role/SPECIALCHARGESImpairmentofLonglivedAssetsDetails" ], "xbrltype": "domainItemType" }, "ew_RestrictedStockAndRestrictedStockUnitAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted stock and restricted stock units awarded by a company to their employees as a form of incentive compensation.", "label": "Restricted Stock and Restricted Stock Unit Awards [Member]", "terseLabel": "Restricted stock or restricted stock units" } } }, "localname": "RestrictedStockAndRestrictedStockUnitAwardsMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_ScheduleOfSelectedCaptionsBalanceSheetDisclosuresTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of the aggregate supplemental balance sheet disclosures, including descriptions and amounts, related to assets and liabilities.", "label": "Schedule of Selected Captions Balance Sheet Disclosures [Table Text Block]", "terseLabel": "Schedule of Components of Selected Captions in the Consolidated Balance Sheets" } } }, "localname": "ScheduleOfSelectedCaptionsBalanceSheetDisclosuresTableTextBlock", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" ], "xbrltype": "textBlockItemType" }, "ew_SeniorNotesDue2018Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to senior notes which are due in 2018.", "label": "Senior Notes Due 2018 [Member]", "terseLabel": "2013 Notes" } } }, "localname": "SeniorNotesDue2018Member", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPreviousPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Grants In Previous Period", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Grants In Previous Period", "terseLabel": "Shares related to previous year's grant (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPreviousPeriod", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardIntrinsicValueOfStockOptionsExercisedAndVestedRestrictedStockUnits": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the intrinsic value of stock options exercised and restricted stock units that vested during the period.", "label": "Share Based Compensation Arrangement by Share Based Payment Award, Intrinsic Value of Stock Options Exercised and Vested Restricted Stock Units", "terseLabel": "Intrinsic value of stock options exercised and restricted stock units vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardIntrinsicValueOfStockOptionsExercisedAndVestedRestrictedStockUnits", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAdditionalInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGrantDateFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the total grant-date fair value of options that vested during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options Vested in Period, Grant Date Fair Value", "terseLabel": "Total grant date fair value of stock options vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGrantDateFairValue", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAdditionalInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_ShareBasedCompensationArrangementsAwardGrantedAnnuallyToNonemployeeDirectorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents details pertaining to an award granted annually to a nonemployee director.", "label": "Share-based Compensation Arrangements Award Granted Annually to Nonemployee Director [Member]", "terseLabel": "Annual award to nonemployee director" } } }, "localname": "ShareBasedCompensationArrangementsAwardGrantedAnnuallyToNonemployeeDirectorMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_ShareBasedCompensationArrangementsAwardsGranted2012AndAfterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents details pertaining to awards granted in 2012 and years after.", "label": "Share Based Compensation Arrangements Awards Granted 2012 and after [Member]", "terseLabel": "Awards granted in 2012 and later" } } }, "localname": "ShareBasedCompensationArrangementsAwardsGranted2012AndAfterMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_ShareBasedGoodsAndNonemployeeServicesTransactionNonemployeeAwardValueMaximum": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the maximum total grant date fair value of stock-based awards that can be granted to nonemployee directors.", "label": "Share Based Goods and Nonemployee Services Transaction Nonemployee Award Value Maximum", "terseLabel": "Limit on total value of the award" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionNonemployeeAwardValueMaximum", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_ShareInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Information [Abstract]", "terseLabel": "Share information (Note\u00a02):" } } }, "localname": "ShareInformationAbstract", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "ew_StockholdersEquityNoteStockSplitNumberOfNewlyIssuedSharesPerHolder": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stockholders' Equity Note, Stock Split, Number Of Newly Issued Shares Per Holder", "label": "Stockholders' Equity Note, Stock Split, Number Of Newly Issued Shares Per Holder", "terseLabel": "Number of newly issued shares of common stock per holder" } } }, "localname": "StockholdersEquityNoteStockSplitNumberOfNewlyIssuedSharesPerHolder", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockSplitNarrativeDetails" ], "xbrltype": "sharesItemType" }, "ew_SurgicalHeartValveTherapyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents the surgical heart valve therapy product line.", "label": "Surgical Heart Valve Therapy [Member]", "terseLabel": "Surgical Structural Heart" } } }, "localname": "SurgicalHeartValveTherapyMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "ew_TaxCarryforwardsExpirationPeriodYears20202027Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax Carryforwards Expiration Period Years 2020-2027 [Member]", "label": "Tax Carryforwards Expiration Period Years 2020-2027 [Member]", "terseLabel": "Carryforward Period Ends 2020-2027" } } }, "localname": "TaxCarryforwardsExpirationPeriodYears20202027Member", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "ew_TaxCarryforwardsExpirationPeriodYears20262039Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax Carryforwards Expiration Period Years 2026-2039 [Member]", "label": "Tax Carryforwards Expiration Period Years 2026-2039 [Member]", "terseLabel": "Carryforward Period Ends 2026-2039" } } }, "localname": "TaxCarryforwardsExpirationPeriodYears20262039Member", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "ew_TaxCarryforwardsNoExpirationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents tax carryforwards with no expiration.", "label": "Tax Carryforwards, No Expiration [Member]", "terseLabel": "Carryforward Period Indefinite", "verboseLabel": "Carryforward period indefinite" } } }, "localname": "TaxCarryforwardsNoExpirationMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "ew_TaxCreditCarryforwardDeferredTaxAssetNetOfValuationAllowance": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the amount after allocation of valuation allowances of deferred tax asset attributable to tax credit carryforwards.", "label": "Tax Credit Carryforward, Deferred Tax Asset, Net of Valuation Allowance", "totalLabel": "Net Tax Benefit" } } }, "localname": "TaxCreditCarryforwardDeferredTaxAssetNetOfValuationAllowance", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "ew_TranscatheterAorticValveReplacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transcatheter Aortic Valve Replacement [Member]", "label": "Transcatheter Aortic Valve Replacement [Member]", "terseLabel": "Transcatheter Aortic Valve Replacement" } } }, "localname": "TranscatheterAorticValveReplacementMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "ew_TranscatheterMitralAndTricuspidTherapiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transcatheter Mitral And Tricuspid Therapies [Member]", "label": "Transcatheter Mitral And Tricuspid Therapies [Member]", "terseLabel": "Transcatheter Mitral and Tricuspid Therapies" } } }, "localname": "TranscatheterMitralAndTricuspidTherapiesMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "ew_TwoPreviousAcquisitionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Previous Acquisitions [Member]", "label": "Two Previous Acquisitions [Member]", "terseLabel": "Two Previous Acquisitions" } } }, "localname": "TwoPreviousAcquisitionsMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_UnitedStatesSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the United States reportable segment of the entity.", "label": "United States Segment [Member]", "terseLabel": "United States", "verboseLabel": "United States" } } }, "localname": "UnitedStatesSegmentMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "ew_UnrecognizedTaxBenefitsAccruedInterestTaxBenefit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The tax benefits pertaining to the amount of interest expense accrued on unrecognized tax benefits.", "label": "Unrecognized Tax Benefits, Accrued Interest, Tax Benefit", "terseLabel": "Tax benefit of accrued interest" } } }, "localname": "UnrecognizedTaxBenefitsAccruedInterestTaxBenefit", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_ValtechCardioLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Valtech Cardio, Ltd [Member]", "label": "Valtech Cardio, Ltd [Member]", "terseLabel": "Valtech" } } }, "localname": "ValtechCardioLtdMember", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/SPECIALCHARGESImpairmentofLonglivedAssetsDetails" ], "xbrltype": "domainItemType" }, "ew_WeightedAverageRemainingContractualTermYearsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Term Years [Abstract]", "terseLabel": "Weighted- Average Remaining Contractual Term" } } }, "localname": "WeightedAverageRemainingContractualTermYearsAbstract", "nsuri": "http://www.edwards.com/20211231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r167", "r220", "r233", "r234", "r235", "r236", "r238", "r240", "r244", "r373", "r374", "r375", "r376", "r377", "r378", "r380", "r381", "r383", "r385", "r386", "r955", "r956", "r957", "r958", "r959", "r960", "r961", "r962", "r963", "r964", "r965" ], "lang": { "en-us": { "role": { "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.", "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r167", "r220", "r233", "r234", "r235", "r236", "r238", "r240", "r244", "r373", "r374", "r375", "r376", "r377", "r378", "r380", "r381", "r383", "r385", "r386", "r955", "r956", "r957", "r958", "r959", "r960", "r961", "r962", "r963", "r964", "r965" ], "lang": { "en-us": { "role": { "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.", "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of investment including named security. Excludes entity that is consolidated.", "label": "Investment, Name [Domain]", "terseLabel": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_EuropeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Continent of Europe.", "label": "Europe [Member]", "terseLabel": "Europe" } } }, "localname": "EuropeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "srt_LitigationCaseAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim.", "label": "Litigation Case [Axis]", "terseLabel": "Litigation Case [Axis]" } } }, "localname": "LitigationCaseAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails" ], "xbrltype": "stringItemType" }, "srt_LitigationCaseTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information.", "label": "Litigation Case [Domain]", "terseLabel": "Litigation Case [Domain]" } } }, "localname": "LitigationCaseTypeDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r391", "r426", "r563", "r573", "r799", "r800", "r801", "r802", "r803", "r804", "r824", "r881", "r884", "r923", "r924" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "High", "verboseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/LEASESNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r391", "r426", "r563", "r573", "r799", "r800", "r801", "r802", "r803", "r804", "r824", "r881", "r884", "r923", "r924" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Low", "verboseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/LEASESNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r247", "r464", "r467", "r827", "r880", "r882" ], "lang": { "en-us": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESShippingandHandlingCostsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r247", "r464", "r467", "r827", "r880", "r882" ], "lang": { "en-us": { "role": { "documentation": "Product or service, or a group of similar products or similar services.", "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESShippingandHandlingCostsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r391", "r426", "r499", "r563", "r573", "r799", "r800", "r801", "r802", "r803", "r804", "r824", "r881", "r884", "r923", "r924" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/LEASESNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r391", "r426", "r499", "r563", "r573", "r799", "r800", "r801", "r802", "r803", "r804", "r824", "r881", "r884", "r923", "r924" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/LEASESNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r184", "r568", "r943" ], "lang": { "en-us": { "role": { "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact.", "label": "Forecast [Member]", "terseLabel": "Forecast" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r184", "r189", "r568" ], "lang": { "en-us": { "role": { "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r299" ], "lang": { "en-us": { "role": { "documentation": "Information by name of investment including named security. Excludes entity that is consolidated.", "label": "Investment, Name [Axis]", "terseLabel": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": { "auth_ref": [ "r175", "r954" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]", "terseLabel": "VALUATION AND QUALIFYING ACCOUNTS" } } }, "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTS" ], "xbrltype": "textBlockItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r248", "r249", "r464", "r468", "r883", "r914", "r915", "r916", "r917", "r918", "r919", "r920", "r921", "r922", "r944", "r946", "r947", "r948", "r949", "r950", "r951", "r952", "r953" ], "lang": { "en-us": { "role": { "documentation": "Geographical area.", "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r248", "r249", "r464", "r468", "r883", "r909", "r914", "r915", "r916", "r917", "r918", "r919", "r920", "r921", "r922", "r944", "r945" ], "lang": { "en-us": { "role": { "documentation": "Information by geographical components.", "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r184", "r189", "r362", "r568", "r791" ], "lang": { "en-us": { "role": { "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails" ], "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]", "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]" } } }, "localname": "ValuationAndQualifyingAccountsAbstract", "nsuri": "http://fasb.org/srt/2021-01-31", "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]", "terseLabel": "Valuation and Qualifying Accounts Disclosure" } } }, "localname": "ValuationAndQualifyingAccountsDisclosureLineItems", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsDisclosureTable": { "auth_ref": [ "r168", "r169", "r170", "r173", "r174", "r954" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]", "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]" } } }, "localname": "ValuationAndQualifyingAccountsDisclosureTable", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "xbrltype": "stringItemType" }, "srt_WeightedAverageMember": { "auth_ref": [ "r799", "r801", "r804", "r923", "r924" ], "lang": { "en-us": { "role": { "documentation": "Average of a range of values, calculated with consideration of proportional relevance.", "label": "Weighted Average [Member]", "terseLabel": "Weighted Average" } } }, "localname": "WeightedAverageMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "stpr_CA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CALIFORNIA", "terseLabel": "California" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/stpr/2021", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax" } } }, "localname": "AOCIAttributableToParentNetOfTaxRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AcceleratedShareRepurchasesDateAxis": { "auth_ref": [ "r446" ], "lang": { "en-us": { "role": { "documentation": "Information by date of execution of accelerated share repurchases.", "label": "Accelerated Share Repurchases, Date [Axis]", "terseLabel": "Accelerated Share Repurchases, Date [Axis]" } } }, "localname": "AcceleratedShareRepurchasesDateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails", "http://www.edwards.com/role/SUBSEQUENTEVENTDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AcceleratedShareRepurchasesDateDomain": { "auth_ref": [ "r446" ], "lang": { "en-us": { "role": { "documentation": "Date upon which the accelerated share repurchase agreement was executed.", "label": "Accelerated Share Repurchases, Date [Domain]", "terseLabel": "Accelerated Share Repurchases, Date [Domain]" } } }, "localname": "AcceleratedShareRepurchasesDateDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails", "http://www.edwards.com/role/SUBSEQUENTEVENTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare": { "auth_ref": [ "r446" ], "lang": { "en-us": { "role": { "documentation": "Final price paid per share for the purchase of the targeted number of shares, determined by an average market price over a fixed period of time.", "label": "Accelerated Share Repurchases, Final Price Paid Per Share", "terseLabel": "Final settlement per share price (in dollars per share)" } } }, "localname": "AcceleratedShareRepurchasesFinalPricePaidPerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare": { "auth_ref": [ "r446" ], "lang": { "en-us": { "role": { "documentation": "The price paid per share to immediately purchase the targeted number of shares on the date of executing the accelerated share repurchase agreement.", "label": "Accelerated Share Repurchases, Initial Price Paid Per Share", "terseLabel": "Initial delivery, price per share (in dollars per share)" } } }, "localname": "AcceleratedShareRepurchasesInitialPricePaidPerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_AcceleratedShareRepurchasesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accelerated Share Repurchases [Line Items]", "terseLabel": "Accelerated Share Repurchase" } } }, "localname": "AcceleratedShareRepurchasesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AcceleratedShareRepurchasesTable": { "auth_ref": [ "r446" ], "lang": { "en-us": { "role": { "documentation": "A table reflecting activity in an accelerated share repurchase (ASR) program.", "label": "Accelerated Share Repurchases [Table]", "terseLabel": "Accelerated Share Repurchases [Table]" } } }, "localname": "AcceleratedShareRepurchasesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AcceleratedShareRepurchasesTextBlock": { "auth_ref": [ "r446" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of accelerated share repurchase (ASR) programs. An ASR is a combination of transactions that permits an entity to purchase a targeted number of shares immediately with the final purchase price of those shares determined by an average market price over a fixed period of time. An accelerated share repurchase program is intended to combine the immediate share retirement benefits of a tender offer with the market impact and pricing benefits of a disciplined daily open market stock repurchase program. ASRs can be disclosed as part of stockholders' equity.", "label": "Accelerated Share Repurchases [Table Text Block]", "terseLabel": "Schedule of Accelerated Share Repurchases" } } }, "localname": "AcceleratedShareRepurchasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesAndLoansReceivableLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]", "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]" } } }, "localname": "AccountsNotesAndLoansReceivableLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities.", "label": "Accounts Payable and Accrued Liabilities [Member]", "terseLabel": "Accrued and other liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r49", "r788" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r5", "r31", "r253", "r254" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net of allowances of $9.3 and $9.6, respectively" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r24", "r836", "r865" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 1.0, "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "terseLabel": "Taxes payable" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accrued Liabilities and Other Liabilities [Abstract]", "terseLabel": "Accrued and other liabilities" } } }, "localname": "AccruedLiabilitiesAndOtherLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccruedMarketingCostsCurrent": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 3.0, "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Marketing Costs, Current", "terseLabel": "Accrued marketing expenses" } } }, "localname": "AccruedMarketingCostsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r13", "r14", "r52" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 6.0, "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Professional Fees, Current", "terseLabel": "Accrued professional services" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r88", "r95", "r103", "r104", "r105", "r690" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "netLabel": "Unrealized Pension Costs", "terseLabel": "Unrealized pension costs, net", "verboseLabel": "Amortization of pension adjustments" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember": { "auth_ref": [ "r90", "r95", "r103", "r104", "r105", "r690" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to prior service cost (credit) component of defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]", "terseLabel": "Net prior service cost arising during period" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember": { "auth_ref": [ "r87", "r95", "r103", "r104", "r105", "r690" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]", "terseLabel": "Net actuarial loss arising during period" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r47", "r349" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "auth_ref": [ "r95", "r103", "r104", "r105", "r106", "r689" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "terseLabel": "Unrealized Gain (Loss) on Hedges", "verboseLabel": "Gain (loss) on hedges" } } }, "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": { "auth_ref": [ "r84", "r85", "r86", "r95", "r103", "r104", "r105" ], "lang": { "en-us": { "role": { "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.", "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]", "terseLabel": "Unrealized (Loss) Gain on Available-for-sale Investments", "verboseLabel": "(Loss) gain on available-for-sale investments" } } }, "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": { "auth_ref": [ "r89", "r95", "r520" ], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax", "negatedTotalLabel": "Total" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "verboseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r34", "r92", "r94", "r95", "r869", "r889", "r890" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r103", "r104", "r757", "r758", "r759", "r760", "r761", "r763" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r91", "r95", "r103", "r104", "r105", "r177", "r178", "r179", "r690", "r885", "r886", "r967" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Loss", "verboseLabel": "Total Accumulated Other Comprehensive Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r81", "r95", "r103", "r104", "r105", "r690", "r758", "r759", "r760", "r761", "r763" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Foreign Currency Translation Adjustments", "verboseLabel": "Foreign currency translation adjustments" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]", "terseLabel": "Amounts included in the measurement of lease liabilities:" } } }, "localname": "AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r32" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r177", "r178", "r179", "r611", "r612", "r613", "r730" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income to cash provided by operating activities:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r575", "r577", "r617", "r618" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Stock-based compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit": { "auth_ref": [ "r439", "r444" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from a stock split in which per-share par value or stated value is not changed proportionately.", "label": "Adjustments to Additional Paid in Capital, Stock Split", "negatedTerseLabel": "Stock issued to effect stock split" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalStockSplit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r577", "r607", "r616" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Total stock-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Expense, after Tax", "terseLabel": "Total stock-based compensation expense, net of tax" } } }, "localname": "AllocatedShareBasedCompensationExpenseNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForCreditLossMember": { "auth_ref": [ "r168", "r169", "r170", "r173", "r174" ], "lang": { "en-us": { "role": { "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]", "terseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForCreditLossMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r38", "r259", "r304" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r145", "r332", "r340" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization expense related to other intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r201" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Anti-dilutive securities excluded from the computation of earnings per share (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsperShareNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r201" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsperShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsperShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r201" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsperShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AssetBackedSecuritiesMember": { "auth_ref": [ "r278", "r500" ], "lang": { "en-us": { "role": { "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.", "label": "Asset-backed Securities [Member]", "terseLabel": "Asset-backed securities" } } }, "localname": "AssetBackedSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r161", "r228", "r235", "r242", "r302", "r373", "r374", "r375", "r377", "r378", "r379", "r380", "r382", "r384", "r386", "r387", "r686", "r691", "r751", "r786", "r788", "r834", "r864" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r7", "r9", "r64", "r161", "r302", "r373", "r374", "r375", "r377", "r378", "r379", "r380", "r382", "r384", "r386", "r387", "r686", "r691", "r751", "r786", "r788" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r735" ], "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "totalLabel": "Total assets" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "auth_ref": [ "r269" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "order": 1.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax", "terseLabel": "Gross Unrealized Gains" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "auth_ref": [ "r270" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "order": 2.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax", "negatedLabel": "Gross Unrealized Losses" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": { "auth_ref": [ "r267", "r310" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Amortized Cost", "totalLabel": "Amortized Cost" } } }, "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Available-for-sale [Abstract]", "terseLabel": "Available-for-sale" } } }, "localname": "AvailableForSaleSecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Available-for-sale Securities, Debt Maturities [Abstract]", "terseLabel": "Available-for-Sale" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Available-for-sale, Maturity, Amortized Cost, Rolling Maturity [Abstract]", "terseLabel": "Amortized Cost" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]", "terseLabel": "Fair Value" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 4.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost", "terseLabel": "Due in 1\u00a0year or less" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 3.0, "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value", "terseLabel": "Due in 1\u00a0year or less" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 1.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in rolling sixth through tenth fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Through Ten Years, Amortized Cost", "terseLabel": "Due after 5\u00a0years through 10\u00a0years" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 4.0, "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in rolling sixth through tenth fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Through Ten Years, Fair Value", "terseLabel": "Due after 5\u00a0years through 10\u00a0years" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 3.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost", "terseLabel": "Due after 1\u00a0year through 5\u00a0years" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 2.0, "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value", "terseLabel": "Due after 1\u00a0year through 5\u00a0years" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost": { "auth_ref": [ "r272" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 2.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.", "label": "Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost", "terseLabel": "Instruments not due at a single maturity date (a)" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": { "auth_ref": [ "r272", "r854" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 1.0, "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.", "label": "Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value", "terseLabel": "Instruments not due at a single maturity date (a)" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "auth_ref": [ "r264", "r268", "r310", "r842" ], "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": 2.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 }, "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "order": 3.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale", "terseLabel": "Fair Value", "totalLabel": "Fair Value", "verboseLabel": "Available-for-sale investments:" } } }, "localname": "AvailableForSaleSecuritiesDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r579", "r609" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]", "terseLabel": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted.", "label": "Award Date [Domain]", "terseLabel": "Award Date [Domain]" } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r579", "r609" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockbasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r702", "r708" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BankTimeDepositsMember": { "auth_ref": [ "r849" ], "lang": { "en-us": { "role": { "documentation": "Certificates of deposit (CD) or savings accounts with a fixed term or understanding the customer can only withdraw by giving advanced notice with a bank or other financial institution. A CD is a short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest.", "label": "Bank Time Deposits [Member]", "terseLabel": "Bank time deposits" } } }, "localname": "BankTimeDepositsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BuildingAndBuildingImprovementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.", "label": "Building and Building Improvements [Member]", "terseLabel": "Buildings and improvements" } } }, "localname": "BuildingAndBuildingImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r556", "r569" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSNarrativesDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/SPECIALCHARGESAcquisitionofIntellectualPropertyDetails", "http://www.edwards.com/role/SPECIALCHARGESImpairmentofLonglivedAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r556", "r569", "r673", "r674" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSNarrativesDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/SPECIALCHARGESAcquisitionofIntellectualPropertyDetails", "http://www.edwards.com/role/SPECIALCHARGESImpairmentofLonglivedAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.", "label": "Business Acquisition, Transaction Costs", "terseLabel": "Acquisition transaction costs" } } }, "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SPECIALCHARGESAcquisitionofIntellectualPropertyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSNarrativesDetails", "http://www.edwards.com/role/SPECIALCHARGESAcquisitionofIntellectualPropertyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.", "label": "Business Acquisition, Share Price", "terseLabel": "Consideration per share to be transferred (in dollars per share)" } } }, "localname": "BusinessAcquisitionSharePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSNarrativesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r677", "r678", "r680" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Cash purchase price" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSNarrativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": { "auth_ref": [ "r144", "r682" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.", "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability", "negatedTerseLabel": "Change in fair value of contingent consideration liabilities, net", "terseLabel": "Change in fair value of contingent consideration liabilities, net", "verboseLabel": "Change in fair value of contingent consideration liabilities, net (Note 11)" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": { "auth_ref": [ "r740" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure contingent consideration liability from business combination.", "label": "Business Combination, Contingent Consideration, Liability, Measurement Input", "verboseLabel": "Contingent consideration liability measurement input" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": { "auth_ref": [ "r676", "r679" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.", "label": "Business Combination, Contingent Consideration, Liability, Noncurrent", "terseLabel": "Contingent consideration liabilities (Notes 8 and 11)" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r683" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "ACQUISITIONS" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONS" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "auth_ref": [ "r150", "r151", "r152" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.", "label": "Capital Expenditures Incurred but Not yet Paid", "verboseLabel": "Capital expenditures accruals" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedComputerSoftwareGross": { "auth_ref": [ "r925" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 5.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.", "label": "Capitalized Computer Software, Gross", "terseLabel": "Software" } } }, "localname": "CapitalizedComputerSoftwareGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r43", "r147" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": 1.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Cash equivalents" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r17", "r148" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r139", "r147", "r153" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of year", "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of year", "totalLabel": "Total cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r139", "r756" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net (decrease) increase in cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": { "auth_ref": [ "r726" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.", "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months", "terseLabel": "Cash flow hedge loss to be reclassified" } } }, "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r698" ], "lang": { "en-us": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Cash flow hedges" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "verboseLabel": "Non-cash investing and financing transactions:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1": { "auth_ref": [ "r724" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement.", "label": "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments", "terseLabel": "Derivatives designated as hedging instruments" } } }, "localname": "ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1": { "auth_ref": [ "r724" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.", "label": "Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge", "terseLabel": "Hedged items" } } }, "localname": "ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfTreasuryStockTable": { "auth_ref": [ "r447", "r448", "r449", "r450" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Class of Treasury Stock [Table]", "terseLabel": "Class of Treasury Stock [Table]" } } }, "localname": "ClassOfTreasuryStockTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommercialPaperMember": { "auth_ref": [ "r371" ], "lang": { "en-us": { "role": { "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.", "label": "Commercial Paper [Member]", "terseLabel": "Commercial paper" } } }, "localname": "CommercialPaperMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r57", "r361", "r843", "r873" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Notes\u00a06, 10, and 18)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r358", "r359", "r360", "r368", "r911" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "LEGAL PROCEEDINGS" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/LEGALPROCEEDINGS" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r177", "r178", "r730" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r30", "r439" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r30", "r788" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "verboseLabel": "Common stock, $1.00 par value, 1,050.0 shares authorized, 642.0 and 636.4 shares issued, and 624.1 and 624.3 shares outstanding, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]", "terseLabel": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "auth_ref": [ "r584" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.", "label": "Compensation Related Costs, Policy [Policy Text Block]", "terseLabel": "Stock-based Compensation" } } }, "localname": "CompensationRelatedCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Components of Deferred Tax Assets [Abstract]", "terseLabel": "Deferred tax assets" } } }, "localname": "ComponentsOfDeferredTaxAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Components of Deferred Tax Liabilities [Abstract]", "terseLabel": "Deferred tax liabilities" } } }, "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r99", "r100", "r101", "r111", "r846", "r875" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r110", "r124", "r845", "r874" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income (Loss) Note [Text Block]", "terseLabel": "ACCUMULATED OTHER COMPREHENSIVE LOSS" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r155", "r688" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConstructionInProgressGross": { "auth_ref": [ "r348" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 6.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress, Gross", "terseLabel": "Construction in progress" } } }, "localname": "ConstructionInProgressGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r452", "r453", "r465" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "terseLabel": "Deferred revenue" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r466" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "terseLabel": "Revenue recognized that was previously deferred" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateDebtSecuritiesMember": { "auth_ref": [ "r500", "r549", "r892" ], "lang": { "en-us": { "role": { "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.", "label": "Corporate Debt Securities [Member]", "terseLabel": "Corporate debt securities" } } }, "localname": "CorporateDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r233", "r234", "r235", "r236", "r238", "r244", "r246" ], "lang": { "en-us": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate, Non-Segment [Member]", "verboseLabel": "Corporate items" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r116", "r827" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "negatedLabel": "Cost of sales", "terseLabel": "Cost of sales" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESShippingandHandlingCostsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of sales", "verboseLabel": "Cost of sales" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r113" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "negatedTerseLabel": "Corporate items" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CurrencySwapMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.", "label": "Currency Swap [Member]", "terseLabel": "Cross currency swap contracts", "verboseLabel": "Cross currency swap contracts" } } }, "localname": "CurrencySwapMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeandInterestRateRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Federal, State and Local, Tax Expense (Benefit) [Abstract]", "terseLabel": "United States:" } } }, "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r162", "r653", "r660" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Federal Tax Expense (Benefit)", "terseLabel": "Federal" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r162", "r653" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails": { "order": 3.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense (Benefit)", "terseLabel": "Outside of the United States, including Puerto Rico" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r162", "r653", "r660", "r662" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense (Benefit)", "totalLabel": "Current income tax expense" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Current" } } }, "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r162", "r653", "r660" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current State and Local Tax Expense (Benefit)", "terseLabel": "State and local" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r158", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r405", "r412", "r413", "r415", "r423" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "DEBT AND CREDIT FACILITIES" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r22", "r24", "r25", "r160", "r167", "r388", "r389", "r390", "r391", "r392", "r393", "r395", "r401", "r402", "r403", "r404", "r406", "r407", "r408", "r409", "r410", "r411", "r419", "r420", "r421", "r422", "r770", "r835", "r838", "r861" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Basis spread on variable rate (as a percent)" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r25", "r416", "r838", "r861" ], "calculation": { "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross", "terseLabel": "Amount" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r388", "r419", "r420", "r768", "r770", "r771" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Fixed-rate unsecured senior notes" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r403", "r419", "r420", "r750" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "terseLabel": "Fair value of the notes, based on Level 2 inputs" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r54", "r418", "r768", "r770" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Effective Interest Rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r54", "r389" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Fixed interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r55", "r160", "r167", "r388", "r389", "r390", "r391", "r392", "r393", "r395", "r401", "r402", "r403", "r404", "r406", "r407", "r408", "r409", "r410", "r411", "r419", "r420", "r421", "r422", "r770" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r857" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument, Redemption Price, Percentage", "terseLabel": "Price equal to principal amount, plus accrued and unpaid interest (as a percent)" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r55", "r160", "r167", "r388", "r389", "r390", "r391", "r392", "r393", "r395", "r401", "r402", "r403", "r404", "r406", "r407", "r408", "r409", "r410", "r411", "r414", "r419", "r420", "r421", "r422", "r440", "r441", "r442", "r443", "r767", "r768", "r770", "r771", "r858" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Term of the credit agreement (in years)" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r401", "r767", "r771" ], "calculation": { "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "negatedLabel": "Unamortized discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": { "auth_ref": [ "r289", "r315", "r318" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails": { "order": 2.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer", "terseLabel": "Fair value, 12 months or greater" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": { "auth_ref": [ "r289", "r315" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails": { "order": 2.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss", "negatedTerseLabel": "Gross unrealized losses, 12 months or greater" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": { "auth_ref": [ "r289", "r315", "r318" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails": { "order": 1.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months", "terseLabel": "Fair value, less than 12 months" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": { "auth_ref": [ "r289", "r315" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails": { "order": 1.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss", "negatedTerseLabel": "Gross unrealized losses, less than 12 months" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleTable": { "auth_ref": [ "r293" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale [Table]", "terseLabel": "Debt Securities, Available-for-sale [Table]" } } }, "localname": "DebtSecuritiesAvailableForSaleTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": { "auth_ref": [ "r285", "r311", "r318" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.", "label": "Debt Securities, Available-for-sale, Unrealized Loss Position", "totalLabel": "Total fair value" } } }, "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": { "auth_ref": [ "r286", "r312" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss", "negatedTotalLabel": "Total gross unrealized losses" } } }, "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": { "auth_ref": [ "r284", "r314", "r318" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table Text Block]", "terseLabel": "Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position" } } }, "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": { "auth_ref": [ "r287", "r313" ], "lang": { "en-us": { "role": { "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions", "terseLabel": "Number of investments in an unrealized loss position" } } }, "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": { "auth_ref": [ "r632" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESNarrativeDetails": { "order": 2.0, "parentTag": "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.", "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible", "terseLabel": "Estimated decrease in unrecognized tax benefits" } } }, "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationCashbasedArrangementsLiabilityClassifiedNoncurrent": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for deferred compensation arrangements payable after one year (or the normal operating cycle, if longer). Represents currently earned compensation under cash arrangements (such as a profit-sharing plan, rabbi trust, and employee contract--excluding equity-based arrangements) that is not actually paid until a later date.", "label": "Deferred Compensation Cash-based Arrangements, Liability, Classified, Noncurrent", "terseLabel": "Deferred compensation plans" } } }, "localname": "DeferredCompensationCashbasedArrangementsLiabilityClassifiedNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements. Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.", "label": "Deferred Compensation Liability, Current and Noncurrent", "terseLabel": "Amount accrued under nonqualified plans" } } }, "localname": "DeferredCompensationLiabilityCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationPlanAssets": { "auth_ref": [ "r48" ], "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": 3.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.", "label": "Deferred Compensation Plan Assets", "terseLabel": "Investments held for deferred compensation plans" } } }, "localname": "DeferredCompensationPlanAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r162", "r654", "r660" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Federal Income Tax Expense (Benefit)", "terseLabel": "Federal" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]", "terseLabel": "United States:" } } }, "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r48", "r401", "r769" ], "calculation": { "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails": { "order": 3.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "negatedTerseLabel": "Unamortized debt issuance costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNoncurrentGross": { "auth_ref": [ "r48", "r769" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Cost, Gross, Noncurrent", "verboseLabel": "Issuance costs" } } }, "localname": "DeferredFinanceCostsNoncurrentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r162", "r654", "r660" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Foreign Income Tax Expense (Benefit)", "terseLabel": "Outside of the United States, including Puerto Rico" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r625", "r626" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r145", "r162", "r654", "r660", "r661", "r662" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "totalLabel": "Deferred income tax (benefit) expense" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Deferred" } } }, "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r27", "r28", "r643", "r837", "r860" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "negatedTotalLabel": "Total deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r162", "r654", "r660" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "terseLabel": "State and local" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsCapitalLossCarryforwards": { "auth_ref": [ "r651", "r652" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails": { "order": 1.0, "parentTag": "ew_DeferredTaxAssetsCapitalLossCarryforwardsNetOfValuationAllowance", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.", "label": "Deferred Tax Assets, Capital Loss Carryforwards", "terseLabel": "Tax Benefit Amount" } } }, "localname": "DeferredTaxAssetsCapitalLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r644" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Total deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsHedgingTransactions": { "auth_ref": [ "r651", "r652" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from hedging transactions.", "label": "Deferred Tax Assets, Hedging Transactions", "terseLabel": "Cash flow and net investment hedges" } } }, "localname": "DeferredTaxAssetsHedgingTransactions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsInventory": { "auth_ref": [ "r651", "r652" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.", "label": "Deferred Tax Assets, Inventory", "terseLabel": "Inventories" } } }, "localname": "DeferredTaxAssetsInventory", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r646" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Deferred Tax Assets, Net", "totalLabel": "Net deferred tax assets" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r651", "r652" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails": { "order": 1.0, "parentTag": "ew_DeferredTaxAssetsOperatingLossCarryforwardsNetOfValuationAllowance", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "terseLabel": "Tax Benefit Amount" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r651", "r652" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 11.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Deferred Tax Assets, Other", "terseLabel": "Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsStateTaxes": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from state taxes.", "label": "Deferred Tax Assets, State Taxes", "verboseLabel": "State income taxes" } } }, "localname": "DeferredTaxAssetsStateTaxes", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "auth_ref": [ "r649", "r651", "r652" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.", "label": "Deferred Tax Assets, Tax Credit Carryforwards", "terseLabel": "Net tax credit carryforwards" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": { "auth_ref": [ "r651", "r652" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits", "terseLabel": "Compensation and benefits" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": { "auth_ref": [ "r651", "r652" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities", "terseLabel": "Accrued liabilities" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves": { "auth_ref": [ "r651", "r652" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other.", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves", "terseLabel": "Benefits from uncertain tax positions" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r645" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance", "terseLabel": "Valuation allowance that reduces certain deferred tax assets" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails", "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesDerivatives": { "auth_ref": [ "r651", "r652" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from derivatives.", "label": "Deferred Tax Liabilities, Derivatives", "negatedLabel": "Cash flow and net investment hedges" } } }, "localname": "DeferredTaxLiabilitiesDerivatives", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": { "auth_ref": [ "r651", "r652" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.", "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets", "negatedLabel": "Other intangible assets" } } }, "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesOther": { "auth_ref": [ "r651", "r652" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.", "label": "Deferred Tax Liabilities, Other", "negatedLabel": "Other" } } }, "localname": "DeferredTaxLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "auth_ref": [ "r651", "r652" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.", "label": "Deferred Tax Liabilities, Property, Plant and Equipment", "negatedLabel": "Property, plant, and equipment" } } }, "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": { "auth_ref": [ "r651" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.", "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings", "negatedLabel": "Deferred tax on foreign earnings" } } }, "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries": { "auth_ref": [ "r671" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to undistributed earnings of foreign subsidiaries.", "label": "Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Foreign Subsidiaries", "terseLabel": "Estimated net tax liability on permanently reinvested earnings" } } }, "localname": "DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": { "auth_ref": [ "r26", "r474", "r475", "r497" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.", "label": "Liability, Defined Benefit Pension Plan, Noncurrent", "terseLabel": "Other long-term liabilities" } } }, "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": { "auth_ref": [ "r508" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.", "label": "Defined Benefit Plan, Accumulated Benefit Obligation", "terseLabel": "Accumulated benefit obligation" } } }, "localname": "DefinedBenefitPlanAccumulatedBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax [Abstract]", "terseLabel": "Accumulated other comprehensive loss, net of tax:" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax": { "auth_ref": [ "r95", "r520" ], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails": { "order": 1.0, "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.", "label": "Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax", "terseLabel": "Net actuarial loss" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax": { "auth_ref": [ "r95", "r520" ], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails": { "order": 2.0, "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax", "negatedLabel": "Net prior service cost" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": { "auth_ref": [ "r489", "r549" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.", "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)", "terseLabel": "Actual return on plan assets" } } }, "localname": "DefinedBenefitPlanActualReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanActuarialGainLoss": { "auth_ref": [ "r482" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.", "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)", "negatedLabel": "Actuarial loss" } } }, "localname": "DefinedBenefitPlanActuarialGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "auth_ref": [ "r476", "r515", "r543", "r549", "r550" ], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails": { "order": 4.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Gain (Loss)", "negatedTerseLabel": "Amortization of actuarial loss" } } }, "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": { "auth_ref": [ "r476", "r516", "r544", "r549", "r550" ], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails": { "order": 5.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)", "terseLabel": "Amortization of prior service credit" } } }, "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract]", "terseLabel": "Net amounts recognized on the consolidated balance sheet:" } } }, "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": { "auth_ref": [ "r522" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate", "verboseLabel": "Discount rate (as a percent)" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": { "auth_ref": [ "r523" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase", "verboseLabel": "Rate of compensation increase (as a percent)" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average interest crediting rate used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, cash balance and other defined benefit plans with promised interest crediting rate.", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Weighted-Average Interest Crediting Rate", "verboseLabel": "Cash balance interest crediting rate (as a percent)" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": { "auth_ref": [ "r522" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate", "verboseLabel": "Discount rate (as a percent)" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": { "auth_ref": [ "r524", "r548" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets", "verboseLabel": "Expected return on plan assets (as a percent)" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": { "auth_ref": [ "r523" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase", "verboseLabel": "Rate of compensation increase (as a percent)" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average interest crediting rate used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, cash balance and other defined benefit plans with promised interest crediting rate.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate", "verboseLabel": "Cash balance interest crediting rate (as a percent)" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligation": { "auth_ref": [ "r477" ], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Benefit Obligation", "negatedLabel": "Projected benefit obligation", "periodEndLabel": "End of year", "periodStartLabel": "Beginning of year" } } }, "localname": "DefinedBenefitPlanBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": { "auth_ref": [ "r484", "r553" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.", "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid", "negatedLabel": "Benefits paid" } } }, "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": { "auth_ref": [ "r481" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation.", "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant", "terseLabel": "Participant contributions" } } }, "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": { "auth_ref": [ "r499", "r500", "r502", "r503", "r504", "r505", "r506", "r507", "r527", "r549" ], "lang": { "en-us": { "role": { "documentation": "Information by defined benefit plan asset investment.", "label": "Defined Benefit Plan, Plan Assets, Category [Axis]", "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]" } } }, "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember": { "auth_ref": [ "r500" ], "lang": { "en-us": { "role": { "documentation": "Cash and cash equivalent in which defined benefit plan asset is invested.", "label": "Defined Benefit Plan, Cash and Cash Equivalents [Member]", "terseLabel": "Cash" } } }, "localname": "DefinedBenefitPlanCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]", "terseLabel": "Change in projected benefit obligation:" } } }, "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]", "terseLabel": "Change in fair value of plan assets:" } } }, "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "auth_ref": [ "r491", "r500", "r502", "r547", "r549", "r550" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.", "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer", "terseLabel": "Employer contributions" } } }, "localname": "DefinedBenefitPlanContributionsByEmployer", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDebtSecurityMember": { "auth_ref": [ "r500" ], "lang": { "en-us": { "role": { "documentation": "Debt instrument issued by corporation, government and governmental agency, municipality, and other institution; in which defined benefit plan asset is invested.", "label": "Defined Benefit Plan, Debt Security [Member]", "terseLabel": "Debt securities" } } }, "localname": "DefinedBenefitPlanDebtSecurityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]", "terseLabel": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanEquitySecuritiesMember": { "auth_ref": [ "r500", "r549" ], "lang": { "en-us": { "role": { "documentation": "Security representing ownership in corporation or other legal entity for which ownership is represented by share of stock, in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.", "label": "Defined Benefit Plan, Equity Securities [Member]", "terseLabel": "Equity securities" } } }, "localname": "DefinedBenefitPlanEquitySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember": { "auth_ref": [ "r500", "r502", "r549" ], "lang": { "en-us": { "role": { "documentation": "Security representing ownership in corporation or other legal entity, not domiciled in United States of America (US), for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.", "label": "Defined Benefit Plan, Equity Securities, Non-US [Member]", "terseLabel": "International equities" } } }, "localname": "DefinedBenefitPlanEquitySecuritiesNonUsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember": { "auth_ref": [ "r500", "r502", "r549" ], "lang": { "en-us": { "role": { "documentation": "Security representing ownership in corporation or other legal entity, domiciled in United States of America (US), for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.", "label": "Defined Benefit Plan, Equity Securities, US [Member]", "terseLabel": "United States equities" } } }, "localname": "DefinedBenefitPlanEquitySecuritiesUsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": { "auth_ref": [ "r509" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years", "terseLabel": "2024-2026" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofBenefitPaymentsWhichReflectExpectedFutureServiceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": { "auth_ref": [ "r509" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One", "terseLabel": "2022" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofBenefitPaymentsWhichReflectExpectedFutureServiceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": { "auth_ref": [ "r509" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five", "terseLabel": "2026" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofBenefitPaymentsWhichReflectExpectedFutureServiceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": { "auth_ref": [ "r509" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four", "terseLabel": "2025" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofBenefitPaymentsWhichReflectExpectedFutureServiceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": { "auth_ref": [ "r509" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three", "terseLabel": "2024" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofBenefitPaymentsWhichReflectExpectedFutureServiceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": { "auth_ref": [ "r509" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two", "terseLabel": "2023" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofBenefitPaymentsWhichReflectExpectedFutureServiceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": { "auth_ref": [ "r510", "r550" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year", "terseLabel": "Expected employer contributions" } } }, "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "auth_ref": [ "r476", "r514", "r542", "r549", "r550" ], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails": { "order": 3.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "negatedTerseLabel": "Expected return on plan assets" } } }, "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": { "auth_ref": [ "r488", "r500", "r502", "r503", "r549" ], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.", "label": "Defined Benefit Plan, Plan Assets, Amount", "periodEndLabel": "End of year", "periodStartLabel": "Beginning of year", "terseLabel": "Plan assets at fair value" } } }, "localname": "DefinedBenefitPlanFairValueOfPlanAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": { "auth_ref": [ "r483" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.", "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)", "negatedTerseLabel": "Currency exchange rate changes and other" } } }, "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": { "auth_ref": [ "r474", "r497", "r549" ], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.", "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan", "totalLabel": "Underfunded status" } } }, "localname": "DefinedBenefitPlanFundedStatusOfPlan", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]", "terseLabel": "Funded Status" } } }, "localname": "DefinedBenefitPlanFundedStatusOfPlanAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanInterestCost": { "auth_ref": [ "r476", "r480", "r513", "r541", "r549", "r550" ], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.", "label": "Defined Benefit Plan, Interest Cost", "terseLabel": "Interest cost", "verboseLabel": "Interest cost" } } }, "localname": "DefinedBenefitPlanInterestCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r511", "r539", "r549", "r550" ], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "totalLabel": "Net periodic pension benefit cost" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAmendments": { "auth_ref": [ "r485" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan.", "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment", "negatedTerseLabel": "Plan amendment" } } }, "localname": "DefinedBenefitPlanPlanAmendments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": { "auth_ref": [ "r493", "r553" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.", "label": "Defined Benefit Plan, Plan Assets, Benefits Paid", "negatedLabel": "Benefits paid" } } }, "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": { "auth_ref": [ "r492" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets.", "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant", "terseLabel": "Participant contributions" } } }, "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r490" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)", "terseLabel": "Currency exchange rate impact", "verboseLabel": "Currency exchange rate changes and other" } } }, "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": { "auth_ref": [ "r499", "r549" ], "lang": { "en-us": { "role": { "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.", "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage", "terseLabel": "Target asset allocations (as a percent)" } } }, "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanRealEstateMember": { "auth_ref": [ "r500", "r549" ], "lang": { "en-us": { "role": { "documentation": "Property composed of building, land and land improvement; in which defined benefit plan asset is invested.", "label": "Defined Benefit Plan, Real Estate [Member]", "terseLabel": "Real estate" } } }, "localname": "DefinedBenefitPlanRealEstateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanServiceCost": { "auth_ref": [ "r478", "r512", "r540", "r549", "r550" ], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Service Cost", "terseLabel": "Service cost", "verboseLabel": "Service cost, net" } } }, "localname": "DefinedBenefitPlanServiceCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]", "terseLabel": "Weighted-average assumptions used to determine the benefit obligations" } } }, "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]", "terseLabel": "Weighted-average assumptions used to determine the net periodic benefit cost" } } }, "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedContributionPlanCostRecognized": { "auth_ref": [ "r554" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for defined contribution plan.", "label": "Defined Contribution Plan, Cost", "terseLabel": "Matching contributions relating to entity's employees" } } }, "localname": "DefinedContributionPlanCostRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Contribution Plan Disclosure [Line Items]", "terseLabel": "Defined Contribution Plans" } } }, "localname": "DefinedContributionPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.", "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent", "terseLabel": "Maximum contributions of a participant's eligible compensation (as a percent)" } } }, "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedContributionPlanTable": { "auth_ref": [ "r554" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans.", "label": "Defined Contribution Plan [Table]", "terseLabel": "Defined Contribution Plan [Table]" } } }, "localname": "DefinedContributionPlanTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r145", "r347" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation expense for property, plant and equipment" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r145", "r223" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetFairValueGrossLiability": { "auth_ref": [ "r66", "r78", "r706" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails": { "order": 2.0, "parentTag": "us-gaap_DerivativeAssets", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Asset, Fair Value, Gross Liability", "negatedTerseLabel": "Gross Amounts Offset in the Consolidated Balance Sheet" } } }, "localname": "DerivativeAssetFairValueGrossLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection": { "auth_ref": [ "r70", "r74" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after effects of master netting arrangements, deduction of assets not subject to a master netting arrangement and elected not to be offset, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, offset against an obligation to return collateral.", "label": "Derivative Asset, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election", "totalLabel": "Net Amount" } } }, "localname": "DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction": { "auth_ref": [ "r68", "r74" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails": { "order": 2.0, "parentTag": "us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be offset, deducted from derivative assets.", "label": "Derivative Asset, Not Offset, Policy Election Deduction", "negatedLabel": "Financial Instruments" } } }, "localname": "DerivativeAssetNotOffsetPolicyElectionDeduction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r67", "r73", "r76", "r750" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails": { "order": 1.0, "parentTag": "us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection", "weight": 1.0 }, "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": 4.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Derivatives", "totalLabel": "Net Amounts Presented in the Consolidated Balance Sheet", "verboseLabel": "Fair Value" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Asset [Abstract]", "terseLabel": "Assets" } } }, "localname": "DerivativeAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeCollateralObligationToReturnCash": { "auth_ref": [ "r69", "r74", "r75", "r720" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails": { "order": 3.0, "parentTag": "us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to return cash collateral under master netting arrangements that have not been offset against derivative assets.", "label": "Derivative, Collateral, Obligation to Return Cash", "negatedTerseLabel": "Cash Collateral Received" } } }, "localname": "DerivativeCollateralObligationToReturnCash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeCollateralRightToReclaimCash": { "auth_ref": [ "r69", "r74", "r75", "r720" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails": { "order": 3.0, "parentTag": "us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of right to receive cash collateral under master netting arrangements that have not been offset against derivative liabilities.", "label": "Derivative, Collateral, Right to Reclaim Cash", "negatedTerseLabel": "Cash Collateral Received" } } }, "localname": "DerivativeCollateralRightToReclaimCash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeandInterestRateRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "auth_ref": [ "r65", "r76", "r77", "r706", "r806" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails": { "order": 1.0, "parentTag": "us-gaap_DerivativeAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.", "label": "Derivative Asset, Fair Value, Gross Asset", "terseLabel": "Gross Amounts" } } }, "localname": "DerivativeFairValueOfDerivativeAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "auth_ref": [ "r65", "r76", "r77", "r706", "r806" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails": { "order": 1.0, "parentTag": "us-gaap_DerivativeLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Fair Value, Gross Liability", "terseLabel": "Gross Amounts" } } }, "localname": "DerivativeFairValueOfDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r704" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "terseLabel": "Amount of Gain or (Loss) Recognized in Income on Derivative" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r76", "r703", "r707", "r713", "r716" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeandInterestRateRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r729", "r733" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r700", "r703", "r713" ], "lang": { "en-us": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r700", "r703", "r713", "r716", "r717", "r722", "r725" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]", "terseLabel": "Derivative Instruments, Gain (Loss) [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments, Gain (Loss)" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred": { "auth_ref": [ "r728" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings.", "label": "Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred", "terseLabel": "Amount of Gain or (Loss) Recognized in\u00a0Income on Derivative (Amount Excluded from Effectiveness Testing)" } } }, "localname": "DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r67", "r73", "r76", "r750" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails": { "order": 1.0, "parentTag": "us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection", "weight": 1.0 }, "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Derivatives", "totalLabel": "Net Amounts Presented in the Consolidated Balance Sheet", "verboseLabel": "Fair Value" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Liability [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "DerivativeLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r67" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 2.0, "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Current", "terseLabel": "Fair value of derivatives" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityFairValueGrossAsset": { "auth_ref": [ "r66", "r75", "r78", "r706" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails": { "order": 2.0, "parentTag": "us-gaap_DerivativeLiabilities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of asset associated with financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Liability, Fair Value, Gross Asset", "negatedTerseLabel": "Gross Amounts Offset in the Consolidated Balance Sheet" } } }, "localname": "DerivativeLiabilityFairValueGrossAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection": { "auth_ref": [ "r70", "r74" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after effects of master netting arrangements, deduction of liabilities not subject to a master netting arrangement and elected not to be offset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, offset against the right to receive collateral.", "label": "Derivative Liability, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election", "totalLabel": "Net Amount" } } }, "localname": "DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction": { "auth_ref": [ "r68", "r74" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails": { "order": 2.0, "parentTag": "us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be offset, deducted from derivative liabilities.", "label": "Derivative Liability, Not Offset, Policy Election Deduction", "negatedLabel": "Financial Instruments" } } }, "localname": "DerivativeLiabilityNotOffsetPolicyElectionDeduction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeandInterestRateRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r694", "r696" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "terseLabel": "Notional Amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeandInterestRateRiskDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r693", "r695", "r696", "r700", "r701", "r709", "r713", "r718", "r721", "r725", "r729" ], "lang": { "en-us": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeandInterestRateRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesFairValueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivatives, Fair Value [Line Items]", "terseLabel": "Derivatives designated as hedging instruments" } } }, "localname": "DerivativesFairValueLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r166", "r693", "r695", "r700", "r701", "r719" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivatives" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r700" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Derivatives designated as hedging instruments" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeandInterestRateRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DevelopedTechnologyRightsMember": { "auth_ref": [ "r675" ], "lang": { "en-us": { "role": { "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.", "label": "Developed Technology Rights [Member]", "verboseLabel": "Developed technology" } } }, "localname": "DevelopedTechnologyRightsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails", "http://www.edwards.com/role/SPECIALCHARGESImpairmentofLonglivedAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Tax Authority [Member]", "terseLabel": "Federal research expenditure tax credits", "verboseLabel": "United States federal net operating losses" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DomesticPlanMember": { "auth_ref": [ "r555", "r559", "r572" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Domestic Plan [Member]", "terseLabel": "Domestic Plan" } } }, "localname": "DomesticPlanMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings per share:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r112", "r181", "r182", "r183", "r184", "r185", "r190", "r193", "r198", "r199", "r200", "r203", "r204", "r731", "r732", "r847", "r876" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic (in dollars per share)", "verboseLabel": "Basic earnings per share (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "terseLabel": "Basic:" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r112", "r181", "r182", "r183", "r184", "r185", "r193", "r198", "r199", "r200", "r203", "r204", "r731", "r732", "r847", "r876" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted (in dollars per share)", "verboseLabel": "Diluted earnings per share (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted [Abstract]", "terseLabel": "Diluted:" } } }, "localname": "EarningsPerShareDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r201", "r202" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Earnings per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Effect of Cash Flow Hedges on Results of Operations [Abstract]", "terseLabel": "Gain (loss) on cash flow hedging relationships:" } } }, "localname": "EffectOfCashFlowHedgesOnResultsOfOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r756" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "terseLabel": "Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Effect of Fair Value Hedges on Results of Operations [Abstract]", "terseLabel": "Gain (loss) on fair value hedging relationships:" } } }, "localname": "EffectOfFairValueHedgesOnResultsOfOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r52" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 12.0, "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Employee compensation and withholdings" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "terseLabel": "Allocation of stock-based compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r608" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Employee stock purchase subscriptions" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAdditionalInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r608" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Weighted-average remaining requisite service period (in months)" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAdditionalInformationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": { "auth_ref": [ "r607" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Expense, Tax Benefit", "negatedTerseLabel": "Income tax benefit" } } }, "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Employee Stock [Member]", "terseLabel": "ESPP" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityClassOfTreasuryStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Equity, Class of Treasury Stock [Line Items]", "terseLabel": "Treasury Stock" } } }, "localname": "EquityClassOfTreasuryStockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r103", "r104", "r105", "r177", "r178", "r179", "r180", "r186", "r188", "r206", "r303", "r439", "r444", "r611", "r612", "r613", "r656", "r657", "r730", "r757", "r758", "r759", "r760", "r761", "r763", "r885", "r886", "r887", "r967" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investment, Financial Statement, Reported Amounts [Abstract]", "terseLabel": "Equity method investments" } } }, "localname": "EquityMethodInvestmentFinancialStatementReportedAmountsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r299" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Equity method investment, ownership percentage (as a percent)" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r44", "r229", "r297" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails": { "order": 1.0, "parentTag": "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Carrying value of equity method investments" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesFvNi": { "auth_ref": [ "r748" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails": { "order": 2.0, "parentTag": "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.", "label": "Equity Securities, FV-NI, Current", "terseLabel": "Carrying value of non-marketable equity securities", "verboseLabel": "Investment" } } }, "localname": "EquitySecuritiesFvNi", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesMember": { "auth_ref": [ "r18", "r23", "r293", "r862", "r905", "r906", "r907" ], "lang": { "en-us": { "role": { "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.", "label": "Equity Securities [Member]", "terseLabel": "Equity Securities" } } }, "localname": "EquitySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount": { "auth_ref": [ "r295" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cumulative loss from downward price adjustment on investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount", "terseLabel": "Decrease in non-marketable equity securities due to observable price changes" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount": { "auth_ref": [ "r295" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of impairment loss on investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount", "terseLabel": "Impairment of equity securities" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount": { "auth_ref": [ "r296" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain from upward price adjustment on investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount", "terseLabel": "Upward price adjustments" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount": { "auth_ref": [ "r296" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount", "terseLabel": "Increase in non-marketable equity securities due to observable price changes" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "auth_ref": [ "r403", "r419", "r420", "r750" ], "lang": { "en-us": { "role": { "documentation": "Measured as an estimate of fair value.", "label": "Estimate of Fair Value Measurement [Member]", "terseLabel": "Estimate of Fair Value Measurement" } } }, "localname": "EstimateOfFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r735", "r736", "r737", "r745" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r403", "r419", "r420", "r500", "r502", "r503", "r504", "r505", "r506", "r507", "r549", "r736", "r796", "r797", "r798" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r744", "r745" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]", "terseLabel": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinFairValueofContingentConsiderationObligationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementBasisAxis": { "auth_ref": [ "r403", "r419", "r420", "r735", "r746" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement basis.", "label": "Measurement Basis [Axis]", "terseLabel": "Measurement Basis [Axis]" } } }, "localname": "FairValueByMeasurementBasisAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r735", "r736", "r739", "r740", "r747" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "auth_ref": [ "r403", "r419", "r420" ], "lang": { "en-us": { "role": { "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.", "label": "Fair Value Measurement [Domain]", "terseLabel": "Fair Value Measurement [Domain]" } } }, "localname": "FairValueDisclosureItemAmountsDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r744" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "FAIR VALUE MEASUREMENTS" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueHedgingMember": { "auth_ref": [ "r697" ], "lang": { "en-us": { "role": { "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.", "label": "Fair Value Hedging [Member]", "terseLabel": "Fair value hedges" } } }, "localname": "FairValueHedgingMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel12And3Member": { "auth_ref": [ "r502" ], "lang": { "en-us": { "role": { "documentation": "Fair value measurement input including quoted price in active market for identical asset or liability reporting entity can access at measurement date (level 1), input other than quoted price included within level 1 either directly or indirectly observable for asset or liability (level 2) and unobservable input reflecting entity's own assumption (level 3).", "label": "Fair Value, Inputs, Level 1, 2 and 3 [Member]", "terseLabel": "Total plan assets measured at fair value" } } }, "localname": "FairValueInputsLevel12And3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r403", "r500", "r502", "r507", "r549", "r736", "r796" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level\u00a01" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r403", "r419", "r420", "r500", "r502", "r507", "r549", "r736", "r797" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level\u00a02" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r403", "r419", "r420", "r500", "r502", "r503", "r504", "r505", "r506", "r507", "r549", "r736", "r798" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level\u00a03" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations": { "auth_ref": [ "r735", "r736" ], "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of obligations measured on a recurring basis.", "label": "Obligations, Fair Value Disclosure", "terseLabel": "Contingent consideration liabilities" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisObligations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r741" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]", "terseLabel": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinFairValueofContingentConsiderationObligationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinFairValueofContingentConsiderationObligationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinFairValueofContingentConsiderationObligationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r741", "r745" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinFairValueofContingentConsiderationObligationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r741", "r745" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of Changes in Fair Value of Contingent Consideration Obligation" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": { "auth_ref": [ "r502", "r734", "r747" ], "lang": { "en-us": { "role": { "documentation": "Fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Measured at Net Asset Value Per Share [Member]", "terseLabel": "Alternative investments measured at net asset value" } } }, "localname": "FairValueMeasuredAtNetAssetValuePerShareMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r742" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "negatedTerseLabel": "Changes in fair value" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinFairValueofContingentConsiderationObligationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": { "auth_ref": [ "r743" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases", "terseLabel": "Additions" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinFairValueofContingentConsiderationObligationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r741" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Fair value ending balance", "periodStartLabel": "Fair value beginning balance" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinFairValueofContingentConsiderationObligationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r403", "r419", "r420", "r500", "r502", "r503", "r504", "r505", "r506", "r507", "r549", "r796", "r797", "r798" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r744", "r747" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value on a Recurring Basis" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "auth_ref": [ "r702", "r709", "r722" ], "lang": { "en-us": { "role": { "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]" } } }, "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r278", "r282", "r294", "r295", "r296", "r305", "r306", "r307", "r308", "r309", "r314", "r316", "r317", "r318", "r414", "r437", "r729", "r793", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r807", "r808", "r809", "r810", "r811", "r812", "r813", "r814", "r815", "r816", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r934", "r935", "r936", "r937", "r938", "r939", "r940" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]", "terseLabel": "Financial Instrument [Axis]", "verboseLabel": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Weighted-Average Useful Life (in years)" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r339" ], "calculation": { "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r341" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofEstimatedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r341" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofEstimatedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r341" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofEstimatedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r341" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofEstimatedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r341" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofEstimatedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r333", "r336", "r339", "r343", "r828", "r829" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails", "http://www.edwards.com/role/SPECIALCHARGESImpairmentofLonglivedAssetsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r339", "r829" ], "calculation": { "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Cost" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r333", "r338" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails", "http://www.edwards.com/role/SPECIALCHARGESImpairmentofLonglivedAssetsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r339", "r828" ], "calculation": { "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Net Carrying Value" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net [Abstract]", "terseLabel": "Finite-lived intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Tax Authority [Member]", "netLabel": "Non-U.S.", "terseLabel": "Non-United States net operating losses", "verboseLabel": "Foreign tax authority" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r752", "r753", "r754", "r755" ], "calculation": { "http://www.edwards.com/role/OTHERINCOMENETDetails": { "order": 1.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), before Tax", "negatedLabel": "Foreign exchange gains, net", "terseLabel": "Foreign currency" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERINCOMENETDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r765" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Foreign Currency Translation" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignExchangeContractMember": { "auth_ref": [ "r76", "r500", "r715" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange Contract [Member]", "terseLabel": "Foreign currency contracts" } } }, "localname": "ForeignExchangeContractMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignExchangeForwardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.", "label": "Foreign Exchange Forward [Member]", "terseLabel": "Foreign currency forward exchange contracts" } } }, "localname": "ForeignExchangeForwardMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeandInterestRateRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignGovernmentDebtSecuritiesMember": { "auth_ref": [ "r500", "r892" ], "lang": { "en-us": { "role": { "documentation": "Debt security issued by government not domiciled in United States of America (US).", "label": "Debt Security, Government, Non-US [Member]", "terseLabel": "Foreign government bonds" } } }, "localname": "ForeignGovernmentDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignPlanMember": { "auth_ref": [ "r555", "r559", "r572" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Foreign Plan [Member]", "terseLabel": "Foreign Plan" } } }, "localname": "ForeignPlanMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralAndAdministrativeCostsInInventoryAmountIncurred": { "auth_ref": [ "r62" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate amount of general and administrative costs incurred in each period and charged to inventory.", "label": "General and Administrative Costs in Inventory, Amount Incurred", "terseLabel": "General and administrative costs allocated to inventory" } } }, "localname": "GeneralAndAdministrativeCostsInInventoryAmountIncurred", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInventoriesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeCostsInInventoryAmountRemaining": { "auth_ref": [ "r62" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Actual or estimated amount of general and administrative costs remaining in inventory.", "label": "General and Administrative Costs in Inventory, Amount Remaining", "terseLabel": "General and administrative costs included in inventory" } } }, "localname": "GeneralAndAdministrativeCostsInInventoryAmountRemaining", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInventoriesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeographicAreasLongLivedAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Geographic Areas, Long-Lived Assets [Abstract]", "terseLabel": "Long-lived Tangible Assets by Geographic Area" } } }, "localname": "GeographicAreasLongLivedAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r326", "r327", "r788", "r833" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "terseLabel": "Goodwill (Note\u00a09)" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r346" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r328" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "terseLabel": "Currency translation adjustment" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Carrying amount of goodwill" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r115", "r161", "r228", "r234", "r238", "r241", "r244", "r302", "r373", "r374", "r375", "r378", "r379", "r380", "r382", "r384", "r386", "r387", "r751" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r700", "r717" ], "lang": { "en-us": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeandInterestRateRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r700" ], "lang": { "en-us": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeandInterestRateRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r700" ], "lang": { "en-us": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HeldToMaturitySecurities": { "auth_ref": [ "r261", "r273", "r304", "r307" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss", "totalLabel": "Amortized Cost" } } }, "localname": "HeldToMaturitySecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Held-to-Maturity, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]", "terseLabel": "Held-to-maturity" } } }, "localname": "HeldToMaturitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain": { "auth_ref": [ "r275", "r280" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "order": 1.0, "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain", "terseLabel": "Gross Unrealized Gains" } } }, "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss": { "auth_ref": [ "r276", "r281" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "order": 2.0, "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss", "negatedLabel": "Gross Unrealized Losses" } } }, "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Held-to-maturity, Maturity [Abstract]", "terseLabel": "Held-to-Maturity" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Held-to-maturity, Maturity, Fair Value, Rolling Maturity [Abstract]", "terseLabel": "Fair Value" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity [Abstract]", "terseLabel": "Amortized Cost" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 4.0, "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value", "terseLabel": "Due in 1\u00a0year or less" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 1.0, "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in sixth through tenth rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Rolling after Five Through Ten Years, Fair Value", "terseLabel": "Due after 5\u00a0years through 10\u00a0years" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 3.0, "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in second through fifth rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value", "terseLabel": "Due after 1\u00a0year through 5\u00a0years" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": { "auth_ref": [ "r277", "r283", "r854" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 2.0, "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), without single maturity date and not allocated over maturity grouping.", "label": "Debt Securities, Held-to-maturity, Maturity, without Single Maturity Date, Fair Value", "terseLabel": "Instruments not due at a single maturity date (a)" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount": { "auth_ref": [ "r277", "r853" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 3.0, "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) without single maturity date and not allocated over maturity grouping.", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, without Single Maturity Date", "terseLabel": "Instruments not due at a single maturity date (a)" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesFairValue": { "auth_ref": [ "r274", "r279", "r842" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "order": 3.0, "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-maturity, Fair Value", "terseLabel": "Fair Value", "totalLabel": "Fair Value" } } }, "localname": "HeldToMaturitySecuritiesFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 1.0, "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following current statement of financial position date. For interim and annual periods when interim period is reported on rolling approach.", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling within One Year", "terseLabel": "Due in 1\u00a0year or less" } } }, "localname": "HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 4.0, "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in sixth through tenth rolling fiscal year following current statement of financial position date. For interim and annual periods when interim period is reported on rolling approach.", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling after Five through Ten Years", "terseLabel": "Due after 5\u00a0years through 10\u00a0years" } } }, "localname": "HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 2.0, "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in second through fifth rolling fiscal year following current statement of financial position date. For interim and annual periods when interim period is reported on rolling approach.", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling after One through Five Years", "terseLabel": "Due after 1\u00a0year through 5\u00a0years" } } }, "localname": "HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": { "auth_ref": [ "r145", "r344" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.", "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)", "terseLabel": "Impairment of intangible assets" } } }, "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SPECIALCHARGESImpairmentofLonglivedAssetsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfInvestments": { "auth_ref": [ "r266" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.", "label": "Other than Temporary Impairment Losses, Investments", "terseLabel": "Impairment charges (Note 4)" } } }, "localname": "ImpairmentOfInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Impairment of Goodwill and Long-lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InProcessResearchAndDevelopmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.", "label": "In Process Research and Development [Member]", "verboseLabel": "In-process research and development" } } }, "localname": "InProcessResearchAndDevelopmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r163", "r663" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofIncomeBeforeProvisionsforIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "terseLabel": "United States" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofIncomeBeforeProvisionsforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r109", "r228", "r234", "r238", "r241", "r244", "r830", "r844", "r850", "r878" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 }, "http://www.edwards.com/role/INCOMETAXESScheduleofIncomeBeforeProvisionsforIncomeTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Income before provision for income taxes", "verboseLabel": "Consolidated pre-tax income" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/INCOMETAXESScheduleofIncomeBeforeProvisionsforIncomeTaxesDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "auth_ref": [ "r163", "r663" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofIncomeBeforeProvisionsforIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "terseLabel": "Outside of the United States, including Puerto Rico" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofIncomeBeforeProvisionsforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r228", "r234", "r238", "r241", "r244" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "terseLabel": "Total segment operating income", "totalLabel": "Income before provision for income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]", "terseLabel": "Segment Operating Income" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r351", "r354" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails", "http://www.edwards.com/role/INVESTMENTSNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r354" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails", "http://www.edwards.com/role/INVESTMENTSNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r633" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r164", "r629", "r641", "r648", "r658", "r664", "r668", "r669", "r672" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXES" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss": { "auth_ref": [ "r632" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Estimated amount of loss resulting from an adverse tax position.", "label": "Income Tax Examination, Estimate of Possible Loss", "terseLabel": "Additional federal tax" } } }, "localname": "IncomeTaxExaminationEstimateOfPossibleLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r165", "r187", "r188", "r226", "r627", "r659", "r666", "r879" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 }, "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Provision for income taxes", "terseLabel": "Provision for income taxes (Note\u00a017)", "totalLabel": "Total income tax provision" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails", "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxHolidayAggregateDollarAmount": { "auth_ref": [ "r664" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of income taxes from which a reporting entity is exempt or for which it will receive a reduction in income taxes as a result of the income tax holiday granted by the taxing jurisdiction.", "label": "Income Tax Holiday, Aggregate Dollar Amount", "terseLabel": "Tax reductions compared to local statutory rates" } } }, "localname": "IncomeTaxHolidayAggregateDollarAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare": { "auth_ref": [ "r664" ], "lang": { "en-us": { "role": { "documentation": "Per share amount effect of the income tax benefit resulting from the income tax holidays granted by taxing jurisdictions.", "label": "Income Tax Holiday, Income Tax Benefits Per Share", "terseLabel": "Tax reductions compared to local statutory rates per diluted share (in dollars per share)" } } }, "localname": "IncomeTaxHolidayIncomeTaxBenefitsPerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r102", "r623", "r624", "r641", "r642", "r647", "r655" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationDeductions": { "auth_ref": [ "r628" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 7.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations attributable to deduction. Includes, but is not limited to, dividend deduction, deduction for dividend paid to employee stock ownership plan (ESOP), Medicare prescription drug benefit subsidy deduction, and other deductions.", "label": "Effective Income Tax Rate Reconciliation, Deduction, Amount", "negatedTerseLabel": "Foreign-derived intangible income deduction" } } }, "localname": "IncomeTaxReconciliationDeductions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r628" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount", "terseLabel": "Foreign income taxed at different rates" } } }, "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r628" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount", "terseLabel": "Income tax expense at United States federal statutory rate" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": { "auth_ref": [ "r628" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 10.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount", "terseLabel": "Nondeductible employee share-based compensation" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationOtherAdjustments": { "auth_ref": [ "r628" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 11.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount", "terseLabel": "Other" } } }, "localname": "IncomeTaxReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": { "auth_ref": [ "r628" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 5.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount", "terseLabel": "Build of reserve for prior years' uncertain tax positions" } } }, "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r628" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 3.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount", "terseLabel": "State and local taxes, net of federal tax benefit" } } }, "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationTaxCredits": { "auth_ref": [ "r628" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 4.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Amount", "negatedLabel": "Tax credits, federal and state" } } }, "localname": "IncomeTaxReconciliationTaxCredits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r141", "r149" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "verboseLabel": "Income taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables": { "auth_ref": [ "r144" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.", "label": "Increase (Decrease) in Accounts and Other Receivables", "negatedLabel": "Accounts and other receivables, net" } } }, "localname": "IncreaseDecreaseInAccountsAndOtherReceivables", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r144" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "auth_ref": [ "r144" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.", "label": "Increase (Decrease) in Income Taxes Payable", "terseLabel": "Income taxes" } } }, "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": { "auth_ref": [ "r144" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.", "label": "Increase (Decrease) in Deferred Income Taxes", "negatedLabel": "Deferred income taxes" } } }, "localname": "IncreaseDecreaseInDeferredIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r144" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInNotesReceivables": { "auth_ref": [ "r144" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period of the amounts due from borrowers for outstanding secured or unsecured loans evidenced by a note.", "label": "Increase (Decrease) in Notes Receivables", "negatedTerseLabel": "Issuances of notes receivable" } } }, "localname": "IncreaseDecreaseInNotesReceivables", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "auth_ref": [ "r144" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net", "negatedLabel": "Other" } } }, "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r144" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r194", "r195", "r196", "r200" ], "calculation": { "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements", "terseLabel": "Dilutive effect of stock plans (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r334", "r342" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets [Axis]", "terseLabel": "Indefinite-lived Intangible Assets [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Indefinite-lived Intangible Assets [Line Items]", "terseLabel": "Indefinite-lived Intangible Assets [Line Items]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails", "http://www.edwards.com/role/SPECIALCHARGESImpairmentofLonglivedAssetsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r342" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)", "terseLabel": "In-process research and development" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Indefinite-lived Intangible Assets (Excluding Goodwill) [Abstract]", "terseLabel": "Indefinite-lived intangible assets" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r334", "r342" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets, Gross (Excluding Goodwill)", "terseLabel": "Cost" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r331", "r337" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Other intangible assets, net (Note\u00a09)", "totalLabel": "Net Carrying Value" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r107", "r222", "r766", "r769", "r848" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "verboseLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which reported facts about interest income have been included.", "label": "Interest Income [Member]", "terseLabel": "Interest expense" } } }, "localname": "InterestIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r138", "r140", "r149" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "verboseLabel": "Interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r39", "r322" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished products" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r4", "r61", "r788" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories (Note\u00a05)", "totalLabel": "Total inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory, Net [Abstract]", "verboseLabel": "Inventories" } } }, "localname": "InventoryNetAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r16", "r62", "r156", "r205", "r319", "r321", "r323", "r825" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "auth_ref": [ "r41", "r322" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.", "label": "Inventory, Raw Materials, Net of Reserves", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterialsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r40", "r322" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work in process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r320" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Inventory Write-down", "terseLabel": "Inventory write off (Note 2)" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInventoriesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r119", "r221" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "negatedLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentPolicyTextBlock": { "auth_ref": [ "r300", "r877" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment in financial asset.", "label": "Investment, Policy [Policy Text Block]", "terseLabel": "Investments" } } }, "localname": "InvestmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r893", "r894", "r895", "r896", "r897", "r898", "r899", "r900", "r901", "r902", "r903", "r904", "r905", "r906", "r907" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]", "terseLabel": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r893", "r894", "r895", "r896", "r897", "r898", "r899", "r900", "r901", "r902", "r903", "r904", "r905", "r906", "r907" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]", "terseLabel": "Investments [Domain]" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsAllOtherInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, All Other Investments [Abstract]", "terseLabel": "Equity securities" } } }, "localname": "InvestmentsAllOtherInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.", "label": "Investments Classified by Contractual Maturity Date [Table Text Block]", "terseLabel": "Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity" } } }, "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, Debt and Equity Securities [Abstract]", "terseLabel": "Investments, Debt and Equity Securities [Abstract]" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": { "auth_ref": [ "r44" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.", "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures", "totalLabel": "Total investments in unconsolidated entities" } } }, "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "auth_ref": [ "r293", "r831", "r855", "r908", "r941" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investments in certain debt and equity securities.", "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]", "verboseLabel": "INVESTMENTS" } } }, "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_Land": { "auth_ref": [ "r11", "r46" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.", "label": "Land", "terseLabel": "Land" } } }, "localname": "Land", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]", "terseLabel": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_LegalMattersAndContingenciesTextBlock": { "auth_ref": [ "r368" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.", "label": "Legal Matters and Contingencies [Text Block]", "verboseLabel": "INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET" } } }, "localname": "LegalMattersAndContingenciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNET" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/LEASESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r778" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/LEASESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r775" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseDiscountRate": { "auth_ref": [ "r777" ], "lang": { "en-us": { "role": { "documentation": "Discount rate used by lessee to determine present value of operating lease payments.", "label": "Lessee, Operating Lease, Discount Rate", "verboseLabel": "Weighted-average discount rate (in years)" } } }, "localname": "LesseeOperatingLeaseDiscountRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r783" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Schedule of Lessee, Operating Lease, Liability, Maturity" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/LEASESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r783" ], "calculation": { "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r783" ], "calculation": { "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails_1": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r783" ], "calculation": { "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails_1": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r783" ], "calculation": { "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails_1": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "terseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r783" ], "calculation": { "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails_1": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r783" ], "calculation": { "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails_1": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r783" ], "calculation": { "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails_1": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r783" ], "calculation": { "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r776" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Term of Contract", "terseLabel": "Lease term (in years)" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/LEASESNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r785" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "LEASES" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/LEASES" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r51", "r161", "r236", "r302", "r373", "r374", "r375", "r378", "r379", "r380", "r382", "r384", "r386", "r387", "r687", "r691", "r692", "r751", "r786", "r787" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r37", "r161", "r302", "r751", "r788", "r839", "r871" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r53", "r161", "r302", "r373", "r374", "r375", "r378", "r379", "r380", "r382", "r384", "r386", "r387", "r687", "r691", "r692", "r751", "r786", "r787", "r788" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r735" ], "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure", "totalLabel": "Total liabilities" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Disclosure [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": { "auth_ref": [ "r56" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 8.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.", "label": "Liability for Uncertainty in Income Taxes, Noncurrent", "terseLabel": "Uncertain tax positions (Note 17)" } } }, "localname": "LiabilityForUncertainTaxPositionsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r25", "r838", "r861" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term Line of Credit", "terseLabel": "Borrowings outstanding" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.", "label": "Line of Credit Facility, Commitment Fee Percentage", "terseLabel": "Facility fee (as a percent)" } } }, "localname": "LineOfCreditFacilityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r50" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "verboseLabel": "Aggregate borrowings in multiple currencies" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Credit Facility" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LitigationReserveNoncurrent": { "auth_ref": [ "r57", "r361" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.", "label": "Estimated Litigation Liability, Noncurrent", "terseLabel": "Litigation settlement accrual (Note 3)" } } }, "localname": "LitigationReserveNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationSettlementExpense": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.", "label": "Litigation Settlement, Expense", "terseLabel": "Intellectual property litigation expenses, net (Note 3)", "verboseLabel": "Intellectual property litigation expenses" } } }, "localname": "LitigationSettlementExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate (LIBOR) [Member]", "terseLabel": "LIBOR" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r25", "r402", "r417", "r419", "r420", "r838", "r867" ], "calculation": { "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "totalLabel": "Total carrying amount" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r55" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt (Note\u00a010)" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermInvestments": { "auth_ref": [ "r44" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).", "label": "Long-term Investments", "terseLabel": "Long-term investments (Note\u00a07)" } } }, "localname": "LongTermInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r55" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r55", "r372" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongtermDebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.", "label": "Long-term Debt, Weighted Average Interest Rate, at Point in Time", "terseLabel": "Weighted-average interest rate under all debt obligations (as a percent)" } } }, "localname": "LongtermDebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r369", "r370" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MachineryAndEquipmentGross": { "auth_ref": [ "r12", "r348" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 3.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment, Gross", "terseLabel": "Machinery and equipment" } } }, "localname": "MachineryAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery and equipment" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MaterialReconcilingItemsMember": { "auth_ref": [ "r238" ], "lang": { "en-us": { "role": { "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.", "label": "Segment Reconciling Items [Member]", "terseLabel": "Segment reconciling items" } } }, "localname": "MaterialReconcilingItemsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge": { "auth_ref": [ "r727" ], "lang": { "en-us": { "role": { "documentation": "Maximum period of time the entity is hedging its exposure to variability in future cash flows for forecasted transactions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes forecasted transactions related to payment of variable interest on existing financial instruments.", "label": "Maximum Length of Time, Foreign Currency Cash Flow Hedge", "terseLabel": "Period when cash flows associated with future transactions and certain local currency expenses are expected to occur (in months)" } } }, "localname": "MaximumLengthOfTimeForeignCurrencyCashFlowHedge", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_MeasurementInputDiscountRateMember": { "auth_ref": [ "r738" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate to determine present value of future cash flows.", "label": "Measurement Input, Discount Rate [Member]", "terseLabel": "Measurement Input, Discount Rate" } } }, "localname": "MeasurementInputDiscountRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r738" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]", "terseLabel": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]", "terseLabel": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MortgagesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A loan to finance the purchase of real estate where the lender has a lien on the property as collateral for the loan.", "label": "Mortgages [Member]", "terseLabel": "Mortgages" } } }, "localname": "MortgagesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MovementInValuationAllowancesAndReservesRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]", "terseLabel": "Movement in Valuation Allowances and Reserves" } } }, "localname": "MovementInValuationAllowancesAndReservesRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MunicipalBondsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments.", "label": "Municipal Bonds [Member]", "terseLabel": "Municipal securities", "verboseLabel": "Municipal securities" } } }, "localname": "MunicipalBondsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r207", "r215" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature of Operations [Text Block]", "terseLabel": "DESCRIPTION OF BUSINESS" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DESCRIPTIONOFBUSINESS" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r139" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]", "terseLabel": "Cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r139" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]", "terseLabel": "Cash flows from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r139", "r143", "r146" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]", "terseLabel": "Cash flows from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r181", "r182", "r183", "r184", "r190", "r191", "r197", "r200", "r228", "r234", "r238", "r241", "r244" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "terseLabel": "Net income", "totalLabel": "Net income" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentHedgingMember": { "auth_ref": [ "r699" ], "lang": { "en-us": { "role": { "documentation": "Hedges of a net investment in a foreign operation.", "label": "Net Investment Hedging [Member]", "terseLabel": "Net investment hedges" } } }, "localname": "NetInvestmentHedgingMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent": { "auth_ref": [ "r476" ], "calculation": { "http://www.edwards.com/role/OTHERINCOMENETDetails": { "order": 3.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.", "label": "Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component", "terseLabel": "Non-service cost components of net periodic pension benefit cost" } } }, "localname": "NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERINCOMENETDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "New Accounting Standards Not Yet Adopted" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonUsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Countries excluding the United States of America (US).", "label": "Non-US [Member]", "terseLabel": "International", "verboseLabel": "Foreign" } } }, "localname": "NonUsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NoncurrentAssets": { "auth_ref": [ "r249" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.", "label": "Long-Lived Assets", "terseLabel": "Long-lived tangible assets" } } }, "localname": "NoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NondesignatedMember": { "auth_ref": [ "r700" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Not Designated as Hedging Instrument [Member]", "verboseLabel": "Derivatives not designated as hedging instruments" } } }, "localname": "NondesignatedMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r120" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "terseLabel": "Non-operating income" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ObligationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The carrying values as of the balance sheet date of all debt, including all short-term borrowings, long-term debt, and capital lease obligations.", "label": "Obligations [Member]", "terseLabel": "Obligations" } } }, "localname": "ObligationsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent": { "auth_ref": [ "r95" ], "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.", "label": "OCI, before Reclassifications, before Tax, Attributable to Parent", "terseLabel": "Other comprehensive (loss) income before reclassifications", "verboseLabel": "Prior service credit arising during period" } } }, "localname": "OciBeforeReclassificationsBeforeTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OffsettingAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Offsetting Assets [Line Items]", "terseLabel": "Offsetting Assets [Line Items]" } } }, "localname": "OffsettingAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OffsettingAssetsTable": { "auth_ref": [ "r71", "r72" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements.", "label": "Offsetting Assets [Table]", "terseLabel": "Offsetting Assets [Table]" } } }, "localname": "OffsettingAssetsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OffsettingAssetsTableTextBlock": { "auth_ref": [ "r71", "r72" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative and other financial assets that are subject to offsetting, including master netting arrangements.", "label": "Offsetting Assets [Table Text Block]", "terseLabel": "Schedule of Effect of Master-Netting Agreements and Rights of Offset, Assets" } } }, "localname": "OffsettingAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OffsettingDerivativeAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Offsetting Derivative Assets [Abstract]", "terseLabel": "Derivative Assets" } } }, "localname": "OffsettingDerivativeAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OffsettingDerivativeLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Offsetting Derivative Liabilities [Abstract]", "terseLabel": "Derivative Liabilities" } } }, "localname": "OffsettingDerivativeLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OffsettingLiabilitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Offsetting Liabilities [Line Items]", "terseLabel": "Offsetting Liabilities [Line Items]" } } }, "localname": "OffsettingLiabilitiesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OffsettingLiabilitiesTable": { "auth_ref": [ "r71", "r72" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about derivative and financial liabilities that are subject to offsetting, including enforceable master netting arrangements.", "label": "Offsetting Liabilities [Table]", "terseLabel": "Offsetting Liabilities [Table]" } } }, "localname": "OffsettingLiabilitiesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OffsettingLiabilitiesTableTextBlock": { "auth_ref": [ "r71", "r72" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative and other financial liabilities that are subject to offsetting, including master netting arrangements.", "label": "Offsetting Liabilities [Table Text Block]", "terseLabel": "Schedule of Effect of Master-Netting Agreements and Rights of Offset, Liabilities" } } }, "localname": "OffsettingLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r228", "r234", "r238", "r241", "r244" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "terseLabel": "Operating income", "totalLabel": "Operating income" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r779", "r784" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/LEASESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r773" ], "calculation": { "http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "totalLabel": "Total operating lease liabilities", "verboseLabel": "Total lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails", "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r773" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liabilities, current portion", "verboseLabel": "Operating lease liabilities (Note 6)" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r773" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities, long-term portion", "verboseLabel": "Operating lease liabilities (Note 6)" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r774", "r780" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Operating cash flows from operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r772" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets", "verboseLabel": "Operating lease right-of-use assets (Note 6)" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r782", "r784" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted-average remaining lease term (in years)" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r649" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "terseLabel": "Carryforward Amount" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Loss Carryforwards [Line Items]", "terseLabel": "Operating Loss Carryforwards [Line Items]" } } }, "localname": "OperatingLossCarryforwardsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsTable": { "auth_ref": [ "r650" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Operating Loss Carryforwards [Table]", "terseLabel": "Operating Loss Carryforwards [Table]" } } }, "localname": "OperatingLossCarryforwardsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsValuationAllowance": { "auth_ref": [ "r645" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails": { "order": 2.0, "parentTag": "ew_DeferredTaxAssetsOperatingLossCarryforwardsNetOfValuationAllowance", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.", "label": "Operating Loss Carryforwards, Valuation Allowance", "negatedLabel": "Valuation Allowance" } } }, "localname": "OperatingLossCarryforwardsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r233", "r234", "r235", "r236", "r238", "r244" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r13", "r14", "r15", "r52" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 11.0, "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Other accrued liabilities" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r63", "r788" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r48" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "auth_ref": [ "r95", "r103", "r104", "r106", "r757", "r759", "r763" ], "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeOtherNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "totalLabel": "Prior service credit arising during period" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": { "auth_ref": [ "r93", "r103" ], "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax", "negatedLabel": "Prior service credit arising during period" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeTax": { "auth_ref": [ "r103", "r104", "r110", "r298", "r757", "r762", "r763", "r845", "r874" ], "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails_1": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeOtherNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Tax", "totalLabel": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), before Tax [Abstract]", "terseLabel": "Pre-Tax Amount" } } }, "localname": "OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "auth_ref": [ "r82", "r92" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax", "terseLabel": "Unrealized gain (loss) on hedges" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r82", "r92", "r705", "r710", "r723" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax", "terseLabel": "Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": { "auth_ref": [ "r92", "r96" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax", "terseLabel": "Amount of gain (loss) reclassified from accumulated OCI into income" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": { "auth_ref": [ "r92", "r96", "r711" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax", "terseLabel": "Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax": { "auth_ref": [ "r83", "r92", "r96", "r712" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.", "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax", "terseLabel": "Amount excluded from effectiveness testing recognized in earnings based on an amortization approach" } } }, "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r80" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Foreign currency translation adjustments" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r714" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.", "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax", "terseLabel": "Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)" } } }, "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "verboseLabel": "Net of Tax Amount" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r98", "r100", "r684", "r685", "r689" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "terseLabel": "Other comprehensive income (loss), net of tax", "totalLabel": "Other comprehensive income (loss), net of tax" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]", "terseLabel": "Other comprehensive income (loss), net of tax (Note\u00a015):" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r89", "r92" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "negatedLabel": "Unrealized pension credits (costs)" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": { "auth_ref": [ "r92", "r96", "r97", "r292" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 5.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.", "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax", "negatedTerseLabel": "Reclassification of net realized investment loss to earnings" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTax": { "auth_ref": [ "r93", "r103", "r110", "r627", "r665", "r667", "r757", "r760", "r763", "r845", "r874" ], "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails_1": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeOtherNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Tax", "negatedTotalLabel": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Tax [Abstract]", "terseLabel": "Tax (Expense) Benefit" } } }, "localname": "OtherComprehensiveIncomeLossTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": { "auth_ref": [ "r684", "r685", "r689" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent", "negatedLabel": "Deferred income tax (expense) benefit" } } }, "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeOtherNetOfTax": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in other comprehensive income, after tax, from changes classified as other.", "label": "Other Comprehensive Income, Other, Net of Tax", "totalLabel": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeOtherNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "auth_ref": [ "r84", "r92" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 4.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax", "terseLabel": "Unrealized (loss) gain on available-for-sale investments" } } }, "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentAssetsMember": { "auth_ref": [ "r702", "r722" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other current assets.", "label": "Other Current Assets [Member]", "terseLabel": "Other current assets" } } }, "localname": "OtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherIncomeAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income and Expenses [Abstract]", "terseLabel": "Other Income and Expenses [Abstract]" } } }, "localname": "OtherIncomeAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": { "auth_ref": [ "r471", "r619" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.", "label": "Other Income and Other Expense Disclosure [Text Block]", "terseLabel": "OTHER INCOME, NET" } } }, "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERINCOMENET" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets classified as other.", "label": "Other Intangible Assets [Member]", "terseLabel": "Other" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment": { "auth_ref": [ "r42" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of inventory owned by the entity but in the hands of a customer, typically a reseller.", "label": "Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross", "terseLabel": "Finished goods inventories held on consignment" } } }, "localname": "OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInventoriesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherInvestmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other investments.", "label": "Other Investments [Member]", "verboseLabel": "Other" } } }, "localname": "OtherInvestmentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of other liabilities.", "label": "Other Liabilities, Fair Value Disclosure", "terseLabel": "Other liability" } } }, "localname": "OtherLiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesMember": { "auth_ref": [ "r702", "r722" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other liabilities.", "label": "Other Liabilities [Member]", "terseLabel": "Other Liability" } } }, "localname": "OtherLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinFairValueofContingentConsiderationObligationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r56" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r146" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedLabel": "Other" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent assets.", "label": "Other Noncurrent Assets [Member]", "terseLabel": "Other assets" } } }, "localname": "OtherNoncurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Member]", "terseLabel": "Other long-term liabilities" } } }, "localname": "OtherNoncurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r121" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 }, "http://www.edwards.com/role/OTHERINCOMENETDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "negatedLabel": "Other income, net (Note\u00a016)", "negatedTotalLabel": "Total other income, net", "netLabel": "Other income, net", "terseLabel": "Other income, net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails", "http://www.edwards.com/role/OTHERINCOMENETDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).", "label": "Other Nonoperating Income (Expense) [Member]", "terseLabel": "Other income, net" } } }, "localname": "OtherNonoperatingIncomeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails", "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonrecurringIncomeExpense": { "auth_ref": [ "r122" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 6.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other expense (income) that is infrequent in occurrence or unusual in nature.", "label": "Other Nonrecurring (Income) Expense", "negatedLabel": "Special charges", "terseLabel": "Special charges (Note\u00a04)" } } }, "localname": "OtherNonrecurringIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingIncomeExpenseNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.", "label": "Other Operating Income (Expense), Net", "terseLabel": "Other income, net" } } }, "localname": "OtherOperatingIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPaymentsToAcquireBusinesses": { "auth_ref": [ "r129" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs.", "label": "Other Payments to Acquire Businesses", "negatedTerseLabel": "Payment for acquisition option" } } }, "localname": "OtherPaymentsToAcquireBusinesses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivables": { "auth_ref": [ "r63" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from parties in nontrade transactions, classified as other.", "label": "Other Receivables", "terseLabel": "Other receivables" } } }, "localname": "OtherReceivables", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PatentsMember": { "auth_ref": [ "r675" ], "lang": { "en-us": { "role": { "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.", "label": "Patents [Member]", "verboseLabel": "Patents" } } }, "localname": "PatentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForLegalSettlements": { "auth_ref": [ "r142" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.", "label": "Payments for Legal Settlements", "terseLabel": "Payments for legal settlements" } } }, "localname": "PaymentsForLegalSettlements", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r127", "r131" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "negatedLabel": "Other" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r135" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Purchases of treasury stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": { "auth_ref": [ "r125", "r128", "r265" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Payments to Acquire Debt Securities, Available-for-sale", "negatedLabel": "Purchases of available-for-sale investments (Note\u00a07)" } } }, "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r129", "r681" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "negatedLabel": "Acquisition (Note\u00a08)" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireHeldToMaturitySecurities": { "auth_ref": [ "r128", "r265" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow through purchase of long-term held-to-maturity securities.", "label": "Payments to Acquire Held-to-maturity Securities", "negatedLabel": "Purchases of held-to-maturity investments (Note\u00a07)" } } }, "localname": "PaymentsToAcquireHeldToMaturitySecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r130" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedTerseLabel": "Investments in intangible assets and in-process research and development" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r130" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Capital expenditures" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "auth_ref": [ "r499", "r501", "r507", "r526", "r528", "r529", "r530", "r531", "r532", "r549", "r551", "r552", "r554", "r574" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for retirement benefits.", "label": "Retirement Benefits [Text Block]", "terseLabel": "EMPLOYEE BENEFIT PLANS" } } }, "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANS" ], "xbrltype": "textBlockItemType" }, "us-gaap_PensionPlansDefinedBenefitMember": { "auth_ref": [ "r472", "r474", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r499", "r500", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r522", "r524", "r525", "r527", "r530", "r534", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r554", "r555", "r569", "r570", "r571", "r572" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.", "label": "Pension Plan [Member]", "terseLabel": "Defined benefit pension plans" } } }, "localname": "PensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details" ], "xbrltype": "domainItemType" }, "us-gaap_PlanAssetCategoriesDomain": { "auth_ref": [ "r499", "r500", "r502", "r503", "r504", "r505", "r506", "r507", "r527", "r549" ], "lang": { "en-us": { "role": { "documentation": "Defined benefit plan asset investment.", "label": "Defined Benefit Plan, Plan Assets, Category [Domain]", "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]" } } }, "localname": "PlanAssetCategoriesDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details" ], "xbrltype": "domainItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r579", "r609" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "auth_ref": [ "r749" ], "lang": { "en-us": { "role": { "documentation": "Measured at fair value for financial reporting purposes.", "label": "Portion at Fair Value Measurement [Member]", "terseLabel": "Portion at Fair Value Measurement" } } }, "localname": "PortionAtFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r29", "r424" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r29" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, authorized shares (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r29" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r29", "r788" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "verboseLabel": "Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r6", "r8", "r324", "r325" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromCollectionOfNotesReceivable": { "auth_ref": [ "r126" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from Collection of Notes Receivable", "terseLabel": "Collections of notes receivable" } } }, "localname": "ProceedsFromCollectionOfNotesReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r133" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from Issuance of Long-term Debt", "verboseLabel": "Proceeds from issuance of debt" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r134", "r137" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "Other" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": { "auth_ref": [ "r125", "r126", "r265" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-sale", "terseLabel": "Proceeds from sales and maturities of available-for-sale investments (Note\u00a07)" } } }, "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities": { "auth_ref": [ "r126", "r265" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities.", "label": "Proceeds from Sale and Maturity of Held-to-maturity Securities", "terseLabel": "Proceeds from sales and maturities of held-to-maturity investments (Note\u00a07)" } } }, "localname": "ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r132", "r610" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Cash from exercises of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAdditionalInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockPlans": { "auth_ref": [ "r132" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from the stock plan during the period.", "label": "Proceeds from Stock Plans", "terseLabel": "Proceeds from stock plans" } } }, "localname": "ProceedsFromStockPlans", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]", "terseLabel": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESShippingandHandlingCostsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r47", "r350" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r46", "r348" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "totalLabel": "Total property, plant and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r19", "r20", "r350", "r788", "r856", "r872" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, plant, and equipment, net (Note\u00a05)", "totalLabel": "Total property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Net [Abstract]", "terseLabel": "Property, plant, and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNetAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r45", "r350", "r912", "r913" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r19", "r348" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Estimated useful life (in years)" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]", "terseLabel": "Amounts reclassified from accumulated other comprehensive loss to affected line on Consolidated Statements of Operations" } } }, "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "auth_ref": [ "r95", "r103", "r104", "r757", "r761", "r763" ], "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "negatedLabel": "Amortization of prior service credit" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "auth_ref": [ "r95", "r103", "r104", "r106", "r757", "r761", "r763" ], "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeOtherNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "negatedTotalLabel": "Amortization of prior service credit" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent": { "auth_ref": [ "r95" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.", "label": "Reclassification from AOCI, Current Period, before Tax, Attributable to Parent", "negatedLabel": "Amounts reclassified from accumulated other comprehensive loss" } } }, "localname": "ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAociCurrentPeriodTax": { "auth_ref": [ "r93", "r97", "r103" ], "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails": { "order": 2.0, "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).", "label": "Reclassification from AOCI, Current Period, Tax", "terseLabel": "Amortization of prior service credit" } } }, "localname": "ReclassificationFromAociCurrentPeriodTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": { "auth_ref": [ "r105" ], "lang": { "en-us": { "role": { "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": { "auth_ref": [ "r105" ], "lang": { "en-us": { "role": { "documentation": "Item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r105" ], "lang": { "en-us": { "role": { "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]", "terseLabel": "Amount Reclassified from Accumulated Other Comprehensive Loss" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": { "auth_ref": [ "r105" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]", "terseLabel": "Schedule of Information About Amounts Reclassified from Accumulated Other Comprehensive Loss" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]", "terseLabel": "Unallocated amounts:" } } }, "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]", "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns" } } }, "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofUncertainTaxPositionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities": { "auth_ref": [ "r136" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.", "label": "Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security", "negatedTerseLabel": "Payments on debt and finance lease obligations" } } }, "localname": "RepaymentsOfLongTermDebtAndCapitalSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff": { "auth_ref": [ "r335" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of the write-off for research and development assets that were acquired in a transaction other than a business combination.", "label": "Research and Development Asset Acquired Other than Through Business Combination, Written-off", "netLabel": "Purchased in-process research and development (Note 4)" } } }, "localname": "ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r620", "r826", "r925" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development expenses" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]", "terseLabel": "Research and development expenses" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r620" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development Expense, Policy [Policy Text Block]", "terseLabel": "Research and Development Costs" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchMember": { "auth_ref": [ "r650" ], "lang": { "en-us": { "role": { "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.", "label": "Research Tax Credit Carryforward [Member]", "terseLabel": "Research expenditure tax credits" } } }, "localname": "ResearchMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashCurrent": { "auth_ref": [ "r3", "r17", "r153" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Current", "terseLabel": "Restricted cash included in other current assets" } } }, "localname": "RestrictedCashCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashNoncurrent": { "auth_ref": [ "r10", "r21", "r153", "r910" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Noncurrent", "terseLabel": "Restricted cash included in other assets" } } }, "localname": "RestrictedCashNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted stock units", "verboseLabel": "Nonvested restricted stock unit activity" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringReserveCurrent": { "auth_ref": [ "r24", "r353", "r356" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 7.0, "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.", "label": "Restructuring Reserve, Current", "terseLabel": "Accrued realignment reserves" } } }, "localname": "RestructuringReserveCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r33", "r444", "r614", "r788", "r870", "r888", "r890" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r177", "r178", "r179", "r180", "r186", "r188", "r303", "r611", "r612", "r613", "r656", "r657", "r730", "r885", "r887" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanNameAxis": { "auth_ref": [ "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r499", "r500", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r522", "r523", "r524", "r525", "r527", "r530", "r534", "r535", "r536", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r573" ], "lang": { "en-us": { "role": { "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.", "label": "Retirement Plan Name [Axis]", "terseLabel": "Retirement Plan Name [Axis]" } } }, "localname": "RetirementPlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanNameDomain": { "auth_ref": [ "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r499", "r500", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r522", "r523", "r524", "r525", "r527", "r530", "r534", "r535", "r536", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r573" ], "lang": { "en-us": { "role": { "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.", "label": "Retirement Plan Name [Domain]", "terseLabel": "Retirement Plan Name [Domain]" } } }, "localname": "RetirementPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanSponsorLocationAxis": { "auth_ref": [ "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r499", "r500", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r522", "r523", "r524", "r525", "r527", "r530", "r535", "r536", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r555", "r559", "r572" ], "lang": { "en-us": { "role": { "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Axis]", "terseLabel": "Retirement Plan Sponsor Location [Axis]" } } }, "localname": "RetirementPlanSponsorLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanSponsorLocationDomain": { "auth_ref": [ "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r499", "r500", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r522", "r523", "r524", "r525", "r527", "r530", "r535", "r536", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r555", "r559", "r572" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Domain]", "terseLabel": "Retirement Plan Sponsor Location [Domain]" } } }, "localname": "RetirementPlanSponsorLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r472", "r473", "r474", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r499", "r500", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r522", "r524", "r525", "r527", "r530", "r534", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r554", "r555", "r556", "r557", "r558", "r559", "r569", "r570", "r571", "r572" ], "lang": { "en-us": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]", "terseLabel": "Retirement Plan Type [Axis]" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTypeDomain": { "auth_ref": [ "r472", "r473", "r474", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r499", "r500", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r522", "r524", "r525", "r527", "r530", "r534", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r554", "r555", "r556", "r557", "r558", "r559", "r569", "r570", "r571", "r572" ], "lang": { "en-us": { "role": { "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Domain]", "terseLabel": "Retirement Plan Type [Domain]" } } }, "localname": "RetirementPlanTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r219", "r220", "r233", "r239", "r240", "r247", "r248", "r251", "r463", "r464", "r827" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Net sales", "verboseLabel": "Total segment net sales" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r157", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r470" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue from Contract with Customer [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]", "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]" } } }, "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable": { "auth_ref": [ "r469" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information when using transition method for cumulative effect in initial period of application for revenue from contract with customer.", "label": "Revenue, Initial Application Period Cumulative Effect Transition [Table]", "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition [Table]" } } }, "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "auth_ref": [ "r454" ], "lang": { "en-us": { "role": { "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "terseLabel": "Revenue, remaining performance obligation, expected timing of satisfaction, period (in years)" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Segment Net Sales", "verboseLabel": "Net Sales by Geographic Area and by Major Product Area" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenues from External Customers and Long-Lived Assets [Line Items]", "terseLabel": "Enterprise-Wide Information" } } }, "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r781", "r784" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Right-of-use assets obtained in exchange for new lease liabilities" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RoyaltyExpense": { "auth_ref": [ "r117" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.", "label": "Royalty Expense", "terseLabel": "Royalty expense" } } }, "localname": "RoyaltyExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": { "auth_ref": [ "r60" ], "lang": { "en-us": { "role": { "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]", "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r95", "r762", "r763" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": { "auth_ref": [ "r498" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.", "label": "Schedule of Allocation of Plan Assets [Table Text Block]", "terseLabel": "Schedule of Target Weighted-Average Asset Allocations and Fair Value" } } }, "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r519" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.", "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Change in Unrealized Pension Costs" } } }, "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r201" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsperShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.", "label": "Defined Benefit Plan, Assumptions [Table Text Block]", "terseLabel": "Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations" } } }, "localname": "ScheduleOfAssumptionsUsedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Securities, Available-for-sale [Line Items]", "terseLabel": "Debt Securities, Available-for-sale [Line Items]" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": { "auth_ref": [ "r271", "r272", "r288", "r289", "r290", "r291", "r852", "r853" ], "lang": { "en-us": { "role": { "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.", "label": "Schedule of Available-for-sale Securities [Table]", "terseLabel": "Schedule of Available-for-sale Securities [Table]" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r673", "r674" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSNarrativesDetails", "http://www.edwards.com/role/SPECIALCHARGESAcquisitionofIntellectualPropertyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of cash and cash equivalents.", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Schedule of Cash and Cash Equivalents" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.", "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]", "terseLabel": "Schedule of Cash Flow Information" } } }, "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r655" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Schedule of Provision for Income Taxes" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r55", "r167", "r419", "r421", "r440", "r441", "r442", "r443", "r767", "r768", "r771", "r858" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "terseLabel": "Schedule of the Notes" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r646" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Schedule of Deferred Tax Assets and Liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r533", "r534", "r537", "r538", "r549" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "auth_ref": [ "r703", "r713", "r717" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "terseLabel": "Schedule of Effect of Derivative Instruments" } } }, "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r200" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Computation of Basic and Diluted Earnings Per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock": { "auth_ref": [ "r503" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the effect of fair value measurements using significant unobservable inputs (Level 3) on changes in plan assets of pension plans and/or other employee benefit plans for the period.", "label": "Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block]", "terseLabel": "Summary of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3" } } }, "localname": "ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r628" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r577", "r606", "r616" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r577", "r606", "r616" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "terseLabel": "Schedule of Stock-Based Compensation Expense" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Equity Method Investments [Line Items]", "terseLabel": "Schedule of Equity Method Investments [Line Items]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "auth_ref": [ "r2", "r161", "r301", "r302", "r751" ], "lang": { "en-us": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.", "label": "Schedule of Equity Method Investments [Table]", "terseLabel": "Schedule of Equity Method Investments [Table]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": { "auth_ref": [ "r509" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.", "label": "Schedule of Expected Benefit Payments [Table Text Block]", "terseLabel": "Schedule of Benefit Payments Which Reflect Expected Future Service" } } }, "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r735", "r736" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r333", "r338", "r828" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r333", "r338" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Other Intangible Assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock": { "auth_ref": [ "r707" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the presentation of foreign exchange contracts on the statement of financial position, including the fair value amounts and location of such amounts.", "label": "Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block]", "terseLabel": "Schedule of Location and Fair Value Amounts of Derivative Instruments" } } }, "localname": "ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r329", "r330" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r329", "r330" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Schedule of Changes in the Carrying Amount of Goodwill, by Segment" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Held-to-maturity Securities [Line Items]", "terseLabel": "Schedule of Held-to-maturity Securities [Line Items]" } } }, "localname": "ScheduleOfHeldToMaturitySecuritiesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfHeldToMaturitySecuritiesTable": { "auth_ref": [ "r278", "r282", "r283" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-maturity [Table]", "terseLabel": "Debt Securities, Held-to-maturity [Table]" } } }, "localname": "ScheduleOfHeldToMaturitySecuritiesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]", "terseLabel": "Schedule of Income Before Provisions for Income Taxes" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r342", "r345" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.", "label": "Schedule of Indefinite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails", "http://www.edwards.com/role/SPECIALCHARGESImpairmentofLonglivedAssetsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r342", "r345" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.", "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Indefinite-Lived Other Intangible Assets" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A tabular presentation of the information summarizing investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates, as prescribed by the SEC. It reflects specified information about ownership, financial results from, and financial position in such entities. Includes the tabular presentations that disaggregate investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates.", "label": "Schedule of Investments in and Advances to Affiliates, Schedule of Investments [Table Text Block]", "terseLabel": "Schedule of Investments in Unconsolidated Affiliates" } } }, "localname": "ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "auth_ref": [ "r511" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.", "label": "Schedule of Net Benefit Costs [Table Text Block]", "terseLabel": "Schedule of Net Periodic Benefit Cost" } } }, "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [ "r592" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.", "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]", "terseLabel": "Schedule of Restricted Stock Unit Activity" } } }, "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": { "auth_ref": [ "r694" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.", "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]", "terseLabel": "Schedule of Derivative Financial Instruments Used to Manage Currency Exchange and Interest Rate Risk" } } }, "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.", "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]", "terseLabel": "Schedule of Other Expense, Net" } } }, "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERINCOMENETTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]", "terseLabel": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESShippingandHandlingCostsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r47", "r350" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": { "auth_ref": [ "r17", "r153", "r832", "r868" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.", "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Schedule of Restricted Cash" } } }, "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": { "auth_ref": [ "r114", "r250" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]", "terseLabel": "Schedule of Enterprise-Wide Information" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "auth_ref": [ "r108", "r250" ], "lang": { "en-us": { "role": { "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r228", "r231", "r237", "r329" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r228", "r231", "r237", "r329" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of Information About Reportable Segments and Reconciliation of Segment Net Sales and Pre-Tax Income" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r579", "r609" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockbasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r585", "r597", "r599" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Schedule of Stock Option Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": { "auth_ref": [ "r601" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of Weighted-Average Assumptions for ESPP Subscriptions" } } }, "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r601" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of Weighted-Average Assumptions for Options Granted" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt and Equity Securities, FV-NI [Line Items]", "terseLabel": "Debt and Equity Securities, FV-NI [Line Items]" } } }, "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security with change in fair value recognized in net income (FV-NI).", "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]", "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]" } } }, "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of Estimated Amortization Expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r216", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r233", "r234", "r235", "r236", "r238", "r239", "r240", "r241", "r242", "r244", "r251", "r355", "r357", "r880" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails", "http://www.edwards.com/role/SPECIALCHARGESImpairmentofLonglivedAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r216", "r217", "r218", "r228", "r232", "r238", "r242", "r243", "r244", "r245", "r247", "r250", "r251", "r252" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "SEGMENT INFORMATION" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATION" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r118" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "negatedLabel": "Selling, general, and administrative expenses", "terseLabel": "Selling, general, and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, general, and administrative expenses", "verboseLabel": "Selling, general, and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeniorNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.", "label": "Senior Notes [Member]", "terseLabel": "Senior Notes" } } }, "localname": "SeniorNotesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r144" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation (Notes\u00a02 and 14)" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r580" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Vesting period (in years)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r591" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedTerseLabel": "Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r596" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r594" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r594" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r593" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r593" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Ending balance (in dollars per share)", "periodStartLabel": "Beginning balance (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted- Average Grant-Date Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r595" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Vested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r595" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r604" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Expected dividend yield (as a percent)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r603" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "verboseLabel": "Expected volatility (as a percent)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r605" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "verboseLabel": "Average risk-free interest rate (as a percent)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockbasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": { "auth_ref": [ "r609" ], "lang": { "en-us": { "role": { "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate", "terseLabel": "Maximum percentage of compensation employees can authorize to be withheld for common stock purchases (as a percent)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r582" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized", "terseLabel": "Common stock available for issuance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r588" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "terseLabel": "Exercisable as of period end (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r588" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Exercisable as of period end (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r591" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "negatedTerseLabel": "Options forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r589" ], "lang": { "en-us": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures", "terseLabel": "Options granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r598" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Fair value, per share (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r609" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Outstanding as of period end" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r587", "r609" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r586" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Ending balance (in dollars per share)", "periodStartLabel": "Beginning balance (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted- Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "auth_ref": [ "r599" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value", "terseLabel": "Vested and expected to vest as of period end" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "auth_ref": [ "r600" ], "lang": { "en-us": { "role": { "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number", "terseLabel": "Vested and expected to vest as of period end (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r600" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price", "terseLabel": "Vested and expected to vest as of period end (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r576", "r583" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Options exercised (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Options forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Options granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareRepurchaseProgramAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by share repurchase program.", "label": "Share Repurchase Program [Axis]", "terseLabel": "Share Repurchase Program [Axis]" } } }, "localname": "ShareRepurchaseProgramAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareRepurchaseProgramDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the share repurchase program.", "label": "Share Repurchase Program [Domain]", "terseLabel": "Share Repurchase Program [Domain]" } } }, "localname": "ShareRepurchaseProgramDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [ "r580" ], "lang": { "en-us": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage", "terseLabel": "Percentage vesting upon retirement for each full year of employment subsequent to the grant date (as a percent)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockbasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r581" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period", "terseLabel": "Expiration date (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r602", "r615" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected life (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r609" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value", "terseLabel": "Exercisable as of period end" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r609" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Exercisable as of period end" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r600" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Outstanding as of period end" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r600" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Vested and expected to vest as of period end" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase price of common stock expressed as a percentage of its fair value.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent", "terseLabel": "Percentage of lower of fair market value of common stock on effective date of subscription or date of purchase (as a percent)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_ShippingAndHandlingMember": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "Packing and transport of product.", "label": "Shipping and Handling [Member]", "terseLabel": "Shipping and Handling" } } }, "localname": "ShippingAndHandlingMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESShippingandHandlingCostsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermInvestments": { "auth_ref": [ "r23", "r840", "r841", "r863" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Short-term Investments", "terseLabel": "Short-term investments (Note\u00a07)" } } }, "localname": "ShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r154", "r176" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.", "label": "Software and Software Development Costs [Member]", "terseLabel": "Software" } } }, "localname": "SoftwareAndSoftwareDevelopmentCostsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.", "label": "State and Local Jurisdiction [Member]", "netLabel": "California research expenditure tax credits", "terseLabel": "State and local jurisdiction", "verboseLabel": "United States state net operating losses" } } }, "localname": "StateAndLocalJurisdictionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r1", "r216", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r233", "r234", "r235", "r236", "r238", "r239", "r240", "r241", "r242", "r244", "r251", "r329", "r352", "r355", "r357", "r880" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails", "http://www.edwards.com/role/SPECIALCHARGESImpairmentofLonglivedAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r59", "r103", "r104", "r105", "r177", "r178", "r179", "r180", "r186", "r188", "r206", "r303", "r439", "r444", "r611", "r612", "r613", "r656", "r657", "r730", "r757", "r758", "r759", "r760", "r761", "r763", "r885", "r886", "r887", "r967" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r177", "r178", "r179", "r206", "r827" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StockCompensationPlanMember": { "auth_ref": [ "r201" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.", "label": "Share-based Payment Arrangement [Member]", "terseLabel": "Stock compensation plan" } } }, "localname": "StockCompensationPlanMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsperShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r29", "r30", "r439", "r444" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Common stock issued under equity plans (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r29", "r30", "r439", "r444", "r590" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "negatedLabel": "Options exercised (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockSplits": { "auth_ref": [ "r29", "r30", "r439", "r444" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of a stock split.", "label": "Stock Issued During Period, Shares, Stock Splits", "negatedTerseLabel": "Stock issued to effect stock split (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockSplits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r29", "r30", "r444", "r578", "r598" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Common stock issued under equity plans" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Amount Paid", "verboseLabel": "Authorized amount for share repurchase" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails", "http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails", "http://www.edwards.com/role/SUBSEQUENTEVENTDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r30", "r35", "r36", "r161", "r262", "r302", "r751", "r788" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders' equity (Notes\u00a014 and 21)" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r159", "r425", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r438", "r444", "r451" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "COMMON STOCK" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCK" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": { "auth_ref": [ "r445" ], "lang": { "en-us": { "role": { "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.", "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio", "terseLabel": "Stock split, conversion ratio" } } }, "localname": "StockholdersEquityNoteStockSplitConversionRatio1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockSplitNarrativeDetails" ], "xbrltype": "pureItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUBSEQUENTEVENTDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r764", "r790" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUBSEQUENTEVENTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r764", "r790" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUBSEQUENTEVENTDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r764", "r790" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUBSEQUENTEVENTDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r764", "r790" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUBSEQUENTEVENTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]", "terseLabel": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r789", "r792" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENT" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUBSEQUENTEVENT" ], "xbrltype": "textBlockItemType" }, "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": { "auth_ref": [ "r631", "r640", "r642" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.", "label": "Summary of Income Tax Contingencies [Table Text Block]", "terseLabel": "Reconciliation of Beginning and Ending Amount of Uncertain Tax Positions" } } }, "localname": "SummaryOfIncomeTaxContingenciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": { "auth_ref": [ "r650" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Summary of Operating Loss Carryforwards [Table Text Block]", "terseLabel": "Schedule of Net Operating Loss Carryforwards" } } }, "localname": "SummaryOfOperatingLossCarryforwardsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock": { "auth_ref": [ "r650" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of tax credit carryforwards available to reduce future taxable income, including amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances.", "label": "Summary of Tax Credit Carryforwards [Table Text Block]", "terseLabel": "Schedule of Tax Credit Carryforwards" } } }, "localname": "SummaryOfTaxCreditCarryforwardsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "auth_ref": [ "r79" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "terseLabel": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS" } } }, "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "verboseLabel": "Cash paid during the year for:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardAmount": { "auth_ref": [ "r649" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails": { "order": 2.0, "parentTag": "ew_TaxCreditCarryforwardDeferredTaxAssetNetOfValuationAllowance", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Tax Credit Carryforward, Amount", "terseLabel": "Carryforward amount", "verboseLabel": "Carryforward Amount" } } }, "localname": "TaxCreditCarryforwardAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxCreditCarryforwardAxis": { "auth_ref": [ "r650" ], "lang": { "en-us": { "role": { "documentation": "Information by specific tax credit related to an unused tax credit.", "label": "Tax Credit Carryforward [Axis]", "terseLabel": "Tax Credit Carryforward [Axis]" } } }, "localname": "TaxCreditCarryforwardAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Tax Credit Carryforward [Line Items]", "terseLabel": "Tax credit carryforwards and the related carryforward periods" } } }, "localname": "TaxCreditCarryforwardLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardNameDomain": { "auth_ref": [ "r650" ], "lang": { "en-us": { "role": { "documentation": "The name of the tax credit carryforward.", "label": "Tax Credit Carryforward, Name [Domain]", "terseLabel": "Tax Credit Carryforward, Name [Domain]" } } }, "localname": "TaxCreditCarryforwardNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxCreditCarryforwardTable": { "auth_ref": [ "r650" ], "lang": { "en-us": { "role": { "documentation": "A listing of tax credit carryforwards available to reduce future taxable income including descriptions, amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances.", "label": "Tax Credit Carryforward [Table]", "terseLabel": "Tax Credit Carryforward [Table]" } } }, "localname": "TaxCreditCarryforwardTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardValuationAllowance": { "auth_ref": [ "r645" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails": { "order": 1.0, "parentTag": "ew_TaxCreditCarryforwardDeferredTaxAssetNetOfValuationAllowance", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from tax credit carryforwards for which it is more likely than not that a tax benefit will not be realized.", "label": "Tax Credit Carryforward, Valuation Allowance", "negatedLabel": "Valuation Allowance" } } }, "localname": "TaxCreditCarryforwardValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxPeriodAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information about the period subject to enacted tax laws.", "label": "Tax Period [Axis]", "terseLabel": "Tax Period [Axis]" } } }, "localname": "TaxPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxPeriodDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identified tax period.", "label": "Tax Period [Domain]", "terseLabel": "Tax Period [Domain]" } } }, "localname": "TaxPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxesPayableCurrentAndNoncurrent": { "auth_ref": [ "r24", "r836", "r866" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.", "label": "Taxes Payable", "terseLabel": "Taxes payable (Note 17)" } } }, "localname": "TaxesPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [ "r255", "r256", "r257", "r258", "r260", "r263" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for accounts receivable.", "label": "Accounts Receivable [Policy Text Block]", "terseLabel": "Accounts Receivable" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r278", "r282", "r294", "r295", "r296", "r414", "r437", "r729", "r793", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r807", "r808", "r809", "r810", "r811", "r812", "r813", "r814", "r815", "r816", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r934", "r935", "r936", "r937", "r938", "r939", "r940" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]", "terseLabel": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r58", "r447" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury Stock" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r58", "r447" ], "lang": { "en-us": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury Stock, Shares", "terseLabel": "Treasury stock, shares (in shares)" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockSharesAcquired": { "auth_ref": [ "r30", "r439", "r444" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.", "label": "Treasury Stock, Shares, Acquired", "negatedLabel": "Purchases of treasury stock (in shares)", "negatedNetLabel": "Purchases of treasury stock (in shares)", "terseLabel": "Shares repurchased (in shares)" } } }, "localname": "TreasuryStockSharesAcquired", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails", "http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.edwards.com/role/SUBSEQUENTEVENTDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r58", "r447", "r450" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury stock, at cost, 17.9 and 12.1 shares, respectively" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "auth_ref": [ "r439", "r444", "r447" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.", "label": "Treasury Stock, Value, Acquired, Cost Method", "negatedLabel": "Purchases of treasury stock" } } }, "localname": "TreasuryStockValueAcquiredCostMethod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_USGovernmentDebtSecuritiesMember": { "auth_ref": [ "r851" ], "lang": { "en-us": { "role": { "documentation": "Debt securities issued by the United States government.", "label": "US Government Debt Securities [Member]", "terseLabel": "United States government bonds" } } }, "localname": "USGovernmentDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_USTreasuryAndGovernmentMember": { "auth_ref": [ "r500", "r851", "r892" ], "lang": { "en-us": { "role": { "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).", "label": "US Treasury and Government [Member]", "terseLabel": "United States government and agency securities" } } }, "localname": "USTreasuryAndGovernmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UndistributedEarningsOfForeignSubsidiaries": { "auth_ref": [ "r621", "r670", "r859", "r891" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.", "label": "Undistributed Earnings of Foreign Subsidiaries", "terseLabel": "Foreign earnings to be indefinitely reinvested" } } }, "localname": "UndistributedEarningsOfForeignSubsidiaries", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of unrealized gains and losses on investments.", "label": "Unrealized Gain (Loss) on Investments [Table Text Block]", "terseLabel": "Schedule of Investments in Debt Securities" } } }, "localname": "UnrealizedGainLossOnInvestmentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r622", "r634" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESNarrativeDetails": { "order": 1.0, "parentTag": "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Uncertain gross tax positions, ending balance", "periodStartLabel": "Uncertain gross tax positions, beginning balance", "terseLabel": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESReconciliationofUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r635" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions", "negatedLabel": "Decrease in prior year tax positions" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": { "auth_ref": [ "r637" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities", "negatedLabel": "Settlements" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "auth_ref": [ "r636" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.", "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions", "terseLabel": "Current year tax positions" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r635" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions", "terseLabel": "Increase in prior year tax positions" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued": { "auth_ref": [ "r630" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense accrued for an underpayment of income taxes.", "label": "Unrecognized Tax Benefits, Interest on Income Taxes Accrued", "terseLabel": "Accrued interest related to unrecognized tax benefits, net of tax benefit" } } }, "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense": { "auth_ref": [ "r630" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense for an underpayment of income taxes.", "label": "Unrecognized Tax Benefits, Interest on Income Taxes Expense", "terseLabel": "Interest expense (benefit), net of tax benefit" } } }, "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": { "auth_ref": [ "r638" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.", "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations", "negatedTerseLabel": "Lapse of statutes of limitations" } } }, "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "auth_ref": [ "r639" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESNarrativeDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.", "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate", "totalLabel": "Net amounts favorably affecting tax rate" } } }, "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock": { "auth_ref": [ "r123" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for an event or transaction that is unusual in nature or infrequent in occurrence, or both.", "label": "Unusual or Infrequent Items, or Both, Disclosure [Text Block]", "terseLabel": "SPECIAL CHARGES" } } }, "localname": "UnusualOrInfrequentItemsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SPECIALCHARGES" ], "xbrltype": "textBlockItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r208", "r209", "r210", "r211", "r212", "r213", "r214" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": { "auth_ref": [ "r168", "r169", "r170", "r173", "r174" ], "lang": { "en-us": { "role": { "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.", "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]", "terseLabel": "Tax valuation allowance" } } }, "localname": "ValuationAllowanceOfDeferredTaxAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowancesAndReservesBalance": { "auth_ref": [ "r168", "r174" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount", "periodEndLabel": "Balance at End of Period", "periodStartLabel": "Balance at Beginning of Period" } } }, "localname": "ValuationAllowancesAndReservesBalance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": { "auth_ref": [ "r171" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense", "terseLabel": "Charged to Costs and Expenses" } } }, "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts": { "auth_ref": [ "r172" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account", "terseLabel": "Charged to Other Accounts" } } }, "localname": "ValuationAllowancesAndReservesChargedToOtherAccounts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDeductions": { "auth_ref": [ "r173" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction", "negatedLabel": "Deductions" } } }, "localname": "ValuationAllowancesAndReservesDeductions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDomain": { "auth_ref": [ "r168", "r169", "r170", "r173", "r174" ], "lang": { "en-us": { "role": { "documentation": "Valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]" } } }, "localname": "ValuationAllowancesAndReservesDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowancesAndReservesTypeAxis": { "auth_ref": [ "r168", "r169", "r170", "r173", "r174" ], "lang": { "en-us": { "role": { "documentation": "Information by valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]" } } }, "localname": "ValuationAllowancesAndReservesTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r192", "r200" ], "calculation": { "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted (in shares)", "totalLabel": "Dilutive weighted-average shares outstanding (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Weighted-average number of common shares outstanding:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r190", "r200" ], "calculation": { "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted-average shares outstanding (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233" }, "r123": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "220", "URI": "http://asc.fasb.org/subtopic&trid=114868817" }, "r124": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "http://asc.fasb.org/topic&trid=2134417" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column B))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(1)))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(2)))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column D))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column E))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r176": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(12))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r215": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r252": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "8A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=SL6284422-111562" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269825-111563" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27337-111563" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27340-111563" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563" }, "r293": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "http://asc.fasb.org/topic&trid=2196928" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(b)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r323": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b),(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r346": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r368": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r423": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 4.C)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r451": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(i)(1)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r471": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "610", "URI": "http://asc.fasb.org/topic&trid=49130413" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(9)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(l)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(o)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(p)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r574": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f(1))", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907" }, "r619": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "720", "URI": "http://asc.fasb.org/topic&trid=2122503" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123452999&loc=d3e28200-109314" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r672": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "b", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(1)(i)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479" }, "r683": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(2)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(i)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(iii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "4CCC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80845-113994" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r733": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "54B", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=122636397&loc=SL7495116-110257" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226016-175313" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226038-175313" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r765": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "http://asc.fasb.org/topic&trid=2175825" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226003-175313" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r785": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888251" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r79": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "210", "URI": "http://asc.fasb.org/topic&trid=2122208" }, "r790": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r792": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r795": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r796": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r797": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r798": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r804": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r812": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r813": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r815": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r816": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r817": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r818": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r819": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r820": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r821": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r822": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r823": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r824": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r825": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411" }, "r826": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r827": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r828": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r829": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(dd)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r830": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953" }, "r831": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "940", "URI": "http://asc.fasb.org/subtopic&trid=2176304" }, "r832": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r833": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r834": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r835": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r836": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r837": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r838": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r839": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r840": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(4))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r841": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r842": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(6))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r843": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r844": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r845": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r846": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r847": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r848": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r849": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Subparagraph": "b.", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123398031&loc=d3e60009-112784" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r850": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r851": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803" }, "r852": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803" }, "r853": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62586-112803" }, "r854": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803" }, "r855": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/subtopic&trid=2209399" }, "r856": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r857": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r858": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r859": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Subparagraph": "(b)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r860": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r861": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r862": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(b))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r863": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(g))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r864": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r865": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r866": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r867": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r868": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r869": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r870": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r871": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r872": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r873": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r874": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r875": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r876": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r877": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(b))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r878": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r879": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r880": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r881": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r882": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r883": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r884": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r885": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r886": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r887": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r888": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r889": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r890": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r891": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556" }, "r892": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473" }, "r893": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r894": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r895": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r896": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r897": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r898": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r899": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r900": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r901": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r902": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r903": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r904": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r905": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r906": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r907": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r908": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "946", "URI": "http://asc.fasb.org/subtopic&trid=2324412" }, "r909": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r910": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580" }, "r911": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r912": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r913": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r914": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r915": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r916": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r917": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r918": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r919": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580" }, "r920": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r921": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r922": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r923": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r924": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r925": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r926": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r927": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r928": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r929": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580" }, "r930": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r931": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r932": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r933": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r934": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r935": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)" }, "r936": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)" }, "r937": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)" }, "r938": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)" }, "r939": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580" }, "r940": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)" }, "r941": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1403" }, "r942": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r943": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "11", "Subsection": "03" }, "r944": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r945": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29" }, "r946": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column B", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r947": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column C", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r948": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column D", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r949": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column E", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580" }, "r950": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column F", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r951": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column G", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r952": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column H", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r953": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column I", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r954": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "09" }, "r955": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(i)", "Subsection": "01" }, "r956": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(i)", "Subsection": "02" }, "r957": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(ii)", "Subsection": "01" }, "r958": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)", "Subsection": "01" }, "r959": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(A)", "Subsection": "01" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580" }, "r960": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(A)", "Subsection": "02" }, "r961": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(B)", "Subsection": "01" }, "r962": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(B)", "Subsection": "02" }, "r963": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(C)", "Subsection": "02" }, "r964": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "01" }, "r965": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "02" }, "r966": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r967": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" } }, "version": "2.1" } ZIP 163 0001099800-22-000005-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001099800-22-000005-xbrl.zip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

-?+V]*LCM!'_32$,+BOAYY M7

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

#3@I%&:-NJX2TR4&> M)SW1. &!0#1XC^0VO"X=TE89_&&L4:(]."Y$L):" M9XO7@Q"&3X0+H1M\AM,<@@SM$3&N+TOP$-X.HT;(T8.;R-%&UR#0YOIO=;H< M@64N1,7!B0LI77;A0@8RS!4G_PN3D/@[231')FHGW3E^LT@N;^&GBTHW\%/: MZ#&$+?9/0$;_#ZF+IYU'AEV][XYGYD=(UM?7V6FWM7[??.R.E.Y[KDO M5'-]3FZ.G5$)"1SD0H)_%M)]6^S$&2$#]?KE-7.G,W@? M78^?FM$;O%JTX$%RM//T"@W;ML@(-1EF-O3JM0M9OO&LRNC^'!(Z''T(F@;? MT2".Z<$*+)MIL=R&02;6Z>6Q<^23[VNIXKM65(]YG4F3]%&^\IQ\'NKI A=%B[D5][)_!@^;I7QHDNB)O,!,J3OP!::? MM@QB3Y/ MH:,7.W'VG]Z8A4T-;\=\=U-)V#/0W#&R1\A.S^YUSNQLBT.,@*Z:N(>-\/%B MDQN2AF]Y9X-N)6=\D+0VU^"E8L?;HPR!GW3\<:#Z1S:-;+L>L M=K&.9HDNWO:H?Q5TX,=TX++VO<7+QLZG" "\V6-/^@!2 H6P_YC33'8XO\;8 M]RXH7T$EY8VQ//MIK*O^+UFQZT+,/2XN-DQ3E,OGBL3[\W.J>9OQ4Z:1O\_8 M<(7T_[^31QP1+FW/7>P\C;M?F-C)5XC7V?,*BY7< MW*^(\MX9V[FSC[^'2/L-\7,[9@#.N()1X4+ZG>[-PZJMDRN7>!E7AM#*Y*(6 M_ENLL/ @BNZV3F*D,\ATYN;&<7+,1O'4)NP8\M.(Y7$F^M2 M186?4/C3#T^-<$:HQ<=_ZB*]=_9EO(I-\$[R/Y*Q9IM^J.F)D(<(C1B/ MD47)V]"L;DA<<[6*+7";7T<'-VKMM9!KDYLK%'RY&QU&9L)AJ)-KS8;K'XH* M6ZX+I"[KVYUT,WY^8WE'O\B7ZTVO''!X'C-ISB!"* P:BY#5ES6 0P-P0E,N M;5':M<:6>X[?-/GMU=XOA;$?]@:*4ZT7[]$2J-A6!65J3JEN8L52U-&!]H>^ MSU'(]LBT^^]]=A#O[*Q\O#GY[?W/*8]^D,_SML/).8CMK%!:1@="GNA%E$)U MH%A[4F&Q,&@# M?^"Z;BS6][T.51<66,-#6X[[L]53G./Z;KAT MWRB/0P!-O87$C];KPU+D:%:W,IT*(G34V L]VJW?%0;L],NDTOW=OP\<>[<8 MH?(Q4KV%N/T+YN!P@U*K.MYY1+DZACK[]1S'KD+PZ+5^X6UW^",N3GRL^]#Z M*!IB=H'>T>9P"[:M+I0.940!? 1"O#XVALCO15Q#%=[^Z*'D7CW7-W7 M=WUW>&5=!.U4,CIG3UC#+3F]) DB!846H/FV>^7+BU.)0F<#EBZ>Q9<_3+YZ MMUW@JT0#S[GXUB55&#;>_G7M5 MLG7S_34]2L;%))4[9QJO\??I*PA9T1H2O"GX[?.WQ_S7PYY=JY*ZUA^7MM7K M1*+<<_*>YY#MC2?X:OZ\57H8ZVVKN1ON2Q RR;RCIV#RN>)\!K.#<)CS 30; M<^TPYJIF[*];I[O^_F^-OW_<$Z"Q";:X!.>@/;D0XA'OA*5,INXF_U/!%B_>0;M'@J4LRZM,>O8\D(G8^ZYE(I#*A8 6E89, M8(G93F>U+D5-&[;AQ_)<1DPY/0$V])10HU]\] ("^3-N6^ M?!G]$@)96=[8DTVDC8$ @21#/ \=DVO_U$.;;I2S?\H??ZD$S>PL?E4I$W8@ M(KJGR[3Y[.0QEX:(BS[!MA=G08\ W+4P]5N)6ATRV$G&?+(**(4N\C/5 9QCYE\ &(KT8L+B:4! M%N;#!B\,@D[V,CW63D0][$@ZF&V=S?#/5[YX;!-R?.\Q2+GX'3(7 JAE+4:1 M$2)^-3DW:%]9_AXR],W9:S=9TN'4J)\LXZJX]Q][[E M]%#M]A]K>!_BV"K>I:2RK[/[C.(9'[+<3QB5GR5JP0AVV!0P@257PROMLYWM M[[9A2S #70;WBFX:J^3H[?"D.C5Y3SV I/9\O+YQ1Z@+C0M9]*5B1^'M-0B6 MA'Q;Z!FC(8&6W/Q]$J-;=?0&$/*438\=3Y>Y>*H,^5HN&.6'*2W%KS__ZA-@9Z MCB4[S+)XC@J>:%F3,KK*T1C*(]9:!%T/16H=F3WHZ4).._LL36#S,=>M5)6+ MV>N9#8=!1 WZ?[_!ST,G LDLQ':X5_7 1OWQK5Z?YC.QV_B>O\[I=:AZD!LS M.SZ6OI\Q8*6<<;GPV[M:E8F=2@T-_[R^R9\>P6L>L+[52:S+9GT'$C=D1LMAJ9CIB_:AP3;">E4/0&])G1)?7SB/ MD:/]2&C6A(I^E?M1V?Z8;^#KH&V4DF2\=3KJ=ON$X82M[#E:N6(YXQH[$4O. MQ_-B Y83B*)<2* #H*G)ND)[Y&ST^!E&M [P*@#<)Z9Z"C[=+YD^4/ZV-NSH M Y.R_46:!RGNT=":Y_]UI57^CU-.TKY]&V\>MIT8&];P//*][>3F/-W.9++M ;+4XFH6&CF$?>& 2=D MQ\H%B/J,\/O&7#&2G 4]\0M9J/2]\&3=I,LR'6!2=VLP/CS*Q\52NXFFOF^1'9W73W&.=%&GY/VVH<4H6E$:E3R72U(4H:K.RKB,[\XMC*O?FW#G3H1]\O#FX(#91Z:[B9 M./U<&C%HURED2($Y="KED1'^9;KF5TOZEIB.@(5K-W.BW0G R H\R9W/]N;* M?5O=Y*N::M1*=*K!>_FOXT/Z4S5C4R/8/D6%T,?VJMV%.ZZF%]L\FTI^8/JX MJB'5V#]_M?Y>S9YJQ@<<%W+8#M?_\%D77=69R%^^;[!7L61%Y&S'Z? MI&)V.>BD]CE-<+@0 M#_QV\_W!V^P]\F#(-^XX>&59?JOPM=63Q>QDA:(H4?4G8H*FJ<@9;$B4*^)=P\HJ MG.'(A62$TPCL6!PG)7)USPIR[-2I02]V#EH+][SQF?_M#SK@*M MVF%C+)-%G';L,FN[TO+V0A*!79R/[;,G@>/1!4?W^R]=9DV]VV>2]LC\T#;R M%6W#\NXSV=,M "^VLRFHEO-?!'W:77'_-4D/SMOHS/8U#)3F.[;Z-B4\,J7A MM\N[FU+W97DNIT"#QI8\JBPSJ&]B#?.R/!N,RFP0WI-$E1)2NLFG:?V6BP_. MN8=AX[-KOS%59R?3?T#E61@:(O8;R;9*+, P])&-P@L>9;.4N10V3P?:&5[( M&8Q<-CJ?EC4I(MOH-M\71(QY[';$NM*1HN3T68"C@3[,[Y!/G,:M6O' MM2UUN@IGQUB]R?3 Y 7JI*M>ZD'$,8VVHHBWZNJS@QXV,!? M\V5/T6_;8AE M^CR_58521>LD39Z/X%]P-5A1;X;*3P+*[==&A Y)99U\9=@_%W\DM/;KL\\8 MY;>$@H6?(ZW!_%F;???EV0=?#=#QLUG.*T\ISI\N>.%2D).=SRS<1$>C:O>$ M^4K*54P69(Y_?5:74V-ZRB[PC:.EY$\ZH^E/>:3\7YS_!*G.S!'_N!_U^YS3 M/QUDK7&. _@Y)P7 B6**ZA/8,A]_+8B&!M<%7S*00669NH5R(,*B: MB97!3VFPMD&T!Z@>O0#2$8!$V;:_XU0LN2TKN6+B9YU-_B=W%1CR]4>O,:3N M772+R:ZCM\MR[[$7HVIQP.X/.#J"<9.=C-F#YF.GUEF0EYRI5Z6NB=H\"QC, M[YE_N;;WMP&9.RU-U[2';8H?5-W9<[3[,$_"^Q'2:T/6#EXJ0@(53K4J!\?A M##CPWT(?\HSR+0QP(FX>C)R8?'4$1=(J4JH]C-SM]%M$)OT1NH*'@5C4)J#U MZ Z+]91E<;0J;>V6?I#ZB=HAG6!]7.64RM[#B$)+%LJ^TB_]LQPF!MS M?GFYA'57U=-%IZ3 .]%F:_YI\6J#^8J_= 35R3YOFK3I"T=G$,U3! S:5(Y4 MWE=_:-VO$R:3_FW]H+F>R=YR_GLG]F?NV7JNY>#[0&G=<@_SAO= ME"NS4TJ89[7^GZ5BH1 L<1+G6$XQ%^(U!4I2OMI&"N<_"/7-_WYQ=L%_B1!< MUP;%$%2<=PB@<\'8_@;$_,D(_;Y?\\,W+/^UN9.TQSGU0;*>A>Y[[_.L>=WF MJ>6LGX&E1@99A_L'80-5[RT*:>GMLO$*O=UMM56IGB/=&Q R(N*YS]_I4CIT:&FL9.0+Z!#ZF]L;5]33M MQ9.-K7>\P]1&<&-N>= 2Z$CQ>7]2.;Z5V7-CV_##(+\'LR[+(C> 75[KSHPT M_M:TK1WG,]4.?@UQJDWYG& M!WY9Q?BK:;Y-9CO>T)%)BV@X4A99X:YQ%T=)V5&+$10@Y#XD+[=(R9@)E[,D M< MG.-(LE7Z,O&M=?P^C^$C8A.FTVEZC)4>6\@_X;84@[$%4!M5)&?[A0EGD M2N&1=/^#W2>N!"UHJCVN.+Y[H7: @:BE24/ZNBZ_,!E(47?-LRO(TSE:E3H> MP*P..N Z/K>/"Q'THF#9 L/$M<&-$M:T C/0->M[',B%7(<#(PZ6F A.92B< MS0_.:Q,XUY]Q;[D0YX-1G.AY+/D-]LX[;/-] ,&%' DCL%>YD&EKUFY<'!>R MJN[*A9 <. :#_=;K0ZW@'Q3XL_ M+:S:+ U4O#X%V&8F9D^65.AOUSJ&_[_N;P*!"1Z $0+0 M@7V^C*?E;>3^]3V%LCD9(*;,XTA@FXGK$KM &#R I9\9ZG=@!U$)ZU ""-L" ML-^/<"%.;ZYPHE_\C?3N/_5UIX$?O<"9;F0)W)P8 ^,E4C&TA9 1^(4YY8JD0,-@W*.Y7$4L$Q!;/_F:K#! MMZ=<2)?D,DCTFU D6QA\*WD9)"6\80N.(YC A2BAU[B0[<7L&"[DRTWL3/]+[/CW'4EQ>8+]; MPF@+R-%"3F(:R)8XG_P-WJRJ2F!+T*"L6@AN3"AV@SF/]FTPATASAW=NT!/$ M!.>H?]]'..W51^)/)1P05KT(#N)HQPDNI+G\)$AB$L@7^(@9J,2>QF%9\O"_ MD;*Q,R_W-Y'$1& FL*4.BPLT7*O_LTO2* MB70&6=B<"(1S(6;.>&#_0U!T":4;NXWX[P8 @M,T EO?%SB;#?8#&J+4))*$)=".4T\!1B=.6.6@"G.9MR(5(6K,T\ G8E9D(4+QV$X&7 MBWYY["N@,$%!)1VKRO'DO*2-L'D&N)!&98ZU KCJU2DDUD\/++D;R=F# QSA M4.O=@9&%Y3KY!ZPYIN=2-U@%KMC#/["TB\1W\"$/.9 2<-EMQG:"PDJQ1H$. M.YZS#035(*] ?SJ#A^R*&YVQ*@W,D-LIW$%^ M0QU T//^^+6D&62L#BBW3\:)@#P7 J**,R@DYP8XK62-_]VGRN6,@*2HO4.J MG>S 7J(?-'Y847Q G^UV[$U]IG((W3[XV_BY9\\U4U:9Q>O.;X:Q275Z!:@6 M\S^W:'2I7EG9#-M$-MN/A4,\X:%/VX57[3_GD,H100TV&097 MRUVL=HK&ZZP/[^]T'BI-3QCE;/[Q:IOQT6&#J!O^^?[.AOLS;NP0T<-W"G+Z M&^=<[+UCSK[31GW(<)X]Z>11C[^Z.'+JIX7TW5F4L%LS5:/;0+Q:TYX+T>'8 MG3.[D>L_(M=0[I\_OGO_IT_/'&]\?0?AA/T8BD VP6(,,=*U"&E4C:I;VRF& MK;E%Q"$9K=;0VAT\$V;UIL>)=TU\J8NUB7K9!R\)?YRG?,S('NNVNW*YX85& M\;5@QJ S6YWB(#S]?7 M3E=^U(>/BU,3EGB*_3@'Z!S<2P??5[KXZ;=7BU*U9Q*'LC^ZNFV6(MR_A[LO MLM=)<8:>P=C('O%%93!NT DQ6#*H VBGD7) ,/+F2%4VL@7."U1/-_:1#O?# MRY=*GC3$VSS6,3B4XU( N^1[CRX _O2P+V/>>/MT7ENK3G^<66)OL*?1>Y;W&S0BI[U99>I?V6VN6 MJL_@1#>N>,-Z@^I&HS>1Q43GX$%WT&$)BR*.-V.MIZV,2[ MT'[\7G4"VHNZ51 1N&[:D!^&+/BJ-R-2ER7EZ&8_<-=B5]:[\5H&+H2@S;YE MHD#SI9 6K]-Z*(<12:JSQMV/Q M![O?>&OVG4?<5-A- M^"5<-!GY22\0&'/ 6$4A[3QWE@=9$7MF+:OX0&]<0\+P4^6!G?+AY>VX7DX;GN8(3\7O:%":0$NP2XGG M<=*8WJF](_J)E<@MXX$YNRJ'K[(C!Q1RT*%3;GNV(I5<1*<&3KML$FL)L9Z@ M+R]N9$F@@9],%\Q09.$2&Z3&AI: ,Y'T>HHK8PD"QF'TE5:Y#X44 U7A[+O9 M;SZZSNXF]<@<*S!WFK.-]:$\JCN=K@SP-FNH0_R.*:55=-C+0IH.PU_W^8#K-X^I)YF6?]AN4&__EXV4]8"#J"(QC& MW+@X7<-$G?K>^2AM+>7J]5,=<.G@"FTK-^,)MECW[N'>WVPHWND:.L'DL$=Y MRA5^(@=&0H;J=M%]0)\)-#LQ R@D@X\V6X0&S1;'B*5=,\*"42;85FYW:?4VDZ7F,'H R MK2NAEO$"?7RH;C?-?O PW70V)T>T;U$Y<>?'2VUUS\4=L_T5_77LY]Z%YKY. MO>93!BVJ=L0(6DBS93X@I PDT-CZ(0X MNVH0BFSS'UG7C?_A75[Q<:D$6??VY.?VF(@SL3HG>F;P6MZ'+D5CDOI=8"(F MR"=H/9I:)1W6=O)=ML>-9Y\"C)(G)BH&MNY,?)9QT4_(..A4W F;@Y"+(]3" M14\LDQ_;Y(WU2R9)LXZ!0EN$^6BV&: 0 KY_S>YMO&Y,%Y8UZ9UTL3?IK#0YX7M,E9R+6(41S-3QCSV#^!9F/)):37 M597@:I)CQYCX,K50;JU.D3Z5+[J\GONE?XWCM)E.WOOD[#CQZ>?YU_$(C=9W M3^Z2ZC0EQR.0$\FMQ*IY]N,&"?0Y=BK\PKTAC"I@3)4X50A";=$%AE3FL$A7 M[M>:BVEK^]RWRDWI5N6]2#-W.9*R2T5W9/4$/P[3!.?CZ*!YV??JC,G0<=XV MH^#RZ=J'DV[GZ,6<5''5.T.5YTXNGZY-&C4T.WIERD8B G(WU9[_.$/NKVV> M_/(0M8GD&G#:U1/,=I 8XY@'%-I :-,XT*6)$&SDF2V8U#?+1DIX?$)*M'Q M/.".JX+&Q'O-PBS.[=Z95DF3N_=DCY_7_8)?4F :LY39KQH$4 F,<&"9DC5L MHDI]:% U?/4+8:XRPO&BS>E7KXV.I93<:BS:?CI,5K(9#8*0&!3G/;Y\\EOB M2^ :3 :5MM+\I8?BAK^%%37 @E;<P!X+*]T>?!A4& M0= /F XHO9, :./Y]3D?X#"6!:_U$[0%($U R=LVA#*?#5WR6'/V3 MAGGHFR*>]&WJ2\;DQV[3OJP=@\R#;L %]6P2J/ ;ET51^+8K%H^K7G^UCM5X+&Q9 MZIQE*)4@L;#>]J'PY==EL4LW'<*O+FM:BXF5MLI8BZ6+2HC?AFYRE!CS%T3R M"(D'E7"<'5-WA=[C7)HM!$M!*+(4O@(1G%KZ?3 MMAK\J&[# ^JDQ39Z5H?9+B".BMT6&(EY.JU]8)MQ1R %*Q/@>E1Q=T7<<4NI M?,F[=-71LV.YG\AO$U,L4R[F1X[$F>RFX#:AO.QI#C%UIM[/_-8M4YPBG>X5 MC#^38ERC[SQ&2=+G<90T/_$$ H&TPK:2 %VW-[7Q@X[1+2:9 MAMK"W<]B[X;-."A8!CJ:*X+8)BVN'#%:O_QH:BS:]PA&YKLS!(+$T[8WRHS!0 M.^ ?DEA" :.YT2#\I/ /P.=F03R]:1P''%[%_?Q9#\I"57&2!B_LWVAIMG$+ M0(+?< T\R<1 X57&WBB!KI5\;5;@H,%*_E\-K/T[#_\4J6SMYNH$%Q)M)E.; M3?VBG[GY=I86_WK'%\V&/Q T@_WS(? GPMC?C2;O[R,INI $Z?A#8_CO6%"E M\=_0$(HCDI^.&Y3@J+AMUH$J[Q2;+Z/G;;%RJ^_1\_]>)N%?*9*X5KU83S$] M "XH:+S.[)N:;:HW5%1[>#BEZX++Q-^1\A;QQY,&S_]-"?C+LE,T>\Z6<95F MV$:8*&H?ETX,NXZ9DG?8ZI^USRRKV/;2S.C=70^VNX3P\Q,-?MS[QEA"JKZ#&*HYL-XH5$N4!!1$//5IDKGJ%;]CU6!A=:-8#NB#-[UO MA0)JE6D.K&$'?BYD_H,16YB@R"9P(><)8U&,%=IC?#0Q ,>W8*;@KK(DZ1Z/Q3I> MFA$.% <).PDI46836]-F]Q]_BGO?*%I*>(W9S>G!;VXPY'Q8[U@LHF-;I'-4 M:6;$_"K\*_^:V?JH,-./PA.F4:.^,=U/YSL('4D)AY3"6.))QFIUQ M<4"G00[ MM8\[DT(&B>U2)L=HD\547F?'NGT\EM=_1CLD]8HTV7!"$LI2W]U M[. 3*.H_78#_3\^O)PE':GZ]ZL?OCS>N_%3G"-IP(+"J"+E2?5X$_( M)_XY]O0?OGJ%+?A+.+-N[<_;L_^T]?\0LC2;6;Q_6K=G+Z4<6PN7=IBS.C^('O.*V8=,=(](?V#= M(\)P -1(2UT4!*"!6XRCX,>1+1R%C",-1$,Y;!+:P&3J8K8.(5#3(MSO_8TW M6DDN,M&NAJFW^%Y#3,?_GS3]MTH3(1E+KB)5+2_Y,_DX'R)UVW7'B"T-@ID? MF.WC!^** S JZ=2HVM/U;_=F5E5:GDW6[4I(=X(=8O>/"T&NYUN&D"IZE_AI M*XP3;+R)-_,XVKD^';H=4&ZI=FUXZ0GI40EI=^M.$>,]MKA)Z;/W8^M(H+8= M5DU<:J&I,S;1B"Q)PK0QZO)RT_@C5ROBM$-LMG7"J,-3E-NI;(EX6[<5W0=F M>4&2[\3?SSZ)=_\M><=!9PCLZ>DSNMM0N"-T7((^%R*-0IR.9_XV="FW;I 0 M-'$U7.3XC>D[#F'>YP^O&ES[SR\/&]Z[GO*05H5G*>2!?G/8 Q+-ORWN6S(H MFL^PVQ>^S)?,XZ5,; *I9_.Y$!>%=0?8_;+PR=0'O?K8IA*I]6?$,GB'KKC1 MZP&#WG%"V\B4@M>:8E^;I^+GI?)W:8X=80'K4BT<@9_T6+(SKD$K !1_V!)? M+@K: CKS86]-#E.#8&ZTJ]D/OQBQZ%J&V55WZ5/F+U2;58+[/J3G]LIU;F_N MJR[%=,+*<,VP42PCF%:X6$W3/)X]TN(A-MCPWF?D91'1J^K2"/)SY"*]A5]IX-O\9"=XY1 MTG!NM(DN1V&9YL"))RF KISW%8Y!,XK$V3K/U :6W8R^Y4TC;C'*9&)D%M$7 M.A^)78E/35175S?X<5V"A][+.B3$L.-"& MW>#K+F&!H>NIEA#T%1#+'&%G8+_DH4]Q()%TKH&20($/55P5@ .N"R]^) +L92GXCE2H-"G.H]^/,'? M :=]UATSY"09ML%9VCB0GWF<'7%,-=!=M (*N9"X4BYD^@S#X/\B0E=@_ZN] M[PQKH5A['% H#,HXGP%49SSF4I M#UTI@7>P*-WEG\]B>B)9"@Q;0(:TG+< G]_=4*5IJP( M^?7UK\R>QOY9]-9N,!@T_2NKL#^+CJ]Y_AB:COW3C-K]5>Z*Q>!=FV9Q?YG2 M4_^#W%S%5 CP^6\^_^;S?Y]/C_OK"3N6 VZB;Q;6$;M>D%%!)FTK;FQ@6Y5< M4!R/;BDY*FLD>^3P7=[X0FP!7Q9OQ2\0;%W ;K+8'$N7\#@7+W#$2U&#]4R( MH>45%D_;SZ] :.^%!Q!_6[O_GQBMJ&?!>-*SG&M 3'%U2G$T@3RH2Y"Q)-_5 M_GY&YH'TSL50_3$..E='C'DL*9Z*%C;)V[VLU#I=)MH+--#2R0 M#]V6;'OHPL!1'])ZNOIS*4]Y<@VR:Q0<^F4/"-#YIF1$4>3R&$\.)1!ELPT% M8LXL#6<^CJ?'/?:%"JUM1LD@*9^FF9]O/!VM#GC4ZV=L?ROX0)FB@N@K.=\C M#[8]@EA,"B0O?N Y56/;H!CSL\!OICYSEN:VKQY>$(Z:\!V[^BL? M'JG$B$:[4UW30Y<, MX.J<4P;2T1XLQTZ,!@N?R#M;+N_'>$8@IG]GY%FMR>Q-70*=48O#D7NL M-$+RZ@M=!PV8Q '-^35(X*N"756#QF8T MLONZ9V2!W0PH9'Y&JXXU=L/"23L[CF'>7M$SI=R/3VZ&:YX^I'3>5FS'T\ \@6B+/IXG?Z4-JP@/):6K[FFR8[GMV;R_KX#4U6U!,9\X=@ MLC\@5/_%G*KP^.E_]H_7O]*_V^;D%Y>S?O%I'F80U,\,GI0K8XQYEGL:> !\ M[L(*$>T8<#$ T550%&"E&V+^9M&8FT\U?^K>8L M+X:ET.T\<50@,EV$;7,BZK ].BD93 DZ2OP+5LH"P8CSZU1PZ6 <:(Q%UEFJ M?YM\N_P;CA.;4IPZK6&3T)/($/G:U%H(5'"M='AR"730\B[!0G#*Q#"Z<_PC M-9;D0X8G0B)Z4^<@\N",1O.PNDSQ@L+)FSH38=OQ/G9 M8)#K-TGPM-@KG+WKM^;P(M8O=M4AXQ30=H!1$=IR$!U(^XI77AAXOJ JWTC$ M]2I>: P_;B_/L#EZLU[H?%&!>QP6V",QUN4LA)E!U/@TT#,R9DP([WFN;,&8 MXYB%#+)BCZ+-L(-8;Y+]A6/(-U<#^-_?;+ARX_$N"*RX]O_*?>'_68K.8^JS M7 MNQ#Z?4->5NRMFJ9, GKYS=NIW)X?L'_Q>"1G:9S$V<2_1Z(]PDG4&=Y"@-ZL M#4#O?!RB.%Q07Q;(Q\<^M^R?[5)VTNB/-1Z\]U)SPT'F=DW(V10(L"(0K$+(M8#?%-]DRINS4Z,ISUZ\R/8=O@6!3HOLY% M=1E29FG=%8SI0/LAIZ0<0]X>R^OMXH?$P_U39WI7MY\DG&\NWQ)7\>IAQ0T) MZD04*-8:)*#_J <;V@U702IF=$/36M7B/+H5'^S_A:4C4HB6C/L&M^]V MLHE&E>1#_$GR+G]L4^]^T8VM*?ST-0@MC03ZSG$EQ@B5[#QAQ[FDJLCVYZ1H MWXNH\HYN/C.BR57.LM'HKL!&F=GE)L'SK4,W&L4?7A3L 2<)]$@!AG=;3=G0 M3D,9(,1SZ"=T!_(%Z+KLJMM569IBT-[=+_]Y\]L3OGO\ MM/[XR\QDY;7/SD'2>;PR[_+(8D \>5:!3)*-'NHHOKKKXM"SD%C[)Y28#07O M;(6;7:L/7$(5TZ;D2WN'*L'(,CJT,I2Q["L4&&R!3]%&\X;6()NKU##CB!<^ MSKRI3R1!EDDL=C$*E#\,9"<<\YHJ7RTPP_3""3=88W<,:QV,[Z0%?^VB=)?I MC'_,VJUJXLEM'+2HWNCKK(S;/\.B M7A>\#'X$;:H!TJKG:^85*@AA;Z7&9SJD'9<-!P@Z#Q[]9FWY,C7!Z47"\:&J M'\UG=:*K'MN7A!3F%1PIAVS^F$EX,ZY,D.Y<=M QL?Q?]U!_T]_T9_*/_MI) M924".F?8&>.M0_SLIUX^_,*W$W._3ADM3B2Z)](/VVPR[-K MD&_!*]1T[/(Q(AAE^U87K4&>#'K,?8+$@>$W5'\-4JZW!LF#K4&NG/K3LT>? M\4GA>=)--/A%T=+XJ]CM_#N+5 K%K65I@M@O\"B4;NT?5ZIIWO'ZG9G82+4G M+9!WSU 8.UX!AOKSQI'#_ZA+<6'+I1/*@O(.6,'&MA3&[HFN)QVH.)A%G1GO MW+(J@RC$L7[#408$8HWCB6%;Z\0#T3 M>]#?,Y]B&:"3B-BDFZ\WIK\2M.E'>RK0)Q#Y"1H7:S:9)ZOA %2Q*F;'VON- MVN'R5IN!;R@Q]-$7+.94]KS'05']3L>(H,$Y&]NLT4];P[TR=AU@P,0;P1^? MYC=;8+DP"EH)\&#%70V!R_.N *2G@((#VS!%7Y71T<&>:EC"/Q**[N\L/U!Y M,L\F\-+9^C)WR&IWZJ\$SE'@)YNQQ.D&6K@[>)Y 0BGO, &( N&[Y%=YC$7- M^Y*AT@:B.6Z M8]Y9Z7_8$SD "4HK ^/%Z#O6!SD%J3'OR]+J^V6ZCRATZ$5JJ-VTAOUV"B$K M>-=$Y-%<@5J3 '*M&6_,?88QY:H7T#++A+;/G0P)U MGA7NI,(IR)G*J%%7.IJ+%/M)[FLQCP1DL,(GWO_/V=;Y*-UF#^)^&!O,]XRUTWATB"_^<<#N]Z\#PQ:'L MG-KP?4T?+ T^UE%6<87LJ)2S"''?UC+%\#K_@$%T^<$1'_?K=559UU%^*TFI M/ L RCTO>(\C/&O9@F=]9>@#=>G6@1\,OZG&*N4,Z+)J7K^9O+3=X^O8 M8A'W>+0KIQ(PN<#'PVE%,W*@ ^SEP=<;7*-5@26:BD8';)N5 M$C6Z6B(6 ?@9/(UY9MD\LRFD7M]V(L!%/UORVKU7'P^8?H$'4H'=#FIN"$(N%;[0XF#7462*3EI1I[AYZX29M^=M;SW-296I^0 MI"FBHR"*\U'Q[W5K!+ MB'U.I[JJ&-NFIM&?NRK5ZLX^\>3>S]MFG:((N5?,*S=J MT-',PN#^<[4F_R))>L[B0!N^?0TR7O$<.V^<\ZL1\90D]\/)N9,D3G2D]TM/ M#K0,&XOWA=A'E?_*(DH^;_2%]*A=S+0,82 7SPE4)!2*G /)0$_(3'^<@M8 M5A>B=H OX\RKG,"R%^#T5!(2MZJ-^W46Q/:SPQLXR:\'?JG[2*Y!:CR2[3U"3:PC;9E"!(^=>OHV MS6(UKGVFB:'5^JH4A%WJ. MA^&G$9'50%VKP<)E()LA?!=](59Y=::HNE%]08FZVTT]:\>)LD_%3*7\-NS> M-VN0 QCJJD<7"CCD2L-V0X4PW=^1UPT328$HU7[8#:*;NGGPC %[)@_5:E_Y M25H=R7%0&?B= -OW+"MH:GN64?,"[ :<=9R: J_!,=/8FV;)B_Y<5R1&&O!C M'SV=X<$.;%.)HD\N7$,_@J M7C=%;D/FS9>'$BH3#V9"<6L0OXR[) DXK1S.8\EY$O652"\]A3'II@H=Z%DO(VKAZ8?+!UP-<8BL&THHL1C MM#'(D HODF68.'DR#.X$1.UQ[R__JF"6V(:HM;VBU36\C!!02ZS9A%4B,62ZR !EN$.HG MU1;.O4]7S_"]=20U"Y7#)W#6BU(B!.]!D(+GR7SM)-4@4N%A]W7&!#L/[P*2 MV3 ?((;38S#CH!96+W]@A?-BGO7DDHB+15]BQSZD8X^:\!-LFP'VTPX< <_/ MQ(F (*E@L'4+OT!_D@QC106223MX>ORY##KIYC4S5 :*:7IS:49?TR9\\=#^ MFXI;5>TF+JJ;IR0YXL4I.YT4Q^H\RFZ@I/Q7VG)M;G@U.,HW232U/]7[C_6[QM2K[ M'Q7$6PYV*E&5YF?$AU&M2E]RK^7 5+>_9('Z S M+X/,1'Y66(4Z!3_=W:,?>==RJZ2W*#)IYHV6EYS7ZC"2Y( MG =8"?)*M]W=4R3#JO1^CAY+;:BX>I*R\ GDM1^]+53 MG3]'=_8>1Q48Y5&<^S6KZZ\YAE6=_^.@<';K(?YS8RUV:S(7'BU\E"U'4!+] M>2B2Z5WE,C+PZ/F''.&(2]MAJW-UR_)WBK^J:HXP:Z'0>0^%L;'L/0=RKV76 M9O5K*.OJ/M=*L8#H<80%HHU<[6#$2_QK0LCL]E,6IQB.B:UC&K82G),*H>Z3 MR5M/.4K;*7V\) I17";Z#"Q/E23J)..WGRYSZ[)]4#U4^_N# J?C/?I#YVJ; MQG\0]_9$_,))V];M."[UY,FG0Y0%-E*3$LQL*;CNO7YL.0VTOEIKD))+0"SX M= O'D17K)NL1_9]/^1L>5G[K=UG MS[V?(WQ'#V:3WOYX<<:!-O^JMW;!>^;[IZ9EKYITG,9R V>J#LB.6H,(PP7O M/J!UQHPMX9XP0G?]Z'?@SO&"Y>'G>:Y3:$FSX:",USN& MPW>-IAOAS]K1?34D>7 ][\-J0<\)Z ;&PVFEBE',!+K^_L^O?:2;6:,9M'S, M-B^OPY:)9$I?_C?;VO2A@"^97VZ3FIRS,_.9T7PGQ3;LNJ93. M?E[\SC5'!X%:"[J"-D,:O[@.'X\5,X&F(&1]1^K@4!YJ!+,[^%1T0KMB%F** M'%R_6S*5Z;]($Y!IL8\MW*4*94>NG@W.\IQ(C'U^_E[N+H-QC8!/.QUR[7RWRWE=)W6@ M '4/9B)7'7V._1NXID)?08Y*%G!B&+'H242AQW"KX@S:HF;TZ?N ^W/^@]4& M$UE3>W^=O"^PEGKU,%-F@51GQY,N80AW9Z@(WJV"DJ H(0XLGPRN&9!NB3HR M5+<&@4R%C%V?'K=Q4.1\Y[J,-^8(O4BC)P> R5 *@L!5K#H@[7!?,6 MA(R.T!M-&2EH4Q [I@'X6:@\S[:AA1W)?)M'FF@ZH;#MRXVE.. M4G&#Y2_-]^9WQ$D4"]K@DO +5$IA-Z+!;A%$(ZXTZA8$;^\KPIC5)B#0+K[O MZ$A=B/>*0[F=Q2]\NM/0MT^9!KIU)M/N4@SS99#K\5NC0K&01 M:X6![4!)'65 DV$R:'/_)F\%5^OFR3?(#=&:N^[Z?=^T)56#R-R)QY!!L$-E MGJ7AI72ZH)-<3C],T<+5_ZG3,P SX,SRKDXL0>[MK_5RYIRYPBELS)';NBRE M<9<84;PG*Q]BI0"8"4$T F#-#F;"9&CJ>+NH/8]F.,O26->W0:[3JB MSC9,_HFJ:S:+V4]VTWCV,_T*5MCA,(RE0;?S*O2>"+FGF7_E=7@;N 4.,O.XRL!G;R","SJR-G<3:C(,0G2H=BYS8,W-OI8_5U]$9QM] M*Z ZMC8'RM-OGG\9$W/DZ'Y'-8.9-J[M>@- 8B3;E9/$?V"U%ZW"+ZXUW!*$ M(+AZX\0 A!N O5+95R9>:!^FI>"1[':S<.4DKU(&LQ)P+?.]< )Z(["9-EE5S3$Q85%57==U]DO;<6=B[O;N/ M3+Y$]XA^(IP$1]Z$#3"<6&E'U$8QL0S$5K3Z^T5#XC:N1W2& RNM_VFF[6!H M:[\R-C!!63WTWM@F@N*JAP$EY-^#XWD3K[D$.>F4LDQ)7>7%;DV;^ MQQ/Q%EW6AX7E:"26&VZ<1,];Q(,Z2FKA$[!^7TM9>=WPA *#0H:3 F,T;Y\9 M^3:Q[+Q"2(5WUL41W\;$N4#'W'MG)QRV]^):L"&P"2S=D%G"-8UNYG@!GTMZ M8NFH'?/Z?F5DE)I#L7FN?6G*[9W^J:?33_N*0!6S1&@\LA\X5B?_.48-TV/F MP9,AA0J] MJ5?@-'BX(A<=>FY;/#F_ZK&0W.&#D MWQ0;+'ZS9N8&Z$R-]<-8+E1 >Z4+-DFV!=QH:Y D7&U4LI7B%ZR8E<87P8'! MT*= B#9>J[ODF6CNJ'I/&>7)M:( M>Z:;^:VRI)Z"ZBMGL"CH2,-#>Q'-1>P M9>6XNNGY@A#*X9U3EUQV:.=GAKUNN_?RL$4@9--WZ*SSXEG)3&0P-H?HOJVKY)O/A,<%2$ MS5RS&7G/^TZQ;S0U_ L3'*"#ZW9R%8@UEV+;G,[SGUF8R]7C6&\ 4;00&!V7 M7HO3JA-N#3Q(I90H:-N^SGXS+@N=ELFZ8@5^VK:7&,=:X;SG%\&#$6#0 ^/I MSWH+MW/"(TG DXY-.[<&2;: ,_CBG"*87)T#T<5PSC.V.3]P M7U 04[E\Z"AGV^4P9D>Y;?-YFPH07P\L=K (9"KH%R;V69F!UKWT=N22 D^: MK4F5JA/7N>$(74'N>^M;Y9=^;2_I!F?B&7FKMP$2]MRTR#+UQ1HR0UZD8>?==O\%#9*7]6TXJMW"%K?Y2/B#=^-I^ MCP;!*)9U@B2/]N:7M@IC1G $&!,:QL(C@'TE"^<(1 _X,_;*TZK MQ]"E'!1W+D\MG;37$O':*SRJ&)?X*.?"EKQ2SST'..\K3QY)$+O]>/.I1ENY>BI-M'4\0EAJ3M!O<=?//N,HK3H=CL9.=8/^0^'&ZK.3*N'-+]\ M=K;W^>:IYVY3$=DWMCB\5M%CH&[#62>@E$!P\V&KL6U65F:8X1DI-KP#+H6X MIUV_!I&IA1DF2K,'J] MTT8V\@K/JZ5PMJ6+W-9=R\(O$A]MKQT.O?HL[NA5@6Y3[G+DRSH/Z]P*_?;* MNYLJ)?0"S)8' '6[5(N(,FR;/BEH(!FS=QBO"FID%^FVCP)K-#^FP@%M''> M(C*C)U*:N26Z&'G135,2"MFZ@:FJ"X[H@0Y@)?-DI;&3(9PC_!=#]$\9*:VP M^9EM[+'$2,0FOCI4) MAHP3;;7@J;,RF#5\0BG/DXTA50-8@3048K/W@\[(K1"+,8S3L"'6[,GQ^['1Y&JEFD9WW;J[G/>3=2T4%C MBMKL8F:XGMF#\O3*P3>-*BPMBU0;1=Y.]"[^<@D'V%B@Z$NB!]*>(Z-VQ^A/ M*?AXSGCK]2AG_4Y['+VR&[8O>)R_WG/C(:F!VD&2^B)/:L#R9%=. 4-TF)#7 MT0BZL[@G(#UF?W#LDC)E)K@A>-D+82RT)T7&5/5J1.^2AMIC:"HVA*K*.P@( ML_UF\8M@]+7Y$3_/Y*%1QQI$@1A1!;N%K5=-*\8&=Q4A\TH"\OWT.Z-?#:7] M?D'JL-+FS#V%Q;N6G0R9VO? M)+F[B&C$BYBP!SH1@(X'TY-M1!/NPHU_[B;5P>)_4I.H\<9WXQ"L$CH^4; 5K<\::UL2 M.FI\W?#6#W%+)?MT!F*_35W=3;7;1E@9(9N>;S&/)5;_$V>!_E_1,BX5\6)E M$(ZQ^KXOT'CQ>FU&*)O0T"P=,O*\^JV\WWW_G)9J MR=HR1Z(F0_!CR#0B6EG^@N,$H\SV2>QQ7<=OR)(!@92@ETH@O?9,:@4<6=GV M'[Y-B"D!]/U33$N/=[_7WG2.:-[2LC%5=U_T5(!5\B);_]M%7'_3W_0W_4W_/&U8F_@O4$L#!!0 M ( /*!3E3Q&Q!="U( (9@ 3 97,K#IR%74E6O -0#:^'B3P#& GV]C MV]CS;VR" AM[(4%! 4%A(6'AOQ41,5&HB @+BTJ(BHEO;-"1I(2XY,;)QDW^ MI2J_D(" D+B(L(CX?WOCM0"RHGPI?(,"?!H ORR?@"P?KQV 07T4^EOW^(!_ MW?CX!02%A$6@;DA 7ZB3@;HO( !U6@CJ,70U#+H.",H*;=Z^[XBPG--E$8V; M\OO#4Y^+:AZM:E4X/4#7,KQR*T),7%%IRU;E'3NU=7;M-C(V,3UP\- Q*VL; M6SO[XV?.GG-V<74[[WGUVG4O;Q_?VW>"@D/0=^]%/HB*CGD8&Y>6_B@C,^OQ MD^S\@A>%+XN*2UY5U]36U3>\>=OXH:V]HY/8U?UQ<.C+\,CHV/@$A4K[^FWV M^]S\#\;JVL]?S'7P]Y^-1RS?E-/:'B\H?37U>U2JF:7B:KG#EUH"XHI8190=C8VA_&]E_;6 1 M_Z.1_=O _C&N"4!2@ \RGH L #_+__?*\5!:K:(@9^_?X6=_Z/B M[N!ZWB\G)_:HK:2OA&&-NL)AP30T<':80J"?J91$KW7BZ2=AR5A9$"FY"L:< M OC"&($,C/UK&JC+Y61%SJQSP86$7A =+=A;[-L+?1 M=FD48XESV:Z!^G*M?M0DRPZG/ MI\_HL*AB>KF7M2?OG*'-^<:P84+% M4]<<;5_^4$G65D=?5G/;7M4*6_/1M2<\0&@,=*0B^=$HKE@RA;35]NXS],HI M^IXGS]'?W89R%B<>92E6H8/U[$U,C5*ZC5N/_I[XW+[)KO($]/P>L^'T$/9F M::[$,&L7^S@GQB@4+W8>XY1'M %CGKGZAFPF4K<4#J<-SCK@#TX79;M6A._Y M%ILMF/6$[PH?JP]7//_GW-NF+RO/ZQ_L/:.W^N"4?= M)-%O(3MQXRQ:R")#NQ,AS-X!W@PM1(M0/#A MOG&D[7]8=,K2=747VXN3P0,"".-97*D4<(VNPA67?3[AX7M18.39.] A]&;E ML5?3/HUF2%=132713P/=$O9!RKGCL@[?DE/X#L/>R%T\[VXO;ZKDU+G6W'5N M2D#STE,=BY-\!]3"BW_I>]H/7'9/]#Q;7YOXU75@V !<0G9-,019 *< M;@4'-5<^X"<-F)LXZ;A U(0$#=7NT^1&'T(VCC0I%?I&)'4G0(5:N;1&(4WH4D6B"3XX)70,);BR M$I1NNX>,]GS_'C1X,3$^<^&(Q31G9NQ.1M1%4D!=;?+-.W2BZ2.)],.P!BZ< M 1G(4@&M>0[,8.AV!"LKQ?S4%4,%)7J=:W0-*%NBG>[32VH7.L6GE4U'C&V^VNF\TNY#RI2T0P;Y%"+FYA]M\LO- VZ M29C=#]C;_NV!AK-KVU6-5P!@33S' P03.2FXZRH$T$2)"*OU^-ZRLJF7EGN; M3&QW#W-I7YO_L1XB%A!2W(W*]*?DASIXV6RYZBT;+G3DF?0@"=3B 0D$<@'V M$"=U*8@$[K9M*U=J@\M]?A^ZY?5 MO2,S[.B5+T>E%ZJ5F%"@:^)B=[5^QU1 M8;"@XGFF@63(:/^'T[CK7=Z:5?+L#9PFGGPPP.,G LY6WLHY> M1-=_MC@98'B1H<#,-5[]7>EW6])$2GZ@YFK!\\];+B7@SR"-,=Z<'*[R>0@% MRB$O@F;;P9,UMQF[)VD[AC,SJ X$&0^[/^?PS.B*ER.#AMI9*!5[_I.3\ONR M]K@_ V##QQIM"J^L%IL25%3_L'>CKP,+41Q$R;^ M^F9?R1#L8D]-R">-0H;IX@#]#)4'L-4DR' )+A$FRC:L8&_KMU1Q_4%2V$:W MD_56-GF6=7 MV'+Q7#'-0O!HCR-= Z'=OI+4;#KT[4M9V>:MSEM=3E;'N692VC]IV*0=K=F; M\JK,YSML(#FQ/L^8 .ZC+L"BA\RQ&CEM2HRYS3:3;BC'V@A^:<]9A5F"$)Q, MY+A8#V)UL(-YXJ.75S&V)EF4$G+$-_'/*4+"\ MT:-<\5&6-+97>;03%X-3:!)@5$BI?X(_W#YB+OAG3VFA>UK)GB+_D09$P)T4 M_B&+VI3GXRJRNIZ>8:TA=WTN^Z\WK#NU2OHUVE^_\2KR2WJ+?(/)R&C]H-N, M^XO7'Z-VQ)V5K'AQJ40D0I2F\#L1,L!!>M3+=.C_;="8H4);[\1M8MO2A8LH MNKTJ;;!J\V8%#Y0+8V>Y5LAQ5'E9$0\XEJ"[)?>72D/4]J01NYXH/6^!G]3/ MJT.GZI+^?/AQD)PA8&VT9ZL:XJ@H.?E>HG' ;K?9^N0S#3[Z7ZW>)%X_/6#H MZ?NZ[^-)&[Z%;+8.Y%7()@?&VH5(YB(G RN/?D5KLW_FJX79WU^Q@IF$B_T8 M192WE,MX?'RE+N'QC4^*&;1-G:L-N5C"XX M3\;'CS1F/< :'BM\,&P\?33 JH^#KW!(6:=/;[VH@S+OOO)[B12HN>8J\-/6 M'9IT9=BQF4U0-U*:#*&[%GQ!86#%& /&SHR@DOA42O>5X0":.JSYBV9,GY*0 MBC^SR_2NYZW->Z5[D2_K0YB'$FS"+)F[!CQ2FO8+\STB5]C>0&O6826QHR0Q MK,64%Z19'F9.WKZC=QIZ)WG7-% MQ=G+/-U7 8%Y>P)&%.K5*'<25D7\,+YL1(B>4'Q7BLA'.^[Y&NJN6#LJ529L M''Q 5_"EQ?C4QX=;<@L 6+WE@<$FMW+PXHHCW33^2G^=FQQ'^FR.HWM[>,W3 M6KV/JL&:M_+0FN58"URK'(Y<3J*?Y0&@KDLG*@XO"CW^>(I7>%];O-G=*X0J M\,Q-'',VC>IMI_/GA3NPVA!T\+/% C.0\'@%-"%01I=2&:8T[:5K%,)8,C.* M3FK#*_4\LZK_0WC(5I]XU;44&JSI.G8R8C@2U^,<1]LJ\M'_TGUL/7J%&0$- MJQ0C0/=:DJI@GP [Z 4=YVTCN(*]#!&*=!+;@*P;[^=QTOWLNTQH-HVOS*J6 MR=P?.&'3/=PF]^AB$5>*!T W>,"^"^VSL2U^+ ?N0#T6%MGNU=F8F5'3=OY. M9OV,E03?L:JO*Q'"M]=G)4AX>FUPC4>4=N"[ZA;S&\LV6KQM!_M#&= M."6XZP:@?D,;/CJ%!UR; >-/(&*QL-!SW@;+5\;# KX_5U'W*7=>%M $;,"F,WYV/RK&U5Y&=_\%@8C)GK -J)#GQ/ ;[PZKE6J MR9.*&D-23)G(Q&9])D:6EP;*7]IZ\69$?<=H3>Y MKR>GA)Q]X@Z(+$1EEK[TO=%Q\^6/4Q=L#RE%V^UT<9.7D=@EDB(FH#E25$GL M TT13!HG#A> FE#R8,#O8P5\\()8DWF85,YQQGH;0L+'S^>9WPWKL$";#NS7]-'VV0/OQH![SY!-*2MJ2D M)(?\.+C;;C+!N_/ <$;J49<9^5,B%!Q;;:5H"KH+?M'ZQ?B"J?*=47$P?UARCXX&8(/89P''&>\K'IN_6TN)'MXN"?W8(@PW,M)Q]7^FO,. M0.^@:J8-SA%GWB0Y7->E;:U/&SDORK'S^MFI8:;@Z%J%HN MK!Z*T#(XJE('Y =)$)$2LN>$X_Q]+"4PY_9V2,=FKGSH>37_IWY,<>SCE?W/ MA):&/=-VNMB;Z";KMP;_X@$3!5RQ#$8\LQ0:60C8P]1G$)9R]4?C+;4N3/30 M\+&-I/"1K\>K' 3S').>H$("%!(.NUL]#)_BFS7[7?UQ%?_:^YET'@\@9^&J M#.*@_[GP*EP4W!,OB[GVFC%=&6G]Y;S->Q^*Z:!6FEC%R[>Z1HYW[VP=GKVT MU8WO%&'/+00Q3PZ*#P%-QRB("15F*IA8B&NU;?(K0FLRT^I&+C-0D49X<3>) M)^FG_)Z8OXMG13\I3-JUIY"8KKK9[D&!G<)3TQ\6\GQTZ44SZ!GOCV=>AL9Q MF0VIJX@K&"2GI)(=1$F&'2MN%2YX"3I+[:@]^^ZHLMVC'K,>@R?U1Z^F%'6] MDK6A,KA=<+H-(IE47<26"^TDT$\^X+P/,)Y6\:!WOH/4F 2RC_[V-$KNAVQC'F':CU4Y@-C>,\ M#Z^?C2WQP8UBP-U3XQA9V9,%<6>= 4>I-Z@'T>+W+--&27YM2GS)>:Y?X> MU3,G.T_D]GPK/K?[$P]X=>>4R%=MMJ((966I@"['].'76$A]E18%] MKHHA]3XIG5R*WY1K0J1*O8PL:K?*I73Y0G&;H2-L&O(,=1%)>$1:XF>(:RX\6,QM!IJ\&F(Y7( M"S]&)^YUO?,(J# HS':X\3'X=>*CO>2O-P^KER#S2(IP\H,%,F+RU0)7' %9 M?XA30* <9SN,.+8RDB*+P:M^ZLH,G=R,YF.VT'DE4A+Z??]H^?14X>(8;@0 M7-"-D8[[^JA ?7:+B;U6:DWGC!S+#4+X3>8AC'6N>!TE&9(1K2N3I':\9%"Y MTK&8$TU#1@2Q\[XN_#LB_'P4!_V(Z&UNE_*L=?5K*1Y/6G;<1_;?TQ%8BV1N M@>S,MP![7=3>-V':WKR)4Q-D$=J&5*_-F;2A+Q=1#CC/#MI'?4_7'V8\F2&W MHUYVQV[;;[+UCZ7Z.0.PZ-7T-N^!)[_XYTIJ[=+*T*'^+2%(:N%[S\.]8#5B:1;PV*QNZ%^ M#'GCZ*[%.']]Y8FUM@6F&0PP_3!_-;9V[65?D3GB+J=,['';;5VQ!T>.+5DZ M 25(4/L[6]:6ZK)X!((=&%@#[<5&H.HJ':MLSYQS6>TS<@V@QY[LS-Z[& .7 MQ5%MYZ?/DJPE8I(/*\$<1&MURD/EY4OC:R]K-H6VWQ7:3;IR)I >O[2Z)XZ'X?!5B=::3D,(2WH [+(0W$6>Y_3P =AE,)!.4_/;_: Q\5PCJ MS64G)0?/*KD]JEN:L&/T"I[>/A&I,M!6F@*WFH-0PA'%%56C54X(4!H6.:Q] MV E<+3,*XE$/"#6EVP;N&&Q":P0435B^T3>G%MLA"\+;A^R ;'81B]B.G\)H Q@S#9"+ZRYG^J. M-#SD>-_=+]%T6V*I<298T[6IJNI,@\("KMYT<8WA15N/8.L6L87!1;P4QH%B MH.(&1IY@J* QOC>CHB4>7AQQ0!Z2U3MC:V:M\3L.TX"1N6'[VNDP3)G;C:,? MOVLI"_G+,>PV7"O"T@1\]^%>;7.Y971JP5+U"ZTQLO<"*C9.KMJZ:RHQ^D)"N.N,%B>%RP>NTZ+ZED08 M<,I,!K525DU82LD^J_V>OVFJ-U-GU8XQH55LI6^4EIE![-V6I'#%64N 9@!J MF2[V4$@1,/H9Z4FO=D)-4JQB%/WD0J[OM+L%BJI>J5'*G,V2%W<8CBK7" MSV*EV#C0F'7$>WV"U-KW\![VG6(6QK_..^!">6?N+7EXZFV!J,P9QX2*S=;. MNW^T7 Z'/V;BZEQB":A*4!>^J$1&J6C I#M8)D5$M3-6YSIJ_RP_+^I#!>@6 M'1VIJ&# R#ZN274_8.J6FK[P&CQ;M8!^YCB]L+MN".YM$'&^,X;FKO-Y+'#9 MZ%K3%[V5JTYM)QZ6\W?=L@IT*03",AB1S'Y(P@/@"[0N#4;$;9I3?C6FSYG. M6%KINWR]KRIPN3Y"7[^'/_]NOK6QS2\$CYK8[CAX@W2FM""XP^1G:K7#%A2SE%' [([D=+FWD-]E] M(JWYR?5^A&]9^]>'M'VH MA#Z2F&5HQ[$=BOK"?"IFYM<<%1]O=]EK7[/]F.HFB]L_GTE?S:_B=M!P?Z3& M<>1]/$#9\J\GP-A_ZVJI C'A^G#AH))+G;2D@^:^>G(DV"]B;>W)B>_D 3]5 MJGE BR?7*.Q_.^.K^G_8=6/D6=Q6G_.8QH2)C@*]76\S I(0"X?5A!1BA0B) M7E':'KZ?1$ZUJ'A.A4%!\0J#P!%>)- A1I((^#NY_N^?P/Y[E\_]'/NUI?RH M;Y9LSQY:5JQ)0C"U[!2?M?Q_N8A\(-'/$$!]^&(H2X5]O(J3Q'9CG?6Y*,"H M>']=FZ$4F^/P]DM.ZX1?L09*8T*LX8>@AL.4ZIUW/3:TDE96P#+O)^MS'TTF&0T9\OW\Q5F@NBVT\0$0&BF2[FBTP MC(AJG=F=$WPW(ES X+.$EF5#0 _>M MG+C7PWP#Q5\%;WS5:.OX\R^6F8,G8N*VGDJ^W-JN;5^>?-K@W+;F!2GIXJ+/$JQA=1#ST2.D\9SGGI82N M74&$P>Z9D0FI9<]8OM3ND)"[@=JW6@[EWY,_;Y,N7+BG9E-68%9Z9XGQ1$N^ MF_P=9_^KX6-RAV%/X"KPJY,(4%M[B<-2Y8Y53T>#GF3X PGZ,:IV[#>/%&^3 M@8E#\\I1/>K;Z].6)G;MO+59@[&,>NKB%D!V,)BLY$I0R*2)'HIS44 %9C_G MJ:4<:3X-371\XC6TPG9Y5?=IL\_(T/9]4T:*9U!/"JZOYJ:9MJFZS#V@'[LM M,7GA0[6M1D::Z:ESCQ)DCOS8;0$_.?0S1^?GTNY.%3^TB_\I]W99F7M"JGR0 M8W\B@%K(!*P"KG4;5QSCPX&4B!]"W6=&.H<2TEZ.]* CF1V#1[G:]$)ZDI_$ M>XLMD:&:=CL:O"_/S!]P?3CS4;H,,E@SH=JVPV#E_Q+P7: .M5KP@*^Q/TA,BP7XG]-^T[H?()8( M">-5JU\HEOHO/&>7$=_R(R=K0!XJ"LG7>(#F^Q7.76MVK[^S118[:9WPZYO2 MVH8+_Q-_<&N&,"GURCKWC?)@&0ERL:ZJ4!YP00JX,$3X"A/AW$1^W>T;HR4Q8:CV* M[4?AHUA*Z"9EW?^)>3=EN= M(#L*KH.I$%.^2']90J_I)-"=2(F6DJ-G:#T>^D5M^IJMNPI)H'#0T)X@5_D+ M+Q[,6&VK0VLG7360'SHL^-DT$&"9D5?KVT?VMQB= M\A\I"@+[8.@EZPMY-Y[=X2]\)HF#88[2I3_@19'L(^!S6H!F6_:F++Z<,R._ MIFUT'1SLB"YI/FY.2E.I)T _AF8+84LSS)N@T+P%S!L]3__^L+8K2$W:I?I* M_\S$IW#J$S&!W1^/B/2//H F+M)2'2U!%6'+R=% 1E_$S_)+\TBA)I>PPOJB M(J*9FX=MP;31[0\>]DGG+HDW4L)5E;W8L@U)8K6(I@7:L,Q^C?+K&^/.O/"NCRJ&=.$F)Z<_.30P)^ M+R&?DN@(Y&0Z!;?HPC*?@S>0V/*>%'R'F_E-UA$/=R2:!]"8I6139?58AQ7>?B]M<(W=2MV:UG=3=J;)L'40%))A$WWJ/4*B:'E;-5P9BB MA2J?D,X>Y^CACU,^H]N/_5;:>\ MX.O81XK6N2L59<);Y.A>2WX,2UPR@7YC M=+&.M>O"CWV^ZF)T>)L4DEI<'>>TH^)YR:>&>D4EQX2R1-37)U=0%$-%D>P& M!HUJ4L Z")GD(US(J%+\0HZ'(3,"W%'FC36N3EB*7J;9N/<>_09H>OSC#9BKZLQ27%[PU M!J=>[];.N7JU5(JTBUAXWF."--$1YGE;M=]1N5MRX,#55-&N:YH1H@<%76:_ MLU5B*BN7PECJF,N<:NQ>G]<+RGW$RH0_G-GFB80K2,/C23K^2T9#[\IK9)^]B4&*HEPR6 S1HX1^/9FB70$; O[&'W-YGW3HV[=^

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

]VO0TCPUV]A(2%!H?7"Z]?_ MR40V;H!,9/WZ#6(;-HK^.J"S36*BFWZ]^/4A_U9TG;"@H+"HR'H1T;_[X#<" M$AO69:Y;%!38 ZR3$!"4$."W C"HCL)_JIX \.^'P#I!(>'U(E UQ* W5&Z% MJB\H"%5:&*HQ=#4P*D#M]-?KY!Z519D[3U5X;R M$=>;D1M%M\OLD)53V:NZ3VV_MHZNWM%CQT^?,3(V,34[>]'FDJV=O8.CF[O' M-4\O;Y];@4'!(>C0VU'WHF-B[\?%IZ0^2DO/^.UQ9DYN7OZ+@I>%K]Z45U16 M5;^MJ6UN:6UK[WC_H;.GMZ]_8'!HF$0=ITU\GYR:GOG!7%SZN=M!*Y&B"YY_#=#5*G MDI^7-6U4.F+-D':]^55TN[(V587YJVE_:ME_K6&1_U#+_E?#_MPN$K!)4 : M/$$) %P.3GQ^X!_V;_L?XO5R[-6N/4<2?9F4+YECB?QCHG#<;"$-NI"-'&+ M=FB//GG;CYZ'VW)I9]D^I]Y M-U ZQPR@:@E-F_OFS)2VZO9ETC[6U28#PU.R>\P.?V*A%U_=4#PUN0W6 MM<.JB?06ABIK'8/(D2;0]-$W%YI(3QR-B33+J$R3V"'+YVBGBYE2,>9.2UJ/ MX;F^TA\E/TT^BW$^E[#SJ!T >VYC]X$/5/(!.KL8Q-(L&[N'9ED6?3_-%Q0Y M$6%/3Y]E'BBX/A@L)Q)3HKEY=*#X2VZ[GS*:J5#A\5716"7.9M\"J,>^RC$' M_?F L&@?EI*)KUBX_Y,;=JF? V3K@$ZT+$/-Z_(.969C8RN6=7=WM&OM2C;H M1T?F/82?53(VOQ/N9(0Q9YBP:KFO^ E)WL/^(GF/]0[KAI=#Z-@HR..O&-X M1OKI=&]Z:@KV7BZ+4YP?G^%,?Y3SS]*X8:S)5,<=OKAOU541:H30"+?&0!VJ MA@3W8?T1M@6(;7GC93JG>WCYT65?ZPDGFRMM%3-FE@%5 M@$B=E9$G2&B+V,G0BSW <1H?=9'?K-LLJ?E]8FKCML!O 2.9P)><^ER>/)YE MP@=REI_Q ?(4'QA'$1C^[;AH_-8*;:969+V_Q\LA@\2X(+^)0H^C2LE#7T2L MC*[Q@68W*FYM\TD^$&[%!S;B8A#3.B+Q?Q?Y_7NRT&]:S\,2!8K_M]A]V'?_YR>*$L)35?]E@:8@* M1(LAB@5!2E0.1XG1TGI27JS[,\?2CE-'+D_-#3*56*G<)"REVI' D;S5AE7 ()GJ5$0K\IXE MC;RNF_;I\K*A7?/*PU&=>A;>+W6EW*DL_M3V4R,AC0+O'W[XF4%W8F^T8&:P MHL$@MA=F&QCM2R$F8#?OJ7W=NYS%52#\Y/H;U5H?",QB!V;*H./@[M;*=Y]E M'!!T+^P%]=D*E\$P%IXI3J]C=K7?QL;!56;A$M6,%ZGPU#R=]*?4T?5J8Q/# M3B;*;SXH==V<]"Y(7MIMVF^M8I$GV$2D3%K 6DE3G*TKM$K\/5K:O%MO!2IN M8&M(>+IFB&4ZA3ET*D62]UX'!Z&E_D"]%HH/K!]!=]M4I"N]L&0;SJ@5O&YO M5JDJ-SVT?. WCCK4C9&^G#W<_/HP1@+--[527*]K&[$+.F( MR>F],J Q3]_A8WOA_N7T,/N/"5O3Y'TZ_?9DZT-FO,V+C'+ M68\JF'J-XB+D(:$O?( JC=:!QL=;+G &_C371X;LXR4WMC=>*,74EY826)V$ MO1E2?@>#8BN"=NW9XE!=/O":MW(NQ*"_(QCG/ZE:O)$Y$:GC%(:*J<-EO]$X M7U='21Q\RQO93JJJY@,B.A'M51$[1#Y]Y-T3JWD#<^VRS MB?DV?FV6U<"]'T@DZ;7A-\./8@R9@8I;0#SCEDN&-1@VGM'3,.R[TVZK/(JN M^V/8/>Y%>G;!H\G[Z+I@JMJE@NTRM M%F=;,D>?D/NB[@7&GJE"B'/-X+J'S!A$N'X@!^MZ&GR%1NBMTX\4WGL^L+/^ MW(\6TT&$#U$&B0["?0L[+7TO++6J^_ Q$X7^HFDG<5!UJEW\K@L<+"OBM6(K MML=1$.(<[X$)IDA<1;A_4X^/_[/9I=;78SZDBQVAZ_(R-B37G3Y^-L$ M4M? M[-18&WM71"=B _8J'QBN:\:_(3>6[$=M:0,)ZZ\G=B 9 M10VR?."K_A$$/]GBUP=)I&J$PF[4%Z=FGD>%YXU'C,8KR265_"!568L MCROZZ0T?2!Y;X=7G\*Y5[5L'FZ,C>!BH\XFG<'\^?9%S9S?OZA; M6B01.V'_C@^4KB_U)B^*1_'>$A:E *RG-Q]8HHESUZ3^?"JM(R4@S@K&\P'X M08@;/C?YW?E%JQ-;^< _02E@:#Q>>GB33\)TT=WS.?' OK_'=AWK8N?M_?;Z]0M:PX:KC<;*N+^_$8'5F-CZW"0(B.'_$HEE*!KRA]%THSU&>Y,B;S&#/!M@$^ M\#VF>)C/VX>IFRQ_O+SKWG&J)]+8RB+<;OV-!J7$(VNA06HW"T+/.BVV^='[ MYS*R[+ZL?E8?W[]3*Z5;P=K@DX.Q_BVS.<)(,"?UQVW5#B2HL=#X:9M3MRA' MG;&W9+P2:"<]24V0]US!W:Y/1(P9L=Y/%H 081!^"@I,Y]5/L.8JD&J^-0DJ@_6VKB*_?W;U6 M_J[\L7N\UY#[X3/1[?$S+E_7])%->;5(; MX3UR>DT]^FA\K)3[ZXZ+./40ZP><-TX$B\Q%+VB<5R].-_\CP_F?;+6;)XI@ M7\28@8*,I1;\)@@HQ"5 T8YQ/M#*Q;)EJ!_ M$+#J@2AY#.#>B$AUPS>NSX8 MVWM"23@S+"$06'B%>"T3BZ64UMI6CYL30;7J5O&[M]/N5E9;;G3 ["SK:UEM M>]*MTI?Q01&PVF%DY#OR+:7NQ!7Q%R]+Y5F/N<]XBA&=L/*I1**W9?S*FY-4 MLA Z>-:N_]PN6?<'.[I"K2)/>"O<.>.<6/YR 2F#;F&M<-]&"/$:762@7J[D M>/ION0SJ7TPP'>1X,VZ9,M@;?VJ)^=PZ]? #*L)C2;7/-Z(+(2R9&ZV(J4K?=ERV'.,*JC..(,0GM(PR:&17L--;40)H>J.J0T^NTR MXJELE,62QX,-;0TJ 9-G/6 :IX<1E"QLM6HTEI*#>",3@_4FBH/!%J)KG&_> M/#5&WU)HBE?MN^*2S:.YNNLI;]3<706\QG1W;6\$5GSVY=P1_4^H&Y:/1G(D MR3S3[!(^X#96S@?R]]XQ[/D;TV93F-:JP@)VME-K$N5:-D><"($B(F$?\7') MWQ$\BK7D.!= %(/42R=OY>V:SI32#]FH$VZM?L6D^K<61'3HEAK(F56YZ;Z5 M(E\X&PDH%[V^7M[5!E$&O>UGTDP,J:PJ//N=\Q:CI]<")INO3NF,&E6\\T!I M91E\NW;KT??%[ZV#]V">RED_[>I6E<:F"=D(Z@OB=<1]A"KDYD-1%WHU)]B9 MA%;#" 5$U\]1GYI'/)%X!-4:VW0Z0NEJ/99] 6W7I+O JVJ!IIO>>3MV3EBS MK#C;//,GMC_S$8(<8..U>CS^)A]H]'J58ODA[P8?*)::Q=9>_='_,RH2^O>K M6F^"]O!/C5XC?TE+@U?WX\WKJM;AK"W/+L'N(ZL(<\\9U;?1W31R[.Y,K>7T MJI#FQ4!XC'KX/&+_^'-H>OMC=C&E$D*8'>-ZN(8]'W<<,1DG;O_LVX(MEUI_ ML(CWV91P'@QCZ_"ZR:*ZB!9"E(M\SS6LG2K1/!6? M2K*7L39M\]?94MY$:M46W[3U&9/!RY( M>T5/?-$Y]FC5MTZ>_KT#[D1'_K;.ZLXNB1JG>0-#FA^,VJ <;?EJO\V+)RI6 MGV]EGO^$I$;7I$Q6:M-?A,XD;/4-9)X^&>_05KB_8L:]]J^]E?7_UX3J7 MX ;N(,U(^AOF,C>3=YRS<6#OUP8USL'^BG+)-*?J2L_*K+%CO8?>(T;=%N*1 M][#ER [_![6MCGK-Y!BYAI<>-TJ"TQ/3OTS5IT)A"5O?,J+##>*6I''-9[/' M%#L'IR9QFG5++N0X3ALWZS>N_X^&=IT$B= BUMH82\)'?V M-N;\E2\52:<65V-/RH]4UD[Q1(X'\*37OKML9@M'M,EIS84P)L,L3JTIF+0Y M#IOI<,]+PQWIG[O0Y=WI65F3NV1,V3YY,$-,J4EP*5;#ZT5)6R*>P0*G_ MP+S^$4.+T'])IW7<&"(EEQ04C:=',^ PZ4^YP]W^SWU@I,'@##G7CY?RO!3' M;$AMR1O?[Z[:=^5$&V84*A3%4.U8&/)D-8+=T*M")K&MQ']B4[#Z%WH"GYYR>BEOGGWN:J2YS_C!@\].S;V*/"D7+L$VPHA"W1J+QK%P M7QNT(CHAL(NI5Z5NJ(?7!MCM@8AE.O?,'SGSF R2)3_ZAGH%O'@59:GW> MR'X6]E"_>YC-NE$.JH6,(Q7!U/8,^'[F5%+IE;=,7"*A1*D:12QO=ZNJBMS M,T?I!WI*G!#;ZIX\.I'NX'%#/ /[+X7D7PK)_^<*29%JA\N6'MXNT!@B^[=' MV[[I9B:NEYTHJ_&Z=DEY9RYA/_J'NF,\ 7N$&(38DT>$\('HM.ZP0%5CF1' MHZ,V3#!(/;"V05TF2:"8<#Y544)]LV*0%H9F^ )_,!A!X1W-Z';1;/PW9_6N )5UZ',C H M4/QSE>QT!.W.I[;IV6XV_/R>GNNQAUKMGMHW@/_=VZP@C%9ZM\ -->)\NGYA M/>+WEW[_O?UE1H ;'_CSE\-^][U.4O\'2DIW@[3QCN:%&%L^@ *3F/*GON2. M/"0U%&UNH-(G#W93';_F.DE87[7*Z(#VQ68GMR M3JW")7BMO=.L;A[!%HP>WU?,NNU7@3O,,VZ(-%#"M^^WCS\;O^!HE;^R_X$F M)Y5XNC5#TKUD\4LA'>ECE6;9+FJ&(1D2>5O#E7@1_EB&9F&&XM8OOKO"BDI. M_=B7:]UCIC)SZ<+Q%#.*71S4$9D02$5BC+HP1MPB@V.4$6BF.Q5@$(SJ;%/> M]-MZN&OX"6TV%MQ+;C*\'=@ #M.P"ASCM[:;L%0MIF]K,L3/KQT]=V7?7,$> M/ MN$L,'PC[NX;QL#H*1$1[BM;YB[(MZK=BZ*YE+14>;PK^R4MCCCPE,,58! M-PDNDX%KXP,5!QZ5F[2FUP:7#I87_CPT$OI O$RZ'3,O!^W M^I#@#FS16T?BPB4?:$I)D9!'3Z= 84' 0+T9R[ @#BTUAR!(",8KUWY_V6KS ML'&Q&JV)-&)]LVL7/B=^65.&:A=E<.Q*+3*V@O6ZTK+&UYUG@_IY"1"=GB:H MP[(F:_)JRM*FH E^^SPR:*1LYLKBQ^H#MLU?HQ&,-I-%X[_E!:$= ?\X"'P$ M,YH=/1Y$!85L;OOJ-:XL4N.*D+"]7B^3;^XI57(K-#W.K*W7+=_ICU2=(UBJ M2 ]B:G*%#ZPCX<"3/W&KJU RTUA5$K]/$/;G:?L2(KPP4SZ SR)SQ'R&_20\"FY4)'=KSM?&F]TE36I:^'H/0DP-KQZ M^(?STNA/J\L38W$16NY9!I@%>"<8(KQ<''3>?JZVBJU]%/&5?)R:_:KEN3ZGYR=V4 PYI'QKWGRUD.Z\T\0Z_ M?[VMK?-@T8:BKN$/U=+]%;3M],%T%MEMX@U6"FUWM+U#3/;LDSRZ8F"*?T[M MHQ2B^4C5U/ C*Z,(QXAX*;MC-&(B8B-/IM$/KHPQ_Q*H(O90Q]=1_B;YQ)P8 M[.I />X2!(J/>)\.(\UR,8?]):&:6N%B7C-,HN?]889WKMF<7MYD=!O<&:7_ MD=H=W7(^@.H0 M$%]^@8$S7M\TR?DVBC]TZ(= *1]8]K&!,N% K]5;; C-M"\9XU.KGS[0HH,# M?""PY5+1U(?W#6NEF:A/R,ZI+R$AP57;NT/#;^T\V%Z7EVXG^LK0S$# Q8XI MPIKF)C?L*&\;)^ B8$>>MSC.A!CSKI!'U:XK7PF_+]WIB&W2C1!"R:B]Y'@P M[9)X>T:5_)<,/,9'XA[JO3GC=L%0:L+M :H?#L, H (C_R)/FMB,V#+]1M4\ M"6$:?PQ7\_ "SZ1:8C;0(TX7EG4\#71V^2[VO$4]LPS5KU%'.C=DU/7:?V2 M%Q ?R7[1K :K&M M#S0XAQAD:N63J$G>EW=9]L0$+EE]JZ[A[/3M?;S1KAOD>;0HBMV_\U77O.]% M/M!YE8O#$7C+25F+D4E'N3/'^,#$5#>,T4K>;A#$[L8AJJ9:-WLCN4&QT1^/ M2Q='L1,?KM<@WM];*R[X;QJP&UG@6Y)Q-R7]\2N7[:.:"_?'+,Z:P=@==(T? MXE]$6;?5]W]S:-7QK@UH/7X#>RW3)I'+]U,4WXF%:E?E\& M3UA/%4P+#! MT;[_@P/DL*97C:0N"/R!K??_@Q41:(#SG:KHD#F M?XMF^3>L7HNW<8$/*%M"\:ULP8$/]*2ZS/R2"X4@R$Q1+<(.K13S@1FS9^*! M?T6&%_R(O=X=OU;0!!L.:2=*:JLEVK'D]$T*/A]O"3A2+&%JV/_=EJ/.X#EX M9-MFA\J.#I77/4E7+52M(7R#C1RA&D/Y+NLRD]!B*"JIR7N>6Y&)$2P>W%K; M+>5F.#Q^J?M=!,Q5XA6L(KCE;7+;+WYXGP@:B#9 ?,ZPL26Z4 MC%@#;ZJE!.8X8R YI. ^MGJA9-Z_4K]F][5(LX_.I_+SDCY<))/J+$$HBXF# M'^-.=72/7!R'W1>\I1,;>RWA='DJ-ST>&,E@2H]&M&-%=2PC86\6(GFRLZ]_ M(_SD*KCW[?)[_>TJ;4\ M;C-;; A5L[CL,*-I/H MJ;L("IY1Y.RK$>V?N M?>SOZ;NU-9CUNM@K:M@&V-\FO3@T-WCDX]2G1,)Q''OQ)F<$GB"2_GT5$WJC MPLT"&[P?D7+22,I.@/3W""37P Z>40)YC>(S^90/[ (1L_%\8+<-!_*D/6T+ MW!LZM\[S@8<8V'(;]N&SC2__WD#\MZS4DP9K(PMPA,'+I9BK8%91EH)X"VMS M$/;PF1[3QBL:5L;/*LI-O[L]4!&>2/XJM?V*>">,88(8*6>E<=]6(DC;L:2+ M30,NLG5@.+-JH>4X+%HS13?#J#QF8/WV\H_W$N+ZA^L_".QWKB(_VO=,O-+K M7U+]_U2IOD&;6T6DI-;*=""WC6'L0-E2!S2VU:Y'-NCR@=4=]N3.T,,Q)QPW MBJN\+BX-W6UV#>'QU65!G+DWH!E<3NAZM6CIV6\6G');!RSI/<=(N.=.*U$AEFHV)0CG>=I\ZY-:A1?W)<75:HUC;#-?'Z=96=<>9'-QM$ M1=9JI--O]A]+,C,8,Z-IXXY3$B]7FY 8JY-7?"Z:?_Y7(]5<-*1HQC& X M$D%W/,FD%5L^Q3EBR5&&,7!<'&\OE(D\#D^E*X8_D4'\:.C8^ZDAF-QPJ]K M4W"^EK/OE\8&A7K3!B4^\ W&!\ZQ+BWM=/B-=OACK?2-GN^IF79O;CM:O@I/ M9N/N&,!:GOBVZS".]8NCSAX-M3C@W=QS2G-RL,38'8RK'/K6)XT/[R#2A!.+'& M>9]#A.B"$SJ*A\5.O(9HAN4L$W@/X>9B.'.0G'YK']X0\,V?5/B1BWX-!V\=$@$,K= MA*[S@4?)F*-\X&T'[_$":L6%>(IJT"'[^'MO45R&]B/2NY2>K^';YKLG+&%O M$;%'51.]KMQT5.Q\])J9Y=S[=.+'I820)WFLQ$L$7]TZB%G8]>)C_YZ=?/]I M9]\C9'4'_3W"54L2$]@; <.8@,_'8:3<<<\$F1:R('R;,SK+L;Y74].OF+ZK MLB]P5-=L\]UH;'C@TO7KES?NZA3VN RYVLH<@ *?#&*%"SZ<*4J[E'"ARN) V.,#4Q7IMN8.KGU)CX(7?Y(DABR(&X**5W+=83WPD3P;$ M!@9IT17[,V$[0[95/5;824X,U&R#]\\U( M\]>*[5L[L\^Y/QGM7'Q3Y'BBXP.10H:-=%!B6_$C@JQ"\"IU5*G]T _D-C[@ MA=N*+F]Y@P1U%\?&U,7WZ X'J3]S0YP_1A@\NTICR7.C+.><:(0' MO*.P[0BJ$D*N0>L'_/CVJ5-L&$N+E"PS%U:_&O&U_!KFF\D3;M,)16CJBASV MXNT=1%!BB0K%'-6=A%N*3W.=S[^.JILK0]5BJD4>-$L]Q+-.%F-!M;%*:AA4 M@9'VV_EY90J'L<,+9A:&,;H2FI69)W&%@1W4RW8<27^J#%V31KZ'E(?F]T@+ M*[.2FVNPL1BU;<91*\G/0&=[UOHRSQ"O%NLW]T[-E9/:W>WOO1RQO1BP[PB) MMJL[PT,E^J=$^5W.WIO//)-:[:"@M#)W.I_WM4$#]&:V4!<2GC%"6OE 5.;/ MVHP6LE1#&JO+:_SMG1&D=[5ME[*%SM./(EU!9DI!^Q\\T$WSX0,"?,#5]W0S ML=(DCNA'((EU.&(3X&HHGDPUHS0C('>Z^^H+M'\+X^/@NN;/:GLSC;W]%%YD MABJK#.VSB;/S!E;U>9N/OG[W%4MYA*..ABOHC!X9[XC3Q)A+$6>5B&:TI>WG MV67EQR9QH$XSV2:#90)^'_>TE3.N85\":]DMQ1$TTHYBI6]/JT*3.X_.ER!/ M#6&;$/"#&%'F2EL2DJ7$?59A*0!B:>>K5>\;6.3.1FQ)O1@N@LQ6B5FR[9_&I+CI/&'OBXX@JMDQ9+B8 M-&^ETM973-<8//(6,.CI7#P[!P@_H>QK!!33'.#'&<$93)%F/9[8P/P!:D7? ME8/=*DE=IP\7[OJN$'JQP\JQ[X)(-!]H>^C-"('(U2;'L9@I(-7_?U M&2A?Z)3?S[2O]W[5FC=V2%EY9+WEK6A9P\\6X; _3#J<_T+10?Q.S*G:]VP3 M]G>"3NZ?9: BUWB@XY^KX!;KP>;:P&RUVM?>\\$FOO)J,IOKE+-?5/R%/I7P MNTT"_WQRV3]72<]$G@KG*'C+F\4'[B.W:ENLWUQ73_>\%--_:/:Q@[%ZNX$W M'Q ^SXTRD SB9JG210I0,HDC5\L9GYZVO^C5RZFL\(ME7C&7)R2=0C+ZZ?P J?(;_&M6M) MSO.!B]A7TVJY0UTS56&Q!K>_&T/\)CH!^BAW,#Z BAWNI?JWO'3G:I@UQ#PMG#$+9B MY@M&!:=_/_]>$"-_VC_\H/*=]"JQ7(<&B)1@EOG IB+HZP#P[A+'_M>:<%?N M"&+MDSIU)5+35_[A8^RALWB&V<+P5*M?.2< 3&#JC3L__AC5/@:O3=O! MUEBOL>FGPLNU,7@!@T''QELAURSU.8)LD>C7Q(70"H_OIY+.XA:*EM'$1YE+ M^MWW$178N1 &X3::#[ >,0:RM+&W>Y#2K8.P>_LF3X.:H;Z#'*D.%KR_5+&% MLDQHQ<7)F+995-\UV!T>V$:LW52T#?_R*,$%Q+(W170@Q>+-*+CA@J:JH)T6OF!T/X0$=17XFOYG7?E,^=I*-7DX([I$RE;6X#1]<].$=ZL73/ M<,\$CS5.7+RPU@U0X9O@2EO9G_./'UIM/EBD5?MJ&6Z.J$#2$V@+J10R1[*@ M+?B+V4J0UGVX7E4/YOE09?4GI7"!3Q$.V"83D[9D]C7P/>=FCS9*7 H_1RL< MGI:YV>V]X7A069RU6<0UN%W&VVR]^8X=A.GM1%$$Y0UV,47K/A]8$>$#O89I M&)PLM2W;N#/(M\7?"/O(^C&'$J/\NO>=.YYT?L?! M)XO_BXI#A$]$'[%.TWU4TK6;6XGW@W.8=G'(=>S]<5ZX0".%S<72WG! MDP!7&:6C.C*Z<&G&WJRMEF@]DFI%"-.4]W 0/[D2"2@P42XQ[!T')X0EQ'V,IV1F,:;F.!\7+<0T: M''7&2OR!H,WP[G.59:%7!OQ\/3(OO:YQ:JNH3.I(FU*9>!:[V/=,9/I/E%]H MO;#]N@T3K6^3NG#F=8MK_RTIO=2!WP+=Q#M[[ACD+/J>2Q8UE L)O.49^<1M<*:T\_&2W_(=A M^0LM@ZU]-M--G9;NJ?[S)B9&&/IX-[A_<$Z%FK PAQ)/*@-CK5S/',=&!R:4 M&'V'QW]I=T.L]+M#7*0E0@U-G@ W_VH 6$.8'Y>9H,6V+BKE.J%GW M5B7+XP-)1PKO-68YGS2\K/U6)%%5V/K%%IL<5AK**F%ILI@J'_IM+2)^-8H' M$7I0W;_5?U4 P--&.-CED0^L%'K_H'*L+>Q;(3[NKW^!"G8L B+QEPE,V-Y MHOHE#B-$-B]-; MV#",YECV46Z^@;RW=NB2YI[!J]G4B-?-CI:,B MK5G15\:P#^I#0F^:WTX6.R/^)='N)0;!322ZDZ.SE!DR<]\IHW OYANZ 4+P MFSC[^H\>&/O' PSIQ9=[ANX3O(DDV?LJ,#VQ&LC$@E%R# MT+G07&U/"7G>A[@5@T)YE/<&O1+4FD#-#.4\V#&PP\WFS(67\0>EMMS9TO<# M7H0KY)P[C:0DVO'2H#1M*V^4ZJS%?F&=/^52>18WG[^,YC)1[Z&!D>8#'&G\ M^$$^$)_!N@->8DS*'A??@'8,=T1GD.FMN_T+I+ M-1@4#3F&07/?11P$,T+6 M9A7D'7%&95E]VMNGT:Q-AY"67TU8MG+(UIMX,']OP^PB3X#W;BHPL.G4 P5L M[RNI7!4^$+!3P9+S9'6A"<\XNS"DUY2!)6$9SZX'%0WX]KJ V6M3%T.S^M/' M34Z#^Z3G>*(@DM%-K20,-2A@]+]4; BF+P9>WB-_J>/%GDO2=4:!7YHH#')3 MP8XU9:)2^\>WN/NW\"NK4:KH) M!3$TU9:]JR&V [\ML,3R N,%?CLN0%FRZ:I,U@T7ZH4VB0T;!88\=_QX+]\[ M^YTXP@=XHH\I"%"5W I;CS%D6L[AF%WCUPIHX<=YLV=@(A@)_Y+#FKFG#FP[ M@WJ;;VQEH-DLO;OCT\,3 #C"$]O,/@\!;PT?D"5ZA5^DP#A2=B9,#:0T')87 M?&3692P!E.A #$K+GYF$I]Q"; M&O2&(CX@&6?%8QV[T-7MP1DA$?N8L/N!AF?E!\K*[^:/J@P\5YR1^71HSTC; MFT/O\G9)M[!NZW%DLJAZL1C+8K#[-,2B#D1\8]46W'<1&5BXRLW^8CA[>FO\ MWE3>WIUIB4(BI5]$KEX>G)N!:%< T_/9SMA#,'=OE =&"";,;D4450X A;0 M8ENLGC=M:RGX6"+]*.Z6UF/]U6>'7Y.4[(ZJ>E\0KYW^*]JU^G_:C:0SG_8? MUY&!E;-_ :A_-KCKO^MK>A'_KJ]9;K\$6B%KH9#K@%@U7FC%LJ,@*!_O)(JJ M+T;H0\2A'C%+@A _#QL>#CG4!-F5.+_/++T^':=IWY)QYR[#UN<2(H5NC81N<7 O?BZ+V4O3FK.DE(02 M_9 [T7;-&0C2:4L&(7*NI%CES:6^TA3+G]^T4V2275<1FO\K9707^N6G6_U$%&=93M6TKXD'=_? M*3%@;88(\JFQP9,]QSI6GW;4V&UL>7#+\>VW#TL&%L%4XWL%^ZIM+=-JWSR7 M+\E*>.3/J%'7&^6;;7Q!;TLH'$O/U\*V#S^X C3L$GTF3YY8<\=*F'3V:Q'<5 MQ,6+$[R:1K0E]:KZ8/@/V^BC'*KHS8Q1&PC0Y% \436FR'<0"?4YMY*Q7,X' M7O5'[ +GQQ#L'P/"2W9+N3QI2XXT:AS*,^([6 6@/V/M&)SC(LQPSLQZQ0=" M@I^UB'P+-(B'0A>B/!\Q/O"D 4-<.Y7 .FMHT0![T9Z"?>F9CLFNKJ\XCUX[5:ZR#GU$)< M(0+G#OQ<&":>Z?/3\TNAM?KKONS1"[X:O'C LE>Q?Z'BDLG^KMP#_NY9\]RI MEA:G):\V._37V+U.>])WHKO*/$W" L__C_=TK'I MEZSXO@PBELZ;G7N)$S 1;@!R8C_^C^Y)$]#Y?Z&G_LDP^%_/;N"^Q7K!AA'C M"]",$.% >4&D'XH/*%1J27D?+VE[ ?$;"2?[KESNXY)[S)ILD0UO-+X\#"GE MYEVA$XK5NS#8<1RIH8-5R!");H!A]C :G73FA-T+4B MC;AM*\9%W_HLX'KV^KH3X@^A+)I.9%P27[.K'H_E*6BJ0[-NT))]#-MTB@_X M(4F"K!*&2+,E29RWT7S_J\PG%*AZ=X\H9%E:!0 MY$>-'7F'=PD=H>(K1.B7H#81>Q#>W0J8 ]PT+ 6/W,1QHN V7QXNC1TG2X#< MGQ]TCI9JNOV6+)F<*E^1?$C0;_KS1KH;RPN$LE'A0B:>;D4AB/%(V++!EH58 M_.;YF!S_2IPP^!8E(TE62?SD[Z_K_-O5ZZ;LYIM,X_S!X$& '?^GX6/@28,6 M4/?= 5=LHJ@+-3M=7E9//K.+I,&5%R6 M3W&91L#[]M,RF=@F&.+Z BF+]8JAVJ85PP>J_"-_RFO=QPLW[$>BE9"#'"6I MN+S9;O^=-S4_BNU6V5$<=3.@1$C-YW'7^PS Q)1/AC1V(IEG/"5"RH MCFP/9GPG1U4>K4C"MN-%M''BK_&G&%4%VFJ;TJLGD8?#C4GJOZEF?3JYZ>WC M[4=OE *(4R\)J7P FBHC*PX,/M".OXLO&YS+*IS.&#,$.2O'8]+&+Y\?+IW3 M%M_LZ"A?5^+PW"3QFRES7-^K*\<@T7S;2RLRPY_5 F8PR#Q1Z9>0A^H@O,D2 M,VNLHB)0P #%J.[0O>TXI%ONFOKNW3P^9-VA1)>3>T)?,87-=F$>&2=F &M5 M\6 &!47%;1:BJ$1C7Q E.,91ND6^H;*ECV>S'Q1Y[;- M<+2M=_7K;]ID77M*HM.XG:+["ZO%5L-4WL9J]DVT'4]4B;T;[[PWH8C4^664=.2*G]B>=.-=VY-HK@+7 ?'@_Y;;^E83>&*J M?&#?* BEG3>P7 ,'.ZH1]@RYRG(.PO+-OFP]-(Z%X0/WNG@2$)DWA7?P 4GL MW$(E%_^^/G**:_=8D3MVGMQPJ,Z )D)%@+'R/ (4/@]-\0&,^M*8QONE<]V' MHIUUX%XO5<+:4*'PDA"3Y:D[\'TWM(0809@M00FL2Q[W'_6P@CS1M8$Y3ZD; M-6DJ*+)%\=?5!*.(C)-\8/U\*.G;FAY'=[W!;[:61WY15V=6!RO:&0IT <0? MBX@E1>Q*H T$P-(DS/M_[OM'!9>JQ[<\AW#H*;<< M@2(G-@AQ,Q#7_84P @Q$L[_4,!AFWKO DW>:72NM]>C5]'_P_%#MJEND9:6K MDJ+ XJCIJ/R1(&QYQEPE]!$W02>V+5JD_1>6<*123X#O*/;7^BC833/X+15\ M8(N9\,_,0)[1P)75TLA7'[-MS9!Z$3W2CPW(4 F&)9[4RYKXM;K$N<6L;B6 M^S+:")'I$;(-/8'^L;P=H"%6\>%:;$Q28LA6'QF9D^:CN6-=+UNEFQ9?1'ZW MB=Z-^HKPQ((J'3B$.Y;42YUJ1\A@FR[ =3GVU0[+%L"C2U=K(39X#)N8+0?FTL1CC^-C>)LY%RH9GO?] MZ"1]\6VCZ-"@DU=:)28UR[OD3!LI21.$G86?, H0\3!DDNF7&6XT7 <95%FA MWPW/0>-;81N7L[0DO;&2@88JUT?:@FN7G"^_ZQ_?)U":>*?\6%>ZM_1CSK.% MGX,=XO>(#"M?2U9\.9C*UHT8&EO_U6 ]:6?P[8P6W$[.?E];E;IMQ\*F"9K^ M)0?,WQS6>M03ZM;U>C]_ N[-!Z(>:V,E47C&:?*# M@0C)!W8UN/-?2U7M3XZR["M'X4Y1'5=%32W9NP80'*D%1\8[ D?>EV9HW6/_ MX#%B;B7O17:+_(9TTJ=='7VU;HS2(@C1& FL=.9"LU82OGR*3F5;./*^9@L- MZ,0%ELBT5RO*)5A$V9?755PM=#BU.]B![G98XY2-;Y':V[CSNP (N"BI$7 F M?JZ7J@6J=K=WDZQ[6\F 0Q[11)R[7N7*(.O7EKP4DOD>&%SU#HS'W; MS'97/S#K&=/A?AC[+, DS(51D7)H!(1M[ VGF:=D:8\@3-37?JK[_O*Z#?V^ M]%*Y>?CM]V7'YQ=?$ADSLY^MMPP> 6F9P)>ING3 QYZ=KU):5[; M,-S(DSQVX4C[N/HL@<1F[>[A U[D[1AMD,I8:?N"UA_'-GVZ?=F?GJ][#?2HX#74W:N>4JD62MK56WHM#%*VS4GM/U-4 M<0?S%,+#)_8NTT3&61/&?,.#S/G'3+?6] :5>.1R,CF/N9J@&CXT_&3)A"-' M]7]ESE;BW&0>*=JLY,Q]Q;D<3AU !- WV4K,GQ\Q>/]]9X@MX?EU! 6/WP$7 M1K/'VPEL"=X71]4[' 2SP"FU57'OUV6BB%EA0Q2A>UM+:)&WI<*$:(KS'F/Z MIIG]&LSB.W.:8F$ROP-@-+-4)5@8-WG&U)7 /&SQ7@%!Q!R]F8]%E9\.<$"X9BR3GMV9/:6 MQL$/R3&!,+2;@6VEE "4OD%]UG02,4T$)?G 1C,$^ I*$B+10R S8OT/W MT':P99+XP+2>!Q^XT\'Q^HM7*-=_7?]GOSZ),?<>[_OBE\VVK43?,_EXIGI7 M\IS/IS1\TN8GQIK7/FH]JCM9=4P0YEC]1^0!N,9-@+SNI_P;/M#HQM,.__TK MG5\W#/T/OV[7Z];G6KGQE;.)1MT#%V72H9'XLO\BVV)DT 4@>%WF-9,K$70S M&H&408N>2IJO1,@Z.UHH/GT.?EZRJ.XEZ=M3LEP;:2&97S5*\#35^!%N&H)R MCUCF.6?&-D/?8F5SG_C5>WB43E=5L^QNH!/:JAV+98)#;.GR.24M>+762-4M M!0^+\Q2:TJOIOQX=^ $T9.BQHIEZ!Z MA=GW. _ST,FEBRMU"AM%BW.5MW\K?H[U6 UM!(0/OZDD&9D^4<\X[PX29*J M4E6S)?=6R#@R";]EXJOF7G.4R4,G1\1OS4XQX8DG9^000@]M!.FO?HE>&S:) MOA:2>*]M=6(SE$3&78W1.6,D>C]7X,0T,*?6]Q\2]O\,J.]Z_F#QXX3BS-_8 M_;;>,(/S8(6X_%UF2:?,_B\>N?(/WTW\__5FV?JZC@8);G$EC)35"-<"PY@A M+8XAS1;Z9GTT,)8J-BK45?AC)<4D05:SM/R^[3'XM9WNZX7@##< #&G#RD#L MIAA1WL&1DJ&QDME;L4UJVEH*Z".7![6?VET:6&C0=/!B_+B=-1/,Y#9(U=H$ M>5;'[]AK) [+NN9\T#,5F\_[C*Q4Y4A7CQ?0G2@PP8AAB"];6(A09>Y.X*UK M('I49 $F%(#)WQMPY]]N)=&C-+UK7#R7;NB%1KA0%-*>@VQ&"$]LE(8GX3IP M;!T>"2'&D634BA7I,8RJXWB**MR),C.4_/G$Z:=*;Y--?FQ!_L$Q&"/S/&>T7D=J_Y;:XW]^":?O["?8/JU.R#5#< M3'9=X;V5JRG OH>+KXT3WU]"_)$^MF^=SU_1D__+%K-RX76OJXQ3-[8DAP'9^GO[,H>=JS.[;Y!KP]#W*+!;*$4EQDILH!A>&HQR>5/6,T=W MG%RPKJ\U+:'.Z-S*3+MQ(UHVKF* M&MT51UP4QPQ5V+2IT;U]T>+L@$G[ 9S.5O*/"5[;RR[-^VA<:FG;YC4*98Y?\#O,BW/Z] M"%-0G763Z3]GQ [ R.!8U[GW> !'?<#@>F9I]+BF")4/M%\V[QRL$/.%FQ<> M(&@2J?)W%+()IH!E?&G(:M M)UX)-VG,7E_64_&2@+%D'AD_D'3K95[U$>U(3?WS%?=SWD\GQZEF&^]+,-@? M_QGIF0F55"7Z$TD=-&P[/I$/O/:D0VZ*V.)-W@%?3_;NL&**1 YD#=IPW:@/:W%6'21UDP;N_1R:?VT MQ)M%![Y?D762M180DLBY/+HEOX77BRXG1$?H^L(KY:$;6V83Q+84O M/A2X@#4T;ZWLSV;6=M7;]+DI6,:T:R0*12C^P$K! ME5&(JSW:+T]_,WU=\:9SKFE/Y(Z',IFA[N[Q1R\<^:!\_W[Q1P$&>4B8-'#R2;[CXM=/-PPI3@I['=R3\NL"WV2?#%&SC]R=^MN V2G\V%; H)NW MQ?TKQZ(4VR0>H>\ GC_F,FFH;_SVZ561D&'7PVJ[$7-1]E#HOO@. MU"J3<-[2/INYFU\_S7V/R/39$#WM6)KXOVVA55?QB M7.7H'0 *L)$6(+L=6VYYCTC!(^01WN:6DAB $<3YTA MZ3X/9[VX6S+N]G!%->RH2#NQ;"$:XPWE$* &?FZW>-L&SP<7 M?VU,Z DE2==5;U-O5V3VMLW4-&SZ%X>AEOD4H+..6W1S*DWH',PJC MAB0N5+:?Q!_H-!>;5O(4!,]]/]$M?Y]02D0M#,6:6FP+6>8D92'N MU_-!9H*T8AO4PM7IZ5_; @2J&GK]2M)-,U'ZOXFG_T@Q_G%)8:?O_GZ>(*^5 M%!N-]<%)1HPB*V0>5/"![1CK08Z6/_7R 9K)U^R6 M;_H6VHNFYJ\O%&XK[1%8#.'(!5P-RX$B@!JLI7;M.*K6LPVWS1%,5\,.F$2D M=DQJ/%UQNW;K$XR!BFXHU/JU+M_ZN5@[Z1:KB!FT$FO/[:@X9&]2HW]]2>E1 MP*AC0_1KJ+%VM;B ;F MFR=+\@U"'NXWNQ$G7W$D[V5Y^QO!UQ6:<\@W(G.YC%@6C)M5K\;6Y(CVO*AD M#-ZK6"AWJ/R68YY0Z$!R*/6\ 83FITVD#0%BQQJM[@"&^]]@@CQI\GQ@ WF8 M@_B_VGOSJ*:>;%\\B(J(@H" @A %!)1)95*FX "(B(@R" A1!@$CQ@$D2$B4 M>1!0$%!0 B*3@F$.DX0999!Y"@(9%$2()(CA2)*3%_J]WUK=_>W??:]OW[NZ M[UK]1ZUE5G$\^^RJ^NR]JW9]]JBF+O?ZZ2U#>&1)3VFKBL7N_E#*(^;_R3=N M$>2;[HT\"/^KR;:<_$H_5=?&6H&#+\'![9A.Y+^[-]_RO[]G]$G>F%TK%VUW<"N M\XVKR$/_WJ_Z&;0OWO_O/,KO[M7569AQHOT#>/?]D6>GWF;QYP9[*T^8NI_V8W#R*0 M! S\Q:_1]23-_^']<)LDN[AAE:+;>\I_'$.E^';>/-C^=]YD.R[PT!$2=FQS MG)I F?E.<8U#'84Q.78[KZC)0^0C#?\G\(_RFV@0M2]F968+QV 4;?VVNWSZ MT\?7F.";S^Q^G(.L*I:@39B.J;0DP7EWS8'],PBLYYZRGUU?[A1,G;-GA\./ M\N4_ 6KS()U)S2]E%]B$ND_K!,P>L+=/0$HN*#S/Q(*PQFT+!O#I]P,$')N[ M@[M';+47$FKS]]X:_'O;OT9H+67IRK2,0NN)D8PMJ>KRIL8^H732J<._/-1C MQF (Z 3[1/IB'U.6M.QQZ_'\K8\!E]<$)4JYOH(#OGAU'B0J?>177WH3%(+V M>S/WX[+;_(+W31[$2EGU]SJGOS8]F K_O0FMSRB(&JA?N%\_;9B$K'B@\RM; MS/[U-8<+/4V0(U8FZMTPR@6P'U2<:Y^I#)\X-7-_J+5NYWG:O(X$/S 082NB MCPZ/6]'Z)% %[=M?$%AS,=Z!JO,*/6+7(0MH[]U5 + M'54N0Q@Y6&M%1/ @$80[>L1P3?1QJI\]K:M?5SA/>6T#18"SD,=8:H*'@3M) M))G6[=*J\'K=-&'E<' SF;#@=OE\^T;K;>('%1\=5"0++*H)=F,I=SD!3#&% MK=SGO[;DWDPW51RA5$S\\/B:U"_;Q6RL8#OX-HH/HWVH?;M11BUK&-SUH8_< M3$_-+V2!%A"(T#BWTS/L--X/GX8EYZSO+]$ZR9\2 KF34S[KE-2'H2,?>)!; M_4*]"JI,T_(=,^N')8'W'Y,LUXI/Y M\Y^+S4_LWK=;2>M@)T>R@A:42/1#CNN0E^@B3$.$L[$E#1E%,B6\,TFMB9*N MJZU,=#ZS5]7CA^?#E(=F"MW_KI/SSZJ3PP]P_V G$%-_3/;4%?CQ]#_8)OX+ M2F^IOT"VOX)/J4P\T-<,2IW4CN4XY<]W;0Z"SUANX8/\A^SM!]5[J["D&;)H M*FR\A!-0E_#QJ'6HRB=$&C;'7'UMQ!;P79):(&JO)SCV=1A&8;Z0\NK\&,2: M8&':S$Z![T^=4GF0&^"X*7_N)HEM1AFUVA'@=!L+UX^/0X+W[H.YK]^!,F#2 MVHR!/E9Z8Y3^ H(R)2MG0[0*]@3B(+\.>"?NZJDX71AWI*<3(E9RIU$16&+X MM&2FNP,O7[4LK.:XKB0?YT$@)UQ7WGEH3PA1S!?C80E58N*HK/-W9Q%KG,'D MT%N1FP(Q\H J([HEQ+5U9KNNM0^\_M!0KA]LJ7H3T07R%G7YI>=@ MOB5NP\,'$/)6%\@R$;#$(I;X*/OA(E4UHD$WH=^7=#8]66WUYX<+F!=\!-\V M\@Z!,TCB07RU=W]_SF8XPS4?B?U*/(3B($;4LL6.#<"\9B9XD%.9=#@#O[?Q MQ8N&M9(V@GE?D409?+ ^5*PE2X;1XVX9Q3&X6I!_N+RC5W'7VEXIS#]W+^;/ MK2<_7&;8S_RVT*;S?2\O:#L/LN9=7PP#E)"<5W=9_#59?H!"Y!J<='_(1G $ MF7-T6[8F,,?R9T#;^--;C#:S];NIPG#5U,56B>LS/A7O*]-(U^)V-E2UY7CO M=W[Y5+Q+[SPW''L-KX#IQ);[A!&]E^30SH,-5QH%&5/YT:\1)&2DU^"VZK3^ M8KO=.2'=V8/^=K6I(U:@N!G4$-OH#]BUU(F#"G>J?.PM\QR2+]_Y@ M:[C\P&DVTTHCE56YCQ%0<&M0"SM+V:$&'M?^VQ MYW>WPX"3P_H"!\S9UJA5BDQ'W\1/%H.;7X+U[=N D&VK M(AT:+L[94:_!*GLNO>^@_LC3SZ<*=D 4^)JR(D)1?2P_1CI':0L^&7)!P*, ML4P8^ 1C*!]D4K@1^X"<; MRMXQCZU$QIO*HF\!(=1OQO),&'GVO58>8[5=.R^TG'3TW5[],9+_2/E'21N? MNP++4Q=.3YW)S4W(?925\;ZN4H@/)S/0<#Q)^3D,[ [L5P*" MX)8V06>!,JHU7*)=>^W#TB"*TY[2N'CC4W NN/T6860_]PEX#/5\).K).\P( M1JN1L0"M846I;UE5]<_RNI-H]-:IOQK*L.U[!-W0$,KT=.+&\->?IF03!@H, ME7RDBDGZKLV$OQZ>.3XV%WNU8:2R('%YDY66N-*]J(!4:=2HV3WIR/?Q+#/N M4\P.D ]R%4&1,&_B0Q?[T4991MI+%D*__JG5[4!U(VN]GA\0,=WRAN1ZB(#/ MT:V'($)YCK:)Q1Q/+$6.#8M>:\_'E5@)R ;2?]6F[?+ZT&HHUG XZ_\0D9IA MR=FX%3A'F.]CO<9Q'#RPS<8WT"BB8.!^G%N9GU""GIVZR,6HQS;12ED"_FVB M37%KIG_S*++V7SP(^\?Z@WWH(?P 0\J@11V_N(#7=A@-VYL+L92CO MN?T5_/* !V$R'ZW\A,6S4W\)C3?P MP>AXO39G,XP&?Q[X:VYQE>G#>@KTDB\5-\B]15F,Z'HG?F*Q[:UCD7LBY+S4 MB*H]1EEY+@],:'\>=1?^4&(&OM"\&T0U,57K]WZ=O/V-4*U*#1:X )4U/MZ7 M"/-[[^,9&-Y:=T-?3BC[R9W.[^:F,RPSP$"W.XCZH0HG_JE ,33D!KQ(4>]!@&70Q]))-Y74Y8\NO;:.W/E71 H6Z3G26@R-(A!V^)J M51(HSF=]/E=&'C)ANJ=09B)@6SG[JQH,& OF%8'S&H8W/&S;F35@X, #2--. M 1I_BNS@01"V.PB?/,*D+]N>%#%ZCK)T9*U#O_LU) MGM*PD8GYMQ*@=5SMO]C4^M?O[P'2AMJ+LJ=,6"77F5N2GL7>/*XT/I*I#I.5 M._K(I?<9_,"]\!MW-IM6(?\V65SOOWB:SS_:C\_O+&R_+FE?D^@@LYOB><[\Z,OXK;DO;G=PU;7O[U(=0_ZJ-+,0S^!&?2?>V3 MZW"F15!Q=V2L>: IZ*W,)WC/H#>9#%M_633F&:IUQ_ MY\_<:KY2GZZZD?8D/'Q2ZF<0Q\@:?.L$NN*X0V90C;$B\ .<'Y52+J+=JL"! MNN65$A]IES1:I$WGZAW<*GRW26K&>P4Q0-7R94E?+K:%VIFR]>,LML5DS*2, M%5?+@X@.KE\GXD'2YGB0@'ZAX6%'IS!=$WBKJ?A0@PD>P8.0"/<DB?Y&JW0;?@.G%5?3%-AX\R;A_',E4=V"PW&P,4'U"RM MV)R#V%M+>DEYWSAR^M%N^5V;+2T<(44[!2;^"1'Q_WO[YQ-V)ENH/>J*C-D8 M*<\M\LT6ZQ4#].3L1XSY7[>Q<<14"Y5%*1CCW&6FMY%68[6\9JWPLQG*3SYG M68O+SAD/$\"!A]MB6;X (PY7E/8K9#ZBW3YL0F07-\>\%'8=*R$,J MPYY)GP8"M:L^M[!*)S];OM=2<@YO5H+^>J.(7+]R:@,V)_-'\Q@/XH$7 _L: M]S$U&VNI]9D+[T,ZZ^BOGHCFE$QW>=>B5B%G_99//#J1=MHA9N-CB&G*/Y!" MO1QB.^$$;HUFC'WJ;]P #O$!3C=!@OK=]:,_LL% ^=W-O#O+C>X'MFQ\\K!> ML%2*Y;U3@-G'.8 %-)%9M+>42/8$P6 M9H3]L0C;Z -O_0SE2WY-30)6Z%C%U!B'RZX_/A_^9"8U^3?_\[<3'#DR7.82 MAH31!1X&9_B8.>JRHW^A@KP98798HG8/VAW&/NWQ%R\KB9(P_U1P] _#AA;-N[?XOY/%#?" M5!^P!47V,8@4BWJF8-M,55\KXNWV@VU]@4AORK[9#]D/(Z=N;@[^@4"VPK;R M!:O,F(M:X5[O9K4"[H^G+[4;']".P'@[F37M"I =1;,6!.98?,RD" MK?3:&EL$_T:7>OD"(I.Z>H"D,Q.W $(O3D],O&+;E M/&6';_H_2W__Y.$V9K-\&4MT>0HV*MR:6X39YXM185JR(O#< @H7MLB7 MX=H^=.5$&>;*22]RH$+J-]U_\([W?]B<^J#5EC$P) \B U38 G+L3=B6W11$ M;M[VB^TX28RB7[I,]?T ;:5VI(^GG[!=4)"2N4YMD'BSQ($KO<8HR)I"'&"T MSAH4C"%-*W'+035L,]\Y)N>Z[V2\)DHT*@#WQMI *'/L ?UK]%FF5K1Q[([4 MG*J9.X 49^ MC=T)\\<"JNF11%\>9)POR4C$C&0#_ TQ*K.E\4##4[\LJ;$K?H[<7P=RX(=< M7$L:!A.RK8[Z*KDE&=*9]MQ*_A-O<0Q;'F0RD[S:A /4HO",(2I_(26Y\R=* M!*(5/ *$4!82#OYLK5MX^*59X\CI;F71'HBJAKW1TL7=B69B@UWJ7W@0?AQ8 M#6_K4^!/M).Z2$ %OOC^W7R="L&'O!N-9%IV&D8]T\X\,OEJ*GU)0[BVOVX9B*'O9-O:O2 2+8UYRKW(=$W.."CZ7ZT?%UI??SE08W> M$D*<,:S0K,+YN["@T;-K-M/F;=?;-V8?N>JUY0'T_-_GPGNCYMK/ S+-AIT) M/W3CN2=,Y,[4-(9L/SC>%WA',>'UX9.[9JWD;H[8??00N@\9>44\A/77)KF" M(JML*31T&$;.4= N Z1*4)*M=RP+@6[RM2>>]\?6'!\-'JRQ<7XFDEGXI#G- MW#Q&*NCT%[,=7#$VW]MJ/K<([@"[>1 AC!)G$^-]-9Z&(QE=9H#1#.P)IO3* M0ZU %"WUYE*:BJ@F/2>E)]7NH:K'9AOVL.#"??4O\DZL2F"2O0>.6XK-L'D[,A4+\!N":V&4HD9V?QT2(L">S\R$RG8EMW M<:"T)%%4P7D&+HD#N]XS.DIJC]_[K,GM>4.ULY)_<8]=O,K%BYE3@K6T;JHF?_^N/'7[KF%G3>$1 M-?LXO1]!>ZX(T@_^HZGN_YG6"3Q<9Q7AJ#/.%3&A5.U8S?7R N4A[R]>?)]R MXQXCN_NPB6VVH'(R9.-C=8]&R_4B/V +C"!$#V):MRAHKG-9;9(>!"51=YLK M\G,\*7Y\;$8E(/6\5;L;:T/J5^(NBG7U[XO>\<&X_VR\7(= &5L2_)2E-HPQ M0:]3*L1SO!@-:ZJ/&C6:/?-1\-:,"->;:!V*]4[%+A+E?MY46]+^KVW!IJ[6 M>TRN:LP8_+\5#AOKAY>G+SKQ)1,&D,SI,2J1_IS_P^D],)#C9^C6$ M"-F@2,TKPRHBT$F?Y"ZJ1?V$\$OIW0+GAX1V>>T.C>9(_J0)->&AZ$LC_. ! M1A(YQ8!&@[H+=U#A;213 GE>SZ _\#?U$E+/_P"MX>$%ZXC34SDO]YMGZ3V6 MC\RY(I;%#W=$0B_ )Z"T]-B7E_QDY^A.U(4ET3)VDJ]':=*=>Q.SEFJTNJJ0 MZ2K&8">X58!]"P6EH4N+^08.YO/2UJZ&TZ4QYKMRE3_ZH M6"V]NAC.WNDW4Q&4T*C$03/['J6TS^P$M1'W2$E)'%?I=)::@M&E3>\3<3XW MO%)+%NDYGY:4I 7,_L/T]3\V=1FJ:3JM%]GDTI'$('9(*T"94J,O M-5RT:M_XEA1.CE\N?YSR\7K%"1^'HTCM7IOQ#HH9=#V5R<)8KQ!#OX6O> MEW.4&,"?@8/JSJ;:"ZS.I&TH^T\*7E,?9 A4U2I"S)<(1.R'RKN)SBZ#+(]MZ9*V)C\; M\)&GW+Y$)!ZEF17)'F0OM1,!E=%TYA#K",-ID<:TI:75O@&6F@RK,ZE848Y' MQH!HKC]UX5C"AU''J>>/U3_]O%DU57I2YT1QC>5YL0PLN7%T+;^"?1G;#./H M4"*OC7SAOEFI_Y8&:]34S*M.GJ^9\^BX,]V:PDWC'[.*<@@PWQO@V;8G4 MV@*O=J*',[7-F/!8C)RO !=4U>;%E*;FZ!X M\;UGE$:ATQUO_![@)5\Y_( \K!!XR\IEPNC'&#.@B'HN8$%S#6?#S ?267Y# M54=7MN_WFJ[6'YS^?N%(U)4DG7>MQC&/:.)M3QZ$KG/W_>(FZN+'X2RW@48A MK<:ZZ7K-K],$&E9"PQ3.^E0?:G1YQBT2W.EWN?AZ\*5D/>5494XK P8Z>@,4 MOA?825GB'BT)U6:+8GIAE<3%50[:Y'(6! ]]>5M&%U2M6_UZ!?!!9=_AJ7Y M=_MO;G@#;B'QNG;43'ETJY_I/O2)FF!WIT/SAC858J8@VDM1<,#LZPM&[O!C M,4>13?$]9;=:*%?F+MP@$TN,L)1&4IB>OM,GKR;AKF'!M^)C\@39F>=Q2_?PPTP%X=OMV\1& M=_IU6<&?V,ZLC*@1YE6_WOV98:K)B+SA4WKGA0/]$^T'>-/J?GLP+K_2$1[6 MX$?!QC1*#G'NDDNNRUN>&?%WI+8L3Y67=[3N70L?#P_;LO?!<:DB>/)PP854 M2^'\UR\S[NN.SK^;FW_\XN#Q$3Z] MZGF[4]"D8@&NC/($M[(9K_B66&8=00>X.: 8*I>";-ON<]+M8G-0EDI#6:8U MT_CLC\*T(.FA1K>>BY'.4L*^\D=#WS1!W>S<;=G7P6%)L -7@8\E^B'Z(DC$ M^!7XYF]CLH28XDKU2=]WE/*'!MT:B%O?ROW->NP/';WXZ(7@--J0"8UK<*:( MP':@AIID%'8-:WF*Z<<&AV[OJ:Z%1 8]S#C2FK.U1V"/Y.@# [57%2M0:12B M748V%1\=V(T8&]3;7#H\2CK/1Y;:2X,6D64#+1\B$B=+@S]D;]^J_H!;!//# M1\#*^IIL)3"#;[=V8;RZ+W6F$R:RL_R4S"/DT-YNGME.+].5#Z^FF6^ M6_#)S[Y.''#0ML-VPIIL6L0^AQE8OP=+C'4Q"%O4K6X(>2D)']1SI1NI/TN_ M4!E%ULN^ML_]=$+7*=H#KXZ5)RU M/V,^U4I\W_/!0ST6 D$.'[\^^)@M8N_T":&[@GN?RI MIW>W%!XK/DN<_1!\A].] 60"UU\H!V M)2RJ<6OBYO?6&_WQA=.]MS4<6=+7>1#ME\;QM>5EQ8^V]@LUV,$/@ -0AAT^ M'E=&;-%TI271+=DBP)ON5D/OLF1_>%/C_K(QCS+/-H]?.AM'F16ICAE'\^., MOTXXI?SR_MN'*$X?8+M@Y'RBU-!)H("&':]G&=4 8SFAD_ MELW%-FZK*HB[J=&@EPL0[,-"IN!GQ-N591\].24TL9O3X4CPF-5/B%I=,%/H M-?A[? MU3N^?V?5?0#;C"Q!U$1E3= M>CQ!^0H3('ZS 2+YDUYO#'#J#W#JYV(CB=\V%X!B<,YK!IC7AEW9+<:1Y$&F M;'%_^/NY)<[.(59:/"N)'W=(?8J4+O+/^>9R5K_./ZW$BS58G&@\\=H7EZKA M;!%2[(M@21./$/GVH&*62)F)'X56FJ87?-1*H,JIW:@RBKA@_GY%O>HDCB*V MQ:8Q7Y6%'^+LZT&YW7ZJM,VXR/ZI%/9GWP*0Y+$6 M&R0?N!.,VNHBJ]**"2Z'!W2M\)$-=P_\5$)J0#60)\@*^9:F52L\R%]KZ@N6 M_!C'EYL1Q JN9_;%5_[6U(/*N7>&;*]\XS#8H:M^\Y)")*%[+P_B/=A8AJO2L_?XDGS!+^18Z-N%H"#\Q;7NL&50I:!E_%*W^*Z0 M.@O[%QGQ_NT&?="*FW&3 :9H'B3Z*6O1[PA2(3[A;2*EZ$)R05A&ZDM< M];F^7$*YTTH=\>[W(HH.,'P.5:,7ZE1>->: ]:4O7)/Z7<"/(53X^.2#-EDO M,8/Y#-V)V?7]_A" [#25Y>*,A8HY6LQ?3[SJ&+,5"D3J;)Q#0.OO3 M-]113].\N1KX=&-!?_;) HZ47"=4N@HWH=U>%_3@UTQ$HRRC\25-+B'$#.6R M:CNB5U_T&H&J4JF]Y&)R0;/DZTV5 P+'EW_\'OILJC)().?#Q;%^VH#R$OTJ M6P3\G'$"\&1E CH,S[9["D8#[_0[C$_Z9@3$2U==WRQ]ZK'NM9/0C\\]G]S> M,U#(]F1QN-55V@]ANT%QL,M=>$0O5-T-*#,M"PRAV@@V.V4I-@X$A!Z9/J:U MO[JT*NQ>VJR5#R'.(%DU:N]@U_S>1Q:@&%\-7+X"=+_S;=IY>&0"^P38E5(= MS9QK<=DTG7GUKG> )I:B,:"EF*Q>(DT]6_B;FF8G>8RT+4EN1W+ZN4Y01(RM MA)G(.@*D,YS K2+K[+I# 25WJ80F?]>+/$B3&:"IZM"A10 MG9*(OC/BJ#01W".%0U$\R)G1&S<^3[LGF"&']]>)BT2E=I6I$[N[7Z@U=0Y" MR[ =?8":)?TX-<9TW_K!9/E63!\H-5#L=-N0Q;C&)Q]Q?P&S;3TMA\3N\K6>BVE)@S(NB(U' M=V#+O1H-,EL-UK[<&W,1B[EZ@@>96$O(:PO2'SP2)F(Y>^H-67Y2/H[R0.EG M_2G^H^_!86*9]U,BPQ8)'.UF^3:$MRIH#6D9'T:RS5!G-M<.H(_[&&MN3+BG M>-Y ]VS[]-X*M2ON(\>N<_EK-2SF$F;$"5M1:3!3%A3EKX>/,?1)-#Y6.%]G MD?LF7MUUTC749=3U@^H+'N1M+/U"@(? T9L"1Z7X0+KSI!TW%T;.GBGS>03S M,#$ A7-HH;#V1M/!L;/^)SOKTB*,32A%W47@"&(!\9MT^V;KIYCC(F<78[;= M_EK]($2(GL+49F5G\CT"825@$^VE7 MLTR\\W<:)IMVQ,J*;HAVU\D'#T>VH M2X)E#\&[X66+[NSN--W+E*#->*WUXVO,9Z(TS!='BF>]Y*8VA#+C8+&&T.:D M':@[MAO1IW"G"*7O1U:F/#JH7R]0-/>%35\4)^SSB=LUZA!*ECJ(^(3U0X[/ ML+JY+S$',>T,SAY@7R&F'[X%%$0=0H6T@5O"X:6E-?[NVPW5C>1## ME<9=3'K04:+V.5=H.=Q(4V%P!K=I??\<7N5$EV&&LVS*JAC8C@2C%L-\7+'O MM'%%W:5,JX%WFCQ(!3FA[8YMP$^;/3<&2QI$OG:U.%Z$/A/X,L.PQI$(K?#2 M&8ZD)VN<6V+LG-N8YT>&DW!4E5<97G=^7V.1]9)=)Y>:)V;/,COKA7S19)K4 M&#@ J^(;GFCR;"2#31M;I)5P+@.][X@Q&BE47+,SW^5UL[8:\!Y2L3"XZ+M: MX7?(S;5!]7J'%E(K*,IQ+]W[!GQ\?9?L.=OZ3R5( C&CQ%(\W8&A?0FX&L3$ M4\?B.$X4>:3=F&ZH!>DH?GH0(;AW"%]P6_GNY.;D(SEGM+N^9!DNC2_1X!R9 M.':3H<$BC'T<;#&TC0KLE>TPD73BY@FU(0ZLS"P"P^;<(F2!8L.8 5WBJ])^ M3QVI8$?EJ5V0;Z .MOG4XABXU9.&'X=1^^@O@]C&??DHQ*DZX/C=VSGS<$]F M,>'>LM5=8X)A2?$'T*$S_49UF=6-'Y[I$D;ZBFPHRX< 3/FP35 J? L\3-?& M[#.GQ"LSJ[Y&V"E+?@^3DCEB48:.2U"AYJ @<;^M64. @2K=AXJ/(U:DT[OY M^#0RUG@0K^ %)-#<=)SKR^*^J\G*BYQ) M7B97) N(=_X4[U2MNJ=K;W_QUG71OMPJ'F2[Z"-EQC#S4)JBZ"V;N^:FCF/V M>7XNW$7Z^.\D4*&=;8#MCV;RW>CM7^?^Y&][<#.)WTX".!XD:ODG1WV^2SUZ M_!KVYQH,$.)!;H8ZL0H$>9#^1W?^\8EE'7#K=J:.&=#)]D(M4.&1 MBU5R(=M=[:*L?0,1,M4UYZO["3YKA\AU/F8^[B^JJ=J;#3D_F@C]AKS )J$_R;$?5@5;9$OK=/K%IMA4[$M[B;#C7N16';G?!O MO^M+N$)%43=#?AW?:&$/W[&7!)@8 V>@L7!63*#/,B* M0SOFR=C"9SUKJ$9R?('#_G>),FQ;_!%.TL_NCA?8K79,HT-1VH(7\D[-3]N] MR\;]R$%8CG>-.L(E&T'+'BR#I3U1#T; 8GD0 *D-:ZD7>X@EX)K[2&*= YQC M#-O(!G^_4,WBBF+24L1-C9*6[(WARN&^Q@RCL6H[=Z[AL;",NV\ROM=J C]U MEF^X>[9('1I*A&H7"5?^]F)NM3)-Z!SO8-$#,11X"M\$(Z/CW_$@OEA #4Z? M8]MR;._>I5UEWH&*3'(+?V2>&;@QVQA'ZM7I4AE7/"&TS=\^RQQ3ZC07%$N\ M B>%K)?VXH_'068Z9R><)0B$(IE"33S([NSC3"*YS:6W,;-(_KC\R\"7!Q$% MB23GH(9!7OX2YQ@ M\&,20V&U)4NB'!AB'NEL)2V%!]*5X5/F>L M-E<0R>683=Q"(ODMK/13 7LGYA.Q#- ML[Q["NF==:W%7\1_V^]/=Q_VF?._^ (WBP=!P&-G=L.\0FW),HOU[U +-H ! M$V'#M$VHLM%NN[__J=U$ZXZPTV2W$^"TU;5F'Y'2?5LW,VPA.SA\DX9%SHQ' M-BJ 'W&R,+\98?19 ,\^@49FF@/^M(V,;?'5[)9>4=;R_'WYIEQX M' ]2"6V&QN,8]KA'N IN9R+Q&EX:?80AQA^)6'T>1-S83C6I8&ATU6ZD..>) M1D#WZ1OOWHED9S@F^WU^;:[D\*CK\B*$%@@'U&SC30]C2'!YF$=FTF0XN!/6 MCA5:L"I RS"T"!2N*MN@73^IP+77O]!:/P>A3.@S&4XI"AM%[=YWFO56?_5= M-&N";U8B@4R6-?">;QBA99$[7)DVNLKR8!O0%1CVULTE[4@@43G\'M+;I MR[XK$UOD,F&M!$/%+M;R4JA)[WA#8JC!Q^=A'U*RXRZ]LKBJ4['_WD=&)BL- MP#(\*9:+#]F>F.X[X"!TNPRY)/$)\Z(SP4WG? A<@A1A7L,VX0QH5<^I]]=N>^L0PE(OV477WE/0X?LW9,-4BW.K)A%,\1O\B28RXM MJC(JJ$%AV@&A/JT* DQHN_])%\"&,0=+V=ENY>)1JBRW^.PM>[1,Q-Q2@MJ1$\+?PLDZS M#DR[H)3P>N_>H'WVI1IF&_LW^[3!2#AP:S3?'D[S!^T16H(!I<>R+8"+-+'F M&9)JNV5+6LDKCE%TZT^4@=NS5Y,GA=(URFT%K10A0]WJY<)WJYXX?P=":$$< M:776P'+<8A "XMID-'$OR.B^\(-IWVFAD MJ>':Z&WW!=E%\>#[@0FOI<<)[-"-;O:!97/'+SVEGM\7!R)]V/_UY0 M9#?; >0#OB1_&"2 $,I2QUOD%DN*MJ0[*L7LQ2F25O*-60-I5MVCBH[]]U2. ME)4UR;7X/-B^SL)=2:0+LGW <:(4S).O$S0:UVQHN1RTI;KZS)?]P!HP6.XH1-MRS )3';P8$TV<"Y^)69+5/\578# M=;'-4>U;2FC&#Y1Y[^L6Y_'*LVXNY[?Z)UBO01=#V ?1YQCI="QSO=C+;68( MQ9N53H7'C:Y9I%#$HF]]E[YXW>5:=+Z+\D$M;V?P@]:/?/BQ7.>,HT\4X;IE M: AZ=9V:$FT(C(*[N'EHJWQPT !T2*??96X87+ 81NMXZN47% ;?>Z,G$BYK M>53%(M$B:O>KDU_]Y4Y*ND$7G=GGP4EHU>JB^GH61,LT][5H"@T>!95#(\A+ MHBABL^GNRC+#T,24@HERS;UC[,+CSKMUFT_L MVM+L97K-0*J'KT 'S/IMYO167 2NBMB")4FR D<:! PZD(D*>LST\%^:3FVR M)BMBGL63S=O$K;@O0VXQ>Z*.?,K3I^6641\80@$#[5:LN#^1_!2[Q1A!77I$ M>D?T+ :L7I?V+ZTLG+(Y#$[><4M#T9SSMRPN=@LM@FT4PLN#83,78 MHBIY:<*6]9:;@:4(- "(?)O7*CD&\1I54/H8^_*@9GN=O(&A9G=)()X2,K,)-=(? M]NXX#AG-DPKX;I]G=VY[D6K :()>A6VM3L3!XRW7Y[\-C>A-X':@S_"UN1>] MC[FY0B67T4K]44:I][M,8(6RLNH>W?;B#B./J)*,;EXS?3WFQC;%-N^#^22% MUW&)\0V!;Z:!2;O*QU;^H@4;3GHDBIZ4"]2<%?_VHQOL#8(3;#NZ^Z*S1"H9 MME%ZJH217\]/X76UH\-(^AM+3>*/;C4QN[^2]!"^\P9XB'-HR-A?<&]-FK;Z M^4C8U]2NVXJTTKX>V,15."*&J9IX^RCTC7VG3?/;T%25AMGDS)\-5:9GDB , M#'3WK\(KM+Z07[=MNS1K\#4+J0[V!Q] =D'NY;V* ^XN_.\J)=XMULIB>R2# M;WXX844P.G?TZ%+2&4X[-X=(+L55PCB2EN!6W&M,#YQ@0:#@Q='"3&S42O=; M6&P&-*)@R(>1,)M[-Q1Y+2,S,_8J:F*EN[0G!W;/N%_HZ3".N64PNT$!BI MT1#=LLNTD[%@R1R-I(B8&%!M$S0YQTN4/>EK>5E/-5ZE,G3*=RR5W7VQH>?V M<%:E0*VYU"P_WK2DVS!PK K&:JRQ#\/5-09&A M'::'%'=.0)QDAY;0G)VM;VE^.:YQX\VL2?U(>>TGT4,H,4 )3Q=GGP3'8:6P M!WP?3)MDV5XG]8- H^^OVC1D?(SRTQ-1H/BY3_;54H;3XZ>G]C]_\.$HY+S0 M<,#_[1X(PY*^7EZ'#Z116=P.!<^RJ=U.R/T)A6YGI$K?.&:)ZTHCE M14>7#;J%IS4+$.>.N+8;Y84:P YCJ7N0:PU)G$XF5]JI'Q M*DX]>_D/"1B-ONMUDL@XV1GZ $T[8EHEG3:<)1Y.7FWSAW6:RE>6,[KEDI :>3=U:SYJW9W]1HVJWU) M$;Q[4.>8N:KR@6M[;]?\*BK\;SB=S:%F)HF34/=_S+48!KZ??OWDVB?2=\\] M=V"YA[X=Y.X4^$IDI&'&H"M6:'4>)'SN3WOV&MQWL&_) #\@$>H#I;[;GQ?B M6\H69_9E[,!^!AX4PW$.RBW)8T;JO!^1TG(8A)9;DY-M@WVZ67MOK7,8G#.$ M".,OX06Y[]=)=%J@C#7MJ#7ST4E^?#-'=[4]/%'TNS%S4N2'8+]0U\PNTP,( M'F07)SB(EK0C9M"JI7-[@_(SPP.N;;C*JID8?\T&-\9D:W4&HFO3U]YWY8-6LO??//F(/\D? M!:";!E_L9'BR/G ;&PTQO;A*H0C%4NX=I*ISH M^UGCR8=C3N9*>:&9[NM\ Q,^K%B^UT4?H-J2?CIS7W'VA^2BDIH-;2/S&=[$ M5NMG*F%]MN^)]5'FC885X8=#SWQU?B1W>ID1[O=9X+-UP3>5JY?C;%B^@V<[W%R'L>0W.,99VS HPP$Y<6^5+-9^I>XF MWN] (\/VT;XJB<_?9&-V.=M[!3\Y^GM_]"V)?=_?%PUG6J&Q][6VOLS%1&>5+@#[ ^,[&-FT+E.K 5JQ%HN]#"^?2, MIL^M%ZK"; R[IB>RI):_Q.D*I/=?>C;8K_'HB+35MO6J MLS9+@,I2&Q%0K2ZAP;=,@"-W4#C*NRJ:C6N;^TZ&,P.M'R1[F131XBPQNV*C MY%:,VK?AM9)63W-Y_"ZA7/[7GB%^W3,#)2[& F]Y$!L9A]_SC-S6'4 XN'UC MY7 '\=T\X;Y8D[R/T]#-%;$=TWZ#FKVU[U&K5<5ESU]]^)V3$N#?\?7H+JXR MM])T$]J"6P"[AI3%],%$,0?\%$33.Q5DAG6W6[J--*BKX%DAKMU^FE]1.=;= ME\](GW!X/G%<\&!KW&]B$XQA-9.DL(4_<);?88PS.NRK*/P&#@'I-+HJ:YVN<=J*S0]LXN2M*7VM2P^L:4!#A3T\H8C"KLGJ43AD%93A:.)L$ MW9EH0KI$R=,D3VG6Q9LWM?=E?A3>SB+QCS:]S2QFW? MTPT-.J$;. K50$(^)["T 0E8!9J,ZQD9>YPLW M[(6_,97'-IO@.4X,);[CSP_6D,B$,;AL@SG3U4Q6.^'71]U+ 2%'*T>L'.7D M33]]3JU,5,GR.U6?Y?.\YQ$/HH& IJ-406$$VWX>6_86VZS#"67[S1O.--OS M T4*U,8#)M@M%)_'Z."'7)YZ8Y.R UO"N3)TC\\XU8<2M1)J0MWP*M4$CBU_ MRA! X4BV+0K7[GZ0,?J>B7"NQK4[9LC$OJ-42ECGMAI9(Z\OZTK_<'M]X(C% M?I&]OY??M.8S.Q<=&.%D,8Y,01.T8JS)WZ=#83O#H&,F3'9JIATN^LU=?U@* M;6F2VK&2X??E^0\))X$+5J^>[/<6-4C2A^M\Q_&-@W T#9X$WT7T02J@I8&? M%%QTEASW1>#386-URN[&/39O-/M=425I4W-N%R:[(Z\D>;SIK)%,[GWDT!<' M8]AJ)\+$L>2\&3$L.8<_>JN1BTI *$5D2=0%T 1W7;9A=2-Z.RC32VRW>Q]K MBDXHDG)N.2S;0-"=;+EY!?'UIBS$R"8 =6P$=RG^X!-NLQ5%GDKHIZ2TU MH#;ZQ* 24R6);?$9?7%$B6D:^38S99\^:!'G/KA%7G;JQK[Z'1VQE1(6-!:R M%0>H&K3CMV";;?Z402[,-*#+4Q(\;8"'Y'CXUNM8L3'*T_Z88LWG+HJ$A#QT8MZ5RN&H7^51-;8S4!6DK*9R M>\+_R?9.KI-8@6S&QH+[D%*HA>8E+&9 P^+:B%:N@,RK2"L'^\!OALGW,W[X M9HMI\#W=@]SGQ&\9V*_7^&YOTCK%D@-;!SN@RX-T]2[Q( KXBZ\>'"/RS?J6 M]6J)9;5#&(5OM@63TV?VUT3,V!ZI>)C0=(9>20M_Y"-HLBG@Z7_G[9]_MW^W M?[>_IT%Y$_\+4$L#!!0 ( /*!3E1F4ORZGEP ("% 2 97QL/Z^?G^P_+TZ.GY];F%>#E MX_]Y07?;!/BW_&_"O%QL[!R<7-P\DA@!4H$$8$I^# Q*:"Y(8>AH%/0.7E)*6D556457; MLU=73]_@X"%#LV/F%I96UL=/G3[CY.SBZN;E[>/KYQ\0&'8U_%H$\OJ-N/B$ MQ*3DE-3L.W=S[;_ )E;?W[!G43_+'U4R\V@(/M_[[^4B\12"_VGV/ M\U,O-O:(GP5$.+EV[><6-77@.7]9;+?.35[QHUF/:]KY% \XDB4N7!GBEU32 MG56F_%3M;YK]!_T_^F_TFI M^BT"/,3#Y-^@(5E ^RX4@MQRBO&PU9P0A3 '\Q2:O@9$[R''W[%YTE9PT?CS MD(?E5_6TF5LO3\%.M7!L/,,":,*/#YC:U?$>/.WF(Z$&%D H1)#M0\$]>+HH M8E8[D04$H5-PSIU"&7 ^+3TY&SO9]D=(Q\U.V97$$&3BF:SJU>"OR34B*_L? M;Z=H[?LR_BE:*QH'WP$/$@*5E<>7,UD YXVA>KP4.-ZU)?@*?_,J7CBY:,_. M%JOJ\]F'O%W:1D/2KK2Y6S_O$Y:Y'#-SF07PB"T8[QA!$V(QTG)=J\*)H=O\ M[:>4BE&;FL_FB<)%+T6#0X-?+B/NL NINQB(YSLB^B&*8 T$R$-N-3.T6CY M!0-[(?V>R8U7DAT!P0_2AQ)O(WJZK=Y<9R/D PPQ%A#[%.HH:S3A*9I\,A-4 M"NU X#:[<98Q]8BT3=P'3"'=AES"3 Y=,N]^W_"QA8C4NFN^.^J>P=[ZK)6L MC@=[[VQ)T%3HMA18#W;2:[:TQTZZI':!J0FBBX+MZ-;=\8RP4.A MEL/?\:!BTY(IZ;UAAWI4*%-$4^'UPN!.FSN!J"/!JK>]8?LSD8+U#_P>> _R M?+=$&#-'$62'S)LLH'9S68"<1+4?U5/3LTM&2*-\5(:_,+/%55.S[&GS\ M$ML>_A^^NCS8HX:",L15T'"$&@Y&$3,3;X0\ M+J2;D*O2(TE'#%?TD1O7<327^-;7F-]^. VJGI-4Y@#L>5;?OW_?D-,R/7-6 MR>%827&N,__3HC(E,I?DIK#'ZSRGNN(LJYM%V?K;*HJ]A2WM+6_0'2#Q4E&> M07!0&[;4#=E/)7FN_7$E79AL&9]8$T0.Z5C!C=N-;]C5!#KBKO=%['9_+]'B M-J5[N?]XHO71V.$+]1ON"'"/)5U4G:K#:#;6[2-O:;/3=4=5#%=?"PF9$@\? MGC22BBA;X!Z[&BOGAUPNLFLT-^S"-ELV_;#LGP1H04R!-)HW"L6(PQ(PQGJ, M*K2OG2321X\% )\"+%C ,8ID:NAL:RK-L;Z&OUTUA;!7:]O-E]--TBM'Q)A\ M'C1;E"6C%DLHP/"C X72G@?4(/-Z"J0]S%PR+1O\@YU.::30ZOVNE"?LD(2[ MT8TH=DNA9'824U!H%!ZB:=9Q=)6XFM)P<"-4E&X6^7)[6851@7YJU]3,V1!\ M>,CN#'WAXZZ<%(WV8S%ZT:_1[5CL6F+FY#JS2Y<%#*<\Y>A#$Z 14L,L)T$= M5\VXA]*F.43W%ZB2'_:[]696H@Z@9_$22->50;Z*T*J$_C#+RV)[N <"CDJ+ MJ)C*71\&]2CJ3/Y9FF5T!WH[.@ =CVW8;'='R-,MP8@ HJW ZX+=H'F81.5H MUUC E;&@:_DOKPI@%4*S)P@Y (7 L@W,NF%+:^Q5,35:H;.8C@6DB(1/$0+ MF+_! I;.4R*)!KV"A[NPO$\8N5H:K7JSE=J=\,GWLU,_-'7O281XKY?0PMYR M^CAY?4E84V)7FK$!HE.B>Q"BT8HH'T8F4YR. #N+V\\35R7H^H,;F>(34^ZZ M^Z<"#0Q18F=[LNKVISLY7Q*OV;E-]'+^=SE!+^M1I0+- Z<;7P8%&+7DQ(:' MB9$.NW"L/;BF1\;2I7HM*$(] Z"J\7,6P(\-A?/3Q8>N:LMVH,*) R)V^VH_ M:E3F(T.N)NHOK%DM7_X2%Y+\U3?FM85\0O0E9"0Q(X<\Q]P>SGBP,3#I12C9 M;*_F0]F"H:5/JF<7$4+NW_8CG_2X-!R36I^_]J%CYA JV3M#YO4]H^2'0U , MB#XJ(?]JNF0&FKP>EMHYNS+L-#LO7AX]:2@RC[B)(3O:)3@S52&X:# 6IN\# MO8CE>"Z8#/+D!X1P8('T;;=IPSZ_9[V1NB%%GYLC77!Z+]JO!F=L_\S]"L/D MSX.Z_#;C-S3A'IQ\%(Z+, ?EGX$8-UMT]PW+-$TM(Y\RR\C+A3.-E:53Z,+C M-8J[UCQ=^BODI*L6=-0V(B-KF^*G&W;_XKOKQU]X)/+D[ MV9'+"&5TN[L1&L*S8+)4@K&"+?0R#&@^BY ,S(O>)P(NP$7?LZ=%"I9_80'5 M!3MW^6HI7U4YS:;/EJM(]J(N@'R$T 08.31SZ3KM"M*0YIE&?#60X=V8UE.' MS%BQ*5?W,2P>7UO=DZ)! M2.J6_3C2719T[7F%LUC'V+4[/S2^L?EW9:P\C3ZCU<7VXC/'9H?.%[8B\X6+FPI^$[4^ M_FBD?%4:JN/$]6JZB!]5C]$0K8ANYV,! 4(R=%FR9W4AZB3ENX&A7T>HY(+4 MN&1^[JO"O5,V1UHU-6Y**$U=WG9@%GU=/7/?7O9'L$'!JNH2A."8V\/6S@'_ M,/%W^-:SN2>%9J0/R5L(NE2W:X,&O=1VQMTVE>A1O #6ISH=4R=8_;H:9SFK MD%:&C%89,H(S'@:1II#?YW?ERQ_'\Y(7:C0N$/K4KC#/](S9&?3!&F$-EO&M MVJ3JR=+>&3$*)JEBPT-GLWTK=7HB4+)/5^=FR)*!.OMV:?8CO)Q7U#B:VCY> M9>B(7"Y#F(7*63VM-GK,YGOPS-L5:V#[UR?57XN8O&DT/CH[HQY.2& !#? , M)OQ;4]O.,;KV]6H[0GFEI?/#QV3&1E,2H3F#BM.<%?6];:%TA0])=!GH>R'/ M N(AW')B 5,\[7ARX,F7Q&5UXLGZ@OW#;?MA"3>TT_,I4_9UP][UL2S@QLF3 MA/EMM6Y*]Z9EEW!FNV^S,63< PVCED;<)_%FNKG#%U]8E6R[<-$OB&WS).]! MXP:]Z(/,#_B:IN4(GFZ[B31J'>3;4,QWDE@AHSVS+(![G@J7TYML]2CN047, M+H(5RD$O28T/9[;.5:.OR5[^>GW$XO7*/$%V?&G5CQ+'W Z"=30=,++;K3JN M5:8*=(&G5K;*W;@Z/U?W@OSD85B$N(YY7,BX@6@T]717@N_];56TUSS?Q8*N M!T0)X32JBO)U^@NM'NA\%N5]L\*[=!@% MD]@J143?LKZ,KD"94Z(R<97U1XY(AC?%CGWJD[6-C#A2?]ORJW'7!8Q2HHG4 M)):0CR>?M(N#D6TPD^_L)O,(EFE&#A7?KB!S-]UHSFFAQ!X=OP.IBPR!()%&^R+ANO! M(;KW?ZP,"T1V.[2\"TH3J,SN<9WUN7WW$D%8R'\,Y0/!D BC !TX$ <3:/4B M8?A1UJ SB06(+\@BDEO/SD@9^KXJLI-,*/.F)& H+:VU?AH+)D>12!83:;V%)R=B'@:MN.7'FG&?B2P"N+ M@RC*)8?&]^Q5JQHA)_<)Z5%"Z6(T*@VJWXYNE\.&9B9BR;8P<*]Y01&1!4#. M5[C5-. QTNSL:#4+J,__^.ED[FV/>5R>]I%F:PUUY?I)9)%/QS$K9SRC/%H8 MM"3UTA5.S<+BF<9YCK(JU80K^16R3N5Z=_/L51.T/T=>RY5TY72,7_M\YGR; MP575;?X7E<'E' MW(S[2Z,6E[F'#D_0*X]4OQIW8(6QA"D?. ><4 =OG%NZ3.XADFS!8,@6Q0*' MOWF*N[]4:GBNG[^4>UMZ=(*0K+36YQ>V5X4X96$D15T#(TI ZH@H[95A%)$ M-$B"!V!NR:IV>1@@VL"1V6K!(H-.9/'HQ4=I=B]&5U*;3]"\$W1;Q'2F>![H M=VG&",VS%^6N#?,5-A8LZ&9?4^<,(>C&LULY?(KA(SVO[H)-&?04*(,4:%9< M!-$D=#?#"2$,8NW(XTE*=13]9S/AWQU+4RHO<>]J&/-4Z+O7WXH6HJY5/8 M-PS9 @,JXCO0.#.J"^/V3PJ#D3?6HYN_@AKKG-X3KKW=Q15,.665^NYPBGE) MWF2^BEK,WK?J%N_6K35FO'3NG@88R.:/5VE['C>UMB7*:'E/AF2_$W\WH1H8 MMYG!=E A1P]MA*^Q2V%J0V[(MY318F1'@D\VAJ8B1!I*C6%@0'F@V\K]4*G. M@\<7>*QM3*_KV 26AVW3::7;KQV^#5/EC"E04I';T?]>OY MD8FCA>Q'I0FUDEC+Y!2 1]C0S( @W,-" MF?-86>80-==8$[3D?E"P@_(E*5Y!SGTHP/MBH]V%\2NU*;MP+A6?4X3WR87) M, 0*8^#:;1J0,6#Q]7.] U-B!,SR%TH2DS\HN)QN IKDGQ*PP<0]O5K>6--J ML$=\7WO9Z\%C/P[WZ68?:'EQU3'+<@%-=A "=\]4TKRC9]"\6$(1@AL;>(", M)ZIVM-A$2AC,"-H&]MK7QWZ-3$[*#CFW_T50>H7N-MBDBS]?#A .O MR7+*2F0\]#[36)GP@"M[3WSFUX:^O*R9@W4-NS/TMFZD O2<&F@0PN!!:EC" M@^@]$!0Z>:+;;2].S1[IP2H\)H!%H& MBL9P[)F'KX,_50V:[JR+3!!GHQC0)4N9?)H4(:8 %QEAPB@86+8I1ATFMR41 M7Q@=NT8_=,>I[45KZMC"I/A[1FE(FF3?2VN$6N-1^@2GC/$V9CN6?*IZDD:U M)/2[2<8S^7X0$5.G7#*[% !*%#XEM$W1$SSW M24@D4"H,;Q=Q9#2K1?"K4=[Z0?21U)J+*S.7'Q('0(-2XD J"PA>C<4T/8'" M JY#E)!J$C9A2_/)_:I%A9WD[0]UFYO=ZVG&[[*D']4J>'1E$:VJ3J*1RXIY MFEN7S8'H:/HUJ,_WH$Z!$$GFNDG.HTM4VS)JZH^H0(;I]-SE6QL/9O;LN'U# MOFF8@-*XF7-Z@854&&R_E\GV@=LQ9I%S=(D#5 6H+\4CJ6H4Q%+0(Y1/+5D> M>\N[UL.]2\I3(LJ#U-34DKCJ;5\Y_=PY8.QR?HH1T:=VQ_O:7;E%2N MUMRVUXTL8)J@,H:?@N0\A27$HR7@A*=8+F-!E PE:;FN$'E2.QYWV;5!T&!6 MHTF[PO.W"_$?)#82)"D_+CW9W9]TV>NK\-'J;U_$V7XL0HJ;0)V@3/>&/N_1 M0T!URD 7HC$O":7X%"5]/N)\@!Q_8\: MO:^8BH(D)B^&@NC!DEVUH?"G_9PRH_:J7-2I3OTA5W>DC+%X_]C:) OPL_7: MJ_=VS(!/1LO7YTY?1\V)(JY=6%/_1T(=+"#]!I8N&4F"TR7\J'$*.:@ D4.0>PO1(E/%)!=ZVH"*H$\SKS M(@S-F4^$SQN/'KEU^]6'H=?K-N1MUQ>34D2Y,--$1X+:6>9# <9 ]QMB.7$T71?0H&$)=G8549/([ MT-SII\@GL<35Q#;Q^Y;DI6AVLGBS-K6[*ZM/B)I1/.+YZ9[\[@+S#,X?]K>G MWK"I+\(RNX1N&NLIL8#^DC+TO$;.V!@\D\XS&YJJP/^1J8#$VV6O6HY=G!DY M59^QXF(\Q''+R(?HTP79YQ M'QN(%0(%+"D#&=JH \0I.U&D1(-3ZC#)JLZZJD(E<6%Z><5-QE-E_1BE-EYM M5[B.P8)J$I9P$U_K^Q-#;V,@+(FL6FARDR<$'UWO*90>L8]"]M>E.YS*.5KU M-%8CZ[-:H)Y/'U6N;(_!E!& MRIK)W.;B5YIJU7(^J.1<-9]0CW@=MKC, 8FUIMZ!"3D2/AT=F@:;6J=&,ZIX;C8\U)Y-APCLK-C'5E5& M>7'0)-^B6[*> 8Y M;J$$? -\>9(BU]'<#^=,)M1OV=$EM;2GA,QCU\VYAT=F:2C-'&+PP?FZ M@/?0C AB]]TWH,@7;WKLOMW=T^+P1Y 6A":;3."S*L._+I:G"] (+3U7R'P>");-PT_JU2K2W2 MON8O"^AX(43]1$=XN^'H]PO1URSL/#5/H']_:H#LCA MM#^'*K.AHAGWX(1'"OM^$MU[&++]?G+:<3 G0G=&G^Q40V9JADQ<'[[W94W2 M>EC?X<"!KHIG@RL^HCK[S;;TR$FS _2]Z"2WT)@OE,1JHER:;M;J!N-&>/:Z M8W.N16[DO>-["^O>KX M=FXQK/GR@WR@Z4_E_E$Z_5'/Y3NMW-TYY;=IFR]E/"L/_%0J_^)=__7$DP#! M#^2M/ZREW P5S\=\D)GH+^ MK%W$ L;G6<"@[<4_Y(&+?ZSP#Q);)A'Q0^ ;"]C80G\7R>S^-*T_I)Q\@;S5UK V6(Z[#6'.'= M/;W2MQ7BO-^:TWE&=R\H+#O7MO)ZG!T2K1']&UVCVKN!$2 MIA?R1&K.=)%&Z^\VP;"N,/ L;>SL^H3;A(5VCPR>;)*T<;O%LXK8M+).\N[ M.>S2&^KGO)< W)8L3[,"<.!Y46:$%*,^HP"B]LYJ*YG\2E%'<+EO[T3?6;M\%T/$'>RRVB5+Z&; MDB$O';O1DO8B6$]ZVX&W7E<&^Y]9';+T/$WYZ S1_U_YL8#CMI$EJ%D(K"EDR72>U]/'I[6J4[M)MD[**I2472H3 M.I$/U-ZN7 F:9@&S/,/PN:^;+( =%Z.O5H$&3;]G_OCQ"G*RC45,X2A%9G0H MFJSYE.-"*M2/\3 K%H"YCZ<+!,+_>RJJP[JP:U)#+&#Q.POXII+Y2RL5[\,Z MFL.KBIYT[MA4LKMRIN_L_IW!R_,F\AX2F2R USB+!< -L*#D1W2'4#%ZX/TJ MDZL!FHXN+( <-P];7X]D 3>#+>D[MRSI]!EHJKO;A>"28J@[[95!_-Z# M1&'-[^PH\_](S?+YYJNR9Y[6-UV7,1.[=[9F[M-H*J!6^,^G'W-,?E.:"G,$ MUAC1CC3FCQ[ -,ICVAF24NK@?IQP6X[[".#,ER?[E-Y6CM]3?' M_ )E).V40&B2<:[^W%W#5<7QTWUWFIT"6PS_#P B)8\.LAM:H6WKD/GXFZU7!P%VT;W9>1:61- M$3K!R#;6 3T'VF'"K3Z1Q#>M!TAVO)\0\,2&R.%*Y%B=^TS[',YZ]X_RP(5$ M?0W.*1>NK<148 T_,4=U(&LO>9&U!@BE-QO4*RV9*A%;;2V5^$*EK<;RJ##E MT2]3%>=VA^8[[TW5+^0T[4C=V/LOJVE" I#2D,6]%1O%+D6.H;\7CS<[_X5S M_?.AC0JT* MX@[!D =4C+.!1_L0?OX#&])\_ \+Q>]QH_ ..-/X_-_LK0_"O>'/ 2?_ZS95J?! S"@TN'H:4]U MBF57*"Z4V@ V%2U$2#5)L@ A7722@N']X\-T12\Y\88"-45[K5!E?M4"UTWZ M\ _K^!3I8180%\4T8(Z@9='GTLJU<=6]8F +@JS:58ENQZ'35_IT9Y2>CU1Q M[I]Y,Z?BM&[T#=5A8W!;(/=*OXGQ&XHV/>$[>HL!W^*K3%W#XEH(7YLHJQW- M\(Y%[=3FS7C=]Y8N'%TWDA*T94=.OZ@1.104%%1_> EGN=9I"UOEO&!N)M?\ M#B/+[&$!M99=F1,M3 %UHG8\NA;?S0+D%]%L(6V"O>4H4_+ +;I'1*4;&-EU MQ_-N;2HNLO2ZXHO\&=7?>OK=WRD_R(F\!, MGU9_0-QB ?5^G:[0L#0U)RU! M>,?%-?YDN)6O K5O> 7N-WW ]6-)/7FEJ:R^-MVAE"U7[J$9.D=<71]5GYS< MT4KJWX Z,R^%J0261.M]:7;MVJE7=9W=NR#W,=#9K+G(0S!4QG MA=+Q#?7PYZ7+NVA[4!:@(,7&:=A[U$CQ,_2'E]Y=UI(*K,7(($;\(O=Y+CF'S3-$UD'K4$_+ ^4/K-J4*7(=L5%U'A M>=N29IUOOI9H# (>$*)<2P"=3U1S#KP:!G3:3#\)+)3LG%E"S"@W8 M\!W/>4\I"$4AX,]6+4=/;%:P@'GKZJM_7L"OH=NP@%U1,";6CAD;=.%W67\H MOOCG]@&$1!DE;7N1B]U;K?A:YZ6!:@$$;-'-/RJL6\1".>UU_NFIVPMA'&L- M4PE9%YK&M.\Z<2 5-?427R[?_-L9 'B6RE[X[%G,,^ [_B:";",T<9CJ MQ_BM-92V@RX BBC<)*\3=2/F29H21J9//_4]3>LSKW\Q'1YV6;ECY>;1]%K@ M00ZN*YMM<6OCPQUB#3^C.$B_P;@9K$%K M.(W''_X\@BZE3N#I@4V$N8Y_3T-G!!/30C,4MKV@2$PSGI3Z^90*)(PJT4YD M&]XM<+E;$USH=-->^[=9)@:$:#UG,2.UU8MFB-K#N*W=RE'N="4>GFJ?O3%M>?6'%D,X_K=+?F3F;;0N9&WQB M/_"V/N9G+EB7J)Q7LQJZ@09W^Z7_/-B79*P*XB$-/C*J6J^APJ-HAX)N*&?& MMRFU^OB,ZVJ>?&=3KE:E8VT@;";+\]:7W=MQH!X*.QSICHQ,8UZ4,UA7BHKZ M>/65NSEE)J^X[4XH28AO<=/-@]X<"?_M8I7"C+E[RV75#S4G:_<>TKKI:/2TPG]W;6NC76/;,N6VQ.ISX^LDPMO['P=-S V7G[^EGK&D63 MX8 \FM^60-LS+_NUA"0D;(%1PE$; M@D(%,U(S9ZPJ!_$GB@Z+NMM/K"? M69JRNRZ5^CUX+VP[3K#-9RS\T)#OB[W].TUWU)2GK\4^VYWW&NW# M(19">[ M;3-( VH$^>?NFALLGBG\\+#DI+/TI%]?&VD?1#_W(,X"H-8$- MD0/-0$>A5(0 -F@ 5!U8%J1Y@QBB1N]\'I$%PRWWHVN$^J"3>X=;>/Z1-<3ZZ88 MAHIVJE(;BXQB9;X_J8&UGMG76HPUV;U(&^7X IM:90K^# VCD4E4#?#A8^8; M&-EN@+.7 M9_(MDLWIAX@"\B:N="7R:,-L38LU*F7ALQUYGML=LD?MLWREE+8Q?S0F$B]+B\_;"W0 M6=^\W^RYA%(8PG20VRZC@NZ%GI6CP9.VNI]@*JW99,.7-U[F2GN_Z304:MU? MH/X&/M_<8ONIF2;$\?[_@X M6RQV_LU[7^&7/ V@D&XZC\D!HU0K_CEDM.>&3[2&0ORC19O.#2=9 M_IIQ%_\_]M0U_TMUJK/#B-/BZ<:(H.R=/C$QE4UE&U55O_DMP$DW8 MSP)DC7_-T/L*8^"VQO^UYU;A?0AQB/Q7CI5=7!E7,NEC8W,//;7HAKY P3*X ME[!D:0A#HGV&3&!/,+]^!?L_^=R;#D#1B]RL$$VR OO]N+.'"?3MOUOZHH.) MQ/>)#>G*HX%Y(GU:I+P4_5O7B!7_Q15<)((NAF=:%52R *^9.A90HO)JN/6O MHBT3+G&'WRZ?\T-LW@R'I[ 2518,1C4 MF:]9]G)T8SK"/F-L^,-.$VVE6N&G.B:?UZSD;:]CEUY"^O P4N#!D:_L;!EW M64# *@_X==W25*6L])M;[9'W]=X)HO6:*9P^R>RV+=:D0U5W2$U+(V0,-<=8 M=J1-#WE%2-B_0&;+"#)T)DN-45U!9-HRJ"0+;DII7Z !ZQV!DBMVO67\N_ MWIJQLTS1)D+W>8^5QHR[@GGS,L!0K=X/MM/\H]]A 92CD00EDX1-NBIXYJ(D M<^4==7/N>9W?1%.$NZED[I>;#D93BLHN(3].'M&;]C)3;)2PL#Z2$'T1"C!? MW-ABCN-KYGI@4ZHD[OO;:RKH-\"!ZIF@Y:<]RNNZ3XF)'T9L#S=/F?*_E;6X M(N&1%&8"*[Z6=ZV)6H-P^=2K*V91:Z9[4D;IJ(Z,%2%VNZF$=&'YUU5[/7:-&>V;E6(#(MP*)EG&MY9TZIL43M2E5]Q4_'_WDMSCO:<8" M!,]3ZIBWT+UH4"*8!73;L_T%OZI^ "<4&.\9\P'ERHXS!=HLT+*!56]OZG?(HY"[L7[& MMS,_Z::O;\L-13]O9&@ V?']60VY/6MC0S"9#(^URKJ M?#5K>O1H>]7?%IG_WC[\UZ;_97GZWYK_I3W_?UV=_A]449V$ -4&Z+F",&;W M4Q;PO?#&5M\O'? 9#JHI;WQX3/&RSE^TS1U-2O)B4U94NKX>UON#&&.D\(\( M\-!J#&S-#+4+[6(#XE"Y!F6J6 M;JC:M:,9-?(5! 7\S]W! 3C941O<@UX:@29,-Z@NU(W \?0X.34UCTX^)R?> MU%BI"QS'J,$7ABUMD''E _O2Z?5&ZBV61'!3 2('IKIQ P(W1_-J*K$N$! M,>WNX:-,57().2-(X-41Z;A(12OE)O_S,_,'79)GW@G-Y\\W7UG0K-#" "U( M)ZEF$:']18XNNRYZ/]7HVAYS9]'Z>G& 8?K[5U\?ETP-Z!4G+/OD<_DF)+=[ M*_F4?9+'V/ZCQIF_U7CDK&_FG;ZJ^\]=]6D'Z7>G^W%/EK#@*/ M/Q;^-8'C3/X#+$ YSA)R_(%PAEI!V[OJ=#2A"+[FHHNF21;]_$G1-XXYW#]H M!&[9!J#?"I*3&&E.B"UE]:HJ2P(/_3:>%SW1 %E"H6/SPG^(J8,VU-5&B/7" M<(>[X=P_SV4F8P7H9A2;KNCM@W13$C:N37?,;V15^?GPAEZ0A]/P"F^)R $I MR6%S'0GO-7FWW95SE]K$&/&0$3[%-N4MCY#[J,^@F/TA F5$%NK$Q[I-!;5! M;R'/.6$<\EF &W#=.6_<<7?9VH0B>VFAN$CI/<4F,YHOZNO:\^S \]I:T@%WWIY;<7_KM8-2'R"0I3\> M(*DGH/ 0S0)X!%1[5A/SXLOA"("B_:,C M!]\V7PO]V-4F_-/0^EC L9+PT3=_X@O_;@3Y5_'@ P39?I43% SH@F\>'AF<&99*\;H"@,.O5:4T8SVP2;@&^'Q3*D) MJ+_TZ.$T2U0@F3L=EG)U*I,-R8YWQ+1?R].B]*I['C=S-ZH4V9O,>_A,BF"3 M,1>YB:3=S@*DT.UF1O(T2U6ZW%N*]BRZ*U0&.=-G-\K4I9N02[-\2N3RUKXV M^Z3?LHG0R4WPPV5X/Y"\IE04$_UBZ.=Q!ZN5K+*(<\^*E.[$<%W&\[ ?_1- M1+WP.)[@U_V*HWL(B7 /AB%>DE=*Y3_I.R^*7WE5]U9FS]>]-C(^G#F:<;&\ M@'R.N#.<*;R0Y3IET7_MV3UE'X]^ M*_Z7?:( 9S[P3:T"GH0106E2;#H=0&Q[-MZFM/_+N0*:UN8ON(D)S'CH'YPIV3KR1]YQ!?Y[9O+/'\9! M_#P(>(QY,'H:P=$J0UA=G&.\0CE[^#%9HSN.NY2_V\ M9\S]48V?KKBY=,2>5/^6JL:Q-HR'0HZXQ.\8W-%5Z@/R.%U,C%" J5KTE(SK M9.Y-A:<]NS"F&>R;&R1UYT'%V.KEJR+M/[(7S"]-7=B_!4N$^R- ;5@*T);<-W0RY:FG-DYW= AC[#RIVUNPVF^/\,7'UE0,51'C9B2B=>UY@%\0N)A8LZUV9CZ[GEU](L?EGN:GHN <4[,, M02#ZGC,)NT2A1>"B)S"-4CUP<(]S#VR21*SN%DJ"L;>>"9]%WXR6(*O&&^.] M"BW]L91]E#VN7Q+ERG_$J0PHE[R(%5U\SB$'&YZ6HLXP'K::TOR#8,^WYQ'+ M>\'[CY%[M24"W:R'M20Y1SS]B=NU^*^?F"I)4Y,[>#M\5RS=&O(E)\:9.]#M M^XWE4;[0;(]BCD4;#QD)5*.,P*(*9)IY*\6B5.*N\6YRP[<,&UO/,>M[YAT^ M2AGV";>T4C,;DL79-C.7BFC.*%Y&8QN'/[P>LS1-^@UE.@L7,1GPNI&E>\5R M]W[K<[D&;(4Y\JZNTNR\I)VQ49)MDI"UHE@ %!C(_#R%69.4IDT_-1N)%YI M'0<'B' YI%FG6TZY^Z< 0PE2IT2\SM'7TC*/&UWIM1QJ#[CYIV)H3V(.T)V) MV.U(N2Y@GW?2(-EA)_L(\&#/,!,F8$@*389#>8#%#BH MBDE'[3%XO7P2V?!&1HG26*ETD>]'UMQ,Z;TG]S+X'X$D93R;BRA M !?R ,O9<,;#&.#)"(\!DB]QM0-7EP!80F0U]1J&!1CO@WC!8Q/Q7RO^/,+1 MVPG[+AO'W"K'3.+0=+"3!40GP/Y^"YSZI4P14PRV#3T8*$1;J$+[!;" =9(0 M8TO\EULVN[\7R01/H/9#OOTI?/792\9#R,T/W()O?G/X^ZT]%_R7,O"_"_9L M[A>9+?]=^$UF[DE" U2U)F!I64X$W4>&J^CF7^_ MC=D#T:Q_*P1!-E]F(OR;'@]CPQE>!T'&#TH2D\'_RRU0^DL92[J*,<1''GV$ M;8Z>97Z V,Q<#XSV7>V76W;,+V5@_R;:F3#:83L6@)%&KPX6_?WV$?__8.E1 M/\,?OH]+>H@TMV-;X<,GTF8G/M8J) T\(&U4U_WR%I#$Y-^S;1_*[]]H+/7U*!O,H4CZI+OS+;LMK[ES?P25/6?[W'V'N: 8XR'RR>-FFR3\/G\ M_/L['(ZV[$IWB)*XM.?C/W4&-(<8RHZ$]=QQ^83L;6]VJE2Y=T7KZOC'[]]* M]>]LSS[F89=+XOAZ5F%O02GYSNS))A*O\:Y%^+;6(Q%$ RUT0Q M81?[$\9#+RH<=I[37LZAV2,Q5#4(,4;/HLZ3+9?,:>9T_X]Z^)AK-WP?>Y$7 M;8,M;88K,DIT4\(XK7NT8@11"ZY*<(IB2>*):1.N MIHM&4-/ T&"(*,O-;UD\)H6F>O($R:N>:,H]\3) XOYF-M=:T;;3H3DGK=FD M.;YO_]"F;^NZ\RHEQ\WW\^%MS M0W?#3%D1[E.?G^J] ,WNYA83.NJ-U;L"'L7ARO\RNT! <-X>C W&XT:H HP' MWQ&W$'7H))2$YL/-]/I@ ;>/=&OEKLUK99%7SFL&!Z;62"+N""E5&(?1BNHE M:<>Q1^"$K_@?%@V9C%P[*%Z=_V (, 2JU1GE#3 <_U1'L_$=VG[_YFUM6J/A M-P/\RI$5;W">:3(ITZLA%U)RW1/L[SOQ3KI9*]TZT'/_L]WI"FWIRJF9@)3S M1I=/ANPP51J2.A:5Q'57)Q<@[=PW\'31!";"?(MOL*2+HV<-Z!+<QH-NOVPDPK/,04%TXJ6,V&BG7#W! MR.-C!+*WH6<)8?[J?=?J1\_3^OQ41G0.GWO3WE]W_%WM+AU7:$".!> 2(5_% M5?-S'VH^>I^3[052MS%?2[UK[X4F(@8G MUX.7POI49^C?\&GJ1MQ4V)=I3@GZ-F@DF=^=\-&"=&)T-F$:-QT2W*[)%['V M.?WUA9*@^7SZ!\;-X U;/^;V$XQFE&VANGZ:SZP0^\1"F.6F(&58T^AY9(B MX.N-'[;1O_WU.?7_J=01@V]:[18"U3)3X!=YOP],NA/AB<;R=%W01CN^REAI M83Q?PSD??PO>H'?&:;@RW^J!NYL2K\ ;_OW91]F"B[4?,:?1#?ADK-? E"HU MDIQ;1'1IM9P-S80)W^F08G)\7-:<\=":][+6#+_/_W^L-48VG]@RKF'!? 8[UYL1DEN&=#W@N;,TJJ)*8_[ MR:+K)Y&^B<09.IV*'C#!F9.W8#APKH137G= MZ Q8O4I<<3]3="CZ<,#[HO>%KCGGE7ONE?Z6+5HLEUF"IKLB+XIBUZ"8@0$3M4"C"J90MX_.:ZU&FK$I=40 MIDL])5-X3-&AP6KPA>WKXVHZ5-7*GP1>9;$/1^US\C8U& MC?0B?4K .0ORI(ONJZ,NWE;:7K4%UYMX'V;12W/BQ'?>WLX3CX1,*AP2.64B MNA_-VR9#/\C UK>@4STEVII"I<'-+K2@YH: G63A,:*5;X-HS]B"S:[UW5G> MQLY*4DI1[G]: X%(@A#<&Y_F_M304HVA/55'4R?BFI!!SH,BC0N-/M>02\3US,%*-;41Y0!0+#;8_:2W@E M JO4("M% 7'AT-N%''G7_*Y1'05*6?1T/0[>&:+"! &R#*KRIS8AXV/2%%-J@S6<@SJY.O-'PB_F#TA;AJ; MEW$VP5%H896NJ* Q=?WF6+[BZ;2W9=@%PQC;O'9MK& ^\TI\V^Q!SA.]AS M,G20IP].MAL ]VZ^QH-[I+KP"N!A CR.[E$ZSV0?TK5IF<)*(Z]X:$6F-/"% MB_/MT'G8G]JX<_4UYQN3#R.99<]N& :?.'AWJ+0M8%"F8R-H'XUU+C3 M3[!8V,+CA?W3N"\F3P_AGAU\)#28KU;] 38EQN2=)\%N8;F-_&B.]..,UNC] M_@CYX*M!>&'_YLU$XUUG)[X92[Q,-"B0U__P3C.Y<7^P2[Y9RA?Z")X:"X[33J/;=8P%HP=A]:>O4_)24#OO+!I8?#H6VFBKY. I;B]Q M@MR[8\Y?X-[)06ZN*/7_1)S! S'$1LPR%R5R5KLKW< $C"*N+M%LTD6T5-*6 M)-=6;K_?F]N?5;-C[RV.#/5>[&P#.@"SM0?]PZ*6!9#TQO_L>P;JV1;09!RV M?H ACJ47N:(I^? _U/IRUYZGC 5T!C)'X-\=6Z V$D<93]#?2EC M%UEH;M\:SX6T@9!#L)QV@@4,V;" =WIY$*M]&@(Q?YSAFK_?2S#MY3(>I4K; MW1]\L >9A.EI?9<*;,#!8 3.CYF*8#I48,'WL-^+L_9.C>,C!*&_$TH7_0=Q M@OJ@*7GJ3S(-_5F<:HW"F"-V3#EGZCT64 A])- MU%N4\0YYCMGQ#D0"7'0#PX5,(OIU\5ZM!D_4HP$[(M_5=$/<\*+C*V3EV!AQ MCY92XMM*DK5(,LW,YGF%5M_WT>O8Y5,T73"4^@R$.GV['D8&3.K )50]WEXZ M6RV-/$YW6\CG+MF.*N\+X*]-9"O0=W*R5LRUFC[^4IR- J.+WV$*'!9:BJ/! M_3%UFTN89T@\,719@C2)K6WE""*N)DGE.E>V8N^7#UQL#B\^U1OR*.:V6>*Y M^W>?O1GM90X@1.&!=A-F;F2[;D0&C.RPFHJ7^\X"1, DVZ'HO4C+'AA[0[F[ MC76#S/"8W'M9$NV(4GQ[A)$Z]=J[3\<&&D0=9,>'$,_Q=)'.URR@MG=9N9(Y M!9/'^N-E4>%@7WD =O*:\6$PY@+/L9$?W#,],_MK\9>476_22G+8^92$EN [ M6( /%-XH, \BA7J,E4'PHA$;(52LG0@#G7&(Q!R8VT=-(KJVXBJ1X__X=2]#M\#28%=8JX.CG>H;!K*!05 M6ODIR%C# '*\&^\=-4\Y/EC)I[I4K_JF5^U@S%];/?(>N+$5E*^4/P(&ZZ4Y M??1J=$_1X.JXERMYH7S7B15>5RO!6Z*\RP@CYD@/C3KQ:AQ]'IOH-MK=E%#, MWDM*NG7UQW%&:LVD927YT)79<]DY+"#3W?7>U,4Z]\1EC9];59/5=HRJ M#?S4D]YV _N?_R(R5JS#K3IYU]C*H'%NK5*!V[%:7E+4D#GMHSVI[ZQ(KNJ< MO#-3$,+!6.U%7,[7NJKHMSWM.\H7<>U" M?Z]2MO4'?XXE3&(>8EMPJS&*AYQ/LO;0;E]5B+_Z7N;.V^%\WMU3?@T';_6* M=>FC>7>>SW]PKJBVE%"#;"[=>O5)<[CAS M[ZOWJNX?797TJ7.Z^W3W]_V^Y=?G0:_-I/:LV791-5"T-,@7F&DFP5K ZTN1TQ Y2TO2;"-1\?0'+%E1OO3CDDV'Q\62OPC MIV)U3R$@]YM[<3_#!1M8VE(TLD=%A;P.&IZX]< +^QC\)PPMYVM?09D"WV0[ M#?T:9ZJQG(D9:$"R;LW8.3)@Z^I.J*C0?>8R2;P9 3E,CUX2^2*N&?N=(W$L M3-< $+M&0(-BG*>M3;"ED U.U6FN.Z+1?1%#C.8H?(YT"L7"OL[N*UM.'OPF MNZ]6K5#T&[3 +V]K=C7'?XA8FWM70J^J!-3[_D:- .?QFW MC3.-_1Y5YX/R&/3*AT9\/$ZJ/HLZJU<@7W5&Y/P3WZ=-@D$SG_:R$O%Y,/>[ M?<;%./P !OU9^D!@AL3)6/3-)^L&Y7Q&]7DA: M4:,F\/ S>^>+%F=+?WPV8E9&R-^L?.U_AL/Q3SD>/V+1"7QA$2PR10_D+D,NYY4!-ND9Q@5N.@Z4 -)2>2T"*>GC<].FO82V*7NRQ&=M8 MH>:Z\_S^72*K%B2]8AC*S K.KSS0*0Q)8NS^960P)O668 9[*X/0 J.G0%(^ M+)\ZY0M)PCJK>/E=/UYRRUP_H\?UCN//>;]>L KT=3J%XTLY0?%I4CP\D), MA_ZF(2'F@AC";46Y7DN>RW)^G'%'ARRG]'B&'&',%8^JZ]+9:N6J M*1%A9(EFQM1Q2VX5D67Z:VEG9I2_>?O'1!#BYF ;K$J09LFR6 XWFS.J6B"" MIL932 D]8B):N@:U*@ A;[HIW:$^9\9^* L6="_0D?W;Q)D]Y&;F19?K9\Z< MOQA[&Y:*K@'/IC,:F=7 )(,'X@I+\]]0:%;L1K(U8QM7%*B@TV?J#&IARE-Y7XP8W7S,=\U10M9*UX%2N:2QA9PRG%6H\] MTQ.S:ZD=O/;.+>)Z^8[?'E2D#TO*+.KHQ:$=7GF&J+];:Q MK14MF!36C?EE.7?PSU)X%PV_%%N8J.^KN6_N!XV5$@:_+_A[*@#TX?"_AY?\ MI;B\T!5#S$L$_:Q MQJ9'2>]C8FB;8;UY3A\/]FL52[G!R'M7KZDX7/I3E)]F\H2W!I'&QY"PU-$M M/%" 3M)HM2 -PT@GC.BBQ]X/>P!29O3["3MZ0V"N!3N2[,\P_!OK=5]4Q"LF M"EL+V,SG;;F#FFY0$VBOAL3CJ_N3:81R>$P_/J@^S%1J-&JCO,9AP!1N*+PC MZ4'575PQLWO$)RMMYE$F?.ZH\N%E, Y^1&P+&UIH06_X0'RE/*Z3.,N69(BT M.>,TTPFF>O2,U@4@V+E)?3 C6+]I5B&V*$OG5NW#$A_O)_8U<;"2@$()+4XF MT@^\FML&63W+%8Z2.]'P$DGU1Y;--+Q>4H*6!=4-ZGIZ>3:TK=ZY6'R^Y&[0 M]D/;U# G_D+JF^G7/%KHX"F=+_37M^=HI<+ O)#] N:)-_P_\*/]!TC]6X#4 MPCPIEUD '&!M@PL-\GNHYU9\CK=YA)KJ4E=5 2S)I&FW(,#PYF2+(EFIDNC%T:':, M_$DTM+O<)7!)/W7=O$N36I?T+Z _+I*>=_7N&\^R>FK5 HK1EW[&!@%5_HSY M,4@\PBB0I-<0@<\P4;XWTQVXT*$2_O2D_1@0! M?R620ZSYL'E%) ?.^G;@!8&"?QZTF11;675,T//_0?CH?_Q6>3P0_9Q">>D, M1 KI+1&?J_N8/I^.#)X718:UB&\<.WA.UEIJ*5Y;Q1BZ]5B,,)*]K0\3Y 4" M]%E[V*[TVU@O)?I'VF7*K@NN%![(Q87\3K-'-,+Y_:#&L+:$] =GMG057YML9K[^0 U5 M+N!PX%)LJDSB5<"A#V2Q6%YS@ MQKQ&!S_MG=EPB3']_LF)<<\HD;.;W9*Z'\4;MOI67%5^[5$<2[PTCB;I4"5H MEZCX5\E4B=D;0:.KYQ"RJ50@WS#U=#;+_7B!N>B2@PMJ1/VFUPE8H60$Y]WE M]R@:7X:MXY=FB,E!E@S\:#CZFY[5E5 ME[NA0P3CM?)=H%A'OOQ[SC!,8B^?6O\'H,3=QEB;6:C)W1@51*(/O2["'9HI M(LVE,K-KVJQ.OM_;V_0"!^>+_5.(5KPX_G384&U8I@N(O+G_W@S$FF9G3*HD4DN>6.T/"6?LQA5,"JNU.B#UX>@8'3>!X M]T$'BN(RC)A+PYVBNKZG\P5'MA"7T68*#NL_QEO0H% M#'[=C_(I^_3NIW_*^1*4B@?45-P>0&3T;O3/46]! 6L?]1[KZK4+;\<7!Z\, M=L-6)$PNT+[M>EV2I._L:YVG.S\-#2XCJ5@3:L_H!Y^W@>WX2>CK;I2*J%'N ME8LP0!39AOKD]S\\)?^":[B#R_#9LI3 !Y>>7G.[BOB8[Z)N^:88,YCI64A^ M[&]?D2_=@L3J[[B7$0EPH6I&#%N:?MOM'3-5DD[+RW ;SMK\N\?JX >?,T55 MO\B"_V?$4\R]]I+6(*F3CS-=([=A;:M]ZJ2]__>.:/D*%R 64XC_ A;\F-&Q MHBK.Z-W_=?[!M\I_(.K?A*@:P6X#*$J3PGR+J5)_^0,]EHC_8QRN*=\[:633 M":)*9HNZ4HE*Q7:0D/XD7WUYQ9=*(>Z-DSME^?$YLQ0]<+1(;,S+*GIW*R#Q=QN2#4R M":LUOB.C@X,YR/((#0]J":^U51B-+%7>M68/7R#$S3"/#T!\,60(A4F6 M#V[&5R?=H*1V528LL"%EKX;OW?4^%^=S34MI%735#1?1$OX+:E@ 7P77)L^6 MT05;E9MA6[C&0*19OU-SV-PL)@P1(V(0FQX942T9>-9%6JJK4M)_G M@)ZN\>F3OME#SF^);+ED#(86RU* G^94(G8'/IJ1);9CKBYQWN)(5[UA>P]G MJH70]/H:RZLW/+A6Y*_H.!2IMVK).C R&!DL_4?&\W!SO6"5O84%:]G MKM_^1O*$\R2:+7>0<:459\2)P]K2H:T-$VU%INOA/@P)0I:[44 MJ6S/?J5]W6 M=*7I(:TV!.X&7TD-@.4@4^WL2![HLM,HVQ$$7BE& '=*+DV?=0+1&;UCDI!A MS!7J8X!;S[T.WAQ=\G+6U=N2=>0!UTE:90UFJW$]T=P3S#:YSZSD@8J@; <> MZ$D%#_3LPRJFOC2#^)4+2$(',EAGZ1 /U IABX#9*#/)KR'2;FX/>AL^6 ?% MW5W%@+&-D=2";*:]?J@ID6ENRK:9;[S8TC[:MH=X*>>FN[BB\V;R P%&(TO0:PD&5 ^7""P P0*?ZWG@726NW9W M/;#\$:W37+U+R)I3=1YDB'! M+2>O*!A=8=@2;)?O/46>?N09^ X5H>;9JBPX7[O_"C*JN[C'CS0BG&9?-J;;D%SV(IHZ^*5SQ^* M0P%(%I([X+66;H :PP,18:W&F-ER SEH]6*SR:C6ZCGR&_GZMG/9*#<0ZV(: M,,E5<."WV*O*7>ZH"Q]^1$,H$Q#^0)20_$;7HKC6A1(5)9A,Y(K:NU_>"&+) M_MD'?BG6LK^\CX$A[1W/I?DQ>* V&80&#Y0XDS$M9 O^>!^(MP-RH-">P$CUO_I27TN"FF=;0Z M+*E&:Z_-(,0[+&4@UZBUIZ[O5$-?O\*[8XUI5A*C(>&7234K9\XRG+OB:9]W MQTQ^[=]?0DNQ*V/O<$LZ?X?Q0)P'6)&Q4' SDOYN-"T2]LHMQ =N!!_">>V M]G7=,^/PJ^.J"C48'DAB%[_1:3Z276Y"$_G^ "@VPQ(>_I4+8/I[-'^(UR#+ MXUG=S@,I=PL.O71&([K 6["1C$Y*(:.]!7K9;9+09,VR<$<"UECS[<$HK=6T MVXK.$R$_[^-*>5WY,9--$-D<@_<'I\ D<:+P'9P'B(U11UFP0?P9'BCCED2+ M<;Z@75W@PQIYI=Z(X*G"5"O?:\>L#7HZ-<4+9;8[BRW;5(\!OC&UU@]H8FEQ M.Y"5HRUBX'99F3Q&Y%'@#D/9D_[BCOS$O50*QVCD](:&'"4G(1W9Z3OQ!H1& MC=K7%?7@8D<8M%\L"#5O'N_N#_Y[:U-=.,IT8HYJ-ZJB5N&M$:6 M<50RLWL BL#LLM:N$H'3XJ@ML1M#0?SP/5:F=M9D 2=1+" M73RGIUKD7LF::S4>%/]H^[3%BGD,>63P^ZG$=EW*MB_/AL[KBVF/7"I7T0G6 M[-;0T[024516/S=\3+!EE!Z&F;W&L&,>Y\3=/@Y,4V(R!-OPTNR8,K8Y0S5Y M?L.#)8^&=*M'Y X)#;7:^.&&#<+&NI(W]#^*?8<09SH43[0Y,N-TH[K'IJ9]: /;/77KCJT%#;A K\OGPK]"^Y"'ZT M;!/D*U#K*#FF$V 9RXALCSY:7]J^ADX*1"C0:Z]_7'I8AS1.H_+;CD M$5?V,VCX>4?:&LJ!L>7;1$UOP!%9\R>CV77S(C>Z"FJ^U:]-D/ M]?<3]KH=/9TCH.G+&=ACKW=I&^U:LD4P=9X<.=:52VOF-[:#4X#8# 1UG:GD M%& /\T ;$8I O-ZSOIV[$WKUBI&+\Q&ZMY/3XVN9:324@=83A4F6!8+D)0OL M9Z"?PBKG+YN((5B,%IYU_(I<7Y(:8H1UP]3<3JVN<_5+=Q=]W M-"MG/#M?A>@:K6TG@$GK".W19^Z?CA@;E8;OZB?; _D4\$8/BSH%\'4+;>7\ M-QFD_:$[ZY2BSCK68B^]&'"V!(A,L_X:V#9D,Q%=4WN7&NAE37=NQ@M-*6S; M^,O-$.W069V)0Q\/LN4E&0MCM(% 1+;;H.MZ?W M?LJ!IEFZY]"KUDG%18_86U07NK6&HOQ>,WE8*PS8=_ I6*"X#Z& MD:W'G&=K6)!F_LS/>*$=>O1=9[5,=OE3GN7,+;34#3XO\_$_K3 AU?73B\9U M8X\[J]0U=K_7 ;3$\V(8,8Q;3^]H1 M:O2)ML:Q,GEKEQI\-6-MC*%+P^7VV,C:DDZ*=\_J+Q?S% M,C58 Q9 #.'I?$$/CG(=.1 $(:6U6Z>Y'%4QD+WB3O9J63\9W'*Q+D0A^$/M M]RV),4@@AF3\9+2R[JG&?#K.N#>BRVF?:E*?'?UC8O5]?']$X^*P=9B/7PA: M;Z'CS5J/N'5OSYQT.CW:?\"!T"!>%W,_R*@-%1I^KLCK=I-V($5T(/NF7USG M5DC$50=[!6MCW]/=MT# W3%5MLPXP70WIQQ[@"7#5YD5=:T2<5ZZC"YL%MLH MFRI64S44E5 X/, 8)C][EKNE?6Y1+L6B^94T9Y*9P*G&ZM/#QR$)>+_1U5&R M/% [9!,V]'3$;P%MBYL59^XD:\M=S/$_"] MS-? 7C_63\AF6Z0_.I$K6^7Z .^/V8AO0:<@MF?HZOU^55$O8Q>,&_/ZR#T* M=:R\Z==&GZ[TR!S$,]G:LG$4L'^!6?L2;J_QC"L,&%(."!#B';+%$KN:$MDE M!6EGY8UL7)43*)18R!>"JM,M4MQ&B>\ M3[%L"<=>:[36*AIX Q7KJ!U$[2=U3.'5V8X\T)4$$T6ZD:#%71+)=[5J:2TN&DVZ(X8?K#&PQF M@6P.N- YFCY:H5W/VA0E8E/7SX<&_>/TW"O5>=GG6[QLWC2^?"NPTSA8SB]K M8J)-0,7&])*/$V@)=@+(IJ1#D@]2_>R^S]RU\W8EVFW&0.L6.CKEB, M/DH/2_S D8 6(/$J,CD]Y+L&D)0'I]#10!A7K J$:$=+FVT18-YFX"!T;740 M1_1O^'C^E!^H!1G& Z7A:Z%/T:^6/A[C)$#\IDUWP0^]W"ESRPFMD_+AM4&? MG:CX##D97Y]PN$2PP1T?ZI8D),^LC5[8&?HP\#&M3YA&J-]( _U'SC R;[:LI\ MZW/4YBZFX#HUO;P;VH[W^"K&W6?M7DZIES,18-EQN_%T1U0:9$V$"!K,MNF= MO8!.Q@L]^",#PK*&=E\@^]J$GJF/N>PO_WJ6D5H$.W G>;W)@'$J!,VF5:P_!#MD)HPON&^#R[$*:Z!"4X906F;Z;!VV<@6$;"@ M>>GVBAOL)Q]'MAKF^2Z6=Y Y)6"MM[76'59O,,,7EG&2).0,,1U,/Q9&[AM+ MIDDP8&,%C?0%"GZ6'2$?">TU@45XDW)3V/:1V_:0:4D=;RE*M9626TT&K[G9 MWE17MC(A,+O^":7<2YF%9#MR*A&;N,3!AN1919:.+<..NO/.[NK>ZD6X];WI MVELNIR*]A@]PGBLYFIFZW!U^,6%.:KP9$[%IU6([RQ0>PM\ +8" =2]".,J0 MN_[FB"AL Q!OR(AL16WE]HS(#]Q+HKX]Z=YUD4GJ.N%IX7<$GRUI7KN/FGI" MSV;P)4*3VS'*!_G^1$#=$<_>U#[F3XCA@;8&X/8!9^'2C,BG;M*MU='7=G9LBC0_!_')T]GCZJ$U5;G@2FVL)@A__^Q/.P"?"JIW9,JSF L-! MKB'<@C\N80^@K)WTKJDHNHS;5R!34]-[H?@Z5M;S.@R[VV)WY6%6WMS.YYD6 M#_8<7(JT!%V:;$9+LQ&0JISD<20*+^H#33%TLQB-NM*,D&FJS9[=K%N1S3+: M]39_>UZALXN;CU)1AI31SUN$%WVXZR'TS %7K/!U!1W<@**D Z38/PB:A$G1!W>L7FQYX_SZY+_\BQ__*?\I M?[<(\E[]%U!+ P04 " #R@4Y4'7&&L162 (X $@ &5W+3(P,C$Q M,C,Q7VM9ZV90?!1, =L/'C Y0 @M$X(. 7_ ()%8(/]6@E8Q,7$)*0D MUDO^.>!WTE*2TG\&?T[RW[ZZ3E186%127$Q<\K]\"%X!LA+K"H1+A86T@'6R M0L*R0H(N GK*/I/Z@D!__T06B7M$W#V7&!0<,CYB"N15Z.BKUV_ M<3,Q*3DE-2T[Y\[=W+Q[^07%):6/GY0]+7]66U??T$AN>M'-SBM&W /^0? M\@_Y_Z:0\@3 W'-BO0E3AK,%UZZYAU>)"A0 RL%7K:EQY@2FT@C6D;:"#RW? M4J3R-JPQN$A+\4&2AVW6[=#ODA"#OT%2 -PQQ0VBV=I$WO:$."U(C@*>-)E$ MLO> 3DPI&F+*C.9?2((8M+$\NHV&^E%(^R+[ZJI5[DX_J:!\BT*^5XBEZCHY M\7?/>2,_EQ;6JKA'6%:OW(6A' ;NQH:[##>'#K5S ^D_^Z/93D'/7$+5_3HJ M7C0^.W3VB.E%\>-C;9J\+ $0B)S*Z:$\3UZHHB-E8[3I; MJ8#S&/,4Y<.%3-RLCMRV) NYKZ)/.'8=J&C'8/X86ED7X@@ T3;(30"(#$&I MVGW@V,#<^\'VA:_'$:]+GIP 2 M/X3.MYZ]8<*5Y_"ER& ).X#WX"%Q'[2;?5<6,Y/I 3^P8+W[4G MX" 4PPGZ_K7=XP=+_GBFGV6H?/B9PD5;AM%TV[%N(";W;HESWZV>9><%(8Z: M\Q'O%&"#"ZG0@C E@P]>^MA+3^XE?BRC:Q*D^0HY7=:X1'JLNPM_I*:Y>?AF MJF%-[R;6^C,A9R)=K.YN%N\L!SBD3*[4G !(G=TPVJ;)W0O^:B05AUIB0I_- M1]4L)7T75XF>P:=Z7;2?2[ GO3&!-O>^&KBIJ08K;H"UAUX\Q-J.&-FZFJ,V MUI='/C7J>#_F$A'1*"T +EX[.H=_ODV828*T"4QY5A2[#OY.(%:+5V)G"Q5: M$)6ANL[AV=""!UVH&( L M"!WXQIF>&GH.RYVV&O<(]CW4:*(XNY>ODJL1NLY&94O6YL2#>=*SWEEO$_/[ M3ABP*4PIS@&N)^\1ZH+)1![;IAG$)V'=2Z"1N24+ MW%=-#8>MOHWKUMS$:\.?12OS!\8G;\S[,-DYYD4R+*.&SG:[C(KM\F$7LWL< MGEV+]W \OM+U/KD*B&E07'/D6'*C02IS $9*'N3*$9N.WD[="]VM@-@FB7@Y M[!Z,2MK73L_KZKR*+K6\OK=F+S/JLW5>)1@W[+(_T_5UR&[+]TER[Q*T'9.. M/^6FQXZ%+C%0R43Q-NG@J *K#@&@"16'F3@6Q:P]D4=WX.J)3 ]P16Z._,%#95 E&KU"]I* IL9 M^UBZ;)( D,R<1>]"ZYC-.L)))/!4@*R.OW?`.%_W7$+?,!T2P8KR7E%-4 M-5P?L>Y]%3BPG^698L+=605U?#V<[-@*Y919WE555OZ-O1"N>\QSP'-TW5_K M=8P^WTC>C*RYX_F)E$8Y0TRD-(AS-R%8O>QPZ 6=NHD:C4#S\BLM9$([^QDS M[LJFT^>/]@1X%T086GY_DYT>G+^%NNG:OK2C>>R!X2VP)T[S!WT\4R@AQ(\1 M74A- 7 V5H^V(9&&EH'B?,M22&VJKJ?"Y;Y\C_%]D,6^FRV6^U,A[/F^- '0 M(GM$_(>;(@T-NJF3)A97V4A0<7RAC'6N%0,N^QKDVQK0=_M[%,0$M19V'<]/ MO3,@&R"==,CY;&K_]IKM=E=XY6VZT H[!=;@Y12_W1TDM>-LP.1$.R&]C*T@ MH@NA-/!X_OH[WFSE6%CD)06?R._?I<(4CE9>?(?,)43JW#/.N@/P@&**61M2 M +3OI@0/3 304$QT"=1/%\N@86X468(G^11PG.;>24R9['>=BST@I2HS\''Q MII*11FGMCMOM:I6NG":V8A\^J]6/H\6U?"D ;OAQM3G1U.B<[A&L'Z@7=X47 M]0IG86?\,A.SX7!!ATSNQ6XM>[G:^OBI?M/=EQ<7WE0^1+X\R=++H)S'3'9V MH$ _8C(5C]P30@FDO?)N,I?6_^CDO]VT=;(DG]!UO M2G*("WTO (+QD]I=J 9EK@*2?1C>CVO8_:.?">TX2\@SDJ5'#\P3>:+"]3;T MN&#XLZ]1MFTH*#,TM>K]L5-9%>5[[3]_YN6W2>+>4< (JXYT?+R=\'/P20Z) M_][GU\QXLODVI2FWA'D3Z3!SI?*4JDG']:T'GE4/)6^N,]LA_GV/XIH>QQ9K M MV DWX.+]M.AQL(Q7-V8PU8210&8A-4<1#\FF&+9ID=:1BS%6;[3C#-OUWY MIC44CJISJW?!6&YN.GYQSCL M"EXY)11Q$PUZ+TUXLD\/VFT+9G$-(,HYAKX%5<87\M]Y3:?@<*+N6US8 DG; M-/]3FOVG2A&)A)K;2@.3/A^J2V)+IR>^_2[[&/XX/G=VY;7Q&F%T-SWZOO,^RDF5V?UNIE/15]W( M^B$27@&%8[&USL_4[*7M4Y?'D>4_A=:J.&*X,21X C.%8C_C/;83G>:/(*5L M=Y=A1:!T 2 Q1KQ(%0O'/!X+B&I>_IJG]E9+2VDF2NOKI8BDOR+&?E#!$^C) M&+82KZY5BJ.';W?G(Z-UN?JL0.X\10:W&VN9L-A[*.?8=$JC=2[QFD7GA/,[ M'7RK;ZJVYIFB$P<'00JX3P"L.8]S%=SY_;_(*Z.AMV#,MA>36>@%;;"$)IYX MR@IGQW+J?:>%7#<_ELPS]HT/BI4W]UI[KAF]D0$](4S&H7R"2>\Q2M%UO=1& M#%?1AH%9R&$0XJD;<-N@@+G>.%N]#<0Y3&J1<=/(SXKT0I])^O?5$Y8NCZG= M>&.[=^&D[:2)NQ*$^ZDRT;T],^KL+["WM\(1:$8)UB>U[8[&NP]R75D(U_2Y MML)'T6FK7CFTJ_D5W[?.+BJ^:&M,+-BV9?.41KS'R:CMZ[?$H4YM(Q'X6_#M MVGRQ>8H2;@-_D%J'(7R!'$E8(Y:T9]$VUH;DX.P92 "X;+$;*0NUPFCUQ7P- MZVMJ"BD\E+U#G7@1)"5=@N[S)3$<1_[H=<]NX@2>ANG.4*9][>XG)/.1X&H7 M)44Y5XHV)65C$,!.M]E5GSZ:%).>_.(>M33UXL'24\]\>V\C1GP,6$B^9"@' MB?N K]7CJONRM&EYS-.<@]-09S=R ]?O5)'TA]:=C+"3N1J2JR>'Y]QLCE(_ MQ;XL<4V_>=0VO%S>L2Y\QQY?OI0&1P>29Y^"R)SMN''D.FP8PP3!]61%,5UI MA'50!=W0?UM1K-/)X8X(:("E?PLL$4<1)6$9E &^0::>:+EEXO3/SUB8O)#3HC MVHRT# &6+S^RVF&GQ\IC8R T!X#]$HD*8#JQ?=-]!_&TZ(\0QP5ZGH?3IXRB M:'IN*)>$Q;'0QI8BC]RS10%Z!8?I1R]'5\?,H1><0!/V-U@+N!IK=\"IXH:/ M0#<\P)M65.G)U0Z?H#03\Y8]ASW!7Z\S74O.Z1QW_RP:FY5O6S5<9VI3ZJ;R MAQ>@,+B"FDQGI\)G.<+O1X%'!B9<7Z&4&MY%[.,]:! Z]O!J"[_+:U643AD M'6M_A<3-@]^GVGJR>[!%97I8MR8[DL/;W-1<:/FT89 M&<5_J%+I^^O_1I4*U_;%E>"(6&EH-PTY\75N(+%-!%H7=L -T:$F4YU5VE;U M=,],'YF<&D!X6[#/Y\!DB0X?D :$ELG,SU7P<@%5MD8,?":Z%IEIIQ!MLA=4 MO,N<39\CJ4:?#W,_PKI@&3Q@.#+3>S'+RW#6=VUC<9W"MN%^>1LG!!G^LIT M.&\4P1[AI>!4^1^:O\8CDBV0&M'[IDZV#&E,]2<$'5/O#U2_9?BJ]8+]5BN' M]Z%P]Y) Q+U%-I0Q(SG&T>ESQ(5'G",A1.E?1D&N!;/+,7!)8OS0PFO".51_ M:PAJZ/3="/5F1^W$B+@#)U90X/Z!R7%Z$#,#+JY600JAS9QK.X(U82!DOOLD MW\2Z/@YN#,6<(?OX=?HH)>BL:>VK>1+@GK7)^J&DPA$QY85(3CAN#*6,GWN& MKDT:A".B;NQRZ M$L6NA"9@NOH-HML'-O)GJ1(7<-(A_AO Q7R3E%.0+"G8L^Y'3O".DD,"X$*; MG%9UR2=A;=\N1=GX#/\#Z%E/D=NNQFI+H4_-H,"VZZ+MR[JLI M_F]WF\/YQ05R>EN]&DN3/$5O8VFPU1\A&1IBHG_.?WZ0TQ\!\W#[B.7O)R2.(G8S2$R2)?K! M?PJ!X\\[^OHNRIC%#UW6K:V[9]KG?^S57.-X^./;?>Q,N8?&LFT#L'TS;/X,_U#?X@? MWV[?9H6;$@ RN"W14NQJR.\)Y$Y?;<*+&5 MGCHCS&\A=&XZ>F8?<&9$H>'=3+C"?^TSL% &EG5=IW;UWS>@I*(4;2\]A;[2 M8Q<+NJOR/"D7>]Y/W!.S''M>Z3&4D]$AOT7R[&;@6N0X\P7')P0-^F(V\%_Y M[P27$BKM-OU B_TR40D9^;;\E]]YSV/=,6RO[J[ARA E2[.U2SV7OIQZS0EE M;N?^A.#BWL 6JR\ ZES'\#^7?\%H%54$\YA'0\I7K7SX'WS3,AQ)D9][%6$_X7/OHK.1R-USUZ!C"!I-K9\_+K[8- M85 ARQ9V$;B:T1I!;[G&5X"2Z8IY-Z;<60W$^#*&3D8WDA;XY]S@JZ(":Z.=+'I\SD8U^;&21&?:';0;JT6 '<2U >AN,'@^;R M3Q2T=;7KIS)*V@Z)E6B"DJNB#W[Z,M!=,#IY2\F#A=Z/\VWQ#0XT,T3^8U8$? MYAJ.FR\NOS-/5[DCIZ&-,;,[=GOGK[P>*C(ZG9;<41C1JRD#BGY-:Z@PT#)' MR7@Y:^<<;[LJ.S6U=E,Q4=/3,>1>6*J4#?99Z$H)^RBOB*^ >T<%(SR[EL2Q M2F"EFMB-I_R^QNL/[) CX_TU(Z4Y?N0,1GT<-G>P;O_9Y1+)!)>SIX0BT$\5 MA-;.<<[B)E&@+QK234HMYD]2&V;+P.-TDW8R2Z.0T$42Y]H-8BJ76@W"(DV[ M83OU*EQ-HT5U>Z>3A7#![A/+%(/$NFD7H*L MGT^P5<'GBFGO;VJ.&2^:1QM"'F8P0B:W'="*:SWC@C!6LA378\] (0%P6*M" MR<7\3H^-5=3. JK0J'QWKX'M_ M0(RKQR(D+X7_&I"?'_N?\.B@L>D8H_[ MPX5JD@ X5:C7D=;#<1O&1L26M\:>J;$.\3!V,SQSI_H0)D9U MG5MII=,U])TT B.(FPZ>U"?6>>)DX'I2_A=13@!T7 /Q^UKKAXI'N/8Z'O)],>>?_]7P5E@K8#5E.;_INNE1 $P]P150^G"3*VRG5F>"SESE(S?3G$PX:F%T'O]QS!=%1RJST+Z0P>FE4!=?.26W=;5*?3 MTD,^K80_\7KR(CNT(K\PP/->W\:-/=K[#[50;& %YO^I83_#2\)MQ0:SR+?P M(57"/;_Q/?C4Z\F9D1K;.VE=D_L+ LNN=KYU?A)V[)NMT$D%;;AARK-9TVJK M+HZ3A$+9Q^!S',+&\K)P -:=E]>FR9]6\O1?S_)[3]&+O_+2EY;MC+6S"%'] M$EJNW9;I9D^7IAN1PN->+WQ?P1K@;@_A#[&%8]A5E$#^Q-37H$\K5LQ>;MV 102[!?ZP)033#:0/>GS= MRZO2 _5Z\7$>69USR%M%LF"%;\_KS9FJIYM&/K7<:3U6JO_BT*=UZ(1L%WG> M!T< ^Y6C@.O#PZ[NR#B#3Z>0E9D$5 \FQ>2QY=W266_H\/B^X7JC/9\RO>F- M]8T"P-MPV4&J_Y*^X7Y9+#A_MX,O1V3*2>]S=Q^MSM)T- ME\)TSGFO:ZF1;N_9H:I2ZH;\Z"\"*B?8*4=;'8*BP*D.M<#XA\%C(2&EP./T5-0]8I,_&<,O\P4CVVXMY0/[+Y7*J1U@,;:^45/;,W[[2R$^Q"Z1BN MG U[%/KU#"L"/6*5\25/:U );>)05:2-D>=!Z&B(&/%2>%B7*7VB6C7C4[SG ME65G\!8VMV\%PQ,JCK,[ ,7"%G^!?LSAH>U*+^$-4VOF5?R4.3C5A4(PL:HQ M<^5M*F^R"RUGZ;L9>I 2B@!^7S]\.R8LB_TYZR@Z]0(XBYYG^]9[U MZF95J_UG@TV;&U]_4*B[[=<:P9?TA'4O9GDR;[#NO\(WNB^0.$>^XT7MK+F[ MZO+C1,F_']K@1 M6X*!6UN0U]ODLT=[BB*>XMLU<&;?D:#3%3BZ#J"8J;2&D3Q'@J.=-7)]V V81IADL!?+\I",HC)=J)<;RB&X^D; M; E=.0M="Z%*N;@<#\I?,61&;G?T&]G^TC'OF/21G_M-DRHHO,47# M3*+F"!TOI6@HIC#=1)A[$M*FZV,=P"4Z\T/S^:C>DTWW_D*_P\NK#'_&Z&E> M>6-IS#V-?3ED-7GGB'@[?QN\L#]N"J]."27&H1OQ3"$.-OH:]BAX3..J12WH MU%%:7_?"[>"8NHN';G-+T[DLFORU'&<_L\\2#]-#ZW@#E=V5 Z73G;0?G%!? M=GQBX3MFB;OTL8#/01EG,TJ/7'\:J?>$-E8YM!K\TC8KXD]7RR96ZZ^@0AW]%AH2Q=NOMRN]/F M3\2]T"48<95#,(F,N_":!4 8,O,WJ0>3ZJ],CK855?Q"V'"7MB1AP%LS9YIN MS;G G+WVI>CPQ@15V>2Q*T?$.RED$E?.E4[J&9@<<8"MOHEK%P"-BDNOJ+=^ M7XTSUX@Y+@!N7M_CZ\HRSB6]V-S:D/7!^P[CZ^G-6KO:C@R5D$[#<#.LIV12 M:LA=R(DR]A+$JN3ZL$RZ0R6VL$B$S+N8Q[9B$ZW](B-56\34=X7IOAWJ75G, M=?'?QP^5_/TF#8 "V%;PN@'\&;1$3B=2&A5*@/3?"8!N="(%L1B?P MU>_[)N8:Q,3T.QO>5K>)/J:[(6NJ<]-YTY;W H#Y _;%-UXQ*APOR540ZZO#2\8L,G:\WXPV_.$JRFVS<1H? M/2+>AVS0X\JWP%&_A1/*7<>KK4*=1TL&'^>*\,=S#H$?,(\WZJ[L M7 PSY6VPQZ:N9Z6]+5]"+N7(D/\DK$1H"^; VK/P'% MTQ IN/7$HPE2&<9#56'&%\(-EXQ*";(M2TE[:?WD]Q1C*BGX(2*O%?:&R&-( M_!IG)]8';FVLSN?-6HS:[4'/?$:KM% R<*^IH MRBC*7D4O@V'&OP9ZH^H':R!>"_.@$%P@O "1D'A<] M+O_887_C4-L'J3X;[^H/3HF(I1(QK6-: :3!\]N$/PU(P"%OP]\%H?F2C^DF MD/Y^8H-R4K4AUV5NEZU&U)PLV'-EY_S%Z<=O+Y"ID[T\'>O;9W>HO([@/(IS M&KMR="_2-)BZ#C]7/NG9A5'ICN3@(>&CH >EZJ]IZ,)YM,A*%13XQBE H[!U M\/R.J4-#VJ+>BZ?NU3@&.8G>YB 6/G"LN>:\.W:2P42A-KF)OWI+@K/>[%]= MU8S\P'P[8KMJ%25WZEK..]O:=]JGUBU; BK"S3!I'83$X6U;@I; &+[D;A:* M+0!8XDPG6EB(W?9O!0?N5D%V([3([GOU-PXGGHEKOS+9U;5;*#TO-=ZDXZG* M,W1C;@XGR!='%0#"6&_.;MSX_&D:B3SE!0W,^42?5R M3AM4=%&]FI[R,'4#)]M@87MPDF)^M9*NG&EBD%0?D"UD=T-OQ:Y>".V;[-TT MA-D,?GD4%O+T967ZZ,UE@WEE$+8U\59D\F@#TUX G M3^W+ML?:%HZGA%NLW.4B>V?7H M_>O!TR?.U?W6@Z.'0H)=9L[$[8*;F5^(CT3V&XA'PKJ--_3I4L;MMEO M'$EH4+\?MF]88H)>:_GVN<[1 X=.;Y:P]SAUA-].56RSQ 9!:%8HFPK-P+V/ MN@,8R/SE+A:,4P:O%+@UL%M/+Q_WH.FL-U M"[*^ERM?PI<\RT^5PC)8[D^,?.STF YK\@P\BD7%;+5EK&) MW)PZ$V$)Y-*.648>B3,\I7N=LF#/T>>/4]?9.M#QZOP)"GADCP/C?4.E?5@( M;0W1^0,E[1ULF55/V.X8$F2>U:_SGI67SX]]?N#%J]V_M=* -8,>*GA8 &3R M#>"=*X:B^)(NYSA'(9_W*)EHR1_M8SB)'%ID5[&?:4RYL7=IJUI'SD75T6L) M&^^Y_\*.C]7#F%6#QOGK[[)67> 39$,5;(AW#\[E6^9?GL4>"*=JK+[369 MEU=Q2; :$OQA(NCLGB$ ZO%,V&GP M!]&(*TY#%@C9[KG>%X/8XZ4MSDL!464O)[*T90P3O0XOM SHYNJE,^%6@DY- M@!GQ$&72MX,('NNCS)42E2EAOC*AGJ-MRK[1-GY@;W*;AF/9Q%\=><30LW'] M$;:Y@^+.SU6?Y*A@\FBG(#H700C091"QQ603_M:WJ#JS:F-'J8 MT\'P]M.]%S=B]*@I_MSMK<0] ,F73WY'RK1M_M[XKOR0KFMD8W,"3\UY M=G%V&3A&VU_S^FMHJF(>L?C;0T11&P+75;!8R/'\@21CF/(,GD$W2CX03*Z0%5?B^>#%.:_#/LE38H0Y,?"?O,MR*W%H828_UZ=F:UK'B5>#Z8MA>(D#;7OI2Z0C]0(<0 M\)N>!K"HZ2@1 1!"4N&/X:5Q.['6O(JMX$ G2=+G_"5HB580':Z>R#J1TUD[ M\6YD1[1M62>(F'[5PR:=*4X#MOU#_J?%( /RY-AS%2%J-=32B5YOIQ-2M/DE MB$PAVK.PUA<>"X#:7SH9.C'>ZNK8;D^_5_+UGP^K;-R%FF30>PGG*$/X%G.M&*.],9IKY.M[E@LWW:[C?85 $@ MML2U LO:J:IPNI6TE0HUM[9*1IU_&71X1/M%\[7/&SLQZ_2OG=7]=%G9<,'5 M3,Y%)VQ1]0U.-]]#6+(:^VV+WSZD8%0N@+P*_+K?H MC2KE@UOD1@]3WY+ZI[+D;9,?60.0,9EIQ5C1'?K1I_7YX^T'DW&]60K]AB*CS9AN2<^D>G6Y](AG/ZS*1;8OMFO?4M*.:*DMWMQOL^.DR.WMA'8* M =X12K"1)L<7VLU"N(^?&5[*R*V2J;C;-%*]+WG9^-3%VJF^FKL=SL^Z_;RD M=^BM: ZPG[&LF+_@_CB(E\"589QUH$&4P%&(\2PXK:F1Z#=JOL9D/K[RS>?# MAUEMKHR![-A+!T9O%YS.(P3 C3LXR1!_A1>6S4%,4=#5:Y ;>DYU2F:FYQ:Y M(+%P(6U72);B0^\-SAEO?CY$U+;MP$TB:TFOD H$46P '(4SPB=]12DMM2]? MKBT83K"-9L8&'1^_.'7"W?)UGX=ZVW'"P?J6!DI#VN^>+[L?%EADJQ9?[-.2 MO?W&263C90G2NP'("H%&3W+8ME GYRSWU,CI,0LB :WZB_,NMD&EJRWP[J8C M$Y,A95&^P5N\M9W?[ZMXOAB*XHMYUU'0MFM)N8!3[RAU(! MKD%')&20.X[Z()P4DS 3^$!_7X8<,50#*=_.=BKKO#_[]F3OYQ8N7?+^I^^J_0Q[;B?[_'Q$[]>:/"HUVU? M:"SZ6.18Y:M(::'&/;UC1+:)N@ 8#.\7 $($:%"L6Y'P-W\9^L?\/^;_+YS_ MX,LAJ,RO6C;6?F=7AC]>'JPB PS;E;T:BO\O4_1_O7FG@S?024[6W5QY??1M M1Z5A&?^'Z]*V_:<%D6ZW!]^^70 $8U+Q#4YP/@]9NH$'3Q!3J=(ZK%;K"\HX M)+B:_+/EGE'80M7-'>V;R#OK$S8S+]F]393S._3JW$=B'GZ.BIHH8V!N4$*7 M)BMZVG1X]=P TGS1!MXCKGUQ-*&3_/M<@2]4+0!>W\*'SIANCEXTM9]07;^< M:?!K+(L<9K.S95/0DV#AE1\,:@]I(IF_X<\#K,>QUR$]C@QW?^QESD*O6P+U MQ$C@R">W,\/!#5*BD4TG#:27I_8K^<?P%(N'[M*,$#0N5?+0(XM";9\T7]_84V@? 5!=ES"TY46VRV='1WMU.9%R MXJ B$/7=>>USV"Z*1LC,XX-'&&Y9T9N,V[@S%@=4O+(@7J&$\8Z*7<2RT(7Y_[;9OE1_[A)]OC4.9 MXBQQ?8U$\+#[%(>]FU=SKD4&['V%EU">2^YREW_3LGDPK*0^-QTH MHT*DDZ'W=$:JGNP+: HV?$(U._#NLXT.)FD7:6C]7-(7Y<87B6\NC\Y,E;EF-@]<>'Y!2MS3\E=PG/[T7FXT%GB@H7!D*" M/5*;$=:D58=2ZD^;2US%&9Z:2+7G>9*VS2F?/WZ3C'V@=NNX8.= M+X:#K:S@$B,&30=D6J+BDX,&OX\ MZF.1-'ODFK=CO=+GP;BC$[=OE9,:,>89>D=?D%M'S5NN?:F__;*R;F_E8(V* MXP]/U"_ MCP4+S_RGBG*K'M2RH;\ &!?V.7F?@5Q3,L'_B'\H51#%O3$'H\. F^AV9)ZZ MC+C!;R(M*UH "D<=_VZB2*"CUZ2^"8!?O_$_Y7W_=@AS_-]QJ?]0%1H>=,>O M:5TG\PC7!_AW"E8/@A1(C\+-VN/+[WT9) .N@$QCQ6.[A7]CR00ZN4[IE-_ MSX4>K,,&" "M[B7>17.AB,,"X#86^:L;?[O\F88-WQ[$CROR]SWY+^6H?UO6 M/-G/8%SDE7404]IT(5F.-5;S)93*0 OWTYZPOEA(&-93-CQI>.H0=@YSR;96 M/+2<$96]BYZY]YGPFZ,'DWZZ)Z :DQ/Y>L'HC20[7:X9RZ33R)7F-I'<>SWH MUMC'JE+\6=_V*)GNTA&'B/.#.R+OJMN:UI88; /8YPUH&'D8?AA#.SEL!&@5 MCPHA?C1A(#L10MA#+'-K\7B^?G1CSSO#:I.ON\BN_<%E(3^7K$2>O53[Z%15=-SA<CCY<8Q^"D5/.]M9( MD4A+\ZJ9 UQ(^0+@- '21W<@H6V$#@T,.P-43H9[/QI:@NLR9FO#'I!]_?QE ME]+&;FUT\X[C%VYE)RU3O^PMN[IA+_"[((W+@BH$@+A$M,/:H;DPZ$70G M$?R1D.*S\[;C(WJD\E^+PRXKI MR F#I-@7H9,/N?;@UWBL&\O,@U4ZU#F'$,?N&NEY]!1*G97?E8W,#\B@'9:_.#<25?F":ZP=-#T[Z'4R6G3:W#US^G?(YHWD7J90O MQ#T\UF;.508'NDD;N08L\?A%KE-)YU-7FHF2;Z5UT1U=OW[1T?-=CCN.6?4< M_G3FY/-7<4+C1QT5@+^;^"MS?'$317H\HH4Z7HBKR+O+C6#=[QF9ITX>A]#M M6\=$1RY(-1N]^SSSJ:83R&+W@<$?II MI.#9@5*@S#6I)2>V68>BQ/G2,(:-8=*GIC4?ODO7-W?%I[2M@ZZ,:VJ,&M/R M%E;MW'Y8]P0D?0Z,_ZRC52^W:2XPSFZQN#69_8Q7PQ7E&-C#^7+##TW-T58G M!B9E=K,?@K8:]U,LA1KJ.>N=_9=Y=58G1N3TXR+Z@?4* ;9U6A;N<:C&\'A6 M*",H#7^.F((3>0E:=2/%YSV:>TIH1@=_JY=2AHV]LS4.]]"U&[]_?$.0RG[* M.IBHH7S9+"[&37$%G2H YHH'OQ-E<5J0//L"KPC&WC'DC6$I?*H/*;E!RB:Z MRH1+W/.S0O:25J'#DKN_;-J]YQGA*OP0W@D6WR_%&JJ*T%QP$KS;H M[QO7]W$OOOC\Q77%7O/,GT[2:\-!?[C:J4 F'=YB+CRGWF^II*J A=#-3"? M_243XH&YA?_D]1+F';$XXY!_9AV',OQK.\1O.N7UB=&_!_*$UK0%@&@B[S;^ MPL#')78J*X^K:,+>4H!0BW:GZ\+TG<,@M[<4>ZR<(+J,&AYW:Q[1L-]ZYDR: M3)Q9><$^N=/Z7OP__Q40R9]%U>*Y"LDTF'J94AQK:9DPG0*I/,(K%KH)@0EMXK : H (1"M$W7N6A M%+"J3[&FK(&;I/K^>XXIHU=0-NXM#3'WJD\_\'>\'( W8ERR7C=/SN7WX>N0 M3%50F+[*A(E)5.-3Y>8]YX=94\ MTJ]#:GCL')4Q;&-V6^@+$O3#3Y;X_[D0-+=8QCF)Z\3I?: $HL2Q'B.V#@SW M5+4#+X/,',I?^9DO6?:8Z52YD;O:\E(D>\57_L>?P&PW7P\V9 M,3$IN5Y;4V\8IG1N?Y7Y,$'" H0W0S2 XP;'DQ?JK(83>R^4R)&*'ICK)F<6 MO1FG;WC)>!?EV-PX?$&K.8G^*:2C9_G:4KCWF0DI%]'6@P-?;(154CD4:%L0 M,XIS$-?.1DDWH"8X; NDK)VF2X44,M6G2U,OZ0U:;01O"W:E+D\,A%TPXMQCT&T M:ER7TB#W&)&>ES;^2DE-\\63!GX535]MUL^ZPR"IA6/1&@[>,EP^T$) M#Q%!'PW35?KJ@FLUKEMSW;#1+XP&-S*:JSO'W'IVND8Y>[?QK]UQ?9F3/1-G M7UR[%-CV[)KD[R< +CB^;6W@S1IP)>*G1M0_R$ U-NVX-M%C;$G&R-OXSQ&Y-9E2TJWKJQ;U?E YVV>*@\8A,F6QB>7$6J,R^[ M5>HQ5X:7])GEU(U4F3(4 '(HF@J4^FC^"+1U]L"*;DW]B]%PB::7SM0%UG3E ML5>:6Q\DK6F=DB2!@?WL6CC6)KY1&X*2%D:C ]AA4.Q3R >_L8=H7$7/.$1$ MN6?\=M7(N)^C+[Y^SQQA2><1;H:4B#I+R""")YZV^LVA)KHI$) _/ M4Z&SEA_L;()GM2TMCR87G?"U,34V-@XOU?1NB@J4^\M\&&.3$8L .0P$,X". MG/Q*]^QP5^/W;PRF2&-W%\^/:P)0+O:X='+7>,1^-;I8PY&S9-G7?E8[&&]F M5M8K T@)_BBR5IRK),Y?WT['IZ+ (^X?<]AC!/I8'*-LF$CW><FN!<=3IMVQ"6O,S,LK^3F$IQ$ !G29,.[91&Q)_'G2?3:;Q2 M]J13)M+1,1I\D>EM5,8)8VPG[@S+_>!Q0$@M M^L:U])_N"RVQVU5+M&]JW M_6KB7[P'-AT1O^:H<$3H[R3B1BQ"-\X.1';.'._&2^(0T]#7KB.^\D^@\!'/ MAI%)]M[U)T+OYYY(-6L/:+H%EA5 3GR)]1P'"$4/?,39Q[6 TD%Q'RB L\\; MZ]W,TH,[KA]1ZW>$5CFW^+@$:3V5"7Z^MT:+.[TM!UL4G<6_!]$XGOQ1E#@E MN *5Q/_S?\U7HK_2D7$F];L6Y>G(^%;/XOS3HVI.'G5Y[J/&88>"GVEC4.\W MK]V36JY11=6*+Y 8"&G^B !016'0Z46R9' UW<[D27K91/1!]8_5YX;J8[=/ M/"+[EM.VZIMLO::3?53>]NBS3C67K3U9K_9PZ&(W2%#%JX+Q)%L#^GPKZMEY M:[?NZD*2[Y3A<$A=G[Q.E+XZMWJH9H-BD^Y>6\]//35E^/9#J+F96+,.N]TL M$G,7L5YOX6Y0A=>WHAVU8ZV[-3)?SKF&YN=*+!7G6D9QKL^2NA][/VL'F7IZ$@AA!G0:O*<]QJFXLN0]5D=_" \Q\ MMXPJ^N_:NOQAF;3<>!I;_%:RGW'?9-*7+YD/;IAB7X:8'$1T^APYT8+#LT:G MR4431]:49T53:P./_;12;ZEV)EV HC^PP85Y]O@ MO'>CG+\N6MOW[M1!$+_PKBIT4MIT4V74.-DGL?!MZK=WTCOUEVYJE%,;,2D6 M)J*PQN]0M2)\9>.ZZ#J:R:TK&%E#/3%ZAY3KU,< _$G?>Q]ZHM_\'F_"S5!J M!$!7Q=*4S1S,Q2WL:# ]FM"-7C]U=) ;,/M$RSB@G'FR,9O&2)F> M?/.%OJTTVSSG2MI?&@]'(6^./O80[Q%JKEP&3H]F$ .D<]H+K.+Y:D11[E8P MZ45$V-;'YG4#AN._W[V9[#>\.C7L7N>@?.]]P.RRX=EG@^*W8%V?3CXI9YA MNNQR5D37JHP=A4&\U;9UO-4E0L_4#6\^I)/Y:=DK97SW%[AN%7OQ8S*C=R&2 M=?_5ENEO;3(\.$F50/Z&_$4IF49/+1V-=:GA6\-W]1.O+Z+.+L51Z@E6QU5^4&Y)FZ7OF M+ZF]U5P/EU951^5CE+ER&+9T'G_] $K7!&H79?Y5Z=.*&?A6>A[P,]5GQ92AV$K_0)^3UZ6[;, MG^J;?SKIT"VSAYQ.57K#TX<(*0%P4YPON5X . J 5T3HH(L Z/;0X\KW]/:F M@U;'O']-*=V.'CDI][QA5XC(Q\N[YY2F]RY(D$I^=, 5;)$ 6-[_"\/1_$7D MZ9L+_2">85%X8@L4$-8^ _DO!Q>.[H5__6,:R#C*,BI+/V[?',/T^4"71>Z4 MFTYPJJDN^)?7&XZ]&>A)>J^M5!>H_,;OX=2F>$*5Z]]<,AW+A:&X&4+]2!, M6XX?$?NW;[?X*OQC]O_Y6?0NW!0:/"8 H !2NA(:#CK:00'0X<1^MT[#G4D% MLV,)@6MEZ?T3[! S@IX-&:^TL\>=@.^$V[+O'^ 8@P3 HAIGFMRIN>L=:,ZZ M=TC/PCJ-A1O.;OX9X88=MC-#TA$2Y^[UT2[M*O*Y?37[T],%W@DU3OYJ\K^M MDK@ ^-OSHV@< ?#KO !8P^)79:["B7DS2YX?1UE^C.1[7<9WN<]A?L.:OXG$ MKPDO(6JBJ?P;5]&0-+Z'\"_>MR$$0#+<8WZH$ "?60)@VOQ?68&B;XR&F]^] MZ+5C! %@B(!2N7#JML>O'2;!D(ZE_3LW"L;;!0#($P"_&_#<-A0GB0#A! #/ MA\)'(WF=3MQ]"%G4-UC![4?AI>,%@"PJGO+-1 #HPVM_0K3:=3/POV4F\',[ M!8#:WPP@%!])$0 >L )YO0+@XI 0% %0(6G .AG"("F8 &08D_7XPGA/Q]$ M<9^CZ'J@%0\FN<_6%&[\WV[Q7]2,-AE25UC0_C%LV)ZV$@$@P5NFAN2:U5// M^M:?BZ[6(6_0*G N5*2'*-XZ+/QD7"BY!_]WLNGMN!'V6'-F =GG<5W+7UG" MAB*B82_=J["._\J<\T5E,%>^Y@^UU#4+@"3T!-OEUGT\S?(]?R\1 #_5X;+^50#?_&]&%B">B\+S MJ] "P(3 IY7\#YNZ\4:7^^]U,(+NX-=._0-/_QD\_9="%LF2L-TO !Z:<,N= M!$"N.'<_7PP>4KAE\,JW[4".^PV/Q6>2_27]8Y+^R/721F&BW2P D%H(M MG7@Y?"V_4P"LWQ ?5,Y+'UC!#7Q]E;T6PZ[FM;!:A'>]%S^XMKAYKGHK[?R. MBH(C[$OWSYL4R+7X4)*.D=^REP\;T?C:%=;7(L.OV?MQZC)R1IB..)%_EXS1 MAK&J_]Z]R+%N!:'_:/Y_O%?Y7WR:2E\U2M^OZVR ]M/'Q7&[J4D42:P,F./< M/&PK6]J'8"=RJ-_)Y*C+TS/?K<*?9ERZ=,G,O*ZO=M>@6]P2^'4F0H"_9P//Y, M4^,:D69,)MSY;E$T,B_%&L7/=N&[UBA.A&(R-?GI\=[_'?5AM38:0TX%KKF\_VK:R) M+5Z\FJMRZL#MS5'3[: V+H(M"B5RHKL?8]7R&(BN/?)TDSC^9JQ=[LH1EC1_ M4^Z [Y"%UZ,DKY*"X*_1QG.%:A=VINDYI:P;QJ@ G*UID"L[>QQN!5K0"NI= M N!/L1LS<(,O _;$1UXMDH3PC"JQY25OUDW+6M-KJV;)S@N.0QD%L[I"-R_O M/Y=M&2C+@5L< GN%P)<\SI&$3-@-3:!-=.CQL>SO UUJ2NRS]:-&QCJ-#PZ\ MZTLM,IU_\-Q3LJNV /AM_,_PM%BAGGZ C8<\KU M>""X39ME;F*<_[#ONFY46U.&SJV!VET: (XD6GME#(\<"1G;U+GVH= M#1PY$\), .G_+ZYV8S&<*/X(I3'L:P]2BM]- =V0:EB5$;Z^5;)XFJTGJF?/ M@?DPHY^Y5\D-C>2D=_XAX4%WC75$]+T8-;%=JMH#OF +G"D32K"&O-167SIR M$C=.*R/86:N&'V_WL>J8LOEXQ4&G0D%)]OUJO.Y'XTW]EW9*U'0VQ6%KWPK] MG%%<<^-X8<_"W7H>O!64B7$_7@E.E^O)N[U4>65;U7&.^KY!BS4,9G$Q_$Q# M8QW96\G\VKFFHFUY$=MT>YP5?]\ EY'J4Y"PPPUZ&#-C(/5_8^]=P*%:^S[@ M)8F2R/D\%44AE5,AD^24D%T28BK)*4URFC)F%2'G4!2;D4,Z:&U(-_\SY*MG,S[N)FZ8A\IHVVO=JI''#7==8]X-K_>U4VY MV#!ZX_J<;=I(1%\9QBDS4D%2\'WD4\*"A Z*+$%N"(=I2)-:2DVAR2EHH_OO M53RK3.UTG XN1FT=5*HY.UC3Y^_[?I]1QD^L!.:=;8(%O;B BEL.V!^.'.2G ME3*F0R,0&%3"!5*>=:"GC)&#SM9!B$FNK$3"4[(4$NA)/O/H^-W?8*NU6(CR M&7&TH<]FC7]F>@SS$E-$9*?/U&%9(@$@9U,D6=!GP8IY!+FG"^2+6,HZ!++D M'>[[-M/)#YM*:RXM:G*4.>4UZ$79TXA04!S5F?LY,; C.J?V+[Y<%E[-*0R@ M0*K"B8$61HIP0]4NNGD="Q?0<>D1WIA1%KZEZ&QF9J^!H(%TP?45*T,^/;]3 M]K!5M$D^[LS.2P7L]=^8[S@/R-ZD%?A?("SK+*1I7 1%TYUI^0MA.ARP=J=% MNDTED]&TZ7UUD:A=S&L]%?E=NMTC;IA[A%TX'UIBG)'\%X(3M;&B MW'/*T"IP]&,/7[B(^>VR-G4O)=XPO>3*BP4Z]&"VR$(36!I]7+7BC?CVQWSCGG,AC_G M?X\J:9OFIW]C'N80#=U9!_$.KY*%UT%*=>5.50]/ :W*%QJ=6^)$>2VF5FSZ MX)YI?AFJ:$25DZ?KZ"K,%70R6X(T9H"[.%,S^*N3&7G,-CS=/*K?]B[.^4BZ M>*25\S?-.T:YOA)OQ-Y^RHX\<2A6?K>#')'NOR61YNL/"X0P!MMJ_5H6=DX, MZM1/"AA4M4I6%+1>P$UMM%S-!<[((A P+'/25:H4L4O?2H^'3E;KNU0X67,W MN_K=3HD..>9)+Z4=(HCS?*$@OYAF/49 M<*XO2)8_LE!#:+CW<7MNXWEE'$.AQ+U#T6QS]%'5&4B/=8IM!2%HD6]--TA- M)Y;,7)_CA-CWL($L'6(R,+MA57I1LU-R09]N#"\FX8'50R MLV*+L10AA\8L!&V'-<.U(NS#D;B/:+K-6Q7K(JE]83K.(3Z1%8E91>HV%174 MN+[G\)#D8%DY%^#7(326$:3YWW; 4KAWK!-G9&:G\IY6A>E>0%][=W0MXWD, M,)\8AB[MFT;<&I\X0ZH1*T=H)*XWU$ )R];C9$Y$VXHYO<$=^:+>6/Z=)S% M0K"4[;C9R2[\@%O83FSTB4O)=\Q;19BVT!;*=/,H!E)-G(H8)0YBZV"%E/U5 M9#U9, :O8SAR)GT[R4?-)-CS[=7GZC&.TE><].*O\STU0M!$N(VZ9@ &VJP$ M!6/,K8,/0<]H5AC1!LVEUS.=.'9#2M74N7>7$ M'L+V*OHDZCDS4DU@0<4WZ\S%!(-'A_DGXL6/V294*N2SC>D(?@Z;KXA][JLC MO5:KV>UB^YN'%GO,78\RN@^O*OUS'$^$@LDUZ"4Y?# "?V^U0;TJ;+&F:B=M M%&^@6L#+*C6I>)WC-S,:E:]EG&S^>B%7Y45SMG#NY\<@9#R7N+CX"LFQRG)A MD5 EF( %Z1KW$?^+:-8UE 47(&90V(+>Z%'^3O3X)R1!6#%X15?U_U+#.C0U MCT*W3AQ@P6M\Z)=;1S$-')-?VMG&R_G+-,B#&ZL+=C4K'"TTU9U^64Z8O)$Q M9JC;L^%1WGGBKT&PH6[B 6Z36VR;"]Z9AI'M9N0H=D MEEA/Y=;<+^DVCT:Y@#@NR,7!BL%W:ZKL8I'E1Q?G5E]U[-EX^==OX]_(R!P/ M'R,^BV*+?J-9EU70/9A7.*5L?Y] &B:\BH]H 852,>L%Y%K\]65,#^1L-:KPJ!-_@68$F3605]I"&9MM&JQ-&%ZNE=% >H<,QSO M6 M\$S1^]HY[BGJ[7"&]V._8[2HUP>EI"+Q86UZXU=.!/D,FH=00RG"AH'NPE%2 MR2->\/K.RCOS5C>'MN=?4D_<._PA7$5(I[ZHQ4%Y.R>;NF91ZBBBDM9@C3UY M%(5+D:-FQJ%C :^SEN>21C<^Z:&%_]N M1NE\\-F];3'@:=)@Q2BBEN,T5+@AB%CL23)*8G[R0Q68N-1W;;ID,E1QO491 MX6/9,_ZW-<9V'* G:M3)G,\ZK'=#E?<(+!ARBK4'?Y"3%# SX#!67K>%D?", MD=+X$KQ6)?/Y H:3X%EILB>HO)NOW5PW:3"GU3!E)3B<:UYDJ]>*O8&8B0S: M"PUM46&+:UEQXD%JOBBZ(60FFB"1LA^!M=8NEH9I6UI:-AIF*69MS;OA)+GU MTTZ33Y9;8]\DCQ[RY>^^K#(EP_!AMG$BC 1\,"6)#;[.^Z!Q.NN7+K;S*$71 M-GMELL(OPWG'W:NZUEY?\=[I96S&3N5S)"75@#,K@ZMV<*X;^C#<:(E780-" M-T:D1.,H>VOZY!%Z5!1>+>>]LW/9L[W%3J6<-^5Z6H97-R;;B0N(*%FXC/PB MLH%_)RL K!$D4XEH^N&W!UFT\@9LE'Y"+&/74DO_<;8-O>I5H,]#KV_&HN;8 M;9JW3X+JFTZY[MK]N@[?38$V4AHT!\$&2A$ECK &[AO9F=)@I TI,< 3D#\Z M?DMS2GWJ(*X:!W!?K4T^[5#Y^L?U$YD;61L0P+-5A ]RC!B/$2,)B M/PO1AQJDK/SS(+=Z<'7JMR/TRK,[9$<:OPI.XCY\<'?]M+7VP_GXUZ?A,23H M'8?<67OQ^N60']4GT]4SXN-;9L%#;Z>KJ=^.=6\_>^GKS),S/ =2WFHG6TQ) M.&A$V!]^"!@:,()\P=#\STX-E 8*Z@"QSB-G.MPR^EN-Z)>^ M&X?XCW!^A6_-]^#0M6!_ UN!Y<2VYSS$^XR9]6 -L6XYGE52Q5%OCK7/N1BM MEIMJ&$A@IC*_S([&1$CC^E;>.\B^O+R\T5/S.EJ1(,8VAO:P'#"02@V\OH=T MWD@)M\/SV8BPM'.KJ+K(XM>:PLHRQSV'_N!( EIG78@:UQL#J3)]1 MTE0#ZZ IO: ^/3_NJ3%B@)!IW]&LOHLBAOF7GQ$\]0+YW8 M,X5NA*(OT6GP3&WJ:M\"[QN#)FMO#)O+;LLI MSJN7:9-=@)[E!49D35$8<2JYM&&\M.Z>N%LT_1TWV& MR.M\HX^9AGUI/5+LDSFK9N0QG*CE*6U7@62B9[']?:--4TU4*RX@B MVZ=7Q MM:U7W%C)$(XSM'KP_GY%7V!LF9#?I1W1]N*9]V.N/TQJ$O>[7[L&F!]40_W! MQ_XGQPSTYSSC G_PSHE_\,S90C%_MP38S>5PBI7-6./%E^:)7U3?.K@V0BX09Z5K4&[&L&)U2FJQ!\^;I+ M"A;@ A/F#^V.4: M?2X@8)3$!=!Z9$BR&ZP5S@/;WL[ ?*7 .;NC 84K6LV3/I2F!FU_;G2N(6K2 MX?[/<#'Q5AOMQF]>]E+>8(D]L9XX4,QLI.M&4W7;QXJ[J^1QXZ-'O)]I]">U M4DPO^81Z771)2L+?2VE5=+T0_&L %RB.FBHNP*_IJ_1B8.KAG: X_@"4=-_9 M%3?6,.LUZ9FVHE=X4V?GX(!C0VEFI7.J:NSKQ63S9$M%<_])<1%IB9,"2C<\ M>6E(=*'4:@XZ-Y$%JG0);<3RJ&D='Y893NQX[^;.$HSL>YRWAJ[0Z7=?.R+S MW04B!CQ*XUX_6VU7]O@>;?/N*\#"VU96\OA_:RLA7# _10SA5K M87B]0SB&L2JIP"9E8E#W;BCSWM5"FF>VI7+DR!X5*US?@DH(>I!A*KY>?4?C M_>MW[<1/JBH "A'Z5PQ1S"K.]0#RH%X#40@1TUY&@.(Z",DO7--^@4)H:9U5 M [[R#B)R/M.Z7P;.1-\K?G%E\?P#Y?/Y=AV-G848*GK*^C[.@7F?H3?=PS+& M3=HR/!HTP%HF+-'Y53M49DJ[30@BR*13CSLV*'=9O-6H*^FR5;Y6P;I_=/M36?K &;;0#OX:QT!"/82IQLDML>9 LQ*9XD85W*D5!^3-;F MR&_'.K,,7DLH/S\0/RC3>=1QS)&GWTF2J3G R[2#3%C"\-L1<4XJS.=UQ GR MJ74*'G@\^-5N*MOSQW*3&&!%K-&!@- M*;$V0[DT;"T'9&F=Z,JJ=Z2$IFZM).]:$B!^N..XSJ[_8H',Z_%59%UP] NF MO( C!;)+Y\BP*:GCN7F=/"M^U\#84WLOL_49X4=N=KVT2QNX=JMPS35N8]<:NAYL/;@M."SVF.^3XMA7M"5\6W^+&J,-5LQG708[$"C?BD$\ M]P*^8<%\B9X0*I56F(!RL!ZWG'A!>Y@ GBPA&Y MM83#2N:"8%LZ!5J+7CS%DG&LVLD%DDXOP,]EV1%<(.H!880XY\(%9OLZD:M* MYE0N3YG!PYS%7B>$C'K_2)K6Z',D8+60!GKUI'DF*( 6KGW M4J&PVT:&WD::>F\6)C+?WB:X^.;)M HIE1#K5VF^;4\_Y\0@&B_^HU<\[&?? M01>GP!I?](>I %N6B"]ZKHA9M???@"^!$2R]989*I])V32Y/5MHM*C[A WR(X\=+\&RH.\0Q'$6A-0KQ&YY=E M49:CDB)^ZFU1)%B#@*JQ+EHB)Z #O#5/N-3WV8,MD@CO-5)%;F0MM8AQ^)2U M VRN:.0"[]$<@T,L!+XCW7E1"[ZWY>AIS8G&J))H2DL?_M:0WSZSB8/!HZ@& MTN"*SB;J0@1!YT3&?FF=Y$%YS@=+,O 6P6&5:DXI5Y*3N6+@!':EGEA<[/=GWYMF!C[0O M1DL)N;V5X:,+;)%Q>+4,?:1O:LF!+;8P6O9H([C+AR+U6>W)^W>+[UTMY\4, MD[7DDQVC]^QYYW.C TU-P]!-->.KM*O(G#M5BGA]^G@"6PPG:BO"YF-H.^D6 MC\;6/%?;T^F.V;+/1"@E5^UDI)F,. ^S1^(U6[(35L.%U!#I,>Q3#'DG9D'> M^])"_T*DSUKW6X=WJ:=9'@]*2]6-K ;L,-H$_I1=-MA M%QL,=2:;9M%IL;I1 M?=[:6B<>*PHIOF=]X7UK$5J3]TJ5H_M1T8C#PATM:DHT_O@YX4C"RMXJ)>BA M8XI5NW9&O+E=2$A0NO'*]=K)Y^)Y/'P?7GBX6@58F\X^RHG3Y (G9R!UTO3Z M$"2ACD;1[;=5$>9UI5Y]M M94^LO=A6AKAL5?ZO$A)T[#078'"!!J(X2+U'*9Y!/'S-R+8>;4TAJ,*TFXUE MG!_?W^U>7%G5/I63>6ZN/DO2<5/8IZ_\CBV[*LRN\OH&"_%?,U*GP'48NI.M M$%Q=)=^#)8YBFC 1Y4Y<()QM -YOO9BEP-AR^YO.^Z"S9\]&=H;LKFR\HA"[ M2VI?!>4"/T7;X5,36^RR,P92'P^#M0D#H+RA.^U:9Z!FM%-YA-'J04\CEK]7F<@=K*;*;HN4>V,)[]M71?QYFKD<''W!!KZ<%B MJ+5@N[$[C^^B9AT!G3C$XNI/>Q%F5S06JEG/HICK4G&PXO)0M MM.V'K>A$:%L;^S883YZ\=X<+%*@YL8-)?21H&S9:6\.$*P[I93V7&H!/D[49X;#UB!X\BOC M00\*A$'N_TX,IH$3+XAW2XYAV5N,I+E =C=JH0=%OPVYP>&'08H]^P!X(OWH M#[X]RI._O+E2K=MHXI(0 I=#[;C ZL1(]&<=?L[\/ME_:S/4;9#N;+MHH" & MU\O9+G IC@I#CX-3B8,48GL M^)T@-1&^>3E0(N,/_3+_@RA =6+'V5L__!KPLG,D_RXM\'=!'5YU2\+!MG@A]1CY FR< .%;ILHY0V68*:% M:#4%G[F XAR&_T&G=IOP^X%!IXSHTIO-7?&O*G_9?\I?[M*7\_LNU! K.8G@ M:=1 &I./DU_%2V@%BQ*GRFFM&#'(RJQ'N*$MP8ZMU?WXL0[K2/XADGOPH^;S M3UU?->9NSN^V4R]27M%T^J:RFB9[DN>RFP*2GPI:YF@,2! MUZ>%9A>O,D4>?^99$$+&6M&?98(G)%(_W2F ?&J-%!&7D=8TLC79"LL+ZF]E B "72)!)> M,- T(U(H;49^\A>^R,EZIY1+5O[^$E6?/!]/=P\YFR@>K%M3(W,VZ#T;/;W, M'G\:>5P_PC!*RGF,A/1=ZQ@#$_V.*''-H8VA4J_KYSQD9G3\5'D).49 ;,]I M)=.U4^\&SI[5!Y\ELD6MX-7+_)S?&%FO&"K, YRLJ(A2BJB75\&DTZ]5JCV! MED\T[.K#-F"_%LPV?OPER'?XF7]F+J#(NH?KJAD<24)?U\9*>J4%219;2?3, M%[(OFJQ->N:X/M/2WOVDR8J+ C4-^(U(O.4G-,%\4"M+?0)$$10]=5\&-U%6 M0F-U!512S-SGU+UV\Y=*?3Q//W64$M:V40[>F6R_EG >B(\_#S>@Z69M R!U MH9H8CRFNRJ=O63@ F3)B[:^21X]-NFY]494NB"OL47Z9'OC\1HV_-GG'\;-& M)X)Z\YZGX3"^RQ/JU RPJ& J8TM2(+VO#M[<_15O<+X7EG[!:$N8QX@HK)$T MD3,ON)?KKQT$-!Y$%3]VOWGKM'$#@"]@V>*T?H'#EF9O"Y3S-7 H[RGQ:76>F)H)R#0;CC4.\0@\/Z%36"OJIVY3&.FN_&B' MCM$J0BMQ%1?PB.6 ]6CA (.!P!E)%U,_&DE\E.+U897/'FG%+T<3!'3FRQN(D IEJH&1UF2T$8J@@4(^EPEW MQS1TA0R:?$9!:6^G XI;2R(.FDKF2]QD;.X_/I#SGOHB.LXT[DS^Y;X(PZVC MB2MP;C9TV[#*O>YYGDNF<<Q[W V "'5T68 MAIYR>^AD6? ER.Z$QBN+C=Q?T'8-B=57D%8(K@.O:1R6>HWYG":SVN0 MFC5X_E?RRE)[%R. /R'P"G#] E\-$# %H")"AK]7BU;!,K!%S!<#B$B2#9T3!G#7HWP_38X"H'S41_G6Y>*@LZ )*"&!>P?L-B_:"KOZ6"/Y3# M7Q#=_V@3-@FQ@+ZZM:A20LR- _?1HRM*=MM7(]UN'83@JMKO)*HCKO)@LV : M,@JE2\3&7R\A4"E2CXV=6Z.:4]6_N.&G9@?>4P:.U2*1!O$PD5^9=J)XOMSD M0V[$.54?>@LY@.R.7M2A1%*8&Y!(NF0J!!IQ-H ?[,*0 4]&!MQV"(](/NF> M)GL]\E?"V(_D_S%E2?TO2.;,L=YVT9/E!U0>'.#57OIOUERU"$-;RZ!>(]]187E%4#4&4CJG?FIUE8''2SD_46?WB&R;M<^NN MZWVMU]\_7[3R?P_6(!F4.R;": _4,XH=DF(N;TO:B;?EW,/O&266#_@H*D!7 M&8(L)R&=)U,?XE6<+\0PRXW#KFPQU1!/%C';L23U,I@MBAD=GUYD)#81EY>> MK,=O+X9>@4^&K$9]9A+2@@X/FH_:N9U+Y3753Y*LW;CAI>,AU"N6Q?-ON]7N M(#ZU':3;V,:!]*/"*R!;>+4O@HH%O--[(^Y^F66?8Q!KWTJJ:A^ELYSTG1Q= M7)PW.8^\6TKKSXOR2LJU"HF36#=Z!7W@\X^(:_ZT=$SGZZU_? T +!S\0Z6L M43#2_\=A&7+I:2FBYSKG_O+/R2+@9;?.$"\S!FZ7P2NVD,S;ZE M#4Z^ >=>7C45=YAN^G#JIZKX[A+I^]'0')3+!5RT,1\1QQ#XLXZ!LS(G1@VZ M#K_X42DP6AVDEA%G@_15.-=UB4N.(1C%OG[,GP [J[4N<7'C1<02F.0C4%#4L^1QEJ97I#N51T)/E9&ENLU$@?'5'0:*$_9 ).;N MY;W:5NZ$FEC[C>DP/+RN(H^M]:RWY/G(ITZU^Q_+7ES2XM6VR:;F?I!0*O5< MYAT'SZ&%<.!8^370#7L5062VU\%B]#6=^6[-^;W8!HHPM>,QUKV\.*E78*3_ M5OKT:X=AI;39NS=\#7<5H8;Z8,$Q["7=NU@NL(KNM=7OHO@)FV7R\O 6<9&* MV]N=@5\][OD\X?R*/I<(;:,TD 8KJD$AY([0YD)2#6J52_.#$^B8'"@S'\J= M#O:;6%@EMY-I^O;NR3,I;UZ?%;G)[[/[I/"+WVR.I,TI0*XR@&'NH,>3$D!O M4B)!AK[E#GC1=VZ";?H@3^B2*E!D@J+,I59Q0/VI-T%56J69>! MC247$QO>\C96R58DY40YTC\5*'0K>H_A#QW.3-YN]N'4,RX<9UC%32@XGBLQQ@C2V0P/>[8,OG./U/ZB" MFS[Q"VI49LB<4(YY;-]SI6[%/H,U:F\(_Z/?WLO0.TC&E)%UY,A M-4QXE2I.JA9-MR:%.>JR]J2(_46@U#1]&#)#O.0S8/C1S%!638>O?PJEUSH?9&&W#;%HR_!6J< MG1@3=-=YU0M>3+(PV2&]TMTB](L;L"@,BY$A?5OX.G;J%!<(;T.ZP&B9!,\2 M)9?W4IW'#!)K],'I87H;-36)WD$NR3A<">T)>6A[ 6L:1SYKU59FL7]([)/( M_K%WQXU/'HQ\Q&!1*6PI4A,*@3R)FSGI9%]T!+P:.B4TG(';U%7/!825R)7) M6S7IZ-CT;Z8(8-JE$B5PI"" MI6: YBJ<<< EVJL0F8C2^KS[6O7D5]97GU^R*],=[K@2VK!,&G$'2F&:0/QC ME 0I= D*N5/498>8R@,!TMHN6S#K)YZ.F.;VYS8K-7DFWQ4IZ3SHY(#2#MMM M'WW\AG 2$)#Z:?0[!.G@FEM@[D'Z:CX MP,F=Z.N5AP9=WN6-K.MR,1:[)-EN33Y\1SHT74:J]<3BM[,Z%D_T$-M/Q]!_ MT82V8*?Y[CO#38A;LB9)NR[O1FT;F=]=^M:,4K<47_KDUWA]_(*>_K6=>X<_ M=G^S4MO]3=;,.5KY @7'ZP +%K*LH2'F/N1QK-@^T Q]R#Z]KE[253;J4,>\ MH(>:QJ]+\=-5OY:O?_KQ3.+T6=/S;ZXPEWMV/I2E-IE'.ZI^37+J7H4O+.0\KK5FA8(TC%SA)YL4-B$ $S8%2 MH]U?TC<]T2CH"Q0R"@GQH1L2I ]8^HI:9*L=/&5VAUH@+5E$*S9 M@\;.](\S&U*G].I0/.P-F##4>D/;;5/AQF4)'7T6W=N/,X1*TLYW6&K=2))* M],?37K9B5S@2AD$Z1G@5W(M94VK@ZS^:-C5*1WS\H91&_7.M1D20]LK^R!2J,38 MP-9X"[P(U$1#1:7K3'^X9XDY5.RI4GKL],4#?L/7'3HVVG_FNXC^WR*WS!9^ M[J/2Y+JQQW#KJ!R227S.DJCHVSZ]89=Q7G]1]),,I0_[WWM,3CAU'^:/X )U MQ_'GN$ NBD&!^9Q!AGTT$FP8#)MBS>KA@PYTEUDMJ,L^:'_K30U=6L&PY;;0 M[KZ.^3_%S_DVR#(07!+7!&?RG1S#Q?X?/@5%ZA*+5/-7@O^L.%B&KPFY8FW'O$I)6YZG/[Q[4OM]//N26F" M7$!,SFUHEO0Z_=\4D[-1=)-,FV\VI5 &TT71Y]6LYU!E\JKW@B,OYN%;BUS@ MST$['5?#!;;,(-*_P 7FIK5FV$B"F#R^F@OXH>?>MU7\)S$D_BZ"PO\(W#NY MP ]_H,J+^EU.GO])N/TY5_XW6J*WH:DE4GU27*#4)E[G78;&(^$53CSR>6<2 MRUS]FQ9I56:DI^0_ 8Z%M"C4[/Z/R"A-$PH8!8I@\ZEX+B#'07)R4IF1Q4^% M>.8WIC-CW0/AJ6;Z)VFV6O"F@JO:5XK4MDL+JKY .;%-?FKIZ+U_IK"_P8^_ MK-*Y^=[E+Z\EI#DI,^\Z;,Q7$IIN^.^L1E:C82!UDZ3%[]D;Z4]>KJ7M#N"RY/>6QG+!M77/&,YRA@J4SEV8>*HP!L6R[ MOQ)N=]V:-DI !,)W#W(>):*Q*&T*D0Q?#13*.HLW8)#9XOS,7GI4 S'J&#CX6IO$#^U7T)D; MMK'6=R^O)#87106$&$(F6J.N@2YYKP5&T=1L)#H[HB 5<%KAL=Y4.$N'T-Q' M*0NN]_%ZDWXVEJJQ,[]KSN#&/BEPR//:H,1NM%>)1KE\JZ*6:P4R%+H=*6Y$#+/Z"\]0+;AV[8(L\\7HO,K.FNTOE#\6"-R]*OIJDKSR MT.UM^XRFEB>U\GR';-Z<;Y*92'=2Y7U+X"&T26+X \F2;.->':N])@U&>[JS M7_;-! SO<'0RE5]_Z1BSK!WK+V^Q-L&JHJ+5SR"5IT>L/:=3^[;.UL#; 14! ME5DZED]Z^41?Y^84NRFOJTY_9@KHXC:^B)A^E@L]S];2UF AOF)12) M!5Y+UCV___TUB_36>2-YQ\#MO??L3OW-RDL2#_I! 0AP=8J[W M)E!O"%J(SSUB#E$K2*\XZ2!/GCU)483TQP*%:XE M#V0P^[OPZ[--PCF9HS-7+_,]OU/==$>-CV)X+3!Y_[N0%!E9X<'WN8 7Y#16_=(U^8:M+M%/7(KF?,Y2:6-05,N']0'. MO*=TJ!@1PO(:Y+=DGOFMAGJCQ($*9@#$N'=@Z)RA]=U)*2/YJN>)V2&/G(=J MQ"]FY9\Z:]PNYD19K4&FTFP'(Q>UR8.*D]2"J;[1/3MTY(@KAYII:(DB+B#J MK/W-NF"?Q6O1EZ\/WSB C3O,/S(8]"+7>\&AS.G8(ZR_;D: 1JE ]AW'PGL[ ME7/V &BE2Q<;6;8&9XZTQY2>:$,4]5J5$*1 7["%O*C'MT?$AU7L?9=[>4$O MN%S4P%*GY\VLZ+?W5FJ&R0<_%%<4B[T-^#Z_ZI\K[7R&_SR'H8?S F/ MF#\?8O@IPHQR3D 7>NZC#R9AGK7^>V,?-R*^(91"BG4J',!#BW?(5YL7M M,*TJ<\=_IA3F&#::[3:*6NDU\0C7U:!_/LE'N5;Y18]F;GE\WH8;5_,V2&X\ M/O:$9ZYP&V0 KRF@:5')@UU4CP0CO0GRJC$(DS?HTY;SA2Q3::D3&>M+6W V M]ES8[NL>MC6U.5"SJ"2*+YWPB^FUW?Q#3HC_9:\>M5WYGGV081L?$*]7EQJT M:FFF7C8R7USWL%/$B,>EX6L^BI2,2P9^[_Q.-%5K#A8PSW(>SJFUB1'><($2 M_G \>*K@A(".'!+=$X;LK"QM+"P/K1MQ%EG-\RSI]>M/9%25.MN>\QBDTC"# MB%J[:88?(PI_17O8ANLW/,EGH.L5I1G'\J6B*D,(\7+.GQD409T[M$,68*!D MW=,65*P'VF8"4[P0ASY#&NJBAJ95:PY$(>:.I8'BSI.R-B]RV;J]FND_/H%"BZ\4[YM?J/H!8#*.XKHT*7$Z:NL8S@YI@;$2T,/ MJM'TPMF.A9]AZ<[S.@IFK34P*AG^[%PC9J4>)><6(2%QNUFK\F&U_!D' M8<3J; !$8W>"GNWF['80B<03J5^?(C8<3YZ-;AL@PZ\+(A'E&18"0K=B!-C+ M6W93O14EH8G';!2$A-:5%9P"PK8)?8?K>1T:\"9(<+3K!"[X<$4DIOC]HM[C M29D$N5OI_#=OQ+1;^%]-9V'^G2R75)XE8Y8]H1]>P;F530>C A.%O5V5&.7U M6)'M4716]67> ]C21S/JS=ME'2Q&R\-V=+;Y*:V,V9GEF"1;4(T:TML'E3** M&]!%;?7H%:Z0'"TQ?.Z1BYL=/34_5*@3,R&EWKRNP,UO_5#@.7?SB.:CN/S] M";$O9.#=G.Q27X<&,CT076V[TN=BA9>K,.=.:6&(<:3)K80EYN3AXA=)>V7N M1F[>2P\O-6"^9:S*IY*A/07,?<3:C[U82?QF1D(\;?,UZOOCQEXA(6NQ7Q[Y MRSYOD\$X 4L^]0CRM/,,M+U.7H]?S=(EM!EM@1X(UTSPD>L+'>H&(S(KCZ7! MMEE+]M>?)]G0S6&[JW[X"&N%5X=^A!_ M@K&WSI8$C8]I1I?.B)YH?I.">:MMJ?3",'63SKM+R%@]N%0!<)6_CF:=T6,YGVT-$XQC[9GG_,X=%_VC'KMYF 9PP:6Z@[-32H M(4]1N^? 8PT;66-=^00<7[F(P0I5WL]+:J@I5STND#V_.P@/D\/HF,J] M#S98FQLSMJ0(S=_J#)->O>&.H_P*GCK>UZO*5;/7^8SJU1"OH7@,);#T(:I' M+7D=3J^N+*'-]R[.X4"X;7'T[8]W3EV5X%%)]DL9*6+KL';"[[+60UV:/B=!F\ZN$G?CE+.8R?C,DP^BC?GI$;9/ "5?+.D3- MAVH=Z9Z;?*;-3'U6.UNG$=%3[RLG_EJ]I=_P/BGG=Y*V;.&89:+_(2X KY%@ ME%-M&X,8"VRQU+XZM)R1C*LI)YS>@KV>6NA#,O&721]8E_V04:.72KH%WBH6 M_"AY\AA&?H#02:$?;;L21"E.:\+VA]1C^"JWDB@3G>S#&4V*RITD]^?%I161 M7ZW15M9&-(_;[^CJ&OX74VMW9PZ+FJ_)_3+S%RCB#O._1I=CIT#&-A;S'82H M+M]V3I;AIA$EAD-M4'< 6AK2'_PJ&$)<#[G918S=\LU[CJ/IZ1:]>!ZS53E> M>7A3&K^GCI$DH04CAO:TA;:9(/$=WLW>744_&T\%(PMJP-65&Y^<&+)\8*W^ MK54'+KY85M2J4#:7,M7>\$GK]D)EK,RV4J:U. _=82J3+L5,0L;@*%C[&1*D M.S/=>PF;(;6&D;UD1D%-["O>8UV%U*XMW6Z)[SH"-4O?US*?#KTW?[5=R3&\ M1@DU_W 3=KFPTQJN24;,: ^"GDG"<%O51H9&U0M:1<;DJY"FE],Y2>ON%HZT MN+_ +0"'O&;WQ^U/M;"_OO*&4 ?RWT88R0 M3Z._<_+?4KW^IU5)7F/\[(Q*+*>."W25M)'I9-CJ5Q4.@CVZ_-'&2-8!;T(_ MV?\W"]__/ O?WZKQ_S_54*LG4W.(^"WF65H]."C,#**3K\V[!%?#@CV& M^]IQM;.?#+!;6CJMTE88! P;W+I^WT192=F]X3CBGH+PYQE]TQJL57@%SEV" MBK6/RG6V+WW(O'>^J:AI=>N!E5,N;R[LNJ#*.^#Y1(YYAY,-*Q): M4,7C<60OVYB%(N-1RDI MKIN[I]._UNVC]^3?K7C9DRZ.>UN?J*A4%O=2Z77]LVT1"EQ@%14I!L^B*JDDT2. M)O,W'_!LOB#\R),431" ^S"E&+;XD7J,3*4O2Q9_@%X>SA:FDQJ#J];2K1M? MC*8\0,GZE.U4&G[O@LZ4";?^YIX@T%"UV>_307>4NLD FIH!EJM$@-0<=)%4 M).A%%H:"K-*&,?)PQ.V34Q;QN,+7B(>ZTM?,4,[@L>>A0 MQ_ZTU.:16%[3%[B'J*G>H96]ZIZA""A%Z-86/U'>*DJ@ER)>US\2'6 M],?IQJF=@Q(Q2MJ:EP)DK1_J[7KY %VKRCMN"^U),6?HOD >:"\T[3&Z^V/( M[;EI65K@-06*>ZQ+U\?GAD$B>=>X0)&0&P*+;.9)@H/(_V4C6CT:FZ]/I,!M MEP]Z3>U\&NW[N'-MJ-4]])HO9,1J!,A>6$7V)FB 9408097TD*9EJ-9NQ],. M=N!]_$;OE_3KQ!I4F,G>NKE)RCVK5VM3_6:SP:*,ZS=I "\%7JTW-B,#OS42 M19P/GGV.DZ]A:$WGK5E@\FBC(5-7(;!>UBQ3W[; W/;ZIZR2&13RMH,N,9'G6V"2AAO M_>)4*6[XOO[M*$BA*LS_O8(4%?S.% M[M40\759,?/ =9.?)YY,$"4-+7UHQ_.Y@*/"DBWJ=E'PBX+:@V-YP2O'#=/&;!+NF0.\ER3IX]2(CG.J06*7N MC1@@:IHO!R>,V+9LX M#8YHORID>D)[Q69_-4-=++[O)&-GW8'.M\OGV=\DY M;;*OU]6VES\CO$85)=:B^D'F>7K!5#E=[6!Z7YVK:%?5V[-]%Z.W;\_W\#K[ M(K.:YU.J0[+#24!]G,<, .8>-C/ZPDO(UXW6D^FNY7[!0O=R>2(OJ9]WDKEE MR:\ZV9*E'].+V(XFK#!#MX4C*4A(&'7WAW5^F]JA2\;S5P\?'-Y.BFD8LSZV M>0LC>N.6_ETAOZHV?[WH\WGIS\0NE\?_0$)D]T<"HIYGI@"BV+^S$*'^0%WT MVVX+_ZPE'DG_^2SI99GWX#J"UJNPD-2 %.OJY-';_O>'UD5-8I)T_FWO,O:A MJ5'Z"EG%/@SM8:M=BQ<]A_!W8L8W+3S1GR.U+7'6(K:$/$I300-J:2*'"ZA] M87!'!49"=MMN6A4CXWJ?0@1^1-)VSP]2;SS?_D,3I/S8B M^0']T[%EVO/_A9:+R,#Q97=.SR4.%IB5E24?.T*U,MOB*"C/*:('H@\NRO[+ M%Y\,M0U@:P9=VI8+/3Y9Q3[MQ(E9G!4,J#XS< "G\(BQ[F<+2C-^1#C6_QMK M0O$/"WH.6N86O2NH8__[>VG'._YG]RMRYCGZC$@ M;,^J&%6>9W_FH?J;M.-OTHZ_:5W^UI"_KA&\_WZ:$,UIY%]6AM=F.#=87&1_ M1'ZZUXI-JE\L#7DP/&!-#049C:N$77"K/J:)$I4N]"23L5!CM)L^ :G17NEO M3CP:ZNKK-"C]6-*T[JU8M,*;,[=,4!E7E-SVR:+*N[O>GS&[AS M)UW.:'Q*.Y=0%Q%\JX[OB[UE(X\V0(&VS)61Z8YM?&Q/3A&\&]?: ML#KO"T:T%+L&+U;2CK>]5%!P+# <&7OAT)ITT>JJ_9V9T>[67&L; )0WOV5:E8K MRV9W T)?6?M.\(R!]'.HR/-5O& -NM*?M1V:*XRZ7B6,/\_0BZH\PM>Q_G:6 M7F3@[7%4!>[C6M*"HYGQAJ,4NL_,E4J3?$*-ZQ[HXZ/^MWR)C9J)!%5&0=2! MSX>;"P[U,I,L2V9Y=7Z-$P[<9KY2%N!L>,P%)"!27=8J^D=*+-[Y4=VI>_W[ MW2LK?QW=9).18.#O)"$Q'Y'PP&L+\<& J1]VVW3JZK%U"7O79 ED"VMP@)MX]QL\@ MG>,"$2[T-CAZ!/==!*'T6!:F4911HUFC8.]A>X1G+/ ELDN>YL$_! . ? MW:?8]0.JBA/P.^2K\484:T[U#X>A[4,K^;O2I1%DG1^\D2Z7F>[ZFAK]ZZS:2-_HPQ> UCSP\ MA**+=+FV#F7@8FF##H\$+ZS);[X MTN354.(GM6^SY/T@-4*R=T&2+&X(K6=LB8__LFYW%>FMX4D$T0?'Y0!$7J L.48TV6M'1O&5GV])_$0Y1?Z S0O].@/1PG!E$Y ++ M](24N^9_.%ZNR7*T_3X=T@M.)C)R;7'HA<]VOQ\>YD/_Y#WVK9]8&DEY6&%> M@&G2VM"Z+8(!^R_?W*=E^]/;@ZQ#CR'I!?H:L1150UR/1#D% MMH(D>10E,?'6[6L;83F M(B\IC! >37.Q&:\KF\:.QA+EH1E[!D_[W3,[2RY?]M;3,C^Y]LQ=EGZCH^4Q M97F'2KM]\N9-;0-M5"XPK4-E85:RW>@/NGU+IETIQSI(&MB"XE>=@7)!&GS3 MF3T5>;WE I;US_3+9&XF/Z[NAF18V_%RG"S->2X@PM[;/N/>5^D8*-$44WF$ M-"FEG_7H4:5ET?J]PUV5A?(6!YM$3LD?M#APV"9T30S P,2BZ;;D@=@QS02\ M"4.P'I;MG>.8-#J=DPU.Z*N%=W277#<\XK7F9HS&0;6M-*NGSXI-7]3XBTG' M2CMP1VI4UQ);\RD$OEPEULM.N9BI1_/%:I9EUIH3$W3]B75B7NNR-EV MY>X^ *U_R-CO]&QW_G3W]KR%_]F ?&KTWHMY=19HKS?,)(HWV%!QRHPC'F M854[V<'TKU2!%Z[*X4)[%GI\&F<+1=%(DV'LA3QISA%A!U>3R=E MVYI(<4N<3U6#<: MHOJ8J("+.DHON(9EF^?@CLV@/:JMDB%T84I5ILIS7/&[N\C43/1ZMH-"[[/@A_$V#:G* MF)*6MH^G?MEWD)%2\>N<.,^"M02CC6U8P$0B?YXM^P@2Z!#=>CT'UK6 /II+ M![A YHMB&(G[D.YV6'D$7CP#^?-O].8AZGSW[VJP@);P@,^A&ZDS'<=X@)= MMPH)!GV?]:8=60Z$7DS)>'4HEIK&-E"C945SGO86L&Q;I8QL4_S%N< 7=LDP M41,[(CVVELL1[ C=UD:M18@XPMZ M-)F,"$,;C $A2V%XKSG;E NL6]YME ML[>4"'Q$$*5*7 'X6XP+;?D$&OFUO MSBM!6$9M6:JYYA!BC==N('ZF&ZS;C,AJ#E$'1"ST9!3[-"O$]++4G^5U_SM]94BQ#1!H3&$7."-]B6*;K-N# M_&G+?H"8=HHA,V9.$SI#&FR%XU$T(BQJP@42[;[3T?\L'F$H4MZ?"^PC+OZ2 MACB42],2GS'_*-.'BBJ<#"[@A>7WE')586A.53"VU-:V*&WN^3@3*;D[!S.C M)?,T=^2?]_-7=XF1?KB%4FJ3Z[[NKCM+!7\X58;FN"E5<\TJAV,R*U$&-XS? M>6.^TX/U8!UY26AYUUWRXG&P?L<8<6GE\HZ\Y$6M_Z92Y,*;N$ 4."?'!6Y. M@K-/_]:(G]&(/X50O,^?+[(DQUS/6)AV9XDUT*Z31T?0XFQKY,'5')&.>0AJ M%H<2VYAIA!F#(;F0\<0HAE(]86T;I"5QI?KTBR]MR1T?[I.\;Z3T'K8ZD-$# MJ_3142O\7*T:6=&IC76+R69XI'G$]Z*R&)"[#^$ MJ@[.[D719XE(5Y/0RQ);T?3_M'>E44UEV3H*R% @(#,*H00!F:)0B"@0$#4, M4I'! E%,"<5LC!93*&*B4! &!0&U!)0H* &)(C*5$A(# 51*0$ A80P1<0"2 M((1+);F\T&OU6N^UOO6JWNKNZNY5/_:?>\\Y]YYA?V=_9]A[!6(\N!I"Y,R% MWYJ\5WYH(+ 3_LGS%Y_)#?GW*O8O=Z,^N>Y'*Y20B2LB+Z=ZY*X8Q;<-'U-U?#3$4@X]O]"_O(-@),,015)' U%(KHRW._UI)SG3%O99-_:(7T_6! M-S^G%G\S6 ,'"$P4GP>F$>:O8\!O<+Q_&N25?TZ/__N_0 7*.Z?!<_#YVS#P MP$>V92_]$[CXG 9+56-B%(1OJCLHEO_01OVT1R\.;)A+_#YPT_M?" MI?_T;OO=T]C@9UB!E-1\HE6C<"4"!LKNXN2U\E16G1$1#^/\:=+V2G&MZW<9 M?J- >_':-3^YQ.D*JSDB\35WY],/J%R@K8-JU^Z8J'TE$,7VTB@LF+IVHO@! M4+Y1G#= M>'8&'%^P6^N"$,4V&5[C_UXKY_.*A0C'T;5Y!(X4W!I-383I-^7 MRP,1Y:"AO[2C^\Q6*SH1))TX?Q K2VZ(]+.!Z4]?P?\F]PW5VLK?5"9$6B"_ MA^4OI ](ENID <, MI^,O.F_Z,S37Y/&;04\2D3 C%[T"*?-KBO[+-KW:_M5M>K6_AHOZ.Q]]9K>! MWI&/5R BPRGI3!91$U]IL]!B"V)M,/5O30M>^0C[?)3J]@YU3)G@R ;M$.3O M.7#P3Y"U=A95$4806\]9% DN-8\FZ* > (V&=:30 ;/QSA#4A'/CC2L?Q?'] M8OC:=W&N?S<\FAKBI>:LHGV"SV;VWAM<^OP[UV#(3P7&_P(H0[.(+#TZ"=A6N*] MV02B;91V,>UR];M3];QJ]T1CT:;$6HC^XWE.1SX;LC3.%H%*A$DH2S1I(KJF6L)NA0R)DK M4JOM/7^?(F _/6VGZB*X@7VCW5O]CV"3OET-NL6B+O,4DRP@P M/BTCU[-HO7+\FL7O5R ,%$V_BX]'#J\;GR!GC0M3B$PS[T*N#AM-+5>@BM1? MOFHCL(]XZSBZGSYGVANNIDLL0H4<'@N.TB9[-=3OG7* M358-$2P6]N,4.;%0P!Z'#3T2="$'WY9WQDPFZKK8_.3Y\I$#[8S%-RUYH$(R M%Z6)YHS[4 \QYSVP31^>XTH4UBX=^ MSR+>_R*&X:(@<&!,35* UT4(Y)G'5 0.V0D&W@$Y7ORF-">=6R6S**;^I2R3 MK.C8]0':\Y/%@4GA'I,9G@:I-^T_=LZ05D]R\8D=/#8;.N0OO"BY1#/&K0-N M5T?;QI2J]]*,AA^_ C#-\F%D2L4RB;7DUZHW>SZGX9G&DC?LFV$E>+GV=%1T-!:P"&35Z M0,QSU![)I84+<7X"8J8QL@"=$MS0E-&Y#\$S^>8MIL+W>I9UY8GDUK/.=5S$ M;,,MK(Z0V+<"^4XU;06BP@.-< <'I#O^ M7+5(:NXQX+1=. O =W(TPMEA#]#"1:JZRYW_WAN\XSTU==N=U^ST MO79%IG@9#GZ1PG^Y I$R5A:^"U2LGFC&SE%#!'1F,)H*FU)KG,7XZ":/[M%!+""/66\-;?Y7+RXC/9%E_]6'G7;1OR9:P"VO- MS>B0.%=#J4DK.R-Y1#,D,#SHX=:JPF; GV,=ME<*/ID-!E[C!^X/,O?PNNII MQ?V_Y(=&[K4Y#JNW0ZNWGD+J6C*(_,P]]FD0MV7AXY>^>[ M?#7MC47[/<0O^4FSJP=4Z_M VU@Z%%P-]KL.AO.?3&[O('%,"X57^7=OUQ#C M(R[:LH;W/?(K>.;G\/#GI\FC:L=#,W3+)3O+SKKH2&I6W1RRN:#2=FGKBOF1 MV2Y; 6C;N"H]"B.#%79..IRC;GO4&C(457R/E&3,?A' LE\WR>P: M&'J/>:@*'@5G?>"BQ)K3PG1 /D$0)DP>!/7%.X#M7 \Q8;($J1NS*WXP># 3 M?7,K^9VP*BSN5(VLK:=5X5&/0R8A6;IGNOWGO,QE/HX+GP,-T@H%"%"SWWR% MDI/6QW"1D$62=]))T>HA&I5PI2/#0^Q=[6X*+.[^V;3TL.&8=D!*;/1:=2.- M9Q5[TXT6"6E5HN^D^=SP*N+@52>(O>[J)?V+8+F8X&C8:PA0<' MCC>G8GFPTKFNI8-R@>FA.2<7$_)SMK'R*%$W5)]'$2)J //5J^D''<3JWOX,XN?7$1 &WFTZ_PA[4T4^?62XZ3V$636W8F3!BN; A&P(T\H2A M0)5(:E\QD-0SHB2<+N!3C>4RH)NH>N0@G >?ESY='X+T&ERHG6+%J+O>3BY:DM-PS"54!=L4&M;VW MUB^::$@9OEHVW[?GV5V3-HNS!9[3#Z7J9"!E%#AX)(F-$3JOQAG!1@H#)=5X M2 Q-08!(7PPY%LV>#NG#S&(V\/Q^;G97OJ)32+IL>K!UW]=N'0C[):T_'H7^ ME#_E3_G'BOP*Z[\ 4$L#!!0 ( /*!3E0"X,&"/FP +:U 2 97S?'_/?=^_^_N[ MG_MY7O_G_WR/U\=KSESG7.?Z7)_E_?Y?@'X"W M &RP.A_J[0OX O#!QYL #@+K^'X?OW^O^WT(\/_^+2@@P"\@)"@D]$\BO%X$ M%F$A(1$QD?6BOP_XD[B8J/COD]^=_/.MZP3Y^05%A86$1?_A@]<"2(FLR^,O MYN=3 ]9)\?%+\?$Z 0\1L%_&AX?\%\/OG7\ H)"PO PQ. +:C?"P^?GAP$3)T^YN)X^X^9SWO>"GW] 8%AX MQ-5(=-2UZS<2$I-N)J=D9MVYFYUS+S>OL*BXY''IDZ?/7E37U-;5OWS5T-;> MT=G5_:;G[>#0\,>1T4]CXU3:U/37F=EOWW\PEI9__F*N0*MKO_7B _CY_MOQ MK^HE!>NU[K<-A'_KQ;GR0QAK MZC(NZ.G6@DWO@NO\"]3D'B2Z6&3<#OHA"DUQ-XCR@#N&V \HICJ!LR,^5@V2 M)H&G#,81S'V@+5V,*CFQF^J93X2FJ",Y-',596=(_1+SZHII]BX/,;]Z5MK&+^!! M\MD1BW468CZ!H48W%8[FT[&3&M+;$XVE9P4?LRS;D&AK?^X(2D$38O$ P6;( MD0<(#$#)ZCW@2#_E?0E#IL-3Z>Z;&D;(P]$K8VYNGK:#,^-?SN5-O;G8L7#R M#?'K$P"!&T#EFDU>-V#+L+AB]6 1TX?SX"'A +27=92]C[$.ND]M3KZL69E; M&&1VJGA4Z]30HX0[ 8L:#N).TU%>J;L?O#S0[ P_M9<'Q%]D"W.JV3$L-\B6 M>9V!Z]CGCZ5D=^S,36"#/3'?&#\A@?-?_-1-2^HF?"JEJ>+%N;)9'6;8!%J,DSUW MJ*JA8?!&LFY5]V;&>N\ [PA[T[M;A-N? BQB.EN,P@.2)S<,-ZNR]X._ZHB% M02:A0<^^1U8M)OX0WH3^@DL^?ENZ;^AJ@0/7 =C!;UZB+$8 MTK-P,$)NK'D:\42O[?V(?5A8G3@/N!3E3,$]W\Y/)T+J>+H,(Y)9#=]S :/& M*;*T@/*-"0I0=?O@9%#>@ZL;W,\6VXNB]=5;0LAA-U)?81;'NHSD!NG\X ?I^R$OWV5 \GS8BP .TAZ M(4P?8 C3LG,O@\LM.'XVCOIR?(B"BF\Z$?-DW'^-K0<$'^C<]KPF941;?9G] MZ5&::W@&>*"2' )K?1O;J;J9TXP[CU+@]H^.7__N1F=F&15(,/1JVULMT\IV MR 1?RNPZ^"PJSL7ZQ'+'^Z0*(+I6;M6:9<)&@V1Z/^PI.9 #2^@S>@=Y/W2W M#&(:)."D,?M"-Z7,MKM>4^:4=2CE]+S;_3JM)E.C)5Z_=H^5=\?L@.76'^/U MW8O0CM!4W#E'+68,='D*F400;A;WC\PS;>,!JE!AL(%U0?3J8QE4[0,WWY^N M,YLR1T0ZWLA_;KJ5&Y!\3'(@3V?9EHJ?UV(Y<;N0+_!T5W"9YD1_147&$\2: M//RV$<&&J0,,32:1!XBF3Z+VH#1V3UK#2>3".1\I#<\S:=PC5[RO _D,,UYL&[%T54-OLT23K)BBKU.2NHH+"&N9BB.9Q MUW[7X75GUVOH?;V>M 51=<=UFIA"\B8DD&J%V9LE&=W,$.@5C;R9C)9$<7++ MC26"VGNGOC@I&'X.=.[R.9,7IFORXVUFJG_N5O+FJ ,ISCG,_L&ML"6\N!_< M7&^2 @B?PCH0JCS@?(P6=4,"%24!Q;J7WB0V*SJ<"Y&>^1'M_B"#>3=3*/NG M;/#S RD\H%'JF/"3 M$BSYM-*V@9(=DO+])=^O]7$FRT>"(R[+ND7\^"$6+.M!TJ, MC9BB1/^GA1OR>BK%+W;>;E4J=V"]9,KUX#*:/%AJ;)/7/."Z!UN=A2:CLSJ' M,!Z@5FPX)[(%:VRI_SH]=,/1O#:)[$N=:E;2+VKB)GH-]UY9F'];_A#Q^A1# M*XT4&#K>WH8$/0A)<(AV+G9*J(8F8'6@W650+F:?#]6?^LK]I;ZX]JR'W5+/ MM@^-$R\3#\8&O>E!RQ?OCYS+*GNZW^OJ5D]LLBNTC@6&F;:FX M.$O^Y^#C+"+WO=NO+Z-)1MOE)QSCOQN(!QO)/[U9,6Z]OLGF6>5 TI;JW3N% M?^R36]5B66 ,H.MPTL_B9%IJL"] <:R]&!U&(FE*ZC]&-OH5_4QL(058[UMB'FFQY>>+2PN#;L-U\I0SU#E(MH=T1Q52$53#' MCO" &@%/K8_-ZG.6L)LE=$X1Q'_4[ZJ_^3-?5%%?SZCTU>7-=.9=$_!+?:_& M8_GC'4>HL?M8S#+.4U*0Y T4>&9QS)7I]<%RNS^#K0.1?*>TCG6#K635RXNJE]#&JV&L(]RW2 !W81':$\24&[7D8QL.8E2":8Y:M .!;@J) MY9F]CH83Z*N.]=H!(J=]\D=B7M@]4[(2MTI>&D4\_!G[A!"S&)O*48 2N4!(B.$2V2AD-"2$9_(AJ79'*5W:FKR7R+59B^' M)9X-&YDC@R=1X]%,>4YUDQA+"]?JQ$6@-=G:C OL[R0)[%Z,2?Q"]Y&LXY]O MUIEE$Z*,V\?L^C1P3>[)ZJK>!2L&HWRI9UXO;^JE\>#KH%^VQK M83T#-:\.%E&%$\Z98BT9MMU]:HAUWT>2./KN<7XQ,D:G5Y^KHC=.08_QX[%( M-W_B^U!Y='4WN2Z4+6<^%3J?-86/(V_ ;H=\*-VQ%EH;")30Y +]ET,_RU+S MW<9I/U9.FMB7D#MQ^I9](<0=Q+&[(OC[R1+H[JXORLP9V-K;X C<3?+7)C;O M1>.G6/7)Q\Z7#QN6?N MW;Z'%5G9GJ%-SZ%ZLPY^A]D[$!K;'N0+QCTV[IH)/ M9:N(KIP:I#B:.Y.G8UX7.:3><+8(>2IC71VR@XM=!931=S^T%,;:G!B/\*SL_7RGOI-=QJ9B7V5("^^_8 MW=T9R_\KI5D=GM,P[C"Y%M\9"FDCZ:DL ^P 038<)^5/$B9BY!#QU ]L/=5< MP>)K^0F_IMFAV7[>@@T(DP!@Z.FW[@ !<,,:CR5F0SWU/* M]:U@9(?GUB;32"RBFG&H3.3&X1\3S5V9W3OB2P[%35Q0]EKSFRIE2Y.9V0S+ M5R!IBC0?09&\CA"PB*1(RISY,5[:J:=%JZMX-HDFV9PFTUW,FI*LZX,=0PPS MC58,WY)U>$"_BQ'?FIN/]CBOW M7E"^I=O2=-%JF^G!]T%P]1)/P+Y#U);2(UCZZ%0*8?X1ZU@ 0?R7GI]#WN12 M-$Q)]!\:GQZS"]+>%H <\+H;IMQ@K9X0%FMSD&QB'$O^ZH%#O>C>/=C?Y>(U5M0-5CWV<,C:;/125/2:D M,!_!"L&.(!5PE&>H&L0\BK'2SA4;_(E(:)8#%QY1RW#KC3O;'3A%RD?[]_6U M%1VF'NY.2-%47C\>EL$UAOT2!/_U1='+R M>J5L;]D"H(=R)6@YDED.C<%PM0:B6OLWQX@&>&\"%7(.;YR IHK]K M]5R6_\ZB(SS@8K.T6F71-+^Z>X><5%R:IPUJ$IOI^IX 'JN([D+(62H'(IX3 M6E*G52TAXL// 3EYZ7T,R*E]E*]BL;8QUBPXN21]W-"JX%LA/G/O]$W^]Y;Z MORUJ(4D)A316KI,HQ=A-4.B^F0J&CN-@L 4_1:>L!1]-4[%N>A+.O,=WQ_Y0 M^1(@9LW_XM;M&MCC$+5X^FYX:EE0%7A4BNN\%HBG M3F8R<1)<%>XP5GA@NCZC_F:P5[K=PZC[B-U1EWM?O?GZ(*LW#,;AUB&3M<=$ MEAQF"TA(E")XP%\%P/%W!GUM#VG$>$Z3<6O;WB^MW^?VJZZR7#QQK6Z6ANPC MHQ@%EB"40R6T(\4A.^L0[@XHZY''#U=/K>&"R;WCYJ>].ZXR=R4?W_;22P-O M^/99G'?OP&_@Q[5:-9MB)WB !'8K6HQ9"7D\AIQH*ZTXQ&?(G"97$+LP'OSE MW7[9AKK)=Z-PPM?\W6;]E'[ MM/G)<^,/7LDSY9_821K=DM2X8>V::6,W%8F"9S,^G/O&K7^^%"SMN$;NZ+VO M0TI&REEC]T3,AEY7NXRD)76)K-5]/P6("IBE/Z* MY1: MU#-W!;/'>!B_'EEIOG4$*_##8%#'U;.NL1Z'J\,YIYNK-CL#Q WF3W MZN6NRS/GWK""Z#O8/R&8W.M88+1Y0+7#".[GTB_86P7EP!RZ,TBB)'5(0MIG M!]CGEIN1/TR1(K1JL'_^'5>AYO5S\&WM]R"\U)>^:+,QMZA/=O+V=T,4G4*TQW*_'/'#AV?,3GV\+'<@5CLQP%4$J*N?KZ'XA1+!@\BQWJYHB]W%G:-AY^3#=^4F>7;*/%G9O"8PT'U9LJ>8 / M^S*4$\KR@)WFRD\DM&VEXZ<"4MP2@1%Y"255H ]/S_1WY@V/WY)W8: .8=T; MW?TO[-:5O#=^X?.W231Z^\\)%2>\)H8:G/*'73'6D5]=#=EL=O[_J5TT5&H%.I26WY8=VJ M$J#@;$IMF8Z:$5+BM)UZUHGFJU(3$ZLWY!)47:T#[@4GBYECG@4M%S&=.05< M66P?&0QS[5@4QLB#Y4I"UY]P>^JN/;!$#(WV5@T59WG4ITW5Q&*R/U0?.K]4 M)!IO?_X<7QCJB2S?JB_K/'8<";JC(,W$Y$+N.+EVLA0\03-HK6>HY.,[B,)L MRP^AY8M-.L$1AAU98U_.6LX]3W][OT0Q,ARE=S '_X,\,NT5PW#M0$/TZ8"QK?;J,4V>=M+ZLN; M"&LQOT !/G!8*T))A=QVEXT5Y/9^473U$89"=_ )Y8?WSKS)J5-5/CBPH+]- M?D4F-DRP/*A1(F(#1HQ9,_1+S R,V">^Z#MDP!5!/QZR"A!^,\HX^*3G MD@SGD4"&3/HE:R!&$)Q@MD!%8!!7%!$$IY\I3FG3*2^:/3N(LM?"%2SJOMIP M^/MR(/)"QM2PT?V7ZC[*9P\]TY<^':]SH//,P>Y7[';F/48]6Z&TDZO,,* ; ML[;6MY+%T>X'W>_W"[&U&/BDQ9!?_3+?1[ZF]$9=4C6J?OGJD*%U8-QAW:KB M%^7WWS+(X'&QF!.>,%%-Y 'G\K7:4KI8CH.8L)BG33'>568!+OJVUELUK0K6 M7XPD5N&"":G8/1\L$?4MH6.K6QNA:H9TU^Q1T+&F^%Y-\0[UER.+N]Z>&=,M M4U>UZ!$W^<[J^;!1S5\M[D_TN_2AFD!!8"9A/ROPB2/. MB@0=Z"I9J!PB&VEX2+3$QWX_&SM M.WXUGY6;6RK1Y"9!_B__A]9+"3R \AA91>H(G5AAVC%(Z%LA6W5>V(=Q5_&N7 _^OA\?9')O7 0Y//$QA;&6A!A7B;)0#!1G%P8 M;\PQ-E!I$=3)EJ#&(/S+G#.^D.1@V/-W;]H02 MA:?#Y%2 1F!F0W-@-_,=),,(ME1A!T"VE\V@H(X5,^WA?^K%C._\L,@E7A<+7.HW'((-ALNI*0R8U63$0=N"1 MR4V@9DY2TU[CRE1J:L#T;[N-[KV;BQ2_W0D4:2.3R [_]4 ML'MS$K';,/Z,^ENX@ K^KC5<%R[Y6E)ZA,J.=FK'^*&\"Z57V]_9/0X^_LV" M[Y2L.EPPY9BOJC57%L:*0D',XW ?1S QG PL@''BY#2KS%7'"" MU*O@3]:X=F_HXO=N&[.=C'[VC@#N ),_FEE!NL =FYCUFUXVI7>SJ_N-PYB- M\,4F$ PWD#;H,KN?4Z$%:G7C8ETRVBF(6P528)E[UYLMZ8I>+X>F&^\T'2_6 M?G5D>ATJ/M->AO/1&L#,LF2Q/3C8U&UIWKA44KT"'8_L"KUI4&)RMWCR#'1T M],!@C=Z^Z?0SM+J:.AYP1G?IH%CO96W=0U)JNH'%R!KV<:@3Q%,B$X73FHW9 M)\#9ZS]=&E,&(G"R<]EK,4\+#MZD+?N%.RZ@3[T__5.HP8Q""I DUOLFEJ1ZY4BNR8TC44,3]S!^S8*'D722&0 M7JS,,VA$2!M!5X"3K0ZDEO'E&W=[4PU8>?WIF$=Y0P2'O7'_^$*17_6TMMX[ MEVRBVG3-6G!/C[C.0:[H5MC(>5 "RYX[V"S->8WT[A_O/P8A&-UM;NK^5]"9 M$J+[G)Q&:[+4[707@S5\SZQKK!)O[=JIN*G8$?')4P!4B+=40)L>@2+!B3:E M"W$/_4<" HK]&XQ3W-W&]E\7DW6V65<8]P$0##HFW(&3A\/I-M>4\Q1WCIR" MJ%:@XUB^09XF4!+#N_UHDCMT7S*QH@8R^CA4.;+L5%LSM,4W64_M@;F9PK+6 M[K=]:IGQED&T4+:T.7,8^O4,(P ]8I1R1;U4R/AF8:@BPES/]3#D'"!$N!P2 MW&%(&ZM43)N.-F]ZFYEO,DG;.Y5#[WTV1??]L) USSTC;;)UTR9ZDS5K M'W:4J\@IL@ACX"E$NC!E#*Z!RG1$%II5H=%65]-= :/9S-Z+HQ^^3$QVG>Y5 M*NSAMT[:V"&0<;N#(VP-H(ELF5FF)FC EIE@GOE NH $YJX$W@[(B:Q?2WS" M#+I8'UF?8WCV/:/E1D63U5>=S5OJWGR4K;[MT13&%76%QU[(<*5?9]QOP=4Y MS1-9QW[@!"W-V'NJ\F.3MWQ Y9X'4G[AQ]( ,Q M14BR%&2?@:)9KNYH'68\AU ^V-^&@NM_P0ROIVY1.N(CD7D7ZZ]D)YX\+K(\ M$7I_9^L9T>$U4[:, O,EPY4MBZ#VLV5W3Q'H/44>05PQ4&\4KALE(20U\_2G MR8.7=YMW"H^'5&HD7+(*T(C*?>![:(>)ZV?98\*SCOULJ6CF2TX!"2X0-K-A MS(X_#U/!PPM<<4B+1KRI.6IQ&5P^!44%T,0<' _[Y"X:,<*VV'GT'_ID$OOL MS("TT4^#"5.NR 0U=!Q)P;>]%J,BZ?PT W[V*4B=IHTY""[2Z!\; B.[3[V\ M=Q;5AY/9-/@U5$LU_*V)/ML+\WK =/S.,>%6[G;XP9[8"9PR*8@0BZK#T?E8 M&'04QAD\KG+5^ 5HVU9<4_W*\?"(LKV+9D/C2]\,JDQ4EIW'[J\B#U.#JCG] MY9WE_<6?VZESK"!W9EQ"?A^]R$G\N,]7O[3S:<7'KCV)T'I,'2D?V(\0PO; MI.$P#Y@(8^Z!?C'JIV;;X)-^:L&C&,9HEQ[-2?H[5YU#")U)[)JVH&^^^EA2 MIJW-6$&\>.^55MLMTX3]T&78X\H'8! 9M># MWW"7NBBBPUDUHAMNR[I(GXR:*3BZ,5Y1*FDD_)AP.ZF>R)9VH!&[^L>'#L): MW\"V\H ZN<46\JVUJ[%&*M$G>,"-:_O<'1CZV<176YIJ,SZ>N3,UZ[5%;4_S ML8$BHA?L;KHUI'1257T'8JR4N0@QRMEN#(/.()&M#"(^_6YHB8706%.OP%#% M5B'E/<&:[P:ZEQ>R[3T/<(-$U]ZF ) /TQ1^K@_W"THDJQTAC@S"0]I]/* 3 ME4"27*!O PDW]##\P24>/VSZ!N:%GF(U,J-O5DSN^7Q >84HK7@^0LCD#:>0 M1,&C:J[>9P5#>.8BW)T_=K(>P=_DP) >GT2D>&X>;E(4:BR:>W'@OOIK^:4W M99M_-'$&'78_1[-[^#D<..JL63ZX5C7L5NP($CQ:$<:4;.14S:2>9$Q6!Y5C MCD&/:*'\E:5/T/%YOEYM?00<9!&RA.?[+2C=.;M@>J[6 MUBFR>K:B]'9SV]'A8\(]B%HMMDPC'/5;64'L=9P7%X\ M?ER];00'-@77G(3BJ)(WL>L)SO%B:?H#%<'Z%T-T%_6*\5*-BXG[J;WU[TGZ M9*+_0\F<)M@: B60BRV&FKB!L'BG,W-9+2L&_(H#UB@D1)R\:S+-E1L"4JYI ;N7R0 M!PUO#^%X@(A$24')TT]M5M>/-'\4ZS$_4_G1-D%RL4A([;B:#_%#X';^Z7X1 M..3-N7L@%%>TA&8 :1\BU"HD5NJR[2E[+%0B*5)@5_BN[Y<^E[R[6$\>[^9H MF-T^OW/3FS#6HUC;D7#G_0A#?_(Z'.7IN&M'Z*;."!8.XG<&74@59S]#%P-1 M LL5T(6WMCXJ^4T? G=.'!E0%SRS<.Y>E;6?K>!MEN3\1Y89VXASQU+4G\#7 M+#UVMKO(/^/MH945U8B/]'=#%BNFD=+GHK+Z+%[TJ9];MV0";.)O@$'K,"0, M3]LBM A&O-A\@96IL[\#O]$N=Q*>4UIPP0_L1X@D\_R MNM:R90T?RCWIS,N!T"W@S*/@@">ORU.](J+]1S>V[SHN-9T,IZ']GS3Y'YT3 M$7_UALT$<]C2C5RQ];_K]=+.9G'8;HL!3#/"K8BDX5JZ%0_P#5::B2I1O^B< M'&*\?O-!4>\]C]Z_^>!UTK=Z30N.'A(1-ID1';L'+F9^27XB,-]"'"+&<;2V M1Y,T:KG#^,:UD,((?*WR_> #@R)CM!7S8IZ&OE>\@9Y: MINV504PJ8M@(YBV(FFZV3!%7]!0CBUGWDE.*W8AK=0O')XUDNT5_GQ0'GW(* M=".>L)$!VRRF-M&S?P:GWM>56P0'45]?4 M4H!5G2XR>)0'I'-UX)DKA"*YHO:^+&?([3U2 BTZUSJ"%AA&/]4_ M4]RDU)9U27$X*G[C/:=?F-&1&MAGE:!1[OJ[C!5[N(-,J(P)<>[!N7PKQ0&5 M7" _%(Z"\_FPQ?H-1 U:JX#+BHE,KUE)>>&NN!EKH\!W\SW;@U-G26(X2C)" MR5(&V\D#5'F -UX2.^D0!D]FFNH6AN#'_)%:<,0\9Z#"^)+\W+NE1:_HQM?/ M'EU85D^VO[TJ\?HJ-A$>A@AWD #:.:7Q@!H<6[J_%04>";9E=H$C67Y4/5.K MH5)&?GW;F>D\YJBMNY=?ZH61 YW:)F]]8Q:(C:(9*V.<*A(E&[4)NP<[@)3 MA9+&YIA%0Y8JW \HR7#; 6-)J4Y*]ZL/F!/%C7:+/I&EK\0Z(4$Q1(P>X20:[#S0KN:',/L#NI6<6Z M=.QL6PXAZ'QL;YA%]@=AN^>*CW-3#V.^NAQR*L7Y$P39%Z!4$(4"D?,L1EXO M=3:UUD$]M!@]R&J;.N.A>2]V2._1RSC?V]OH]PF!KUQ\;Z]+&X?A^ %)DD2Y M@P)/$V[P (ESD!,XQ!7[$EH4L%/W95#HF/NAS!]G?*]F!B6':#9'77B9;1NE MD3]6$J62_Z!*#V7+'2" 3C'"4Z;7N5(_5"6AK.A';!M(YNGX#X1$\Y8?=7U/ MCV@Z1-0UQ'.4["87)I> X]1#56]F@Y+E<@B%WQY*%C1+8COR%O)9KG.(^E"Z MS!1'IQ,I$X)1+9 !&[XUR&:[.24:G,2F[1?991V!6[ ML+H@"6G.LN6F;*':*<2MR8VP(]&^*]E43;D/YSC[PR&AC299YCP M9BA-/&=W^%)-[KMY_Q(*8+^-8;[BS7!$N'AX0 MY)MW&[3A!+ACL \=S9CJ%V0KCNI&],G8#S8AMN5'T&+(AFT\8'K-%2 8Y%2G P*(F[@C.''L+HP9IVP;V-].%'4+O PM M4O/0(ON,*N6<]_=X.P%\/=M>.5U'U BW&HSO;A_EZD-BC!,'&8D9CX-DOKOF MU2=%R#;6.KPYH.@EW7787/^7<, 6F5O3&\TD9=$GVKBF'RHM#*:<)#X%KOE^ MMIP,7W_J>=O1=Y08J-=9_O9RKN+ CPW?,NT,-CCX M^N-@@-%K0[^ 4'W:#7ZC@8F."AWK33O.W]9_LR+QSG#W1TBG:W(#E$'5,^\F M2V)<2X,:5*LNY%P[6E7L6=)7,;W!,+-3]WSYS99IPTP);#2N=0MV2^#OUUID M9YE?.8\M+F]M? W6=Y0Y)7"E=ZNT.PP:76VT/W<=>5GK@5@2?V+6#/&.,(O6/4;XB.E<+8U#9 @<'%.\(%&3%3K1HN<%H_GKULWJ]4 MN<[BEJT;P+D&+M)K69KH>EH*>Q,X2N>CWB=+]3SM?SSQJ?6)D,-]2+:&>:R/ M^RSH27Q5YA>5DOUIKVQ&NI^ZSKC2/[(LOR%$2)0Q=Z?UD!2NJM8I@2S"WDW# MB<\I12TMA'-"6LL7T]C'-QR/O'?DW91 [C2706P@^4BFN>'IFBQ5MC;GT:][ MZBG+W3B)G\B-DP>EZ:=GFIXG4H?HG,+ZBO$7!GYV;N]61A- MMOZP,'C5='#.S>=L>16=>G*=R8/E/&#^&S&7:^#)_<(#A"V5@I RO_K3524: M:@8N]G4PF06RH;N&-^YL?""^_'FT'FTYVYT'%Q4UKZ_&A/3&+.0++'*3TSV- M?;K0<_M53LGAF0;*/.!#2"\/X,-# W]S]D&H\Z_V?Z?]?>?E*<7:@/"$C_2# M[=)OW@6_W,(U#IKWA'G]PR\Y7'X$XZ%$B@[BCU\4_=7Z5^O_AM9G#=;=MR)2 M+S1<=ZT]]J+F_+[ZO2?P;L"W)^6X*C29>_TJ"A+'=>'_\#G69/O_RVW/S$XJ ML0WWCAA0<@^SX[?7W0[\!<@Z6_]I<688)+.-*:]%9SLM=S$DTK,>G[&=\0PT MRQ^W$EA_V]0B_<"3'GZ-]-K55AX@U(5QA]RG0L=0-%)BDSI#X=!P[5;6(73[ M<;.([*>R.0COO!FAQ-E>%[WIE[X3VTSJT,9K[M8 -I3;>=5R \PNO7&MAWE M( ]((M=$WOJ)%T8CIUR3'T(EX$1G@>:P=]70K]T['\RYQ-,NG.[LK%FXY?6E MJ8UV5G"F"45=9,NHTU#T698\EXS<)'3]FG6$YGL*,(\$"%#-,,,CTA^XB#ZP^*W,F4'C M)R6U]2."OXAK\;:$??"&\.;"HSM*T<$I=\4 M%5;[:&QHR:O:+RCKO%_5F17& WJ*H!5NBP$/>%01B1(C3>?"]6&+"V%-4R>! M\XH'3 ^PHWG .04XBX\T$A/(2T?8YO"YCA-'^@Y?H[7L,;X_(4+[.^G:HZS17F ;^7L+?AI\@L@,1-K/V"T>[+.!L_9\EZ%*VK ^S2GP+&3+9N_8?94I;!;8W4F$M&L+T3Q@"A]'\D?P8:RS M]G^PV$7\ DDC!-[G'7WD%7D^)"3+KD!GI$!1P+U Z_;G]6,;98^OHE"<2M+% M4!6T$_,S!%-8@37H%"U-JRVOO]-1RWV$V.1;$=!&KYC_^6F@N=N+W\Q6;_K= M_$2Q;H:U6'W.5E]1OE]Z/A"":R4-S\\\>4T.LP@BF/E0=^'OU_::?.$.EZ#& MRC-0USXM:DC^%'D#---]V-W\IEZEP6Q5EN.PS\U[CBV9"#-MM=/7.SHV+=V? M>)##I$$$1BGSZ2C2"_G)_?"'A0@\OVPCU,XP[QC)_/)==:.">!?Y:.*XHG<0 MY_ IUU"#OO3M')PS-#$N4I^3,93W#/ M&N.]GG?9;2F3MADYKN@><'P3OX=Q%)$>"2IT$&KJ6_:Y4K7BN7J>:!EW@O-@ M[3[)SA&S\,C,@,AQ;$GP$_?>:;NWU0;W ^.*O/EU=O8;\:TJ/BREV\) 2<9$ M0:DTR01\&<:;DV'D>- JJ5O)I?:J!D,KKH(HEU SDKEY/?U1@.A%JCM:T%OC M/;8,AL<>C"[T>[MW P/7LOBIE\HMB?)B$#JNG$6/4G&='M)+#@%7>$7] MB+2!NYE>NU@64N/Q!1=+-O=(Q>Z9A.+@Z/G*J<(%O8ZD.;62)\2F3*_3+14A M6N@&7)M7& 6QOM\O>DK,76"2>2GWEW+B8&&4G+SWH4&SK][A K71?G0QUGID M.M+?()%42YYG334B!#$'(=^B27\3Y+C2UN;!B/QUWUW[AO0KIO(4-^IT91XT M.LXO$W_X<*DO@"F%'^X+?6244@AT)T80=_T7%@:C4X>HN1) !G.=&('O9^RG MH-)'Q84CD_..!KM28[Z+7_TFO7WX39FXWN9'30Y<"0XG%>/*\H0S@1[;EP%G M4&8#5$'!W<3)/=A8[P ].![J=/(C;:MEPW;4C4GW8POQ'^=QHNWRALN M]*VAP"&FS8@ZIVR!!P03TYL-!FM)F[7BD=2-X,?'<46O\Q.3BU]_:,RWO6_T MXNQ91\,NSPO;'ZD=LALR-"KP85EP6W%*2%_',-IY9!6N&R6!#FI%2+-=HVA: M8'T*1D&_A >(U-5?DM.OK)E-61+TU_R4&9-Y:FQSZIV86SX/Q7D M(5(O\M8 M9H["ML2=0?4K6M8M^-9X5S@<"C7!6YM[$E Y\$ MA?T9_>-S3L.Z),JWT+'=9T=/Y3@T0WJT1D?!8H0ZJC/TR>L6%+,I6>W]WE:Y MGR'5OS<-&*.M9$@K'%EEP)8A,^^2($>:LK9WP2CMU$+JAHKHRU=6"G]P9VBF MGUXXAO>9S'@\PKS;+OK(UI7E@6W__5<.G-+V4 0O+E#GF3HP^9C$C(KWC^\-=WF;:ZW>(@PX^K['W1OMQ0B1O#S\G3D6$TP2) MFC;9"B:&\]L4.9[8?!]RE:0<0#+I V0[:VD#9#C"4_<7(P9%LSGK5M<+8O MXNZIHW[);RDR+2U$7"(Z3*4SJL/PLT:18I_)@PGGE1,A=.U]V7FJ!AO]7A[= M_'86W]%U5.I%H+9IF7W(X)<5R\^%I,T\@/H#55_*4<"Q:W^2N-9%7-42UC7< M0"0/Z$7!5&[:C7.0NP6Q"=>_AH#DG+@GL5&P0Q4ED&;[0ME""/9SSJT_U0N2 MQL=(8L-4EP?$G>0!7ZW^ZN7/]5*.X^AQV[D7T%258F\&G,'>WXO2TE@.MF7OM]S) P@_D> . M OL)DF9TJ9Z]6L$#8MMY0#;BQ4G7*0)[GP/S)QP-B_ WS3GPPVIP[<.D4*O!GW'L5/_G5ZJ[OS5R__67J:=8GD Y0FBWK)V*E_!=IB[)ZIN]%IMC:D4 M#VC;_5C_9\"IT^?=UQFNGPY#57X$FWQ:E-$SD3U*,O+Y MXC9JV9WPLEN7]NU4P0:9E,>#F!\ZM-<5 0[UMYWA?&,[\F?*GG]3Y*AN9'I) M% TYKMQ)JE:8IX+79KL]U:%H'Y_+4ZSOO]X8]9E:9S.WY0UV]&V)VM:8*;=< M9RN5)O6A1TWAE!FI.HE>#48R;T'6-&*J_&($U1ED=2@]OLY0MV,X'!3G*@S_ M'&A8$LM)M[WQS.:XL]$5HV#9F]3G=H!JJS4&7PS#ECL;X $2%@8L9ZB=$IJ" MV0OJ=#7\JLNADE.58*RS*8M CLW7*O?J<6,*\L-V'4JA+K6_3RA)D8UIG_OG MK8XE_-^%@[,&?[>R?"@QOKTP5O1/R*YYTG3D:QY W$[*K4CI?@$'\>0*MZF0 M>Z'N/_BV:Q\1TL>Q[_3SX3Z)PIYFJX?-')T992L@N8?]8DGS@G#"*%E-G&R)_)B'PT3$8UCJJ/(-;..B7 ZG,_(K/6I6Q_^(^(!#F!O'3"PIP' M>$TX<3;?9QUA;:_.RGO2/>YMPF(4#@K$7D(^9,,^>[7[ MVA#[,8R;N+V$AH3_!:=#9!# 8_U2V(\XT!$F9MJN'083!MSUA)+2SD:B(K2A MUXU3Q!5,M?>+V2:V1^)Q?F6WQJ&HD!^W!)];AI=)M#^SB)ZNG\8%(I+) !QO ME%$4'E53.N_%R.,!7?4DN=JXO[T*IJ E;3A/+(*>!KE8BE9EBUVG;IJN2]0)^+R?'A+2UX&\&)XPJ;EMS\?/ MVVA\N7 ML0O42@@G0";W.PL$6+JV1P9X@%^:O/DF9MJSX.#Y/#+"-L70,KX9 M#I/X8/1H)T(:1\DG\6'5T.,S9W[E1U+Z$WY)N-&N./2&F60%:Z2/S>K.NQ=$ M$3.:M;E]I/HDNA/,1[O!?K:T$TVA==_!=J6?#5=3J\[R%GZ)A0[66"8HU3NMMDKJ]"RZ+RMP:5\:-=:QY! M1X+N9N]KVA%K,U00YI$OR[?D1'>GD">.MC,C&!&S'9*WN)+#1J=_9INEW<4G MJ6H_QE_YZMR+*=TS \<8U0.?;MLNN4%X5#<5=VYL.O7$Z!NG:[,\( 2W:H13 MY0&?!'G 3^/*.6HD.PNY 3X7'>(!ATH A[^SG3+2*O2-S$I$3UHA[+ MK=;"C? %F;D4 Q8?#*3?OA*'V8H\("LN$89I)XZ:[:SG#A[0(W/S5Q(W1X9Z M>'LAJ=9INN4?Q#[^,.KM,(9Z>YL)'ZE>SR33# %C3M@?-YN(;4[_ J3>X>R< M5II(,!+N07S BO" 1I_7 =P3N[B=4[@UB3$<91':#/$;;%E>W857@<[E2 M;O)A*N[?RW A W^RBOZ;>M;ECSL*_S'DQ@;C6L/@ZNY.#Q-EYFZ8YJG\IGD]J.8(=O?/ M&SP@&DYF[2>6XSC"%#RKSGR$\'5G88K.ZCO.\'_6NS5_$<[_RPCG'^7_WDV\ M?S4Y#[JQQV%Z"#.CGB.@ B>V$DX:5T9_8,7A+UK:<8FEW SU9:(<;CJYXQI< MF#HD@R6RSJCQTJ5S_^BB7"/8"'M)$F[>/ #VDDP29@[<#>>F._V_<]-5.#?9 M:F)71Y<1@S*<18/?6/%>^"JL^PTNJ];/9L/EEYNV:&JC5Z8"!V M%\D?-6'.M.-DSE-?%N>F"TJAR<4I)^OB%I' MU=_ 41()X!$5]=.O&,0.PECJ$>@1[8LC^TMT%TE!WY>QK?39>QOQH7US%E[X M%9]#UBVBSP"YI*E02'.4O?$Z#=F1S2$8X'P78\U%Z,)98#2[^>H)K4,K=.,TAOSC]*= M1.::M4FLH]5^JG8QE@M7^#UW8-(D>F=<;,[?J[;1O#_TY%\ [EODOP,LETA_ M=]$UUM3_3Z;'OTE4.JJ]7-MH\MI2ZFK>IW\H9_QW^=Y0&KV@7K M?D,GF9ONQG%J):SNV10*#L-8HX&-H!'9&7OPIW'?+UO*P@C .LD]\F>R[A_% M%*N @^-JD9,4C/QYQ74Q'RN$^9^1B.NS=@#W^BM%>!VTY$RIS3DOW MG*WEV#/8'_]HE&/487^4SQYEAG.>5)*">Y"4_((=$)TV@4QP<=-J+2,(0YN" M,K_E_31=N[5X,!&K[;*T7R,<0(K9E,M=$K9:L\_E'RL^53;JZV_Q;UE?B!+J4[J$DQ<7+-( M OP_;?ZK#TCFXH+P$Z,H*)IE!9U@2G+N-"F6HKNG<+=^]ACCJ@)7)%6SJ"JB MIF/ZM<^:4$U+]=P%'32S:_IG<6R9)&8XB?,"27G" M ^IG.\DI!*7F+>A0UR'NMG'(L,="AG:PV,.VQ*W;XNHM_4=.-5W-9W<:%E_1 M"'$UU+BA3U[/J<2:8C\UPRX3__N?Q1SD 90"G I6,Y"\L39T;*AS:D(/K[^0,O)QTEZD1V:CO:@$$-,Z)3E!9E(A&18?&L45 M'67D-^V-I-"/ZJFC&*6M?>KM\UH?FO2>]HD>U*Q8S7E'<*Y+F5D_LWSLH/XV MZ_3-.G@2QIBV3ZS+]_%NG/"' MT18R>.)U4!N3! ;7W_KE8.]M=IX'5$]FYD6+7U1S#S*ZCCC^'=_6G/W[K_C\ MFS7!6;9,&#,&7+E5=-[]EN3JF_' -'S!7'_=VM/Q;77/!NM/,FH'VJ'FX(_;OO=[B^(]>& MSI\ "=25^3G:HI)_@0;CQNBUJYE#5BHK*7YY\N?>[OS6+;[W6Q"9*PS@6=[^.!Q2LWZ_R6@[/ T0L,W@ TI0$R0_CVB2+ %[_CEA>AF$_+MB6O67-ELV&X9KB?NSW.YK_+]S)]\=RP54[B.IAYB3[ MY;31BKEZ7=J=U,0OF4XGW'!_N'N_LJP+\@\]./_-<_FJK'UXP/]X..*O._\3 M[_S7X$^"!]Q V/$ PGTR6RR0#<=3_.=O(PW(#ORZ[B"-=XB##5KO[]2SZU!_ M#RD1_VE(*<@VM-+JP$O:=%!K>_=?PGU_X;HP^P>57/\-JMB7HH/@;HQ1YV)# M<:#>D[]1BAN&C/C]RB5D]1._N@J71BUU17^XEM\[I?MOKD=2A0>1LS,K/&#= M^#^]C^D2YUOT9LFMUUSA+,+$N_U7V?"?XKZKK'_ZCX9W,6*TQ615"4YELQFN M]10[BF6*YF\M4&UZ_C*GK6!OL';IB,;MF&QW_T^&3?W!)D6RS6ZY^?)RRAGN M"$MN-Z+:=GZ4Y8,Y#-;?)/E*0GO*II*ZHA?YT:SV2:UA[F9H@G8V> I7;9I2X7:3GFO8['^[J:[W!>8_1X@ 7 1XCB+ /P.9]C().62CX M@C^4<=>OTVY4$1.\1OM^3<#F6G?.P2FAVIA23O:^B(6'K%UUZ8*1)B.7W07C-V&Z MS^^WSYCVRWB]E@) N; 396$M&83Y(:H!I-7?U3]^?*B##%@@<.=D8*2]<8HR MRK8J#A@J7KN:]@05\_1A$#ION[3]UOIT^\%)8T[/9#^S:6=[J*C[1$=55XJ< ME +??@H@;'7TGQW:HNCO(Y+8WRTCM_-?_9/T5CS:8%5E$3?WUF FR+OJ;RK^ M_]#BA,YR$%>,\'MII 7%7-?( P9Z4<6U_\?6]2+_94E(\6M;A!/5[R4N>BDW M_3!GF3B#+-9B3:*X2H0'DM^0 K@O59,U/$ ;KO%1[_T6'OTCJVJ>'JQ3W &L M%N>^A3$U="/:G7F9T=_Q"F,[56':/NH6&5OSL8%@%__M9EU;O^EO6^/ MAVIM^Y]"38-$L4$2:$2C4E4CE,3BEA M, Y)&8><1AD&.6=&3(N96?-;GM_O\^Z>7<]^=\^[]_.^[^_9?]R?SS+6NM=U MW?=U?:_#?=WWJEHVA(]VT3YH<714MY?,M/&E><,^86+Y_,$KRX 3U*[M.#>6 MQ%#,^7?+L2($Z=SK]3+C$3V&5^[V)1F\O.#Q^F+T\F.#%7N7(N=#QC3\AW)! M$-/O@V)CP!18H$M (F?W"%Z?64AK]>Q9PM1]5)9Y,^>SO4A"T%I)JZ)BW]K8W<56[+O4ST37HQF2M;>V'8/PK3^Y&W/O?! M)488'(=XH22"XVL'5S1M/OPT+T[;[-PU8LD&0V+W&"06G!U$J8#D0%C$!&WS MP0M]+NZ,P"N%DU)!;6B]X7O*T.MG1.?\:(;OL^[5L+4):!0,5[)9LS?VUGUD M\],?H/Y?2O*_1$E@WT!("KS$">3J@+*9( S^_X)2=T!-!)NF>.)$\J9'9BDZH8\Z>D-C!%8?&5TPA>*J B>%CQ"^!T>W_4FB0?W0$KO4VGLB12"9>8%]JH!YG"Z%VX**]47+>SF] MI[W?MKG]5,V7[<7:LZ9XZJ?9C$O5:W6&O/M&FO,%R7.\ M#*Y(KY; NSZQ8I91^2;F^9!;UPY$C*Y>NJN0/-GWXI3X%6S>UM%^]&[,22QH ML)-:BQ=IP\.36+FS7 9,J=)#295N#NR7$* R!3+,G++L?;L@=)HPX3(DT<< MM1\*O=<6^'(D%!_]@Z3[OZ!,#7N;7$"8J/];V:5%$560&\ C A[6$EQ#9B.Y MWW>%QST%YC70N,@^0G.#=KQ%SNE748]N'Q-D+-ZKM-?/+#(^?T!@^FGT%U+7 MKCI 'JW,%6PVLN:8@)B]3;@SJF7Y+/2M-)'RZI2 X@)::3)T5EON^)3)U4,) MMJ9;E1.G]L$((&0!%K <(+%=O=A.>A\^UEVXLLRL$J_Z I"R.DW2BM8UWK9# MO-7IY:"FYFRML$OX0\&W"$^ :*-C-9O!2T=6H381:K1&=Z14(9VB&G=C*M_,N*WFO=[UX.S[^=7Y'W:WR A>MJ\S M("GS[I,]"32 O9Y)K.0CXI0V@H-]]&B:6K5U%%J)2;QZ7E.]*N]0W;IVE:FT MLJ;!"(?K5^]DARE$O-"N0DD]1+Q?P/[IW/2_U5**^M DN+X#'EK:EWZ'\:@L MT)>]!(Q*!QT8M7>S/6^3PV=B3SU^;I&CM>8NPZ?I;>3;*)48X=CK*92C%LK# M\NL$6 )]U&H^ C0H/L0J2JDDP_$MTQX521?B H!^_-$^K6B4<&&W2MN)D6*K M]V[/$BAV5!7-PLEU IKRYTD!J6PT'Q%.@!E3Q*';\6B@TJP<%01'#K=]:\C" M]*#6*M<53*&R*Q/L6XO(;IJU]6FMS4EN)MHOEH36*81UOD9GPI*K!!O[5J!2 M"Y+JIN/?*&DW'^6EX7QR\O)0@J5"?<.EEL;37(;8#4IW]8[:X<["BG-K3CDD MPSJKCI8 *KW,ZHZ#+QGOQ"CT@KKQL4 -JZ,<3!#5N905D"51[O>;3@#MLNB0KG#U0%@_TKMI^<58FU3J:3_)F$ M2,Q1$K@>4_D$DN*J@OZ< T'*U7A%\&*F%\TUO']2DKLMD>.PXUE"M3,MHZW$ MRW-YAH;'D^TN)6:DK5#MI.QL?C<9N<+GF\>59XY;2XAG$#7 1,A MT4R.A >9Z4COZF?X5OE&T"4+L8@@X=Z @CYGER68*_(91>]ROXKX*):E[E0) MDEP8OB8L*\X*7X*O!O(F*5J=N]BGF'S$>"LS[3/TU;JYO-GXO[)?9GNN&4-_7(&/$.$CN-*9\X=FZ4/+25V8/BP7 MW8;;#(?PD6S4+38?\;RF&F5^Y W>1\K 0AJ%&93$%&)Y42$ M=&="?8S:18:LZ+"'HCH"S%G(!)&YTF2V)HO.E59G^[/(XU?ZK&-#'"YI&+FG M=SN-W6[[&I[>OO:06TG$F56FY46'.F_N2>BN184NKF=KA9&7H%5Q!J#$0ZXZ M*Z4Z1\N^0^?B0DUME)1'C_R%Q3=K%M:LI)^X/3HD+OIYU9L#TQ72"RA I25> M WJ'$20?U8HB+P5.(1<#5:;,SRB)LLRK.!A($[P7CK30%-9%.$B]TVG>'?LR MP##KM,NKR$%?"C*<7$CG+GW57URI)0-UR^L0I,^8UNX0JU M%^FMRY/@''L5)0DU:NW=4RE8OJ=[A9,8L7G^"*P^UF0=$5R;_(0C,&^KR9X\ M2T9N<6X=ADVLOB8AK[AV:JL]9R)YRRXIV8,)72T+Q8[K)T4(6<@\8&FQUX$S M'#ON9N9D!:9[2W_D9:Y%[T?UPRU%ULM($;AE>L1@QHC.V./!%K+_TD_4$BR:_\QHKJ+^W; )VX.>+(W;^S%I,^?S' M5K+Q;]%K>47DXZF$+E05(.]K).37#X=/GB$7&\F/>F8=L$?C>EUZ***S\;>Z M)C0_+[BF=BY"=4^$S'2L'U:V?%D0IC^0PIF,1.O'C3OVG K*G>[N*'J5]R*V M^OI'9^L52$&6^1.5<^O%LT/A,#^1/9\]5_2F,ZT!4:(8OAY3U$:XXGK()'#N M/;!(QS+6EGL& "YL"AYM YH=>LT MX2HDVS9#78*A&,O7Z%IM:W#.?U5R*5=YH3G93SSVQM9CK\[L6HKK8'S ,,_* MCE. M;:4F/(ZSMWIMA,7V 8VW M5\^<,T7@(R7\=F_K8M)&GP_M=[8YU[[FQ!=[J1K!*UNN9UQ"3*N:*THXD?1Y MM\GNA\H104[C0=<8Z*)^HMQ8@2HUQBB88:WA.B8KFKY.LBI+)J?P2#[%6S3; M1GTSXE6]\MS_,_8.C<1B/J(.$Q6B=GEPO@[]9.RI0]P]+/=(W\G&TCP1X=CT^PM%O@Y3\.G=U%@QZ0IRS8_2\8JY\1Q^].[#&H0 , M/\RL"_6_D+5>-^N)FG[)'=K@QYS;C>/=71+53>HKATZ?I85B;(=)#1@">B%8 MSUD'5"H4:H'KBR]#&\!4&]Z#4LV^BTB&\#6N=790V.@AW.X.+1^]S'27[N![ M%JT0]:R.C7.ZQ[/@3:4[% ,=1F0KJ-=<%4$.T[*2KEBJ%%=B'8M3SQRC.;W> M<=0GV$>Q>GM\;8!YX8*V/]P5=P@'*LW16[A[0!'.)BS.!+1B6(_?/:GHU"@W MB:X3!\T2Q?7VQMV) ZD9^(!?UX5CT\\0KWS84;O5N:[W:4N,]!V?K5:&Z<2N MRTE%+M9A#*RDMNORM_9(V7WIZ8R,H,=%)VEC!J]&.G_GQH,Y S%'>4C,,- M[T',K,T7/H(E;^ ,X=IACP;^O0'9^4:=1?U^P\*O._YVVNF65&0#N/M^X?7@S^]0!.G-&J[L5ND:&G.:P?,2: M9CYB*3(&,\1#5YZ$&"5ZM119.FM;GBYX360ZJ;"DB?EQM_TQ2-!R/^B')!2*$:)98-W^EV&O M/5A> 2W(PMFE>ZU2[N4II%&\NK.O7+("$7,%E)[U3.JUPJ(.(S6&NH1M_:TD M7YVQZGMKS 2%=^XVPWM3(4FH&Y7743>)&B6*EB^"VE!(HZ,,'^FM;>>1XF#M MF[FISM6BX\V[E T.'I-)E;/OO1Y$>N/;O87-XSW!^&*7>0),4RJXUOTJ7LSR M0G_.^M0Z8"DD&I0[9M/,5>RKJ7@1^]FM,$XNYBFN8"#EB)QIZ)>-]-W@0]C7 MG87-=-A%KC#H C );"O>7:,5#+HPUY29F\KDU-Y6B_(78J%SL@Z/)K=']#B3 MQE\/ELN>M30*W/Q*>DKII&B::N>"N1I3&V8#F("5&)D*JJ75*KID']N6O>WX MI&9AH*'P[3S#IUMJ46?L3]CN%D&P'/Y6'20P-0=AP8V^5?Y@0_\K>J=AG_!5 M$L[/[S'U*5C^E<&I.5-BM%XGY.*-36+GUD30VN(ZPQ5;+<^J*WYY;5V/+:BC M^':KL>_#CH^Y42#3SA[42G,$L>9,E6U4BJ*[:Z M\;6FZ.[[>8F!<@8RG*Z<89KOU6EG*M);K\?_+B\[^>N9R1/T94_L#S\1/"ZE MO5BW#GI'+G"HQ'0MZPT(Y^CCJ6A1)103&W$D67&9Z;;8=[W%<8[I=SO>E218 M8+4ME7&?.S]>JD @<.JPQJB"77V^TD!E_FU2-5'\@]@+(T^F/B5@FV+98[KJ MN]HT#A%AOMX*#QU2AAM$!0D=YHCRCHV,<3 M.^#25?/NT5U!J1@"N]]KR @%3U<+CX 38TC(VC6A%;&QZA2E58FN3&+89ZXU M@(D\KVGS<4 _(.1 HFY&:?24.6L\1D-"N7"G=C4Q^/["%]08NH#1:A9U;WX+ M#OO4VSZOL[%U)VUCCNK#+3*T7=(9\[,?3RI/Q@:'6Q4*3V MG#SW 0DVJJ"&,/>6/0RR1S]B^(C='0-7@"/@,M@9.\!'C$W#4'83U5"^&:AW M1,W-H'@;=L#8.#XTN/IGRZS'2=QEG"HGGZ_CGDSHL_>U^RT>P:LW'D+.D)H< M\KY=!?\23V#ORG\UWY#C,POO?0Q/%; MX<.!)K,MR7Q$LD$,Y'6"60 []=JR>+H']53@!L MYJW&]$S!#+SG]@([0&5H(FXF4T;)^8TU M'<+O;C[C_:[J__VCVP*(62-?1K85Q>C;%^\OU-?KD!2.\^B4.7[B5(2MB*#2 M8EU=Z055."D>// G?;O2)'9WL\_Q[G(E>N5F@B_3\H.TJ@)"#I5==_>V9'NT MOE7V._+\;&)T8 SY)*:KE:%58XSLCR24+P+MG%F$"$4LY=ZZMO-R&[6FGZ^@ M.+\==9725SH0_BY0YU^R 6'!U%?N<@%8@>S@YS\383_!>VHGV7G^J\>HJ1-. M1%[D>3Z"IX!-D.&%]UISX^';2' O+4> C6 -'Z%Z'!A[#TP_$8)=E +BC9_- MHZ.*,$QKU*PV*9+(AN,^6KY#04<,4&D$#+PI5P(Z8?Z\ZEVIV*%,::#>*@Y^ M=1LP_1+5/5_+K0(AH3*8FI:E-J:PYK[^=T_L_$9#KOM/2N*3JJ#_1*@0'[]5 M_\')[\T ?OX#=4

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ɰ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

MHZT[V#3$NH,-60Z&"TS6V4?Q,=*ZCY;SF<9 Q\CB[ L;-ZQ6MU!KT79&=M2=H4K3')1\HD#OOB:5V31N@96^!/ T[U M?U>&U!2*^PMYCP>G6%T\[)N+$<#I4X%/[-E_F MM7W@3C!P^TX6ZN:0*!F+!FTU8YJC;F+(!1/;ZG#D.[EIIJP,@ MWL_)KJ&*W!:#PH)GL:;A//TJ&I)A)H;1R3J>]L0&[\#9EY,VPK4Q@4?JZXC% M&75"33XV(!APQFKG0]G!KM:1!5<,I(+DN5BIP6>=03.E5/0\9V2/Q@G'T]&K M>W<< $^OH@D;T^^/GZY[&'(04:,WX'6IVXPB@Y@"UAXMGGPV/GKS*-@>^9+^ M)Q<>B*0QA=ME'F,]BTK:9"E83ZFF8HS3=4XL0A$4;&-PUM\=#[T_/B9R\\=6 MW*-X&";%#KRI'RSDO8P)H4U]3"+Q:'(30]3D)M(Y4D8P[6/AS+::![0GB=.X M](TPUE9!?9J@'='\9 T=XGXS[7+G.M(B$%^!5$SC M>[=#W$FU,IK#W;['?^>$_G&;^Q_^BE9=_0,8.T4[OV'11:^ A5)WE)GZ/)TY M<$?.5Q1%J])X(NOX[?P[);Q]^BBF(..VK@JA:&:SG#8J!5(6G2,OB8Y!)6*V=$JK1Z^*3:MT? MI.U]6_>'B+X#"#W6\6N,"ABL@91)VVJSK8@G#2(%1]&)ERFWJ2@?H_GZ].W\ M@[0_L/EZB"HF7V6^>S9!S;KE;!)(FWU=@(5DLK,%K1B%$SP%8=N@Z?"1$*=O MX#\&0\>+O0.;M+-_/"3NM&8*5$1"OZO]?9EER%:K.FW.Q+N]"O]Z3?O'(.=H MH4\Z[^'A#F-"O_:)I=J%D4$%SVLK(-W[H3#GT=)=O]>NAJ?P+OM MV"_%)V>8 V:*(":X@Z 5AYRTTL$X:_)>L_E^OH[]0>K=JV-_B*RG!,SYE]7L M^;.9M$4AA@#::3*.66D(WD;P&-!:GPQ=M ] XZI=OW[<)33JKVX:];=?TV.7 M_B!%+0^76A]C&80S0?F4P 5#]U^Q=>RR36#HYLN)6<'+0^633<8RG+@)_Q"% M'RC!#ES/VV,#@JD]#%Q#83*2\T.<1TVF3D=6E.0V!-8FHSMT+,/HCN;XB#A6 MOI,ZEU=P?OMNQK7SIA"10DB;OA&V1 MJ1]' ;TBZ77XC%<3]TK,+J9(IRFKNFVI,L8*Y%(3-(GN4-OFO?01PCI\_QFN M_GU =: N.H#6.]()$?!I>[%J9-;6RC->5 W/M ;GK:D;O O3F9O(V[S^?$]' MA\ Y5,7+T>0];;G?-LEW+9NKD<'(K?"UGMX%"0H3Q?.R6#"(]%.1A8J/]]KO M_NP.DUY'@F <,4Z+@[<7A-ZPQN_(SUD[SJ6$(LUFDKFA6SHDR"I9)9P-S#W> ME;#KDSOT2X['P-$B[.#>N#,HRP;II4Q@M=/DF==!65892-9E]$5DYGN9--=R M_D8C)_9 0?>$DNV!L2%9Z5D 5Q?E$?EU XOU%,9;E#%X&5.;[9D]#YD;HM)' MALP-D6]?93#5-$KL)Y]KFG&&4?-;"@:#(N,W/!,#IW@KK:OBR!MR5&T:8][ M@*C)[=-HNM\K/3=<$5UL"]G)S([&F,TT::<%U(T6M;.T[L50 ;RU127&H[^[ MI;DEP@[L9#IMT-T0;4*K@,_$LK=" MDQPC\V:_H9N'4M!A;'\&LE@9=$**_ M79YW;'E#V?KS>+WLV6LIOP\+#[.XQF^6OZC\IHO_]XV@1L5>;W) MZ5K8I$$)K2'62@GCE \BRB32G;MX1W9I5)+VPJ)Y*EB<5&']7L>_8K[8-+Z3 M\3=2:6XL(*O+VS)%9$'%!!YEMHC5^6@\1.@^TO9"HGTJ2&RCD2Z&T^USPIXO M%W58+0F>?K6>9UQM$X(ATG]R_FUFR0L)RF8PLJ2Z2*60$R(B>..EQ"*2W&-3 MWAB4[ 4[]U1@-X5ZG@PHKP_=^T^DG!C6F)\O/]=\UE8HZ_.MV6>J."&5 2ML M7?/C$2(7'IP6WC!AF7=E%'3N3=)>,/4_&4S;*&QZO#YR.;Q>UB>*RCFY)=N$ MZT8"O^R2P,SGZI($!B*$S=CO ,Y+SD$/RUD5 6VQ3&+TG M@?MA\F=YVSE*/3VA[ONWJ9G)UAF3-$@OZ$Y(G$-$MEFEYICC3+/4^)GQ>X+V M0]73?78Y0OQ/KV[CST7"U7F8UUS"V^5ZOHGE6M1E//A%C>LN]F?R!'45D6G+ MM640Z_.("E)!X)F!I:O18='%R39=$@WK*NX88A+XBG[R<3'_YZ8N:GN4UB_^ M2F<7F0*V2V]W_?92*_2##\L7?X7/\\7F/W^'YQ>KQ?K=\NSLM\L:JYDJP9#% MEN!S[9^*.H-C]9SGX%ER9,X;%:.TYJS?ZHLA./VQ#[8C/'1PM=_#_TP%BO/0 M1. NDHP1([@4.&AT)7'RC)EMTY!]#T'3HK$OU"S'5^'!2/RR:2)Z?QY6XPQA MO8<9,@GYQ:IJ[[*1Z?8-.K.1H]4R0$%)O'-?ARR@ M R=-5D[)],,J]K;P'4C_M.5#3Q'M+0'2KYG>S?7F07@'S[QXSE.(8$W-=3A3 MP/'"(*@0;=!,JD;S:,>@?MKBI9_G2(P!CGX/Q*\XA.>8N?0V.BA,F%J7F,!I M*<$RQ;(O!J:AY%P;PID"YXT$:21ZI8N)N4T9PZAL3%L(]O,7==-O(=_Z_"ES6^*<^^?#F;I]K8?MF.03]Z-?\\OT04"<'Q1)P+L,XK M4%YFB%$C<&6M]9S9I-HDT!HP,VW9VE,\.2>#3C_/Z_>E'BBF M%D"'X*%PC4[Z9),[Z>4Q;>7;4P3S(!4>F3UZLO?C]V:NW[]X\?_'B MUY>O?W\__.7HAT\8XTGH8;)&>NMYOOQ,!F9S:3];Y.N*M$3W]8ZLNA'.*$0+ MG)="%B@D4K@T('Q,UI?(.&\S(6(0F<=:K+V^[ ,IX!?Z6_\]<\X)ETP"XXL% MQ4,!'SV"2"PQ3J$Q=VUN]&%T3IL=;X>SN\:JH?9&RVFTM5\'/X#?]T$MK%G+ M!^QA8(L4PWN# ;2*=1]TU."E);!E+;A/(6C[A(T:_F.VV8Q]_>G?GI^%^>?U MAT_A_&6YC-GHNR_.\M_"5WSV!SE_JWDX>Y:_5LR^_/R%OOOUQ69*F[)&8W(< M\J:\D\0#G@OR(XRWF*Q2[FXISXYZW)&(>4K6; C ;M7F3J&V:=N\GJ6TN@C5 M97VQ^#I?+1=5PMO-[K=E_('0M?ZT/-M.Y*+__D;JLQ2M8BH+R"77F97$N!?$ MKN1&1J]2EG?G>.Y Z1B43/M =Q*(GEQAG=[ [U_\_L>+UQ]>OO[MS;L_GGUX M^>;U\,MWQV>,<>\^1MI(5^YVL1]'1JX7O?.XNI]+[HFRN+V,8.3&= H24&Q.^H3YX@S?E+O?\')1EJO/&T7]\FW[AS? C\XJ+8T$ MJU.-I8N#6)_ODW4RF) 9WAU5/98@#B.X4_LT!$\_V*<3J*Z#>HL;-M_A5UQ< MX+J^;;R@@[Y:A+/G%^OSY6?ZLLW G<7'5_.OF#_?/MN%VM]6]R8C!M) MU"L@,:8 K42RWJJ +V3"-4H=$+D1LLW\FG8\31L>-,;YI !X,M?WE;R6Y98= M>!:7%UN];%X"+Q5U>%?+.%_;QC$X6@"MO8C(&:])8/!&U_8I21:84UR,14CM M S>\T?*83KR(S7Q^;40.O-;!*F5!B8UK7A!80(U1>\U8F\GS!Q#;J?@^#53;QIOHZ^V)Y-L^7$T[K@.O-ZIF4&-GTY"!5L2E6/(1B,_#$$4,J7)J] M0+?7FOK=-$R,I=9J7XZJ@^Y0M%U:HRGH-X*DH:6BD^>R!G*K/0BM2F(QQUCV M>MTY$$=3[G0:2[,/ N4 ,7<0JKSYLAFVL_AXY5U<[;P41KLL$!S6141!U%') M(H$I4C*!3AO?)EMY#T$] ><032_'%WL'Z-G,C:WT_W*QGB]PO;YB9W.VA&11 M*^8!F2H#;)>W;\Y>+$T%E M"8:B8%"^ON1:P\B(6\90*NM#FS'GWY$QL6\TGGIW/R4<(.MIG\[_7,S/,6_D M.D1;RY%%-_& MW(O5\@M^3[TSTC&%'C++MJ[LD1"X<(#>2VLS=Y$]OJ-RQP=WD;@\3N7'BFM: M9?][^!(6WQ,?F6=-'8..W5!KIJHN]B!?SHNKQ"_O@///^TI#_Y MBMOIK==*85EE&TP!@4A"TB2N4)\ &0_:F)*CU2WW?IV4V2X"PW;FN'?X=&#Q M3RBB&<\4E'MGP3A);EK1530D)$9NO*(0/C@AG_K)ZF&^9L> G^Z #D+?DZE' MNSMY>&M27^/Y^W"&Z[#(;U=5;IO!%BON<_&K%LK2%U;:K;3B7.UD5P MSB8N.19P=3BYJF-T'5,X'N7ZH(;I#:'R^"&Z*#[E"TS:(KR5U"52#HXD'9'.MR[0BL6,YLY"SA M7I.Z?ZXBN$&:W:<(;HB8.XC6[JO&DLEPJPL'+K2H4RV)(28\:.Z8C\D7']IT MC#V=(KA!FMZS"&Z(V#M S]7(B6LOEVQRE=#50YL@6UM'C3&+%"#)NE!3^@#9 MZ22R]UGX-B!ZF*YIE! M@D_*0N2<9UY78:DV#?7WDC3-NV8S((TC^B[2_'LE@D7)D3$G@/-:36 CR2K6 M3([3,EB67;J[ [RW-_.N:G4/\;F;Z:L#2_;CXYQ,2KJ(4#P%P(JN>/(UT8%0 MRJ'F7+.[!3O_NF_F@W3]Z)OY ,'W YQ!#[%."KKH,R-KS^GP8>#@*+:!(HWP M6AE?4IO4U$_P9CX$'2.\F0]150=HG.(%*'FA&$8&IM255 PE!') 0#B9+;+( M2J.U3/_[8CZV,>X=/AVK99F?7TGQ*G?UX;M7RVLA"H/9 M((4"3DFZ5P69#N=5 B.=B3FXY!J5)(]"_K1F^:F!_O2(Z>"8/%^N-X-5M^NV MU[/,I$4T&5B4H3861 @\9>#",H$I:)?;%$7?I61J#_OD8/@ADW6$9OI9F_+F M_!.N7B_KYHV+U>KZ2MER-6,D"FM5@*RRHUN%"W ZRCI#MUBE3)"^S=#RA^GJ M:RGIZ<$WHM8FW8"%_YC5N^3L#-/Y13A[6]LE5^??7LW/YQ\WPKWB*(C(M=<& MZ.^23X.Y%ITK#D8D59//.?''FTSW^JJ^EGN>#EI-5-'%>K6KYOWGR\]QOMCP MB??ZI_O+EXG*4^)MRSU]Y-0^1U'7^C<\LVBA8 MW=+H8_7 K0//DX#DK(S:">=M:&(K3\1@7UL^3V]T>\11/X[$;Q0JS#\N+M=< MIV\?2 +KL-E!]WN8+ZIZ+L.)FIZ,.?.@I -)%@.435B'9&LP61AK$S-1M'D5 M&T!D7^LZ3X_V5OKL(*@BQVGY?0;EZFY3NC!+4@$K:^FHL!DB(X&)9.BBX[SH M1CNV[B6IK]V7IX?A.+KJ '0'I%M>_$7R(Q739;/ZMDF3DS12?0-:GFU*<+9I MF)E3F\*M".CIGE""(42+$5*B.,"AR-RWF=74D*EI_?"GEASK!5TC5N:<;BKV MB\KIE]5\C?])_MBMYZDFP[ ?_;;6,["'L=NZZRHO0LN!TU<(-C$B8FB-/@4!)#'YBPOA6FV M5TYCKXZ.>\GHI3FH/0Z68RME:F1='LS;+&RKB,EI*(:E.N6P+LIB64"4PH+( MWFH;@PQIO,'K]Y(Q7<_'2.I=CBWK"0&3:H9L]6WVY_N95$+E6#=#LFA!!5D+ M?94 Y(6%Q%S6_*&(9HWI_WQ F3[FPT^-LBX^;X)83".TI9'27!B M(W$Y)G/;!R B$X4[(E1OS"4B."L$,%,"FI31RS2:7;C]S=.U[(R+@:,DVL'I M__>WL\A1A7WO ((>2 ";,KXHYG\/#0T2FGC8ZOY*-%-K&Q?[M: MYHMT_F;U'E=?YPDO6Z0U.L4WM3-64YCF-OM3'1AILO(\>3%BF+&+@EY:H4X: M81RMBCZ@5.6RY>"J19$N-FE][;87=69@7?D1DE(@3=TT6)*,<:\VJ"%X^I&, MZ;S*XS7[(TR.%/.TM\SF^9+^_!/2QSVK2:+T]W#V%=_AE[.0\%8?:C%2!HL9 MK/&>3"G3=3X[_:/^?F*0O1%_K": MIXOUEWG^\ GI1I_C]6@%5H+.P8 NN;Z4& M.<_*_? BR.!3!\V'8>?0[IXM: MV@)H7&%/BZ+W%ZN/U>O[&X;5^>9,7/+R[28[L/#CYTX7_8RN_B.%UD$IR$ G_]5UDZ3W& ++A:[+4@MI MD#C.T@.%D,H:I9-B>\W7.KB[?RC%O6QE.%E8=5(5=P3EF\&ZQ5JE:G;1FPB* M:P]>:PZ<3K/F(9A@VC2,]#6 XC3Z?VPHQ1!E=#%3YY!9!X4K([C7P'.1=76/ M@VBB@&RT]T5)6WB;LONG/Y9B$#Y&&$LQ1%4=&+>;C.VS%8;UG3-[+<7 ''DK MS(+TGOQ-+3?5SQFBYR8&)2,+;0"X'WU3]\I-8 @;**X#.-;RS$TU_ODE'[/( MK&;&U77&SM!Q*HJ.D_(@40MEDDK(VMRU=RF9UJRUT/:/5>B'B[[3N?Q_?_;J MSTUEZ+/7O_['G\]>O?SMOUZ^_OW9\^=O_GS]X?WPFM='/F^,JM8A)!]9MUI# MU[^'LXM+%"_R?UR$LWGY5B^TM'EGO0&6E#&[4@3H["CZS-Q"9%J#<4$EZ8PS M:;S'AOUH.JIDZSIJ>OB[?IVOT]ER?;'"#R3K7^BO__D[1I!Y?S[_>Q[2U[L;/F/L$A8PZ%W MI+S55UQ_H$_9/-HG;7W$.EK;J=H41BZGSZB (G3R6KWCK-$ X?WHZQ5[1X%C MV5Q3W>-O^T03<[%2.@\A^@Q*L;JZ0C'Z;1TE$Y'CW;$K)T'?E.4U+5$Q"'@' MJ*@#V%VS\MMR]9R^_K*)_.KEU@CAH@M0ZNM=#:+!RU@ ,P8>E./$4Q.X/415 MSS [! /+1@KI %P_"NM-^75+RH?PUV7N9LM:0B,-RPR$28:BG3HBF:.!S'06 M.2'7ISP%$3INZ;0Z]5NJ:N"QU7\_D)MLP-@?)H"#E$(T=#,,ON)HO M\_OSL#H_ 1B??PJKC^2H+.LDX)M!P#/,T1=O1&VSD*"D4$!"#)#K8JOH,9=) M,C;WD#NMB]D76,?0:/ZEP!4%F)"=;Z.!T M22+E*5'[';73EI5V"MK#]=D]9G_%6D)>IYC-T+FP?JK8NIT?OY-1*]%R@SU)VZ)#LOP6-RP!S/ 962 M(;O./=%F,VS[PN(A&CO2$WVQN W%D><9_OG+^Q?_\>>+UQ]>_)W^,;RFX>X' MC#)U\"&BQAHD>!'7^#\71-^+K]^-S_0ZU%$F-0F9Z!]"2#(N04$IUCC%A-"- MWJKNH^CH08)W/O>F4@=3HDB2>T MC8&)'\;_C2+^3@NE[IS4PP>=[OZ+8\\P)H6>U/U[R.3#!0 M B8I T,*_YZR3;E,G L?BW%T&XI 4:UR-A"7EH.3F!DB.B\;C6#=04VGEF0( M$AZQ),.%WD& =I>'J_H&3Y902*M 9Y*&XLQ0B%DRI%1JJH_,H6RTX'PW05W! MYP!-/P*=0\3>)WJV[\?:>NDM^?H)ZYA"4SPXRP)X&]&2_Y^4;],\=2])?2'H M((4_#J(#I-\?C+:E 0$%JS-C@)/?!0I+@NB9 %V\#RZ6$$N;E8@[R>D./H>H M^F$ '2#W#L#S+"4\J]L0,+__1,)\AU\N5NE36./Z5_KAY8@LR1QWB5A"5G>* M9))/T0E\4II^SI+S>[7R#"] >YRXB4?4C7VSC:V._A%V53&50K1*.8A:UN6, M44,,P=&YS&3'4;I@)\%8#[??Z* 8!KH#-#3M *%_#XN+L/I&"A?OSY?IOV_X M>;NJ3;&?MZ;:*5O+D#U@\;$.@V;@2IUGPHS,B3$>_9T"LQU3A?;\LJX1=(B& METW%W8'=NF/;7UT7*]D84=>13-GJ.A_"(WBE#20A2_ \(8MMY@W=1]'$\X0: M1W>'";X' .T\#,\NSC\M5_-_8K[&MQ-#(P,C$N:'1M[7U9=QM7DN;[ M_(H<5W4-.0>DN6BUJGT.35(VN[0U29>[^V5. GE!II7(1.5""O[U$^M=<@%) M61+!I1^J+0+(O$O;EYN;M9E&??GQY_CX]Z\GU6%)793.KDNQ__CG^!_S5Q\N/_^OO_WMB(#HI) M,S-Y'4U*$]/7OY/'XR M>;XUWAUOC9^^>+K[W&Q/7TPG_V]W%T;Y/7R??U35B\S\^W>S--\X-SB 'Y[L M;#Y_.J]?7:9)??[#]M;6OWU'7_WQ[],BK^&%)?R>_Y,?TWE8;3[5&W&6GN4_ MT)R^XY_JQY,B*\H?_K)%__<*/]F8QK,T6_SP?T[3F:FB=^8R.BYF5'&*(I1M"(#?5/D M9QNGIIQ%)W4Q^1@=P4CS.KTP,-K9W.05#_=#69R5\6Q51OUS5HSC+'I7Y/]J M0#BG*9Q%'O_[.8UW#Y<_VCLKC>&#=@.)Z1']WYNJ3J>+5_2G-$_@D3_L[&S" MT?KJY^%)[P*<_G)T$NW]?'QX^/;PW>DH2O-)UB2HC.)\$<5SV+DD_11-BS*J MSTWT(2[K=)+.X[S^VU]>[&P_?U5%DZ+)ZW(1K>$7\*\[6Z]@03=^W3S9A,W' M#U,8\%Z2B/*,4$S@#_)P^LGVJ_41O<&^<@)CC].%5Q9N#'9729UN?TXIL,F8>J+^8_PL'4F> KVLL5BM5)#6J? M;H"XKN/).7!8< R\B0J M?JB)1%>II%$4PPYD,7S+P.N=JO(?CTH! M),S;^Z*S8GD\@S?"#_$#.^=1-&_*JL$OR&_F97&15OX4O:>3B-Y0.?D#E;_I M0#>CZ#38&!8%)P-V[]T65^=QED5C7 PP(!)3TJR,M[GX&URMTDQ-6;(P@'": M-(_B*I U_A+/BPI2D67!IY4CB=V!C M00&*R,(VR!Z T-/.H*B# !R1D,%VH1R EL2?P,96-7R^@'VN+XW)O6.HAWDO MV._6YW8:(_\?5H+YFRQ)$Y#9S-0F6T15,S=E91)#CRS-/(LGAAX 0YIFZ:2F M6?8/ Z:RAX^+YVD-V_N'5:O\FO/X@A\U,S$N%DRVFI3IV.JJ&>=@U_",\F$X%BOVTR++B$I3J MTQ>O'HR4]YLIVYLZ[&__]E=S/$Z@/S,SK7]XAFOP,UX&*$_^G?:-AMBO!J+H M<#HU$U+IL3U1!W"(\;]YO)X@=JX4[]+@JZ[JNY#B7)4%? BWT.0\KOB(Y,UL M#,8$+LDY*/)JZD1QEV(H>)H#:IFO'OL*2Z M$,M,"M7 K-<"'7.#\_:%CNGNK5Y&9WHV:!V[ ?73X"/3HV:O0DN+LGJ 'Q M6.[227P"G\,-.NK('CTDA[O9Z'1]88TG8 &1"RAB>V$J,B,J]%.:;+F6LN-I MOQ3]N31O3"4":\"(*1;L4OCJ%Z4VIPU(00N?-&,PF=.8_+'ZO"R:LW/U$\&\ MB<>9&U\"@X ]?%>X>=%,)Y.F1&U6F7\UQKD-DZS@C1YC] WM%O11TO5 .QY^ MFJ?JOL3+U/HZ#GPMA9_3V35QF:5POA)Y#G[7N&?)7W3%_0>[?8QV'\Z1'%:H MG:L58Q%\%_I2.S9@%L.G* RD!A.5 I*1T&>$G^D:[SCW#(0K1\E-BDNKLG-8 M"GA;D=F!B!8U%R1*YW*9-Y7=9KF2X[.E9@ 8ZU63U58KVVF@)/LCIP %?'DN M=W$<3D;^XU#^\:S)>2 MP;,I:"9H>X_@ -1T$^'*D@$/ MT\JC:3JM%]':TZUU7?FXYCL(CF<-VVSM_:FYI*ND]TRB0P566II;)7-( M2M:/7-[&,?Y6+ES@J3QYB;][=<73-[9W;S%ZL1:O?^5]H2?^0/[]Y#JFQD^+ MZ,#$J*_*Z U4)JE]>+6A8<"%4TNRETTBUJP[A)@59[.9@9,!@J0X"](O_#] M$&A6YRCVA;7MS>V=*#!5DN[JP+$;'!%=$,L&D:K!%><3H]%H[W[:!1F)*/J. MVA?L]C@K39PLABZZSYH4/+%BA=$SO9'>(NKQ)FP\-F#/97P7BK%33'FSEAA1 MH6,$7W_YRAI.Y)RD987>[%>1N&>D$:X2N5?S@M.\/Y0FBS&D\*HNYC]LD*)X M=6%P5>-,=,H8U@,?\-V/U:VJ6,PYY##4LHK+Q9>6@"4WZY]6N?=-HX_7H]52 MZ:#1CTV=EF8EK !TZ-0$5!7W9$1&W>>H=Y5B(^H53=BI26N73U.WTNE%WR7K M.R%U:$(9:T+A.7%+*='SY9H?%;8JZL]1S.YUWU8)3T$%K#V]>TJX/K]32MB7 MID<5>UT5.UDU%?L:#L]^W%3F]M7KT;#0>8HL=5H.%,E4AT\A+D582%SB2EC% M.FMOSQR]KB+WE/>-=6.HF"E=H6&4T#DF:[VZ=76S8@MTF^MQE^W:J207U0DD&:-P+CZ+_SJ4HL#P M1#PN+LR541#?%AX,6N@DX-W> /VA+QLL)G26#;>B\8[@?\<45-E%6X)&WS6O MOXIEG8/N$OI^(7JTMJ]_#9I5NP:I#F-J MREN__>A"IHQ?4\)Y,CT0.\3"UC+>:XJICQ^T2CYG8(?-AB\($*)?]9/DZQZR M!/19@N-(^E.0P?K@Z;+>7?X^I6<[!2B^ET M9.$NB(P@5(P;1C"*+A[B,NW@ *] 5>@B# ]8 MTZQP_^-=M_9I?>E^^'8$&??\0A)#3ASC@#E_W9U(G/.-VMI/!]U@[#@9'L$@ M\9I;K'N[P[^%D8'+DHQ@HQK:J&"?(E"-SB2X>B4(!H7SF<""X(/PGTE:HN5% M&6WY[SD8&PS#\A>[D*7PG@#7?U4U,\Y3VP1TC@/(Q<2AG$Q["6_-F;Q[%\AT MU2Z0G@0GZ$"U*@8SZ)NWZE_T1'9 \%%AH]A/FA*/HS&,J9T:,-NPMJ"Z&KAJ9Y0 MP'(^AQ,/R@+-F:H&WT,JGN&K#O>.;D^)6I T5U# 5Y2=VC=13/ C5BFDY:68XE DB61'0&SYDI.A;1-Y&25-J! P&4,/SP0#Z M "M8)%WWUKE5G^G#4C%0> L(2#=PVH>-3?%Y' 0O)Z?.7 [. M_9;>[/.=:SS\5JN-T7W _Q,X^Y!@<8X""P'@/)(-E7Z*UIZM@QV2@[[Q%%7G M6(7GQEK*IJI&GEMSI=6USBP'%1RF+.D3!*F*$3U"PW##97#_=8Y",Q>/K?N" MY:>$*X2#LB6L6J)4#!IFW916]PV74AO_V8DO/I4PQ:\EG_=,^%GZE^0FI1C& MY(GU'$#T-TCL5;Y$)O/B)D*I!T'\^5&[B'7X(%S38/^J>WLG+-/QJH7I;F2" M1AO1_M%^EZCG%DW2C@GW-0PS6TU.9J$>.HQM]^B[KFF(#!94!+80@\%?PY%O ME:REF)1?4&*E4WUW0[/KDC2 7"MR90[%W >FXN!>B6&%Q,]HARIO4,A.KPL6 MX#'(?P-,YIW0'KCKAW"'+,(P?]Z]BVY?@>SA,84);.^V:1:4Z(9BIV%W:OWU>#$V M+GCJ?L$&=14<5>^7?O7N\++@=-!(Z!K5[!AI,L BF_JL!Y]FP7\&&YDV.V++ MW*<:"F@QZQP%*Y*JEO=@M]>:5. JFHY.=0.ROL<<"M M,SB(S1Z6P4=->%=@HP3;3E7V^-7]QJV$=Y"WW[4#GXD""MZHVRG*#J)FO4R;=2^50I##4N)0PJ M@);+,JU!,3MNP/4 $!:R427!U4WWO^7 L^$7-7] QRM1"HT 3@-'J?B^L-Q1 M KF*F3/(XWT,WM4E-%J[A@O0O:[6EUDLM>_@72\&BF\A]V2$0T:/BQ:X3>C"7[1;>DV_XN8'XP9W MZ5TX=7#L3JW#I@<0,P-R\$;VC^V#U_Z"ER^P'Z&H.)+/((>B!]M2( K_"M++ M];(A6I/3(A2OK)NZ)2%8Y3SR4V)OJI$(#T[[J8_7OE7LU5Z^^(QT3$MENBJ[ M:Z6U?-;8V:S)02.)'H[M)9'S6HDZ8PW%P1P$0L(/-$>HA)RA4Z5)TI[\)B@^ M#,YC>)\/"J@S>II5:8S(("V9&-#6G)B8QI-:8BM^0C.:9'$ZXZ.BWF4,J ME8OJQHOKV.O<-*I"YVV2;X$^6.6C] R.S#'<1F4ZL=>5 N=OF%_+='_=]351$>$ R7,W-\B0IX;O#2:0^9J_2*\@P,)IG5VN4YT^[# M[_#<"Y%;\!WF\4-'0$PIY\4'>$0V]^ FL?GC9R_6.X,09XM(IF-2 DJ?#853^_KIQ2\- BL]J7!.$-03T#;CZQEV,6,P=QR6*5I%EC"SMR<"K/!*8T94K9ZJ'KA1>@%\#( MGY@$J6_1Y/"97E>"X[5]+0:TC1;X9<$]Z-J:(&XM:7B<8"^IF'L>'EE>"G@& MF&CC+*W. R>?Q1 7+5ZH)+4%6D':/HG,SIZMQ84V(>+[I#Q9D9-!D9'6@NTJ*I ML#YJ BJ@=+79:_!%27F %FVHX4B&:&BNC8)%0=9N"I> ;\AA#7#LP6X^0_7; MY=UN96?M#A@LH[(9R0(4?SA@5#JROI[*8$U<^G9=L,3XL)OT,5D6V'\8BN$E MV\ESK/RS(/0R.HT_F>J6%<(QR%294.6?F U2O=="!RSWEK!@$$Y4DDZI@46] M'G0W.93OV#XO=?Q1+M^ .)97'^% PG9$0!.%:=9[- M'4,2F^Y$E8^N"Q]J7PAMI2R9.^[1J!-060K!=CRC965=E3%^]MQD?2 2_*=N MMR1?@_ #NS0#D_0*D?_VER?/7[6>%ZUMK\/0/F)SH< C(<^S9&\=1(OB9B7) MM7I%-7; FWFV<<^B=2/$S'Q!XME)/=.FX NSA24']JU;_/R,FQYHO!;-)L\> M<,]C(?"XP[4P61F1]?[P#38N.=7G:9B^-!.3SNTT03_"398GE04A1FL[B Z7 MG@!X!=N^0!SM@+4MX*H^8_''%]5E,Z$+W^%:9/C2AJ <7JD:=RII)G2!PB4G MF+YA3S4.]6-KD_!5D_/4('Y3[>U)@_D-..H"$_<]YYY;7BF\O0NO5QAF7*<3 MYP2,^AT\["I))VZ[KCZS5XHSFU,SK(.6OY%M[U3*NM[.I1$)0%P4GKXB2W@Q M6./UK];263QTUOJ6K%'@!LPI4M8O>HZ;QR) DQ+/V41G^$,%"J8XIIA:"JM)J6Q M\#T[T# %YJ^@TSY=$Z$KXV-FBI<(Q6S<"O#:++VKS/7?-2V+V: RNB1R?9>5 MBZMS*3I+8KMC8@)A/NVT05+S$J6FE M0E/FP\"P$JW!O "Q0(\BQ1 *GHON*.C.6FIZT8W(?VZ_H&RRH&L"7WSJ.6YO M80$5_OP8VY!L;XTWGNK"DLMSPDH 1WCX28)L>WSS;;_)O;FMWT3^5^E#" M::55U2S?0X?Q\B[E 6VOVB/EY>I]\8@S(:#<%!LS3%0BK"Y*4C)&>(",F(X6 MEF9T6U*%,%@77%"9;(-NV*+N/@@M$C8R8PQ$@B[)%A9O((/'KX-.57NKNR9) M8Z(V[4O'5+FI$P![E X??=^T6*O6V\6% ML-38#G'#>V]_QR R8/$VP6:(#9=XT +:7Z-,B$>"-CMJY36Z)\!R)0H6UAE6 M D%17H!"XZ^S<*WC#4;6X2.":AF":K![VK\(M.CX(D+=W2.A= ]<+:(M>QR-.J\7:(\2(K8@APAJ#62IHO@R5OJWWJ[7 M8(5E60\'EC.#6[9M6S^2EN9#CB"-SIIVG*P^!7M-QZEU0=PX)E24_;_1UHWN M3F.>JSC79+1_77-$&R%^7N08<\<$_Y%8B@^@1U&OR/0Y+W*9?A /<%^@6QO' M*7%F^JZ,J; AUY[T_MFCY'5XU]/XS03=JW97()%O>OCV_D]P9?>"_WA.*T# M+5JW0!!^,KF9PFJB&7]@$+.P"O"E4Y__8'N+-2_*%V(.EF1;Y#"19=V)%X*< MCT298VX#)9"JAK%I-^F(L;<6Q%6H_\17KUV>%ZH(N,TWEY.@HYHI,P!"8N%, M9%IT5LR\!]<^S:P#+ME""_( V0JAT^*%6IG61?A>7 ))[)O*CW93*$]>B$PV M\43*TA*WNZ(Z0344&#Q +4H!#.\K50^T8^0 (YBNHW@3*AA%%89N%:.PU/XW MMMDM[>$E8FTUK9WTP4AZ*^/(OZ,0(@W1+P7Q]?*VTC?DM@@ (82.B-O"J70$8 M6)\!0OXL)A&\,5=NS"V)X JM_*QYMPWI.3)RCA%>3E^(BLO5)7"YM\/A_Z-E8+B)\.1,$ M%C]X4<4&F&_3:F*R+,X-V.DWPS?+U]3&Q*DI5L-]CF<6FV06M9YB4; MEW:#'RD*KD*34(P]^$_JL=MC.?K8.4FB@/#)L23VPCA:?!;[]JQ2T*.V8S"F )0#('41,6]) $<^'LA'PE-,^5H M!49Q8;07'E&A3!.CA63/I0RKL ' D3WQF+"MQ9X*QB?;YJ(K9+]/38)5XIHF M0QL<4= C#T@O#CEGN]1V(Y"GT5@Z9<@(W42*E7D@F,/+A89KM$:S5%F=;9:E MC"E$Q%00B402R$H3]!I(;=X>8"N5X+T+[4TFOOZ$5G-%S=#@L3#D(@FB$++3 M7K:#HPXJ*(J+!5/8C 1Y)9:\DDN(Y($;C'04@@:;(_*U3$E]\Z8O%3TY=BUZ M> 2F3W4EU;@=IQS"[KN^'DDI;M*+$0_[3T5<,IK.WK<(CJXP43!BC41YTUF1 M(+%Y=\LZN@9_XI]JN9M1CRUG>A.;X.RW=7)>=/@19 U8('E=*L'2T))0)5%7G/$(Z.]:6HY624PAQ$:5F*&_ M)"V-S++,3#^E*V7 [I&KJ<_'=SJ0]2R=?CK 'E#U\]MEM&5:L<852E M"!IS[NO"5D0QECI[T=HA%Z=_&8U$^^,AZU?_*$-RD:(Z].%RP_+QN-\WX*KH M]Z#&'9O/VU"V&\@T&[5MLY$F][GV!&_(BSBK%!Y^AKG"'%\$^@!1*1-AL&=% M%-HG:G60P==*&CSN\0WZ]U"?6C^FWPFBJ FXS%)I WX"HY;$ILT"ID#<.5XU MS,8T\JT;L:0=^4&8>1I%6BS$ST1+3<**S"QH?]?#1=O7$T2R/J.A8BB_MG!$ MC^&J081_PC6+]4/90BTV?.&X ;6$EX]GYL959>KV$C^RAO>YZT@;_BXF_"HL MU\]E?.OAI",*DX.%I@%O'P4\!"L=J=\!4L#.JMZ98/$MYYIYV$SH@_'Z^$&/E+M\.(!0KRU[N1JT^' FWKD(1:) MVF4"/@O?X51.K2SG$\3WK28BVEALXC< M!RQ+31-\KOQO\@X3C MXIM<$I<2E&GACUNWY>/6W-2([Z1[JT"!>A@91IQZBG?Y8C]B[1XEKM>E\*X) MVYRRC7]ONQ4C&TZ3(D)* N#?+JA6UN*;9E(LS^6\)=U+>5'.^-XPG^;,U10@ M_M%.CS.XC1ZUQPV[\VE[28]7!>W7Q"4P U:$;[+K>F''E8576X#]2+JOM&!I M4JIGR@OB1.I!AUKFH3M,L]7L//%Y,GR%:9X&:8 NS!Y)Q M/2AGT-^+\NWSTDB],$&GPH[A:FM&E%23Z!2B/-I"W8&G2LWDHT1\!8DXE^Z+ M;"L&Y[]=L4M5,TV.;C9QT]A,'/6+Q[RS!>N"(&!Y@VHL29#4CYMS8Y+3=&@O MI"P9-'A)A)AP.&GW@BN!C'P%<-''CSMPHQWX?9TR@R$W\F 0JK<%E+K5>@^V M=%^WS[7C(^^TJN[X%+"M69&?,3D*(7/E3J5V+?S&ZJKZ@;4RX+7@P"TQ'DZ+ MLI.;%$+7@#2*^H;"M[&<),U!T-)$3 )T"^#W(8R+8 1RF_BU4/C8LG>>MA4' MLUNU)^A1VU^7EK9P.Q('C=6QI89B(EI6F,7C]K:?0T\\!.MR@GI83&RDY<(# M.0:IYZ8H!^8<(_@.4"LC &=J92S*"E"#"W?Y^I?:UK?) MI]S3.N8])E^#P?'KCU?CC:[&CWPU>MN!RUM(K4H/,1C9F;81@%<%Z.$16/IN MOR? G2/F_H;Q'W3U2/]2BF">Q1,AF!&0DF)8RR <=(/3]-^Q5 M3=T=1I$']2MM8W679?.-$7DBIU]S*NF_8,20='/SKT2*VWE[J&$[=D$TO<2$>#_<-#C><;M@JXE]G=MB AJ$=0D_B&5'KR,U8HF%,Y]HC M%PWM)@;=.(*Q>W0F!TSN:_>T?? 'Y +.A]?D+DAU7#QHTA4LAVB<6 NGAX*@79)2TBQV$.*V&L%+F%0 M>NR TL'$<0N4:"^AXWULJ3(9'7?;/ (!&(BRLU:A46DBLKYR6P*LZ &MFQ,W M7TRSX?K)M-UO\J/^ND3Z1RPH$)1JR!-ZTX01F1L>8)P$LDJ]7/%PZJ&'[D"L M'#1Q$&-*B0;OZ<5ECN&:BCQ,;QD(VAZL0U64?W9J2EU0N[439N VAZ[4O#UP MCN?M9U\;5DI/[&O)V#^@"#N/QLCT?1I>61R@K^US%LEH=)&]=[?CT)<\L M?.*_"A],,1$ M3O$P_UJ!+[5*$Z"C[-_B:D]:0W?",Q@QZ117-D1(5:55A_:22W-$78A;-=9J MO(#?QJM:'L/GY&UAU3)=4,-YJIPB1N<84H(35>HH:I.9^3DRRC(AY2A"\IA, MOS.2#LW3:)R6B ;J(Z>O*NQVZ5Q.9."N78&C/O@1#MEY[8WUW,KH-$8%CFR) M65K#/WXOQA$%0D:^TX(!$(&%8?"A8I;3- \]0VYW5VF!T/NYI;EWG<-;81;W M?(_STD;9*!B'M<(3E-,,_\MRV#!'/?Y_V^ ;I=?KJ[J$^7,:7R#9K60;446Y MY@8MOE::CF7UI3/KRN.U?2OL3GQFK=: 4('-7>KH-Y)8B-;J>>]BI4*U7U.V M@<0=Z!N]5/0^EOK]B?M\O'YG;E!BIN+.5GLAC<*)!+L^,""B_-IMS/_ 4_V1Q%1_EDT\\^DT;0T!*#G.,< M[-WU:$UN9TIO^[UOO2>[ \Z4$DAZ 2>NLA5M;IB"@[2'7KD PL6WY]ZX.O\> M-A7+?5D9'*+K-T-ZT65?;8)"]U+UEV "":V!VI)7CD9)85SI;BH_6X/EH$=) M*L&F*6"H>6]_$^6?J3X*^0=&3JF),[? \REM$GRUIZSFB"3EC#Z.)USQD3=( M&XZ%5W$C/7^[PY/GO')8&F@NK,L?';P9+/@.^5@TDO M&G7?Y'CY6XF8("@0CJW];8GV@<=B>*Q>J(_8B6&D2"1H\IAPQZ(P.)Q#*2+; MC.*< M$FM:BG+%VB^^I>.;*YV<-XBH@)_>Y;6QRPR-J\Y@U_%8- M IC!7(#-_U%52I&-0$>,"QYLB^]L4S@MT5Q!76G/=6F$LY0I3QDS.S3%WE0Z M*BP']\;NV@US'7OF&?<8)=QIU=+*CH].EB*^''F)/40D3TW..3YI34W0+ 3_ M3,[3"XX#Q9./&\V0],)@NN M2_(@T8')I6OS;R!S21E?QMDJS9*4V8=EN3JO%'OA(',MT\2E4?%#N:HK8N%$ MY!@Z.'!($-3L2!?(-N@W=ASY C^)*R:[WV/L"_;GJ!A>20SF@:TCOQ]4-!1< M8].F"+#I7*(%[E#9)<(- /:,5C ) U?P:Z3Y)TXBJ(TU=DR05HV7(@KX3Z5] M2WL:3S@,/KY&&"2Y#-$+VK%CN4> N#X4A,;P+[J[OB''0W(JC\31;\^+R[1XV1E MR_ZC):M#:P]+@F(B%&,L^3SEFZCS(OTY&#:$G=8?@[B4DOPCZ.'<#ZMIW(R> MUC](]HEQZ6$83<\LY"B!E^:BH1N&_AH\%.3*5[LK+OLQX?J02BQ0S'<1DR MLJ#32+%+09+C=6HD@D (URRC!6 $I@T>P'?SC;99ZQ,=LA7KT2+C&EZX)6SS M0G?S&_ #[_N8?-3XGQ.M;L\+,M5M'1,!QZ43BBL*;.'6][5JQJ16ZL ?@V&08G-E5"B ML:ZNJ8L91;LI/(2+!H+*^TJ2T,MY:^D&>])*0\)%CX9G9T5RQK*1X6TN@5V2 M%:(N])J 75<7^B2 ^!(Z:MHQ#^FPG1V$&6YABN/DM2MFF!?DLI//& M6:%N=SQ9$["\7.HZ0)15QBN+:15=VL\&HUYXY) YP;,#&89ZWL"%A4)?-"7: MZ7ZC[XLEW0=6SP3:>;Y"]L]@2S:?5K!CW'*?,50/.;&9:)21W(+>C&O9$R]L MYUY4@%5C]6HGRZ.2L^TH3)]R%J0O[>)'+$&V"%;[V[#4.=GR^\?Q*RX\4QO;^.^ M!JIA!OZSH*)IW@GNW,)*Z;7=2MP!<5'&TZ, MH1?K?FL;VKG=EW93WJWDAM,]AHT^H3HWMF%OO M_],F&&\Q)5#[$AZO\,:DTK666Y-C4;K_!$K9:+6YEG:#B&K,3+Q$KB'/WC\]@OT,]-J MCJ6AQX9P<^D*=%4<[%_FW%EB1IUK_I^A$=JUFPG1BP35&*CE1";(]TV-+DQ9 M+:@&SZ43>IG/VC)?F;K.6,O!$=76Y*@*RW$JN ZYG]T?J$FY84_@$0%Y1YHO MTUTG_6&IJE +T1!VTDSDJL,"%"Y%L0K&VW@JW>+UT;5OE2'Z=4BH)04OV5;GWLM M$K*%P<#9XL*4CO$NQ1D-P%6:.-3SW MT?4!4?7>($Z"BKO\1+VWL#+7$AD89*/,T(BA@&$X:#X)>2&^)S_1Q>%@"3EI M1;" )/#3A7K(E.C#+FN+R. /N3I46Q.^'&;S+)?POTJ9:;$CX1673.51W'\ MV'NN/',D/1=CI$OJ)B8*SY5GW)DC*^CTE70QE*28-!Q"&2A+[;4A^ARE$6>3O!2AUTO5R&FX$59R;5'4'ZK M:<%(*!B9GXY&SI=MG]@S@P-)L 1;EQ=X+]A7Y'6AI$A/@$UN4 L7\9IH,/^A M'4GX/!GM(HC*+8VZ@4=0-&>D7."Z3#ETXCVQ6E2UF04-7!B(QTB);L0-3S*> M[C*AURYL?_C.5Q_\(<'^VT=,K(3@0V_%A(NYI_],M44N6:NN0ZXTQUV#"\?>([9BQV-P\>DK7-D(=Z@* M@Y%"MS+"$$X&UWE=HW=&C?A,U@ITSG021+\\J.SRBP1D1**-Y338H8N&E[DV.SP] TKU)?Y3]54*DID:#+1; M+=?5*UU[3]GR8KM"L:Y0NX F"('!0I6Z4 %:CQO]N*ZPI.8=#=B(,*.2;[5/ M\R RSCBB=NQ>C38('D9 $W*]H5] M3;3>\+SBK"H&)A>#*B2.QSCS=MG6#4P;E (;L.J1N!M#=KHU"!T_P_KC@=^, M>P\#8XGPEQ25/%7)*XZ2RKRXA(R&/J_[%J7CLP41RL^]76YXS)>>[^O=32$? MGST_75J^QVLKN+:H/W.1;U!ZCS(A)9ZP/5$J!X+TYZ?Y/MPS(>%?4*&^6 M&$? ^@JYZ711"7H7]?:];]5&6GX(2^K@,CS+3FO0NP2_?,-%?0LG!O.FHW[* M.U;KY+H3J&GJQ2!8(SH2\IN^?23Y_*L706!W,F/76*%'G;7[Q'= E1: Y<6* M1(-H_L]2.W<&$]0)4_$62 !I'B)A)^.Y5=1+WAD8]12>C2<8::&&-KTP!I>] M>.CZ ;EJCV:*YZ&L*=V)QYZ.7@&0EDH5)MO*"[9#7+41>UW:C-J_78IA2^** M$O*@M1)!P/(K.F38_'GK8/2>"2YC&A#R:\KV,$PG;.]0Z)KTI04E$MG2DR%V MFN;(3+6ANQL H]$$0*NAXE@IV@AGA>_X/-0S]@P.T&\QIFM6W0<$\_*2!MK) M]4P]*OW@4NY)(;OV&<7<4"P%+5KCX83(Q)8WR0,];JC^QXX\TG./MUR&)>-M M%_W:!WL?#,OC(S#RX1Q*!,'_Q.R-T1MD-+WEL]EC^:+#=Q:9K&)GBI.PRB=0 M#KBR5\%N7Y/+/T!CYW!$MQER8?0@_#9T, MX_<'RG(Z;7S7I=K?"Q:[=D*(;2WAI.-_RQSD[MTO$F.YI7=>;/V\-EY?VUDG MLU<*_/W&-^H[VLDK@97G-6"#GHG/^*:HR>"^J[!987\F5(()%2/3\%.8-3$U MP/)H[RUNW< +AO:+'27OA:,^\):!8S0]:X$5BVGX8'[,(C59TDTON#%AT32J ME@WTTMV8'+4IT]0P43W#<"0XA9L*_CY5)<)OP^!WL"U/7KY\J395T(7(OL45 MQ?:5(/6)E!AD:;)^$AV,S]>O#$XX(Q=Y)Q&X^NK&M$!_V/JJF?,[D.\Q2;961 M50_/12V0(&(\RK7NZCE35A'!7]3]I#AR#\>(C3[0D%W6M$]U^-8]G>A@U%B> MQ?/O?A;9YI5P\(Q)J A?.R0R-8.NF#=3QQDA[HNO8=PLJ:@BI]\5%WQPF"L1%A7%]*L%@F7YF:0@^%17RWN:?J7&%[O/5H"!:'G/KW@] M:HM6=%I2_^@%MERR.?VAG2.CU,>+)"DE$A 06C$RIIK#?R,[0Y8M;!L#T@9U M7#>5E)G]H",Y!5[AB-(B"("A0#ZJ=()OLYRAM6B/\A?,W3*6H7OML& MGBX.KS_5-0WA>G- T<*0U!F?&&MH>%-WP^*AHH8#]V%L4SC9TB#.GY2<^R66 MXY98]HKD-41/2'"&A4XE NX?T2(L2YSV\GT:ZM+-5#VEK;ME;"8G_)DK)4FI M0E#+1YFE-T[YARTX+T>2O*=1#,9ALGJ?K$-RE8R>>#'.1WT S.I?F@LFBD!& MI:EKUYB<^1SF?6\:M9;+\SF\Y4),5J!S-1^+7V>.!WV1L"S4R"9$JULV60 / M$ KH#';Y BO]E.U^%!&+S4SF"].;&\?+83,N\CA=H#EFK$O9 K>!2];6<1*& M5Q!9,/*[H3'JRJ;@S<);6F/Q-4 4[<$?S2=L-LHIJ898B'J+F74:CH">9E)5 MWM4H[]+UL,82/ZB>D3?]:Z@=^ >++.(K>&\-VS!Q23;V6D%Q0$D+I M$6['0)4I0]@XI'=P=0W^SPDLN"%H11A[G%*/93THO6+,Q]YZ4O9GGRF:@R7F M=\&<'PB;(HW#?@L<$D9ZME[NW7K"T/?X7]AF$JEA^AWB'?G:#]2KGJAP,ZB^ECU@(K-T"NYHD& MPAJMWCEK4H[2VH;=@KY:M^V$.B_3UB-1A?%-4@)D@TIDM)L^M);IM .U0,0. M'+(XJZ5 F?G;EH8)67A.KXHH^R7 FE(BI"Z\ M2,%&S%%T4JW>UGH(;"/NUT MP*\QVH%11@M3LT8K+TRT)E*5FYA^)-+%;:Q!+!:$WT:8U;KH.1$CM>95>KIQ M)243=Y/7+B@S?H3((<+!.)JAQ)26/\F&M[ *.EB7%B"C,TMN^N8[X"ZW-S8> MRMGQI^,+9O%'C\?)@MT)BL1)C0Z01QYL2: \#C0:/.' :'GHV<+6=P;JN@H' M*#]PC9UM)(I-8X3T7% M JCQG@F'APW#VC5&R0,AYW 6W07P.L$(4'UW CP M4I=4'-YM44W=="6_BO$*VYQ:8/-V%LHVY%8\H%%T9#38O=I5&<$?6AE17'0L M\>.DK!\_QXM2EQNFC=R,?!YD+/9$8*=I7'RK^'@9EBG 8%F7/?LJW?!MHVD3 M@^.Z)6/N_T;Z?[W_]?6MC@?_LT7'X[NA#-H8 +7%'!E4E#I]1G!.O4(WJ MUNA"O>6#\N/?.65CQ1Y3(AM(1AS/*_.#_L/%#2G7G&_2C5[.X/ -! ME;."0HI$>AAME1'08/ACD=^7NYL[SY^@"-OMA\ MN37\\=;FMOWL>WHV/Q]F4($@_/MWN]^U)BG#W@8K'DXVW(!Z .1SBA@,?EJR M7 ]]7!?SG@\E&/'#SOQ3M-T?BFBO8#%?'89<+E <]2"UOOXY3@PR+9O*&:8^.XO" M0V&XU%RMMP+I7<7YB.+64%T3=NPV$X]!:=ES;<7_>SJBP4E?I@7NT%6*CTZ3 M?_\N'4_BE\GNBV?/7CZ/GTR>;XUWQUOCIR^>[CXWV],7T\G_>[+[W6W>OZMI MJO:?[7?OWTDUPOM?WYT>'QV>1'L'!T>G1^_?[;V)3@^/W\(?/GPX?'=P]%\K M/YG#@]_VC@].HC='KP]/]H\.W^W#=/;?'W]X?[R',UKY"?S\YOU/L.RX*?_Y MZQY,X^CP(#HY?;__C^C]!YQ!M/?S\>'AV\-WISSLA.DZB/2G1.*^-M"YN32?"3PA5%0!LMC71$9."#9Y#/+P2 1J"%(A%? @X@Q'/!<.4)!P M<\%M(J_5'X29RW1M//FW:W!_)>SZ/7QZK"7*&4] /XP.=,*H?6D^"'++5=; MTE)632;DEVL39S'C)*:&B_(CM3]3;I.P(Y=M)'P@;,H_E[&V# WXM^)P8+EE M*Z;A4<\1X1P_9 R-U^^7+Y]':?GV^ M'JWA-P7" A]9T(H"?=:\4CZQZRRS!&M>^-6-:JQ63CX>N BG2E06L&=QJ1=^=^^OVULC&*F#.S'4%ZYL9+'RS(,0 MJ[)F-L\LZ2><5@(G6R:L(9XS:3"41WL-,DP@YH\9JO!0@]U9U8P5%L2O-V9E M#8/O$I1XFF;24HFIQI;P#?[P;-/;X#-K983J2N#;\&CP M7*HF=FE<_MF=ON^7"MV;> SW!C:;VK.)9;2;[IKD=?@)D2EAQL0#!.]'42&# M4&L5'!$Q29(25.,_O"[G(A\2K9FFGVQO VI?CYER>BL\E?\;K$1YUH4XUBJD M) MM*6*XB9?I:\3\!4L8S#2D30Q';6'[,VZ-+,F%\0)OZ9W;'=:L3TZ,OV]X!S1 M-$F=$$T[.NE;UNU]79\*Y)EAUF"FQ._'4; MO1OR<*2PWV.QZ#0,;]& 2.&D5S>I6D=[M_U$]+I3'0J.(L\;KGW+8L>AQW4+ M[9E0(JL].Z;# VGAT>#N4%:;6>FO3M@LH:!<&=#4 \,?]PO]AXQ, U#5QMZ! M=$BQ\R+<<2!&E64C=Z8R/:2)K/M@B(GN$;, M*N+HA&659?3<(('.N"QBJ58C4A(KB3Y%D04[VH[U-4,OE0K;9@QXX'?ZPKDR ML@HJX+7EE3YU,8UH[>C]Z_5;CB-]4)H3CVS?2]9S2T+F.Q==QNSFQ-LE:L\K M*+PJ!!0I23T%I1)+F<]%/\*NIJSXZI:!H&NK/%+J!_+VXS<=_X]^WXI<=;L* M+-L5U,I]QXG.1^#(AA3F2Y\9=@"X I/1]_86H[GZNFG(:&Y[;9 Y[8 ,B0%' M-JMN1!YTE\[9LO#8_MZ[O8/'S-7=G?Z5D_4(D@ZM.W/K.:RT\LAG08=B]R57 M1;[]9.WW]4XEPGVX!Z_7C'I)]&; ;V9D@7BH82=JCUS$]@43N<".>HR]RY!X M0HE"N)3!$J;X'"=X<"P?6$F>=$9$F].BX0 EMF7*P<=(DQ'8WUE\.6TRX4]U MG,;>X'VH3-"R6ILY=W :TG2*RV IX$$<$CSW:J1,4%[+W1M$'AQAJH8,UD>" MRJ,0:5QBSA.M,^(*B]:VUYTY=[,W!;L$\W*[(J&6G>%'.\I3V()4RG:NPWTY M\'XOX+*[Y*T4/(FR(C_#*CP"+V:+GDVPGF!(U,D*",-?H=1Q;3;-0R)^16G_ M:TJ!;I 06/C&NHOR=>N02F&@LSA"$?.LL/ZJ)"(PJHMR@=\>*=N#_%O"6;-9 M0<'X]2\IKU]:7$&]_IKSPM;*-&D^(7="9;>JKXR*([*6YR5D71E60[8K +%9 MIGF@NS3F1BK(BK<<)^9.BY&OQK:$HBUWOY.6A\.LLC9CX:DG5)HM;MP&-QZ7KC$':0D8V#@$__1#)?S9F;"82 MA(1?21L-5W?9,2-ORO&YJCL\W+ZEI^.Y]'O[0X#NEN UQ(DZ76.$/HPBGYV. MKMPO;8U:\PTT(2?J&P2:-E6E$8%$DBY)BTM"M,A*3@^-'DHSGD"Y515(9,NFDNAA%9Z YI7.( M<%U[4!EIS$FE"U(5E8#%.$'KD7YB_\7?9!K&,K[,HV:.!_8P/T/BN3M]) =# M=_T[_,94=H=1S^5YG%;,U'!1T,:F9W_[R\[N[BNP<6^UO']5 I7(U3N\K273O+$UAD3[/ =W4*W:IJLUD&] M;0+CXOTA;GI6MV+O&?H*\3O#!, M+P\#8XCH$\:->1@+(4*.TCB/DS@8F;3$3#E5@8&L8O+1E;\7?H5E)>\MC?!6 MB$W;]C=/W/=<%:8P74CQ F[6?Q?EQ^B$WJ<5'G=:U_U95-HM-]$[X8X=7$A# M8V7._7KA!PRNE+U1%]"%4 %P3Z/3[>W=I]&:+H64J_T3!ZQ$NI:>;UU=H;H MO0'7(65I!//0&I_4^%31_MY!M"T0.)_O2\*T^+B%B9&1FB.ME32^;PUX8T/J MW[%U"?;US%,>P<:&#.JO^A8:%YPG4R%ZB?(#VEI*B0U@U)+/&US@?CB@G"YO MZ72@Z+Y3B&9O7L+0=K)[FL6UJ\.%X7RO"NU4M?;CQOIQM4^EMB\A' MREZCU;Q!?1ST^]+:RR\W8TLS=O9UJQ1=?YOHBVRG)KI[9S.38 0?;NUF3BE< M>95-2"M@$PT)L*5'$8V-:F[(*K<+-#6])TWT G6=EO\MK"3 M'68I6P_8[DEAK?^0FQZOXVYQ()/A!)V5[/S/8ZP,QGZ^U.LSM8;[\G[F?:FD MKB-CNUOF1:N305R6S&:EC5W%?<'_E@UN%QM>+2^V$[.E 9IC07;HB4326X(S M*C;5;ALD.+0H/Y4DPKZ)^^!0564NWMN%R8JYMC&P+"_WUUM97:CA5?I_]V'J M_WZMHMK_>)_8@N"$4%GN:5MH<\\D S[-U&5?HIF\*YS#_YN M82CNQ[QGU*_1C#JH'-FT*MI=B^&^P0Z !%J;=N&BK9;L2R EPT-/>*T2$X-: M!J5TD%:B5$=P)=9:(8(9FVX:+K'M-B:@M, I=+]6N,O@BQ%R,Z8U\*])\VE. ML**>.\-*LUT7;%&>('@1MDU^S[FPBH N@2=NP6?=Q^CR2IV NU%1/38E"%%E ME7.3UVGFX21+!Y.4(DYES#K$F039>1XBXQ#][NI6;+!X+,5*!\J_#^]FCTRA MXRNH5F0&Q-T<^;L![PMW4Y_1L_'7$?G[J^8[G"_'GNUXRZK^^HIM(&4.'T9* M\#+R2N/[K%A;]V-"0]&JMB6&B5J!Q_L]5E6'O-ZK Z=8%M4&V?<1%YPQ"KUV MPTJ\U]CX;9FU(3^Q!8$9=4*_%P73Q1\*IWYV2X 27 MET6)[M&B)>U#CZNA\]'A@VW'F)NQH:2ZR5+N/T45[C,)6\FZ=Y=2FPZ"N!#S M:8)--4I2XVS$<7AZLHB&S%W+K>?*=L/7Q&7_.Z[@!&C1-?3)),:)F[EVT^/' M,BN0K@Z\DKVWJG 6>^\J! M'$3MYQK)I<2F:R%ZX7M>9G8^Y&G82B'27VV_9 MS?!JX!!P>A_T[_5R31IE7:8U:@*FJ\#$N+6TQZX'O,7Z>WD8\I!MHUO]0G?/ M$P2ZI>.F'CACP99C[/R*H;;97I$F&2M7T!/6EAMVWZ=9,ZEME^^80>'%!#[_ M8O.30HNDIY/*PQ.S =(BV]2Q@ZYMX]1TM0,D;,5BNK*V'B#!VF1&[R8FYR)RY!HC.!UVLXL MMMES-8.%G[,],+FK6FX>TNWI QB5YU&C@=4^M9P&8/@GR,+%50S$!3+R:=32 MW#[(=8Y@&\@1-6 ;/PUR"@R IW6$%R]*\6/ M#&4>9+_7?']?JI^1SYKLMQY7D$&X%H4@>NLYW+WM! ?GSL5W!AP(_UE*T M'7F7$%+T1@D>XMUQ\/[MT3LP'-[=B_MC-4V(1T#*W3@+KX_WWNT?WF7Y?T2D M7%7DM?&?#0R&0'5\.=VZ!14T.B;+11@\_T4C7=AT^#2^ *'%VXO =ECR6I#A M(=8$FEQGB%X$0^-U29;JQ_?PY/E[_]>+9QK;>UU((MX]U M\B4]&[O"4TE4/*.!>3WG*+'&$<.86UO1'8\%VE7; *CDT1O_TN5W\>+V)_HC M#46FE?LHB!BT(X)0W]8]<_S>GM7@S)F.]'6UE.%7W]1$=;+M]<0)"P,BZUWD=MK M9@J[*@X.DY[MGFG>M!ESH^_'+Q+W72NRTTH.X,=>7T-L)(@&FPOF^[URNQGY M^VJ8??>CW\KCI!EO$*TNJ>5;UTO&4TLM7-4RDM_C)G,L1H?)95PF5?0FG9IJ MDG*OM_VBG,OM&[V!$[2!\Q5<_U&.W5R1L6+?YVC091+]A"LUQY7R>Y-XG^$J M*BH-YZ+.B70V4J0WOI;*X&QS3#"XPIJ,4$?9AX_Z"22I"RC[G -*;23X('AC MV".E]0+IJ@3ZZB*^SQ20?H^,6Y?X*UC)NKW1.ZTEI1&:UD=:F?$(!%@']R(NXQ+8M#P]SR$7C7@EN!E@2] M%K3LK$O$W\@>VN(;1&KISO.>4]/@6'1L3B P)OO*L=D<%IOP!>+!PL JP&!0 MXG 08.]>RP @^A)M)L.$(2TXKH1\6)7J\+<%8ZWNMWKLTKCWL;L%5(!^ M49@ U_!T-;E@^"SR3J%\P2'T$>Y$&X8G#IZ(IKZ$:LDGB9MCZ\+\$C^-:#^4Q-6INDSX=KCQMU;B_IJ" M^Q20)X-X7[O9K\*EV-)]?1CRY[;3X_H$E/I;Y)7:]P^^TV-V08^,PE^6A_N9R=^GN7R YCFRY^4/XF+(&"7 P M!UMB6VR!+V"':21.;>USS<@ >$QF&JZ,,!7_7G=[%/VK2>&I:50P#<[N[BNA MT&%H\ R+Z7/>8*,D1[C/_\3G\NAA=!B> D6E*36A00K(?:CI-M%+410=OX!& MV/W<[X<,K;G#K9\(J@KVLK8.<:0M?"?Z%0QA^QKL$"OS9G1XKK69>-$(2*;R M&Y<0>$+_[E0L@FZ8UYKH+1.?-@-O;_3RUR/"?VCKIW%<88:"D#"SZ%VQ&>V^ MW'Z&;*%GS"KO46%Z.8G2U$V)*9C7<9H)5I30'8: NT'OGKI,S\ZPM0F,+LX( M8\-^A818+3.B#^5=TACJ;LOXLGSWSX?';_?>_?==GOFC5KM;@,']LJBJC3%8 M4)BAU/9*08 0;(O=9T]>;>^,GFYM=;F!R!_/%AJ2_!DL!5 OKTUBM.=V8V;_=V&MDU"[/]'/N':^5O?WGR_)6D@MN= MLJZL^AIFC%KOW&V"TR20J QI6#XB@PC+LLA!$2!CDV.?D$SBSTSF1.%M;+L^ MJ9PY$'V _Q]GDET$4Q=9^&+7DXU/UO[J6OA6?9 *9%GP%&.7O3$S<4)P:JSLW$"M M!J=$E)E#( 2=]:P"DQIW;/^++OJ:R>)8K M'[#D#'T+>;-= H2=;B\:F X?9_0LF!-="0?\%Q:7X.QO_YOVNE6]T6Z&$/0U M;]]%2ARH=L%3VS[7,A;(3P@5)=P7VUO_UGJ;(Y\0MD)J+D1T=Q)C3]Z=W!TIROJ'N' PY-]R_101$:R@E1U MRQ-.#XVTKJT0Z?I939LZ+VXU24,4%C[]-**".[Z9(P0)>4IJL!Z*"[B+9_9T M: YZQ!WNNCG\**VJAO*V55TV4KI&5 #V9A?FMP'V/VE.8QR&W.(6 @JXO)F- MB5-(K]C"0*!UZ(5>1ZW0=SAH6(E47 KR94$ 5XLQGF"8*NQ2W2O#!4 MBJ1_CGN;&?E@X<5R0?B#1X#@0NUL.*C-'1*W-D09@JF0>@>'K^4 M$__>E2QW9COF_9V6D\< [=T*T+9O6I^NI<5!I)$W)<*Z%I?3LAX$!:P#J'U% M8+$:U?H6+&P29)CC1>^V?5U6$9WF_(*>:0IDC2+#7L5XFF/]@A"X4BX82]99 M0HWEP'U]Y$APW<0IM];?%38Q%.)AO:7O4E:;8?\OJ%;"ER)PSURP9G3MF\,X MZ[3!K0NX$*E,@U4G!T3A:[SR[;(=JAVO:L(_(2W]-'C\G59,=SQJU!81QZF? M,&6E)'OS12O9JVE:2=YW2!)>YWPQ54]!(:Y 1XC%3V1 MBN/#-WOO#N[!S%>L=/\N[/W)\=[AF[L\\<\1LI^' MXDP>CY*-:'Y2K"W XTDE($W56U>LYI\EG:1!Z.JC(V61IY"[/' M#7'K1:O>??OI@8WC!\LXBK9?/GN!<(1BGKIJ5;_HDYKHG&R\H)IZVUBXTH(G M&T70WW!FTD;F?\T)]D\%4I7_=GRV9_YKMP#2;2Z9/"T-&73PO1*^1]T)Q!93 MYM$^CYG]ZE^.T<"$C^]\Z?0-\1 #$=1*6N6"/'F+AEFI@I8=W0(2*HU6A&5G M=WD!E^O1$EX/_(C^@&TP.1C0%L05SYN1,I6HI^Q*TZ^D%\%P+JWHNITG JA0]O^P3K/D T/A >1FYF"8?#?V_).6 MEM[:"=[^2Y&1*_*!?FC+^._!,;Q>;D.B[.+!L;!_E>S.'-N:Y&<;F9F"BMB! MP78?Q']*W](J;=]BL\-7P4IM;VT^Q648CI*U=809:5;8#+K>Y-7 5,W'U#&^FM^HBPZ[SVA@?VEHXGE7DR>]>HS0_: M[OL22M5(4@:Y6$A=2X%/@C7H W-G7)0Y,;MCO?M-^-H?IA;=73DM>F7R*;P= M0P_ 5@JBA3DO-'\T,>F<.9FRS)F@($"@HN-,$E7J*U $6J()X*T_2DPH,4]6 M7F)19\%SJ2-9B@\_CY7\ M&]- 36YIG_OS3)1:PL) L6_\2G9_^/=AW_LC/K^5"#&AM"957W_ M8AR]_?#^^'3OW>EMK@&?J]XJWYC)3.,,3QRU7IQ0EYTXL(=Z8DX2AA'&"(M2 MD'_;J$[*5>[R+#HL=+,BE4=BKAU(Z^'11[4*9A_2@E7$NP\G5AI*25E?G36:HK/D\AHO9T>?_4B /DCA'+LP+MT+)37G%L48)%PN3 M5_=]=A9'']+ZC_3CR&;TWX+&.4,N_2M?B8&UO>B7>!R7?Q@L"ML<1^S*I M @[+&*DCZ4L86'\;Q+O0**VT\WPXJ8.5@9J_W]%KY@A?(R!'6X5.SU/4;+WNN M+YACDU'LPB;A[: MD K)\RO$R=^_VRGL_-%?!R0+ZF>8NO5 6)MTS6*E^V X M]JM-#ACP3;%G!6,% $'7YIOL%^=V/,4YT7 ^YXL^W%^@D^DO_,.+U%R:9/G7 M?N3=:I"&NBR>&4B=&B%7N[*9JI]T*+[(WW,EH[#COTB68SU?K(;_ZR]C:M M)J /XMP43?#9DVCM74RM@M7#]C]]%JV!]QUCM>=%/%D@F;W0$&DLQ?\V#.=G MK.&C$DU$UN+W_FGRQC @2[^X\S1:.YIIOI@P&;1NQ]ZM=[?!28\5>G>2&++= MU*:/(])K5"H-2=$TT7H@U[E4ZH!LQ^XS(<"JXT\4)A0F1@3*HGT7K1&^#_3B M-(] )NT-+9,-ZC+ZRY3_$D4*CX@)2P-&#$N-NN!9H(IRUCP[UF, MC)SRILJUI2?$YAK2SS?"ETTS( (=[VMVP?W5+<"ZLA:76V(99(97&+$A8W!( M>H.)'>8JZSD0WS,F6UT?S&B=FH;0*[2Z6=KWQB7:5BD/)I[1T9&A+5M8?#S: M>6AQXK8A5VG[:S0>$6?;\TV8=F+;4[@^A_'C,;C3RODS@QS_L?=A[]U=GO!_W%JWI;. _. MX\!OLH4,%P?WF?6^JZ;,/E.)_^/]\>%#HA][&)[%*G-_%$)@Q)P1H*=0W?P# M%&X\%+ =+Z29*S6])$[Z5@AO !]2C+F#C(+. E"PQ[>!C6.MQ6C9/8C* 'Y. M8]-$,%KB.<(W"WS:A(.V"2J;%>-M3C?-+0(IO_N1MX36T-K/RN4I49[V-@2! M< S8LO+'7];8;7G&!0,Q>5K8',6@*['>,LP<$HM*66=T1&IF\R?83 M0-Q%S#$93*C(/:!-.UA\A M%?Y/;8%$XF_OJ$=P%XXA.;&Z;,%3#O2D\O\^V MI%BYAAZCR-233>*H79!!B@K4YX=1OC4RS9QCG=>* M=H*W")80V]27&V<40*7CEWDX:NJV8;6PU=EX##$4X:X[+8XE,X^F,5(5()/R M\?@2,6=. 0D.]5NL*BX2?;"$ON&G2N7[C^/?(NHT !H)E<@:54]%:#]?8*RC MUO!%FG>XFJ2[R8+K8CGA\^CXZ/MI_?P]F_[C_-]W_DZ-W/^]] M ,?Y+L_]T6^^F@C)G_1MN\W.';Z,JS9]D>_[M/$O8DW])V/SI0RVGGNVO;ZVM3RQ9R K^-Y^B#M:B&7C?H B&JHX[6]L_C.1IS.R]>CJ*= MK:UGT6$"!J$6B)R\WK-L&Q&L3TJ)[A 0D;=HCZC-.X&-LB(YXV9PS)ADJ,RR MZN%_PM^_+7)3(W.SXV["0GF=QG"X$4Q2#1ZZ6*,K O5P7W:QGCZWR_1ZKZ\3 MP71:8=/++""C0<0Q?2!$:A';6C 9Y..9U&%N?R![#R6K1XB9N<<5'T M>_I1*4_U7X@SIF(=+,SC(@1L6ZWMLD-Z%H%,C&RSBK8T6FE3B!ZO^H#LT6"\<3"+=II+EU5'^L@) M3MOXM9B./+YE+T++<6[X0 MT.H0#6XH##M,6:TB&1X<.#J]E0E_S!')$"9)KUJTM;:;'#:K0@6.Z8^^";CV M=4A/C&JVJE^M5TYQ M#)[$C,,UJGSNZXVQU'7ZL'?TD# C#ZHP9@AZ>V?PW2WB1X_4H011H:5'MNAI)/_M]U6M?/=C"Y>] M A[Y=5MI;3_Y-KVT'E%DJQ1#/ 34/%<[!-S _V M/@AE^'L%7TESC& D#1* (:L#D]5%AO5TOZ'NV_C2/PT1,OBURZ+,M,@.!U)) M-"J.LG1&1.#VKS15^(C2JH3'AN%8NC+S:@A #QS(,P40 3 M1"-/N-!U;'(S39'4)LY0"*;RK'E3@FHV01^5RER Y%+#('BQR2LRM]?#/F%< MJ7@)RU(5^/VKW,]E^W!I\3@P 2\$?9[.;!>^QM'6NTVJPEVJ GYKS#2E.?-N MU>=-#V%$AZ(;J>NSA:UAHW%*[%;7'^E IYUAH.>75H@FRMEW=K^9MN-_,L^9 MJ>TNP#56R:*Q''HT@2"DLDR6*S)OF$U$BT*]U7W.9WRA8!-),=C65 M>)6HR>4HHD0@IH2*-::&5)C<>$3NB?%77'=JV4ADXAW)[+9V9]E$/*[/^-?DT3A%'##<$EF +PRWJ MZK.BP(DAC]2*1,T9VXA5ZN]QMG"P3NL.= M7O%T0CCE !I\!(_2,#:M.?:<8_5%&:V$*1;PB&:9?"R/B3-YV6[W97K.8(+> MC>@>9E%88*U\I*IVOF6D8"NXF;P'$)7+#@3BK+D+/ ]L$ M3-VUW1\?A;]BLSQ[9\-P^>V8R7K:&8#5/-[;O3%-PSN8UMV[A$<$#)OSQ;*/ MNJ)C'[&Y%JJU:XQAZJ;#>%3>\8HO,:QT0$ZWGJ@S&*<63T<&7E94G)L4,F^) M2C14[FE)+I:FHF-KXR:2'?3RJ8,JF[BYX1Q.RG3LKH3!BO0[?:\^HC#N),"X M71<-YN<)9NNJ?.M!TV5G,H:)A*-0AB7)1=;+%?T@:+ MG;9*VE*JW$"_%CX'S;C[[(F4M2&"-:H7<_IES#(U7.,V8CR$VT;T!GM*QCV( M<53D?AF;^*AIZ==^3[5AC6!TQ0A&P[).ZP:[D#M0S90!"^SPJ7/A)7U'Y&99 M32P*^E'&^O.SZ]:A]WUNWJJK5OI.7R[+@Y-3#](RZE%?VGE9^!$\X::V=<]W MMC 1D1<1F5J,S'D;ER#B<)Q<8+P.N0JP/\<%V@9R#O884.2='NZ6!@>!K! > M@)$*KSX(.KMVQ*7*'1OXJ%DX%+ZH"]/G/M+F(J5@WX:^1@>1YA,TG6"YL?C, MUAV)7MDAO0*C?QVG&16:VOI7B061%.E8_8Z%:&?2SD*O =?FA ']N M9_?Y*S3LT>O!F"=\9(B$FGJ[W6Z*UF)##W[>/[+,X:(OWH(JJ+!@"/Y]2/'G MA:339W,#-R?XK82SH$./%7H5^2]6J<,VRUIHT)DWN <- B=]FF:,T3C8>,8D M+F07_$><-QJ,=2QS(-<5@U&)X$_*<;"RI[C,7?.[KD/DV1UVGMS!!G45>YWG MQ24[BFW%-?A^+342';4]>KJU,WJZNS4PZSBK*)+E>HJF:,@8Z;ZGPY+7T%N( MDS"NO'OC/JBM?J'LWH=<.E@5(;\DQD[*(A>?V2H/5A':]Y[-5<+Y>LAI6W#H M(OK=@KIUGXEF%)32I6 ZE@TGFCO=U=='-O7A5;4*.!HK^KH3])[AX1TJ3^CT MF'CAD_6.@-9A(6WETP<%M[\"%\9Q%A-3O3(2!>WCN\5U_KR[AGR?G:'$/?9H M;&WI#=Y=AC[*B58E'%7,P=@RL GH^;'XPVI2S-6I)5',XDLRL^<-",>$ M$?D@*SPP' V?%CP.=F'OJ_ LQ1+^=G3Z/UR'>9=G_Q@"O%,JPY4L8>)%F"&H M9,G%^V?H$:>(^V#@%=Y^A:\E,,WH0C^M^B4N2Y$?D?&8P5=VGT8&4=G_VK1% M)Y>@#*+7)B%+'XNOT#>WA 8GIKQ(J0&,F-?PT8DMOAI1+DD@*:QI.)M9E^F8 M6@#E <*#KG[7.QZ+(.!F^P/.(JG+@DT&NN BKU0':]P%[]+*NW")T.ZZ5]V% M'(22IG56Z4C90MC2;>8XK8K-:P)9T"HP=RZ94$6RZ%W"Z"D9![0*%J%!/SYV M/..V4JS-[MWMQE;[W:$ONW:M\C*?"J0 M,"NEQC4S7>1)CTE.U3/$!=^!WA$#&Q$4%:5W.[>%R3Z),@>76&D--D!.M.RV MZ>X$$W !^2::G8_0S\YK5]%]Y$P">">7U$JY\@L)*<(X8E(/YP34=.03PF?!C)R7QD*3_>.?GODF;V+ M\[ZC%C[:#K:XWL'Q"=088E&T,EX;^0U"N\ES;Z&+;OHFZM,9! 7"$ "S&)[& MZ66<8SVFUD/>6PFZ2YDEROH1ZV6+W LWFDTTKMRVC _2=U[X,7E;M21 *"C1 MV_B#07^FE[D2OV9KV)HY/O_7D[\^M5R_"(R0/.Q1)W!K&.?NZRE<=G'_^N[H]/ @VCO> M^RDZ?'MTO'=Z>*?YTAZO\:NO\=51P1^NN$['ABD&IA2GMSG^CH7UE=X4/17*]1LT^P#],%0P:&'RA/^C6G"HB],A[#E],2 M<<2JN(9[1Y$F!L\E<>!OCN Q+HUG16DSUFN5Y9= !T\:9I-K,6):I2SE*BNL MMG!.*_\8EU7BE(@7EV*JTIH[GC&B"^OT;-),E'JRN,P)JIVDL-S8I5K+NKR$ M!L]<%Z)-.06&U:Q(^-\N[L;MS*GRNE6'[N*#\(\+%*J%YCGU3JGZFI7[59,A M754?,$&)JPZ:<9Q&!P9-.NWP=BC%<_!GV_F-NU8D9CPW^HF/4,0PG102NF(K7$AXD'T]-[EK+QT)CUVD!WR1_>/H MW<\'[]_>Y05X9*^X<^P5I^=7M7E]^6VX!58FMOJ;%-I1V;-SG 978YCH@P!0 MV 4U,[9PIJ\-*O^+"EV=F[#,OK#@$ &EBI,P0.R!.GF,+4DN3!Y;&H"%$ ." M]NWIJ1[SN23J)HP/,A*\PPQ"^+$DI7YN?U+0 MPK,<;S2<[4=CYO9/J4G:,9:ELXW/8D0.#6RRECHO.A%7W(G"M;FG_&"\X*^)<% M0@Y2_D54SPMF(MFF8'^F$PZ1^4*"W8V4JNO<4%L181ISS4'7/EI4I@TQ[4VP ML2?E[@)2H":7^DDJ5*,&AKCA7&R@'\@+X4W8DG7MY=:ZI05KH>-_W?S')CV M4&L8-?(*1&(E!^C3(X4F>[Q&Q-Z \/2\B^7O1QC-$-Z W'H+[GR_.]JO[/E6 MB !3'?65J%3WK\&_2"U%M<6_$Z!_08!=S]RI MF7JW.4":#H&P E^>*X8UD M,V3Q8*@%NUF6+M5?P>5\3@IT$!'A3C@^?P)B,08OOS^=%IH0B<@MV61[!P=' MIT?OW^V]B0X.7Q^] RO\]/#X[4FT]^'#X;N#H_^Z\0SZYWU+A@Q>WDVE-:X@ M22V;Q:NB(4N$Z.PA\FZ;%$^WPM@MQJ\L62GMC^(0G6)2!-2ZC?M$UY!T$KGUM[ MAX@TIC$%VD%WC/;KET[S!F2LR47D1>FI4M&*_ ML<&V("B4NNRF]RN]\.17CNF(K7'M F1?K^2(]CY<]CH/ O5R:P,;&L_A*2 < MZ6QF$N1XSA9.7.-'C%3WM$=$2J))TPYR!S1B984$S,?$3:5FG1?E,/ M<1BIM^NKM^5.G4CY[K//.2Y?UP59NI%JH8]XK7+8U@E-?^I(!&(NXEAV[?B& M-KB*%IHKJDT->NGMDH"^HJTOY)KBF#?_N$91H+"K4F#GX/Y. MBG(NV7!F-!BYJ"L:U[G^RVJ2JBXF'S%)XF%"5*2HN'N,<6)A=F'H'@4:"@H' M4^UMY2 B\)#S=$X@5WQNIW[,U;8X;T*O;N\G&KM\0:/EV,&\F@U![[,@?3SS6U\ M Y84+V3'/U1?PE 7&U,L_5C;>;(N7=A&':YQN97'YBS--<.E*#!\LI=6PN_] M5,1EXDY4;KP668%/[OZAV6<(0;DID,J^>CH /J2[@D1A'X5%PNJVH^%<61LO$-+P<3GKA(4H+N MN4W%GR'N3(*B1'K<^E[[Q 9:_)+Y7AB71AM]4?"%#B*6@3U88\^C#50;204R M22FT77L;J;B('@"9RS O*>E9$E4E4<+9LHS M1IO@9T66)H$SJ,>!$?6.'1CN(RS#=MK'H26'G\EQ/N:I=S1KE,+ENVKX&O3O MJ)[ ,FXXRX7&TID+DJ].VPM@3(4><_H9W=/7N)^O7H=2.XJ&+Q]4@I8K_U;MM7D>;9VOI2D2 MUA1+[QW1T!CD%[.0[O=2J_!GMN0 M5%>61<(EZ=P6K[%$>P+*]2N7B7^GG\<73"RG8LJB?A5%Q+T+?OR,@:5CNF6_ M3=CCAH'?6[4A"=HSLM&VH2B@]N_!#JZUR;5[U.AS< ->NQ,OR_JA!!N/%/$' M,K<>9FP&=10<:?!RM(:C'2U%)A'.6P?)(^+_JNK Z._;2(5]$D,(/VC4R7ZS M5X8Q_":@Z&,+&IOEI'6F7^OEG$4"Y,J/>(P\G*2'>NN'3$KBP,O<8T9-=&^< M89<%'P&M]5"E#GE)VX+>^1-"K[T$(:-0FGLJF4,=E'F@%8^]=!_./TF[N&BX M6F;SVIHNU"UM7HN[C7Z)F/?1&=*+]L3)EZ. MD 7+(;:@/X<#@Y?QALVWYRXZ_] 8(C8?K:@8R)-6U< ^6]SO.R"\I MA[?A,.YYZJ1K?PVM#DJ/]D=#MPK_64J:P>^$UB*K?33!.R:XIAY;_I3S<[FO M@D2IW*YT3'?0X_4&E[T4,&M.6FC]:[ I9,^SGN]$X.FPU4J5+E^<@W\XH5M@ MCA6S?.G96'_PZ+@L\?3::LY^EBZOPR8\21*E[2_![3%',*$F35MM.:4J%D?( MMXV2%;2?\XA%Z[QV);%HI([;RAJ$O)1L-PFHZPA5>X>GI;C\P[,LD>^*QVHN MRN4V(KTI,J('&T6P]>=D:!$:7-L;VH(4'65DP5; M!]5N>7W%I;/J?NLU,1J6?]TV0V7SP,(+'<35"Q4/>KF^FG'>EV^D4]T94YFD M@KB/HK5/W2(T;9.TG#0S ME$ D#IUD<3H3]2?J+1:F.@JD>&#KMHEL@_#>4F@=%$VXKQRA> MN+:K,_#XU.!_5T%P7=@X$6V'.W5L\^1B^HQ!]< MKT:3X)+R@\3198R,(;CUTG:*;D[%\^/7"#OB*1+W.!0A?_I\[]UA$?F\(&@W MO/88"1V,A'JBU5=W-/*SPHC&ARM#-14UG=18$-PZ<.R] MV78;1Y8N?/\_11Y7=QWR+)#F(,F25:?6@BG*9I>F)BF[NV_^%<@,D%E*9*)R M( 4__=E33#F I"P9 ,FZ*%, ,C*&'7O>W_[;_WKU_NC\OS\<1Y?U+(L^?/SI MSOSE]%OYR_?1,]V=W;C\Y+E5=IG1:YRK[__OC==]%W MEW4]__'[[Z^OKW>O#W>+\N+[\]/O<:@GWV=%4>G=I$Z^^_O?\!/X?ZV2O_]_ M?_M?.SO1JR)N9CJOH[C4JM9)U%1I?A']ENCJ4[2S([\Z*N:+,KVXK*.#O8.# MZ+>B_)1>*?Z^3NM,_]V,\[?O^=]_^YY>\K=)D2S^_KX?J M67*@GL0OGL0'^\^?/-M/GAUJO:?B@Z=Z[_\_/(19?@^_YX>J>I'I__O=+,UW M+C5.X,I'_2&OZCA\U7\=%5I0__F6/_O<2O]F9JEF:+7[\W^?I3%?1.WT=G18S ME?_O407GL%/I,IWR#ZOT=PUS@NG1/Z]YRC_ .%F::[.$_0.<]/'GRW22UM'^ MWN[^03CE9ZBE.=QS#V45'.BU(A*4;1 MFDST39%?[)SK9U>J5AMK.YSBN>[H>RN"C5;%UF_7-63%06 MG>JJ+M,8;R+/_F,.-#+&K8_&%Z76?,GN0"T]9/_/IJK3Z>(E?93F"0SYX\'! M[N'\V]^%)[V+/__EY"P:_WQZ?/SV^-WY*$KS.&L29$0J7T1J#J>6I)^C:5%& M]:6./JBR3N-TKO+ZKW]Y?K#_P\LJBHLFK\M%M(4_P$\/]EZ^*_*=C[MGNW#P M^&4*$QXGB3#."$D$/I#!Z9']E]LC>H-]90QS5VE.4W&/)GH*:TBBFH8H=4:L MLRXB%<67*K_0L )ZM"RR8$;>ZU_)&+W3@'4G,)/B0L/#972=UIWM'*"_LQH62&)"U;6*+WFQ^.RT1'(IIO"/M(J4H=!@T?9I M^^I*UQ6>IJR*MQ&G WO&JZEX3 V;:R=4T80:G) __.G91SLPW.@*SH,#86)P5& /WQUM=:FR+)K@9H!VD>B2 M5J6]0\5G<+=*/=5ER40 Y*F!V%454)MY9%[=/7.!Q\%9M[ZW:QCY_[#4R[]D*HJ!7C-=ZVP15::84[!8NM MXC*=6/XT0T8& M'R*7Q^DAR4^++"NN@:4^?;X>)/[T3R#Q?OUE?]=,^\]_^\LYWB7@G9F>UC\^ MPSWX&04!TA/EXCEYBIA2>*)MHH#0D>]1ER$[RPAZ/H":WD&?P$Y-#(*@K7 M*=#?%2PY4C'H"F1)"9U>R494J,4WF?:%7XOY1%O6CBIGH*68/3R31YU6;*?7 MO@EH Z5YHRNA9 UJ0;%@!=WG;$C1.9U$"ISMK)F IHJLF_JR[)H+BZ-608* M@YID;AT)3';7WSO]>0Y'68%8M[-B63Z24W:*;@H4X$R9@)'"KXJ"U-IYJ6"_ M^:5J"IPSVB(]#+Z$4?251EZ,!AI\\L,3F,^BXM]M+YORR&?)J-=74T7'BGN M Y^KSSNG8EB>P'E4\-K*&IZ.#*+]0S[];>;8'5L#C68R&6OU>:X6H(N%\L:2 M$]/2_AX/]]"9QB&J?B FTUR98SDFXF5#]L]1^ *]YLD>JGKY/-$.V35-#ER!/2T M,%\R@EL4"V93Z6RF@162*<4QRV7XGN[A=1 M3[;7C*:1J$]UG9:!,WAUM'RJ+T -);-:*'.)DM&U<.03DJ3+2+M%TFX'1"RK M"U"!TVF]V)FBL;7U]"F+1'*>JCK*M(+K4^L\VMK?VXX66I4T85C[50IJH'6R M>DH)_L=J(XO1@*;?N:.PI(.G_VX6@Y<9I;!6H/A/&W@ WXW?:BM1^M_NO1M= M'%6#3K=I6P9RG.JV=AF2FYEB093>W.+-P MO<$)PN2W7N,.?5;H-P*:Z P)*\-?BV[%]DY:(C_,[GV+N0$)E,'4!F:!ZGI.T5P.;>2^ MQQ*WS=QRA8XQI-<*_G-=-%G"CCF5E5HE?"589\4%W;P*4J]O10!%@RQEZ5*< M+5[J6),7!BG8K>3NJ\"@LW.SF*+.<].5).@;F"#;1R6;IF M.[3*_3AS]K$Q=9^-R#1><\DV%;VA))H23UU]J7+A>D1I S;X(9I0.$G0.HVXK&59.UL3DK/FNIRY=R$&!RY@YIR7E2Z)\"&4?!:YKN,W'W-S8L>VGN3 M)RU=F;S:YJ>^0V_;$\EP%1.<1X*S&+I0N[2,94OH41;2*O UPN4C70:]CHK< MDD#%=5.C.N%/FH,>\ OY=0RW5;/K36$J0I.1B:*B2F7$'O2_&OQ=FL/T@2E9 M7SP_C[M;S=-\IYA.1]9MCTY='DP2GMU:;'NGP\^FZ.K-DA$<5$,'->P6::4@ CV2$ODC)0"! M:ME)2C0/3HJZ+F8_[KE'U 1>"OMXUSQ&_O_+TG'K"[TS :'R:8>V\D>57:M% M]=VW2Y^\G7Q8D33PKU@$DV8]@0*=-Q(QA>&0%&.@91P(_YF R0%*"/P-LH[_ MGH/2P9X*_YX40L7>""#)JZJ9Z'^>&Y:+4D#W4O@ KDOWKG&#P!--: M.B$[TK9@:XFK&7WQJ$BT51J?[+T8>[[.U02.@*<*0S@V.X=6CBE9M:1O3.SD1;4Z+MJL9][16E$PT# MP70UT$6*<2Q\HG3>-VM ]EG6I+H)CK74Q0V_%[SRD/0:RD6)$?B5L&L)OQ]"1,>#!?29N%YDKT2PW\S M4!9PI 4J=[@12%4VC=?&),W!48(L M65 GM@[WMCF7P-U&DA.JA(M*IMI6NNVYP1-E75V-"OP[W"4 MFYP;0SN!*G0JK[UI# HYPL%_G O;U)_G:6GM.])XYD!.1<)>'?I *,0F.*D9 MYKEW4S9:FXHL.,J:V1Q&F?5L\6YTHPUI!8FR./NZ%BHY1PWJL$<4TV%G\;:YACR8TSU2^ MX\^N1ZWHH667X;2+T]DYW/KG]M:3[:WT\S:\N!4W]O4CN-CH7*)+ XN>J4\\ M8;8H_-/^1N,1-=-JDXH5YR91/BW1-KBT\Q'FIK]*B MP72^"7H2YRI-.FKYEQ\'RTYX>Q''S29)U9.0^%7-91Z>?1S&2%)\-%-H38! M33.3,S%PTT=D$FJ5F+FD'QU >*@Z#&R&%41B6 4F60Z>DZQ M\H4/_K5*R^BM*C\!.?VJLD9;%2%8QLB7H_VQFO[U/ K!+Q2"H-!Z>8^8E:I7 M&B7MDKZUDW6;%LEE,M6@ RD@Z*HV <"LB('RO(A&C:L"YO2O)BVM+QT9R*7. M.M:W7W77WAE;AVA\)DFC63F%-VK4WCCUAR[L'!,2$O$.TL>IX?&>"Z+C"G%\ M;T*>_V*YW-ABKZ0-3,!%A+51;=B?Y>CQQ,?7\^X,9'J,A/U[[\PP[6N"N 88 MH_ X>G@FP>:W#]9(4SA/Y$$9YIMT8L<1S"W^!")J850/W!=8CB[-[B<@,%39 MRP([KQRB1])1@#3F5G""36,J&# +##AD3O&(;!'6#X$0$'9J=3/5P.,EA:I@ MBCC?JD#9GE8QGCQJ/^0RSS)Z6]\\;3Y:0$L++FGAG69C;J;A76"^R#M_[^2Q M,[T\^KX[7.\IG.N[(GI=]RJ9,7#BO!!&S$(?SWS:GJ5C64B>YH(; MXJP+$$91WLPF[-8PYHW/Z<0I7L/D79['%<5;Y=:';G2P9N"N4R@5!BD+Y$T) M7+YKZWO,X9=PWY'6Z85(B7Q3,=7MJDB3CMJC_)55^-"C5G$;XGVVVV-'K[;4 MZO'<-K.:XT-15:29C'T5Q/C,ULI9PPDXP+4[@1"T2R]NCH%PS)D%JRE>3Z?# MOAFR8"6"\U.!<69)_@'I/TOK6FLJ*Y3H$R>D2[Z&V)X4K9Z+RZ.9<)#<9&-\ M%F 3O_15-&,5HZ)"U96E%S^7P#B'U25H7K.(WQ;=%3U7;=Y=PL%>H0KAZECC MM(R;&88#)CF"(\%0Q8?*)+:RJ:E,$Y/P;[9S0I&\^_(G^P;Y1W M/&NR?AK%/<39RR:\-X)77\/GY4CR3+P'R8'ALA);X[3CE7&F&M#P<#HC.T9[ MV^!/F%Q3>Y26V$S)$;_1T[/IE5OH%1J0G/CY!:9+:RI?YY]A)-J[>:,@E<<$ M<[:]I3Q*R TM,1KDM$>Z1$ DOS9R]6G3C-+AO'%MJ!TOUOV,(M9#0>H_P)N! M%PUF=+B7Q]N@AFIQ4-,LC%WN\[@^!]\H$BR-L-.=0T&&ML+@EBV!D?UC8LKS[_\P3KL\-;#/TG^4T& M!"LH=HZYD$>?R048<)AER.0/NJ2ZH=6ZZG&_Y- M \+K=CB>9/(AF+P#DFY,&L7 L,2C3>#ERPD?AOE6AW_/*(M(:TEED?BL=)Y8 M3M$^:$,K>?'EQ')+#?N;'M>ZR8UVK@\84.SB9FM5%%HX(QO1D/(5Y7SGJ&8) M8!!8DW2]/:W2OUACY/2@*>\?MB&T7*$+JWK&AO(QR?[8SMXO,VC]*D3O9 9% M.]'1R5$7IG>%9E$W3> ;V :CP#]OF!WY$;I"LFN=4'H[(BPN6 D*]G#DZ_-; MZ/_*%U0[96)U7^8-(;8;9L@,564,K,,)V^6I?7= WZ/7!:M_=)]L: DH@3NG M:^(_UQ/2PH%UZG'B5LT.1Q)[/(G;$=O3YVM/;*CW2?I'O](6 MY@JKOA\L,S%54 @90$FZLK4!=5'J,%-AJC)-!TE.L?CK7)?593HGM[[%)HW# MR8<(U2,NAI.!9-CN>%08BX$#8.NIRMKY.*I"W._^-[A\/0OF2\%@/R?:/I'< M-O)Z=W*Z V/.!(DF*.29A<$HKT(PQBR6(]ER7&&/* M'5KX=E H'J+4)L'12S:4P&(;D/\^/9UF />![76FKFU#%U**K1@3U4."#][5 M+;_8NH7JX')LC1*QW:#N/$"%5H4XSPBFCFD5J@M%5/ ."DRRW M/*5"FB28Q%R,H"GVGG+BC:]F2*"IUPIJY63S#^UYKMN=6X\+!C?LW.ITYJZA M\UKNF*TL&9(3]@>>2[O]5=O%;[]'JNE6KOPD.7GFFEN8=(EU(K_O14RW_BV; M+GACPXHOH(HO2\U:ASRL'R@/JTXY(.X1=_'X1 MLUF3 _,1?JNL,,AYKX1M,3-B2P^KZ>$!$\,R1N4Z:N21T -2$\1X[VEF!=$,;;)APH0,%9#*8'CK""W4]#:2?JO1.&D.V:32;Y7 MTKRH@O.MC35E!_$,/N^1'#$_RPLT#-'V*[(T,?5H5M0'K;)ZH(9:>5)3F0;Z MQ\MBKI$3MZ?,=5I%>0'Z@:QJZ_J2^U#!'%'F2A+0<]/^K>;,GLYDYA8?*88D[:OVDPX M 14C>*IT@MIJ2SQ*^EQ?)>73W2=6(&0J9_G!5).DF4N?R\%@NI#W]L-\5?6@.W;.H.]KP# 8OIK.86$^C+!$ DK$2;A!0<&K:#F*@E#QPL? M!96J/'",:IG' Y4'Q7E#I*@+Q;9FBN0GT2IA6GZ7*?499!M(KHSQB@QH693. MT"^8#&'$F"9(W:0JM_R@>5A=-H*Z1*^ "V':X[G$^MF\J>TE)J\"\;U;S'8( MR6:AJ:8*B^ZU->ISK>@AFUPJ2B'P%@GM<(JG/3NI9_)32-MRN'/VJ$W TM6, MA_#RM$8VH4G0*YF8*&'J)32.O M"$P/6'W/>IUHI:B-^LPH2\'MXD(NRK=@("KK>'(&@ ^VB'YVX0W^5'/3 J@G MPH9?F248) RWVZ$9PXC%\#'\FF'^C7\H !P!K14!^;@D,N@^Q-:9V6LJC!P] MIM!U7VM_\6=+,^:(0A>6)V*=:9%;N!1#CX:).5KL0&S[A__)@EQ?S69 M_5UQI\64G_I*HT5(W&W%9="A4K,?*C6]\.D5^=>%W9(Z0W+=_Q%(LI$4=%*M M72%2#'N<$D>8>'M!9;;FG_AJL!,*(PRY*RI#FEW ,68++UY M:D2QB]FWL"U M#^8<*%>^E17(7U'>VIR1\0*)(7H@H<)CG%&VG2+2#/%!*-D9")XX6,G;*1%3-B3 M[_X=_^$N^DGG6+DFNAKJ7514O^+S_]I[/IA0M XQ/,1,#%L8D6;/@K5E3RQW M_%,MY31*TBEU8JZW>\!"=&E!0M!^J3IP#IZUOLU6-K%B3QR.O3:Y!R0H4D!8%=TNB:VO"MLW7 MGDWK08.COABF1M8Z3F5:]+ILX3"]VG:S=,PM;9J!-PB?>Q=;RH#:##;/I)@A M&,GZ7PUY# 2-7SEX/"Y*9F],\&;72KTVZN'<;@CP+%"2\Z1RG8BV#K!D3U*P MT!7,V>*VT2Z<0NCQ0/=73)UX7;*GO-GN17M/M6DE##-NV)&CLU1*"X;5-A7* MC=99XGOBRU2+2\!S&J$O@POW$!F3J7$I]K/G(>^EF1F#[: \SW7T3U WJR25 M@,;MKO:-5%]0GZ@9(O_+9ZT"EFUC>OC .71)03WAS6#&V+];2U?Q!8FX7R_K M=AV$)()A?K"%:A0BDC)]H"7<_1$1E7=Z(K J'30$4,E;V("0(F8?YC66(DCMV5MGEN45IG_DW$Y'M!^V2',812PT%[J-B M&%6W>>-(V&5:^CDX"@WCRJ3/IV4O]I+OKO7XH;^#CO]TU8DNH8.XHF1^CD'. M)JV\!IO.RWF[F._JOZL/[W M_76W%HZ%@3V 2P,;:+#CM2_R!MBIN9DIKZCWI2-.K@'&87+3AWO?2*,@T_>& MT$ =V#$72790I%J5%U+J04?53G>7Y&LWA+-!<3&LZ2F,X<,ES18V3U5F+H5B M1NOI;@BZ:-MMA#I:P%TU<3B05YH2\?"<^"M_IQER+42!:]\LE)JW%Y.3A<5: MH:0#QY% 6TEGS8R %ALB:W\F)44O'+!W/R>C7_D:Y$Q]ID']]%8:*1V^%+[@ MWJJVVV *L-48]MGQWMNE.MP4VS 2_IHV7,=)&VB?1IH0L\!@G&X1 T98-.Z= MR>7>$F-V?,M> 4*.)]V+>U1.":NL?T*5UI_<;"S/\HTOE,$"Z9=V<21@ :2T MWKSVEAJ%8MB+S?90-_7&<>'TUD264N#N%^!QW2_M"E%6H]<@B+-LL(4I'D%+ MO6G?9"\BB>FIG4/R9&L'Q;&CB/>QB5LJURTV]V7NA5CE)D//ER/X.RY;2*Q3 MO=W3!2MQ2[_F_0GLL-CA9GE\P:>8[HI G2A(.%+.V)ZN$<$MM((>ET>/+355 M:28-J%P*2-_>>+*UQQSOERY+CO;AV"X#?M8GNY1RG^:-573='JW="+%1C"1I[O16S#,=9:I M7!?- ^*J2\(FY]TJ8G*J7J9*BKEH-0E:.%5=!NX29XB=!\]Z M(5.[):1I4":-2:$.JR3ZW-<=TWY\3?XH166^.$,TC&%R5VFE'&@[K0IM,%(V M4FGN9\PJEY:(3N9:8OK!=.24G&GAH^D;KQXF?6!1P\C+,&HGM%+^ &6=.PQ1 MU":IUP.)MVY?$\7.\QRF9QIX6J=0J<@^8D 'DP5G,]DP^R.]R-L3; 6HO'>A MB<3M:3]C* 4;C="P,.4B";1B.5C/NR))K4(7)E$?LU]Y?NRU!#(P$!%":$%N M)LRL+.8E)2B*(KF4TN26M9HX8YW)U.RD2;"8I.P8Z%,B'CS_FFSSE66L7+Q( M5I49,3O!6HQJ3@!.0+!%@DV%NP?181CXJ N3L_-'I;6R7D@7QLTX2 MF]%KEHG?;DL6IZCU-J@P>3-SY/9(_3\C2)3D<=CHO8A"10, M$FB?ZT'I[6MIWI1 )A7,8:#BT"]_'=$P7-CJH;UD"Z.%X MMOQU/=6/\E]8. M/QPB'# LG^U&[Q2EB\#&_%RJE;ND3BB%3,]M<;Y-U!G*XA@9E1D.F\TJ(\= ML_E"M-H-/>0EQK+/1*3Z!OA.=8D(+!(E3K'-82<>3LW[;%* P'#E1#.L4S[T MW9W([DIZE4NH:NTE67E$V2@F1UYPGC!^XEA5+$"I,-_ M,>8-<!#^7<.A%S23_/&3XJ2,9"_4UEP/X>SP?.9PKG(_B)'M(+ZC%>N\0 ::)[ MDDM.YVZ'+"=IV+^J6@V.I@6G%';CPY(;+:V%^U([;&%U98V!HF33P&O$X5<= M/[+$+KE<>->9]0YSOG=.=PCJZ%N("50_J'(_B&J4D(@<_>(SP *J-I5V4C@D M\?SQE&]]RI=RRJ)-!%>U4_F (K')T2PB7![K]$=_#T6T;$8+G"_FIQG.(K"1 M]>.>VYX=TQ:$_Y =VI=E8#5SPP5;M\0!E2!#Q7MF'/^=IN(]2D]>1%F17U#Y M#C?9%8Y*+1KXC=5-F5I;95!PQBX:0M6;%F6WS0B#@P883)C\@^&NAE!6@#"Y MXA]8"\;LX?DP%82"8,)W_/S(@5;0:>6PX!DLJKU 65%0WG+SN9@341X" 6.Z MFXA>2P#[C1:Z/;A0_4^"C&D.Q R3B376KKQ*4^KEUQ78@;W@\EQY(J&A@GZZE/T@ML5L=]*F1LCJD)(R5 M:C ;+;IR:6%ZY?><;6Y5DTVB#?9R2-4<%NF,PN-N!]O!R,\:!!GPS3HX-M^YA00QOT'W7]66:,;8''S I:ER=O_VG>7\> MTY/676C^K)FL' M]TP]G_X4(]X'DROU/%.Q5'%*$H#)L2H#F_XN'.$/03*O]S&E+5]+K[I^9XL< MEE;#LTA'X63H+ZE'+DW9.3WAN0+Y<)L^+=Y;&\<*2CSV= M)ENZ+D;DH0\5A25FP!W,O?M\6>&VPB$0 C=CI0:%4VV79:)F5&4JLJE$*X%N MKK3>DTBJN?X<^78UGG<&\EYN32['?GBT\P9T^5NWF;S'='^UW0<%.;J3R\YF M&B$6A"3_"G.F!"^;Q0W)0BF>&%%Y<> MU52$^0KT1R68HY3[Z+(' QDJ>"$!:"97Q/:43H49S[H/O4.(\I8(()3^BOT! MLKMDK-V/CA7[/^Q&[XIHG-!U/+5P,.N0:'(>AN8I=&49D,"/CCA5BE*[@4OF MA"FA:#50&]D8OKG,!NC5(R+P-E+P9[$-5E']T:08TL79[)^A7;9PH MJ76XOY!LS[_UE: 1^QH)]D\H>J5JA< K5PJ8L+2>02(XXKSJE4WW)N2X57"4 M$!'UN45$70*&VG:+?$O*/GSV+>GZCH1%&6GK1.LL:!/@V1SB_I&Y*/SJN[_3 M)3@"74/.%B_ QPJL@'5:@(#RAIE[@2X7\PI&7$[.N;$1%J";MG&6XZZ,K.[EO6.9DPUBF80ES"UIQF$UX9F8YA\XLEI^ZP;%?XR)AQGC([GCG7%-S:?8@CVW!=M!0XL^TOE*8:MZ+ M8&JJKJM/4@.+?AYJ+LJMJ?Q"[@1?[7&;.28O<6P3YQ/N^,B;I'4>P:NXP96M M";>5LJ[)A;-P=,N^N9U6Y_&:3650\08QJ!/,<[,5:T2>IDG@>G,DLKY"_H,7 MC'O+F.8*OI?,, ]&+>+^/ [6SA5VHF V#&ZB_8Z$I-'A>^46T8M&W3+Z6 MCSI0 M%84E"96C5:QM-0)?B?<4@2_W1JHJ0&/SJ\*MT]1# O&J7'V$14E!0!^CC190 MBG&1C>!"3PJ>; M0PS2@044 &9N]A-B A'H[7Z16;U"K^ MM-/,67\!'8S!:\4Z6X)7>,\XB=X@3O*K*48R9J5S:2KZ M&Q!(4H+)GZW3*HGS?%CFL/=JKQ8NC:4E]%TL!;\4(5@1!!-FD@+^TX"6I#VPF"XC%U\C M>$)< &(\3VQ<4?E_+S:DAR7%$5YL4$$.0#)[^,$O];3N=;A#K M)=E_)E@GW-%JG:9N-;FV!X.[97J0WP'.3=>RN27F=!N4>S#UAFQ&Z?@MKV:$ M)D[UIVPA4Z^ N:=I3MJ>31'B="%@4)1!:"PAGUNANEKUAQ#HZ9QT&-HO1+\S"02RE1&TIXFOON,>/_HM'Z M)VG:V8(R&(,"2N!R28^&:^5MDS MBW05 :&:>;OA/8O=-I\UDB9WDM#]"H<&K325/D>F)QH+HI&A0-3/X3HNR\ W^8[;27:1RYBG=E#^<,]O');V$8U M[ 8:X 'O]Q@U,GX\1UH];;C1,+!E&92-*ITD7950*WEVBSTO5G4Q-XNN-B+8 M7VG)IA-'BW54B'-8'!S;(^\2A^NARVN,'WO&%O;LII9A5JV!IT&S*1'E&BD: M*X8:$+/DM2;/$6X:$"J?*U&""1L&+8 MTE!/?&>(N&AH&#LKD@NFC0PU$G'0 M$JT0:I$'Z'Y;7NCC_^!+Z*H96'U$=W2*'(8F!3V&HXXN0WI>D(. Z Y>EAIL M25P5\G:'O1&#ZNABCD%>3*6]I'ELT6YL0O^[08<87CDLNO4464Z1NVQ 8"'1 M%TV)AH;?DNOJINZ5(+\N\A__V51U.ET,1\Q6+T$C\[\O7<]::5>#4/L^CE%' M]6?(>.0].57.&^^FZT_>OG=ECY^R': QM\.PPU[69VOVSR:$R<5*D>6<+]*R5Q3S0D\7-":]2W%#YK$.%LC6:/5/ELO:M($IOHSVB M:K"YNMT]AJ$.018+-W"_<:_1WK9%?2UI=4<:]E.-7EW MV+!=;7[G8%=J9RH3DMO(9_86>6\?5Y05N+Q=Y@.Y/ON[T<\$TXM']$9=TZ[^JO-&KYI[!S"T M[!8 (IX+?04@_Q0Y:U.Z(4M&(::G1J9? T'?)SWDQ6R9E![36*^6A-)7.L.4 M2V#G^.[Q'Z&8B^V<)IO$%P MU3C&D(TB/#2U.XZ-?N90BWT%L.A"O?MCH&-D@DK@!)LC4WO8Q&J#%O;8('($ MSH$6,?PY5V/ P%WEO3P":@36G:?*J>V1WY+L4"1+>L8;$IVC;RG9J*@ M;X,A 3?4O<&THK777)XQQE!8X6R$74N>4%E7 MSF<&M,,1,DH82 *S5X!/=$G-G9=@DM^W^S\@.0YV05[D%XVZ6+FH:'L/_+[= M#%DOGJZ.A&4'B&,6>/N6KF3@,CYY%(BKAAA\1 '5QOG/R2 MTG*D$7$7LJH[_,#H[#KB;](<%^?M7,U5P\KN@+&S< !T%WL%L]XXJ."*YNG< M5S2,?T#RJU'?A^P\D/R@!W]9#W>C8U3@RR)/8U1EL'?D.ACHGLN2[&1,@^\T M%V?T- ;&XJZ7I&+T43W7@1,!B^=R>4'I@BTOWA<*7_1XJT1QL)DI'H0V8ZK9 MF83CR6P7@8MKJ0O+]MS&O!?<,\HK<2-6BZK6LP"2G1/T."^CZ[["BXR7NTSH MM>AX9)R3SD\?_!UYLAN=,)P*)GB3S7KJ10A)#WC+W<#&$\RJ?(/IA:N_0H.B MK]=!+P417L.75!9=RZ*#L*BG $DG-$5K-WYA+][J*\Q!XF9765N&0&L]ROB# M25E\\IIYFKQNT?7,/U/3FHUT=->939JR;8&XL5+$ELAX,!!^M;RKT^#>$J%C M3Z :1N@/R4"8US6:I-0"1V;Z43E;NMV-577C8C6Z]9,#X0 M7&MSSBZUG-,US5O\4U8#<3+.NPS@FS.0"YIK(/GS.%6WE1($FT=H T#XTE,BP4@P"]B$A<"@SQ#&;DD M7/I E,NGN]%K@;H:8W%WVW]5$#1B8LCNDS ZU*WX"SQQL5&DV*FSK2ZTC7$\YDL8.#VE$ M::<25?7Z]MI$&*>VQ:JZ],NU@>[0(9TX.2TAL>J+%JXQ2_O ?6-,Q\O0V^HBRYX(\"SH%%1M ++'O M\;>H]15MO>J6"7_#ZU)950PL3M7<\YB.T9ZR+9^8-D@%UI'60W%W3LSIEF)T M+"#K* @,>CQ[F!A3A+^ER..I8-ZD8E)=&M>\T=3G==^F=*S)P'/ZI<+ECM=\ MZ?V^G6@*@GBDSU*K4!J85W MW-&W<%L*:K_="P_&+)T<"I2V-/4\(\P-'3#R7=\^DLR*FS=!$NMDQ0Z,O8>5 MM3O,=M(F;8J5Y\$2[F%BL1:/MC.9M-VT'F\V<1T"AB;SIE6!3 8T=I5&EJ!B M]/]0CXQEO>UOJJR]_ZSAA]WH9&9,-8KCDC0\];CS&NBLAJ8P_%=>ZLN>[ MT6\*0TAK<)66*X8JNJ:)=N)/4P_^.Q#(/5%MA^A?S#4YNU"9U5[&%FG7\B89 MT$.(ZA]VY"$Z>T#,,BV9;[OLV0[L??'@R?'%;O03PP]&;Q#"=3$GGWHFB.:,&6L, MYMB796C\!<.IZ0,5)YW.B=M2YN_YL5UO#TRO+8'&\6]9@SB CPHP_@T [<'S MO9^W)MM;!]ND[TEQO]]]PAA,=O$&$\I3E[%+1NPCGIG,S8#15U53ZO[ I%C0 M%:>)X;<7U,^:[BY&!$AHS=BO@1N&HMO.DL_"81YXV\".B9Z]P$J_-!R8AUFD M.DNZH0\W)RPV1MMY!TU3-R>'SNC1U11GO;HMAPA*U?%)XNO7K\RK8_IM9\ MF:(A<'!"=+;SL&^"2JYN&!^0NB-35F 4$*QFS\3MSI>Z6M[_[^O1T& GP>'1 M5]K&!W'TV[05G6.3IP9N^ZF7;C!T=*24^KDL24K>FM VD)?S 5?&:MH>$MWT^*I(H<#\V%BXQ;94N_% M'R2=^T67DS9=]M+D+6A/T&.&JE+2KE7$D. M*.1^\$EC/6.;*;DJBD]^N(<)&,$8"S[ M6E\Q" )"$4U==[7DP@?Q[GO3J+5=GM'A;1>,7V!>) @"-<+P MT.Z6318$Q056.8-3OL)R0P/W/HH(_F4FZX7ES;7#G+"Q!AG.;- 432&#_5G M[.G(<;2&D)=ZBZP-!3KP?"+"JO+T&GF7(66KB!/'N&TN_J/H"&'DOY7D@"> M\W#B1Z^TMQT,AZ1*KQHKRH6XOWKXDD/=R@PJVB1$G7 5(O[CE(.Z(UFP,'>5 M4I-:P^-ZR9@YMK6"[6/K2)K>0+%&MKP^!MO_L9!3_Z?]WZ^QG+M:LBL*#OS4 MB:.$I,SU2QPS5 )KBP^$-8W+@ZL=6]=##2*?%89=30VOE^V<^" -$IO[D 8 M I6[$T:2PH1]R9.(O6Q]2MY?WKQS\,B^\*3['_O[W]@W9#4*]+WL(%J@FE?Z M1_/'2^19F5K\F%*YV0X]]'*FR@O0 40-P8N,8#1HULD,:#+\M:@&+PYW#WYX M@MI!#;.I$_-B41QV27'XODZZW[UXOOMB;_CKO=U]^]WW-#:/#RNH@ K^[W>' MW[46*=/>G]=82@@I2""E)7EMI2]2%X[:^HU:W'@X9TT5.=!67 MZ<0D/?E7>/=F*+);E= 9;%0[*XD54EXE*852?JJYQ,QH"P5"I)G6VJHU5=<2 M$@'MU028EKW7EOR_IRL:W/1E7.!FQO)HI?0)Y!6)T7?OWTEZWON/[\Y/3X[/ MHO&K5R?G)^_?C=]$Y\>G;^&##Q^.W[TZ^:_;:QGWYX?SK&%:W] GY^\_XGV/;3XS,XBJ/SXU?1V?G[HW]$']^= MG$?CGT^/C]\>OSN_TZU;%YY_;C6@(ZL!_6DJRY\/R 8RX"Z9KR9MMKHQ^Y4D M!*N7-O//Z)\](<]N6>N2IK^IA.OY%[F9OTONE0+GB:6,LBIV =U3=!&=/@?9+.IP,WF0ZNV,Y-7;"-BC/ MC_?+D1'5V]A+YI?UNA+K=C&(W#TAQJH9%JX8 MN,7;E5^)^]Z?IX^B3LYS6QP\4,;"$S:%X:(7RFMD1@0,;G=/T;K>@K9YL(= M?=$986Q1:7>)NG>M!<%7?^:MX9=.2TZDR3#J,';U2,MZZ%F\Z+J]S"]A$E)P M3YE<##=.C8*#4\X8+,[EX 4MD&YY+AB65@U#HP?C2YJQWW-!-'G2T*U>C^SZ MBOH6=$LYJ/B[ZB1O=UCX1O.SFW(1C/P;=;:XDV")GA>=$U0;=F=0MK,K'@8Y M6 =*0EJY]0UV= 6+HG'>=#^C(34M$C#(9 H0_.3"5C:O354R0_-MP+M!:9E MA7T(ZW(WL#]4X U&7"]-CGTI'(NU9#1<"J07T+:^X@Y3MP+/9B@2LS<>Y=L] MN+\4=GN ^QX]"?-BHA@(X'>=,V9"1;W<.0!IP6)JBT'&3$F'@#%M6!!&D,)< MLZ+\1(U'3$EPV O#-@Q\)0BA/Y?*=!L+T$54.+'<8@_2]*C7A:W3,)":M[AN M-]VJSL4AM[Y%V0H!MB2^P/D_L-M>#4JOVMN9C5?T=1^H]:Z=I<8?P40:O+7;^Z4[/6ZP3@M+JE'I AVKF:URHT4;9JA4DR\LL1?L MU9,GW4:O=4_) ]B$;F%'!7 ^X\$=@VI\L+>W'VT=U9?;(_]W9ZZ_*Y+>28[J M&R89GYT<"23/M@D+8X_9GQO$/WCR@L; 'T5'&2@0T7M*4=U_ M0H;K/FRC4:%=1W>8^K('!IJ0V&9">?0>HQ&*&M@\LK M[RL[!P8&BSYQ(G8-KE08>_0#*Z3KS%WA$E/-63-!)!(B^>>'XYTC^5M$6_M) MK!L1W%&NW3>?S8!SOHTY=!(@MZWR,ARWW2<._2/U6HE/#2Y/ !;#11[XV_&_ M[>^-8*:"ED:Y?.*O0- 63ZT7&U&*+K80 W'DH%Z&@'RD44;N\U&"8,&["F*( M"[RM]/-F:6!QX+T?LPB.GLL4P,X6RVR-RFQBV7TPRTUA" M=!'9U#QZ9WCZ3Y:=LA<"@3:QX=^,FRP9I4;\2!8U-O3=1Y&=+1 M(W6@P/&!!I$>4>"8VD;![,GS1F6]&\C! RD\EM87RFY+QK40PT/G9L+90H:O MHAEL4U Y(=IL9Q;<^[CR=](UOD^T2@CR?$K87)G)L@M&P:?_0\$'8,7 ,11F M0TP]YT*KTFU4>ZHM#6+DR5RW"A3&%-6ATB&"N<6?[3_%3ES*&D\SH/!+[\V\ M>]B9V?U&WG\?I/5 @&"(03)>XB/#"QE>8E$C32_K9?KEHPSY0AF"%]>#P019 M17[BB!Y&[#+2,&K%;%*8=K[>[X<$!R+ M7:ESHP;:E1Z%]@>-2% 1KE4\V=SAF\0O8!$U#1B:_87A8H_I?IW7KB,#99K# MUNE,A"/1#/JD"?UD=+-DU8 5D$=G)SNO*=>: M_]F8+"+4L.&[7W4YG\*8ES5]OU+V(QZS>R#>[VJ,_W3\YN>3CV\W>>6/QGA_ M6T<'4L[!$4$NLE#DZ^ F#T/V/6C47KN&15L?\'&\.X:GW\@]3/KG%DN5UVO* M7G_W\H%@%"=QNM[H^*/0C@918M;G !#DU0R-PT/G:F;-6YZ?:"B]O7G,"-2+A1HX59CTRI^K1HZCKGOI48=%,C%],'4 M5&(2Q>5?_W)P>/@2=G"E(?J>^]N"[R9J&\#PMLTEPC8\!G2D!0WN:GZ[N3'W MP2(?2!5@3N!%RVFXWX@5T"17IN"UF2'XSX2#LDW(& M5P33S2BRHJ(<9BLZKO#%G@& G$RK'O$, FV:=YM\K:J7.F$-Z:T($R=2^YN^ MMA'2+]4"3\?_<_)FD^_28]7,\&*/6FTO8$>0&>G3=EU2A7U'JOTVW>J FP2* B$$FFQA9E]4815:<+"D+3 MSACI507)5P9@Q'6EZP2$F)4N\%FA#$ENGZ:?;6M7U*%CC-'06V%4_AN$I8QU M)?JIH3^03&F1V')JO 0ZKX+HV3U3A09RRTU9>^N!WEY;Y90@-6N)9>VV*^S%MJ=\@(4QQ5,P2#0TBI(&%#+9C]C(8B[XB M_N%W"9'*"\60M)&)VS="@)E2IQ+8JE%[RMZJ04MOS?]OW8T*V(VH7P=5AFSJO MEN#;>?!VANN(G>]\&#P5G 7;/HRO$;;.Z:R$LIS;J^-^'1)/LH$*T]CTYK*X M"+@!B2K@ =HR5SK]-*=0*,ROLCWXG%:&W4PX3<&KHG%?.^L,>;7AT#81O;=5 M&,M27(O@C6 Y(,Y.^@OQXLD*E6@>S9=0B>T2?8QR"T+",<$$$Q](538-X&S! M#T]\HSG9G:QZ_(<01]?3*1C_+?EHK/F?3M]$G$+3];_BV8F*[KW!GHWIM=RA MXDI 54S[1[X5[[ Z$?[[@:QX/UWZE!RG4;V8"XQMTFC7U1DO X;3$"=.0F[C M>7D_CGR5O!WHO6U) MTO.M_.1NJU0<=-G)D#>KAV/2-0K,XK WX](QP]:F-]3+][W]CMXT4L6=US_1 M8#5GU9UZKVW275OF:3L:OQN_>DBYSP_*T\8]&SY(QXSW")M@2[?6(%SC%?JQ M6\OFJOH!Q%"'1=;B.NW9ZC?FFH*9ZG(_I7C0] PI@AVXQ[(U['YP;$W@E1]Z M6GDMU4!^9@JSS2Q W3/TAK3!_X;/Z3'G;*.(=<"=UC&V^EVE ]XF1CT0OX[@ MOP!/QXY0'ORVL?8,)#O\N<5!M0Q5;@.ES?B)%@W>!W!'D6';G93$I3)J(\:I M -RH)LW!7$D3C.YGZGK:9-(=SO4J]";OPWC\LP$5*$D%_)NZL[1Y7VI6CEGD MTIF0-$M9>S4RQ0%!<>^M_76N'9QQM&W[68-:E1C-1'Y-K5"BK?UM9ZO>[4W! M*<&ZW*F(@_)@>&AG[,$1I((5>IO.7@/O]]R4A\%;>Y)UR.\8945^@;DQA*N4 M+7I.PCI1PEYDS(?1S0J*;&U_3:+]VC1+CK81[D_0P]'D M0%'_U]'01NF+M&+*0&1S^$5:4_XV;3*#DZ0YMF8P(9&$&],K;_^"@QQF8E:% MH4Y?:>[8GG%R$_>R-T. O4C9:6?RNM0C;+T[:V;#TT&LOE['(%4(J5)R@%T[ M)NE8#@>WPRW(S-)-O9/9"4JS4@ALY1!L=)XL.]+!6>:%M$UI3[5G9D$8BD%O M*ML&^=[:=-_]_17B%'_ 9BCQ8N5JG9\<[O0[5S0WB++D.S3_L]$3'8LO&IZ2 MA"N'7MS1#._:DVM=3W@(_; 5+0 &.UE$J@'V7<(X52!C6JA,CM%HZ1A!&G'5 MQIKG1-4M[%8!1W'!JE'8FH$:B".L4U-5QKF32*X!A30M,)F?/TF^'/R673"Y MSD8AQADK43B?*^[Z8URM80-Q>I?!X&YAZ?>D_4TY.+MLEZAS>C,!PDM-H_,I MU@42F)_LH@7,<)-!0<7[D&%_0?REV13_"<_Y)/ZFZO;3-!J"V+9%*8TG_8V5 MM))/6L^[7RY!A1,YS(6(]]?V?5WJ/,:DHORBP?SK#X8=W2?\9'WF!*1!C M41M_2F])+L4*VS.5U%GPT 74Q1M61'K'_XE]RYYU27>=1 M,\<+>YQ?9+" C;Z2=TPN?Z,K>\+(Y_)3>58 1 ; M[VK& M9%R3]#4\=/ $21S&EA,;3B0ST>9^YR"/I:&$U,OA8?UW47Z*SNA]!JAIHWG=ABJ)O7AUD?B YPOK]_^#3:,ELAF5&_XHR%Y[LF=]L6*:, MO@'BD,(.DL+2FI]-\CH:OXKV)1/2[YHE/EH<3E!\3L\^5MPIHCW;G1U!FLHAR3$)/%42)9,4(KF:J0WOO_*E^;/_'+R[C%]9G.7OW2Q)[.93L@M M>!8(WY5[DH(LBCY?^<$#@R MS95%]_YP:L&]1U$S%[7%A+HH0 &V=J9-5_I;E Q2]8NE)Z/,D2M:]:8/N)=:73*HJNJK*!EL!U56/"LJ-34 M GU'K3[MG)_D:<-[\M->GE M>='"C51ER0V2))9MYN'GD]?M;C$@OV,-T_MHR*O[U"@,75A:PH0 ROZEG+?> MO.)11,D%5%AFH4BFFN/ML<6SKT9]5688UJ$6-JY&MY7.VVE$90M>2Z]%.I6\ M&BL&1\A2-4&#@[N3=*M?N8..S03V+YV7)7BID.(T<#YX3X5JU7W5/'I ;$\] MOK9B.21,MY\6#,L]/1H-QC7@R\A 9_=AZ?F52I9W,J >Y]WKFZY!NVZD,)/J MX0N/68:=UZZCJ._T5?8$(C'^D!PXN45KDZ'G:"?QR,%Z113;:F '=7OM&8B0 M"CLEIT"HW4"Y\@++HV[:5Y_\DZB^]'ONKDFR;Y;7CD@AAZGLD#M#VV'68Z8/ M!$- MR57;'LJ51(:O0<]1WSMNJ+=N5=#W\1!TOC1S@^O)PX;H5_!*U@2KPJD&O;N0 MZ RVK314E%H$F&7+XG(=(;UPOVZSNI:^-Z"-$"B-YMPHG1!F<=T'>7D[ M!ZY1FY=QC9HR%PW!*#Q:.N/Z6DL9KW!(O1IJ8-];[$@D3VW"L*%H9P.AW!U6L*@PIT)_2H MM7.\O7_S_NU//6T[5K*(1R_:QL'S+/&B419B,%>O+V6:>^5*7\O-MFJ^U=$U M1H$S9XR_!-&R?V!S<(]@IK,)EN'R^1X5B1Z%J9/D#6#SWH+;) 7)*]1V.9&* M6N !T\O%E>:%),09!ZHN:-,&5,](MP!&9Z,%S".^E5?- M&-(W K($256.V9MD#VN1S53Y2=?K=ISI8_JAG2>H(VI.9 MV';ZL*O!]@;U@6:7T"2, G>"@7BH,!9,(H1/$X"C+N09L3U,V1*+NN$3+L7!337]3]E:5A\B&C M^)OT0P8F,X>\/D*V30C$OJF;K0,@M&5O5UJZ4GC2T]([KO#]=(K5Q9S!QAD< M"R.XUXP7/Z:"N^FL."?6J&L>>*.+[3B@20=02-8 ?5U9P$"3G*JB6)=4,&M3 M1@>4E$17<9EBH;LRB)K2:#I!JY\]\ 'R@FV%PJ5QHHJ.*/$G5W4C^)[X3YKK M?65UR]W%9^?CZ/3D:*.3-6_RZ>%)DU/"M,G9L3U,K*?SWDJZIDTW1I6BD1NZ= M8Y0TQA-D@(R\/@\V7(N-L$RZ*G49TSEIPN1@,F: ;5VF=R]V>R021R5[&J&9 M ;BXT>M/ $;$U*)\QMA$JA8+FV7HR.]ED.:]S7C0B'#PI7!:F8Z]E$(!9D6S MZ)?B6E^AP6]J+GJBGRXA4;Z:EHRVG"W$=\MX2%P1WMV$EA4RE 0[8(W8?)N! M;,9A:T7*I_P5H )BZM_[886,3U-XWV])MDRGE M48/<+ VRIV^(2T&NR"$F2ISI>.'"%Q2Z,#&I5SK' (2?:3^LWW$.C/0T+/Q+ M@1ZU<0NCJ^KKQ=-I6>OY?&WW!*< JNE4I64ES@ZL#M[H:_:EDOC]VY-W)T?C M=_?"6GUT6'PA&;P^>?=F_.[5/5CYX]G?^>Q/Q^^.CC=YX8^Z^))P'.$3[OPG MB$:&A U=.4^*A#:TBJ!_$32??!?-,>%K6N=JBL@5^I\C2 16 9=D)O'=I7' M7)89]9!\79(C@R6^29A]LQL='#S=V7_QP\X^OL#[]U,:[\SX>>B;G?V]G:G?!_>H3W%IK,J/Y/[K)GL4$\U8M8K9UBVM4NK=]72 MSJ7>[?^/.;JPG>URG&!;'>!1Z517<0K7"88Y M*LJYR/+H#5R['=PG&> $?I%3GL*1#U9N\;H*0XKLU!?6N87ODAQXX77F$ PX M!6Y%UX%!R$?X=H*%G)JJA4E17_;N0VOP47_[0YO)JGKY(+,1>IWLNO"KUNB2 M LL[DK=Y_9VO[*G?^47Y190,7)0#P0JYO@S]N0VBR:]8%F/@@2DWB5*C%=I M9< KME1PL7JH?'O$%=94]>+R2V^K0"$ZL8T5\87A>LT@F#1-RPIO>XZ%R)4J MK01[)1TAB*51&3KEJG*FNFD1(?U%5.5DM&&%K8;?7M0(WMQW^:N.GN?4O%MK M:R.!4&8H>:L)AL^C\PD?-#+<[#MOXYG9QHXF> _(^8ZMOE"K>87$NUXLJ-/S MZW!+=5M^=16\<)DZ6";=T?O-M<; AJ*FZ-:POY=HY&(\<9\PL=)H=8R:FE7 M'=L\QMM?LZ/=/$S[&**O5S:'@3K85%@M&%O$%?9G+#QW-!XI<,LJ_1QM/=N. M9K#FR^5SDTET'>"M>4A1H9D*Y>=]H^F,W'X;*P.XYE2G]7UF,J32BVU< 1EC%+4'*97+\* M>,/^RSLJ.D9WL;I.]8=UG5YM4WYOO>K+=4[F]E58$.)W)T%5V>OM-=@7S_9[ M$Z^+@S]J^6"*G(X=C6N+FI029-^[GNYM:E)<=9.S0DDP,C03JTK?@I<7G:5T M1AA0^YTWH*OYF[K@P#7!]3H^%W4%9]Z%LHSTL>EI][7WB"O;0D55T;TQ1[AJJ?'?O.X;3L,B_V$@?ET#$P8:Z&)GP? <@VJ:;B\U[E_!ZN/LSTI\%#.2^WU'Y.G_89@5SJZ:%($W\H1'[,J_-V# M&QO.FJYBR-Q#">>#7/2R_9%IM^4YV=R ]Y-5Z6%.94MCA6;"[;Z_"O 1)0=Q M\;V:4V#S]W7(#;J%OOOB@>F[)N*G$IS'S(;];(!N85CGR%5.T15*C7)L-)E MH[I+A,PZ\>_OC;#]]8X8N'+%%^&G!6:KZ7EM>' O'#=8(-,4 T27ZHJKFA7# MVPG<7E$D+3]4JQ^DWPQ#95E_N(E_PHU;2IWF(P[+7&/&BQ6>:!F6P#)C2?2$8]'T8'B^-:L$,$RFFY)V75?\O#GE401:&8R:1K@1W+Q+ MFH"Q-C_#CB Y'ZPV;=KP?'_%<7G6,#L,00)K,BJY-'(+VI-QM3TVR"./%OX M2UWNYSD_Y"3D]6\3U).+3 UK)-&XM*G'KNT4"\(@Z9C+G..,M'/@HB8#F*%X M\\2#K)<4Y,K'T:'J??.Y8ZU8[\;.E9BU4J_Q#XIL[(NS'5$#79.:/%$5YJ-0 M#O(,5/G=Z/#%_C.,W5UH?0&Z M!):'Y2JC\C:"L#/*N.WM&H+"WE,:7Y;V^//QZ=OQN__>Y)4_M[L9A8VRA3&9H^!&"K94J&@/?8/U#UWH"JJ..MJZOKWANHK>9]$QD9"2N'5I& MIY\9_#H%8_$ZV,-#32U=97/[-T M0K3.1H9W [K=0S.PB3F8%U7%#I(O$(A0K?.-SLT;<#Q+J=*M GN;^MH7#*+S M1)6D@G6M\J!%1U!^UC?CZTO=:41%9%SYR<5>T=FT'6Z3!HGC:& Y3,FH%\+- M3:>@>FYW7EA<@ZFV_^_XNEE16@>N[=4D;@.+#=3GSS?80(:K/^7&DC#D5BJO ME$DM,M2&:Z6T*Z0 +'(=DZ +)J@@A MU@Q3*EV>WI\O-E%/8_U7%]X]"?O7O7T*=B@=3^:-9MEUK19OM], MI@6O\$6XN,MZCQ>P#PGHJ9)>QX+7I.9@;9BDW+@T'QYD&32-#^&3YOR"GF62 M'B'VE =QE.98K@%?8!MW\J!BI)LI5-N6GZ]/7,]/MW#R2%T3;VMK (DFGRW[ MYG &7IT#]ZLW&++L]E0 U? MJ7WX,+35GZXA/B9-K<_57*HKG1X_XAX\5#WY['1\_&:3%_Z(>[ $@RSLZ'/\ M6<_F:Z KC]&_+E-Q>I^'#$]HG(0\CM>3"I*:JK< W>C MC\UE MUI.J5#I+(V]CQMP!O5ZTLLWWG[ZR3J1@&T?1_HMGSS&24X2M6PB+GZD2&GY?^6_'L3T;R'04YY1+Z[*>EIJT6OA= M";]KYE0"QG4Z:AA+D]L@_'**6C9\O?%E]G<,I9R326'\[DXJ2"8^T).W:>@2 M+6C;T38BHC))FT%EQ49OX'(^6L+K@<[&98G4N!;-!9<@'/;UVX2OSG!-?H9K-0* M:[WB3\;![Z=+VP+=_;V#K0FUWY(_MPYM0:>0XPGG3E O!LQ2(T/@KW]YL?\2 MM_Q7[DP,_SY\20QM/UR6#^%1RU'K_ +4YPZRAX^9(%3AC'IA= =/)(HEG@C+ M]/FVE 8)8J#6R%IH+1:]=Q"\_1>I,.+4: O8< _NX.W*S*2MN=BP3.G?)/%X MCO">^<5.IJ?UCX?/8++=@?BC-,=$FQ]W]I_/ZQ7MTOX*D5=?!CNUO[?[%+=A MV$_8YAT^I9OXEE]; 9>;64L',00+*;XZY6_4N1^LW;F?A14?@T?=#=?*S;:Y MU%:&A>XB)2!15&<*]$*-A]KUII2O*VW6O*9K#K"WQ&54/AJ\WVX*8=_1,\9^ M4:!)$3LA\Z6F?8'K5 7I=IRL03%O4Q2+L6(L"?!BL'WS&AG12?4#C 0V"LM> M]>=Y6EI';G=R(W&PYR)-NU*%M])J?H%HG!1E3E5<6.XOLO!;-E[?J$MWN':7 M[L; 3,@W/<70)IZCXC$O3& EUNF<09FRS&DFKHD;Z39&A237K%B8WP+$>J.( MX\G:$X"J$3\$O1 E^<'IG*)U>R[U?Q6:>/,546&*_XZRN+IM,4W7+I9IY+:!!F<.F0Z( .Y<=\/<2<[:MG804+DH@ M[^[[[$)%']+Z]_33R(:HWP+ON$!4@!M?B7Z2Y$LMWAKMZ,W-:C. M0@2X93JQFY16@KAD6&+M"M_MXL.='%EUQMD&/L!P6%]K:VG7A(-]'0>NZ1_" MJ:5];EQK'0&A%L9]YD!7'HA#]\2 F&T@NE0;RNX+G5Y_NAYE"VG]1Z!O?9VB$&E81,4UW7O"F>!=-EQTZYQ6\L:)W--/,< M JP ,V!'CVM]RD@J'8^Z<0G#D8G1\[M!=356VR)GHU4):!7YPZNT M\I1HAQMEIN?C7FT5G7QT&\>::.!UT\!O3@J:F1%IBMO]$-J@2R(;Q29U9OY5 M;]IW[QJ\>D3=-VW8R8_S%K:'\W:$6$WNL!#"6_P=EP-Y@B,L::ZZ]&);@[OB MSJF6+C4V>EB-K" /RB&7QE/:1[YD8U+C8,D++]V(SIQC1S9*T-T36]Y \VA M^4=]XAM@/#SF*JV/+%J:KW(^?O.0RE4?5+H*FRN\Y+'E-FL06KX=TDD_@VR; MFY8TAJ" (* \>W?5]?\/IE:H2_<6V8&).H1S6=[&75)@'<*/MM,,=0 M$8S\3A);IV&W5I0](#=U!1J!2_V)MMZF5:PSL'(UF'[^=\^BK7?J?)KG> M]:V6I'IBG!C6NY!R[5I])A>%@(%@PA60R2+:(LT:&.,M\3(JUC=B\Q,98Q]DDY1)?8&P-XA MC3;]MH,BE^XVJ<_"47& E,*U8 ,XOY 7F@V6+'/!SS.%H##RIDIVL93DGRT$ MZFX$IXU60%7 WL_LAON[6X#9995XM\4RR0QE& %QH<4KS8C$^LB;V8316-D) MV#.GPC@.@Q5M$R0DO<+4Q4NW=E6FB#''DU$SNCHRM64;B\.CL8%&#!X;PN6T M?T;S$7*V[:6D7%A97,_Z$N:/UV#W(:++_,?XP_C=)J_[42IMI%0:1,R2N^LA M9?V'@J^E/DJ0 _@2(T/[ZU_VGSU]R1 !!!.PQ8T=7H$*3[SJ<#_2"E@D<2$? MO:0?'#T0&3T56)T,=Y%P..FO7A[6BI2REW6.#1MDNCBY1VB! =;VC_>GQX_U MY1NX[@UG;?^ &:K<(MA5P\!^GL9B\?S6"[PJW5UMU@%V_,IW9$>#(M]1#QKB M*-)UO$L0,=S+ K58OTQ8*@N9L3J5$"'6.;*H+,X[X:[O7)#IC_HJ'I+U]Q!4 M85,7"&L0N\)\U%M1B7:(!Z9"@)@T+<-Z\F51?O:9.'NXJDK,FGYY8\A%]&:+ MIQ-^:Y!T_@&6#L&TI5F&VOP6I99&*/VN4$NOC>*=YIV2?8&&7'!QP Z:+-0< M20P*%>KY?>3?DH'LWAJ2?(GFEDNZ_;M^L?8@$2'?CM^,__OL$3ME$]>]=)6O M0!F-:[@(_G*C]X[>UT]I1Z]&E)AY4QO4MRI3BRH%'F#;UU!?&S4%SI::QFHN M+ME2RKV>"\9$S_WM\&I0?9PV]U8>ENI&8PR2CF<%>SXJ'3Z,<\];\4YZU:(U MXM Z$.\/DX91"^^#7[,@EO 4@UE3F1OW]*#N<'E8IJ5W+T#DL;-LVR0*[3]A M;XMA[Y0+H\CK_$#YW_%_G1R]W^2%/T88AQ?[1DW@NF"DQ<47UZ%V]22_38#1 M9:? Y2\N<:_0\%L)284RG>YZZ3]F\*F.-)>073&45'F!-8 ME'FJHA<'S_:?C**/NV>[8^ 7R#2YU*4T@;/,96SX;8)5"% ? MA4?Y#_0C4%I]&C6].JT;PLWR>Y)RI@9\>YG.HXFNKW4/TS3Q2K-758I5L3UR MQYLFG$AKFN3*OP8;@'TEILT2(YM3N-:M%S?/X4+!YZO,=.[-/7W+'10^IW$1 MX9ECLX.CW5]W_Z29]M\)DZML9OQ6X_QLRO(2&A]?[<)UJIKR DTO;'-7@I0[ MW(\^@!F H5UI(!B]AT? 1H:/L.+NJ,C"Y]ZFG^-"Q:/H)YVG(+S_HX%].GCZ MLM2_PZ_3)D''OPYV;P?V[<-NM'?XXF!OE<>\PC*;[_X>_:0JCIN8,,M% 7?H MKMRLG6$@?8$&$BNHV1#,]TIS8MS2ZRNM:T%'4A-J!(.<0(H>;V(MZ%X$(&]7CF;2BKH0 MG+=40RB:3EXR3.$@(H"LRBX0_ MOI3DIYZ\WWM+):_AIH'"-EA;'Z!F='YD]4\Y-FF(PY>[=,58H8(^E>)[#+-IL+;-((F:*BC(!32\@E;B"_ !*:]1I'HS>Z(&\)K"6#56?!\U>Z&Q%U.VOSA"C)XS[0[8#?3IJ2W8^,V'9I[K)< MV-$=TE[_C-Q6L=,%D&*$LO^K[$%OHBL7-IMB%#_M=:#_H9^AVDZ#M:6?KY,'#A7\!4BADIBNO+ZOF05[*Q<>U6TT][NCO_(4C,6\B--9 MJG.*Z47C!@1&G"K\&\N?XA1L\B>'+_.(W'T@51:8L@/2W?LJP?3'Z$.1H?W^ MPTLX>+7>N]'/BL<8WL<2?F!\&3,@!)\PS .UR)I 2V#/T-7UKX;6362*6['_ MDM>O8(^J!F\1.44JBUR9*.J&^06>0U@V3 F&?[KW,D?+2.B=$HEX^YW[T#^8 MS%ZZ!(^HT0$XSA&U):*\7Z9VRSHG9AHW^0* MJPM!E8_PSS*@F$PH!K8-^"1OY:)_QS#8GJCH2O]^XRPM#T053;D]D>.A(OOV M3##9F?V*L(1O[8N[XQU<*S_B'6\,B,+]'_:=8]'-&KYX_L/+[1MNPIKX%T$9 M>474E! /S% UKA'=JES" 80!!##25/3]O$E2N!ZYT&M)=Y)O&MPH M%OV@N>5TG828\;3SH?MN: =>@AUP@',0]>2%?SYF]\"J MLWM=V"/#WQ=@I6#^&),/811(K_":58\EA.*.S#A^@K?((\A .YJ ?][2N+Q? M81)9$'#T1,1$Y7@4<4,:N-)QP\HS[P\S4EA?I+!["*I6W.%N"HH:3(!Z% XL M$KF5HO058,3X3^SHASQ[Y(1IHCT7CUW#B+:\0%40GS0I/]HXB)#M>\_1!^0O MTL0?C8,(Y^9ME)R/)]$B%+]I>3^OP&W-)>-0*KYUQM<=+RMF4PU9,X&3-&'1&1=S,OXRYSBR/[M**^3X@<:#$$U ]25+@B.TBRJ?MP+3)9HGSKEP MXF8ADZ,+5K-N@7Q:;I9[0;+L#;A,%NB6-2FW;!R:UHT#.B^2[NQ IOG>)7A% MB?SYWRA(VKJ.FI>-GO3->]%2+S+T(CG6LO]L^5JBK43G!8HJ^-9W,<'-_-WQ M0_\1YW)*"MQ4,LMYFL")K6Y)RT2?$@QPHWP/S;S&Z:(J0><2T,F(?4JAXGN+ MD5&UG"*QP?I(V/>*>,W-[!63C=ATI$%4=,R^D^F6;S6^IE3QPPMQ-:4#4X O MB&+JT@P)GP ACX4?1[H*[&]<#*DC,2F M!+X[/O_E^!1;))W=@]4_]DBZ^_G_%OW/\7C3>V3]D:SX^Y \<*L62>O34'2] ME+/?5,G.'L)3(5 ^R7#'L LUN.0$*L),X':@)ER!D&<&KLY#V*Y"-'P.:_7& MX )TW8A:&T07^(9.K TV2GVRP9/B.M1D]M;082'9M3 T>PQ3$.+4) M31B$8*Y2F]DFD&Z/0&0;GB)VQXMP$C:=+QL*OE*_,E-OF:28WM!DMF47T.\U M88DW\VY\F#KH3BQM8;27H$]XH#CP_VB5X0YG( %RY/\99:529+J* MYKJ8@\J,4+',[=Q1@V*4--+'@CB25Y[)N)>XI84##:?J4?[4@)OZCZ0&0)%Q M RYU-O?&@$]FR-ZHR@&M-U4"*50-AD5!S! MFG701*#CVJB M8X5HT2EE]7MXUK9X0 O,# *&QI<8>J_B2Q U:*>[), ><&NUH+?"U<63SRU$ MO7^>-$M'2WT7D^Z_RJJ"[_!47Z,\I80"3HD"&JL-OAG77:35 [VK P@8JOH4 M$<8_HYER1@WL:B*>KBJ*X8 I%V@D@+GZ4X0-,1"Q%(EKA( Y_/?1?DI.JN+^)-K8^G2 M%6%O$2^V6LPF16;<2<>_F3)W L2[">I+&@)AV0UJCF717%SRC3&%] .R49-X MIF9$)K'&@Z!EU%E.WT(8J^*:7JN&DW1Z:S;MO!%/3";"(Q,78'HT&\;^:UMJ M]8WTS34FM->8]>XQ4W3TIW#5IRHF<8@9\;%-OFN3Y*2I8,3* Y13(!'B>NC$ MNAQ>N NI6L9*"2: /KZ&.[ 6>>\DQHSXP^@A^"/J#+N_M_,/(N?_;##>C=EU M_(O*_\E_CB0E#V]5NT/L[MGNK1K#8K9CT!P6-$P,8,&67%]?[U8ZWKTHKJBG MUC4U#:N&EG*M)V!7T).7=3TG2Y#"E?1_:;FK.>J^"SR3/Q*]9<=6YFTT\6XX M<,R)E(57 0Z'K6;?$O(*O6-D:K"LOP\ M\A3^^TJ02[V9[T]_&V\TA/:C(_L+C_[#^X?LP][D=6^X\/E04)VM@VTR34Z, M(*J<*M.11-M^%=Q,I3G"ME!UE(&B$AA6$DR";-7RPY !HJ2/Z$\(]06Z'\Q* MB;KM4$]8EYJ@>(BU]4=7H:I%K3A 6T=/*PO 6R!G!2_!8E+SCBVR%4"43=+< M*'GDG2,G0!=O=MMB;WUX\R[ZP2!O,8:.\32P.EN*6HG\$*&%J1KB7U;K9,0" MJ9@XV(/W(AJP*_^@HEC&$2:<2WE2!+L_..NG6,?J(1Q7@=Y)HQDM4O9UX$SN M*W/^[N^>D@Z2JV-5T;3)"4IF&=.8Z6&,.[\\5EJY2OR). M-I[#VW13;K,?'I&BFMK1$E\$'MBHKN:5J+U>I$="''#!?]9^UZH<%'*LC\+\N?Q""X)0MTX+>@&3M&_C#AXL ZM4#-.7!<@ M#^V;0+Z#>BXLY+Q2YC1-U6I,YW1O[]IR1>CT_.//XS>;O/1'F*:4RTO0>K+ MHE4D%93^RB,I--3-B,OR-,99FDC[&9(JUFE=X((THOX^.MUP MY,2OXUCZZ@3PF!*T&;?@[.3=SV-0+8\W^0X\>MAN3A+U%[T&*B4F4UZ#*"0< M'S8_VZ',L!FN-L'U_^1>X.CJ^4 Q&!-KUY_U;,X9+!3]J6PCNL.M_>VMZ;:- MG<*S:HZI$JUHY.L&D48()CG:.KI4<\QI.WC^8A0=[.T]BXZ3W6V+2G+V>FS* M0K"5DP>GX1!,\B*,\[N$MZP ?9AZBGF D(3?!4R9ZL(:3\%]6^0:,3RBL<7% M1Y11LXSAF%5>U"84Y5+F<.M#6&F[4T]_L'OT>MR+P$0Q?TDAXB;L-K\+"ZI4* A;0'F*H M)/;?3X"("J$6E;O-?[ZW[>_^ '29+QY<')02EB\H$>B=]813H"Q-^(-9P>M M"SIVP83@[1MM$=T=4G[U7LSV/0M@Y#'5H2IB@EAWT/)H9JNDN&ZAS7O<+4!I MYX,OI=5V;+J>!Y>R[DL ^G((>C>5KP5!W[NX6Z/.^TCS:]971N^N-MXUH@H% M![7? N(7;MVBGC:X6"?=%%W7-YU>[Y%A2IO-T L+(0;FXL?@;AYR2=]-EJ:5 M#BC%)CD@C@OJZB+8.MIVGW[0EX.&I=L06OW,A"=^Y_FX'M]MD%5Z]8%Y% MAY'85*C4SZ6YQ7;>M,0)F!,S;GAC^$]7:&R09%AJ)+W_>/Y+-'Y]>G+TD'K, M/"CW^U"+[36PE5QLV^&J5@UH<"(SO4[AO;W$UVGS^Q=Z2V1.]ONC/3.*TME, M)Z@1(5:F7ZW'N?)US;L3J/%#QHR13Q;[L&AWWT6.B*BX&*+(8& &F*N%@8>%XNM-#83TP%VNP*K3Q(*'=RQ,<)D+LB6*:UB$DYYHQ7V1__-QOEO M+EHVLJ538^Q750/:1-M@[BFII?H+O"@).T&B:L9E?G!%\*>LH1D>]\("Q9X5 M#5BYXVF)X"&!?4'6\O-H"]TX[XK=Z(=]? 8_V][H:[*I23KGRZJ0!JP&Z3Y, MG@R;:1++TDI]T4AZ/M%=V6#]"WN8?*K [WJ ;JU?SO)[P[J1[7K MM.40!F23MLN\+P[]\9,6&X4A%T"5JWRW,5L[_8^^$*S?>V.ZH]8^S$GJE5A M$?M@ T:79=C;"^?FSAWWX6K<#H&@TV/*9QBX40Y6&,$'8'/^7WM7UMS&F5W_ M2C],JH J4)%,2XGS,%6T2-N,1QH52962O#6 !MD2T(WT0HKZ];GG+M_2"TAF M/.8BOLQ8!-#+M]SO+N>>TX!$M:U5XX/&'W(ZK!+IY2F8U6,I%DJB0^8\ZG>[ M,\4(RJ%+J@&)EMJN^464^39.#&]LJS!8G?98 M@%:W72 0%(K0S]N4-U#FS8F^0G!3?7/6"/-I!CXDI3]&]J$:Y;ZTWRR0"%XQ MI"GFC@C3=?V /(?-QFDJ6[HMMB#T6C#'[4#6FUF !BR&V0K<5"RF(9) M-EZ4V1F2'I+?6S(,9%ZD\_(R,YG"=H #(WB:62QE-3)%,Y<840LC-&/=Y\)S MYTS65WCX4A=G8R\H#ZVEU;36\KA8S2!YFM>!A:3?%29G=UF"$NW)^B2ZJV9^ M"!CQX@82/%F\%^FDMD04-[$6&"4:V55F;:P\ ># L1)S(LTK,W[9YO+X(0R MIN@4#31'A>',Q5YZ]1E/9_85%//TCPSL6?F*T5T#@)G 7,'5P#Y;I7DE>EX@ M.M%^.G@OY^ATD336 P.EY"^R>P:E!"F[U "@#VN,EA3%@VD[WU"4M\C067FO M@V:@5.7O_F%P>?I%N%*5UGR[S@M#BO&8HW-3+!>GP-&)+6(%%-;JQWH91Q:^ MW[^9[3/TP'A'SU],I8)7\-^_).M2"EPS^@:GVZ/#.;@ I"G466Q%;4K,AC[( MCW=\D$!'!5X9';'T1,X;'<8?T5^[,8G<'6#1U[T'<)8GN'OP3*O8#>%Q#UR" M&70M;T?/B)9*)S=HMGF$5GV0VX_[0Y>-VF$HP;&%6]X MS\,]/D6QND!#:!D/+?1); '>4O4 "H8@10@D?7K]DAH@%>1*I4Z$-N!V M64D_ ,+=VL440=5WQG&6L\)JG)_76&>-(4:=:JMD$Z4;9)YN&N9'?;+B!""Z"0ZD M;R?8.HQ,*&@7*%TQ'B F$>)ZFN\EX)A.Z,H9 2'[S+4<"4])EP=)].RSRYP3 MX'MV&WN(O!#Q8Z8DV@A=-KV?&I4?V*@@BS0,"-%5- #64'9_AB&0N7((E*>P MSAX?@FD(HJ3$%PK=I(F3)#$?.6*PU">JS!S)''%1YEI!%9MM1LV^8-TR<@O],B];RT-U6 M$]P77MZR95SC!)'V5>'5W_O!4.!SN-<4I!%,E42;%P:%ZMJML=L;#YOQ7,T@ M]?MZ_^7(.W-^=QZ2^>;P83+IGG1ITG#]5]R*R9&9/SB>@MT:7I7] Y'9BS%N MH2L(]@\R:X5&R\YZB(TP+CEQ5KF9-NA--HZ^H)S1PGX]J39T[BZ0 16 M*:%7GZM06DCQ_8CNCP^HHBSV^B\87"- OM3!LK-]$B1.IKTEBG]$M]2MT3O^ M#<;BZ =[[(46Z%[]]WX(4=#MX??';1V] CO#\,0,[ X\S$[,%0Z6!9! MX8+U#A!@Y_=#?LP3]@&^6]#[%GJW%-AMU^E"(:,^@L6OZD6YM7"V$/:L*_:Q MMRTMC(7#RYMZ#YY R4"])7FJ"V'1,Y[T\;[^8\23W@G_]X>U[3VX M.1O1Y=/")T.SQJ0PS+0:)L1_X#A0P%P"/UZZ]W)!"QE+Y^,F MV[!#$(&D=LS'3 DV LQB]RP80 O+@W[+ZJA\%!!#1YA@YF%!?L*_AVN =YBR M9;;. 6-1YI4>\B%LT B&I_?R$!PZ3ZOE6G.@AK>ZS8,RBTV/I,$],SM>O1L^ M"2C#W8^>X[/_$17>Q_SVSW6G1^6I>BXJ5/J5R)E[LGR!>8-,; [XK: @Q5R8 M=PI0BR\V=%BIA&=(?\&V!W)V^Z^3#!P;__O"]6>2P:J37[(EIY?0BXF$L..F M/LTJB);5+J=#'YT>>*5U(!<4%BP>KF!GFBJ?M[ J182UY7#3$[?#FI-!^D8; MD<^14L)4#JHBQ&P@J!=7^87S:7\:<':5OD_P&6O:N^U#=#1\SFJ&3!1Y89H' M:[=8?;7DWK T9+$BRY^QQS8OE]>#*SUYS7D#7JR&!)$?GTC77AG2M'4!KKHG MW"9XEU9?:-NMFZF.T^:E4A+ZH6N8ZR"H+W[F)R5V)(P15 QN4V*Z37P3RW!5 YRS"Q MAHR4U*X#_;2 &8[+6M9LH+VXHKE!3QQ"<@+-+-6$Q=-EM6I=>Z3/==EV!+GT MS3U+(?-FQ-K:18:72M?(B:5?I8IM6?@J6ZT%XZF'!^WM9)-M:..D1@>I4""D M^C/KRPNE$FKMT?4B+@^K3O,IJYIZ<4%7:S*47[YE-&1%?J^1[536&B:TBW2 MK94,)GT:K8XG:K]V.?YG!\>?#KZGG-.SSW__^29'I;JS6]*H4!D&@3+$6,\= MIY$[ ->[WHD5KJ,,=9R/9O9'Z* M!1-NFCYJT)_!794RE]:D@/H]S\31<+WV[Q44_GO[EM17?&)2G M,*#?.O7N4!Y(KT$+[^S3X5]>ZX^AP"8\(B 7RJ'V$/YJA("&O!&\^\UZ1]J MC'(OYWF7&6=YM6IG\7>DZB9I.=,TLBJDB79C4&Z6(0T\L1X;R7AU,2"@Z=&E M<$&)!DFF\,F2.9[]=G#\G)%[G._]6&WK ,&S(R5V&G6JM"9 16U[MK-T H#L M+.&N^0S?5Y!-PDU'V;*>Q@!GZHD5/[4HJA=B1?IZ_MO7@H% MKNO+Y6X5:;7E+F".BP9?<<"HH^FQ"Q02L/CP4UB'#)3ZULYEZXU#-*D^:Q"< M&8Q@\2S"(4#=*F_60]T'ZCR)8LXHV+F["99E5BLH/ 3N9M(9%18:9X'\F>:N M@Z2&)Y%37)1AOH+U871P.[G,]*-59<_(9O+N&.M@J^*Z?P=6/>[;Z%#/_@1N MP-MR #Z!O71G'^SCR>]'CUK/_=D#NSD_$OA?+_[9(/C=N/&SMOK2A^C"IF_1 M6-KH0C,GHZ:Y[Z-/EO+NP!'M""J9AU,"Q*9,3J=I8,Z7-P5>P-#SZ:K*_1E[L6?U75> M>XSTD+[3^);#L_0>H,_5&@*G;^O4[-CG?' 7J]R<<3VXQ>-XHBV =SW)/[X_ M/CLZ3 Y.#GY.CMX=GQR<'9T^YF%X/M?O=*[?!_@S!T-L5"\7!3;OD$J?(% ^E*Z_<8OJ%?Z6'#^ MXJ!*Y_3EO +WAZ4%QC@KM,^U@1RQ(VP1')3TD\M;<19&S)_B8$X>M<#@^P)/E83BZ H57$%WA>U$96+N$05'!L<+TU7K8+L\8@$0/%RI)L MYCGK7:@_%+0DR-O;8'0E&2DLVY1+^;>'QER(B'+5!W][" _]XQ(+RZMN:"K^ MIE"5GN@9W]6[[4-,UH2JFT/MGQ;+'[;S-$\.,Y0KC8[]2'D[Z<^7V;K<.M@] MBT0*QMD@8Z%5*3LBG\HXE-N/A!ZN;K)M+7SPE:G+A#DV )Z4N124=G(1K'>Z MD+M]<3VTPGF?N[7\'?L\P \=_8\\LZ>YWZ>;C^/1P7L:J?I M]8YRT65&T;)QD%^K MR/%0?XMTNR,-#Y)/SLS7339 Q\_ !1, TY'PNF,5?O ;_=>[]#-=P+=#G8!P MLH4(]CX=46]IOLN-Q\[_]N[DK>-#F$1(?VY ]K+1,]DN6;=V?\BSFN^8\^XZW3:&H5CD.Z4P:@_4\OIT[7M(E9B#Z^^/V%@TQSSBM@ MX4H=>?. '2D-Y6S2K9QR; 9/LW\F&0&9][7>=3ZC5V7JU M!V!Y76^TT$?+5-B8^>;Y9MY6=:<5-(2Q.YMA?-$1/1.&YX;'LTR[RUK"ML.> M#,EXW2"B8DTCND2P9'$F>8&6WWNR6'!&=W6QA=*"Z;CF@2D9.QR"SVW MQ'?>2(7]PW.*(:_DQ'.Z:F;+\MJE;V8:"3)I&3DD3>,MXE59<=)ID6XY(OB6 M+6_A-^+P+9K_V'^S;6YUN&RQ-XKSO76VBGYU_]&-VCIFMU5C=Z^5&IET3")/ M3[E0>(TS.V!!,G"I0^+8PIDH&'3I'!F@=F(:6^NZ'GAS.CASB'6K2$ #>^E$ MY@8>)WDKQR(M:"MY.4YYNR^R=*)-&]NWF3G+=%A7B[SN]D(Z?X>9RE>IH*F6 MRA7,?O3G=GFN=+Q*)21IBNB-W0.A!B4L]]!(89%/DV%A)SZKI[M7_M@BOL/2 M?_TCK8)P!^V]^O=_YF;8N=8FZ31)D@,^_?.BQ8A8AZX14@^0A!D8K'79TBA= ME'M,?_ K.PCU5UYD0[ST1-FGW.U-I5& 6AL H>2O?AG$(_*<]F==-MS#"2\3]@F3_:[3*?]KU>U 2RXCP] MEZGPA8B4PQ*=8G#[15//E1)=[&OXNY]I#4-61>VLLY'TFZQ)J[PC\_0\'7^= M+&"]!J"M@/+F''"I-,<6_=CG;;Z6P/MA-5P6=&>VP/#4JGL5<1#CMB*?$A&R M#Z2$\VL5EA)/&RZ;.:D936!PVZO(H21U3H](T>NB@A>!Q4N6OJBS($+K@!+- MPW&7,X0Q-D<--2"63A(-HR6X05E2AX57:FUGV;;-F Z!!52A17NT7N[.B30G M<"9C590)"TI4(3@T%6J,72=-Z,M1F.+:GM6HF<_8%LSGLR1+Q5-?>N 0?LI_ M'O CQX=W9ZC9Q=O&H6=LZ6T 'A8FHZ?(IU#K'QG-D?X-H]R*BFZ^D\ MA BGDXKK!#RKO*HYL\6A1A3T=(,=)*<1K*P:M2>'*N'!6JQ!F*SK_-2:\K]# M-Q]-,;HH/C#88N;@F[5XA(B96(9-,Q2:2ZJ1"5V*-MZK'_%?!I_SD(DP/8J/ M7_VT_R.G6-,-YQ^FD8,=^3?2'U-MM> JW,0SG]:#-UW8OYP=8; ALO !.L36 M$Y.TSI&(5(IVP?UQ)%MROI&A*K4'B]!%+O(M]P@SB+'+R>-Y:ML:(GKFB-%: M)6>/@8S&_Q9 5.28"[E^+&>Y!1=%7]Y'H#3N&25L$:[F8(2F[/\SN! Y4CGW M=&;E!@RSY->R*9ZP6LV*8W$:GI.6K.JK_>7>?G 6WS"=4FG2Z1R?G[C/NO.. M=#J3409PB:.UO&HX4D-B,9GLO_R7:3>O02\XYX>^+/DWV_*JE\KWVFI(@ '' M;'4#_R!_FK?\#-1YV)80$=RA9 N4F@MI EI0<$:\C$)S14]ZO;<"IGM2T%NYJE64@O!_7F8U M><"I%G731(SWGW-^#[L6]]I3@4&7D#O05,:(.=AB3[L7T$L.$6CTPB;Z2+Z+ MSLA90A&E$+#9(9>KVQ+1>U@K3FUBC[:?63 MEZJ"UIBPR7]]: %S0E1W1M5]Z1WOB7?PDB5)7;HWFB4+B)5TI$D5Z>[*FO:B M4-K]K%RK@$24J^=LAV0[SBZ$O[O=;%R02Z.55>>"XL!GY3I?1A&P[0/7CJRR MAG0,@RK.FQV/0QR_IN0S1537R\1P:52.Z/'3/SR:!Q*SF&E9$):+%B$K\1B2 MB:[?.=.#I+DLUN"2 F(1Z+5OYF;[,/IH=5M=2ENIC,8T. /J_&OHGKQA]^06 M;LG-XZ">7O?FHP.4>@FBD6GQ"I#YSMG+3*.6N^H50L:)8E?]&UPZ0+)8.B

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end

<(5Q!GU\"W8>&67@&YL*Y!>U[S M$1VP)H_8SK/ICEG_LY5*&"^@]QYFZ@06B1F');SH.,F=!.-D6! ,;$DX(YAD M6:@MH>P>F;IO'3R1J3 3V*?P^\YABL% R(*+XH7,4[,J+5J]ROCZCR#NKVT6 M?_0V"^$&.O,0E.<+SUD%4)_D!; 584B9]L&;.["1ES!3 MIM80V9J/L+C$?=4ORTV"32/)!E;T=)A#?"/>]F<7S/#O84 F=\QR\9,OR"*PAC&>PJL_=E)4B#_ M6C@$?J_=G9=0/XS_SRK?WS7U:C["DPBN%QY'<>3!S'U,S(0IQR%(O7);>];B MVPWF[3,W+),OY]EL,7GIP5#9)&4@NN>9<#C!B0G$X)198E4E0!Q.@''7T+E9 MU]NDI*4H=@W;,-7Y]2M6U-CNP03P]#2B_(, WVC01\2%WJ-61IA]ZZ M"+('4KP'C+/:=U&OIU9BN_9A>D5&9GZ$[XR=BXE,3/+PQ 9!GS=ZSXWW_.$U M+L@4\G>&<8X.>UVA\[($"]JX(8PMPS3N==(X:B$P$$WDX8E0HL!L8*W6K+HR M'^$*QXL9YO#@\^YPTW^VZH7WY H LNQW\,.X2.,#1Y" M>TX%\N9/OLIX#='[Z+-J3&!FE A=#X,#^\7L']J6?Z^-&M^VH(S)<1G.R@;O M_LFE."=0L\]:Q@6WO?P5F=5QURB36NDYPS0.59 7,:?) M)\"L0+>,40<"PW&7I%KD1$9><9(M?8,]^UA%?J*/W%J+],@\D,,29L]_56@. MJ%1'&^*I]&=*F7H%?W="L@5A+^]".KR4: %XD6TL!^ 9,IXT',ZZCL>O >C>'N829',B'? M*VOWWVZ,SS'5S"E_II4#=#A6>ES_4*\RE99V/S9JX0'JB-IX%]/=DG>'[(Y% M0-00U2&:!E>DMTR+TIXB%#";U^5D>HH4UR4I #8)>Q^F5E-CR&+E$IVT44#: MR/M$FG//VV-%R3.OI0Q6;-B$-/A4XI61#?I1>I2C5K&6A)_ QS\?;F&WJ2Z^ MN/W(&0^!3W3:)/L5[S;.CZ,#UE6Y2H%U#^FC#G.&IN[N@MFN#A\R/=[,,,K( M?>XQ7 T^0AQG,)93L:/IU.NMF"\UZJ&\YVA4D+ E[T:IWV//>XN;)SZO:?J8 M=D]"6^6\8Y5$_K[4.*E!D*75TF(4@7>H+[4&#\6,(.6H<2!)B\D M9Y0 [IU?:-[Q&#/Y]"7O+@PFU!C,UV&;7R[W"V&^N0?3MYE9QUMTGX\H?SK$ M#H =V_E#;>@/S+ZYWBX-J\Q_W#8?1-514-/RX=!<%K&+!G!!"A^!OX+ZY1*! M(\&0YL=:'O4$7^MT-R M94X]7L!'.&,3DOZ4(*$ R[0F+0/Q#6QM\**W_]/JA+61D;N-PC_5N];S$2*$ M",RPKC!OQM42MNG3^?F);$TP:,K)Y.WYC9:[13!E"66I'$/8@A/E@,DFTI?6 M:,S HSJ@8Y0\=Y@P <'>80(@# ,SC*TCBS._Z<^,NQ8-^Y7WWZ.^MAV&&F&& MAFI1G.EUOUS"_F,"\9N[4,R;H!L4OA^@'_3[Y94/?[F\+PK\QRT'@"JW/L*< MQ X^XN)!ZO@$!II?%R+O)/QR&;J>C_CE)IMO:'/ %!3"F,R*A'BBWUPB?H[^ M=0O_:>H/SLX7>)2W%7YT8%A?0NTKM0CS"#P:K139Z,13^V:$O@1"8HF^@B@I MKN"J*TL512=72XM#L]XSF$7 0.]1,@46%?/XV8YH\I0)PQAF.J,:=(4-U(3= M[*:?M8X?P&-CJ&HBTO#YPK'DRXF=P?784NPO!(/&S%(!EA;E?DQX+NTXT'V< MU$/_9:C_D5=M]XVV//Q%37,!=T\^XDL_DCVE2\L==J=N"AC8\&2 ME-,IB;5/=&D5:8[2Y^U/';_4N6!G,' _#6RL\-1F#G;(W@\K,^(@]\X>M M<;;.FO_L*AK'[@>A8E#=3Z6=829<)<=_:/C^K2I)_U6' M1C,V'[$$%@-,..QIP\1,7X89"3++_ZL(X4=M5AT2R^%8@=WL[3#/EEQO<)+9 M?? VI7JYJWSDWN89,7=US3MSL1/E=XHEGPT>)TR<-#W]-I1]'^GV/_]34"Q] M., 2+VQ0YR,6XQ3;2]U4WT^L;*=IQ&.TYG5+3/.29BRT$R7E-KQX8 !==\MF?IA/H*YWY?VJI)F M2KJ\!AY+1]S^,JL-71KM4X:A6091.T404TL$?!JU0V9T%K ORK"H7*-,=CYL ML:RY,!)5Y/$1KZP-;] MO;TJ:GT/]^5SO&<83P*M@9T+JOLS 4@Q@V6]G6/%*Z.R"0D;G\]:O_)-&:R[ M,]WXV7AL "/DV@-4"R*082D=O$1!(=IPF7NQ:K#6RA252? 0<[#,3 M4-P0 GAM/KAM\H7L5J.TR<@(&-P(+] M)Y'5?$3=8QBX]_"RR8'C#*TP$ XMB'/[BOF(]218,1*6":W$V=M85NQ-GA" M9AC+K,<6I?#D,? $JD3R$4H/?\3FMX.#8HD;#$&7,%,96M#>+S3U)O*O1M/L MAPQ>)??1>8OXB,%M=&XVAB%WELI;" SNP7)O#14ZN'ASC*'FXG*-5TQ3TG@] M2][*_DV[X;6N!*???IQ%F7-._V;IA?3YB/6R3!X_^21I!S(9O^[75K: 7U$W+\?C2<&;@7__OQ\,]!V3^KU^^7[LL 2,D.EI46M7F)ZST$ M3WW(;#%[B"4\<8+C&92Z?1ZGOC"($>1GXVN?3P'Y-4/$,LIIZN?G_7*U$A>_ M1@2W.U(^'#53O'E@($-&YV.&9F]+R_HRNEN_ 2Q9;[>4R^:$5^ZZEWY'(S>Y MQ6IL;7+#RRGCWZ>S;;P=?Z\OCES67[C]WPUJ^5RU>2PO-V@]WL95YVCC=K_W M22M)Z+$8-]++3VM0\#FO8D41J%2,_>V1VBK_%^K^>:C[1\GS5M)WE1-7E61Y MMS#>6A)!J?O@9S=/UFPMKP0DJ(FPJ_P8N\4MHINHTV]0>\9[DO@#W&:2Y,#B M2#!+,CS9P9FVP-+W]]PTWVT$_@VQR+T6H G4;+MWB:7/UF81*(;>BD:' MG;WP*G=T',[)B@UD?F[Z7*E)#_7^\/.I8](=\IV3/,2U: M/[3X8!J^#BM\,G(_R$>PU*N<4)39ET6*;[4]T)3YG\ M7_>$&6OMO;8_T?[:ODNG M!V-4BBU%HQ3-3#5CKAMO"/E#,F-_M\&W:OX(.CYBRF3&EZ,T0^2MU_V>(U8FOF\2G/Z#$KI_1)/Y@IH@\!%"BNUD M=PQ*OY(<2L\C54_&X;7S6QZV&9EFX(R?774:MD_PG<)W!!IJ>)]=%TLS/$Y7 MW[!\P]/]Q:U)\?ZRER"E+N^>K>7RIV-]-OO85=\NK%D56YKEP?!.C5HB7"]4 MZN5"$)&*Z?,0J 9Z[P!,6T(HG6F'O!R264T(G[,ON^_5(]<^T(SS[27('A)S M<::4W !">ABKWFXZ$_#,P-#1W,',M-_?&E3'A@Z"P?THFD,%:B'7C@&$89!% MKW+T:P"9\ZFI=LO$+(RR.!P%;>CB3.S#B&6'U[:8;)&S/7,+@^:J@M[]ON&H M/*WY+\8([62V7PON>X?MCXME^,J!8I87 HI?%C=/?UP^H9,ZXK9*QT'6I"%D M/_=-0;4"\L42$B1BUVLMV@U4/D=+,'W>95MEC (+9NIU%T?'YFYLF?/\,N.9 M3GW?)/P>**1.U#/'V!?!77WTJ')))C8*O6X4O=4CL8]^N5R^<^,#@&&GLJCO M1/BG0RU=1WGC*=K:U5%A%AK1/98<*3ZB\AA.B&,+MR;N7>-6^B3!QT6"E;DU2M8;MF=($Q(H%T;(B:QL-(8F7/*ZD.%I7&\=#ZX]H!.B=WIN^4N5K M&*8TX0J";1U%+%;-3>688?&OR05?JZS,&-;5BL*4ZV,]FYX]:\O)UL 9GC"4 M*7+.>M(MYG?F8(S>:/;;JRU;H_1>^9/SW2>.,DGL-Z Y6A.WX<+8^:*V21U? M28]M;\66/+SOQ4ZX>7JZ^W723;.SXN'B MK7#S;?4CS$A4V>X,JV(JPBOIO, MW.\;!:DG#;:K\1Z=UI%-L$M9OLW9I=O1C/@Y767=Q*4:#+2XDN2EAV(>] 77 M95:]V_HA"+ &"^Y[VR>/ H%*#P!?@%TG\&A(CW5\9G;1A?W"(SY_4($>2@AJ MH3-=U%&A=MZP<>;.'RWV%>SOIUY&+WV_MI!E5JLEX1$PED&*7QWWB=&X-<-1 M2_.8O[_W?2DI-Y_< \(8RWJ./]2P%*K=!8DNT*^YH /NQZTS,C':U_P"FY[TM)38L#O$).&'??^I,>H*>E)[R%RU(M(:CX4U^!G"79K$/SN^4 M<1UKN.CCSVJHA.19O&IQJ[*NNT42>R86F6WB%2VPHGQ..WXR%&."4X.51^%Y M$2N3XHO$-_$1!751D*PG><5&H4R*L7OU[2MW&OSQ3:E7=1JFB^/CB!>--E"E M-8[;;RX]:7IC,0W5C8)$#7/PC7BT;SBP@.R&C:*OY)XXD6'V-.C:'O#"T:5% M33DJ] %>[N> 0^T,&X7"@/IR^P,:!P\\\+V#Z1WS.0UK",#<,XQ7 \\%A&.9 MA!JR^!AZ10D!?:*,J[]1.7[QP"9QL,ZH8_A&5B\1,5)")^C*%4XLZ>G5RV*X M[.M+$'QKWUS;(2NU$IFP6-EV/,C\@+O8=B68*\%^>!1NX&!7,>PF3KD-K8)# MM11-"-@S:XO77NL'!(-**IQ&>Q3?/^2T?Y5<=#0\O.A2)>W-SI)MFMBE,%&6 M^.4>1.;^R<5 I8%#7V0LT+>>=?+*$R\F2-C?1&NP MV9CS68-1)*8WA9A_ MNHB%MI(U"3=G(:]E#$N-/'\2'NPO\CZ3 8V:W>H_*IZWL[&QDIWMJS8> MSRJ 1)-DKY4*,5UE&W+8:.DLJ&;Z/C,(MX.AS7>;U%*(3%0 /W\MD0=W)JX $X"%7 MR NT:3%:[7^DA!")L_-(J#'8U/.A.SVYX\FZQ$9'N3IM&7_SUPDE=% U9=RT MG]3E9PGFL+K["_5L<%;@#$N/CZC%:[46CN6=71(IF%M59VY1L1 HV%FM$WJD M7B75\+]PM_"N8]P/06.J *3^>PAFJQS)U6=C56&>_.NC.K&L?8UYEW8]!*K7<# M2GO,$\[X?EYDTJ'0^#I/<(=#HR=/G9W*BP>\^ A079B[3, %#.38X?2:\1(X MYW(6@B4;:K1U4=ER$NJR[_1L96O+I[GN\X&[CZZ,L#B&33!L>:!O%OY55WH! MTWK"D8ED)\"CG>M)7H06P)WFW9HA1+@N91().M057/<2UJ*@^;OJI^7NGVT>$B=AO_83 MO3.UOXXK[=9?1S#:]1C?27SF$UEA+>XI?WBSA_PIHE3AY+*>L:\)KRW??>H\ MJGDLS*#JYD=+\XY5$=7''6)@2P2#F;?U_)M]\,+X=KP8[SK7+AMG /KW8I8. M._$149JE%GW#UZCXN#P+B=*Y.WZE1YZ>UHBNP(B>,;W(^N]W3?]J?[6_VI_? M '[7_P%02P,$% @ \H%.5 88&I*V> ^[\ !( !E=RTR,#(Q,3(S M,5]G-BYJ<&?LNP=8$_&W+3J( E)$>E.B%%&J(D4!B8AT$;%0A2@H58B*"$A( M$*2+$5 0%*(442D1:5(DTD%$I @"0@HJ-3 !#2-I;SRWO/O..>_=<\Z]WWWM M/WP[7X:9S.S]6WOOM78*[RN/ FRWM[:S!O@V\0$7X#^ MPQLL[B$]KD,7 ;@ MC8\W"5@"F_C^;G\?-_W=-O/_?=RR>3/_9H$M @+_9();A6 3%! 0$A':*OQW M@Y^)B@B+_MWY>Y'_]-)-6_CYMP@+"@@*_[LWWGM 0FA3'G\Q/Y\*L$F"CU^" MC]WS ?][X-O%OWB(@"+LA I]0NQUVGY\?=GH+[#%\- 8^#FR6 MV"*Y^X"%@)3S14&5:]+ZMS.>":D>JVJ5.3T(JAWTN1ZW55A63EY!47V/QMY] MF@:&1L:'#IM8'K>RMK&ULS]S]IR+JYN[A^^ERW[^ 8%!83?";T9$1MV*OY.0 MF)2!A=LZCW+S"HN*2YZ4O7KYZ4UU36U?_MJ&QK;VCLZN[I_?#T/#( ME]&QK^,35-K,]Q\_9^?F%QBK:[]^,]>A/QM_X^(#^/G^R_:OQB4!Q[7I+P:" M?^/BVQ3Q]P2)S5MV'Q"0M' 6O'A-2D7_MI#TL8QG5:U;50^>!F5\K@\*RZH9 M4-49?T/[I\C^;8'%_8]Q30"B_'PP>/P2 !+@L M3]P+_L'_8/^S_ MFT;,X0&4UX0:/;H8:S>V5?D(IQSIQP/D FZ:D&,-\'3988P5=0T7_')W@?S' MD+J A69)XDN9AGW@Q>$H1GN-F$>\$ ?^QG%5"5P-.-B52!)$GA.;P+!/ +: MT$6HXI,'J=[Y1&B&.II#,]VIY RI7F7>7#?./N EXI]KF,]U"S12V"0IV/^: M,_QK9>E/!?L4P_B]$S^4-8.-W_9PQM&R3?'R0-JOODBFC?\KNV EK[:RAKI7 M)RZ=TK\J>&:T19F3P0/\$)-97:3724L5-(08=KQKO6W"#P^2SX^:;3(3\0U" M&R3+G<#F02A%M1<< M':!\*F%(=7@K/NRI880^';L^[N'A;3/T%G M"0\"5]0<1)V^1UU,._CD[;$69_BN?3P@[@I;D%/-CF%Y0#;,> :NXXBO/13- M\E^8;7599$B=N>=E%"P5ZI._;#:C\ZWE="<0G?VPR+;W;M>J[1(?2]'VE'LR ML,V.F&^(GQ3#!:Q\[:8E=1.^EM*4\:)6X3" U*FMXVT*+./@K_KB(7!1NC@5_,152N) M"X+RD5.X%+>K%I0X"^('/6A7]_N!.\J*L.-:& NHX2G&;%C'S,$ N;WF9?@+ MG;9/HW9A876B/.!JE#,%]WHO/YT(J>+I4HP(9C7\&C^,"J?(W S*-R3(0=7M M0]/!>4]N;O4-7=5C8 &>+;<'53 M756T+(83=3WV&8P]5*\]J,4ET M$98UVY7S#'E%;SR':=H(XA(Q3D70,"5\O0,A#3ET%NPC6 ^;G7FA?3.C/>3J M*-,5%Y@H$]T4[S=> ]?> MX_C9..K;B6$**J[Y3,R+B8 -M@X0QG]I<0IZU#,Z?UX\%UZ3:;:^SC=VD,6/AVS@^:[%R;JNU<@370:[H*C!C,& MNC:#3"((MH@&1.09M_$ 9:@P1,^J(/K/KQ\6T-?E/A=@X'-& '..](%LB*VEU#] MJ0(<.,YP3=9C'ZB VF9/)EDU0UFE1@\5Y.0V,%="U4^[#KB.;#J_54WG1WS2 M+D35 ]?OQ%22#R&!5"O(WB'.Z&:&0@TT\@YRI#B*DUMN*!;YGSU1O@<4[Q"7'2B9 MO]7/F2X?#0F_)NT1OK @$B+M7'ZU'Y&-#U=[I)OQ . A:2#+0@>T'J8%# P M[DM%TE%%4!]-()V*CB\P L]Q2> 8U:F=D#S1YT")L191$!OXNGQ'5F=G\9O] M]UL5RQU8;YDRO;B,9B^6"MOH'0^(]V*KLB+)D5F=PQ@O4"/V!B?B/=;07/?= M/?2VDWEM8ME7.U4L)-_4W)[LTS]\?7GI0_E3Q+MS#(UT4A!ZHKT-"7H1DN 2 M[5SI%%-&)V"UH(-E4"[FB"\U@-K@^597=-^LE^UJ[Y[/3;?QO6?>)EK&!G_B M 0&X"=4.9*T<6QK!/ FO1Q3F^,@/?"O6"'(-9VC0_'(V/Y=GNVN[7-'^U5LG MT3+H?R\XI>+3Z0L992^/6OSXP4!-9N]-;ZTJ"Z:PVF6 MT#E#$%VH/U"?_"M?6$%7QZ"TX=H..O.A$3A5WZ?V7/9TQPEJ[!$6LXSSDA0L M?@<%NJ^,NS(O?C;?&\!@:T&DRS/[#,EBGI#W@2BUO),)ZA^Q(4M$5?W<[ZD6 MW\LW"\55W9<=F/#X4ED44_QM?&ZC]&MHR>WLZ;4>R3_;;,2KWEY1OAII^">, M=8+[ 0G@_%:@0\%,F3%S/K;^$&9G",U1@W8LR$,NL3RSSU%_,O*F8_V^0"$W MW_S1F#>VKQ0M1"U25L<0+W_Q_:E@"6!'$>!9]"22^8I38K[E&W<8(6)VN!2S M&4KC 4*CA*MD@5!TR:AO1./J;([B1Q45V:D(E=EK88GGPT87R>!9U$0T4Y93 MW2S"TL"U.G$1D>KL?0P_]CQ)#'L88Q2WW'TBZ_2WY#J3;$*48?NX;;\:KMDS M1579I^"L_6>0!![C 7]LQ]C23MR^W_5K(\%WX9QM+:QGH)94P2*J8,(%8ZPY MPZ:[7P6Q:7XTB:/K>=L_1LK [<]KY6$O$<_=C6M5Y0K, MDV2QV[B?R=5H_$_(BHC188BZ%NQE;$L*R)R">(#=;O/ATF!CM$IO]&Q([]NW M@?DG,O0DN6R M1:B3(J9:OLPTTT,U:2.)T6E)#8_(Q2E7[8LOO/+LOB\^[*'%0'"%@UD([!?< M&PVVDB=#E9I#O\BR_P:U=R*VL;TN%(A^:3XP$W(N>Z?P^KDABJ.I,_E[S+LB MA[0[SF:A+Z6LJD/W'_'DBNQDJ4%2S M0/4L3.X;8A F9T1-GNS(BZ Y4_":H MC*;MO;<@QN;<4'A 9>>WZ^6=]#HN%?,V6V+ST0>V#_?'\O].;5&%US2,.T*N MQ7>BH7U(>AI+#SM(D+Z!DP@@"1(Q,H@XZF>VCG+NEN);^0F_O[/1V?X^6QH1 M1H' ZO5GQOO--1@Y3#2$8@$P+N%(7[H-TS/-\S..&OD58ME!KW.P^T@C2*J& M(](N;GDTN*ZIP"7[4H&O1MY)FO/UR,IH"FK)!M1CSL%>P&JLU1*K@!TZ!<6[ M@'>,R:(3ZVT>_JEZ!DU'3KJ"OWON.11=5COC]&-+3$:N6<50M;YIL:/\7UZ M0F %-9'&3(&O,\J>4!6UO!B [OW-X MF= =^X7)EJ[,;LVXDN.W)_V4+F[XSY2R)@P%3$^2QE(:-D,;0JQ=A1O4Q2KS"ANJ7AQ9*JW MOC[%%_\Q[YB']421&A<0!?A6Z^D_*N#;^5:8Z(.Z92T?J'05E'M*G MTRA$A.]0G96HC7@^_V)P'!.F$ M,8Z<[(OS/ZW4YZ=T5_M]\Q6+/<:6GX+A MZ26.@/V(J"VEA[-T(],HA*5GK%.!!-'?.OX.>=.KT; DT7UJZ#9N&[QO3R!R M\.+#,*5&*]6$L%CKLVM(\/C Q!C-GYX.BZMUD(1O,6";#6/T9L3%%CR2[F < M2@+J@M$^]1Y>[1ZR<6I_5(Y5/?=URMAA\E18^I2 W%(X*Q0[BI3#45ZA:A!+ M*,9Z.U=DZ!QL=^ 4*9T<.-+?5F1/M>].2%57VCH1ELVPHH'>V\#E7+WD"Y $,<"U>C$K8'_1"1YPI452I;+H M.[^J9X>,Q.UT;VO4-#;3]1,!/%41W860,5<*0KPFO$_[KFP.$9]^"\S)N]?/ M@)S:Q_@J5FJ;8DU"4DKN3>A;%,P5XC,/?T_F_V2N^Q=1,W$*&E);CR=1BK'R M$/K(SPJ&EN-0B!D_1:OL/3Z:MM.J^<4-YB.^!W;'RU'=:-ZG59+2J*/+"/ I,C2Q8D,M^/\G=<#(] MF5N8)ZFQQZVN.-%URWT,%8[Z*R1&%1_OH[@N:8!XZG0F$R?&W.D0:-5Q49]S=KFTW&3>2#E])ZW%]7P^A]>W?;I&_Q+_+A6BQ9C M["0/$,/NCA1A5D)>SR$GVGHK#O$-,J7)%,0N3X1,?3PJW5@W_?'<#K12Q/X_ MQB\G55YQ=C)8,SF)2/^!I(/0(NIUT\CRCWSMYB/4_GW\Y,6))PVR3-D7MN(& M=\75[EBY9EK;SD2@X-6,N\'M\1A8*@5+.VZ1._H>:Y%2D#)FUUY L[28Y;S. MBAQ7TM6N3^./!(Q&7Y>[#&:EMTGM%KZT"X@*'Z,WL#P"4: G>AOWO?6 M/G+E:MZ]!C_4S@?C):;ZHTW&/:*^VLK:/0Q5PYE ;GCQT__-#KU M]+G,L5CLET%4$J*N?JF7XA1+!BV1XWU*.E:G,E#_!E7X-RT"PO.&FN_T)">]8[ M?LDA12,3=V5=&*CC6,\FSP"_@]KBCR;\OLU->\@ M\UAI+$Q;"0-LN>AN0I5QAU.JHGD).'D2XI.[VVS\;-Y;]EX_O=+O"Z7VC,'R M:K]!FOP#R9VJZ(/FI^\?^)W3149$IE&3VO+#NI7%P"VSJ;5E6BH&2#$W6]6L M,RTW)28G_]R125!VM0I\%)(B8HIY%;Q6Q'3F%'"EL?UD,,RU8T40(PN6*PK$ MO^#VUMUZ8HX8'NNK&B[.\JI/GZF)Q61_KCY^:;5(.,[NT@6^,-0+:;X_EUF7 ML!-(T!,%J2>F%'(GR+73I> 9FEYK/6-G/KZ#*,@V_XPN7VG6"@G7[\@:GSIO MOOCZWH?')0H1-U ZECGX!?+D&)/*B&AU2B,+X'R=QI?)]@0:L1LOX>418)SW MH^R;^YRB57I#XTAMX-/TF<")O=8JLJ]*<9YMSI"Z=]4*B-D"3C+? M0T5@,%<8$0RWGQE.:?.YBS0[=C#EL)DK6-1]L]%^?BT(Z9^VJXC?ECS\PR.!ID9@SWK!03>0! M%_(UVE*[6(Y#F+"8E\TQ/E4F@2ZZ-E:[U2T*MEZ)(%;A0@AIV$.?S1'U[]'C M?W8W0=4,R:[9DZ!C3?&CFF)-U;>C*P<^N(]KEZDJF_6*&LVS>C]O%]\*DMBR MD]3S/ "T$D%"VGKI9OQ'$LJY2@\'XFE-?=^" V/V/-+V>5!Y AVML,FQN-PF M"O4@%3_C3T]A7<2UFIN)@:7,;$ZMV65J2$0K]Q##)1=NMJF-RBG4H@LMFQI& M'K8,1/A?]8MX6U/_1%LJ9=UNUS5M/S-Y?#\"1*''-5J151'L[=54Y-(PF*= MH@I!EQDV;5<7Z\^\$+L6H$SU;R0@]@96SKJCH(B^]_/>)!X@Z-DG30:M!G8& M9!SU>_<%FDA!8,5A/ M2OTF2/* MB@0=ZRY9K!PF&VAYB+5&QWT^GSM1WX5W_7D7961Y.8M_%/_B]XO M)? RG-D%:D#/;G.M&6X+F512.D;-K$PX2D&TKJ]1]%LN3W5AV(=1=_>=N%^ M\?7]\2:3ZV<)\GEC8PMCS8BP+A-G()@H3B[,-Z88:ZBT".IDBU%CD$>'#?LU MVC+G?M*&/DV81N8%>#,7]1^D.^@WOCS<]H(2A:?#XG0SC<#,AA;!;N9'2(H1 M8KZ3'0C97#.!@CO63?:-E!LZ&E'=0V]46'_Q2_A9G^%]5$'=)KE/5==N9D%S M+_\L,@E7A<+7.DW$($-@L>I*0R8U6S 0MN"):7E0/2>I^;!A91HU+?#[6NAS MM^<-F<%EN?F^KH]ZMV_O4CU^HHED"CLP_T\#NP\G$;L'$\"HOXL+K.#OVL!U MX5)N)=T+WZG93NV8.)[G5WJS_:/M\Y#3:&@0H_@U^JMMQS MM*")TG2(H;$]2PM_K-*6/?;R4Q[ 5SB,\7."5*O@9U:X=A_HRGRWM,Z=WLZ@'#,&83?+(1!-,-M ]TF3W*J= -;IQ ML2X9[13$W0()L,RSJV?7/86+;X>_-SUH/EV\K^'$]TVHN$P[*?G1BNJ@'7(S/%A(\X.8W59*G::J^$J%UVW]14 M)=K:M5]!OM@1\=5[,R@79RX7:7P"B@ GVQ3];C\-& T,+ YH-$SU]!@_&B\B M[6R]J?#V9V!+\"G!#IPL7$[WN<:4*/ MQ1,K:B"#+\.5HVM.M37#NRZGZ*@\,3616],X^*%?)3/./)B&9DN:,D>@WZ\P MFZ%GC%*N\,6=9'R+(%01;JKC:@\Y!PH0KH6&=.C3QBL5TK_?=KVQ:@O>Q63W MKJ$Y?(6QYM90#!SQ3VB1@H,T9=_!"Z;8R"G[)68_V8$4IV,4HBDO6^0_9.8; M3=,.S^30^U[-T"]_7LY:XKI+&NV6EZX"IPBLS &GD*D"U+&X1FH M3$MHN449&FMU-3X0.);-[+LR]GEJ2'Q)8O!YT/S GHGXC\04S^$I]1'V._OE/C/=W*IHM?FCM MV%77\T6Z^KY7"VF)NP#U7G.'UF7_,M MWE,4\B(P\V"3F[='SXL?E0.7K'?RT_%3^"Y6[&J1:!:5.Z3 MR\W#6((K-/J7QJ"([G-O'YU']>.DY(=^H#64;WPPTF5?Q+P; M-)YX<$JPE;L7OK$W=A*G1 HFQ*+J<'0^%B8R"N,,GMYYT_ -:--67%/=X&@_ MJF3GHM[8]/9R!E4J*LO6Z^ /H:=IP=6<@?+.\H'B;^W415:P)_-V0GX_OJO-KN^$H] U../* M!V$2&;/C-/* $,2]#6(7.L5;KC[2;(O,3_RVA]05(2W.'P.Z_IZL*_3IJ)\% M)[?'*4@DC=XX)=A.JB>R)1UHQ*Z!B6%+..H[V%8>4">S\IY\=^-FK,'.Z#,\ MX,ZM(YX.#-UL8L.NYMJ,+^X/9F8O[E(YU')JL(AX$4XW[1K2/5)5?0=BO)2Y M C'*V1X,O0W2)F1_C!@MO M?$@%(%^F,7Q?7^X42BBK'2&*#,9#^_IY0"8M4RHY,KI@]].Z:T3I14N!0N8-3#*211\*B:FX]9(1">N0)?+@ [78_@ M;W9@2$Y,(U*]=XPT*P@T%2V^.?98]9WL:D_9CH5FSI##P=>1[%Y^#@>N.BN6 M+ZY5!;L;.XH$3U:$,<6;.%4_T\XRIJN#RS&GH&9K[C'63) ML+2&;JLO(;96AA:-&J;O_[0+I;UH&T+/U=@]0U;-5I#<:VHS-G)*L!=1J\&6 M:H*K?CO+' )<= M':^*NYM^!E[+$JO_V[ 2H-VLFVPW#LQWE_ 3JFVC.+ YI.8L=)LJGHS=2G". M$TG7':P(T;T2JKVB4XR7:%I)/$KMJ_]$TB43 YZ*YS3#:&PN@02C6 1 MTK$]9- .,4FBI&?C6>;L*!B)BD7D=BX?Y$7#VT$X'B D5E)0\O)KFT7\B98O M(KVF[I5?;!+$5XH$5$ZK^!(_!^WE_SX@!)>\*?<0A.(*E]#TH'W'";5RB97: M;#O*(;.=$10)L.O&@?FKWTH^7JDG3W1SU$SN7]HOWQ/&>A9K,WK#^2A"/X"\ M"4=Y.>':@9;O#&?A('YGT(54JRLUC^GE@R M#^#'N+,.8\?F+U*)]9-NT #%(S)(B4#//[R<7ROF$YT_2;^8^EG&3N%F6O+3 ME&VL3*TES8!$F=Q*675)_01_D5X@D\\\7F/-O(8/Y9GD_G80O0O\^2PD\,6[ M\K2+X=$!8]O;#YR6^)X"MZ&C7]7YGUT0$FWH83/!'+9D$U=DZ]]YO;2S113& M;260:4*X&YXT4DNWX &70Q1_1I6H7G%."37O5R]H0%7 M#XD(0V9 QQZ"AYG?XE\)S \0AXAQ'*OM52>-F6L:WKD56AB.KU5Z'')L2&B< M]L;HXVLU9^L3%W<)6;A<.,5M)) DI[ZMY*GI7HS3TU')M+D^A$E#C!C N@51T\V6*N(*GV-D M,>O>MHH M_%2L]@7U6Z0E"]8^[AAYDYDE#:?$'2>!IXY8SGRJ+;<(":3^$6]?1(JZ!QAE MU. UK0+]#3+ZU#XQ9 MY0QY?$**10HOMHYBA;*HX1V%7OK1+W7=BYL5V[*N*HQ$Q6U_Y/0;,S9: ^>L M(C3&W?J0L6X'7R 3*F-"G$=P+]]-<4"E%,@.WT#!_7S$;.LVHAJM=;/+NI%4 MGTE)>>&!VS^M#((^+O7N#4F;)8G@*"D(17,I;"P@T@Q')HTOL@L&C;?R?V,$K]A,V@H+M%) MZ6[XC#E3W&2[XAM1^FX\0U5,.\'MY%+3@'JV1AH='B5HY#B8$4^0)CS;".#I M7A*EF"!'"O$4"W8=:9'SC#3U KN36G9:E8Z?;\LA!%^*[0LSR_XL:/M:X7EN MFCWFA\MQIU)< &$+VP]* U$H$+G$8N3U46?3:AU4T<610ZRV&7QPSK/ MWMZ^?'\/_3$AJ,'E\OU-Z1,P'3\AB9,H#U"@&^$.#Q"[ #F!PUR1*711X'[M MM\'H<<_CF0ONEV]F!J>$JK=$^;W-MHE2RQ\OB=J9_Z1*!V7#'22 3C&",\;Q M7(D%97$H*_H9VQJ2>CFQ@!!KV;50U__RA+I#>%UC'$?1=GIY>A4X33U>U3,; MG"*30RB<>RI>T"*.[Y+B+JT72I&8Y6)U(J%*-<( 4VSC5*9WLX)1J< MRZ]45HJ\7!"H7A#X&#,FODO[549A5^SRGV5Q2'V6+3-C ]7.(.Y.;X<3B3:O M:%TUXSF2XQP EW"^YLK2Z*" +--H)>*E@YK+_<28^RN:RG:70H8<5$ESCM)\ M:WIW<)3\6SEXTL4!!6XWKAZF-*E7F!LM4+KZ##36E7-KA^+!$Y=61R>7;IXR MN/\U)O="?<"H&3%?RK%>?W^Y CP\/"'(MAS4:\-MYH[#.70R8V9@"UMA3#N\ M7\INJ!FQ)S^<%N/1M2>U;]_%)/H4I@)[_V'_8>MFK'?H >Q]8 (/Z$"D*AL-F1U^.G]5H?8(VFO$IZ:F MYFYXU)Z'#R5B>J4'$DF29B*,-"HSC>%)Q:?0PXG;(M-.)#E__AV]1T>,7MZC MO._^??WRXNTQ8I%.;)DU*CFV91>N]8 Y$K\#TK,?W?80].R,F/ ,NH4)JWTX MBU+ M/;*>ELJ6!\?H?-3'9(G>EP//)[^VOA!P> Q)US!/]7-?!;^(J\JK3['JXUG!1(4L+V($ [7#IN)UTM7PEG7UZV^F(1R<^SFS._YVO;EUQX4JI?RIAQ("[N-Q+]1NG\6*L7&0(1CYBX6M<4$IH(:2&7 MY"AH)16$>"?+J+1[YYGCYSIK-I:?E0Z@0[1*CXU65C(0E$"W>[4+"&5SU2!D M-8&]HP@\8P^6]-8.(P/TXCRZDF8\]W[Z&KIL<+EY1'OEDG/[B>2*33W7CX>Z ME@ Q#QGQS,^DA?&;CH-U 5NEP7IZ/3MZDP MJL[:_O74ZI-;YTJF*CCEKJ/&!_HW#Y;?[Y=*M-M^-_'TH5WQ]ZVPH;C6M[5E7.O@4-$*>#Z2^ZU-<,7M 2/PT[FC9.6@CW*EI?E_%* M"O/$@2'B7>*RT")S$T.C%2F[F*-X']K-P'<@Q0V")WM/9+;D^GUV"BKO^)X\ MT[2=6'BL[+,PP!$M3.UE?"'<1;-5[7??;5>^VW+'M2-BOI^*7"JNXG3.X#;%Q'.4 #U T_V]W@*__ M/S]*?(6\6U-A[F4=XC.8+?WM0UVWQN^GV^)2.^+(7=5M696U?OPO+HA5+9O7 M\("J2#(W_B8*$L5UQ1KM+79$M9[E]7WBR)!EB.RJ6:]7 M\KGTZQ]/ H:PJ-AL"251]'; @^(>+L #VN1F'+5<38S;0D2N\725_:KEL1XVD[6Y3^:NG=PV(#OSV_&RHSK4CL/$(2U;>N^ MEB,8*4XB5\6\(8;I^[P5_2JP.G!U3U6@@4="7.,WS8>)42&%(GI'1?Q%[Q;U M(8.($[?ZF&]A42P30*@::QU_-F*.9-N#V4D@%YVPYU3>IXP**YV*EM=Z%;@Q M]]: ^]]ZU58+"Y^FIVPZ.S"'>Z\W3NNC+-?3R,DF72_]7T26=IL\D//@+#]^ M+J)E6Q2GISD].B&V[)O"E]$;$1$5JG']O4GA+6D/ZRR!$MWJ;3FA.5E=+PTG MWA>Z2]]PN7+I]E>IHXA<6$/N7==9GTB7U[KDNJ,);13US=0R@.>I-$K@B50I[HH[J4AE1B M]#E/S*7(\YF1W8ZY_L,K;-=7M1\E T>'=Q_X9B![!IU;Y+>:GVG;[MC8W*PTSC4^<>W-UNL:!Y!'ER^-?CO;_HFEU*P9&N5TYY=DALO[5E M!Q_,$&KAG8/D)] MQ%(1RW>N+H('\)GKSVU4%H4_G5B44Y;+9NP>U=;15;53S:3UXA\K9JBDL^RE MVJI=DCH&)C68OA"2-CG !_$ &C,_N'S^I@0YV"2DYOI4?XF'N?UY;YU&Y%?J MA7(7N[K=PAV2TA3^X6!$!VE5;I '+/[B 7-[(I.Q/O7[%.#9B'%WI%! MLR<4'Y*20\+W%E=E?RQ]I.L2[JN0YM__4V"R_@FMF=A.KAM8>LD([L9*@P2X MBM/SK#C+[ZZI%2@-Y(J:+*A=SOWUI\3J'N=8W(^*"8N:T/E^(-I+IAMSD?,4 M*XKA>SV\PM5C6P[_LBR;>NRE.!3AWSA2*N156%=_UZ!^V_:##]/=7KWT 3:/ MD 3,3=@[.(7-VPD27 &,_2#[3.&1D;J*%P%C9?I6UR0FM27Y/IY1OFSICIL*PP0HR!SG<1%..X%ET(Y\;(2=0N:F)H)/YZ=]HTK4)SWXY" MI0?',(E^@D*0C\"U>P'\U?]+/N 6@5M6- _HE?I"6HH>Q?TJ'FO\E^D>P#_U M;YGQM(R[D*O:WCQ@C-_CW']-\Z1'L> H/J-1B)SB>FB>OBL=SWQ)790S_ M7=SP?UI/?[[ I/'R+:<$YX>?0#-OP0$]PQA"!U]A3D'1H+73]E:&5JN)Y)^\ MA(3GI<$[&T9U?,QLP:XWHF?+[HZOK4URN*?5^7M,X.1O^8?)]UHD]::ZW'98_K#B);T3:2MN)DUS=6_>\B_=O3MJ\55S?\:C!.OW#+( EIR' M9,NIK%,&EG!4)'\?6$\CM"%3-YQ26XP"-OH[7(:ABS6F=\T4ST8W3^:\?2)O M64BO2^[1T/20R4,GF?-Q2%PXC5OK<=+F.]BB8^S+E4$;RDWE;FSE+YD*# A=>L+_PM;@7%K'F:#6;P"1AL:N*G#)HX7])N+66)O=FN+QTAOY-:*M>;9J69% MH7*+JG:QJQ@$EE%DG5," 0SS[R:-KU,[/SN)1K(HN@]G\'+S1N5F:>CMD^I4\#FPHQ\9 MM\MR'T.MWK&G=BBS?Y09=5D3B!-=T=QZIEZU!TE)1X$GW^$H-AW(5'+]>A9/3@I4+0LCS #^TC'?0QK8<6O34IM6? MZ[9OWX2_J]WW\X7=H%OEN.J%]Q<26]L%G.%Y>LF?9<$68HBS=T2SG"?FD K- M.KQO(;9C>_^ M]WA TDML*^Z7%ZQPQKX@_\B^6S(69ECKWPFF@H:E6[5>6C^8"&X,,@K^S*C: M8=/^U6.H"*5@+W4OW;Y8RJG?^$;,5BO,.@\0/\V)@]F\B0?\(+["K>H@P-]Z M7_6X:22NQT8I#U 9Y0$+_O*XSXTD[M:7/*#G$0^HP.CP (M?./ *\H_JG+W6 M+ FZE;,DQP.LX.% )^8,#\@(^!?>X7\?O(N<\T+!8\ (#((E)YB*WA OX@'Q M%V&<$,><43 V[2.D"Z0-71[P)WB!P$ZS81]Q8,)0%J[P@.R6OW>OP;U\ I]_ M;($'0'O^NH=81(G@/L<@V$KB7-L-R;*%QI,/*]WL2H)O77[WH[POI:+RF;OJ MM;ESMP491/Y_Z=2_YOB90^WO3PZ4SV5'H ,U+/F-."921U ?4:Q9'#L6M_ M.W&MBKC*):PM/& 05G1]J+/P8GD@1S[MYP'/PG%LJ;].BO\F)I#FS/% MH!:S]?QT!94CZ,!03RQ]'I!]<\PXYT?E\JZZXU&?AOM>*_CV+BYZ(_\ETGZ+ M!/ L\JO'FO.P?QTTTZ"S[/ 11U48Z1JL5_@Y26C[[R!VO#21;:K,JP+J>T-43)?K7F M)F/SZ>7._&3^L@-J!<69CD[_4[(F]<_*O^+8/W.=[FUH+U'$'8X];7<.SX9WO_ M)7;$<+ TU4!/"?)T9)0FK+1\>1ZT@3%N#!]XT/NS57.K:DPEO^ZYV^V =10P M1GATR7WZC-# SH27=@['9[=:&(^'J8"^L\&DB -$COCB">W^YT_#[!WC"Z)1+&ER%S;@@H>X#M=S0-* M]L0>&4K=^W33?\^J,;XPDITKG*N&)>XM!^#5]UGGOE4$&DIQ/>;B&S12S]DO MV_)YP"X(N9C* W:?.<5G)?WO-L$?>+;L,/=D]W%8Z @,\P 'O>"9"98(5R20 M!VCX%N*^QL-/2G)J&71<5.0UN#!TX:KT'EO *5Z;96?+DQFDSS!3L7R_Q_U; M@OHO1KI!NHS\8TA.)#-WP8F\826&E1U;SEF"DW=/$SC)[=B)X &VSXBSY&)Q M=NI^U.]5U(8="QV'6S7HA/,&N>%,=K:28;_!625(.Q_=\A\UF23&09I-G/DV MS.$QK@[;@2&J:).$.5!T?J&1^3*,H#OT:7I/=J GD"DC\1B0Z@;&^C?6V=*_ MN*4DU];+G 2?3TRRN=$6Z MW[G>;^"P2_]8T_E=@E\>P(/S%T*=33MYW ,I%!GM_/FWGE1D'\TX62 )7'F_ MP9=&G_BQW*Z6X.%J2ZU/W'4YCV:]5=K7K%K%$!F+K N]S0B>\4_%728D8S>_ M XT[$8+S+HU=150=^PVE8M*0KGOFSI-=--6ZA:\?\"*9+QCV"3OEKA^,C7:4 M64.EP!VC\/,"00*K DDQKW *,(Z,TXCX(1%SO,[E=V')M7>& [*5B%'< A6J2X(^0M9H8L2XPHXXK)RAVV9TDWKC#H MZJ9"M\>[RK0N9AZ_T#/W7M]$__46VZ?;/OQ%NEF/NQ7N!6I.+G""K;CS@*$L M[_F_GWILAA5 ID89[NMZ.0^8MWLJ?N/_4E:9<^!F$KAR!U5%>I^.8Z9!/RJ< M+E/)XI8*;UD[JPI^+@1>MKU0%Z?^T[TDSY9F-:,]HR::,6=(P8%G<%]=C\%) M@^=V3NMRLG[C%*J&E&H*3Y?;'0I>[YP>B[G5DDBWO#I MEZ>)=[!;^9>+F9PQ#P@5AS3OXJIX0)<7DF(32_)Q2L";#(+&E!KC"EC/D\6YF M$6/L[Y=+1,Y1M71,:1IWS?<&$I^Q7=[4DZDHZ:#1"=EXL0K2XQIMN72QNOR( M'N>?7B\NU:-U$+_;!FR';BR6-=&1)^KCHO]TC U;;BK[UJ-JV]YSM._U/8.C M)T^..'_F.XI0Y;:A0)=>9 A^PA+%>?1[X*O3C$W;D8CV%E%\1\X*P^EH_$F! M4<]G(9O*?5SNYWKY[[U)5QGUOO[6/(5EQ_V&W&:^ V.?Q'0%Y1)JBUJ4:ES;Y#7AYS9KZAK;N[6N>5NR^"%F^UDP@KX/ M'L_=&&)E4^.1:YV-Q=.R 9_,5H0@[ZTUBV*YOP$]L.]T(P=9W# MP:?OAWDB#L6&&U;<<[8V6-I&E(EE]3T!8O$/$-B^ X(3#Q%O+YED\:V>,K63NM"2IKM&V]4$Q71((GG28] MWZ/ 4SS@:_U[0NUL>X7BS(DJAO>CG[.V30_L]A"BT ;98T8_WBNU.8K>1HF\ M,VKY,G5[39RM]!J +K/.Q")_,MDX]E( _R_]EFN?D6BB! ;NP7*]/RQ6)RN0<]CZ\6:8=2T,2B M,I \H]&-GTCC"OU@I,TPDU@J4,%:%P]X,]TT,Z[!F+U;@]MF7AH-FG;DE:>I M;QQMN108\^/XHL;#YN[-69[:G6K:.4<1<$Y7(^E*(('9 (E0T1-.%'2RTEFP M]*Y!,6EP^?N=SCUM]C775:]GJI9U+6 7B[9]^3:6CFLUXR*P'U$B2!^G1.QF MSEVVE6P5V-;=ECW;IM@1X1T6)+OJ9]V0P:R\G&F3:2?P1<7FZKD#-=$Z_ZYA M!NL&"XD0Y/>E&TZL[2'(7V^8+4>(KTF4.L+J31,-3K(18<,]&J4\MIZ3A%@] M]H,'_*9C2QFERKC>B^D\0(D#LQ.QSMSVW_/E!:UU!R8LCK*\H! >X+,-SP.* M3XU10[#SV ^XU6"2&&G) E8WOU(5N3$;1V%!5 2+/90Z?!:A#M+@ :HG4) J M3+$[?TL[H_HT?KG]?5/Y/VA\'=@A'B"$W<'&3.^ +I%QHEV%WLPYP2[IZYOS];E,>U:L(T\8*T M7:.!D]E\D3CY%://*=8V.Z+SCM3A*.[4D%+3K[SJ?GZGR81KW)$Q*X<^M&+( MGJV.#,Y33@,/\,]',VLYZ2T:W(\%BHP,D/ML9H!_P4,]NWI-IC:;-C7C]VV.6*2&#/,,&B-=0G7NF>)1,E#2N!\3#E279F1-G9@QT17&>ZY M([5_T\_>"\G!V>L'O R&CL6I:A^PD9M0NMZI=BU>=:\@DG4T*(^02J(LH&*Q M6T9WWLNBK(SGN(_=$%):MHF)"G_A?MYDV^V[VSM*=U %K\! 72%O#_*&)6I\ M'N[25K:NEQ_#OPTE/S>MXG92K/..;$[]ZR[NJ_H#97<9#W\3/3DP.UU$)W-E M.,^1_KC)6>:-0=WFBS1\G.+E[H1F%/7YNS@E'B 3Z;W\>;+G<]]51L=8]E#] M1.9AM71U'I;W69\BMOE[WIF]GW:^LI<^=/P\^6F].4]"LX9M!@D%&+U]%]G&WQKS" MG&<<:7BFU*Y+G>S]FH?H-[%0;S+)5##]%E>):*V\QBZZQ=F+\0*$( M$[UX7)">7 !7+@W9%-<>\K G1?!HH6?*XWOZL]--^'%3BAX=3K[-+WA PB H M1ZE?ZBMG.X"N:+E; A6EGJW/'5]T(_(+%U#!#0GTB_5O\;?.6U<+ MQEDC%\\>GX;UV.;'G'CU?_K9?JM5'9:>KY[ MT'>=L0P\&OZ>()^@?;]L^]9=0(R&N[E)-0.NNSOH)2YB438/6ZNV.7"L?O2G MV\4L5=$Y<[ KLB)H+W\;/!#PP=>/PPWB0 VN9":.<0X6,YL950P:6VPD.^9F M9[&RP9?CY3HG%2V,=MR+W%*_W723UMS&O]#CP*W9K\UH'F#1I,<60,[8_+<[ MGM*G!)#_;S_J[<[R#D+5H>ZTR'^%2$PWL"+GKIEE223A9,,(9D]]W:A^T,2I MG)#O$HXW^H0=OE?KHV^O-8[>!11"8/J,$O\0 6W*9:77X-W$6^<K#,7B>MK5U:,PGZJ6P_K,R]2"JN!AUDZ0;B!)"726+)]TD^^#N(NG6V%))YA"&XQ(=X+W:&)H./0QN> M@Y S1^")TQ%_3X'/#$B]>!372X'4R;!4YRLT* Y&&!Y@FX]? MGCS_Q%#EP5;YND?>1OIU ?[]*5&KMI2??9]*N!;3C,1TU!H7A0_) M]Z^_ZV-S->NN!VVC:YFD7KM1L/9%IP3 M'Q$-3WHQR=0\UU-)[7W$S4"?/E%Q9^97>=&ILI+PW*^7;C-O[4U?N$_$2OF3 M$*-EGU ]F;4;VY[2&SBZB+LH2(]SK VVSBSBD-0S@@,]W":..'HU7@1/7SB1 MEO#*2R5R3&G?F843X2RCHQ=E.7JH*WQ_LIX/S"-!K=72\TA_=>3#K___Q?_/ MV*!\."WF0 SGT8>;=B^CO4"F8.'*=))G)Z?^W;J9MMG!#2QFUA_CKC6KR.)6>_HLRQ&CJ5^U?50 ML6HX5_JP($^+O?A[H0^:\93!?IM0/D!!_4T3KI,@Q0<2'NC!DNA>?,JH,RJ= MTKIN(@(8=L8?=W*CM6;\O?_U1S:Y\-Z/7B8&NJN-2&<3M^: MW?)_T'CPG^G[%IZRIA^HWBU*0W]L=[F+?"0KH7'M%B(P BJ 3&FD$ZGUL>'= MYHP7G.\.>+L/S)E@G#1M8)P=/+GQG44MR.*AYBL"X7(L-Z(\!/4W*#&IBX0Z MD9=>Y-DS193:"T@LBQ0"[8^"O)]HZ=.XNQ.R-;,:;'I=*HM'[BREW.6 M.B,PJ8)@J'S@$(4/W*SE Z?FFC$9?"#;C@_4]_&!YS[?NJ.QO4N" OG %OR, M;3$?T): HF!_-/J!,WMO\@%EXN6_>64LDXMR?&\^,$, I\6)P1\LX&T2B_G M%_29:]#"&;C$!R2Q\> 7/3ZP&N7._1+O_^J=+6 LB.2B^*QD2=%E)$2T(6>0 BL1Z M@5_E\O-R\?P;H!O.C)MCV,*F)JBWT8,?.?*!&T+P#F03NDN%LZSXP%7LMK]^ MXXOB7&&DB\SJE Q*QT,'R:Q8/E!IT+H=TTGVY>+HIJBICRUK*,>5!YZKQ<8; MSLJA=!4EVB1<-':JV1RQ^\A"5(-.5]P66NB2!XGIJ1T^XW!D2I%B*WEAMZ]W MB@.E:A81Z"O7>O><(A%6X[)IJ#YU)#&Y[)YZ4>S^+HT,[%94>"+VV/3*GS2P M2M1C()TL^&X\2I-=Q+.0&\YMM47_[ECPG>"%=2A=>ATXQ#J06[IP1N:=G MEO\9$6_WQ0->0D(VFZ& ;K.6G<';#=XE1H 5J&ON:^XE\C0\T%S92653$ZHX&KPK=\_\-&JNP3[;]@L8O:/R"QD\219.7192$'7AI M.MI$B2"[7F)NCY\PHU8[U9"M%SZ^0_YCB_+CVJS##:$GX$\E5FK.5?D+(>U3SX6@DX9%=)/WMK::./HJ31R=U3JYXD_'I MH HB6M/QP5RUQ.;D(7L\0Y7B?,2X:8XGV##Q_UB]=)[G74SQA\. M;_9Y;88!*Q:#/0ED\3%B8R98@24J>.?+?E,O8Q-#7XZ]';];W4^VT:]365>G M=BLIZ<[G%^)2R*( U RV4&>?U0@?Z$AA#M(HBX/&*XPNJ;(E7N&ES#-\S):7 M*H06W%4_..$FN+;#>/TS8;=C"5LPOC9'2!6^>KW%D:5H%ZSK M'3JAN\KQBPRS]SW^X&0MMD55_VK-IH/S,W9)O8Z2M\S+(#$N\\";FY M#\4V[SD<^Z=:;B?U$6$+/J!$E@9''L3 E.QO[ZC;L3V70?80VP)YZ4E],TLU M8(22&]X- +R7'G70*]_$(8^8S1#*X.E-]6A2S]4+2= M[=]W#12;TM(2)[8,[=?J<,R1I9Q^6.<5(&VE'07DM6BCKJ M4<082V+',,='&[@'8"PDU8,+=UZ9_WXR6Q'/I/O0GY2J-_M2P,+[^D_-+[T= M3;CU6BYZAW+AB=IL'IEZW _2"J2!]-I79AMY>6!/NO-R*+M'TZTEMY_U+(XU MT4A+W/[0[.[I?J>3<3%="VS6+P\CE!^]>%G+&+A(^P\ " ;:'7JV(=^Y^U.M MV-H:9Z_,4X^C%UHM#0(6[S*Z\5* M=HA>,=U\;ZBU)ICGX!.T1\O@ZY):P2VU"KO?XNHQ-S[ "KRGB!H\M^9&N#>6 M98VC!U9=()8]'D8 '.KWV0VI-YZ)Y[3?'_<+SNIZ%>LJ>]4RU;MTJZTE1DTR M0PTQ9>&JG3PXJ/@-"P?=*'2P^L*BIAQ$#:&='I'739WI\'UX1*&^,^6L3IU; M!'/>>+'<$RZG_=G'(BJT*9MC6,!Z97:2Q"JI":3W*3?>=%<+GY0LN 2KGTGS MB*O:)Y1#D.0]H7I3(@L?["E,_U*R1C"+O[WEY[8W8X,A^L0!G 29S(7\;9NNF)(ES MSQCXO/:I)2QV@&ZO!5@MB4NUG[;O3KL?]&S LG_#R1WJC)'9]U;L< M@SA_3C8[8#KR,*^V<-UABQ.9GD\(Z!G3ZY6X[ ?+YGYR MHGD]?'4LU4KA1H2[[=8WQA-9\>DAAMG?SU0 :67((E0Y=O918>TG8$T>MB?5 M;/Z'-$CAD6/F1_;A4J_'5?>[UZFJ=B[$^8?+;7YG#5S$F+NB^D?B/MC8,(XL M*,*PPH8PW[X%\X%+OEL4I ]A8>59"QCN1I_EB$I-8;,$/H UHD++6N;E_9TK ME5 WM0"-&DD2[&+>V6;LY( //GYJ=@P]NHOU[.X#A$;4+PL-OG$VR?I5(O.6 M_\/.Q9$C^ 1#7D"/!IR :LT1F#K9I3)#J@%GUJ":K^T6ZL,#YKKX.DFO?R:= M?NQ1_S8JF(Y,"B#"_O0+WP)?6UJ;=;PB+/*OJ5[J2GSDOSAK" MJ]C]-W2_=A/KB8N;OH+'<9%&ZX\X122]2MZ^UO&!@/H;E5=C?X]0?M3, :&M MDZ29F3(^\.I9!K+DH@I"] -9.MES/'/#3_]^*. 27F.9 M0DW8P<_3?& ^_2\SX Y=%0;R)[!+/!A3:5W?(/=>O.;$4AOX&7;"9 M6,S+(>"Y!Y%6+,NI,88*G# ]>V,?I%?I+ J%&TC5>HF)Z*ZR=P=5QIU"5F M*T&?K0^*NNXDW!\Y*>G<^F7M/L'7F>F)VX1K,-NFYU;GMX)->52S== W1 3? MJQ?>"LI2ICJ]"#H7V4U?WRA8PFNT?1-?>6;9KFK?H2IKM3ILFNHEJ^2QP%_C M52-= EE4QR8A(I=Z\*A[J= IQ3+%]SN\+]SLC(]+U8?LTZL71J=B?"RLK+2R ML]VL@CL8MESIJV/K#;S\3H?>^[16Z,O=_V 9*\:K&\.5 &B,55R%7U"N%71& MT97FK/7AY-G[!6\0-&AEY KI3:#]_A=:ZNC M7[[3D-V&;-6=CEHQ)W:\3MSYQ7:#A<+N?%B(%U4D(8)\5%+GO:1ZZBEZ(=I0 M)@5R9E2^=*HA96R.N,VD2M#TCXB*;KR?["67^?Q=E(%5BX+*H'*P%[M?:SA:(*+_I5-'G[I8U\JWK:[4W? M7WM^_OV;P@DEVXUWQYCZ*)N(;NNNYBH3WV"%P6.H3"BI).#&'>$E':7[?? BE%JY35 M0VD;<^(GXLX_-??G^T:WF4'\/3)K&Q::A#+X@),!?N B/CFH J7%XPI\ &5B MDV/ZX[ >FJ-!%**GL9.?&M_OUDRG7B&-7/W)R#2!B=H?L/F+X6B%+42]4MX' M[.A6=*.IG@YQJ*6E&]%[RZ(/H/A,8>,V?D.LQ/P@QA?T=2_F36S],V,W\2_Q M^60X>9SFQUUR%N2MBJ"*^OS($WX;;Q)"S)?KS<[H\51YQ178&7D7M/9A>)KC M#_]^&^(/4VE)+;40'P7+7=(?CG#A$-FXI,4%$6)7\HF7(OZ/28 M2O=5O/6=:M7!UNN6)[J#&,FQ0HG11SKRGZ03GMSS?#IR*G/75:G\K<4##4"0'2PMR^F#--@6 M?>1H5&&2XLBL[9A8L% 5(S$^]G[D)8YFHNAC%??5=]7+>$>?FTEK]7<,+Q8Q MVVIK$&17+UH>UXIVU\8'\K[,1"Q.5K.([! MFQ2/QHU%V3_Y%'ZQ:1.X1FYA,TUK):\,["G?,)WDO0R-D7X+$V_*KC2O&N+: M!'F:WMLJ^B)TX.FBF@O'7XYWT#BOYU8=@QUXV:5"K#8.#=USH,.2+/=/R==I MT&.]*#H^VJPM4(E\ZE@!QNT(?=G"7:9O(XXMVG*N( +@IO[4ZK]JWZ_:AZ9R M] &A8; 5^EL$F?1&7B+,#=ZAH^HMJ>KEH1^L&76]I7!'?C:_M*"V6XKW> I#I[Q2TH) -IEVP:,R#FOQ<7^O4"CE M+,;(MO5DZMIG^QV[/*972U_6GQ>R\T!D]X.U$E?Y -,$U5WW^<"7"*0& YFR M47*^XDDQQXN-R@O\0=XC6"H+Z6*((8N\,.(*W%U%HHUA-U_>GUXX>;B>XU;* M=;NLDV=V3%#7=.#R,L&'WE1,^=QTQ OP:2X.FL!W9'.:(7P/.6))5T=QJ(XI MCC5APJU;E=BZX;G=6>>$3^EV4M4K7:\FXY'MF].\S4BMO2KA!Y7<'5MVNYT*<#/P,K M$V3AP)E5%XIYI N-R+7DZ=W?#QT*SOQC0X?)W! 9L)\&^\Y!N9&WR:&MKXQ8 M!7Y_$'0*0N&L&@#.\@$]GI$EXLHF([N3L5.?L;-.6]*CM3A]$VO_D:EE_WLL M]/M&:"4&OD"PF6MNUILHIS0:\^:6S9/D [59U9C9(51':@W_71$2.M? LP,\ M\K,&'LP-+,L1-V.B*(54*>!XVF44DL^HWO>MP[P!9BU\]07("\8_@KUJR1.' M7<$:/C"7K3%2XI]JD^4U\:ZA-+R-J(!69=1!#$D;0H[?5S0R\2IV0K,";*L# MAS3&RE'3OFZ61831\RTNFDO;3=3QEOTI/\76@Y?AF;*PC'_5K.REB\K=6.TY]--9Y>=;_$]<[V MD:])8(ZM&71NFW+T45#8*.]3TEG7JID6M].^JSWD,:":> I(DZCQ"R%JH/4G M%/34DZYG4DDM3'"\ M??1DMLIBGR%*=)KV'A9VM]<]:R6TU#LXJOE46I8X7;?$7N8 KIRSKCW4ER%*>YSUK :-P+ M?0VO?=I2Y =IMM7X+:)FX>23S3?'G?JRCG*4:H M^AX99-P M%<0EK$GC)V6]N7J6=W:I%ZESE^?TWFAO4((N&6F[T\Z[GXO+U?3F1I3V<1)Y MJ;)]C A?/ V_-( R'ZK?EFA%$@[Z1B/N=_;2?S[O8_IM!X42K_D/;[2Z>V8* M1XJPJU\7ZB!\"FPH'0S2V]+L=3&Y=_4 MCI8,7HW/M[1O/.-3P**.ON!Z?L$6@C1&%%F*ZIO=>*5.A.K&'#VA7BK:*U'%!Z!-Q3UFF1H1L#[7B/B. MK&3P.L4W,JIPL\L@[6:;Y*1$@$]PT*KX_2TYVJ^-Y_LX,M6*X16[N/L8ZC>Y MV[L(TKQD6$-]889_3\IY4XO>9_A>J^.I7H5?%LG-M[,762H8<'.7ND;CKR(W _+^Z'V_O C+ALR7O([;)Q_,9&P8W8(]_) 2AM;S-+ 0$S.W7&G%7BH:6R$U MH,OJ4KL>-+CH,'>L=;PA_4>P6"ZO;EQQU"4J7:^^8*&3XL+KKF=BYN_ MD/Y5OOBRF38#H>%9#CAQY%7YBH]^9":^%A]>[("Z6-@$?%A_)E61K7[KF^&G M<\>/'X]H"MY86A.B&+->=DL)XY00P\#N-N%5^?[ZUOK=*@5O=I)M[@D.23-QP\ MM+)QC,)6X73SPGO8F%HMB$)<23!CGWO4@U<:WKME5,%@'L9+D!4@K6<#T-)MJ#1EA*GGJS6;UZ.+U^QNUFR<2M5>^,J.WP6 /3B1(?;#7+IK@ M<]^K?$7!4Z,VHG*+H>:]_- 6W6\F[T95#G/@SKK.>/_HSV;SB!^Q!49C=O>< M@U(X'KPT4X4^KKAQS]:'74'8JG/T:(?=9[;M/GINHCW$4CPV?J>%(<1C>_12 MQE"6(K04^3#.E2/(%T+@::XQ0:Y5!ZU7B#*K-KI(LW1S7^>D)YUA$0_9YS0N M==G.??A,,6(?[+AI-G WCUQZC*M&["8+C);/([[%%F310"DHG7&X*: !PWR6 M%^QFZ"?FV&[ZS>J\G]+=I6^42^)?F9M$G%:M- V__AK@K?I/$+VB]F1V*_(H ML!=7PT=I 2^*L/F!M[-NF][8B0#A ,Q2Q941\1-@UA7=CX<[W[$BHM3V.>BO M3EC[^@%5:^Z3+F:F*-]Y\D5I$R\.5F +<.9!YCTQ?B+(>V-IO*B!GBB\QR?& ML1Y2#AH[.W3Z9'I39_WR;X#)MDO1O :**33(74,0X-V'M_?@9 C>+ P')2(T MG&Q%+TFPD?7DKU-.'KPQ-+TAI#:Z3.1L8/7#>;-\-BR6Z"B'@:TT96# MXSW >N*$VJ$+W-[ 4>;C(#V;@F:_AH_Q=WNM#$M:OFKW/5]C%%JLYNHB7?>T MQV-5,1_P8@@.,Q2P/9_)'94,FJ1I*UH.B%!03!6BE;QBK"C2UK%!MT,Q4F1< M*T*TY7%2['R?K^,D<@$9K:QTGPI.^2*HEKG_8:<7O:P\-\/9@8'S"+X_O&'4 M0;33)#MP5^[))4E1+@$G]%>KV5]ZQ-+G'(&,N*;X$60E%'RONYX2E#^L19() MRL*WZ@9LMK,+2G);%5R2==YAX]7K\60 M:)6QW:A,'SG>H2SV_6'8!9KN)7:OWT_\+A>;/DFMD25GA3DX]@\)2'G]=2KVP0O"M%LFY39UO?7V&H6:>9D M1>E6UC0L&USP=H^+MJN:5FOI:B9.+$B*)A\82I!ACNBH6#1INQ0T%>9N^*A< M7% <-=]"S"9-Y,KC^>$ ,P/,=#2J'5>W(0H0SOG!&U7]:<-R;$+Y?KS7G@> M/ZBZ(H.R)FA8RR$:0!5E(+4".ZM "$3)X?5&J%4#EJI]Y6" $0C0.ONR7$LV MSO#PM90:U%%'R1CY 2\>(?^DH^;0W)#QGW74G+#9LORG73QS M5W[3@V4T*NGG4KCBT#O.HJ_V3=9&\ZTBCKW+.&&,R27N:!NU@&4\D#W8&L94 M\QX^T'P]EVC2-M460IZPL$-=\ 1ZZ"SI,Q8-$_V/T'C@C/J"S!:4.%!/8E7^ MG!($T/JWXLNY"PV4JN8 [?J!N@S?B>-:=V*ZGX\T4;%_CGI/>_RL\_%CWE\& M;ZC_M'<2/0'X:>_D7Z;>_/=?*31@ 2\+LRINPGK?E:?3=]GC+NDLO^VF[<^I MKVCA:?5[__M'E_AAW:E"7H'8 @U:RFU=7=JN'NN5MW2:YR6Y2_:] M;<\TTT1^T-OV#XQB.09;0L=8;7T:87K$%01GU,%!V31ZHF#+6R?- ME2&)BZXGO%)>L=8TQ.=,-/"Y7(H@!VUE256@;$Z\?"%!BS481C#Q'.709BGTW=^W:N<11,OW-*Z\6O@8R_!C+^&N/Z"QJ_H/$+ M&O]J:*R^*;O$8C3?\NH7!US4RD3'9[%+1T[Z/^L/6;1J%;QZ\SR#>>-G[4S8 M^WL':1*7NH5+H"1V9"W=+J)086F,_^,1HT>":[Y6J,0N4_$OR4]7KC=9>U#P MZAI2!15EK@NIGCI*7$<()>VX-I>F\;@;N>+9UY\W/]D6.:%[]%1^9UW>]4K+ MQ]5.A\76J@H\32^M[1,:N\== \]C6[+L:K#QB.)[PX-/';DE6IV,U,H&LDM7 MEZ^@@^.-!3N^G8B]?JQD8.-DME6)(_>D:_*B#/N5R1IBB2OEQ%#=(*0< M#23^:ISYU3CSD[38JB^K@BJ"O =%BL P,Y/D+Y[.RI:Y4YT^N]X>GZU_9Y': MT.X_<&0'13#DZ*W/IX15)6<&4%Y;@C'#(O"Q$BUC $ E"= MKL^)80]0(DTUF/4XDWTMNKNTW^YMB5#%&!185JW:F5:@#RP@GB3,]3*%87OB MY6M)[KP\JB>%_I7>5^N7:9T%:52@DK:HGL847V_[A'-Z?*2B#C%D*721U68/W3-+'%SK-#PA MVF7VYKQLQN:\D#K)X3@MR=9,B,U6L.'=0:/# "8TV2YY6PM)6 ZQ\ MQ\YSM,#3&3J?[WD$KXJ7=S/W7+8]4>5,V6KJ,S LP"^4P3K8V$%"1#KZ]"2< M/,T64EF*@S1*=)O#[3EA%%0:'YR[WJ?-UE:3V'F&,_'N[:JH:/>GO3F.04OK M.2.H4(2"C#CYT,%'G3YD,:J'Q.7I6;?4=Y?$!F.-=?,#F@\/6>0/$% MUSH_>W:49KG%L6JEYUU'2X0Y,L+%$VO)R\$3Y%CY$\8U!>R1/C/J>T]D M#78);/J!XJ>V?O>L>\K6S8\+I!)5XD>WE4>)4+9H)\:>%2]A6@< M#1-A;][HI!7K7IX?__:RNS5PD6:/:+'QD:;BS'KJ,JC8+H)F_?1R_?GSFRIW MW#5:<>YSX1JM$5%%VR9K[/[\Z-[N@YW:4C6**R[(F$IN47)$]4PC%W4K'RZ\ M!\>_\0&V80UJ 5/8A[FK7,C;O_K)ECJ-N"(OE:.XMR2S*>RV'(D^YPX^(%+" M)/.DRD11^"^9NZ@?R\+Y&NW%ASH\?D(&!&J-7P$[-L[O"3$^!TA4AFS.0J0P M8N![;PGN, G:0UC'![8^Q(X_?L&[F\4'&F.QTU]L?M_?7YCBV\<<5O;J 8L<^C=.TR[ M54V^N8_\TZ0]-.VCF)E%#FU]7?^&[GXLM#*U('-H U6*6DBQQ:RW5CC^K6T^ M%_O6;G" >!DM$!&=W*\Z1,WS+)5>:P6%EA6G_TM77P;^*8O,M9.H_?OMOO\/ MYV3\#HHGH <:;+[U2?!FI?^P.0_W?QMNB(?!"J\ +?']G.P/)PVXF=>%0L:D M\Y7T.?7=6!O\*KMV#,L!.A;&H7RP%;XN!"L?BA1YCF'/!.,Q_]J.75&./5KE M=?C <6SDAF_#K.RLD,F (VKYM>4H^'-E$^,CD.5U7S G0]$?.78+"4LR$C< MXTJ>U/29F1X2X .K8F5YA)M((K&SAPS'K0-[2,BUN!>M*T)CP"HNQ_>'U?&"$SL/U[35%'1E- 3&:G/_I9O_A9!?"/F%D%\(^8607PCY%R/$(B!.++[]H)PJ1WK> M9_QRK*]$AUV/1+1%:/DZ.)#U]=+CW%!&5X=S-\Q9=H*[[.N(YZJF3T_7:*2X MN66+,U;79CHXT1GTZHNN_BO>6\O7B7W8Z)8@_-I=)51XDZ#=YT%8(9)"&;O( M52(Z!A M,2J_W\-'V7[QU*-Z2PE2[),O3C^2",4LA[>SONTL*[U6IS5TPU>0\_CM7LMX MDSR16=4U94":Q/LWFCEDQ:#( ZRLRWZP17K0H?$C)84A=0N37-ZHOSQ!2A ] M3:9D CX_ #W*=9]"J#;=B>VCPB+/^$!O=F6Y'+$97Z0Q6ISN3-C83.VYBY6$ M[11;\P(?Q^VMOJ&*+WS3.'#,=LMN=E+)G4GI>=/6,NQ&V#2+D\\'[N-@5*V\ M0K'U>A*DO0%]]&9W\(%J+"R*@4E;,*XV^!5\X&^/6_S@XGDMF9Q+W=&$K^=Y+8*/U>M)(/U&;/ZE>:F3+W+F<^?GZD47)T>'?._9MJ MNX*?2#<%QKH5QS1-OX>UJKK%>_>N;!SJ/3.[@G4@8]G,/<4##\:\=FU.'G)M M]*1L0TV\FY=#_?(!68TJ)U4L-(5AU>&+;O+DL6@65"/Y@!*EA=JK!P6B*HPZ MLQ<%@1;6F ]<.5:+G425Z?75X(1'Z@=GM/#$KG/MP0\9<]:HM 39PUAF(A4U MA@$8#4*[))#-%K Y'YA;+\J(#ZQNY0,#J"I80HL'OTCQ@36V:,$W;DXO$T7D MM.:LFF$!H;7Q\E74S[2 -#745I,H'%"SL!(Q\ 42%(/,+9SEA^S/Y0-O:,C* MR+F%LS20 YFH)TT--K\@^[V]'OX@KVQ9>&X!*0:OGAN 2D<_ BM MVDFFG.A)/#/?%]]RY&H1]-^1Z[5?=T!-9:'=(3A!CHGH%%\F-G)O$ M<9-.A>!!4B1;I8HHU@CIRX2\8$]/TD5J.V&)+ZS:C:X,1F#&N" MC&8U 3MGL?FU?$"E;6ZNQL6X?_3T]T+M+7:UV.^.?_C!U<#_6[?]R^2&[[I0 MRC-XS]+14T_@8Y;AI;',4.)JR'_T@J"Q1SN8%_Z9EX33NTU=UV=V;L,8LF+P MCH32]P@$'4_917V2N';J@8103/5$2Y;@_;*[=A[#:-8X$@9.W/5##A'&_]M< M7L:/ZO$?WP7#%MLXB%S"3F3J(7N^T;7>4[]S%S^JP6C58/ 6SBT;R(!SL+W+ M3S?RYH,#N_'P[7_0)/^,/W0?810PQA28N59[F@P;.Y)Z#3/?Y9WUG6S7+=WP M<-HV_)/MVN,SG2MZSOT7?E+E_RZ_]/][L?WI,/:C)9A04?-=K>K"BH!^&'H] MDU0Y+@YO0.]I3]A?CMHK>$M!LUGG9^'R#_U;$LZGF-[H*#E^KK]O8]T(/AZB MU93J5V\ZM^R&'9Z^6RHI<>#.B>1\*$,!)K64ZC)UE9EOB:L>N%HDZD=;=5]^ MTDSM2()Q+SPI\2!S (MF8Q6(/G\!";'(0)3VHP7=I#&7T9[#:."\ (OQTKCR MT=#@]W]A_^;J-(F\A__0/0'TAJS&COV<'*B1NR4H:_][,W6DQGD=Y.'KFA43 MXXNK2HJ(_KJ-2;C&HRNVJY6PQ(/O_G.?MULB7#$WH1%559;4Y? :5 QNA:6A M9JXHTIIJVER*,:H3LO&IU\CVMK.E4 MGF39-8P]'PB["+J1HO'YI%%!.JD6)_K)T\P0HO1UX7LEHDRQ0>$>30,M#H81 MW?O.VYL7+AMX'V+3<37V$>69GT&<^\Y"_P<8U?E'95%:TEKFG%[^-.^CCFKSE(GF$YT!I_P*TV,? M:N_MKY">1V*5(+O(D>#H B\^D&Y;[)5G+BVIO63GPROW;)8K_@ 5VD C63'*6"=/T*OZ@GMEISFJQ%"G:TUPRH M$K(4JP'9^'6_U4LTV?B56?._+4_.KZ:^(OC(@AP\87XRE9 MC9G>YQYM+FK1D:E:+Y9SY56$K4GH(IEO@;",U8$\E PJXG]GB (R;Z1(_@078 M"K!#CGI23P;>$0U&KO=7L/+Q?+OE=J]X&^ MQ$WX!4AW@P^;6D$&L%[X$/I@94-@[\F[ 0&L_A&'HKNC\CG//N04RY_-=WA= M[_O00BK*-.RET4%0UTM.SJ("PSKH=TF?6$]>B.U)P;!P)D[GK+?3' +'9'HN M2E79799QLA[=L^2K.S(:9SHA:"I0S$TOPR*+O=J*] ""/.\6H@U9=^M)!@5S M7K&NO=1F\8$<;=^I99X1QMDS/M>_R@I% ],,.A<1 7LQ'=Q>W5P6F1/,"T>T MX7.MI5H^THA1$O/K[25Y[V.?YK#I=:?U)1IQDWR)X-O#*)"CIF%N$7'JXY7&S0U?:\0,!%A:O MC]O&9VW>,H61&B&+(@N",%7XI;#-^0=!_EN;[[ULA:VS]V1+VSQ^,//U^%$S M%\E-&AHBP)<%1$K:KQ#!1'VYWH1/QJ9+2]C9453/17QU=U8$LVVNK\K M*-#J8_M6']\UI*E K>/(V;"(^%VW%XN=G3=UA@]4X,OEZUE$7.="1D]6%(,3 M'%FE8974)TOW+R!'R[ MDX6I5$W^5E-=.=6=?QFS)+C$P@'F-!,6,7TPD"$AR,7Q<%P,D4:ZJ"'@>1?6 M/!F;\6E/=<74YS(2(GR^#R]-V#HW% %I)*JSX]X6X,D1#A>S&S:I]<=W69?N MJ9K8%:VZ:;-_ZN2\J8/_1._9WR8E=^YAI*5["2^1N-R"+53E+,XVB@Y0M#H0 MLYM5'&8J>S]E#%\E?RU*-=?*50@+HJ9+ORY4[7[4BJXKB%/NY:F\7OYY88Z$E M4_-I1\\F]S5FK\M87\,>>7.,D7L9G;C@!S/DCFG;2KFQV)BB-U+35GIO+/M# M+;;Y](['4Q=J4WTQD+9=!44.\F[ ;^-=FXSSMV5'7E'!)?H&.Q051]2:6XRK M'OKB]\#F;I3.PQ/G*T,V%_19C!7=#Y+E1#;Q 3>),#X@/HXH$_:U$ SUKHP3 ML,<>5KC[I'L.:8;[^7U]L#'<_=:,SHW@(^T]['HIK8P5/7/: M0S#Y8Q'^"I7E. YI^I%*\5IU#SV3!T,GQ;4MP;[N2A.KR0,V\)I*NL:KX3,X M#4-'CG+\NT%D\4I>"2+\:6A?-[3?GE5[*>"NW>X75W:=\&O>5; R&G-3;_!U MKJ%$?=;7;"Y*]RJPY<:$-9!-;]?QS4;;H+(^G,3V M!;%GK)#'5IWN5QM<%4*.+!)**5SJ.G-$KPN_%%$9PHL1%EQD+YS>VF9X2SLW M]E$6A#=/L2U]V;A%%NI@ M*V<7D"+.7NG0,1C9F.MKDZ+F&C=?4X,*^&]10BFMX"CO9;D26&%)==>1X)1 M^YDZKCM0YW.E2'$W8\_3MJIMX_6%YFB!'_X]'I/],"C)1WO&\[GS7DF,N M$!O30\QD>10^X,J@]R$BZU#KPBR/:+/5$(;&D*!Z^@D$<6I[C2Z5KGU9 MZ=3NF?R$'*A"'_+OKCR\5ZEEQO8=6>,.XO*DZN CK">V8Z0/#TL/@^5&: J/(0J:RP3*-DZ7N90>"?;SF2RI+O7FP(UQY"@Q[Q)U;OFXK41QV@,S1 MF\GSHG+*A8.V5YO))]&,<>&^B')[4-*^EF,EH4'C>JE?ZZ?W+; +=XDY.160 M$+.V@Y3CF2;1X D>IT":U)W24B_Y)^(H%!,K1:MAKL+&%2*@Z?'8S@MEZ-9J()958A=!*_TIU01[-F8*FKAALC>U2=Z$OO>4:DW MZ&VR\N&C,[=CX0(^X*+^JP)7.?=Q^.62='=17 M@5E1*I=UF&#)&@\?+'3"[6Z;S!OH\):L#C"5;/35*=@E]7A3@EI5N+UBAR92 MQRC C(ESUW83FT"6#5D:!EZP\364>"7E,)LFHO20LTHS,[5^]]/(T>2]UW5X M5?6>25?:Z_W76'Z@=)'>KMY,.,N5$_67Q37T4IRAZ[V-D')N;32B M"F5[C/0F1"FB J)(4M^^Y^]VSSWG[W7N^<_?B&WR9 MF2MSS3''F./__Y4LP2 MA.U+BB;7,QY)Z.RK:5\P\(##H??B7B:B0VZMJ-F_$)B;>2 MDC.S[F;GY-[+RR\J+BE]7%9>\>1Y;5U]0^.+IN:.SJ[NGM[7?6^&AD<^CHY] M&J?0&=-?OGZ;^3X[Q_JQ_/,7>P7ZO?K'+R% 6.B_'G_3+SG8KS5_8B#^QR^A M-9%_3I 3$=VX0TS>QDW\]"4%;9/K$HK[,A[5M$OJ[#P"*IVY/"BEK&M*UV/] M<>TOGOU]CL7]NSS[;X[]/WY1 !EA(3AXPG( &N!QBY(W _^T?]H_[3^GD7(% M .T9L,-_UQ: M^%W%=659O'(1AK*F\3?69D\[[^]0/S>0\K,?R[8/>.(8K.';\;2IXJ)4>LUUM)^Y\-,;ZD< M+F#BIW3E-R>8R<^(/N:@.M!8VT#^*$9%#^(( -$VR%D B Q"23I]X.@ [7TI M2Z'KI'KVZSI6Z,.QR^/>WB?MA[Y1)D_E3[^^T+5X[#7I:SF ) QB\BRG;AAS M%3A\Z4:PF.W'>_"0N _:S3G,W<-: ]VGMR5=TJO.*PJV/%XRIG]\^%'\W: E M72<9ER]1IU-V/GBQK\T-OFJ_ (B[P!7GU7)C.-Z0/?L&B]"UQ^\@%,T)F)MI M=Y]G*1R][6L>K!!ZIF#1>MKH<]N1;B Z)[O8H2^UYX?#@A!'W<'5ZQ:PUI%4 M8)8^(4L(7/K4RTCL)7XJ8VBER_ 5L[HL\?&,&!='_G!-<_/0S23#FM[U+,DS M065P,WM=3AB1O@;*"FASCK82-K)U/TNKJ*B'*CCO>C MCN'A#3("X&*4&XWP;+,PDP3II#,56)'L6O@S_CAM7C'*&BHP(ZI M9U#4\'Y M#ZZN\Z[\D=+T04Y1(N.A1/+V)Y9GOV2Z#)M!J@*@IK?CZ0!DEMY!:)CLJ6%D ML5SH*[&/X-A##<9*4WOYJCF:P6NL5#=F;(@_F"LSY97Q-CZO[Y@!F\R4YMAQ M/7B/T!>,QW/95LT@(0'G4@P-TR)6NI"*D%-WX1:BW;#UT7+#JQF=(1='V1Z$ MH 2EZ)8;_H.J)2&W!<#<<0?Q[U^50.J"- ? #Y&?BS,'6>*,G+Q+X/(K@C"7 M0']!&:9AXEJ/QI13 E>Y1D#(ONY-S^J21[?H+',_/4KSN)(![JNFAL)>W\%W M:ZWGM1'.8E3X V.4&[/>3':6::$LRZB^LQV5]G2K0LC%S)[]3Z*NN]L>7>YZ MGU@%1-293H]K M&KRG7>JY?6]WODRKR]1]%;>M?I?-F:Z90=3&.4IC[Q*T-2R%<,I9GQT#79I& M)Q+%VV0"(_,M.@2 %E048FQ;&/W[L0*F_H'WN9\>WU0S1R6Z7BM_;DW-"TIR M10SF&RS;T],7]#DN_![T\W2F![C,<&$VT=%Q1.E6WX!-)+!Y>A]+CTT2 %*W MIS"[,+H[IVSA(N)_RD].]Z17V@W5CJ;^*$2JZ8 (3HSWDGR*JH[O(]:^KP(' M#K \;AES=U1!'3.'$VU;H:PR\VPU%955W(50O2,> QXC:TY(ZAI]O9&X 5ES MU^,+*9E\AAA/KA?GKD>P>MFA4!.#NIZ*16!X>95FLL&=_=.3+BHFG\^[]?AY MY8<;FL^]R4P)S-M(71^U+]DMESTPM!&.Q&G^!V^/6^0@XJ?P+J26 #@;HT]? M&T_'R$*Q/F6W2&UJ3J="Y;_-1?L\R&!G9XKE_%0,>;8O60"TR+F*SSLKT3&@ MLP9I?'&%C025QA;*6.=:P\ ?/@9YU@:,W2?=\Z,#6@NZCN8EW1V0\Y-)..1P M-JE_:\U6U!5>19L>M,R^!<_@Y02_W04DM>.MP,1XE)!^VB80T850'BB=O?:. M-U4Y&A)Q2=$[8FY..D31K?+B.V1.>H3NO6T9=P$>4$3>V884 .V[R8$#XWYT M-!-3#/4SQ-+H83<*S<'C?#(X1G?I)-ZB]#O18NRDU60'/BW>5#;2+'F^_4Z[ M>J43YP5;J8^0T>K+T>::OQ0 -WRY.APL%9O5/8SS!?5CK_ B7^'-4-M>W@Y; M>SB_0S;G8K>VC?SSNNL3_2:[+R\NO*E\B'QYG*6?1CX?1NGL0(.^Q$1XBW8O M=B"]R>?%-IDM,[X./_HV?6BYGMYW]$7"_MC@]P(@ MD$#1Z4+7JW 5D>S#\'I$X0Z,?$UOQYM#'A$L?89_KLAC5:Z7H?L%PY]]#7)M M@P&W@Y.JWA\YE?&T8J_-UZ^\O#8I_#LR&&[1D4*XCA)^!C[.(O'?>_^:'$LT MW:P\X1PW:RP38JI<<:N*8BO9:O>D>C!Q0^W.[>)S>Y1^ZW.L<<;0#;CH9_$R M4;I!&?2K#&LG:[UH];";)]QINGW*]^U!T/1M+7$_L=,:PU6 7K/"C J!.Y*3^QS:=>12<9O'= MTT29N<8=C;=^%DBI;3,R+6NZM)[)SC8')QO[=1\K'^DZ1(_=PV$_Y560@Q$W M,:#7TK@'^_0'U.9 %M< (I^;WF)&E?6!3NZ(TLT_'*_W%A^R0-(QR?N2;/.E M4D0BKN:.\@#%^V-U<4S)Y_'OJV6?0DNOYTPMOY;_O=8>4?/B@M9%K-GO<,XA M_ALT0/!?@G8%LY7&4$)7)2.V92^$))\)'YZG@,0PEFJW,JVV5 MYN@3VEWX2*P>=PO+GSM+EL7OQIG'+?8>RCKR^5:#90XQRJQSW.&=+J'5)TE' MZTSAL8,?0#*X3P#\=ACC*KKP^W\U+H\$I\(YVU[4R,(LZ(#%=/'X4Q9X%,N^ M]YTVF.M]=<2:6%)A=M>#/]\FE+@36',K1PS=RRE=A.VH=Z% MDK:2QK,ETN\GR6)[>R8UV-_@:&^"=^!.)A7!*H;45/,(F MKWAFT:_F/9W;-+6HU-36$)^_>>.&"-J.&R8(LP[;[HF9"^%R^" M"@YE;M<@7@1)"9>@^WRI,(XM?^2:1S=QG$ /ZTY3H<]T]Z)_TAX MKL_5\&'IT'.9ISD'/T.=W5GL ME'+3S3JT0L&V-G3['A^^M"9'%U)@GX(:.5OQ8\@UN)!I8P37@Q7)=**GKX&> M,@Q/;BZ,L3\^%!%8W?WY]WNL\*_D-AUX31#PX_(CB^TH?58N.PS"< X+A%H/Z8]VR?%YP.!COT$<1RA9[GX+>01-%W? M&>T8MS@:W-!2Z)YSMM!//_\PP^TRMCJ:AEFP!XW9W^%9P&RL?3]>#3_D"MUP M!V]:4&4H*QW> ==50K8E5B;/J'UR M0F &14EA)\&CN/+[T:#KP+C3*[1R_;OP?;P']0) LAV,[#JYL=4B$H^L91UX M*G'SX-Q$6T]F[]:XT@/7)_PU3J\&3)=QY:GL'!:J"21/DQ5*9[I:MB;:-( M"=O(-H!\.2ZP-^T8#3(,QBEX(]:[I5BN#6>'YYPE-3&WM[EP6^F+D>FTHC]0 MJ3SW^K] I6+4OMAB/!$G ^VF(\=G: /Q;2+0FA [9T2'NFQU1DE;5?F>R;[& MQB2_]+?Y^[SM*,6Z?$ &$/K1R/Q:!5_.K\K::)IP&_,<>1NEB#7>"RIE,Z=2 M:"0U[/D0%U?6!?/ ZE>PLD,N@YD1_7, 1C7Y_C53#5ZT7;#99['\?#*N7 M."+^+;*^C!G!V89-H1$7'G%<@X@ROXP"G/*G?D3#E&3;0S//<8?@+9N"T(.G ML\,UFFUUXL-C[8XMH\$# Y0Q1@ S#297*R YOLN'4HJN8BH+$9Q0_"A:A4![@JE#+F!8 M*YU\Z:&?R/@V)7#Q$?TI0=*LN].)5ZQQ>&#/NX[B@_2#O?')>AJ2E/!\SC[R M'K0?Z;=G,;M7 #P/H"%YVF:K*GME"P.9CZ*3DB35<\XH%@)]M,O!RY'L2F@< MAJM5$-,^L(X_196X@)<).KD67,PSOG4*DB,%>M3.9P5N+SXD "ZTR6M7%W\1 MUO'I4I*[GG;2#C.%S_1X3P1=JZ)[D$HHC?/(9\17*5^T4!#IX>>@W/S;[UB0 M2^>84-52?4NL94A2Z6V*B4WA]Z+TS-U?;@F_1VW[$U%K!"T,TEVY0::5X%6A ML#W?JE@&SD,AUL(T@Z>OTJ,9FK:MY5?8]X3N.AZH_ %(VPH_3[U3!V<6@Y4 QY&3"@P A*X0312ZM2VQ';+T9IB[*E9#)B,+9Q3R7DUP5]UL3J< M5Y0OK[_)LZ$DP4/T#HX.>_T)DJ4CQOMI'@OZ8#I]*I--D.5K\D?PXH-?&C,: M;X6/]Y M8:_M(H^:S>NQ4C?MGFR?G=^K]9OC?I+0[HTRX1X:PZEP1*%<.K$3+0,YV(;R MMT)9CWSG/$[JCQ1.[:98>9[INLK>D71DTXO3NNDF;YYTV;1;X M"0$@B]^(E6970[Z/(1?&2CL!^1FR8B@5QBY20B;?[E5L;IAZ>WQ]F$;D]M\6 M%1/:3WB:+,YT;@(Z8"!Q)S2/>=8RLOBUP+!U#_W=%F'J/.5!DS);N=P!89J* MT+UIZY%IYS =B8%7,^X*_[7WP$(96-9UC=K5?]^ G(16LKY4#LTP8A;SNZMR M/<@7>]Z/WQ,S'WU6Z3Z8E=:AL%'J[ 8@*F*,V<3Q#L* /F%K^:].[@"7XBI1 MZ^XTAW--NSNVNH,DC9?.?O2SV7OIUZS0EF;N7^A&!R M;V"-VR( :IU&"3]__(*S550)S&6Z@61:8A<"VG)BD'MJN0T]9X&68-2" PMO M^2IU+Y^!;^IG@]/E)M]%6XY[1WUR4';,#E5S&T58A>6@;'AYU=9!TU3(O(5= M"*ZDM88S6J+XBE B0RGWQH0+JYX;/GLQZ/409?S^O9+;3D\#\\8/'/EF[OKP ML=*^6/S'04PBLJ%QH8_F$DL%]Z/'^_E21VG&)J&#=EL$.QQ?KN+?'QYOTZK=4"P(]["\E8!9 MO"(>AJWX :Y*="^QQJ++)5D=50I.'(:$5%);+1[-GE2^_8Y9[?^15G_4=/'' M.],4U;ORFCIA.U%'[NSXE=M#16)3Z(D=!>&]6K*@Z$QR_5,#;5.TK*>#3M;1 MMJMR$Q._;RK%:WG8!MT+29*VPCT)7BYFN_$*^8KX=U0PW*-K21RG#%:JB]TH MY_.3)U#S MSVZ_N5^J%GD%8[0_-WV..C'&IK,BVUU2J&($/Y?Q1>I!(H/4FR[GZQUHD?_U MZ6>O[^JV:4W-(_5!#].F@RB;[;1C6\\X(K8IFXOKLR>A(#]X6ZM!B47\3O=U M5=3. 2EL[2&62F_(48V'][Q>YS9H:>P?7-RV27E%(39_5YH.SR^?1_AG3(Z;W7^CX:9PX M\&2;O&>EK)NOP3)FFG$V-K939; ^^WWN#XAQ]5GI MB4NAOP849D>_)O='7=0RK7W1=,#$]OSU@X8U)<\K[[]A4<$CTC%'3\)$-4$ MG"K0[TCNX3@/X<)C*EICSM18!KEOL[?=J&=3*'DADE1#""&FX'=]0"$;7X6- M_][8 M6RY'MF#H/.=27WZDJVZKP87=KQQFO<\*F.EG6?C/DLI^_#.H0D2.8J M3]!/" #05AH-&1JG60OOB:_D:V0/W&"T]'\.#HK9=,_PS-WJ0V'1:FN<2RKM MHS!WD].G YA)G-.$=I2U+%C&SN'56Y^CAT2V\W>QW//@8IOD2T#F6?4%0$<42-C76C=8-,RUT757Z(L^_^Q$_5MA;;^56QNJL=164>')_T7W M2XD"@/8874/N"IM883NP/!:R:.2T5?M8&/#4@QB])T?#N"J;:G?%.LN\N.[. M_^CG]_5Y)M]_/RAT$A];%&M-@GD9@H5D8WAY,-Y8X>R@LF*HFRM+CT'O'39[ MI]^1^?T;8^@]Q0J;'WB2/6]R-\W)I+EB=TKT+)08= I-5#P8ZL=6&A70 #TVI@GJYB:V[S:I3Z"E!7Y9# M'WL^;LH,?II7X.=QKV_=NAZ= X=:R%;P!&;_(MC/\!+PFW"!K,940E"5<,\J MH8>0="WQ=H3FUDYZ%^5 OG_9U+EM6OS/RAXG)5F^[\GZUZ^\]*%G.N!09D%JWX(K=-IN M.]LP9!A&I-#8UPMSOVU3%KTW"]/NPB/LQOF[0#HU\"M;0N<9Z,)LKYWE=M8 M=VL0?Y M',VN(OOSQR=F KXL6S![N;4#9N'L%OADE#^KW M$F+=,SIIR-1".?"I3\_K#;?53K\8_M)RM_5(R9:F0U_68.(R'15X'VT!W Q' M$=]'@$/=D7:&D$)N5&&FHWO";AF7FF>73'E!A\?V#=49[?ERVXO14-<@ +P, M?^R7[K^TQ?" G+;A^1)T'?<(U VFTR(3Q-/:S+A'P9D;/]U;D@_\S:UU8/6-BG'?RN8('G?=7LIB<4#MERU&;]US2-I?ZE9#^OID#/;SI3;" M0=Y+])D!RH KA&3U=GCK!%[&9LI*[7%Q&:O+TG$P7 K1/>>U MIJ5&IKUGNYIJB3/RTTD14"4.I8*U. 1%@A,=ZO[7'P:.!@65!#:;)?MXC^^] M(:WH9K>FZ/H'0#385;R+H QOISM\"UX%X10U&5FKPB1PS@6?-(<266K199?ZNN$-YY*,M!]86:HLZ^]\\TX[,PX5S CCRENQ1Z!? M3W BT"-6&5_JM"8UO4TSF7V/YEFGONPF+7 ]Y(WWZBJRFRUY>S!C_'5>,76X:QT&HDI3AN' M-=!3 XG%-BUHK-W#8D?06 Z[_\+8A\F)J1[/?O6B/F';Q'5=(AEWNGCBM@"6 MQ%688>N!QER%";;7![(_&IB_?/Y.4&YDXVI".3OX0F-D8Z[)B?>L5S>K6FV^ M&JS?T/#ZHV+M'=_6<+Z4!SSW(I8'\P;K_BM"@\L"B>,Z1Q!%67)WU>:Z?.!> M\BO95!Q2'I2YL\7SI/?K-\^[M!P/SESFK[JR7JM=Y=V'D[J8YO+)BEV"KEWJ MDI6>'F.VJ*2CMN$.@)536L3>U;).Z-%0G::E0ZE+K>>L>>[VK;'#UND&SFT! MGF\3S[KU%(:7$]HU\3OGD*#]%7AWV:&92?3ZX5S;=%N4)5*R;/E]86[*E:=L M#+.@Z$)UIWY>(_+'6ZW@I8.;A>GIE'2^I"@+.4U,1(ERO:!HCH JJ+!?L#RX MBDCZ %=QYS21V5?L&\R7!HW&8-V(@-#T3,]/4_LO[;3J%J>$5NO&7[0)THW* M>W#NP%9SC\^*KN(SS@-=A:G@P46^#*3/(-W2&[.^ M!"X?AZ*"&-).S@?]\I9,6>$;''P'#GPRCWWB-2AO^M-XPH(O,4$/HZ!IZ1TO MI>EHIC##6)A['-)A;,'M!Y<8S(_-YR-[C[^X=P+SCJ"@.O0U3%_KRAOS;=S3 MN)>#%I2[KN+M_,WPA4_B)P@:Y&!B+*:!P!3BX+!1.#?PB.95L^>@?4=)76V3 M\\%1#4=WO>:6%^JT\0O\Q?;1R<"]2#-\'DX:# F BG+T+^L5JG)[I@!L# M],)',:RQ'B.&B_PL7X='#/N6T//%FKG^ZF.$0D>'F8I,R>[+[?8;OA#W0I?@ MC*LB MOA4>7A>G)IL55O)/<2.+*.S%(/0.4X?VPUS?Q[0*@06GI%35U]6JLJ6;T M40%P\]H>'R?6MAQ2TX;6^HR/7G>G9TYOT-[5YCI83#H-IYMA'?DVN::Q"SE> MQEZ"6)5<;Y9Q=[#$1A8I_79V6*FUV'AKO\APU48QC5TA>F\'>Y<7VO!, W9AX,F*1N0DDWC3""8>4^L[9 MO1M<$*O ZV9&WZJ:VO5YG\8*25[M;(28^6M>$9F6CJF[>I\3 J6SE^#A O%3 MC4CA5B>6/&4*F7QR_4BKFEA+\?SS??=U7BK_>/UT_5PK;\AIYS,LMT^8QX-W MG2W'C]"NC=^('T6#AZO"V8@67LVWE&.LJ=K@2IPK](@1)EQ=5HZ-XVO<]XG/ M,8B.[G9.6]P* .0_'XCNO"!U*D.(J#4:X4#H[4.M? M0OM9^^V@ZWH+2,GJT.)1L[3M[S=@#.<=0IAY^ANGJ3HY:O*;K>S'1ES%^Y#U M^ER%%GC7;^0$<]?PGE>ASV.D H]R1?AC68= #LZPJ=G9.\3]C883.R>,>>MM MH/OZKBW_B>O(U*"GR(R&V%HR%2"HE'<7;@ MO&%I8W$^=\IL!+4',SF'4;$^9[TE./+I>86ME9U9B1-#NRYLF/VXN?2MQ<:J91>GJ[EG;/;55^'<=N+ M- FDKB'0*B@>76&JW1$< B3L!KJ3JTY\ABZ.)=>4=QL5BTCY4U%9[ZR?O],YM>:'.: JW R#UD%('%ZV)6@)C.9+[6:AV0* )M;*>O$E\@'0?D"F$NJ&_C*H3PO@D>KT8#-L ?GL4 M$E3^LC+E=$1TX-BZSAU'Y+XDP65H[R<]X4>G)&2:7G/98"Y7OH4O+?E'KY=U MM\G <5L*8EL24R,21^J9-@+@7(CZMZA2G0MN2:%FDNOW2YW9]>C]ZP^GCYVK M7=6'=P^9!(?,E(G?!8N97XA/1/8;B$?".8_5]^F1QU!;S6Y>"RV*2*_7N!^R M;TABG/'<_.TS73>[0Z)5P"OYSO7LUM,_CGJ3Y2<_+^7K;CL=9VRDG6E_>0B7@APQA7D+LJZ7JU#, MESK.RF(WO."5X=<1VKVOI">.YGA'ST[)@!6\0L.(V36]VKVJG0S\-NBA@H<%P&V^ ;QR15 D M7\KQ',<-\GZ/EL5*S;>/XB6RZ!%=1;XFT17;O$I:U3NR+JJ-1,6MN^?R"S7,LWTIPP287*PU?[MCZ73T2TOGSSR7]9)AQ=:!O1R]%.8L)1@4.-@1#Q$IOAT M$,$C?61:"5&%'.(C&^PQTJ;B@[7R!7L3VS1MR\9/=.02@\_&]H=;YWP0=WBF M]C@OY2#NJ_L!ES)"(%&4ZP^E@!@,B%[@L/+[Z3,I]4XZ8278(4['M)>OWKW8 M8:-'+ZZ?N[.)>9]XOLG]W)TU:108CA^0$63:70SH2;PI &1/02[@,%]Z,JPX M:+OAB^"P<9\#F7->YZYF!B>%ZK5%^;_(L8_2+1@OC=(L>%!CA+'G#Q)!EQCQ M:8L;?+DY+024%?V(:P\\C&,*;"-,^@&ZT0BM,J5 ";OS+ZC6TL">*PS2*PRZCQM#;#!\DE'4$[OX>Q$!Z.;!%K!M=QT\ND!-7XOH1&&-(4GN"MM4)K>-#36DWMMO?K.0V=_C$XL M7'4UO?,I)N]48^"H-:E P;G19'NE&BP>'A"5VW8:=Q!$^.-P#AW.F!X0Y:J- M&4:\4W <:D5N*HA@Q'CW;$KN6/;,=VH:LI'PT[&1N50RS+#K$ )6&9^_!"W1\[&A&O&L8UF=S\??#6_'6I=U M@HC/KWK8I#-%R<#F?]J_VWI9*UW& '<+&"\ NI#)6N9#UKL?SEY4J]\3YCMR MIJZN+C4B:E-VMEQ,G^) EG>6IJ50F>GL'SHZ4G,"-):;,JA1+^-1>+N9T'U*L8[N^XS\)+H^KR9S4+-V; MUF0WVGN;T!Y!#B)KX%\C04="&D&3KW&^UA,;U]_I.IN/>G3AZ[E:HMO+QN$< MAOGZR@Q>Y>NJ\3M:'Y?AS/_(07U'2I!IXSXNDI )9XJP=W)(,C,JT?] M6+S""VVO7$KC'EE[)/+>H;?3(GE?^*R'B$%T,E$%I8I;"]I2NXBI*-10J]G# M3W=]"CR\7CIL]+@JN?Y4C4;!9+:KBH[*!L!"#LGVCU=4L)"W(\W;]'%(+I7,> M74ODKB\&CQX$2_OJA]&!QG'>/8G3/IO??PI=-#W7.F*X=-:M\]"MJC6O+Q\( M]2@%8K)9-]@?>-EX "K!&DPC>PEKOZL_^63$F\QF+@V<]A^H"5ULB#,RZE]3 M%-5@=_#9Y(\'UXZ73E;Q*CU&+7:\$QFLO/-.(<%Q76K"D5T;;MRQQ8<2VE]< M6X61MF:F!SFA/RUV?VU-)?<:-$":"F:6]^@MFY8S$MX/.ULU3]A(]:G;75;R M30SW(8 AB!Z$,C3/7L/2;TJWX$VLM*[T C3X(F^0YEM>?X?7,Y7=GVY M-=VRCE2T[^D'*8 G4Y3(LT4U_.YIPJKL.(&V0P"HH_ZZ 7SZ M/[R7] 2=6E>%\K4+.3.8H_CY34.O_J^':^.2N^*H/;4=6=7U_L+EIV1K%E%U M J &2^7?N(J!9 @]L>:;*PE_U4[_9]\_^_Y%WQ/J9VRO2U-]?:Y'O5^$<4Y\ MR MQM9E\X'OY?]@I_V_N>V)Y3)UKLGO4F)9WD!NWN>'.^5^ HIOMWVTX&)%% M\5 \#9U(!)V6*&MF>@M-A^J.C?!EH++#PS['1G0:.;Y?*'N&]HE14>(M,O'L4/DV^'G(F53 M'8U:VR5WO$XM4;RP7:MMEB95NJUV;&YJ;U5-A1GE5 MY*5XQ?W"V>N?%/8B\] :Z+,3+I"^/I/'6<__]'PR ?*CH6]*@_L9^DE??>\$ MF@]2+&?5X_NU-C9D,BE;-EV6UV8MACWP\ JA.1E/D/C2=!J5TD]W+PNIQIGP M'J 4J+.9V%[GO(#A):['D_JW\D&CPQMW?#95/AJ65^S_HR#3HG.]Q_>;X/YP MZ8D3'<_MM;,S+5R/WTU=9S.W=0_Z\/#/^YM_,K?V: 1C/2ZX^G3)K;LFNEX( M1KBW9$@7DXI7(K1OX$OA@GAP-(-=M(*F$/?ID5U5&%\0P^X>VL?7!TO!V\'2 M+_>HWHC6<=!K##P]-;O+\];4&T0E'+ V\G/[;N-Q>_::$/OILOA%4Z0ZUX.U M2&*)=Q4B6_?5SEZ>,U+O#-ML75E$D;[\?>_FA==VQ\8F+/+MLLH_3TR=5_=M M7?9V.#GJ]= ]T#-5>9_=L>D73Q4!-UM%P .>4/L> ? E:8[*WC./7CT2/&G0 M :N10@'PX\"O,([6+R)OBZG0XMV_(\>5[D\C?RL;$^:O5VU]QTKGIJB0?[WZ M(/K.BF\#$L:4^/L>EU]9^BW>+@!.>/R6RH^5VESTC[->EC$W_B=AE8=>E:Q* M_NO60]GD?^2%_C4#R9 ^F9NQQX??^S) !QTCB[%8K@*5+Y#894 \)NJ%0"E MFV+W#"5O?KCF7[-:G)\ T.Y>XETT*_5J@TE!QID5_@MUH*F,\!J%6&607Q_[ MN+9 &R T//) F#C45B1PD_2SZ(-_])[7_- MW,-2"5\\7PJ :K&ZIQ8]Z!^&)P7 F/!>%=._RM%'P^0O2''>)?_(6+1 M( =J8;70$:_04J2T-E.NPR!W1VE?I&;IRZE:W)V4E+R=7R>Z5+]Y$44,'=0F MU@O[.N,C".WG0]%!F/%B]GU>(9E6CI'%R\P1%5%:7+FLKNVX@^#AFVW^CTX' M55!Z0R-2/-/EK7=4WD\'MPEM69_9IRH^AGP^PYSD;.9_6C6"<^652VHSZFGY M9*!Y#3TLLQ[WM+W9B3E_?V0]8WA0>[IF;DJ*:'I[%V>!DJ9(;?VU8C$[_H]P9=$ M5//["/5E"RT<%/\C1K0UHB1X:A,4 NZ;>.7]MOD2IF[V1U]PZ?U^Z?H-CAKV MJ,+49.J6M>_OY^Q]MZR4R%5$_/E*'8F?I&KB)?"?,0CC7TA9' '*JL#MAPQ8 M&B[-C9[U3BGWJI@]-Z+V=&64YD_\O@KJ#IMT2W%_*"5EOQ*?>Y?;14R\1NS\ M M6785=LB1W/9S&4#"A?\XCR,*6W?QDULDTXRA]I/+-L$3+Q_M([+*D= 6U> M6=C(.8-S2*$O+9 Y'EB#GM5OZ3N="27?+8><+#M01TWTQ3QO*(D=^!S[_ NW MT[J1JS#&E^2$@9%\23H]?=R'GG0I350G\Y1AP8?G3T M^IZ[B*T;[+1.M'GIF;>]^1W 0':A(7W,G^^TQ25QDL-X4:X76);(C0$)G>J_ M6=JS5V6#]%-*6^L]#7_>VR17Z;%OU+C^ 3_ U$4 MCR8GJ]#(76D[NVZTXPV:P(%DI-/=YMG5^F:[Y?$6/[$#7L63=7>D_7:+(*QY M56UZV*4N"C^+HX$#6(JK 6G<2^?TWC7))EU9J9G. #[#4?=BS] ;^G$;P[<7 4U'LR]MPKQ6LA\QB;KN MRE(\W"AJW5D1?.W#"Y160P)';AYOAUMZ=NB5;][S9PX;S>Q_?.*\^S/,]HGWP\&Z;V8@MX(7 M/<%O8/AJ5E]ICXGDRPJ =/8=2+)Z/,B=+_D8IIK?22C[W$OPT[U-, M>#W*RX[KI%_+?+X8*/QS*/DK2@1+]83R0'0[68Z[_Y11!&(=]NCA$5+5\8L; M\Z,#OU[IO; S _+PV"NJZ/;_K_V/J/%RJ-68+[DD '1=W&'-M^0E (:R]FK- M_CW%\Z_@8ZB2JBH 7M? 5?.$+'#BKTI 3J()(,?P&A9^SS&VE%[\&I-(]86C/1UU*K2^(_,EUV7VH@S_0UZ!<49 M9P]L4^O8!60,-'R,\7 9 MJ58VXE )$@* CFP:WI27=:YR8_59A;W[;:\L[\S.:.*I0&X@B;[R:BFA604& MC'B46J(=2$VHNQ]C<6!X0V1$8T."V6W3J:\%KX^K1?K[[S9TU!U]7$;GB?OD M3,4$'*AMB7:T[O=H;G"4,>Y]&W^=@EV?;K,764@ G3!I_#\/)9Z#R=EF&LN8 M.<:J/3J,4H.B&2>K'G&WLA*3ZUJ:0D.M-Z^FM!>]L[YTX(?M^M?2/;['Y24W MU&DV3E;F6$+446WN"M73]UV8S"5-C M&6^#SY/>DU,^M;IV<\<:;AL$A/S8$2#Y?+I!_M<)/]EUK?T/@ M-NVUM_=(%4JLCFXJ+@GRUGR?]#@P_]S+@KK(JJ\3E(Z:HJ^.NXX#:P.%OX2E M(L&#"(I5#[&N,9T<2+Y!!H^G)Z-E!]*70O3)'ZX@ULY&KIOH#;F0 ^[-_&PW M%.4@_/SQOL1\=^$KMWV^#4#F$^S+T =G4RN$P!=QNOPG_!&8S\):_$C4[O MT7JZ =-\T,AZ_Q.["T[S*VMO:6XK>2USZX#?>BE>2%&LM1/['*^.?#8,VHQY M92R'H*U' MH*WQEH3V[0+@C "8Z&>4W23XA7V29L=\J"/%H;18=_':T"3KJ'U4P- 73\T" MW,Y'SCJM=D%?K:KS!RZX,W9UUF1M'YL_3KUIK4\H=J;W+\D$#0>MR.>%&NH] M3WN4_;;PM/\^\UJ5WS_L(L/'\E^&A8F62 8'K[%5=)#?->WZ)%D, *X 5Q^N MH5 H;RA65E97DE5===T.7#^N*",*7 36GR'^';3FWVR>! 64+E:'-M-90&!0 MN\CKVDNPD9WJ9N^?DL[G[O[!-&0R@ORSGTEN=%-[)F1]419')1':73#TI5=& M&NQ^J)=C F5UD,4BBLO>3QF]'#7\.F*:AEKU+*X?(?W\_JE.^6U _#U[P^$# MSX5U#>H[@!@OVR@5IA?G+&X/+[L83$RLUT0<85FDMNE@8P,):[F(AZIMD]4G M%TPN:V!/2/F5:U[*L-N9[^)SE%(F./_':G<9HXM8WO!HMB)*HQS _'9 MP97G4?(CI$?-3CSMKWD;1Q9"M:U"JU++P::MZ8KE;H.1.KO$ZP8Q9A"1+V6T MMH*EPC"^CO8?&)_IHBIMA/9L:(2RGT#1KK6-R4,PDURF'JQ1D=\R8B9![^R3 M6CBP+2/O0-JS:)6%%1:'CF8Z@T<[,746KP:4.ZLAE^[F$Y&KF\J K7I)SZ6> M-ZCIVLG<3A76*38 CB4#"^5_*-__H*?,%K/I!-"%\%O[6B,O_=H _VX^L'+P M[Q$7_TU6C6;[0[U\VQ3J*BUPS;>_E@#'+".Y-V@PK37@QCO_NY!'RXO5R![E MY1$"T,HVM+!4LCP,-O5.!7N,3]?S>UZ^F!2V*FK[OC%"+?#SJ0>LX8Q"*[Y6 M*4=4 Q&"H!^S#%83GI#8WSI( &@[U=$^'0#?E&:6\]B$IS W!LGC(D7IU2V M=[E7EKE+.=NY'N1[/)Y\Z8,&&&%*V,1- S6JZHH5NXYF.;[9^;*5:4H6P?<0 M.D?(I\BKVP3 [^ Y(C?%GKO'B0WS_B(8"G/:*F LJX=F;&-4N'M1" % _"4 MP*T$;CDH !BFEURXOXL%0.P ?"JRA@C^,OYDS$\A\[U7806C/2@ $$=X<0+@ M>XL ^$IZ0OAAA-\]:/\O!D+_'SG,:&@3C"#[>?$D,TWSZ+#;5IE37UI[^7(% MAT(T+A6&-'$-?B@GHQE"(($K $@"X/I1^&HV D"N.)DP\P[)%2-PG_%2!4!B M!;Z=\-,7W@!C']&_E=.A:[D+,/.UI0H HQCX,QG!K/?_'.<_[#@OQSH*-W]H M#:.'6/04JK1QW/.>SH)3LV.HH_KW1B*5?U$7,1] M5JC)2\.S&Y4D'CI")J+KR%V3 M2#JI$P'I8;A**@R1%?1SCU0S3C0B 5,7GYA8VM@()3V:7=EAGE<\Y61PH\SG M(&C?_+TB*F3:N:1]2QNZ#MF(7EBNXH_^^6&? !C/ZCQI@D*.6$?18IP./!_% MGVEX_MFG]?R0Z._4L\_6BNM)"_61[O"M\>\)6H0+Z9#N9"Y7P9YAO&!/*,(. MN4C,HE3O>WX,^]G7NOOAB7%#.=G+4]\,'N<[N!XXE["9P=D?ZEER>_O9<\", M B4/7J4Y<'5= (1KYH[:X9PFAR3>39/N+9W%#;+8J]:/[-[-+A29M M]?.$>N*"$0O90:[K75CBX/CO\_7&4JW=P/V'7H"-*5S3L6?["0R2]"1%(TI= M+51K5_X/BCOGB+UN1DEIZ1$:4VRL8V#*F6?_](+,MI851_N314/=1+[^&J:GG!&?L$D"9I;T?Z^:QIGWUJM/+=;Y.S,CM+RO- M5^26G&Z-G@(=>GGG;]W_1*9E$9Z=)8.'"9^>=L(IMW0+YQ16C:W^MKITDK78 M$EBROSPX\GE>Z,D]KQ34<7>*UY5F*IT1T@40)?/ZO>[X'60PC4?LY)T9=ADM MB4VS9*]^[I &-.CJLFK,%Q$ '4=<^%MKT+1"[F!_UTK^$PRT/N?JC]X@'">0+'O1->07Z41V"G0UVG/"ZU6].]^%DB_8?7H M^Q6EV1OC*!)WOWF5YCLP;*<-IW5E,N:/TPC@4<(GCWVP#$OG=T]MXV7](JA/ M8OWG?7R"7TIWY03Z_GQW<)2^+:1LJ\14G,-'7QN18O.AJ@1 RYE.@K9X,*6+ ML=.^-1"+HX4M[CRI]ARJ*(+TS"9-EIQ'2@:-S9QDM8)MGK2+C@=^?/RQ*.UQ MP_)T:K.!EO1]:(%UHP.N&C.+OX(WO+/4Y:$]O.M M>N?*< =8B=VR9C_1R:/N'*X!(\U[8M^'T_6-RU?CXUB/&H:K?TM9]]?+Y#"_ M%O-?>,VJ'RZ(B(PIF\V!:>JN_-7 4\>C\T2"5*,DU*[*]=R2[*,D6P*;A1GD M3Y%\J4$&+)<,V DLY *=0?@TS1AH9V(Z^)(NBN=SD*N3:Z#'HK=\K1-_, M&"Z-\Y!4?MA VMRD?$1Y__K%\K,>1VYU9_N,DVEY^6O3.8XNK"4VG16:M[;X M,?<2E!A5#%VVNM5I&T[CR9X=K/2 J6=.>)]6<<2-3NF%Z0<%!,BPBC8J $X9 MJ_+["Z7 7VU5T\:IS2?:Q$%DXM7TJ4G?GB-.10#JA/)5AD^?GHY<:>-*\9V@CJ;EKQ*[PR"]E7@T[0%R+3I(,_B5>[[XS=8]CXBJ0=['(BT\ ME"DG7$6/:C3'R[]L/42S,&BRW$T2Y66@ Y>@+18+2$XT%LV7;/S+TS)YC[D8 ML*P[!.V61>OME47;.Z-^^/1+R':MAI:NP3WA'\QQUYL(UU\Z-S7E(/X]\E-K MF "P:3'FBJ&G_U0.465>"U M5^;HNFNX"MW;7^36NSEN%-FH]%.YI?I[F\J@L;43P]F;TGEXN.IL,YG<6G F M@2(QTO)ZL4O$UM6S9A<@'_P#PY=ZRE*ACS%A(B+RFO>0'()6PPJ _<;E.,O[ M!R$=VN]?@?B/I8%'?"=,F^_F?&TL91?YW3Y2(IXP:A7HX"C[^B)BF!R/VLZ* M[':)G]* B.XX8.)[^_*&J2W+S/GN16$@WHCN,EP*GUT^-YP+@ ME1_?K /?=7(32$TFG$4G1.)56:*WBY7(L77!45^?M3CF[';OD!VLV;?W=$:V M=6KR+\O_8"7M/U\_MQS>)1]LG]ARCGWO?SII:TH&X[S7#=K7A7#.S:ARY[^< MYTC_+3T9A;TD '2W803 R;$Y@OJE&6Z.*I5%_K"Y*)GC]R7N[_F*[;\:.0Q] MK@6M:K'0!WZMJD^Q3844''8\]$P!G6&2>V (95!4 :F[A5=CMD2)[,!(_Q0 JG^>U$$H=/.U MAUJ//_X\AU>PK*]/S6_+W#01'::X8GO&,=7PG1;;=ENR-.!\K5Y1Z+<;QQDG M#OU1GR>'\";X/G7QA28&09PR+P#JB GU5 7L?.^1H&<6<2$76HWIB??VYJR$ M]UVJ<%IOK!@,!.):B@8LA6^LC#&9Y;BH9[PTOG8[QQCK/>,!)99#_U=[WQX/ M5;OVOTI12ICD5(G).<(8 MQTHEY#3*F'$^9<9A+&;-FM^R]WX_^]E//7OO]N_9[W[?WZ\_UGS6K%EKS7U? M]W5]K^M[W]>ZUEFOS;2FIJQG6CJ3A-S@ONS%L^T>E'RL!J\NK=XJ/9AS0.0A MH@1;)GM7,[(\ TH6$G%LHY% C9(5L&R;V<C9M>Q4^)N+6VS-'D0=S:N6+MJ )OUJ3?*F@1,'/XS#9( U MAZ>*;(&?45\H4RHTY0=M'^=74 +BEW*&HY*K_7*FBIIWY\5VW-=>GOZ)MM#O MC%%XXY>KB0[K^W"BWNN\6W Y4#D> ^_4TKA=S!1?=I2'F@ 0ALTJ"N/"VO.] MGC-LY51>%N+S(X6#KJ/)J<5'.MI\K; M-"/5Y+2NT.B02+%W3-T.A;78>5/\NR72: 4CB^IO($;4A(U3".N-&S0TBPXG M.Y]?KM1D_V%>1L]9:P?/L[=GO]T;Y[O")K?NGT_-F=F\CV#-;)F #NYN):R6X\G;C>8Y4BT[4:W,YW7R;W7^T,[2)Z8J# $ !I-@*@ M!M.JERY]XO"Z6N0^%$8=3'D@ %+5;!%/2E_M/%C<;RO9_QDK6P_,>2J;%4R< M4/SZY*"S[:;@=@L[_$$V19)0$[3U!ICJ7S,X:E@?&MM]._=2;''W4JY9.NDC M"?86 'Q;*HK'\@V["L52343 '?!G2"3ARG,.0$P180FQ7!LO@"8SH60$I#G3]7O2T17 MB01 X]@_1JE!HZ4"()!<#8YCF'NO'QH5Z?N;)B>B.*H L*8(@)AJ 7"AN;=8 M"JI8R1Y!;U)'D]W1(SB.)-R+^F"#%*>)[N#/^TUCM:!R#,<'&K'?80'P51:9 M?$SZV_X+H:NA%=A7/'HP&=,Y7,+?M#;-!<<^-C+LNMY+!UWN63,6Z28 8/-L M4OG08?;"\#B<* ".:^&[O?#B+.. %XSQ(+28:#+*AH,9L-Z9Q7C?RGX6K VC2[A>/>'<.]KS%"J %CSBMV&5LACSM6.?[I;01WO@M 1"^1Q0MP93*%'1E6Z![[E/9Q@)@[Y^F+Z,M^E[\H>4Z MODES:B[\%J6=A+[\6H)3#'1!-M8=7*?[='\*U/^VB2H_R%7\SL'IP5*+*45, M,9NGH/Y"XS%<**:4AS#_0]F(!8$#,Z+,QX7[_)?J8.B M)KRO-?)N>^ W0FU<8,_L,\G7W87:)=;.KH SZ;,'7 M^;.&L!2GNWYJR)^V41+=DXFKI-!GUU=W3/IYJPRT"[/#D$MO.O$2L/VX8?KQ MG0N>7_<(;5E3^[XF)W^O7L7N^8L4#FH!R_$X:D<2]87(4#9K*1L:%N>=0;:R M[^3<']/2/UV9E\G8([ZSB?GNF?[;6\=%AB9XCMZO!4!N7-(DE*TRK-GAKL"/ MWC!Y%SY8P$7$T:-NV#RYWZ\".&#S;2#.L1*N$RG]0 MHD#TT M56]P?#,Z#U,I!;(4-)@2@E#2QBR6@5U?.J&O.#0NQ0N#=:PWQYC@5Q7TX8/I M^492-IPE_$L_P^#_VF9-F?.\X--8+$$;64*\"+OP9&;*2AU_BM9!.3HAPN1$ MY$8=42'5I$$/O.SH?,YM3=-!E?U;N!S3^7[O7'N?%LPJ%_8>X^KS Z&S^!89 M;C0LQM- WX)9C! -H@530^X0*&.PS9A=:Y7UHGEX?]2FXJAVBG(A[?JD;&AT MC.7NK-=W1>6##]Q-3^Q,=T=%]7G'T59P68D"^HZ1:U$N &X9S($/L^0TQ/=F M-J+R*<7/!LM7MWZ%W%\H7.O3$VBQX\NA,ILI-H"L2KXB^I^9I M5HO#:RV"M"DX[S?T>')'[_YLR2&X@;<6.<5&!"E^3=!Q^&=92.LU"JSM"H%18[\W9>^Y72%N/..U,:4_-MEV?N9"R_L M7G@QYWD%DCGEBJ-1V\19^'((5K7&@'W.)WXJT3AUD)Y!Z9C#H90Q5K3VNYR@ MOP_>SYTL]/H\KVKCM3E!/6D5TDJW1BUE-^$[:^<@AYL@)W%XJPUW+S\5L7D4 MMZZ6A1_24/LPK%CEZ96Q:.'75Z@C>4&XKKLQQG3#ALQ%PO9J&HP]R,;_M$TP(Z=0) MHYZV"(S'(/X6*@U_F*3%SW_9K+?)0['3_&J5THU7(:ECB1N<2\YGTI;E5V3H MO=F7V!UX0P61=.=VL2F(E#%W)[MV6(Z;S&5L&7%7%[!;<:HB6NE2F4!.1"$=T*8DIKU*(1SC*E*!3,?PS MGOUZWJ?>,*YN<=3#K%?XI=U !(KYE!5%^P;*39K!70GOP2SR^I?*SUMB0X67=V46.)T]K+0BD;*. M,* J9/N=>2IC1)?10>:+E6"A?]G;7L1%$IW?V:$A*WZK,*KP.%XZI"KV^5[S M3HF=YB_.3&ZUC/S<]5&D;MP:1%9.&R-(.X;[=EC\/,\@7 " .E1XZ:=9F4:G ML5N))T&U[T?0N;DXMF\_;FP,B\%NN>Z0D_I[5V(29!\F3VW (!%J-M\L /9; MY\(C^ P&^Q!9U)GN/J33J=NB4N!HJO5Y_OKE =O#7O1YYTY)XIOM9T-OY/$H M%0M5S.O!^X@C%JFDD/C72&C, 0PL^2^1T!_"UF^]PP?J#LR4MLO'9[MPM+Z8 M;9JZY-1&?!#"0R*/3$L?PE-7WTPB6*\Y\WEV]A7\K2;8Y^? M-.EO.@K]53K0$ESSFLK?_QTX;XGYEE^)T/A7XCL@_!^X4J3' EG:@.ZOWHWI MD'"# ##3=.FD3_>BHH;);?VXW/UAKJY*SU-+HT/W92W=QG/H&/".&M7^0Z>< MKU =P"EMAC^#NQ(S\FDC,>^ES<.]0_D=P^M[N6?@RY>5*UN<]>8G;9Y;>&+3 M^<=ZBQK_7E2I;Q6,\;K;.!.,5C]D(*+G0*9(/=C;@W',V?29<#/[U-\YX4_/ MO\&&XZ2IJ6(!4)J7B"[V4D2]W2&VQA.A4\&)R4Y+;?5(RL^S,SUH8V?50=OB M?XH&X.[AV ?=6Q,[=$I'Z-656%B)'YZIF_D9?L46+J\V=1#W090[J($'#?6N MWBU]S%+*.]+]8+BR+MIA"25F2<'%T>C>F4?/\.A;Z@+B94Y:&2-/<^@+=H,D MF,S;!U\N!]VSFO1T.4(L&6Z.K,OQUC>R^_.8TL-NOG.!?<&V:Y56AIX]%L MM]2W1GDW7G8L8J\]?&>;W =\]I-'XF3J.7R+"A;;RD[@_?!2!HL'N?%"L!]; M][ +Q7\[Q;X@)3<_Q3,7<](T2Z&6AP?8 ME&%+EGM;&M>'TT1FU0;;8J'E,**6_-EI>G.+<[P<&]FL7?HB.]@T)3S6+L Y M)=YT_M4%TJL/TV>J11H1K(@OJ47';S[9R1[*.YGQ^;A3P]2C^:X7@!N)8.$M+.0>KNXZ^2,/.GT[TQ+O,;TW MX-EV%E.Z\I)HA9P%7[V80G+AU923IE9=PN")2ST(-Y# KA<870]#9_K5AE/Z MD4EV:5XR;RTFNPQD"P:Y(AAFU:NZL/.^A4'(@+\2ZK+T$0"4".PDBS8BUJ7P M%$T$XUGU=Z;_P;S1=SUA3=$-GA%,IN%S=6Y"CJ+BK=75V]MC.H^K'2RBPN') MSL^F90(4ZO7[YXZWOK/:?RD\U.'^DUG^H_&)>%4L$-E)/<]HJ^&>@Q,[0']J M9@PBF6NP'0S-^;*7]?4B1Z%M!_HVHBZ=9BH[L#1D4?Z"0P]FZ2K)>1_[*.(' MT0PA-] 'DO+>!E.X6V<*H,_9"%?S=AJR4?3+HE=)R.;,IIR7[3WU:D^Z\PJN M;1;2VO^H([%+6C'7:::8%W0>%"- G?DSJ>BW0/8>BT H&[RM/?%)':FE'13O=K6Q+CO@%\<4EPS^+^!Y$KR.44FAORJ%Q+!_A)73*32< M\/$W3X^!P8_AN&0X<=CS8O^DL-Q&KM'[A!-G(M^]/KOXGHC+UA/B!7V_)_*? M-O?_N Z>!*7%4D@IOMT #W8=. M8D2J%NL"Y^T@=):\=.:U&A-X.IFV'1K^PJ[MB YGUU%S'AXH@K?=>&9QP=TH ME'K6K#;/9&>;9,_BG9T?CAB>V.N?QN%U,! 92C4N!],%97XL1BC]T/GP2;$O M#PFK&RH$@+@BM2ABK<9I%S]/HW[YZMB;F>HVSBL]X3-A@" MNN+;=$MQBTODV^1--:]H"A,,KUQC%=]8[I=;D?1D5N^U-WT MJOQ#'X.=-49%I!W1?6 58Z)AGP!HB$KWUFT>,O[.P8GFF^118QM,$4:Q0U=( M/2!F!EU/,;NPQR*WY$^8(E/=0,4?RLCESQ3&PX:A.K42-]W_6 "H#2!CE(^U M\"H<,6,W1DG_$/Y2E+/$5QA.O?W1L&$91";"U65"AW,YZR.?&#FHTZL>7N-N M&4U/_+3:Q29**<=8X739C?G"1W!YS_(RGSLK*-1G> Q#A_,R,[-OI;PJ+HH[ M%3SODT/R& M:O)"!K0T_)/?X]ZED07B]>/M*VFC389)A/ LL7]E)2!2\X-&L5=J/D]W<36WK+EY 5CSX;7 M[#">R186P0;O]8PG% !.PR>I9W"M:=S])?SL$D6[_6<:M/"SG,/6DQ,^^P"O MT+;=:SX^I?',$UQ?]ASAQ$XP8$4JS1U6)Y6+BIE98_<)(YYEQ\(6!Q:U2\(G M'%\VY]:*/]UV9[['&Q6-K48+YT6-'(=7GZ%9S9IT^$.?R13Y\/WY@$S<]X[^ MMTP"_'8B68OCBYJWZZ!,#$WHC@P8H[?*'R11%M1?0'YT#]-.C-ZO^AU-%.DF M?8=(__L3MK['GK^S.M/+2!)'@C?@)T;QTZ8\=Q]H5 NCH3[@M"7#TNA/F5@_ MM*Q%U,>4> <&7&_@)D6&*B^]Z-MB^KGX\J"+"Q;CEC]KCHQ?=\>49 M(_KP XXNEUX$AS#UA4W94UT)XN*MI/7&;UT71_F6;12BF[=.*?A_IOA=Y4][B:L#&0L>R1>G#-\>4_C5\KYG'3K]A[7+7UVYY88;LJVVW?* M=/_5&W)Z)KVXC M;DI79VK\=RGWOHRVOJ84]<;1\ZQ*;/]_/<.,Q&$#%HW68Z9FH(6V4K/P8=[+ MX9XQ$W@C;M@YD7#:U*?LK&&G2XLM/F]@_]L]O&5G0NEVE"\/H@?<8S>[50A- M! ?#(+I A&<(4UE41&J0"\V\'8M@41F;$<0<6=8WG7K'>_T7)]O0/,_\:>5[ M!]/C[T>6U2@=./:E='#;'F.GCRM=,YAIA%VL]P)@2'MF_F+F99S,]]93J#3B M =MY4&"P/'\Z-'\MDR'A3-I\O/KLV;-.KBK9(>^<9K5DK[HB6CP)>(T9>9^' M:#K)N=B??R!H=AH/QW#*J^Q5S56LX*@TPL&.N!1?UHWW^GJ*"2W&$H9/6D.N M'5B3J%6O5W\LKO9^I]%)V2&* W;M"I0N "1 UY$6>_$ER"5J\"1+IGQ$YES\ M7,[7Y#EFLO@!V\N/>-:53-LCROGAI8"[)WUV!R#^XE]\G/%G7/__5%RO4X%N M9)-\M,8;BYQ9<3HFN1$G)8X-Q-2U5=4O-ME1OUAT\?.+S<"T=111'E/T@YSE M;/RP,WMS-4YNG.%[$=&L=]7NK?/ A[8KQ98;Y7%NI#_*N1&S)8LF57.F,*;5 M=I?/>W#MZK(50L/I4#4ZAYWJX^:M3$BM*MSSD%FC*^3ER1+;914LIZJQ=YVYC"=J,,!@S4FPE2.U:%R+C)YNZS9E<6^M5KYT9S^.O7'HB^' MYAQ\Z2BQ3_'UT6,WQ>O7_46)]$31!<>9#,PRJ\A95S,[\"TQY?2SR:SA2VA3 M]8$ 2\ZJ^F5.(RK3!)_APV%%(_.<(@[/3=ST0')AL,LH%5UPNK,67O?U5B>Y MA4&C+@9/X&[;S\MC4X:%$HS8V3O9U(JJE[E%5!^1.\W[8Y8.:&@499(V".6H M+J-\IH_5WH&R4DM!ND6%P1R.315EE@!PQ2-:'**"*AOC!?08:T9K8<[*P(RK MM'7J+0LA3U7"AVL'=^#(C"57Q$/LQ6;>$ 2>P4X\S;W-]B(%4$I4O#_(IOI, MR.EO0;XL?O^38!'OP3_4>;/3P#-JR4^55H6=4 M8M#\(ZR%BD&F\X+GOQ8IA]CG72/X-/MM<'=:R_NYI"I-DK(SO=QJI%)$>XI^":3O)B9"<'],\M M!@]PHA\*QW7FLJFAVAJKQ:7H.Y-7AU@%OR5$#*F?KW.[<*RB:G75)JMBE[)X M*7;U+;V-J005FKU"5KV6U^HJ-7VUO0VN5J(W= EWE2Y4R@)/@A^I'@ 0%5H M9Q;1HV-8DR5^VQV12?]\O-SY2>G)>#.Y:'\'*\.WVT=3[SS.??)('".4 3<0 M#"P2\JLA^.@Q#*A.030]XMQ$0[:.5;Y9&BN3T' XR+3HE(EIWL+XW@6;;OP2 M.VWPW6BXX/>6:/Z94P>OBP3O%:F/H#P7;5Z'OKSC:_3EQXW=7).VD#@C_[HID8Z81\)^XTOL0 M1'/2>N6ER'U:EYZ>%'4/EJ@+BMY9#9XODK>H+]GS[TXMX8YQ[=A78R[S-A&W M%42PAK3BY]0O]_FR8?D62P61<\BN;YE[+=4$-R5U@CK811V/Y#+F"( NYQ L M6(#&$U-^=^DL[\\^]/?7UO)4'RW\G;6UM%/!P'?6UOZ9^F6X"I(_3LQ[$V'3 M)+.ZA6CS M-J(?XA?!;YZB=0I2L!S37+>ZL#&R=:!]<_;'$Z1#1?G7)/;XF]TM.5UEKW4J M^<7>M=6S7\7^S&'\FG7=3("(U9IED1\E=RA,&EVF2ANL)VZ Y3M"J$'@,J)7,L'%,%,U?WM& M]O6[.S.&)+;23NGHOEJW>F%V]MP#IK.?('(P%L2Z<'WJ1G*ION3%X_RK&NOA MUG,?Z05V8=N[5*'5/2*B&D4/EQ]3"GY^N/%F^>P=N@O4WGEO\*;CLBBE."G2 M7.)I>(3Y1>BPW5SJJZSBXJDA]5:NQI>FCT;)!2<.66QY_<9:KN0@:6_.JUQJ M;O!T5<^V1[':$LG=M\9S%E^:]VC^SU77G[,SWVQ=)=N)W%F0X>_'FA/,.)Z7\TN5^_.BKFM#7P(,#E?L99L(S[_C"/@8SA0@M =; M=#JLJ6S'C@!_ ># \+678Y.J+#GEY;&.-+X%K7"%K-<7_U;[&X_%"MGK+('CK9G0>\SF!BV^3XP;S,X8S]*Y.'Z)#/L0E MJ02U8T4&BQN4UXTX2FK$Q*Q/N%17X98A7524=&!/CRJQ=8>^#+<"OO4,<1( MOL'@65P+[_C=6J9F $/,@QPLV;_^\MQVRLKBAJ'4\.N;VY8M#%=X4I\I?PY/ MPBW)Q;76HHLLX;7)!*LN>C\Y1X:F<7H7)_V>XWD=3]E-[>>6>F:I,E-V6]\Z MLVVUCEK]0YXCK&,-:PB N<=F7C35D1Z_B3W1Y-OA(@!FM1.WP^D>3Z-P[("0 MU[V%#6N*/917!PSG:[JK#Y6IWD^Q6[2N,O^6.M6-"FL&^$(NFGZV<7D%[!KN M!=@"2C'ME-_B0+:@CYB5GPQZ^O6K"6'AQQW(\VTVA MA)H[.72-$\!] ]-2RI^[@ HEFP5**D',V1I*=M MW+9ZZ]<*M;Z[S\9G%^#^4W7+/XI\UB:SJ-+PY=+V%:\X[B$>A/-:;?/VY<=$ M_J)DVG"QVLUEY^.2%YF-&DH-$[JJ&1K=Q[-H>B?KJA,.TJ1F=5/9GP5 %LB7 M21=!,28J "2/N2.2M54E4@\[KJ;JV78MC""T64=LF8.\'ALY.+ZN%-4>)K/3 M2C#,J=/]2&5;8A C:;\+TV9NPY5N6/G9LWXVH'?Y.3!GU\WU\X123P"(JA = M8FYD5_.%'PF DB<8ZZLNQXW+^J+3:>16.H3 Y0+ VP_WUUW@X*_.240E<0NA MC^?$>0,9D"-F*F.=XOQIJ5_MSK+XZRDD>!\1BSP,GX CSPKX<9C'K0T%)_LL M_[I[0.0]YGL.,22<; .&-G::F6E8K56ZIO7^26IDV)Z6YBX-[S*(=OC\$)-_ MN\A%R3HS;;[6NTU5LP3 W:AT;_U_SV+_3,[#\L'M]I$N'%W>WHE58TIU>>[Z M%S2SD4IO;YL^"V3Q8WH[JYD50)YMH%2766Q8+?,/,)[7_",R^=-4R;]5Z'/! M7YT#_E4;GO5RKY(%@,$& +^ZN MXEZ@.I"EX4L,[FGXLKL!94$A0=S8QNK:G*,[YU'*Z?SW_*CSZG@N'G8;<5BB M4FJ[3:EJFP#8^7>+;V"*.Y_D#_9IB_ GC)$U!LL$P*-/N,G&8^B'!@'06X7C MC:O^=5=MZ@P:@CGKLM-,TK28H0#PLOS5]39@=@ZFB)P E+_@5[M Z@_]A^IL M?="NWL/&:7P0[CFS_$3 H[1#K]/3'RG1W (MK *%GV3R"OS. MW#%24W)[E+9VV4K?3X>N>\>E]F^Q[*90?N'KE^(*M0OT'+7=( MCVB%J5@6Y!=]TGIUK2?G;O'S[!W//V8N4[\=^K3ZHO7_Q4L,Q.,P;Y@&CIY$ MM\RD\SBBOZ2[<-JII\#O',PHFH-QC^U4/A2#/DR"-L*U D#9'#<]AN.O?V1I M),V[.+7LA]C(-X2J-^Y;WN7<*8(\+'+G8_;5D%-+95-1LU]4^!78M\N@(::[ MZ&HP8^?O**IX#0[62$7B[@0)@%-BJ6BT?7-U+E?F.XD/Z"B[$S4Y1D6+*9]0 MK<[:*?6-U$YHIE?1CZ^'_2PC+$[N4'#XW_ZRS.9 #XL%A#T"H.*ZBI_;1,TK MDX5WG;>H/W9)>3VU.'_Y]/0!X=QOU9T$NXB'D<=/H[H"H#3-'5U7I,:,&=;F M67G77%?N+0_31>E,)8B(XA"2,:*7RLT2 $D6"$8B2C.QT'A\%E=;FE/[G1^@ MWUZ] W?:\I^^*^,[Z^O>OMZ-Y%S/80?>?J)($SH?*L\J6=M';A,[!^4@F9>[ MIG0V6J"4&O/642Z?&=;:NPR4Q_Y-V;L)/^XD #">Q([ (=>IB7J*G1^DF'=D MT_S><10^)#U[:WKI4$PATUR%4&5&*-;T$B\K,N]H5V*M0.-5-!-JY^[=Z!Z[ MI'&O6].]R-:,:#UN\+@F?(9"KT'#<"PR*H%Q>A(6V2^,XAV%ZA)G^E!F G$& M^&;H:@$0 (W+"8![@]!H]A@%]E]Q60#L($]9Q0B -=>&I?OP[#?XW!B^+(C) M0BE "@DHLO59H21: QC3.#V70P6/D$5>/8(Z@N-QKFCUCC.PJV]Z"UP-%D3 MW3=&5_M(9490,7EJ0<$0;"J.ZALCFVR&'03 'A+' N,2JP1 -<8* ZE,!E]X MIMH1 WD.LI9=K.7/AKKWXI$'O3DV"= W4B)]IX=+H'+JM)@ >.M!G3H"56SH M)$]C-OSV'G5J]^QN1O,#:=;(:',[UM!)K"@5BHWFGWUE@<+DD!KJ!+GU=4?;SIN;P^?/!VLC(YM M?+A O^_O=;'*\O@P:2B==VA@RX&!I?@LS\KY)^.5(]:>8C]R\#AYUW"L8,Z* MGN3OM)\C@\P4?&(@J798$P.078MF"CY9($_-!$#D/ZL(($L3]L18,W5J?[X M4!/_J07_0 N^7<6JHO[V'I0$ZDD<#FMNIIZ]:@@JW\FQJ&"P(W+#:[D7LG@Z MK8@ ..=P+ =^.1A<)J\<^G-!3V!G.?SM=WF)-C6HQG M>4&SV"K2744V 56G-R#W.FL]:\WI[ C;/>9?Z^MP3Z5LJD'V*!D31#@X(\W9 MU0) <>9="&NQCO9+_EE_\@/OF\H\B_[MN M._-@PF^700; MG.:]!IN)9SIP-F%+E-AD0,,JA_M2O$*X"VS=V_5&IUZ.*:P MN?>T&X/YX5HI9^2WRFV&O66OC5>]G8F"DXQBX M%/:JG")+G,H\]N;ER77SPW6O0>+%6X879?YKCG\5E.]C!$C ;!HIH2L M %C;A-F)(]:1_S:@ [^QX=^TYJ0 6%Q^!^K#A+_."HN>:O4?%XM^#RJ^8\B8 MC0B C^[H02Q,>%N.K@J8*?^F@A["8.]-_#\MH7\!$:WMBWGZ:%V)[*><]XK' M^ \,%&V/#O9C')WV".F4G<$-LX1U=\\7'(B9%AA]WR9!]EO M7!_F.;KMWQP:GPN/A.JYE.L=C#GI[.#!3TK8MFW]T:HW:9K!&ZFO^69E7R58 MBU94L]:=U;JFN#6IN&_OL"[_ 5C!BPZ&>U&%@U@?ZE5F_KWC"";[ZR"S&\3& M?#6$=70N"36FE-;2Q3.?4.Y O_DA\=MK 9[L/W7/1S,W7,B/ L_5A@J ')%@ M#WTAEON00R?._VK3=L++O$^(Z5:GC*[U,F\LOB1\\;&C LT%'_^E5Y@: J%+ M9AY4G.%3(1Q2&056PM$LPL 7U&'GSO>ZM#'B>C@J;;!$%&TI-,%7H%(E2]Z? M]$Q-7.Q^QGE.WO!"W2\JHDOD6@TGR+!.,]<$3N:IHJ7F3Y K[.(JWTY\,*K? MB*Z$(\LG ZV]UA\W2CSBVBT2=<_.T.WXO+GR#^:]C>6='3.I]Y![>./]+K/\ M>!=347J-UH+WHDM\7IN\_<53^M2/T;A14AL9-<=54[FS(+Z82^. VJ"HO%6] M.7@P*YC5?KA-7;)*?L5U:;TE,UF^HM2N![ G6FI-GE96N_I0RM)0@C;G7&"P M]!+AV;<^SFHY^.0/RQ+Z19\"A)3B&Z?&.+6H*&:0 MY%O<",3QE0#P\4(\&E&AMG/SW<%J<["].\G@QLB:!7) !EAJY+(@9LF*=\ MFFR4YCY:-,;J':[F;49D^.$/N2P.OL(D%;Z\YI9S6K]M28SH_NDCE>[HS;;=L6B;8A0;/SS41)5#EK.%N%&P6 91O=E[37^S#7[1_MRT MH^VT9S6NLC474\V4GX?FT6]?W!KY6C?1PV:T)SS\'G&FSIXU+*DS5, ^C<[' M*.B"3NQ:=0 M.U+157QRR>H!!N9-'*DM>%9MM:M+65ZF1>34+:N6?QTAN&!N1 M%;ESTG7!J\#NL(=N$R*O^#?!CL>X['Q$Z@;W@@7=KF-/(N2#NQW5.W V MFH@TC_F<*M+%?^&*+B#$8=U\2=QYIP)7]HZV3]A2U!C#+_OK?Z%>^.X>Q=6K#Q"(C7YAA7S&09#$VR MW)=]KM&>@AU2Z44-$?8FPY_:*MY9*-U_O"NR>=O(#MSA?V5M[+?/AO?@+U9DK8LVW%YQ'=^.D)?#_06;S5C*53ZAYLFQ>YYBE37I0E M5B3FSE([4M=ND76L=(BT.NE2YC'7BOU"T5:)0R&,17W;HRFG*0.R^CF3A>X/ M^&0/]57Q+:]?'4L KV0A27=,E*ZL*5D/#[)/U7 Q7^Q3293ED/V?-XYKMEJ8 M-&MK+B/X:$VM:]3(S7_:87E+!-V_^A=5H38#+>\V6^-;D).7 M)G<'#++;!0!+I%+,N-P*OC-9SI4-76I=N.9.1* U%QTX'6A]E!0EY11AJBBL M.UMM*[G#>+B7K=;I2(-DB6=*B@O9$Y6A1K']0!D%S1WU% M *H_I)A#-3+"E3W7>$QODP]=2\H:]0!PO71NT(^Q E-N*G35Y(D#G: M>"7M_NWH*K[6PTW+$J8NH<302P;G%_;.OKE]1!:BT10D8)5.<-$ -1=$)'F= MJ644/P6-IM,-5S1#VK78XQN.5"M1!Y**\XXN;-KX 467\1HXF MRR"*75UJPUCL?D7^\E&?MRUO8R&_\:.Y:C49FYY*;5#;+/E1TF_YFQ/;*)&8 M6N93Q?!<*C]FB-H16R*:?V>PDB&'&*6TE:$'[CIMU_!/=/%Z.GC)=_*4CVJT MLE+8I,Q53NB#C?A3\(V=#8CFHR.PHTE81,/^[."FQN59UEL_KO:YP1;1FM5) M9N^O;4MC]B)2(5RKCP+ A>IG(-&D92$.AUA^2A^O$2/N7H^\,NM/UWNS=,V5 MG3T2O%U;/K:\J7)I&QRK1<4< (@FY;WL)MBSC>7.!_$V?0[_.!_I%SXN]IAAT_/6"%-,ELTX6W#M# M>H\7\:[#L>W,-3O7O.)@BHI#%I^:K#10^>68,RKA##J3%M!M8<\]SD(:<3EV MR6O5DQ5O/ R-B:L37JIZ,AAL"%858D)T <#5YV> '8DXMD6M,"&11;Z%Z+-Y M7'^V#NF\MR)!KESTN?(7_Z!G_9.7]#-B](>4;S.'+:+4^T>OU?:L&S*RC>3Z M\N-+M 4 ;3_DA+_IB5\*.L9!3$JYNZ^"%JD:79O#\4],-?=()_C3)6*]R>>B M=706L'68>@R_-+]D*.^XF513F;'(G'7SEX]P=/LQT,,[+N[M*8I;>LS,F5N(V M\'9RG@4B)=/!J*3@"'"=:J>2,V1Y=EB]V?K@H&D*8 [CG,"&_B8&4AB+:B"];VP C&5G8G M41>W7,X*@^3;CN@2_.;7LAFU.?SL#^A[?FT+$B8 G'"$7;P!7B^7""MW4%O3 M.BQ\(4=*P 93!=\.TL(C?==WW/=5M*.7WDW<)G_%$&_ZK$EE$>N;ETSY$]*TG50)QSCC^T'ED-<<^+'D7L\TP_UWAA]3MZLUS MC]Z>IQBM?;'DP.'=5K#X$)63ABYXPWQ8*XQ^0''8Y6J[V.0RF>V(<25Y"6+& MV^7DO3KZP_SU>H.\*=?TBQ>?V-<^N/_VG6F\I6+ \3*JH>HC\1 W 7!6,YB< M68M(\:H9^9XTTFUZ_AV])9P:6JQ'0 5I$6Q_P^C3>#IDIG \.F&%S4':"FY] MFU;X]L0'$L=,#H=_B2 -Q?$VHA\9V6*]PRH8&"[G6)2*DJ61;I'XKQN=]>4%;PT+S-R6%R?);D$[9:^0+ECMP]_'"H!,9 M7B]>-I4[$F2OCO5GP6<"A641G >YPRF]W(?LW.<&^QS"BOV>KWSM>OZ$!!@# M7%4?4%SW M-%[4IK@@6%-#2?U9_;Y-3^8KQ=^(Q>R) >N4V35DY+%0ZU+7BS&7\Q?\!(/1S M^[G]W/Z]&R1H_3]02P,$% @ \H%.5$@226\AO0 T_8 !( !E=RTR M,#(Q,3(S,5]G."YJ<&?LNP=84U^T+W@ D6Y Z2A1BB ("%*4%A&EB(BB="$" M @)";$"0F""]"!%44/A#4$!$!*1+,:%'142*(#4%%0N!1"4<29OCG7;OS+R9 M]^[<^=[,?/?D6PD[Y^Q]UMI[K=_ZK9.-X*. "L@>TE*3TW\;?0?['KL*B(B*BDF*;Q23_FP]!-R G+FPI\EM$ M2 ,0EA,2D1,2] -P2$?1?U%/"/B?#B%AD4VBF\4@-:2@"UID(?5%1""E12&- MH;,WH// )CG1K;N,[39O.Q4HIG%9WN1FWD-QS<,-/0KNHTRM_4%7DB0D%964 M552U=^OH[M$S-3.W.'#0TO[(40=')^=CI\]X>'IY^_@&GP\)#;L0'G'U6DQL M'#K^>G)*:EIZ1F96_IV[]PH*[S\H>E1>4?FXZDGUT\:FYI;6MA?M';U]_0.# MY%>OWXR-3WR8G/HX/4.C+W[Z_&7IZ[?OK)^_?J^QU\$_&W_M$@)$A/[GX__0 M+CG(+N&_:R#VURXAX;B_%\AM$MUEO'FKW2FQP,O;-$QNBLL?SGO8T".AN=^= MJ1!T95124(PE5% M\@^ ,95@+MEA BL^9U/R,.'(C_'MV 5$<3?Y;1)M.#BX0-NW7;ZO*:\I936T>AM.([<_0F]"*@Q,+ MX;*&)58SO"XGK5/2$=KOI%S9-U*PS"R D\[&3/)UT<54G9M<9Q;)+OT8Z_%# MFHS)TL!&2%>"9M,'K9:<.IK'W*S';A-=E0,BU3_\;V"$.#Z8LX6+JUQ%#LV" MN\V1KH77Z?-#)%L6]KO)H2.\-,8'.I+]AT+"P^/A+L61,4F1^%U-V]I/:Y * MRBZK+B0;<;=Q^%)MS')V,.^?,L)A\"#G!->&)0P6TXB9E[7K'CR*M/2HF-+Q M&'^8>C=\5'"Z#/Y[8*J\8!(CD1[*&^!*% F#3- CCA($< M=@L3SQ"C"X",ZX/WF.OLD0\C2;53]-U5VSLN3NZ>&[":BQ_T:\=49@'K!OH. M>7=4MH4O^S M SN9=CO?BZ5&PEM5^:.4!OP #(]H<.NW45?A[M')N,:3ZM\HO<.K"HZ)J938 MZA.<>Y"^M7^L_WL^2N\0+-U=J!S2\C+O$=:0/XEC'A])03:'D0G;'C=!RBJB MK_L-7SV=VROE47HJSE)8X^964R$Y!P7'X__D.X.%?'%CYGZ:6!J)FD61Q1I> M@,-,A]RV#L/Z#?3\(Z0N-;7DGYUC)"/FU,^@X0]0Y6N)LT'4OOSGYP1 M67^7Q5WD/<1=H&0)@&8=1BK'A$^."X Q1S)_XU0Q6XA@,IT@@6X:V/]U)BPK M1C1W[$!4G>K"FU7&OM[ZN$L79S3EI%?C1?[/'<$.NO19(;,/K@'=H/ M=+^7K6KG>PHC8.<$\41@R7)41=[N37(QU;U2BCH[X37-7DL6_39^GB TE:*N M+-2R1 5_A+3%.HSYB[K>D[/EEP.(7*3(NU9^;1K!F?9&LINRCQ.SN'U;?7N4 M'PC/%N;=,3#6O\)8.>XY)Z'%+73!LNN,%^E]^B,[G M> F 5$>4T3]&^2JK&DVXIGW&&?E&>P=[;@6>_9R(<'E23T8HAY>*@S*B]$P,C7Z#'^>.5=27UC_9]&*K MD]^0V);K1@K8 804+@(&'H OXI?G65<'B >)3'429[]WA.I4>B&YH]0PY,5$ M^:W!)M,OWE$?[FDKCIK8$P_\3)4O![ MIY#YE%9L'HR[#<9.&NLZRCG.[RO= M":YS-+\AQ*\928*H?N%YZZ,WF&_\1"X56IR>F?N$;WYVV[2MK#PJ2=Z+]S&+ M^%L )%V8QX[$D9X+@,0Z4@@BVV 1EYX_??8U#2GWYF?S^*S-IQ6-?]X>?XS. M5CYO$F2O=<+'(_.DT JT$ * XL/(91*ULA;:%%F3\6B\WNNDWX5'.<%I%[C-"=5:/==N5>U@"@"^Q##' M 3L$EQ $3SX(%+6%"6%V3C[!#0M\9@C$Y_Q/5AST"N&I4,/+=ST6)GKL]?SXM[?KUOEB*-AN9&9M>_< MS^755!^R WZ[J6$G*"WI*3AJ)P(&>58V)4O5FB+)]6*&>;%,P.ODWM&^*VV7 MSBJ??M>1]SG?]6&<"#R_ZK)T.C U&_/GLM'R,/,T.TH )#\@ROMQ)9@[TE-- M2W#L*U-U*UT''QYJG;FHY(P.#B]K.7XT>DS7E6[F$7OKH.B#!^WUTXLT7#\< MW$M8SF/I+%KTPZ:':,A;9@) &;TTX.N5;AT.X5AF46I= Q7>N# 27F5?9:>8 M?9E7%/7();Y!M+UO="RRN M/D@*6=QC1I'Q P.,X[6*3J1JO\5&+==KFCSXE&7WZ=DF\:2&VXHCB5PGEA$C MC#GNQ4O#47,I+22&D%+F&BIC8R0#1[N,7NJSK'T;1;?1.9SFDNVZ9^6LH]6- M2MDWFW8=B 2V3RR7,X48T=#$Y%&"O2_2H7W&>CT3"YHC6&U=E<^ M1$>\WML\;M"6?G[V2L'MU+2#\V&S6ED/*V3[E0D&EX0V M2/ONK1*U:GW3Z/:G2QRUM)XEL61DL0!X'L8(A+##@=<$N5O]S&FJ_PC#F-G4 M5Q37[99!8N:$K\LP0[]L^(=:)-0;QE]^UJNQ*VKJBF&(P)@F>2'LW%(M*I-X$MF<]RPO936N)NX\ZO@'@'0M[J)E&J[EU)B M0:LG&Z6]]__X+3_"+T^1[#Z^NOM%PAZ5"OQZ]F6MX+>GWV3ZPDGZ/_WXL,U9 ME '<Y S X:89&*DJ7_CO]FC1DM_'1X._=,=3[?'T(D3$&DP1 MW42FM**X"E:+J.4[B_B;E"U873"82DZTUME"H*(R2PU?C/^NR2[QG:%_7S]C M[EP)#6]H.QQ=KU<_?4\<7YPI V!OC2+Q D#M&FJVF"\.S="F=[RRQT3P,XV' ML&<9]=L8&B5MQ*;2]>>#W%)G0NN?%">\\/RR,:-XH2PE^6*LJ(_'W!.M-(X( M78F[%4&-+F:%45<9,AQSD(]*\5WOI<@.Q-/QLE]C,PTH^-_YVQB6L4VQ/_<6 M$F/GBK/3'DR\UA1J7P=@SW7KW]:G70:+^9(HSE'^Q'6O <(TCH8:R%&B+0U M*8H/9Z[WDS*4"J1HLU)6^L'L;*L#S=D3:0G9Z>WW*169EXY5G'OJ1R80$-3' MI(9UAA=' ]?30MIJJX*=A#?7CMRR/L5<'9B4H [[]:F;?_ )?%\?XV^X:;QE M!]]Q=L;TQ8NCVP:_YYGZF2\"(FQZ%K<$P@ R]K7M)MY]6P/^&T(+N9N@AA[J M$P *7'^..QC<3=0#LY6R= BG/EPK\=5OB-M>8YP017J!--1.L9/5WJI]?.<, M.,2QX!KQ$G'4#D(#NYQC,%#[%<'LNHBY4<'U=B')4[[#F7<>$RIZXB+-9OU' M]%U,W(SO#.M0^L M:\>:3*PJ7.%X$,%^Q'N$H]Y%-(YPY?>SW9FP@=JK9]^3P@QPO94KZ,O>47N^NK1VMJPT5#6_*JD_MC)U.^W@(<>5"_5L!D$M@NN!F_/HWEGJA MA@!HF$JTE<;(LBB)UJYA-1$$^69"UDQK33R=IQ*,:_'^_G.'XGR+V8LW3N-S M0_J8>@%@XSTE0Z=\K*?%,1!_.38FFE?,-P#;R!9$$9;8\D#PDQ]8=:3Z=W1' MP>+I7//,T/"WS_UJ-(X9/#J?CCGU65+XEM#&.%*!O^!+X2I:COB)*LP[?$$%%1]H;=^#MO,Q4DH) U_)N5)ZAL?SMG;L+_Y M$N\TV(ZDG:]H*ER&!5O Y$,I9.JSRY6 MF-V]8TKX^OQ->\Z\1EYO>[>FWB%+/*A#81RMP\[@&F!]B)FVL\Q=S"_EB_7B M?A%MUS4[XR\=_VX??['O%N(CC[,8*"8 QS4/PA]>FO^3.*+VX?SNO.G27 M,U6Z5&QWR5$ &\7_0%!#4$D!4N!!.GQVEB:#[\G1[UG8,:[-DH8+FS$DV3>N M1&V6#R$Q@$L]'HI,>[3.N>37$&7$'.R$$O\5$W"11[RQL@;3. X-I M7>M%;?VU%L[-3%AB7;VPS6I&C.+/A^,SYS:?TM[:] HPD-_RQN3P%$3V>PZW MK"ICSH!13["].&&CVV@.G9A\^7% A)4%F8: G=W<1IQ< ;ZU[BZPNO!Z<\*C M+%NGI7RC; 2U$R[4M8MS$"/)2^'+<:W& D9HI#[2#+Y[P[K@ISE+YIGQ:WG8 M_N O*,.#<0>W-^7'1Q^RQ8,-'&_^.(+I1LJ&;Z+R&FQWHU&#I9+@,/TK9EMM MI*I%VI9[ D"\*G/E8?Q%&=)JQ:_F;T5['FI<"5Z,@TG#1W/VV70B=80S^1&E?MCR:X)Z"7+C "L^5F/PYJ.Q714O*M MA_2>BF8;47',:\/$ZAK^ %+<6H>6$C850YK!]7H&J.<:K>51 >S,>!51&X+1^KEB16?L:&^A>UCMVWX+ZN'\E"!$2F)OYRZ?SH= M\8C7.I]K$0/\(?/%&9!RF\%Y#HIK!J92C68Z:;'%-$0V192+NTI=S?"\+M(9 MWA9G#+A_GTTP/G.Y*VJN[]-"U<6LFL,_V'.\6M-Z$$KHN'-&RF!]Y.P-HH=[FF:KJ7!?+![XM>_\C9;O".8)PK24#^\N M7Q[$^X$/KH;$022M*M<,OIWK]G+6R-P+-^"6!31X]BM#EG,$;@+I8(7]++%*=LO8K?R!GI M/?",NY^S'Y'*,+IH;5)[W7>Q/^YJP+M6S]+8K:+Y(7YI9V*2W\U^3H1U7J@? M<)LN6APLA>(Y.9(4O@I#SY)M]=L(-+<,["X?M$TSE&"19-O"S?_D&-0^:,]R M^M31FEER]ZAA<(BD9. 90SBCEF."WD:UX,J.L*] 'GT7E.H/V..6@Y5@CO2I MK<) ^N* 5Y1!91K^B_$5FPPSE#-_ICW MS! BH0O6O$RB!N;DZ)I1VDQ+QUS[-[) MQQ/G&MNR-C1_SL_,VAL_.(<9'#=?AN5#Y.%6Z9G D\Y[;P&&%T1^(Q=1 M^*ZCS#[:B?9%_&90^-> [X=[>:KPM&=:]6RU2S\J MQJ3_SO3\6=L?SW/?%%>JQ%U#&M@7XM?,B]OYW0G9FZLM^ZO:>2-65/G_[VS*HV2DVC177 MXY9-V8P+=IM>H1PCT.O)>#E_WPL619]KYGR^JA[-:>^8: DORUD,G]%UT$CL M"G*&&2J:BUG1VA@W68[4*:Z\[11?@LQQ0S_MZ[\#3G5?0=?3'',9U^Z-?YG M#FN2GX1;7'(8-'^1>>:L5L,FS]2LQG3\52Z'XQN^D5K(W:'$V?.CZ'OCM[]/ M6:Q/AY5Z' M;#%33)[4W_;X7M"G:^Y;SZA0"\C7@65<.%X-UW,=@Z21MO+'D8UJF!U,]U5MYXJ *BM M%$FH+DS2]8$F-1 33E59-@ACSM5AX H+ 8M^+M],>X+E*Z\$)WQ\M35*.\CJ M#;?"JQ,[BU#D7B[#(%")E*:?]G&L,+IVSKL2:G&XLW&XTQG'R[4+P7>;>\ M':SC\Y6CQM?OE"%**$PD:EJG!]$0QY5MHB&6QYE%*B2:.!C"-V2#Q*,&^K^=@CNPKW(:T!<- )UR#>)\OPQ2FO5K2Z#.A!! M5M<;MT:PO.Q'K4TO*G5[6>:W3:\LKTB_6UD MCOHC/@@BR^V+M5MUI:";K:PKUX%1::^N RMK-YXHRA/J8+VQ//'L:Q-"B-JZXEE M0$*E_*E#HO^=! Z1JY[CN&!4A*FEZEFXQ8 ,?-**B MI+YM;'Y0%VXK7^AHH5@0.SK;/WYXOM8./BI7W%0I$ \((L$C",T;V%EHD/I^' R=3+?-HS[H,J:Z&,'05R+] ME?H4QU]_F3_>X'I5:\IKO^5@O7'^SEVW'#(>Q.'*(1WNXJ@E4*8VNH5\/M(_ MDJ-NSL(SS,K0%#=PA&5TDO6NO-(;T:(+KV8'G;M7GJRGUA9VP M-!Y-S\713KNQ\<_5*"U1' OV.XH50N'M,$] M6GF(>NP O!')0##+O0GT5<8 )WB$54R7^N9:&6Y1@-W6\KZY5LHM7K, 75MK M0)ITL;[=^W/NF(O<)J=LU6K8[Q!YH7<8=W" B:?&I8GE$,VXIYE+R;\].[-& M8W#R/PHV;E27VF?0?X5=[SS_KV9"!'%)"Q_B-)$SB)1*W#-2*Y\/37+ M,:XE5 USA^I4Y<;W&OB;B5SUUF MOSJANU28Z=B[NOD;80M?#6U__+VIC.JP@6F.DD.#2Z2?KFQ@4)9N]YF3E@!0 M!L/CJ(_@3.?Z#&0S@:%/,YH=9^_E/5N#W10 VS':C\S3=3)WOB^?^,U+<#8Q M37K''G/PN*W?*?MV>[!07M:143(+Q9> +>)F"MDRX$..,79* +1ZMBRB,G"* M>TV_QI RGX,1LV[)KOZ6#)0IQ\_59+-W_MB>OJ:'.).KUL_&]NAJ0Q1I3WM:N:\RN^+/VB-3(M M.'ZGQ[QUOK4F7+L1,\O3I*USMQ4OUD-:4Y_XKG/E(WZPZ]^;Z:-DN8@69LAJ MTF,P6._8M=F$C*5<9)MA#;ZET+[#K>G/>:>/*>>"?Q3IBBR-R&%'D"T"( UW M860[-QC4Y]B!YFY2Z.]O>JWJTXEF3(_AM[XQGU\VSIK]MHA=;R@P&7S2>&@T ML-]82.N\L144282/A=TDIAMJ.NPP[SY7I/;U4[O'_@N4[ZKET[6-\PL+9U]? MM2(+;VUEB=U]=BEI5O.,^SN[6/9379%%(W /DKLU>P#9"AM$"?&G$8TDAGTU M5Q[\P:2_\T?8LP9R;Q?EM#Y\[/2.$1@?J:DW)!NOK5\RQ/EF3]X9,DNBNGVT M8E<@FE;[9:06IQB=2GA;0\P1YK,%=0)YHZH/?#C6O,/2J=*MR?N;>>$^O<1Q M:[R^*S',^VWZ^5.#!"\HDD6AXMP1>6LCG2LWCZ#FX3E!Z*AKGT>#1]URTWO# MN;^J*NGS>KQ"3MB%8OWGK[]$D;E-8D6=G%,0@NXD:G*O,I>Z2=D(&"[B!TH4 M^Q[9M%;D [K0<_'4QKUF^F[:@47O?KD6K+B_?Y-EIYX0]2M467^7+Z@]#7.5UVX:68OKP8IV0#4@#:J!N28N:FJOHG>'H)&VCA]^^_]235X0T]&D?-IK20E]A *&#M# MB&6E%]7W#;G)^OI&G-X^$E^5_4#X\,KUW3W-HN[O,O*JOK;("[&0C+\.&,5L M8T 300M(91+8-UE*-_EZ7#F6/'$7&,>*_3YO9K7X=.ZXH=$74N:M\"MM=_"6 M(6I*V'W$@*_%L $XTV5D%K48Q[C*E&*/\,H0*#S,*,M6TKYNL#5 '#Q34!"W MI]JW+UROO\TK3KK16@-E$B[U&/-07BXJ%M>E6R8Y\];W[8;K6UMU4FL+Z8*R MS]S"C"ES8+>M)WK2:>:HV--T]^O1.R)IR&D$7P()%;YDN#K1G(L!D9QX[OX) M(Z(E.-#E3/=']..:&-SW'^?22\IS)WKH:&^'1[2[Z8;>NI^VWUDOD1?Z&=:' M![5#AC:#KGZNBH\S[0X+/K7 MB.G/2RFRKVX=A,U"'$X;2O)AC/"_O/DPXIP F)5<[<#?%]]?_;F\J_GM^6V(W4OC$ZMZ.F*?)JWYTN$5')C>#G$G?QA M1!N.G!-&G\K$ZGO;P7(PF&LU-_90S8>_>.\N"1??-]T7;AB:BR!<:SSV4^F7 MMY<"1PVZK[$ B*Y/<:;AT^ M9*[\%P% K^^EI*_'WD&[]2H2A5K'ZM8T0[^R M1)<.9RI1NM$Q6NS%R%,"(<([B>M1)%Q@6[%D6G$&!UOX] M[V6TK1BZD*[=TH60[SI8C3:1B7.<.I]J[GC=X'.>Y\$/\9R*@K!SK#_Y8E]Q M%U&@EEN_T0R9+_&A#MNSCFNU'HTHM9J,BL%GP>6M7:DQ$VLP663?UADC%2G[MJ&($TN!; M KB[P(?EF$/Y;%C*E,6I'ZJ#]\-DC0IB*LS9;^_<9JWF#4EGRN]XA)NYPY>8 M9_U@W^:U\(6PTYZ$%J-4TSU\85SDZ\?H&T3%L_.[:\UK0F0J.2X6[/Y04_TM M01[NP?._3%^\WEB ;B\YRY=@< YS97F=V+W865RC(T..%HD \QG]#"'F.G] MB$TC3WI$!PLO3+86FELHQA6,.6;,K_?MO/1Y=@E9&+V4!N'M71*PB@@URD8V M4089[IS!CG1R#>>E"WWI5E6J0?1:U.$0CUR_:_Y#X0I/$DXQ4'Z2,41H8F+.H7$=""0 @PE9R:JVFF""3XT(MC2%)3SLM!S>U%LC46_=)\7HZB=S"\/H\*?O'R6'1B3<&%*ML_87>Y3YOFGA.7;G_U?%=J:&1JYI%;#WUZ?Q[22G0K>\T=J;5,1%A9:T-!4P>Y;R_Z M;_G.0B4CJ)TS-W*K%G<$KADDG,1-^SFTEX8[S4<=I3MO9^K>[715-E# MY2*GE 3U'6\!(6C?Q)E !.%F]1?9+UD6 5-:!0+@+/AD4NY;1^:D[41T5(N4 MDV98UJM9D^Z\HRK&*8F[1'UN;B1!SHOF]U 4B.:8,!#)BF13P'EH,#5[9BAC MS6WS!:P2\UJ1:PN[*_#G:5_2UOFYU2(MP\ D(P.-?,,:AY3-.(Q95RM4_C/FN/>.U6! V!]VC^H2L)3/:N-N(RV2LOYR%N(.:"+S M?; 36,4F?%^ < KG4G9OXR'-(!< MO :)9E"O$,R-,1RU@JC'(R)"$;-.Z*U3]+#4YGDENE?J&DS8ON;U@>=V"B^' M4WZ^JX[4O74N/L]5M40 ;SS6 !M'"7 !=.4KKS7D$Z-'_H]JO?/_0R=66%_32U^&VN]F[[3^9KTR\YQW ] MNVPM^*,"@.F"$,7U&+? 9]7Z?%T)*X!T0HG8@*5+>:2L#'7]] E"$YA(OD0AQP5]FB_I M8\&5OT-?9]0$UD9L%/;^0(E%$I69ZWU/FCGZ]]U_,2[>5HD.RY\!OBF*F(X; MA[O]\_15)ON>O- =M16"AQF*5&))"IN>GW1K+!O1"FBP('BQ*I<3QUL[' Q M%GKL9W]9>&BGZZR%[8;[ MBF?-VI9K'SG'[&WL=#;K;]M*L6XZZZ+9E7]B>:PK]]T[[X+Z48CY+;G-[.=+ MK)9Q0YFX7AO['@&P%74-D4$1CK'RMZ>U]>_PG&[9DU(=W3IU$EGNK#8_NW!( M\JQNP<'MC,L:C;\L>E8_WO$?)T7P@MD,WB,,KA)=18\:21[OQ2KY*QW.'W)F M#F8UM?3UH:2;AK6:AO>CBFB?1.^YFWJ_WT$Y/'H(7OH>UV.$H-:K(@;JE2$= MTKE*2DYC9GC5A8J.;$?.WF]>N-#6C'UM#6T)+X_Y:#2G[%].CS_YTT4S.M]G M!X_4BV">>.E"ICQ?NB4 @DE0);CV0?*7N-G3HJ]@@"_YZ"M 284F<*7^/LSY84237*I M%+B_SOM'T>X[E6A;5\L?_1LMMUP54K\TF!9>K4B2'71(4EYTKNK/21$6^@Y! MGP1_/,"8]XROS T"8SB>KC1">H!\\\0BB])GRIRSD*)7ZZ2'-!4_/L>,=TNG MPMMOYC "!HX"\J?^4_Z?$H5!KCZOC"_)14UA_&GU*82MIB.R 2"LWZT,).XP M=Q< T]?S'?)MGN7D$(-JZJ@2,U>JI,6WPQF76<'D1LI74F/A\GJM&B*#)!MX M/R=:=](-/'+MP)O*E7:-YWH!"./ UIR;6^==97<.;/]L>T0 ),?QU<#3U%7( M#R]24M5%6XIVJ/416@*:( H[-V_],R.P[:9\5^/6GP>E"F*U'V1JY3N7P<:* MF,AL'/,,'M0QZD9E6N)[*+ZAKI!=Z@O8@IP4XYOR@\,F9H)-H5UQ:Y3?E&O*-6-.Y6!P]*HH*3:!T-?A MF%&+L:-;U52]F$^X_OZU]C^U5@2C_7#M(Q&:6 M-T"!?PM08_*J"G0^Q!0/M*7Z.DAL/]>N5A$7VFA;3="=9/R?/(ZGBN?,ZM%]FJ MTR_CM>C(W7Z*LX]/GEE.PTE@;,'(9]R3!.>K]PW7XD57""'6V:.E'[O/9ZPY MW,OXX"N$-MK$#9KS_8 1>AYU/I;N!U;22;U&+; M@4-$Z;*+B1$W: M8J?PIUT ;*;]^,%!8LD$9=Q%PBW5BY:#3:P?B[:D^/K6O[FR$/35]$"'+M1ZM1VF; M'-L(*;:S>=JT+5\S=_DP,5.R_I"NR&^3+'T=LB?6F,3,X1'Z>$'C;I,5B3F6 M[(VY(6F3\X$E8@O*(_)"M4?12.Y.!/.DVX81?Q-4&;F[\?6:$2&P3+@BT8AK M5-Q?JL\R)-BL/>Y,J!HV]3V7>K9G]]M4Z4L'UD;&$FWRL\@/GPYP$( ME,T7\D7@K/)_W2B3R?K/L___.EM_@%>#"Z_?@ATD;5HSPL-5N.[;CC6\:&UN M:1C[W7W?0S_\21R WFS-NI-ZG'%A!W 7"$F_*.$G M^Y[Y7UC8Q5S*O$9H^JZZNSJJ;:3IQ='0D]_5+39MNY?G/'.E_#T?P;WX'@&% M01)?"P+? QBG<5.$!.CFT7\2GJ*[W#1%FZMFX*:(RZ$@O;4&5H_T&9CY\N/?V>FS5EO&ZZ,V<,QP]@R)XC&8-ZBOAK#Q97Y MX8Y]E$)N82B+?+DZ8.[8Q[;6K4/R+BWG"YRU)/.>>YT'-A2SF$:)E)9W]:S( M1>0M4BA,[:L1E9)I*SJ^W&*#["MD*+RU*/)?8*&>3)_M__BB+2S+N_@*6>N* M@\?BR5/%2\@9+[Y4<@U_B-7'P@U"A5CZ0"3^IIA74B\NM_6ZP<-Q81?=+*NO M#&D!$!FI&.M::*2ZM^=NOQ9,G0E[?UV_='2ERY$NHS$5,&I]NLK?!^FG/5#Y M=E^T\Z,8Z=PJZZ0*V1LR05P_D%#!%04C:S%!X!#KM!US*I5K%;1>--E> ]-; M&%/X_K9_32M5TN3M6P4[+6&A^=$ %JYXU[[OCW5*M ]3\6WF'7->AMGE]FVL8W4!,#[Z"$!((0' MWV\>4,#_FV]&_S]^?BH#73](:D%DXRXPKE)'>DF96/6QX%%3-9<_?F>8?QX@ MWVEAGL$/OOKJ8/-5Y.MU_5?64E3*[(F^@4DE@JSM?A!QOLX#%)8H"H@(_#141+=E16$D6-OH_I5UI/AS4VP^O"DI+'G_[:)^=6E- ,O*N &CV8I0_Q?5L0U!KH#$N&,W">WP? MUS(1[(+&47@O1?;W <4OBWU%C_,>%U^M.'O$6T[^0?X934GISK3E=Z.)V%*, M.?B N;H(3S(5 )E(">[E2O2=OHUG#JY6OJ-&B^VM+TX.^)W/RZ](\W3??_N- M7<\FK]M:2 _1>.\62'-%K%UK&<9 MC0[#[=[EY4!\G^0O$KB[J@=_BR"""''+0JB=:WB_1MCIZ8BL &6F9Q[] M0+3IL!7GQ(%/#6-C?(USM_=E6131]_:'O+AWNX,V2UW]#Z&@C(ON6J//&OZI MT=5S(F\N.2H/G/KWB1 KC%P/:B,9,BPC]A,6B6'#1/$E[["L:"FE%NFN2:M] M?'4FO_"J:.W+>\_3E#4+OIC?/K*C3F?Z]B.7ZOO2G=M^KG+5ECBFW"AF'.,& MQP,]U4]H)=R*X>WOH30C,DS=Y,!8 7"\R06G0/DCAVD$$(&H=6B=S5KIF0]R59AWAF6 M4R4 4GPYC *]%_H6TT<F#UV *G)>\DWP9))3%_8QSK4-(QM M";:7<4],\G=^G]$J*"0JWITCB-DI/D1=MJU]LD^MN35MX6 K&5&X]]V0I+Z* M.!R)$>657(-N8$G.[DJHBS#W+O MM>)Y(-NQ/8WE4=LE$<*)@3@QQEJ-XX/1FV"TC*0AF])[$W@F;LK?FO9NW! M66N>[4FNEC/G=UNE);V)^F5Z<>%THP,8G,63+16/#DR(O._I],F]T>&[9&-> MDKC-4<>J;S/8.R'J)97>?5$H24:6%#I) W:H/-'VKM"?O[LYLEGXWGI0"][C MEH-X3F*$+PY;]?S"&(+W:GX0I?@?.YR0_7QYHMQP8%Q5N2SJ?/BF5H:TU;R. ME)S:M-T: ;288CN!E1Q=?K?K$^XUYLO!Y$5D%M_F W\G>*=O/"#^IH@3^LMI+$:M.&'8WJ6M--)9:F;(5')82B[IE=.; M?^(4@A(E=1\E2C))H Z)FV?CQR>_#!, QUP3*B%*OXW"=RJM%0#!"TT"H')W MHLU8EFZ9\/^5-'!A F!G)NX'&\63;-6'=PN G^*%?%(H!))/(#+[7S'$_YD0 M(8]/>HSM,:?2Y/\7/A%F)A9K\5[WN7".0EJ]A!562/+MUK'7.NU0KQ58*NI.J\(^8 *=DLG?,^/_5=VFI56&AE2*5&Q5/=":M7#NX:XN >#0T.Y!53%4 MB.W^E?1WD/N$>I#,,I=LTH%TDG MJ(-T5]L%I-2L]]?K^YTCPW>\?#ON^N3MT^#3JKR2X/M-KO_LX5C0O1A7.6

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